PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Contreras, E; Schoppmeier, M; Real, MD; Rausell, C				Contreras, Estefania; Schoppmeier, Michael; Dolores Real, M.; Rausell, Carolina			Sodium Solute Symporter and Cadherin Proteins Act as Bacillus thuringiensis Cry3Ba Toxin Functional Receptors in Tribolium castaneum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TENEBRIO-MOLITOR CADHERIN; CRY1AC BINDING-PROTEINS; BRUSH-BORDER MEMBRANE; AMINOPEPTIDASE-N; ALKALINE-PHOSPHATASE; MANDUCA-SEXTA; DELTA-ENDOTOXIN; MIDGUT; EXPRESSION; OLIGOMERIZATION	Understanding how Bacillus thuringiensis (Bt) toxins interact with proteins in the midgut of susceptible coleopteran insects is crucial to fully explain the molecular bases of Bt specificity and insecticidal action. In this work, aminopeptidase N (TcAPN-I), E-cadherin (TcCad1), and sodium solute symporter (TcSSS) have been identified by ligand blot as putative Cry3Ba toxin-binding proteins in Tribolium castaneum (Tc) larvae. RNA interference knockdown of TcCad1 or TcSSS proteins resulted in decreased susceptibility to Cry3Ba toxin, demonstrating the Cry toxin receptor functionality for these proteins. In contrast, TcAPN-I silencing had no effect on Cry3Ba larval toxicity, suggesting that this protein is not relevant in the Cry3Ba toxin mode of action in Tc. Remarkable features of TcSSS protein were the presence of cadherin repeats in its amino acid sequence and that a TcSSS peptide fragment containing a sequence homologous to a binding epitope found in Manduca sexta and Tenebrio molitor Bt cadherin functional receptors enhanced Cry3Ba toxicity. This is the first time that the involvement of a sodium solute symporter protein as a Bt functional receptor has been demonstrated. The role of this novel receptor in Bt toxicity against coleopteran insects together with the lack of receptor functionality of aminopeptidase N proteins might account for some of the differences in toxin specificity between Lepidoptera and Coleoptera insect orders.	[Contreras, Estefania; Dolores Real, M.; Rausell, Carolina] Univ Valencia, Dept Genet, Fac Ciencias Biol, Dr Moliner 50, E-46100 Valencia, Spain; [Schoppmeier, Michael] Erlangen Univ, Dept Biol, Dev Biol Unit, D-91058 Erlangen, Germany	University of Valencia; University of Erlangen Nuremberg	Rausell, C (corresponding author), Univ Valencia, Dept Genet, Fac Ciencias Biol, Dr Moliner 50, E-46100 Valencia, Spain.	carolina.rausell@uv.es	Rausell, Carolina/ABG-4542-2020; Rausell, Carolina/ABG-9554-2020; Contreras, Estefania/AAZ-4659-2020; Real, M. Dolores/ABD-4252-2021	Rausell, Carolina/0000-0002-5849-9102; Contreras, Estefania/0000-0002-1822-6839; Real, M. Dolores/0000-0003-3188-9335	Ministerio de Ciencia e Innovacion [BIO 2007-67860, AGL2010-22300-C03-03]; Conselleria Valenciana d'Educacio i Ciencia	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Conselleria Valenciana d'Educacio i Ciencia	This work was supported by Ministerio de Ciencia e Innovacion Grants BIO 2007-67860 and AGL2010-22300-C03-03r Awarded with a grant from the Conselleria Valenciana d'Educacio i Ciencia.	Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Bayyareddy K, 2009, INSECT BIOCHEM MOLEC, V39, P279, DOI 10.1016/j.ibmb.2009.01.002; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Chen J, 2007, P NATL ACAD SCI USA, V104, P13901, DOI 10.1073/pnas.0706011104; Chen JW, 2009, BIOCHEM J, V424, P191, DOI 10.1042/BJ20090730; Chen LZ, 2010, ARCH INSECT BIOCHEM, V73, P61, DOI 10.1002/arch.20340; Contreras E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055330; Crickmore N, 2005, TRENDS MICROBIOL, V13, P347, DOI 10.1016/j.tim.2005.06.002; Dorsch JA, 2002, INSECT BIOCHEM MOLEC, V32, P1025, DOI 10.1016/S0965-1748(02)00040-1; Fabrick J, 2009, J BIOL CHEM, V284, P18401, DOI 10.1074/jbc.M109.001651; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gao YL, 2011, PEST MANAG SCI, V67, P1076, DOI 10.1002/ps.2149; Gomez I, 2001, J BIOL CHEM, V276, P28906, DOI 10.1074/jbc.M103007200; Hafkenscheid J. C, 1984, METHODS ENZYMATIC AN, VV, P2; Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JONASSEN I, 1995, PROTEIN SCI, V4, P1587, DOI 10.1002/pro.5560040817; Jung H, 2002, FEBS LETT, V529, P73, DOI 10.1016/S0014-5793(02)03184-8; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; Krishnamoorthy M, 2007, INSECT BIOCHEM MOLEC, V37, P189, DOI 10.1016/j.ibmb.2006.10.004; Likitvivatanavong S, 2011, APPL ENVIRON MICROB, V77, P24, DOI 10.1128/AEM.01852-10; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Ma G, 2012, DEV COMP IMMUNOL, V37, P184, DOI 10.1016/j.dci.2011.08.017; Martins ES, 2010, INSECT BIOCHEM MOLEC, V40, P138, DOI 10.1016/j.ibmb.2010.01.005; McNall RJ, 2003, INSECT BIOCHEM MOLEC, V33, P999, DOI 10.1016/S0965-1748(03)00114-0; Morris K, 2009, J PROTEOME RES, V8, P3889, DOI 10.1021/pr900168z; Ochoa-Campuzano C, 2007, BIOCHEM BIOPH RES CO, V362, P437, DOI 10.1016/j.bbrc.2007.07.197; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Rausell C, 2004, BBA-BIOMEMBRANES, V1660, P99, DOI 10.1016/j.bbamem.2003.11.004; REUVENI M, 1991, BIOCHEM BIOPH RES CO, V181, P1089, DOI 10.1016/0006-291X(91)92049-P; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; STEWART GSAB, 1981, BIOCHEM J, V198, P101, DOI 10.1042/bj1980101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka S, 2013, FEBS J, V280, P1782, DOI 10.1111/febs.12200; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Xie YS, 1996, CAN ENTOMOL, V128, P865, DOI 10.4039/Ent128865-5; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	48	33	37	0	35	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18013	18021		10.1074/jbc.M113.474445	http://dx.doi.org/10.1074/jbc.M113.474445			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645668	Green Published, hybrid			2022-12-25	WOS:000320721900008
J	Anafu, AA; Bowen, CH; Chin, CR; Brass, AL; Holm, GH				Anafu, Amanda A.; Bowen, Christopher H.; Chin, Christopher R.; Brass, Abraham L.; Holm, Geoffrey H.			Interferon-inducible Transmembrane Protein 3 (IFITM3) Restricts Reovirus Cell Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; INFECTIOUS SUBVIRION PARTICLES; REVERSE GENETICS SYSTEM; WEST NILE VIRUS; MAMMALIAN REOVIRUSES; PUTATIVE AUTOCLEAVAGE; S-PALMITOYLATION; DENGUE VIRUS; HELA-CELLS; MU-1	Reoviruses are double-stranded RNA viruses that infect the mammalian respiratory and gastrointestinal tract. Reovirus infection elicits production of type I interferons (IFNs), which trigger antiviral pathways through the induction of interferon-stimulated genes (ISGs). Although hundreds of ISGs have been identified, the functions of many of these genes are unknown. The interferon-inducible transmembrane (IFITM) proteins are one class of ISGs that restrict the cell entry of some enveloped viruses, including influenza A virus. One family member, IFITM3, localizes to late endosomes, where reoviruses undergo proteolytic disassembly; therefore, we sought to determine whether IFITM3 also restricts reovirus entry. IFITM3-expressing cell lines were less susceptible to infection by reovirus, as they exhibited significantly lower percentages of infected cells in comparison to control cells. Reovirus replication was also significantly reduced in IFITM3-expressing cells. Additionally, cells expressing an shRNA targeting IFITM3 exhibited a smaller decrease in infection after IFN treatment than the control cells, indicating that endogenous IFITM3 restricts reovirus infection. However, IFITM3 did not restrict entry of reovirus infectious subvirion particles (ISVPs), which do not require endosomal proteolysis, indicating that restriction occurs in the endocytic pathway. Proteolysis of outer capsid protein mu 1 was delayed in IFITM3-expressing cells in comparison to control cells, suggesting that IFITM3 modulates the function of late endosomal compartments either by reducing the activity of endosomal proteases or delaying the proteolytic processing of virions. These data provide the first evidence that IFITM3 restricts infection by a nonenveloped virus and suggest that IFITM3 targets an increasing number of viruses through a shared requirement for endosomes during cell entry.	[Anafu, Amanda A.; Bowen, Christopher H.; Holm, Geoffrey H.] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA; [Chin, Christopher R.; Brass, Abraham L.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA	Colgate University; University of Massachusetts System; University of Massachusetts Worcester	Holm, GH (corresponding author), Colgate Univ, Dept Biol, 13 Oak Dr, Hamilton, NY 13346 USA.	gholm@colgate.edu	Holm, Geoffrey H./C-3188-2009	Chin, Christopher/0000-0002-2140-3197	National Institutes of Health Public Health Service Awards [R15 AI094440, R01 AI091786]; Charles H. Hood Foundation; Bill and Melinda Gates Foundation; Phillip T. and Susan M. Ragon Foundation; University of Massachusetts Medical School Center for AIDS Research; Colgate University Core Incentive Program; Student Diversity Research Initiative; National Science Foundation [DBI-0923310]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI094440, R01AI091786] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service Awards; Charles H. Hood Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Phillip T. and Susan M. Ragon Foundation; University of Massachusetts Medical School Center for AIDS Research; Colgate University Core Incentive Program; Student Diversity Research Initiative; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Awards R15 AI094440 (to G. H. H.) and R01 AI091786 (to A. L. B.). This work was also supported by the Charles H. Hood Foundation, the Bill and Melinda Gates Foundation, the Phillip T. and Susan M. Ragon Foundation, and the University of Massachusetts Medical School Center for AIDS Research. Additional support was provided by the Colgate University Core Incentive Program and Student Diversity Research Initiative.; We thank members of our laboratories for many helpful discussions and Walter Atwood, Karl Boehme, Jenna Daly, Pranav Danthi, Terence Dermody, Alexis Griffiths, Jonathan Knowlton, Bernardo Mainou, John Parker, Andrea Pruijssers, Lauren Richardson, and Yevangelina Rybak for technical assistance, reagents, and advice. The confocal microscope was purchased with support from National Science Foundation Grant DBI-0923310.	Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; BLUMENTHAL R, 1986, BIOCHEMISTRY-US, V25, P2231, DOI 10.1021/bi00356a057; Borden EC, 2011, J INTERF CYTOK RES, V31, P1, DOI 10.1089/jir.2010.0129; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chandran K, 2003, J VIROL, V77, P13361, DOI 10.1128/JVI.77.24.13361-13375.2003; Chandran K, 2002, J VIROL, V76, P9920, DOI 10.1128/JVI.76.19.9920-9933.2002; CHARDONN.Y, 1970, VIROLOGY, V40, P478, DOI 10.1016/0042-6822(70)90190-X; Connolly JL, 2002, J VIROL, V76, P1632, DOI 10.1128/JVI.76.4.1632-1641.2002; DERMODY TS, 1993, J VIROL, V67, P2055, DOI 10.1128/JVI.67.4.2055-2063.1993; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; EVANS SS, 1993, J IMMUNOL, V150, P736; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; Fecek RJ, 2006, J IMMUNOL METHODS, V314, P30, DOI 10.1016/j.jim.2006.05.008; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; FITZGERALD DJP, 1983, P NATL ACAD SCI-BIOL, V80, P4134, DOI 10.1073/pnas.80.13.4134; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; GAUNTT CJ, 1973, INFECT IMMUN, V7, P711, DOI 10.1128/IAI.7.5.711-717.1973; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; IMAI T, 1993, J IMMUNOL, V151, P6470; JACOBS BL, 1991, J VIROL, V65, P5102, DOI 10.1128/JVI.65.9.5102-5104.1991; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kobayashi T, 2007, CELL HOST MICROBE, V1, P147, DOI 10.1016/j.chom.2007.03.003; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Madren JA, 2012, J VIROL, V86, P3466, DOI 10.1128/JVI.06659-11; Maginnis MS, 2008, J VIROL, V82, P3181, DOI 10.1128/JVI.01612-07; Maginnis MS, 2006, J VIROL, V80, P2760, DOI 10.1128/JVI.80.6.2760-2770.2006; Mainou BA, 2012, J VIROL, V86, P8346, DOI 10.1128/JVI.00100-12; Middleton JK, 2007, VIROLOGY, V361, P412, DOI 10.1016/j.virol.2006.11.024; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Mundt E, 2007, J GEN VIROL, V88, P1319, DOI 10.1099/vir.0.82526-0; Nibert ML, 2005, J MOL BIOL, V345, P461, DOI 10.1016/j.jmb.2004.10.026; NIBERT ML, 1992, J VIROL, V66, P6408, DOI 10.1128/JVI.66.11.6408-6418.1992; NILSEN TW, 1982, J BIOL CHEM, V257, P4593; Odegard AL, 2004, J VIROL, V78, P8732, DOI 10.1128/JVI.78.16.8732-8745.2004; Parker JSL, 2000, J VIROL, V74, P1919, DOI 10.1128/JVI.74.4.1919-1930.2000; Parker JSL, 2001, J VIROL, V75, P3896, DOI 10.1128/JVI.75.8.3896-3902.2001; RATNER L, 1978, BIOCHEM BIOPH RES CO, V81, P947, DOI 10.1016/0006-291X(78)91443-2; Sarkar P, 2010, J VIROL, V84, P12723, DOI 10.1128/JVI.01385-10; Schiff L. A., 1853, FIELDS VIROLOGY, P1853; Schulz WL, 2012, J VIROL, V86, P12665, DOI 10.1128/JVI.01861-12; SETH P, 1994, BIOCHEM BIOPH RES CO, V205, P1318, DOI 10.1006/bbrc.1994.2809; Sherry B, 1998, J VIROL, V72, P1314, DOI 10.1128/JVI.72.2.1314-1323.1998; Smith RA, 2006, GENES IMMUN, V7, P113, DOI 10.1038/sj.gene.6364278; SMITH RE, 1969, VIROLOGY, V39, P791, DOI 10.1016/0042-6822(69)90017-8; Stewart MJ, 2003, VIROLOGY, V314, P92, DOI 10.1016/S0042-6822(03)00414-8; STURZENBECKER LJ, 1987, J VIROL, V61, P2351, DOI 10.1128/JVI.61.8.2351-2361.1987; Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004; Tsai B, 2007, ANNU REV CELL DEV BI, V23, P23, DOI 10.1146/annurev.cellbio.23.090506.123454; VIRGIN HW, 1988, J VIROL, V62, P4594, DOI 10.1128/JVI.62.12.4594-4604.1988; Wee YS, 2012, INNATE IMMUN-LONDON, V18, P834, DOI 10.1177/1753425912443392; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Wolf M, 2012, J VIROL, V86, P4009, DOI 10.1128/JVI.06667-11; Wolf M, 2011, J VIROL, V85, P2492, DOI 10.1128/JVI.02082-10; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]	68	86	93	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17261	17271		10.1074/jbc.M112.438515	http://dx.doi.org/10.1074/jbc.M112.438515			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23649619	Green Published, hybrid			2022-12-25	WOS:000320380600022
J	Ginsburg, I; Kohen, R; Shalish, M; Varon, D; Shai, E; Koren, E				Ginsburg, Isaac; Kohen, Ron; Shalish, Miri; Varon, David; Shai, Ella; Koren, Erez			The Oxidant-Scavenging Abilities in the Oral Cavity May Be Regulated by a Collaboration among Antioxidants in Saliva, Microorganisms, Blood Cells and Polyphenols: A Chemiluminescence-Based Study	PLOS ONE			English	Article							MICROBIAL HEMOLYSINS; TEA POLYPHENOLS; OXIDATION; SYSTEM; DAMAGE; ERYTHROCYTES; PROTEINASES; CYTOKINES; PEROXIDE; ALBUMIN	Saliva has become a central research issue in oral physiology and pathology. Over the evolution, the oral cavity has evolved the antioxidants uric acid, ascorbate reduced glutathione, plasma-derived albumin and antioxidants polyphenols from nutrients that are delivered to the oral cavity. However, blood cells extravasated from injured capillaries in gingival pathologies, or following tooth brushing and use of tooth picks, may attenuate the toxic activities of H2O2 generated by oral streptococci and by oxidants generated by activated phagocytes. Employing a highly sensitive luminol-dependent chemiluminescence, the DPPH radical and XTT assays to quantify oxidant-scavenging abilities (OSA), we show that saliva can strongly decompose both oxygen and nitrogen species. However, lipophilic antioxidant polyphenols in plants, which are poorly soluble in water and therefore not fully available as effective antioxidants, can nevertheless be solubilized either by small amounts of ethanol, whole saliva or also by salivary albumin and mucin. Plant-derived polyphenols can also act in collaboration with whole saliva, human red blood cells, platelets, and also with catalase-positive microorganisms to decompose reactive oxygen species (ROS). Furthermore, polyphenols from nutrient can avidly adhere to mucosal surfaces, are retained there for long periods and may function as a "slow-release devises'' capable of affecting the redox status in the oral cavity. The OSA of saliva is due to the sum result of low molecular weight antioxidants, albumin, polyphenols from nutrients, blood elements and microbial antioxidants. Taken together, saliva and its antioxidants are considered regulators of the redox status in the oral cavity under physiological and pathological conditions.	[Ginsburg, Isaac; Koren, Erez] Hebrew Univ Jerusalem, Fac Med Dent, Hadassah Med Ctr, Inst Dent Sci, Jerusalem, Israel; [Kohen, Ron; Koren, Erez] Hebrew Univ Jerusalem, Sch Pharm, Hadassah Fac Med, Inst Drug Res,Richard & Jean Zarbin Chair Med Stu, IL-91120 Jerusalem, Israel; [Shalish, Miri] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Orthodont, Jerusalem, Israel; [Varon, David; Shai, Ella] Hadassah Med Ctr, Coagulat Unit, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Ginsburg, I (corresponding author), Hebrew Univ Jerusalem, Fac Med Dent, Hadassah Med Ctr, Inst Dent Sci, Jerusalem, Israel.	ginsburg@mail.huji.ac.il	Kohen, Ron/ABC-2281-2021	Kohen, Ron/0000-0001-7268-9845	Israel Science Foundation [241/04]; Yedidut Foundation (Mexico)	Israel Science Foundation(Israel Science Foundation); Yedidut Foundation (Mexico)	This work was supported by an endowment fund by the late Dr. S. M. Robbins of Cleveland, Ohio, United States, by the Israel Science Foundation (grant number 241/04) and by the Yedidut Foundation (Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Atsumi T, 1999, ANTIOXID REDOX SIGN, V1, P537, DOI 10.1089/ars.1999.1.4-537; Baxter NJ, 1997, BIOCHEMISTRY-US, V36, P5566, DOI 10.1021/bi9700328; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chapple ILC, 2002, J CLIN PATHOL-MOL PA, V55, P367; Fabian TK, 2008, CHEM BIOL SALIVA HLT; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; GINSBURG I, 1995, FREE RADICAL RES, V22, P489, DOI 10.3109/10715769509150323; Ginsburg I, 1998, MED HYPOTHESES, V51, P337, DOI 10.1016/S0306-9877(98)90059-7; Ginsburg I, 2012, ORAL DIS, DOI [10.1111/odi.12038, DOI 10.1111/0DI.12038]; Ginsburg Isaac, 2004, Inflammopharmacology, V12, P305, DOI 10.1163/1568560043696218; Ginsburg Isaac, 1999, Inflammopharmacology, V7, P47, DOI 10.1007/s10787-999-0025-9; Ginsburg I, 2012, ARCH ORAL BIOL, V57, P1327, DOI 10.1016/j.archoralbio.2012.04.019; Ginsburg I, 2011, ARCH BIOCHEM BIOPHYS, V506, P12, DOI 10.1016/j.abb.2010.11.009; Gorelik S, 2008, FASEB J, V22, P41, DOI 10.1096/fj.07-9041com; Gorelik S, 2012, ARCH INTERN MED, V172, P1424, DOI 10.1001/archinternmed.2012.3638; GRISHAM MB, 1990, AM J PHYSIOL, V258, pC115, DOI 10.1152/ajpcell.1990.258.1.C115; Grossman S., 2011, Trends in Cancer Research, Volume 7, P57; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Halliwell B., 2007, FREE RADICALS BIOL M; HAMILTONMILLER JMT, 1995, ANTIMICROB AGENTS CH, V39, P2375, DOI 10.1128/AAC.39.11.2375; Hua Y, 2006, J NEUROSURG, V104, P305, DOI 10.3171/jns.2006.104.2.305; Koren E, 2010, EXP BIOL MED, V235, P689, DOI 10.1258/ebm.2010.009370; Koren E, 2009, J AGR FOOD CHEM, V57, P7644, DOI 10.1021/jf9006449; Koren E, 2009, EXP BIOL MED, V234, P940, DOI 10.3181/0901-RM-22; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Kusuda M, 2006, BIOSCI BIOTECH BIOCH, V70, P152, DOI 10.1271/bbb.70.152; Lambert JD, 2010, ARCH BIOCHEM BIOPHYS, V501, P65, DOI 10.1016/j.abb.2010.06.013; Lee MJ, 2004, CANCER EPIDEM BIOMAR, V13, P132, DOI 10.1158/1055-9965.EPI-03-0040; Liskmann S, 2007, CLIN ORAL IMPLAN RES, V18, P27, DOI 10.1111/j.1600-0501.2006.01296.x; Lotito SB, 2000, BIOL RES, V33, P151; Mathes SH, 2010, BIOTECHNOL BIOENG, V107, P1029, DOI 10.1002/bit.22893; MEHANSHO H, 1987, ANNU REV NUTR, V7, P423, DOI 10.1146/annurev.nu.07.070187.002231; Mueller S, 1997, BLOOD, V90, P4973, DOI 10.1182/blood.V90.12.4973.4973_4973_4978; Nagler RM, 2002, FREE RADICAL BIO MED, V32, P268, DOI 10.1016/S0891-5849(01)00806-1; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Ofek I, 2003, FEMS IMMUNOL MED MIC, V38, P181, DOI 10.1016/S0928-8244(03)00228-1; Richards RS, 1998, MED HYPOTHESES, V50, P363, DOI 10.1016/S0306-9877(98)90206-7; Sakanaka S, 1996, BIOSCI BIOTECH BIOCH, V60, P745, DOI 10.1271/bbb.60.745; Santangelo Carmela, 2007, Ann Ist Super Sanita, V43, P394; Sculley DV, 2002, P NUTR SOC, V61, P137, DOI 10.1079/PNS2001141; Sies H, 2007, CELL MOL LIFE SCI, V64, P2181, DOI 10.1007/s00018-007-7230-8; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; THOMAS EL, 1978, INFECT IMMUN, V20, P456, DOI 10.1128/IAI.20.2.456-463.1978; TOTH KM, 1984, J CLIN INVEST, V74, P292, DOI 10.1172/JCI111414	46	22	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63062	10.1371/journal.pone.0063062	http://dx.doi.org/10.1371/journal.pone.0063062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658797	Green Published, Green Submitted, gold			2022-12-25	WOS:000321200500053
J	Nichols, EK; Talley, LE; Birungi, N; McClelland, A; Madraa, E; Chandia, AB; Nivet, J; Flores-Ayala, R; Serdula, MK				Nichols, Erin K.; Talley, Leisel E.; Birungi, Nelly; McClelland, Amanda; Madraa, Elizabeth; Chandia, Agnes B.; Nivet, Jacqueline; Flores-Ayala, Rafael; Serdula, Mary K.			Suspected Outbreak of Riboflavin Deficiency among Populations Reliant on Food Assistance: A Case Study of Drought-Stricken Karamoja, Uganda, 2009-2010	PLOS ONE			English	Article							MICRONUTRIENT DEFICIENCIES; IRON	Background: In 2009, a humanitarian response was launched to address a food security and livelihoods crisis in Karamoja, Uganda. During a polio immunization campaign in mid-August 2009, health workers in Nakapiripit District reported a concern about an increase in mouth sores, or angular stomatitis (AS) and gum ulcerations, among children in one village, and an investigation was launched. Objective: This article describes the investigation, lessons learned, and provides guidance for monitoring micronutrient deficiencies among populations receiving food assistance. Design: An investigation into a suspected outbreak of riboflavin (vitamin B2) deficiency was initiated, including a rapid assessment, mass screening, a convenience sample collection of blood specimens (n = 58 symptomatic cases and n = 18 asymptomatic individuals), and analysis of the general food ration (70% ration). Results: Findings showed signs of AS in only 399 (0.2%) of 179,172 screened individuals, including adults and children. Biochemical analysis confirmed riboflavin deficiency in 84.5% of specimens from symptomatic individuals and 94.4% of specimens from asymptomatic individuals. Ration distribution data showed that 55% of distributions provided less than half the riboflavin RDA. Conclusion: Evidence was insufficient to confirm an actual outbreak of riboflavin deficiency, though the present investigation adds further documentation that micronutrient deficiencies continue to persist among populations in emergency settings. This article describes challenges, lessons learned, and guidance for monitoring micronutrient deficiencies among food assistance recipients, including: ongoing nutrition monitoring and surveillance; training and sensitization about micronutrient deficiencies, sensitization of the population about locally-available food, and identifying ways to improve micronutrient interventions.	[Nichols, Erin K.] US PHS, Epidem Intelligence Serv Assigned, Div Nutr Phys Act & Obes, Ctr Dis Control & Prevent,Commissioned Corps, Atlanta, GA USA; [Talley, Leisel E.] Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth, Atlanta, GA USA; [Birungi, Nelly] UNICEF Uganda Country Off, Kampala, Uganda; [McClelland, Amanda] Concern Worldwide Emergency Response Team, Kampala, Uganda; [Madraa, Elizabeth; Chandia, Agnes B.] Minist Hlth Uganda, Nutr Unit, Kampala, Uganda; [Nivet, Jacqueline] United Nations World Food Programme, Off Country Director, Kampala, Uganda; [Flores-Ayala, Rafael; Serdula, Mary K.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Int Micronutrient Malnutr Prevent & Control Tea, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; United States Public Health Service; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Nichols, EK (corresponding author), US PHS, Epidem Intelligence Serv Assigned, Div Nutr Phys Act & Obes, Ctr Dis Control & Prevent,Commissioned Corps, Atlanta, GA USA.	EKNichols@cdc.gov			Concern Worldwide, UNICEF; U.S. Centers for Disease Control and Prevention (CDC); World Food Programme (WFP); World Health Organization (WHO)	Concern Worldwide, UNICEF; U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); World Food Programme (WFP); World Health Organization (WHO)(World Health Organization)	Funding and technical assistance for this investigation were provided by Concern Worldwide, UNICEF, the U.S. Centers for Disease Control and Prevention (CDC), World Food Programme (WFP), and World Health Organization (WHO). The funders had a role in design, data collection, data review, data analysis, and biological testing.	BATES CJ, 1994, BRIT J NUTR, V72, P601, DOI 10.1079/BJN19940062; Bickley LS, 2007, BATES GUIDE PHYS EXA, P230; Blanck HM, 2002, AM J CLIN NUTR, V76, P430, DOI 10.1093/ajcn/76.2.430; Branca F, 2002, ANN NUTR METAB, V46, P8, DOI 10.1159/000066397; de Pee S, 2008, FOOD NUTR BULL, V29, P232, DOI 10.1177/156482650802900309; Orient JM, 2005, SAPIRAS ART SCI BEDS, P260; POWERS HJ, 1995, P NUTR SOC, V54, P509, DOI 10.1079/PNS19950019; Prinzo ZW, 2002, P NUTR SOC, V61, P251, DOI 10.1079/PNS2002151; Ramakrishnan U, 2002, NUTR REV, V60, pS46, DOI 10.1301/00296640260130731; The Sphere Project, 2010, HUM CHART MIN STAND, P103; Uganda Ministry of Health, 2008, SUMM NUTR HLTH ASS K; UNHCR UNICEF WFP WHO, 2002, FOOD NUTR NEEDS EM; WFP, 2009, VULN AN MAPP WFP; ZeptoMetrix Corporation, 2006, GLUT RED ASS KIT	14	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62976	10.1371/journal.pone.0062976	http://dx.doi.org/10.1371/journal.pone.0062976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658790	gold, Green Published, Green Submitted			2022-12-25	WOS:000321200500047
J	de Souza, WR; Morais, ER; Krohn, NG; Savoldi, M; Goldman, MHS; Rodrigues, F; Caldana, C; Semelka, CT; Tikunov, AP; Macdonald, JM; Goldman, GH				de Souza, Wagner R.; Morais, Enyara Rezende; Krohn, Nadia Graciele; Savoldi, Marcela; Goldman, Maria Helena S.; Rodrigues, Fernando; Caldana, Camila; Semelka, Charles T.; Tikunov, Andrey P.; Macdonald, Jeffrey M.; Goldman, Gustavo Henrique			Identification of Metabolic Pathways Influenced by the G-Protein Coupled in Aspergillus nidulans	PLOS ONE			English	Article							AMINO-ACID PERMEASES; MAJOR FACILITATOR SUPERFAMILY; NUCLEAR-MAGNETIC-RESONANCE; SACCHAROMYCES-CEREVISIAE; SEXUAL DEVELOPMENT; KINASE-A; SECONDARY METABOLISM; FUNGAL DEVELOPMENT; MASS-SPECTROMETRY; GENE	Heterotrimeric G-protein-mediated signaling pathways play a pivotal role in transmembrane signaling in eukaryotes. Our main aim was to identify signaling pathways regulated by A. nidulans GprB and GprD G-protein coupled receptors (GPCRs). When these two null mutant strains were compared to the wild-type strain, the Delta gprB mutant showed an increased protein kinase A (PKA) activity while growing in glucose 1% and during starvation. In contrast, the Delta gprD has a much lower PKA activity upon starvation. Transcriptomics and 1(H) NMR-based metabolomics were performed on two single null mutants grown on glucose. We noted modulation in the expression of 11 secondary metabolism gene clusters when the Delta gprB and Delta gprD mutant strains were grown in 1% glucose. Several members of the sterigmatocystin-aflatoxin gene cluster presented down-regulation in both mutant strains. The genes of the NR-PKS monodictyphenone biosynthesis cluster had overall increased mRNA accumulation in Delta gprB, while in the Delta gprD mutant strain the genes had decreased mRNA accumulation. Principal component analysis of the metabolomic data demonstrated that there was a significant metabolite shift in the Delta gprD strain. The 1(H) NMR analysis revealed significant expression of essential amino acids with elevated levels in the Delta gprD strain, compared to the wild-type and Delta gprB strains. With the results, we demonstrated the differential expression of a variety of genes related mainly to secondary metabolism, sexual development, stress signaling, and amino acid metabolism. We propose that the absence of GPCRs triggered stress responses at the genetic level. The data suggested an intimate relationship among different G-protein coupled receptors, fine-tune regulation of secondary and amino acid metabolisms, and fungal development.	[Caldana, Camila] CTBE, Lab Nacl Ciencia & Tecnol Bioetanol, Campinas, SP, Brazil; [de Souza, Wagner R.; Morais, Enyara Rezende; Krohn, Nadia Graciele; Tikunov, Andrey P.; Goldman, Gustavo Henrique] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-05508 Ribeirao Preto, SP, Brazil; [Goldman, Maria Helena S.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Rodrigues, Fernando] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Semelka, Charles T.; Tikunov, Andrey P.; Macdonald, Jeffrey M.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA; [Semelka, Charles T.; Tikunov, Andrey P.; Macdonald, Jeffrey M.] Univ N Carolina, UNC Metab Facil, Chapel Hill, NC USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade do Minho; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Goldman, GH (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-05508 Ribeirao Preto, SP, Brazil.	ggoldman@usp.br	de Souza, Wagner R/D-8907-2019; Rodrigues, Fernando/T-5299-2018; Rodrigues, Fernando/A-3123-2011; Goldman, Maria Helena S./D-1424-2012; Goldman, Gustavo Henrique/F-1848-2013	de Souza, Wagner R/0000-0002-6287-0074; Rodrigues, Fernando/0000-0001-8436-9398; Goldman, Maria Helena S./0000-0002-6786-9320; Goldman, Gustavo Henrique/0000-0002-2986-350X; Krohn, Nadia Graciele/0000-0001-9933-4163	FAPESP (Fundacao para Amparo a Pesquisa do Estado de Sao Paulo); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); NIH [P30ES10126]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	FAPESP (Fundacao para Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors would like to thank FAPESP (Fundacao para Amparo a Pesquisa do Estado de Sao Paulo) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) for financial support. Funding for the metabolomic studies was provided by NIH grants P30ES10126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affeldt KJ, 2012, TOXINS, V4, P695, DOI 10.3390/toxins4090695; Arnaud MB, 2010, NUCLEIC ACIDS RES, V38, pD420, DOI 10.1093/nar/gkp751; Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Bajmoczi M, 1998, BIOCHEM BIOPH RES CO, V243, P205, DOI 10.1006/bbrc.1998.8082; Barker BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-62; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Boernsen KO, 2005, ANAL CHEM, V77, P7255, DOI 10.1021/ac0508604; BRIZA P, 1994, P NATL ACAD SCI USA, V91, P4524, DOI 10.1073/pnas.91.10.4524; Cahova M, 2012, EXP BIOL MED, V237, P211, DOI 10.1258/ebm.2011.011189; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; CHANG YC, 1993, GENETICS, V133, P29; Dechant R, 2008, CURR OPIN CELL BIOL, V20, P678, DOI 10.1016/j.ceb.2008.09.009; Dinamarco TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037591; Dodd KM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1329, DOI 10.1152/ajpendo.00525.2011; Eigentler A, 2012, ARCH MICROBIOL, V194, P427, DOI 10.1007/s00203-011-0773-y; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gehrke A, 2010, APPL ENVIRON MICROB, V76, P3989, DOI 10.1128/AEM.00052-10; Gerke J, 2012, APPL ENVIRON MICROB, V78, P8234, DOI 10.1128/AEM.01808-12; Haas H, 2003, BIOCHEM J, V371, P505, DOI 10.1042/BJ20021685; Han KH, 2004, MOL MICROBIOL, V51, P1333, DOI 10.1111/j.1365-2958.2003.03940.x; Hicks J, 2001, MOL MICROBIOL, V39, P1482, DOI 10.1046/j.1365-2958.2001.02332.x; Hoffmann B, 2001, MOL BIOL CELL, V12, P2846, DOI 10.1091/mbc.12.9.2846; Hoffmann B, 2000, MOL MICROBIOL, V37, P28, DOI 10.1046/j.1365-2958.2000.01954.x; Hynes MJ, 2010, EUKARYOT CELL, V9, P1039, DOI 10.1128/EC.00080-10; Isnard AD, 1996, J MOL BIOL, V262, P473, DOI 10.1006/jmbi.1996.0529; JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x; Kim JD, 2011, EUKARYOT CELL, V10, P820, DOI 10.1128/EC.00231-10; Kosugi A, 2001, BIOSCI BIOTECH BIOCH, V65, P728, DOI 10.1271/bbb.65.728; Krysan DJ, 2005, EUKARYOT CELL, V4, P1364, DOI 10.1128/EC.4.8.1364-1374.2005; Kunze M, 2006, BBA-MOL CELL RES, V1763, P1441, DOI 10.1016/j.bbamcr.2006.09.009; Lafon A, 2006, FUNGAL GENET BIOL, V43, P490, DOI 10.1016/j.fgb.2006.02.001; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lowe RGT, 2010, MOL PLANT MICROBE IN, V23, P1605, DOI 10.1094/MPMI-04-10-0092; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; MARKHAM P, 1993, FEMS MICROBIOL REV, V10, P287; NAKAFUKU M, 1988, P NATL ACAD SCI USA, V85, P1374, DOI 10.1073/pnas.85.5.1374; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Oberegger H, 2001, MOL MICROBIOL, V41, P1077, DOI 10.1046/j.1365-2958.2001.02586.x; PALL ML, 1981, MICROBIOL REV, V45, P462, DOI 10.1128/MMBR.45.3.462-480.1981; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; PEOPLES OP, 1989, J BIOL CHEM, V264, P15298; Perez-Sanchez L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-317; Regenberg B, 2000, YEAST, V16, P1111, DOI 10.1002/1097-0061(20000915)16:12<1111::AID-YEA611>3.0.CO;2-3; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Rolland F, 2000, MOL MICROBIOL, V38, P348, DOI 10.1046/j.1365-2958.2000.02125.x; Roze LV, 2011, FUNGAL GENET BIOL, V48, P35, DOI 10.1016/j.fgb.2010.05.006; Roze LV, 2004, MYCOPATHOLOGIA, V158, P219, DOI 10.1023/B:MYCO.0000041841.71648.6e; Sa-Correia I, 2002, J BIOTECHNOL, V98, P215, DOI 10.1016/S0168-1656(02)00133-5; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; SCHIMIDT A, 1994, MOL CELL BIOL, V14, P6597; Seo JA, 2004, MOL MICROBIOL, V53, P1611, DOI 10.1111/j.1365-2958.2004.04232.x; Shimizu K, 2003, GENETICS, V165, P1095; Shimizu K, 2001, GENETICS, V157, P591; Soid-Raggi G, 2006, MOL MICROBIOL, V59, P854, DOI 10.1111/j.1365-2958.2005.04996.x; Son H, 2011, FUNGAL GENET BIOL, V48, P408, DOI 10.1016/j.fgb.2011.01.002; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; STANBROUGH M, 1995, J BACTERIOL, V177, P94, DOI 10.1128/jb.177.1.94-102.1995; STRINGER MA, 1991, GENE DEV, V5, P1161, DOI 10.1101/gad.5.7.1161; Thevelein JM, 2005, BIOCHEM SOC T, V33, P253, DOI 10.1042/BST0330253; TIKUNOV AP, 2013, CURRENT METABOLOMICS, V1, P1; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1028, DOI 10.1016/j.bbrc.2005.01.064; Valerio A, 2011, AGING-US, V3, P464, DOI 10.18632/aging.100322; Vandamme J, 2012, CELL SIGNAL, V24, P1610, DOI 10.1016/j.cellsig.2012.04.001; Veech RL, 2001, IUBMB LIFE, V51, P241; von Dohren H, 2009, FUNGAL GENET BIOL, V46, pS45, DOI 10.1016/j.fgb.2008.08.008; Yoshizawa F, 2012, J PHARMACOL SCI, V118, P149, DOI 10.1254/jphs.11R05FM; Yu Jae-Hyuk, 2010, Mycobiology, V38, P229, DOI 10.4489/MYCO.2010.38.4.229; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	70	15	16	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62088	10.1371/journal.pone.0062088	http://dx.doi.org/10.1371/journal.pone.0062088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658706	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000029
J	Li, PC; Green, MD; Forsburg, SL				Li, Pao-Chen; Green, Marc D.; Forsburg, Susan L.			Mutations Disrupting Histone Methylation Have Different Effects on Replication Timing in S. pombe Centromere	PLOS ONE			English	Article							FISSION YEAST CENTROMERES; RNA INTERFERENCE; DNA-REPLICATION; CHROMODOMAIN PROTEIN; EPIGENETIC CONTROL; CHP1 CHROMODOMAIN; SILENCING FACTORS; HETEROCHROMATIN; HP1; COMPLEX	The fission yeast pericentromere comprises repetitive sequence elements packaged into heterchromatin marked by histone H3K9 methylation and Swi6 binding. Transient disruption of Swi6 during S phase allows a period of RNA synthesis which programs the RNAi machinery to maintain histone methylation. However, Swi6 is also required for early replication timing. We show that not only Swi6 but also the chromodomain protein Chp1 are delocalized during S phase. Different from loss of swi6, mutations that disrupt histone methylation in the centromere, chp1 Delta and clr4 Delta, undergo early DNA replication. However, timing is modestly delayed in RNAi mutants dcr1 Delta or rdp1 Delta, while hrr1 Delta mutants resemble swi6 Delta in their replication delay. Finally, we show that recruitment of RNA polymerase II in the centromere occurs independently of replication. These different effects indicate that replication timing is not simply linked to histone methylation.	[Li, Pao-Chen; Green, Marc D.; Forsburg, Susan L.] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA USA	University of Southern California	Forsburg, SL (corresponding author), Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA.	forsburg@usc.edu		Forsburg, Susan L/0000-0002-4895-8598	National Science Foundation [MCB 0640103]; National Institutes of Health [R01 GM059321]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059321] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation MCB 0640103 and by National Institutes of Health R01 GM059321 to SLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Alper BJ, 2012, CHROMOSOME RES, V20, P521, DOI 10.1007/s10577-012-9288-x; Asakawa H, 2005, MOL BIOL CELL, V16, P2325, DOI 10.1091/mbc.e04-11-0996; Auth T, 2006, EXP CELL RES, V312, P3349, DOI 10.1016/j.yexcr.2006.07.014; Bailis JM, 2003, NAT CELL BIOL, V5, P1111, DOI 10.1038/ncb1069; Bell O, 2010, NAT STRUCT MOL BIOL, V17, P894, DOI 10.1038/nsmb.1825; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Carmichael JB, 2004, MOL BIOL CELL, V15, P1425, DOI 10.1091/mbc.E03-06-0433; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; DeBeauchamp JL, 2008, MOL CELL BIOL, V28, P2154, DOI 10.1128/MCB.01637-07; Dohke K, 2008, GENES CELLS, V13, P1027, DOI 10.1111/j.1365-2443.2008.01225.x; Dorn ES, 2011, EPIGENETICS-US, V6, P552, DOI 10.4161/epi.6.5.15082; Douglas ME, 2012, CURR BIOL, V22, pR81, DOI 10.1016/j.cub.2011.12.028; Ekwall K, 1996, J CELL SCI, V109, P2637; Ekwall K, 2007, ANNU REV GENET, V41, P63, DOI 10.1146/annurev.genet.41.110306.130127; Gilbert DM, 2010, COLD SH Q B, V75, P143, DOI 10.1101/sqb.2010.75.011; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hayashi A, 2012, P NATL ACAD SCI USA, V109, P6159, DOI 10.1073/pnas.1116972109; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Hayashi MT, 2009, NAT CELL BIOL, V11, P357, DOI 10.1038/ncb1845; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Hodson JA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng134; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kim SM, 2003, GENE DEV, V17, P330, DOI 10.1101/gad.1046203; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Knott SRV, 2009, EPIGENETICS-US, V4, P262; Lejeune E, 2010, COLD SH Q B, V75, P275, DOI 10.1101/sqb.2010.75.024; Li F, 2011, NATURE, V475, P244, DOI 10.1038/nature10161; Li PC, 2013, CELL REP, V3, P638, DOI 10.1016/j.celrep.2013.02.007; Li PC, 2011, CELL CYCLE, V10, P323, DOI 10.4161/cc.10.2.14552; LIMADEFARIA A, 1968, NATURE, V217, P138, DOI 10.1038/217138a0; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Partridge JF, 2000, GENE DEV, V14, P783; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Patel PK, 2008, MOL BIOL CELL, V19, P5550, DOI 10.1091/mbc.E08-06-0645; Petrie VJ, 2005, MOL CELL BIOL, V25, P2331, DOI 10.1128/MCB.25.6.2331-2346.2005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pidoux AL, 2000, J CELL SCI, V113, P4177; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; Rougemaille M, 2008, J BIOL CHEM, V283, P25770, DOI 10.1074/jbc.C800140200; Rougemaille M, 2012, P NATL ACAD SCI USA, V109, P11258, DOI 10.1073/pnas.1204947109; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Schalch T, 2009, MOL CELL, V34, P36, DOI 10.1016/j.molcel.2009.02.024; Schwaiger M, 2010, GENOME RES, V20, P771, DOI 10.1101/gr.101790.109; Shareef MM, 2003, GENETICA, V117, P127; SINGH J, 1993, NATURE, V361, P271, DOI 10.1038/361271a0; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Takami Y, 2007, MOL BIOL CELL, V18, P129, DOI 10.1091/mbc.E06-05-0426; Tran PT, 2004, METHODS, V33, P220, DOI 10.1016/j.ymeth.2003.11.017; Trembecka-Lucas DO, 2012, CELL CYCLE, V11, P2170, DOI 10.4161/cc.20673; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xhemalce B, 2010, GENE DEV, V24, P647, DOI 10.1101/gad.1881710; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501	62	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61464	10.1371/journal.pone.0061464	http://dx.doi.org/10.1371/journal.pone.0061464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658693	gold, Green Published, Green Submitted			2022-12-25	WOS:000319167000014
J	Li, WJ; Nicola, JP; Amzel, LM; Carrasco, N				Li, Wenjing; Nicola, Juan Pablo; Amzel, L. Mario; Carrasco, Nancy			Asn441 plays a key role in folding and function of the Na+/I+ symporter (NIS)	FASEB JOURNAL			English	Article						plasma membrane targeting; helix capping; interhelical interaction; congenital hypothyroidism; protein folding	IODIDE TRANSPORT DEFECT; N-CAPPING BOX; SODIUM/IODIDE SYMPORTER; POSTTRANSCRIPTIONAL REGULATION; MOLECULAR CHARACTERIZATION; CONGENITAL HYPOTHYROIDISM; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; MUTATION; EXPRESSION	The Na+/I- symporter (NIS) is a plasma membrane glycoprotein that mediates active I- transport in the thyroid, the first step in the biosynthesis of the iodine-containing thyroid hormones T-3 and T-4. Several NIS mutants have been identified as a cause of congenital I- transport defect (ITD), and their investigation has yielded valuable mechanistic information on NIS. Here we report a thorough characterization of the ITD-causing NIS mutation in which the sixth intracellular loop residues 439-443 are missing. This mutant protein was intracellularly retained, incompletely glycosylated, and intrinsically inactive. Engineering 5 Ala at positions 439-443 partially recovered cell surface targeting and activity (approximate to 15%). Strikingly, NIS with the sequence 439-AANAA-443, in which Asn was restored at position 441, was targeted to the plasma membrane and exhibited approximate to 95% the transport activity of WT NIS. Based on our NIS homology model, we propose that the side chain of N441, a residue conserved throughout most of the SLC5 family, interacts with the main chain amino group of G444, capping the -helix of transmembrane segment XII and thus stabilizing the structure of the molecule. Our data provide insight into a critical interhelical interaction required for NIS folding and activity.Li, W., Nicola, J. P., Amzel, L. M., Carrasco, N. Asn441 plays a key role in folding and function of the Na+/I- symporter (NIS).	[Li, Wenjing; Carrasco, Nancy] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Nicola, Juan Pablo; Carrasco, Nancy] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Amzel, L. Mario] Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD USA	Yeshiva University; Albert Einstein College of Medicine; Yale University; Johns Hopkins University; Johns Hopkins Medicine	Carrasco, N (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06510 USA.	nancy.carrasco@yale.edu	Carrasco, Nancy/AAH-1053-2019	Carrasco, Nancy/0000-0003-4137-6162; Amzel, L. Mario/0000-0002-0129-9572	Yale University School of Medicine; U.S. National Institutes of Health [DK-41544]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041544] Funding Source: NIH RePORTER	Yale University School of Medicine; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Sabine Costagliola (Free University of Brussels, Brussels, Belgium) for providing the anti-human NIS VJ1 monoclonal antibody. The authors are grateful to Dr. George Rose (Johns Hopkins University, Baltimore, MD, USA) for his insightful comments and to the members of the N.C. laboratory for critical reading of the manuscript. J.P.N. was supported by the Brown-Coxe postdoctoral fellowship from Yale University School of Medicine. This work was supported by U.S. National Institutes of Health grant DK-41544 (N.C.). The authors declare no conflicts of interest.	Altorjay A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-5; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; DE la Vieja A, 2000, PHYSIOL REV, V80, P1083, DOI 10.1152/physrev.2000.80.3.1083; De la Vieja A, 2005, MOL ENDOCRINOL, V19, P2847, DOI 10.1210/me.2005-0162; De la Vieja A, 2007, J BIOL CHEM, V282, P25290, DOI 10.1074/jbc.M700147200; De la Vleja A, 2004, J CELL SCI, V117, P677, DOI 10.1242/jcs.00898; Dohan O, 2001, J CLIN ENDOCR METAB, V86, P2697, DOI 10.1210/jc.86.6.2697; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Dohan O, 2002, MOL ENDOCRINOL, V16, P1893, DOI 10.1210/me.2002-0071; Dohan O, 2000, TRENDS ENDOCRIN MET, V11, P99, DOI 10.1016/S1043-2760(00)00237-X; Dohan O, 2007, P NATL ACAD SCI USA, V104, P20250, DOI 10.1073/pnas.0707207104; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fujiwara H, 1997, NAT GENET, V17, P122, DOI 10.1038/ng0997-122a; Gallo M, 2005, INT J IMMUNOPATH PH, V18, P95, DOI 10.1177/039463200501800111; KAMINSKY SM, 1994, P NATL ACAD SCI USA, V91, P3789, DOI 10.1073/pnas.91.9.3789; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Levy O, 1997, P NATL ACAD SCI USA, V94, P5568, DOI 10.1073/pnas.94.11.5568; Levy O, 1998, J BIOL CHEM, V273, P22657, DOI 10.1074/jbc.273.35.22657; Levy O, 1998, FEBS LETT, V429, P36, DOI 10.1016/S0014-5793(98)00522-5; Narayana N, 2006, J MOL BIOL, V362, P414, DOI 10.1016/j.jmb.2006.06.086; Neumann JM, 2008, TRENDS BIOCHEM SCI, V33, P314, DOI 10.1016/j.tibs.2008.05.001; Nicola JP, 2009, AM J PHYSIOL-CELL PH, V296, pC654, DOI 10.1152/ajpcell.00509.2008; Nicola JP, 2012, J PHYSIOL-LONDON, V590, P6013, DOI 10.1113/jphysiol.2012.241307; Nicola JP, 2011, J CLIN ENDOCR METAB, V96, pE1100, DOI 10.1210/jc.2011-0349; Nicola JP, 2010, MOL ENDOCRINOL, V24, P1846, DOI 10.1210/me.2010-0102; Nicola JP, 2009, ENDOCRINOLOGY, V150, P500, DOI 10.1210/en.2008-0345; Paroder V., 2013, J CELL SCI IN PRESS; Paroder V, 2006, P NATL ACAD SCI USA, V103, P7270, DOI 10.1073/pnas.0602365103; Paroder-Belenitsky M, 2011, P NATL ACAD SCI USA, V108, P17933, DOI 10.1073/pnas.1108278108; Pohlenz J, 2000, J CLIN ENDOCR METAB, V85, P2366, DOI 10.1210/jc.85.7.2366; Purtell K, 2012, FASEB J, V26, P3252, DOI 10.1096/fj.12-206110; Reed-Tsur MD, 2008, ENDOCRINOLOGY, V149, P3077, DOI 10.1210/en.2008-0027; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Riedel C, 2001, J BIOL CHEM, V276, P21458, DOI 10.1074/jbc.M100561200; Schulz A, 2000, J BIOL CHEM, V275, P37860, DOI 10.1074/jbc.M006709200; Spitzweg C, 2010, MOL CELL ENDOCRINOL, V322, P56, DOI 10.1016/j.mce.2010.02.007; STANBURY JB, 1960, LANCET, V1, P1162; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; Tonacchera M, 2003, CLIN ENDOCRINOL, V59, P500, DOI 10.1046/j.1365-2265.2003.01877.x; Wapnir IL, 2003, J CLIN ENDOCR METAB, V88, P1880, DOI 10.1210/jc.2002-021544; WOLFF J, 1983, ENDOCR REV, V4, P240, DOI 10.1210/edrv-4-3-240; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; ZHUKOVSKY EA, 1994, BIOCHEMISTRY-US, V33, P9856, DOI 10.1021/bi00199a006	45	24	24	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3229	3238		10.1096/fj.13-229138	http://dx.doi.org/10.1096/fj.13-229138			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23650190	Green Published			2022-12-25	WOS:000329877600028
J	Bhattacharjee, A; Oeemig, JS; Kolodziejczyk, R; Meri, T; Kajander, T; Lehtinen, MJ; Iwai, H; Jokiranta, TS; Goldman, A				Bhattacharjee, Arnab; Oeemig, Jesper S.; Kolodziejczyk, Robert; Meri, Taru; Kajander, Tommi; Lehtinen, Markus J.; Iwai, Hideo; Jokiranta, T. Sakari; Goldman, Adrian			Structural Basis for Complement Evasion by Lyme Disease Pathogen Borrelia burgdorferi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; ACID-BINDING PROTEIN; FACTOR-H-BINDING; TORSION ANGLE DYNAMICS; OUTER-MEMBRANE PROTEIN; REGULATORS FACTOR-H; INHIBITOR FACTOR-H; SURFACE; DOMAIN; NMR	Borrelia burgdorferi spirochetes that cause Lyme borreliosis survive for a long time in human serum because they successfully evade the complement system, an important arm of innate immunity. The outer surface protein E (OspE) of B. burgdorferi is needed for this because it recruits complement regulator factor H (FH) onto the bacterial surface to evade complement-mediated cell lysis. To understand this process at the molecular level, we used a structural approach. First, we solved the solution structure of OspE by NMR, revealing a fold that has not been seen before in proteins involved in complement regulation. Next, we solved the x-ray structure of the complex between OspE and the FH C-terminal domains 19 and 20 (FH19-20) at 2.83 angstrom resolution. The structure shows that OspE binds FH19-20 in a way similar to, but not identical with, that used by endothelial cells to bind FH via glycosaminoglycans. The observed interaction of OspE with FH19-20 allows the full function of FH in down-regulation of complement activation on the bacteria. This reveals the molecular basis for how B. burgdorferi evades innate immunity and suggests how OspE could be used as a potential vaccine antigen.	[Bhattacharjee, Arnab; Meri, Taru; Lehtinen, Markus J.; Jokiranta, T. Sakari] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Bhattacharjee, Arnab; Meri, Taru; Lehtinen, Markus J.; Jokiranta, T. Sakari] Univ Helsinki, Res Programs Unit, FIN-00014 Helsinki, Finland; [Bhattacharjee, Arnab; Oeemig, Jesper S.; Kolodziejczyk, Robert; Kajander, Tommi; Iwai, Hideo; Goldman, Adrian] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Kolodziejczyk, Robert; Meri, Taru; Goldman, Adrian] Univ Helsinki, Div Biochem & Biotechnol, Dept Biosci, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki	Jokiranta, TS (corresponding author), Univ Helsinki, Haartman Inst, Haartmaninkatu 3, FIN-00014 Helsinki, Finland.	Sakari.Jokiranta@helsinki.fi	Iwaï, Hideo/A-6416-2009; Kolodziejczyk, Robert/G-9274-2015	Iwaï, Hideo/0000-0001-7376-5264; Kajander, Tommi/0000-0002-5094-227X; Goldman, Adrian/0000-0001-8032-9700; Bhattacharjee, Arnab/0000-0002-9613-7911	National Graduate School in Informational and Structural Biology graduate school; Sigrid Juselius Foundation; Academy of Finland [251700, 131413, 137995, 128646, 255922, 259793, 1252206]	National Graduate School in Informational and Structural Biology graduate school; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	Supported by the National Graduate School in Informational and Structural Biology graduate school.; Supported by the Sigrid Juselius Foundation and Academy of Finland Grant 251700.; Supported by the Sigrid Juselius Foundation and Academy of Finland Grants 131413 and 137995.; Supported by the Sigrid Juselius Foundation and Academy of Finland Grants 128646, 255922, and 259793. To whom correspondence may be addressed: Haartman Institute, Haartmaninkatu 3, University of Helsinki, FIN-00014 Helsinki, Finland. Tel.: 358-9-1911; Fax: 358-9-191-26382; E-mail: Sakari.Jokiranta@helsinki.fi.; Supported by the Sigrid Juselius Foundation and Academy of Finland Grant 1252206. To whom correspondence may be addressed: Department of Biosciences, Division of Biochemistry and Biotechnology, Viikinkaari 1, University of Helsinki, FIN-00014 Helsinki, Finland. Tel.: 358-9-1911; Fax: 358-9-191-59940; E-mail: Adrian.Goldman@helsinki.fi.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alitalo A, 2005, EUR J IMMUNOL, V35, P3043, DOI 10.1002/eji.200526354; Alitalo A, 2004, J IMMUNOL, V172, P6195, DOI 10.4049/jimmunol.172.10.6195; Alitalo A, 2002, J IMMUNOL, V169, P3847, DOI 10.4049/jimmunol.169.7.3847; Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; Amdahl H, 2011, MOL IMMUNOL, V48, P697, DOI 10.1016/j.molimm.2010.11.015; Atkinson JP, 2007, J EXP MED, V204, P1245, DOI 10.1084/jem.20070664; Barbour AG, 1996, J INFECT DIS, V173, P403, DOI 10.1093/infdis/173.2.403; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Batsford S, 1998, J INFECT DIS, V178, P1676, DOI 10.1086/314477; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Bhattacharjee A, 2010, MOL IMMUNOL, V47, P1686, DOI 10.1016/j.molimm.2010.03.007; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Capaldi S, 2007, J BIOL CHEM, V282, P31008, DOI 10.1074/jbc.M705399200; Centers for Disease Control and Prevention, 1996, MMWR-MORBID MORTAL W, V45, P481; Chen SY, 2011, J BACTERIOL, V193, P6724, DOI 10.1128/JB.06042-11; Chen SY, 2011, J BACTERIOL, V193, P6379, DOI 10.1128/JB.05849-11; Cordes FS, 2005, NAT STRUCT MOL BIOL, V12, P276, DOI 10.1038/nsmb902; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desveaux D, 2002, NAT STRUCT BIOL, V9, P512, DOI 10.1038/nsb814; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; FIKRIG E, 1991, J INFECT DIS, V164, P1224, DOI 10.1093/infdis/164.6.1224; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; GORDON DL, 1995, J IMMUNOL, V155, P348; Graebsch A, 2009, P NATL ACAD SCI USA, V106, P18521, DOI 10.1073/pnas.0907990106; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haapasalo K, 2012, J IMMUNOL, V188, P426, DOI 10.4049/jimmunol.1102545; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; Hefty PS, 2001, INFECT IMMUN, V69, P3618, DOI 10.1128/IAI.69.6.3618-3627.2001; Herbert AP, 2007, J BIOL CHEM, V282, P18960, DOI 10.1074/jbc.M609636200; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Ho DK, 2010, J IMMUNOL, V185, P1763, DOI 10.4049/jimmunol.1001244; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAM TT, 1994, INFECT IMMUN, V62, P290, DOI 10.1128/IAI.62.1.290-298.1994; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; McDowell JV, 2004, J IMMUNOL, V173, P7471, DOI 10.4049/jimmunol.173.12.7471; Meri T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003308; Meri T, 2002, INFECT IMMUN, V70, P5185, DOI 10.1128/IAI.70.9.5185-5192.2002; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Muona M, 2008, CHEMBIOCHEM, V9, P2958, DOI 10.1002/cbic.200800604; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nichesola D, 2004, BIOCHEMISTRY-US, V43, P14072, DOI 10.1021/bi0489661; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; Rose CD, 2001, J RHEUMATOL, V28, P2555; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Sharma A, 2011, J BIOL CHEM, V286, P31924, DOI 10.1074/jbc.M111.270165; STEERE AC, 1977, ANN INTERN MED, V86, P685, DOI 10.7326/0003-4819-86-6-685; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; VANDAM AP, 1993, CLIN INFECT DIS, V17, P708, DOI 10.1093/clinids/17.4.708; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Xu Q, 2009, J BIOL CHEM, V284, P25268, DOI 10.1074/jbc.M109.018564; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015	70	41	41	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18685	18695		10.1074/jbc.M113.459040	http://dx.doi.org/10.1074/jbc.M113.459040			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658013	Green Published, hybrid			2022-12-25	WOS:000321335800005
J	Balanis, N; Wendt, MK; Schiemann, BJ; Wang, ZH; Schiemann, WP; Carlin, CR				Balanis, Nikolas; Wendt, Michael K.; Schiemann, Barbara J.; Wang, Zhenghe; Schiemann, William P.; Carlin, Cathleen R.			Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; LIGAND-RECEPTOR COMPLEXES; EGF RECEPTOR; METASTATIC OUTGROWTH; EXTRACELLULAR-MATRIX; CELL-LINES; PROGNOSTIC VALUE; TUMOR-CELLS; PHASE-II; EXPRESSION	We previously established that overexpression of the EGF receptor (EGFR) is sufficient to induce tumor formation by otherwise nontransformed mammary epithelial cells, and that the initiation of epithelial-mesenchymal transition (EMT) is capable of increasing the invasion and metastasis of these cells. Using this breast cancer (BC) model, we find that in addition to EGF, adhesion to fibronectin (FN) activates signal transducer and activator of transcription 3 (STAT3) through EGFR-dependent and -independent mechanisms. Importantly, EMT facilitated a signaling switch from SRC-dependent EGFR: STAT3 signaling in pre-EMT cells to EGFR-independent FN: JAK2: STAT3 signaling in their post-EMT counterparts, thereby sensitizing these cells to JAK2 inhibition. Accordingly, human metastatic BC cells that failed to activate STAT3 downstream of EGFR did display robust STAT3 activity upon adhesion to FN. Furthermore, FN enhanced outgrowth in three-dimensional organo-typic cultures via a mechanism that is dependent upon beta 1 integrin, Janus kinase 2 (JAK2), and STAT3 but not EGFR. Collectively, our data demonstrate that matrix-initiated signaling is sufficient to drive STAT3 activation, a reaction that is facilitated by EMT during BC metastatic progression.	[Balanis, Nikolas; Carlin, Cathleen R.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Wendt, Michael K.; Schiemann, Barbara J.; Wang, Zhenghe; Schiemann, William P.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Carlin, Cathleen R.] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Schiemann, WP (corresponding author), Case Western Reserve Univ, Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	william.schiemann@case.edu; cathleen.carlin@case.edu		Wendt, Mike/0000-0002-3665-7413	National Institutes of Health [GM081498, CA129359, CA166140, T32 HL007653]; development funds of the Case Comprehensive Cancer Center Support [CA043703]; NATIONAL CANCER INSTITUTE [R01CA127590, R00CA166140, R01CA129359, K99CA166140, P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); development funds of the Case Comprehensive Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081498 (to C. R. C.), CA129359 (to W. P. S.), CA166140 (to M. K. W.), and T32 HL007653 (to N. B.), and pilot project Grant CA043703 from development funds of the Case Comprehensive Cancer Center Support (to C. R. C. and Z. W.).	Balanis N, 2011, MOL BIOL CELL, V22, P4288, DOI 10.1091/mbc.E10-08-0700; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; COFFER PJ, 1995, BIOCHEM BIOPH RES CO, V210, P74, DOI 10.1006/bbrc.1995.1629; Crooks D, 2000, MOL BIOL CELL, V11, P3559, DOI 10.1091/mbc.11.10.3559; Dawson PJ, 1996, AM J PATHOL, V148, P313; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dickler MN, 2008, CLIN CANCER RES, V14, P7878, DOI 10.1158/1078-0432.CCR-08-0141; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; FILMUS J, 1987, MOL CELL BIOL, V7, P251, DOI 10.1128/MCB.7.1.251; Flynn JF, 2009, J ONCOL, V2009, DOI 10.1155/2009/526963; Fossey SL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-125; Galliher Amy J, 2006, Future Oncol, V2, P743, DOI 10.2217/14796694.2.6.743; Guren TK, 1999, BIOCHEM BIOPH RES CO, V258, P565, DOI 10.1006/bbrc.1999.0684; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Hynes RO, 2002, COLD SPRING HARB SYM, V67, P143, DOI 10.1101/sqb.2002.67.143; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Ioachim E, 2002, EUR J CANCER, V38, P2362, DOI 10.1016/S0959-8049(02)00210-1; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kil SJ, 1999, J BIOL CHEM, V274, P3141, DOI 10.1074/jbc.274.5.3141; Kil SJ, 2000, J CELL PHYSIOL, V185, P47, DOI 10.1002/1097-4652(200010)185:1<47::AID-JCP4>3.3.CO;2-F; Kostenko O, 2006, ONCOGENE, V25, P6604, DOI 10.1038/sj.onc.1209675; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liao HJ, 2009, CANCER RES, V69, P6179, DOI 10.1158/0008-5472.CAN-09-0049; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; McMurray JS, 2006, CHEM BIOL, V13, P1123, DOI 10.1016/j.chembiol.2006.11.001; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; PRUSS RM, 1977, P NATL ACAD SCI USA, V74, P3918, DOI 10.1073/pnas.74.9.3918; Qian XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060046; Quintela I, 2005, ONCOL REP, V14, P1655; Rousseau C, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-20; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Song RXD, 2010, J STEROID BIOCHEM, V118, P219, DOI 10.1016/j.jsbmb.2009.09.018; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Tsonis AI, 2013, FEBS J, V280, P2248, DOI 10.1111/febs.12162; Ueno NT, 2011, J CANCER, V2, P324, DOI 10.7150/jca.2.324; Wendt MK, 2013, ONCOGENE, V32, P2005, DOI 10.1038/onc.2012.230; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Wendt MK, 2011, MOL BIOL CELL, V22, P2423, DOI 10.1091/mbc.E11-04-0306; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Zhu T, 1998, J BIOL CHEM, V273, P10682, DOI 10.1074/jbc.273.17.10682	60	101	103	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					17954	17967		10.1074/jbc.M113.475277	http://dx.doi.org/10.1074/jbc.M113.475277			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653350	hybrid, Green Published			2022-12-25	WOS:000320721900003
J	Huang, H; Cotton, JL; Wang, Y; Rajurkar, M; Zhu, LHJ; Lewis, BC; Mao, JH				Huang, He; Cotton, Jennifer L.; Wang, Yang; Rajurkar, Mihir; Zhu, Lihua J.; Lewis, Brian C.; Mao, Junhao			Specific Requirement of Gli Transcription Factors in Hedgehog-mediated Intestinal Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE ASPECTS; SMOOTH-MUSCLE; MOUSE; SHH; ROLES; HOMEOSTASIS; OSTEOBLAST; SKELETON; STOMACH; PATHWAY	Hedgehog (Hh) signaling is involved in multiple aspects of embryonic gut development, including mesenchymal growth and smooth muscle differentiation. The Gli family transcription factors is thought to collectively mediate Hh signaling in mammals. However, the function of different Gli proteins in gut development remains uncharacterized. Here, we genetically dissect the contribution of Gli transcriptional activation and de-repression in intestinal growth and patterning. We find that removal of the Gli3 repressor is dispensable for intestinal development and does not play a major role in Hh-controlled gut development. However, Gli2 activation is able to fully rescue the Smoothened (Smo)-null intestinal phenotype, suggesting that the Gli2 transcription factor is the main effector for Hh signaling in the intestine. To understand further the molecular mechanism underlying Hh/Gli function in the developing gut, we identify a subset of small leucine-rich glycoproteins (SLRPs) that may function downstream of Hh signaling in the mesenchyme. We show that osteoglycin, a SLRP, inhibits Hh-induced differentiation toward the smooth muscle lineage in C3H10T1/2 pluripotent mesenchymal cells. Taken together, our study reveals, for the first time, the distinct roles of Gli proteins in intestine development and suggests SLRPs as novel regulators of smooth muscle cell differentiation.	[Huang, He; Cotton, Jennifer L.; Rajurkar, Mihir; Mao, Junhao] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Zhu, Lihua J.; Lewis, Brian C.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Huang, He] Cent S Univ, Xiangya Sch Med, Dept Histol & Embryol, Changsha 410013, Hunan, Peoples R China; [Wang, Yang] Univ Massachusetts MassBiol, Boston, MA 02126 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Central South University; University of Massachusetts System; University of Massachusetts Boston	Mao, JH (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA.	junhao.mao@umassmed.edu	Rajurkar, Mihir/I-6238-2019	Rajurkar, Mihir/0000-0002-0573-1705; Zhu, Lihua/0000-0001-7416-0590; Cotton, Jennifer/0000-0003-0106-1801	National Institutes of Health [T32 CA130807]; American Cancer Society [20376-RSG-11-040-01-DDC]; Charles H. Hood Foundation; Worcester Biomedical Research Foundation; National Natural Science Foundation of China [81141068]; NATIONAL CANCER INSTITUTE [T32CA130807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Charles H. Hood Foundation; Worcester Biomedical Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Training Grant T32 CA130807 (to J. L. C.). This work was also supported by American Cancer Society Grant 20376-RSG-11-040-01-DDC, the Charles H. Hood Foundation and Worcester Biomedical Research Foundation (to J. M.), and National Natural Science Foundation of China Grant 81141068 (to H. H.).	Bai CB, 2002, DEVELOPMENT, V129, P4753; Blaess S, 2008, DEVELOPMENT, V135, P2093, DOI 10.1242/dev.015990; Bredrup C, 2005, INVEST OPHTH VIS SCI, V46, P420, DOI 10.1167/iovs.04-0804; Cain JE, 2011, J CLIN INVEST, V121, P1199, DOI 10.1172/JCI45523; Ding Q, 1998, DEVELOPMENT, V125, P2533; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hui C. C., 2011, ANN REV CELL DEV BIO, V27; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Kim JH, 2005, DEV DYNAM, V234, P984, DOI 10.1002/dvdy.20542; Kolterud A, 2009, GASTROENTEROLOGY, V137, P618, DOI 10.1053/j.gastro.2009.05.002; Kosinski C, 2010, GASTROENTEROLOGY, V139, P893, DOI 10.1053/j.gastro.2010.06.014; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Majava M, 2007, HUM MUTAT, V28, P336, DOI 10.1002/humu.20444; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; MCHUGH KM, 1995, DEV DYNAM, V204, P278, DOI 10.1002/aja.1002040306; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Altaba ARI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002540; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; van Dop WA, 2010, GASTROENTEROLOGY, V139, P1665, DOI 10.1053/j.gastro.2010.07.045; Verzi MP, 2009, GASTROENTEROLOGY, V136, P1701, DOI 10.1053/j.gastro.2009.01.009; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Yu J, 2002, DEVELOPMENT, V129, P5301; Zacharias WJ, 2011, DEV BIOL, V355, P152, DOI 10.1016/j.ydbio.2011.04.025; Zacharias WJ, 2010, GASTROENTEROLOGY, V138, P2368, DOI 10.1053/j.gastro.2010.02.057; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	36	29	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17589	17596		10.1074/jbc.M113.467498	http://dx.doi.org/10.1074/jbc.M113.467498			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645682	Green Published, hybrid			2022-12-25	WOS:000320380600050
J	Regot, S; de Nadal, E; Rodriguez-Navarro, S; Gonzalez-Novo, A; Perez-Fernandez, J; Gadal, O; Seisenbacher, G; Ammerer, G; Posas, F				Regot, Sergi; de Nadal, Eulalia; Rodriguez-Navarro, Susana; Gonzalez-Novo, Alberto; Perez-Fernandez, Jorge; Gadal, Olivier; Seisenbacher, Gerhard; Ammerer, Gustav; Posas, Francesc			The Hog1 Stress-activated Protein Kinase Targets Nucleoporins to Control mRNA Export upon Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; OSMOTIC-STRESS; MAP KINASE; TRANSCRIPTIONAL RESPONSE; REGULATORY MECHANISMS; SIGNAL-TRANSDUCTION; CELL-CYCLE; POL-II	The control of mRNA biogenesis is exerted at several steps. In response to extracellular stimuli, stress-activated protein kinases (SAPK) modulate gene expression to maximize cell survival. In yeast, the Hog1 SAPK plays a key role in reprogramming the gene expression pattern required for cell survival upon osmostress by acting during transcriptional initiation and elongation. Here, we genetically show that an intact nuclear pore complex is important for cell survival and maximal expression of stress-responsive genes. The Hog1 SAPK associates with nuclear pore complex components and directly phosphorylates the Nup1, Nup2, and Nup60 components of the inner nuclear basket. Mutation of those factors resulted in a deficient export of stress-responsive genes upon stress. Association of Nup1, Nup2, and Nup60 to stress-responsive promoters occurs upon stress depending on Hog1 activity. Accordingly, STL1 gene territory is maintained at the nuclear periphery upon osmostress in a Hog1-dependent manner. Cells containing non-phosphorylatable mutants in Nup1 or Nup2 display reduced expression of stress-responsive genes. Together, proper mRNA biogenesis of stress-responsive genes requires of the coordinate action of synthesis and export machineries by the Hog1 SAPK.	[Regot, Sergi; de Nadal, Eulalia; Gonzalez-Novo, Alberto; Seisenbacher, Gerhard; Posas, Francesc] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Cell Signaling Unit, E-08003 Barcelona, Spain; [Rodriguez-Navarro, Susana] Ctr Invest Principe Felipe, E-46012 Valencia, Spain; [Perez-Fernandez, Jorge; Gadal, Olivier] Univ Toulouse, CNRS, Lab Biol Mol Eucaryote, F-31000 Toulouse, France; [Ammerer, Gustav] Univ Vienna, Max F Perutz Labs, Dept Biochem, A-1030 Vienna, Austria	Pompeu Fabra University; Prince Felipe Research Center; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	de Nadal, E (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Cell Signaling Unit, E-08003 Barcelona, Spain.	eulalia.nadal@upf.edu; francesc.posas@upf.edu	Perez-Fernandez, Jorge/F-6937-2010; Seisenbacher, Gerhard/K-8562-2014; Seisenbacher, Gerhard/ABE-6162-2020; de Nadal, Eulàlia/J-8178-2014; Posas, Francesc/K-1364-2013; Rodríguez-Navarro, Susana/B-5182-2014; Gadal, Olivier/A-4731-2008	Perez-Fernandez, Jorge/0000-0002-0018-5493; de Nadal, Eulàlia/0000-0003-0039-5607; Posas, Francesc/0000-0002-4164-7076; Rodríguez-Navarro, Susana/0000-0001-7472-3111; Gadal, Olivier/0000-0001-9421-0831; Regot, Sergi/0000-0001-9786-3897	MINECO (Spanish government) [BFU2012-33503]; Consolider Ingenio program [CSD2007-0015]; Fundacion Marcelino Botin [BFU2011-26722]; MINECO [BFU2011-23418]; Agence Nationale de la Recherche (Nucleopol and ODynRib-Jeune chercheur program); Jeune equipe from Fondation pour la Recherche Medicale; ICREA Academia (Generalitat de Catalunya)	MINECO (Spanish government)(Spanish Government); Consolider Ingenio program(Spanish Government); Fundacion Marcelino Botin; MINECO(Spanish Government); Agence Nationale de la Recherche (Nucleopol and ODynRib-Jeune chercheur program)(French National Research Agency (ANR)); Jeune equipe from Fondation pour la Recherche Medicale; ICREA Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya)	This work was supported by MINECO (Spanish government) Grant BFU2012-33503, the Consolider Ingenio 2010 program (Grant CSD2007-0015), the Fundacion Marcelino Botin (to F. P.), and Grant BFU2011-26722 (to E. d. N.).; Supported by the MINECO Grant BFU2011-23418.; Supported by Agence Nationale de la Recherche (Nucleopol and ODynRib-Jeune chercheur program) and Jeune equipe from Fondation pour la Recherche Medicale.; Recipients of an ICREA Academia (Generalitat de Catalunya).	Abruzzi KC, 2006, EMBO J, V25, P4253, DOI 10.1038/sj.emboj.7601305; Ahmed S, 2007, TRENDS GENET, V23, P396, DOI 10.1016/j.tig.2007.05.009; Ahmed S, 2010, NAT CELL BIOL, V12, P111, DOI 10.1038/ncb2011; Aitchison JD, 2012, GENETICS, V190, P855, DOI 10.1534/genetics.111.127803; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Brickner DG, 2010, MOL BIOL CELL, V21, P3421, DOI 10.1091/mbc.E10-01-0065; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Brown CR, 2007, CURR OPIN GENET DEV, V17, P100, DOI 10.1016/j.gde.2007.02.005; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Capelson M, 2009, EMBO REP, V10, P697, DOI 10.1038/embor.2009.147; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Choder Mordechai, 2011, Cell Logist, V1, P37, DOI 10.4161/cl.1.1.14465; Cook KE, 2012, G3-GENES GENOM GENET, V2, P1129, DOI 10.1534/g3.112.003251; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Dieppois G, 2006, MOL CELL BIOL, V26, P7858, DOI 10.1128/MCB.00870-06; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Green EM, 2012, MOL BIOL CELL, V23, P1367, DOI 10.1091/mbc.E11-06-0547; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618; Kohler A, 2010, MOL CELL, V38, P6, DOI 10.1016/j.molcel.2010.01.040; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Liang Y, 2011, CURR OPIN CELL BIOL, V23, P65, DOI 10.1016/j.ceb.2010.09.008; Light WH, 2010, MOL CELL, V40, P112, DOI 10.1016/j.molcel.2010.09.007; Lim RYH, 2008, INT REV CEL MOL BIO, V267, P299, DOI 10.1016/S1937-6448(08)00632-1; Luthra R, 2007, J BIOL CHEM, V282, P3042, DOI 10.1074/jbc.M608741200; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Nadal-Ribelles M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r106; Ni L, 2009, GENE DEV, V23, P1351, DOI 10.1101/gad.1781909; Pascual-Ahuir A, 2006, METHODS, V40, P272, DOI 10.1016/j.ymeth.2006.06.007; Pelet S, 2011, SCIENCE, V332, P732, DOI 10.1126/science.1198851; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Powrie EA, 2011, RNA, V17, P134, DOI 10.1261/rna.1210411; Proft M, 1999, MOL CELL BIOL, V19, P537; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 1999, MOL CELL BIOL, V19, P5474; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Ruiz-Roig C, 2012, MOL BIOL CELL, V23, P4286, DOI 10.1091/mbc.E12-04-0289; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Sole C, 2011, EMBO J, V30, P3274, DOI 10.1038/emboj.2011.227; Taddei A, 2007, CURR OPIN CELL BIOL, V19, P305, DOI 10.1016/j.ceb.2007.04.012; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Therizols P, 2010, P NATL ACAD SCI USA, V107, P2025, DOI 10.1073/pnas.0914187107; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200; Zapater M, 2007, MOL CELL BIOL, V27, P3900, DOI 10.1128/MCB.00089-07; Zhou HJ, 2013, NAT PROTOC, V8, P461, DOI 10.1038/nprot.2013.010	72	26	26	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17384	17398		10.1074/jbc.M112.444042	http://dx.doi.org/10.1074/jbc.M112.444042			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645671	hybrid, Green Published			2022-12-25	WOS:000320380600031
J	Xu, HD; Wu, D; Gu, JH; Ge, JB; Wu, JC; Han, R; Liang, ZQ; Qin, ZH				Xu, Hai-Dong; Wu, Dan; Gu, Jin-Hua; Ge, Jian-Bin; Wu, Jun-Chao; Han, Rong; Liang, Zhong-Qin; Qin, Zheng-Hong			The Pro-Survival Role of Autophagy Depends on Bcl-2 Under Nutrition Stress Conditions	PLOS ONE			English	Article							CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; APOPTOSIS; ACTIVATION; PROTEIN; PHOSPHORYLATION; INHIBITION; CLEARANCE; INDUCTION; NEURONS	Autophagy can be induced under nutrition stress conditions. Bcl-2 is a pro-survival protein which inhibits apoptosis and autophagy. However, the role of Bcl-2 in autophagy regulation and cell survival under nutrition deprivation has not been fully understood. This study sought to investigate if Bcl-2 upregulation is essential in limiting autophagic activity and prevent cell death under nutrition deprivation conditions. Autophagic activity was monitored by the changes in GFP-LC3 localization and protein levels of Beclin1, LC3-II, cathepsin D and p62 in neuroblastoma SH-SY5Y cells underwent serum deprivation. Manipulation of Bcl-2 function was achieved with siRNAs and small molecular inhibitors. The cell viability and apoptosis were assessed with MTT assay and Annexin V/PI staining. The results showed that serum starvation increased protein levels of LC3-II and Beclin1 but decreased autophagy substrate p62. Autophagy activation induced by serum deprivation and rapamycin was accompanied by an upregulation of Bcl-2 protein levels. When Bcl-2 was knocked down with siRNA or inhibited with HA 14-1 or ABT-737, serum starvation induced profound cell death and enhanced autophagic flux under nutrition deprivation conditions, while knockdown of autophagic gene Beclin1 or autophagy inhibitors (bafilomycin A1 and E64D), rescued cell death. In contrast, overexpression of Bcl-2 inhibited autophagy and blocked cell death in response to serum deprivation. These data suggest that Bcl-2 plays an essential role in limiting autophagy activation and preventing initiation of programmed cell death. Thus Bcl-2 may be an important mechanism for balancing beneficial and detrimental impacts of autophagy on cell survival.	[Liang, Zhong-Qin] Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China; Soochow Univ, Sch Pharmaceut Sci, Lab Aging & Nervous Dis, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Liang, ZQ (corresponding author), Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China.	lzq2003cn@yahoo.com.cn; qinzhenhong@suda.edu.cn	Xu, Haidong/Q-1095-2019		Natural Science Foundation of China [30930035]; National Basic Research Key Program (973 program) [CB510003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Key Program (973 program)(National Basic Research Program of China)	This work was supported by the grant from the Natural Science Foundation of China (No.30930035), http://159.226.244.22/portal/proj_search.asp; the National Basic Research Key Program (973 program, CB510003), http://www.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; MANN SS, 1994, J BIOL CHEM, V269, P11492; McPhee CK, 2010, NATURE, V465, P1093, DOI 10.1038/nature09127; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mohan N, 2011, NEUROSCI LETT, V502, P24, DOI 10.1016/j.neulet.2011.07.016; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qin ZH, 1999, J NEUROSCI, V19, P4023; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Robert G, 2012, AUTOPHAGY, V8, P637, DOI 10.4161/auto.19084; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu SW, 2008, STEM CELLS, V26, P2602, DOI 10.1634/stemcells.2008-0153; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang XD, 2009, J NEUROSCI RES, V87, P3600, DOI 10.1002/jnr.22152	42	40	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63232	10.1371/journal.pone.0063232	http://dx.doi.org/10.1371/journal.pone.0063232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658815	gold, Green Published, Green Submitted			2022-12-25	WOS:000321202100058
J	Baleeiro, RB; Wiesmuller, KH; Dahne, L; Lademann, J; Barbuto, JA; Walden, P				Baleeiro, Renato B.; Wiesmueller, Karl-Heinz; Daehne, Lars; Lademann, Juergen; Barbuto, Jose A.; Walden, Peter			Direct Activation of Human Dendritic Cells by Particle-Bound but Not Soluble MHC Class II Ligand	PLOS ONE			English	Article							COLORECTAL-CANCER PATIENTS; ANTIGEN PRESENTATION; SIGNAL-TRANSDUCTION; IN-VITRO; T-CELLS; VACCINATION; PEPTIDE; BLOOD; LYMPHOCYTES; MATURATION	Dendritic cells (DCs) are key activators of cellular immune responses through their capacity to induce naive T cells and sustained effector T cell responses. This capacity is a function of their superior efficiency of antigen presentation via MHC class I and class II molecules, and the expression of co-stimulatory cell surface molecules and cytokines. Maturation of DCs is induced by microbial factors via pattern recognition receptors such as Toll-like receptors, pro-inflammatory cytokines or cognate interaction with CD4(+) T cells. Here we show that, unexpectedly, the PanDR helper T cell epitope PADRE, a generic T helper cell antigen presented by a large fraction of HLA-DR alleles, when delivered in particle-bound form induced maturation of human DCs. The DCs that received the particle-bound PADRE displayed all features of fully mature DCs, such as high expression of the co-stimulatory molecules CD80, CD86, CD83, the MHC-II molecule HLA-DR, secretion of high levels of the biologically active IL-12 (IL-12p70) and induction of vigorous proliferation of naive CD4(+) T cells. Furthermore, the maturation of DCs induced by particle-bound PADRE was shown to involve sphingosine kinase, calcium signaling from internal sources and downstream signaling through the MAP kinase and the p72syk pathways, and finally activation of the transcription factor NF-kappa B. Based on our findings, we propose that particle-bound PADRE may be used as a DC activator in DC-based vaccines.	[Baleeiro, Renato B.; Lademann, Juergen; Walden, Peter] Humboldt Univ, Charite Univ Med, D-10099 Berlin, Germany; [Baleeiro, Renato B.; Lademann, Juergen; Walden, Peter] Free Univ Berlin, Dept Dermatol Venerol & Allergol, Berlin, Germany; [Baleeiro, Renato B.; Barbuto, Jose A.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil; [Wiesmueller, Karl-Heinz] Univ Tubingen, Tubingen, Germany; [Wiesmueller, Karl-Heinz] EMC Microcollect GmbH, Tubingen, Germany; [Daehne, Lars] Surflay Nanotec GmbH, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Universidade de Sao Paulo; Eberhard Karls University of Tubingen; EMC Microcollections GmbH	Walden, P (corresponding author), Humboldt Univ, Charite Univ Med, D-10099 Berlin, Germany.	peter.walden@charite.de	Barbuto, Jose A. M./H-5299-2011	Barbuto, Jose A. M./0000-0001-9526-6781; Jurgen, Lademann/0000-0003-1828-7460	Bundesministerium fur Bildung und Forschung (BMBF, German Ministry for Education and Research) WING Programme for Nanobiotechnology [13N9196, 13N9197]; Coordenacao de aprimoramento de pessoal de nivel superior (Capes); Deutscher Akademischer Austausch Dienst (DAAD); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Bundesministerium fur Bildung und Forschung (BMBF, German Ministry for Education and Research) WING Programme for Nanobiotechnology; Coordenacao de aprimoramento de pessoal de nivel superior (Capes); Deutscher Akademischer Austausch Dienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by grants from the Bundesministerium fur Bildung und Forschung (BMBF, German Ministry for Education and Research) WING Programme for Nanobiotechnology Grants 13N9196 and 13N9197, Coordenacao de aprimoramento de pessoal de nivel superior (Capes), Deutscher Akademischer Austausch Dienst (DAAD), and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daccak R, 2004, CURR OPIN IMMUNOL, V16, P108, DOI 10.1016/j.coi.2003.11.006; Alexander J, 2004, VACCINE, V22, P2362, DOI 10.1016/j.vaccine.2003.11.061; ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; ALTOMONTE M, 1993, J IMMUNOL, V151, P5115; Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Andreae S, 2003, BLOOD, V102, P2130, DOI 10.1182/blood-2003-01-0273; Andrews DA, 2002, BLOOD, V100, P3392, DOI 10.1182/blood.V100.9.3392; Bagley KC, 2004, CLIN DIAGN LAB IMMUN, V11, P77, DOI 10.1128/CDLI.11.1.77-82.2004; Bobbitt KR, 2000, J IMMUNOL, V165, P5588, DOI 10.4049/jimmunol.165.10.5588; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Connolly SF, 2007, IMMUNOL RES, V39, P115, DOI 10.1007/s12026-007-0076-1; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Draber P, 2011, MOL CELL BIOL, V31, P4550, DOI 10.1128/MCB.05817-11; EGNER W, 1995, IMMUNOLOGY, V85, P611; Herrmann TL, 2005, J LEUKOCYTE BIOL, V78, P1397, DOI 10.1189/jlb.0205105; Jang MJ, 2011, VACCINE, V29, P2400, DOI 10.1016/j.vaccine.2011.01.036; Kavanagh B, 2007, J IMMUNOTHER, V30, P762, DOI 10.1097/CJI.0b013e318133451c; Kirit MA, 2000, BLOOD, V96, P1039; Lang P, 2001, SCIENCE, V291, P1537, DOI 10.1126/science.291.5508.1537; Lesterhuis WJ, 2010, ANTICANCER RES, V30, P5091; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Nguyen A, 2004, FEBS LETT, V572, P307, DOI 10.1016/j.febslet.2004.06.061; O'Sullivan B, 2003, CRIT REV IMMUNOL, V23, P83, DOI 10.1615/CritRevImmunol.v23.i12.50; Ocadlikova D, 2010, NEOPLASMA, V57, P455, DOI 10.4149/neo_2010_05_455; Peyratout CS, 2004, ANGEW CHEM INT EDIT, V43, P3762, DOI 10.1002/anie.200300568; QIN SF, 1995, BIOCHEM J, V308, P347, DOI 10.1042/bj3080347; Ressing ME, 2000, J IMMUNOTHER, V23, P255, DOI 10.1097/00002371-200003000-00010; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Schuler G, 1995, ADV EXP MED BIOL, V378, P43; Shumilina E, 2011, AM J PHYSIOL-CELL PH, V300, pC1205, DOI 10.1152/ajpcell.00039.2011; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Sun C, 2012, MOL BIOL REP, V39, P3179, DOI 10.1007/s11033-011-1084-8; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wierecky J, 2006, CANCER RES, V66, P5910, DOI 10.1158/0008-5472.CAN-05-3905; ZHOU LJ, 1992, J IMMUNOL, V149, P735	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63039	10.1371/journal.pone.0063039	http://dx.doi.org/10.1371/journal.pone.0063039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658796	Green Submitted, Green Published, gold			2022-12-25	WOS:000321200500052
J	Boehm, D; Mazurier, C; Giarratana, MC; Darghouth, D; Faussat, AM; Harmand, L; Douay, L				Boehm, Daniela; Mazurier, Christelle; Giarratana, Marie-Catherine; Darghouth, Dhouha; Faussat, Anne-Marie; Harmand, Laurence; Douay, Luc			Caspase-3 Is Involved in the Signalling in Erythroid Differentiation by Targeting Late Progenitors	PLOS ONE			English	Article							SELECTIVE NONPEPTIDE INHIBITORS; NONAPOPTOTIC FUNCTION; CELL-DIFFERENTIATION; ACTIVATION; APOPTOSIS; ERYTHROPOIESIS; DEGRADATION; AUTOPHAGY; CLEAVAGE; POTENT	A role for caspase activation in erythroid differentiation has been established, yet its precise mode of action remains elusive. A drawback of all previous investigations on caspase activation in ex vivo erythroid differentiation is the lack of an in vitro model producing full enucleation of erythroid cells. Using a culture system which renders nearly 100% enucleated red cells from human CD34(+) cells, we investigated the role of active caspase-3 in erythropoiesis. Profound effects of caspase-3 inhibition were found on erythroid cell growth and differentiation when inhibitors were added to CD34(+) cells at the start of the culture and showed dose-response to the concentration of inhibitor employed. Enucleation was only reduced as a function of the reduced maturity of the culture and the increased cell death of mature cells while the majority of cells retained their ability to extrude their nuclei. Cell cycle analysis after caspase-3 inhibition showed caspase-3 to play a critical role in cell proliferation and highlighted a novel function of this protease in erythroid differentiation, i.e. its contribution to cell cycle regulation at the mitotic phase. While the effect of caspase-3 inhibitor treatment on CD34(+) derived cells was not specific to the erythroid lineage, showing a similar reduction of cell expansion in myeloid cultures, the mechanism of action in both lineages appeared to be distinct with a strong induction of apoptosis causing the decreased yield of myeloid cells. Using a series of colony-forming assays we were able to pinpoint the stage at which cells were most sensitive to caspase-3 inhibition and found activated caspase-3 to play a signalling role in erythroid differentiation by targeting mature BFU-E and CFU-E but not early BFU-E.	[Boehm, Daniela; Mazurier, Christelle; Giarratana, Marie-Catherine; Darghouth, Dhouha; Faussat, Anne-Marie; Harmand, Laurence; Douay, Luc] Univ Paris 06, CDR St Antoine Proliferat & Differentiat Cellules, Paris, France; [Boehm, Daniela; Mazurier, Christelle; Giarratana, Marie-Catherine; Darghouth, Dhouha; Harmand, Laurence; Douay, Luc] INSERM, UMR S938, Paris, France; [Mazurier, Christelle; Harmand, Laurence; Douay, Luc] Etab Francais Sang Ile France, Unite Ingn & Rapie Cellulaire, Creteil, France; [Faussat, Anne-Marie; Douay, Luc] Univ Paris 06, IFR St Antoine 65, Paris, France; [Douay, Luc] Hop St Antoine, AP HP, F-75571 Paris, France; [Douay, Luc] Hop Trousseau, Serv Hematol Biol, F-75571 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Douay, L (corresponding author), Univ Paris 06, CDR St Antoine Proliferat & Differentiat Cellules, Paris, France.	luc.douay@sat.aphp.fr	Boehm, Daniela/AAD-7605-2020; Boehm, Daniela/J-9366-2013; ITEMAN, Isabelle/F-8764-2018	Boehm, Daniela/0000-0003-3188-5115; Boehm, Daniela/0000-0003-3188-5115; , Laurence/0000-0001-7265-9726	DIM Stem Pole; Etablissement Francais du Sang; association "Combattre la leucemie"	DIM Stem Pole; Etablissement Francais du Sang; association "Combattre la leucemie"	This work was supported by funding from the DIM Stem Pole, the Etablissement Francais du Sang and the association "Combattre la leucemie". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bratosin D, 2005, CYTOM PART A, V66A, P78, DOI 10.1002/cyto.a.20152; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Carlile GW, 2009, FEBS LETT, V583, P848, DOI 10.1016/j.febslet.2009.01.047; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Fadeel B, 1998, BLOOD, V92, P4808, DOI 10.1182/blood.V92.12.4808.424k01_4808_4818; Feinstein-Rotkopf Y, 2009, APOPTOSIS, V14, P980, DOI 10.1007/s10495-009-0346-6; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Garderet L, 2010, HAEMATOL-HEMATOL J, V95, P398, DOI 10.3324/haematol.2009.012773; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Hashimoto T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018449; Huh JR, 2004, PLOS BIOL, V2, P43, DOI 10.1371/journal.pbio.0020015; Kolbus A, 2002, J EXP MED, V196, P1347, DOI 10.1084/jem.20020562; Krauss SW, 2005, BLOOD, V106, P2200, DOI 10.1182/blood-2005-04-1357; Kuranaga E, 2006, CELL, V126, P583, DOI 10.1016/j.cell.2006.05.048; Larsen BD, 2010, CELL CYCLE, V9, P2940, DOI 10.4161/cc.9.15.12335; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Lee D, 2001, J MED CHEM, V44, P2015, DOI 10.1021/jm0100537; Lee D, 2000, J BIOL CHEM, V275, P16007, DOI 10.1074/jbc.275.21.16007; Lindberg EH, 2001, BRIT J HAEMATOL, V112, P714, DOI 10.1046/j.1365-2141.2001.02581.x; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Mortensen M, 2010, CELL CYCLE, V9, P1901, DOI 10.4161/cc.9.10.11603; Negrotto S, 2006, EXP HEMATOL, V34, P1420, DOI 10.1016/j.exphem.2006.05.017; Newton K, 2003, GENE DEV, V17, P819, DOI 10.1101/gad.1077403; Nhan TQ, 2006, AM J PATHOL, V169, P729, DOI 10.2353/ajpath.2006.060105; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Rubiolo C, 2006, BLOOD, V108, P152, DOI 10.1182/blood-2005-09-3866; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Svingen PA, 2004, CLIN CANCER RES, V10, P6807, DOI 10.1158/1078-0432.CCR-0778-02; Sztiller-Sikorska M, 2009, BRIT J PHARMACOL, V157, P1451, DOI 10.1111/j.1476-5381.2009.00333.x; Vandenabeele Peter, 2006, Sci STKE, V2006, ppe44, DOI 10.1126/stke.3582006pe44; Wang J, 2000, J CELL SCI, V113, P753; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012; YOUSSOUFIAN H, 1993, BLOOD, V81, P2223; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247	38	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62303	10.1371/journal.pone.0062303	http://dx.doi.org/10.1371/journal.pone.0062303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658722	gold, Green Published, Green Submitted			2022-12-25	WOS:000321200500023
J	Mohammed, MA; Marshall, T; Nirantharakumar, K; Stevens, A; Fitzmaurice, D				Mohammed, Mohammed A.; Marshall, Tom; Nirantharakumar, Krishnarajah; Stevens, Andrew; Fitzmaurice, David			Patterns of Warfarin Use in Subgroups of Patients with Atrial Fibrillation: A Cross-Sectional Analysis of 430 General Practices in the United Kingdom	PLOS ONE			English	Article							ORAL ANTICOAGULANTS; STROKE; RISK; MANAGEMENT; POPULATION; PREVALENCE; GUIDELINES; MORTALITY; HISTORY	Background: Despite the proven efficacy of warfarin, its use in patients with Atrial Fibrillation (AF) is reportedly low. We investigated the underuse and overuse of warfarin in the management of AF in general practices in the United Kingdom (UK) against the National Institute of Clinical Excellence (NICE, UK) guidelines whilst seeking to identify subgroups of AF patients to inform efforts to optimise warfarin use. Methodology: A retrospective database analysis to determine warfarin prescribing using tree models based on 50361 patients with AF (classified as low, moderate and high risk of stroke using CHADS2) from 430 general practices in the UK. Results: Over one-third (37.0%, 4573/12351) of low risk AF patients were on warfarin, compared with 47.1% (8349/17709) moderate risk AF patients and 54.9% (11142/20301) high risk AF patients. Clinical subgroups (n = 15 low risk subgroups, n = 15 medium risk subgroups, n = 22 high risk subgroups) were identified. Several factors not supported by current guidelines (age, BMI, dementia, gender) were associated with the use of warfarin. Gender and BMI were associated with warfarin use in low and medium risk AF patients but not in high risk AF patients. Conclusion: Whilst NICE guidelines suggest that all high risk AF patients should be on warfarin, half of those at moderate risk should be on warfarin and none of those at low risk should be on warfarin, we found evidence of over and under use of warfarin. Interventions to optimise warfarin therapy tailored to and targeting specific subgroups of AF patients identified by the tree models are required.	[Mohammed, Mohammed A.; Marshall, Tom; Nirantharakumar, Krishnarajah; Stevens, Andrew; Fitzmaurice, David] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England	University of Birmingham	Marshall, T (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England.	t.p.marshall@bham.ac.uk		Stevens, Andrew/0000-0003-2079-3397; Marshall, Tom/0000-0001-9277-5214	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme(National Institute for Health Research (NIHR))	This study was funded by the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme. The views expressed in this publication are not necessarily those of the NIHR, the Department of Health, University of Birmingham or the CLAHRC-BBC Theme Management/ Steering Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MI, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006186.pub2; Aguilar MI, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001927.pub2; [Anonymous], 2006, NICE CLIN GUID, V36; Atrial Fibrillation, 2006, NAT CLIN GUID MAN PR; Baczek VL, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-5; Baczek VL, 2012, BMC FAMILY PRACTICE, V3, P13; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; DeWilde S, 2006, HEART, V92, P1064, DOI 10.1136/hrt.2005.069492; FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Gattellari, 2010, STROKE, V41, pE398, DOI 10.1161/STR.0b013e3181da4950; Harper Paul R, 2005, Health Policy, V71, P315, DOI 10.1016/j.healthpol.2004.05.002; Havard J, 2009, BRIT J CARDIOLOGY, V16, P237; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Kammersgaard LP, 2006, CEREBROVASC DIS, V21, P187, DOI 10.1159/000090531; KANNEL WB, 1982, N ENGL J MED, V0306; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Meiltz A, 2008, EUROPACE, V10, P674, DOI 10.1093/europace/eun086; Meinertz T, 2011, CLIN RES CARDIOL, V100, P897, DOI 10.1007/s00392-011-0320-5; National Collaborating Centre for Chronic Conditions, 2006, ATR FIBR NAT CLIN GU; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Podgorelec Vili, 2002, J Med Syst, V26, P445, DOI 10.1023/A:1016409317640; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Singer DE, 2008, CHEST, V133, p546S, DOI 10.1378/chest.08-0678; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; Stein PD, 2009, CLIN CHEST MED, V30, P489, DOI 10.1016/j.ccm.2009.05.006; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Steyerberg EW, 2019, CLIN PREDICTION MODE, V2nd, DOI 10.1007/978-0-387-77244-8; The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), 2010, EUR HEART J, V31, P2369, DOI DOI 10.1093/EURHEARTJ/EHQ278; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	38	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61979	10.1371/journal.pone.0061979	http://dx.doi.org/10.1371/journal.pone.0061979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658703	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500014
J	Wappler, EA; Institoris, A; Dutta, S; Katakam, PVG; Busija, DW				Wappler, Edina A.; Institoris, Adam; Dutta, Somhrita; Katakam, Prasad V. G.; Busija, David W.			Mitochondrial Dynamics Associated with Oxygen-Glucose Deprivation in Rat Primary Neuronal Cultures	PLOS ONE			English	Article							INDUCED CELL-DEATH; CORTICAL-NEURONS; PHYSIOLOGICAL FUNCTIONS; PROTEIN DRP1; FISSION; APOPTOSIS; FUSION; MITOFUSIN-2; INJURY; OPA1	Our objective was to investigate the mitochondrial dynamics following oxygen-glucose deprivation (OGD) in cultured rat cortical neurons. We documented changes in morphology, protein expression, and DNA levels in mitochondria following OGD and examined the roles of mitochondrial fission [dynamin-related protein 1 (Drp1), fission protein-1 (Fis1)] and fusion [mitofusin-1 (Mfn1), mitofusin-2 (Mfn2), and optic atrophy-1 protein (OPA1)] proteins on mitochondrial biogenesis and morphogenesis. We tested the effects of two Drp1 blockers [15-deoxy-Delta 12,14-Prostaglandin J(2) (PGJ(2)) and Mitochondrial Division Inhibitor (Mdivi-1)] on mitochondrial dynamics and cell survival. One hour of OGD had minimal effects on neuronal viability but mitochondria appeared condensed. Three hours of OGD caused a 60% decrease in neuronal viability accompanied by a transition from primarily normal/tubular and lesser number of rounded mitochondria during normoxia to either poorly labeled or small and large rounded mitochondria. The percentage of rounded mitochondria remained the same. The mitochondrial voltage-dependent anion channel, Complex V, and mitoDNA levels increased after OGD associated with a dramatic reduction in Drp1 expression, less reduction in Mfn2 expression, an increase in Mfn1 expression, with no changes in either OPA1 or Fis1. Although PGJ(2) increased polymerization of Drp1, it did not reduce cell death or alter mitochondrial morphology following OGD and Mdivi-1 did not protect neurons against OGD. In summary, mitochondrial biogenesis and maintained fusion occurred in neurons along with mitochondrial fission following OGD; thus Mfn1 but not Drp1 may be a major regulator of these processes.	[Wappler, Edina A.; Dutta, Somhrita; Katakam, Prasad V. G.; Busija, David W.] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA; [Institoris, Adam] Univ Szeged, Sch Med, Dept Physiol, Szeged, Hungary	Tulane University; Szeged University	Wappler, EA (corresponding author), Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.	eawappler@gmail.com	K, P/AAL-6310-2021	Wappler-Guzzetta, Edina/0000-0002-2195-5960; Katakam, Prasad/0000-0002-4708-9140	State of Louisiana; National Institutes of Health [HL-030260, HL-065380, HL-077731, HL-093554]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065380, R01HL077731, R01HL030260, R01HL093554] Funding Source: NIH RePORTER	State of Louisiana; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by Regents Professorship from the State of Louisiana, and National Institutes of Health grants HL-030260, HL-065380,HL-077731 and HL-093554 (Dr. David Busija). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Bertoni-Freddari C, 2003, NATURWISSENSCHAFTEN, V90, P68, DOI 10.1007/s00114-002-0398-8; Blackstone C, 2011, NAT CELL BIOL, V13, P521, DOI 10.1038/ncb0511-521; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chbicheb S, 2011, BIOCHEM PHARMACOL, V81, P1087, DOI 10.1016/j.bcp.2011.02.006; Chen H, 2010, ANN NY ACAD SCI, V1201, P21, DOI 10.1111/j.1749-6632.2010.05615.x; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cho MH, 2012, BRAIN RES, V1454, P100, DOI 10.1016/j.brainres.2012.03.010; Cho SG, 2010, AM J PHYSIOL-RENAL, V299, pF199, DOI 10.1152/ajprenal.00716.2009; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gaspar T, 2006, J NEUROCHEM, V98, P555, DOI 10.1111/j.1471-4159.2006.03899.x; Giedt RJ, 2012, FREE RADICAL BIO MED, V52, P348, DOI [10.1016/j.freeradbiomed.2011.10.491, 10.1007/s10439-012-0568-6]; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Grohm J, 2012, CELL DEATH DIFFER; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kageyama Y, 2011, CURR OPIN CELL BIOL, V23, P427, DOI 10.1016/j.ceb.2011.04.009; Kane CJM, 2011, BRAIN BEHAV IMMUN, V25, pS137, DOI 10.1016/j.bbi.2011.02.016; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Karbowski M, 2010, ADV EXP MED BIOL, V687, P131; Katura T, 2010, MOL PHARMACOL, V77, P601, DOI 10.1124/mol.109.061010; Kis B, 2003, J NEUROCHEM, V87, P969, DOI 10.1046/j.1471-4159.2003.02072.x; Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lin TN, 2006, ARTERIOSCL THROM VAS, V26, P481, DOI 10.1161/01.ATV.0000201933.53964.5b; Liu WT, 2012, J NEUROSCI RES, V90, P1183, DOI 10.1002/jnr.23016; Martinez Alma E., 2012, Inflammation & Allergy Drug Targets, V11, P58; Mishra N, 2010, BIOCHEM BIOPH RES CO, V395, P17, DOI 10.1016/j.bbrc.2010.03.093; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Ong SB, 2012, CARDIOVASC RES, V94, P190, DOI 10.1093/cvr/cvr312; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Otera Hidenori, 2011, Small GTPases, V2, P167; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Park SW, 2011, INVEST OPHTH VIS SCI, V52, P2837, DOI 10.1167/iovs.09-5010; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Qi X, 2011, MOL BIOL CELL, V22, P256, DOI 10.1091/mbc.E10-06-0551; Rambold Angelika S, 2011, Commun Integr Biol, V4, P752; Rival T, 2011, EMBO REP, V12, P223, DOI 10.1038/embor.2010.214; Santel A, 2008, IUBMB LIFE, V60, P448, DOI 10.1002/iub.71; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006.abs; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Tian CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005546; Uo T, 2009, EXP NEUROL, V218, P274, DOI 10.1016/j.expneurol.2009.05.010; Wang WL, 2010, BIOCHEM BIOPH RES CO, V400, P587, DOI 10.1016/j.bbrc.2010.08.108; Westermann B, 2010, SEMIN CELL DEV BIOL, V21, P542, DOI 10.1016/j.semcdb.2009.12.003; Xiang ZM, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-18; Yeh CH, 2006, SHOCK, V26, P262, DOI 10.1097/01.shk.0000225863.56714.96; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Zhang WB, 2010, BIOCHEM BIOPH RES CO, V397, P270, DOI 10.1016/j.bbrc.2010.05.099; Zhao J, 2009, BRAIN RES, V1302, P240, DOI 10.1016/j.brainres.2009.09.034	57	52	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63206	10.1371/journal.pone.0063206	http://dx.doi.org/10.1371/journal.pone.0063206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658809	Green Submitted, Green Published, gold			2022-12-25	WOS:000321200500060
J	Beare, D; McQuatters-Gollop, A; van der Hammen, T; Machiels, M; Teoh, SJ; Hall-Spencer, JM				Beare, Doug; McQuatters-Gollop, Abigail; van der Hammen, Tessa; Machiels, Marcel; Teoh, Shwu Jiau; Hall-Spencer, Jason M.			Long-Term Trends in Calcifying Plankton and pH in the North Sea	PLOS ONE			English	Article							OCEAN; ATLANTIC; IMPACTS; CONSISTENCY	Relationships between six calcifying plankton groups and pH are explored in a highly biologically productive and data-rich area of the central North Sea using time-series datasets. The long-term trends show that abundances of foraminiferans, coccolithophores, and echinoderm larvae have risen over the last few decades while the abundances of bivalves and pteropods have declined. Despite good coverage of pH data for the study area there is uncertainty over the quality of this historical dataset; pH appears to have been declining since the mid 1990s but there was no statistical connection between the abundance of the calcifying plankton and the pH trends. If there are any effects of pH on calcifying plankton in the North Sea they appear to be masked by the combined effects of other climatic (e.g. temperature), chemical (nutrient concentrations) and biotic (predation) drivers. Certain calcified plankton have proliferated in the central North Sea, and are tolerant of changes in pH that have occurred since the 1950s but bivalve larvae and pteropods have declined. An improved monitoring programme is required as ocean acidification may be occurring at a rate that will exceed the environmental niches of numerous planktonic taxa, testing their capacities for acclimation and genetic adaptation.	[Beare, Doug; Teoh, Shwu Jiau] Nat Resources Management, Batu Maung, Penang, Malaysia; [McQuatters-Gollop, Abigail] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England; [van der Hammen, Tessa; Machiels, Marcel] Inst Marine Resources & Ecosyst Studies, Dept Fisheries, Ijmuiden, North Holland, Netherlands; [Hall-Spencer, Jason M.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England	Wageningen University & Research; University of Plymouth	Beare, D (corresponding author), Nat Resources Management, Batu Maung, Penang, Malaysia.	dbeare@cgiar.org	Hall-Spencer, Jason/F-9179-2013; Hall-Spencer, Jason/AFN-7866-2022	Hall-Spencer, Jason/0000-0002-6915-2518; McQuatters-Gollop, Abigail/0000-0002-6043-9563	European Union; European Project on Ocean Acidification; Mediterranean Sea Acidification under a changing climate [265103]; NERC [NE/H01702X/1] Funding Source: UKRI; Natural Environment Research Council [NE/H01702X/1] Funding Source: researchfish; Division Of Ocean Sciences [1154661] Funding Source: National Science Foundation	European Union(European Commission); European Project on Ocean Acidification; Mediterranean Sea Acidification under a changing climate; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The Seventh Framework Programme of the European Union partially funded the current work as part of the projects 'Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors', 'EPOCA: The European Project on Ocean Acidification' and MedSeA: Mediterranean Sea Acidification under a changing climate' (grant agreement 265103). The Consultative Group on International Agricultural Research (CGIAR) Program on Climate Change, Agriculture and Food Security, which is a strategic partnership of CGIAR and Future Earth are also owed a debt of thanks. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artioli Y, 2012, J MARINE SYST, V102, P1, DOI 10.1016/j.jmarsys.2012.04.006; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Batten SD, 2003, PROG OCEANOGR, V58, P193, DOI 10.1016/j.pocean.2003.08.004; Beare DJ, 2002, ICES J MAR SCI, V59, P711, DOI 10.1006/jmsc.2002.1207; Beare DJ, 2002, J SEA RES, V48, P29, DOI 10.1016/S1385-1101(02)00131-4; Beaugrand G, 2013, NAT CLIM CHANGE, V3, P263, DOI 10.1038/NCLIMATE1753; Bijma J, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2002GC000388; BRESLOW NE, 1984, J R STAT SOC C-APPL, V33, P38; Briggs RP, 2002, ICES J MAR SCI, V59, P109, DOI 10.1006/jmsc.2001.1144; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Cigliano M, 2010, MAR BIOL, V157, P2489, DOI 10.1007/s00227-010-1513-6; COLEBROOK J M, 1975, Bulletins of Marine Ecology, V8, P123; Comeau S, 2012, P ROY SOC B-BIOL SCI, V279, P732, DOI 10.1098/rspb.2011.0910; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; de Boer MN, 2010, MAR ECOL PROG SER, V408, P265, DOI 10.3354/meps08598; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; Friedman J. H., 1984, VARIABLE SPAN SMOOTH; Granger C.W., 2000, Q REV ECON FINANC, V40, P337, DOI DOI 10.1016/S1062-9769(00)00042-9; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; HAYS GC, 1993, J MAR BIOL ASSOC UK, V73, P967, DOI 10.1017/S0025315400034846; Head EJH, 2010, J PLANKTON RES, V32, P1633, DOI 10.1093/plankt/fbq090; Heath MR, 2008, MAR ECOL PROG SER, V363, P183, DOI 10.3354/meps07460; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; HYDES DJ, 2013, 2012ACOM83 ICES CM; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Kirby RR, 2007, MAR ECOL PROG SER, V330, P31, DOI 10.3354/meps330031; Kirby RR, 2009, P ROY SOC B-BIOL SCI, V276, P4095, DOI 10.1098/rspb.2009.1320; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/NGEO1441, 10.1038/ngeo1441]; Mackas DL, 2012, ICES J MAR SCI, V69, P448, DOI 10.1093/icesjms/fsr163; McQuatters-Gollop A, 2011, NATURE, V472, pE6, DOI 10.1038/nature09950; MONAGHAN P, 1992, BIODIVERS CONSERV, V1, P98, DOI 10.1007/BF00731037; Nielsen LT, 2010, MAR BIOL RES, V6, P542, DOI 10.1080/17451000903476941; Ohman MD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039901; Provoost P, 2010, BIOGEOSCIENCES, V7, P3869, DOI 10.5194/bg-7-3869-2010; Raitsos DE, 2006, LIMNOL OCEANOGR, V51, P2122, DOI 10.4319/lo.2006.51.5.2122; REID CP, 2002, FISH RES, V50, P163; Reid PC, 2009, ADV MAR BIOL, V56, P1, DOI 10.1016/S0065-2881(09)56001-4; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Stumpp M, 2012, P NATL ACAD SCI USA, V109, P18192, DOI 10.1073/pnas.1209174109; Teal LR, 2008, MAR ECOL PROG SER, V358, P219, DOI 10.3354/meps07367; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Weijerman M, 2005, MAR ECOL PROG SER, V298, P21, DOI 10.3354/meps298021; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105	48	22	22	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61175	10.1371/journal.pone.0061175	http://dx.doi.org/10.1371/journal.pone.0061175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658686	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000007
J	Domingo, MS; Alberdi, MT; Azanza, B; Silva, PG; Morales, J				Domingo, M. Soledad; Alberdi, M. Teresa; Azanza, Beatriz; Silva, Pablo G.; Morales, Jorge			Origin of an Assemblage Massively Dominated by Carnivorans from the Miocene of Spain	PLOS ONE			English	Article							MADRID BASIN; FELIDAE; TAPHONOMY; MACHAIRODONTINAE; BATALLONES-1; SYSTEMATICS; MORTALITY; SIMOCYON; SKELETON; EUROPE	Carnivoran-dominated fossil sites provide precious insights into the diversity and ecology of species rarely recovered in the fossil record. The lower level assemblage of Batallones-1 fossil site (Late Miocene; Madrid Basin, Spain) has yielded one of the most abundant and diversified carnivoran assemblage ever known from the Cenozoic record of mammals. A comprehensive taphonomic study is carried out here in order to constrain the concentration mode of this remarkable assemblage. Another distinctive feature of Batallones-1 is that the accumulation of carnivoran remains took place in the context of a geomorphological landform (cavity formation through a piping process) practically unknown in the generation of fossil sites. Two characteristics of the assemblage highly restrict the probable causes for the accumulation of the remains: (1) the overwhelming number of carnivorans individuals; and (2) the mortality profiles estimated for the four most abundant taxa do not correspond to the classic mortality types but rather were the consequence of the behavior of the taxa. This evidence together with other taphonomic data supports the hypothesis that carnivoran individuals actively entered the cavity searching for resources (food or water) and were unable to exit. The scarcity of herbivores implies that the shaft was well visible and avoided by these taxa. Fossil bones exhibit a very good preservation state as a consequence of their deposition in the restricted and protective environment of the chamber. Batallones-1 had another assemblage (upper level assemblage) that was dominated by herbivore remains and that potentially corresponded to the final stages of the cavity filling.	[Domingo, M. Soledad] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Alberdi, M. Teresa; Morales, Jorge] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Madrid, Spain; [Azanza, Beatriz] Univ Zaragoza, Inst Univ Invest Ciencias Ambientales Aragon, Dept Ciencias Tierra, Fac Ciencias, Zaragoza, Spain; [Silva, Pablo G.] Univ Salamanca, Dept Geol, Escuela Politecn Super Avila, Avila, Spain	University of Michigan System; University of Michigan; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Zaragoza; University of Salamanca	Domingo, MS (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA.	soldomingo@gmail.com	Morales, Jorge/L-1476-2014; Silva, Pablo G./ABG-7664-2020; Alberdi, Maria Teresa/ABG-8623-2020; Azanza, Beatriz/B-5206-2008; Domingo, M. Soledad/I-1614-2014; Silva, Pablo G/G-8950-2015	Morales, Jorge/0000-0001-5170-5754; Silva, Pablo G./0000-0003-1470-292X; Alberdi, Maria Teresa/0000-0002-7071-360X; Azanza, Beatriz/0000-0003-2487-547X; Silva, Pablo G/0000-0003-1470-292X; Domingo, M. Soledad/0000-0002-4755-8867	Spanish Ministry of Economy Competitiveness [CGL2008-05813-C02-01/BTE, CGL2011-25754, CGL2010-19116/BOS]; Fundacion Espanola para la Ciencia y la Tecnologia (FECYT)	Spanish Ministry of Economy Competitiveness(Spanish Government); Fundacion Espanola para la Ciencia y la Tecnologia (FECYT)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was funded by the Spanish Ministry of Economy and Competitiveness research projects CGL2008-05813-C02-01/BTE, CGL2011-25754 and CGL2010-19116/BOS and is included in the BSCH-UCM 910607 Research Group. MSD was supported by a postdoctoral fellowship from the Fundacion Espanola para la Ciencia y la Tecnologia (FECYT) and the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCALA L, 1994, MACROMAMIFEROS NEOGE; Andrews P, 1990, OWLS CAVES FOSSILS; Anton M, 2004, J VERTEBR PALEONTOL, V24, P957, DOI 10.1671/0272-4634(2004)024[0957:FKCSOT]2.0.CO;2; AntuEn, 2000, ARQUEOLOGIA PALEONTO, V6, P190; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Behrensmeyer AK, 1975, B MUS COMP ZOOL HARV, V146, P473; Brain C. K., 1981, HUNTERS HUNTED INTRO; CALVO JP, 1989, PALAEOGEOGR PALAEOCL, V70, P199, DOI 10.1016/0031-0182(89)90090-4; Domingo MS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2138; Domingo MS, 2012, NEUES JAHRB GEOL P-A, V265, P131, DOI 10.1127/0077-7749/2012/0251; Domingo MS, 2012, LETHAIA, V45, P386, DOI 10.1111/j.1502-3931.2011.00294.x; Eberth David A., 2007, P265; Eisenberg J.F., 1981, MAMMALIAN RAD; Cano ARG, 2011, PALAEOGEOGR PALAEOCL, V307, P193, DOI 10.1016/j.palaeo.2011.05.014; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Klein R.G., 1984, ANAL ANIMAL BONES AR; Kos AM, 2003, J ARCHAEOL SCI, V30, P769, DOI 10.1016/S0305-4403(02)00251-0; Lyman RL., 1994, VERTEBRATE TAPHONOMY, DOI [DOI 10.1017/CBO9781139878302, 10.1017/CBO9781139878302]; Marean CW, 1995, J HUM EVOL, V29, P515, DOI 10.1006/jhev.1995.1074; Martin Escorza C, 2005, 16 REUNION BIENAL RE, P109; Mein P., 1975, P 6 C REG COMM MED N, P77; Merino L., 2006, ESTUD GEOL-MADRID, V62, P53; Morales J., 2008, Publicaciones del Seminario de Paleontologia de Zaragoza, V8, P41; Peigne S, 2005, ACTA PALAEONTOL POL, V50, P219; Peigne S, 2008, PALAEONTOLOGY, V51, P943, DOI 10.1111/j.1475-4983.2008.00788.x; Pokines JT, 2007, J ARCHAEOL SCI, V34, P1914, DOI 10.1016/j.jas.2007.01.012; Pozo M., 2004, Geogaceta, V35, P143; Salesa MJ, 2008, ZOOL J LINN SOC-LOND, V152, P593, DOI 10.1111/j.1096-3642.2007.00370.x; Salesa MJ, 2012, J SYST PALAEONTOL, V10, P87, DOI 10.1080/14772019.2011.566584; Salesa MJ, 2010, J ANAT, V216, P381, DOI 10.1111/j.1469-7580.2009.01178.x; Salesa MJ, 2006, J ZOOL, V268, P243, DOI 10.1111/j.1469-7998.2005.00032.x; Salesa MJ, 2006, P NATL ACAD SCI USA, V103, P379, DOI 10.1073/pnas.0504899102; Salesa MJ, 2005, ZOOL J LINN SOC-LOND, V144, P363, DOI 10.1111/j.1096-3642.2005.00174.x; Domingo MS, 2007, PALAEOGEOGR PALAEOCL, V255, P361, DOI 10.1016/j.palaeo.2007.08.004; Domingo MS, 2011, PALAIOS, V26, P55, DOI 10.2110/palo.2010.p10-047r; Spencer LM, 2003, PALEOBIOLOGY, V29, P561, DOI 10.1666/0094-8373(2003)029<0561:TAOLMR>2.0.CO;2; Stock C., 1992, SCI SERIES, V37, P1; VOORHIES M R, 1969, Contributions to Geology Special Paper, P1; Wang X., 1993, NATL GEOGRAPHIC RES, V9, P422; Wolverton S, 2006, J HUM EVOL, V50, P540, DOI 10.1016/j.jhevol.2005.12.009	40	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63046	10.1371/journal.pone.0063046	http://dx.doi.org/10.1371/journal.pone.0063046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650542	Green Submitted, Green Published, gold			2022-12-25	WOS:000319167000087
J	Kuo, RL; Kao, LT; Lin, SJ; Wang, RYL; Shih, SR				Kuo, Rei-Lin; Kao, Li-Ting; Lin, Sue-Jane; Wang, Robert Yung-Liang; Shih, Shin-Ru			MDA5 Plays a Crucial Role in Enterovirus 71 RNA-Mediated IRF3 Activation	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; INTERFERON REGULATORY FACTOR-3; HEPATITIS-C VIRUS; RIG-I; ANTIVIRAL RESPONSES; ADAPTER PROTEIN; INNATE IMMUNITY; POLIOVIRUS INFECTION; 5'-TRIPHOSPHATE RNA	Induction of type-I interferons (IFNs), IFN-alpha/beta, is crucial to innate immunity against RNA virus infection. Cytoplasmic retinoic acid-inducible gene I (RIG-I)-like receptors, including RIG-I and melanoma differentiation-associated gene 5 (MDA5), are critical pathogen sensors for activation of type-I IFN expression in response to RNA virus infection. MDA5 is required for type-I IFN expression in mouse models in response to infection by picornaviruses, such as encephalomyocarditis virus (EMCV) and coxsackievirus B3. Enterovirus 71 (EV71) belongs to picornaviridae and contains positive-stranded RNA genome that is linked with VPg protein at the 5' end. Although a recent study showed that EV71 3C protease could suppress RIG-I-mediated IFN-beta response, the cytoplasmic RIG-I-like receptor that is directly involved in the recognition of EV71 RNA remains unclear. Using EV71-derived RNA as an agonist, we demonstrate that MDA5 is involved in EV71 RNA-mediated IRF3 activation and IFN-beta transcription. Our data also show that overexpression of the MDA5 protein reverses the suppression of IRF3 activation caused by EV71 infection. These results indicate that MDA5 is an important factor for EV71 RNA-activated type-I IFN expression. Furthermore, we also show that EV71 infection enhances MDA5 degradation and that the degradation could be inhibited by a broad spectrum caspase inhibitor.	[Kuo, Rei-Lin; Kao, Li-Ting; Lin, Sue-Jane; Wang, Robert Yung-Liang; Shih, Shin-Ru] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Tao Yuan, Taiwan; [Kuo, Rei-Lin; Kao, Li-Ting; Lin, Sue-Jane; Shih, Shin-Ru] Chang Gung Univ, Coll Med, Dept Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Wang, Robert Yung-Liang] Chang Gung Univ, Coll Med, Dept Biomed Sci, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University	Kuo, RL (corresponding author), Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Tao Yuan, Taiwan.	rlkuo@mail.cgu.edu.tw	Shih, Shin-Ru/M-9711-2016; Wang, Robert YL/AAI-8416-2020	Wang, Robert YL/0000-0002-1322-3890; Shih, Shin-Ru/0000-0003-4874-401X	Chang Gung Memorial Hospital [CMRPD 1A0571]; National Science Council, Taiwan [NSC100-2320-B-182-019-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Chang Gung Memorial Hospital (grant no. CMRPD 1A0571) and the National Science Council (grant no. NSC100-2320-B-182-019-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2012, J VIROL, V86, P185, DOI 10.1128/JVI.05245-11; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Drahos J, 2009, J VIROL, V83, P11581, DOI 10.1128/JVI.01490-09; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jin YH, 2012, J VIROL, V86, P1531, DOI 10.1128/JVI.06457-11; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kuo RL, 2010, VIROLOGY, V408, P146, DOI 10.1016/j.virol.2010.09.012; Kuo RL, 2002, J GEN VIROL, V83, P1367, DOI 10.1099/0022-1317-83-6-1367; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; RACANIELLO VR, 2007, FIELDS VIROLOGY, P796; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rodriguez-Pulido M, 2011, J VIROL, V85, P6492, DOI 10.1128/JVI.00599-11; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Thompson SR, 2003, VIROLOGY, V315, P259, DOI 10.1016/S0042-6822(03)00544-0; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Wang JP, 2010, J VIROL, V84, P254, DOI 10.1128/JVI.00631-09; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Weng KF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000593; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	49	69	79	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63431	10.1371/journal.pone.0063431	http://dx.doi.org/10.1371/journal.pone.0063431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650567	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000112
J	Ruano, C; Henriquez, P; Martinez-Gonzalez, MA; Bes-Rastrollo, M; Ruiz-Canela, M; Sanchez-Villegas, A				Ruano, Cristina; Henriquez, Patricia; Angel Martinez-Gonzalez, Miguel; Bes-Rastrollo, Maira; Ruiz-Canela, Miguel; Sanchez-Villegas, Almudena			Empirically Derived Dietary Patterns and Health-Related Quality of Life in the SUN Project	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MEDITERRANEAN DIET; FATTY-ACIDS; DEPRESSIVE SYMPTOMS; NEUROTROPHIC FACTOR; INSULIN-RESISTANCE; METABOLIC SYNDROME; GLYCEMIC INDEX; FAST-FOOD; RISK	Objective: The analysis of dietary patterns has become a valuable tool to examine diet-disease relationships but little is known about their effects on quality of life. Our aim was to ascertain the association between major dietary patterns and mental and physical quality of life after 4 years of follow-up. Materials and Methods: This analysis included 11,128 participants from the "Seguimiento Universidad de Navarra'' (SUN) cohort. Dietary habits were assessed using a validated food-frequency questionnaire. Factor analysis was used to derive dietary patterns. Quality of life was measured with the validated Spanish version of the SF-36 Health Survey. Results: Two major dietary patterns were identified, the 'Western' dietary pattern (rich in red meats, processed pastries and fast-food) and the "Mediterranean'' dietary pattern (high in fruits, vegetables and olive oil). After controlling for confounders, the Western dietary pattern was associated with quality of life in all domains. The magnitude of these differences between the subjects in the highest (quintile 5) and the lowest quintile of adherence to the Western pattern ranged from 20.8 (for mental health) to 23.5 (for vitality). On the contrary, the Mediterranean dietary pattern was associated with better quality of life domains: differences ranged from + 1.3 (for physical functioning) to + 3.4 (for vitality) when comparing extreme quintiles of adherence. Additional sensitivity analyses did not change the reported differences. Conclusions: Whereas baseline adherence to a Western dietary pattern was inversely associated with self-perceived quality of life after 4 years of follow-up, baseline adherence to a Mediterranean dietary pattern was directly associated with better scores in quality of life four years later in the SUN Project.	[Ruano, Cristina; Henriquez, Patricia; Sanchez-Villegas, Almudena] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Angel Martinez-Gonzalez, Miguel; Bes-Rastrollo, Maira; Ruiz-Canela, Miguel; Sanchez-Villegas, Almudena] Univ Navarra, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Ruano, Cristina; Henriquez, Patricia; Angel Martinez-Gonzalez, Miguel; Sanchez-Villegas, Almudena] Inst Salud Carlos III, Ciber Fisiopatol Obesidad & Nutr, CIBEROBN, CB06 03, Madrid, Spain	Universidad de Las Palmas de Gran Canaria; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Ruano, C (corresponding author), Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain.	cruano@proyinves.ulpgc.es	Bes-Rastrollo, Maira/A-1329-2009; Ruiz-Canela, Miguel/I-7738-2016; Sanchez-Villegas, Almudena/T-6733-2019; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Stefanadis, Christodoulos/ABH-2232-2020	Bes-Rastrollo, Maira/0000-0002-9139-4206; Ruiz-Canela, Miguel/0000-0002-7684-2787; Sanchez-Villegas, Almudena/0000-0001-7733-9238; Stefanadis, Christodoulos/0000-0001-5974-6454; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808	Instituto de Salud Carlos III, Official Agency of the Spanish Government for biomedical research [PI01/0619, PI030678, PI040233, PI042241, PI050976, PI070240, PI070312, PI081943, PI080819, PI1002293, PI1002658, RD06/0045, G03/140]; Navarra Regional Government [36/2001, 43/2002, 41/2005, 36/2008]	Instituto de Salud Carlos III, Official Agency of the Spanish Government for biomedical research; Navarra Regional Government	The SUN Project has received funding from Instituto de Salud Carlos III, Official Agency of the Spanish Government for biomedical research (Grants PI01/0619, PI030678, PI040233, PI042241, PI050976, PI070240, PI070312, PI081943, PI080819, PI1002293, PI1002658, RD06/0045, and G03/140), the Navarra Regional Government (36/2001, 43/2002, 41/2005 and 36/2008) and the University of Navarra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; ALONSO J, 1999, MED CLIN-BARCELONA, V12, P113; Ascherio A, 1999, NEW ENGL J MED, V340, P1994, DOI 10.1056/NEJM199906243402511; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Bes-Rastrollo M, 2005, REV ESP OBESIDAD, V3, P352; Bottiglieri T, 1996, NUTR REV, V54, P382, DOI 10.1111/j.1753-4887.1996.tb03851.x; Castren E, 1998, PROG BRAIN RES, V117, P57; Chrysohoou C, 2004, J AM COLL CARDIOL, V44, P152, DOI 10.1016/j.jacc.2004.03.039; Corica F, 2008, INT J OBESITY, V32, P185, DOI 10.1038/sj.ijo.0803687; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; de la Fuente-Arrillaga C, 2010, PUBLIC HEALTH NUTR, V13, P1364, DOI 10.1017/S1368980009993065; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Juan PMFS, 2009, NUTR HOSP, V24, P515, DOI 10.3305/nh.2009.24.5.4461; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Galland L, 2010, NUTR CLIN PRACT, V25, P634, DOI 10.1177/0884533610385703; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Guiterrez-Bedmar M, 2009, INT J ENV RES PUB HE, V6, P310, DOI 10.3390/ijerph6010310; Sanchez PH, 2012, EUR J CLIN NUTR, V66, P360, DOI 10.1038/ejcn.2011.146; Hislop TG, 2006, J CLIN ONCOL, V24, P2311, DOI 10.1200/JCO.2005.04.3042; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Isganaitis E, 2005, ARTERIOSCL THROM VAS, V25, P2451, DOI 10.1161/01.ATV.0000186208.06964.91; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Kim J.-O., 1978, FACTOR ANAL STAT MET; Levitan EB, 2008, METABOLISM, V57, P437, DOI 10.1016/j.metabol.2007.11.002; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; Martinez-Gonzalez MA, 2002, NUTR NEUROSCI, V5, P65, DOI 10.1080/10284150290007047; MARTINEZGONZALE.MA, 2006, BMJ-BRIT MED J, V336, P1348; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Mataix Verdu J., 2009, TABLA COMPOSICION AL, V5th; McKeown NM, 2004, DIABETES CARE, V27, P538, DOI 10.2337/diacare.27.2.538; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Munoz MA, 2009, BRIT J NUTR, V101, P1821, DOI 10.1017/S0007114508143598; Murakami K, 2008, NUTRITION, V24, P140, DOI 10.1016/j.nut.2007.10.013; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Plaisted CS, 1999, J AM DIET ASSOC, V99, pS84, DOI 10.1016/S0002-8223(99)00421-6; Pucci G, 2012, QUAL LIFE RES, V21, P1537, DOI 10.1007/s11136-011-0083-5; Raczek AE, 1998, J CLIN EPIDEMIOL, V51, P1203, DOI 10.1016/S0895-4356(98)00112-7; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Serra-Majem L, 2009, BRIT J NUTR, V101, pS21, DOI 10.1017/S0007114509990559; Serrano-Aguilar P, 2009, QUAL LIFE RES, V18, P171, DOI 10.1007/s11136-008-9427-1; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Terry P, 2001, CANCER EPIDEM BIOMAR, V10, P1281; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Trichopoulos D, 2001, BRIT J NUTR, V85, P133, DOI 10.1079/BJN2000282; TRICHOPOULOU A, 2009, BMJ-BRIT MED J, V23, P338; UTTS J, 1996, SEEING STAT; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; Verberne L, 2010, NUTR CANCER, V62, P860, DOI 10.1080/01635581.2010.509834; Vilagut G, 2008, MED CLIN-BARCELONA, V130, P726, DOI 10.1157/13121076; Vogl M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-203; WANNAMETHEE G, 1991, INT J EPIDEMIOL, V20, P239, DOI 10.1093/ije/20.1.239; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Willet W, 1998, NUTR EPIDEMIOLOGY	64	32	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61490	10.1371/journal.pone.0061490	http://dx.doi.org/10.1371/journal.pone.0061490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23658694	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000015
J	Sanganahalli, BG; Herman, P; Hyder, F; Kannurpatti, SS				Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed; Kannurpatti, Sridhar S.			Mitochondrial Functional State Impacts Spontaneous Neocortical Activity and Resting State fMRI	PLOS ONE			English	Article							RAT SOMATOSENSORY CORTEX; BOLD SIGNAL FLUCTUATIONS; NEURONAL-ACTIVITY; DEFAULT NETWORK; IN-VIVO; INTERHEMISPHERIC SYNCHRONY; ALZHEIMERS-DISEASE; ENERGY-METABOLISM; SLOW OSCILLATIONS; CALCIUM-UPTAKE	Mitochondrial Ca2+ uptake, central to neural metabolism and function, is diminished in aging whereas enhanced after acute/sub-acute traumatic brain injury. To develop relevant translational models for these neuropathologies, we determined the impact of perturbed mitochondrial Ca2+ uptake capacities on intrinsic brain activity using clinically relevant markers. From a multi-compartment estimate of probable baseline Ca2+ ranges in the brain, we hypothesized that reduced or enhanced mitochondrial Ca2+ uptake capacity would decrease or increase spontaneous neuronal activity respectively. As resting state fMRI-BOLD fluctuations and stimulus-evoked BOLD responses have similar physiological origins [ 1] and stimulus-evoked neuronal and hemodynamic responses are modulated by mitochondrial Ca2+ uptake capacity [2,3] respectively, we tested our hypothesis by measuring hemodynamic fluctuations and spontaneous neuronal activities during normal and altered mitochondrial functional states. Mitochondrial Ca2+ uptake capacity was perturbed by pharmacologically inhibiting or enhancing the mitochondrial Ca2+ uniporter (mCU) activity. Neuronal electrical activity and cerebral blood flow (CBF) fluctuations were measured simultaneously and integrated with fMRI-BOLD fluctuations at 11.7T. mCU inhibition reduced spontaneous neuronal activity and the resting state functional connectivity (RSFC), whereas mCU enhancement increased spontaneous neuronal activity but reduced RSFC. We conclude that increased or decreased mitochondrial Ca2+ uptake capacities lead to diminished resting state modes of brain functional connectivity.	[Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Hyder, Fahmeed] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT USA; [Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Dept Magnet Resonance Res Ctr, New Haven, CT USA; [Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Core Ctr Quantitat Neurosci Magnet Resonance, New Haven, CT USA; [Kannurpatti, Sridhar S.] UMDNJ New Jersey Med Sch, Dept Radiol, Newark, NJ USA	Yale University; Yale University; Yale University; Yale University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kannurpatti, SS (corresponding author), UMDNJ New Jersey Med Sch, Dept Radiol, Newark, NJ USA.	kannursr@umdnj.edu	Sanganahalli, Basavaraju G/C-3296-2008; Herman, Peter/E-7028-2010; Hyder, Fahmeed/A-2644-2015	Sanganahalli, Basavaraju G/0000-0002-0851-6621; Hyder, Fahmeed/0000-0001-7822-4002; Herman, Peter/0000-0003-2218-9652	American Heart Association [0930132N]; National Institute of Health [P30NS052519]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067528] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the American Heart Association 0930132N (SK) and National Institute of Health P30NS052519 (FH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bardutzky J, 2005, J CEREBR BLOOD F MET, V25, P968, DOI 10.1038/sj.jcbfm.9600095; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Busche MA, 2012, P NATL ACAD SCI US; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; Fluegge D, 2012, NAT NEUROSCI, V15, P754, DOI 10.1038/nn.3074; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Huttunen JK, 2008, NEUROIMAGE, V39, P775, DOI 10.1016/j.neuroimage.2007.06.042; Hyder F, 2010, P NATL ACAD SCI USA, V107, P10773, DOI 10.1073/pnas.1005135107; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kalthoff D, 2011, NEUROIMAGE, V54, P2828, DOI 10.1016/j.neuroimage.2010.10.053; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1738, DOI 10.1016/j.neuroimage.2007.05.061; Kannurpatti SS, 2008, J CEREBR BLOOD F MET, V28, P772, DOI 10.1038/sj.jcbfm.9600574; Kannurpatti SS, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00007; Kannurpatti SS, 2010, MAGN RESON IMAGING, V28, P466, DOI 10.1016/j.mri.2009.12.007; Kannurpatti SS, 2000, NEUROCHEM RES, V25, P1527, DOI 10.1023/A:1026602100160; Kannurpatti SS BB, 2003, MAP REVERSIBLE MODUL, P1856; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Kreiner L, 2006, J BIOL CHEM, V281, P4691, DOI 10.1074/jbc.M511971200; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESLIE SW, 1985, BRAIN RES, V329, P177, DOI 10.1016/0006-8993(85)90523-2; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Luu P, 2001, J CLIN NEUROPHYSIOL, V18, P302, DOI 10.1097/00004691-200107000-00002; Masamoto K, 2012, J CEREBR BLOOD F MET, V32, P1233, DOI 10.1038/jcbfm.2012.50; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Montero M, 2004, BIOCHEM J, V384, P19, DOI 10.1042/BJ20040990; Moreira PI, 2006, J ALZHEIMERS DIS, V9, P101; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nagayama S, 2007, NEURON, V53, P789, DOI 10.1016/j.neuron.2007.02.018; Nemoto EM, 2005, ADV EXP MED BIOL, V566, P83; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Paxinos G., 1996, RAT BRAIN STEREOTAXI; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Sanganahalli BG, 2009, J NEUROSCI, V29, P1707, DOI 10.1523/JNEUROSCI.5549-08.2009; Sanganahalli BG, 2013, J CEREBRAL IN PRESS; Sarnat HB, 2011, CAN J NEUROL SCI, V38, P909, DOI 10.1017/S0317167100012518; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Schulz K, 2012, NAT METHODS, V9, P597, DOI [10.1038/NMETH.2013, 10.1038/nmeth.2013]; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Simpson PB, 2000, J BIOENERG BIOMEMBR, V32, P5, DOI 10.1023/A:1005552126516; Simpson PB, 1998, BRAIN RES REV, V26, P72, DOI 10.1016/S0165-0173(97)00056-8; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Tsytsarev V, 2012, J NEUROSCI METH, V203, P136, DOI 10.1016/j.jneumeth.2011.09.005; Ueki M, 1992, ACTA ANAESTH SCAND, V36, P5; Verkhratsky A, 2012, MOL CELL ENDOCRINOL, V353, P45, DOI 10.1016/j.mce.2011.08.039; Vern BA, 1997, BRAIN RES, V775, P233, DOI 10.1016/S0006-8993(97)01028-7; Vern BA, 1998, ADV EXP MED BIOL, V454, P561; VITORICA J, 1986, BRAIN RES, V378, P36, DOI 10.1016/0006-8993(86)90284-2; Zetterling M, 2010, NEUROSURGERY, V66, P1102, DOI 10.1227/01.NEU.0000370893.04586.73; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	72	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63317	10.1371/journal.pone.0063317	http://dx.doi.org/10.1371/journal.pone.0063317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650561	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000106
J	Sun, GL; Yang, YF; Xie, FL; Wen, JF; Wu, JQ; Wilson, IW; Tang, Q; Liu, HW; Qiu, DY				Sun, Guiling; Yang, Yanfang; Xie, Fuliang; Wen, Jian-Fan; Wu, Jianqiang; Wilson, Iain W.; Tang, Qi; Liu, Hongwei; Qiu, Deyou			Deep Sequencing Reveals Transcriptome Re-Programming of Taxus x media Cells to the Elicitation with Methyl Jasmonate	PLOS ONE			English	Article							SUSPENSION-CULTURES; EXPRESSION ANALYSIS; TAXOL BIOSYNTHESIS; GENE-EXPRESSION; PACLITAXEL; IDENTIFICATION; ARABIDOPSIS; TRANSPORT; CDNA; ACID	Background: Plant cell culture represents an alternative source for producing high-value secondary metabolites including paclitaxel (Taxol (R)), which is mainly produced in Taxus and has been widely used in cancer chemotherapy. The phytohormone methyl jasmonate (MeJA) can significantly increase the production of paclitaxel, which is induced in plants as a secondary metabolite possibly in defense against herbivores and pathogens. In cell culture, MeJA also elicits the accumulation of paclitaxel; however, the mechanism is still largely unknown. Methodology/Principal Findings: To obtain insight into the global regulation mechanism of MeJA in the steady state of paclitaxel production (7 days after MeJA addition), especially on paclitaxel biosynthesis, we sequenced the transcriptomes of MeJA-treated and untreated Taxus x media cells and obtained similar to 32.5 M high quality reads, from which 40,348 unique sequences were obtained by de novo assembly. Expression level analysis indicated that a large number of genes were associated with transcriptional regulation, DNA and histone modification, and MeJA signaling network. All the 29 known genes involved in the biosynthesis of terpenoid backbone and paclitaxel were found with 18 genes showing increased transcript abundance following elicitation of MeJA. The significantly up-regulated changes of 9 genes in paclitaxel biosynthesis were validated by qRT-PCR assays. According to the expression changes and the previously proposed enzyme functions, multiple candidates for the unknown steps in paclitaxel biosynthesis were identified. We also found some genes putatively involved in the transport and degradation of paclitaxel. Potential target prediction of miRNAs indicated that miRNAs may play an important role in the gene expression regulation following the elicitation of MeJA. Conclusions/Significance: Our results shed new light on the global regulation mechanism by which MeJA regulates the physiology of Taxus cells and is helpful to understand how MeJA elicits other plant species besides Taxus.	[Sun, Guiling; Wu, Jianqiang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming, Peoples R China; [Yang, Yanfang; Liu, Hongwei; Qiu, Deyou] Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Res Inst Forestry, Beijing, Peoples R China; [Xie, Fuliang] E Carolina Univ, Dept Biol, Greenville, NC USA; [Wen, Jian-Fan] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Wilson, Iain W.] CSIRO Plant Ind, Canberra, ACT, Australia; [Tang, Qi] Guangxi Bot Garden Med Plant, Nanning, Guangxi, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; University of North Carolina; East Carolina University; Chinese Academy of Sciences; Kunming Institute of Zoology; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Qiu, DY (corresponding author), Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Res Inst Forestry, Beijing, Peoples R China.	qiudy@caf.ac.cn	Wilson, Iain/D-4839-2009; Wu, Jianqiang/A-7169-2019	Wilson, Iain/0000-0002-4626-8059; Wu, Jianqiang/0000-0002-7726-6216; Tang, Qi/0000-0003-2385-4263	National Natural Science Foundation of China [31170628]; Kunming Institute of Botany; Chinese Academy of Sciences; Yunnan Recruitment Program of Experts in Sciences [2012HA016]; Thousand Youth Talents Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Kunming Institute of Botany; Chinese Academy of Sciences(Chinese Academy of Sciences); Yunnan Recruitment Program of Experts in Sciences; Thousand Youth Talents Program	This work is supported by a grant from the National Natural Science Foundation of China (31170628) and a startup grant from Kunming Institute of Botany, Chinese Academy of Sciences, to the Group of Molecular Ecology, a grant from Yunnan Recruitment Program of Experts in Sciences (2012HA016), and a grant from Thousand Youth Talents Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-600; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Courdavault V, 2009, PLANT CELL REP, V28, P83, DOI 10.1007/s00299-008-0610-1; Croteau Rodney, 2006, Phytochemistry Reviews, V5, P75, DOI 10.1007/s11101-005-3748-2; De Sutter V, 2005, PLANT J, V44, P1065, DOI 10.1111/j.1365-313X.2005.02586.x; Duek PD, 2005, TRENDS PLANT SCI, V10, P51, DOI 10.1016/j.tplants.2004.12.005; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Exposito O, 2010, BIOTECHNOL PROGR, V26, P1145, DOI 10.1002/btpr.424; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fornale S, 2002, PLANT PHYSIOL BIOCH, V40, P81, DOI 10.1016/S0981-9428(01)01332-8; Galis I, 2006, PLANT J, V46, P573, DOI 10.1111/j.1365-313X.2006.02719.x; HABEREDER H, 1989, PLANTA, V177, P58, DOI 10.1007/BF00392154; Hao DC, 2008, BIOL PHARM BULL, V31, P260, DOI 10.1248/bpb.31.260; HAO DC, 2011, PLOS ONE, P6; Holton RA., 1995, TAXOL SCI APPL, P97, DOI DOI 10.1002/CHIN.199552275; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jennewein S, 2004, P NATL ACAD SCI USA, V101, P9149, DOI 10.1073/pnas.0403009101; Katsir L, 2008, CURR OPIN PLANT BIOL, V11, P428, DOI 10.1016/j.pbi.2008.05.004; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Ketchum REB, 2007, PHYTOCHEMISTRY, V68, P335, DOI 10.1016/j.phytochem.2006.10.019; Ketchum REB, 2003, PHYTOCHEMISTRY, V62, P901, DOI 10.1016/S0031-9422(02)00711-2; Ketchum REB, 1999, BIOTECHNOL BIOENG, V62, P97, DOI 10.1002/(SICI)1097-0290(19990105)62:1&lt;97::AID-BIT11&gt;3.0.CO;2-C; Lenka SK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-148; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li FL, 2011, AFR J BIOTECHNOL, V10, P8720; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li ST, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-295; Liao ZH, 2005, MOL BIOL+, V39, P11, DOI 10.1007/s11008-005-0002-3; McGuire WP, 2001, SCIENCE, V292, P1073, DOI 10.1126/science.1058201; Mirjalili N, 1996, BIOTECHNOL PROGR, V12, P110, DOI 10.1021/bp9500831; Morita M, 2009, P NATL ACAD SCI USA, V106, P2447, DOI 10.1073/pnas.0812512106; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Naill MC, 2012, BIOCHEM ENG J, V63, P50, DOI 10.1016/j.bej.2012.01.006; Onrubia M., 2012, THESIS U POMPEU FABR; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Prasad BRV, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-37; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Rao SR, 2002, BIOTECHNOL ADV, V20, P101, DOI 10.1016/S0734-9750(02)00007-1; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rozen S, 2000, Methods Mol Biol, V132, P365; Sasaki Y, 2001, DNA RES, V8, P153, DOI 10.1093/dnares/8.4.153; Schaller F, 2000, PLANTA, V210, P979, DOI 10.1007/s004250050706; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shultz RW, 2009, PLANT PHYSIOL, V150, P658, DOI 10.1104/pp.109.136614; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; SLICHENMYER WJ, 1991, ANTI-CANCER DRUG, V2, P519, DOI 10.1097/00001813-199112000-00002; Smetanska I, 2008, ADV BIOCHEM ENG BIOT, V111, P187, DOI 10.1007/10_2008_103; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Sun GL, 2012, PLANT MOL BIOL, V80, P17, DOI 10.1007/s11103-011-9817-6; Swiatek A, 2002, PLANT PHYSIOL, V128, P201, DOI 10.1104/pp.010592; Tabata H, 2004, ADV BIOCHEM ENG BIOT, V87, P1; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; WAGNER LJ, 1994, PHYTOPATHOLOGY, V84, P1173, DOI 10.1094/Phyto-84-1173; Walker K, 2000, P NATL ACAD SCI USA, V97, P13591, DOI 10.1073/pnas.250491997; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; WITHERUP KM, 1990, J NAT PROD, V53, P1249, DOI 10.1021/np50071a017; Wu Q, 2011, PLANTA MED, V77, P394, DOI 10.1055/s-0030-1250331; Xie FL, 2010, BIOINFORMATICS, V26, P3002, DOI 10.1093/bioinformatics/btq568; YOUNG SA, 1995, PLANT PHYSIOL, V107, P1333, DOI 10.1104/pp.107.4.1333; Yukimune Y, 1996, NAT BIOTECHNOL, V14, P1129, DOI 10.1038/nbt0996-1129; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003; Zhao J, 2011, PLANT CELL, V23, P1536, DOI 10.1105/tpc.110.080804; Zhao J, 2009, PLANT CELL, V21, P2323, DOI 10.1105/tpc.109.067819; Zhou CH, 2005, PLANT CELL, V17, P1196, DOI 10.1105/tpc.104.028514	66	28	33	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62865	10.1371/journal.pone.0062865	http://dx.doi.org/10.1371/journal.pone.0062865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646152	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300105
J	Nielsen, SS; Toft, N; Okura, H				Nielsen, Soren Saxmose; Toft, Nils; Okura, Hisako			Dynamics of Specific Anti-Mycobacterium avium Subsp paratuberculosis Antibody Response through Age	PLOS ONE			English	Article							BOVINE-PARATUBERCULOSIS; DAIRY-COWS; IMMUNE-RESPONSES; DIAGNOSTIC-TESTS; MILK-PRODUCTION; CATTLE; ELISA; INFECTIONS; SIMULATION; MODEL	Mycobacterium avium subsp. paratuberculosis (MAP) causes a chronic infection in cattle. MAP infected cattle with humoral immune (HI) reactions with IgG antibodies are usually those where latency of infection has ceased and their infection is progressing towards reduced milk yield, weight loss and significant bacterial excretion in feces. The proportion of detectable infections among all infected animals that will develop disease is often referred to as 'the tip of the iceberg'. The purpose of this study was to estimate this proportion. Test-records from 18,972 Danish dairy cows with MAP specific IgG antibodies on their final test-record were used to estimate age-specific sensitivities (Se). These cows were the infected ones considered to develop disease in a population with a representative age-distribution and were defined as cases. The specificity (Sp) of the test was estimated based on test-results from 166,905 cows, which had no MAP IgG antibodies in their final four test-records. The Sp, age-specific Se and maximum Se were used to estimate the probability of having HI at a given age resulting in the proportion of infected cows with HI at a given age. For cows 2 years of age, the proportion of detectable cases was 0.33, while it was 0.94 for cows 5 years of age. Thus, there was a significant shift in the tip of the iceberg with aging. This study provided a model for estimating the proportion of latent chronic infections that would progress to disease, and the results can be used to model infection dynamics.	[Nielsen, Soren Saxmose; Toft, Nils; Okura, Hisako] Univ Copenhagen, Dept Large Anim Sci, Frederiksberg C, Denmark	University of Copenhagen	Nielsen, SS (corresponding author), Univ Copenhagen, Dept Large Anim Sci, Frederiksberg C, Denmark.	saxmose@sund.ku.dk		Nielsen, Soren/0000-0003-2417-0787; Toft, Nils/0000-0002-0265-3764	University of Copenhagen; Danish Government	University of Copenhagen; Danish Government	Salaries for the authors were paid by University of Copenhagen based on basic funding from the Danish Government. The Danish Cattle Federation made available the data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begg DJ, 2011, IMMUNOBIOLOGY, V216, P840, DOI 10.1016/j.imbio.2010.12.004; Collins MT, 2005, CLIN DIAGN LAB IMMUN, V12, P685, DOI 10.1128/CDLI.12.6.685-692.2005; Collins MT, 2002, CLIN DIAGN LAB IMMUN, V9, P1367, DOI 10.1128/CDLI.9.6.1367-1371.2002; Coussens Paul M., 2001, Animal Health Research Reviews, V2, P141; Coussens PM, 2004, INFECT IMMUN, V72, P3089, DOI 10.1128/IAI.72.6.3089-3096.2004; Groenendaal H, 2002, PREV VET MED, V54, P225, DOI 10.1016/S0167-5877(02)00027-2; Hastie TJT RJ, 1997, GEN ADDITIVE MODELS; Koets AP, 2001, INFECT IMMUN, V69, P1492, DOI 10.1128/IAI.69.3.1492-1498.2001; Kudahl AB, 2009, J DAIRY SCI, V92, P4340, DOI 10.3168/jds.2009-2039; Kudahl AB, 2007, PREV VET MED, V78, P97, DOI 10.1016/j.prevetmed.2006.05.015; Marce C, 2010, J DAIRY SCI, V93, P4455, DOI 10.3168/jds.2010-3139; Mitchell RM, 2008, PREV VET MED, V83, P360, DOI 10.1016/j.prevetmed.2007.09.006; Nielsen SS, 2007, CATTLE PRACT, V15, P161; Nielsen SS, 2006, J DAIRY SCI, V89, P4557, DOI 10.3168/jds.S0022-0302(06)72505-X; Nielsen SS, 2009, J DAIRY SCI, V92, P149, DOI 10.3168/jds.2008-1488; Nielsen SS, 2008, VET MICROBIOL, V132, P274, DOI 10.1016/j.vetmic.2008.05.018; Nielsen SS, 2012, VET IMMUNOL IMMUNOP, V149, P6, DOI 10.1016/j.vetimm.2012.05.013; Nielsen SS, 2006, J DAIRY SCI, V89, P569, DOI 10.3168/jds.S0022-0302(06)72120-8; OIE, 2009, VAL CERT DIAGN ASS; Parikka M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002944; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Sorge US, 2011, J DAIRY SCI, V94, P754, DOI 10.3168/jds.2010-3404; Stabel JR, 2009, VET MICROBIOL, V136, P306, DOI 10.1016/j.vetmic.2008.11.025; Stabel JR, 2001, VET IMMUNOL IMMUNOP, V79, P69, DOI 10.1016/S0165-2427(01)00253-7; Subharat S, 2012, VET IMMUNOL IMMUNOP, V149, P225, DOI 10.1016/j.vetimm.2012.07.005; Sweeney RW, 2011, VET CLIN N AM-FOOD A, V27, P537, DOI 10.1016/j.cvfa.2011.07.001; van Hulzen KJE, 2012, J DAIRY SCI, V95, P2740, DOI 10.3168/jds.2011-5005; Wells SJKN, 2010, EFFECT DELAYING EXPO, P19; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2; Windsor PA, 2010, VET J, V184, P37, DOI 10.1016/j.tvjl.2009.01.007	30	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e63009	10.1371/journal.pone.0063009	http://dx.doi.org/10.1371/journal.pone.0063009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658660	Green Published, Green Submitted, gold			2022-12-25	WOS:000321662800073
J	Chen, L; Phillips, AL; Condon, AG; Parry, MAJ; Hu, YG				Chen, Liang; Phillips, Andrew L.; Condon, Anthony G.; Parry, Martin A. J.; Hu, Yin-Gang			GA-Responsive Dwarfing Gene Rht12 Affects the Developmental and Agronomic Traits in Common Bread Wheat	PLOS ONE			English	Article							SPRING-WHEAT; COLEOPTILE LENGTH; GRAIN-YIELD; PHOTOPERIOD SENSITIVITY; FLORET DEVELOPMENT; STEM ELONGATION; ISOGENIC LINES; KERNEL NUMBER; EARLY GROWTH; HEIGHT	Opportunities exist for replacing reduced height (Rht) genes Rht-B1b and Rht-D1b with alternative dwarfing genes, such as the gibberellin-responsive gene Rht12, for bread wheat improvement. However, a comprehensive understanding of the effects and mode of action of Rht12 is lacking. In the present study, the effects of Rht12 were characterized by analyzing its effects on seeding vigour, seedling roots, leaf and stem morphology, spike development and carbohydrate assimilation and distribution. This was carried out in the four genotypes of F-2:3 lines derived from a cross between Ningchun45 and Karcagi (12) in two experiments of autumn sowing and spring sowing. Rht12 significantly decreased stem length (43%similar to 48% for peduncle) and leaf length (25%similar to 30% for flag leaf) while the thickness of the internode walls and width of the leaves were increased. Though the final plant stature was shortened (40%) by Rht12, the seedling vigour, especially coleoptile length and root traits at the seedling stage, were not affected adversely. Rht12 elongated the duration of the spike development phase, improved the proportion of spike dry weight at anthesis and significantly increased floret fertility (14%) in the autumn sowing experiment. However, Rht12 delayed anthesis date by around 5 days and even the dominant Vrn-B1 allele could not compensate this negative effect. Additionally, grain size was reduced with the ability to support spike development after anthesis decreased in Rht12 lines. Finally, grain yield was similar between the dwarf and tall lines in the autumn sowing experiment. Thus, Rht12 could substantially reduce plant height without altering seeding vigour and significantly increase spikelet fertility in the favourable autumn sowing environment. The successful utilization of Rht12 in breeding programs will require careful selection since it might delay ear emergence. Nonetheless, the potential exists for wheat improvement by using Rht12.	[Chen, Liang; Hu, Yin-Gang] NW A& F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Phillips, Andrew L.; Parry, Martin A. J.] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England; [Condon, Anthony G.] CSIRO Plant Ind, Canberra, ACT, Australia; [Hu, Yin-Gang] NW A& F Univ, Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Northwest A&F University - China	Hu, YG (corresponding author), NW A& F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	huyingang@nwsuaf.edu.cn	Condon, Anthony G/F-3255-2011	Parry, Martin/0000-0002-4477-672X	Ministry of Science and Technology [2011AA100504, 2013AA102902]; Northwest AF University [ZD2012002]; China 111 Project P. R. China [B12007]; ACIAR Project of Australia [CIM/2005/111]; Biotechnology and Biological Sciences Research Council (BBSRC) of the UK under the 20:20 Wheat(R) Institute Strategic Programme; BBSRC [BBS/E/C/00005202, BB/E006922/1, BB/I000607/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005202, BB/E006922/1, BB/I000607/1] Funding Source: researchfish	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Northwest AF University; China 111 Project P. R. China; ACIAR Project of Australia(Australian Ctr Intl Agr Res); Biotechnology and Biological Sciences Research Council (BBSRC) of the UK under the 20:20 Wheat(R) Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the sub-project of the 863 Program (2011AA100504, 2013AA102902) of the Ministry of Science and Technology, the key project of Chinese Universities Scientific Fund, Northwest A&F University (ZD2012002) and the China 111 Project (B12007), P. R. China, as well as the ACIAR Project (CIM/2005/111) of Australia. ALP and MAJP are supported by the Biotechnology and Biological Sciences Research Council (BBSRC) of the UK under the 20:20 Wheat (R) Institute Strategic Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addisu M, 2009, EUPHYTICA, V166, P249, DOI 10.1007/s10681-008-9838-7; Aldrich J., 1993, Plant Molecular Biology Reporter, V11, P128, DOI 10.1007/BF02670471; ALLAN RE, 1989, CROP SCI, V29, P1103, DOI 10.2135/cropsci1989.0011183X002900050001x; Bancal MO, 2007, ANN BOT-LONDON, V100, P777, DOI 10.1093/aob/mcm163; Berry PM, 2007, EUPHYTICA, V154, P165, DOI 10.1007/s10681-006-9284-3; Berry PM, 2000, FIELD CROP RES, V67, P59, DOI 10.1016/S0378-4290(00)00084-8; Botwright TL, 2005, ANN BOT-LONDON, V95, P631, DOI 10.1093/aob/mci069; Botwright TL, 2001, EUPHYTICA, V119, P349, DOI 10.1023/A:1017527911084; Butler JD, 2005, CROP SCI, V45, P939, DOI 10.2135/cropsci2004.0323; Calderini DF, 1996, ANN BOT-LONDON, V77, P583, DOI 10.1006/anbo.1996.0073; Chapman SC, 2007, EUPHYTICA, V157, P391, DOI 10.1007/s10681-006-9304-3; Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; Chen LA, 2011, AUST J CROP SCI, V5, P318; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Ellis MH, 2005, THEOR APPL GENET, V111, P423, DOI 10.1007/s00122-005-2008-6; Ellis MH, 2004, FUNCT PLANT BIOL, V31, P583, DOI 10.1071/FP03207; FISCHER RA, 1980, AUST J PLANT PHYSIOL, V7, P169, DOI 10.1071/PP9800169; FISCHER RA, 1975, CROP SCI, V15, P607, DOI 10.2135/cropsci1975.0011183X001500050002x; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; FLINTHAM JE, 1983, THEOR APPL GENET, V66, P249, DOI 10.1007/BF00251155; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; GARDNER JS, 1985, AM J BOT, V72, P548, DOI 10.2307/2443587; Gasperini D, 2012, J EXP BOT, V63, P4419, DOI 10.1093/jxb/ers138; Gonzalez FG, 2005, EUPHYTICA, V146, P253, DOI 10.1007/s10681-005-9021-3; Gonzalez FG, 2003, FIELD CROP RES, V81, P29, DOI 10.1016/S0378-4290(02)00196-X; GRIFFITHS FEW, 1985, ANN BOT-LONDON, V56, P501, DOI 10.1093/oxfordjournals.aob.a087035; Hansen H, 2000, PLANT PHYSIOL, V124, P1437, DOI 10.1104/pp.124.3.1437; HAUN JR, 1973, AGRON J, V65, P116, DOI 10.2134/agronj1973.00021962006500010035x; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Iwaki K, 2002, THEOR APPL GENET, V104, P571, DOI 10.1007/s00122-001-0769-0; KEYES GJ, 1989, ANN BOT-LONDON, V64, P683, DOI 10.1093/oxfordjournals.aob.a087894; KIRBY EJM, 1988, FIELD CROP RES, V18, P127, DOI 10.1016/0378-4290(88)90004-4; Korzun V, 1997, PLANT BREEDING, V116, P227, DOI 10.1111/j.1439-0523.1997.tb00987.x; LAW CN, 1976, HEREDITY, V36, P49, DOI 10.1038/hdy.1976.5; Mahdi L, 1998, FIELD CROP RES, V58, P187, DOI 10.1016/S0378-4290(98)00094-X; Miralles DJ, 1995, PLANT BREEDING, V114, P392, DOI 10.1111/j.1439-0523.1995.tb00818.x; Miralles DJ, 1998, FIELD CROP RES, V59, P21, DOI 10.1016/S0378-4290(98)00103-8; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Prasil IT, 2004, ANN BOT-LONDON, V94, P413, DOI 10.1093/aob/mch158; PUGSLEY AT, 1971, AUST J AGR RES, V22, P21, DOI 10.1071/AR9710021; Rebetzke GJ, 2007, FIELD CROP RES, V100, P10, DOI 10.1016/j.fcr.2006.05.001; Rebetzke GJ, 2012, FIELD CROP RES, V126, P87, DOI 10.1016/j.fcr.2011.09.022; Rebetzke GJ, 2004, AUST J AGR RES, V55, P733, DOI 10.1071/AR04037; Rebetzke GJ, 1999, EUPHYTICA, V106, P159, DOI 10.1023/A:1003518920119; Rebetzke GJ, 2000, AUST J AGR RES, V51, P235, DOI 10.1071/AR99043; RICHARDS RA, 1992, AUST J AGR RES, V43, P529, DOI 10.1071/AR9920529; SHACKLEY BJ, 1995, AUST J EXP AGR, V35, P579, DOI 10.1071/EA9950579; Slafer GA, 1996, FIELD CROP RES, V46, P1, DOI 10.1016/0378-4290(95)00081-X; SLAFER GA, 1994, AUST J PLANT PHYSIOL, V21, P393, DOI 10.1071/PP9940393; SLAFER GA, 1990, FIELD CROP RES, V23, P255, DOI 10.1016/0378-4290(90)90058-J; Slafer GA, 2001, EUPHYTICA, V119, P191, DOI 10.1023/A:1017535632171; STAPPER M, 1990, AUST J AGR RES, V41, P1021, DOI 10.1071/AR9901043; SUTKA J, 1987, EUPHYTICA, V36, P521, DOI 10.1007/BF00041496; Thomas SG, 2004, PLANT PHYSIOL, V135, P668, DOI 10.1104/pp.104.040279; VIGLASI P, 1968, ACTA AGRON HUNG, V17, P205; WADDINGTON SR, 1983, ANN BOT-LONDON, V51, P119, DOI 10.1093/oxfordjournals.aob.a086434; Wojciechowski T, 2009, J EXP BOT, V60, P2565, DOI 10.1093/jxb/erp107; Worland AJ, 1998, THEOR APPL GENET, V96, P1110, DOI 10.1007/s001220050846; WORLAND AJ, 1988, PLANT BREEDING, V100, P247, DOI 10.1111/j.1439-0523.1988.tb00250.x; WORLAND AJ, 1994, PLANT BREEDING, V113, P187, DOI 10.1111/j.1439-0523.1994.tb00722.x; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; YOUSSEFIAN S, 1992, FIELD CROP RES, V28, P191, DOI 10.1016/0378-4290(92)90040-G; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang XK, 2006, EUPHYTICA, V152, P109, DOI 10.1007/s10681-006-9184-6	66	52	58	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62285	10.1371/journal.pone.0062285	http://dx.doi.org/10.1371/journal.pone.0062285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658622	Green Submitted, Green Published, gold			2022-12-25	WOS:000318343700046
J	Viotti, J; Duplan, E; Caillava, C; Condat, J; Goiran, T; Giordano, C; Marie, Y; Idbaih, A; Delattre, JY; Honnorat, J; Checler, F; Alves Da Costa, C				Viotti, J.; Duplan, E.; Caillava, C.; Condat, J.; Goiran, T.; Giordano, C.; Marie, Y.; Idbaih, A.; Delattre, J-Y; Honnorat, J.; Checler, F.; Alves Da Costa, C.			Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity	ONCOGENE			English	Article						human brain glioma; glioblastoma cells; tumor grade; parkin; p53; transcription	SUPPRESSOR GENE; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; BRAIN-TUMORS; BAX GENE; IN-VITRO; MUTATIONS; PROTEIN; CANCER; EXPRESSION	Gliomas represent the most frequent form of primary brain tumors in adults, the prognosis of which remains extremely poor. Inactivating mutations on the tumor suppressor TP53 were proposed as a key etiological trigger of glioma development. p53 has been recently identified as a transcriptional target of parkin. Interestingly, somatic mutations on parkin have also been linked to glioma genesis. We examined the possibility that a disruption of a functional interaction between p53 and parkin could contribute to glioma development in samples devoid of somatic parkin mutations or genetic allele deletion. We show here that parkin levels inversely correlate to brain tumor grade and p53 levels in oligodendrogliomas, mixed gliomas and glioblastomas. We demonstrate that p53 levels negatively and positively correlate to bax and Bcl2 respectively, underlying a loss of p53 transcriptional activity in all types of glial tumors. Using various cell models lacking p53 or harboring either transcriptionally inactive or dominant negative p53, as well as in p53 knockout mice brain, we establish that p53 controls parkin promoter transactivation, mRNA and protein levels. Furthermore, we document an increase of parkin expression in mice brain after p53-bearing viral infection. Finally, both cancer-related p53 inactivating mutations and deletion of a consensus p53 binding sequence located on parkin promoter abolish p53-mediated control of parkin transcription, demonstrating that p53 regulates parkin transcription via its DNA binding properties. In conclusion, our work delineates a functional interplay between mutated p53 and parkin in glioma genesis that is disrupted by cancer-linked pathogenic mutations. It also allows envisioning parkin as a novel biomarker of glioma biopsies enabling to follow the progression of this type of cancers.	[Viotti, J.; Duplan, E.; Caillava, C.; Condat, J.; Goiran, T.; Giordano, C.; Checler, F.; Alves Da Costa, C.] CNRS, Inst Pharmacol Mol & Cellulaire, UNSA, Team Labeled Fdn,Rech Med & Lab Excellemce LABEX, F-06560 Valbonne, France; [Marie, Y.; Idbaih, A.; Delattre, J-Y] Univ Paris 06, AP HP, Grp Hosp Pitie Salpetriere,UMR 975, Ctr Rech,Inst Cerveau & Moelle Epiniere,Serv Neur, Paris, France; [Honnorat, J.] Hop Neurol, Hosp Civils Lyon, Ctr Reference Maladies Rares Syndromes Neurol Par, Lyon, France; [Honnorat, J.] Ctr Rech Neurosci Lyon, Inserm U1028, CNRS UMR 5292, Lyon, France; [Honnorat, J.] Univ Lyon 1, Univ Lyon, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Checler, F (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UNSA, Team Labeled Fdn,Rech Med & Lab Excellemce LABEX, Valbonne,PACA, F-06560 Valbonne, France.	checler@ipmc.cnrs.fr; acosta@ipmc.cnrs.fr	Honnorat, jerome/G-6394-2017; Duplan, Eric/AAK-8224-2020; Checler, Frederic/C-1241-2009; da Costa, Cristine Alves/G-8075-2011; Idbaih, Ahmed/N-8746-2017	Honnorat, jerome/0000-0002-4721-5952; Duplan, Eric/0000-0002-1348-1507; Checler, Frederic/0000-0003-2098-1750; da Costa, Cristine Alves/0000-0002-7777-005X; Giordano, Cecile/0000-0003-3641-8647; Idbaih, Ahmed/0000-0001-5290-1204; goiran, thomas/0000-0001-5838-8798	Fondation pour la Recherche Medicale; Conseil General des Alpes Maritimes; LABEX (excellence laboratory, program investment for the future) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease); AMPA (Association Monegasque Pour la recherche sur la Maladie d'Alzheimer); ARC ("Association pour la recherche contre le cancer")	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); LABEX (excellence laboratory, program investment for the future) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease); AMPA (Association Monegasque Pour la recherche sur la Maladie d'Alzheimer); ARC ("Association pour la recherche contre le cancer")(Fondation ARC pour la Recherche sur le Cancer)	Drs Roussel, Bourdon and Serrano are thanked for providing us with p53 knockout cells, MCF-7 cells and mice brains. Drs West and Oren are acknowledged for providing us with parkin-luciferase and PG13 constructs. JV was supported by AMPA (Association Monegasque Pour la recherche sur la Maladie d'Alzheimer) and ARC ("Association pour la recherche contre le cancer"). This work was supported by the 'Fondation pour la Recherche Medicale' and by the 'Conseil General des Alpes Maritimes'. This work has been developed and supported through the LABEX (excellence laboratory, program investment for the future) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease). Cristine Alves da Costa is recipient of a Hospital Contract for Translational Research (CHRT) between INSERM and the Hospices Civils de Lyon.	Agirre X, 2006, INT J CANCER, V118, P1945, DOI 10.1002/ijc.21584; Asker C, 1999, BIOCHEM BIOPH RES CO, V265, P1, DOI 10.1006/bbrc.1999.1446; Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099; Bourdon JC, 2003, CELL DEATH DIFFER, V10, P397, DOI 10.1038/sj.cdd.4401243; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100; Costa SL, 2001, EUR J CANCER, V37, P520, DOI 10.1016/S0959-8049(00)00430-5; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; da Costa CA, 2009, NAT CELL BIOL, V11, P1370, DOI 10.1038/ncb1981; Deguin-Chambon V, 2000, ONCOGENE, V19, P5831, DOI 10.1038/sj.onc.1203960; Edlund K, 2012, P NATL ACAD SCI USA, V109, P9551, DOI 10.1073/pnas.1200019109; Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199; Fulci G, 1998, BRAIN PATHOL, V8, P599, DOI 10.1111/j.1750-3639.1998.tb00187.x; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; GINSBERG D, 1990, ONCOGENE, V5, P1285; Hainaut P, 1997, NUCLEIC ACIDS RES, V25, P151, DOI 10.1093/nar/25.1.151; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Idbaih A, 2005, ANN NEUROL, V58, P483, DOI 10.1002/ana.20607; Idbaih A, 2008, INT J CANCER, V122, P1778, DOI 10.1002/ijc.23270; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Letessier A, 2007, ONCOGENE, V26, P298, DOI 10.1038/sj.onc.1209772; Lim YP, 2007, ONCOGENE, V26, P1517, DOI 10.1038/sj.onc.1209952; Maintz D, 1997, J NEUROPATH EXP NEUR, V56, P1098, DOI 10.1097/00005072-199710000-00003; Midgley CA, 1997, ONCOGENE, V15, P1179, DOI 10.1038/sj.onc.1201459; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, ONCOGENE, V9, P1799; MIYASHITA T, 1994, CANCER RES, V54, P3131; Nayak A, 2004, NEUROL INDIA, V52, P228; Nozaki M, 1999, Neuro Oncol, V1, P124, DOI 10.1093/neuonc/1.2.124; OHGAKI H, 1991, CANCER RES, V51, P6202; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Picchio MC, 2004, CLIN CANCER RES, V10, P2720, DOI 10.1158/1078-0432.CCR-03-0086; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; ROTTER V, 1983, P NATL ACAD SCI-BIOL, V80, P2613, DOI 10.1073/pnas.80.9.2613; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sigal A, 2000, CANCER RES, V60, P6788; Soussi T, 2010, HUM MUTAT, V31, P1020, DOI 10.1002/humu.21313; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Wang F, 2004, GENE CHROMOSOME CANC, V40, P85, DOI 10.1002/gcc.20020; Watanabe K, 1997, CLIN CANCER RES, V3, P523; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; West AB, 2003, J MOL BIOL, V326, P11, DOI 10.1016/S0022-2836(02)01376-1; Yeo CWS, 2012, CANCER RES, V72, P2543, DOI 10.1158/0008-5472.CAN-11-3060; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	53	45	46	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2014	33	14					1764	1775		10.1038/onc.2013.124	http://dx.doi.org/10.1038/onc.2013.124			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RE	23644658				2022-12-25	WOS:000334345500003
J	Kaan, HYK; Major, J; Tkocz, K; Kozielski, F; Rosenfeld, SS				Kaan, Hung Yi Kristal; Major, Jennifer; Tkocz, Katarzyna; Kozielski, Frank; Rosenfeld, Steven S.			"Snapshots" of Ispinesib-induced Conformational Changes in the Mitotic Kinesin Eg5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC INHIBITION; MONASTROL INHIBITION; CRYSTAL-STRUCTURE; SMALL-MOLECULE; NECK-LINKER; MOTOR; MODEL; MECHANISM; KINETICS; BINDING	Kinesins comprise a superfamily of molecular motors that drive a wide variety of cellular physiologies, from cytoplasmic transport to formation of the bipolar spindle in mitosis. These differing roles are reflected in corresponding polymorphisms in key kinesin structural elements. One of these is a unique loop and stem motif found in all kinesins and referred to as loop 5 (L5). This loop is longest in the mitotic kinesin Eg5 and is the target for a number of small molecule inhibitors, including ispinesib, which is being used in clinical trials in patients with cancer. In this study, we have used x-ray crystallography to identify a new structure of an Eg5-ispinesib complex and have combined this with transient state kinetics to identify a plausible sequence of conformational changes that occur in response to ispinesib binding. Our results demonstrate that ispinesib-induced structural changes in L5 from Eg5 lead to subsequent changes in the conformation of the switch II loop and helix and in the neck linker. We conclude that L5 in Eg5 simultaneously regulates the structure of both the ATP binding site and the motor's mechanical elements that generate force.	[Kaan, Hung Yi Kristal; Tkocz, Katarzyna; Kozielski, Frank] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Major, Jennifer; Rosenfeld, Steven S.] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Beatson Institute; Cleveland Clinic Foundation	Kozielski, F (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	f.kozielski@beatson.gla.ac.uk; rosenfs@ccf.org			National Institutes of Health [GM102875]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM102875 (to S. S. R.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beer TM, 2008, CLIN GENITOURIN CANC, V6, P103, DOI 10.3816/CGC.2008.n.016; Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; Burris HA, 2011, INVEST NEW DRUG, V29, P467, DOI 10.1007/s10637-009-9374-x; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endow SA, 2010, J CELL SCI, V123, P3420, DOI 10.1242/jcs.064113; Garcia-Saez I, 2004, J MOL BIOL, V340, P1107, DOI 10.1016/j.jmb.2004.05.053; Goulet A, 2012, J BIOL CHEM, V287, P44654, DOI 10.1074/jbc.M112.404228; Kaan HYK, 2010, BIOCHEM J, V425, P55, DOI 10.1042/BJ20091207; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Maliga Z, 2006, J BIOL CHEM, V281, P7977, DOI 10.1074/jbc.M511955200; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Nesmelov YE, 2011, P NATL ACAD SCI USA, V108, P1891, DOI 10.1073/pnas.1012320108; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Rosenfeld SS, 1996, J BIOL CHEM, V271, P9473, DOI 10.1074/jbc.271.16.9473; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Talapatra SK, 2012, ACTA CRYSTALLOGR D, V68, P1311, DOI 10.1107/S0907444912027965; Tcherniuk S, 2010, BIOCHEM PHARMACOL, V79, P864, DOI 10.1016/j.bcp.2009.11.001; TRYBUS KM, 1982, BIOCHEMISTRY-US, V21, P1284, DOI 10.1021/bi00535a028; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	33	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18588	18598		10.1074/jbc.M113.462648	http://dx.doi.org/10.1074/jbc.M113.462648			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23658017	Green Published, hybrid			2022-12-25	WOS:000320721900058
J	Auffret, AG; Cousins, SAO				Auffret, Alistair G.; Cousins, Sara A. O.			Humans as Long-Distance Dispersers of Rural Plant Communities	PLOS ONE			English	Article							HUMAN-MEDIATED DISPERSAL; SEED DISPERSAL; LANDSCAPE; HISTORY; TRAITS; SHEEP	Humans are known for their capacity to disperse organisms long distances. Long-distance dispersal can be important for species threatened by habitat destruction, but research into human-mediated dispersal is often focused upon few and/or invasive species. Here we use citizen science to identify the capacity for humans to disperse seeds on their clothes and footwear from a known species pool in a valuable habitat, allowing for an assessment of the fraction and types of species dispersed by humans in an alternative context. We collected material from volunteers cutting 48 species-rich meadows throughout Sweden. We counted 24 354 seeds of 197 species, representing 34% of the available species pool, including several rare and protected species. However, 71 species (36%) are considered invasive elsewhere in the world. Trait analysis showed that seeds with hooks or other appendages were more likely to be dispersed by humans, as well as those with a persistent seed bank. More activity in a meadow resulted in more dispersal, both in terms of species and representation of the source communities. Average potential dispersal distances were measured at 13 km. We consider humans capable seed dispersers, transporting a significant proportion of the plant communities in which they are active, just like more traditional vectors such as livestock. When rural populations were larger, people might have been regular and effective seed dispersers, and the net rural-urban migration resulting in a reduction in humans in the landscape may have exacerbated the dispersal failure evident in declining plant populations today. With the fragmentation of habitat and changes in land use resulting from agricultural change, and the increased mobility of humans worldwide, the dispersal role of humans may have shifted from providers of regular local and landscape dispersal to providers of much rarer long-distance and regional dispersal, and international invasion.	[Auffret, Alistair G.; Cousins, Sara A. O.] Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden	Stockholm University	Auffret, AG (corresponding author), Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden.	alistair.auffret@natgeo.su.se	Cousins, Sara/A-2437-2012; Auffret, Alistair/AGB-4949-2022; Auffret, Alistair/AAJ-7335-2020	Cousins, Sara/0000-0003-2656-2645; Auffret, Alistair/0000-0002-4190-4423	Stockholm University; cross-disciplinary project EkoKlim at Stockholm University	Stockholm University; cross-disciplinary project EkoKlim at Stockholm University	Funding was provided by AEW Smitt's scholarship from Stockholm University 2009/10 and and the cross-disciplinary project EkoKlim at Stockholm University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggemyr E, 2012, J BIOGEOGR, V39, P1645, DOI 10.1111/j.1365-2699.2012.02733.x; Aronsson M., 2010, 2010 RED LIST SWEDIS, P201; Auffret AG, 2012, J VEG SCI, V23, P970, DOI 10.1111/j.1654-1103.2012.01413.x; Auffret AG, 2011, APPL VEG SCI, V14, P291, DOI 10.1111/j.1654-109X.2011.01124.x; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Bruun HH, 2002, AMBIO, V31, P425, DOI 10.1639/0044-7447(2002)031[0425:TPIOLH]2.0.CO;2; Bullock JM, 2011, OIKOS, V120, P1201, DOI 10.1111/j.1600-0706.2010.19092.x; Chown SL, 2012, P NATL ACAD SCI USA, V109, P4938, DOI 10.1073/pnas.1119787109; CLIFFORD H. T., 1956, Proceedings of the Botanical Society of the British Isles, V2, P129; Cortes MC, 2013, BIOL REV, V88, P255, DOI 10.1111/j.1469-185X.2012.00250.x; Cousins SAO, 2001, LANDSCAPE ECOL, V16, P41, DOI 10.1023/A:1008108704358; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; FALINSKI J B, 1972, Acta Societatis Botanicorum Poloniae, V41, P357, DOI 10.5586/asbp.1972.028; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Holl S, 2009, GEOINFORMATICS; Hovstad KA, 2009, J VEG SCI, V20, P455, DOI 10.1111/j.1654-1103.2009.01049.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Keitt TH, 2012, RDBIPGSQL POSTGRESQL; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Mount A, 2009, J ENVIRON MANAGE, V91, P168, DOI 10.1016/j.jenvman.2009.08.002; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Ozinga WA, 2009, ECOL LETT, V12, P66, DOI 10.1111/j.1461-0248.2008.01261.x; Partel M, 1999, LANDSCAPE ECOL, V14, P187, DOI 10.1023/A:1008040114832; Pickering C, 2010, J SUSTAIN TOUR, V18, P239, DOI 10.1080/09669580903406613; Pickering CM, 2011, BIOL INVASIONS, V13, P1869, DOI 10.1007/s10530-011-0006-y; R_Development_Core_Team, 2011, R LANG ENV STAT COMP; Romermann C, 2005, OIKOS, V110, P219, DOI 10.1111/j.0030-1299.2005.13911.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Satterthwaite D, 2010, PHILOS T R SOC B, V365, P2809, DOI 10.1098/rstb.2010.0136; Solymos P, 2009, J STAT SOFTW, V29, P1; Soons MB, 2005, DIVERS DISTRIB, V11, P165, DOI 10.1111/j.1366-9516.2005.00148.x; Stein C, 2008, OIKOS, V117, P1469, DOI 10.1111/j.0030-1299.2008.16766.x; Taylor K, 2012, DIVERS DISTRIB, V18, P942, DOI 10.1111/j.1472-4642.2012.00926.x; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Vargas P, 2012, ECOGRAPHY, V35, P33, DOI 10.1111/j.1600-0587.2011.06980.x; von der Lippe M, 2012, PERSPECT PLANT ECOL, V14, P123, DOI 10.1016/j.ppees.2011.09.006; Wagner HH, 2013, ECOGRAPHY, V36, P374, DOI 10.1111/j.1600-0587.2012.07463.x; Ware C, 2012, BIOL INVASIONS, V14, P567, DOI 10.1007/s10530-011-0098-4; Wichmann MC, 2009, P ROY SOC B-BIOL SCI, V276, P523, DOI 10.1098/rspb.2008.1131; Wilson JB, 2012, J VEG SCI, V23, P796, DOI 10.1111/j.1654-1103.2012.01400.x; Woodruffe-Peacock EA, 1918, J ECOL, V6, P110, DOI 10.2307/2255362	43	33	34	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62763	10.1371/journal.pone.0062763	http://dx.doi.org/10.1371/journal.pone.0062763			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658770	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500037
J	Qian, YF; Dai, JH; Liu, R; Chen, MJ; Zhou, XT; Chu, RY				Qian, Yi-Feng; Dai, Jin-Hui; Liu, Rui; Chen, Min-Jie; Zhou, Xing-Tao; Chu, Ren-Yuan			Effects of the Chromatic Defocus Caused by Interchange of Two Monochromatic Lights on Refraction and Ocular Dimension in Guinea Pigs	PLOS ONE			English	Article							FORM-DEPRIVATION MYOPIA; EYE GROWTH; SPECTACLE LENSES; ACCOMMODATION; ABERRATION; COMPENSATION; SIMULATIONS; SIGNALS; EMMETROPIZATION; RESPONSES	To investigate refractive and axial responses to the shift of focal plane resulting from the interchange of two monochromatic lights separately corresponding to the peak wavelengths of the cones absorption spectrum in retina, fifty 2-week-old pigmented guinea pigs were randomly assigned to five groups based on the mode of illumination: short-wavelength light (SL), middle-wavelength light (ML) and broad-band white light (BL) for 20 weeks, SL for 10 weeks followed by ML for 10 weeks (STM), as well as ML for 10 weeks followed by SL for 10 weeks (MTS). Biometric and refractive measurements were then performed every 2 weeks. After 10 weeks, SL and STM groups became more hyperopic and had less vitreous elongation than BL group. However, ML and MTS groups became more myopic and had more vitreous elongation. After interchange of the monochromatic light, the refractive error decreased rapidly by about 1.93D and the vitreous length increased by 0.14 mm in STM group from 10 to 12 weeks. After that, there were no significant intergroup differences between STM and BL groups. The interchange from ML to SL quickly increased the refractive error by about 1.53D and decreased the vitreous length by about 0.13 mm in MTS group after two weeks. At this time, there were also no significant intergroup differences between MTS and BL groups. The guinea pig eye can accurately detect the shift in focal plane caused by interchange of two monochromatic lights and rapidly generate refractive and axial responses. However, an excessive compensation was induced. Some properties of photoreceptors or retina may be changed by the monochromatic light to influence the following refractive development.	[Qian, Yi-Feng; Dai, Jin-Hui; Liu, Rui; Chen, Min-Jie; Zhou, Xing-Tao; Chu, Ren-Yuan] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Qian, Yi-Feng; Dai, Jin-Hui; Liu, Rui; Chen, Min-Jie; Zhou, Xing-Tao; Chu, Ren-Yuan] Minist Hlth PR China, Key Lab Myopia, Shanghai, Peoples R China	Fudan University	Dai, JH (corresponding author), Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China.	daijinhui8@126.com	zhou, xt/GWZ-9212-2022		National Natural Science Foundation of China [81070750, 81271040, 81100689]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants from the National Natural Science Foundation of China (No. 81070750 and 81271040 to JHD, No. 81100689 to RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FINCHAM EF, 1951, BRIT J OPHTHALMOL, V35, P381, DOI 10.1136/bjo.35.7.381; FLITCROFT DI, 1990, VISUAL NEUROSCI, V5, P547, DOI 10.1017/S0952523800000705; Graham B, 1999, VISION RES, V39, P189, DOI 10.1016/S0042-6989(98)00189-8; Howlett MHC, 2009, VISION RES, V49, P219, DOI 10.1016/j.visres.2008.10.008; Howlett MC, 2002, INVEST OPHTHALMOL VI, V43; Howlett MHC, 2006, VISION RES, V46, P267, DOI 10.1016/j.visres.2005.06.036; HUNG LF, 1995, NAT MED, V1, P761, DOI 10.1038/nm0895-761; JACOBS GH, 1994, BEHAV NEUROSCI, V108, P993, DOI 10.1037/0735-7044.108.5.993; Kroger RHH, 1996, J COMP PHYSIOL A, V179, P837; KROGER RHH, 1994, VISION RES, V34, P1807, DOI 10.1016/0042-6989(94)90305-0; Kruger PB, 2005, VISION RES, V45, P1265, DOI 10.1016/j.visres.2004.11.017; KRUGER PB, 1993, VISION RES, V33, P1397, DOI 10.1016/0042-6989(93)90046-Y; KRUGER PB, 1995, VISION RES, V35, P2415, DOI 10.1016/0042-6989(94)00316-5; Kruger PB, 1997, VISION RES, V37, P2511, DOI 10.1016/S0042-6989(97)00056-4; Lee JH, 1999, OPHTHAL PHYSL OPT, V19, P223, DOI 10.1046/j.1475-1313.1999.00440.x; Liu R, 2011, EXP EYE RES, V92, P447, DOI 10.1016/j.exer.2011.03.003; Lu F, 2009, EXP EYE RES, V89, P101, DOI 10.1016/j.exer.2009.02.019; MCBRIEN NA, 1992, VISION RES, V32, P843, DOI 10.1016/0042-6989(92)90027-G; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; ROHRER B, 1992, J PHYSIOL-LONDON, V449, P363, DOI 10.1113/jphysiol.1992.sp019090; Rucker FJ, 2008, VISION RES, V48, P1929, DOI 10.1016/j.visres.2008.06.021; Rucker FJ, 2004, VISION RES, V44, P2931, DOI 10.1016/j.visres.2004.07.005; Rucker FJ, 2008, VISION RES, V48, P1980, DOI 10.1016/j.visres.2008.06.003; Rucker FJ, 2009, VISION RES, V49, P1775, DOI 10.1016/j.visres.2009.04.014; SCHAEFFEL F, 1991, VISION RES, V31, P717, DOI 10.1016/0042-6989(91)90011-S; Seidemann A, 2002, VISION RES, V42, P2409, DOI 10.1016/S0042-6989(02)00262-6; Shaikh AW, 1999, OPTOMETRY VISION SCI, V76, P308, DOI 10.1097/00006324-199905000-00019; Siegwart JT, 1998, VISION RES, V38, P3505, DOI 10.1016/S0042-6989(98)00053-4; Smith EL, 1999, OPTOMETRY VISION SCI, V76, P428, DOI 10.1097/00006324-199906000-00023; SMITH EL, 1987, INVEST OPHTH VIS SCI, V28, P1236; Smith EL, 1999, VISION RES, V39, P1415, DOI 10.1016/S0042-6989(98)00229-6; SMITH EL, 1994, VISION RES, V34, P293, DOI 10.1016/0042-6989(94)90088-4; Smith EL, 2000, VISION RES, V40, P371, DOI 10.1016/S0042-6989(99)00184-4; Stark LR, 2002, VISION RES, V42, P1485, DOI 10.1016/S0042-6989(02)00074-3; TROILO D, 1993, VISION RES, V33, P1311, DOI 10.1016/0042-6989(93)90039-Y; WALLMAN J, 1987, VISION RES, V27, P1139, DOI 10.1016/0042-6989(87)90027-7; WIESEL TN, 1977, NATURE, V266, P66, DOI 10.1038/266066a0; WILDSOET C, 1995, VISION RES, V35, P1175, DOI 10.1016/0042-6989(94)00233-C; WILDSOET CF, 1993, VISION RES, V33, P1593, DOI 10.1016/0042-6989(93)90026-S; Zhou XT, 2007, VISION RES, V47, P1103, DOI 10.1016/j.visres.2007.01.002	40	18	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63229	10.1371/journal.pone.0063229	http://dx.doi.org/10.1371/journal.pone.0063229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658814	gold, Green Published, Green Submitted			2022-12-25	WOS:000321200500063
J	Di Domizio, J; Dorta-Estremera, S; Cao, W				Di Domizio, Jeremy; Dorta-Estremera, Stephanie; Cao, Wei			Methylated BSA Mimics Amyloid-Related Proteins and Triggers Inflammation	PLOS ONE			English	Article							BACTERIAL-DNA; P-COMPONENT; MISFOLDING DISEASES; NALP3 INFLAMMASOME; IMMUNE-RESPONSE; NUCLEIC-ACIDS; STRANDED-DNA; NORMAL MICE; ARTHRITIS; OLIGOMERS	The mechanistic study of inflammatory or autoimmune diseases requires the generation of mouse models that reproduce the alterations in immune responses observed in patients. Methylated bovine serum albumin (mBSA) has been widely used to induce antigen-specific inflammation in targeted organs or in combination with single stranded DNA (ssDNA) to generate anti-nucleic acids antibodies in vivo. However, the mechanism by which this modified protein triggers inflammation is poorly understood. By analyzing the biochemical properties of mBSA, we found that mBSA exhibits features of an intermediate of protein misfolding pathway. mBSA readily interact with a list of dyes that have binding specificity towards amyloid fibrils. Intriguingly, mBSA displayed cytotoxic activity and its binding to ssDNA further enhanced formation of beta-sheet rich amyloid fibrils. Moreover, mBSA is recognized by the serum amyloid P, a protein unanimously associated with amyloid plaques in vivo. In macrophages, we observed that mBSA disrupted the lysosomal compartment, signaled along the NLRP3 inflammasome pathway, and activated caspase 1, which led to the production of IL-1 beta. In vivo, mBSA triggered rapid and prominent immune cell infiltration that is dependent on IL-1 beta induction. Taken together, these data demonstrate that by mimicking amyloidogenic proteins mBSA exhibits strong innate immune functions and serves as a potent adjuvant. These findings advance our understanding on the underlying mechanism of how aberrant immune responses lead to autoimmune reactions.	[Di Domizio, Jeremy; Dorta-Estremera, Stephanie; Cao, Wei] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Cao, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	wcao@mdanderson.org	Di Domizio, Jeremy/L-1777-2019	Cao, Wei/0000-0002-8952-9159; Dorta-Estremera, Stephanie/0000-0003-4440-6806	National Institutes of Health [AI074809]; University of Texas M. D. Anderson Cancer Center Institutional Research Grant Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas M. D. Anderson Cancer Center Institutional Research Grant Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grants from National Institutes of Health Grant AI074809 and The University of Texas M. D. Anderson Cancer Center Institutional Research Grant Program (to WC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asquith DL, 2009, EUR J IMMUNOL, V39, P2040, DOI 10.1002/eji.200939578; BALTZ ML, 1986, CLIN EXP IMMUNOL, V66, P691; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; BRACKERTZ D, 1977, ARTHRITIS RHEUM, V20, P841, DOI 10.1002/art.1780200314; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Di Domizio J, 2012, P NATL ACAD SCI USA, V109, P14550, DOI 10.1073/pnas.1206923109; Di Domizio J, 2012, J BIOL CHEM, V287, P736, DOI 10.1074/jbc.M111.238477; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; EDGINGTON SM, 1992, MOL IMMUNOL, V29, P609, DOI 10.1016/0161-5890(92)90197-6; FLANDERS KC, 1988, BIOCHEMISTRY-US, V27, P739, DOI 10.1021/bi00402a037; FUCHS S, 1975, J IMMUNOL, V114, P1287; Gilkeson GS, 1996, J EXP MED, V183, P1389, DOI 10.1084/jem.183.4.1389; GILKESON GS, 1989, J IMMUNOL, V142, P1482; GILKESON GS, 1989, CLIN IMMUNOL IMMUNOP, V51, P362, DOI 10.1016/0090-1229(89)90034-2; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257; HENEKA MT, 2012, NATURE, V493, P674, DOI DOI 10.1038/NATURE11729; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lindgren M, 2010, FEBS J, V277, P1380, DOI 10.1111/j.1742-4658.2010.07571.x; Masters SL, 2011, TRENDS MOL MED, V17, P276, DOI 10.1016/j.molmed.2011.01.005; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Meroni PL, 2011, J AUTOIMMUN, V36, P1, DOI 10.1016/j.jaut.2010.10.004; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; PEPYS MB, 1979, CLIN EXP IMMUNOL, V38, P284; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; Pisetsky DS, 1996, IMMUNITY, V5, P303, DOI 10.1016/S1074-7613(00)80256-3; PLESCIA OJ, 1964, P NATL ACAD SCI USA, V52, P279, DOI 10.1073/pnas.52.2.279; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Salminen A, 2008, J CELL MOL MED, V12, P2255, DOI 10.1111/j.1582-4934.2008.00496.x; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Sideras K, 2009, ADV CLIN CHEM, V47, P1, DOI 10.1016/S0065-2423(09)47001-X; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; VANDENBERG WB, 1984, J CLIN INVEST, V74, P1850, DOI 10.1172/JCI111604; VANLENT PLEM, 1989, IMMUNOLOGY, V67, P447; Verri WA, 2008, P NATL ACAD SCI USA, V105, P2723, DOI 10.1073/pnas.0712116105; Whitehouse M, 2012, LUPUS, V21, P217, DOI 10.1177/0961203311429818; WILCOX BJ, 1982, NEUROSCI LETT, V29, P105, DOI 10.1016/0304-3940(82)90337-8	43	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63214	10.1371/journal.pone.0063214	http://dx.doi.org/10.1371/journal.pone.0063214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650555	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000100
J	Kuster, CJ; Von Elert, E				Kuster, Christian J.; Von Elert, Eric			Interspecific Differences between D. pulex and D. magna in Tolerance to Cyanobacteria with Protease Inhibitors	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DAPHNIA-MAGNA; MICROCYSTIS-AERUGINOSA; TOXIC CYANOBACTERIA; GROWTH-RATE; GALEATA; LAKE; IDENTIFICATION; POPULATION; DYNAMICS	It is known that cyanobacteria negatively affect herbivores due to their production of toxins such as protease inhibitors. In the present study we investigated potential interspecific differences between two major herbivores, Daphnia magna and Daphnia pulex, in terms of their tolerance to cyanobacteria with protease inhibitors. Seven clones each of D. magna and of D. pulex were isolated from different habitats in Europe and North America. To test for interspecific differences in the daphnids' tolerance to cyanobacteria, their somatic and population growth rates were determined for each D. magna and D. pulex clone after exposure to varying concentrations of two Microcystis aeruginosa strains. The M. aeruginosa strains NIVA and PCC- contained either chymotrypsin or trypsin inhibitors, but no microcystins. Mean somatic and population growth rates on a diet with 20% NIVA were significantly more reduced in D. pulex than in D. magna. On a diet with 10% PCC-, the population growth of D. pulex was significantly more reduced than that of D. magna. This indicates that D. magna is more tolerant to cyanobacteria with protease inhibitors than D. pulex. The reduction of growth rates was possibly caused by an interference of cyanobacterial inhibitors with proteases in the gut of Daphnia, as many other conceivable factors, which might have been able to explain the reduced growth, could be excluded as causal factors. Protease assays revealed that the sensitivities of chymotrypsins and trypsins to cyanobacterial protease inhibitors did not differ between D. magna and D. pulex. However, D. magna exhibited a 2.3-fold higher specific chymotrypsin activity than D. pulex, which explains the observed higher tolerance to cyanobacterial protease inhibitors of D. magna. The present study suggests that D. magna may control the development of cyanobacterial blooms more efficiently than D. pulex due to differences in their tolerance to cyanobacteria with protease inhibitors.	[Kuster, Christian J.; Von Elert, Eric] Univ Cologne, Inst Zool, Cologne, Germany	University of Cologne	Kuster, CJ (corresponding author), Univ Cologne, Inst Zool, Weyertal 119, Cologne, Germany.	meroder@gmx.de	von Elert, Eric/S-1666-2018	von Elert, Eric/0000-0001-7758-716X	German Research Foundation (DFG) [El 179/6-1]; Collaborative Research Centre Molecular Basis of Evolutionary Innovations [680]	German Research Foundation (DFG)(German Research Foundation (DFG)); Collaborative Research Centre Molecular Basis of Evolutionary Innovations	This study was supported by two grants to EvE from the German Research Foundation (DFG): grant number El 179/6-1 and by a grant within the Collaborative Research Centre 680 Molecular Basis of Evolutionary Innovations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal MK, 2005, ENVIRON TOXICOL, V20, P314, DOI 10.1002/tox.20123; Agrawal MK, 2001, HYDROBIOLOGIA, V464, P37, DOI 10.1023/A:1013946514556; Blom JF, 2006, ARCH HYDROBIOL, V167, P547, DOI 10.1127/0003-9136/2006/0167-0547; Brzezinski T, 2007, LIMNOL OCEANOGR, V52, P2350, DOI 10.4319/lo.2007.52.6.2350; CARMICHAEL WW, 1994, SCI AM, V270, P78, DOI 10.1038/scientificamerican0194-78; Codd GA, 2005, TOXICOL APPL PHARM, V203, P264, DOI 10.1016/j.taap.2004.02.016; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Czarnecki O, 2006, ENVIRON MICROBIOL, V8, P77, DOI 10.1111/j.1462-2920.2005.00870.x; DEMEESTER L, 1994, OECOLOGIA, V97, P333, DOI 10.1007/BF00317323; DeMott WR, 1997, FRESHWATER BIOL, V38, P649, DOI 10.1046/j.1365-2427.1997.00222.x; DeMott WR, 2005, OECOLOGIA, V142, P20, DOI 10.1007/s00442-004-1716-y; DeMott WR, 2002, ECOLOGY, V83, P3426, DOI 10.1890/0012-9658(2002)083[3426:SCVADT]2.0.CO;2; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; Dokulil MT, 2000, HYDROBIOLOGIA, V438, P1, DOI 10.1023/A:1004155810302; Gademann K, 2008, CURR ORG CHEM, V12, P326, DOI 10.2174/138527208783743750; Gustafsson S, 2004, AQUAT ECOL, V38, P37, DOI 10.1023/B:AECO.0000020985.47348.5e; Haag CR, 2009, GENETICS, V182, P313, DOI 10.1534/genetics.109.101147; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; Hairston NG, 2001, EVOLUTION, V55, P2203, DOI 10.1111/j.0014-3820.2001.tb00736.x; Hansson LA, 2007, FRESHWATER BIOL, V52, P1290, DOI 10.1111/j.1365-2427.2007.01765.x; Johnk KD, 2008, GLOBAL CHANGE BIOL, V14, P495, DOI 10.1111/j.1365-2486.2007.01510.x; Koch U, 2009, OECOLOGIA, V159, P317, DOI 10.1007/s00442-008-1216-6; Kuster C, 2012, HYDROBIOLOGIA, P1; Kuster CJ, 2012, MOL ECOL RESOUR, V12, P1048, DOI 10.1111/j.1755-0998.2012.03177.x; LAMPERT W, 1991, ARCH HYDROBIOL, V120, P447; Lampert W, 1996, FUNCT ECOL, V10, P631, DOI 10.2307/2390173; Lurling M, 2003, LIMNOL OCEANOGR, V48, P2214; Lurling M, 2003, ENVIRON TOXICOL CHEM, V22, P1281, DOI [10.1002/etc.5620220614, 10.1897/1551-5028(2003)022&lt;1281:LHCODE&gt;2.0.CO;2]; Martin-Creuzburg D, 2004, J CHEM ECOL, V30, P483, DOI 10.1023/B:JOEC.0000018624.94689.95; Martin-Creuzburg D, 2008, LIMNOL OCEANOGR, V53, P456, DOI 10.4319/lo.2008.53.2.0456; Matthes M, 2004, HYDROBIOLOGIA, V526, P33, DOI 10.1023/B:HYDR.0000041616.86446.01; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pflugmacher S, 1998, BBA-GEN SUBJECTS, V1425, P527, DOI 10.1016/S0304-4165(98)00107-X; PIJANOWSKA J, 1993, OECOLOGIA, V96, P40, DOI 10.1007/BF00318028; Pires LMD, 2011, AQUAT TOXICOL, V104, P230, DOI 10.1016/j.aquatox.2011.05.001; PORTER KG, 1984, LIMNOL OCEANOGR, V29, P365, DOI 10.4319/lo.1984.29.2.0365; Rohrlack T, 1999, APPL ENVIRON MICROB, V65, P737; Rohrlack T, 2001, APPL ENVIRON MICROB, V67, P3523, DOI 10.1128/AEM.67.8.3523-3529.2001; Sarnelle O, 2005, LIMNOL OCEANOGR, V50, P1565, DOI 10.4319/lo.2005.50.5.1565; Sarnelle O, 2007, LIMNOL OCEANOGR, V52, P2120, DOI 10.4319/lo.2007.52.5.2120; Schaack S, 2010, P ROY SOC B-BIOL SCI, V277, P2381, DOI 10.1098/rspb.2009.2253; Schwarzenberger A, 2013, OECOLOGIA, V172, P11, DOI 10.1007/s00442-012-2479-5; Schwarzenberger A, 2012, MOL ECOL, V21, P4898, DOI 10.1111/j.1365-294X.2012.05753.x; Schwarzenberger Anke, 2010, BMC Physiology, V10, P6, DOI 10.1186/1472-6793-10-6; Sigee DC, 1999, HYDROBIOLOGIA, V395, P161, DOI 10.1023/A:1017097502124; Sivonen K, 1999, MONITORING MANAGEMEN, P41; THRELKELD ST, 1979, ECOLOGY, V60, P165, DOI 10.2307/1936478; Tucker S, 2005, APPL ENVIRON MICROB, V71, P629, DOI 10.1128/AEM.71.2.629-635.2005; von Elert E, 2005, J NAT PROD, V68, P1324, DOI 10.1021/np050079r; von Elert E, 2004, COMP BIOCHEM PHYS B, V137, P287, DOI 10.1016/j.cbpc.2003.11.008; von Elert E, 2003, P ROY SOC B-BIOL SCI, V270, P1209, DOI 10.1098/rspb.2003.2357; von Elert E, 2002, LIMNOL OCEANOGR, V47, P1764, DOI 10.4319/lo.2002.47.6.1764; von Elert E, 1997, LIMNOL OCEANOGR, V42, P1796, DOI 10.4319/lo.1997.42.8.1796; von Elert E, 2012, J EXP BIOL, V215, P2051, DOI 10.1242/jeb.068742; Wacker A, 2001, ECOLOGY, V82, P2507, DOI 10.2307/2679932; Wang DM, 2011, SCI TOTAL ENVIRON, V409, P1351, DOI 10.1016/j.scitotenv.2010.12.024; Watanabe H, 2005, GENOME, V48, P606, DOI 10.1139/G05-038; Weckesser J, 1996, SYST APPL MICROBIOL, V19, P133, DOI 10.1016/S0723-2020(96)80038-5	58	12	12	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62658	10.1371/journal.pone.0062658	http://dx.doi.org/10.1371/journal.pone.0062658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650523	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000067
J	Chodavarapu, H; Grobe, N; Somineni, HK; Salem, ESB; Madhu, M; Elased, KM				Chodavarapu, Harshita; Grobe, Nadja; Somineni, Hari K.; Salem, Esam S. B.; Madhu, Malav; Elased, Khalid M.			Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASES; ACE2 ACTIVITY; GLOMERULAR INJURY; RENAL ACE2; EXPRESSION; RECEPTOR; NEPHROPATHY; SYSTEM; OVEREXPRESSION; HYPERTENSION	Alterations within the renal renin angiotensin system play a pivotal role in the development and progression of cardiovascular and renal disease. Angiotensin converting enzyme 2 (ACE2) is highly expressed in renal tubules and has been shown to be renoprotective in diabetes. The protease, a disintegrin and metalloprotease (ADAM) 17, is involved in the ectodomain shedding of several transmembrane proteins including ACE2. Renal ACE2 and ADAM17 were significantly increased in db/db mice compared to controls. We investigated the effect of the insulin sensitizer, rosiglitazone, on albuminuria, renal ADAM17 protein expression and ACE2 shedding in db/db diabetic mice. Rosiglitazone treatment of db/db mice normalized hyperglycemia, attenuated renal injury and decreased urinary ACE2 and renal ADAM17 protein expression. Urinary excreted ACE2 is enzymatically active. Western blot analysis of urinary ACE2 demonstrated two prominent immunoreactive bands at approximately 70 & 90 kDa. The predominant immunoreactive band is approximately 20 kDa shorter than the one demonstrated for kidney lysate, indicating possible ectodomain shedding of active renal ACE2 in the urine. Therefore, it is tempting to speculate that renoprotection of rosiglitazone could be partially mediated via downregulation of renal ADAM17 and ACE2 shedding. In addition, there was a positive correlation between blood glucose, urinary albumin, plasma glucagon, and triglyceride levels with urinary ACE2 excretion. In conclusion, urinary ACE2 could be used as a sensitive biomarker of diabetic nephropathy and for monitoring the effectiveness of renoprotective medication.	[Chodavarapu, Harshita; Grobe, Nadja; Somineni, Hari K.; Salem, Esam S. B.; Madhu, Malav; Elased, Khalid M.] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Elased, KM (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA.	khalid.elased@wright.edu			American Heart Association [SDG0735112N]; National Institutes of Health [R01HL093567, 1F32DK093226]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK093226] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the American Heart Association (SDG0735112N to KME) and the National Institutes of Health (R01HL093567 to KE and 1F32DK093226 to NG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghamri MS, 2013, J CARDIOVASC PHARM T, V18, P138, DOI 10.1177/1074248412460124; Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; Arita DY, 2012, CLIN EXP HYPERTENS, V34, P389, DOI 10.3109/10641963.2011.649932; Basu R, 2012, AM J PHYSIOL-RENAL, V303, pF1341, DOI 10.1152/ajprenal.00349.2012; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cooper ME, 2004, AM J HYPERTENS, V17, p16S, DOI 10.1016/j.amjhyper.2004.08.004; de Galan BE, 2009, J AM SOC NEPHROL, V20, P883, DOI 10.1681/ASN.2008070667; Elased KM, 2006, HYPERTENSION, V47, P1010, DOI 10.1161/01.HYP.0000215588.38536.30; Forbes JM, 2002, J HYPERTENS, V20, P985, DOI 10.1097/00004872-200205000-00034; Gall MA, 1997, BMJ-BRIT MED J, V314, P783, DOI 10.1136/bmj.314.7083.783; Garton KJ, 2003, J BIOL CHEM, V278, P37459, DOI 10.1074/jbc.M305877200; Grobe N, 2012, AM J PHYSIOL-ENDOC M, V302, pE1016, DOI 10.1152/ajpendo.00515.2011; Guy JL, 2003, BIOCHEMISTRY-US, V42, P13185, DOI 10.1021/bi035268s; Harte A, 2005, CIRCULATION, V111, P1954, DOI 10.1161/01.CIR.0000161954.17870.5D; Jia HP, 2009, AM J PHYSIOL-LUNG C, V297, pL84, DOI 10.1152/ajplung.00071.2009; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; LARKINS RG, 1992, DIABETOLOGIA, V35, P499, DOI 10.1007/BF00400475; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Lew RA, 2008, EXP PHYSIOL, V93, P685, DOI 10.1113/expphysiol.2007.040352; Liu CX, 2011, MOL MED, V17, P59, DOI 10.2119/molmed.2010.00111; Maluf-Meiken LCV, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/581780; Mizuiri S, 2011, NEPHROLOGY, V16, P567, DOI 10.1111/j.1440-1797.2011.01467.x; Monteiro MB, 2008, HYPERTENSION, V52, pE91; Nadarajah R, 2012, KIDNEY INT, V82, P292, DOI 10.1038/ki.2012.83; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Oudit GY, 2006, AM J PATHOL, V168, P1808, DOI 10.2353/ajpath.2006.051091; Park SE, 2013, EUR J ENDOCRINOL, V168, P203, DOI 10.1530/EJE-12-0782; Perico N, 2008, NAT REV DRUG DISCOV, V7, P936, DOI 10.1038/nrd2685; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pistrosch F, 2005, DIABETES, V54, P2206, DOI 10.2337/diabetes.54.7.2206; Ren LQ, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-10; Ribeiro-Oliveira A, 2008, VASC HEALTH RISK MAN, V4, P787; Saito T, 2009, AM J MED SCI, V338, P478, DOI 10.1097/MAJ.0b013e3181b90c25; Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341; Sarafidis PA, 2005, AM J HYPERTENS, V18, P227, DOI 10.1016/j.amjhyper.2004.09.010; Senador D, 2009, EXP PHYSIOL, V94, P648, DOI 10.1113/expphysiol.2008.046474; Shaltout HA, 2007, AM J PHYSIOL-RENAL, V292, pF82, DOI 10.1152/ajprenal.00139.2006; Soler MJ, 2007, KIDNEY INT, V72, P614, DOI 10.1038/sj.ki.5002373; Song J, 2008, EXP CLIN ENDOCR DIAB, V116, P315, DOI 10.1055/s-2008-1042429; Soro-Paavonen A, 2012, J HYPERTENS, V30, P375, DOI 10.1097/HJH.0b013e32834f04b6; Tan F, 2010, SINGAP MED J, V51, P151; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; *UKPDS GROUP, 1998, INT BLOOD GLUC CONTR; Verma A, 2012, MOL THER, V20, P28, DOI 10.1038/mt.2011.155; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wang G, 2008, DIABETOLOGIA, V51, P1062, DOI 10.1007/s00125-008-0988-x; Wang XD, 2002, J BIOL CHEM, V277, P50510, DOI 10.1074/jbc.M208738200; Weatherford ET, 2007, HYPERTENSION, V50, P844, DOI 10.1161/HYPERTENSIONAHA.107.097519; Wysocki J, 2006, DIABETES, V55, P2132, DOI 10.2337/db06-0033; Xiao FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037649; Yamaleyeva LM, 2012, AM J PHYSIOL-RENAL, V302, pF1374, DOI 10.1152/ajprenal.00656.2011; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P1558, DOI 10.1681/ASN.2006060554; Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423	54	75	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62833	10.1371/journal.pone.0062833	http://dx.doi.org/10.1371/journal.pone.0062833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646149	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300102
J	Heilkenbrinker, U; Dietrich, R; Didier, A; Zhu, K; Lindback, T; Granum, PE; Martlbauer, E				Heilkenbrinker, Uta; Dietrich, Richard; Didier, Andrea; Zhu, Kui; Lindback, Toril; Granum, Per Einar; Maertlbauer, Erwin			Complex Formation between NheB and NheC Is Necessary to Induce Cytotoxic Activity by the Three-Component Bacillus cereus Nhe Enterotoxin	PLOS ONE			English	Article							HEMOLYSIN BL; MONOCLONAL-ANTIBODIES; EMETIC TOXIN; THURINGIENSIS; STRAINS; BINDING; PCR	The nonhemolytic enterotoxin (Nhe) is known as a major pathogenicity factor for the diarrheal type of food poisoning caused by Bacillus cereus. The Nhe complex consists of NheA, NheB and NheC, all of them required to reach maximum cytotoxicity following a specific binding order on cell membranes. Here we show that complexes, formed between NheB and NheC under natural conditions before targeting the host cells, are essential for toxicity in Vero cells. To enable detection of NheC and its interaction with NheB, monoclonal antibodies against NheC were established and characterized. The antibodies allowed detection of recombinant NheC in a sandwich immunoassay at levels below 10 ng ml(-1), but no or only minor amounts of NheC were detectable in natural culture supernatants of B. cereus strains. When NheB- and NheC-specific monoclonal antibodies were combined in a sandwich immunoassay, complexes between NheB and NheC could be demonstrated. The level of these complexes was directly correlated with the relative concentrations of NheB and NheC. Toxicity, however, showed a bell-shaped dose-response curve with a plateau at ratios of NheB and NheC between 50:1 and 5:1. Both lower and higher ratios between NheB and NheC strongly reduced cytotoxicity. When the ratio approached an equimolar ratio, complex formation reached its maximum resulting in decreased binding of NheB to Vero cells. These data indicate that a defined level of NheB-NheC complexes as well as a sufficient amount of free NheB is necessary for efficient cell binding and toxicity. Altogether, the results of this study provide evidence that the interaction of NheB and NheC is a balanced process, necessary to induce, but also able to limit the toxic action of Nhe.	[Heilkenbrinker, Uta; Dietrich, Richard; Didier, Andrea; Zhu, Kui; Maertlbauer, Erwin] Univ Munich, Dept Vet Sci, Oberschleissheim, Germany; [Lindback, Toril; Granum, Per Einar] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway	University of Munich; Norwegian University of Life Sciences	Martlbauer, E (corresponding author), Univ Munich, Dept Vet Sci, Oberschleissheim, Germany.	e.maertlbauer@mh.vetmed.uni-muenchen.de	Märtlbauer, Erwin/I-2897-2016; Märtlbauer, Erwin/Y-8646-2019; Lindbäck, Toril/AAZ-9278-2020	Märtlbauer, Erwin/0000-0003-3390-8173; Märtlbauer, Erwin/0000-0003-3390-8173; Lindback, Toril/0000-0002-5245-1087; Zhu, Kui/0000-0001-8242-3952	German Ministry of Economics and Technology (via AiF); FEI (Forschungskreis der Ernahrungsindustrie e.V., Bonn) [AiF 15047 N]	German Ministry of Economics and Technology (via AiF)(Federal Ministry for Economic Affairs and Energy (BMWi)); FEI (Forschungskreis der Ernahrungsindustrie e.V., Bonn)	This research project was supported by the German Ministry of Economics and Technology (via AiF) and the FEI (Forschungskreis der Ernahrungsindustrie e.V., Bonn), Project AiF 15047 N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATA N, 1995, FEMS MICROBIOL LETT, V129, P17, DOI 10.1016/0378-1097(95)00119-P; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BEECHER DJ, 1995, INFECT IMMUN, V63, P4423, DOI 10.1128/IAI.63.11.4423-4428.1995; BEECHER DJ, 1994, INFECT IMMUN, V62, P980, DOI 10.1128/IAI.62.3.980-986.1994; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Phung D, 2012, FEMS MICROBIOL LETT, V330, P98, DOI 10.1111/j.1574-6968.2012.02538.x; Didier A, 2012, INFECT IMMUN, V80, P832, DOI 10.1128/IAI.05681-11; Dietrich R, 1999, APPL ENVIRON MICROB, V65, P4470; Dietrich R, 2005, APPL ENVIRON MICROB, V71, P8214, DOI 10.1128/AEM.71.12.8214-8220.2005; Ehling-Schulz M, 2005, MICROBIOL-SGM, V151, P183, DOI 10.1099/mic.0.27607-0; Fagerlund A, 2008, MICROBIOL-SGM, V154, P693, DOI 10.1099/mic.0.2007/014134-0; Fagerlund A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-43; Fagerlund A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-304; FRIGUET B, 1983, J IMMUNOL METHODS, V60, P351, DOI 10.1016/0022-1759(83)90292-2; Gohar M, 2005, PROTEOMICS, V5, P3696, DOI 10.1002/pmic.200401225; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Granum PE, 1999, FEMS MICROBIOL LETT, V177, P225, DOI 10.1111/j.1574-6968.1999.tb13736.x; GRANUM PE, 1993, INT J FOOD MICROBIOL, V17, P269, DOI 10.1016/0168-1605(93)90197-O; Guinebretiere MH, 2002, J CLIN MICROBIOL, V40, P3053, DOI 10.1128/JCM.40.8.3053-3056.2002; Hansen BM, 2001, APPL ENVIRON MICROB, V67, P185, DOI 10.1128/AEM.67.1.185-189.2001; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Lapidus A, 2008, CHEM-BIOL INTERACT, V171, P236, DOI 10.1016/j.cbi.2007.03.003; Lindback T, 2004, MICROBIOL-SGM, V150, P3959, DOI 10.1099/mic.0.27359-0; Lindback T, 2010, INFECT IMMUN, V78, P3813, DOI 10.1128/IAI.00247-10; Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x; Lund T, 1996, FEMS MICROBIOL LETT, V141, P151, DOI 10.1016/0378-1097(96)00208-X; Madegowda M, 2008, PROTEINS, V71, P534, DOI 10.1002/prot.21888; Moravek M, 2006, FEMS MICROBIOL LETT, V257, P293, DOI 10.1111/j.1574-6968.2006.00185.x; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Schoeni JL, 2005, J FOOD PROTECT, V68, P636, DOI 10.4315/0362-028X-68.3.636; Stadler V, 2008, ANGEW CHEM INT EDIT, V47, P7132, DOI 10.1002/anie.200801616; Wehrle E, 2009, J MICROBIOL METH, V78, P265, DOI 10.1016/j.mimet.2009.06.013	35	33	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63104	10.1371/journal.pone.0063104	http://dx.doi.org/10.1371/journal.pone.0063104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646182	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300137
J	Misra, UK; Pizzo, SV				Misra, Uma Kant; Pizzo, Salvatore Vincent			Evidence for a Pro-Proliferative Feedback Loop in Prostate Cancer: The Role of Epac1 and COX-2-Dependent Pathways	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; MTOR COMPLEX 1; CYCLIC-AMP; CELL-PROLIFERATION; REGULATED KINASE; C-MYC; RECEPTOR; INFLAMMATION; ACTIVATION; GROWTH	Objective: In human prostate cancer cells, a selective Epac agonist, 8-CPT-2Me-cAMP, upregulates cell proliferation and survival via activation of Ras-MAPK and PI- 3-kinase-Akt-mTOR signaling cascades. Here we examine the role of inflammatory mediators in Epac1-induced cellular proliferation by determining the expression of the pro-inflammatory markers p-cPLA2, COX-2, and PGE(2) in prostate cancer cells treated with 8-CPT-2Me-cAMP. Methods: We employed inhibitors of COX-2, mTORC1, and mTORC2 to probe cyclic AMP-dependent pathways in human prostate cancer cells. RNAi targeting Epac1, Raptor, and Rictor was also employed in these studies. Results: 8-CPT-2Me-cAMP treatment caused a 2-2.5-fold increase of p-cPLA2(S505), COX-2, and PGE2 levels in human prostate cancer cell lines. Pretreatment of cells with the COX-2 inhibitor SC-58125 or the EP4 antagonist AH-23848, or with an inhibitor of mTORC1 and mTORC2, Torin1, significantly reduced the Epac1-dependent increase of p-cPLA2 and COX-2, p-S6-kinase(T389), and p-AKT(S473). In addition, Epac1-induced protein and DNA synthesis were greatly reduced upon pretreatment of cells with either COX-2, EP4, or mTOR inhibitors. Transfection of prostate cancer cells with Epac1 dsRNA, Raptor dsRNA, or Rictor dsRNA profoundly reduced Epac1-dependent increases in p-cPLA2 and COX-2. Conclusion: We show that Epac1, a downstream effector of cAMP, functions as a pro-inflammatory modulator in prostate cancer cells and promotes cell proliferation and survival by upregulating Ras-MAPK, and PI 3-kinase-Akt-mTOR signaling.	[Misra, Uma Kant; Pizzo, Salvatore Vincent] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Pizzo, SV (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	salvatore.pizzo@duke.edu						AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Beasley D, 1999, AM J PHYSIOL-HEART C, V276, pH1369, DOI 10.1152/ajpheart.1999.276.4.H1369; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bundscherer A, 2008, ONCOL REP, V19, P547; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Dada S, 2008, BIOCHEM BIOPH RES CO, V372, P875, DOI 10.1016/j.bbrc.2008.05.154; de Groot DJA, 2007, CRIT REV ONCOL HEMAT, V61, P52, DOI 10.1016/j.critrevonc.2006.07.001; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Fang Y, 2007, J PHARMACOL EXP THER, V322, P1189, DOI 10.1124/jpet.107.119933; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Fujita H, 2002, PROSTATE, V53, P232, DOI 10.1002/pros.10152; Fujita T, 2002, J BIOL CHEM, V277, P22191, DOI 10.1074/jbc.M110364200; Ghosh S, 2011, DEV BIOL, V360, P329, DOI 10.1016/j.ydbio.2011.09.027; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; HOFFMAN M, 1988, AGENTS ACTIONS, V25, P360, DOI 10.1007/BF01965043; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Irani J, 1997, J UROLOGY, V157, P1301, DOI 10.1016/S0022-5347(01)64957-7; Jang MW, 2012, J CELL PHYSIOL, V227, P3756, DOI 10.1002/jcp.24084; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Kojima F, 2009, PROSTAG OTH LIPID M, V89, P26, DOI 10.1016/j.prostaglandins.2009.03.001; Krysan K, 2005, CANCER RES, V65, P6275, DOI 10.1158/0008-5472.CAN-05-0216; Kuehn HS, 2011, J BIOL CHEM, V286, P391, DOI 10.1074/jbc.M110.164772; Liu XH, 1998, CANCER RES, V58, P4245; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mancini AD, 2011, INFLAMM RES, V60, P1083, DOI 10.1007/s00011-011-0385-7; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McCarty Mark F, 2004, Integr Cancer Ther, V3, P349, DOI 10.1177/1534735404270757; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739; MISRA UK, 1993, BIOCHEM J, V290, P885, DOI 10.1042/bj2900885; Misra UK, 2005, J BIOL CHEM, V280, P38276, DOI 10.1074/jbc.M507332200; Misra UK, 2002, J BIOL CHEM, V277, P4069, DOI 10.1074/jbc.M109764200; Misra UK, 2001, ARCH BIOCHEM BIOPHYS, V386, P227, DOI 10.1006/abbi.2000.2199; Misra UK, 2001, CELL SIGNAL, V13, P801, DOI 10.1016/S0898-6568(01)00202-9; Misra UK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051735; Misra UK, 2012, J CELL BIOCHEM, V113, P1488, DOI 10.1002/jcb.24018; Misra UK, 2011, J BIOL CHEM, V286, P1248, DOI 10.1074/jbc.M110.129767; Misra UK, 2009, J CELL BIOCHEM, V108, P998, DOI 10.1002/jcb.22333; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Pruthi RS, 2006, CLIN CANCER RES, V12, P2172, DOI 10.1158/1078-0432.CCR-05-2067; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Salman H, 2012, BIOMED PHARMACOTHER, V66, P330, DOI 10.1016/j.biopha.2012.03.004; Saylor PJ, 2012, ONCOLOGIST, V17, P212, DOI 10.1634/theoncologist.2011-0321; Sciarra A, 2008, J STEROID BIOCHEM, V108, P254, DOI 10.1016/j.jsbmb.2007.09.013; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; SETHI G, 2010, BIOSCIENCE REP, V32, P1; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Terada N, 2010, CANCER RES, V70, P1606, DOI 10.1158/0008-5472.CAN-09-2984; Thill M, 2010, J STEROID BIOCHEM, V121, P387, DOI 10.1016/j.jsbmb.2010.03.049; UHING RJ, 1991, BIOCHIM BIOPHYS ACTA, V1093, P115, DOI 10.1016/0167-4889(91)90111-A; van der Giet M, 2008, BIOL CHEM, V389, P1381, DOI 10.1515/BC.2008.165; Wang CY, 2007, J PHYSIOL-LONDON, V584, P191, DOI 10.1113/jphysiol.2007.135616; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Xuan YT, 2005, CIRCULATION, V112, P1971, DOI 10.1161/CIRCULATIONAHA.105.561522; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Yu L, 2009, INT J CANCER, V125, P2540, DOI 10.1002/ijc.24607; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	68	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63150	10.1371/journal.pone.0063150	http://dx.doi.org/10.1371/journal.pone.0063150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646189	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300144
J	Strickertsson, JAB; Desler, C; Martin-Bertelsen, T; Machado, AMD; Wadstrom, T; Winther, O; Rasmussen, LJ; Friis-Hansen, L				Strickertsson, Jesper A. B.; Desler, Claus; Martin-Bertelsen, Tomas; Machado, Ana Manuel Dantas; Wadstrom, Torkel; Winther, Ole; Rasmussen, Lene Juel; Friis-Hansen, Lennart			Enterococcus faecalis Infection Causes Inflammation, Intracellular Oxphos-Independent ROS Production, and DNA Damage in Human Gastric Cancer Cells	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; GENERATING NADPH OXIDASES; GENE SET ENRICHMENT; EXTRACELLULAR-SUPEROXIDE; MITOCHONDRIAL-DNA; EPITHELIAL-CELLS; MISMATCH REPAIR; NOX FAMILY; KAPPA-B; EXPRESSION	Background: Achlorhydria caused by e.g. atrophic gastritis allows for bacterial overgrowth, which induces chronic inflammation and damage to the mucosal cells of infected individuals driving gastric malignancies and cancer. Enterococcus faecalis (E. faecalis) can colonize achlohydric stomachs and we therefore wanted to study the impact of E. faecalis infection on inflammatory response, reactive oxygen species (ROS) formation, mitochondrial respiration, and mitochondrial genetic stability in gastric mucosal cells. Methods: To separate the changes induced by bacteria from those of the inflammatory cells we established an in vitro E. faecalis infection model system using the gastric carcinoma cell line MKN74. Total ROS and superoxide was measured by fluorescence microscopy. Cellular oxygen consumption was characterized non-invasively using XF24 microplate based respirometry. Gene expression was examined by microarray, and response pathways were identified by Gene Set Analysis (GSA). Selected gene transcripts were verified by quantitative real-time polymerase chain reaction (qRT-PCR). Mitochondrial mutations were determined by sequencing. Results: Infection of MKN74 cells with E. faecalis induced intracellular ROS production through a pathway independent of oxidative phosphorylation (oxphos). Furthermore, E. faecalis infection induced mitochondrial DNA instability. Following infection, genes coding for inflammatory response proteins were transcriptionally up-regulated while DNA damage repair and cell cycle control genes were down-regulated. Cell growth slowed down when infected with viable E. faecalis and responded in a dose dependent manner to E. faecalis lysate. Conclusions: Infection by E. faecalis induced an oxphos-independent intracellular ROS response and damaged the mitochondrial genome in gastric cell culture. Finally the bacteria induced an NF-kappa B inflammatory response as well as impaired DNA damage response and cell cycle control gene expression.	[Strickertsson, Jesper A. B.; Friis-Hansen, Lennart] Univ Copenhagen, Rigshosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark; [Strickertsson, Jesper A. B.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Copenhagen, Denmark; [Desler, Claus; Machado, Ana Manuel Dantas; Rasmussen, Lene Juel] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Ageing, Copenhagen, Denmark; [Martin-Bertelsen, Tomas; Winther, Ole] Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark; [Martin-Bertelsen, Tomas; Winther, Ole] Univ Copenhagen, Fac Sci, Bioinformat Ctr, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Wadstrom, Torkel] Lund Univ, Dept Clin Microbiol, Lund, Sweden; [Winther, Ole] Tech Univ Denmark, DTU Informat, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Lund University; Technical University of Denmark	Friis-Hansen, L (corresponding author), Univ Copenhagen, Rigshosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark.	lfh@rh.regionh.dk	Strickertsson, Jesper/G-6814-2016	desler, claus/0000-0002-0125-004X; Rasmussen, Lene Juel/0000-0001-6864-963X; Friis-Hansen, Lennart/0000-0002-7222-0163; Martin-Bertelsen, Tomas/0000-0002-5842-8187	Portuguese Science, Technology Foundation; Danish MRC; Danish Cancer Society; University of Copenhagen SUND; Novo Nordisk Foundation; NORDEA-fonden	Portuguese Science, Technology Foundation; Danish MRC(Danish Medical Research Council); Danish Cancer Society(Danish Cancer Society); University of Copenhagen SUND; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NORDEA-fonden	AMDM is supported by a fellowship from Portuguese Science, Technology Foundation. LFH is supported by the Danish MRC. JABS is supported by the Danish Cancer Society, and University of Copenhagen SUND. TMB and OW are supported by a grant from the Novo Nordisk Foundation to the Bioinformatics Centre. CD and LJR are supported by NORDEA-fonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Argent RH, 2008, CLIN CANCER RES, V14, P2227, DOI 10.1158/1078-0432.CCR-07-2022; Balamurugan R, 2008, J GASTROEN HEPATOL, V23, P1298, DOI 10.1111/j.1440-1746.2008.05490.x; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bellance N, 2009, FRONT BIOSCI-LANDMRK, V14, P4015, DOI 10.2741/3509; Boonanantanasarn K, 2012, INFECT IMMUN; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Caruso R, 2007, WORLD J GASTROENTERO, V13, P5547, DOI 10.3748/wjg.v13.i42.5547; CORREA P, 1990, CANCER RES, V50, P4737; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Machado AMD, 2009, CLIN CANCER RES, V15, P2995, DOI 10.1158/1078-0432.CCR-08-2686; DAVIES GR, 1994, GUT, V35, P179, DOI 10.1136/gut.35.2.179; Dicksved J, 2009, J MED MICROBIOL, V58, P509, DOI 10.1099/jmm.0.007302-0; Ding SZ, 2007, INFECT IMMUN, V75, P4030, DOI 10.1128/IAI.00172-07; El-Omar EM, 2001, GUT, V48, P743, DOI 10.1136/gut.48.6.743; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Friis-Hansen L, 2006, SCAND J CLIN LAB INV, V66, P607, DOI 10.1080/00365510600873894; Friis-Hansen L, 2006, GASTROENTEROLOGY, V131, P246, DOI 10.1053/j.gastro.2006.04.031; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Handa O, 2011, REDOX REP, V16, P1, DOI 10.1179/174329211X12968219310756; Hansson LE, 2000, WORLD J SURG, V24, P315, DOI 10.1007/s002689910050; Hirano T, 2008, J RADIAT RES, V49, P329, DOI 10.1269/jrr.08049; Howlett M, 2005, GASTROENTEROLOGY, V129, P1005, DOI 10.1053/j.gastro.2005.06.068; Howlett M, 2012, GUT, V61, P1398, DOI 10.1136/gutjnl-2011-300539; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Huycke MM, 1996, J INFECT DIS, V173, P743, DOI 10.1093/infdis/173.3.743; Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529; Huycke MM, 2001, MOL MICROBIOL, V42, P729, DOI 10.1046/j.1365-2958.2001.02638.x; Judd LM, 2005, J GASTROEN HEPATOL, V20, P1266, DOI 10.1111/j.1440-1746.2005.03867.x; Kamada T, 2005, ALIMENT PHARM THER, V21, P1121, DOI 10.1111/j.1365-2036.2005.02459.x; Kang WQ, 2005, LAB INVEST, V85, P702, DOI 10.1038/labinvest.3700260; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kido S, 2001, EUR J CANCER, V37, P1482, DOI 10.1016/S0959-8049(01)00147-2; Kim JJ, 2002, GASTROENTEROLOGY, V123, P542, DOI 10.1053/gast.2002.34751; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lee WC, 2004, J ENDODONT, V30, P209, DOI 10.1097/00004770-200404000-00006; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Maximo V, 2001, GENE CHROMOSOME CANC, V32, P136, DOI 10.1002/gcc.1175; Mueller A, 2004, GASTROENTEROLOGY, V127, P1446, DOI 10.1053/j.gastro.2004.08.054; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Park DI, 2005, HELICOBACTER, V10, P179, DOI 10.1111/j.1523-5378.2005.00309.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pillar CM, 2004, FRONT BIOSCI-LANDMRK, V9, P2335, DOI 10.2741/1400; R Development Core Team, 2011, R LANG ENV STAT COMP; Rokutan K, 2006, ANTIOXID REDOX SIGN, V8, P1573, DOI 10.1089/ars.2006.8.1573; Rozen S, 2000, Methods Mol Biol, V132, P365; Salles N, 2005, EXP GERONTOL, V40, P353, DOI 10.1016/j.exger.2005.01.007; Spooner R, 2011, INT J MOL SCI, V12, P334, DOI 10.3390/ijms12010334; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154; Zavros Y, 2005, ONCOGENE, V24, P2354, DOI 10.1038/sj.onc.1208407; Zavros Y, 2002, GASTROENTEROLOGY, V122, P119, DOI 10.1053/gast.2002.30298	68	48	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63147	10.1371/journal.pone.0063147	http://dx.doi.org/10.1371/journal.pone.0063147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646188	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300143
J	Chen, H; Wang, HY; Liu, YF; Dong, L				Chen, Hong; Wang, Haiyang; Liu, Yanfang; Dong, Li			Altitudinal Variations of Ground Tissue and Xylem Tissue in Terminal Shoot of Woody Species: Implications for Treeline Formation	PLOS ONE			English	Article							FUNCTIONAL TRAIT; CAMBIAL ACTIVITY; NORTH-AMERICAN; PLANT HEIGHT; GROWTH; ALLOMETRY; TREES; PATTERNS; FOREST; DIFFERENTIATION	1. The terminal shoot (or current-year shoot), as one of the most active parts on a woody plant, is a basic unit determining plant height and is potentially influenced by a variety of environmental factors. It has been predicted that tissues amount and their allocation in plant stems may play a critical role in determining plant size in alpine regions. The primary structure in terminal shoots is a key to our understanding treeline formation. The existing theories on treeline formation, however, are still largely lacking of evidence at the species level, much less from anatomy for the terminal shoot. 2. The primary structures within terminal shoot were measured quantitatively for 100 species from four elevation zones along the eastern slope of Gongga Mountain, southwestern China; one group was sampled from above the treeline. An allometric approach was employed to examine scaling relationships interspecifically, and a principal components analysis (PCA) was performed to test the relation among primary xylem, ground tissue, species growth form and altitude. 3. The results showed that xylem tissue size was closely correlated with ground tissue size isometrically across species, while undergoing significant y- or/and x-intercept shift in response to altitudinal belts. Further, a conspicuous characteristic of terminal shoot was its allocation of contrasting tissues between primary xylem and ground tissues with increasing elevation. The result of the PCA showed correlations between anatomical variation, species growth form/height classes and environment. 4. The current study presents a comparative assessment of the allocation of tissue in terminal shoot across phylogenically and ecologically diverse species, and analyzes tissue, function and climate associations with plant growth forms and height classes among species. The interspecific connection between primary xylem ratio and plant size along an elevation gradient suggests the importance of primary xylem in explaining the treeline formation.	[Chen, Hong; Wang, Haiyang] Southwest Univ, Inst Landscape Ecol Mountainous Hort, Chongqing, Peoples R China; [Chen, Hong; Liu, Yanfang; Dong, Li] Southwest Univ, Coll Hort & Landscape, Dept Bot, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Chen, H (corresponding author), Southwest Univ, Inst Landscape Ecol Mountainous Hort, Chongqing, Peoples R China.	chenh.swu@gmail.com	liu, yan/HCI-5542-2022		Southwest University [SWU110032]	Southwest University(Southwest University - China)	The research was funded by Southwest University (SWU110032) to Hong Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas P., 2011, CLIMATE CHANGE ECOLO, P141; Baas P., 2004, EVOLUTION PLANT PHYS, DOI DOI 10.1016/B978-012339552-8/50016-0; Bazzaz FA., 1997, PLANT RESOURCE ALLOC; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; [程根伟 Cheng Genwei], 2002, [生态学报, Acta Ecologica Sinica], V22, P1049; Die A, 2012, ANN BOT-LONDON, V110, P861, DOI 10.1093/aob/mcs145; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; Falster D. S., 2006, SMATR STANDARDISED M; Falster DS, 2005, J ECOL, V93, P521, DOI 10.1111/j.0022-0477.2005.00992.x; Fan ZX, 2012, J ECOL, V100, P732, DOI 10.1111/j.1365-2745.2011.01939.x; Fonti P, 2012, NEW PHYTOL, V195, P734, DOI 10.1111/j.1469-8137.2012.04252.x; Gartner B.L., 1995, PLANT STEMS PHYSL FU; GLEESON SK, 1992, AM NAT, V139, P1322, DOI 10.1086/285389; Gricar J, 2006, ANN BOT-LONDON, V97, P943, DOI 10.1093/aob/mcl050; Grierson CS, 2011, NEW PHYTOL, V192, P6, DOI 10.1111/j.1469-8137.2011.03859.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Holtmeier F.K., 2009, MOUNTAIN TIMBERLINES, V2nd edn; Iida Y, 2012, FUNCT ECOL, V26, P274, DOI 10.1111/j.1365-2435.2011.01921.x; Ishii H, 2011, TREE PHYSIOL-NETH, V4, P215, DOI 10.1007/978-94-007-1242-3_8; JAMES JC, 1994, J ECOL, V82, P297, DOI 10.2307/2261297; Kempes CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020551; King DA, 2011, SIZE AGE RELATED CHA, P175; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Korner C, 2012, ALPINE TREELINES FUN, DOI 10.1007/978-3-0348-0396-0; Leps J, 2003, MULTIVARIATE ANAL EC; Li GY, 2008, FUNCT ECOL, V22, P557, DOI 10.1111/j.1365-2435.2008.01407.x; Li MH, 2008, PLANT CELL ENVIRON, V31, P1377, DOI 10.1111/j.1365-3040.2008.01848.x; Liu Z., 1985, VEGETATION GONGGA MO; Losos JB, 2011, AM NAT, V177, P709, DOI 10.1086/660020; Moles AT, 2009, J ECOL, V97, P923, DOI 10.1111/j.1365-2745.2009.01526.x; Niklas KJ, 2007, TREE PHYSIOL, V27, P433, DOI 10.1093/treephys/27.3.433; Niklas KJ, 2006, NEW PHYTOL, V171, P27, DOI 10.1111/j.1469-8137.2006.01760.x; NIKLAS KJ, 1995, ANN BOT-LONDON, V75, P133, DOI 10.1006/anbo.1995.1004; NIKLAS KJ, 1995, ANN BOT-LONDON, V75, P217, DOI 10.1006/anbo.1995.1015; Oberhuber W, 2004, TREE PHYSIOL, V24, P291, DOI 10.1093/treephys/24.3.291; Osada N, 2002, TREE PHYSIOL, V22, P625, DOI 10.1093/treephys/22.9.625; Osada N, 2011, FUNCT ECOL, V25, P777, DOI 10.1111/j.1365-2435.2011.01833.x; Petit G, 2011, NEW PHYTOL, V189, P241, DOI 10.1111/j.1469-8137.2010.03455.x; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Pigliucci M., 2004, PHENOTYPIC INTEGRATI; Pitman EJG, 1939, BIOMETRIKA, V31, P9, DOI 10.2307/2334971; Poorter L, 2010, NEW PHYTOL, V185, P481, DOI 10.1111/j.1469-8137.2009.03092.x; Rossi S, 2011, J EXPT BOT; Rossi S, 2008, GLOBAL ECOL BIOGEOGR, V17, P696, DOI 10.1111/j.1466-8238.2008.00417.x; Rossi S, 2007, OECOLOGIA, V152, P1, DOI 10.1007/s00442-006-0625-7; Rowe N, 2005, NEW PHYTOL, V166, P61, DOI 10.1111/j.1469-8137.2004.01309.x; Schweingruber F.H, 2007, WOOD STRUCTURE ENV; [沈泽昊 Shen Zehao], 2004, [生物多样性, Chinese Biodiversity], V12, P89; Song Y.C., 2001, VEGETATION ECOLOGY; SPRUGEL DG, 1991, ANNU REV ECOL SYST, V22, P309, DOI 10.1146/annurev.es.22.110191.001521; Statsoft I, 2001, STATISTICA 6 0; Sterck F, 2011, TREE PHYSIOL, V31, P1024, DOI 10.1093/treephys/tpr065; STEVENS GC, 1991, ANNU REV ECOL SYST, V22, P177, DOI 10.1146/annurev.es.22.110191.001141; Sveinbjornsson B, 2000, AMBIO, V29, P388, DOI 10.1639/0044-7447(2000)029[0388:NAAETE]2.0.CO;2; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Swenson NG, 2010, ECOLOGY, V91, P2234, DOI 10.1890/09-1743.1; Turnbull C., 2005, PLANT ARCHITECTURE I; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2002, BIOMETRICAL J, V44, P161, DOI 10.1002/1521-4036(200203)44:2<161::AID-BIMJ161>3.0.CO;2-N; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452	63	0	1	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62163	10.1371/journal.pone.0062163	http://dx.doi.org/10.1371/journal.pone.0062163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658621	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700036
J	Wen, KK; McKane, M; Rubenstein, PA				Wen, Kuo-Kuang; McKane, Melissa; Rubenstein, Peter A.			Importance of a Lys(113)-Glu(195) Intermonomer Ionic Bond in F-actin Stabilization and Regulation by Yeast Formins Bni1p and Bnr1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONS; BINDING; POLYMERIZATION; ACTG1; NUCLEATION; RESIDUES; INSIGHT; COMPLEX; LYSINE; SITE	Proper actin cytoskeletal function requires actin's ability to generate a stable filament and requires that this reaction be regulated by actin-binding proteins via allosteric effects on the actin. Aproposed ionic interaction in the actin filament interior between Lys(113) of one monomer and Glu(195) of a monomer in the apposing strand potentially fosters cross-strand stabilization and allosteric communication between the filament interior and exterior. We interrupted the potential interaction by creating either K113E or E195K actin. By combining the two, we also reversed the interaction with a K113E/E195K (E/K) mutant. In all cases, we isolated viable cells expressing only the mutant actin. Either single mutant cell displays significantly decreased growth in YPD medium. This deficit is rescued in the double mutant. All three mutants display abnormal phalloidin cytoskeletal staining. K113E actin exhibits a critical concentration of polymerization 4 times higher than WT actin, nucleates more poorly, and forms shorter filaments. Restoration of the ionic bond, E/K, eliminates most of these problems. E195K actin behaves much more like WT actin, indicating accommodation of the neighboring lysines. Both Bni1 and Bnr1 formin FH1-FH2 fragment accelerate polymerization of WT, E/K, and to a lesser extent E195K actin. Bni1p FH1-FH2 dramatically inhibits K113E actin polymerization, consistent with barbed end capping. However, Bnr1p FH1-FH2 restores K113E actin polymerization, forming single filaments. In summary, the proposed ionic interaction plays an important role in filament stabilization and in the propagation of allosteric changes affecting formin regulation in an isoform-specific fashion.	[Wen, Kuo-Kuang; McKane, Melissa; Rubenstein, Peter A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Roy A & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [DC8803]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC008803, R01DC008803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC8803 (to P. A. R.).	Boldogh IR, 2005, GENE, V354, P28, DOI 10.1016/j.gene.2005.03.049; Bugyi B, 2006, J BIOL CHEM, V281, P10727, DOI 10.1074/jbc.M510252200; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Clark MG, 2007, GENETICS, V176, P1527, DOI 10.1534/genetics.107.072066; Durer ZAO, 2011, J MOL BIOL, V414, P204, DOI 10.1016/j.jmb.2011.09.035; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2003, J CELL BIOL, V163, P1057, DOI 10.1083/jcb.200308144; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Goley ED, 2010, P NATL ACAD SCI USA, V107, P8159, DOI 10.1073/pnas.0911668107; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Ishikita H, 2010, FEBS LETT, V584, P3464, DOI 10.1016/j.febslet.2010.07.003; Kruth KA, 2012, J BIOL CHEM, V287, P27217, DOI 10.1074/jbc.M112.377283; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Lee CY, 2013, P NATL ACAD SCI USA, V110, P5022, DOI 10.1073/pnas.1218407110; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Malloy LE, 2012, J BIOL CHEM, V287, P28398, DOI 10.1074/jbc.M112.371914; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Papp G, 2006, BIOPHYS J, V91, P2564, DOI 10.1529/biophysj.106.087775; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; RUBENSTEIN PA, 1990, BIOESSAYS, V12, P309, DOI 10.1002/bies.950120702; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHMIDT DE, 1971, BIOCHEMISTRY-US, V10, P1249; Stokasimov E, 2008, J BIOL CHEM, V283, P34844, DOI 10.1074/jbc.M804419200; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; Thompson ME, 2013, NAT STRUCT MOL BIOL, V20, P111, DOI 10.1038/nsmb.2462; Ujfalusi Z, 2010, J PHOTOCH PHOTOBIO B, V98, P7, DOI 10.1016/j.jphotobiol.2009.10.001; Wen KK, 2003, J BIOL CHEM, V278, P48386, DOI 10.1074/jbc.M308980200; Wen KK, 2010, J BIOL CHEM, V285, P21185, DOI 10.1074/jbc.M110.121426; Wen KK, 2009, J BIOL CHEM, V284, P16776, DOI 10.1074/jbc.M109.006981; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	42	7	7	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19140	19153		10.1074/jbc.M113.474122	http://dx.doi.org/10.1074/jbc.M113.474122			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23653364	hybrid, Green Published			2022-12-25	WOS:000321335800048
J	Bianchetti, CM; Harmann, CH; Takasuka, TE; Hura, GL; Dyer, K; Fox, BG				Bianchetti, Christopher M.; Harmann, Connor H.; Takasuka, Taichi E.; Hura, Gregory L.; Dyer, Kevin; Fox, Brian G.			Fusion of Dioxygenase and Lignin-binding Domains in a Novel Secreted Enzyme from Cellulolytic Streptomyces sp SirexAA-E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; PROTOCATECHUATE 3,4-DIOXYGENASE; CRYSTAL-STRUCTURE; KEY ENZYME; CELL-WALL; 1,2-DIOXYGENASE; SUBSTRATE; CLEAVAGE; CRYSTALLOGRAPHY; BIOSYNTHESIS	Streptomyces sp. SirexAA-E is a highly cellulolytic bacterium isolated from an insect/microbe symbiotic community. When grown on lignin-containing biomass, it secretes SACTE_2871, an aromatic ring dioxygenase domain fused to a family 5/12 carbohydrate-binding module (CBM 5/12). Here we present structural and catalytic studies of this novel fusion enzyme, thus providing insight into its function. The dioxygenase domain has the core beta-sandwich fold typical of this enzyme family but lacks a dimerization domain observed in other intradiol dioxygenases. Consequently, the x-ray structure shows that the enzyme is monomeric and the Fe(III)-containing active site is exposed to solvent in a shallow depression on a planar surface. Purified SACTE_2871 catalyzes the O-2-dependent intradiol cleavage of catechyl compounds from lignin biosynthetic pathways, but not their methylated derivatives. Binding studies show that SACTE_2871 binds synthetic lignin polymers and chitin through the interactions of the CBM 5/12 domain, representing a new binding specificity for this fold-family. Based on its unique structural features and functional properties, we propose that SACTE_2871 contributes to the invasive nature of the insect/microbial community by destroying precursors needed by the plant for de novo lignin biosynthesis as part of its natural wounding response.	[Bianchetti, Christopher M.; Harmann, Connor H.; Takasuka, Taichi E.; Fox, Brian G.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Hura, Gregory L.; Dyer, Kevin] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Fox, BG (corresponding author), Univ Wisconsin, 433 Babcock Dr, Madison, WI 53706 USA.	bgfox@biochem.wisc.edu	Takasuka, Taichi/AAF-9441-2020	Takasuka, Taichi/0000-0002-4413-2924; Hura, Greg/0000-0003-0501-8464	United States Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; College of Agricultural and Life Sciences, Department of Biochemistry; Graduate School of the University of Wisconsin; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]; DOE program Integrated Diffraction Analysis Technologies [IDAT-DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); College of Agricultural and Life Sciences, Department of Biochemistry; Graduate School of the University of Wisconsin; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant; DOE program Integrated Diffraction Analysis Technologies(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Dr. Craig A. Bingman (University of Wisconsin Center for Eukaryotic Structural Genomics) for access to crystallization robotics, Grzegory Sabat (Biotechnology Center, University of Wisconsin-Madison) for assistance with mass spectrometry, Dr. John Ralph and Dr. Yuki Tobimatsu (Great Lakes Bioenergy Research Center, University of Wisconsin) for gifts of synthetic lignins and 5-OH-ferulate, and Dr. Curtis Wilkerson and Saunia Withers (Great Lakes Bioenergy Research Center, Michigan State University) for the gift of the caffeoyl-CoA synthesis enzyme Nt4CL1. We also thank Dr. Ralph for many stimulating discussions on the complexities of lignin. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-ENG-38. Use of the Life Science Collaborative Access Team at the Advanced Photon Source was supported by the College of Agricultural and Life Sciences, Department of Biochemistry, the Graduate School of the University of Wisconsin, the Michigan Economic Development Corporation, and Michigan Technology Tri-Corridor Grant 085P1000817). X-ray scattering studies at the SIBYLS was supported by DOE program Integrated Diffraction Analysis Technologies (IDAT-DE-AC02-05CH11231).	Adams AS, 2011, ISME J, V5, P1323, DOI 10.1038/ismej.2011.14; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akagi K, 2006, J BIOCHEM, V139, P483, DOI 10.1093/jb/mvj062; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Beuerle T, 2002, ANAL BIOCHEM, V302, P305, DOI 10.1006/abio.2001.5574; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Blommel PG, 2006, PROTEIN EXPRES PURIF, V47, P562, DOI 10.1016/j.pep.2005.11.007; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Brown CK, 2004, ANNU REV MICROBIOL, V58, P555, DOI 10.1146/annurev.micro.57.030502.090927; Brun E, 1997, BIOCHEMISTRY-US, V36, P16074, DOI 10.1021/bi9718494; Carnegie AJ, 2006, ANN FOREST SCI, V63, P119, DOI 10.1051/forest:2005104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dagley S, 1971, Adv Microb Physiol, V6, P1, DOI 10.1016/S0065-2911(08)60066-1; Denness L, 2011, PLANT PHYSIOL, V156, P1364, DOI 10.1104/pp.111.175737; Ferraroni M, 2004, J BIOL CHEM, V279, P27646, DOI 10.1074/jbc.M401692200; Ferraroni M, 2005, J BIOL CHEM, V280, P21144, DOI 10.1074/jbc.M500666200; Ferraroni M, 2006, J MOL BIOL, V360, P788, DOI 10.1016/j.jmb.2006.05.046; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; GILKES NR, 1992, J BIOL CHEM, V267, P6743; Gonzales-Vigil E, 2011, P NATL ACAD SCI USA, V108, P5897, DOI 10.1073/pnas.1016157108; Grabber JH, 2008, BIOMACROMOLECULES, V9, P2510, DOI 10.1021/bm800528f; Hoebeke E. R., 2005, Newsletter of the Michigan Entomological Society, V50, P24; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Ikegami T, 2000, J BIOL CHEM, V275, P13654, DOI 10.1074/jbc.275.18.13654; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; KUKOR JJ, 1983, SCIENCE, V220, P1161, DOI 10.1126/science.220.4602.1161; Matera I, 2010, J STRUCT BIOL, V170, P548, DOI 10.1016/j.jsb.2009.12.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Micalella C, 2011, BBA-PROTEINS PROTEOM, V1814, P817, DOI 10.1016/j.bbapap.2010.09.008; OHLENDORF DH, 1988, NATURE, V336, P403, DOI 10.1038/336403a0; Ohmiya K, 1997, BIOTECHNOL GENET ENG, V14, P365, DOI 10.1080/02648725.1997.10647949; Orville AM, 1997, BIOCHEMISTRY-US, V36, P10039, DOI 10.1021/bi970468n; Orville AM, 1997, BIOCHEMISTRY-US, V36, P10052, DOI 10.1021/bi970469f; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; SEIDMAN MM, 1969, J BACTERIOL, V97, P1192, DOI 10.1128/JB.97.3.1192-1197.1969; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; STOCKIGT J, 1975, Z NATURFORSCH C, V30, P352; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobimatsu Y, 2012, CHEMSUSCHEM, V5, P676, DOI 10.1002/cssc.201100573; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vanholme R, 2012, NEW PHYTOL, V196, P978, DOI 10.1111/j.1469-8137.2012.04337.x; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vetting MW, 2000, STRUCTURE, V8, P429, DOI 10.1016/S0969-2126(00)00122-2; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WHITTAKER JW, 1990, METHOD ENZYMOL, V188, P82; WHITTAKER JW, 1984, J BIOL CHEM, V259, P4466; WHITTAKER JW, 1984, J BIOL CHEM, V259, P4476	60	22	23	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18574	18587		10.1074/jbc.M113.475848	http://dx.doi.org/10.1074/jbc.M113.475848			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653358	Green Published, hybrid			2022-12-25	WOS:000320721900057
J	Chiu, TT; Sun, Y; Koshkina, A; Klip, A				Chiu, Tim Ting; Sun, Yi; Koshkina, Alexandra; Klip, Amira			Rac-1 Superactivation Triggers Insulin-independent Glucose Transporter 4 (GLUT4) Translocation That Bypasses Signaling Defects Exerted by c-Jun N-terminal kinase (JNK)- and Ceramide-induced Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN-KINASE; PLECKSTRIN HOMOLOGY DOMAIN; NUCLEOTIDE-EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEIN; RICTOR-MTOR COMPLEX; PHOSPHATIDYLINOSITOL 3-KINASE; AKT PHOSPHORYLATION; GLUCOSE-UPTAKE; L6 MYOTUBES	Insulin activates a cascade of signaling molecules, including Rac-1, Akt, and AS160, to promote the net gain of glucose transporter 4 (GLUT4) at the plasma membrane of muscle cells. Interestingly, constitutively active Rac-1 expression results in a hormone-independent increase in surface GLUT4; however, the molecular mechanism and significance behind this effect remain unresolved. Using L6 myoblasts stably expressing myc-tagged GLUT4, we found that overexpression of constitutively active but not wild-type Rac-1 sufficed to drive GLUT4 translocation to the membrane of comparable magnitude with that elicited by insulin. Stimulation of endogenous Rac-1 by Tiam1 overexpression elicited a similar hormone-independent gain in surface GLUT4. This effect on GLUT4 traffic could also be reproduced by acutely activating a Rac-1 construct via rapamycin-mediated heterodimerization. Strategies triggering Rac-1 "superactivation" (i.e. to levels above those attained by insulin alone) produced a modest gain in plasma membrane phosphatidylinositol 3,4,5-trisphosphate, moderate Akt activation, and substantial AS160 phosphorylation, which translated into GLUT4 translocation and negated the requirement for IRS-1. This unique signaling capacity exerted by Rac-1 superactivation bypassed the defects imposed by JNK- and ceramide-induced insulin resistance and allowed full and partial restoration of the GLUT4 translocation response, respectively. We propose that potent elevation of Rac-1 activation alone suffices to drive insulin-independent GLUT4 translocation in muscle cells, and such a strategy might be exploited to bypass signaling defects during insulin resistance.	[Chiu, Tim Ting; Sun, Yi; Koshkina, Alexandra; Klip, Amira] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Chiu, Tim Ting; Klip, Amira] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Klip, A (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	amira@sickkids.ca			Canadian Institutes of Health Research (CIHR) [7307]; CIHR; Research Training Centre from the Hospital for Sick Children; Canadian Diabetes Association	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Research Training Centre from the Hospital for Sick Children; Canadian Diabetes Association	This work was supported in part by Canadian Institutes of Health Research (CIHR) Grant 7307 (to A. K.).; Supported by studentships from the CIHR and the Research Training Centre from the Hospital for Sick Children.; Supported by a fellowship from the Canadian Diabetes Association.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bilan Phillip J., 2009, Archives of Physiology and Biochemistry, V115, P176, DOI 10.1080/13813450903079314; Bohdanowicz M, 2011, METHODS MOL BIOL, V748, P183, DOI 10.1007/978-1-61779-139-0_13; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chiu TT, 2010, MOL BIOL CELL, V21, P3529, DOI 10.1091/mbc.E10-04-0316; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Crompton AM, 2000, J BIOL CHEM, V275, P25751, DOI 10.1074/jbc.M002050200; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Fazakerley DJ, 2010, J BIOL CHEM, V285, P1653, DOI 10.1074/jbc.M109.051185; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; GARVEY WT, 1988, J CLIN INVEST, V81, P1528, DOI 10.1172/JCI113485; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Habegger KM, 2012, ENDOCRINOLOGY, V153, P2130, DOI 10.1210/en.2011-2099; Hajduch E, 2001, DIABETOLOGIA, V44, P173, DOI 10.1007/s001250051596; Henstridge DC, 2012, DIABETOLOGIA, V55, P2769, DOI 10.1007/s00125-012-2652-8; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Huynh N, 2010, BBA-MOL CELL RES, V1803, P1106, DOI 10.1016/j.bbamcr.2010.05.007; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jebailey L, 2004, MOL ENDOCRINOL, V18, P359, DOI 10.1210/me.2003-0294; JeBailey L, 2007, DIABETES, V56, P394, DOI 10.2337/db06-0823; Kewalramani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026947; Khayat ZA, 2000, J CELL SCI, V113, P279; KINSELLA BT, 1991, J BIOL CHEM, V266, P9786; Mao K, 2008, J MOL CELL CARDIOL, V44, P429, DOI 10.1016/j.yjmcc.2007.10.016; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Ng Y, 2010, J BIOL CHEM, V285, P2255, DOI 10.1074/jbc.M109.060236; Niu WY, 2010, AM J PHYSIOL-ENDOC M, V298, pE1058, DOI 10.1152/ajpendo.00773.2009; Patel N, 2003, MOL CELL BIOL, V23, P4611, DOI 10.1128/MCB.23.13.4611-4626.2003; Randhawa VK, 2008, J BIOL CHEM, V283, P27208, DOI 10.1074/jbc.M804282200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Somwar R, 2001, J BIOL CHEM, V276, P46079, DOI 10.1074/jbc.M109093200; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Stratford S, 2001, BIOCHEM J, V354, P359, DOI 10.1042/0264-6021:3540359; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Sun Y, 2010, P NATL ACAD SCI USA, V107, P19909, DOI 10.1073/pnas.1009523107; Sylow L., 2013, DIABETES IN PRESS; Talior-Volodarsky I, 2008, J BIOL CHEM, V283, P25115, DOI 10.1074/jbc.M801750200; Tan SX, 2012, J BIOL CHEM, V287, P6128, DOI 10.1074/jbc.M111.318238; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Teruel T, 2001, DIABETES, V50, P2563, DOI 10.2337/diabetes.50.11.2563; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI12348; Torok D, 2004, J CELL SCI, V117, P5447, DOI 10.1242/jcs.01421; Ueda S, 2008, BIOL CELL, V100, P645, DOI 10.1042/BC20070160; Ueda S, 2010, FASEB J, V24, P2254, DOI 10.1096/fj.09-137380; Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang HW, 2012, MOL CELL, V47, P281, DOI 10.1016/j.molcel.2012.05.007; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723	79	35	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17520	17531		10.1074/jbc.M113.467647	http://dx.doi.org/10.1074/jbc.M113.467647			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640896	Green Published, hybrid			2022-12-25	WOS:000320380600043
J	Svensson, KJ; Christianson, HC; Wittrup, A; Bourseau-Guilmain, E; Lindqvist, E; Svensson, LM; Morgelin, M; Belting, M				Svensson, Katrin J.; Christianson, Helena C.; Wittrup, Anders; Bourseau-Guilmain, Erika; Lindqvist, Eva; Svensson, Lena M.; Morgelin, Matthias; Belting, Mattias			Exosome Uptake Depends on ERK1/2-Heat Shock Protein 27 Signaling and Lipid Raft-mediated Endocytosis Negatively Regulated by Caveolin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVESICLES; CELLS; PATHWAY; TRANSFORMATION; CANCER; SIMIAN-VIRUS-40; BIOGENESIS; MECHANISMS; REVEALS; PROVIDE	The role of exosomes in cancer can be inferred from the observation that they transfer tumor cell derived genetic material and signaling proteins, resulting in e.g. increased tumor angiogenesis and metastasis. However, the membrane transport mechanisms and the signaling events involved in the uptake of these virus-like particles remain ill-defined. We now report that internalization of exosomes derived from glioblastoma (GBM) cells involves nonclassical, lipid raft-dependent endocytosis. Importantly, we show that the lipid raft-associated protein caveolin-1 (CAV1), in analogy with its previously described role in virus uptake, negatively regulates the uptake of exosomes. We find that exosomes induce the phosphorylation of several downstream targets known to associate with lipid rafts as signaling and sorting platforms, such as extracellular signal-regulated kinase-1/2 (ERK1/2) and heat shock protein 27 (HSP27). Interestingly, exosome uptake appears dependent on unperturbed ERK1/2-HSP27 signaling, and ERK1/2 phosphorylation is under negative influence by CAV1 during internalization of exosomes. These findings significantly advance our general understanding of exosome-mediated uptake and offer potential strategies for how this pathway may be targeted through modulation of CAV1 expression and ERK1/2 signaling.	[Svensson, Katrin J.; Christianson, Helena C.; Wittrup, Anders; Bourseau-Guilmain, Erika; Lindqvist, Eva; Belting, Mattias] Lund Univ, Sect Oncol, Dept Clin Sci, SE-22184 Lund, Sweden; [Svensson, Lena M.] Lund Univ, Immunol Sect, Dept Expt Med Sci, SE-22184 Lund, Sweden; [Morgelin, Matthias] Lund Univ, Dept Clin Sci, Sect Clin & Expt Infect Med, SE-22184 Lund, Sweden; [Wittrup, Anders] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Mol & Cellular Med, Boston, MA 02115 USA; [Belting, Mattias] Skane Univ Hosp, Dept Oncol, SE-22241 Lund, Sweden	Lund University; Lund University; Lund University; Harvard University; Boston Children's Hospital; Harvard Medical School; Lund University; Skane University Hospital	Svensson, KJ (corresponding author), Lund Univ, Sect Oncol, Dept Clin Sci, Barngatan 2B, SE-22185 Lund, Sweden.	Katrin.Svensson@med.lu.se	Svensson, Katrin J./AAA-4770-2021	Svensson, Katrin J./0000-0001-5376-5128; Wittrup, Anders/0000-0003-4918-0500; Belting, Mattias/0000-0003-1585-5434	Swedish Cancer Fund; Swedish Research Council; Swedish Society of Medicine; Physiographic Society, Lund; Crafoordska Foundation; Gunnar Nilsson Foundation; Lundbergs Foundation; Kamprad Foundation; Skane University Hospital; Governmental Funding of Clinical Research within the National Health Services	Swedish Cancer Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Physiographic Society, Lund; Crafoordska Foundation; Gunnar Nilsson Foundation; Lundbergs Foundation; Kamprad Foundation; Skane University Hospital; Governmental Funding of Clinical Research within the National Health Services	This work was supported by grants from the Swedish Cancer Fund; the Swedish Research Council; the Swedish Society of Medicine; the Physiographic Society, Lund; the Crafoordska, Gunnar Nilsson, Lundbergs, and Kamprad Foundations; the Skane University Hospital donation funds; and the Governmental Funding of Clinical Research within the National Health Services (to A. L. F.).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Baroni M, 2007, FASEB J, V21, P1926, DOI 10.1096/fj.06-7238com; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Chen HY, 2006, INT J BIOCHEM CELL B, V38, P1402, DOI 10.1016/j.biocel.2006.02.006; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Fujioka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016324; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Koppers-Lalic D, 2013, ADV DRUG DELIVER REV, V65, P348, DOI 10.1016/j.addr.2012.07.006; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Medina RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002584; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Razandi M, 2010, MOL CELL BIOL, V30, P3249, DOI 10.1128/MCB.01354-09; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sasai K, 2007, ONCOGENE, V26, P449, DOI 10.1038/sj.onc.1209792; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Svensson KJ, 2011, P NATL ACAD SCI USA, V108, P13147, DOI 10.1073/pnas.1104261108; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Wittrup A, 2010, P NATL ACAD SCI USA, V107, P13342, DOI 10.1073/pnas.1002622107	40	434	446	7	83	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17713	17724		10.1074/jbc.M112.445403	http://dx.doi.org/10.1074/jbc.M112.445403			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23653359	Green Published, hybrid			2022-12-25	WOS:000320380600061
J	Biron-Pain, K; Grosset, AA; Poirier, F; Gaboury, L; St-Pierre, Y				Biron-Pain, Katherine; Grosset, Andree-Anne; Poirier, Francoise; Gaboury, Louis; St-Pierre, Yves			Expression and Functions of Galectin-7 in Human and Murine Melanomas	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MMP-9 GENE-EXPRESSION; MALIGNANT-MELANOMA; INDUCED APOPTOSIS; PROGRESSION; CANCER; SURVIVAL; MODEL; MECHANISMS; LYMPHOMA	The identification of galectin-7 as a p53-induced gene and its ability to induce apoptosis in many cell types support the hypothesis that galectin-7 has strong antitumor activity. This has been well documented in colon cancer. However, in some cases, such as breast cancer and lymphoma, its high expression level correlates with aggressive subtypes of cancer, suggesting that galectin-7 may have a dual role in cancer progression. In fact, in breast cancer, overexpression of galectin-7 alone is sufficient to promote metastasis to the bone and lung. In the present work, we investigated the expression and function of galectin-7 in melanoma. An analysis of datasets obtained from whole-genome profiling of human melanoma tissues revealed that galectin-7 mRNA was detected in more than 90% of biopsies of patients with nevi while its expression was more rarely found in biopsies collected from patients with malignant melanoma. This frequency, however, was likely due to the presence of normal epidermis tissues in biopsies, as shown our studies at the protein level by immunohistochemical analysis. Using the experimental melanoma B16F1 cell line, we found that melanoma cells can express galectin-7 at the primary tumor site and in lung metastasis. Moreover, we found that overexpression of galectin-7 increased the resistance of melanoma cells to apoptosis while inducing de novo egr-1 expression. Overexpression of galectin-7, however, was insufficient to modulate the growth of tumors induced by the subcutaneous injection of B16F1 cells. It also failed to modulate the dissemination of B16F1 cells to the lung.	[Biron-Pain, Katherine; Grosset, Andree-Anne; St-Pierre, Yves] INRS Inst Armand Frappier, Laval, PQ, Canada; [Poirier, Francoise] Univ Paris Diderot, CNRS, Inst Jacques Monod, Sorbonne Paris Cite,UMR 7592, Paris, France; [Gaboury, Louis] Inst Rech Immunol & Cancerol, Montreal, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal	St-Pierre, Y (corresponding author), INRS Inst Armand Frappier, Laval, PQ, Canada.	yves.st-pierre@iaf.inrs.ca		St-Pierre, Yves/0000-0002-1948-2041	Canadian Institute for Health Research [14 MOP-89697]; Fond de la Recherche en Sante du Quebec (FRSQ); Ligue Contre le Cancer, Comite de Paris	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Fond de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Ligue Contre le Cancer, Comite de Paris(Ligue nationale contre le cancer)	This work was funded by grants to YSP from the Canadian Institute for Health Research (Grant No. 14 MOP-89697). KBP and AAG were supported by studentships from the Fond de la Recherche en Sante du Quebec (FRSQ). FP was supported by a grant from Ligue Contre le Cancer, Comite de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MM, 2004, CURR CANCER DRUG TAR, V4, P43, DOI 10.2174/1568009043481704; Alves PM, 2011, PATHOL RES PRACT, V207, P236, DOI 10.1016/j.prp.2011.02.004; Aoudjit F, 1998, BLOOD, V91, P623, DOI 10.1182/blood.V91.2.623.623_623_629; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Biron-Pain K, 2012, CELL MOL LIFE SCI, V69, P783, DOI 10.1007/s00018-011-0777-4; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Demers M, 2005, CANCER RES, V65, P5205, DOI 10.1158/0008-5472.CAN-05-0134; Demers M, 2007, CANCER RES, V67, P2824, DOI 10.1158/0008-5472.CAN-06-3891; Demers M, 2010, AM J PATHOL, V176, P3023, DOI 10.2353/ajpath.2010.090876; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; FIDLER IJ, 1975, CANCER RES, V35, P218; Gendronneau G, 2008, MOL BIOL CELL, V19, P5541, DOI 10.1091/mbc.E08-02-0166; George J, 2011, PROTEOMICS, V11, P4411, DOI 10.1002/pmic.201100233; Hersey P, 2006, CURR OPIN ONCOL, V18, P189, DOI 10.1097/01.cco.0000208794.24228.9f; Ivanov VN, 2003, ONCOGENE, V22, P3152, DOI 10.1038/sj.onc.1206456; Ke HN, 2010, CELL RES, V20, P458, DOI 10.1038/cr.2010.21; Lim JH, 2007, APOPTOSIS, V12, P411, DOI 10.1007/s10495-006-0576-9; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lu JX, 1997, MOL CARCINOGEN, V20, P204, DOI 10.1002/(SICI)1098-2744(199710)20:2<204::AID-MC7>3.0.CO;2-M; MADSEN P, 1995, J BIOL CHEM, V270, P5823, DOI 10.1074/jbc.270.11.5823; Magnaldo T, 1998, DIFFERENTIATION, V63, P159, DOI 10.1046/j.1432-0436.1998.6330159.x; MAGNALDO T, 1995, DEV BIOL, V168, P259, DOI 10.1006/dbio.1995.1078; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Okamoto I, 2005, NEOPLASIA, V7, P303, DOI 10.1593/neo.04514; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Robbins PF, 2002, J IMMUNOL, V169, P6036, DOI 10.4049/jimmunol.169.10.6036; Rorive S, 2002, MODERN PATHOL, V15, P1294, DOI 10.1097/01.MP.0000037306.19083.28; Sapoznik S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/818214; Saussez S, 2006, ANN SURG ONCOL, V13, P999, DOI 10.1245/ASO.2006.08.033; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; St-Pierre Y, 2012, FRONT BIOSCI-LANDMRK, V17, P438, DOI 10.2741/3937; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Ueda S, 2004, CANCER RES, V64, P5672, DOI 10.1158/0008-5472.CAN-04-0985; Villeneuve C, 2011, MOL BIOL CELL, V22, P999, DOI 10.1091/mbc.E10-06-0534; Wang JL, 2004, BBA-GEN SUBJECTS, V1673, P75, DOI 10.1016/j.bbagen.2004.03.013; Zhu H, 2009, J PROTEOME RES, V8, P3969, DOI 10.1021/pr900287a; Zhu X, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-290	40	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63307	10.1371/journal.pone.0063307	http://dx.doi.org/10.1371/journal.pone.0063307			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658821	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000321202100061
J	Bruneau, A; Feuilloy, M; Dussaussoy, C; Gagnadoux, F; Leftheriotis, G; Abraham, P				Bruneau, Antoine; Feuilloy, Mathieu; Dussaussoy, Corinne; Gagnadoux, Frederic; Leftheriotis, Georges; Abraham, Pierre			The Walking-Induced Transient Hack Concept Is Valid & Relies on a Transient Early-Exercise Hypoxemia	PLOS ONE			English	Article							INDUCED ARTERIAL HYPOXEMIA; TRANSCUTANEOUS OXYGEN; GAS-EXCHANGE; TREADMILL; DISEASES; HYPOXIA	Background: Decreased arterial oxygen pressure obtained at peak exercise is strong evidence of walking-induced hypoxemia, assuming that the lower pressure occurs just before exercise is stopped. Using empirical predefined models and transcutaneous oximetry, we have shown that some patients reporting exercise intolerance show a minimal value at the onset of walking and a post-exercise overshoot. These changes are referred to as transcutaneous "walking-induced transient hacks''. Methods: In 245 patients, walking-induced transcutaneous oxygen pressure changes in the chest were analyzed using observer-independent clustering techniques. Clustering classes were compared to the profile types previously proposed with the cross-correlation technique. The classifications of patients according to both approaches were compared using kappa statistics. In 10 patients showing a hack on transcutaneous oximetry, we analyzed the results of direct iterative arterial sampling recorded during a new walking treadmill test. Results: Clustering analysis resulted in 4 classes that closely fit the 4 most frequently proposed empirical models (cross-correlation coefficients: 0.93 to 0.97). The kappa between the two classifications was 0.865. In 10 patients showing transcutaneous hacks, the minimal direct arterial oxygen pressure value occurred at exercise onset, and these patients exhibited a recovery overshoot reaching a maximum at two minutes of recovery, confirming the walking-induced transient hypoxemia. Conclusions: In patients reporting exercise intolerance, transcutaneous oximetry could help to detect walking-induced transient hypoxemia, while peak-exercise arterial oximetry might be normal.	[Bruneau, Antoine; Dussaussoy, Corinne; Leftheriotis, Georges; Abraham, Pierre] Univ Nantes Angers Mans, Univ Angers, Ctr Hosp, Lab Vasc Investigat, Angers, France; [Feuilloy, Mathieu] Univ Maine, Grad Sch Engn, CNRS U6613, Acoust Lab,Unite Mixte Rech, Angers, France; [Gagnadoux, Frederic] Ctr Hosp Univ Angers, Dept Resp Dis, Angers, France; [Gagnadoux, Frederic] Univ Nantes Angers Mans, Inst Natl Sante & Rech Med U1063, Angers, France; [Abraham, Pierre] Univ Nantes Angers Mans, CNRS U6214, Unite Mixte Rech, Angers, France; [Abraham, Pierre] Inst Natl Sante & Rech Med, U1083, Angers, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Le Mans Universite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm)	Abraham, P (corresponding author), Univ Nantes Angers Mans, Univ Angers, Ctr Hosp, Lab Vasc Investigat, Angers, France.	piabraham@chu-angers.fr			University Hospital in Angers; Direction departementale de la cohesion sociale; Comite departemental olympique et sportif	University Hospital in Angers; Direction departementale de la cohesion sociale; Comite departemental olympique et sportif	The project was funded and promoted by the University Hospital in Angers, and AB benefits the support of the "Direction departementale de la cohesion sociale'' and "Comite departemental olympique et sportif''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2003, CIRCULATION, V107, P1896, DOI 10.1161/01.CIR.0000060500.60646.E0; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Banerjee M, 2008, CANADIAN J STAT, V27, P3; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Carter R, 2000, RESP MED, V94, P350, DOI 10.1053/rmed.1999.0714; Chetta A, 2006, RESP MED, V100, P1573, DOI 10.1016/j.rmed.2006.01.001; Daw CS, 2003, REV SCI INSTRUM, V74, P915, DOI 10.1063/1.1531823; DeLorey DS, 2007, APPL PHYSIOL NUTR ME, V32, P1251, DOI 10.1139/H07-121; Everitt B. S., 2001, CLUSTER ANAL; Grouiller F, 2006, INT ANGIOL, V25, P190; Hansen P, 1997, MATH PROGRAM, V79, P191, DOI 10.1007/BF02614317; Heidrich H, 2004, VASA-J VASCULAR DIS, V33, P155, DOI 10.1024/0301-1526.33.3.155; Hopkins SR, 2009, J APPL PHYSIOL, V107, P993, DOI 10.1152/japplphysiol.91489.2008; HUGHES JA, 1984, THORAX, V39, P424, DOI 10.1136/thx.39.6.424; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jain AK., 1988, TECHNOMETRICS; Jaquinandi V, 2007, J VASC SURG, V45, P312, DOI 10.1016/j.jvs.2006.09.050; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Lim CS, 2011, J VASC RES, V48, P185, DOI 10.1159/000320624; Lim CS, 2012, J VASC SURG, V55, P1427, DOI 10.1016/j.jvs.2011.10.111; Lovering AT, 2008, J APPL PHYSIOL, V104, P1418, DOI 10.1152/japplphysiol.00208.2007; Ouedraogo N, 2011, PHYSIOL MEAS, V32, P181, DOI 10.1088/0967-3334/32/2/003; Pancholy S, 2008, CATHETER CARDIO INTE, V72, P335, DOI 10.1002/ccd.21639; Picquet J, 2005, Eur J Intern Med, V16, P575, DOI 10.1016/j.ejim.2005.06.013; Planes C, 2001, ARCH PHYS MED REHAB, V82, P1686, DOI 10.1053/apmr.2001.26248; Popping R, 1988, SOCIOMETRIC RES, P90, DOI DOI 10.1007/978-1-349-19051-5_6; Romer LM, 2006, ADV EXP MED BIOL, V588, P47; Romer LM, 2006, AM J PHYSIOL-REG I, V290, pR365, DOI 10.1152/ajpregu.00332.2005; SABIN S, 1976, CHEST, V69, P437, DOI 10.1378/chest.69.3.437; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Tanabe Y, 2000, J AM COLL CARDIOL, V35, P1228, DOI 10.1016/S0735-1097(00)00517-9; Theodoridis S, 2006, PATTERN RECOGNITION, 3RD EDITION, P1; vonKemp K, 1997, INT ANGIOL, V16, P114; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141	35	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62651	10.1371/journal.pone.0062651	http://dx.doi.org/10.1371/journal.pone.0062651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658759	Green Submitted, Green Published, gold			2022-12-25	WOS:000321202100027
J	Corey, KE; Misdraji, J; Zheng, H; Malecki, KM; Kneeman, J; Gelrud, L; Chung, RT				Corey, Kathleen E.; Misdraji, Joseph; Zheng, Hui; Malecki, Kyle M.; Kneeman, Jacob; Gelrud, Louis; Chung, Raymond T.			The Absence of Obstructive Sleep Apnea May Protect against Non-Alcoholic Fatty Liver in Patients Undergoing Bariatric Surgery	PLOS ONE			English	Article							CHRONIC INTERMITTENT HYPOXIA; DISEASE; OBESE; STEATOHEPATITIS; RISK	Background: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide and its progressive form, steatohepatitis, will be the leading indication for liver transplant by 2020. While risk factors for steatohepatitis have been identified, little work has been performed to identify factors protective against NAFLD development. Aim: This study sought to identify factors predictive of normal liver histology in a bariatric cohort. Methods: Patients undergoing weight loss surgery with liver biopsies at the time of surgery were included. Patients with other causes of chronic liver disease were excluded. Results: One hundred fifty-nine patients were included. Forty-nine patients had normal liver histology and 110 patients had NAFLD. Several previously identified factors associated with normal liver histology were found. Black race was the strongest predictor of the absence of NAFLD with an odds ratio (OR) of 6.8, 95% confidence interval (CI) 2.4-18.9. Low HOMA-IR was also associated with normal histology (OR 1.4, 95% CI 1.03-1.9). In contrast, low HDL was associated with a decreased chance of normal histology (OR 0.38, 95% CI 0.05-0.83). Interestingly, a novel protective factor, the absence of obstructive sleep apnea (OSA) was strongly associated with normal histology (OR 5.6, 95% CI 2.0-16.1). In multivariate regression controlling for BMI, black race, absence of OSA, low HOMA-IR and low ALT independently predicted normal liver histology with an area under the ROC curve of 0.85. Conclusions: Our study confirmed several factors associated with normal liver histology, including black race and identified a novel factor, absence of OSA. Further evaluation of these factors will allow for improved understanding of the pathogenesis of NAFLD.	[Corey, Kathleen E.; Malecki, Kyle M.; Kneeman, Jacob; Chung, Raymond T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Misdraji, Joseph] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Zheng, Hui] Massachusetts Gen Hosp, MGH Biostat Ctr, Boston, MA 02114 USA; [Corey, Kathleen E.; Zheng, Hui; Gelrud, Louis; Chung, Raymond T.] Harvard Univ, Sch Med, Boston, MA USA; [Gelrud, Louis] Bon Secours Richmond Hlth Syst, Dept Internal Med, Richmond, VA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Corey, KE (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.	kcorey@partners.org; rtchung@partners.org	Misdraji, Joseph/AGX-4779-2022; Misdraji, Joseph/AAD-4588-2019		American Association for the Study of Liver Disease Clinical and Translational Research Award; NIH [2T32DK0007191-37, DK078772]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191, P30DK043351, K24DK078772, K23DK099422] Funding Source: NIH RePORTER	American Association for the Study of Liver Disease Clinical and Translational Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	KEC receives support from the American Association for the Study of Liver Disease Clinical and Translational Research Award. JK receives support from the NIH 2T32DK0007191-37. RTC receives support from NIH DK078772. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron-Wisnewsky J, 2012, J HEPATOL, V56, P225, DOI 10.1016/j.jhep.2011.04.022; Charlton M, 2008, HEPATOLOGY, V47, P1431, DOI 10.1002/hep.22246; Corey KE, 2012, CLIN GASTROENTEROL H; Dunn W, 2008, AM J GASTROENTEROL, V103, P2263, DOI 10.1111/j.1572-0241.2008.02034.x; Gholam PM, 2007, AM J GASTROENTEROL, V102, P399, DOI 10.1111/j.1572-0241.2006.01041.x; Greenfield V, 2008, CURR OPIN GASTROEN, V24, P320, DOI 10.1097/MOG.0b013e3282fbccf2; Gupte P, 2004, J GASTROEN HEPATOL, V19, P854, DOI 10.1111/j.1440-1746.2004.03312.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Machado M, 2006, J HEPATOL, V45, P600, DOI 10.1016/j.jhep.2006.06.013; Norman D, 2008, SLEEP, V31, P121, DOI 10.1093/sleep/31.1.121; Piguet AC, 2010, CLIN SCI, V118, P401, DOI 10.1042/CS20090313; Savransky V, 2007, AM J PHYSIOL-GASTR L, V293, pG871, DOI 10.1152/ajpgi.00145.2007; Targher G, 2008, DIABETOLOGIA, V51, P1947, DOI 10.1007/s00125-008-1135-4	13	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62504	10.1371/journal.pone.0062504	http://dx.doi.org/10.1371/journal.pone.0062504			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658732	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100011
J	Ikeda, H; Delargy, AH; Yokogawa, T; Urban, JM; Burgess, HA; Ono, F				Ikeda, Hiromi; Delargy, Alison H.; Yokogawa, Tohei; Urban, Jason M.; Burgess, Harold A.; Ono, Fumihito			Intrinsic Properties of Larval Zebrafish Neurons in Ethanol	PLOS ONE			English	Article							DANIO-RERIO; LOCOMOTOR-ACTIVITY; MODEL SYSTEM; ALCOHOL; HINDBRAIN; BEHAVIOR; APOPTOSIS; EXPOSURE; MAUTHNER; EMBRYOS	The behavioral effects of ethanol have been studied in multiple animal models including zebrafish. Locomotion of zebrafish larvae is resistant to high concentrations of ethanol in bath solution. This resistance has been attributed to a lower systemic concentration of ethanol in zebrafish when compared with bath solution, although the mechanism to maintain such a steep gradient is unclear. Here we examined whether the intrinsic properties of neurons play roles in this resistance. In order to minimize the contribution of metabolism and diffusional barriers, larvae were hemisected and the anterior half immersed in a range of ethanol concentrations thereby ensuring the free access of bath ethanol to the brain. The response to vibrational stimuli of three types of reticulospinal neurons: Mauthner neurons, vestibulospinal neurons, and MiD3 neurons were examined using an intracellular calcium indicator. The intracellular [Ca2+] response in MiD3 neurons decreased in 100 mM ethanol, while Mauthner neurons and vestibulospinal neurons required >300 mM ethanol to elicit similar effects. The ethanol effect in Mauthner neurons was reversible following removal of ethanol. Interestingly, activities of MiD3 neurons displayed spontaneous recovery in 300 mM ethanol, suggestive of acute tolerance. Finally, we examined with mechanical vibration the startle response of free-swimming larvae in 300 mM ethanol. Ethanol treatment abolished long latency startle responses, suggesting a functional change in neural processing. These data support the hypothesis that individual neurons in larval zebrafish brains have distinct patterns of response to ethanol dictated by specific molecular targets.	[Ikeda, Hiromi; Delargy, Alison H.; Urban, Jason M.; Ono, Fumihito] NIAAA, Sect Model Synapt Syst, Lab Mol Physiol, NIH, Rockville, MD 20852 USA; [Yokogawa, Tohei; Burgess, Harold A.] NICHD, Unit Behav Neurogenet, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ono, F (corresponding author), NIAAA, Sect Model Synapt Syst, Lab Mol Physiol, NIH, Rockville, MD 20852 USA.	onof@mail.nih.gov	Burgess, Harold/B-8474-2015	Burgess, Harold/0000-0003-1966-7801; ono, fumihito/0000-0001-7532-5262	intramural program at the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000437] Funding Source: NIH RePORTER	intramural program at the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the intramural program at the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradfield JY, 2006, NEUROTOXICOL TERATOL, V28, P629, DOI 10.1016/j.ntt.2006.06.004; Budick SA, 2000, J EXP BIOL, V203, P2565; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; CHARNESS ME, 1989, NEW ENGL J MED, V321, P442, DOI 10.1056/NEJM198908173210706; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P425, DOI 10.1016/j.ntt.2012.03.002; Dlugos CA, 2003, PHARMACOL BIOCHEM BE, V74, P471, DOI 10.1016/S0091-3057(02)01026-2; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2006, PHARMACOL BIOCHEM BE, V85, P752, DOI 10.1016/j.pbb.2006.11.010; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; Mueller T, 2004, BRAIN RES, V1011, P156, DOI 10.1016/j.brainres.2004.02.073; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Pan Y, 2011, BEHAV BRAIN RES, V216, P66, DOI 10.1016/j.bbr.2010.07.017; Panula P, 2006, ZEBRAFISH, V3, P235, DOI 10.1089/zeb.2006.3.235; Takahashi M, 2002, J NEUROSCI, V22, P3929, DOI 10.1523/JNEUROSCI.22-10-03929.2002; Tucker B, 2007, ZEBRAFISH, V4, P113, DOI 10.1089/zeb.2007.0508	26	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63318	10.1371/journal.pone.0063318	http://dx.doi.org/10.1371/journal.pone.0063318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658822	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100062
J	Schulz, BL; Jen, FEC; Power, PM; Jones, CE; Fox, KL; Ku, SC; Blanchfield, JT; Jennings, MP				Schulz, Benjamin L.; Jen, Freda E. C.; Power, Peter M.; Jones, Christopher E.; Fox, Kate L.; Ku, Shan C.; Blanchfield, Joanne T.; Jennings, Michael P.			Identification of Bacterial Protein O-Oligosaccharyltransferases and Their Glycoprotein Substrates	PLOS ONE			English	Article							PILIN GLYCOSYLATION; GENETIC-CHARACTERIZATION; LINKED GLYCOSYLATION; SITE; BIOSYNTHESIS; SEQUENCE; REVEALS; PATHWAY; OST6P; OST3P	O-glycosylation of proteins in Neisseria meningitidis is catalyzed by PglL, which belongs to a protein family including WaaL O-antigen ligases. We developed two hidden Markov models that identify 31 novel candidate PglL homologs in diverse bacterial species, and describe several conserved sequence and structural features. Most of these genes are adjacent to possible novel target proteins for glycosylation. We show that in the general glycosylation system of N. meningitidis, efficient glycosylation of additional protein substrates requires local structural similarity to the pilin acceptor site. For some Neisserial PglL substrates identified by sensitive analytical approaches, only a small fraction of the total protein pool is modified in the native organism, whereas others are completely glycosylated. Our results show that bacterial protein O-glycosylation is common, and that substrate selection in the general Neisserial system is dominated by recognition of structural homology.	[Jen, Freda E. C.; Ku, Shan C.; Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Schulz, Benjamin L.; Fox, Kate L.; Blanchfield, Joanne T.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Power, Peter M.] Univ Oxford, Dept Paediat, Oxford, Oxon, England; [Jones, Christopher E.] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia	Griffith University; University of Queensland; University of Oxford; Western Sydney University	Jennings, MP (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.	m.jennings@griffith.edu.au	Blanchfield, Joanne T/C-1725-2014; Schulz, Benjamin L/B-3911-2009; Jennings, Michael P/G-4822-2013; Jones, Christopher/C-5725-2014	Blanchfield, Joanne T/0000-0003-1338-7446; Schulz, Benjamin L/0000-0002-4823-7758; Jennings, Michael P/0000-0002-1027-4684; 	ARC Discovery Project Grant [DP110101058, 486]; National Health and Medical Research Council (NHMRC) [565526]; NHMRC CDF [APP1031542]	ARC Discovery Project Grant(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC CDF(National Health and Medical Research Council (NHMRC) of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by ARC Discovery Project Grant DP110101058 to M.P.J and 486 B.L.S., National Health and Medical Research Council (NHMRC) Program Grant 565526 to M.P.J. and NHMRC CDF APP1031542 to B.L.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonsen JH, 2012, J PROTEOME IN PRESS; Bailey UM, 2012, J PROTEOME RES, V11, P5376, DOI 10.1021/pr300599f; Borud B, 2011, P NATL ACAD SCI USA, V108, P9643, DOI 10.1073/pnas.1103321108; CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247; Charbonneau ME, 2012, MOL MICROBIOL, V83, P894, DOI 10.1111/j.1365-2958.2012.07973.x; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Faridmoayer A, 2008, J BIOL CHEM, V283, P34596, DOI 10.1074/jbc.M807113200; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Gebhart C, 2012, GLYCOBIOLOGY, V22, P962, DOI 10.1093/glycob/cws059; Harada Y, 2009, P NATL ACAD SCI USA, V106, P6945, DOI 10.1073/pnas.0812489106; Hartley MD, 2011, BIOCHEMISTRY-US, V50, P4936, DOI 10.1021/bi2003372; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kline KA, 2007, J BACTERIOL, V189, P3462, DOI 10.1128/JB.01911-06; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Ku SC, 2009, BIOCHEM BIOPH RES CO, V378, P84, DOI 10.1016/j.bbrc.2008.11.025; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lizak C, 2011, BIOCONJUGATE CHEM, V22, P488, DOI 10.1021/bc100511k; Marolda CL, 1999, MICROBIOL-UK, V145, P2485, DOI 10.1099/00221287-145-9-2485; Metzgar D, 2004, NUCLEIC ACIDS RES, V32, P5780, DOI 10.1093/nar/gkh881; Perez JM, 2008, MOL MICROBIOL, V70, P1424, DOI 10.1111/j.1365-2958.2008.06490.x; Pinta E, 2012, MOL MICROBIOL, V83, P125, DOI 10.1111/j.1365-2958.2011.07918.x; Porstendorfer D, 2000, J BACTERIOL, V182, P3673, DOI 10.1128/JB.182.13.3673-3680.2000; Power PM, 2006, BIOCHEM BIOPH RES CO, V347, P904, DOI 10.1016/j.bbrc.2006.06.182; Power PM, 2003, MOL MICROBIOL, V49, P833, DOI 10.1046/j.1365-2958.2003.03602.x; Power PM, 2003, FEMS MICROBIOL LETT, V218, P211, DOI 10.1111/j.1574-6968.2003.tb11520.x; Power PM, 2000, MICROBIOL-UK, V146, P967, DOI 10.1099/00221287-146-4-967; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schulz BL, 2009, MOL CELL PROTEOMICS, V8, P357, DOI 10.1074/mcp.M800219-MCP200; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200; Zalucki YM, 2010, BBA-BIOMEMBRANES, V1798, P1244, DOI 10.1016/j.bbamem.2010.03.010	40	33	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62768	10.1371/journal.pone.0062768	http://dx.doi.org/10.1371/journal.pone.0062768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658772	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100038
J	Tomasicchio, M; Avenant, C; Du Toit, A; Ray, RM; Hapgood, JP				Tomasicchio, Michele; Avenant, Chanel; Du Toit, Andrea; Ray, Roslyn M.; Hapgood, Janet P.			The Progestin-Only Contraceptive Medroxyprogesterone Acetate, but Not Norethisterone Acetate, Enhances HIV-1 Vpr-Mediated Apoptosis in Human CD4(+) T Cells through the Glucocorticoid Receptor	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HERPES-SIMPLEX-VIRUS; BLOOD MONONUCLEAR-CELLS; BREAST-CANCER PATIENTS; VITAMIN-A-DEFICIENCY; HORMONAL CONTRACEPTION; DEPOT MEDROXYPROGESTERONE; NUCLEAR-LOCALIZATION; DISEASE PROGRESSION; CYCLE ARREST	The glucocorticoid receptor (GR) regulates several physiological functions, including immune function and apoptosis. The HIV-1 virus accessory protein, viral protein R (Vpr), can modulate the transcriptional response of the GR. Glucocorticoids (GCs) and Vpr have been reported to induce apoptosis in various cells, including T-cells. We have previously shown that the injectable contraceptive, medroxyprogesterone acetate (MPA) is a partial to full agonist for the GR, unlike norethisterone acetate (NET-A). We investigated the functional cross talk between the GR and Vpr in inducing apoptosis in CD4(+) T-cells, in the absence and presence of GCs and these progestins, as well as progesterone. By using flow cytometry, we show that, in contrast to NET-A and progesterone, the synthetic GR ligand dexamethasone (Dex), cortisol and MPA induce apoptosis in primary CD4(+) T-cells. Furthermore, the C-terminal part of the Vpr peptide, or HIV-1 pseudovirus, together with Dex or MPA further increased the apoptotic phenotype, unlike NET-A and progesterone. By a combination of Western blotting, PCR and the use of receptor-selective agonists, we provide evidence that the GR and the estrogen receptor are the only steroid receptors expressed in peripheral blood mononuclear cells. These results, together with the findings that RU486, a GR antagonist, prevents Dex-, MPA- and Vpr-mediated apoptosis, provide evidence for the first time that GR agonists or partial agonists increase apoptosis in primary CD4(+) T-cells via the GR. We show that apoptotic induction involves differential expression of key apoptotic genes by both Vpr and GCs/MPA. This work suggests that contraceptive doses of MPA but not NET-A or physiological doses of progesterone could potentially accelerate depletion of CD4(+) T-cells in a GR-dependent fashion in HIV-1 positive women, thereby contributing to immunodeficiency. The results imply that choice of progestin used in contraception may be critical to susceptibility and progression of diseases such as HIV-1.	[Tomasicchio, Michele; Avenant, Chanel; Du Toit, Andrea; Ray, Roslyn M.; Hapgood, Janet P.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, Western Provinc, South Africa	University of Cape Town	Hapgood, JP (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, Western Provinc, South Africa.	Janet.Hapgood@uct.ac.za	Hapgood, Janet P/P-2549-2018; Ray, Roslyn/AAB-2898-2019	Hapgood, Janet P/0000-0002-4414-4861; Tomasicchio, Michele/0000-0003-2421-7215	LIFElab; South African Government's Department of Science and Technology; Claude Leon Foundation; Carnegie corporation; National Research Foundation; National Research Foundations (NRF); Poliomyelitis Research Foundation (PRF)	LIFElab; South African Government's Department of Science and Technology; Claude Leon Foundation; Carnegie corporation; National Research Foundation; National Research Foundations (NRF); Poliomyelitis Research Foundation (PRF)	This work was funded by LIFElab (www.lifelab.org.za) with funds from the South African Government's Department of Science and Technology, under the SHARP program (South African HIV/AIDS Research and Innovation Platform) by a grant to JPH. Thanks is given to the Claude Leon Foundation for postdoctoral funding to MT, as well as the Carnegie corporation for post-doctoral funding to CA and PhD funding to RMR. RMR was also funded by the National Research Foundation. ADT was supported by scholarships from the National Research Foundations (NRF) and the Poliomyelitis Research Foundation (PRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africander A, 2013, BIOCH BIOPH IN PRESS; Africander D, 2011, STEROIDS, V76, P636, DOI 10.1016/j.steroids.2011.03.001; Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; Andersen JL, 2008, EXP MOL PATHOL, V85, P2, DOI 10.1016/j.yexmp.2008.03.015; Arokium H, 2009, J VIROL, V83, P11283, DOI 10.1128/JVI.00756-09; Arunagiri C, 1997, APOPTOSIS, V2, P69, DOI 10.1023/A:1026487609215; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Bandera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010788; Borgne-Sanchez A, 2007, CELL DEATH DIFFER, V14, P422, DOI 10.1038/sj.cdd.4402018; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Boutwell CL, 2009, J VIROL, V83, P2460, DOI 10.1128/JVI.01970-08; Buckingham JC, 2006, BRIT J PHARMACOL, V147, pS258, DOI 10.1038/sj.bjp.0706456; Burleson MH, 1998, PSYCHOSOM MED, V60, P17, DOI 10.1097/00006842-199801000-00004; Busca A, 2012, J BIOL CHEM, V287, P15118, DOI 10.1074/jbc.M111.312660; Chen MZ, 1999, J VIROL, V73, P3236, DOI 10.1128/JVI.73.4.3236-3245.1999; Coeytaux E, 2003, J BIOL CHEM, V278, P18110, DOI 10.1074/jbc.M300248200; Conti L, 2000, J IMMUNOL, V165, P3293, DOI 10.4049/jimmunol.165.6.3293; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Draper BH, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005214.pub2; FOTHERBY K, 1978, CONTRACEPTION, V18, P1, DOI 10.1016/0010-7824(78)90096-3; Gagliardo R, 2000, AM J RESP CRIT CARE, V162, P7, DOI 10.1164/ajrccm.162.1.9911032; Garg H, 2012, VIRUSES-BASEL, V4, P3020, DOI 10.3390/v4113020; Genesca M, 2007, J MED PRIMATOL, V36, P266, DOI 10.1111/j.1600-0684.2007.00244.x; Ghanem KG, 2005, J INFECT DIS, V191, P358, DOI 10.1086/427190; GHOSH K, 1993, VIROLOGY, V194, P858, DOI 10.1006/viro.1993.1331; GOEBELSMANN U, 1979, CONTRACEPTION, V19, P283, DOI 10.1016/0010-7824(79)90022-2; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Gouws E, 2008, AIDS, V22, pS5, DOI 10.1097/01.aids.0000341773.86500.9d; Gray RH, 2012, LANCET INFECT DIS, V12, P507, DOI 10.1016/S1473-3099(12)70111-1; Hadley KE, 2011, STEROIDS, V76, P1176, DOI 10.1016/j.steroids.2011.05.007; Hapgood J, 2013, REDOCRINOLO IN PRESS; Hapgood JP, 2010, ARCH VIROL, V155, P1009, DOI 10.1007/s00705-010-0678-0; Hapgood JP, 2004, TRENDS PHARMACOL SCI, V25, P554, DOI 10.1016/j.tips.2004.09.005; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Heffron R, 2011, SEX TRANSM INFECT, V87, P283, DOI 10.1136/sti.2010.045617; Hel Z, 2010, ENDOCR REV, V31, P79, DOI 10.1210/er.2009-0018; Henklein P, 2000, J BIOL CHEM, V275, P32016, DOI 10.1074/jbc.M004044200; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; HIROI M, 1975, STEROIDS, V26, P373, DOI 10.1016/0039-128X(75)90082-3; Hoshino S, 2007, AIDS RES HUM RETROV, V23, P391, DOI 10.1089/aid.2006.0124; HOWARD G, 1975, CONTRACEPTION, V12, P45, DOI 10.1016/S0010-7824(75)80035-7; Huijbregts RPH, 2013, ENDOCRINOLOGY, V154, P1282, DOI 10.1210/en.2012-1850; Ishibashi H, 2003, J CLIN ENDOCR METAB, V88, P2309, DOI 10.1210/jc.2002-021353; Jochmann R, 2009, J VIROL, V83, P3704, DOI 10.1128/JVI.01384-08; Kino T, 1999, J EXP MED, V189, P51, DOI 10.1084/jem.189.1.51; KIRTON KT, 1974, CONTRACEPTION, V10, P39, DOI 10.1016/0010-7824(74)90130-9; Kleinschmidt I, 2007, CONTRACEPTION, V75, P461, DOI 10.1016/j.contraception.2007.02.002; Kleynhans L, 2013, INFECT IMMU IN PRESS; Kogan M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-25; KONTULA K, 1983, BIOCHEM PHARMACOL, V32, P1511, DOI 10.1016/0006-2952(83)90474-4; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; Koubovec D, 2004, MOL CELL ENDOCRINOL, V221, P75, DOI 10.1016/j.mce.2004.03.006; Kumwenda NI, 2008, INT J STD AIDS, V19, P339, DOI 10.1258/ijsa.2007.007165; Lavreys L, 2004, J INFECT DIS, V189, P303, DOI 10.1086/380974; LEVY DN, 1994, P NATL ACAD SCI USA, V91, P10873, DOI 10.1073/pnas.91.23.10873; Lewis JS, 2005, JNCI-J NATL CANCER I, V97, P1746, DOI 10.1093/jnci/dji400; LU YL, 1993, J VIROL, V67, P6542, DOI 10.1128/JVI.67.11.6542-6550.1993; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; MAHALINGAM S, 1995, VIROLOGY, V212, P331, DOI 10.1006/viro.1995.1490; MAJUMDER MSI, 1987, NUTR REP INT, V36, P1285; MALLMANN P, 1990, METHOD FIND EXP CLIN, V12, P699; Mann CL, 2000, ENDOCRINOLOGY, V141, P528, DOI 10.1210/en.141.2.528; Miguel RDV, 2012, J IMMUNOL, V189, P3449, DOI 10.4049/jimmunol.1103054; Mishell DR, 1996, J REPROD MED, V41, P381; Mishra S, 2007, J BIOL CHEM, V282, P4288, DOI 10.1074/jbc.M608307200; Miura R, 2006, J PHARMACOL SCI, V102, P288, DOI 10.1254/jphs.FP0060801; Morrison CS, 2012, AIDS, V26, P497, DOI 10.1097/QAD.0b013e32834fa13d; Morrison CS, 2012, LANCET INFECT DIS, V12, P2, DOI 10.1016/S1473-3099(11)70254-7; Morrison CS, 2011, JAIDS-J ACQ IMM DEF, V57, P157, DOI 10.1097/QAI.0b013e318214ba4a; Morrison CS, 2010, AIDS, V24, P1778, DOI 10.1097/QAD.0b013e32833a2537; Morrison CS, 2004, SEX TRANSM DIS, V31, P561, DOI 10.1097/01.olq.0000137904.56037.70; Mostad SB, 1997, LANCET, V350, P922, DOI 10.1016/S0140-6736(97)04240-2; Mostad SB, 2000, J INFECT DIS, V181, P58, DOI 10.1086/315188; Muthumani K, 2005, CELL DEATH DIFFER, V12, P962, DOI 10.1038/sj.cdd.4401583; Muthumani K, 2002, J BIOL CHEM, V277, P37820, DOI 10.1074/jbc.M205313200; Myer L, 2007, INT J EPIDEMIOL, V36, P166, DOI 10.1093/ije/dyl251; Naglieri E, 2002, ANTICANCER RES, V22, P3045; Patel CA, 2000, J VIROL, V74, P9717, DOI 10.1128/JVI.74.20.9717-9726.2000; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piller SC, 1998, P NATL ACAD SCI USA, V95, P4595, DOI 10.1073/pnas.95.8.4595; Pronsato L, 2012, J ENDOCRINOL, V212, P371, DOI 10.1530/JOE-11-0234; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Roumier T, 2002, CELL DEATH DIFFER, V9, P1212, DOI 10.1038/sj.cdd.4401089; Sambrook J, 2001, MOL CLONING LAB MANU; SCAMBIA G, 1988, CANCER-AM CANCER SOC, V61, P2214, DOI 10.1002/1097-0142(19880601)61:11<2214::AID-CNCR2820611115>3.0.CO;2-V; Sherman MP, 2002, VIROLOGY, V302, P95, DOI 10.1006/viro.2002.1576; Sherman MP, 2000, J VIROL, V74, P8159, DOI 10.1128/JVI.74.17.8159-8165.2000; SHRIMANKER K, 1978, J STEROID BIOCHEM, V9, P359, DOI 10.1016/0022-4731(78)90631-3; Sibeko S, 2011, OBSTET GYNECOL, V118, P895, DOI 10.1097/AOG.0b013e31822be512; Snyder A, 2010, AIDS, V24, P1107, DOI 10.1097/QAD.0b013e328337b0ab; Somasundaran M, 2002, P NATL ACAD SCI USA, V99, P9503, DOI 10.1073/pnas.142313699; Stanczyk Frank Z, 2002, Rev Endocr Metab Disord, V3, P211, DOI 10.1023/A:1020072325818; Stanczyk FZ, 2012, ENDOCR REV IN PRESS; Stewart SA, 2000, J VIROL, V74, P3105, DOI 10.1128/JVI.74.7.3105-3111.2000; Stringer EM, 2009, AIDS, V23, pS69, DOI 10.1097/01.aids.0000363779.65827.e0; Stringer EM, 2009, AIDS, V23, P1377, DOI 10.1097/QAD.0b013e32832cbca8; Stringer EM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.031; Tang FM, 2009, J BIOL CHEM, V284, P32353, DOI 10.1074/jbc.M109.042994; Thorsby E, 1970, HISTOCOMPATIBILITY T, P665; Trunova N, 2006, VIROLOGY, V352, P169, DOI 10.1016/j.virol.2006.04.004; Tungaturthi PK, 2003, BIOMED PHARMACOTHER, V57, P20, DOI 10.1016/S0753-3322(02)00328-1; Vasconsuelo A, 2010, CELL STRESS CHAPERON, V15, P183, DOI 10.1007/s12192-009-0132-y; Wand H, 2012, AIDS, V26, P375, DOI 10.1097/QAD.0b013e32834f990f; Wang CC, 2004, AIDS, V18, P205, DOI 10.1097/00002030-200401230-00009; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Watts DH, 2008, CONTRACEPTION, V77, P84, DOI 10.1016/j.contraception.2007.10.002; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Yamashita J, 1996, CANCER, V78, P2346, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2346::AID-CNCR12>3.3.CO;2-1; Yang JH, 2000, FERTIL STERIL, V74, P261, DOI 10.1016/S0015-0282(00)00622-1; Yovel G, 2001, GYNECOL ONCOL, V81, P254, DOI 10.1006/gyno.2001.6153; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006	114	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62895	10.1371/journal.pone.0062895	http://dx.doi.org/10.1371/journal.pone.0062895			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658782	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100045
J	Verdier, J; Deroche, L; Allez, M; Loy, C; Biet, F; Bodier, CC; Bay, S; Ganneau, C; Matysiak-Budnik, T; Reyrat, JM; Heyman, M; Cerf-Bensussan, N; Ruemmele, FM; Menard, S				Verdier, Julien; Deroche, Louis; Allez, Matthieu; Loy, Caroline; Biet, Franck; Bodier, Christelle C.; Bay, Sylvie; Ganneau, Christelle; Matysiak-Budnik, Tamara; Reyrat, Jean Marc; Heyman, Martine; Cerf-Bensussan, Nadine; Ruemmele, Frank M.; Menard, Sandrine			Specific IgG Response against Mycobacterium avium paratuberculosis in Children and Adults with Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; SUBSP PARATUBERCULOSIS; PULMONARY-DISEASE; HUMORAL IMMUNITY; LIPID ANTIGENS; CELIAC-DISEASE; TUBERCULOSIS; ANTIBODY; IMMUNOGLOBULIN	Background and Aims: Presence of serum antibodies against Mycobacterium avium paratuberculosis (MAP) in Crohn's Disease (CD) as a disease characteristic remains controversial. In the present work, we assessed antibody reactivity of serum and intestinal fluid against four distinct MAP-antigens, including the recently identified MAP-specific lipopentapeptide (L5P). Methods: Immunoglobulin concentrations and specificity against 3 non MAP-specific antigens: glycosyl-transferase-d (GSD), purified protein derivative from MAP (Johnin-PPD), heparin binding haemagglutinin (MAP-HBHA) and one MAP-specific antigen: synthetic L5P were determined by ELISA in gut lavage fluids from adult controls or patients with CD, and in sera of children or adult controls or patients with CD, ulcerative colitis or celiac disease. Results: Total IgA and IgG concentrations were increased in sera of children with CD but were decreased in sera of adults with CD, thereof specificity against MAP antigens was assessed by normalizing immunoglobulin concentrations between samples. In CD patients, IgG reactivity was increased against the four MAP antigens, including L5P in gut lavage fluids but it was only increased against L5P in sera. By contrast, anti-L5P IgG were not increased in patients with ulcerative colitis or celiac disease. Conclusions: A significant increase in anti-L5P IgG is observed in sera of children and adults with CD but not in patients with other intestinal inflammatory diseases. Anti-L5P antibodies may serve as serological marker for CD.	[Verdier, Julien; Deroche, Louis; Loy, Caroline; Heyman, Martine; Cerf-Bensussan, Nadine; Ruemmele, Frank M.; Menard, Sandrine] INSERM, UMR989, Paris, France; [Verdier, Julien; Deroche, Louis; Loy, Caroline; Reyrat, Jean Marc; Heyman, Martine; Cerf-Bensussan, Nadine; Ruemmele, Frank M.; Menard, Sandrine] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Allez, Matthieu] Hop St Louis, APHP, Dept Gastroenterol, Paris, France; [Biet, Franck; Bodier, Christelle C.] INRA, UMR ISP 1282, Ctr Tours, Nouzilly, France; [Bay, Sylvie; Ganneau, Christelle] Inst Pasteur, Unite Chimie Biomol, Dept Biol Struct & Chimie, Paris, France; [Bay, Sylvie; Ganneau, Christelle] CNRS, UMR 3523, Paris, France; [Matysiak-Budnik, Tamara] CHU Nantes, IMAD, EA BIOMETADYS, Hotel Dieu, Nantes, France; [Reyrat, Jean Marc] INSERM, UMR 570, Unite Pathogenie Infect System, Grp Avenir, Paris, France; [Ruemmele, Frank M.] Hop Necker Enfants Malad, APHP, Serv Gastroenterol, Paris, France; [Menard, Sandrine] INRA, Toxalim Res Ctr, Neurogastroenterol & Nutr Unit, F-31931 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; INRAE	Menard, S (corresponding author), INSERM, UMR989, Paris, France.	sandrine.menard@toulouse.inra.fr	Biet, Franck/ABA-4151-2021; Menard, Sandrine/ABF-8935-2021; Cerf-Bensussan, nadine/H-9505-2017; matysiak-budnik, Tamara/K-2705-2015	Biet, Franck/0000-0001-8425-6158; Menard, Sandrine/0000-0001-8867-199X; Cerf-Bensussan, nadine/0000-0003-0665-1245; Verdier, Julien/0000-0002-5618-0579; Allez, Matthieu/0000-0002-2012-7522	foundation Princesse Grace de Monaco; INSERM; Association Francois Aupetit; Bourses de Recherche Fondamentale sur les Maladies Inflammatoires Chroniques de l'Intestin (BREMICI)	foundation Princesse Grace de Monaco; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francois Aupetit; Bourses de Recherche Fondamentale sur les Maladies Inflammatoires Chroniques de l'Intestin (BREMICI)	The authors acknowledge grants from the foundation Princesse Grace de Monaco, the INSERM, Association Francois Aupetit and Bourses de Recherche Fondamentale sur les Maladies Inflammatoires Chroniques de l'Intestin (BREMICI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal ABM, 2008, J MED CHEM, V51, P167, DOI 10.1021/jm701091d; [Anonymous], 2005, J PEDIAT GASTROENTER, V41, P1; Behr MA, 2008, CURR OPIN GASTROEN, V24, P17, DOI 10.1097/MOG.0b013e3282f1dcc4; BENJAMIN RG, 1984, J MED MICROBIOL, V18, P309, DOI 10.1099/00222615-18-3-309; Bernstein CN, 2007, J CLIN MICROBIOL, V45, P968, DOI 10.1128/JCM.02062-06; Biet F, 2008, VACCINE, V26, P257, DOI 10.1016/j.vaccine.2007.10.059; Biet F, 2011, DIGEST DIS SCI, V56, P1794, DOI 10.1007/s10620-010-1523-8; BRANDTZAEG P, 1989, GASTROENTEROLOGY, V97, P1562, DOI 10.1016/0016-5085(89)90406-X; CARTWRIGHT GA, 1995, J IMMUNOL METHODS, V179, P31, DOI 10.1016/0022-1759(94)00267-Z; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; CHIODINI RJ, 1989, CLIN MICROBIOL REV, V2, P90, DOI 10.1128/CMR.2.1.90-117.1989; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Cohavy O, 1999, INFECT IMMUN, V67, P6510; Kotze Lorete Maria da Silva, 2010, Arq. Gastroenterol., V47, P242, DOI 10.1590/S0004-28032010000300006; Eckstein TM, 2006, J BIOL CHEM, V281, P5209, DOI 10.1074/jbc.M512465200; Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6; Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Fujita Y, 2006, J MED MICROBIOL, V55, P189, DOI 10.1099/jmm.0.46087-0; GASPARI MM, 1988, J IMMUNOL METHODS, V110, P85, DOI 10.1016/0022-1759(88)90086-5; Gill CO, 2011, J FOOD PROTECT, V74, P480, DOI 10.4315/0362-028X.JFP-10-301; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kitada S, 2002, CLIN INFECT DIS, V35, P1328, DOI 10.1086/344277; Koets AP, 2001, INFECT IMMUN, V69, P1492, DOI 10.1128/IAI.69.3.1492-1498.2001; Konrad A, 2006, GASTROENTEROLOGY, V130, P2050, DOI 10.1053/j.gastro.2006.02.055; KONST H., 1958, CANADIAN JOUR COMP MED AND VET SCI, V22, P157; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI 10.1099/00207713-52-5-1505; MOMOTANI E, 1986, J COMP PATHOL, V96, P659, DOI 10.1016/0021-9975(86)90062-9; Momotani E, 2012, VET IMMUNOL IMMUNOP, V148, P55, DOI 10.1016/j.vetimm.2012.03.005; Muller S, 2008, WORLD J GASTROENTERO, V14, P3650, DOI 10.3748/wjg.14.3650; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Nishimura T, 2009, CLIN INFECT DIS, V49, P529, DOI 10.1086/600888; OMAHONY S, 1990, GUT, V31, P1341, DOI 10.1136/gut.31.12.1341; OMAHONY S, 1992, ANN RHEUM DIS, V51, P1296, DOI 10.1136/ard.51.12.1296; Pethe K, 2000, J BIOL CHEM, V275, P14273, DOI 10.1074/jbc.275.19.14273; Peyrin-Biroulet L, 2007, INFLAMM BOWEL DIS, V13, P1561, DOI 10.1002/ibd.20226; Pinedo PJ, 2009, VET MICROBIOL, V134, P346, DOI 10.1016/j.vetmic.2008.09.052; Polymeros D, 2006, GASTROENTEROLOGY, V131, P85, DOI 10.1053/j.gastro.2006.04.021; Primm TP, 2004, CLIN MICROBIOL REV, V17, P98, DOI 10.1128/CMR.17.1.98-106.2004; Qiu B, 2000, BIOPOLYMERS, V55, P319, DOI 10.1002/1097-0282(2000)55:4<319::AID-BIP1005>3.0.CO;2-W; Ruemmele FM, 1998, GASTROENTEROLOGY, V115, P822, DOI 10.1016/S0016-5085(98)70252-5; Ruemmele FM, 2010, CURR OPIN GASTROEN, V26, P332, DOI 10.1097/MOG.0b013e328339ec2d; Sechi LA, 2006, VACCINE, V24, P236, DOI 10.1016/j.vaccine.2005.11.030; THOREL MF, 1990, INT J SYST BACTERIOL, V40, P254, DOI 10.1099/00207713-40-3-254; Tizard M, 1998, MICROBIOL-SGM, V144, P3413, DOI 10.1099/00221287-144-12-3413; Travis SPL, 2008, J CROHNS COLITIS, V2, P24, DOI 10.1016/j.crohns.2007.11.002; Turenne CY, 2007, CLIN MICROBIOL REV, V20, P205, DOI 10.1128/CMR.00036-06; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909	54	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62780	10.1371/journal.pone.0062780	http://dx.doi.org/10.1371/journal.pone.0062780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658774	Green Submitted, Green Published, gold			2022-12-25	WOS:000321200500039
J	Blum, CA; Mueller, C; Schuetz, P; Fluri, F; Trummler, M; Mueller, B; Katan, M; Christ-Crain, M				Blum, Claudine A.; Mueller, Cornelia; Schuetz, Philipp; Fluri, Felix; Trummler, Michael; Mueller, Beat; Katan, Mira; Christ-Crain, Mirjam			Prognostic Value of Dehydroepiandrosterone-Sulfate and Other Parameters of Adrenal Function in Acute Ischemic Stroke	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; CORTICOSTEROID INSUFFICIENCY; CARDIOVASCULAR-DISEASE; STIMULATION TEST; FREE CORTISOL; BRAIN-INJURY; ALL-CAUSE; MORTALITY; DHEA; SEVERITY	Background and Purpose: Acute stroke has a high morbidity and mortality. We evaluated the predictive value of adrenal function testing in acute ischemic stroke. Methods: In a cohort of 231 acute ischemic stroke patients, we measured dehydroepiandrosterone (DHEA), DHEA-Sulfate (DHEAS), cortisol at baseline and 30 minutes after stimulation with 1 ug ACTH. Delta cortisol, the amount of rise in the 1 ug ACTH-test, was calculated. Primary endpoint was poor functional outcome defined as modified Rankin scale 3-6 after 1 year. Secondary endpoint was nonsurvival after 1 year. Results: Logistic regression analysis showed that DHEAS (OR 1.21, 95% CI 1.01-1.49), but not DHEA (OR 1.01, 95% CI 0.99-1.04), was predictive for adverse functional outcome. Neither DHEA (OR 0.99, 95% CI 0.96-1.03) nor DHEAS (OR 1.10, 95% CI 0.82-1.44) were associated with mortality. Baseline and stimulated cortisol were predictive for mortality (OR 1.41, 95% CI 1.20-1.71; 1.35, 95% CI 1.15-1.60), but only basal cortisol for functional outcome (OR 1.20, 95% CI 1.04-1.38). Delta cortisol was not predictive for functional outcome (OR 0.86, 95% CI 0.71-1.05) or mortality (OR 0.92, 95% CI 0.72-1.17). The ratios cortisol/DHEA and cortisol/DHEAS discriminated between favorable outcome and nonsurvival (both p<0.0001) and between unfavorable outcome and nonsurvival (p=0.0071 and 0.0029), but are not independent predictors for functional outcome or mortality in multivariate analysis (adjusted OR for functional outcome for both 1.0 (95% CI 0.99-1.0), adjusted OR for mortality for both 1.0 (95% CI 0.99-1.0 and 1.0-1.01, respectively)). Conclusion: DHEAS and the cortisol/DHEAS ratio predicts functional outcome 1 year after stroke whereas cortisol levels predict functional outcome and mortality.	[Blum, Claudine A.; Schuetz, Philipp; Mueller, Beat] Cantonal Hosp, Med Univ Clin, Dept Endocrinol, Aarau, Switzerland; [Mueller, Cornelia; Christ-Crain, Mirjam] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Fluri, Felix] Univ Basel Hosp, Div Neurol, CH-4031 Basel, Switzerland; [Katan, Mira] Univ Zurich Hosp, Neurol Clin, CH-8091 Zurich, Switzerland; [Trummler, Michael] Bioanalytica AG, Luzern, Switzerland	University of Basel; University of Basel; University of Zurich; University Zurich Hospital	Blum, CA (corresponding author), Cantonal Hosp, Med Univ Clin, Dept Endocrinol, Aarau, Switzerland.	claudine.blum@ksa.ch	Müller, Christian/AAB-4783-2022; Mueller, Beat/G-2662-2012; Blum, Claudine Angela A/G-8467-2016; schuetz, philipp/C-8475-2013	Müller, Christian/0000-0002-1120-6405; Blum, Claudine Angela A/0000-0003-0487-5587; schuetz, philipp/0000-0001-6400-4949; Katan, Mira/0000-0002-9265-8066; Christ-Crain, Mirjam/0000-0002-6336-0965	Department of Endocrinology, Diabetology, Clinical Nutrition of the University Hospital of Basel; Medical University Clinic, Aarau, Switzerland; grant for young research scientists of the University of Basel, Switzerland; Bangerter-Rhyner-Foundation, Basel, Switzerland; Swiss National Foundation [PP00P3-12346]	Department of Endocrinology, Diabetology, Clinical Nutrition of the University Hospital of Basel; Medical University Clinic, Aarau, Switzerland; grant for young research scientists of the University of Basel, Switzerland; Bangerter-Rhyner-Foundation, Basel, Switzerland; Swiss National Foundation(Swiss National Science Foundation (SNSF))	This study was supported by in-house grants from the Department of Endocrinology, Diabetology, Clinical Nutrition of the University Hospital of Basel and the Medical University Clinic, Aarau, Switzerland, as well as by a grant for young research scientists of the University of Basel, Switzerland, and a grant from the Bangerter-Rhyner-Foundation, Basel, Switzerland, to CAB and by research grants of the Swiss National Foundation, PP00P3-12346, to MCC. MT of Bioanalytica AG, Lucerne, Switzerland, granted a discount for analyzing DHEA and DHEAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anne M, 2007, CURR NEUROVASC RES, V4, P170, DOI 10.2174/156720207781387169; Arlt W, 2006, J CLIN ENDOCR METAB, V91, P2548, DOI 10.1210/jc.2005-2258; Armanini D, 2003, ENDOCRINE, V22, P113, DOI 10.1385/ENDO:22:2:113; Arnlov J, 2006, ANN INTERN MED, V145, P176, DOI 10.7326/0003-4819-145-3-200608010-00005; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BARRETTCONNOR E, 1986, NEW ENGL J MED, V315, P1519, DOI 10.1056/NEJM198612113152405; Baulieu EE, 1998, P NATL ACAD SCI USA, V95, P4089, DOI 10.1073/pnas.95.8.4089; Baulieu EE, 1999, ACTA PAEDIATR, V88, P78, DOI 10.1111/j.1651-2227.1999.tb14408.x; Beishuizen A, 2002, CRIT CARE, V6, P434, DOI 10.1186/cc1530; BOLOGA L, 1987, J NEUROSCI RES, V17, P225, DOI 10.1002/jnr.490170305; Chehab O, 2007, CR BIOL, V330, P755, DOI 10.1016/j.crvi.2007.08.004; Christensen H, 2004, J NEUROL SCI, V217, P175, DOI 10.1016/j.jns.2003.09.013; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; CORPECHOT C, 1981, P NATL ACAD SCI-BIOL, V78, P4704, DOI 10.1073/pnas.78.8.4704; Creatsa M, 2011, METABOLISM; D'Astous M, 2003, SYNAPSE, V47, P10, DOI 10.1002/syn.10145; de Bruin VMS, 2002, BRAIN COGNITION, V50, P316, DOI 10.1016/S0278-2626(02)00519-5; de Jong Margriet Fleur Charlotte, 2012, J Intensive Care Med, V27, P37, DOI 10.1177/0885066610393456; Delahanty DL, 2005, PSYCHONEUROENDOCRINO, V30, P121, DOI 10.1016/j.psyneuen.2004.06.004; Dickstein G, 2005, J CLIN ENDOCR METAB, V90, P4973, DOI 10.1210/jc.2005-1196; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; Dimopoulou I, 2004, INTENS CARE MED, V30, P1216, DOI 10.1007/s00134-004-2297-2; FEIBEL JH, 1977, JAMA-J AM MED ASSOC, V238, P1374, DOI 10.1001/jama.238.13.1374; Folan MM, 2001, CRIT CARE MED, V29, P965, DOI 10.1097/00003246-200105000-00012; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Hougaku H, 2006, AM J PHYSIOL-ENDOC M, V290, pE234, DOI 10.1152/ajpendo.00059.2005; Johansson A, 1997, J NEUROL SCI, V147, P43; Kancheva R, 2011, NEUROSCIENCE, V191, P22, DOI 10.1016/j.neuroscience.2011.05.054; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P221, DOI 10.1007/978-3-211-98811-4_41; Kleindienst A, 2009, J NEUROTRAUM, V26, P1435, DOI 10.1089/neu.2008.0601; Kolditz M, 2010, EUR RESPIR J, V36, P615, DOI 10.1183/09031936.00191709; Kumpfel T, 1999, NEUROENDOCRINOLOGY, V70, P431, DOI 10.1159/000054505; Lapchak PA, 2000, STROKE, V31, P1953, DOI 10.1161/01.STR.31.8.1953; Laughlin GA, 2000, J CLIN ENDOCR METAB, V85, P3561, DOI 10.1210/jc.85.10.3561; LEVINE A, 1994, J PEDIATR-US, V125, P853, DOI 10.1016/S0022-3476(05)81998-5; Li Z, 2009, J CEREBR BLOOD F MET, V29, P287, DOI 10.1038/jcbfm.2008.118; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Marklund N, 2004, J INTERN MED, V256, P15, DOI 10.1111/j.1365-2796.2004.01334.x; Marx C, 2003, CRIT CARE MED, V31, P1382, DOI 10.1097/01.CCM.0000063282.83188.3D; Michalaki M, 2010, EUR J ENDOCRINOL, V162, P341, DOI 10.1530/EJE-09-0883; Miyajima M, 2011, DRUG METAB DISPOS, V39, P814, DOI 10.1124/dmd.110.036863; Moraes RB, 2011, ARQ BRAS ENDOCRINOL, V55, P295, DOI 10.1590/S0004-27302011000500001; Jeckel CMM, 2010, NEUROIMMUNOMODULAT, V17, P9, DOI 10.1159/000243080; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Neidert S, 2011, J INTERN MED, V269, P420, DOI 10.1111/j.1365-2796.2010.02327.x; Ohlsson C, 2010, J CLIN ENDOCR METAB, V95, P4406, DOI 10.1210/jc.2010-0760; Ohtsuki S, 2004, BIOL PHARM BULL, V27, P1489, DOI 10.1248/bpb.27.1489; OLSSON T, 1992, STROKE, V23, P1573, DOI 10.1161/01.STR.23.11.1573; Pappa T, 2012, METABOLISM, V61, P84, DOI 10.1016/j.metabol.2011.06.003; PARKER LN, 1985, J CLIN ENDOCR METAB, V60, P947, DOI 10.1210/jcem-60-5-947; PAVLOV EP, 1986, J CLIN ENDOCR METAB, V62, P767, DOI 10.1210/jcem-62-4-767; Phillips AC, 2010, EUR J ENDOCRINOL, V163, P285, DOI 10.1530/EJE-10-0299; Phillips AC, 2010, EUR J ENDOCRINOL, V162, P919, DOI 10.1530/EJE-09-1078; RANKIN J, 1957, Scott Med J, V2, P200; Rasmuson S, 2001, BIOL PSYCHIAT, V49, P547, DOI 10.1016/S0006-3223(00)01015-5; ROSENFELD RS, 1971, J CLIN ENDOCR METAB, V33, P87, DOI 10.1210/jcem-33-1-87; Salluh JIF, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2010.03.004; Sanders JL, 2010, J AM GERIATR SOC, V58, P421, DOI 10.1111/j.1532-5415.2010.02724.x; Shufelt C, 2010, J CLIN ENDOCR METAB, V95, P4985, DOI 10.1210/jc.2010-0143; Slowik A, 2002, J NEUROL SCI, V196, P27, DOI 10.1016/S0022-510X(02)00018-7; Thijs L, 2003, ACTA CARDIOL, V58, P403, DOI 10.2143/AC.58.5.2005304; Truelsen T, 2006, EUR J NEUROL, V13, P581, DOI 10.1111/j.1468-1331.2006.01138.x; Urwyler SA, 2010, STROKE, V41, P1564, DOI 10.1161/STROKEAHA.110.584649; Valenti G, 2004, J Endocrinol Invest, V27, P62; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WADE CE, 1988, J CLIN ENDOCR METAB, V67, P223, DOI 10.1210/jcem-67-2-223; Wang L, 2011, ATHEROSCLEROSIS, V214, P47, DOI 10.1016/j.atherosclerosis.2010.07.043; Widmer IE, 2005, J CLIN ENDOCR METAB, V90, P4579, DOI 10.1210/jc.2005-0354; Wolf OT, 1999, BRAIN RES REV, V30, P264, DOI 10.1016/S0165-0173(99)00021-1	72	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63224	10.1371/journal.pone.0063224	http://dx.doi.org/10.1371/journal.pone.0063224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650556	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000319167000101
J	Nagy, NT; Chakraborty, S; Harami, GM; Sellers, JR; Sakamoto, T; Kovacs, M				Nagy, Nikolett T.; Chakraborty, Saikat; Harami, Gabor M.; Sellers, James R.; Sakamoto, Takeshi; Kovacs, Mihaly			A Subdomain Interaction at the Base of the Lever Allosterically Tunes the Mechanochemical Mechanism of Myosin 5a	PLOS ONE			English	Article							VITRO MOTILITY ASSAY; HAND-OVER-HAND; MOTOR DOMAIN; PROCESSIVE TRANSLOCATION; CONFORMATIONAL STATES; FLUORESCENT-PROBE; ATP HYDROLYSIS; NECK LENGTH; ACTIN; ACTOMYOSIN	The motor domain of myosin is the core element performing mechanochemical energy transduction. This domain contains the actin and ATP binding sites and the base of the force-transducing lever. Coordinated subdomain movements within the motor are essential in linking the ATPase chemical cycle to translocation along actin filaments. A dynamic subdomain interface located at the base of the lever was previously shown to exert an allosteric influence on ATP hydrolysis in the non-processive myosin 2 motor. By solution kinetic, spectroscopic and ensemble and single-molecule motility experiments, we determined the role of a class-specific adaptation of this interface in the mechanochemical mechanism of myosin 5a, a processive intracellular transporter. We found that the introduction of a myosin 2-specific repulsive interaction into myosin 5a via the I67K mutation perturbs the strong-binding interaction of myosin 5a with actin, influences the mechanism of ATP binding and facilitates ATP hydrolysis. At the same time, the mutation abolishes the actin-induced activation of ADP release and, in turn, slows down processive motility, especially when myosin experiences mechanical drag exerted by the action of multiple motor molecules bound to the same actin filament. The results highlight that subtle structural adaptations of the common structural scaffold of the myosin motor enable specific allosteric tuning of motor activity shaped by widely differing physiological demands.	[Nagy, Nikolett T.; Harami, Gabor M.; Kovacs, Mihaly] Eotvos Lorand Univ, Dept Biochem, ELTE MTA Eotvos Lorand Univ Hungarian Acad Sci, Momentum Motor Enzymol Res Grp, Budapest, Hungary; [Chakraborty, Saikat; Sakamoto, Takeshi] Wayne State Univ, Dept Phys & Astron, Detroit, MI 48202 USA; [Sellers, James R.] NHLBI, Lab Mol Physiol, Bethesda, MD 20892 USA	Eotvos Lorand University; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kovacs, M (corresponding author), Eotvos Lorand Univ, Dept Biochem, ELTE MTA Eotvos Lorand Univ Hungarian Acad Sci, Momentum Motor Enzymol Res Grp, Budapest, Hungary.	kovacsm@elte.hu	Harami, Gábor/I-2756-2017; Kovacs, Mihaly/A-6841-2011	Harami, Gábor/0000-0001-7234-2710; Kovacs, Mihaly/0000-0002-1200-4741	National Institutes of Health [R00HL089350]; TAMOP Grant [4.2.1/B-09/1/KMR-2010-0003]; Human Frontier Science Program [RGY0072/2010]; "Momentum" Program of the Hungarian Academy of Sciences [LP2011-006/2011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004232, R00HL089350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TAMOP Grant; Human Frontier Science Program(Human Frontier Science Program); "Momentum" Program of the Hungarian Academy of Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health K99/R00 Career grant (R00HL089350) to T.S.; and TAMOP Grant (4.2.1/B-09/1/KMR-2010-0003), the Human Frontier Science Program (RGY0072/2010) and the "Momentum" Program of the Hungarian Academy of Sciences (LP2011-006/2011) to M.K. M.K. is a Bolyai Fellow of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; Bing W, 2000, BIOCHEM J, V350, P693, DOI 10.1042/0264-6021:3500693; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; GEEVES MA, 1988, BIOCHEM J, V256, P41, DOI 10.1042/bj2560041; Greenberg MJ, 2010, CYTOSKELETON, V67, P273, DOI 10.1002/cm.20441; Gyimesi M, 2010, NUCLEIC ACIDS RES, V38, P4404, DOI 10.1093/nar/gkq145; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Jacobs DJ, 2011, J MOL BIOL, V407, P716, DOI 10.1016/j.jmb.2011.02.001; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KONRAD M, 1982, EUR J BIOCHEM, V128, P547; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; Malnasi-Csizmadia A, 2001, J BIOL CHEM, V276, P19483, DOI 10.1074/jbc.M010886200; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Malnasi-Csizmadia A, 2007, J BIOL CHEM, V282, P17658, DOI 10.1074/jbc.M701447200; Malnasi-Csizmadia A, 2010, TRENDS BIOCHEM SCI, V35, P684, DOI 10.1016/j.tibs.2010.07.012; Nagy NT, 2010, FASEB J, V24, P4480, DOI 10.1096/fj.10-163998; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sellers J. R., 1999, MYOSINS; Snyder GE, 2004, BIOPHYS J, V87, P1776, DOI 10.1529/biophysj.103.036897; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sweeney HL, 2004, PHILOS T R SOC B, V359, P1829, DOI 10.1098/rstb.2004.1576; Takacs B, 2011, FASEB J, V25, P111, DOI 10.1096/fj.10-164871; Takacs B, 2010, P NATL ACAD SCI USA, V107, P6799, DOI 10.1073/pnas.0907585107; TAYLOR EW, 1991, J BIOL CHEM, V266, P294; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; WARSHAW DM, 1990, J CELL BIOL, V111, P453, DOI 10.1083/jcb.111.2.453; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	40	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62640	10.1371/journal.pone.0062640	http://dx.doi.org/10.1371/journal.pone.0062640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650521	Green Submitted, gold, Green Published			2022-12-25	WOS:000319167000065
J	Arimappamagan, A; Somasundaram, K; Thennarasu, K; Peddagangannagari, S; Srinivasan, H; Shailaja, BC; Samuel, C; Patric, IRP; Shukla, S; Thota, B; Prasanna, KV; Pandey, P; Balasubramaniam, A; Santosh, V; Chandramouli, BA; Hegde, AS; Kondaiah, P; Rao, MRS				Arimappamagan, Arivazhagan; Somasundaram, Kumaravel; Thennarasu, Kandavel; Peddagangannagari, Sreekanthreddy; Srinivasan, Harish; Shailaja, Bangalore C.; Samuel, Cini; Patric, Irene Rosita Pia; Shukla, Sudhanshu; Thota, Balaram; Prasanna, Krishnarao Venkatesh; Pandey, Paritosh; Balasubramaniam, Anandh; Santosh, Vani; Chandramouli, Bangalore Ashwathnarayanara; Hegde, Alangar Sathyaranjandas; Kondaiah, Paturu; Rao, Manchanahalli R. Sathyanarayana			A Fourteen Gene GBM Prognostic Signature Identifies Association of Immune Response Pathway and Mesenchymal Subtype with High Risk Group	PLOS ONE			English	Article							ADJUVANT TEMOZOLOMIDE; ASTROCYTIC GLIOMAS; STRONG PREDICTOR; GLIOBLASTOMA; EXPRESSION; SURVIVAL; GRADE; MARKERS; CANCER; ALPHA	Background: Recent research on glioblastoma (GBM) has focused on deducing gene signatures predicting prognosis. The present study evaluated the mRNA expression of selected genes and correlated with outcome to arrive at a prognostic gene signature. Methods: Patients with GBM (n = 123) were prospectively recruited, treated with a uniform protocol and followed up. Expression of 175 genes in GBM tissue was determined using qRT-PCR. A supervised principal component analysis followed by derivation of gene signature was performed. Independent validation of the signature was done using TCGA data. Gene Ontology and KEGG pathway analysis was carried out among patients from TCGA cohort. Results: A 14 gene signature was identified that predicted outcome in GBM. A weighted gene (WG) score was found to be an independent predictor of survival in multivariate analysis in the present cohort (HR = 2.507; B = 0.919; p < 0.001) and in TCGA cohort. Risk stratification by standardized WG score classified patients into low and high risk predicting survival both in our cohort (p = <0.001) and TCGA cohort (p = 0.001). Pathway analysis using the most differentially regulated genes (n = 76) between the low and high risk groups revealed association of activated inflammatory/immune response pathways and mesenchymal subtype in the high risk group. Conclusion: We have identified a 14 gene expression signature that can predict survival in GBM patients. A network analysis revealed activation of inflammatory response pathway specifically in high risk group. These findings may have implications in understanding of gliomagenesis, development of targeted therapies and selection of high risk cancer patients for alternate adjuvant therapies.	[Arimappamagan, Arivazhagan; Shailaja, Bangalore C.; Pandey, Paritosh; Balasubramaniam, Anandh; Chandramouli, Bangalore Ashwathnarayanara] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India; [Somasundaram, Kumaravel; Peddagangannagari, Sreekanthreddy; Srinivasan, Harish; Patric, Irene Rosita Pia; Shukla, Sudhanshu] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Thennarasu, Kandavel] Natl Inst Mental Hlth & Neurosci, Dept Biostat, Bangalore, Karnataka, India; [Thota, Balaram; Santosh, Vani] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore, Karnataka, India; [Samuel, Cini; Prasanna, Krishnarao Venkatesh; Hegde, Alangar Sathyaranjandas] Sri SatyaSai Inst Higher Med Sci, Bangalore, Karnataka, India; [Kondaiah, Paturu] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Rao, Manchanahalli R. Sathyanarayana] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	National Institute of Mental Health & Neurosciences - India; Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Rao, MRS (corresponding author), Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India.	mrsrao@jncasr.ac.in	Shukla, Sudhanshu/K-7830-2017; Shukla, Sudhanshu/AAC-8650-2020	Shukla, Sudhanshu/0000-0002-5069-9708; Shukla, Sudhanshu/0000-0002-5069-9708	CSIR, Government of India	CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	Funded by CSIR, Government of India. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the mansucript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Arivazhagan A, 2012, J NEURO-ONCOL, V107, P289, DOI 10.1007/s11060-011-0758-3; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Cai Z, 2005, BIOCHEM BIOPH RES CO, V331, P261, DOI 10.1016/j.bbrc.2005.03.163; Chigurupati S, 2005, CANCER RES, V65, P8519, DOI 10.1158/0008-5472.CAN-05-0848; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; COX DR, 1972, J R STAT SOC B, V34, P187; de Tayrac M, 2011, CLIN CANCER RES, V17, P317, DOI 10.1158/1078-0432.CCR-10-1126; Engler JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043339; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Godard S, 2003, CANCER RES, V63, P6613; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hastie TTR, 1999, TECHNICAL REPORT; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jarvinen TAH, 2003, BREAST CANCER RES TR, V78, P299, DOI 10.1023/A:1023077507295; Johansen JS, 2006, CANCER EPIDEM BIOMAR, V15, P194, DOI 10.1158/1055-9965.EPI-05-0011; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Komai K, 2002, BIOCHEM BIOPH RES CO, V299, P455, DOI 10.1016/S0006-291X(02)02645-1; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Li WX, 2005, J NEUROCHEM, V93, P1542, DOI 10.1111/j.1471-4159.2005.03146.x; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mennel HD, 2006, CLIN NEUROPATHOL, V25, P107; Mizoguchi M, 2006, J NEUROPATH EXP NEUR, V65, P1181, DOI 10.1097/01.jnen.0000248549.14962.b2; Nagarajan RP, 2009, SEMIN CANCER BIOL, V19, P188, DOI 10.1016/j.semcancer.2009.02.005; Nutt CL, 2003, CANCER RES, V63, P1602; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; *R DEVL COR TEAM, 2010, R LANG ENV STAT COMP; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Santosh V, 2010, CANCER EPIDEM BIOMAR, V19, P1399, DOI 10.1158/1055-9965.EPI-09-1213; Somasundaram K, 2005, ONCOGENE, V24, P7073, DOI 10.1038/sj.onc.1208865; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Takei H, 2008, J NEURO-ONCOL, V86, P183, DOI 10.1007/s11060-007-9455-7; TIBSHIRANI RJ, 2002, STAT APPL GENET MOL; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Zhang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006274	49	39	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62042	10.1371/journal.pone.0062042	http://dx.doi.org/10.1371/journal.pone.0062042			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646114	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300024
J	Cai, Y; Wang, Y; Zheng, ZJ; Wang, J; Yao, W; Ma, J				Cai, Yong; Wang, Ying; Zheng, Zhijie; Wang, Jin; Yao, Wen; Ma, Jin			Predictors of Reducing Sexual and Reproductive Risk Behaviors Based on the Information-Motivation-Behavioral Skills (IMB) Model among Unmarried Rural-To-Urban Female Migrants in Shanghai, China	PLOS ONE			English	Article							CONSISTENT CONDOM USE; HIV RISK; WORKERS; WOMEN; ADOLESCENTS; PREVENTION; MIGRATION; KNOWLEDGE; ATTITUDES; CITIES	Background: Due to the increase of premarital sex and the lack of reproductive health services, unmarried rural-to-urban female migrants experience more risks of sex and reproductive health (SRH). This study was designed to describe SRH related knowledge, attitude and risk behaviors among unmarried rural-to-urban female migrants and examine the predictors of reducing sexual and reproductive risk behaviors based on information-motivation-behavioral skills (IMB) model and to describe the relationships between the constructs. Methods: We conducted a cross-sectional study to assess SRH related information, motivation, behavioral skills and preventive behaviors among unmarried rural-to-urban female migrants in Shanghai, one of the largest importers of migrant laborers in China. Structural equation modeling (SEM) was used to assess the IMB model. Results: A total of 944 subjects completed their questionnaires. The mean age was 21.2 years old (SD = 2.3; range 16 to 28). Over one-fourth of participants reported having had premarital sex (N = 261, 27.6%) and among whom 15.3% reported having had the experience of unintended pregnancy, 14.6% with the experience of abortion. The final IMB model provided acceptable fit to the data (CFI = 0.99, RMSEA = 0.034). Reducing sexual and reproductive risk behaviors was significantly predicted by SRH related information (beta = 0.681, P<0.001) and behavioral skills(beta = 0.239, P<0.001). Motivation (beta = 0.479, P<0.001) was the significant indirect predictor of reducing sexual and reproductive risk behaviors mediated through behavioral skills. Conclusions: The results highlight the importance and necessity of conducting reproductive health promotion among unmarried rural-to-urban female migrants in China. The IMB model could be used to predict reducing sexual and reproductive risk behaviors and it suggests future interventions should focus on improving SRH related information and behavioral skills.	[Cai, Yong; Wang, Ying; Zheng, Zhijie; Ma, Jin] Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Wang, Jin] Shanghai Pudong Populat & Family Planning Managem, Shanghai, Peoples R China; [Yao, Wen] Shanghai Hongkou Ctr Dis Control & Prevent, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Center for Disease Control & Prevention	Ma, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Shanghai 200030, Peoples R China.	Majin@shsmu.edu.cn			National Natural Science Funds [71273174]; New Hundred Program on Outstanding Teacher of the School of Medicine of Shanghai Jiaotong University; Young Teachers Overseas Training Program from Shanghai Municipal Education Commission; Key Discipline Construction of Health Economics from Shanghai Health Bureau	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); New Hundred Program on Outstanding Teacher of the School of Medicine of Shanghai Jiaotong University; Young Teachers Overseas Training Program from Shanghai Municipal Education Commission; Key Discipline Construction of Health Economics from Shanghai Health Bureau	This study was funded by the National Natural Science Funds (71273174) and also supported by the New Hundred Program on Outstanding Teacher of the School of Medicine of Shanghai Jiaotong University, the Young Teachers Overseas Training Program from Shanghai Municipal Education Commission, Key Discipline Construction of Health Economics from Shanghai Health Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benotsch EG, 2007, J COMMUN HEALTH, V32, P343, DOI 10.1007/s10900-007-9054-8; Chan KW, 2007, EURASIAN GEOGR ECON, V48, P383, DOI 10.2747/1538-7216.48.4.383; Del Amo J, 2011, EUR J PUBLIC HEALTH, V21, P620, DOI 10.1093/eurpub/ckq150; Fisher CM, 2011, J HIV-AIDS SOC SERV, V10, P5, DOI 10.1080/15381501.2011.549064; Fisher J.D., 1998, AIDS BEHAV, V2, P101; Fisher JD, 1996, HEALTH PSYCHOL, V15, P114, DOI 10.1037/0278-6133.15.2.114; Hirsch JS, 2002, AM J PUBLIC HEALTH, V92, P1227, DOI 10.2105/AJPH.92.8.1227; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huang H, 2008, INT J STD AIDS, V19, P342, DOI 10.1258/ijsa.2007.007208; Kline RB, 2005, PRINCIPLES PRACTICE; Li SH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-195; Liu ZY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-74; Mantell JE, 2011, HEALTH EDUC RES, V26, P283, DOI 10.1093/her/cyr002; NA H, 2007, BIOSCI TRENDS, V1, P72; Qian X, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-1; Qiu PY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-520; Saggurti N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S6; Scott-Sheldon LAJ, 2010, J HEALTH PSYCHOL, V15, P1093, DOI 10.1177/1359105310364174; Tang J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-917; Tilahun M, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-19; *UNIT NAT, 2011, POP DISTR URB INT MI; Walsh JL, 2011, ANN BEHAV MED, V42, P235, DOI 10.1007/s12160-011-9284-y; [王英 Wang Ying], 2013, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University .Medical Science], V33, P209; Xiao ZW, 2011, AIDS CARE, V23, P105, DOI 10.1080/09540121.2010.532537; Yang H, 2005, AIDS CARE, V17, P819, DOI 10.1080/09540120500099902; Ye XX, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-599; Yi HS, 2010, PSYCHOL HEALTH MED, V15, P172, DOI 10.1080/13548501003623914; Zhang H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-113; Zheng ZZ, 2001, REPROD HEALTH MATTER, V9, P118, DOI 10.1016/S0968-8080(01)90015-1; Zhuang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031986	30	11	12	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62787	10.1371/journal.pone.0062787	http://dx.doi.org/10.1371/journal.pone.0062787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146GG	23646145	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300098
J	Davila, W; Basterreche, N; Arrue, A; Zamalloa, MI; Gordo, E; Davila, R; Gonzalez-Torres, MA; Zumarraga, M				Davila, Wendy; Basterreche, Nieves; Arrue, Aurora; Zamalloa, Maria I.; Gordo, Estibaliz; Davila, Ricardo; Gonzalez-Torres, Miguel A.; Zumarraga, Mercedes			The Influence of the Val158Met Catechol-O-Methyltransferase Polymorphism on the Personality Traits of Bipolar Patients	PLOS ONE			English	Article							NOVELTY SEEKING; HARM AVOIDANCE; FUNCTIONAL POLYMORPHISM; CHARACTER DIMENSIONS; II DISORDER; TEMPERAMENT; ASSOCIATION; GENE; SCHIZOPHRENIA; INVENTORY	Introduction: Certain personality traits and genetic polymorphisms are contributing factors to bipolar disorder and its symptomatology, and in turn, this syndrome influences personality. The aim of the present study is to compare the personality traits of euthymic bipolar patients with healthy controls and to investigate the effect of the catechol-O-methyltransferase (COMT) Val158Met genotype on those traits. We recruited thirty seven bipolar I patients in euthymic state following a manic episode and thirty healthy controls and evaluated their personality by means of the Cloninger's Temperament and Character Inventory (version TCI-R-140). We assessed the influence of the polymorphism Val158Met in the COMT gene on the personality of these patients. The patients scored higher than controls in harm avoidance (61.3 +/- 12.5 vs. 55.3 +/- 8.1) and self-transcendence (45.3 +/- 12.8 vs. 32.7 +/- 8.2) and scored lower than controls in self-directedness (68.8 +/- 13.3 vs. 79.3 +/- 8.1), cooperativeness (77.1 +/- 9.1 vs. 83.9 +/- 6.5) and persistence (60.4 +/- 15.1 vs. 67.1 +/- 8.9). The novelty seeking dimension associates with the Val158Met COMT genotype; patients with the low catabolic activity genotype, Met/Met, show a higher score than those with the high catabolic activity genotype, Val/Val. Conclusions: Suffering from bipolar disorder could have an impact on personality. A greater value in harm avoidance may be a genetic marker for a vulnerability to the development of a psychiatric disorder, but not bipolar disorder particularly, while a low value in persistence may characterize affective disorders or a subgroup of bipolar patients. The association between novelty seeking scores and COMT genotype may be linked with the role dopamine plays in the brain's reward circuits.	[Davila, Wendy] AMSA, Bilbao, Spain; [Basterreche, Nieves; Gordo, Estibaliz] Hosp Zamudio, Red Salud Mental Bizkaia, Unidad Hospitalizac Corta Estancia, Zamudio, Bizkaia, Spain; [Basterreche, Nieves; Gonzalez-Torres, Miguel A.] Univ Basque Country, Dept Psiquiatria, Leioa, Bizkaia, Spain; [Arrue, Aurora; Zamalloa, Maria I.; Davila, Ricardo; Zumarraga, Mercedes] Hosp Zamudio, Red Salud Mental Bizkaia, Dept Invest Neuroquim, Zamudio, Bizkaia, Spain; [Gonzalez-Torres, Miguel A.] Hosp Basurto, Dept Psiquiatria, Bilbao, Spain	University of Basque Country; Basurto Hospital	Zumarraga, M (corresponding author), Hosp Zamudio, Red Salud Mental Bizkaia, Dept Invest Neuroquim, Zamudio, Bizkaia, Spain.	mercedes.zumarragaortiz@osakidetza.net	Zumarraga, Mercedes/R-1235-2019	Zumarraga, Mercedes/0000-0003-0073-8198; Gonzalez-Torres, Miguel Angel/0000-0002-4017-2785	Basque Government's Department of Health [2008111051]; Fondo de Investigacion Sanitaria and FEDER Funds, Spain [PS0901760]	Basque Government's Department of Health; Fondo de Investigacion Sanitaria and FEDER Funds, Spain	Supported in part by grant 2008111051 of the Basque Government's Department of Health and by Grant PS0901760 of the Fondo de Investigacion Sanitaria and FEDER Funds, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti V, 2002, J AFFECT DISORDERS, V71, P113, DOI 10.1016/S0165-0327(01)00393-7; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Gonzalez-Torres MA, 2009, J NERV MENT DIS, V197, P514, DOI 10.1097/NMD.0b013e3181aacc1a; Basterreche N, 2008, NEUROPSYCHOBIOLOGY, V58, P111, DOI 10.1159/000170391; Benedetti F, 2010, J AFFECT DISORDERS, V125, P341, DOI 10.1016/j.jad.2010.01.005; Benjamin J, 2000, MOL PSYCHIATR, V5, P96, DOI 10.1038/sj.mp.4000640; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Blairy S, 2000, AM J MED GENET, V96, P360, DOI 10.1002/1096-8628(20000612)96:3<360::AID-AJMG24>3.0.CO;2-E; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cloninger CR, 1994, TCI GUIDE ITS DEV US; Correll CU, 2007, SCHIZOPHRENIA BULL, V33, P703, DOI 10.1093/schbul/sbm028; Cortes MJ, 2009, EUR PSYCHIAT, V24, P476, DOI 10.1016/j.eurpsy.2009.06.002; Demetrovics Z, 2010, COMPR PSYCHIAT, V51, P510, DOI 10.1016/j.comppsych.2009.11.008; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Engstrom C, 2004, J AFFECT DISORDERS, V82, P131, DOI 10.1016/j.jad.2003.09.004; Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/00041444-200303000-00006; Evans L, 2005, J AFFECT DISORDERS, V85, P153, DOI 10.1016/j.jad.2003.10.015; Evans LM, 2008, AM J MED GENET B, V147B, P326, DOI 10.1002/ajmg.b.30601; Gjedde A, 2010, P NATL ACAD SCI USA, V107, P3870, DOI 10.1073/pnas.0912319107; Golimbet V E, 2007, Neurosci Behav Physiol, V37, P601, DOI 10.1007/s11055-007-0058-8; Guillem F, 2002, SCHIZOPHR RES, V56, P137, DOI 10.1016/S0920-9964(01)00257-2; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hansenne M, 1999, J PSYCHIATR RES, V33, P31, DOI 10.1016/S0022-3956(98)00036-3; Harley James A, 2011, Depress Res Treat, V2011, P529638, DOI 10.1155/2011/529638; Hashimoto R, 2007, NEUROSCI LETT, V428, P17, DOI 10.1016/j.neulet.2007.09.036; Henry C, 2010, CURR PSYCHIAT REP, V12, P505, DOI 10.1007/s11920-010-0156-0; Hori H, 2008, PSYCHIAT RES, V160, P175, DOI 10.1016/j.psychres.2007.05.015; Hosak L, 2006, NEUROENDOCRINOL LETT, V27, P799; Ishii G, 2007, EUR PSYCHIAT, V22, P462, DOI 10.1016/j.eurpsy.2007.05.005; Jylha P, 2011, PSYCHOL MED, V41, P1579, DOI 10.1017/S0033291710002606; Kim SJ, 2006, NEUROSCI LETT, V401, P154, DOI 10.1016/j.neulet.2006.03.006; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Light KJ, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-3; Lin CI, 2010, PSYCHIAT RES, V177, P364, DOI 10.1016/j.psychres.2010.03.005; Loftus ST, 2008, J PSYCHIATR RES, V42, P1131, DOI 10.1016/j.jpsychires.2007.11.005; Lovdahl H, 2010, COMPR PSYCHIAT, V51, P607, DOI 10.1016/j.comppsych.2010.03.003; Marijnissen G, 2002, J AFFECT DISORDERS, V70, P219, DOI 10.1016/S0165-0327(01)00364-0; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Miettunen J, 2012, COMPR PSYCHIAT, V53, P152, DOI 10.1016/j.comppsych.2011.03.008; Mikolajczyk E, 2010, BRAIN RES, V1307, P142, DOI 10.1016/j.brainres.2009.10.035; Nery FG, 2008, J PSYCHIATR RES, V42, P569, DOI 10.1016/j.jpsychires.2007.06.004; Nowakowska C, 2005, J AFFECT DISORDERS, V85, P207, DOI 10.1016/j.jad.2003.11.012; Oeltmann T, 2004, AUTON NEUROSCI-BASIC, V116, P1, DOI 10.1016/j.autneu.2004.08.013; Ozgurdal S, 2009, PSYCHOPATHOLOGY, V42, P337, DOI 10.1159/000232977; Osher Y, 1999, J AFFECT DISORDERS, V53, P87, DOI 10.1016/S0165-0327(98)00075-5; Osher Y, 1996, J PSYCHIAT RES, V30, P353, DOI 10.1016/0022-3956(96)00023-4; Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0; Poustka L, 2010, EUR PSYCHIAT, V25, P26, DOI 10.1016/j.eurpsy.2009.09.006; Savitz J, 2008, GENES BRAIN BEHAV, V7, P869, DOI 10.1111/j.1601-183X.2008.00426.x; Sayin A, 2007, COMPR PSYCHIAT, V48, P446, DOI 10.1016/j.comppsych.2007.04.004; Simons CJP, 2009, GENES BRAIN BEHAV, V8, P5, DOI 10.1111/j.1601-183X.2008.00434.x; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Strobel A, 2003, MOL PSYCHIATR, V8, P371, DOI 10.1038/sj.mp.4001253; Tost H, 2010, NEUROSCI BIOBEHAV R, V34, P689, DOI 10.1016/j.neubiorev.2009.06.005; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V50, P153, DOI 10.1159/000079107; Yamano E, 2008, COMPR PSYCHIAT, V49, P503, DOI 10.1016/j.comppsych.2008.03.001; YOUNG LT, 1995, PSYCHIAT RES, V58, P139, DOI 10.1016/0165-1781(95)02684-O; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	59	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62900	10.1371/journal.pone.0062900	http://dx.doi.org/10.1371/journal.pone.0062900			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646156	Green Published, gold			2022-12-25	WOS:000319077300110
J	Li, AM; Chan, B; Felix, JC; Xing, YM; Li, M; Brody, SL; Borok, Z; Li, CG; Minoo, P				Li, Aimin; Chan, Belinda; Felix, Juan C.; Xing, Yiming; Li, Min; Brody, Steven L.; Borok, Zea; Li, Changgong; Minoo, Parviz			Tissue-Dependent Consequences of Apc Inactivation on Proliferation and Differentiation of Ciliated Cell Progenitors via Wnt and Notch Signaling	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; STEM-CELLS; TUMOR-SUPPRESSOR; CLARA CELLS; LUNG; EXPRESSION; MAINTENANCE; PROTEIN; AIRWAY; BETA	The molecular signals that control decisions regarding progenitor/stem cell proliferation versus differentiation are not fully understood. Differentiation of motile cilia from progenitor/stem cells may offer a simple tractable model to investigate this process. Wnt and Notch represent two key signaling pathways in progenitor/stem cell behavior in a number of tissues. Adenomatous Polyposis Coli, Apc is a negative regulator of the Wnt pathway and a well known multifunctional protein. Using the cre-LoxP system we inactivated the Apc locus via Foxj1-cre, which is expressed in cells committed to ciliated cell lineage. We then characterized the consequent phenotype in two select tissues that bear motile cilia, the lung and the testis. In the lung, Apc deletion induced beta-catenin accumulation and Jag1 expression in ciliated cells and by lateral induction, triggered Notch signaling in adjacent Clara cells. In the bronchiolar epithelium, absence of Apc blocked the differentiation of a subpopulation of cells committed to the ciliogenesis program. In the human pulmonary adenocarcinoma cells, Apc over-expression inhibited Jag1 expression and promoted motile ciliogenic gene expression program including Foxj1, revealing the potential mechanism. In the testis, Apc inactivation induced beta-catenin accumulation in the spermatogonia, but silenced Notch signaling and depleted spermatogonial stem cells, associated with reduced proliferation, resulting in male infertility. In sum, the present comparative analysis reveals the tissue-dependent consequences of Apc inactivation on proliferation and differentiation of ciliated cell progenitors by coordinating Wnt and Notch signaling.	[Li, Aimin; Chan, Belinda; Xing, Yiming; Li, Min; Li, Changgong; Minoo, Parviz] Univ So Calif, Keck Sch Med, Los Angeles Cty Univ So Calif Med Ctr, Div Newborn Med,Dept Pediat, Los Angeles, CA 90033 USA; [Felix, Juan C.] Los Angeles Cty Univ So Calif Med Ctr, Dept Pathol, Los Angeles, CA USA; [Brody, Steven L.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Borok, Zea] Univ So Calif, Keck Sch Med, Div Pulm & Crit Care Med, Will Rogers Inst,Pulm Res Ctr,Dept Med, Los Angeles, CA 90033 USA; [Borok, Zea] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Xing, Yiming] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	University of Southern California; Washington University (WUSTL); University of Southern California; University of Southern California; China Agricultural University	Minoo, P (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles Cty Univ So Calif Med Ctr, Div Newborn Med,Dept Pediat, Los Angeles, CA 90033 USA.	minoo@usc.edu	Borok, Zea/J-9015-2013	Borok, Zea/0000-0001-8673-8177	Hastings Foundation [HL107307, HL95349]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112638, R01HL121791, R01HL095349, R01HL107307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070489] Funding Source: NIH RePORTER	Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Hastings Foundation HL107307 and HL95349. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Carothers AM, 2001, J BIOL CHEM, V276, P39094, DOI 10.1074/jbc.M103450200; Collu GM, 2012, DEVELOPMENT, V139, P4405, DOI 10.1242/dev.081885; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Dirami G, 2001, J ANDROL, V22, P944; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; HACKETT BP, 1995, P NATL ACAD SCI USA, V92, P4249, DOI 10.1073/pnas.92.10.4249; Hanson CA, 2005, GENE, V361, P1, DOI 10.1016/j.gene.2005.07.024; Hellman NE, 2010, P NATL ACAD SCI USA, V107, P18499, DOI 10.1073/pnas.1005998107; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Katoh M, 2006, INT J MOL MED, V17, P681; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Kitadate Y, 2010, P NATL ACAD SCI USA, V107, P14241, DOI 10.1073/pnas.1003462107; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Li AM, 2010, DEV DYNAM, V239, P2288, DOI 10.1002/dvdy.22364; Li CG, 2009, DEV BIOL, V334, P97, DOI 10.1016/j.ydbio.2009.07.021; Li M, 2011, J CLIN INVEST, V121, P277, DOI 10.1172/JCI42090; Li M, 2008, J BIOL CHEM, V283, P36257, DOI 10.1074/jbc.M806786200; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Love D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013600; Luo JP, 2009, J CELL PHYSIOL, V220, P460, DOI 10.1002/jcp.21789; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Maric S, 2004, ANDROLOGIA, V36, P24, DOI 10.1046/j.1439-0272.2003.00597.x; Midgley CA, 1997, J PATHOL, V181, P426; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; Okegbe TC, 2011, DEVELOPMENT, V138, P1259, DOI 10.1242/dev.056994; Perera D, 2007, DEV CELL, V13, P566, DOI 10.1016/j.devcel.2007.08.008; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reynolds SD, 2000, AM J PHYSIOL-LUNG C, V278, pL1256, DOI 10.1152/ajplung.2000.278.6.L1256; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; Reynolds SD, 2010, INT J BIOCHEM CELL B, V42, P1, DOI 10.1016/j.biocel.2009.09.002; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Senda T, 2007, MED MOL MORPHOL, V40, P68, DOI 10.1007/s00795-006-0352-5; Tanwar PS, 2011, MOL ENDOCRINOL, V25, P1725, DOI 10.1210/me.2011-0057; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Tsao PN, 2008, J BIOL CHEM, V283, P29532, DOI 10.1074/jbc.M801565200; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; VanGompel MJW, 2010, HUM MOL GENET, V19, P2360, DOI 10.1093/hmg/ddq109; Weiss Daniel J, 2011, Proc Am Thorac Soc, V8, P223, DOI 10.1513/pats.201012-071DW; Xing YM, 2012, STEM CELLS, V30, P946, DOI 10.1002/stem.1059; Xing YM, 2010, DEVELOPMENT, V137, P825, DOI 10.1242/dev.040535; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhang Y, 2007, AM J RESP CELL MOL, V36, P515, DOI 10.1165/rcmb.2006-0475RC	51	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62215	10.1371/journal.pone.0062215	http://dx.doi.org/10.1371/journal.pone.0062215			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646120	Green Submitted, gold, Green Published			2022-12-25	WOS:000319077300030
J	Li, DG; Wang, YY; Wu, HY; Lu, L; Wang, XC; Zhang, JL; Zhang, H; Fan, SJ; Fan, FY; Zhou, DH; Meng, AM				Li, Deguan; Wang, Yueying; Wu, Hongying; Lu, Lu; Wang, Xiaochun; Zhang, Junling; Zhang, Heng; Fan, Saijun; Fan, Feiyue; Zhou, Daohong; Meng, Aimin			The Effects of p38 MAPK Inhibition Combined with G-CSF Administration on the Hematoimmune System in Mice with Irradiation Injury	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ACTIVATED PROTEIN-KINASE; IONIZING RADIATION; SUPPRESSION; APOPTOSIS; P38-ALPHA; PATHWAYS	The acute and residual (or long-term) bone marrow (BM) injury induced by ionizing radiation (IR) is a major clinic concern for patients receiving conventional radiotherapy and victims accidentally exposed to a moderate-to-high dose of IR. In this study, we investigated the effects of the treatment with the p38 inhibitor SB203580 (SB) and/or granulocyte colony-stimulating factor (G-CSF) on the hematoimmune damage induced by IR in a mouse model. Specifically, C57BL/6 mice were exposed to a sublethal dose (6 Gy) of total body irradiation (TBI) and then treated with vehicle, G-CSF, SB, and G-CSF plus SB. G-CSF (1 mu g/mouse) was administrated to mice by intraperitoneal (ip) injection twice a day for six successive days; SB (15 mg/kg) by ip injection every other day for 10 days. It was found that the treatment with SB and/or G-CSF significantly enhanced the recovery of various peripheral blood cell counts and the number of BM mononuclear cells 10 and 30 days after the mice were exposed to TBI compared with vehicle treatment. Moreover, SB and/or G-CSF treatment also increased the clonogenic function of BM hematopoietic progenitor cells (HPCs) and the frequency of BM lineage(-) Sca1(+) c-kit(+) cells (LSK cells) and short-term and long term hematopoietic stem cells (HSCs) 30 days after TBI, in comparison with vehicle treated controls. However, the recovery of peripheral blood B cells and CD4(+) and CD8(+) T cells was not significantly affected by SB and/or G-CSF treatment. These results suggest that the treatment with SB and/or G-CSF can reduce IR-induced BM injury probably in part via promoting HSC and HPC regeneration.	[Li, Deguan; Wang, Yueying; Wu, Hongying; Lu, Lu; Wang, Xiaochun; Zhang, Junling; Zhang, Heng; Fan, Saijun; Fan, Feiyue; Meng, Aimin] Chinese Acad Med Sci, Inst Radiat Med, Tianjin, Peoples R China; [Li, Deguan; Wang, Yueying; Wu, Hongying; Lu, Lu; Wang, Xiaochun; Zhang, Junling; Zhang, Heng; Fan, Saijun; Fan, Feiyue; Meng, Aimin] Peking Union Med Coll, Tianjin Key Lab Mol Nucl Med, Tianjin, Peoples R China; [Zhou, Daohong] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Zhou, Daohong] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Meng, AM (corresponding author), Chinese Acad Med Sci, Inst Radiat Med, Tianjin, Peoples R China.	aiminmeng@irm-cams.ac.cn			National Program on Key Basic Research Project (973 Program) [2011CB964800-G]; National Natural Science Foundation of China [30770645, 81129020, 81102873]; National Institute of Allergy and Infectious Diseases [R01AI080421]; Natural Science Foundation of Tianjin [12JCQNJC09100]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080421] Funding Source: NIH RePORTER	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Program on Key Basic Research Project (973 Program, 2011CB964800-G), the National Natural Science Foundation of China (No 30770645,81129020,81102873), the National Institute of Allergy and Infectious Diseases (R01AI080421), and the Natural Science Foundation of Tianjin(12JCQNJC09100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Beekman R, 2010, BLOOD, V115, P5131, DOI 10.1182/blood-2010-01-234120; Chen BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011056; Dainiak Nicholas, 2003, Hematology Am Soc Hematol Educ Program, P473; Dainiak N, 2010, HEALTH PHYS, V98, P838, DOI 10.1097/HP.0b013e3181b3fce5; Dalmas DA, 2008, TOXICOL PATHOL, V36, P958, DOI 10.1177/0192623308327121; Drouet M, 2010, INT J RADIAT BIOL, V86, P636, DOI 10.3109/09553001003789604; Duarte RF, 2002, LEUKEMIA LYMPHOMA, V43, P1179, DOI 10.1080/10428190290026231; Feng YD, 2009, ARCH PATHOL LAB MED, V133, P1850, DOI 10.1043/1543-2165-133.11.1850; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Greenbaum AM, 2011, LEUKEMIA, V25, P211, DOI 10.1038/leu.2010.248; Griffin J D, 1988, Oncology (Williston Park), V2, P15; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Katsoulidis E, 2005, CANCER RES, V65, P9029, DOI 10.1158/0008-5472.CAN-04-4555; Kim JS, 2012, FOOD CHEM TOXICOL, V50, P3174, DOI 10.1016/j.fct.2012.05.059; Li DG, 2011, J RADIAT RES, V52, P712, DOI 10.1269/jrr.11007; Meng A, 2003, EXP HEMATOL, V31, P1348, DOI 10.1016/j.exphem.2003.08.014; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Navas T, 2008, LEUKEMIA LYMPHOMA, V49, P1963, DOI 10.1080/10428190802322919; Navas TA, 2006, BLOOD, V108, P4170, DOI 10.1182/blood-2006-05-023093; Pape H, 2006, EUR J MED RES, V11, P322; PATCHEN ML, 1990, INT J CELL CLONING, V8, P107, DOI 10.1002/stem.5530080204; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ren ML, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/310928; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; Schindler JF, 2007, J DENT RES, V86, P800, DOI 10.1177/154405910708600902; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; UCKUN FM, 1990, BLOOD, V75, P638; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Weiss JF, 2009, INT J RADIAT BIOL, V85, P539, DOI 10.1080/09553000902985144; Xiao Mang, 2009, Curr Mol Pharmacol, V2, P122; Zhou L, 2007, CELL CYCLE, V6, P534, DOI 10.4161/cc.6.5.3921	33	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62921	10.1371/journal.pone.0062921	http://dx.doi.org/10.1371/journal.pone.0062921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646161	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300115
J	Rossignol, T; Kocsis, B; Bouquet, O; Kustos, I; Kilar, F; Nyul, A; Jakus, PB; Rajbhandari, K; Prokai, L; d'Enfert, C; Lorand, T				Rossignol, Tristan; Kocsis, Bela; Bouquet, Orsolya; Kustos, Ildiko; Kilar, Ferenc; Nyul, Adrien; Jakus, Peter B.; Rajbhandari, Kshitij; Prokai, Laszlo; d'Enfert, Christophe; Lorand, Tamas			Antifungal Activity of Fused Mannich Ketones Triggers an Oxidative Stress Response and Is Cap1-Dependent in Candida albicans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; RESISTANCE; AZOLE; BASES; AGENTS; GLABRATA; CAP1P; IDENTIFICATION	We investigated the antifungal activity of fused Mannich ketone (FMK) congeners and two of their aminoalcohol derivatives. In particular, FMKs with five-membered saturated rings were shown to have minimum inhibitory concentration (MIC(90)s) ranging from 0.8 to 6 mg/mL toward C. albicans and the closely related C. parapsilosis and C. krusei while having reduced efficacy toward C. glabrata and almost no efficacy against Aspergillus sp. Transcript profiling of C. albicans cells exposed for 30 or 60 min to 2-(morpholinomethyl)-1-indanone, a representative FMK with a five-membered saturated ring, revealed a transcriptional response typical of oxidative stress and similar to that of a C. albicans Cap1 transcriptional activator. Consistently, C. albicans lacking the CAP1 gene was hypersensitive to this FMK, while C. albicans strains overexpressing CAP1 had decreased sensitivity to 2-(morpholinomethyl)-1-indanone. Quantitative structure-activity relationship studies revealed a correlation of antifungal potency and the energy of the lowest unoccupied molecular orbital of FMKs and unsaturated Mannich ketones thereby implicating redox cycling-mediated oxidative stress as a mechanism of action. This conclusion was further supported by the loss of antifungal activity upon conversion of representative FMKs to aminoalcohols that were unable to participate in redox cycles.	[Rossignol, Tristan; d'Enfert, Christophe] Inst Pasteur, Unite Biol & Pathogenicite Fong, Dept Genomes & Genet, Paris, France; [Rossignol, Tristan; d'Enfert, Christophe] INRA, USC 2019, Paris, France; [Kocsis, Bela; Nyul, Adrien] Univ Pecs, Dept Med Microbiol & Immunol, Fac Med, Pecs, Hungary; [Bouquet, Orsolya; Kilar, Ferenc] Univ Pecs, Inst Bioanal, Fac Med, Pecs, Hungary; [Kustos, Ildiko] Alder Hey Childrens NHS Fdn Trust, Dept Microbiol, Liverpool, Merseyside, England; [Jakus, Peter B.; Lorand, Tamas] Univ Pecs, Dept Biochem & Med Chem, Fac Med, Pecs, Hungary; [Rajbhandari, Kshitij; Prokai, Laszlo] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; University of Pecs; University of Pecs; Alder Hey Children's NHS Foundation Trust; University of Liverpool; University of Pecs; University of North Texas System; University of North Texas Health Science Center	Lorand, T (corresponding author), Univ Pecs, Dept Biochem & Med Chem, Fac Med, Pecs, Hungary.	tamas.lorand@aok.pte.hu	Rossignol, Tristan/B-9398-2008; Kilár, Ferenc/A-5160-2010	Rossignol, Tristan/0000-0003-0718-0684; Kilár, Ferenc/0000-0001-5737-5514; Prokai, Laszlo/0000-0002-4559-3458; d'Enfert, Christophe/0000-0002-6235-3886	NPARI consortium [LSHE-CT-2006-037692]; Hungarian Scientific Research Fund [OTKA K-100667]; Robert A. Welch Foundation [BK-0031]	NPARI consortium; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Robert A. Welch Foundation(The Welch Foundation)	TR was the recipient of a post-doctoral fellowship in the framework of the NPARI consortium (LSHE-CT-2006-037692). FK and LP were supported by the Hungarian Scientific Research Fund (OTKA K-100667) and by the Robert A. Welch Foundation (endowment number BK-0031), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhila JS, 2007, CURR SCI INDIA, V93, P917; Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; ANDERSON DMW, 1959, J CHEM SOC, P3992, DOI 10.1039/jr9590003992; Arana DM, 2010, J ANTIMICROB CHEMOTH, V65, P54, DOI 10.1093/jac/dkp407; Arnaud MB, 2009, TRENDS MICROBIOL, V17, P295, DOI 10.1016/j.tim.2009.04.007; Batova M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-153; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; BROWN E, 1971, B SOC CHIM FR, P2195; BUNDGAARD H, 1982, INT J PHARM, V10, P181, DOI 10.1016/0378-5173(82)90068-0; Cabral Vitor, 2012, Methods Mol Biol, V845, P227, DOI 10.1007/978-1-61779-539-8_15; Chiranand W, 2008, EUKARYOT CELL, V7, P268, DOI 10.1128/EC.00240-07; Coste AT, 2008, MICROBIOL-SGM, V154, P1491, DOI 10.1099/mic.0.2007/016063-0; DIMMOCK JR, 1993, EUR J MED CHEM, V28, P313, DOI 10.1016/0223-5234(93)90148-8; DIMMOCK JR, 1992, J PHARM SCI, V81, P1147, DOI 10.1002/jps.2600811203; Enjalbert B, 2003, MOL BIOL CELL, V14, P1460, DOI 10.1091/mbc.E02-08-0546; FONZI WA, 1993, GENETICS, V134, P717; Fostel JM, 2000, DRUG DISCOV TODAY, V5, P25, DOI 10.1016/S1359-6446(99)01430-0; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gul M, 2001, ARZNEIMITTEL-FORSCH, V51, P679; HODGE H C, 1949, Am Ind Hyg Assoc Q, V10, P93; Hoehamer CF, 2010, ANTIMICROB AGENTS CH, V54, P1655, DOI 10.1128/AAC.00756-09; Hoffmann K, 1944, HELV CHIM ACTA, V27, P1782, DOI 10.1002/hlca.194402701226; Huang Y, 1996, EUR J MED CHEM, V31, P281, DOI 10.1016/0223-5234(96)80365-5; Inglis DO, 2011, NUCL ACIDS RES; Karababa M, 2004, ANTIMICROB AGENTS CH, V48, P3064, DOI 10.1128/AAC.48.8.3064-3079.2004; Kelly J, 2009, MED MYCOL, V47, P697, DOI 10.3109/13693780802552606; Kim JH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00261; Kim JH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00088; Kocsis B, 2009, EUR J MED CHEM, V44, P1823, DOI 10.1016/j.ejmech.2008.10.038; Lelandais G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r164; LICHTFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; Liu TT, 2005, ANTIMICROB AGENTS CH, V49, P2226, DOI 10.1128/AAC.49.6.2226-2236.2005; Lorand T, 2004, ARKIVOC, P34, DOI 10.3998/ark.5550190.0005.704; Lorand T, 2002, EUR J MED CHEM, V37, P803, DOI 10.1016/S0223-5234(02)01404-6; Lorand T, 2001, EUR J MED CHEM, V36, P705, DOI 10.1016/S0223-5234(01)01264-8; Manavathu EK, 1999, ANTIMICROB AGENTS CH, V43, P2950, DOI 10.1128/AAC.43.12.2950; Mannich C, 1937, ARCH PHARM, V254, P54; Mosettig M, 1940, J ORG CHEM, V5, P528; MUTUS B, 1989, ANAL BIOCHEM, V177, P237, DOI 10.1016/0003-2697(89)90045-6; Okamoto Y, 2004, MYCOPATHOLOGIA, V158, P9, DOI 10.1023/B:MYCO.0000038430.20669.80; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Panackal AA, 2006, J CLIN MICROBIOL, V44, P1740, DOI 10.1128/JCM.44.5.1740-1743.2006; Pati HN, 2007, MINI-REV MED CHEM, V7, P131, DOI 10.2174/138955707779802642; PELLETIER SW, 1980, TETRAHEDRON LETT, V21, P809, DOI 10.1016/S0040-4039(00)71511-5; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P3185, DOI 10.1128/JCM.00946-09; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Ramsdale M, 2008, MOL BIOL CELL, V19, P4393, DOI 10.1091/mbc.E07-09-0946; Rognon B, 2006, MICROBIOL-SGM, V152, P3701, DOI 10.1099/mic.0.29277-0; Rossignol T, 2011, ANTIMICROB AGENTS CH, V55, P4670, DOI 10.1128/AAC.00319-11; Ruan SY, 2008, ANTIMICROB AGENTS CH, V52, P2919, DOI 10.1128/AAC.00323-08; SanJose C, 1996, J BACTERIOL, V178, P5850, DOI 10.1128/jb.178.19.5850-5852.1996; SOKOLANDERSON ML, 1986, J INFECT DIS, V154, P76, DOI 10.1093/infdis/154.1.76; Sommers AH, 1958, MORPHOLINOMETHYL KET; Srivastava BK, 1996, INDIAN J CHEM B, V35, P495; Tarbell DS, 1952, J AM CHEM SOC, P74; TURNER RB, 1956, J AM CHEM SOC, V78, P5923, DOI 10.1021/ja01603a057; Wang Y, 2006, FREE RADICAL BIO MED, V40, P1201, DOI 10.1016/j.freeradbiomed.2005.11.019; Welch W, 1977, 2 AMINOMETHYL 3 4 DI; WELCH WM, 1977, J MED CHEM, V20, P699, DOI 10.1021/jm00215a016; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zhao YJ, 2009, INT J PHARMACEUT, V379, P90, DOI 10.1016/j.ijpharm.2009.06.013; Znaidi S, 2009, EUKARYOT CELL, V8, P806, DOI 10.1128/EC.00002-09	63	2	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62142	10.1371/journal.pone.0062142	http://dx.doi.org/10.1371/journal.pone.0062142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646117	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300027
J	Fernandez, BG; Jezowska, B; Janody, F				Fernandez, B. G.; Jezowska, B.; Janody, F.			Drosophila actin-Capping Protein limits JNK activation by the Src proto-oncogene	ONCOGENE			English	Article						capping protein; Src family kinases; JNK signaling; F-actin; Drosophila wing discs epithelium	REGULATE CELL-PROLIFERATION; RING CANAL MORPHOGENESIS; TUMOR-SUPPRESSOR GENES; FAMILY TYROSINE KINASE; N-TERMINAL KINASE; SMALL GTPASES; F-ACTIN; SIGNALING PATHWAY; DUAL FUNCTION; ORGAN GROWTH	The Src family kinases c-Src, and its downstream effectors, the Rho family of small GTPases RhoA and Jun N-terminal kinase (JNK) have a significant role in tumorigenesis. In this report, using the Drosophila wing disc epithelium as a model system, we demonstrate that the actin-Capping Protein (CP) alpha beta heterodimer, which regulates actin filament (F-actin) polymerization, limits Src-induced apoptosis or tissue overgrowth by restricting JNK activation. We show that overexpressing Src64B drives JNK-independent loss of epithelial integrity and JNK-dependent apoptosis via Btk29A, p120ctn and Rho1. However, when cells are kept alive with the Caspase inhibitor P35, JNK acts as a potent inducer of proliferation via activation of the Yorkie oncogene. Reducing CP levels direct apoptosis of overgrowing Src64B-overexpressing tissues. Conversely, overexpressing capping protein inhibits Src64B and Rho1, but not Rac1-induced JNK signaling. CP requires the actin-binding domain of the alpha-subunit to limit Src64B-induced apoptosis, arguing that the control of F-actin mediates this effect. In turn, JNK directs F-actin accumulation. Moreover, overexpressing capping protein also prevents apoptosis induced by ectopic JNK expression. Our data are consistent with a model in which the control of F-actin by CP limits Src-induced apoptosis or tissue overgrowth by acting downstream of Btk29A, p120ctn and Rho1, but upstream of JNK. In turn, JNK may counteract the effect of CP on F-actin, providing a positive feedback, which amplifies JNK activation. We propose that cytoskeletal changes triggered by misregulation of F-actin modulators may have a significant role in Src-mediated malignant phenotypes during the early stages of cellular transformation.	[Fernandez, B. G.; Jezowska, B.; Janody, F.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Instituto Gulbenkian de Ciencia	Janody, F (corresponding author), Inst Gulbenkian Ciencias, Rua Quinta Grande 6,Apartado 14, P-2780156 Lisbon, Portugal.	fjanody@igc.gulbenkian.pt	Janody, Florence/AAT-1367-2020; Janody, Florence/A-4378-2017	Janody, Florence/0000-0003-4326-0163; Garcia Fernandez, Beatriz/0000-0001-9215-2447	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/SAU-OBD/73191/2006, PTDC/BIA-BCM/121455/2010]; FCT [SFRH/BPD/35915/2007, SFRH/BD/33215/2007]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	We thank T Xu, B Hay, R Mann, A Laughon, G Morata, J Whited, the Bloomington Drosophila Stock Center, the National Institute of Genetics, The Vienna Drosophila Research Center and the Developmental Studies Hybridoma Bank for fly stocks and reagents. The manuscript was improved by the critical comments of Miguel G. Ferreira, Joana Vaz, Monica Bettencourt Dias and Christen Mirth. This work was supported by grants from Fundacao para a Ciencia e Tecnologia (FCT) (Grants PTDC/SAU-OBD/73191/2006 and PTDC/BIA-BCM/121455/2010). BGF and BJ were the recipients of fellowships from FCT SFRH/BPD/35915/2007 and SFRH/BD/33215/2007, respectively).	Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; AMATRUDA JF, 1992, J CELL BIOL, V119, P1151, DOI 10.1083/jcb.119.5.1151; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Brumby AM, 2011, GENETICS, V188, P105, DOI 10.1534/genetics.111.127910; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chan HL, 2010, J BIOL CHEM, V285, P4307, DOI 10.1074/jbc.M109.047027; Chang YWE, 2009, RECENT PAT ANTI-CANC, V4, P110, DOI 10.2174/157489209788452830; Chen F, 2012, CANCER RES, V72, P379, DOI 10.1158/0008-5472.CAN-11-1982; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Cozzolino M, 2003, MOL BIOL CELL, V14, P1964, DOI 10.1091/mbc.E02-08-0469; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Delalle I, 2005, GENETICS, V171, P1757, DOI 10.1534/genetics.105.049213; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Dodson GS, 1998, DEVELOPMENT, V125, P2883; Doggett K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-57; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Enomoto M, 2013, EMBO REP, V14, P65, DOI 10.1038/embor.2012.185; Fan Y, 2010, CELL DEATH DIFFER, V17, P534, DOI 10.1038/cdd.2009.185; Fanning PJ, 2003, J BIOL CHEM, V278, P50940, DOI 10.1074/jbc.M305107200; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Forster D, 2012, NAT CELL BIOL, V14, P526, DOI 10.1038/ncb2456; Gates J, 2009, DEV BIOL, V333, P90, DOI 10.1016/j.ydbio.2009.06.030; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harden N, 1999, J CELL SCI, V112, P273; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; HAY BA, 1994, DEVELOPMENT, V120, P2121; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Janody F, 2006, DEVELOPMENT, V133, P3349, DOI 10.1242/dev.02511; Jezowska B, 2011, DEV BIOL, V360, P143, DOI 10.1016/j.ydbio.2011.09.016; Khoo P, DIS MODEL MECH; Kim JY, 2009, BIOCHEM PHARMACOL, V79, P431; Kim K, 2004, J CELL BIOL, V164, P567, DOI 10.1083/jcb.200308061; Klein T, 1998, DEV BIOL, V194, P196, DOI 10.1006/dbio.1997.8829; Kulshammer E, 2013, J CELL SCI, V126, P927, DOI 10.1242/jcs.114462; Kurant E, 1998, DEVELOPMENT, V125, P1037; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; Leong GR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-62; Lu N, 2004, EMBO J, V23, P1089, DOI 10.1038/sj.emboj.7600127; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Mahadev K, 2002, EXP CELL RES, V279, P40, DOI 10.1006/excr.2002.5583; Mammoto A, 2009, CURR OPIN CELL BIOL, V21, P864, DOI 10.1016/j.ceb.2009.08.001; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; Nagao M, 1999, ONCOGENE, V18, P4425, DOI 10.1038/sj.onc.1202832; Neisch AL, 2010, J CELL BIOL, V189, P311, DOI 10.1083/jcb.200912010; Nelson KS, 2012, NAT CELL BIOL, V14, P518, DOI 10.1038/ncb2467; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oktay M, 1999, J CELL BIOL, V145, P1461, DOI 10.1083/jcb.145.7.1461; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pedraza LG, 2004, ONCOGENE, V23, P4754, DOI 10.1038/sj.onc.1207635; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; Read RD, 2004, MOL CELL BIOL, V24, P6676, DOI 10.1128/mcb.24.15.6676-6689.2004; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Roulier EM, 1998, MOL CELL, V1, P819, DOI 10.1016/S1097-2765(00)80081-7; Rudrapatna VA, DEV DYN, V241, P107; Saito K, 2001, J BIOL CHEM, V276, P16201, DOI 10.1074/jbc.M100873200; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; SCHAFER DA, 1992, J CELL BIOL, V118, P335, DOI 10.1083/jcb.118.2.335; Shah V, 1998, SOMAT CELL MOLEC GEN, V24, P273, DOI 10.1023/B:SCAM.0000007130.08611.fc; Shindo M, 2008, DEVELOPMENT, V135, P1355, DOI 10.1242/dev.015982; SIMON MA, 1985, CELL, V42, P831, DOI 10.1016/0092-8674(85)90279-X; Smadja-Lamere N, 2008, J BIOL CHEM, V283, P34352, DOI 10.1074/jbc.M803364200; Somogyi K, 2004, MECH DEVELOP, V121, P57, DOI 10.1016/j.mod.2003.10.003; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Spradling AC, 1999, GENETICS, V153, P135; Stewart RA, 2003, ONCOGENE, V22, P6436, DOI 10.1038/sj.onc.1206820; Takahashi F, 1996, GENE DEV, V10, P1645, DOI 10.1101/gad.10.13.1645; Tateno M, 2000, SCIENCE, V287, P324, DOI 10.1126/science.287.5451.324; Thomas JH, 2004, DEVELOPMENT, V131, P863, DOI 10.1242/dev.00989; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Vidal M, 2007, CANCER RES, V67, P10278, DOI 10.1158/0008-5472.CAN-07-1376; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Warner SJ, 2010, CURR BIOL, V20, P677, DOI 10.1016/j.cub.2010.03.025; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Wear MA, 2004, TRENDS BIOCHEM SCI, V29, P418, DOI 10.1016/j.tibs.2004.06.003; Wear MA, 2004, J BIOL CHEM, V279, P14382, DOI 10.1074/jbc.M313412200; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; Yamamoto N, 2009, DEVELOPMENT, V136, P1977, DOI 10.1242/dev.030718; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	96	27	27	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 17	2014	33	16					2027	2039		10.1038/onc.2013.155	http://dx.doi.org/10.1038/onc.2013.155			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF3GH	23644660				2022-12-25	WOS:000334599100003
J	Matsumura, T; Imamichi, Y; Mizutani, T; Ju, YF; Yazawa, T; Kawabe, S; Kanno, M; Ayabe, T; Katsumata, N; Fukami, M; Inatani, M; Akagi, Y; Umezawa, A; Ogata, T; Miyamoto, K				Matsumura, Takehiro; Imamichi, Yoshitaka; Mizutani, Tetsuya; Ju, Yunfeng; Yazawa, Takashi; Kawabe, Shinya; Kanno, Masafumi; Ayabe, Tadayuki; Katsumata, Noriyuki; Fukami, Maki; Inatani, Masaru; Akagi, Yoshio; Umezawa, Akihiro; Ogata, Tsutomu; Miyamoto, Kaoru			Human glutathione S-transferase A (GSTA) family genes are regulated by steroidogenic factor 1 (SF-1) and are involved in steroidogenesis	FASEB JOURNAL			English	Article						transcriptional regulation; chromatin structure; gene cluster; isomerase activity	MESENCHYMAL STEM-CELLS; TRANSCRIPTION; RECEPTOR; DIFFERENTIATION; ESTABLISHMENT; ENHANCERS; PROMOTER; HORMONES; PATHWAY; ENZYMES	Steroidogenic factor 1 (SF-1) is a master regulator for steroidogenesis. In this study, we identified novel SF-1 target genes using a genome-wide promoter tiling array and a DNA microarray. SF-1 was found to regulate human glutathione S-transferase A (GSTA) family genes (hGSTA1-hGSTA4), a superfamily of detoxification enzymes clustered on chromosome 6p12. All hGSTA genes were up-regulated by transduction of SF-1 into human mesenchymal stem cells, while knockdown of endogenous SF-1 in H295R cells down-regulated all hGSTA genes. Chromatin immunoprecipitation assays, however, revealed that SF-1 bound directly to the promoters of hGSTA3 and weakly of hGSTA4. Chromosome conformation capture assays revealed that the coordinated expression of the genes was based on changes in higher-order chromatin structure triggered by SF-1, which enables the formation of long-range interactions, at least between hGSTA1 and hGSTA3 gene promoters. In steroidogenesis, dehydrogenation of the 3-hydroxy group and subsequent (5)-(4) isomerization are thought to be enzymatic properties of 3-hydroxysteroid dehydrogenase (3-HSD). Here, we demonstrated that, in steroidogenic cells, the hGSTA1 and hGSTA3 gene products catalyze (5)-(4) isomerization in a coordinated fashion with 3-HSD II to produce progesterone or (4)-androstenedione from their (5)-precursors. Thus, hGSTA1 and hGSTA3 gene products are new members of steroidogenesis working as Delta(5)-Delta(4) isomerases.	[Matsumura, Takehiro; Imamichi, Yoshitaka; Mizutani, Tetsuya; Ju, Yunfeng; Yazawa, Takashi; Kawabe, Shinya; Kanno, Masafumi; Miyamoto, Kaoru] Univ Fukui, Fac Med Sci, Dept Biochem, Fukui 9101193, Japan; [Matsumura, Takehiro; Inatani, Masaru; Akagi, Yoshio] Univ Fukui, Fac Med Sci, Dept Ophthalmol, Fukui 9101193, Japan; [Imamichi, Yoshitaka; Mizutani, Tetsuya; Yazawa, Takashi; Kawabe, Shinya; Miyamoto, Kaoru] Univ Fukui, Translat Res Ctr, Org Life Sci Adv Programs, Fukui 9101193, Japan; [Imamichi, Yoshitaka] Univ Fukui, Fukui 9101193, Japan; [Ayabe, Tadayuki; Katsumata, Noriyuki; Fukami, Maki] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan; [Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan; [Ogata, Tsutomu] Hamamatsu Univ Sch Med, Dept Pediat, Shizuoka, Japan	University of Fukui; University of Fukui; University of Fukui; University of Fukui; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Hamamatsu University School of Medicine	Mizutani, T (corresponding author), Univ Fukui, Fac Med Sci, Dept Biochem, Fukui 9101193, Japan.	mizutani@u-fukui.ac.jp	Fukami, Maki/ABE-4694-2020; Yazawa, Takashi/AEZ-6785-2022	Fukami, Maki/0000-0001-9971-4035; Yazawa, Takashi/0000-0003-4526-6585; Ogata, Tsutomu/0000-0001-7178-9991	Health and Labor Sciences Research grant; Japan Ministry of Education, Culture, Sports, Science, and Technology; Smoking Research Foundation; Kanzawa Medical Research Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23390249, 22227002, 25861481] Funding Source: KAKEN	Health and Labor Sciences Research grant(Ministry of Health, Labour and Welfare, Japan); Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are grateful to Dr. T. Yanase (Fukuoka University, Fukuoka, Japan) for providing KGN cells, Dr. H. Takemori (National Institute of Biomedical Innovation, Osaka, Japan) for providing H295R cells, Dr. J. Toguchida (Kyoto University, Kyoto, Japan) for providing hMSC-hTERT-E6/E7 cells, and Dr. K. Morohashi (University of Kyushu, Fukuoka, Japan) for providing anti-Ad4BP/SF-1 antibody. The authors also thank K. Matsuura, H. Fujii, Y. Yamazaki, and Y. Usami for technical assistance and Y. Inoue for administrative assistance. This work was supported by a Health and Labor Sciences Research grant; a grant from the Japan Ministry of Education, Culture, Sports, Science, and Technology; the Smoking Research Foundation; the Kanzawa Medical Research Foundation; and the Takeda Science Foundation.	Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Eskiw CH, 2011, J CELL SCI, V124, P3676, DOI 10.1242/jcs.087981; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hirai H, 2010, INT J DEV BIOL, V54, P1589, DOI 10.1387/ijdb.103194hh; Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200; Ju YF, 2012, ENDOCRINOLOGY, V153, P5522, DOI 10.1210/en.2012-1334; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Mizutani T, 2000, J BIOL CHEM, V275, P22512, DOI 10.1074/jbc.M001631200; Mizutani T, 2001, MOL ENDOCRINOL, V15, P1693, DOI 10.1210/me.15.10.1693; Mizutani T, 2010, J BIOL CHEM, V285, P28240, DOI 10.1074/jbc.M110.129510; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Morel F, 2002, PHARMACOGENETICS, V12, P277, DOI 10.1097/00008571-200206000-00003; Morohashi KI, 1996, FASEB J, V10, P1569, DOI 10.1096/fasebj.10.14.9002548; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Prasad M, 2012, J BIOL CHEM, V287, P9534, DOI 10.1074/jbc.M111.333278; RAINEY WE, 1993, J CLIN ENDOCR METAB, V77, P731, DOI 10.1210/jc.77.3.731; Rajapaksha M, 2011, BIOCHEMISTRY-US, V50, P11015, DOI 10.1021/bi2016102; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Yazawa T, 2006, ENDOCRINOLOGY, V147, P4104, DOI 10.1210/en.2006-0162; Yazawa T, 2010, MOL ENDOCRINOL, V24, P485, DOI 10.1210/me.2009-0352; Yazawa T, 2009, ENDOCRINOLOGY, V150, P3885, DOI 10.1210/en.2008-1310	28	22	22	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3198	3208		10.1096/fj.12-222745	http://dx.doi.org/10.1096/fj.12-222745			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23650189				2022-12-25	WOS:000329877600025
J	Lagakos, WS; Guan, XD; Ho, SY; Sawicki, LR; Corsico, B; Kodukula, S; Murota, K; Stark, RE; Storch, J				Lagakos, William S.; Guan, Xudong; Ho, Shiu-Ying; Rodriguez Sawicki, Luciana; Corsico, Betina; Kodukula, Sarala; Murota, Kaeko; Stark, Ruth E.; Storch, Judith			Liver Fatty Acid-binding Protein Binds Monoacylglycerol in Vitro and in Mouse Liver Cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL CACO-2 CELLS; ENDOCANNABINOID SYSTEM; DIFFERENT MECHANISMS; MEMBRANES; TRANSPORT; IDENTIFICATION; ABSORPTION; VESICLES; SITE	Liver fatty acid-binding protein (LFABP; FABP1) is expressed both in liver and intestinal mucosa. Mice null for LFABP were recently shown to have altered metabolism of not only fatty acids but also monoacylglycerol, the two major products of dietary triacylglycerol hydrolysis (Lagakos, W. S., Gajda, A. M., Agellon, L., Binas, B., Choi, V., Mandap, B., Russnak, T., Zhou, Y. X., and Storch, J. (2011) Am. J. Physiol. Gastrointest. Liver Physiol. 300, G803-G814). Nevertheless, the binding and transport of monoacylglycerol (MG) by LFABP are uncertain, with conflicting reports in the literature as to whether this single chain amphiphile is in fact bound by LFABP. In the present studies, gel filtration chromatography of liver cytosol from LFABP(-/-) mice shows the absence of the low molecular weight peak of radiolabeled monoolein present in the fractions that contain LFABP in cytosol from wild type mice, indicating that LFABP binds sn-2 MG in vivo. Furthermore, solution-state NMR spectroscopy demonstrates two molecules of sn-2 monoolein bound in the LFABP binding pocket in positions similar to those found for oleate binding. Equilibrium binding affinities are similar to 2-fold lower for MG compared with fatty acid. Finally, kinetic studies examining the transfer of a fluorescent MG analog show that the rate of transfer of MG is 7-fold faster from LFABP to phospholipid membranes than from membranes to membranes and occurs by an aqueous diffusion mechanism. These results provide strong support for monoacylglycerol as a physiological ligand for LFABP and further suggest that LFABP functions in the efficient intracellular transport of MG.	[Lagakos, William S.; Ho, Shiu-Ying; Kodukula, Sarala; Storch, Judith] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Storch, Judith] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Guan, Xudong; Stark, Ruth E.] CUNY, Grad Ctr, New York, NY 10031 USA; [Guan, Xudong; Stark, Ruth E.] Inst Macromol Assemblies, New York, NY 10031 USA; [Rodriguez Sawicki, Luciana; Corsico, Betina] Univ Nacl La Plata, Inst Invest Bioquim La Plata, Fac Ciencias Med, RA-1900 La Plata, Argentina; [Murota, Kaeko] Kinki Univ, Dept Life Sci, Fac Sci & Engn, Osaka 5778502, Japan	Rutgers State University New Brunswick; Rutgers State University New Brunswick; City University of New York (CUNY) System; National University of La Plata; Kindai University (Kinki University)	Storch, J (corresponding author), Rutgers State Univ, Dept Nutr Sci, 96 Lipman Dr, New Brunswick, NJ 08901 USA.	storch@aesop.rutgers.edu	Murota, Kaeko/GRO-6464-2022	Storch, Judith/0000-0001-5482-1777	National Institutes of Health [DK-38389]; National Center for Research Resources [2G12 RR03060]; National Institute on Minority Health and Health Disparities [8G12MD007603]; City University of New York [80209]; New Jersey Agricultural Experiment Station; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038389, R01DK038389] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); City University of New York; New Jersey Agricultural Experiment Station; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-38389 (to J. S.) and Grant 2G12 RR03060 from the National Center for Research Resources and Grant 8G12MD007603 from the National Institute on Minority Health and Health Disparities for additional infrastructural support at The City College of New York. This work was also supported by City University of New York Collaborative Grant 80209 (to R. E. S.) and funds from the New Jersey Agricultural Experiment Station (to J. S.).	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN RE, 1992, BIOCHIM BIOPHYS ACTA, V1113, P375, DOI 10.1016/0304-4157(92)90007-W; Chon SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043962; CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P711, DOI 10.1021/bi00402a033; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; DiPatrizio NV, 2011, P NATL ACAD SCI USA, V108, P12904, DOI 10.1073/pnas.1104675108; EPSTEIN LF, 1994, BIOCHEM BIOPH RES CO, V204, P163, DOI 10.1006/bbrc.1994.2440; Francis F., 2007, THESIS CITY U NEW YO; FUJITA M, 1995, EUR J BIOCHEM, V233, P406, DOI 10.1111/j.1432-1033.1995.406_2.x; GLASSTONE S, 1941, THEORY RATE PROCESSE; GLATZ JFC, 1983, ANAL BIOCHEM, V132, P89, DOI 10.1016/0003-2697(83)90429-3; Gomori G, 1942, J LAB CLIN MED, V27, P955; Guan X., 2011, THESIS CITY U NEW YO; Hansen KB, 2011, J CLIN ENDOCR METAB, V96, pE1409, DOI 10.1210/jc.2011-0647; He Y, 2007, BIOCHEMISTRY-US, V46, P12543, DOI 10.1021/bi701092r; He Y, 2011, BIOCHEMISTRY-US, V50, P1283, DOI 10.1021/bi101307h; Ho SP, 2001, AM J PHYSIOL-CELL PH, V281, pC1106, DOI 10.1152/ajpcell.2001.281.4.C1106; Hsu KT, 1996, J BIOL CHEM, V271, P13317, DOI 10.1074/jbc.271.23.13317; Huang C, 1974, Methods Enzymol, V32, P485; Izzo AA, 2009, BRIT J PHARMACOL, V158, P451, DOI 10.1111/j.1476-5381.2009.00183.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KEUPER HJK, 1985, CHEM PHYS LIPIDS, V38, P159, DOI 10.1016/0009-3084(85)90064-7; KIM HK, 1992, J BIOL CHEM, V267, P77; Lagakos WS, 2011, AM J PHYSIOL-GASTR L, V300, pG803, DOI 10.1152/ajpgi.00229.2010; Maccarrone M, 2010, ANNU REV NUTR, V30, P423, DOI 10.1146/annurev.nutr.012809.104701; Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200; MATAYOSHI ED, 1981, BIOPHYS J, V35, P215, DOI 10.1016/S0006-3495(81)84783-2; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Murota K, 2005, J NUTR, V135, P1626, DOI 10.1093/jn/135.7.1626; Narayanan VS, 1996, BIOCHEMISTRY-US, V35, P7466, DOI 10.1021/bi952979k; OCKNER RK, 1990, MOL CELL BIOCHEM, V98, P3; PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587; Phan CT, 2001, FRONT BIOSCI-LANDMRK, V6, pD299, DOI 10.2741/Phan; ROSEMAN MA, 1980, BIOCHEMISTRY-US, V19, P439, DOI 10.1021/bi00544a006; SCOTT TG, 1970, J AM CHEM SOC, V92, P687, DOI 10.1021/ja00706a043; STORCH J, 1993, MOL CELL BIOCHEM, V123, P45, DOI 10.1007/BF01076474; STORCH J, 1990, J BIOL CHEM, V265, P7827; STORCH J, 1986, BIOCHEMISTRY-US, V25, P1717, DOI 10.1021/bi00355a041; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storr MA, 2007, CURR OPIN PHARMACOL, V7, P575, DOI 10.1016/j.coph.2007.08.008; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; Thumser AEA, 2000, J LIPID RES, V41, P647; THUMSER AEA, 1994, BIOCHEM J, V301, P801, DOI 10.1042/bj3010801; Thumser AEA, 1996, BIOCHEM J, V320, P729, DOI 10.1042/bj3200729; TSO P, 2006, BIOCH PHYSL ASPECTS, P125; Wang H, 2002, BIOCHEMISTRY-US, V41, P5453, DOI 10.1021/bi011914g; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WOOTAN MG, 1993, BIOCHEMISTRY-US, V32, P8622, DOI 10.1021/bi00084a033	52	31	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19805	19815		10.1074/jbc.M113.473579	http://dx.doi.org/10.1074/jbc.M113.473579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23658011	Green Published, hybrid			2022-12-25	WOS:000321515800049
J	Honaker, MT; Acchione, M; Zhang, W; Mannervik, B; Atkins, WM				Honaker, Matthew T.; Acchione, Mauro; Zhang, Wei; Mannervik, Bengt; Atkins, William M.			Enzymatic Detoxication, Conformational Selection, and the Role of Molten Globule Active Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE TRANSFERASE A1-1; HIGH CATALYTIC EFFICIENCY; LIPID-PEROXIDATION; S-TRANSFERASE; SUBSTRATE-SELECTIVITY; CRYSTAL-STRUCTURES; INDUCED FIT; PROMISCUITY; MECHANISM; DYNAMICS	The role of conformational ensembles in enzymatic reactions remains unclear. Discussion concerning "induced fit" versus "conformational selection" has, however, ignored detoxication enzymes, which exhibit catalytic promiscuity. These enzymes dominate drug metabolism and determine drug-drug interactions. The detoxication enzyme glutathione transferase A1-1 (GSTA1-1), exploits a molten globule-like active site to achieve remarkable catalytic promiscuity wherein the substrate-free conformational ensemble is broad with barrierless transitions between states. A quantitative index of catalytic promiscuity is used to compare engineered variants of GSTA1-1 and the catalytic promiscuity correlates strongly with characteristics of the thermodynamic partition function, for the substrate-free enzymes. Access to chemically disparate transition states is encoded by the substrate-free conformational ensemble. Pre-steady state catalytic data confirm an extension of the conformational selection model, wherein different substrates select different starting conformations. The kinetic liability of the conformational breadth is minimized by a smooth landscape. We propose that "local" molten globule behavior optimizes detoxication enzymes.	[Honaker, Matthew T.; Acchione, Mauro; Atkins, William M.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Zhang, Wei; Mannervik, Bengt] Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden	University of Washington; University of Washington Seattle; Stockholm University	Atkins, WM (corresponding author), Box 357610, Seattle, WA 98177 USA.	winky@uw.edu			National Institutes of Health [GM862284]; Swedish Research Council; Swedish Cancer Society	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This work was supported, in whole or in part, by National Institutes of Health Grant GM862284 (to W. M. A.) and the Swedish Research Council and Swedish Cancer Society (to B. M.).	AINSLIE GR, 1972, J BIOL CHEM, V247, P7088; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Balogh LM, 2009, BIOCHEMISTRY-US, V48, P7698, DOI 10.1021/bi900895b; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Blikstad C, 2008, BBA-GEN SUBJECTS, V1780, P1458, DOI 10.1016/j.bbagen.2008.07.007; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Dong D, 2012, XENOBIOTICA, V42, P808, DOI 10.3109/00498254.2012.663515; Ekonomiuk D, 2009, PROTEIN SCI, V18, P1003, DOI 10.1002/pro.110; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Fersht A, 2002, STRUCTURE MECH PROTE, P139; Freire E, 1995, Methods Mol Biol, V40, P191; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; FRIEDEN C, 1970, J BIOL CHEM, V245, P5788; Grahn E, 2006, ACTA CRYSTALLOGR D, V62, P197, DOI 10.1107/S0907444905039296; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Honaker MT, 2011, J BIOL CHEM, V286, P42770, DOI 10.1074/jbc.M111.304386; Hou L, 2007, J BIOL CHEM, V282, P23264, DOI 10.1074/jbc.M700868200; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Ibarra C, 2001, BIOCHEMISTRY-US, V40, P10614, DOI 10.1021/bi010672h; Jackson CJ, 2009, P NATL ACAD SCI USA, V106, P21631, DOI 10.1073/pnas.0907548106; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Le Trong I, 2002, PROTEINS, V48, P618, DOI 10.1002/prot.10162; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Munoz V, 2004, P NATL ACAD SCI USA, V101, P17646, DOI 10.1073/pnas.0405829101; Naganathan AN, 2005, J AM CHEM SOC, V127, P17970, DOI 10.1021/ja055996y; Nath A, 2008, BIOCHEMISTRY-US, V47, P157, DOI 10.1021/bi701448p; Nilsson LO, 2000, P NATL ACAD SCI USA, V97, P9408, DOI 10.1073/pnas.150084897; Pervushin K, 2007, NAT STRUCT MOL BIOL, V14, P1202, DOI 10.1038/nsmb1325; Thummel KE, 1998, ANNU REV PHARMACOL, V38, P389, DOI 10.1146/annurev.pharmtox.38.1.389; Vamvaca K, 2004, P NATL ACAD SCI USA, V101, P12860, DOI 10.1073/pnas.0404109101; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; WANG RW, 1989, ARCH BIOCHEM BIOPHYS, V269, P536, DOI 10.1016/0003-9861(89)90137-9; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Zhan YP, 2004, BIOCHEMISTRY-US, V43, P7244, DOI 10.1021/bi0363329; Zhang W, 2012, BIOCHEM J, V445, P39, DOI 10.1042/BJ20120136	38	34	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18599	18611		10.1074/jbc.M112.445767	http://dx.doi.org/10.1074/jbc.M112.445767			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649628	Green Published, hybrid			2022-12-25	WOS:000320721900059
J	Otsu, W; Kurooka, T; Otsuka, Y; Sato, K; Inaba, M				Otsu, Wataru; Kurooka, Takao; Otsuka, Yayoi; Sato, Kota; Inaba, Mutsumi			A New Class of Endoplasmic Reticulum Export Signal Phi X Phi X Phi for Transmembrane Proteins and Its Selective Interaction with Sec24C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; ANION-EXCHANGER 1; ERYTHROCYTE-MEMBRANE BAND-3; ER EXPORT; COPII COAT; CONDUCTANCE REGULATOR; NEUTROPHIL ELASTASE; CYTOPLASMIC DOMAIN; PLASMA-MEMBRANE; BINDING-SITES	Protein export from the endoplasmic reticulum (ER) depends on the interaction between a signal motif on the cargo and a cargo recognition site on the coatomer protein complex II. A hydrophobic sequence in the N terminus of the bovine anion exchanger 1 (AE1) anion exchanger facilitated the ER export of human AE1 Delta 11, an ER-retained AE1 mutant, through interaction with a specific Sec24 isoform. The cell surface expression and N-glycan processing of various substitution mutants or chimeras of human and bovine AE1 proteins and their Delta 11 mutants in HEK293 cells were examined. The N-terminal sequence (V/L/F)X(I/L)X(M/L), (VSIPM30)-V-26 in bovine AE1, which is comparable with Phi X Phi X Phi, acted as the ER export signal for AE1 and AE1 Delta 11 (Phi is a hydrophobic amino acid, and X is any amino acid). The AE1-Ly49E chimeric protein possessing the Phi X Phi X Phi motif exhibited effective cell surface expression and N-glycan maturation via the coatomer protein complex II pathway, whereas a chimera lacking this motif was retained in the ER. A synthetic polypeptide containing the N terminus of bovine AE1 bound the Sec23A-Sec24C complex through a selective interaction with Sec24C. Co-transfection of Sec24C-AAA, in which the residues (LIL897)-L-895 (the binding site for another ER export signal motif IXM on Sec24C and Sec24D) were mutated to (895)AAA(897), specifically increased ER retention of the AE1-Ly49E chimera. These findings demonstrate that the Phi X Phi X Phi sequence functions as a novel signal motif for the ER export of cargo proteins through an exclusive interaction with Sec24C.	[Otsu, Wataru; Kurooka, Takao; Otsuka, Yayoi; Sato, Kota; Inaba, Mutsumi] Hokkaido Univ, Mol Med Lab, Grad Sch Vet Med, Dept Vet Clin Sci, Sapporo, Hokkaido 0600818, Japan	Hokkaido University	Inaba, M (corresponding author), Hokkaido Univ, Mol Med Lab, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan.	inazo@vetmed.hokudai.ac.jp		Otsu, Wataru/0000-0002-5930-1954	Japan Society for the Promotion of Science [19208027, 22658095, 23658257]; Research Fellowship for Young Scientist from Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Fellowship for Young Scientist from Japan Society for the Promotion of Science	This work was supported by Grants-in-Aid for Scientific Research 19208027, 22658095, and 23658257 (to M. I.) from the Japan Society for the Promotion of Science.; Supported by a Research Fellowship for Young Scientist from Japan Society for the Promotion of Science.	Adachi H, 2010, JPN J VET RES, V58, P101; Adachi H, 2009, JPN J VET RES, V57, P135; Alper SL, 2006, EXP PHYSIOL, V91, P153, DOI 10.1113/expphysiol.2005.031765; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Benson KF, 2003, NAT GENET, V35, P90, DOI 10.1038/ng1224; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Devonald MAJ, 2003, NAT GENET, V33, P125, DOI 10.1038/ng1082; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; GOMEZ S, 1993, J BIOL CHEM, V268, P19593; Horwitz M, 2004, TRENDS MOL MED, V10, P163, DOI 10.1016/j.molmed.2004.02.002; Inaba M, 1996, J CLIN INVEST, V97, P1804, DOI 10.1172/JCI118610; Ito D, 2006, J CELL SCI, V119, P3602, DOI 10.1242/jcs.03101; Khoriaty R, 2012, BLOOD, V120, P31, DOI 10.1182/blood-2012-01-292086; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Mancias JD, 2005, TRAFFIC, V6, P278, DOI 10.1111/j.1600-0854.2005.00279.x; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; MICHAELY P, 1995, J BIOL CHEM, V270, P22050, DOI 10.1074/jbc.270.37.22050; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759; Nufer O, 2002, J CELL SCI, V115, P619; Okkenhaug H, 2006, FASEB J, V20, P2390, DOI 10.1096/fj.05-5588fje; Quilty JA, 2002, BIOCHEM J, V368, P895, DOI 10.1042/BJ20020574; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Tanner MJA, 2002, CURR OPIN HEMATOL, V9, P133, DOI 10.1097/00062752-200203000-00009; Toye AM, 2004, J CELL SCI, V117, P1399, DOI 10.1242/jcs.00974; Toye AM, 2002, BLOOD, V99, P342, DOI 10.1182/blood.V99.1.342; Tzetis M, 2001, HUM GENET, V108, P216, DOI 10.1007/s004390100467; Van Beneden K, 2001, J IMMUNOL, V166, P4302, DOI 10.4049/jimmunol.166.7.4302; Van Dort HM, 1998, J BIOL CHEM, V273, P14819, DOI 10.1074/jbc.273.24.14819; Wang CC, 2012, J VET MED SCI, V74, P17, DOI 10.1292/jvms.11-0345; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Williamson RC, 2008, J CELL SCI, V121, P3422, DOI 10.1242/jcs.035584; Yenchitsomanus Pa-Thai, 2005, J Mol Genet Med, V1, P49; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zhang DC, 2000, BLOOD, V96, P2925; Zhou Z, 2005, BIOCHEMISTRY-US, V44, P15115, DOI 10.1021/bi050931t; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200	45	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18521	18532		10.1074/jbc.M112.443325	http://dx.doi.org/10.1074/jbc.M112.443325			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23658022	Green Published, hybrid			2022-12-25	WOS:000320721900053
J	Yoo, EJ; Cooke, NE; Liebhaber, SA				Yoo, Eung Jae; Cooke, Nancy E.; Liebhaber, Stephen A.			Identification of a Secondary Promoter within the Human B Cell Receptor Component Gene hCD79b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-HYPERSENSITIVE SITES; GROWTH-HORMONE GENE; LOCUS-CONTROL REGION; ANTIGEN RECEPTORS; CD79B GENE; CHROMATIN; TRANSCRIPTION; BETA; ALPHA; ACTIVATION	The human B cell-specific protein, CD79b (also known as Ig beta and B29) constitutes an essential signal transduction component of the B cell receptor. Although its function is central to the triggering of B cell terminal differentiation in response to antigen stimulation, the transcriptional determinants that control CD79b gene expression remain poorly defined. In the present study, we explored these determinants using a series of hCD79b transgenic mouse models. Remarkably, we observed that the previously described hCD79b promoter along with its associated enhancer elements and first exon could be deleted without appreciable loss of hCD79b transcriptional activity or tissue specificity. In this deletion setting, a secondary promoter located within exon 2 maintained full levels and specificity of hCD79b transcription. Of note, this secondary promoter was also active, albeit at lower levels, in the wild-type hCD79b locus. The activity of the secondary promoter was dependent on the action(s) of a conserved sequence element mapping to a chromatin DNase I hypersensitive site located within intron 1. mRNA generated from this secondary promoter is predicted to encode an Ig beta protein lacking a signal sequence and thus unable to serve normal B cell receptor function. Although the physiologic role of the hCD79b secondary promoter and its encoded protein remain unclear, the current data suggest that it has the capacity to play a role in normal as well as pathologic states in B cell proliferation and function.	[Liebhaber, Stephen A.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Liebhaber, SA (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, 415 Curie Blvd,CRB 560A, Philadelphia, PA 19104 USA.	liebhabe@upenn.edu			National Institutes of Health [DK019525, DK050306, CA016520]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD025147] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, P30DK050306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the University of Pennsylvania Transgenic and Chimeric Mouse Facility (supported by National Institutes of Health P30 Grants DK019525, DK050306, and CA016520) for generation of the transgenic mice.	Anish R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005103; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Bennani-Baiti IM, 1998, GENOMICS, V48, P258, DOI 10.1006/geno.1997.5171; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Cajiao I, 2004, EMBO J, V23, P3854, DOI 10.1038/sj.emboj.7600365; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Dobbs AK, 2007, J IMMUNOL, V179, P2055, DOI 10.4049/jimmunol.179.4.2055; Ferrari S, 2007, J EXP MED, V204, P2047, DOI 10.1084/jem.20070264; GOLD MR, 1991, P NATL ACAD SCI USA, V88, P3436, DOI 10.1073/pnas.88.8.3436; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gordon MS, 2000, P NATL ACAD SCI USA, V97, P5504, DOI 10.1073/pnas.090087097; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; He HSHS, 2012, GENOME RES, V22, P1015, DOI 10.1101/gr.133280.111; HIRZMANN J, 1993, NUCLEIC ACIDS RES, V21, P3597, DOI 10.1093/nar/21.15.3597; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; Huang XG, 2011, PATHOL INT, V61, P122, DOI 10.1111/j.1440-1827.2010.02634.x; JACOBS SM, 1994, CANCER GENET CYTOGEN, V75, P31, DOI 10.1016/0165-4608(94)90212-7; JACOBS SM, 1994, ONCOGENE, V9, P227; Ji XJ, 2003, MOL CELL BIOL, V23, P899, DOI 10.1128/MCB.23.3.899-907.2003; JONES BK, 1995, MOL CELL BIOL, V15, P7010; Kimura AP, 2007, MOL CELL BIOL, V27, P6555, DOI 10.1128/MCB.00273-07; Komatsu A, 2002, EUR J BIOCHEM, V269, P1227, DOI 10.1046/j.1432-1033.2002.02757.x; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Malone CS, 2002, J IMMUNOL, V168, P3369, DOI 10.4049/jimmunol.168.7.3369; OMORI SA, 1993, P NATL ACAD SCI USA, V90, P11723, DOI 10.1073/pnas.90.24.11723; PARANJAPE SM, 1994, ANNU REV BIOCHEM, V63, P265, DOI 10.1146/annurev.biochem.63.1.265; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; SHENKAR R, 1991, MOL CELL BIOL, V11, P1813, DOI 10.1128/MCB.11.4.1813; Shewchuk BM, 1999, J BIOL CHEM, V274, P35725, DOI 10.1074/jbc.274.50.35725; STALDER J, 1980, CELL, V20, P451, DOI 10.1016/0092-8674(80)90631-5; Thompson AA, 1997, BLOOD, V90, P1387, DOI 10.1182/blood.V90.4.1387.1387_1387_1394; Thompson AA, 1996, BLOOD, V87, P666, DOI 10.1182/blood.V87.2.666.bloodjournal872666; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Yoo EJ, 2006, MOL CELL BIOL, V26, P5569, DOI 10.1128/MCB.00405-06; Yoo EJ, 2012, MOL CELL BIOL, V32, P2020, DOI 10.1128/MCB.06650-11; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	45	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18353	18365		10.1074/jbc.M113.461988	http://dx.doi.org/10.1074/jbc.M113.461988			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649625	Green Published, hybrid			2022-12-25	WOS:000320721900039
J	Ghosh, B; Satyshur, KA; Czajkowski, C				Ghosh, Borna; Satyshur, Kenneth A.; Czajkowski, Cynthia			Propofol Binding to the Resting State of the Gloeobacter violaceus Ligand-gated Ion Channel (GLIC) Induces Structural Changes in the Inter- and Intrasubunit Transmembrane Domain (TMD) Cavities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; X-RAY-STRUCTURE; GABA(A) RECEPTOR; CYS-LOOP; BENZODIAZEPINE MODULATION; GENERAL-ANESTHETICS; AGONIST BINDING; A RECEPTOR; SITES; IDENTIFICATION	General anesthetics exert many of their CNS actions by binding to and modulating membrane-embedded pentameric ligand-gated ion channels (pLGICs). The structural mechanisms underlying how anesthetics modulate pLGIC function remain largely unknown. GLIC, a prokaryotic pLGIC homologue, is inhibited by general anesthetics, suggesting anesthetics stabilize a closed channel state, but in anesthetic- bound GLIC crystal structures the channel appears open. Here, using functional GLIC channels expressed in oocytes, we examined whether propofol induces structural rearrangements in the GLIC transmembrane domain (TMD). Residues in the GLIC TMD that frame intrasubunit and intersubunit water-accessible cavities were individually mutated to cysteine. We measured and compared the rates of modification of the introduced cysteines by sulfhydryl-reactive reagents in the absence and presence of propofol. Propofol slowed the rate of modification of L240C (intersubunit) and increased the rate of modification of T254C (intrasubunit), indicating that propofol binding induces structural rearrangements in these cavities that alter the local environment near these residues. Propofol acceleration of T254C modification suggests that in the resting state propofol does not bind in the TMD intrasubunit cavity as observed in the crystal structure of GLIC with bound propofol (Nury, H., Van Renterghem, C., Weng, Y., Tran, A., Baaden, M., Dufresne, V., Changeux, J. P., Sonner, J. M., Delarue, M., and Corringer, P. J. (2011) Nature 469, 428 - 431). In silico docking using a GLIC closed channel homology model suggests propofol binds to intersubunit sites in the TMD in the resting state. Propofol-induced motions in the intersubunit cavity were distinct from motions associated with channel activation, indicating propofol stabilizes a novel closed state.	[Ghosh, Borna; Czajkowski, Cynthia] Univ Wisconsin, Mol Biophys Program, Madison, WI 53711 USA; [Satyshur, Kenneth A.; Czajkowski, Cynthia] Univ Wisconsin, Dept Neurosci, Madison, WI 53711 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Czajkowski, C (corresponding author), Univ Wisconsin, Dept Neurosci, 601 Sci Dr, Madison, WI 53711 USA.	cmczajko@wisc.edu		Satyshur, Kenneth/0000-0001-9371-2493; Ghosh, Borna/0000-0003-1952-6523	National Institutes of Health [34727]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 34727 (NINDS; to C. C.).	Ahrens J, 2008, ANESTH ANALG, V107, P1875, DOI 10.1213/ane.0b013e3181875a31; Akk G., 2008, V182, P53, DOI 10.1007/978-3-540-74806-9_3; Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Boileau AJ, 1999, J NEUROSCI, V19, P10213; Borghese CM, 2003, J PHARMACOL EXP THER, V307, P42, DOI 10.1124/jpet.102.053710; Brannigan G, 2010, P NATL ACAD SCI USA, V107, P14122, DOI 10.1073/pnas.1008534107; Chen QA, 2010, BIOPHYS J, V99, P1801, DOI 10.1016/j.bpj.2010.07.023; Chen YH, 2006, J BIOL CHEM, V281, P18184, DOI 10.1074/jbc.M600349200; Chiara DC, 2013, BIOPHYS J, V104, p636A, DOI 10.1016/j.bpj.2012.11.3513; Collins T, 2010, MOL PHARMACOL, V78, P198, DOI 10.1124/mol.110.064295; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Hamouda AK, 2011, J BIOL CHEM, V286, P20466, DOI 10.1074/jbc.M111.219071; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jayakar SS, 2013, J BIOL CHEM, V288, P6178, DOI 10.1074/jbc.M112.435909; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Koltchine VV, 1999, MOL PHARMACOL, V56, P1087, DOI 10.1124/mol.56.5.1087; LeBard DN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002532; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Liu RY, 2012, ANESTH ANALG, V114, P947, DOI 10.1213/ANE.0b013e31824c4def; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Morlock EV, 2011, MOL PHARMACOL, V80, P14, DOI 10.1124/mol.110.069542; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Morris KDW, 2004, MOL PHARMACOL, V66, P56, DOI 10.1124/mol.66.1.56; Mowrey D, 2013, J AM CHEM SOC, V135, P2172, DOI 10.1021/ja307275v; Murail S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002710; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Sancar F, 2011, NEUROPHARMACOLOGY, V60, P520, DOI 10.1016/j.neuropharm.2010.11.009; Sauguet L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2682; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Trattnig SM, 2012, J BIOL CHEM, V287, P25241, DOI 10.1074/jbc.M112.360370; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Venkatachalan SP, 2007, PFLUG ARCH EUR J PHY, V454, P155, DOI 10.1007/s00424-006-0183-1; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Willenbring D, 2011, BIOPHYS J, V101, P1905, DOI 10.1016/j.bpj.2011.09.026; Williams DB, 2002, J NEUROSCI, V22, P7417; Ye Q, 1998, J BIOL CHEM, V273, P3314, DOI 10.1074/jbc.273.6.3314; Zeller A., 2008, V182, P31, DOI 10.1007/978-3-540-74806-9_2; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107; Zhu FQ, 2009, BIOPHYS J, V97, P2456, DOI 10.1016/j.bpj.2009.08.020	60	26	28	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17420	17431		10.1074/jbc.M113.464040	http://dx.doi.org/10.1074/jbc.M113.464040			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640880	Green Published, hybrid			2022-12-25	WOS:000320380600034
J	Gierman, LM; van El, B; van der Ham, F; Koudijs, A; Stoop, R; Verheijen, JH; Kloppenburg, M; van Osch, GJVM; Stojanovic-Susulic, V; Huizinga, TWJ; Zuurmond, AM				Gierman, Lobke M.; van El, Benno; van der Ham, Frits; Koudijs, Angela; Stoop, Reinout; Verheijen, Jan H.; Kloppenburg, Margreet; van Osch, Gerjo J. V. M.; Stojanovic-Susulic, Vedrana; Huizinga, Tom W. J.; Zuurmond, Anne-Marie			Profiling the Secretion of Soluble Mediators by End Stage Osteoarthritis Synovial Tissue Explants Reveals a Reduced Responsiveness to an Inflammatory Trigger	PLOS ONE			English	Article							GROWTH-FACTOR; CARTILAGE; DEGRADATION; EXPRESSION; INHIBITION; HYPOXIA; DISEASE	Objective: Evidence is accumulating that synovial tissue plays an active role in osteoarthritis (OA), however, exact understanding of its contribution is lacking. In order to further elucidate its role in the OA process, we aimed to identify the secretion pattern of soluble mediators by synovial tissue and to assess its ability to initiate cartilage degeneration. Methods: Synovial tissue explants (STEs) obtained from donors without history of OA (n = 8) or from end stage OA patients (n = 16) were cultured alone or together with bovine cartilage explants in the absence or presence of IL-1 alpha. The secretion of 48 soluble mediators was measured and the effect on glycosaminoglycan (GAG) release and matrix metalloproteinase (MMP) activity was determined. Results: Normal and OA STEs secreted comparable levels of almost all measured soluble mediators. However, in the presence of IL-1 alpha these mediators were less secreted by OA than by normal STEs of which 15 differed significantly (p<0.01). No effect of normal or OA STEs on GAG release from the cartilage explants was observed, and no differences in MMP activity between OA and normal STEs were detected. Conclusions: Unexpectedly, a comparable secretion profile of soluble mediators was found for OA and normal STEs while the reduced responsiveness of OA STEs to an inflammatory trigger indicates a different state of this tissue in OA patients. The effects could be the result of prolonged exposure to an inflammatory environment in OA development. Further understanding of the pro-inflammatory and inflammation resolving mechanisms during disease progression in synovial tissue may provide valuable targets for therapy in the future.	[Gierman, Lobke M.; van El, Benno; van der Ham, Frits; Koudijs, Angela; Stoop, Reinout; Verheijen, Jan H.; Zuurmond, Anne-Marie] TNO, Leiden, Netherlands; [Gierman, Lobke M.; Kloppenburg, Margreet; Huizinga, Tom W. J.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [van Osch, Gerjo J. V. M.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Orthopaed, Rotterdam, Netherlands; [van Osch, Gerjo J. V. M.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Otorhinolaryngol, Rotterdam, Netherlands; [Stojanovic-Susulic, Vedrana] Janssen, Pharmaceut R&D, Malvern, PA USA	Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA	Zuurmond, AM (corresponding author), TNO, Leiden, Netherlands.	Anne-Marie.Zuurmond@tno.nl		, Reinout/0000-0002-8773-8248	Top Institute Pharma [T1-213-1]	Top Institute Pharma	This work is financially supported by: Top Institute Pharma, Grant T1-213-1 Generation of models, mechanisms and markers for stratification of osteoarthritis patients. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Attur M, 2010, BEST PRACT RES CL RH, V24, P71, DOI 10.1016/j.berh.2009.08.011; Beekhuizen M, 2011, ARTHRITIS RHEUM-US, V63, P1918, DOI 10.1002/art.30364; Beekman B, 1999, ANN NY ACAD SCI, V878, P150, DOI 10.1111/j.1749-6632.1999.tb07681.x; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Bonnet CS, 2005, RHEUMATOLOGY, V44, P7, DOI 10.1093/rheumatology/keh344; Brandt KD, 2006, ANN RHEUM DIS, V65, P1261, DOI 10.1136/ard.2006.058347; Deiters B, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2357; FARAHAT MN, 1993, ANN RHEUM DIS, V52, P870, DOI 10.1136/ard.52.12.870; GOLDENBERG DL, 1982, J RHEUMATOL, V9, P204; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Hunter DJ, 2009, OSTEOARTHR CARTILAGE, V17, P1402, DOI 10.1016/j.joca.2009.04.014; Hunter DJ, 2006, BMJ-BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639; Jackson JR, 1997, J RHEUMATOL, V24, P1253; Jacques C, 2006, VITAM HORM, V74, P371, DOI 10.1016/S0083-6729(06)74016-X; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Musumeci G, 2011, KNEE SURG SPORT TR A, V19, P307, DOI 10.1007/s00167-010-1215-0; Ning L, 2011, INT ORTHOP, V35, P831, DOI 10.1007/s00264-010-1045-1; Piecha D, 2010, INFLAMM RES, V59, P379, DOI 10.1007/s00011-009-0112-9; Pretzel D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2618; Roemer FW, 2011, ANN RHEUM DIS, V70, P1804, DOI 10.1136/ard.2011.150243; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Smith MD, 1997, J RHEUMATOL, V24, P365; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153	24	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62634	10.1371/journal.pone.0062634	http://dx.doi.org/10.1371/journal.pone.0062634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658758	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100025
J	Zhang, W; Miao, JF; Wang, SS; Zhang, YS				Zhang, Wei; Miao, Jinfeng; Wang, Shanshan; Zhang, Yuanshu			The Protective Effects of Beta-Casomorphin-7 against Glucose -Induced Renal Oxidative Stress In Vivo and Vitro	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; LIPID-PEROXIDATION; SUPEROXIDE-DISMUTASE; BETA-CASOMORPHINS; KIDNEY-DISEASE; MALONDIALDEHYDE; MELLITUS; CASEIN; INJURY; RAT	Oxidative stress is implicated in the pathogenesis of diabetic nephropathy. The present study aimed to investigate the effect of beta-casomorphin-7 (BCM7) on the oxidative stress occurring in kidney tissue in streptozotocin (STZ)-induced diabetic rats and proximal tubular epithelial cells (NRK-52E) exposure to high glucose (HG) by using biochemical methods. There is a significant decrease in plasma insulin and a significant increase in plasma glucagon in the rats of diabetic group. Oral administration of BCM7 for 30 days to rats with STZ-induced diabetes resulted in a significant increase in serum level of insulin, and a decrease in the level of glucagon. Moreover, rats with STZ-induced diabetes had lower levels of superoxide dismutase (SOD), glutathione peroxidase (GPx) and total antioxidative capacity (T-AOC), higher levels of malondialdehyde (MDA) and hydrogen peroxide (H2O2) in the kidney than that in the control rats. The administration of BCM7 altered the changes of SOD, GPx, T-AOC, MDA and H2O2 in the kidney of diabetic rats. Furthermore, BCM7 alleviated high glucose-induced decreasement in SOD and GPx activity, increasement in MDA contents in the NRK-52E cells. BCM7 ameliorated the changes of angiotensin converting enzyme (ACE) and ACE2 levels in the kidney of diabetic rats and BCM7 lowered the levels of angiotensin (Ang)II in the kidney of diabetic rats and culture medium for cells. Moreover losartan (antagonist of angiotensin II type I receptor) lowered the high glucose-induced oxidative stress in the NRK-52E cells. Our results suggest that administration of BCM7 would alleviate high glucose-induced renal oxidative stress in vivo and in vitro, which may be associated with down regulation of the concentration of Ang II partly.	[Zhang, Wei; Miao, Jinfeng; Wang, Shanshan; Zhang, Yuanshu] Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Zhang, YS (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	zhangyuanshu@njau.edu.cn		Zhang, Wei/0000-0003-0798-667X	National Natural Science Foundation of China [30871838]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate Students' Innovative projects of Jiangsu Higher Education Institutions [CXZZ12-0296]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate Students' Innovative projects of Jiangsu Higher Education Institutions	This work was supported by a grant (30871838) from National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (http://www.jsnsf.gov.cn/index.aspx); and Graduate Students' Innovative projects of Jiangsu Higher Education Institutions (CXZZ12-0296) (http://www.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOVERIS A, 1984, METHOD ENZYMOL, V105, P429; BRANTL V, 1984, EUR J PHARMACOL, V106, P213, DOI 10.1016/0014-2999(84)90702-7; BRANTL V, 1979, H-S Z PHYSIOL CHEM, V360, P1211, DOI 10.1515/bchm2.1979.360.2.1211; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Calderon-Salinas JV, 2011, MOL CELL BIOCHEM, V357, P171, DOI 10.1007/s11010-011-0887-1; Chang SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/521076; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; DeRubertis FR, 2004, DIABETES, V53, P762, DOI 10.2337/diabetes.53.3.762; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Elliott RB, 1999, DIABETOLOGIA, V42, P292, DOI 10.1007/s001250051153; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Griendling KK, 2000, REGUL PEPTIDES, V91, P21, DOI 10.1016/S0167-0115(00)00136-1; Gui DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039824; JAIN SK, 1990, METABOLISM, V39, P971, DOI 10.1016/0026-0495(90)90310-9; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Jones CA, 2005, KIDNEY INT, V67, P1684, DOI 10.1111/j.1523-1755.2005.00265.x; Kedziora-Kornatowska K, 2008, IUBMB LIFE, V49, P303; Kim S, 2012, PLOS ONE; Lakshmanan AP, 2011, FREE RADICAL RES, V45, P575, DOI 10.3109/10715762.2011.560149; Liu CX, 2011, MOL MED, V17, P59, DOI 10.2119/molmed.2010.00111; Makni M, 2010, FOOD CHEM TOXICOL, V48, P2407, DOI 10.1016/j.fct.2010.05.079; MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x; MOHANDAS J, 1984, CANCER RES, V44, P5086; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nielsen F, 1997, CLIN CHEM, V43, P1209; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; Obrosova IG, 2003, FREE RADICAL BIO MED, V34, P186, DOI 10.1016/S0891-5849(02)01195-4; Onozato ML, 2002, KIDNEY INT, V61, P186, DOI 10.1046/j.1523-1755.2002.00123.x; Ott IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042623; Oudit GY, 2006, AM J PATHOL, V168, P1808, DOI 10.2353/ajpath.2006.051091; PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9; Song X D, 2009, WORLD J GASTROENTERO, V17, P1947; SOULISLIPAROTA T, 1991, DIABETES, V40, P1328, DOI 10.2337/diabetes.40.10.1328; Takayanagi R, 2011, J CLIN BIOCHEM NUTR, V48, P72, DOI 10.3164/jcbn.11-014FR; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; Yin H, 2010, PEPTIDES, V31, P1725, DOI 10.1016/j.peptides.2010.05.016; Zhang W, 2012, PEPTIDES, V36, P186, DOI 10.1016/j.peptides.2012.05.022; Zhou QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047360; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	41	32	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63472	10.1371/journal.pone.0063472	http://dx.doi.org/10.1371/journal.pone.0063472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658831	Green Submitted, Green Published, gold			2022-12-25	WOS:000321202100066
J	Ma, B; Shi, JG; Jia, LS; Yuan, W; Wu, JF; Fu, ZY; Wang, Y; Liu, N; Guan, ZM				Ma, Bin; Shi, Jiangang; Jia, Lianshun; Yuan, Wen; Wu, Jianfeng; Fu, Zhiyi; Wang, Yuan; Liu, Ning; Guan, Zhengmao			Over-Expression of PUMA Correlates with the Apoptosis of Spinal Cord Cells in Rat Neuropathic Intermittent Claudication Model	PLOS ONE			English	Article							CAUDA-EQUINA COMPRESSION; BCL-2 FAMILY-MEMBERS; NEURONAL APOPTOSIS; BAX ACTIVATION; STENOSIS; P53; STRESS; PAIN	Background: Neuropathic intermittent claudication (NIC) is a typical clinical symptom of lumbar spinal stenosis and the apoptosis of neurons caused by cauda equina compression (CEC) has been proposed as an important reason. Whereas, the factors and the mechanism involved in the process of apoptosis induced by CEC remain unclear. Methodology and Results: In our modified rat model of NIC, a trapezoid-shaped silicon rubber was inserted into the epidural space under the L5 and L6 vertebral plate. Obvious apoptosis was observed in spinal cord cells after compression by TUNEL assay. Simultaneously, qRT-PCR and immunohistochemistry showed that the expression levels of PUMA (p53 upregulated modulator of apoptosis) and p53 were upregulated significantly in spinal cord under compression, while the expression of p53 inhibitor MDM2 and SirT2 decreased in the same region. Furthermore, CEC also resulted in the upregulation of Bcl-2 pro-apoptotic genes expression and caspase-3 activation. With the protection of Methylprednisolone, the upregulation of PUMA and p53 expression as well as the decrease of MDM2 and SirT2 in spinal cord were partially rescued in western bolt analysis. Conclusions: These results suggest that over-expression of PUMA correlates with CEC caused apoptosis of spinal cord cells, which is characterized by the increase of p53, Bax and Bad expression. PUMA upregulation might be crucial to induce apoptosis of spinal cord cells through p53-dependent pathway in CEC.	[Ma, Bin] Tongji Univ, East Hosp, Sch Med, Dept Spine Surg,Bone & Joint Med Ctr, Shanghai 200092, Peoples R China; [Shi, Jiangang; Jia, Lianshun; Yuan, Wen; Wu, Jianfeng; Fu, Zhiyi; Wang, Yuan; Liu, Ning; Guan, Zhengmao] Second Mil Med Univ, Changzheng Hosp, Orthoped Inst PLA, Div Orthoped, Shanghai, Peoples R China	Tongji University; Naval Medical University	Shi, JG (corresponding author), Second Mil Med Univ, Changzheng Hosp, Orthoped Inst PLA, Div Orthoped, Shanghai, Peoples R China.	shijiangang616@163.com						BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Coggeshall RE, 1997, NEUROSCIENCE, V77, P1115, DOI 10.1016/S0306-4522(96)00528-3; Cregan SP, 2004, J NEUROSCI, V24, P10003, DOI 10.1523/JNEUROSCI.2114-04.2004; Cregan SP, 1999, J NEUROSCI, V19, P7860; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; EVANS JG, 1964, BRIT MED J, V17, P985; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Ghosh AP, 2009, J NEUROPATH EXP NEUR, V68, P747, DOI 10.1097/NEN.0b013e3181a9d524; Jin YH, 2008, BIOCHEM BIOPH RES CO, V368, P690, DOI 10.1016/j.bbrc.2008.01.114; Kobayashi S, 2007, SPINE, V32, P627, DOI 10.1097/01.brs.0000257559.84494.15; Maione S, 2002, NEUROREPORT, V13, P101, DOI 10.1097/00001756-200201210-00024; Mao GP, 1998, SPINE, V23, P1641, DOI 10.1097/00007632-199808010-00004; Morishita Y, 2009, J SPINAL DISORD TECH, V22, P130, DOI 10.1097/BSD.0b013e318167b054; Murakami M, 1997, J SPINAL DISORD, V10, P499; OLMARKER K, 1989, J ORTHOP RES, V7, P817, DOI 10.1002/jor.1100070607; PORTER RW, 1992, SPINE, V17, P9, DOI 10.1097/00007632-199201000-00002; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sekiguchi M, 2004, SPINE, V29, P1105, DOI 10.1097/00007632-200405150-00011; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; STERMAN AB, 1985, EXP NEUROL, V89, P408, DOI 10.1016/0014-4886(85)90100-1; Takenobu Y, 2001, J NEUROSCI METH, V104, P191, DOI 10.1016/S0165-0270(00)00342-3; Yamaguchi K, 1999, SPINE, V24, P845, DOI 10.1097/00007632-199905010-00003	23	12	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e56580	10.1371/journal.pone.0056580	http://dx.doi.org/10.1371/journal.pone.0056580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658678	gold, Green Published, Green Submitted			2022-12-25	WOS:000321200500001
J	Takahashi, T; Miyakawa, T; Zenno, S; Nishi, K; Tanokura, M; Ui-Tei, K				Takahashi, Tomoko; Miyakawa, Takuya; Zenno, Shuhei; Nishi, Kenji; Tanokura, Masaru; Ui-Tei, Kumiko			Distinguishable In Vitro Binding Mode of Monomeric TRBP and Dimeric PACT with siRNA	PLOS ONE			English	Article							RNA-INTERFERENCE; HUMAN RISC; PKR ACTIVATION; DICER; PROTEIN; COMPLEX; PHOSPHORYLATION; ARGONAUTE2; SELECTION; DOMAINS	RNA interference (RNAi) is an evolutionally conserved posttranscriptional gene-silencing mechanism whereby small interfering RNA (siRNA) triggers sequence-specific cleavage of its cognate mRNA. Dicer, Argonaute (Ago), and either TAR-RNA binding protein (TRBP) or a protein activator of PKR (PACT) are the primary components of the RNAi pathway, and they comprise the core of a complex termed the RNA-induced silencing complex (RISC)-loading complex (RLC). TRBP and PACT share similar structural features including three dsRNA binding domains (dsRBDs), and a complex containing Dicer and either TRBP or PACT is considered to sense thermodynamic asymmetry of siRNA ends for guide strand selection. Thus, both TRBP and PACT are thought to participate in the RNAi pathway in an indistinguishable manner, but the differences in siRNA binding mode and the functional involvement of TRBP and PACT are poorly understood. Here, we show in vitro binding patterns of human TRBP and PACT to siRNA using electrophoresis mobility shift analysis and gel filtration chromatography. Our results clearly showed that TRBP and PACT have distinct in vitro siRNA binding patterns from each other. The results suggest that monomeric TRBP binds to siRNA at the higher affinity compared to the affinity for own homodimerization. In contrast, the affinity between PACT and siRNA is lower than that of homodimerization or that between TRBP and siRNA. Thus, siRNA may be more readily incorporated into RLC, interacting with TRBP (instead of PACT) in vivo.	[Takahashi, Tomoko; Nishi, Kenji; Ui-Tei, Kumiko] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan; [Miyakawa, Takuya; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan; [Zenno, Shuhei] Maebashi Inst Technol, Fac Engn, Dept Biotechnol, Gunma, Japan	University of Tokyo; University of Tokyo	Ui-Tei, K (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan.	ktei@bi.s.u-tokyo.ac.jp		Tanokura, Masaru/0000-0001-5072-2480; Takahashi, Tomoko/0000-0002-5094-8882	Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research Project for Private University; Research Fellowship for Young Scientists of the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [21115004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research Project for Private University; Research Fellowship for Young Scientists of the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Core Research Project for Private University: matching fund subsidy to K.U.-T. and a Research Fellowship for Young Scientists of the Japan Society for the Promotion of Science to T.T. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; Daviet L, 2000, EUR J BIOCHEM, V267, P2419, DOI 10.1046/j.1432-1327.2000.01256.x; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Gredell JA, 2010, BIOCHEMISTRY-US, V49, P3148, DOI 10.1021/bi902189s; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Laraki G, 2008, RNA BIOL, V5, P92, DOI 10.4161/rna.5.2.6069; Lee HY, 2012, RNA, V18, P2012, DOI 10.1261/rna.035501.112; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Noland CL, 2011, MOL CELL, V43, P110, DOI 10.1016/j.molcel.2011.05.028; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Peters GA, 2001, MOL CELL BIOL, V21, P1908, DOI 10.1128/MCB.21.6.1908-1920.2001; Peters GA, 2009, BIOCHEMISTRY-US, V48, P7441, DOI 10.1021/bi900433y; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Singh M, 2011, BIOCHEMISTRY-US, V50, P4550, DOI 10.1021/bi200104h; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Yamashita S, 2011, PROTEIN SCI, V20, P118, DOI 10.1002/pro.543; Yang SW, 2010, STRUCTURE, V18, P594, DOI 10.1016/j.str.2010.02.006; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	33	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63434	10.1371/journal.pone.0063434	http://dx.doi.org/10.1371/journal.pone.0063434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658827	Green Submitted, Green Published, gold			2022-12-25	WOS:000321200500069
J	Vermeulen, CJ; Pedersen, KS; Beck, HC; Petersen, J; Gagalova, KK; Loeschcke, V				Vermeulen, Cornelis J.; Pedersen, Kamilla S.; Beck, Hans C.; Petersen, Jorgen; Gagalova, Kristina Kirilova; Loeschcke, Volker			Proteomic Characterization of Inbreeding-Related Cold Sensitivity in Drosophila melanogaster	PLOS ONE			English	Article							GENE-EXPRESSION; FLESH FLY; PCR DATA; DEPRESSION; SELECTION; STRESS; CONSEQUENCES; EVOLUTIONARY; TEMPERATURES; RESISTANCE	Inbreeding depression is a widespread phenomenon of central importance to agriculture, medicine, conservation biology and evolutionary biology. Although the population genetic principles of inbreeding depression are well understood, we know little about its functional genomic causes. To provide insight into the molecular interplay between intrinsic stress responses, inbreeding depression and temperature tolerance, we performed a proteomic characterization of a well-defined conditional inbreeding effect in a single line of Drosophila melanogaster, which suffers from extreme cold sensitivity and lethality. We identified 48 differentially expressed proteins in a conditional lethal line as compared to two control lines. These proteins were enriched for proteins involved in hexose metabolism, in particular pyruvate metabolism, and many were found to be associated with lipid particles. These processes can be linked to known cold tolerance mechanisms, such as the production of cryoprotectants, membrane remodeling and the build-up of energy reserves. We checked mRNA-expression of seven genes with large differential protein expression. Although protein expression poorly correlated with gene expression, we found a single gene (CG18067) that, after cold shock, was upregulated in the conditional lethal line both at the mRNA and protein level. Expression of CG18067 also increased in control flies after cold shock, and has previously been linked to cold exposure and chill coma recovery time. Many differentially expressed proteins in our study appear to be involved in cold tolerance in non-inbred individuals. This suggest the conditional inbreeding effect to be caused by misregulation of physiological cold tolerance mechanisms.	[Vermeulen, Cornelis J.; Loeschcke, Volker] Aarhus Univ, Dept Biol Sci, Aarhus, Denmark; [Vermeulen, Cornelis J.; Gagalova, Kristina Kirilova] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Pedersen, Kamilla S.] Aarhus Univ, Fac Agr Sci, Dept Genet & Biotechnol, Tjele, Denmark; [Beck, Hans C.] Odense Univ Hosp, Ctr Clin Prote, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Petersen, Jorgen] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Gagalova, Kristina Kirilova] Univ Bologna, Dept Pharm & BioTechnol, Bologna, Italy	Aarhus University; University of Groningen; Aarhus University; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Bologna	Vermeulen, CJ (corresponding author), Aarhus Univ, Dept Biol Sci, Aarhus, Denmark.	C.J.Vermeulen@rug.nl	Beck, Hans Christian/AAK-9147-2021; Loeschcke, Volker/J-2527-2013	Loeschcke, Volker/0000-0003-1450-0754; Beck, Hans Christian/0000-0002-7763-3637; Vermeulen, Corneel/0000-0002-3280-1414	Danish Research Council (FNU); Villum Kann Rasmussen Foundation	Danish Research Council (FNU)(Danish Natural Science Research CouncilDet Frie Forskningsrad (DFF)); Villum Kann Rasmussen Foundation(Villum Fonden)	Funding was provided by the Danish Research Council (FNU) and the Villum Kann Rasmussen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Ayroles JF, 2009, CONSERV BIOL, V23, P920, DOI 10.1111/j.1523-1739.2009.01186.x; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Biron DG, 2006, PROTEOMICS, V6, P1712, DOI 10.1002/pmic.200500423; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Chevalier F, 2004, PROTEOMICS, V4, P1372, DOI 10.1002/pmic.200300750; Colinet H, 2007, INSECT BIOCHEM MOLEC, V37, P1177, DOI 10.1016/j.ibmb.2007.07.004; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dierks A, 2012, POPUL ECOL, V54, P83, DOI 10.1007/s10144-011-0291-4; Doucet D, 2009, CELL MOL LIFE SCI, V66, P1404, DOI 10.1007/s00018-009-8320-6; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; Garcia C, 2012, GENETICS, V192, P161, DOI 10.1534/genetics.112.142687; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kristensen TN, 2005, GENETICS, V171, P157, DOI 10.1534/genetics.104.039610; Kristensen TN, 2008, P ROY SOC B-BIOL SCI, V275, P2055, DOI 10.1098/rspb.2008.0426; Kristensen TN, 2010, TRENDS ECOL EVOL, V25, P44, DOI 10.1016/j.tree.2009.06.014; Kristensen TN, 2006, GENETICS, V173, P1329, DOI 10.1534/genetics.105.054486; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Li A, 2008, INSECT MOL BIOL, V17, P565, DOI 10.1111/j.1365-2583.2008.00827.x; Mackay TFC, 2010, PHILOS T R SOC B, V365, P1229, DOI 10.1098/rstb.2009.0315; Mikkelsen K, 2010, CONSERV GENET, V11, P479, DOI 10.1007/s10592-009-0030-y; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Overgaard J, 2005, J INSECT PHYSIOL, V51, P1173, DOI 10.1016/j.jinsphys.2005.06.007; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Paige KN, 2010, BIOSCIENCE, V60, P267, DOI 10.1525/bio.2010.60.4.5; Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222; Pedersen KS, 2010, HEREDITY, V104, P125, DOI 10.1038/hdy.2009.132; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; R Development Core Team R, 2009, R LANG ENV STAT COMP; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reed DH, 2012, ANN NY ACAD SCI, V1256, P33, DOI 10.1111/j.1749-6632.2012.06548.x; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Rogers S, 2008, BIOINFORMATICS, V24, P2894, DOI 10.1093/bioinformatics/btn553; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sarup P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015644; Sawyer SA, 2007, P NATL ACAD SCI USA, V104, P6504, DOI 10.1073/pnas.0701572104; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sorensen JG, 2007, J EVOLUTION BIOL, V20, P1624, DOI 10.1111/j.1420-9101.2007.01326.x; Teets NM, 2012, PHYSIOL GENOMICS, V44, P764, DOI 10.1152/physiolgenomics.00042.2012; Telonis-Scott M, 2009, J INSECT PHYSIOL, V55, P549, DOI 10.1016/j.jinsphys.2009.01.010; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vermeulen CJ, 2008, J EVOLUTION BIOL, V21, P1236, DOI 10.1111/j.1420-9101.2008.01572.x; Vermeulen CJ, 2004, GENETICS, V167, P1241, DOI 10.1534/genetics.103.023721; Vermeulen CJ, 2004, HEREDITY, V92, P275, DOI 10.1038/sj.hdy.6800412; Zhang J, 2011, J EXP BIOL, V214, P4021, DOI 10.1242/jeb.059535	50	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62680	10.1371/journal.pone.0062680	http://dx.doi.org/10.1371/journal.pone.0062680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658762	Green Submitted, Green Published, gold			2022-12-25	WOS:000321200500032
J	Anders, CK; Adamo, B; Karginova, O; Deal, AM; Rawal, S; Darr, D; Schorzman, A; Santos, C; Bash, R; Kafri, T; Carey, L; Miller, CR; Perou, CM; Sharpless, N; Zamboni, WC				Anders, Carey K.; Adamo, Barbara; Karginova, Olga; Deal, Allison M.; Rawal, Sumit; Darr, David; Schorzman, Allison; Santos, Charlene; Bash, Ryan; Kafri, Tal; Carey, Lisa; Miller, C. Ryan; Perou, Charles M.; Sharpless, Norman; Zamboni, William C.			Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer	PLOS ONE			English	Article							NERVOUS-SYSTEM METASTASES; WHOLE-BRAIN RADIOTHERAPY; POLY(ADP-RIBOSE) POLYMERASE; ANTICANCER AGENTS; CKD-602 S-CKD602; TUMOR MODEL; IN-VITRO; INHIBITOR; CHEMOTHERAPY; XENOGRAFTS	Introduction: Breast cancer brain metastases (BCBM) are a challenging consequence of advanced BC. Nanoparticle agents, including liposomes, have shown enhanced delivery to solid tumors and brain. We compared pharmacokinetics (PK) and efficacy of PEGylated liposomal doxorubicin (PLD) with non-liposomal doxorubicin (NonL-doxo) in an intracranial model of BC. Methods: Athymic mice were inoculated intracerebrally with MDA-MB-231-BR-luciferase-expressing cells. Tumor-bearing mice were administered PLD or NonL-doxo at 6mg/kg IVx1 and were euthanized prior to and 0.083, 1, 3, 6, 24, 72 and 96 h post-treatment. Samples were processed to measure sum total doxorubicin via HPLC. PLD and NonL-doxo were administered IV weekly as single agents (6 mg/kg) or in combination (4.5 mg/kg) with the PARP inhibitor, ABT-888, PO 25 mg/kg/day. Efficacy was assessed by survival and bioluminescence. Results: Treatment with PLD resulted in approximately 1,500-fold higher plasma and 20-fold higher intracranial tumor sum total doxorubicin AUC compared with NonL-doxo. PLD was detected at 96 h; NonL-doxo was undetectable after 24 h in plasma and tumor. Median survival of PLD-treated animals was 32 days (d, [CI] 31-38), which was significantly longer than controls (26d [CI 25-28]; p = 0.0012) or NonL-doxo treatment (23.5d [CI 18-28], p = 0.0002). Combination treatment with PLD/ABT-888 yielded improved survival compared to NonL-doxo/ABT-888 (35d [CI 31-38] versus 29.5d [CI 25-34]; p = 0.006). Conclusions: PLD provides both PK and efficacy advantage over NonL-doxo in the treatment of an in vivo model of BCBM. The results provide preclinical rationale to translate findings into early phase trials of PLD, with or without ABT-888, for	[Anders, Carey K.; Carey, Lisa; Sharpless, Norman] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Anders, Carey K.; Adamo, Barbara; Karginova, Olga; Deal, Allison M.; Rawal, Sumit; Darr, David; Schorzman, Allison; Santos, Charlene; Bash, Ryan; Kafri, Tal; Carey, Lisa; Miller, C. Ryan; Perou, Charles M.; Sharpless, Norman; Zamboni, William C.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Adamo, Barbara] Univ Messina, Integrated Therapies Oncol Unit, Dept Human Pathol, Messina, Italy; [Deal, Allison M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biostat, Chapel Hill, NC 27599 USA; [Rawal, Sumit; Schorzman, Allison; Zamboni, William C.] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA; [Rawal, Sumit; Zamboni, William C.] Univ N Carolina, Translat Oncol & Nanoparticle Drug Dev Initiat TO, Chapel Hill, NC USA; [Kafri, Tal] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA; [Kafri, Tal] Univ N Carolina, Dept Microbiol & Immnunol, Chapel Hill, NC USA; [Miller, C. Ryan] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Sharpless, Norman] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Zamboni, William C.] Univ N Carolina, Carolina Ctr Canc Nanotechnol Excellence, Chapel Hill, NC USA; [Zamboni, William C.] Univ N Carolina, Inst Pharmacogen & Individualized Therapy, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Messina; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Anders, CK (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.	carey_anders@med.unc.edu	Miller, Ryan/B-9365-2008; , Animal Studies Core/ADK-4234-2022; Perou, Charles M/H-9934-2014; , Animal Studies Core/AAF-4432-2022; , Pathology Services Core/CEZ-2246-2022	Miller, Ryan/0000-0002-0096-8762; Perou, Charles M/0000-0001-9827-2247; Sharpless, Norman/0000-0001-7078-9455	National Cancer Institute [K23CA157728]; Breast Cancer Research Foundation-AACR Grant for Translational Breast Cancer Research [10-60-26-ANDE]; Damon Runyon Cancer Research Foundation [CI-64-12]; University Cancer Research Fund; Lineberger Cancer Center; University of North Carolina at Chapel Hill; Lineberger Comprehensive Cancer Center; University of North Carolina SPORE Career Development Award [5P50CA058223]; NATIONAL CANCER INSTITUTE [U54CA151652, K23CA157728, P50CA058223, P30CA016086] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation-AACR Grant for Translational Breast Cancer Research; Damon Runyon Cancer Research Foundation; University Cancer Research Fund; Lineberger Cancer Center; University of North Carolina at Chapel Hill; Lineberger Comprehensive Cancer Center; University of North Carolina SPORE Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding Sources: The project described was supported by Grant Number K23CA157728 (CKA) from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. Research supported by the 2010 Breast Cancer Research Foundation-AACR Grant for Translational Breast Cancer Research, Grant Number 10-60-26-ANDE (CKA). Carey Anders, MD is a Damon Runyon Clinical Investigator supported (in part) by the Damon Runyon Cancer Research Foundation (CI-64-12). Funding also came from The University Cancer Research Fund, Lineberger Cancer Center, University of North Carolina at Chapel Hill (BZ and Mouse Phase I Unit) and Lineberger Comprehensive Cancer Center, University of North Carolina SPORE Career Development Award, 5P50CA058223 (SPORE, CKA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2011, MOL CANCER THER, V10, P2320, DOI 10.1158/1535-7163.MCT-11-0356; AMSELEM S, 1990, J PHARM SCI, V79, P1045, DOI 10.1002/jps.2600791202; Baschnagel A, 2009, MOL CANCER THER, V8, P1589, DOI 10.1158/1535-7163.MCT-09-0038; Beijnen J, 1985, PDA J PHARM SCI TECH, V39, P220; Bendell JC, 2003, CANCER-AM CANCER SOC, V97, P2972, DOI 10.1002/cncr.11436; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coombes RC, 1996, J CLIN ONCOL, V14, P35, DOI 10.1200/JCO.1996.14.1.35; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Ewend Matthew G, 2008, J Natl Compr Canc Netw, V6, P505; FORNARI FA, 1994, MOL PHARMACOL, V45, P649; GABIZON A, 1989, JNCI-J NATL CANCER I, V81, P1484, DOI 10.1093/jnci/81.19.1484; GABIZON AA, 1993, PHARMACEUT RES, V10, P703, DOI 10.1023/A:1018907715905; Gerstner ER, 2007, J CLIN ONCOL, V25, P2306, DOI 10.1200/JCO.2006.10.0677; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; Koukourakis MI, 2000, BRIT J CANCER, V83, P1281, DOI 10.1054/bjoc.2000.1459; Lay JC, 2009, THORAX, V64, P313, DOI 10.1136/thx.2008.096222; Lin NU, 2008, CANCER-AM CANCER SOC, V113, P2638, DOI 10.1002/cncr.23930; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; Lockman PR, 2010, CLIN CANCER RES, V16, P5664, DOI 10.1158/1078-0432.CCR-10-1564; Madhankumar AB, 2009, MOL CANCER THER, V8, P648, DOI 10.1158/1535-7163.MCT-08-0853; Mason KA, 2008, INVEST NEW DRUG, V26, P1, DOI 10.1007/s10637-007-9072-5; Muldoon LL, 2007, J CLIN ONCOL, V25, P2295, DOI 10.1200/JCO.2006.09.9861; Niwinska A, 2010, ANN ONCOL, V21, P942, DOI 10.1093/annonc/mdp407; Niwinska A, 2010, CANCER-AM CANCER SOC, V116, P4238, DOI 10.1002/cncr.25391; O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093/annonc/mdh097; Park JW, 2004, SEMIN ONCOL, V31, P196, DOI 10.1053/j.seminoncol.2004.08.009; Roberts PJ, 2012, CLIN CANCER RES, V18, P5290, DOI 10.1158/1078-0432.CCR-12-0563; Sharma US, 1997, PHARM RES-DORDR, V14, P992, DOI 10.1023/A:1012136925030; Shroff K, 2012, LANGMUIR, V28, P4729, DOI 10.1021/la204466g; SIEGAL T, 1995, J NEUROSURG, V83, P1029, DOI 10.3171/jns.1995.83.6.1029; van Rooijen N, 2007, LIPOSOME TECHNOLOGY, V3, P303; Walsh MD, 2012, CLIN CANCER RES, V18, P2591, DOI 10.1158/1078-0432.CCR-11-1554; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Zamboni WC, 2005, CLIN CANCER RES, V11, P8230, DOI 10.1158/1078-0432.CCR-05-1895; Zamboni WC, 2010, DRUG DELIV SYST, V25, P58; Zamboni WC, 2008, ONCOLOGIST, V13, P248, DOI 10.1634/theoncologist.2007-0180; Zamboni WC, 2007, CLIN CANCER RES, V13, P7217, DOI 10.1158/1078-0432.CCR-07-1035; Zamboni WC, 2011, J LIPOSOME RES, V21, P158, DOI 10.3109/08982104.2010.496085; Zamboni WC, 2009, CLIN CANCER RES, V15, P1466, DOI 10.1158/1078-0432.CCR-08-1405	41	73	76	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61359	10.1371/journal.pone.0061359	http://dx.doi.org/10.1371/journal.pone.0061359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650496	gold, Green Published			2022-12-25	WOS:000319167000011
J	Boehlke, C; Kotsis, F; Buchholz, B; Powelske, C; Eckardt, KU; Walz, G; Nitschke, R; Kuehn, EW				Boehlke, Christopher; Kotsis, Fruzsina; Buchholz, Bjoern; Powelske, Christian; Eckardt, Kai-Uwe; Walz, Gerd; Nitschke, Roland; Kuehn, E. Wolfgang			Kif3a Guides Microtubular Dynamics, Migration and Lumen Formation of MDCK Cells	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT PROTEINS; ADENOMATOUS POLYPOSIS-COLI; KINESIN SUPERFAMILY; TIGHT JUNCTION; KIDNEY INJURY; PRIMARY CILIA; N-CADHERIN; POLARITY; GROWTH; ENDS	The microtubular motor Kinesin-2 and its subunit Kif3a are essential for the formation of primary cilia, an organelle implicated in a wide spectrum of developmental abnormalities. Outside cilia, Kinesin-2 mediated transport has been implicated in vesicle and N-cadherin transport, but it is unknown if and how extraciliary Kif3a affects basic cellular functions such as migration or the formation of multicellular structures. Here we show that tetracycline inducible depletion of Kif3a in MDCK cells slows epithelial cell migration. Microtubules at the leading edge of Kif3a depleted cells failed to grow perpendicularly into the leading edge and microtubular dynamics were dampened in Kif3a depleted cells. Loss of Kif3a retarded lateral membrane specification and completely prevented the formation of three-dimensional spheres in collagen. These data uncover that Kif3a regulates the microtubular cytoskeleton in the cell periphery and imply that extra-ciliary Kif3a has an unexpected function in morphogenesis.	[Boehlke, Christopher; Kotsis, Fruzsina; Powelske, Christian; Walz, Gerd; Kuehn, E. Wolfgang] Univ Hosp, Dept Nephrol, Freiburg, Germany; [Buchholz, Bjoern; Eckardt, Kai-Uwe] Univ Hosp, Dept Nephrol, Erlangen, Germany; [Walz, Gerd; Nitschke, Roland; Kuehn, E. Wolfgang] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79106 Freiburg, Germany; [Nitschke, Roland] Univ Freiburg, Life Imaging Ctr, Ctr Biosyst Anal, D-79106 Freiburg, Germany	University of Freiburg; University of Erlangen Nuremberg; University of Freiburg; University of Freiburg	Kuehn, EW (corresponding author), Univ Hosp, Dept Nephrol, Freiburg, Germany.	wolfgang.kuehn@uniklinik-freiburg.de	Boehlke, Christopher/AAZ-6627-2021; Nitschke, Roland/F-9525-2010	Boehlke, Christopher/0000-0002-6985-0201; Nitschke, Roland/0000-0002-9397-8475; Buchholz, Bjoern/0000-0003-3730-5425	DFG [KU 1504, SFB 592 Z2, KFO 201]; BIOSS cluster of excellence 294; European Community [241955]; Interdisciplinary Center of Clinical Research at the University of Erlangen-Nuremberg [J3]	DFG(German Research Foundation (DFG)); BIOSS cluster of excellence 294; European Community(European Commission); Interdisciplinary Center of Clinical Research at the University of Erlangen-Nuremberg	This work was supported by DFG grants KU 1504 (EWK), SFB 592 Z2 (RN) and BIOSS cluster of excellence 294 (RN, EWK, GW). GW is supported by the DFG KFO 201, and by the European Community's Seventh Framework Program (grant agreement number 241955, SYSCILIA). BB is supported by a junior career development grant (J3) of the Interdisciplinary Center of Clinical Research at the University of Erlangen-Nuremberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettencourt-Dias M, 2008, TRENDS CELL BIOL, V18, P8, DOI 10.1016/j.tcb.2007.11.002; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Boehlke C, 2010, J CELL SCI, V123, P1460, DOI 10.1242/jcs.058883; Bowen JR, 2011, J CELL BIOL, V194, P187, DOI 10.1083/jcb.201102076; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Buchholz B, 2011, J MOL MED-JMM, V89, P251, DOI 10.1007/s00109-010-0715-1; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gierke S, 2012, CURR BIOL, V22, P753, DOI 10.1016/j.cub.2012.02.069; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Jaulin F, 2010, J CELL BIOL, V190, P443, DOI 10.1083/jcb.201006044; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kotsis F, 2007, PFLUG ARCH EUR J PHY, V453, P819, DOI 10.1007/s00424-006-0168-0; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Kroboth K, 2007, MOL BIOL CELL, V18, P910, DOI 10.1091/mbc.E06-03-0179; Lolkema MP, 2007, FEBS LETT, V581, P4571, DOI 10.1016/j.febslet.2007.08.050; Manneville JB, 2006, BIOL CELL, V98, P557, DOI 10.1042/BC20060017; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; Mattie FJ, 2010, CURR BIOL, V20, P2169, DOI 10.1016/j.cub.2010.11.050; Mimori-Kiyosue Y, 2011, CYTOSKELETON, V68, P603, DOI 10.1002/cm.20540; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Song B, 2007, DEV BIOL, V305, P202, DOI 10.1016/j.ydbio.2007.02.003; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Thoma CR, 2010, J CELL BIOL, V190, P991, DOI 10.1083/jcb.201006059; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAP AS, 1995, EXP CELL RES, V218, P540, DOI 10.1006/excr.1995.1189; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9	45	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62165	10.1371/journal.pone.0062165	http://dx.doi.org/10.1371/journal.pone.0062165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658710	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000032
J	Ekins, S; Olechno, J; Williams, AJ				Ekins, Sean; Olechno, Joe; Williams, Antony J.			Dispensing Processes Impact Apparent Biological Activity as Determined by Computational and Statistical Analyses	PLOS ONE			English	Article							CHEMISTRY DATABASES; INHIBITORS; IDENTIFICATION; OPTIMIZATION; DISCOVERY; QUALITY	Dispensing and dilution processes may profoundly influence estimates of biological activity of compounds. Published data show Ephrin type-B receptor 4 IC50 values obtained via tip-based serial dilution and dispensing versus acoustic dispensing with direct dilution differ by orders of magnitude with no correlation or ranking of datasets. We generated computational 3D pharmacophores based on data derived by both acoustic and tip-based transfer. The computed pharmacophores differ significantly depending upon dispensing and dilution methods. The acoustic dispensing-derived pharmacophore correctly identified active compounds in a subsequent test set where the tip-based method failed. Data from acoustic dispensing generates a pharmacophore containing two hydrophobic features, one hydrogen bond donor and one hydrogen bond acceptor. This is consistent with X-ray crystallography studies of ligand-protein interactions and automatically generated pharmacophores derived from this structural data. In contrast, the tip-based data suggest a pharmacophore with two hydrogen bond acceptors, one hydrogen bond donor and no hydrophobic features. This pharmacophore is inconsistent with the X-ray crystallographic studies and automatically generated pharmacophores. In short, traditional dispensing processes are another important source of error in high-throughput screening that impacts computational and statistical analyses. These findings have far-reaching implications in biological research.	[Ekins, Sean] Collaborat Chem, Fuquay Varina, NC USA; [Olechno, Joe] Labcyte Inc, Sunnyvale, CA USA; [Williams, Antony J.] Royal Soc Chem, Wake Forest, NC USA		Ekins, S (corresponding author), Collaborat Chem, Fuquay Varina, NC USA.	ekinssean@yahoo.com	Williams, Antony John/C-3089-2009	Williams, Antony John/0000-0002-2668-4821				Bardelle C, 2008, BIOORG MED CHEM LETT, V18, P5717, DOI 10.1016/j.bmcl.2008.09.087; Bardelle C, 2008, BIOORG MED CHEM LETT, V18, P2776, DOI 10.1016/j.bmcl.2008.04.015; Bardelle C, 2010, BIOORG MED CHEM LETT, V20, P6242, DOI 10.1016/j.bmcl.2010.08.100; Barlaam BC, 2008, N PHENYL N MORPHOLIN; Barlaam BC, 2010, PYRIMIDINE DERIVATIV; Barlaam BC, 2009, 2 4 DIAMINO PYRIMIDI; Barlaam B, 2011, BIOORG MED CHEM LETT, V21, P2207, DOI 10.1016/j.bmcl.2011.03.009; Belaiche C, 2009, CLIN CHEM, V55, P1883, DOI 10.1373/clinchem.2009.130054; Comley J., 2007, DRUG DISCOVERY, P36; Ekins S, 2007, BRIT J PHARMACOL, V152, P9, DOI 10.1038/sj.bjp.0707305; Ekins S, 2002, J PHARMACOL EXP THER, V301, P427, DOI 10.1124/jpet.301.2.427; Ekins S, 2010, LAB CHIP, V10, P13, DOI 10.1039/b917760b; Gilchrist MA, 2008, J BIOMOL SCREEN, V13, P486, DOI 10.1177/1087057108319212; Grant RJ, 2009, J BIOMOL SCREEN, V14, P452, DOI 10.1177/1087057109336588; Harris D, 2010, J BIOMOL SCREEN, V15, P86, DOI 10.1177/1087057109351027; Hubalek F, 2003, ACTA CRYSTALLOGR D, V59, P1874, DOI 10.1107/S0907444903016883; Li J, 2007, J CHEM INF MODEL, V47, P1923, DOI 10.1021/ci700136x; Matson SL, 2009, J BIOMOL SCREEN, V14, P476, DOI 10.1177/1087057109336593; McDonald GR, 2008, SCIENCE, V322, P917, DOI 10.1126/science.1162395; Meslamani J., 2010, J CHEM INF MODEL; PAPKE RL, 1994, J PHARMACOL EXP THER, V268, P718; REUHL TOK, 1990, BRAIN RES BULL, V25, P433, DOI 10.1016/0361-9230(90)90234-Q; Spicer T, 2005, DRUG DISCOVERY TECHN, V384; Turmel M, 2010, JALA-J LAB AUTOM, V15, P297, DOI 10.1016/j.jala.2009.04.002; Watson J, 2009, J BIOMOL SCREEN, V14, P566, DOI 10.1177/1087057109336594; Williams AJ, 2012, DRUG DISCOV TODAY, V17, P685, DOI 10.1016/j.drudis.2012.02.013; Williams AJ, 2011, DRUG DISCOV TODAY, V16, P747, DOI 10.1016/j.drudis.2011.07.007; Wingfield J, 2012, IMPACT ACOUSTIC DISP; Wingfield J., 2008, AM DRUG DISCOV, V3, P24	29	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62325	10.1371/journal.pone.0062325	http://dx.doi.org/10.1371/journal.pone.0062325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658723	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000040
J	Pathak, AP; McNutt, S; Shah, T; Wildes, F; Raman, V; Bhujwalla, ZM				Pathak, Arvind P.; McNutt, Stephen; Shah, Tariq; Wildes, Flonne; Raman, Venu; Bhujwalla, Zaver M.			In Vivo "MRI Phenotyping'' Reveals Changes in Extracellular Matrix Transport and Vascularization That Mediate VEGF-Driven Increase in Breast Cancer Metastasis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CARCINOMA-CELLS; TUMOR MICROENVIRONMENT; PLASMINOGEN-ACTIVATOR; LYMPHATIC METASTASIS; INDUCED ANGIOGENESIS; INTERSTITIAL FLOW; LYMPHANGIOGENESIS; PERMEABILITY; FLUID	Purpose: To gain new insights into the relationship between angiogenic factors in breast cancer and their effect on extracellular matrix (ECM) remodeling and metastasis, we characterized and validated the "metastatic signature'' of human breast cancer cell lines engineered to overexpress VEGF in terms of in vivo MRI-derived angiogenesis and ECM transport parameters. Methodology: MRI was used to evaluate the effects of overexpressing VEGF-A (VEGF(165)) on tumor angiogenesis and ECM remodeling in vivo, for two differentially metastatic human breast cancer cell lines: MCF-7 and MDA-MB-231. Principal Findings: Overexpression of VEGF elevated vascular volume in both MCF-7-VEGF and MDA-MB-231-VEGF tumors relative to their wild-type counterparts, but vascular permeability was elevated only in MCF-7-VEGF tumors. A significant increase in the volume of extravascular fluid drained as well as the number of ECM drainage voxels was detected in MCF-7-VEGF tumors relative to MCF-7 tumors, but not in MDA-MB-231-VEGF versus MDA-MB-231 tumors. The angiogenic effects of VEGF overexpression in both MCF-7-VEGF and MDA-MB-231-VEGF tumors were validated histologically. MCF-7-VEGF tumors exhibited enhanced invasion and a greater fraction of cancer positive lungs and lymph nodes relative to MCF-7 tumors. Conclusions and Significance: In vivo MRI and histological data demonstrate that VEGF overexpression results in the progression of noninvasive MCF-7 and invasive MDA-MB-321 tumors to a more angiogenic phenotype. However, VEGF overexpression significantly altered ECM integrity only in MCF-7 tumors, causing them to progress to an invasive and metastatic phenotype. This study for the first time demonstrates the concurrent effects of VEGF overexpression and ECM remodeling on metastasis in vivo. Collectively, these findings demonstrate that in vivo MRI can non-invasively monitor changes in the tumor microenvironment that can potentially predict a cancer's ability to metastasize.	[Pathak, Arvind P.; McNutt, Stephen; Shah, Tariq; Wildes, Flonne; Raman, Venu; Bhujwalla, Zaver M.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, JHU ICMIC Program,Div Canc Imaging Res, Baltimore, MD 21218 USA	Johns Hopkins University	Pathak, AP (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, JHU ICMIC Program,Div Canc Imaging Res, Baltimore, MD 21218 USA.	pathak@mri.jhu.edu; zaver@mri.jhu.edu			NIH [R01CA90471, R01CA136576, R01CA138515, R01CA73850, R01CA82337, R01CA138264, P50CA103175]; Susan G. Komen for the Cure Career Catalyst Award [KG90640]; NATIONAL CANCER INSTITUTE [R01CA138264, R01CA073850, R01CA090471, P50CA103175, R01CA136576, R01CA082337, R01CA138515] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure Career Catalyst Award(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH R01CA90471, R01CA136576, R01CA138515, R01CA73850, R01CA82337, R01CA138264, P50CA103175 and a Susan G. Komen for the Cure Career Catalyst Award KG90640. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerstaff E, 2007, NEOPLASIA, V9, P222, DOI 10.1593/neo.06673; AUKLAND K, 1981, PHYSIOL REV, V61, P556, DOI 10.1152/physrev.1981.61.3.556; Bachelder RE, 2003, CANCER RES, V63, P5230; Bachelder RE, 2002, CANCER RES, V62, P7203; Balduyck M, 2000, CLIN EXP METASTAS, V18, P171, DOI 10.1023/A:1006762425323; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bhujwalla ZM, 2001, NEOPLASIA, V3, P143, DOI 10.1038/sj.neo.7900129; Boudreau N, 2003, BREAST CANCER RES, V5, P140, DOI 10.1186/bcr589; Brown LF, 1999, CLIN CANCER RES, V5, P1041; BUTLER TP, 1975, CANCER RES, V35, P3084; Cao MS, 2009, IEEE T MED IMAGING, V28, P861, DOI 10.1109/TMI.2008.2012035; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dafni H, 2002, NMR BIOMED, V15, P120, DOI 10.1002/nbm.724; Dafni H, 2002, CANCER RES, V62, P6731; Donahue KM, 1997, JMRI-J MAGN RESON IM, V7, P102, DOI 10.1002/jmri.1880070114; Eccles S, 2007, CLIN EXP METASTAS, V24, P619, DOI 10.1007/s10585-007-9123-5; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gasparini G, 2000, Oncologist, V5 Suppl 1, P37; Haessler U, 2012, INTEGR BIOL-UK, V4, P401, DOI 10.1039/c1ib00128k; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Ji RC, 2006, CANCER METAST REV, V25, P677, DOI 10.1007/s10555-006-9026-y; KUREBAYASHI J, 1993, CANCER RES, V53, P2178; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Manders P, 2002, BRIT J CANCER, V87, P772, DOI 10.1038/sj.bjc.6600555; Mercurio AM, 2005, J MAMMARY GLAND BIOL, V10, P283, DOI 10.1007/s10911-006-9001-9; Miralem T, 2001, ONCOGENE, V20, P5511, DOI 10.1038/sj.onc.1204753; Mohammed RAA, 2007, BRIT J CANCER, V96, P1092, DOI 10.1038/sj.bjc.6603678; Monsky WL, 1999, CANCER RES, V59, P4129; Monsky WL, 2002, CLIN CANCER RES, V8, P1008; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Ogan M D, 1988, Invest Radiol, V23, P961, DOI 10.1097/00004424-198812000-00022; Pathak AP, 2005, CANCER RES, V65, P1425, DOI 10.1158/0008-5472.CAN-04-3682; Pathak AP, 2006, CANCER RES, V66, P5151, DOI 10.1158/0008-5472.CAN-05-1788; PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P902, DOI 10.1016/0006-291X(91)91276-I; Price DJ, 2001, CELL GROWTH DIFFER, V12, P129; Ratel D, 2007, THROMB RES, V121, P203, DOI 10.1016/j.thromres.2007.03.024; Robinson BD, 2009, CLIN CANCER RES, V15, P2433, DOI 10.1158/1078-0432.CCR-08-2179; Russ JC, 1999, CLASSICAL STEREOLOGI, P39; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SHAFIE SM, 1980, CANCER LETT, V11, P81, DOI 10.1016/0304-3835(80)90097-X; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Swartz MA, 2012, NAT REV CANCER, V12, P210, DOI 10.1038/nrc3186; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Van den Eynden GG, 2007, J PATHOL, V213, P56, DOI 10.1002/path.2211; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wong SY, 2007, J CELL BIOCHEM, V101, P840, DOI 10.1002/jcb.21146; ZHANG HT, 1995, J NATL CANCER I, V87, P213, DOI 10.1093/jnci/87.3.213	52	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63146	10.1371/journal.pone.0063146	http://dx.doi.org/10.1371/journal.pone.0063146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650550	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000095
J	Qiu, YW; Jiang, GH; Su, HH; Lv, XF; Zhang, XL; Tian, JZ; Zhuo, FZ				Qiu, Yingwei; Jiang, Guihua; Su, Huanhuan; Lv, Xiaofei; Zhang, Xuelin; Tian, Junzhang; Zhuo, Fuzhen			Progressive White Matter Microstructure Damage in Male Chronic Heroin Dependent Individuals: A DTI and TBSS Study	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; VOXELWISE ANALYSIS; DECISION-MAKING; DRUG-ABUSERS; BRAIN-AREAS; NETWORK; COCAINE	Background: To investigate the WM microstructure deficits in heroin dependent individuals (HDIs) with different length of heroin dependence, and to investigate whether these WM deficits can be related to the duration of heroin use and to decision-making deficits in HDIs. Methodology/Principal Findings: Thirty-six HDIs [including eighteen sHDIs (duration of heroin dependent is less than 10 years) and eighteen lHDIs (duration of dependent is between 10,20 years)] and sixteen healthy controls participated in this study. Whole brain voxel-wise analysis of fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (Da) and radial diffusivity (Dr) were performed by tract-based spatial statistics (TBSS) to localize abnormal WM regions among groups. TBSS demonstrated that sHDIs had significantly lower FA than controls in right orbito-frontal WM, bilateral temporal WM and right parietal WM. The lHDIs had significantly lower FA throughout the brain compared with the controls and sHDIs. The lHDIs had significantly lower Da than controls in bilateral inferior frontaloccipital fasciculus, bilateral splenium of corpus callosum, left inferior longitudinal fasciculus, and had significantly higher Dr than controls in bilateral uncinatus fasciculus, bilateral inferior frontaloccipital fasciculus and bilateral cortical spinal fasciculus. Volume-of-interest (VOI) analyses detect the changes of diffusivity indices in the regions with FA abnormalities revealed by control vs sHDIs. In most VOIs, FA reductions were caused by the increase in Dr as well as the decrease in Da. Correlation analysis was used to assess the relationship between FA and behavioral measures in HDIs and controls available. Significantly positively correlations were found between the FA values in the right orbital-frontal WM, right parietal WM and IGT performance. Conclusions: The extent and severity of WM integrity deficits in HDIs was associated with the length of heroin dependent. Furthermore, abnormal WM microstructure may correlate with decision-making impairments in HDIs.	[Qiu, Yingwei; Jiang, Guihua; Su, Huanhuan; Tian, Junzhang] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Lv, Xiaofei] Sun Yat Sen Univ, Ctr Canc, Dept Med Imaging, Guangzhou 510275, Guangdong, Peoples R China; [Lv, Xiaofei] Sun Yat Sen Univ, Ctr Canc, Dept Intervent Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xuelin] Sun Yat Sen Univ, DongGuan KangHua Hosp, Dept Radiol, Donggua, Peoples R China; [Zhuo, Fuzhen] Guangdong 2 Prov Peoples Hosp, Addict Med Div, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Qiu, YW (corresponding author), Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.	qiuyw1201@gmail.com; tianjz2010@163.com		Tian, Junzhang/0000-0002-6212-1882; Qiu, Yingwei/0000-0003-1298-8506	Natural Scientific Foundation of China [81201084]; Planned Science and Technology Project of Guangdong Province, China [2011B031800044, 2010B031600116]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Planned Science and Technology Project of Guangdong Province, China	This work was supported by the grants from the Natural Scientific Foundation of China [grant number 81201084 for Yingwei Qiu], and the Planned Science and Technology Project of Guangdong Province, China [grant numbers 2011B031800044 and 2010B031600116 for Guihua Jiang]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SN, 1999, FORENSIC SCI INT, V102, P51, DOI 10.1016/S0379-0738(99)00040-7; Barros-Loscertales A, 2011, PSYCHIAT RES-NEUROIM, V194, P111, DOI 10.1016/j.pscychresns.2011.05.001; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 1998, J NEUROSCI, V18, P428; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bora E, 2012, ADDICT BIOL, V17, P141, DOI 10.1111/j.1369-1600.2010.00266.x; Buttner A, 2006, ADDICTION, V101, P1339, DOI 10.1111/j.1360-0443.2006.01505.x; Daglish MRC, 2003, NEUROIMAGE, V20, P1964, DOI 10.1016/j.neuroimage.2003.07.025; Fingelkurts AA, 2006, PSYCHOPHARMACOLOGY, V188, P42, DOI 10.1007/s00213-006-0474-4; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; GRANT I, 1978, ARCH GEN PSYCHIAT, V35, P1063; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; Knapen T, 2011, J NEUROSCI, V31, P10293, DOI 10.1523/JNEUROSCI.1727-11.2011; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Liu HH, 2008, AM J DRUG ALCOHOL AB, V34, P562, DOI 10.1080/00952990802295238; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Ma N, 2011, PLOS ONE, V26; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Murphy ML, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-3; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Qiu YW, 2011, RADIOLOGY, V261, P551, DOI 10.1148/radiol.11102466; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Schumacher EH, 2005, NEUROPSYCHOLOGIA, V43, P1444, DOI 10.1016/j.neuropsychologia.2005.01.002; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Vassileva J, 2007, DRUG ALCOHOL DEPEN, V86, P287, DOI 10.1016/j.drugalcdep.2006.06.015; Verdejo-Garcia AJ, 2007, ADDICT BEHAV, V32, P950, DOI 10.1016/j.addbeh.2006.06.032; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Wang YR, 2011, NEUROSCI LETT, V494, P49, DOI 10.1016/j.neulet.2011.02.053; Yuan Y, 2009, BRAIN COGNITION, V71, P223, DOI 10.1016/j.bandc.2009.08.014; Zalesky A, 2012, BRAIN, V135, P2245, DOI 10.1093/brain/aws136	38	35	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63212	10.1371/journal.pone.0063212	http://dx.doi.org/10.1371/journal.pone.0063212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650554	gold, Green Submitted, Green Published			2022-12-25	WOS:000319167000099
J	Seppanen, E; Roy, E; Ellis, R; Bou-Gharios, G; Fisk, NM; Khosrotehrani, K				Seppanen, Elke; Roy, Edwige; Ellis, Rebecca; Bou-Gharios, George; Fisk, Nicholas M.; Khosrotehrani, Kiarash			Distant Mesenchymal Progenitors Contribute to Skin Wound Healing and Produce Collagen: Evidence from a Murine Fetal Microchimerism Model	PLOS ONE			English	Article							MARROW-DERIVED CELLS; BONE-MARROW; STEM-CELLS; MATERNAL BLOOD; MOUSE; DIFFERENTIATION; PARTICIPATE; FIBROBLASTS; FIBROCYTES; IDENTIFICATION	The contribution of distant and/or bone marrow-derived endogenous mesenchymal stem cells (MSC) to skin wounds is controversial. Bone marrow transplantation experiments employed to address this have been largely confounded by radiation-resistant host-derived MSC populations. Gestationally-acquired fetal MSC are known to engraft in maternal bone marrow in all pregnancies and persist for decades. These fetal cells home to damaged maternal tissues, mirroring endogenous stem cell behavior. We used fetal microchimerism as a tool to investigate the natural homing and engraftment of distant MSC to skin wounds. Post-partum wild-type mothers that had delivered transgenic pups expressing luciferase under the collagen type I-promoter were wounded. In vivo bioluminescence imaging (BLI) was then used to track recruitment of fetal cells expressing this mesenchymal marker over 14 days of healing. Fetal cells were detected in 9/43 animals using BLI (Fisher exact p = 0.01 versus 1/43 controls). These collagen type I-expressing fetal cells were specifically recruited to maternal wounds in the initial phases of healing, peaking on day 1 (n = 43, p<0.01). This was confirmed by detection of Y-chromosome+ ve fetal cells that displayed fibroblast-like morphology. Histological analyses of day 7 wounds revealed vimentin-expressing fetal cells in dermal tissue. Our results demonstrate the participation of distant mesenchymal cells in skin wounds. These data imply that endogenous MSC populations are likely recruited from bone marrow to wounds to participate in healing.	[Seppanen, Elke; Roy, Edwige; Ellis, Rebecca; Bou-Gharios, George; Fisk, Nicholas M.; Khosrotehrani, Kiarash] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Bou-Gharios, George] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Fisk, Nicholas M.] Royal Brisbane & Womens Hosp, Ctr Adv Prenatal Care, Herston, Qld, Australia	University of Queensland; University of Oxford; Royal Brisbane & Women's Hospital	Khosrotehrani, K (corresponding author), Univ Queensland, UQ Ctr Clin Res, Herston Campus, Brisbane, Qld, Australia.	k.khosrotehrani@uq.edu.au	Seppanen, Elke/AHD-5402-2022; Khosrotehrani, Kiarash/M-8025-2015; Fisk, Nicholas M/B-2126-2009	Khosrotehrani, Kiarash/0000-0002-6406-4076; Fisk, Nicholas M/0000-0003-0031-7975; Seppanen, Elke/0000-0003-1673-4167; roy, edwige/0000-0003-1991-5844	National Health and Medical Research Council in Australia [569822]	National Health and Medical Research Council in Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council in Australia, project grant #569822. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Barisic-Dujmovic T, 2010, J CELL PHYSIOL, V222, P703, DOI 10.1002/jcp.21997; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Bou-Gharios G, 2011, CELLS TISSUES ORGANS; BouGharios G, 1996, J CELL BIOL, V134, P1333, DOI 10.1083/jcb.134.5.1333; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Cilloni D, 2000, BLOOD, V96, P3637; de Almeida PE, 2011, AM J PHYSIOL-HEART C, V301, pH663, DOI 10.1152/ajpheart.00337.2011; Direkze NC, 2003, STEM CELLS, V21, P514, DOI 10.1634/stemcells.21-5-514; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Fujiki Y, 2008, BIOL REPROD, V79, P841, DOI 10.1095/biolreprod.108.068973; Fujiki Y, 2009, BIOL REPROD, V81, P26, DOI 10.1095/biolreprod.108.074468; HATAMOCHI A, 1991, J INVEST DERMATOL, V96, P473, DOI 10.1111/1523-1747.ep12470171; Higashiyama R, 2011, J INVEST DERMATOL, V131, P529, DOI 10.1038/jid.2010.314; Huu SN, 2007, P NATL ACAD SCI USA, V104, P1871, DOI 10.1073/pnas.0606490104; Huu SN, 2009, AM J PATHOL, V174, P630, DOI 10.2353/ajpath.2009.080566; Ishii GH, 2005, STEM CELLS, V23, P699, DOI 10.1634/stemcells.2004-0183; Johnson KL, 2000, BIOTECHNIQUES, V29, P1220, DOI 10.2144/00296st01; Kara RJ, 2012, CIRC RES, V110, P82, DOI 10.1161/CIRCRESAHA.111.249037; Khosrotehrani K, 2005, J REPROD IMMUNOL, V66, P1, DOI 10.1016/j.jri.2005.02.001; Khosrotehrani K, 2004, JAMA-J AM MED ASSOC, V292, P75, DOI 10.1001/jama.292.1.75; Khosrotehrani K, 2008, J IMMUNOL, V180, P889, DOI 10.4049/jimmunol.180.2.889; Kopecki Z, 2007, J PATHOL, V211, P351, DOI 10.1002/path.2113; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Nassar D, 2012, CHIMERISM, V3; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; Nassar D, 2012, FASEB J, V26, P149, DOI 10.1096/fj.11-180695; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; O'Donoghue K, 2003, MOL HUM REPROD, V9, P497, DOI 10.1093/molehr/gag063; O'Donoghue K, 2008, REPROD BIOMED ONLINE, V16, P382, DOI 10.1016/S1472-6483(10)60600-1; Opalenik SR, 2005, FASEB J, V19, P1561, DOI 10.1096/fj.04-2978fje; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Phinney DG, 2013, CYTOTHERAPY, V15, P140, DOI 10.1016/j.jcyt.2012.11.005; Pritchard S, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101147; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Rieger K, 2005, EXP HEMATOL, V33, P605, DOI 10.1016/j.exphem.2005.02.004; Rossi G, 2004, LANCET, V364, P1936, DOI 10.1016/S0140-6736(04)17469-2; Santos MA, 2008, HUM REPROD, V23, P2319, DOI 10.1093/humrep/den261; Sawaya HHB, 2004, RHEUMATOLOGY, V43, P965, DOI 10.1093/rheumatology/keh211; Seppanen E, 2012, J REPROD IM IN PRESS; Seppanen EJ, 2012, STEM CELLS DEV; Shohara R, 2012, CYTOTHERAPY; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Srivatsa B, 2001, LANCET, V358, P2034, DOI 10.1016/S0140-6736(01)07099-4; Sunami R, 2010, J REPROD IMMUNOL, V84, P117, DOI 10.1016/j.jri.2009.11.006; Tan XW, 2005, STEM CELLS, V23, P1443, DOI 10.1634/stemcells.2004-0169; Wang ZC, 2011, KIDNEY INT, V79, P300, DOI 10.1038/ki.2010.326; Zeng XX, 2010, STEM CELLS DEV, V19, P1819, DOI 10.1089/scd.2010.0046	52	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62662	10.1371/journal.pone.0062662	http://dx.doi.org/10.1371/journal.pone.0062662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650524	Green Submitted, gold, Green Published			2022-12-25	WOS:000319167000068
J	Vanzelli, AS; Medeiros, A; Rolim, N; Bartholomeu, JB; Cunha, TF; Bechara, LG; Gomes, ERM; Mattos, KC; Sirvente, R; Salemi, V; Mady, C; Negrao, CE; Guatimosim, S; Brum, PC				Vanzelli, Andrea S.; Medeiros, Alessandra; Rolim, Natale; Bartholomeu, Jan B.; Cunha, Telma F.; Bechara, Luiz G.; Gomes, Eneas R. M.; Mattos, Katt C.; Sirvente, Raquel; Salemi, Vera; Mady, Charles; Negrao, Carlos E.; Guatimosim, Silvia; Brum, Patricia C.			Integrative Effect of Carvedilol and Aerobic Exercise Training Therapies on Improving Cardiac Contractility and Remodeling in Heart Failure Mice	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; OXIDATIVE STRESS; BETA-BLOCKERS; HYPERACTIVITY; ABNORMALITIES; DYSFUNCTION; MORTALITY; SYSTEM; IMPACT	The use of b-blockers is mandatory for counteracting heart failure (HF)-induced chronic sympathetic hyperactivity, cardiac dysfunction and remodeling. Importantly, aerobic exercise training, an efficient nonpharmacological therapy to HF, also counteracts sympathetic hyperactivity in HF and improves exercise tolerance and cardiac contractility; the latter associated with changes in cardiac Ca2+ handling. This study was undertaken to test whether combined b-blocker and aerobic exercise training would integrate the beneficial effects of isolated therapies on cardiac structure, contractility and cardiomyocyte Ca2+ handling in a genetic model of sympathetic hyperactivity-induced HF (alpha(2A)/alpha 2C(-)adrenergic receptor knockout mice, KO). We used a cohort of 5-7 mo male wild-type (WT) and congenic mice (KO) with C57Bl6/J genetic background randomly assigned into 5 groups: control (WT), saline-treated KO (KOS), exercise trained KO (KOT), carvedilol-treated KO (KOC) and, combined carvedilol-treated and exercise-trained KO (KOCT). Isolated and combined therapies reduced mortality compared with KOS mice. Both KOT and KOCT groups had increased exercise tolerance, while groups receiving carvedilol had increased left ventricular fractional shortening and reduced cardiac collagen volume fraction compared with KOS group. Cellular data confirmed that cardiomyocytes from KOS mice displayed abnormal Ca2+ handling. KOT group had increased intracellular peak of Ca2+ transient and reduced diastolic Ca2+ decay compared with KOS group, while KOC had increased Ca2+ decay compared with KOS group. Notably, combined therapies re-established cardiomyocyte Ca2+ transient paralleled by increased SERCA2 expression and SERCA2: PLN ratio toward WT levels. Aerobic exercise trained increased the phosphorylation of PLN at Ser16 and Thr17 residues in both KOT and KOCT groups, but carvedilol treatment reduced lipid peroxidation in KOC and KOCT groups compared with KOS group. The present findings provide evidence that the combination of carvedilol and aerobic exercise training therapies lead to a better integrative outcome than carvedilol or exercise training used in isolation.	[Vanzelli, Andrea S.; Bartholomeu, Jan B.; Cunha, Telma F.; Bechara, Luiz G.; Mattos, Katt C.; Negrao, Carlos E.; Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Medeiros, Alessandra] Univ Fed Sao Paulo, Dept Biosci, Santos, Brazil; [Rolim, Natale] Dept Circulat & Med Imaging, Trondheim, Norway; [Rolim, Natale] KG Jebsen Ctr Exercise Med, Trondheim, Norway; [Gomes, Eneas R. M.; Guatimosim, Silvia] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [Sirvente, Raquel; Salemi, Vera; Mady, Charles; Negrao, Carlos E.] Univ Sao Paulo, Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Minas Gerais; Universidade de Sao Paulo	Brum, PC (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil.	pcbrum@usp.br	Guatimosim, Silvia/AAN-7441-2021; Bechara, Luiz R G/K-4095-2012; Negrao, Carlos E/C-4281-2012; Brum, Patricia C/E-6605-2011; Salemi, Vera MC/C-9104-2013; Medeiros, Alessandra/E-8132-2012; Cunha, Telma F/I-5222-2016; Salemi, Vera/AAY-5024-2020; Medeiros, Alessandra/F-6149-2014; Gomes, Eneas RM/G-3153-2010; Mady, Charles/C-8870-2012	Guatimosim, Silvia/0000-0001-8386-3722; Brum, Patricia C/0000-0002-4750-6506; Salemi, Vera MC/0000-0002-7152-1810; Medeiros, Alessandra/0000-0002-7962-7185; Medeiros, Alessandra/0000-0002-7962-7185; Gomes, Eneas RM/0000-0001-8528-8741; Mady, Charles/0000-0002-8838-199X; Bechara, Luiz/0000-0002-1642-1008; Negrao, Carlos Eduardo/0000-0003-4652-1226	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo [FAPESP:2010/50048-1]; FAPEMIG and Instituto Milenio (S.G.); Conselho Nacional de Pesquisa e Desenvolvimento; FAPESP [06/56123-0]; CNPq [302201/2011-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPEMIG and Instituto Milenio (S.G.); Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo. SP (FAPESP:2010/50048-1), FAPEMIG and Instituto Milenio (S.G.), Conselho Nacional de Pesquisa e Desenvolvimento (CNPq, S.G. and P.C.B.) for funding the present investigation, and Laboratories Baldacci S.A. for donating carvedilol. A.S.V. held a scholarship from FAPESP (06/56123-0). P.C.B. holds a scholarship from CNPq (302201/2011-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos S, 2003, INT J CARDIOL, V90, P1, DOI 10.1016/S0167-5273(02)00504-1; Barretto ACP, 2009, INT J CARDIOL, V135, P302, DOI 10.1016/j.ijcard.2008.03.056; Bartholomeu JB, 2008, J MOL CELL CARDIOL, V45, P240, DOI 10.1016/j.yjmcc.2008.05.011; Brum PC, 2011, BRAZ J MED BIOL RES, V44, P827, DOI 10.1590/S0100-879X2011000900002; Brum PC, 2002, AM J PHYSIOL-HEART C, V283, pH1838, DOI 10.1152/ajpheart.01063.2001; Burger AJ, 2001, J CARD FAIL, V7, P122, DOI 10.1054/jcaf.2001.24964; Chung CJ, 2011, PHYSICIAN SPORTSMED, V39, P37, DOI 10.3810/psm.2011.11.1937; COHN JN, 1988, AM J CARDIOL, V62, pA25, DOI 10.1016/S0002-9149(88)80081-X; De Matos LDNJ, 2004, J CARD FAIL, V10, P496, DOI 10.1016/j.cardfail.2004.03.006; Flesch M, 1999, CIRCULATION, V100, P346, DOI 10.1161/01.CIR.100.4.346; Fraga R, 2007, EUR J HEART FAIL, V9, P630, DOI 10.1016/j.ejheart.2007.03.003; GRASSI G, 1995, CIRCULATION, V92, P3206, DOI 10.1161/01.CIR.92.11.3206; Guatimosim S, 2001, AM J PHYSIOL-CELL PH, V280, pC1327, DOI 10.1152/ajpcell.2001.280.5.C1327; Johns C, 1996, HYPERTENSION, V28, P1064, DOI 10.1161/01.HYP.28.6.1064; Khattar R S, 2003, Minerva Cardioangiol, V51, P143; Koitabashi N, 2005, BIOCHEM BIOPH RES CO, V328, P116, DOI 10.1016/j.bbrc.2004.12.139; LIKOFF MJ, 1987, AM J CARDIOL, V59, P634; Mahon Niall G., 2002, Eur J Intern Med, V13, P96, DOI 10.1016/S0953-6205(02)00010-9; Medeiros A, 2008, BRAZ J MED BIOL RES, V41, P812, DOI 10.1590/S0100-879X2008000900012; Medeiros A, 2008, J APPL PHYSIOL, V104, P103, DOI 10.1152/japplphysiol.00493.2007; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nakahira A, 2010, CIRC J, V74, P1711, DOI 10.1253/circj.CJ-10-0149; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Rolim NPL, 2007, PHYSIOL GENOMICS, V29, P246, DOI 10.1152/physiolgenomics.00188.2006; Vanzelli AS, 2010, ARQ BRAS CARDIOL, V95, P373, DOI 10.1590/S0066-782X2010005000098; Zhuang XF, 2009, J INT MED RES, V37, P1354, DOI 10.1177/147323000903700510; Zucker IH, 2012, HEART FAIL CLIN, V8, P87, DOI 10.1016/j.hfc.2011.08.007	27	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62452	10.1371/journal.pone.0062452	http://dx.doi.org/10.1371/journal.pone.0062452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658728	Green Submitted, Green Published, gold			2022-12-25	WOS:000319167000045
J	Young, SD; Szekeres, G; Coates, T				Young, Sean D.; Szekeres, Greg; Coates, Thomas			The Relationship between Online Social Networking and Sexual Risk Behaviors among Men Who Have Sex with Men (MSM)	PLOS ONE			English	Article							INTERNET; TECHNOLOGIES; PARTNERS; BENEFITS	Online social networking usage is growing rapidly, especially among at-risk populations, such as men who have sex with men (MSM). However, little research has studied the relationship between online social networking usage and sexual risk behaviors among at-risk populations. One hundred and eighteen Facebook-registered MSM (60.1% Latino, 28% African American; 11.9% other) were recruited from online (social networking websites and banner advertisements) and offline (local clinics, restaurants and organizations) venues frequented by minority MSM. Inclusion criteria required participants to be men who were 18 years of age or older, had had sex with a man in the past 12 months, were living in Los Angeles, and had a Facebook account. Participants completed an online survey on their social media usage and sexual risk behaviors. Results from a multivariable regression suggest that number of sexual partners met from online social networking technologies is associated with increased: 1) likelihood of having exchanged sex for food, drugs, or a place to stay within the past 3 months; 2) number of new partners within the past 3 months; 3) number of male sex partners within the past 3 months; and 4) frequency of engaging in oral sex within the past 3 months, controlling for age, race, education, and total number of sexual partners. Understanding the relationship between social media sex-seeking and sexual risk behaviors among at-risk populations will help inform population-focused HIV prevention and treatment interventions.	[Young, Sean D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Family Med, Los Angeles, CA 90095 USA; [Szekeres, Greg] Univ Calif Los Angeles, David Geffen Sch Med, Program Global Hlth, Los Angeles, CA 90095 USA; [Coates, Thomas] Univ Calif Los Angeles, David Geffen Sch Med, Program Global Hlth, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Young, SD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Family Med, Los Angeles, CA 90095 USA.	sdyoung@mednet.ucla.edu		Young, Sean D./0000-0001-6052-4875	National Institute of Mental Health, Young PI [K01 MH090884]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH090884, P30MH058107] Funding Source: NIH RePORTER	National Institute of Mental Health, Young PI; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Institute of Mental Health, Young PI (K01 MH090884). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tayyib AA, 2009, SEX TRANSM INFECT, V85, P216, DOI 10.1136/sti.2008.032631; [Anonymous], HIV GAY BIS MEN; [Anonymous], STAT STAT SOFTW; Berry M, 2008, AIDS, V22, P787, DOI 10.1097/QAD.0b013e3282f55559; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Grov C, 2012, AIDS EDUC PREV, V24, P102, DOI 10.1521/aeap.2012.24.2.102; Harris Interactive, 2007, GAYS LESB BIS LEAD U; HIV Epidemiology Program Los Angeles County Department of Health Services, 2002, SPEC DAT RUN; HIV Epidemiology Program Los Angeles County Department of Health Services, 2008, SPEC DAT RUN; HIV Epidemiology Program-Los Angeles County Department of Public Health, 2011, 2011 ANN HIV SURV RE; Horrigan JB, 2007, PIP BROADBAND; MacKellar DA, 2011, SEX TRANSM DIS, V38, P419, DOI 10.1097/OLQ.0b013e31820369dd; McFarlane M, 2000, JAMA-J AM MED ASSOC, V284, P443, DOI 10.1001/jama.284.4.443; Mineta NY, 2000, FALLING NET DIGITAL; Rietmeijer CA, 2003, SEX TRANSM DIS, V30, P15, DOI 10.1097/00007435-200301000-00004; Rosser BRS, 2009, AIDS BEHAV, V13, P746, DOI 10.1007/s10461-008-9399-8; Smith A, 2010, PEW INT AM LIF PROJ; Smith A, 2010, MOBILE ACCESS 2010; Smith A, 2011, WHOS WHAT SOCIAL MED; Tashima KT, 2003, INT J STD AIDS, V14, P285, DOI 10.1258/095646203321264926; Young S, INT J STD A IN PRESS; Young S. D., J ADDICTIVE IN PRESS; Young SD, 2012, AIDS BEHAV, V16, P1743, DOI 10.1007/s10461-012-0251-9; Young SD, 2011, AIDS BEHAV, V15, P253, DOI 10.1007/s10461-010-9810-0	24	57	58	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62271	10.1371/journal.pone.0062271	http://dx.doi.org/10.1371/journal.pone.0062271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658716	gold, Green Published			2022-12-25	WOS:000319167000035
J	Zetterqvist, AV; Mulinari, S				Zetterqvist, Anna V.; Mulinari, Shai			Misleading Advertising for Antidepressants in Sweden: A Failure of Pharmaceutical Industry Self-Regulation	PLOS ONE			English	Article							MEDICAL JOURNALS; ADVERTISEMENTS; PROMOTION; ACCURACY; QUALITY; DRUGS; CODES	Background: The alleged efficacy of pharmaceutical industry self-regulation has been used to repudiate increased government oversight over promotional activity. European politicians and industry have cited Sweden as an excellent example of self-regulation based on an ethical code. This paper considers antidepressant advertising in Sweden to uncover the strengths and weaknesses of self-regulation. Methodology: We analyzed all antidepressant advertisements in the Swedish Medical Journal, 1994-2003. The regulation of these advertisements was analyzed using case reports from self-regulatory bodies. The authors independently reviewed this material to investigate: (1) extent of violative advertising; (2) pattern of code breaches; (3) rate at which the system reacted to violative advertising; (4) prevalence of and oversight over claims regarding antidepressant efficacy and disease causality, and (5) costs for manufactures associated with violative advertising. Principal Findings: Self-regulatory bodies identified numerous code breaches. Nonetheless, they failed to protect doctors from unreliable information on antidepressants, since as many as 247 of 722 (34%) advertisements breached the industry code. Self-regulatory bodies repeatedly failed to challenge inflated claims of antidepressant efficacy, lending evidence of lax oversight. On average, 15 weeks elapsed between printing and censure of a wrongful claim, and in 25% of cases 47 weeks or more elapsed. Industry paid roughly (sic)108000 in fines for violative advertising, adding an estimated additional average cost of 11% to each purchased violative advertisement, or amounting to as little as 0.009% of total antidepressant sales of around (sic)1.2 billion. Conclusions: Lax oversight, combined with lags in the system and low fines for violations, may explain the Swedish system's failure to pressure companies into providing reliable antidepressants information. If these shortcomings prove to be consistent across self-regulatory settings, and if appropriate measures are not taken to amend shortcomings, many countries may want to reconsider the current balance between self-regulation, and legislative control with government oversight.	[Zetterqvist, Anna V.] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Mulinari, Shai] Lund Univ, Dept Gender Studies, Lund, Sweden	Lund University; Lund University	Mulinari, S (corresponding author), Lund Univ, Dept Gender Studies, Lund, Sweden.	shai.mulinari@genus.lu.se		Mulinari, Shai/0000-0001-8773-9796	Riksbankens Jubileumsfond in Sweden	Riksbankens Jubileumsfond in Sweden	SM was supported by Riksbankens Jubileumsfond in Sweden (http://www.rj.se/). AVZ received no funding for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andree Bengt, 2012, Lakartidningen, V109, P2106; Apoteksbolaget, 1991, ANN REP; Coombes R, 2005, BRIT MED J, V331, P1225, DOI 10.1136/bmj.331.7527.1225-a; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; EFPIA, 2007, EFPIA COD PROM PRESC; European Federation of Pharmaceutical Industries and Associations, 2008, EFPIA CONTR EUR COMM; Fugh-Berman A, 2006, PLOS MED, V3, P762, DOI 10.1371/journal.pmed.0030130; GAO, 2006, IMPR NEED FDAS OV DI; Hakansson J, 2001, LAKARTIDNINGEN, V98, P1834; Healy D., 1997, ANTIDEPRESSANT ERA; Healy D, 1992, DIS NERVOUS SYSTEM C, V1, P815; Heimans L, 2010, NETH J MED, V68, P46; HERXHEIMER A, 1990, BRIT MED J, V300, P307, DOI 10.1136/bmj.300.6720.307; High Level Pharmaceutical Forum, 2008, FIN CONCL REC PHARM; House of Commons Health Committee, 2005, INFL PHARM IND HLTH, V2; Huskamp HA, 2008, PHARMACOECONOMICS, V26, P603, DOI 10.2165/00019053-200826070-00007; Ilyas S, 2012, BRIT J PSYCHIAT, V200, P393, DOI 10.1192/bjp.bp.111.104257; International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), 2012, IFPMA COD PRACT; International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), 2012, SELF REG PHARM PROM; Charan J, 2011, J PHARM BIOALLIED SC, V3, P403, DOI 10.4103/0975-7406.84449; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Korenstein D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023336; Lacasse JR, 2005, PLOS MED, V2, P1211, DOI 10.1371/journal.pmed.0020392; Lal A, 1997, J Indian Med Assoc, V95, P19; Lankinen KS, 2004, PHARMACOEPIDEM DR S, V13, P789, DOI 10.1002/pds.1017; Lennholm B, 2001, LAKARTIDNINGEN, V98, P923; Lexchin J, 1997, CAN MED ASSOC J, V156, P351; Lexchin J, 2003, AM J BIOETHICS, V3, P49, DOI 10.1162/15265160360706570; Lexchin J, 2010, INT J CLIN PRACT, V64, P1015, DOI 10.1111/j.1742-1241.2010.02398.x; Lexchin J, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-24; Liebman M, 2000, MED MARKET MEDIA, V35, P88; Lynch R, 2005, REGULATORY RAPPORTEU, V2, P7; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Melander H, 2008, EUR NEUROPSYCHOPHARM, V18, P623, DOI 10.1016/j.euroneuro.2008.06.003; MENDELS J, 1974, ARCH GEN PSYCHIAT, V30, P447; Mulinari S, 2013, SOCIOL HEALTH ILL, V35, P761, DOI 10.1111/j.1467-9566.2012.01528.x; Mulinari S, 2012, J HIST NEUROSCI, V21, P366, DOI 10.1080/0964704X.2011.623917; Mulinari Shai, 2011, Lakartidningen, V108, P1839; National Institute for Health and Clinical Excellence (NICE), 2018, DEPR AD REC MAN; O'Brien C, 2003, IRISH TIMES     1005; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Othman N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-294; Othman N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006350; Otto Cars Sigvard Molstad, 2012, LAKARTIDNINGEN; PERMAN E, 1990, NEW ENGL J MED, V323, P616, DOI 10.1056/NEJM199008303230921; Ratanawijitrasin S, 2002, EFFECTIVE DRUG REGUL; Roughhead EE, 1999, AUST PRESCR, V22, P78; Ruff TA, 2005, MED J AUSTRALIA, V183, P73, DOI 10.5694/j.1326-5377.2005.tb06926.x; Shorter E., 2009, PROZAC TROUBLED HIST; Simmonds H, 2003, LANCET, V361, P878, DOI 10.1016/S0140-6736(03)12686-4; Spielmans GI, 2008, J NERV MENT DIS, V196, P267, DOI 10.1097/NMD.0b013e31816a436b; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Swedish Association of the Pharmaceutical Industry (LIF), 2011, ETH RUL PHARM IND SW; Swedish Association of the Pharmaceutical Industry (LIF), 2012, IGM NBL DAT; Swedish Association of the Pharmaceutical Industry (LIF), 2011, FORM ADV ACC ETH RUL; The Swedish Pharmaceutical Industry Information Examiner (IGM), 2012, BIANN REP 1994 2003; The Swedish Pharmaceutical Industry Information Examiner (IGM), 2012, BIANN REP IGM 2011 2; The Swedish Riksbank, 2012, ANN AV EXCH RAT; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; van Winkelen P, 2006, RHEUMATOLOGY, V45, P1154, DOI 10.1093/rheumatology/kel073; Villanueva P, 2003, LANCET, V361, P27, DOI 10.1016/S0140-6736(03)12118-6	61	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62609	10.1371/journal.pone.0062609	http://dx.doi.org/10.1371/journal.pone.0062609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650519	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000062
J	Hagmann, CA; Herzner, AM; Abdullah, Z; Zillinger, T; Jakobs, C; Schuberth, C; Coch, C; Higgins, PG; Wisplinghoff, H; Barchet, W; Hornung, V; Hartmann, G; Schlee, M				Hagmann, Cristina Amparo; Herzner, Anna Maria; Abdullah, Zeinab; Zillinger, Thomas; Jakobs, Christopher; Schuberth, Christine; Coch, Christoph; Higgins, Paul G.; Wisplinghoff, Hilmar; Barchet, Winfried; Hornung, Veit; Hartmann, Gunther; Schlee, Martin			RIG-I Detects Triphosphorylated RNA of Listeria monocytogenes during Infection in Non-Immune Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; ANTIVIRAL SIGNALING PROTEIN; ADAPTER PROTEIN; MESSENGER-RNA; DENDRITIC CELLS; IFN-BETA; EPITHELIAL-CELLS; CYTOSOLIC DNA; E-CADHERIN; RECOGNITION	The innate immune system senses pathogens by pattern recognition receptors in different cell compartments. In the endosome, bacteria are generally recognized by TLRs; facultative intracellular bacteria such as Listeria, however, can escape the endosome. Once in the cytosol, they become accessible to cytosolic pattern recognition receptors, which recognize components of the bacterial cell wall, metabolites or bacterial nucleic acids and initiate an immune response in the host cell. Current knowledge has been focused on the type I IFN response to Listeria DNA or Listeria-derived second messenger c-di-AMP via the signaling adaptor STING. Our study focused on the recognition of Listeria RNA in the cytosol. With the aid of a novel labeling technique, we have been able to visualize immediate cytosolic delivery of Listeria RNA upon infection. Infection with Listeria as well as transfection of bacterial RNA induced a type-I-IFN response in human monocytes, epithelial cells or hepatocytes. However, in contrast to monocytes, the type-I-IFN response of epithelial cells and hepatocytes was not triggered by bacterial DNA, indicating a STING-independent Listeria recognition pathway. RIG-I and MAVS knock-down resulted in abolishment of the IFN response in epithelial cells, but the IFN response in monocytic cells remained unaffected. By contrast, knockdown of STING in monocytic cells reduced cytosolic Listeria-mediated type-I-IFN induction. Our results show that detection of Listeria RNA by RIG-I represents a non-redundant cytosolic immunorecognition pathway in nonimmune cells lacking a functional STING dependent signaling pathway.	[Hagmann, Cristina Amparo; Herzner, Anna Maria; Zillinger, Thomas; Jakobs, Christopher; Schuberth, Christine; Coch, Christoph; Barchet, Winfried; Hornung, Veit; Hartmann, Gunther; Schlee, Martin] Univ Bonn, Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Abdullah, Zeinab] Univ Bonn, Inst Mol Med, Bonn, Germany; [Abdullah, Zeinab] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [Higgins, Paul G.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany; [Hornung, Veit; Hartmann, Gunther] German Ctr Infect Res, Cologne, Germany	University of Bonn; University of Bonn; University of Bonn; University of Cologne; German Center for Infection Research; University of Cologne	Schlee, M (corresponding author), Univ Bonn, Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany.	martin.schlee@uni-bonn.de	Coch, Christoph/AAW-5336-2021; Abdullah, Zeinab/HII-5346-2022; Hartmann, Gunther/P-7492-2017; Higgins, Paul/B-6708-2011; Hornung, Veit/C-3565-2012; Zillinger, Thomas/AAD-7320-2020; Schlee, Martin/AAL-1238-2021	Hartmann, Gunther/0000-0003-1021-2018; Higgins, Paul/0000-0001-8677-9454; Hornung, Veit/0000-0002-4150-194X; Zillinger, Thomas/0000-0002-0866-4835; Barchet, Winfried/0000-0002-6745-6606; Schlee, Martin/0000-0003-3671-7639	BMBF Biofuture [0311896]; BMBF [01KI0771]; Deutsche Forschungsgemeinschaft [SFB670, SFB704, SFB832, KFO177]	BMBF Biofuture(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Grants BMBF Biofuture 0311896, BMBF-grant 01KI0771 (www.bmbf.de/) to GH and from the Deutsche Forschungsgemeinschaft (www.dfg.de; SFB670 to MS, GH and VH, SFB704 to GH, SFB832 and KFO177 to GH). GH, WB and VH are members of the DFG Excellence Cluster ImmunoSensation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Z, 2012, EMBO J, V31, P4153, DOI 10.1038/emboj.2012.274; ABLASSER A, 2009, NAT IMMUNOL; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; BIEGER CD, 1989, J BACTERIOL, V171, P141, DOI 10.1128/jb.171.1.141-147.1989; Burckstummer T, 2009, NAT IMMUNOL; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Coch C, 2009, J LEUKOCYTE BIOL, V86, P663, DOI 10.1189/jlb.0509314; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; Fernandes-Alnemri T, 2009, NATURE; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; GREGORY SH, 1992, J LEUKOCYTE BIOL, V51, P421, DOI 10.1002/jlb.51.4.421; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HORNUNG V, 2009, NATURE; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Li XD, 2011, P NATL ACAD SCI USA, V108, P17390, DOI 10.1073/pnas.1107114108; Mackie GA, 2000, J BIOL CHEM, V275, P25069, DOI 10.1074/jbc.C000363200; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Paschen A, 2000, EUR J IMMUNOL, V30, P3447, DOI 10.1002/1521-4141(2000012)30:12<3447::AID-IMMU3447>3.0.CO;2-M; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pizarro-Cerda J, 2012, COLD SPRING HARB PER, P2; Popov A, 2006, J CLIN INVEST, V116, P3160, DOI 10.1172/JCI28996; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Schlee M, 2010, MOL THER, V18, P1254, DOI 10.1038/mt.2010.90; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seveau S, 2007, MICROBES INFECT, V9, P1167, DOI 10.1016/j.micinf.2007.05.004; Soulat D, 2006, FEBS LETT, V580, P2341, DOI 10.1016/j.febslet.2006.03.057; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Tsai HN, 2003, APPL ENVIRON MICROB, V69, P6943, DOI 10.1128/AEM.69.11.6943-6945.2003; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Warren SE, 2010, J IMMUNOL, V185, P818, DOI 10.4049/jimmunol.1000724; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt1211; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	68	57	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62872	10.1371/journal.pone.0062872	http://dx.doi.org/10.1371/journal.pone.0062872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23653683	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300106
J	Menden, MP; Iorio, F; Garnett, M; McDermott, U; Benes, CH; Ballester, PJ; Saez-Rodriguez, J				Menden, Michael P.; Iorio, Francesco; Garnett, Mathew; McDermott, Ultan; Benes, Cyril H.; Ballester, Pedro J.; Saez-Rodriguez, Julio			Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; INTEGRATIVE ANALYSIS; SMALL MOLECULES; ANTICANCER; DISCOVERY; PATTERNS; COMPARE; QSAR	Predicting the response of a specific cancer to a therapy is a major goal in modern oncology that should ultimately lead to a personalised treatment. High-throughput screenings of potentially active compounds against a panel of genomically heterogeneous cancer cell lines have unveiled multiple relationships between genomic alterations and drug responses. Various computational approaches have been proposed to predict sensitivity based on genomic features, while others have used the chemical properties of the drugs to ascertain their effect. In an effort to integrate these complementary approaches, we developed machine learning models to predict the response of cancer cell lines to drug treatment, quantified through IC50 values, based on both the genomic features of the cell lines and the chemical properties of the considered drugs. Models predicted IC50 values in a 8-fold cross-validation and an independent blind test with coefficient of determination R-2 of 0.72 and 0.64 respectively. Furthermore, models were able to predict with comparable accuracy (R-2 of 0.61) IC50s of cell lines from a tissue not used in the training stage. Our in silico models can be used to optimise the experimental design of drug-cell screenings by estimating a large proportion of missing IC50 values rather than experimentally measuring them. The implications of our results go beyond virtual drug screening design: potentially thousands of drugs could be probed in silico to systematically test their potential efficacy as anti-tumour agents based on their structure, thus providing a computational framework to identify new drug repositioning opportunities as well as ultimately be useful for personalized medicine by linking the genomic traits of patients to drug sensitivity.	[Menden, Michael P.; Iorio, Francesco; Ballester, Pedro J.; Saez-Rodriguez, Julio] Wellcome Trust Genome Campus Cambridge, European Bioinformat Inst, Cambridge, England; [Iorio, Francesco; Garnett, Mathew; McDermott, Ultan] Wellcome Trust Genome Campus Cambridge, Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Benes, Cyril H.] Massachusetts Gen Hosp, Ctr Canc, Ctr Mol Therapeut, Charlestown, MA USA; [Benes, Cyril H.] Harvard Univ, Sch Med, Charlestown, MA USA	European Molecular Biology Laboratory (EMBL); University of Cambridge; Wellcome Trust Sanger Institute; Harvard University; Massachusetts General Hospital; Harvard University	Ballester, PJ (corresponding author), Wellcome Trust Genome Campus Cambridge, European Bioinformat Inst, Cambridge, England.	pedro.ballester@ebi.ac.uk; saezrodriguez@ebi.ac.uk	Iorio, Francesco/H-3284-2019; Iorio, Francesco/H-3282-2019; Saez-Rodriguez, Julio/H-7114-2019; Ballester, Pedro/A-1148-2008	Iorio, Francesco/0000-0001-7063-8913; Saez-Rodriguez, Julio/0000-0002-8552-8976; Ballester, Pedro/0000-0002-4078-743X; McDermott, Ultan/0000-0001-9032-4700	European Molecular Biology Laboratory PhD programme; Sanger/European Bioinformatics Institute ESPOD programme; Medical Research Council Methodology Research Fellowship; Wellcome Trust grant; Cancer Research UK; MRC [G0902106] Funding Source: UKRI; Medical Research Council [G0902106] Funding Source: researchfish	European Molecular Biology Laboratory PhD programme; Sanger/European Bioinformatics Institute ESPOD programme(Agency for Science Technology & Research (A*STAR)); Medical Research Council Methodology Research Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust grant(Wellcome Trust); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the European Molecular Biology Laboratory PhD programme to MPM, the Sanger/European Bioinformatics Institute ESPOD programme to FI, a Medical Research Council Methodology Research Fellowship to PJB, a Wellcome Trust grant to MG and CHB, and Cancer Research UK to UM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, J CHEM INF MODEL, V50, P716, DOI 10.1021/ci9003865; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.69; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; GREVER MR, 1992, SEMIN ONCOL, V19, P622; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Iorio F, 2013, DRUG DISCOV TODAY, V18, P350, DOI 10.1016/j.drudis.2012.07.014; Jeff H., 2011, PROGRAMMING NEURAL N; Jeff H, 2008, INTRO NEURAL NETWORK; Jorgensen C, 2010, CURR OPIN GENET DEV, V20, P15, DOI 10.1016/j.gde.2009.12.003; Kelloff GJ, 2012, NAT REV DRUG DISCOV, V11, P201, DOI 10.1038/nrd3651; Kim YA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001095; KUBINYI H, 1990, J CANCER RES CLIN, V116, P529, DOI 10.1007/BF01637071; Kutalik Z, 2008, NAT BIOTECHNOL, V26, P531, DOI 10.1038/nbt1397; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li GH, 2012, BIOINFORMATICS, V28, P3334, DOI 10.1093/bioinformatics/bts625; Liu YC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r77; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Park ES, 2010, MOL CANCER THER, V9, P257, DOI 10.1158/1535-7163.MCT-09-0743; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; RIEDMILLER M, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P586, DOI 10.1109/ICNN.1993.298623; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Ruderfer DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006907; Sanseau P, 2011, BRIEF BIOINFORM, V12, P301, DOI 10.1093/bib/bbr047; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Shi LM, 1998, J CHEM INF COMP SCI, V38, P189, DOI 10.1021/ci970085w; Shi LM, 2000, J CHEM INF COMP SCI, V40, P367, DOI 10.1021/ci990087b; Silberberg Y, 2012, J COMPUT BIOL, V19, P163, DOI 10.1089/cmb.2011.0264; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Stevens J., 1996, APPL MULTIVARIATE ST, V3rd ed., DOI 10.4324/9780203843130; Swamidass SJ, 2005, BIOINFORMATICS, V21, pI359, DOI 10.1093/bioinformatics/bti1055; Torkamani A, 2011, PHARMACOGENOMICS J; Ulitsky Igor, 2010, PLoS One, V5, pe13367, DOI 10.1371/journal.pone.0013367; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Zaharevitz DW, 2002, J MOL GRAPH MODEL, V20, P297, DOI 10.1016/S1093-3263(01)00126-7; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	40	283	294	7	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61318	10.1371/journal.pone.0061318	http://dx.doi.org/10.1371/journal.pone.0061318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646105	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300006
J	Mishra, MK; Chaturvedi, P; Singh, R; Singh, G; Sharma, LK; Pandey, V; Kumari, N; Misra, P				Mishra, Manoj K.; Chaturvedi, Pankaj; Singh, Ruchi; Singh, Gaurav; Sharma, Lokendra K.; Pandey, Vibha; Kumari, Nishi; Misra, Pratibha			Overexpression of WsSGTL1 Gene of Withania somnifera Enhances Salt Tolerance, Heat Tolerance and Cold Acclimation Ability in Transgenic Arabidopsis Plants	PLOS ONE			English	Article							STEROL GLUCOSYLTRANSFERASE; SIGNAL-TRANSDUCTION; MEMBRANE-LIPIDS; PHOTOSYSTEM-II; STRESS; THALIANA; THERMOTOLERANCE; PHOTOSYNTHESIS; EXPRESSION; GLUCOSIDE	Background: Sterol glycosyltrnasferases (SGT) are enzymes that glycosylate sterols which play important role in plant adaptation to stress and are medicinally important in plants like Withania somnifera. The present study aims to find the role of WsSGTL1 which is a sterol glycosyltransferase from W. somnifera, in plant's adaptation to abiotic stress. Methodology: The WsSGTL1 gene was transformed in Arabidopsis thaliana through Agrobacterium mediated transformation, using the binary vector pBI121, by floral dip method. The phenotypic and physiological parameters like germination, root length, shoot weight, relative electrolyte conductivity, MDA content, SOD levels, relative electrolyte leakage and chlorophyll measurements were compared between transgenic and wild type Arabidopsis plants under different abiotic stresses - salt, heat and cold. Biochemical analysis was done by HPLC-TLC and radiolabelled enzyme assay. The promoter of the WsSGTL1 gene was cloned by using Genome Walker kit (Clontech, USA) and the 3D structures were predicted by using Discovery Studio Ver. 2.5. Results: The WsSGTL1 transgenic plants were confirmed to be single copy by Southern and homozygous by segregation analysis. As compared to WT, the transgenic plants showed better germination, salt tolerance, heat and cold tolerance. The level of the transgene WsSGTL1 was elevated in heat, cold and salt stress along with other marker genes such as HSP70, HSP90, RD29, SOS3 and LEA4-5. Biochemical analysis showed the formation of sterol glycosides and increase in enzyme activity. When the promoter of WsSGTL1 gene was cloned from W. somnifera and sequenced, it contained stress responsive elements. Bioinformatics analysis of the 3D structure of the WsSGTL1 protein showed functional similarity with sterol glycosyltransferase AtSGT of A. thaliana. Conclusions: Transformation of WsSGTL1 gene in A. thaliana conferred abiotic stress tolerance. The promoter of the gene in W. somnifera was found to have stress responsive elements. The 3D structure showed functional similarity with sterol glycosyltransferases.	[Mishra, Manoj K.; Singh, Ruchi; Singh, Gaurav; Sharma, Lokendra K.; Pandey, Vibha; Misra, Pratibha] CSIR, Natl Bot Res Inst, Lucknow, Uttar Pradesh, India; [Chaturvedi, Pankaj] Sanjay Gandhi Post Grad Inst Med Sci, Lucknow, Uttar Pradesh, India; [Kumari, Nishi] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Sanjay Gandhi Postgraduate Institute of Medical Sciences; Banaras Hindu University (BHU)	Misra, P (corresponding author), CSIR, Natl Bot Res Inst, Rana Pratap Marg, Lucknow, Uttar Pradesh, India.	pratibhaflora@yahoo.com		Singh, Gaurav/0000-0002-3798-2111; SINGH, RUCHI/0000-0003-4696-5150; Kumar Mishra, Manoj/0000-0001-7836-6254; PANDEY, VIBHA/0000-0001-7868-122X	Department of Biotechnology, Government of India [GAP-231225]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Funding provided by Department of Biotechnology, Government of India, for financial support through GAP-231225 project. Website: http://dbtindia.nic.in/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; BAKER J, 1988, PLANT MOL BIOL, V11, P277, DOI 10.1007/BF00027385; Bartwal A, 2012, J PLANT GROWTH REGUL, DOI [10.1007/s00344-012-9272, DOI 10.1007/S00344-012-9272]; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Bhattacharya SK, 2000, PHYTOMEDICINE, V7, P463, DOI 10.1016/S0944-7113(00)80030-6; BOUVIERNAVE P, 1984, PLANT SCI LETT, V36, P19, DOI 10.1016/0304-4211(84)90271-2; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaturvedi P, 2012, MOL BIOL REP, V39, P9755, DOI 10.1007/s11033-012-1841-3; Chaturvedi P, 2011, APPL BIOCHEM BIOTECH, V165, P47, DOI 10.1007/s12010-011-9232-0; Chen JP, 2006, PLANT CELL ENVIRON, V29, P1437, DOI 10.1111/j.1365-3040.2006.01527.x; Chen LX, 2011, NAT PROD REP, V28, P705, DOI 10.1039/c0np00045k; Chen RJY, 2009, ACTA PHARMACOL SIN, V30, P61, DOI 10.1038/aps.2008.6; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cui LJ, 2006, BOT STUD, V47, P61; da Silva EN, 2011, SCI AGR, V68, P62, DOI 10.1590/S0103-90162011000100010; DeBolt S, 2009, PLANT PHYSIOL, V151, P78, DOI 10.1104/pp.109.140582; GHOSAL S, 1989, PHYTOTHER RES, V3, P201, DOI 10.1002/ptr.2650030510; Gill T, 2010, J PLANT GENET TRANSG, V1, P1; Glombitza S, 2004, PLANT MOL BIOL, V54, P817, DOI 10.1007/s11103-004-0274-3; Grille S, 2010, PROG LIPID RES, V49, P262, DOI 10.1016/j.plipres.2010.02.001; Hadi MZ, 2002, PLANT CELL REP, V21, P130, DOI 10.1007/s00299-002-0473-9; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Houde M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-149; Husar S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-51; Jayaprakasam B, 2003, TETRAHEDRON, V59, P841, DOI 10.1016/S0040-4020(02)01601-0; Kalaji HM, 2011, ENVIRON EXP BOT, V73, P64, DOI 10.1016/j.envexpbot.2010.10.009; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KINGSTON RE, 1987, MOL CELL BIOL, V7, P1530, DOI 10.1128/MCB.7.4.1530; Kunimoto S, 2000, CELL STRESS CHAPERON, V5, P3, DOI 10.1379/1466-1268(2000)005<0003:EOCGBH>2.0.CO;2; Kunimoto S, 2002, CELL STRUCT FUNCT, V27, P157, DOI 10.1247/csf.27.157; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Lee JY, 2010, J PLANT BIOL, V53, P240, DOI 10.1007/s12374-010-9111-1; Levitt J, 1980, RESPONSES PLANTS ENV, P14; LILJENBERG CS, 1992, PROG LIPID RES, V31, P335, DOI 10.1016/0163-7827(92)90012-8; Lim CC, 1998, J AM SOC HORTIC SCI, V123, P246, DOI 10.21273/JASHS.123.2.246; Lin Fan-Yun, 2008, Yichuan, V30, P1608, DOI 10.3724/SP.J.1005.2008.01608; Lu CM, 2002, PLANT SCI, V163, P1063, DOI 10.1016/S0168-9452(02)00281-9; Madina BR, 2007, BBA-PROTEINS PROTEOM, V1774, P1199, DOI 10.1016/j.bbapap.2007.06.015; Madina BR, 2007, BBA-PROTEINS PROTEOM, V1774, P392, DOI 10.1016/j.bbapap.2006.12.009; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P1499, DOI 10.1016/S0968-0896(01)00024-4; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; MurakamiMurofushi K, 1997, J BIOL CHEM, V272, P486; Napoli C, 1997, BASIC RES CARDIOL, V92, P96, DOI 10.1007/BF00805570; Nishiyama R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032124; PALTA JP, 1993, PLANT PHYSIOL, V103, P793, DOI 10.1104/pp.103.3.793; PATTERSON GW, 1993, PHYTOCHEMISTRY, V33, P1381, DOI 10.1016/0031-9422(93)85095-9; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Schaller H, 2003, PROG LIPID RES, V42, P163, DOI 10.1016/S0163-7827(02)00047-4; Schumacher K, 2000, CURR OPIN PLANT BIOL, V3, P79, DOI 10.1016/S1369-5266(99)00038-2; Sharkey TD, 2005, PLANT CELL ENVIRON, V28, P269, DOI 10.1111/j.1365-3040.2005.01324.x; Sharma LK, 2007, ARCH BIOCHEM BIOPHYS, V460, P48, DOI 10.1016/j.abb.2007.01.024; Surjus Durand M, 1996, J EXP BOT, V47, P17; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Warnecke D, 1999, J BIOL CHEM, V274, P13048, DOI 10.1074/jbc.274.19.13048; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Zhao J, 2002, CHEM PHARM BULL, V50, P760, DOI 10.1248/cpb.50.760	59	49	51	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63064	10.1371/journal.pone.0063064	http://dx.doi.org/10.1371/journal.pone.0063064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646175	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300130
J	Remm, L; Lohmus, P; Leis, M; Lohmus, A				Remm, Liina; Lohmus, Piret; Leis, Mare; Lohmus, Asko			Long-Term Impacts of Forest Ditching on Non-Aquatic Biodiversity: Conservation Perspectives for a Novel Ecosystem	PLOS ONE			English	Article							OLD-GROWTH FORESTS; BOREAL SPRUCE FORESTS; ARTIFICIAL-DRAINAGE; SPECIES RICHNESS; STAND STRUCTURE; LAND; HABITAT; TREE; COMMUNITIES; PEATLANDS	Artificial drainage (ditching) is widely used to increase timber yield in northern forests. When the drainage systems are maintained, their environmental impacts are likely to accumulate over time and along accompanying management, notably after logging when new forest develops on decayed peat. Our study provides the first comprehensive documentation of long-term ditching impacts on terrestrial and arboreal biodiversity by comparing natural alder swamps and second-generation drained forests that have evolved from such swamps in Estonia. We explored species composition of four potentially drainage-sensitive taxonomic groups (vascular plants, bryophytes, lichens, and snails), abundance of species of conservation concern, and their relationships with stand structure in two-ha plots representing four management types (ranging from old growth to clearcut). We found that drainage affected plot-scale species richness only weakly but it profoundly changed assemblage composition. Bryophytes and lichens were the taxonomic groups that were most sensitive both to drainage and timber-harvesting; in closed stands they responded to changed microhabitat structure, notably impoverished tree diversity and dead-wood supply. As a result, natural old-growth plots were the most species-rich and hosted several specific species of conservation concern. Because the most influential structural changes are slow, drainage impacts may be long hidden. The results also indicated that even very old drained stands do not provide quality habitats for old-growth species of drier forest types. However, drained forests hosted many threatened species that were less site type specific, including early-successional vascular plants and snails on clearcuts and retention cuts, and bryophytes and lichens of successional and old forests. We conclude that three types of specific science-based management tools are needed to mitigate ditching effects on forest biodiversity: (i) silvicultural techniques to maintain stand structural complexity; (ii) context-dependent spatial analysis and planning of drained landscapes; and (iii) lists of focal species to monitor and guide ditching practices.	[Remm, Liina; Lohmus, Asko] Univ Tartu, Dept Zool, EE-50090 Tartu, Estonia; [Lohmus, Piret] Univ Tartu, Dept Bot, EE-50090 Tartu, Estonia; [Leis, Mare] Estonian Univ Life Sci, Dept Bot, Tartu, Estonia	University of Tartu; University of Tartu; Estonian University of Life Sciences	Lohmus, A (corresponding author), Univ Tartu, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia.	asko.lohmus@ut.ee		Lohmus, Piret/0000-0003-4664-1682; Lohmus, Asko/0000-0001-7283-8716	Estonian Science Foundation [7402, 7987, 9051]; Estonian Ministry of Education and Science [SF0180012s09, SF0170052s08]; Estonian State Forest Management Centre; herbarium of the Estonian University of Life Sciences (TAA); European Union through the European Regional Development Fund (Centre of Excellence FIBIR)	Estonian Science Foundation; Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Estonian State Forest Management Centre; herbarium of the Estonian University of Life Sciences (TAA); European Union through the European Regional Development Fund (Centre of Excellence FIBIR)(European Commission)	The research was supported by the Estonian Science Foundation (grants 7402, 7987, 9051), the Estonian Ministry of Education and Science (projects SF0180012s09, SF0170052s08), The Estonian State Forest Management Centre, the herbarium of the Estonian University of Life Sciences (TAA), and the European Union through the European Regional Development Fund (Centre of Excellence FIBIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERMANN V, 2009, ESTONIAN FORESTS 200; Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; Angelstam Per, 2004, Ecological Bulletins, V51, P1; Anshari GZ, 2010, BIOGEOSCIENCES, V7, P3403, DOI 10.5194/bg-7-3403-2010; Asada T, 2004, CAN J FOREST RES, V34, P1730, DOI 10.1139/X04-042; Asplund J, 2010, J ECOL, V98, P218, DOI 10.1111/j.1365-2745.2009.01584.x; Baar J, 2000, PLANT BIOLOGY, V2, P505, DOI 10.1055/s-2000-7468; Baltzinger M, 2011, ANN FOREST SCI, V68, P395, DOI 10.1007/s13595-011-0026-x; Bergstedt J, 2001, FOREST ECOL MANAG, V154, P105, DOI 10.1016/S0378-1127(00)00642-3; Bernes C., 1994, BIOL DIVERSITY SWEDE; Blann KL, 2009, CRIT REV ENV SCI TEC, V39, P909, DOI 10.1080/10643380801977966; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; Brinson MM, 2002, ENVIRON CONSERV, V29, P115, DOI 10.1017/S0376892902000085; Cameron RAD, 2005, J CONCHOL, V38, P529; Chapman MG, 2009, OECOLOGIA, V161, P625, DOI 10.1007/s00442-009-1393-y; COPPINS AM, 2002, INDICES ECOLOGICAL C; Doering M, 2010, BOTANY, V88, P144, DOI 10.1139/B09-096; Dolny A, 2012, BIOL CONSERV, V145, P109, DOI 10.1016/j.biocon.2011.10.020; Douda J, 2011, OECOLOGIA, P1; DUBE S, 1995, WATER RESOUR RES, V31, P1741, DOI 10.1029/95WR00427; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dynesius M, 2007, BIOL CONSERV, V135, P423, DOI 10.1016/j.biocon.2006.10.010; Ecke F, 2009, FRESHWATER BIOL, V54, P119, DOI 10.1111/j.1365-2427.2008.02097.x; Ek Tommy, 2001, Svensk Botanisk Tidskrift, V95, P357; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Etverk I, 1974, FORESTS ESTONIA, P40; Fenton NJ, 2008, BIOL CONSERV, V141, P1389, DOI 10.1016/j.biocon.2008.03.019; Furukawa Y, 2005, NUTR CYCL AGROECOSYS, V71, P81, DOI 10.1007/s10705-004-5286-5; Gloer P., 1994, SUSSWASSERMOLLUSKEN; Grigaliunas V, 2011, BALT FOR, V17, P102; GUSTAFSSON L, 1992, LICHENOLOGIST, V24, P255, DOI 10.1017/S0024282992000367; Hanley ME, 2009, ANN BOT-LONDON, V103, P1347, DOI 10.1093/aob/mcp081; Hartley MJ, 2002, FOREST ECOL MANAG, V155, P81, DOI 10.1016/S0378-1127(01)00549-7; Hautala H, 2011, RESTOR ECOL, V19, P418, DOI 10.1111/j.1526-100X.2009.00545.x; Hensgen F, 2011, FLORA, V206, P534, DOI 10.1016/j.flora.2011.01.002; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Holden J, 2004, PROG PHYS GEOG, V28, P95, DOI 10.1191/0309133304pp403ra; Holien H, 1998, NOVA HEDWIGIA, V66, P283; Hollmen A, 2008, J INSECT CONSERV, V12, P163, DOI 10.1007/s10841-007-9076-7; HOLOPAINEN AL, 1992, HYDROBIOLOGIA, V243, P457, DOI 10.1007/BF00007063; Honnay O., 2004, FOREST BIODIVERSITY; Hoover JP, 2006, BIOL CONSERV, V127, P37, DOI 10.1016/j.biocon.2005.07.017; Hornberg G, 1998, BIOSCIENCE, V48, P795, DOI 10.2307/1313391; Horsak M, 2007, ACTA OECOL, V32, P161, DOI 10.1016/j.actao.2007.03.011; Hunter ML, 2002, CONSERV BIOL, V16, P660, DOI 10.1046/j.1523-1739.2002.01108.x; Hylander K, 2004, CONSERV BIOL, V18, P1052, DOI 10.1111/j.1523-1739.2004.00199.x; Ingerpuu N., 1998, KEY ESTONIAN BRYOPHY; Jonsson BG, 2005, SILVA FENN, V39, P289, DOI 10.14214/sf.390; Juriado I, 2009, BIODIVERS CONSERV, V18, P105, DOI 10.1007/s10531-008-9460-y; Jutras S, 2007, FOREST CHRON, V83, P723, DOI 10.5558/tfc83723-5; Jutras Sylvain, 2005, Suo (Helsinki), V56, P95; Kerney M. P., 1979, LAND SNAILS BRITAIN; KRALKA RA, 1986, AM MIDL NAT, V115, P156, DOI 10.2307/2425845; KUKK T, 1999, VASCULAR PLANT FLORA; Kuuluvainen T, 2002, SILVA FENN, V36, P409, DOI 10.14214/sf.572; Kuusinen M, 1996, ECOGRAPHY, V19, P41, DOI 10.1111/j.1600-0587.1996.tb00153.x; Laiho R, 2006, SOIL BIOL BIOCHEM, V38, P2011, DOI 10.1016/j.soilbio.2006.02.017; Laine J, 1995, J APPL ECOL, V32, P785, DOI 10.2307/2404818; Laine Jukka, 1995, Environmental Reviews, V3, P286, DOI 10.1139/a95-015; Lavoie Martin, 2005, Environmental Reviews, V13, P21, DOI 10.1139/a05-006; Lohmus A., 2004, ECOL BULL, V51, P401; Lohmus A, 2011, SILVA FENN, V45, P1015, DOI 10.14214/sf.84; Lohmus A, 2011, CAN J FOREST RES, V41, P1352, DOI [10.1139/X11-047, 10.1139/x11-047]; Lohmus A, 2011, J FOREST RES-JPN, V16, P194, DOI 10.1007/s10310-011-0256-7; Lohmus A, 2010, FOREST ECOL MANAG, V260, P155, DOI 10.1016/j.foreco.2010.04.018; Lohmus E, 1981, ANTHROPOGENOUS CHANG, P77; Lohmus E., 1984, ESTONIAN FOREST SITE; Lohmus P, 2006, CAN J FOREST RES, V36, P1319, DOI 10.1139/X06-032; Lohmus P, 2012, NOVA HEDWIGIA, V95, P493, DOI 10.1127/0029-5035/2012/0064; Lohmus P, 2009, LICHENOLOGIST, V41, P61, DOI 10.1017/S002428290900807X; Ludwig GX, 2008, J APPL ECOL, V45, P325, DOI 10.1111/j.1365-2664.2007.01396.x; Marmor L, 2011, ECOL INDIC, V11, P1270, DOI 10.1016/j.ecolind.2011.01.009; Martin K, 2004, J BIOGEOGR, V31, P531, DOI 10.1046/j.1365-2699.2003.01005.x; Masing V, 2010, WETL ECOL MANAG, V18, P397, DOI 10.1007/s11273-008-9130-6; McCune B., 2011, PC ORD MULTIVARIATE; METLA, 2010, FINN STAT YB FOR 201; Moser M., 1996, P 6 M C CONTR PART B, P21; Nitare J., 2000, SIGNALARTER INDIKATO; Ohlson M, 1997, BIOL CONSERV, V81, P221, DOI 10.1016/S0006-3207(97)00001-3; Ostlund L, 1997, CAN J FOREST RES, V27, P1198, DOI 10.1139/x97-070; Paavilainen E., 1995, PEATLAND FORESTRY EC, Vvol 111; Pilte D, 2003, FINNISH ENV, V485, P216; Prieditis N, 1999, ENVIRON CONSERV, V26, P332, DOI 10.1017/S0376892999000442; Proctor MCF, 2007, BRYOLOGIST, V110, P595, DOI 10.1639/0007-2745(2007)110[595:DIBAR]2.0.CO;2; Pulkki R, 2003, SUSTAINABLE MANAGEME; Pykala J, 2004, APPL VEG SCI, V7, P29, DOI 10.1111/j.1654-109X.2004.tb00592.x; Rajala P., 1982, Suomen Riista, P93; Ray D, 1998, FORESTRY, V71, P169, DOI 10.1093/forestry/71.2.169; Remm J, 2006, FOREST ECOL MANAG, V221, P267, DOI 10.1016/j.foreco.2005.10.015; Richardson PJ, 2010, ECOL APPL, V20, P728, DOI 10.1890/08-1092.1; Rosenvald R, 2011, FOREST ECOL MANAG, V262, P1541, DOI 10.1016/j.foreco.2011.07.002; Santesson R., 2004, LICHEN FORMING LICHE; Schmalholz M, 2011, ECOGRAPHY, V34, P637, DOI 10.1111/j.1600-0587.2010.06652.x; Somermaa A, 1972, ECOLOGY EPIPHYTIC LI; Sorrell B. K., 2007, Wetlands Ecology and Management, V15, P361, DOI 10.1007/s11273-007-9035-9; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Speiser B., 2001, P259, DOI 10.1079/9780851993188.0259; Stokland J.N., 2001, ECOL BULL, V49, P71; Strakova P, 2011, BIOGEOSCIENCES, V8, P2741, DOI 10.5194/bg-8-2741-2011; Suija A, 2011, FOLIA CRYPTOG ESTONI, V48, P154; Suislepp K, 2011, FOREST ECOL MANAG, V262, P1078, DOI 10.1016/j.foreco.2011.06.001; Szybiak K, 2009, POL J ECOL, V57, P525; Tapper PG, 1996, ECOGRAPHY, V19, P237, DOI 10.1111/j.1600-0587.1996.tb01250.x; Trass H, 1999, ANN BOT FENN, V36, P67; Ulevicius Alius, 2011, Ekologija, V57, P47; Uuttera J, 1997, FOREST ECOL MANAG, V96, P125, DOI 10.1016/S0378-1127(97)00035-2; VALOVIRTA I, 1998, J CONCHOL SPECIAL PU, V2, P251; Vellak K., 2007, Forestry Studies / Metsanduslikud Uurimused, V47, P87; Vindigni MA, 2009, FOREST ECOL MANAG, V258, P2056, DOI 10.1016/j.foreco.2009.07.058; Von Arnold K, 2005, FOREST ECOL MANAG, V210, P239, DOI 10.1016/j.foreco.2005.02.031; WOLDA H, 1971, OECOLOGIA, V7, P361, DOI 10.1007/BF00345860; Yule CM, 2010, BIODIVERS CONSERV, V19, P393, DOI 10.1007/s10531-008-9510-5	112	36	36	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63086	10.1371/journal.pone.0063086	http://dx.doi.org/10.1371/journal.pone.0063086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646179	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300134
J	Strnad, L; Peelen, MV; Bedny, M; Caramazza, A				Strnad, Lukas; Peelen, Marius V.; Bedny, Marina; Caramazza, Alfonso			Multivoxel Pattern Analysis Reveals Auditory Motion Information in MT plus of Both Congenitally Blind and Sighted Individuals	PLOS ONE			English	Article							VISUAL-CORTEX; FUNCTIONAL SPECIALIZATION; BRAIN; HUMANS; AREAS; ORGANIZATION; ACTIVATION; EXPERIENCE; DIRECTION; VISION	Cross-modal plasticity refers to the recruitment of cortical regions involved in the processing of one modality (e.g. vision) for processing other modalities (e.g. audition). The principles determining how and where cross-modal plasticity occurs remain poorly understood. Here, we investigate these principles by testing responses to auditory motion in visual motion area MT+ of congenitally blind and sighted individuals. Replicating previous reports, we find that MT+ as a whole shows a strong and selective responses to auditory motion in congenitally blind but not sighted individuals, suggesting that the emergence of this univariate response depends on experience. Importantly, however, multivoxel pattern analyses showed that MT+ contained information about different auditory motion conditions in both blind and sighted individuals. These results were specific to MT+ and not found in early visual cortex. Basic sensitivity to auditory motion in MT+ is thus experience-independent, which may be a basis for the region's strong cross-modal recruitment in congenital blindness.	[Strnad, Lukas; Peelen, Marius V.; Caramazza, Alfonso] Univ Trent, Ctr Mind Brain Sci, Rovereto, Italy; [Strnad, Lukas; Caramazza, Alfonso] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Bedny, Marina] MIT, Brain & Cognit Sci Dept, Cambridge, MA 02139 USA; [Bedny, Marina] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA	University of Trento; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Caramazza, A (corresponding author), Univ Trent, Ctr Mind Brain Sci, Rovereto, Italy.	caram@wjh.harvard.edu	Peelen, Marius V/D-1780-2010	Peelen, Marius V/0000-0002-4026-7303	Fondazione Cassa di Risparmio di Trento e Rovereto	Fondazione Cassa di Risparmio di Trento e Rovereto(Fondazione Caritro)	The research was financially supported by the Fondazione Cassa di Risparmio di Trento e Rovereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alink A, 2012, HUM BRAIN MAPP, V33, P969, DOI 10.1002/hbm.21263; Amedi A, 2004, NAT NEUROSCI, V7, P1266, DOI 10.1038/nn1328; Bedny M, 2008, J NEUROSCI, V28, P11347, DOI 10.1523/JNEUROSCI.3039-08.2008; Bedny M, 2010, CURR BIOL, V20, P1900, DOI 10.1016/j.cub.2010.09.044; Collignon O, 2007, CEREB CORTEX, V17, P457, DOI 10.1093/cercor/bhj162; Collignon O, 2011, P NATL ACAD SCI USA, V108, P4435, DOI 10.1073/pnas.1013928108; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Downing PE, 2007, J NEUROSCI, V27, P226, DOI 10.1523/JNEUROSCI.3619-06.2007; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Mahon BZ, 2011, TRENDS COGN SCI, V15, P97, DOI 10.1016/j.tics.2011.01.004; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Peelen MV, 2006, NEURON, V49, P815, DOI 10.1016/j.neuron.2006.02.004; Peelen MV, 2013, J COGN NEUROSCI; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Poirier C, 2005, COGNITIVE BRAIN RES, V25, P650, DOI 10.1016/j.cogbrainres.2005.08.015; Reich L, 2011, CURR BIOL, V21, P363, DOI 10.1016/j.cub.2011.01.040; Renier LA, 2010, NEURON, V68, P138, DOI 10.1016/j.neuron.2010.09.021; Ricciardi E, 2007, CEREB CORTEX, V17, P2933, DOI 10.1093/cercor/bhm018; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Saenz M, 2008, J NEUROSCI, V28, P5141, DOI 10.1523/JNEUROSCI.0803-08.2008; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Wolbers T, 2011, NEUROIMAGE, V56, P681, DOI 10.1016/j.neuroimage.2010.04.266	27	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63198	10.1371/journal.pone.0063198	http://dx.doi.org/10.1371/journal.pone.0063198			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646195	Green Published, gold			2022-12-25	WOS:000319077300152
J	Tonnessen, R; Hauge, AG; Hansen, EF; Rimstad, E; Jonassen, CM				Tonnessen, Ragnhild; Hauge, Anna G.; Hansen, Elisabeth F.; Rimstad, Espen; Jonassen, Christine M.			Host Restrictions of Avian Influenza Viruses: In Silico Analysis of H13 and H16 Specific Signatures in the Internal Proteins	PLOS ONE			English	Article							A-VIRUS; NS1 PROTEIN; HEMAGGLUTININ SUBTYPE; WILD WATERFOWL; PB1 GENE; NUCLEOPROTEIN; EVOLUTION; NUCLEAR; BIRDS; ECOLOGY	Gulls are the primary hosts of H13 and H16 avian influenza viruses (AIVs). The molecular basis for this host restriction is only partially understood. In this study, amino acid sequences from Eurasian gull H13 and H16 AIVs and Eurasian AIVs (non H13 and H16) were compared to determine if specific signatures are present only in the internal proteins of H13 and H16 AIVs, using a bioinformatics approach. Amino acids identified in an initial analysis performed on 15 selected sequences were checked against a comprehensive set of AIV sequences retrieved from Genbank to verify them as H13 and H16 specific signatures. Analysis of protein similarities and prediction of subcellular localization signals were performed to search for possible functions associated with the confirmed signatures. H13 and H16 AIV specific signatures were found in all the internal proteins examined, but most were found in the non-structural protein 1 (NS1) and in the nucleoprotein. A putative functional signature was predicted to be present in the nuclear export protein. Moreover, it was predicted that the NS1 of H13 and H16 AIVs lack one of the nuclear localization signals present in NS1 of other AIV subtypes. These findings suggest that the signatures found in the internal proteins of H13 and H16 viruses are possibly related to host restriction.	[Tonnessen, Ragnhild; Hansen, Elisabeth F.; Rimstad, Espen] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway; [Tonnessen, Ragnhild; Hauge, Anna G.; Jonassen, Christine M.] Norwegian Vet Inst, Dept Lab Serv, Oslo, Norway	Norwegian University of Life Sciences; Norwegian Veterinary Institute	Tonnessen, R (corresponding author), Norwegian Vet Inst, Dept Lab Serv, Oslo, Norway.	ragnhild.tonnessen@vetinst.no			Norwegian Research Council [178275]; Animalia Meat and Poultry Research Centre; Norwegian Food Safety Authority	Norwegian Research Council(Research Council of NorwayEuropean Commission); Animalia Meat and Poultry Research Centre; Norwegian Food Safety Authority	This work was supported by the Norwegian Research Council (www.forskningsradet.no) (project number 178275), Animalia Meat and Poultry Research Centre (www.animalia.no) and the Norwegian Food Safety Authority (www.mattilsynet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; BEAN WJ, 1984, VIROLOGY, V133, P438, DOI 10.1016/0042-6822(84)90410-0; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; Brown J, 2012, AVIAN DIS, V56, P969, DOI 10.1637/10158-040912-Reg.1; Bui VN, 2012, VIROLOGY, V423, P77, DOI 10.1016/j.virol.2011.11.019; DAOUST PY, 2012, VET PATHOL IN PRESS; Dillon D, 2010, INFECT GENET EVOL, V10, P1085, DOI 10.1016/j.meegid.2010.07.004; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Galloway SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003151; Gambaryan A, 2005, VIROLOGY, V334, P276, DOI 10.1016/j.virol.2005.02.003; Germundsson A, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-28; GORMAN OT, 1990, J VIROL, V64, P1487, DOI 10.1128/JVI.64.4.1487-1497.1990; GORMAN OT, 1990, J VIROL, V64, P4893, DOI 10.1128/JVI.64.10.4893-4902.1990; GREENSPAN D, 1988, J VIROL, V62, P3020, DOI 10.1128/JVI.62.8.3020-3026.1988; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2009, VIROLOGY, V383, P6, DOI 10.1016/j.virol.2008.10.002; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hrincius ER, 2010, CELL MICROBIOL, V12, P831, DOI 10.1111/j.1462-5822.2010.01436.x; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jonassen CM, 2007, AVIAN DIS, V51, P425, DOI 10.1637/7555-033106R1.1; Kawaoka Y, 1998, VIRUS RES, V55, P143, DOI 10.1016/S0168-1702(98)00038-0; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Keawcharoen J, 2010, VACCINE, V28, P5803, DOI 10.1016/j.vaccine.2010.06.072; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Lebarbenchon Camille, 2008, J Mol Genet Med, V3, P121; Li Z, 2009, J VIROL, V83, P4153, DOI 10.1128/JVI.02642-08; Lu XS, 2012, J VIROL, V86, P12861, DOI 10.1128/JVI.01606-12; Manzoor R, 2008, VIRUS GENES, V37, P144, DOI 10.1007/s11262-008-0248-7; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; *NCBI, 2012, INFL VIR RES; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Phipps LP, 2004, J VIROL METHODS, V122, P119, DOI 10.1016/j.jviromet.2004.08.008; Pielak RM, 2011, BBA-BIOMEMBRANES, V1808, P522, DOI 10.1016/j.bbamem.2010.04.015; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Ramey AM, 2010, VIROLOGY, V406, P352, DOI 10.1016/j.virol.2010.07.031; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tisoncik JR, 2011, J GEN VIROL, V92, P2093, DOI 10.1099/vir.0.032060-0; Toennessen R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-21; Tonnessen R, 2011, AVIAN DIS, V55, P680, DOI 10.1637/9701-030411-ResNote.1; Van Borm S, 2012, ARCH VIROL, V157, P1509, DOI 10.1007/s00705-012-1323-x; Wallensten A, 2005, ARCH VIROL, V150, P1685, DOI 10.1007/s00705-005-0543-8; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Widjaja L, 2004, J VIROL, V78, P8771, DOI 10.1128/JVI.78.16.8771-8779.2004; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1; World Health Organization (WHO), 2002, MAN AN INFL DIAGN SU; Yamnikova SS, 2003, AVIAN DIS, V47, P1164, DOI 10.1637/0005-2086-47.s3.1164; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11	57	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63270	10.1371/journal.pone.0063270	http://dx.doi.org/10.1371/journal.pone.0063270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646204	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300163
J	Guo, R; Li, Y; Ning, JY; Sun, D; Lin, LJ; Liu, XM				Guo, Rong; Li, Yong; Ning, Jinying; Sun, Dan; Lin, Lianjun; Liu, Xinmin			HnRNP A1/A2 and SF2/ASF Regulate Alternative Splicing of Interferon Regulatory Factor-3 and Affect Immunomodulatory Functions in Human Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; HEPATOCELLULAR-CARCINOMA; NUCLEAR TRANSLOCATION; LINKING INFLAMMATION; ACTIVATION; IRF-3; TRANSCRIPTION; IMMUNITY; SURVIVAL	Heterogeneous nuclear ribonucleoparticule A1/A2 (hnRNP A1/A2) and splicing factor 2/alternative splicing factor (SF2/ASF) are pivotal for precursor messenger RNA (pre-mRNA) splicing. Interferon regulatory factor-3 (IRF-3) plays critical roles in host defense against viral and microbial infection. Truncated IRF-3 proteins resulting from alternative splicing have been identified and characterized as functional antagonists to full-length IRF-3. In this study, we examined the molecular mechanism for splicing regulation of IRF-3 pre-mRNA and first reported the regulatory effect of hnRNP A1/A2 and SF2/ASF on IRF-3 splicing and activation. RNA interference-mediated depletion of hnRNP A1/A2 or SF2/ASF in human non-small cell lung cancer (NSCLC) cells increased exclusion of exons 2 and 3 of IRF-3 gene and reduced expression levels of IRF-3 protein and IRF-3 downstream effector molecules interferon-beta and CXCL10/IP-10. In addition, direct binding of hnRNP A1 and SF2/ASF to specific binding motifs in IRF-3 intron 1 was confirmed by RNA electrophoretic mobility shift assay. Subsequent minigene splicing assay showed that IRF-3 minigenes with mutated hnRNPA 1/A2 or SF2/ASF binding motifs increased exclusion of exons 2 and 3. Moreover, knockdown of hnRNP A1/A2 or SF2/ASF in NSCLC cells reinforced phytohemagglutinin-induced tumor necrosis factor-alpha release by peripheral blood mononuclear cells (PBMC) but suppressed that of interleukin-10 in NSCLC/PBMC co-cultures. Taken together, our results suggest that specific knockdown for hnRNP A1/A2 or SF2/ASF increase exclusion of exons 2 and 3 of IRF-3 pre-mRNA and influence immunomodulatory functions of human NSCLC cells.	[Guo, Rong; Sun, Dan; Lin, Lianjun; Liu, Xinmin] Peking Univ First Hosp, Dept Geriatr, Beijing 100871, Peoples R China; [Li, Yong] Beijing Canc Hosp, Peking Univ Canc Hosp, Beijing Inst Canc Res,Dept Lab Anim, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China; [Ning, Jinying] Crown Biosci Inc Beijing, Dept Cell Biol, Beijing, Peoples R China	Peking University; Peking University	Liu, XM (corresponding author), Peking Univ First Hosp, Dept Geriatr, Beijing 100871, Peoples R China.	lxm2128@163.com			National Natural Science Foundation of China [30572072, 30871366]; Beijing Municipal Natural Science Foundation [5092009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by the National Natural Science Foundation of China (Grant No. 30572072) to XL and by the Beijing Municipal Natural Science Foundation (Grant No. 5092009) and the National Natural Science Foundation of China (Grant No. 30871366) to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altraja S, 2009, RESPIROLOGY, V14, P39, DOI 10.1111/j.1440-1843.2008.01414.x; BRENNAN FM, 1989, LANCET, V2, P244; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4359, DOI 10.1093/nar/gkm444; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Chew V, 2012, GUT, V61, P427, DOI 10.1136/gutjnl-2011-300509; Colobran R, 2007, CLIN EXP IMMUNOL, V150, P1, DOI 10.1111/j.1365-2249.2007.03489.x; Cui HQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-356; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Duguay D, 2002, CANCER RES, V62, P5148; Ezponda T, 2010, CLIN CANCER RES, V16, P4113, DOI 10.1158/1078-0432.CCR-10-0076; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; He YW, 2005, J CELL SCI, V118, P3173, DOI 10.1242/jcs.02448; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Karpova AY, 2001, MOL CELL BIOL, V21, P4169, DOI 10.1128/MCB.21.13.4169-4176.2001; Karpova AY, 2000, GENE DEV, V14, P2813, DOI 10.1101/gad.813800; Kim TY, 2003, J BIOL CHEM, V278, P15272, DOI 10.1074/jbc.M205792200; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Levy DE, 2003, CURR OPIN IMMUNOL, V15, P52, DOI 10.1016/S0952-7915(02)00011-0; Li QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028683; Li Y, 2011, BBA-GENE REGUL MECH, V1809, P166, DOI 10.1016/j.bbagrm.2011.01.006; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038868; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mole S, 2009, J PATHOL, V219, P383, DOI 10.1002/path.2608; Mougiakakos D, 2010, ADV CANCER RES, V107, P57, DOI 10.1016/S0065-230X(10)07003-X; Navarro L, 1998, MOL CELL BIOL, V18, P3796, DOI 10.1128/MCB.18.7.3796; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Owens BMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041050; Paladino P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010428; Pan H, 2008, J BIOL CHEM, V283, P623, DOI 10.1074/jbc.M704934200; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pino I, 2003, LUNG CANCER-J IASLC, V41, P131, DOI 10.1016/S0169-5002(03)00193-4; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Sadik CD, 2009, NUCLEIC ACIDS RES, V37, P5041, DOI 10.1093/nar/gkp525; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shen ML, 2012, NUCLEIC ACIDS RES, V40, P428, DOI 10.1093/nar/gkr713; Slattery ML, 2011, CARCINOGENESIS, V32, P1660, DOI 10.1093/carcin/bgr189; Somberg M, 2010, J VIROL, V84, P8219, DOI 10.1128/JVI.00462-10; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tarassishin L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-187; Tauler J, 2009, CURR OPIN PHARMACOL, V9, P384, DOI 10.1016/j.coph.2009.06.004; tenOever BR, 2002, J VIROL, V76, P3659, DOI 10.1128/JVI.76.8.3659-3669.2002; Tokunaga T, 2010, BIOCHEM BIOPH RES CO, V397, P202, DOI 10.1016/j.bbrc.2010.05.085; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wang SS, 2009, J INFECT DIS, V199, P20, DOI 10.1086/595563; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhao W, 2012, J IMMUNOL, V188, P3179, DOI 10.4049/jimmunol.1101175; Zhou J, 2001, BREAST CANCER RES TR, V66, P217, DOI 10.1023/A:1010631915831	59	36	40	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62729	10.1371/journal.pone.0062729	http://dx.doi.org/10.1371/journal.pone.0062729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658645	Green Submitted, Green Published, gold			2022-12-25	WOS:000321662800058
J	Menger, R; Dijkerman, HC; Van der Stigchel, S				Menger, Rudmer; Dijkerman, H. Chris; Van der Stigchel, Stefan			The Effect of Similarity: Non-Spatial Features Modulate Obstacle Avoidance	PLOS ONE			English	Article							TO-GRASP MOVEMENTS; EYE-HAND COORDINATION; AUTOMATIC AVOIDANCE; VISUAL AWARENESS; OPTIC ATAXIA; TARGET; REACH; DEVIATIONS; INTERFERENCE; PREHENSION	The introduction of non-target objects into a workspace leads to temporal and spatial adjustments of reaching trajectories towards a target. If the non-target is obstructing the path of the hand towards the target, the reach is adjusted such that collision with the non-target, or obstacle, is avoided. Little is known about the influence of features which are irrelevant for the execution of the movement on avoidance movements, like color similarity between target and non-target objects. In eye movement studies the similarity of non-targets has been revealed to influence oculomotor competition. Because of the tight neural and behavioral coupling between the gaze and reaching system, our aim was to determine the contribution of similarity between target and non-target to avoidance movements. We performed 2 experiments in which participants had to reach to grasp a target object while a non-target was present in the workspace. These non-targets could be either similar or dissimilar in color to the target. The results indicate that the non-spatial feature similarity can further modify the avoidance response and therefore further modify the spatial path of the reach. Indeed, we find that dissimilar pairs have a stronger effect on reaching-to-grasp movements than similar pairs. This effect was most pronounced when the non-target was on the outside of the reaching hand, where it served as more of an obstacle to the trailing arm. We propose that the increased capture of attention by the dissimilar obstacle is responsible for the more robust avoidance response.	[Menger, Rudmer; Dijkerman, H. Chris; Van der Stigchel, Stefan] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands	Utrecht University	Menger, R (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	r.menger@uu.nl		van der Stigchel, Stefan/0000-0002-5918-3521	University Utrecht	University Utrecht	This research was funded by an internal and independent funds of the University Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aidroos N, 2010, VIS COGN, V18, P26, DOI 10.1080/13506280802456939; Biegstraaten M, 2003, EXP BRAIN RES, V149, P530, DOI 10.1007/s00221-003-1374-z; Chapman CS, 2008, EXP BRAIN RES, V191, P83, DOI 10.1007/s00221-008-1499-1; Gentilucci M, 2001, EXP BRAIN RES, V137, P36, DOI 10.1007/s002210000639; Hesse C, 2012, EUR J NEUROSCI, V36, P2383, DOI 10.1111/j.1460-9568.2012.08131.x; Howard LA, 1997, EXP BRAIN RES, V113, P144, DOI 10.1007/BF02454150; JACKSON SR, 1995, EXP BRAIN RES, V102, P519; Jonikaitis D, 2011, PSYCHOL SCI, V22, P339, DOI 10.1177/0956797610397666; Kritikos A, 2000, Q J EXP PSYCHOL-A, V53, P131, DOI 10.1080/027249800390709; Kritikos A, 2001, EXP BRAIN RES, V138, P54, DOI 10.1007/s002210000641; Ludwig CJH, 2003, EXP BRAIN RES, V152, P60, DOI 10.1007/s00221-003-1520-7; Ludwig CJH, 2002, J EXP PSYCHOL HUMAN, V28, P902, DOI 10.1037//0096-1523.28.4.902; McIntosh RD, 2004, P ROY SOC B-BIOL SCI, V271, P15, DOI 10.1098/rspb.2003.2545; Meegan DV, 1998, Q J EXP PSYCHOL-A, V51, P225, DOI 10.1080/02724989843000004; Menger R, 2012, ACTA PSYCHOL, V141, P1, DOI 10.1016/j.actpsy.2012.06.006; Mon-Williams M, 2001, EXP BRAIN RES, V137, P497; Mon-Williams M, 2000, EXP BRAIN RES, V134, P268, DOI 10.1007/s002210000479; Mulckhuyse M, 2009, J NEUROPHYSIOL, V102, P1451, DOI 10.1152/jn.00068.2009; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Rice NJ, 2008, NEUROPSYCHOLOGIA, V46, P1549, DOI 10.1016/j.neuropsychologia.2008.01.012; Rice NJ, 2006, EXP BRAIN RES, V174, P176, DOI 10.1007/s00221-006-0435-5; Sailer U, 2000, EXP BRAIN RES, V134, P163, DOI 10.1007/s002210000457; Saling M, 1998, EXP BRAIN RES, V118, P251, DOI 10.1007/s002210050279; Schenk T, 2005, EXP BRAIN RES, V167, P95, DOI 10.1007/s00221-005-0027-9; Schindler I, 2004, NAT NEUROSCI, V7, P779, DOI 10.1038/nn1273; Schot WD, 2010, J NEUROSCI METH, V187, P147, DOI 10.1016/j.jneumeth.2010.01.004; Song JH, 2009, J NEUROPHYSIOL, V102, P2681, DOI 10.1152/jn.91352.2008; Thompson AA, 2007, NEUROSCI LETT, V426, P111, DOI 10.1016/j.neulet.2007.09.006; Tipper SP, 1997, VIS COGN, V4, P1, DOI 10.1080/713756749; Tresilian JR, 1998, EXP BRAIN RES, V120, P352, DOI 10.1007/s002210050409; Verhagen L, 2008, J NEUROSCI, V28, P4726, DOI 10.1523/JNEUROSCI.0057-08.2008; Welsh TN, 2011, ACTA PSYCHOL, V137, P300, DOI 10.1016/j.actpsy.2011.03.011; Welsh TN, 1999, EXP BRAIN RES, V127, P207, DOI 10.1007/s002210050790	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e59294	10.1371/journal.pone.0059294	http://dx.doi.org/10.1371/journal.pone.0059294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658606	Green Published, Green Submitted, gold			2022-12-25	WOS:000321662800002
J	Eastburn, DJ; Sciambi, A; Abate, AR				Eastburn, Dennis J.; Sciambi, Adam; Abate, Adam R.			Picoinjection Enables Digital Detection of RNA with Droplet RT-PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ELECTROCOALESCENCE; MICROFLUIDICS	The ability to add reagents to drops in a sequential fashion is necessary for numerous applications of microfluidics in biology. An important method for accomplishing this is picoinjection, a technique in which reagents are injected into aqueous drops using an electric field. While picoinjection has been shown to allow the precise addition of reagents to drops, its compatibility with biological reactions is yet to be thoroughly demonstrated. Here, we investigate the compatibility of picoinjection with digital RT-PCR Taqman assays, reactions that incorporate nucleic acids, enzymes, and other common biological reagents. We find that picoinjection is compatible with this assay and enables the detection of RNA transcripts at rates comparable to workflows not incorporating picoinjection. We also find that picoinjection results in negligible transfer of material between drops and that the drops faithfully retain their compartmentalization.	[Eastburn, Dennis J.; Sciambi, Adam; Abate, Adam R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Abate, AR (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	adam.abate@ucsf.edu			Department of Bioengineering and Therapeutic Sciences; California Institute for Quantitative Biosciences [QB3]; Rogers Family Foundation; UCSF/Sandler Foundation; University of California	Department of Bioengineering and Therapeutic Sciences; California Institute for Quantitative Biosciences; Rogers Family Foundation; UCSF/Sandler Foundation; University of California(University of California System)	This work was supported by startup funds from the Department of Bioengineering and Therapeutic Sciences, a Research Award from the California Institute for Quantitative Biosciences (QB3), the Bridging the Gap Award from the Rogers Family Foundation, a New Frontiers Research Award from the UCSF/Sandler Foundation Program for Breakthrough Biomedical Research, and a grant from the University of California Proof of Concept Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate AR, 2010, P NATL ACAD SCI USA, V107, P19163, DOI 10.1073/pnas.1006888107; Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Ahn K, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2164911; ATTEN P, 1993, J ELECTROSTAT, V30, P259, DOI 10.1016/0304-3886(93)90080-Q; Beer NR, 2008, ANAL CHEM, V80, P1854, DOI 10.1021/ac800048k; Brouzes E, 2009, P NATL ACAD SCI USA, V106, P14195, DOI 10.1073/pnas.0903542106; Chabert M, 2005, ELECTROPHORESIS, V26, P3706, DOI 10.1002/elps.200500109; Clausell-Tormos J, 2008, CHEM BIOL, V15, P427, DOI 10.1016/j.chembiol.2008.04.004; Garstecki P, 2006, LAB CHIP, V6, P693; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kiss MM, 2008, ANAL CHEM, V80, P8975, DOI 10.1021/ac801276c; Nakano M, 2005, J BIOSCI BIOENG, V99, P293, DOI 10.1263/jbb.99.293; O'Donovan B, 2012, LAB CHIP, V12, P4029, DOI 10.1039/c2lc40693d; PULVERTAFT RJV, 1964, LANCET, V1, P238; Seemann R, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/1/016601; Song H, 2006, ANGEW CHEM INT EDIT, V45, P7336, DOI 10.1002/anie.200601554; Teh SY, 2008, LAB CHIP, V8, P198, DOI 10.1039/b715524g; Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Zheng B, 2004, ANAL CHEM, V76, P4977, DOI 10.1021/ac0495743	20	52	61	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62961	10.1371/journal.pone.0062961	http://dx.doi.org/10.1371/journal.pone.0062961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658657	gold, Green Published, Green Submitted			2022-12-25	WOS:000318343700081
J	Piao, Y; Kimura, A; Urano, S; Saito, Y; Taru, H; Yamamoto, T; Hata, S; Suzuki, T				Piao, Yi; Kimura, Ayano; Urano, Satomi; Saito, Yuhki; Taru, Hidenori; Yamamoto, Tohru; Hata, Saori; Suzuki, Toshiharu			Mechanism of Intramembrane Cleavage of Alcadeins by gamma-Secretase	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CARBOXYL-TERMINAL FRAGMENT; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; BETA-PROTEIN; CELL BIOLOGY; A-BETA; NOTCH; PRESENILIN; MEMBRANE	Background: Alcadein proteins (Alcs; Alc alpha, Alc beta and Alc gamma) are predominantly expressed in neurons, as is Alzheimer's beta-amyloid (A beta) precursor protein (APP). Both Alcs and APP are cleaved by primary alpha-or beta-secretase to generate membrane-associated C-terminal fragments (CTFs). Alc CTFs are further cleaved by gamma-secretase to secrete p3-Alc peptide along with the release of intracellular domain fragment (Alc ICD) from the membrane. In the case of APP, APP CTF beta is initially cleaved at the epsilon-site to release the intracellular domain fragment (AICD) and consequently the gamma-site is determined, by which A beta generates. The initial epsilon-site is thought to define the final gamma-site position, which determines whether A beta 40/43 or A beta 42 is generated. However, initial intracellular e-cleavage sites of Alc CTF to generate Alc ICD and the molecular mechanism that final gamma-site position is determined remains unclear in Alcs. Methodology: Using HEK293 cells expressing Alcs plus presenilin 1 (PS1, a catalytic unit of gamma-secretase) and the membrane fractions of these cells, the generation of p3-Alc possessing C-terminal gamma-cleavage site and Alc ICD possessing N-terminal epsilon-cleavage site were analysed with MALDI-TOF/MS. We determined the initial epsilon-site position of all Alc alpha, Alc beta and Alc gamma, and analyzed the relationship between the initially determined epsilon-site position and the final gamma-cleavage position. Conclusions: The initial epsilon-site position does not always determine the final gamma-cleavage position in Alcs, which differed from APP. No additional gamma-cleavage sites are generated from artificial/non-physiological positions of epsilon-cleavage for Alcs, while the artificial epsilon-cleavage positions can influence in selection of physiological gamma-site positions. Because alteration of gamma-secretase activity is thought to be a pathogenesis of sporadic Alzheimer's disease, Alcs are useful and sensitive substrate to detect the altered cleavage of substrates by gamma-secretase, which may be induced by malfunction of gamma-secretase itself or changes of membrane environment for enzymatic reaction.	[Piao, Yi; Kimura, Ayano; Urano, Satomi; Saito, Yuhki; Yamamoto, Tohru; Hata, Saori; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Sapporo, Hokkaido, Japan; [Taru, Hidenori] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Neural Cell Biol, Sapporo, Hokkaido, Japan; [Taru, Hidenori] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Suzuki, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Sapporo, Hokkaido, Japan.	tsuzuki@pharm.hokudai.ac.jp	Suzuki, Toshiharu/B-5342-2013; Yamamoto, Tohru/A-3801-2012; Taru, Hidenori/B-7059-2009; Hata, Saori/AAP-9634-2020	Yamamoto, Tohru/0000-0002-1652-0233; 	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23390017, 24790062]; New Energy and Industrial Technology Development Organization (NEDO) in Japan; Grants-in-Aid for Scientific Research [23790070, 23390017] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO) in Japan(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (23390017 to TS, 24790062 to SH) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a grant from the New Energy and Industrial Technology Development Organization (NEDO) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hata S, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-16; Hata S, 2011, ANN NEUROL, V69, P1026, DOI 10.1002/ana.22343; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; Kakuda N, 2012, EMBO MOL MED, V4, P344, DOI 10.1002/emmm.201200214; Lichtenthaler SF, 2007, EMBO REP, V8, P537, DOI 10.1038/sj.embor.7400978; Mizumaru C, 2009, J NEUROCHEM, V111, P1213, DOI 10.1111/j.1471-4159.2009.06399.x; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Okochi M, 2012, CELL REPORTS, V3, P1; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2007, J NEUROCHEM, V100, P1234, DOI 10.1111/j.1471-4159.2006.04302.x	27	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62431	10.1371/journal.pone.0062431	http://dx.doi.org/10.1371/journal.pone.0062431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658629	Green Submitted, gold, Green Published			2022-12-25	WOS:000318343700057
J	Hunter, KE; Palermo, C; Kester, JC; Simpson, K; Li, JP; Tang, LH; Klimstra, DS; Vlodavsky, I; Joyce, JA				Hunter, K. E.; Palermo, C.; Kester, J. C.; Simpson, K.; Li, J-P; Tang, L. H.; Klimstra, D. S.; Vlodavsky, I.; Joyce, J. A.			Heparanase promotes lymphangiogenesis and tumor invasion in pancreatic neuroendocrine tumors	ONCOGENE			English	Article						tumor microenvironment; tumor-associated macrophages; matrix-degrading enzyme; heparan sulfate proteoglycans	MOUSE MODEL; SULFATE; MICE; METASTASIS; GROWTH; CANCER; ANGIOGENESIS; MACROPHAGES; CELLS	Heparan sulfate proteoglycans are an important and abundant component of the extracellular matrix, which undergo substantial remodeling throughout tumorigenesis via the enzymatic activity of heparanase. Heparanase has been shown to be upregulated in many human cancers; however, its specific functions in human pancreatic neuroendocrine tumors (PanNETs) and spontaneous mouse models of cancer have not been evaluated. Here, we investigated the role of heparanase in PanNETs using patient samples and the RIP1-Tag2 (RT2) PanNET-transgenic mouse model. High heparanase expression significantly correlated with more advanced tumor stage, higher tumor grade and the presence of distant metastasis in PanNET patients. We genetically manipulated heparanase levels in the RT2 model using heparanase-transgenic mice, which constitutively overexpress heparanase, and heparanase-knockout mice. Heparanase was found to have a critical role in promoting tumor invasion, through both macrophage and cancer cell sources in the tumor microenvironment. In addition, elevated heparanase levels significantly increased peritumoral lymphangiogenesis in vivo and promoted the trans-differentiation of macrophages into lymphatic endothelial cell-like structures in culture. Conversely, we found that heparanase deletion led to increased angiogenesis and pericyte coverage. Together, these data identify important roles for heparanase in regulating several critical aspects of tumorigenesis, demonstrating that heparanase represents a potential therapeutic target for PanNET patients.	[Hunter, K. E.; Palermo, C.; Kester, J. C.; Simpson, K.; Joyce, J. A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Hunter, K. E.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10021 USA; [Li, J-P] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Tang, L. H.; Klimstra, D. S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Vlodavsky, I.] Technion Israel Inst Technol, Rappaport Fac Med, Canc & Vasc Res Ctr, IL-32000 Haifa, Israel	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Uppsala University; Memorial Sloan Kettering Cancer Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Joyce, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave,Box 372, New York, NY 10065 USA.	joycej@mskcc.org			National Cancer Institute [R01 CA125162]; Grayer Fellowship; NATIONAL CANCER INSTITUTE [R01CA125162] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grayer Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Joyce Lab; Drs Jacqueline Bromberg and Andrew Koff for discussion on this topic; and Robert Bowman, Daniela Quail, Alberto Schuhmacher and Hao- Wei Wang for reading the manuscript. We gratefully acknowledge Xiaoping Chen and Lin Song for excellent technical assistance; Marsha Quick and Karoline Dubin for project assistance; Elyn Reidel, MSKCC Epidemiology and Biostatistics Department for statistical analysis of RT2 tumor grades; Sho Fujisawa and the Molecular Cytology Core Facility for assistance with the MetaMorph lymphangiogenesis analysis; the MSKCC Flow Cytometry Core for technical assistance and advice; and Aisha Khan of the cGMP Cell Processing Facility, Cell Transplant Center, Diabetes Research Institute, University of Miami School of Medicine for providing normal islets. This research was funded by the National Cancer Institute R01 CA125162 and Cycle for Survival (JAJ). KEH was supported in part by a Grayer Fellowship.	Arvatz G, 2011, CANCER METAST REV, V30, P253, DOI 10.1007/s10555-011-9288-x; Cohen-Kaplan V, 2008, INT J CANCER, V123, P2566, DOI 10.1002/ijc.23898; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ferrone CR, 2007, J CLIN ONCOL, V25, P5609, DOI 10.1200/JCO.2007.12.9809; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hu Wenwei, 2010, Genes Cancer, V1, P360; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Joyce JA, 2005, ONCOGENE, V24, P4037, DOI 10.1038/sj.onc.1208602; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Nolan-Stevaux Olivier, 2010, Genes Cancer, V1, P125, DOI 10.1177/1947601909358722; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Ori A, 2011, J BIOL CHEM, V286, P19892, DOI 10.1074/jbc.M111.228114; Parish CR, 1999, CANCER RES, V59, P3433; Pyonteck SM, 2012, ONCOGENE, V31, P1459, DOI 10.1038/onc.2011.337; Stenzel D, 2009, BLOOD, V114, P915, DOI 10.1182/blood-2008-10-186239; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tuveson D, 2011, NATURE, V471, P316, DOI 10.1038/471316a; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2007, ANN SURG ONCOL, V14, P3492, DOI 10.1245/s10434-007-9566-6; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181; Zumsteg A, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006494; Zumsteg A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007067	30	30	31	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2014	33	14					1799	1808		10.1038/onc.2013.142	http://dx.doi.org/10.1038/onc.2013.142			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RE	23644656				2022-12-25	WOS:000334345500006
J	Shavkunov, AS; Wildburger, NC; Nenov, MN; James, TF; Buzhdygan, TP; Panova-Elektronova, NI; Green, TA; Veselenak, RL; Bourne, N; Laezza, F				Shavkunov, Alexander S.; Wildburger, Norelle C.; Nenov, Miroslav N.; James, Thomas F.; Buzhdygan, Tetyana P.; Panova-Elektronova, Neli I.; Green, Thomas A.; Veselenak, Ronald L.; Bourne, Nigel; Laezza, Fernanda			The Fibroblast Growth Factor 14.Voltage-gated Sodium Channel Complex Is a New Target of Glycogen Synthase Kinase 3 (GSK3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR HOMOLOGOUS FACTOR; PROTEIN-PROTEIN INTERACTIONS; FIBROBLAST-GROWTH-FACTOR-14 GENE; CRYSTAL-STRUCTURE; C-TERMINUS; PHOSPHORYLATION; IDENTIFICATION; MODULATION; MUTATION; KINASE-3-BETA	The FGF14 protein controls biophysical properties and subcellular distribution of neuronal voltage-gated Na+ (Nav) channels through direct binding to the channel C terminus. To gain insights into the dynamic regulation of this protein/protein interaction complex, we employed the split luciferase complementation assay to screen a small molecule library of kinase inhibitors against the FGF14.Nav1.6 channel complex and identified inhibitors of GSK3 as hits. Through a combination of a luminescence-based counter-screening, co-immunoprecipitation, patch clamp electrophysiology, and quantitative confocal immunofluorescence, we demonstrate that inhibition of GSK3 reduces the assembly of the FGF14.Nav channel complex, modifies FGF14-dependent regulation of Na+ currents, and induces dissociation and subcellular redistribution of the native FGF14 . Nav channel complex in hippocampal neurons. These results further emphasize the role of FGF14 as a critical component of the Nav channel macromolecular complex, providing evidence for an novel GSK3-dependent signaling pathway that might control excitability through specific protein/protein interactions.	[Shavkunov, Alexander S.; Wildburger, Norelle C.; Nenov, Miroslav N.; James, Thomas F.; Panova-Elektronova, Neli I.; Green, Thomas A.; Laezza, Fernanda] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Wildburger, Norelle C.; James, Thomas F.; Buzhdygan, Tetyana P.] Univ Texas Med Branch, Grad Program Neurosci, Galveston, TX 77555 USA; [Wildburger, Norelle C.] Univ Texas Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA; [Green, Thomas A.; Laezza, Fernanda] Univ Texas Med Branch, Addict Res Ctr, Galveston, TX 77555 USA; [Veselenak, Ronald L.; Bourne, Nigel] Univ Texas Med Branch, Dept Pediat Vaccinol, Galveston, TX 77555 USA; [Bourne, Nigel] Univ Texas Med Branch, Galveston Natl Lab, Assay Dev Serv Div, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Laezza, F (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Addict Res Ctr, Ctr Biomed Engn, 301 Univ Blvd, Galveston, TX 77555 USA.	felaezza@utmb.edu	Laezza, Fernanda/X-4076-2019; Buzhdygan, Tetyana/AAN-4245-2021; Nenov, Miroslav/C-5252-2008; Laezza, Fernanda/L-6019-2016	Laezza, Fernanda/0000-0003-1141-1852; Nenov, Miroslav/0000-0001-6000-2372; Laezza, Fernanda/0000-0003-1141-1852; Wildburger, Norelle C./0000-0002-0036-8927; Shavkunov, Alexander/0000-0003-2390-9391	National Institutes of Health Grant, NIMH [MH095995]; NIAID [5UC7A107008304]; NCATS [UL1TR000071]; PhRMA Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095995] Funding Source: NIH RePORTER	National Institutes of Health Grant, NIMH; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); PhRMA Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH095995 from NIMH (to F. L.) and 5UC7A107008304 from NIAID (to N. B.) and by Clinical and Translational Science Award UL1TR000071 from NCATS (to F. L.). This work was also supported by a Research starter grant from the PhRMA Foundation (to F. L.).	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Berendt FJ, 2010, J PROTEOME RES, V9, P1976, DOI 10.1021/pr901171q; Brusse E, 2006, MOVEMENT DISORD, V21, P396, DOI 10.1002/mds.20708; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Dover K, 2010, J PHYSIOL-LONDON, V588, P3695, DOI 10.1113/jphysiol.2010.192559; Eldar-Finkelman H, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00032; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldfarb M, 2007, NEURON, V55, P449, DOI 10.1016/j.neuron.2007.07.006; Goslin K., 1998, CULTURING NERVE CELL, P339; Hernandez F, 2010, EXP NEUROL, V223, P322, DOI 10.1016/j.expneurol.2009.09.011; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Kim WY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00044; Kim YT, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00048; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Laezza F, 2009, MOL CELL NEUROSCI, V42, P90, DOI 10.1016/j.mcn.2009.05.007; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; Li XH, 2010, NEUROPSYCHOPHARMACOL, V35, P2143, DOI 10.1038/npp.2010.105; Liao YX, 2010, BRAIN, V133, P1403, DOI 10.1093/brain/awq057; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Liu CJ, 2001, J BIOL CHEM, V276, P18925, DOI 10.1074/jbc.M101606200; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Namekata K, 2012, J NEUROSCI, V32, P264, DOI 10.1523/JNEUROSCI.4884-11.2012; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Polter AM, 2012, CELL SIGNAL, V24, P265, DOI 10.1016/j.cellsig.2011.09.009; Rinnab L, 2008, NEOPLASIA, V10, P624, DOI 10.1593/neo.08248; Schiavon E, 2006, J BIOL CHEM, V281, P20326, DOI 10.1074/jbc.M600565200; Schutz SV, 2010, J CELL BIOCHEM, V109, P1192, DOI 10.1002/jcb.22500; Shakkottai VG, 2009, NEUROBIOL DIS, V33, P81, DOI 10.1016/j.nbd.2008.09.019; Shavkunov A, 2012, ASSAY DRUG DEV TECHN, V10, P148, DOI 10.1089/adt.2011.413; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Wang CJ, 2011, J BIOL CHEM, V286, P24253, DOI 10.1074/jbc.M111.245803; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Wei EQ, 2011, TRENDS CARDIOVAS MED, V21, P199, DOI 10.1016/j.tcm.2012.05.010; Wildburger NC, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00080; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Xiao ML, 2007, MOL CELL NEUROSCI, V34, P366, DOI 10.1016/j.mcn.2006.11.020; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	45	66	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19370	19385		10.1074/jbc.M112.445924	http://dx.doi.org/10.1074/jbc.M112.445924			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23640885	Green Published, hybrid			2022-12-25	WOS:000321515800007
J	Wang, ZP; Fu, M; Wang, LF; Liu, JJ; Li, YH; Brakebusch, C; Mei, QB				Wang, Zhipeng; Fu, Meng; Wang, Lifeng; Liu, Juanjuan; Li, Yuhua; Brakebusch, Cord; Mei, Qibing			p21-Activated Kinase 1 (PAK1) Can Promote ERK Activation in a Kinase-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; CANCER	PAK1 plays an important role in proliferation and tumorigenesis, at least partially by promoting ERK phosphorylation of C-RAF (Ser-338) or MEK1 (Ser-298). We observed how that overexpression of a kinase-dead mutant form of PAK1 increased phosphorylation of MEK1/2 (Ser-217/Ser-221) and ERK (Thr-202/Tyr-204), although phosphorylation of B-RAF (Ser-445) and C-RAF (Ser-338) remained unchanged. Furthermore, increased activation of the PAK1 activator Rac1 induced the formation of a triple complex of Rac1, PAK1, and MEK1 independent of the kinase activity of PAK1. These data suggest that PAK1 can stimulate MEK activity in a kinase-independent manner, probably by serving as a scaffold to facilitate interaction of C-RAF.	[Wang, Zhipeng; Liu, Juanjuan; Li, Yuhua; Mei, Qibing] Fourth Mil Med Univ, Key Lab Gastrointestinal Pharmacol Chinese Mat Me, State Adm Tradit Chinese Med, Dept Pharmacol,Sch Pharm, Xian 710032, Peoples R China; [Fu, Meng] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China; [Wang, Zhipeng; Wang, Lifeng] Fourth Mil Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Xian 710032, Peoples R China; [Brakebusch, Cord] Univ Copenhagen, Inst Biomed, BRIC, DK-2200 Copenhagen, Denmark	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; University of Copenhagen	Mei, QB (corresponding author), Fourth Mil Med Univ, Key Lab Gastrointestinal Pharmacol Chinese Mat Me, State Adm Tradit Chinese Med, Dept Pharmacol,Sch Pharm, Xian 710032, Peoples R China.	qbmei@fmmu.edu.cn	Li, yu/HHZ-5236-2022; fu, meng/GZG-3120-2022	fu, meng/0000-0002-8867-0951; Brakebusch, Cord/0000-0002-9342-1634	Danish Cancer Foundation; National Natural Science Foundation of China [81071689]	Danish Cancer Foundation(Danish Cancer Society); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Danish Cancer Foundation (to C. B.) and the National Natural Science Foundation of China (Grant 81071689).	Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Eswaran J, 2012, CLIN CANCER RES, V18, P3743, DOI 10.1158/1078-0432.CCR-11-1952; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Huynh N, 2010, BBA-MOL CELL RES, V1803, P1106, DOI 10.1016/j.bbamcr.2010.05.007; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Wang Z, 2010, ONCOGENE, V29, P3362, DOI 10.1038/onc.2010.95	12	44	49	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20093	20099		10.1074/jbc.M112.426023	http://dx.doi.org/10.1074/jbc.M112.426023			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23653349	hybrid, Green Published			2022-12-25	WOS:000321515800071
J	Matsuda, M; Tamura, K; Wakui, H; Maeda, A; Ohsawa, M; Kanaoka, T; Azushima, K; Uneda, K; Haku, S; Tsurumi-Ikeya, Y; Toya, Y; Maeshima, Y; Yamashita, A; Umemura, S				Matsuda, Miyuki; Tamura, Kouichi; Wakui, Hiromichi; Maeda, Akinobu; Ohsawa, Masato; Kanaoka, Tomohiko; Azushima, Kengo; Uneda, Kazushi; Haku, Sona; Tsurumi-Ikeya, Yuko; Toya, Yoshiyuki; Maeshima, Yohei; Yamashita, Akio; Umemura, Satoshi			Upstream Stimulatory Factors 1 and 2 Mediate the Transcription of Angiotensin II Binding and Inhibitory Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED PROTEIN; FAMILIAL COMBINED HYPERLIPIDEMIA; CONVOLUTED TUBULE CELLS; TYPE-1 RECEPTOR; GENE-EXPRESSION; INTERACTING MOLECULE; FACTOR USF; DOWN-REGULATION; KIDNEY-DISEASE; INFUSED MICE	The angiotensin II type 1 receptor (AT1R)-associated protein (ATRAP/Agtrap) promotes constitutive internalization of the AT1R so as to specifically inhibit the pathological activation of its downstream signaling yet preserve the base-line physiological signaling activity of the AT1R. Thus, tissue-specific regulation of Agtrap expression is relevant to the pathophysiology of cardiovascular and renal disease. However, the regulatory mechanism of Agtrap gene expression has not yet been fully elucidated. In this study, we show that the proximal promoter region from -150 to +72 of the mouse Agtrap promoter, which contains the X-box, E-box, and GC-box consensus motifs, is able to elicit substantial transcription of the Agtrap gene. Among these binding motifs, we showed that the E-box specifically binds upstream stimulatory factor (Usf) 1 and Usf2, which are known E-box-binding transcription factors. It is indicated that the E-box-Usf1/Usf2 binding regulates Agtrap expression because of the following: 1) mutation of the E-box to prevent Usf1/Usf2 binding reduces Agtrap promoter activity; 2) knockdown of Usf1 or Usf2 affects both endogenous Agtrap mRNA and Agtrap protein expression, and 3) the decrease in Agtrap mRNA expression in the afflicted kidney by unilateral ureteral obstruction is accompanied by changes in Usf1 and Usf2 mRNA. Furthermore, the results of siRNA transfection in mouse distal convoluted tubule cells and those of unilateral ureteral obstruction in the afflicted mouse kidney suggest that Usf1 decreases but Usf2 increases the Agtrap gene expression by binding to the E-box. The results also demonstrate a functional E-box-USF1/USF2 interaction in the human AGTRAP promoter, thereby suggesting that a strategy of modulating the E-box-USF1/USF2 binding has novel therapeutic potential.	[Matsuda, Miyuki; Tamura, Kouichi; Wakui, Hiromichi; Maeda, Akinobu; Ohsawa, Masato; Kanaoka, Tomohiko; Azushima, Kengo; Uneda, Kazushi; Haku, Sona; Tsurumi-Ikeya, Yuko; Toya, Yoshiyuki; Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2360004, Japan; [Maeshima, Yohei] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008558, Japan; [Yamashita, Akio] Yokohama City Univ, Grad Sch Med, Dept Mol Biol, Yokohama, Kanagawa 2360004, Japan	Yokohama City University; Okayama University; Yokohama City University	Tamura, K (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2360004, Japan.	tamukou@med.yokohama-cu.ac.jp		Azushima, Kengo/0000-0002-5136-0730	Health and Labor Sciences Research grant; Japanese Ministry of Education, Science, Sports and Culture; Salt Science Research Foundation [1134]; Kidney Foundation, Japan [JKFB13-17]; Novartis Foundation for Gerontological Research; Grants-in-Aid for Scientific Research [23591193, 25460906] Funding Source: KAKEN	Health and Labor Sciences Research grant(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation; Kidney Foundation, Japan(Kidney Foundation, Japan); Novartis Foundation for Gerontological Research(Novartis Foundation for Gerontological Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Health and Labor Sciences Research grant, the Japanese Ministry of Education, Science, Sports and Culture, the Salt Science Research Foundation Grant 1134, the Kidney Foundation, Japan, Grant JKFB13-17, and the Novartis Foundation for Gerontological Research (2012).	Azuma K, 2007, HYPERTENSION, V50, P926, DOI 10.1161/HYPERTENSIONAHA.107.096115; Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; Carabana J, 2005, J IMMUNOL, V174, P4144, DOI 10.4049/jimmunol.174.7.4144; Chen BH, 2012, BIOCHEM J, V446, P89, DOI 10.1042/BJ20111942; Coon H, 2005, HUM GENET, V117, P444, DOI 10.1007/s00439-005-1340-x; Daviet L, 1999, J BIOL CHEM, V274, P17058, DOI 10.1074/jbc.274.24.17058; Dejima T, 2011, J HYPERTENS, V29, P1919, DOI 10.1097/HJH.0b013e32834a5a46; Dickson ME, 2008, CIRC RES, V103, P940, DOI 10.1161/CIRCRESAHA.108.180653; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FRIEDMAN PA, 1995, KIDNEY INT, V48, P1427, DOI 10.1038/ki.1995.432; Fukui T, 2003, HYPERTENS RES, V26, P979, DOI 10.1291/hypres.26.979; GESEK FA, 1995, AM J PHYSIOL-RENAL, V268, pF89, DOI 10.1152/ajprenal.1995.268.1.F89; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; Hein L, 1997, MOL ENDOCRINOL, V11, P1266, DOI 10.1210/me.11.9.1266; Henrion AA, 1996, MAMM GENOME, V7, P803, DOI 10.1007/s003359900241; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Horiuchi M, 2012, CLIN SCI, V123, P193, DOI 10.1042/CS20110677; Jiang B, 2003, MOL CELL BIOL, V23, P6117, DOI 10.1128/MCB.23.17.6117-6128.2003; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; KUIPERS OP, 1991, NUCLEIC ACIDS RES, V19, P4558, DOI 10.1093/nar/19.16.4558; Lim M, 2010, LAB INVEST, V90, P222, DOI 10.1038/labinvest.2009.128; Liu S, 2007, AM J PHYSIOL-RENAL, V293, pF1727, DOI 10.1152/ajprenal.00316.2007; Lopez-Ilasaca M, 2003, MOL BIOL CELL, V14, P5038, DOI 10.1091/mbc.E03-06-0383; Ma ZC, 2008, J ALLERGY CLIN IMMUN, V121, P1006, DOI 10.1016/j.jaci.2007.11.015; Masuda S, 2010, AM J PHYSIOL-RENAL, V299, pF720, DOI 10.1152/ajprenal.00667.2009; Matsuda M, 2011, PHYSIOL GENOMICS, V43, P884, DOI 10.1152/physiolgenomics.00005.2011; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Miura S, 2003, HYPERTENS RES, V26, P937, DOI 10.1291/hypres.26.937; Mogi M, 2007, ARTERIOSCL THROM VAS, V27, P2532, DOI 10.1161/ATVBAHA.107.144154; Navar LG, 2011, HYPERTENSION, V57, P355, DOI 10.1161/HYPERTENSIONAHA.110.163519; Ng MCY, 2005, DIABETOLOGIA, V48, P2018, DOI 10.1007/s00125-005-1914-0; Nowak M, 2005, MOL CELL BIOL, V25, P1537, DOI 10.1128/MCB.25.4.1537-1548.2005; Olave NC, 2010, J CELL BIOCHEM, V111, P720, DOI 10.1002/jcb.22760; Oshita A, 2006, HYPERTENSION, V48, P671, DOI 10.1161/01.HYP.0000238141.99816.47; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; Park S, 2012, HYPERTENSION, V59, P1212, DOI 10.1161/HYPERTENSIONAHA.112.192971; Purvis TL, 2010, GENE, V460, P20, DOI 10.1016/j.gene.2010.03.015; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rohman MS, 2005, KIDNEY INT, V67, P1410, DOI 10.1111/j.1523-1755.2005.00218.x; Sakai M, 2007, AM J PHYSIOL-RENAL, V292, pF1526, DOI 10.1152/ajprenal.00451.2006; Sanchez AP, 2011, AM J PHYSIOL-RENAL, V301, pF271, DOI 10.1152/ajprenal.00221.2011; Satoh M, 2001, J AM SOC NEPHROL, V12, P317, DOI 10.1681/ASN.V122317; SAWADOGO M, 1988, J BIOL CHEM, V263, P11994; Schoenhard JA, 2003, J MOL CELL CARDIOL, V35, P473, DOI 10.1016/S0022-2828(03)00051-8; Shi LH, 2009, AM J PHYSIOL-RENAL, V296, pF257, DOI 10.1152/ajprenal.90493.2008; Shigenaga A, 2008, HYPERTENSION, V52, P672, DOI 10.1161/HYPERTENSIONAHA.108.117341; Sirito M, 1998, P NATL ACAD SCI USA, V95, P3758, DOI 10.1073/pnas.95.7.3758; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; SWICK AG, 1989, NUCLEIC ACIDS RES, V17, P9291, DOI 10.1093/nar/17.22.9291; TAMURA K, 1993, J BIOL CHEM, V268, P15024; TAMURA K, 1992, NUCLEIC ACIDS RES, V20, P3617, DOI 10.1093/nar/20.14.3617; TAMURA K, 1994, J CLIN INVEST, V94, P1959, DOI 10.1172/JCI117547; Tamura K, 2000, P NATL ACAD SCI USA, V97, P8513, DOI 10.1073/pnas.100519097; Tamura K, 2007, CURR HYPERTENS REP, V9, P121, DOI 10.1007/s11906-007-0022-6; Tamura K, 2013, CURR PHARM DESIGN, V19, P3043; Tanaka Y, 2005, FEBS LETT, V579, P1579, DOI 10.1016/j.febslet.2005.01.068; Tsurumi Y, 2006, KIDNEY INT, V69, P488, DOI 10.1038/sj.ki.5000130; Vallet VS, 1997, J BIOL CHEM, V272, P21944, DOI 10.1074/jbc.272.35.21944; Vallet VS, 1998, J BIOL CHEM, V273, P20175, DOI 10.1074/jbc.273.32.20175; van Deursen D, 2008, DIABETOLOGIA, V51, P2078, DOI 10.1007/s00125-008-1125-6; Viollet B, 1996, J BIOL CHEM, V271, P1405, DOI 10.1074/jbc.271.3.1405; Wakui H, 2010, AM J PHYSIOL-RENAL, V299, pF991, DOI 10.1152/ajprenal.00738.2009; Wakui H, 2010, HYPERTENSION, V55, P1157, DOI 10.1161/HYPERTENSIONAHA.109.147207	64	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19238	19249		10.1074/jbc.M113.451054	http://dx.doi.org/10.1074/jbc.M113.451054			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23653383	Green Published, hybrid			2022-12-25	WOS:000321335800056
J	Bankston, AN; Li, WQ; Zhang, H; Ku, L; Liu, GL; Papa, F; Zhao, LX; Bibb, JA; Cambi, F; Tiwari-Woodruff, SK; Feng, Y				Bankston, Andrew N.; Li, Wenqi; Zhang, Hui; Ku, Li; Liu, Guanglu; Papa, Filomena; Zhao, Lixia; Bibb, James A.; Cambi, Franca; Tiwari-Woodruff, Seema K.; Feng, Yue			p39, the Primary Activator for Cyclin-dependent Kinase 5 (Cdk5) in Oligodendroglia, Is Essential for Oligodendroglia Differentiation and Myelin Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT; NERVOUS-SYSTEM; CELL-MIGRATION; RAT-BRAIN; TYROSINE KINASE; MESSENGER-RNA; WHITE-MATTER; EXPRESSION; PHOSPHORYLATION; REMYELINATION	Cyclin-dependent kinase 5 (Cdk5) plays key roles in normal brain development and function. Dysregulation of Cdk5 may cause neurodegeneration and cognitive impairment. Besides the well demonstrated role of Cdk5 in neurons, emerging evidence suggests the functional requirement of Cdk5 in oligodendroglia (OL) and CNS myelin development. However, whether neurons and OLs employ similar or distinct mechanisms to regulate Cdk5 activity remains elusive. We report here that in contrast to neurons that harbor high levels of two Cdk5 activators, p35 and p39, OLs express abundant p39 but negligible p35. In addition, p39 is selectively up-regulated in OLs during differentiation along with elevated Cdk5 activity, whereas p35 expression remains unaltered. Specific knockdown of p39 by siRNA significantly attenuates Cdk5 activity and OL differentiation without affecting p35. Finally, expression of p39, but not p35, is increased during myelin repair, and remyelination is impaired in p39(-/-) mice. Together, these results reveal that neurons and OLs harbor distinct preference of Cdk5 activators and demonstrate important functions of p39-dependent Cdk5 activation in OL differentiation during de novo myelin development and myelin repair.	[Bankston, Andrew N.; Li, Wenqi; Zhang, Hui; Ku, Li; Liu, Guanglu; Zhao, Lixia; Feng, Yue] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Cambi, Franca] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Bibb, James A.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Bibb, James A.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Tiwari-Woodruff, Seema K.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA	Emory University; University of Kentucky; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Los Angeles	Feng, Y (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	yfeng@emory.edu	Zhang, Hui/G-4770-2016; Papa, Frederico O/M-4310-2013	Papa, Frederico O/0000-0002-5858-8535; Feng, Yue/0000-0002-7905-2182	National Institutes of Health [NS053905, NS053905-03S2, MH083711, DA033485, NS073855, T32GM008602]; National Multiple Sclerosis Society [NMSSRG 4010-A]; Emory University Research Committee grant; National Institutes of Health Shared Instrument Program [S10 RR026827-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS075198, R01NS053905, R01NS073855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Emory University Research Committee grant; National Institutes of Health Shared Instrument Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS053905 (to Y. F.), NS053905-03S2 (to F. C.), and MH083711, DA033485, and NS073855 (to J. A. B.). This work was also supported by National Multiple Sclerosis Society Grant NMSSRG 4010-A (to Y. F.) and an Emory University Research Committee grant (to Y. F.).; Supported by National Institutes of Health Training Grant T32GM008602.; We thank Dr. Zixu Mao for the p39 construct, Dr. Nancy Ip for the anti-p39 antibody, and Gabriel Mettlach for technical assistance. We also thank Jennifer Strange for excellent technical assistance with the FACS isolation of OL. The FACS sorting facility at the University of Kentucky is supported in part by the National Institutes of Health Shared Instrument Program (S10 RR026827-01A1).	Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; An JH, 2009, J PROTEOME RES, V8, P2873, DOI 10.1021/pr900020q; Bankston AN, 2013, NEUROSCI BULL, V29, P216, DOI 10.1007/s12264-013-1321-3; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibbb JA, 2001, J BIOL CHEM, V276, P14490, DOI 10.1074/jbc.M007197200; Brinkkoetter PT, 2010, KIDNEY INT, V77, P690, DOI 10.1038/ki.2009.548; Cai XH, 1997, NEUROSCI RES, V28, P355, DOI 10.1016/S0168-0102(97)00063-1; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen YT, 2007, J BIOL CHEM, V282, P23553, DOI 10.1074/jbc.M702045200; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Crawford DK, 2009, J NEUROSCI METH, V182, P25, DOI 10.1016/j.jneumeth.2009.05.013; Delalle I, 1997, J NEUROCYTOL, V26, P283, DOI 10.1023/A:1018500617374; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Filippova N, 2012, J BIOL CHEM, V287, P32277, DOI 10.1074/jbc.M112.353912; Gold BT, 2012, BBA-MOL BASIS DIS, V1822, P416, DOI 10.1016/j.bbadis.2011.07.009; Grant P, 2001, EUR J BIOCHEM, V268, P1534, DOI 10.1046/j.1432-1033.2001.02025.x; He XJ, 2011, NEUROCHEM RES, V36, P1293, DOI 10.1007/s11064-010-0391-0; Honjyo Y, 1999, NEUROREPORT, V10, P3375, DOI 10.1097/00001756-199911080-00022; Humbert S, 2000, J CELL SCI, V113, P975; Humbert S, 2000, NEUROREPORT, V11, P2213, DOI 10.1097/00001756-200007140-00030; Kansy JW, 2004, J NEUROCHEM, V91, P374, DOI 10.1111/j.1471-4159.2004.02723.x; Ko J, 2001, J NEUROSCI, V21, P6758; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lazaro JB, 1997, J CELL SCI, V110, P1251; LEW J, 1992, J BIOL CHEM, V267, P13383; Liebl J, 2010, J BIOL CHEM, V285, P35932, DOI 10.1074/jbc.M110.126177; Lilja L, 2001, J BIOL CHEM, V276, P34199, DOI 10.1074/jbc.M103776200; Liu R, 2008, P NATL ACAD SCI USA, V105, P7570, DOI 10.1073/pnas.0712306105; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Miyamoto Y, 2007, J CELL SCI, V120, P4355, DOI 10.1242/jcs.018218; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Philpott A, 1997, GENE DEV, V11, P1409, DOI 10.1101/gad.11.11.1409; Ren Y, 2013, INT J NEUROPSYCHOPH, V16, P691, DOI 10.1017/S1461145712001095; Rosales JL, 2006, BIOESSAYS, V28, P1023, DOI 10.1002/bies.20473; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Tang XM, 1998, J CELL BIOCHEM, V68, P128, DOI 10.1002/(SICI)1097-4644(19980101)68:1<128::AID-JCB13>3.0.CO;2-D; Tripathi BK, 2009, MOL CELL BIOL, V29, P6488, DOI 10.1128/MCB.01098-09; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wu DC, 2000, NEUROCHEM RES, V25, P923, DOI 10.1023/A:1007544106645; Yang Y, 2013, DEV BIOL IN PRESS; Zhao LX, 2006, MOL BIOL CELL, V17, P4179, DOI 10.1091/mbc.E06-04-0355; Zheng M, 1998, J NEUROBIOL, V35, P141, DOI 10.1002/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4; Zhu H, 2012, GLIA, V60, P69, DOI 10.1002/glia.21248	55	12	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18047	18057		10.1074/jbc.M113.453688	http://dx.doi.org/10.1074/jbc.M113.453688			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645679	hybrid, Green Published			2022-12-25	WOS:000320721900011
J	de Araujo, MEG; Stasyk, T; Taub, N; Ebner, HL; Furst, B; Filipek, P; Weys, SR; Hess, MW; Lindner, H; Kremser, L; Huber, LA				de Araujo, Mariana E. G.; Stasyk, Taras; Taub, Nicole; Ebner, Hannes L.; Fuerst, Beatrix; Filipek, Przemyslaw; Weys, Sabine R.; Hess, Michael W.; Lindner, Herbert; Kremser, Leopold; Huber, Lukas A.			Stability of the Endosomal Scaffold Protein LAMTOR3 Depends on Heterodimer Assembly and Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY CONTROL; CELL-LINE; COMPLEX; SIGNAL; P14; BINDING; MP1; P21(WAF1/CIP1); ACTIVATION; RAGULATOR	LAMTOR3 (MP1) and LAMTOR2 (p14) form a heterodimer as part of the larger Ragulator complex that is required for MAPK and mTOR1 signaling from late endosomes/lysosomes. Here, we show that loss of LAMTOR2 (p14) results in an unstable cytosolic monomeric pool of LAMTOR3 (MP1). Monomeric cytoplasmic LAMTOR3 is rapidly degraded in a proteasome-dependent but lysosome-independent manner. Mutational analyses indicated that the turnover of the protein is dependent on ubiquitination of several lysine residues. Similarly, other Ragulator subunits, LAMTOR1 (p18), LAMTOR4 (c7orf59), and LAMTOR5 (HBXIP), are degraded as well upon the loss of LAMTOR2. Thus the assembly of the Ragulator complex is monitored by cellular quality control systems, most likely to prevent aberrant signaling at the convergence of mTOR and MAPK caused by a defective Ragulator complex.	[de Araujo, Mariana E. G.; Stasyk, Taras; Taub, Nicole; Fuerst, Beatrix; Filipek, Przemyslaw; Weys, Sabine R.; Huber, Lukas A.] Med Univ Innsbruck, Bioctr, Div Cell Biol, A-6020 Innsbruck, Austria; [Lindner, Herbert; Kremser, Leopold] Med Univ Innsbruck, Bioctr, Core Facil Prot Microanal, A-6020 Innsbruck, Austria; [Ebner, Hannes L.; Hess, Michael W.] Med Univ Innsbruck, Div Histol & Embryol, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Huber, LA (corresponding author), Med Univ Innsbruck, Bioctr, Div Cell Biol, Innrain 80-82, A-6020 Innsbruck, Austria.	lukas.a.huber@i-med.ac.at	Hess, Michael/AAE-1985-2019; Huber, Lukas Alfons/AAM-3499-2021	Hess, Michael/0000-0002-5154-3553; Stasyk, Taras/0000-0003-0568-6841; Eca Guimaraes de Araujo, Mariana/0000-0003-0576-2680; Huber, Lukas Alfons/0000-0003-1116-2120; Schider, Nicole/0000-0002-3579-3667	FWF Austrian Science Fund Special Research Program "Cell Proliferation and Cell Death in Tumors" [SFB021, P19486-B12]; Austrian Proteomics Platform APP Austrian Genome Program, GEN-AU; Austrian Bundesministerium fur Bildung, Wissenschaft, und Kultur	FWF Austrian Science Fund Special Research Program "Cell Proliferation and Cell Death in Tumors"; Austrian Proteomics Platform APP Austrian Genome Program, GEN-AU; Austrian Bundesministerium fur Bildung, Wissenschaft, und Kultur	This work was supported by FWF Austrian Science Fund Special Research Program "Cell Proliferation and Cell Death in Tumors" Grant SFB021 (to L. A. H.) and Grant P19486-B12 (to M. W. H.) and by funds from the Austrian Proteomics Platform APP Austrian Genome Program, GEN-AU (to L. A. H.).; Recipient of the Bertha von Suttner Grant from the Austrian Bundesministerium fur Bildung, Wissenschaft, und Kultur.	Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Brahma A, 2007, ARCH BIOCHEM BIOPHYS, V460, P85, DOI 10.1016/j.abb.2006.11.031; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; CATLING AD, 1995, MOL CELL BIOL, V15, P5214; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gonzalez L, 1999, CELL, V96, P755, DOI 10.1016/S0092-8674(00)80585-1; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoshino D, 2011, J BIOL CHEM, V286, P3139, DOI 10.1074/jbc.M110.159715; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lunin VV, 2004, J BIOL CHEM, V279, P23422, DOI 10.1074/jbc.M401648200; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Qian CM, 2005, J MOL BIOL, V347, P309, DOI 10.1016/j.jmb.2005.01.031; Salerno M, 2005, MOL CELL BIOL, V25, P1379, DOI 10.1128/MCB.25.4.1379-1388.2005; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Stasyk T, 2010, PROTEOMICS, V10, P4117, DOI 10.1002/pmic.201000258; Taub N, 2012, J CELL SCI, V125, P2698, DOI 10.1242/jcs.100073; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; THOMPSON WC, 1979, P NATL ACAD SCI USA, V76, P1318, DOI 10.1073/pnas.76.3.1318; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765	43	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18228	18242		10.1074/jbc.M112.349480	http://dx.doi.org/10.1074/jbc.M112.349480			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653355	Green Published, hybrid			2022-12-25	WOS:000320721900027
J	Makthal, N; Rastegari, S; Sanson, M; Ma, Z; Olsen, RJ; Helmann, JD; Musser, JM; Kumaraswami, M				Makthal, Nishanth; Rastegari, Sheila; Sanson, Misu; Ma, Zhen; Olsen, Randall J.; Helmann, John D.; Musser, James M.; Kumaraswami, Muthiah			Crystal Structure of Peroxide Stress Regulator from Streptococcus pyogenes Provides Functional Insights into the Mechanism of Oxidative Stress Sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUR HOMOLOGS; PERR; IRON; VIRULENCE; PROTEIN; GENE; DNA; TRANSCRIPTION; SUPEROXIDE; REGULON	Regulation of oxidative stress responses by the peroxide stress regulator (PerR) is critical for the in vivo fitness and virulence of group A Streptococcus. To elucidate the molecular mechanism of DNA binding, peroxide sensing, and gene regulation by PerR, we performed biochemical and structural characterization of PerR. Sequence-specific DNA binding by PerR does not require regulatory metal occupancy. However, metal binding promotes higher affinity PerR-DNA interactions. PerR metallated with iron directly senses peroxide stress and dissociates from operator sequences. The crystal structure revealed that PerR exists as a homodimer with two metal-binding sites per subunit as follows: a structural zinc site and a regulatory metal site that is occupied in the crystals by nickel. The regulatory metal-binding site in PerR involves a previously unobserved HXH motif located in its unique N-terminal extension. Mutational analysis of the regulatory site showed that the PerR metal ligands are involved in regulatory metal binding, and integrity of this site is critical for group A Streptococcus virulence. Interestingly, the metal-binding HXH motif is not present in the structurally characterized members of ferric uptake regulator (Fur) family but is fully conserved among PerR from the genus Streptococcus. Thus, it is likely that the PerR orthologs from streptococci share a common mechanism of metal binding, peroxide sensing, and gene regulation that is different from that of well characterized PerR from Bacillus subtilis. Together, our findings provide key insights into the peroxide sensing and regulation of the oxidative stress-adaptive responses by the streptococcal subfamily of PerR.	[Makthal, Nishanth; Rastegari, Sheila; Sanson, Misu; Olsen, Randall J.; Musser, James M.; Kumaraswami, Muthiah] Methodist Hosp Syst, Ctr Mol & Translat Human Infect Dis Res, Methodist Hosp Res Inst, Houston, TX 77030 USA; [Makthal, Nishanth; Rastegari, Sheila; Sanson, Misu; Olsen, Randall J.; Musser, James M.; Kumaraswami, Muthiah] Methodist Hosp Syst, Dept Pathol & Genom Med, Houston, TX 77030 USA; [Ma, Zhen; Helmann, John D.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University	Kumaraswami, M (corresponding author), Methodist Hosp Syst, Dept Pathol & Genom Med, Houston, TX 77030 USA.	mkumaraswami@tmhs.org	Makthal, Nishanth/J-8609-2019	Makthal, Nishanth/0000-0003-3464-8537; Helmann, John/0000-0002-3832-3249	American Heart Association Scientist Development grant; Office of Science, Office of Basic Energy Sciences, Material Sciences Division, of the United States Department of Energy at Lawrence Berkeley National Laboratory	American Heart Association Scientist Development grant(American Heart Association); Office of Science, Office of Basic Energy Sciences, Material Sciences Division, of the United States Department of Energy at Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	This work was supported in part by an American Heart Association Scientist Development grant (to M. K.).; We thank the beamline scientists and staff at Advanced Light Source beamline 8.3.1 for their great help with data collection. We also acknowledge the Advanced Light Source supported by the Director, Office of Science, Office of Basic Energy Sciences, Material Sciences Division, of the United States Department of Energy at Lawrence Berkeley National Laboratory.	Ahn BE, 2006, MOL MICROBIOL, V59, P1848, DOI 10.1111/j.1365-2958.2006.05065.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beres SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/pnas.0911295107; Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x; Brenot A, 2007, MOL MICROBIOL, V63, P1185, DOI 10.1111/j.1365-2958.2006.05577.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butcher J, 2012, P NATL ACAD SCI USA, V109, P10047, DOI 10.1073/pnas.1118321109; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; CONDON S, 1987, FEMS MICROBIOL LETT, V46, P269, DOI 10.1111/j.1574-6968.1987.tb02465.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delany I, 2001, MOL MICROBIOL, V42, P1297, DOI 10.1046/j.1365-2958.2001.02696.x; Dian C, 2011, MOL MICROBIOL, V79, P1260, DOI 10.1111/j.1365-2958.2010.07517.x; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Faulkner MJ, 2012, J BACTERIOL, V194, P1226, DOI 10.1128/JB.06566-11; Faulkner MJ, 2011, ANTIOXID REDOX SIGN, V15, P175, DOI 10.1089/ars.2010.3682; Fuangthong M, 2003, J BACTERIOL, V185, P6348, DOI 10.1128/JB.185.21.6348-6357.2003; Gibson CM, 2000, J BACTERIOL, V182, P448, DOI 10.1128/JB.182.2.448-455.2000; Grifantini Renata, 2011, J Bacteriol, V193, P6539, DOI 10.1128/JB.05924-11; Gryllos I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000145; Herbig AF, 2001, MOL MICROBIOL, V41, P849, DOI 10.1046/j.1365-2958.2001.02543.x; Huffman JL, 2002, CURR OPIN STRUC BIOL, V12, P98, DOI 10.1016/S0959-440X(02)00295-6; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jacquamet L, 2009, MOL MICROBIOL, V73, P20, DOI 10.1111/j.1365-2958.2009.06753.x; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; King KY, 2000, J BACTERIOL, V182, P5290, DOI 10.1128/JB.182.19.5290-5299.2000; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Lee JW, 2006, J BIOL CHEM, V281, P23567, DOI 10.1074/jbc.M603968200; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Leslie A. G. W., 1992, CRYSTALLOGRAPHY, V26, P27; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li J, 1997, P NATL ACAD SCI USA, V94, P13251, DOI 10.1073/pnas.94.24.13251; Lucana DOD, 2000, MOL GEN GENET, V264, P341; Lucarelli D, 2007, J BIOL CHEM, V282, P9914, DOI 10.1074/jbc.M609974200; Lukomski S, 2000, INFECT IMMUN, V68, P535, DOI 10.1128/IAI.68.2.535-542.2000; Nunoshiba T, 1999, J BIOL CHEM, V274, P34832, DOI 10.1074/jbc.274.49.34832; Olsen RJ, 2009, CELL MICROBIOL, V11, P1, DOI 10.1111/j.1462-5822.2008.01225.x; Ricci S, 2002, INFECT IMMUN, V70, P4968, DOI 10.1128/IAI.70.9.4968-4976.2002; Robinson JM, 2009, HISTOCHEM CELL BIOL, V131, P465, DOI 10.1007/s00418-009-0565-5; Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x; Shelburne SA, 2011, MOL MICROBIOL, V82, P1481, DOI 10.1111/j.1365-2958.2011.07902.x; Shin JH, 2011, P NATL ACAD SCI USA, V108, P5045, DOI 10.1073/pnas.1017744108; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P501, DOI 10.1107/S0907444998012657; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traore DAK, 2006, MOL MICROBIOL, V61, P1211, DOI 10.1111/j.1365-2958.2006.05313.x; Traore DAK, 2009, NAT CHEM BIOL, V5, P53, DOI 10.1038/nchembio.133; van Vliet AHM, 1999, J BACTERIOL, V181, P6371, DOI 10.1128/JB.181.20.6371-6376.1999; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102	50	43	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18311	18324		10.1074/jbc.M113.456590	http://dx.doi.org/10.1074/jbc.M113.456590			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645680	hybrid, Green Published			2022-12-25	WOS:000320721900035
J	Sasser, TL; Lawrence, G; Karunakaran, S; Brown, C; Fratti, RA				Sasser, Terry L.; Lawrence, Gus; Karunakaran, Surya; Brown, Christopher; Fratti, Rutilio A.			The Yeast ATP-binding Cassette (ABC) Transporter Ycf1p Enhances the Recruitment of the Soluble SNARE Vam7p to Vacuoles for Efficient Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; VERTEX RING DOMAIN; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; HOMOTYPIC FUSION; HOPS COMPLEX; PROTEIN; DOCKING; LIPIDS; CELLS	The Saccharomyces cerevisiae vacuole contains five ATP-binding cassette class C (ABCC) transporters, including Ycf1p, a family member that was originally characterized as a Cd2+ transporter. Ycf1p has also been found to physically interact with a wide array of proteins, including factors that regulate vacuole homeostasis. In this study, we examined the role of Ycf1p and other ABCC transporters in the regulation of vacuole homotypic fusion. We found that deletion of YCF1 attenuated in vitro vacuole fusion by up to 40% relative to wild-type vacuoles. Plasmid-expressed wild-type Ycf1p rescued the deletion phenotype; however, Ycf1p containing a mutation of the conserved Lys-669 to Met in the Walker A box of the first nucleotide-binding domain (Ycf1p(K669M)) was unable to complement the fusion defect of ycf1 Delta vacuoles. This indicates that the ATPase activity of Ycf1p is required for its function in regulating fusion. In addition, we found that deleting YCF1 caused a striking decrease in vacuolar levels of the soluble SNARE Vam7p, whereas total cellular levels were not altered. The attenuated fusion of ycf1 Delta vacuoles was rescued by the addition of recombinant Vam7p to in vitro experiments. Thus, Ycf1p contributes in the recruitment of Vam7p to the vacuole for efficient membrane fusion.	[Sasser, Terry L.; Lawrence, Gus; Karunakaran, Surya; Brown, Christopher; Fratti, Rutilio A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Fratti, RA (corresponding author), Univ Illinois, Dept Biochem, 419 Roger Adams Lab,B-4,600 S Mathews Ave, Urbana, IL 61801 USA.	rfratti@illinois.edu			National Institutes of Health [GM101132]; University of Illinois Research Board; National Science Foundation-Cellular and Molecular Mechanics and BioNanotechnology Integrative Graduate Education Research Training fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois Research Board; National Science Foundation-Cellular and Molecular Mechanics and BioNanotechnology Integrative Graduate Education Research Training fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM101132 (to R. A. F.). This work was also supported by a grant from the University of Illinois Research Board (to R. A. F.).; Supported by a National Science Foundation-Cellular and Molecular Mechanics and BioNanotechnology Integrative Graduate Education Research Training fellowship.	Bared SM, 2004, MOL BIOL CELL, V15, P5399, DOI 10.1091/mbc.E04-03-0182; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Efe JA, 2005, CURR OPIN CELL BIOL, V17, P402, DOI 10.1016/j.ceb.2005.06.002; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Fratti RA, 2007, J BIOL CHEM, V282, P13133, DOI 10.1074/jbc.M700584200; Ganeshan R, 2003, J BIOL CHEM, V278, P2876, DOI 10.1074/jbc.M211790200; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Gueldry O, 2003, EUR J BIOCHEM, V270, P2486, DOI 10.1046/j.1432-1033.2003.03620.x; Gulshan K, 2011, TRAFFIC, V12, P1257, DOI 10.1111/j.1600-0854.2011.01228.x; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JONES EW, 1982, GENETICS, V102, P665; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; Jun Y, 2007, P NATL ACAD SCI USA, V104, P13010, DOI 10.1073/pnas.0700970104; Karunakaran S, 2013, TRAFFIC, V14, P650, DOI 10.1111/tra.12064; Karunakaran S, 2012, J CELL SCI, V125, P1683, DOI 10.1242/jcs.091900; Lee ME, 2011, GENETICS, V188, P859, DOI 10.1534/genetics.111.130724; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Ortiz DF, 1997, J BIOL CHEM, V272, P15358, DOI 10.1074/jbc.272.24.15358; Parrish WR, 2004, MOL BIOL CELL, V15, P3567, DOI 10.1091/mbc.E04-03-0209; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Petrovic S, 2000, YEAST, V16, P561, DOI 10.1002/(SICI)1097-0061(200004)16:6<561::AID-YEA551>3.0.CO;2-L; Qiu QS, 2010, J CELL SCI, V123, P3266, DOI 10.1242/jcs.067637; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sasser TL, 2012, BIOCHEM J, V448, P365, DOI 10.1042/BJ20120847; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Wemmie JA, 1997, MOL MICROBIOL, V25, P683, DOI 10.1046/j.1365-2958.1997.5061868.x; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525	57	16	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18300	18310		10.1074/jbc.M112.441089	http://dx.doi.org/10.1074/jbc.M112.441089			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23658021	Green Published, hybrid			2022-12-25	WOS:000320721900034
J	Cortes, AJ; Monserrate, FA; Ramirez-Villegas, J; Madrinan, S; Blair, MW				Cortes, Andres J.; Monserrate, Fredy A.; Ramirez-Villegas, Julian; Madrinan, Santiago; Blair, Matthew W.			Drought Tolerance in Wild Plant Populations: The Case of Common Beans (Phaseolus vulgaris L.)	PLOS ONE			English	Article							GENETIC DIVERSITY; SELECTION; RESISTANCE; RESPONSES; ECOLOGY; SALT	Reliable estimations of drought tolerance in wild plant populations have proved to be challenging and more accessible alternatives are desirable. With that in mind, an ecological diversity study was conducted based on the geographical origin of 104 wild common bean accessions to estimate drought tolerance in their natural habitats. Our wild population sample covered a range of mesic to very dry habitats from Mexico to Argentina. Two potential evapotranspiration models that considered the effects of temperature and radiation were coupled with the precipitation regimes of the last fifty years for each collection site based on geographical information system analysis. We found that wild accessions were distributed among different precipitation regimes following a latitudinal gradient and that habitat ecological diversity of the collection sites was associated with natural sub-populations. We also detected a broader geographic distribution of wild beans across ecologies compared to cultivated common beans in a reference collection of 297 cultivars. Habitat drought stress index based on the Thornthwaite potential evapotranspiration model was equivalent to the Hamon estimator. Both ecological drought stress indexes would be useful together with population structure for the genealogical analysis of gene families in common bean, for genome-wide genetic-environmental associations, and for postulating the evolutionary history and diversification processes that have occurred for the species. Finally, we propose that wild common bean should be taken into account to exploit variation for drought tolerance in cultivated common bean which is generally considered susceptible as a crop to drought stress.	[Cortes, Andres J.] Uppsala Univ, Evolutionary Biol Ctr, Uppsala, Sweden; [Cortes, Andres J.; Madrinan, Santiago] Univ Los Andes, Lab Bot & Sistemat, Bogota, Colombia; [Monserrate, Fredy A.] Serv Ensenanza Nacl, Ctr Agr, Buga, Colombia; [Ramirez-Villegas, Julian] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Ramirez-Villegas, Julian] CGIAR Program Climate Change Agr & Food Secur CCA, Cali, Colombia; [Blair, Matthew W.] Cornell Univ, Dept Plant Breeding, Ithaca, NY USA	Uppsala University; Universidad de los Andes (Colombia); University of Leeds; CGIAR; Cornell University	Cortes, AJ (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Uppsala, Sweden.	andres.cortes@ebc.uu.se; mwb1@cornell.edu	Ramirez-Villegas, Julian/AAY-8073-2020; Madriñán, Santiago/A-1149-2010	Ramirez-Villegas, Julian/0000-0002-8044-583X; Madriñán, Santiago/0000-0002-0807-6523; Cortes, Andres J./0000-0003-4178-0675	Generation Challenge Program	Generation Challenge Program	This research was supported by the Generation Challenge Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gallegos JA, 2007, CROP SCI, V47, pS44, DOI 10.2135/cropsci2007.04.0008IPBS; Amede T, 2003, ETHIOP J SCI, V26, P137; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Beebe SE, 2008, CROP SCI, V48, P582, DOI 10.2135/cropsci2007.07.0404; Blair MW, 2013, THEOR APPL GENET, V126, P535, DOI 10.1007/s00122-012-1999-z; Blair MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049488; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Chen CN, 2004, MOL PHYLOGENET EVOL, V32, P616, DOI 10.1016/j.ympev.2004.01.015; Cortes AJ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-58; Cortes AJ, 2012, THEOR APPL GENET, V125, P1069, DOI 10.1007/s00122-012-1896-5; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; Debouck D.G., 1999, COMMON BEAN IMPROVEM, P25, DOI DOI 10.1007/978-94-015-9211-6_2; Debouck DG, 2000, BIODIVERSITY ECOLOGY, P95; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Frahm MA, 2004, EUPHYTICA, V136, P223, DOI 10.1023/B:euph.0000030671.03694.bb; Galeano CH, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-48; Gepts P, 2008, GENOMICS OF TROPICAL; Gepts Paul, 2003, Environmental Biosafety Research, V2, P89, DOI 10.1051/ebr:2003009; Griffiths H, 2002, ANN BOT-LONDON, V89, P801, DOI 10.1093/aob/mcf159; Hamon W.R., 1961, J HYDRAULICS DIVISIO, V87, P107, DOI DOI 10.1061/JYCEAJ.0000599; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Heyman DP, 1990, STOCHASTIC MODELS; Hijmans R.J., 2001, PLANT GENETIC RESOUR, V127, P15, DOI DOI 10.1016/j.compositesa.2008.10.018; Jarvis A., 2002, Plant Genetic Resources Newsletter, P29; Jarvis A, 2003, CROP SCI, V43, P1100, DOI 10.2135/cropsci2003.1100; Jones P, 2007, SAT EJOURNAL, V4, P1; Kelleher CT, 2012, TREE GENET GENOMES, V8, P821, DOI 10.1007/s11295-012-0467-x; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Kotlik P, 2008, MOL ECOL, V17, P1076, DOI 10.1111/j.1365-294X.2007.03638.x; Lane A., 2007, Journal of SAT Agricultural Research, V4, P1; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Perez JC, 2008, ANNUAL REPORT OUTCOM; Seki M, 2003, CURR OPIN BIOTECH, V14, P194, DOI 10.1016/S0958-1669(03)00030-2; Singh SP, 2005, GENETIC RESOURCES CH; THORNTHWAITE C. W., 1955, PUBLICATIONS CLIMATO, VVIII, DOI DOI 10.1017/CBO9781107339200.011; Thornthwaite C.W., 1957, PUBL CLIMAT, V10, P311, DOI DOI 10.1007/S10584-011-0148-Z; Tiranti B, 2007, MOL ECOL, V16, P4942, DOI 10.1111/j.1365-294X.2007.03566.x; Tohme J, 1996, CROP SCI, V36, P1375, DOI 10.2135/cropsci1996.0011183X003600050048x; Tohme J, 1995, CORE COLLECTIONS OF; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; van der Sluijs I, 2008, PHILOS T R SOC B, V363, P2871, DOI 10.1098/rstb.2008.0045; Vermeulen S, 2012, CURR OPIN ENV SUST, V4, P128, DOI 10.1016/j.cosust.2011.12.004; Xu CY, 2002, WATER RESOUR MANAG, V16, P197, DOI 10.1023/A:1020282515975	45	66	69	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62898	10.1371/journal.pone.0062898	http://dx.doi.org/10.1371/journal.pone.0062898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658783	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100046
J	Khelaifia, S; Michel, JB; Drancourt, M				Khelaifia, Saber; Michel, Jean Brunel; Drancourt, Michel			In-Vitro Archaeacidal Activity of Biocides against Human-Associated Archaea	PLOS ONE			English	Article							SP-NOV.; METHANOBREVIBACTER-SMITHII; GEN-NOV; METHANOGENS; PREVALENCE; SQUALAMINE; ORGANISMS; BACTERIA; ORALIS	Background: Several methanogenic archaea have been detected in the human intestinal microbiota. These intestinal archaea may contaminate medical devices such as colonoscopes. However, no biocide activity has been reported among these human-associated archaea. Methodology: The minimal archaeacidal concentration (MAC) of peracetic acid, chlorhexidine, squalamine and twelve parent synthetic derivatives reported in this study was determined against five human-associated methanogenic archaea including Methanobrevibacter smithii, Methanobrevibacter oralis, Methanobrevibacter arboriphilicus, Methanosphaera stadtmanae, Methanomassiliicoccus luminyensis and two environmental methanogens Methanobacterium beijingense and Methanosaeta concilii by using a serial dilution technique in Hungates tubes. Principal Findings: MAC of squalamine derivative S1 was 0.05 mg/L against M. smithii strains, M. oralis, M. arboriphilicus, M. concilii and M. beijingense whereas MAC of squalamine and derivatives S2-S12 varied from 0.5 to 5 mg/L. For M. stadtmanae and M. luminyensis, MAC of derivative S1 was 0.1 mg/L and varied from 1 to >= 10 mg/L for squalamine and its parent derivatives S2-S12. Under the same experimental conditions, chlorhexidine and peracetic acid lead to a MAC of 0.2 and 1.5 mg/L, respectively against all tested archaea. Conclusions/Significance: Squalamine derivative S1 exhibited a 10-200 higher archaeacidal activity than other tested squalamine derivatives, on the majority of human-associated archaea. As previously reported and due to their week corrosivity and their wide spectrum of antibacterial and antifungal properties, squalamine and more precisely derivative S1 appear as promising compounds to be further tested for the decontamination of medical devices contaminated by human-associated archaea.	[Khelaifia, Saber; Drancourt, Michel] Aix Marseille Univ, URMITE, Inserm 1095, IRD 198,CNRS UMR63 7278, Marseille, France; [Michel, Jean Brunel] Aix Marseille Univ, CRCM, CNRS, Inst Paoli Calmettes,UMR7258,UM 105,Inserm,U1068, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Drancourt, M (corresponding author), Aix Marseille Univ, URMITE, Inserm 1095, IRD 198,CNRS UMR63 7278, Marseille, France.	Michel.Drancourt@univmed.fr		Khelaifia, Saber/0000-0002-9303-3893; jean michel, brunel/0000-0002-9355-8980				Alhanout K, 2010, J ANTIMICROB CHEMOTH, V65, P1688, DOI 10.1093/jac/dkq213; ASAKAWA S, 1993, INT J SYST BACTERIOL, V43, P683, DOI 10.1099/00207713-43-4-683; BELAY N, 1988, APPL ENVIRON MICROB, V54, P600, DOI 10.1128/AEM.54.2.600-603.1988; Bringuier A, 2013, J CLIN MICROBIOL, V51, P993, DOI 10.1128/JCM.02863-12; de Macario EC, 2009, INT J MED MICROBIOL, V299, P99, DOI 10.1016/j.ijmm.2008.06.011; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Dopson M, 2004, APPL ENVIRON MICROB, V70, P2079, DOI 10.1128/AEM.70.4.2079-2088.2004; Dridi B, 2011, INT J SYST EVOL MICR, V62, P1902; Dridi B, 2012, APMIS, V120, P773, DOI 10.1111/j.1600-0463.2012.02899.x; Dridi B, 2011, J ANTIMICROB CHEMOTH, V66, P2038, DOI 10.1093/jac/dkr251; Dridi B, 2011, ANAEROBE, V17, P56, DOI 10.1016/j.anaerobe.2011.03.001; Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063; FERRARI A, 1994, CURR MICROBIOL, V29, P7, DOI 10.1007/BF01570184; KANDLER O, 1994, J BIOL PHYS, V20, P165; Khelaifia S, 2012, CLIN MICROBIOL INFEC, V18, P841, DOI 10.1111/j.1469-0691.2012.03913.x; Koga Y, 2012, ARCHAEA, V2012, DOI 10.1155/2012/789652; Ma K, 2005, INT J SYST EVOL MICR, V55, P325, DOI 10.1099/ijs.0.63254-0; MILLER TL, 1985, ARCH MICROBIOL, V141, P116, DOI 10.1007/BF00423270; MILLER TL, 1974, APPL MICROBIOL, V27, P985, DOI 10.1128/AEM.27.5.985-987.1974; MILLER TL, 1982, APPL ENVIRON MICROB, V43, P227, DOI 10.1128/AEM.43.1.227-232.1982; MOORE KS, 1993, P NATL ACAD SCI USA, V90, P1354, DOI 10.1073/pnas.90.4.1354; Oxley APA, 2010, ENVIRON MICROBIOL, V12, P2398, DOI 10.1111/j.1462-2920.2010.02212.x; PATEL GB, 1990, INT J SYST BACTERIOL, V40, P79, DOI 10.1099/00207713-40-1-79; Rea S, 2007, INT J SYST EVOL MICR, V57, P450, DOI 10.1099/ijs.0.63984-0; Salmi C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002765; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576	26	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62738	10.1371/journal.pone.0062738	http://dx.doi.org/10.1371/journal.pone.0062738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658767	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100036
J	Newton, RL; Han, HM; Zderic, T; Hamilton, M				Newton, Robert L., Jr.; Han, Hongmei; Zderic, Theodore; Hamilton, Marc			The Energy Expenditure of Sedentary Behavior: A Whole Room Calorimeter Study	PLOS ONE			English	Article							TELEVISION VIEWING TIME; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; SKELETAL-MUSCLE; RISK-FACTORS; INACTIVITY PHYSIOLOGY; LIFE-STYLE; OBESITY; EXERCISE; COSTS	It has recently been recommended that sedentary behavior be defined as sitting or reclining activities expending less than 1.5 metabolic equivalents (METs), which is distinct from the traditional viewpoint based on insufficient moderate-vigorous activity or formal exercise. This study was designed to determine the energy expenditure associated with common sedentary behaviors. Twenty-five African American adults (BMI 27.8 +/- 5.5) participated in the metabolic chamber study. Participants entered the metabolic chamber in the morning and their basal metabolic rate was estimated. They were fed breakfast and then engaged in four different sedentary behaviors sequentially, lasting 30 minutes each. The activities included reclining, watching TV, reading, and typing on a computer. In the afternoon, the participants were fed lunch and then the activities were repeated. The results show that the energy expenditure values between the morning and afternoon sessions were not significantly different (p = .232). The mean energy expenditure of postprandial reclining (0.97 METs) was slightly, but significantly, lower than postprandial watching TV (p = .021) and typing (p<.001). There were no differences in energy cost (1.03-1.06 METs) between the seated (i.e., reading, typing, watching TV) sedentary activities. The energy expenditure of several common sedentary behaviors was approximately 1.0 METs in the postprandial state. The results support the conclusion that the average energy cost of common sedentary behaviors is narrowly banded around 1.0 METs in the postprandial state.	[Newton, Robert L., Jr.; Han, Hongmei; Zderic, Theodore; Hamilton, Marc] Pennington Biomed Res Ctr, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Newton, RL (corresponding author), Pennington Biomed Res Ctr, Baton Rouge, LA USA.	Robert.Newton@pbrc.edu	Newton, Robert/N-1981-2017	Newton, Robert/0000-0002-6863-913X	National Heart Lung and Blood Institute [K01 HL088723-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL088723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by the National Heart Lung and Blood Institute (K01 HL088723-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bassett DR, 2002, PREV MED, V34, P179, DOI 10.1006/pmed.2001.0969; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Bey L, 2003, PHYSIOL GENOMICS, V13, P157, DOI 10.1152/physiolgenomics.00001.2002; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Crovetti R, 1998, EUR J CLIN NUTR, V52, P482, DOI 10.1038/sj.ejcn.1600578; Dallal CM, 2012, BREAST CANCER RES TR, V134, P1279, DOI 10.1007/s10549-012-2129-y; Dos Anjos LA, 2011, MED SCI SPORT EXER, V43, P2211, DOI 10.1249/MSS.0b013e31821f5798; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Florez H, 2005, DIABETES RES CLIN PR, V69, P63, DOI 10.1016/j.diabres.2004.11.018; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Hamilton MT, 2001, INT J SPORT NUTR EXE, V11, pS97, DOI 10.1123/ijsnem.11.s1.s97; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Javed F, 2010, AM J CLIN NUTR, V91, P907, DOI 10.3945/ajcn.2009.28512; Kanade AN, 2001, EUR J CLIN NUTR, V55, P708, DOI 10.1038/sj.ejcn.1601211; Keogh JB, 2007, EUR J CLIN NUTR, V61, P597, DOI 10.1038/sj.ejcn.1602564; Lanningham-Foster L, 2009, J PEDIATR-US, V154, P819, DOI 10.1016/j.jpeds.2009.01.009; Lante K, 2010, RES DEV DISABIL, V31, P1380, DOI 10.1016/j.ridd.2010.06.022; Levine JA, 2006, ARTERIOSCL THROM VAS, V26, P729, DOI 10.1161/01.ATV.0000205848.83210.73; Levine JA, 2000, AM J CLIN NUTR, V72, P1451; Li TY, 2006, CIRCULATION, V113, P499, DOI 10.1161/CIRCULATIONAHA.105.574087; Luke Amy, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P370, DOI 10.1097/MED.0b013e3282c48a7c; Lyons EJ, 2012, AM J CLIN NUTR, V96, P234, DOI 10.3945/ajcn.111.028423; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; McAlpine DA, 2007, BRIT J SPORT MED, V41, P903, DOI 10.1136/bjsm.2006.034900; McCrady SK, 2009, OBESITY, V17, P2103, DOI 10.1038/oby.2009.117; Nguyen-Duy TB, 2003, AM J PHYSIOL-ENDOC M, V284, pE1065, DOI 10.1152/ajpendo.00442.2002; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Rao S, 2008, PUBLIC HEALTH NUTR, V11, P142, DOI 10.1017/S1368980007000055; Ritz P, 2012, BR J NUTR, P1; Sharp TA, 2002, OBES RES, V10, P726, DOI 10.1038/oby.2002.99; Spittaels H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-149; Steeves JA, 2012, MED SCI SPORT EXER, V44, P330, DOI 10.1249/MSS.0b013e31822d797e; Stephens BR, 2010, METABOLISM; Swartz AM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-69; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Thorp AA, 2010, DIABETES CARE, V33, P327, DOI 10.2337/dc09-0493; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Weyer C, 1999, AM J CLIN NUTR, V70, P13; Yancey AK, 2004, AM J PREV MED, V27, P146, DOI 10.1016/j.amepre.2004.03.012; Zderic TW, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-137; Zderic TW, 2006, J APPL PHYSIOL, V100, P249, DOI 10.1152/japplphysiol.00925.2005	49	45	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63171	10.1371/journal.pone.0063171	http://dx.doi.org/10.1371/journal.pone.0063171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658805	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100054
J	Assmus, J; Kleffe, J; Schmitt, AO; Brockmann, GA				Assmus, Jens; Kleffe, Juergen; Schmitt, Armin O.; Brockmann, Gudrun A.			Equivalent Indels - Ambiguous Functional Classes and Redundancy in Databases	PLOS ONE			English	Article								There is considerable interest in studying sequenced variations. However, while the positions of substitutions are uniquely identifiable by sequence alignment, the location of insertions and deletions still poses problems. Each insertion and deletion causes a change of sequence. Yet, due to low complexity or repetitive sequence structures, the same indel can sometimes be annotated in different ways. Two indels which differ in allele sequence and position can be one and the same, i.e. the alternative sequence of the whole chromosome is identical in both cases and, therefore, the two deletions are biologically equivalent. In such a case, it is impossible to identify the exact position of an indel merely based on sequence alignment. Thus, variation entries in a mutation database are not necessarily uniquely defined. We prove the existence of a contiguous region around an indel in which all deletions of the same length are biologically identical. Databases often show only one of several possible locations for a given variation. Furthermore, different data base entries can represent equivalent variation events. We identified 1,045,590 such problematic entries of insertions and deletions out of 5,860,408 indel entries in the current human database of Ensembl. Equivalent indels are found in sequence regions of different functions like exons, introns or 5' and 3' UTRs. One and the same variation can be assigned to several different functional classifications of which only one is correct. We implemented an algorithm that determines for each indel database entry its complete set of equivalent indels which is uniquely characterized by the indel itself and a given interval of the reference sequence.	[Assmus, Jens; Schmitt, Armin O.; Brockmann, Gudrun A.] Humboldt Univ, D-10099 Berlin, Germany; [Kleffe, Juergen] Charite, Inst Mol Biol & Bioinformat, Berlin, Germany	Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Assmus, J (corresponding author), Humboldt Univ, D-10099 Berlin, Germany.	Jens.Assmus@hu-berlin.de; Gudrun.Brockmann@hu-berlin.de		Schmitt, Armin/0000-0002-4910-9467	German Research Foundation (DFG) through the Collaborative Research Centre 852 [SFB852/1]	German Research Foundation (DFG) through the Collaborative Research Centre 852(German Research Foundation (DFG))	This study was supported by the German Research Foundation (DFG) through the Collaborative Research Centre 852 (grant no. SFB852/1) (http://www.sfb852.de) (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Assmus Jens, 2011, Advances in Bioinformatics, V2011, P657341, DOI 10.1155/2011/657341; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; BENSON D, 1990, GENOMICS, V6, P389, DOI 10.1016/0888-7543(90)90583-G; Chang YC, 2011, J NEUROCHEM, V118, P288, DOI 10.1111/j.1471-4159.2011.07304.x; Chen YA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-293; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gillespie JJ, 2004, MOL PHYLOGENET EVOL, V33, P936, DOI 10.1016/j.ympev.2004.08.004; Hague SM, 2005, J NEUROL NEUROSUR PS, V76, P1058, DOI 10.1136/jnnp.2004.060186; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Krawitz P, 2010, BIOINFORMATICS, V26, P722, DOI 10.1093/bioinformatics/btq027; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Posso SR, 2010, BRAZ J BIOL, V70, P195, DOI 10.1590/S1519-69842010000100027; Rios D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-238; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yun JY, 2011, PARKINSONISM RELAT D, V17, P338, DOI 10.1016/j.parkreldis.2011.01.015	20	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62803	10.1371/journal.pone.0062803	http://dx.doi.org/10.1371/journal.pone.0062803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658777	Green Submitted, Green Published, gold			2022-12-25	WOS:000321200500040
J	Jackson, ND; Austin, CC				Jackson, Nathan D.; Austin, Christopher C.			Testing the Role of Meander Cutoff in Promoting Gene Flow across a Riverine Barrier in Ground Skinks (Scincella lateralis)	PLOS ONE			English	Article							POPULATION-STRUCTURE; MICROSATELLITE LOCI; GENOTYPING ERRORS; DIFFERENTIATION; EVOLUTION; PHYLOGEOGRAPHY; CONSEQUENCES; LINEAGES; SOFTWARE; PATTERNS	Despite considerable attention, the long-term impact of rivers on species diversification remains uncertain. Meander loop cutoff (MLC) is one river phenomenon that may compromise a river's diversifying effects by passively transferring organisms from one side of the river to the other. However, the ability of MLC to promote gene flow across rivers has not been demonstrated empirically. Here, we test several predictions of MLC-mediated gene flow in populations of North American ground skinks (Scincella lateralis) separated by a well-established riverine barrier, the Mississippi River: 1) individuals collected from within meander cutoffs should be more closely related to individuals across the river than on the same side, 2) individuals within meander cutoffs should contain more immigrants than individuals away from meander cutoffs, 3) immigration rates estimated across the river should be highest in the direction of the cutoff event, and 4) the distribution of alleles native to one side of the river should be better predicted by the historical rather than current path of the river. To test these predictions we sampled 13 microsatellite loci and mitochondrial DNA from ground skinks collected near three ancient meander loops. These predictions were generally supported by genetic data, although support was stronger for mtDNA than for microsatellite data. Partial support for genetic divergence of samples within ancient meander loops also provides evidence for the MLC hypothesis. Although a role for MLC-mediated gene flow was supported here for ground skinks, the transient nature of river channels and morphologies may limit the long-term importance of MLC in stemming population divergence across major rivers.	[Jackson, Nathan D.; Austin, Christopher C.] Louisiana State Univ, Dept Biol Sci, Museum Nat Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Jackson, ND (corresponding author), Louisiana State Univ, Dept Biol Sci, Museum Nat Sci, Baton Rouge, LA 70803 USA.	nathanjackson@glel.carleton.ca			National Science Foundation [DEB 0445213, DBI 0400797, DEB 1146033]	National Science Foundation(National Science Foundation (NSF))	The authors received funding from National Science Foundation Grants DEB 0445213, DBI 0400797, and DEB 1146033 to CCA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin JA, 1998, COPEIA, P519, DOI 10.2307/1447455; [Anonymous], RIVER MEANDERING; Arnold ML, 1994, NATURAL HYBRIDIZATIO; Austin CC, 2010, CONSERV GENET, V11, P889, DOI 10.1007/s10592-009-9931-z; Austin JD, 2004, MOL PHYLOGENET EVOL, V32, P799, DOI 10.1016/j.ympev.2004.03.006; Autin W.J., 1991, QUATERNARY NONGLACIA, P547; BAKER JA, 1991, REV AQUAT SCI, V3, P313; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Benke A.C., 2005, RIVERS N AM; Blum MD, 2000, GEOL SOC AM BULL, V112, P221, DOI 10.1130/0016-7606(2000)112<221:LPEOTL>2.0.CO;2; Brandley MC, 2010, MOL PHYLOGENET EVOL, V57, P552, DOI 10.1016/j.ympev.2010.07.015; BRICE JC, 1974, GEOL SOC AM BULL, V85, P581, DOI 10.1130/0016-7606(1974)85<581:EOML>2.0.CO;2; BROOKS GR, 1967, ECOL MONOGR, V37, P71, DOI 10.2307/2937336; Capparella A.P., 1991, P307; Colwell RK, 2000, P NATL ACAD SCI USA, V97, P13470, DOI 10.1073/pnas.250497697; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DeWoody JA, 2004, BIOTECHNIQUES, V37, P348, DOI 10.2144/04373BM02; Endler J.A., 1977, Monographs in Population Biology, pi; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faubet P, 2008, GENETICS, V178, P1491, DOI 10.1534/genetics.107.082560; Fisk H.N., 1944, GEOLOGICAL INVESTIGA; FITCH HS, 1977, HERPETOLOGICA, V33, P303; Fontanella FM, 2008, MOL PHYLOGENET EVOL, V46, P1049, DOI 10.1016/j.ympev.2007.10.017; Fouquet A, 2012, BIOL J LINN SOC, V106, P356, DOI 10.1111/j.1095-8312.2012.01871.x; Frazier DE, 1967, T GULF COAST ASS GEO, V11, P121; Gaggiotti OE, 1999, MOL ECOL, V8, P1513, DOI 10.1046/j.1365-294x.1999.00730.x; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; Gavrilets S, 2000, EVOLUTION, V54, P1126; Gavrilets S, 2003, EVOLUTION, V57, P2197; Goudet, 2002, FSTAT PROGRAM ESTIMA; Guiher TJ, 2008, MOL PHYLOGENET EVOL, V48, P543, DOI 10.1016/j.ympev.2008.04.008; Haffer J, 2008, BRAZ J BIOL, V68, P917, DOI 10.1590/S1519-69842008000500003; Haffer Juergen, 1992, Boletim do Museu Paraense Emilio Goeldi Serie Zoologia, V8, P217; Hayes FE, 2004, J BIOGEOGR, V31, P1809, DOI 10.1111/j.1365-2699.2004.01139.x; Haywood AM, 2001, PALAEONTOL ELECTRON, V4, P1; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jackson ND, 2012, BIOL J LINN SOC, V107, P192, DOI 10.1111/j.1095-8312.2012.01929.x; Jackson ND, 2011, CONSERV GENET RESOUR, V3, P95, DOI 10.1007/s12686-010-9299-x; Jackson ND, 2010, EVOLUTION, V64, P409, DOI 10.1111/j.1558-5646.2009.00840.x; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kesel RH, 2008, GEOMORPHOLOGY, V101, P78, DOI 10.1016/j.geomorph.2008.06.006; Kolb C. R., 1966, DELTAS THEIR GEOLOGI, P17; Li JW, 2010, MOL ECOL, V19, P494, DOI 10.1111/j.1365-294X.2009.04494.x; Makowsky R, 2009, GENETICA, V135, P169, DOI 10.1007/s10709-008-9267-5; MATHER CM, 1970, TEX J SCI, V21, P429; McLuckie AM, 1999, J HERPETOL, V33, P36, DOI 10.2307/1565541; Nei M., 1987, MOL EVOLUTIONARY GEN; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; O'Donnell RP, 2012, CONSERV GENET, V13, P1167, DOI 10.1007/s10592-012-0384-4; O'Reilly PT, 2004, MOL ECOL, V13, P1799, DOI 10.1111/j.1365-294X.2004.02214.x; Paetkau D, 1997, GENETICS, V147, P1943; PEMBERTON JM, 1995, MOL ECOL, V4, P249, DOI 10.1111/j.1365-294X.1995.tb00214.x; Peres CA, 1996, FOLIA PRIMATOL, V67, P113, DOI 10.1159/000157213; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Postma E, 2005, NATURE, V433, P65, DOI 10.1038/nature03083; Pritchard JK, 2000, GENETICS, V155, P945; Pyron RA, 2010, J BIOGEOGR, V37, P2005, DOI 10.1111/j.1365-2699.2010.02336.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Saucier, 1994, GEOMORPHOLOGY QUATER, P399; Saucier RT, 1996, ENG GEOL, V45, P67, DOI 10.1016/S0013-7952(96)00008-7; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Smith LM, 1996, ENG GEOL, V45, P139, DOI 10.1016/S0013-7952(96)00011-7; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starkey DE, 2003, EVOLUTION, V57, P119; Stolum HH, 1996, SCIENCE, V271, P1710, DOI 10.1126/science.271.5256.1710; Tatarenkov A, 2010, MOL ECOL, V19, P257, DOI 10.1111/j.1365-294X.2009.04464.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WRIGHT S, 1978, P580; Zamudio KR, 2003, EVOLUTION, V57, P1631; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	83	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62812	10.1371/journal.pone.0062812	http://dx.doi.org/10.1371/journal.pone.0062812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658778	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500041
J	Kaspersson, R; Sundstrom, F; Bohlin, T; Johnsson, JI				Kaspersson, Rasmus; Sundstrom, Fredrik; Bohlin, Torgny; Johnsson, Jorgen I.			Modes of Competition: Adding and Removing Brown Trout in the Wild to Understand the Mechanisms of Density-Dependence	PLOS ONE			English	Article							SALMON SALMO-SALAR; DWELLING ATLANTIC SALMON; EXPLOITATION COMPETITION; BODY-SIZE; INTERSPECIFIC COMPETITION; ASYMMETRICAL COMPETITION; STOCKING EXPERIMENTS; POPULATION-DENSITY; HATCHERY ORIGIN; RAINBOW-TROUT	While the prevalence of density-dependence is well-established in population ecology, few field studies have investigated its underlying mechanisms and their relative population-level importance. Here, we address these issues, and more specifically, how differences in body-size influence population regulation. For this purpose, two experiments were performed in a small coastal stream on the Swedish west coast, using juvenile brown trout (Salmo trutta) as a study species. We manipulated densities of large and small individuals, and observed effects on survival, migration, condition and individual growth rate in a target group of intermediate-sized individuals. The generality of the response was investigated by reducing population densities below and increasing above the natural levels (removing and adding large and small individuals). Reducing the density (relaxing the intensity of competition) had no influence on the response variables, suggesting that stream productivity was not a limiting factor at natural population density. Addition of large individuals resulted in a negative density-dependent response, while no effect was detected when adding small individuals or when maintaining the natural population structure. We found that the density-dependent response was revealed as reduced growth rate rather than increased mortality and movement, an effect that may arise from exclusion to suboptimal habitats or increased stress levels among inferior individuals. Our findings confirm the notion of interference competition as the primary mode of competition in juvenile salmonids, and also show that the feedback-mechanisms of density-dependence are primarily acting when increasing densities above their natural levels.	[Kaspersson, Rasmus; Sundstrom, Fredrik; Bohlin, Torgny; Johnsson, Jorgen I.] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg	Kaspersson, R (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	rasmus.kaspersson@bioenv.gu.se	Sundstrom, Fred/E-6736-2011	Sundstrom, Fred/0000-0002-3157-7289	Swedish Research Council for Agricultural Research and Spatial Planning	Swedish Research Council for Agricultural Research and Spatial Planning	This work was supported by a grant from the Swedish Research Council for Agricultural Research and Spatial Planning (www.formas.se)(to J.I.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT JC, 1989, BEHAVIOUR, V108, P104, DOI 10.1163/156853989X00079; Alanara A, 1996, J FISH BIOL, V48, P242, DOI 10.1111/j.1095-8649.1996.tb01116.x; Alanara A, 2001, J ANIM ECOL, V70, P980, DOI 10.1046/j.0021-8790.2001.00550.x; Armstrong JD, 2006, J ZOOL, V269, P403, DOI 10.1111/j.1469-7998.2006.00157.x; Baer J, 2008, ECOL FRESHW FISH, V17, P455, DOI 10.1111/j.1600-0633.2008.00297.x; BERG S, 1991, J FISH BIOL, V39, P151, DOI 10.1111/j.1095-8649.1991.tb04353.x; BOHLIN T, 1994, AM NAT, V143, P478, DOI 10.1086/285614; Bohlin T, 2002, J ANIM ECOL, V71, P683, DOI 10.1046/j.1365-2656.2002.00631.x; BOHLIN T, 1989, HYDROBIOLOGIA, V173, P9, DOI 10.1007/BF00008596; Brannas E, 2004, CAN J ZOOL, V82, P1638, DOI 10.1139/Z04-147; Bremset G, 1999, ANIM BEHAV, V58, P1047, DOI 10.1006/anbe.1999.1218; Cameron TC, 2007, J ANIM ECOL, V76, P83, DOI 10.1111/j.1365-2656.2006.01185.x; Davey AJH, 2009, ENVIRON MODEL ASSESS, V14, P555, DOI 10.1007/s10666-008-9171-5; Davey AJH, 2006, CAN J FISH AQUAT SCI, V63, P597, DOI 10.1139/f05-246; Eccard JA, 2002, OIKOS, V99, P580, DOI 10.1034/j.1600-0706.2002.11833.x; Einum S, 2006, OIKOS, V113, P489, DOI 10.1111/j.2006.0030-1299.14806.x; Einum S, 2011, OECOLOGIA, V167, P1017, DOI 10.1007/s00442-011-2055-4; EJIKE C, 1980, T AM FISH SOC, V109, P423, DOI 10.1577/1548-8659(1980)109&lt;423:SASHRI&gt;2.0.CO;2; Elliott J.M., 1994, QUANTITATIVE ECOLOGY; Elliott JM, 2002, J FISH BIOL, V61, P1268, DOI 10.1006/jfbi.2002.2154; Grant JWA, 2005, J FISH BIOL, V67, P100, DOI 10.1111/j.0022-1112.2005.00916.x; GRANT JWA, 1988, BEHAV ECOL SOCIOBIOL, V22, P435, DOI 10.1007/BF00294982; HAMRIN SF, 1986, OIKOS, V47, P223, DOI 10.2307/3566049; HART DD, 1987, OECOLOGIA, V73, P41, DOI 10.1007/BF00376975; Harwood AJ, 2003, BEHAV ECOL, V14, P902, DOI 10.1093/beheco/arg080; Hojesjo J, 2004, BEHAV ECOL SOCIOBIOL, V56, P286, DOI 10.1007/s00265-004-0784-7; HUBERT WA, 1993, HYDROBIOLOGIA, V259, P179, DOI 10.1007/BF00006597; Huntingford F.A., 1987, ANIMAL CONFLICT; Huntingford FA, 1998, J FISH BIOL, V53, P847, DOI 10.1111/j.1095-8649.1998.tb01838.x; Imre I, 2005, J ANIM ECOL, V74, P508, DOI 10.1111/j.1365-2656.2005.00949.x; Jenkins TM, 1999, ECOLOGY, V80, P941, DOI 10.1890/0012-9658(1999)080[0941:EOPDOI]2.0.CO;2; Johnsson JI, 1999, J FISH BIOL, V54, P469, DOI 10.1111/j.1095-8649.1999.tb00846.x; Jonsson N, 1996, FUNCT ECOL, V10, P89, DOI 10.2307/2390266; JORGENSEN J, 1991, J FISH BIOL, V39, P171, DOI 10.1111/j.1095-8649.1991.tb04354.x; Kaspersson R, 2009, J FISH BIOL, V74, P2196, DOI 10.1111/j.1095-8649.2009.02227.x; Kaspersson R, 2012, OECOLOGIA, V169, P733, DOI 10.1007/s00442-012-2248-5; Kaspersson R, 2010, ANIM BEHAV, V79, P709, DOI 10.1016/j.anbehav.2009.12.025; Keddy P., 2001, COMPETITION; Kim JW, 2007, ANIM BEHAV, V73, P275, DOI 10.1016/j.anbehav.2006.08.003; Klemetsen A, 2003, ECOL FRESHW FISH, V12, P1, DOI 10.1034/j.1600-0633.2003.00010.x; METCALFE NB, 1986, J FISH BIOL, V28, P525, DOI 10.1111/j.1095-8649.1986.tb05190.x; NAKANO S, 1995, J ANIM ECOL, V64, P75, DOI 10.2307/5828; OLIVER JD, 1979, T AM FISH SOC, V108, P130, DOI 10.1577/1548-8659(1979)108&lt;130:OMOFSB&gt;2.0.CO;2; PERSSON L, 1985, AM NAT, V126, P261, DOI 10.1086/284413; Pettersson J, 1996, J FISH BIOL, V49, P370, DOI 10.1111/j.1095-8649.1996.tb00033.x; PUCKETT KJ, 1985, BEHAVIOUR, V92, P97, DOI 10.1163/156853985X00398; Scharf I, 2008, POPUL ECOL, V50, P319, DOI 10.1007/s10144-008-0081-9; Sundstrom LF, 2004, J FISH BIOL, V65, P1385, DOI 10.1111/j.0022-1112.2004.00537.x; TILMAN D, 1987, AM NAT, V129, P769, DOI 10.1086/284672; Ward DM, 2007, J ANIM ECOL, V76, P135, DOI 10.1111/j.1365-2656.2006.01169.x; Weir LK, 2004, ETHOLOGY, V110, P63, DOI 10.1046/j.1439-0310.2003.00948.x	51	16	16	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62517	10.1371/journal.pone.0062517	http://dx.doi.org/10.1371/journal.pone.0062517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658736	gold, Green Submitted, Green Published			2022-12-25	WOS:000321200500027
J	Kim, B; Fatayer, H; Hanby, AM; Horgan, K; Perry, SL; Valleley, EMA; Verghese, ET; Williams, BJ; Thorne, JL; Hughes, TA				Kim, Baek; Fatayer, Hiba; Hanby, Andrew M.; Horgan, Kieran; Perry, Sarah L.; Valleley, Elizabeth M. A.; Verghese, Eldo T.; Williams, Bethany J.; Thorne, James L.; Hughes, Thomas A.			Neoadjuvant Chemotherapy Induces Expression Levels of Breast Cancer Resistance Protein That Predict Disease-Free Survival in Breast Cancer	PLOS ONE			English	Article							P-GLYCOPROTEIN EXPRESSION; MULTIDRUG-RESISTANCE; SYSTEMIC THERAPY; ABC TRANSPORTERS; DRUG-RESISTANCE; GENE-EXPRESSION; CARCINOMA; MDR1; EFFLUX; MRP1	Three main xenobiotic efflux pumps have been implicated in modulating breast cancer chemotherapy responses. These are P-glycoprotein (Pgp), Multidrug Resistance-associated Protein 1 (MRP1), and Breast Cancer Resistance Protein (BCRP). We investigated expression of these proteins in breast cancers before and after neoadjuvant chemotherapy (NAC) to determine whether their levels define response to NAC or subsequent survival. Formalin-fixed paraffin-embedded tissues were collected representing matched pairs of core biopsy (pre-NAC) and surgical specimen (post-NAC) from 45 patients with invasive ductal carcinomas. NAC regimes were anthracyclines +/- taxanes. Immunohistochemistry was performed for Pgp, MRP1 and BCRP and expression was quantified objectively using computer-aided scoring. Pgp and MRP1 were significantly up-regulated after exposure to NAC (Wilcoxon signed-rank p = 0.0024 and p < 0.0001), while BCRP showed more variation in response to NAC, with frequent up- (59% of cases) and down-regulation (41%) contributing to a lack of significant difference overall. Pre-NAC expression of all markers, and post-NAC expression of Pgp and MRP1 did not correlate with NAC response or with disease-free survival (DFS). Post-NAC expression of BCRP did not correlate with NAC response, but correlated significantly with DFS (Log rank p = 0.007), with longer DFS in patients with low post-NAC BCRP expression. In multivariate Cox regression analyses, post-NAC BCRP expression levels proved to predict DFS independently of standard prognostic factors, with high expression associated with a hazard ratio of 4.04 (95% confidence interval 1.3-12.2; p = 0.013). We conclude that NAC-induced expression levels of BCRP predict survival after NAC for breast cancer, while Pgp and MRP1 expression have little predictive value.	[Kim, Baek; Perry, Sarah L.; Valleley, Elizabeth M. A.; Thorne, James L.; Hughes, Thomas A.] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Kim, Baek; Fatayer, Hiba; Horgan, Kieran] Leeds Gen Infirm, Dept Breast Surg, Leeds, W Yorkshire, England; [Hanby, Andrew M.; Verghese, Eldo T.; Williams, Bethany J.] St James Univ Hosp, Dept Histopathol, Leeds LS9 7TF, W Yorkshire, England	University of Leeds; Leeds General Infirmary; University of Leeds; Saint James's University Hospital	Hughes, TA (corresponding author), Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England.	t.hughes@leeds.ac.uk	horgan, kieran/I-3892-2016; Horgan, Kieran/AAM-1280-2020; Hughes, Thomas/M-7063-2019; thorne, james/R-9878-2019; Hughes, Thomas A/O-8031-2015	Hughes, Thomas A/0000-0003-1169-3386; Kim, Baek/0000-0001-9759-7533; Williams, Bethany/0000-0002-6641-5503; Thorne, James/0000-0002-3037-8528	Breast Cancer Research Action Group; Leeds Teaching Hospitals Charitable Foundation; Yorkshire Cancer Research; Medical Research Council; Medical Research Council [G0902032] Funding Source: researchfish; MRC [G0902032] Funding Source: UKRI	Breast Cancer Research Action Group; Leeds Teaching Hospitals Charitable Foundation; Yorkshire Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this work was received from the Breast Cancer Research Action Group (http://www.bcrag.org/), the Leeds Teaching Hospitals Charitable Foundation (http://www.leedshospitalsfundraising.org.uk), Yorkshire Cancer Research (http://www.yorkshirecancerresearch.org.uk), and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri-Kordestani L, 2012, DRUG RESIST UPDATE, V15, P50, DOI 10.1016/j.drup.2012.02.002; Aomatsu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045865; Bark H, 2008, FEBS LETT, V582, P2595, DOI 10.1016/j.febslet.2008.06.036; Barry WT, 2010, J CLIN ONCOL, V28, P2198, DOI 10.1200/JCO.2009.26.7245; Burger H, 2003, CLIN CANCER RES, V9, P827; Chintamani, 2005, World J Surg Oncol, V3, P61; Clarke R, 2005, SEMIN ONCOL, V32, pS9, DOI 10.1053/j.seminoncol.2005.09.009; Darb-Esfahani S, 2012, BRIT J CANC; Dexter DW, 1998, CLIN CANCER RES, V4, P1533; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Filipits M, 1996, CLIN CANCER RES, V2, P1231; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Hanrahan EO, 2005, EXPERT OPIN PHARMACO, V6, P1477, DOI 10.1517/14656566.6.9.1477; Kaufmann M, 2012, ANN SURG ONCOL, V19, P1508, DOI 10.1245/s10434-011-2108-2; Larkin A, 2004, INT J CANCER, V112, P286, DOI 10.1002/ijc.20369; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Leonessa F, 2003, ENDOCR-RELAT CANCER, V10, P43, DOI 10.1677/erc.0.0100043; Marinovich ML, 2012, BREAST, V21, P669, DOI 10.1016/j.breast.2012.07.006; Mechetner E, 1998, CLIN CANCER RES, V4, P389; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Mieog JSD, 2007, BRIT J SURG, V94, P1189, DOI 10.1002/bjs.5894; Mo Wei, 2012, Int J Biochem Mol Biol, V3, P1; Morrow CS, 2006, MOL PHARMACOL, V69, P1499, DOI 10.1124/mol.105.017988; Moureau-Zabotto L, 2006, BRIT J CANCER, V94, P473, DOI 10.1038/sj.bjc.6602958; Nakanishi T, 2012, CHIN J CANCER, V31, P73, DOI 10.5732/cjc.011.10320; Rivera E, 2010, BREAST J, V16, P252, DOI 10.1111/j.1524-4741.2009.00896.x; Rudas M, 2003, BREAST CANCER RES TR, V81, P149, DOI 10.1023/A:1025751631115; Shukla S, 2011, CURR DRUG TARGETS, V12, P621, DOI 10.2174/138945011795378540; Tamura A, 2007, CANCER SCI, V98, P231, DOI 10.1111/j.1349-7006.2006.00371.x; Tanei T, 2011, EJSO-EUR J SURG ONC, V37, P155, DOI 10.1016/j.ejso.2010.10.009; Tsukamoto, 1997, Breast Cancer, V4, P259, DOI 10.1007/BF02966518; van Nes JGH, 2012, BREAST CANCER RES TR, V133, P49, DOI 10.1007/s10549-011-1684-y; Xiang L, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-90	33	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62766	10.1371/journal.pone.0062766	http://dx.doi.org/10.1371/journal.pone.0062766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658771	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500038
J	Hwang, K; Oh, J; Kim, TK; Kim, BK; Yu, DS; Hou, BK; Caetano-Anolles, G; Hong, SG; Kim, KM				Hwang, Kyuin; Oh, Jeongsu; Kim, Tae-Kyung; Kim, Byung Kwon; Yu, Dong Su; Hou, Bo Kyeng; Caetano-Anolles, Gustavo; Hong, Soon Gyu; Kim, Kyung Mo			CLUSTOM: A Novel Method for Clustering 16S rRNA Next Generation Sequences by Overlap Minimization	PLOS ONE			English	Article							RECOMBINATION; ENVIRONMENT; BACTERIA; PROGRAM	The recent nucleic acid sequencing revolution driven by shotgun and high-throughput technologies has led to a rapid increase in the number of sequences for microbial communities. The availability of 16S ribosomal RNA (rRNA) gene sequences from a multitude of natural environments now offers a unique opportunity to study microbial diversity and community structure. The large volume of sequencing data however makes it time consuming to assign individual sequences to phylotypes by searching them against public databases. Since ribosomal sequences have diverged across prokaryotic species, they can be grouped into clusters that represent operational taxonomic units. However, available clustering programs suffer from overlap of sequence spaces in adjacent clusters. In natural environments, gene sequences are homogenous within species but divergent between species. This evolutionary constraint results in an uneven distribution of genetic distances of genes in sequence space. To cluster 16S rRNA sequences more accurately, it is therefore essential to select core sequences that are located at the centers of the distributions represented by the genetic distance of sequences in taxonomic units. Based on this idea, we here describe a novel sequence clustering algorithm named CLUSTOM that minimizes the overlaps between adjacent clusters. The performance of this algorithm was evaluated in a comparative exercise with existing programs, using the reference sequences of the SILVA database as well as published pyrosequencing datasets. The test revealed that our algorithm achieves higher accuracy than ESPRIT-Tree and mothur, few of the best clustering algorithms. Results indicate that the concept of an uneven distribution of sequence distances can effectively and successfully cluster 16S rRNA gene sequences. The algorithm of CLUSTOM has been implemented both as a web and as a standalone command line application, which are available at http://clustom.kribb.re.kr.	[Hwang, Kyuin; Oh, Jeongsu; Kim, Kyung Mo] Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Taejon, South Korea; [Hwang, Kyuin; Kim, Kyung Mo] Univ Sci & Technol, Dept Bioinformat, Taejon, South Korea; [Kim, Tae-Kyung; Yu, Dong Su; Hou, Bo Kyeng] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Kim, Byung Kwon] Yonsei Univ, Dept Syst Biol, Seoul 120749, South Korea; [Caetano-Anolles, Gustavo] Univ Illinois, Dept Crop Sci, Evolutionary Bioinformat Lab, Urbana, IL 61801 USA; [Hong, Soon Gyu] Korea Polar Res Inst, Div Polar Life Sci, Inchon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Yonsei University; University of Illinois System; University of Illinois Urbana-Champaign; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Kim, KM (corresponding author), Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Taejon, South Korea.	kmkim@kribb.re.kr		Hou, Bo Kyeng/0000-0002-9324-5263	KRIBB Research Initiative Program; Next-Generation BioGreen 21 Program, Rural Development Administration [PJ0090192013]; KOPRI research program [PE12030]	KRIBB Research Initiative Program; Next-Generation BioGreen 21 Program, Rural Development Administration; KOPRI research program(Korea Polar Research Institute of Marine Research Placement (KOPRI))	Funding: KRIBB Research Initiative Program; the Next-Generation BioGreen 21 Program, Rural Development Administration [PJ0090192013 to K.M.K]; KOPRI research program [PE12030 to S.G.H]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher Y, 2004, J BACTERIOL, V186, P3980, DOI 10.1128/JB.186.12.3980-3990.2004; Cai YP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr349; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; COLE JR, 2011, HDB MOL MICROBIAL EC, P313, DOI DOI 10.1002/9781118010518.CH36; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Hanage WP, 2006, PHILOS T R SOC B, V361, P2039, DOI 10.1098/rstb.2006.1926; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jackson SA, 2012, MICROB ECOL, V64, P105, DOI 10.1007/s00248-011-0002-x; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Konstantinidis KT, 2008, ISME J, V2, P1052, DOI 10.1038/ismej.2008.62; Lee JH, 2012, J MICROBIOL, V50, P181, DOI 10.1007/s12275-012-1214-6; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Sun YJ, 2012, BRIEF BIOINFORM, V13, P107, DOI 10.1093/bib/bbr009; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Wittkop T, 2010, NAT METHODS, V7, P419, DOI 10.1038/nmeth0610-419; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656	29	12	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62623	10.1371/journal.pone.0062623	http://dx.doi.org/10.1371/journal.pone.0062623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650520	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000063
J	Mackenzie, GG; Huang, LQ; Alston, N; Ouyang, NT; Vrankova, K; Mattheolabakis, G; Constantinides, PP; Rigas, B				Mackenzie, Gerardo G.; Huang, Liqun; Alston, Ninche; Ouyang, Nengtai; Vrankova, Kvetoslava; Mattheolabakis, George; Constantinides, Panayiotis P.; Rigas, Basil			Targeting Mitochondrial STAT3 with the Novel Phospho-Valproic Acid (MDC-1112) Inhibits Pancreatic Cancer Growth in Mice	PLOS ONE			English	Article							HISTONE DEACETYLASE; SIGNAL TRANSDUCER; SULINDAC OXT-328; COLON-CANCER; ACTIVATOR; RECEPTOR; INDUCTION; SUPPORTS	New agents are needed to treat pancreatic cancer, one of the most lethal human malignancies. We synthesized phosphovalproic acid, a novel valproic acid derivative, (P-V; MDC-1112) and evaluated its efficacy in the control of pancreatic cancer. P-V inhibited the growth of human pancreatic cancer xenografts in mice by 60%-97%, and 100% when combined with cimetidine. The dominant molecular target of P-V was STAT3. P-V inhibited the phosphorylation of JAK2 and Src, and the Hsp90-STAT3 association, suppressing the activating phosphorylation of STAT3, which in turn reduced the expression of STAT3-dependent proteins Bcl-x(L), Mcl-1 and survivin. P-V also reduced STAT3 levels in the mitochondria by preventing its translocation from the cytosol, and enhanced the mitochondrial levels of reactive oxygen species, which triggered apoptosis. Inhibition of mitochondrial STAT3 by P-V was required for its anticancer effect; mitochondrial STAT3 overexpression rescued animals from the tumor growth inhibition by P-V. Our results indicate that P-V is a promising candidate drug against pancreatic cancer and establish mitochondrial STAT3 as its key molecular target.	[Mackenzie, Gerardo G.; Huang, Liqun; Alston, Ninche; Ouyang, Nengtai; Vrankova, Kvetoslava; Mattheolabakis, George; Rigas, Basil] SUNY Stony Brook, Dept Med, Canc Prevent Div, Stony Brook, NY 11794 USA; [Ouyang, Nengtai; Constantinides, Panayiotis P.] Medicon Pharmaceut Inc, Stony Brook, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rigas, B (corresponding author), SUNY Stony Brook, Dept Med, Canc Prevent Div, Stony Brook, NY 11794 USA.	basil.rigas@stonybrookmedicine.edu	Mackenzie, Gerardo G/AAW-5114-2020		NIH [2R01 CA92423, R01 CA10101902]; Stony Brook University-Department of Medicine seed-grant; National Cancer Institute (NCI), National Institutes of Health;  [R01 CA154172]; NATIONAL CANCER INSTITUTE [R01CA154172, R01CA092423] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stony Brook University-Department of Medicine seed-grant; National Cancer Institute (NCI), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the NIH 2R01 CA92423 and R01 CA10101902 to BR and a Stony Brook University-Department of Medicine seed-grant to GGM. This work was also supported in part by grant R01 CA154172 (BR), awarded by the National Cancer Institute (NCI), National Institutes of Health. The study sponsors had no role in the study design, in the collection, analysis and interpretation of data, in the writing of the manuscript, nor in the decision to submit the manuscript for publication.	Algul H, 2002, J GASTROINTEST CANC, V31, P71, DOI 10.1385/IJGC:31:1-3:71; Barksdale KA, 2009, J NEUROCHEM, V108, P1289, DOI 10.1111/j.1471-4159.2009.05878.x; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Buettner R, 2011, ACS CHEM BIOL, V6, P432, DOI 10.1021/cb100253e; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kashfi K, 2007, BIOCHEM BIOPH RES CO, V358, P1096, DOI 10.1016/j.bbrc.2007.05.038; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Lang SA, 2007, CLIN CANCER RES, V13, P6459, DOI 10.1158/1078-0432.CCR-07-1104; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Mackenzie GG, 2011, CANCER PREV RES, V4, P1052, DOI 10.1158/1940-6207.CAPR-11-0067; Mackenzie GG, 2010, GASTROENTEROLOGY, V139, P1320, DOI 10.1053/j.gastro.2010.06.044; Mamon HJ, 2011, CANCER-AM CANCER SOC, V117, P2620, DOI 10.1002/cncr.25742; Naito A, 2008, INT J CANCER, V122, P1506, DOI 10.1002/ijc.23235; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Sahu RP, 2009, JNCI-J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Schuller HM, 2008, CANCER-AM CANCER SOC, V112, P767, DOI 10.1002/cncr.23231; Sclabas Guido M, 2003, Int J Gastrointest Cancer, V33, P15, DOI 10.1385/IJGC:33:1:15; Surucu O, 2004, INFLAMM RES, V53, pS39, DOI 10.1007/s00011-003-0318-1; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Wang W, 2009, PANCREAS, V38, pE114, DOI 10.1097/MPA.0b013e3181a0b6f2; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062; Yamamoto H, 2011, P NATL ACAD SCI USA, V108, P91, DOI 10.1073/pnas.1014918108; Zhang ZQ, 2006, INT J ONCOL, V29, P185; Zhao WP, 2009, CARCINOGENESIS, V30, P512, DOI 10.1093/carcin/bgp015	31	57	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61532	10.1371/journal.pone.0061532	http://dx.doi.org/10.1371/journal.pone.0061532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650499	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000016
J	Otwinowski, J; Nemenman, I				Otwinowski, Jakub; Nemenman, Ilya			Genotype to Phenotype Mapping and the Fitness Landscape of the E. coli lac Promoter	PLOS ONE			English	Article							DNA-BINDING SITES; BENEFICIAL MUTATIONS; REGULATORY PROTEINS; EPISTASIS; EVOLUTION; SELECTION; YEAST; NETWORKS; MODEL	Genotype-to-phenotype maps and the related fitness landscapes that include epistatic interactions are difficult to measure because of their high dimensional structure. Here we construct such a map using the recently collected corpora of high-throughput sequence data from the 75 base pairs long mutagenized E. coli lac promoter region, where each sequence is associated with its phenotype, the induced transcriptional activity measured by a fluorescent reporter. We find that the additive (non-epistatic) contributions of individual mutations account for about two-thirds of the explainable phenotype variance, while pairwise epistasis explains about 7% of the variance for the full mutagenized sequence and about 15% for the subsequence associated with protein binding sites. Surprisingly, there is no evidence for third order epistatic contributions, and our inferred fitness landscape is essentially single peaked, with a small amount of antagonistic epistasis. There is a significant selective pressure on the wild type, which we deduce to be multi-objective optimal for gene expression in environments with different nutrient sources. We identify transcription factor (CRP) and RNA polymerase binding sites in the promotor region and their interactions without difficult optimization steps. In particular, we observe evidence for previously unexplored genetic regulatory mechanisms, possibly kinetic in nature. We conclude with a cautionary note that inferred properties of fitness landscapes may be severely influenced by biases in the sequence data.	[Otwinowski, Jakub; Nemenman, Ilya] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Otwinowski, Jakub] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Nemenman, Ilya] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Nemenman, Ilya] Emory Univ, Computat & Life Sci Initiat, Atlanta, GA 30322 USA	Emory University; University of Pennsylvania; Emory University; Emory University	Otwinowski, J (corresponding author), Emory Univ, Dept Phys, Atlanta, GA 30322 USA.	jotwinowski@physics.emory.edu; ilya.nemenman@emory.edu	Otwinowski, Jakub/B-1289-2011; Otwinowski, Jacek/W-1159-2018	Otwinowski, Jakub/0000-0002-0341-8790; Otwinowski, Jacek/0000-0002-5471-6595; Nemenman, Ilya/0000-0003-3024-4244	HFSP program; James S. McDonnell Foundation	HFSP program; James S. McDonnell Foundation	The work has been funded, in part, by the HFSP program and the James S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Bauer AL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001007; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-42; BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Cocco S, 2009, P NATL ACAD SCI USA, V106, P14058, DOI 10.1073/pnas.0906705106; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Franke J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002134; FRIEDMAN J, 2010, J STAT SOFTWARE, V33; Garcia HG, 2012, CELL REP, V2, P150, DOI 10.1016/j.celrep.2012.06.004; Gerland U, 2002, J MOL EVOL, V55, P386, DOI 10.1007/s00239-002-2335-z; Goldenfeld N, 1999, SCIENCE, V284, P87, DOI 10.1126/science.284.5411.87; Goldenfeld N, 2011, ANNU REV CONDEN MA P, V2, P375, DOI 10.1146/annurev-conmatphys-062910-140509; Green W.H., 2003, ECONOMETRIC ANAL, V6th ed.; Hall DW, 2010, J HERED, V101, pS75, DOI 10.1093/jhered/esq007; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Kouyos RD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002551; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Liu B.H., 1997, STAT GENOMICS LINKAG; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; MacKay D. J. C., 2003, INFORM THEORY INFERE; Margolin AA, 2010, IET SYST BIOL, V4, P428, DOI 10.1049/iet-syb.2010.0009; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Moore JH, 2005, NAT GENET, V37, P13, DOI 10.1038/ng0105-13; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Mustonen V, 2005, P NATL ACAD SCI USA, V102, P15936, DOI 10.1073/pnas.0505537102; Mustonen V, 2008, P NATL ACAD SCI USA, V105, P12376, DOI 10.1073/pnas.0805909105; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Perfeito L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002160; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Poelwijk FJ, 2011, J THEOR BIOL, V272, P141, DOI 10.1016/j.jtbi.2010.12.015; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Shaw RG, 2010, EVOLUTION, V64, P2510, DOI 10.1111/j.1558-5646.2010.01010.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Szendro I, 2012, ARXIV12024378; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tkacik G, 2006, ARXIVQBIO0611072ARXI; Wall ME, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000614; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	56	35	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61570	10.1371/journal.pone.0061570	http://dx.doi.org/10.1371/journal.pone.0061570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650500	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000017
J	Bos, MGN; Jentgens, P; Beckers, T; Kindt, M				Bos, Marieke G. N.; Jentgens, Pia; Beckers, Tom; Kindt, Merel			Psychophysiological Response Patterns to Affective Film Stimuli	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RESPIRATORY SINUS ARRHYTHMIA; FEAR-POTENTIATED STARTLE; INDIVIDUAL-DIFFERENCES; AUTONOMIC RESPONSE; SUSTAINED EXPOSURE; EMOTION; MODULATION; ANXIETY; ASSOCIATION	Psychophysiological research on emotion utilizes various physiological response measures to index activation of the defense system. Here we tested 1) whether acoustic startle reflex (ASR), skin conductance response (SCR) and heart rate (HR) elicited by highly arousing stimuli specifically reflect a defensive state and 2) the relation between resting heart rate variability (HRV) and affective responding. In a within-subject design, participants viewed film clips with a positive, negative and neutral content. In contrast to SCR and HR, we show that ASR differentiated between negative, neutral and positive states and can therefore be considered as a reliable index of activation of the defense system. Furthermore, resting HRV was associated with affect-modulated characteristics of ASR, but not with SCR or HR. Interestingly, individuals with low-HRV showed less differentiation in ASR between affective states. We discuss the important value of ASR in psychophysiological research on emotion and speculate on HRV as a potential biological marker for demarcating adaptive from maladaptive responding.	[Bos, Marieke G. N.; Beckers, Tom; Kindt, Merel] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Bos, Marieke G. N.; Beckers, Tom; Kindt, Merel] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands; [Jentgens, Pia] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Jentgens, Pia] Netherlands Inst Neurosci, Dept Vis & Cognit, Amsterdam, Netherlands; [Beckers, Tom] Katholieke Univ Leuven, Dept Psychol, Louvain, Belgium	University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); KU Leuven	Kindt, M (corresponding author), Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands.	m.kindt@uva.nl	Beckers, Tom/C-6164-2008	Beckers, Tom/0000-0002-9581-1505; Bos, Marieke/0000-0003-1632-9217	Vici grant from the Netherlands Organization for Scientific Research (NWO) [453-07-006]; Vidi grant from NWO [452-09-001]	Vici grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Vidi grant from NWO	This study was funded by a Vici grant (Merel Kindt) from the Netherlands Organization for Scientific Research (NWO; #453-07-006). Tom Beckers is supported by a Vidi grant from NWO (#452-09-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; Bernat E, 2006, PSYCHOPHYSIOLOGY, V43, P93, DOI 10.1111/j.1469-8986.2006.00380.x; Berntson GG, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P182, DOI 10.1017/CBO9780511546396.008; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Bradley MM., 2000, SER AFFECTIVE SCI, P242; Carvalho S, 2012, APPL PSYCHOPHYS BIOF, V37, P279, DOI 10.1007/s10484-012-9201-6; Carvalho S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029530; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Frazier TW, 2004, PSYCHOPHYSIOLOGY, V41, P75, DOI 10.1046/j.1469-8986.2003.00131.x; FRIJDA NH, 1988, AM PSYCHOL, V43, P349, DOI 10.1037/0003-066X.43.5.349; Gomez P, 2005, BIOL PSYCHOL, V68, P223, DOI 10.1016/j.biopsycho.2004.06.003; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Hamm AO, 2005, INT J PSYCHOPHYSIOL, V57, P5, DOI 10.1016/j.ijpsycho.2005.01.006; Hamm AO, 1996, PSYCHOPHYSIOLOGY, V33, P698, DOI 10.1111/j.1469-8986.1996.tb02366.x; Hamm AO, 1997, PSYCHOPHYSIOLOGY, V34, P97, DOI 10.1111/j.1469-8986.1997.tb02420.x; Herring DR, 2011, INT J PSYCHOPHYSIOL, V79, P211, DOI 10.1016/j.ijpsycho.2010.10.007; HODES RL, 1985, PSYCHOPHYSIOLOGY, V22, P545, DOI 10.1111/j.1469-8986.1985.tb01649.x; Houtveen JH, 2002, PSYCHOPHYSIOLOGY, V39, P427, DOI 10.1017/S0048577202394022; JANSEN DM, 1994, PSYCHOPHYSIOLOGY, V31, P565, DOI 10.1111/j.1469-8986.1994.tb02349.x; Kaviani H, 1999, INT J PSYCHOPHYSIOL, V32, P47, DOI 10.1016/S0167-8760(98)00063-4; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; Koukounas E, 2000, BEHAV RES THER, V38, P573, DOI 10.1016/S0005-7967(99)00075-3; Kreibig SD, 2007, PSYCHOPHYSIOLOGY, V44, P787, DOI 10.1111/j.1469-8986.2007.00550.x; Kreibig SD, 2011, BIOL PSYCHOL, V87, P161, DOI 10.1016/j.biopsycho.2011.02.008; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; LAZARUS RS, 1991, AM PSYCHOL, V46, P819, DOI 10.1037/0003-066X.46.8.819; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Licht CMM, 2009, PSYCHOSOM MED, V71, P508, DOI 10.1097/PSY.0b013e3181a292a6; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; Melzig CA, 2009, INT J PSYCHOPHYSIOL, V71, P109, DOI 10.1016/j.ijpsycho.2008.07.013; Palomba D, 2000, INT J PSYCHOPHYSIOL, V36, P45, DOI 10.1016/S0167-8760(99)00099-9; Peterson RA., 1992, ANXIETY SENSITIVITY; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Ruiz-Padial E, 2003, PSYCHOPHYSIOLOGY, V40, P306, DOI 10.1111/1469-8986.00032; Sarlo M, 2002, BIOL PSYCHOL, V60, P91, DOI 10.1016/S0301-0511(02)00030-3; Schaefer A, 2010, COGNITION EMOTION, V24, P1153, DOI 10.1080/02699930903274322; Smith JC, 2005, BIOL PSYCHOL, V69, P247, DOI 10.1016/j.biopsycho.2004.09.001; Spielberger C.D., 1970, CONSULTING PSYCHOL; Thayer JF, 1996, BIOL PSYCHIAT, V39, P255, DOI 10.1016/0006-3223(95)00136-0; Thayer JF, 2005, PSYCHONEUROENDOCRINO, V30, P1050, DOI 10.1016/j.psyneuen.2005.04.014; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Van Boxtel A, 1998, PSYCHOPHYSIOLOGY, P35; VRANA SR, 1988, J ABNORM PSYCHOL, V97, P487, DOI 10.1037/0021-843X.97.4.487; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wendt J, 2008, PSYCHOPHYSIOLOGY, V45, P205, DOI 10.1111/j.1469-8986.2007.00620.x; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4	54	39	41	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62661	10.1371/journal.pone.0062661	http://dx.doi.org/10.1371/journal.pone.0062661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146GG	23646134	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300086
J	de Almeida, J; Jourdan, I; Murer, MG; Belforte, JE				de Almeida, Julian; Jourdan, Ivan; Gustavo Murer, Mario; Belforte, Juan E.			Refinement of Neuronal Synchronization with Gamma Oscillations in the Medial Prefrontal Cortex after Adolescence	PLOS ONE			English	Article							POSITRON EMISSION TOMOGRAPHY; RISK-TAKING BEHAVIOR; BRAIN MATURATION; SCHIZOPHRENIA-PATIENTS; COGNITIVE-DEVELOPMENT; SOMATOSENSORY CORTEX; NEURAL SYNCHRONY; FRONTAL-CORTEX; DEVELOPMENTAL-CHANGES; NEOCORTICAL NEURONS	The marked anatomical and functional changes taking place in the medial prefrontal cortex (PFC) during adolescence set grounds for the high incidence of neuropsychiatric disorders with adolescent onset. Although circuit refinement through synapse pruning may constitute the anatomical basis for the cognitive differences reported between adolescents and adults, a physiological correlate of circuit refinement at the level of neuronal ensembles has not been demonstrated. We have recorded neuronal activity together with local field potentials in the medial PFC of juvenile and adult mice under anesthesia, which allowed studying local functional connectivity without behavioral or sensorial interference. Entrainment of pyramidal neurons and interneurons to gamma oscillations, but not to theta or beta oscillations, was reduced after adolescence. Interneurons were synchronized to gamma oscillations across a wider area of the PFC than pyramidal neurons, and the span of interneuron synchronization was shorter in adults than juvenile mice. Thus, transition from childhood to adulthood is characterized by reduction of the strength and span of neuronal synchronization specific to gamma oscillations in the mPFC. The more restricted and weak ongoing synchronization in adults may allow a more dynamic rearrangement of neuronal ensembles during behavior and promote parallel processing of information.	[de Almeida, Julian; Jourdan, Ivan; Gustavo Murer, Mario; Belforte, Juan E.] Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, Neural Circuit Physiol Lab,Syst Neurosci Grp, Buenos Aires, DF, Argentina; [Belforte, Juan E.] Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, Physiol Anim Behav Lab,Syst Neurosci Grp, Buenos Aires, DF, Argentina; [Jourdan, Ivan] Univ Buenos Aires, Sch Engn, Inst Ingn Biomed, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Belforte, JE (corresponding author), Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, Neural Circuit Physiol Lab,Syst Neurosci Grp, Buenos Aires, DF, Argentina.	jbelforte@fmed.uba.ar	Belforte, Juan/Q-6633-2019	Belforte, Juan/0000-0002-6300-5314	Secretaria de Ciencia, Tecnologia e Innovacion Productiva, Fondo para la Investigacion Cientifica y Tecnologica, Argentina [PICT2007-05-01000, PICT2008-05-2205, PICT2011-0521, PICT2009-05-0010, PICT2010-05-1679]; Universidad de Buenos Aires, Argentina [UBACYT 2011-2014 562]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP0077, PIP707]; NARSAD Young Investigator Award from the Brain and Behavior Research Foundation	Secretaria de Ciencia, Tecnologia e Innovacion Productiva, Fondo para la Investigacion Cientifica y Tecnologica, Argentina; Universidad de Buenos Aires, Argentina(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NARSAD Young Investigator Award from the Brain and Behavior Research Foundation(NARSAD)	This work was supported by Secretaria de Ciencia, Tecnologia e Innovacion Productiva, Fondo para la Investigacion Cientifica y Tecnologica, Argentina (PICT2007-05-01000, PICT2008-05-2205, PICT2011-0521 to M.G.M. and PICT2009-05-0010, PICT2010-05-1679 to J.E.B.); Universidad de Buenos Aires, Argentina (UBACYT 2011-2014 562); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (PIP0077 to M.G.M. and PIP707 to J.E.B.); and 2010 NARSAD Young Investigator Award from the Brain and Behavior Research Foundation to J.E.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS I, 1982, BRAIN RES, V239, P349, DOI 10.1016/0006-8993(82)90514-5; Adriani W, 1998, BEHAV NEUROSCI, V112, P1152, DOI 10.1037/0735-7044.112.5.1152; Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; ANDERSON SA, 1995, NEUROSCIENCE, V67, P7, DOI 10.1016/0306-4522(95)00051-J; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Basar-Eroglu C, 2007, INT J PSYCHOPHYSIOL, V64, P39, DOI 10.1016/j.ijpsycho.2006.07.007; Blakemore SJ, 2006, DEVELOPMENTAL SCI, V9, P11, DOI 10.1111/j.1467-7687.2005.00456.x; BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; Cheetham CEJ, 2010, J NEUROSCI, V30, P12566, DOI 10.1523/JNEUROSCI.2544-10.2010; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Contreras D, 1997, NEUROSCIENCE, V77, P933; Darmani NA, 1996, PHYSIOL BEHAV, V60, P1495, DOI 10.1016/S0031-9384(96)00323-X; Destexhe A, 2007, TRENDS NEUROSCI, V30, P334, DOI 10.1016/j.tins.2007.04.006; DYSON SE, 1980, BRAIN RES, V183, P43, DOI 10.1016/0006-8993(80)90118-3; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Erickson SL, 2002, J COMP NEUROL, V448, P186, DOI 10.1002/cne.10249; Feinberg I, 2010, BRAIN COGNITION, V72, P56, DOI 10.1016/j.bandc.2009.09.008; Ferrarelli F, 2008, AM J PSYCHIAT, V165, P996, DOI 10.1176/appi.ajp.2008.07111733; Fisher NI, 1996, STAT ANAL CIRCULAR D; Flynn G, 2008, SCHIZOPHR RES, V105, P262, DOI 10.1016/j.schres.2008.05.029; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Galinanes GL, 2009, J NEUROSCI, V29, P2496, DOI 10.1523/JNEUROSCI.4421-08.2009; Gallinat J, 2004, CLIN NEUROPHYSIOL, V115, P1863, DOI 10.1016/j.clinph.2004.03.013; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Gandal MJ, 2010, BIOL PSYCHIAT, V68, P1100, DOI 10.1016/j.biopsych.2010.09.031; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; Hall MH, 2011, SCHIZOPHRENIA BULL, V37, P778, DOI 10.1093/schbul/sbp134; Harris LW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-28; Hascoet M, 1999, PHYSIOL BEHAV, V66, P567, DOI 10.1016/S0031-9384(98)00333-3; Heng LJ, 2011, SYNAPSE, V65, P278, DOI 10.1002/syn.20844; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; JACOBS B, 1995, CEREB CORTEX, V5, P222, DOI 10.1093/cercor/5.3.222; Kasanetz F, 2002, J PHYSIOL-LONDON, V543, P577, DOI 10.1113/jphysiol.2002.0024786; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kikuchi M, 2011, SCHIZOPHR RES, V130, P187, DOI 10.1016/j.schres.2011.06.003; Kremer Y, 2011, J NEUROSCI, V31, P10689, DOI 10.1523/JNEUROSCI.6541-10.2011; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lewis DA, 2011, CURR OPIN NEUROBIOL, V21, P866, DOI 10.1016/j.conb.2011.05.013; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; Macri S, 2002, ANIM BEHAV, V64, P541, DOI 10.1006/anbe.2002.4004; MARKUS EJ, 1987, EXP NEUROL, V96, P262, DOI 10.1016/0014-4886(87)90045-8; Nakazawa K, 2012, NEUROPHARMACOLOGY, V62, P1574, DOI 10.1016/j.neuropharm.2011.01.022; Norra C, 2004, NEUROPSYCHOBIOLOGY, V49, P71, DOI 10.1159/000076413; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Ringli M, 2011, PROG BRAIN RES, V193, P63, DOI 10.1016/B978-0-444-53839-0.00005-3; Seamans JK, 2008, NEUROTOX RES, V14, P249, DOI 10.1007/BF03033814; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Spear LP, 2010, DEV PSYCHOBIOL, V52, P236, DOI 10.1002/dev.20457; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Spencer KM, 2008, BIOL PSYCHIAT, V63, P744, DOI 10.1016/j.biopsych.2007.10.017; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Terranova ML, 1998, J COMP PSYCHOL, V112, P3, DOI 10.1037/0735-7036.112.1.3; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Tseng KY, 2007, CEREB CORTEX, V17, P1235, DOI 10.1093/cercor/bhl034; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31; Van De Werd HJJM, 2010, BRAIN STRUCT FUNCT, V214, P339, DOI 10.1007/s00429-010-0247-z; VANEDEN CG, 1985, J COMP NEUROL, V241, P268, DOI 10.1002/cne.902410303; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Whitford TJ, 2007, HUM BRAIN MAPP, V28, P228, DOI 10.1002/hbm.20273; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Whittington MA, 2011, DEV NEUROBIOL, V71, P92, DOI 10.1002/dneu.20814; Zecevic N, 1991, CEREB CORTEX, V1, P510, DOI 10.1093/cercor/1.6.510; Zold CL, 2007, EUR J NEUROSCI, V26, P1267, DOI 10.1111/j.1460-9568.2007.05754.x; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	89	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62978	10.1371/journal.pone.0062978	http://dx.doi.org/10.1371/journal.pone.0062978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646166	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300121
J	Ley, D; Harraghy, N; Le Fourn, V; Bire, S; Girod, PA; Regamey, A; Rouleux-Bonnin, F; Bigot, Y; Mermod, N				Ley, Deborah; Harraghy, Niamh; Le Fourn, Valerie; Bire, Solenne; Girod, Pierre-Alain; Regamey, Alexandre; Rouleux-Bonnin, Florence; Bigot, Yves; Mermod, Nicolas			MAR Elements and Transposons for Improved Transgene Integration and Expression	PLOS ONE			English	Article							CULTURED-MAMMALIAN-CELLS; MEDIATED GENE-TRANSFER; HOMOLOGOUS RECOMBINATION; PIGGYBAC; PRODUCTIVITY; VECTORS; THERAPY; LINES	Reliable and long-term expression of transgenes remain significant challenges for gene therapy and biotechnology applications, especially when antibiotic selection procedures are not applicable. In this context, transposons represent attractive gene transfer vectors because of their ability to promote efficient genomic integration in a variety of mammalian cell types. However, expression from genome-integrating vectors may be inhibited by variable gene transcription and/or silencing events. In this study, we assessed whether inclusion of two epigenetic control elements, the human Matrix Attachment Region (MAR) 1-68 and X-29, in a piggyBac transposon vector, may lead to more reliable and efficient expression in CHO cells. We found that addition of the MAR 1-68 at the center of the transposon did not interfere with transposition frequency, and transgene expressing cells could be readily detected from the total cell population without antibiotic selection. Inclusion of the MAR led to higher transgene expression per integrated copy, and reliable expression could be obtained from as few as 2-4 genomic copies of the MAR-containing transposon vector. The MAR X-29-containing transposons was found to mediate elevated expression of therapeutic proteins in polyclonal or monoclonal CHO cell populations using a transposable vector devoid of selection gene. Overall, we conclude that MAR and transposable vectors can be used to improve transgene expression from few genomic transposition events, which may be useful when expression from a low number of integrated transgene copies must be obtained and/or when antibiotic selection cannot be applied.	[Ley, Deborah; Harraghy, Niamh; Mermod, Nicolas] Univ Lausanne, Inst Biotechnol, Lausanne, Switzerland; [Ley, Deborah; Harraghy, Niamh; Mermod, Nicolas] Ecole Polytech Fed Lausanne, Ctr Biotechnol UNIL, CH-1015 Lausanne, Switzerland; [Le Fourn, Valerie; Girod, Pierre-Alain; Regamey, Alexandre] Selexis SA, Geneva, Switzerland; [Bire, Solenne; Bigot, Yves] Ctr INRA Val de Loire, UMR INRA CNRS 7247, PRC, Nouzilly, France; [Rouleux-Bonnin, Florence] UFR Med, UMR CNRS 7292, GICC, Tours, France	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Centre National de la Recherche Scientifique (CNRS)	Mermod, N (corresponding author), Univ Lausanne, Inst Biotechnol, Lausanne, Switzerland.	Nicolas.Mermod@unil.ch	Rouleux, Florence/AFT-8675-2022		Commission for technology and Innovation of the Swiss Confederation; Selexis SA; University of Lausanne; Egide Germaine de Stael grant; French Association for Research on Myopathies (AFM)	Commission for technology and Innovation of the Swiss Confederation; Selexis SA; University of Lausanne; Egide Germaine de Stael grant; French Association for Research on Myopathies (AFM)	This work was supported by grants of the Commission for technology and Innovation of the Swiss Confederation and Selexis SA and by the University of Lausanne to NM, and by an Egide Germaine de Stael grant and by the French Association for Research on Myopathies (AFM) to YB and NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belay E, 2011, CURR GENE THER, V11, P406; Brezinsky SCG, 2003, J IMMUNOL METHODS, V277, P141, DOI 10.1016/S0022-1759(03)00108-X; Derouazi M, 2006, BIOCHEM BIOPH RES CO, V340, P1069, DOI 10.1016/j.bbrc.2005.12.111; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; FOLGER KR, 1982, MOL CELL BIOL, V2, P1372, DOI 10.1128/MCB.2.11.1372; Galbete JL, 2009, MOL BIOSYST, V5, P143, DOI 10.1039/b813657b; Gao X, 2007, AAPS J, V9, pE92, DOI 10.1208/aapsj0901009; Gaussin A, 2012, GENE THER, V19, P15, DOI 10.1038/gt.2011.70; Girod PA, 2007, NAT METHODS, V4, P747, DOI 10.1038/NMETH1076; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Grandjean M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr436; Handler AM, 1998, P NATL ACAD SCI USA, V95, P7520, DOI 10.1073/pnas.95.13.7520; Harraghy N, 2008, CURR GENE THER, V8, P353, DOI 10.2174/156652308786071032; Hart CM, 1998, CURR OPIN GENET DEV, V8, P519, DOI 10.1016/S0959-437X(98)80005-1; HOGLUND M, 1992, GENE, V116, P215, DOI 10.1016/0378-1119(92)90518-T; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Kwaks THJ, 2006, TRENDS BIOTECHNOL, V24, P137, DOI 10.1016/j.tibtech.2006.01.007; Le Fourn V, 2014, METAB ENG, V21, P91, DOI 10.1016/j.ymben.2012.12.003; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Matasci M, 2011, BIOTECHNOL BIOENG, V108, P2141, DOI 10.1002/bit.23167; McBurney MW, 2002, EXP CELL RES, V274, P1, DOI 10.1006/excr.2001.5443; Meir YJJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-28; Nakanishi H, 2011, J BIOTECHNOL, V154, P205, DOI 10.1016/j.jbiotec.2011.05.009; RHOUNIM L, 1992, EMBO J, V11, P4451, DOI 10.1002/j.1460-2075.1992.tb05546.x; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; URLAUB G, 1983, CELL, V33, P405, DOI 10.1016/0092-8674(83)90422-1; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028	28	25	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62784	10.1371/journal.pone.0062784	http://dx.doi.org/10.1371/journal.pone.0062784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646143	gold, Green Submitted, Green Published			2022-12-25	WOS:000319077300096
J	Ruzsnavszky, O; Dienes, B; Olah, T; Vincze, J; Gall, T; Balogh, E; Nagy, G; Batori, R; Lontay, B; Erdodi, F; Csernoch, L				Ruzsnavszky, Olga; Dienes, Beatrix; Olah, Tamas; Vincze, Janos; Gall, Tamas; Balogh, Eniko; Nagy, Gabor; Batori, Robert; Lontay, Beata; Erdodi, Ferenc; Csernoch, Laszlo			Differential Effects of Phosphatase Inhibitors on the Calcium Homeostasis and Migration of HaCaT Keratinocytes	PLOS ONE			English	Article							CELL-MIGRATION; OKADAIC ACID; MYOSIN-II; IN-VITRO; PROTEIN; ACTIVATION; PHOSPHORYLATION; RECEPTORS; DYNAMICS; RELEASE	Changes in intracellular calcium concentration ([Ca2+] i) as well as in the phosphorylation state of proteins have been implicated in keratinocyte wound healing revealed in scratch assays. Scratching confluent HaCaT monolayers decreased the number of cells displaying repetitive Ca2+ oscillations as well as the frequency of their Ca2+-transients in cells close to the wounded area and initiated migration of the cells into the wound bed. In contrast, calyculin-A (CLA) and okadaic acid (OA), known cell permeable inhibitors of protein phosphatase-1 and 2A, increased the level of resting [Ca2+] i and suppressed cell migration and wound healing of HaCaT cells. Furthermore, neither CLA nor OA influenced how scratching affected Ca2+ oscillations. It is assumed that changes in and alterations of the phosphorylation level of Ca2+-transport and contractile proteins upon phosphatase inhibition mediates cell migration and wound healing.	[Ruzsnavszky, Olga; Dienes, Beatrix; Olah, Tamas; Vincze, Janos; Gall, Tamas; Csernoch, Laszlo] Univ Debrecen, Dept Physiol, H-4012 Debrecen, Hungary; [Batori, Robert; Lontay, Beata; Erdodi, Ferenc] Univ Debrecen, Dept Med Chem, H-4012 Debrecen, Hungary; [Nagy, Gabor] Univ Debrecen, Dept Microbial Biotechnol & Cell Biol, H-4012 Debrecen, Hungary; [Balogh, Eniko] Univ Debrecen, Dept Internal Med 1, H-4012 Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Csernoch, L (corresponding author), Univ Debrecen, Dept Physiol, H-4012 Debrecen, Hungary.	csl@edu.unideb.hu	Batori, Robert K/I-4846-2017; Batori, Robert/ABE-7191-2021	Batori, Robert/0000-0002-1400-6732; Szeman-Nagy, Gabor/0000-0003-1906-0188; Csernoch, Laszlo/0000-0002-2446-1456; Olah, Tamas/0000-0002-3834-6272	European Union and the European Social Fund [TAMOP-4.2.2/B-10/1-2010-0024]; Hungarian Republic and the European Social Fund [TAMOP4.2.2. A-11/1/KONV-2012-0025]; Hungarian National Science Fund [OTKA NK78398, K75604, CNK80709]; Baross Gabor project [REG_ EA_ INFRA_ 09]	European Union and the European Social Fund; Hungarian Republic and the European Social Fund; Hungarian National Science Fund; Baross Gabor project	This work was supported by TAMOP-4.2.2/B-10/1-2010-0024 project (co-financed by the European Union and the European Social Fund) and TAMOP4.2.2. A-11/1/KONV-2012-0025 project (co-financed by the Hungarian Republic and the European Social Fund). Research grants from the Hungarian National Science Fund (OTKA NK78398, K75604 and CNK80709) and the Baross Gabor project (REG_ EA_ INFRA_ 09, LSM_ LIVE) also supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayguinov PO, 2010, J PHYSIOL-LONDON, V588, P4453, DOI 10.1113/jphysiol.2010.196824; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Betapudi V, 2010, EXP CELL RES, V316, P980, DOI 10.1016/j.yexcr.2010.01.024; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Farkas E, 2010, TOXICOL IN VITRO, V24, P267, DOI 10.1016/j.tiv.2009.08.021; Feng CY, 2012, EXP EYE RES, V100, P73, DOI 10.1016/j.exer.2012.04.007; Grando SA, 1996, J INVEST DERMATOL, V107, P412, DOI 10.1111/1523-1747.ep12363399; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Helmlinger G, 1996, J VASC RES, V33, P360, DOI 10.1159/000159164; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Jackson B, 2011, MOL BIOL CELL, V22, P593, DOI 10.1091/mbc.E09-10-0859; Kawashima H, 2009, CIRC J, V73, P1133, DOI 10.1253/circj.CJ-08-0871; Kiss A, 2008, CELL SIGNAL, V20, P2059, DOI 10.1016/j.cellsig.2008.07.018; Koivisto L, 2003, J CELL SCI, V116, P3749, DOI 10.1242/jcs.00693; Liu HW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007330; Lontay B, 2005, CELL SIGNAL, V17, P1265, DOI 10.1016/j.cellsig.2005.01.008; Matta C, 2008, CELL CALCIUM, V44, P310, DOI 10.1016/j.ceca.2007.12.010; Nesti LJ, 2007, J CELL BIOCHEM, V101, P348, DOI 10.1002/jcb.21180; Pullar CE, 2003, J BIOL CHEM, V278, P22555, DOI 10.1074/jbc.M300205200; Resjo S, 1999, BIOCHEM J, V341, P839, DOI 10.1042/0264-6021:3410839; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ruzsnavszky O, 2011, J PHOTOCH PHOTOBIO B, V105, P113, DOI 10.1016/j.jphotobiol.2011.07.009; Saino T, 2009, AM J PHYSIOL-CELL PH, V296, pC88; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Szabo LZ, 2010, J THEOR BIOL, V264, P1279, DOI 10.1016/j.jtbi.2010.04.005; Szappanos H, 2004, J BIOCHEM BIOPH METH, V59, P89, DOI 10.1016/j.jbbm.2003.12.002; Szentesi P, 2004, BIOPHYS J, V86, P1436, DOI 10.1016/S0006-3495(04)74213-7; Toth BI, 2011, J INVEST DERMATOL, V131, P1095, DOI 10.1038/jid.2010.421; Wong K, 1998, INFLAMMATION, V22, P631, DOI 10.1023/A:1022318631686; Zhao SM, 1998, BIOCHEMISTRY-US, V37, P18102, DOI 10.1021/bi982144k	31	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61507	10.1371/journal.pone.0061507	http://dx.doi.org/10.1371/journal.pone.0061507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646108	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300009
J	Li, HH; Kong, LZ; Wu, XH; Li, L				Li, Huahui; Kong, Lingzhi; Wu, Xihong; Li, Liang			Primitive Auditory Memory Is Correlated with Spatial Unmasking That Is Based on Direct-Reflection Integration	PLOS ONE			English	Article							INTERAURAL CORRELATION; INFORMATIONAL MASKING; BINOCULAR UNMASKING; ENERGETIC MASKING; SPEECH; SEPARATION; NOISE; REVERBERATION; RECOGNITION; RELEASE	In reverberant rooms with multiple-people talking, spatial separation between speech sources improves recognition of attended speech, even though both the head-shadowing and interaural-interaction unmasking cues are limited by numerous reflections. It is the perceptual integration between the direct wave and its reflections that bridges the direct-reflection temporal gaps and results in the spatial unmasking under reverberant conditions. This study further investigated (1) the temporal dynamic of the direct-reflection-integration-based spatial unmasking as a function of the reflection delay, and (2) whether this temporal dynamic is correlated with the listeners' auditory ability to temporally retain raw acoustic signals (i.e., the fast decaying primitive auditory memory, PAM). The results showed that recognition of the target speech against the speech-masker background is a descending exponential function of the delay of the simulated target reflection. In addition, the temporal extent of PAM is frequency dependent and markedly longer than that for perceptual fusion. More importantly, the temporal dynamic of the speech-recognition function is significantly correlated with the temporal extent of the PAM of low-frequency raw signals. Thus, we propose that a chain process, which links the earlier-stage PAM with the later-stage correlation computation, perceptual integration, and attention facilitation, plays a role in spatially unmasking target speech under reverberant conditions.	[Li, Huahui; Kong, Lingzhi; Li, Liang] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Wu, Xihong] Peking Univ, Dept Machine Intelligence, Beijing 100871, Peoples R China; [Wu, Xihong; Li, Liang] Peking Univ, Speech & Hearing Res Ctr, Beijing 100871, Peoples R China; [Wu, Xihong; Li, Liang] Peking Univ, Minist Educ, Key Lab Machine Percept, Beijing 100871, Peoples R China; [Li, Liang] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Li, L (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	liangli@pku.edu.cn			National Natural Science Foundation of China [31170985]; "973'' National Basic Research Program of China [2009CB320901, 2011CB707805]; Peking University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973'' National Basic Research Program of China(National Basic Research Program of China); Peking University(Peking University)	This work was supported by the National Natural Science Foundation of China (31170985), the "973'' National Basic Research Program of China (2009CB320901; 2011CB707805), and "985'' grants from Peking University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd MA, 1999, J ACOUST SOC AM, V105, P2807, DOI 10.1121/1.426897; Arbogast TL, 2002, J ACOUST SOC AM, V112, P2086, DOI 10.1121/1.1510141; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BILSEN FA, 1974, J ACOUST SOC AM, V55, P292, DOI 10.1121/1.1914500; BLAUERT J, 1986, J ACOUST SOC AM, V79, P806, DOI 10.1121/1.393471; Boehnke SE, 2002, J ACOUST SOC AM, V112, P1617, DOI 10.1121/1.1504857; Brungart DS, 2001, J ACOUST SOC AM, V110, P2527, DOI 10.1121/1.1408946; Brungart DS, 2005, J ACOUST SOC AM, V118, P3241, DOI 10.1121/1.2082557; Burger J., 1958, ACTA ACUST UNITED AC, V8, P1; CARTMILL M, 1974, SCIENCE, V184, P436, DOI 10.1126/science.184.4135.436; CHERRY EC, 1954, J ACOUST SOC AM, V26, P554, DOI 10.1121/1.1907373; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; COWAN N, 1984, PSYCHOL BULL, V96, P341, DOI 10.1037/0033-2909.96.2.341; Culling JF, 2003, J ACOUST SOC AM, V114, P2871, DOI 10.1121/1.1616922; Culling JF, 2001, J ACOUST SOC AM, V110, P1020, DOI 10.1121/1.1383296; Culling JF, 2007, J ACOUST SOC AM, V122, P2803, DOI 10.1121/1.2785035; Darwin CJ, 2000, J ACOUST SOC AM, V108, P335, DOI 10.1121/1.429468; Du Y, 2011, NEUROSCI BIOBEHAV R, V35, P2046, DOI 10.1016/j.neubiorev.2011.05.008; Durlach NI, 2003, J ACOUST SOC AM, V114, P368, DOI 10.1121/1.1577562; FREYMAN RL, 1991, J ACOUST SOC AM, V90, P874, DOI 10.1121/1.401955; Freyman RL, 1999, J ACOUST SOC AM, V106, P3578, DOI 10.1121/1.428211; GABRIEL KJ, 1981, J ACOUST SOC AM, V69, P1394, DOI 10.1121/1.385821; Goupell MJ, 2006, J ACOUST SOC AM, V119, P3971, DOI 10.1121/1.2200147; Hall DA, 2005, J NEUROPHYSIOL, V94, P3181, DOI 10.1152/jn.00271.2005; Heesy CP, 2009, EVOL ANTHROPOL, V18, P21, DOI 10.1002/evan.20195; HENNING GB, 1973, VISION RES, V13, P2455, DOI 10.1016/0042-6989(73)90243-5; Huang Y, 2008, HEARING RES, V244, P51, DOI 10.1016/j.heares.2008.07.006; Huang Y, 2011, J COGNITIVE NEUROSCI, V23, P1003, DOI 10.1162/jocn.2010.21470; Huang Y, 2009, J EXP PSYCHOL HUMAN, V35, P1618, DOI 10.1037/a0015791; Huang Y, 2009, J ACOUST SOC AM, V126, P300, DOI 10.1121/1.3147504; Huang Y, 2008, NEUROREPORT, V19, P1673, DOI 10.1097/WNR.0b013e32831576c7; JULESZ B, 1964, SCIENCE, V145, P356, DOI 10.1126/science.145.3630.356; KAUFMAN L, 1964, AM J PSYCHOL, V77, P393, DOI 10.2307/1421009; Kidd G, 2005, ACTA ACUST UNITED AC, V91, P526; KIDD G, 1994, J ACOUST SOC AM, V95, P3475, DOI 10.1121/1.410023; Koehnke J, 1996, EAR HEARING, V17, P211, DOI 10.1097/00003446-199606000-00004; KOEHNKE J, 1986, J ACOUST SOC AM, V79, P1558, DOI 10.1121/1.393682; Kong LZ, 2012, J ACOUST SOC AM, V132, pEL114, DOI 10.1121/1.4734241; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li L, 2005, HEARING RES, V202, P235, DOI 10.1016/j.heares.2004.10.007; Li L, 2004, J EXP PSYCHOL HUMAN, V30, P1077, DOI 10.1037/0096-1523.30.6.1077; Li L, 2009, EAR HEARING, V30, P273, DOI 10.1097/AUD.0b013e318198703d; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; MASSARO DW, 1972, PSYCHOL REV, V79, P124, DOI 10.1037/h0032264; MORAGLIA G, 1992, VISION RES, V32, P375, DOI 10.1016/0042-6989(92)90146-A; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; OToole AJ, 1997, PERCEPT PSYCHOPHYS, V59, P202, DOI 10.3758/BF03211889; POLLACK I, 1959, J ACOUST SOC AM, V31, P1250, DOI 10.1121/1.1907852; Rakerd B, 2006, J ACOUST SOC AM, V119, P1597, DOI 10.1121/1.2161438; Rakerd B, 2000, J ACOUST SOC AM, V107, P1061, DOI 10.1121/1.428287; Reznikoff I., 2008, J ACOUST SOC AM, V123, P3603, DOI [10.1121/1.2934773, DOI 10.1121/1.2934773]; RITTER W, 1995, EAR HEARING, V16, P52, DOI 10.1097/00003446-199502000-00005; SCHNEIDER B, 1989, SCIENCE, V243, P1479, DOI 10.1126/science.2928782; Schneider BA, 2007, J AM ACAD AUDIOL, V18, P559, DOI 10.3766/jaaa.18.7.4; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; WALLACH H, 1949, AM J PSYCHOL, V62, P315, DOI 10.2307/1418275; Wardle SG, 2010, J VISION, V10, DOI 10.1167/10.14.38; Wu XH, 2005, HEARING RES, V199, P1, DOI 10.1016/j.heares.2004.03.010; Yang ZG, 2007, SPEECH COMMUN, V49, P892, DOI 10.1016/j.specom.2007.05.005; YOST WA, 1981, J ACOUST SOC AM, V70, P397, DOI 10.1121/1.386775; ZUREK PM, 1980, J ACOUST SOC AM, V67, P952, DOI 10.1121/1.383974; Zurek PM, 2004, J ACOUST SOC AM, V115, P1609, DOI 10.1121/1.1650333	63	19	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e63106	10.1371/journal.pone.0063106	http://dx.doi.org/10.1371/journal.pone.0063106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658664	Green Published, gold			2022-12-25	WOS:000321662800076
J	Barry, RL; Coaster, M; Rogers, BP; Newton, AT; Moore, J; Anderson, AW; Zald, DH; Gore, JC				Barry, Robert L.; Coaster, Mariam; Rogers, Baxter P.; Newton, Allen T.; Moore, Jay; Anderson, Adam W.; Zald, David H.; Gore, John C.			On the Origins of Signal Variance in FMRI of the Human Midbrain at High Field	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS DOPAMINE; BRAIN ACTIVATION PATTERNS; CEREBROSPINAL-FLUID FLOW; FUNCTIONAL MRI; PHYSIOLOGICAL NOISE; NAVIGATOR CORRECTION; MAGNETIC-FIELD; IN-VIVO; 1.5 T; RESOLUTION	Functional Magnetic Resonance Imaging (fMRI) in the midbrain at 7 Tesla suffers from unexpectedly low temporal signal to noise ratio (TSNR) compared to other brain regions. Various methodologies were used in this study to quantitatively identify causes of the noise and signal differences in midbrain fMRI data. The influence of physiological noise sources was examined using RETROICOR, phase regression analysis, and power spectral analyses of contributions in the respiratory and cardiac frequency ranges. The impact of between-shot phase shifts in 3-D multi-shot sequences was tested using a one-dimensional (1-D) phase navigator approach. Additionally, the effects of shared noise influences between regions that were temporally, but not functionally, correlated with the midbrain (adjacent white matter and anterior cerebellum) were investigated via analyses with regressors of 'no interest'. These attempts to reduce noise did not improve the overall TSNR in the midbrain. In addition, the steady state signal and noise were measured in the midbrain and the visual cortex for resting state data. We observed comparable steady state signals from both the midbrain and the cortex. However, the noise was 2-3 times higher in the midbrain relative to the cortex, confirming that the low TSNR in the midbrain was not due to low signal but rather a result of large signal variance. These temporal variations did not behave as known physiological or other noise sources, and were not mitigated by conventional strategies. Upon further investigation, resting state functional connectivity analysis in the midbrain showed strong intrinsic fluctuations between homologous midbrain regions. These data suggest that the low TSNR in the midbrain may originate from larger signal fluctuations arising from functional connectivity compared to cortex, rather than simply reflecting physiological noise.	[Barry, Robert L.; Coaster, Mariam; Rogers, Baxter P.; Newton, Allen T.; Moore, Jay; Anderson, Adam W.; Gore, John C.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37203 USA; [Barry, Robert L.; Rogers, Baxter P.; Moore, Jay; Anderson, Adam W.; Gore, John C.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [Coaster, Mariam; Zald, David H.; Gore, John C.] Vanderbilt Univ, Neurosci Grad Program, Nashville, TN USA; [Rogers, Baxter P.; Anderson, Adam W.; Gore, John C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Zald, David H.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Zald, David H.] Vanderbilt Univ, Dept Psychiat, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Barry, RL (corresponding author), Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37203 USA.	robert.barry@vanderbilt.edu		Rogers, Baxter/0000-0002-5666-2797	National Institute of Biomedical Imaging and Bioengineering (NIBIB) [R01EB000461]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000461, T32EB001628] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding source: National Institute of Biomedical Imaging and Bioengineering (NIBIB): R01EB000461. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandettini PA, 1994, P SMR 2 ANN M SAN FR, P434; Barry RL, 2005, MAGN RESON MED, V54, P411, DOI 10.1002/mrm.20591; Barry RL, 2008, NEUROIMAGE, V39, P1142, DOI 10.1016/j.neuroimage.2007.09.060; Barry RL, 2012, MAGN RESON MED, V67, P867, DOI 10.1002/mrm.23072; Barry RL, 2011, NEUROIMAGE, V55, P1034, DOI 10.1016/j.neuroimage.2010.12.086; Barry RL, 2010, MAGN RESON IMAGING, V28, P235, DOI 10.1016/j.mri.2009.07.005; Bernstein M.A., 2004, HDB MRI PULSE SEQUEN, DOI 10.1016/B978-012092861-3/50021-2; BRUDER H, 1992, MAGNET RESON MED, V23, P311, DOI 10.1002/mrm.1910230211; Buckholtz JW, 2010, NAT NEUROSCI, V13, P419, DOI 10.1038/nn.2510; Coaster M, 2012, THESIS VANDERBILT U; Dagli MS, 1999, NEUROIMAGE, V9, P407, DOI 10.1006/nimg.1998.0424; Duyn JH, 1996, NEUROIMAGE, V4, pS76, DOI 10.1006/nimg.1996.0057; Eapen M, 2011, AM J NEURORADIOL, V32, P688, DOI 10.3174/ajnr.A2355; EHMAN RL, 1989, RADIOLOGY, V173, P255, DOI 10.1148/radiology.173.1.2781017; ENZMANN DR, 1992, RADIOLOGY, V185, P653, DOI 10.1148/radiology.185.3.1438741; FARZANEH F, 1990, MAGNET RESON MED, V14, P123, DOI 10.1002/mrm.1910140112; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gati JS, 1997, MAGNET RESON MED, V38, P296, DOI 10.1002/mrm.1910380220; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Golay X, 2000, MAGNET RESON MED, V43, P779, DOI 10.1002/1522-2594(200006)43:6<779::AID-MRM1>3.0.CO;2-4; GRACE AA, 1984, J NEUROSCI, V4, P2866; GREITZ D, 1992, NEURORADIOLOGY, V34, P370, DOI 10.1007/BF00596493; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; GRUETTER R, 1992, J MAGN RESON, V96, P323, DOI 10.1016/0022-2364(92)90085-L; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; Haacke E. M., 1999, MAGNETIC RESONANCE I; HORNAK JP, 1988, MAGNET RESON MED, V6, P158, DOI 10.1002/mrm.1910060204; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Krebs RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008691; Kruger G, 2001, MAGNET RESON MED, V45, P595, DOI 10.1002/mrm.1081; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; LIU GY, 1993, MAGNET RESON MED, V30, P764, DOI 10.1002/mrm.1910300617; Manova ES, 2009, AM J NEURORADIOL, V30, P569, DOI 10.3174/ajnr.A1401; MANSFIELD P, 1994, J COMPUT ASSIST TOMO, V18, P339, DOI 10.1097/00004728-199405000-00001; Menon RS, 2002, MAGNET RESON MED, V47, P1, DOI 10.1002/mrm.10041; Naidich T.P., 2009, DUVERNOYS ATLAS HUMA; Neggers SFW, 2008, NMR BIOMED, V21, P663, DOI 10.1002/nbm.1235; Novak P, 2001, J COMPUT ASSIST TOMO, V25, P242, DOI 10.1097/00004728-200103000-00016; Paxinos G., 1995, ATLAS HUMAN BRAINSTE; PONCELET BP, 1992, RADIOLOGY, V185, P645, DOI 10.1148/radiology.185.3.1438740; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Ramsey NF, 1998, NEUROIMAGE, V8, P240, DOI 10.1006/nimg.1998.0358; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Salamone JD, 1996, J NEUROSCI METH, V64, P137, DOI 10.1016/0165-0270(95)00125-5; SCHNEIDER E, 1991, MAGNET RESON MED, V18, P335, DOI 10.1002/mrm.1910180208; SCHROTH G, 1992, NEURORADIOLOGY, V35, P10, DOI 10.1007/BF00588271; SCHROTH G, 1992, NEURORADIOLOGY, V35, P1, DOI 10.1007/BF00588270; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sexton JA, 2009, P INT SOC MAGN RESON, V1549; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Soellinger M, 2007, J MAGN RESON IMAGING, V25, P709, DOI 10.1002/jmri.20882; Stenger VA, 1998, MAGNET RESON MED, V40, P481, DOI 10.1002/mrm.1910400320; Swisher JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034626; Takahashi H, 2004, NEUROIMAGE, V22, P1247, DOI 10.1016/j.neuroimage.2004.03.028; Thomas BP, 2008, J MAGN RESON IMAGING, V28, P1266, DOI 10.1002/jmri.21576; Tomasi D, 2007, BRAIN RES, V1171, P83, DOI 10.1016/j.brainres.2007.06.102; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; van der Meulen P, 1985, Magn Reson Imaging, V3, P297, DOI 10.1016/0730-725X(85)90362-5; VANDERMEULEN P, 1988, MAGN RESON IMAGING, V6, P355, DOI 10.1016/0730-725X(88)90472-9; VANGELDEREN P, 1995, P NATL ACAD SCI USA, V92, P6906, DOI 10.1073/pnas.92.15.6906; Versluis MJ, 2010, NEUROIMAGE, V51, P1082, DOI 10.1016/j.neuroimage.2010.03.048; Weisskoff R., 1993, P ISMRM 12 ANN M, P7; Weisskoff RM, 1996, MAGN RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yamada S, 2008, RADIOLOGY, V249, P644, DOI 10.1148/radiol.2492071985	69	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62708	10.1371/journal.pone.0062708	http://dx.doi.org/10.1371/journal.pone.0062708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658643	gold, Green Submitted, Green Published			2022-12-25	WOS:000318343700067
J	Maryon, EB; Molloy, SA; Yu, KIH; Kaplan, JH				Maryon, Edward B.; Molloy, Shannon A.; Yu, Kristin Ivy Huijun; Kaplan, Jack H.			Rate and Regulation of Copper Transport by Human Copper Transporter 1 (hCTR1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOCHEMICAL-CHARACTERIZATION; STIMULATED ENDOCYTOSIS; TRANSMEMBRANE DOMAIN; HUMAN CTR1; CELLS; MECHANISM; MOUSE; IDENTIFICATION; COMPONENTS; KINETICS	Human copper transporter 1 (hCTR1) is a homotrimer of a 190-amino acid monomer having three transmembrane domains believed to form a pore for copper permeation through the plasma membrane. The hCTR1-mediated copper transport mechanism is not well understood, nor has any measurement been made of the rate at which copper ions are transported by hCTR1. In this study, we estimated the rate of copper transport by the hCTR1 trimer in cultured cells using Cu-64 uptake assays and quantification of plasma membrane hCTR1. For endogenous hCTR1, we estimated a turnover number of about 10 ions/trimer/s. When overexpressed in HEK293 cells, a second transmembrane domain mutant of hCTR1 (H139R) had a 3-fold higher Km value and a 4-fold higher turnover number than WT. Truncations of the intracellular C-terminal tail and an AAA substitution of the putative metal-binding HCH C-terminal tripeptide (thought to be required for transport) also exhibited elevated transport rates and K-m values when compared with WT hCTR1. Unlike WT hCTR1, H139R and the C-terminal mutants did not undergo regulatory endocytosis in elevated copper. hCTR1 mutants combining methionine substitutions that block transport (M150L, M154L) on the extracellular side of the pore and the high transport H139R or AAA intracellular side mutations exhibited the blocked transport of M150L, M154L, confirming that Cu+ first interacts with the methionines during permeation. Our results show that hCTR1 elements on the intracellular side of the hCTR1 pore, including the carboxyl tail, are not essential for permeation, but serve to regulate the rate of copper entry.	[Maryon, Edward B.; Molloy, Shannon A.; Yu, Kristin Ivy Huijun; Kaplan, Jack H.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kaplan, JH (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA.	kaplanj@uic.edu		Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [P01 GM067166]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 GM067166 (to J. H. K.).	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; BRAHM J, 1983, J PHYSIOL-LONDON, V339, P339, DOI 10.1113/jphysiol.1983.sp014720; BRAHM J, 1977, J GEN PHYSIOL, V70, P283, DOI 10.1085/jgp.70.3.283; Cabrera A, 2008, BIOMETALS, V21, P525, DOI 10.1007/s10534-008-9139-6; De Feo CJ, 2010, J MEMBRANE BIOL, V234, P113, DOI 10.1007/s00232-010-9239-4; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Gupta A, 2009, FORM METHOD SYST DES, V35, P1, DOI 10.1007/s10703-009-0072-2; Holzer AK, 2004, CLIN CANCER RES, V10, P6744, DOI 10.1158/1078-0432.CCR-04-0748; Hua HQ, 2010, J BIOL INORG CHEM, V15, P107, DOI 10.1007/s00775-009-0599-0; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; JORGENSEN PL, 1986, KIDNEY INT, V29, P10, DOI 10.1038/ki.1986.3; Karakossian MH, 2005, J MEMBRANE BIOL, V203, P65, DOI 10.1007/s00232-004-0732-5; Klomp AEM, 2003, BIOCHEM J, V370, P881, DOI 10.1042/BJ20021128; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Liang ZD, 2009, MOL PHARMACOL, V76, P843, DOI 10.1124/mol.109.056416; MacPherson IS, 2007, CELL MOL LIFE SCI, V64, P2887, DOI 10.1007/s00018-007-7310-9; Maryon EB, 2007, BIOMETALS, V20, P355, DOI 10.1007/s10534-006-9066-3; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Maryon EB, 2009, J BIOL CHEM, V284, P28104, DOI 10.1074/jbc.M109.044925; Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; McMillin GA, 2009, AM J CLIN PATHOL, V131, P160, DOI 10.1309/AJCP7Z9KBFINVGYF; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Pope CR, 2012, CURR TOP MEMBR, V69, P97, DOI 10.1016/B978-0-12-394390-3.00004-5; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Schushan M, 2010, P NATL ACAD SCI USA, V107, P10908, DOI 10.1073/pnas.0914717107; Tsigelny IF, 2012, CELL BIOCHEM BIOPHYS, V63, P223, DOI 10.1007/s12013-012-9358-x; WIRTH PL, 1985, J NATL CANCER I, V75, P277; Wu XB, 2009, J BIOL CHEM, V284, P4112, DOI 10.1074/jbc.M807909200; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zimnicka AM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702653200; Zimnicka AM, 2011, AM J PHYSIOL-CELL PH, V300, pC588, DOI 10.1152/ajpcell.00054.2010	40	47	49	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18035	18046		10.1074/jbc.M112.442426	http://dx.doi.org/10.1074/jbc.M112.442426			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23658018	Green Published, hybrid			2022-12-25	WOS:000320721900010
J	Raleiras, P; Kellers, P; Lindblad, P; Styring, S; Magnuson, A				Raleiras, Patrcia; Kellers, Petra; Lindblad, Peter; Styring, Stenbjorn; Magnuson, Ann			Isolation and Characterization of the Small Subunit of the Uptake Hydrogenase from the Cyanobacterium Nostoc punctiforme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAIN PCC 7120; NIFE HYDROGENASE; DESULFOVIBRIO-GIGAS; 4FE-4S CLUSTER; OXIDATION-REDUCTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRANSCRIPTION; FERREDOXIN; PROTEIN	In nitrogen-fixing cyanobacteria, hydrogen evolution is associated with hydrogenases and nitrogenase, making these enzymes interesting targets for genetic engineering aimed at increased hydrogen production. Nostoc punctiforme ATCC 29133 is a filamentous cyanobacterium that expresses the uptake hydrogenase HupSL in heterocysts under nitrogen-fixing conditions. Little is known about the structural and biophysical properties of HupSL. The small subunit, HupS, has been postulated to contain three iron-sulfur clusters, but the details regarding their nature have been unclear due to unusual cluster binding motifs in the amino acid sequence. We now report the cloning and heterologous expression of Nostoc punctiforme HupS as a fusion protein, f-HupS. We have characterized the anaerobically purified protein by UV-visible and EPR spectroscopies. Our results show that f-HupS contains three iron-sulfur clusters. UV-visible absorption of f-HupS has bands similar to 340 and 420 nm, typical for iron-sulfur clusters. The EPR spectrum of the oxidized f-HupS shows a narrow g = 2.023 resonance, characteristic of a low-spin (S = 1/2) [3Fe-4S] cluster. The reduced f-HupS presents complex EPR spectra with overlapping resonances centered on g = 1.94, g = 1.91, and g = 1.88, typical of low-spin (S = 1/2) [4Fe-4S] clusters. Analysis of the spectroscopic data allowed us to distinguish between two species attributable to two distinct [4Fe-4S] clusters, in addition to the [3Fe-4S] cluster. This indicates that f-HupS binds [4Fe-4S] clusters despite the presence of unusual coordinating amino acids. Furthermore, our expression and purification of what seems to be an intact HupS protein allows future studies on the significance of ligand nature on redox properties of the iron-sulfur clusters of HupS.	[Raleiras, Patrcia; Kellers, Petra; Lindblad, Peter; Styring, Stenbjorn; Magnuson, Ann] Uppsala Univ, Dept Chem, Angstrom Lab, SE-75120 Uppsala, Sweden	Uppsala University	Magnuson, A (corresponding author), Uppsala Univ, Dept Chem, Angstrom Lab, Bx 523, SE-75120 Uppsala, Sweden.	ann.magnuson@kemi.uu.se	Magnuson, Ann/D-6132-2016; Raleiras, Patrícia/A-2375-2016; Lindblad, Peter/D-1809-2009; Lindblad, Peter/ABC-4091-2020; Styring, Stenbjörn/L-8414-2016	Magnuson, Ann/0000-0002-7918-4441; Raleiras, Patrícia/0000-0001-7898-7827; Lindblad, Peter/0000-0001-7256-0275; Styring, Stenbjörn/0000-0002-2803-9244	Knut and Alice Wallenberg Foundation; Swedish Energy Agency	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC))	This work was supported by the Knut and Alice Wallenberg Foundation and the Swedish Energy Agency.	Armstrong FA, 2009, CHEM SOC REV, V38, P36, DOI 10.1039/b801144n; Bingemann R, 2000, EUR J BIOCHEM, V267, P6612, DOI 10.1046/j.1432-1327.2000.01755.x; Busch JLH, 1997, BIOCHEM J, V323, P95, DOI 10.1042/bj3230095; CAMMACK R, 1977, BIOCHIM BIOPHYS ACTA, V490, P311, DOI 10.1016/0005-2795(77)90006-X; Camsund D, 2011, FEMS MICROBIOL LETT, V316, P152, DOI 10.1111/j.1574-6968.2010.02206.x; CLEMENTS AP, 1994, J BACTERIOL, V176, P2689, DOI 10.1128/JB.176.9.2689-2693.1994; Dasgupta CN, 2010, INT J HYDROGEN ENERG, V35, P10218, DOI 10.1016/j.ijhydene.2010.06.029; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; Dementin S, 2006, J AM CHEM SOC, V128, P5209, DOI 10.1021/ja060233b; Dementin S, 2008, INT J HYDROGEN ENERG, V33, P1503, DOI 10.1016/j.ijhydene.2007.09.046; DERMAN AI, 1993, SCIENCE, V262, P1744, DOI 10.1126/science.8259521; Devine E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-53; Fischer J, 1996, ARCH MICROBIOL, V165, P289, DOI 10.1007/s002030050329; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; Germer F, 2009, J BIOL CHEM, V284, P36462, DOI 10.1074/jbc.M109.028795; Green J, 1996, BIOCHEM J, V316, P887, DOI 10.1042/bj3160887; Hansel A, 2001, FEMS MICROBIOL LETT, V201, P59, DOI 10.1111/j.1574-6968.2001.tb10733.x; Hilberg M, 2012, J BIOL INORG CHEM, V17, P49, DOI 10.1007/s00775-011-0828-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HS, 2010, TRENDS BIOTECHNOL, V28, P262, DOI 10.1016/j.tibtech.2010.01.007; Leitao E, 2005, APPL ENVIRON MICROB, V71, P4567, DOI 10.1128/AEM.71.8.4567-4576.2005; Lindberg P, 2012, APPL ENVIRON MICROB, V78, P273, DOI 10.1128/AEM.05957-11; LINDBLAD P, 1990, PROTOPLASMA, V159, P9, DOI 10.1007/BF01326630; Matias PM, 2001, J BIOL INORG CHEM, V6, P63, DOI 10.1007/s007750000167; Moura J. J.G., 2001, HDB METALLOPROTEINS, P553; Ogata H, 2002, J AM CHEM SOC, V124, P11628, DOI 10.1021/ja012645k; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Rather LJ, 2011, BBA-PROTEINS PROTEOM, V1814, P1609, DOI 10.1016/j.bbapap.2011.05.023; Rousset M, 1998, P NATL ACAD SCI USA, V95, P11625, DOI 10.1073/pnas.95.20.11625; Schroder O, 2007, J BIOL INORG CHEM, V12, P212, DOI 10.1007/s00775-006-0185-7; Seabra R, 2009, FEMS MICROBIOL LETT, V292, P57, DOI 10.1111/j.1574-6968.2008.01471.x; Stout CD, 2001, HDB METALLOPROTEINS, P560; Styring S, 2012, FARADAY DISCUSS, V155, P357, DOI 10.1039/c1fd00113b; SUMMERS ML, 1995, J BACTERIOL, V177, P6184, DOI 10.1128/jb.177.21.6184-6194.1995; Tamagnini P, 2007, FEMS MICROBIOL REV, V31, P692, DOI 10.1111/j.1574-6976.2007.00085.x; TEIXEIRA M, 1989, J BIOL CHEM, V264, P16435; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uppoor R, 1996, Pharm Dev Technol, V1, P127, DOI 10.3109/10837459609029887; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0	44	12	12	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18345	18352		10.1074/jbc.M113.468587	http://dx.doi.org/10.1074/jbc.M113.468587			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649626	hybrid, Green Published			2022-12-25	WOS:000320721900038
J	Cakir, I; Cyr, NE; Perello, M; Litvinov, BP; Romero, A; Stuart, RC; Nillni, EA				Cakir, Isin; Cyr, Nicole E.; Perello, Mario; Litvinov, Bogdan Patedakis; Romero, Amparo; Stuart, Ronald C.; Nillni, Eduardo A.			Obesity Induces Hypothalamic Endoplasmic Reticulum Stress and Impairs Proopiomelanocortin (POMC) Post-translational Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; PROTHYROTROPIN-RELEASING HORMONE; MELANOCYTE-STIMULATING HORMONE; PRO-NEUROPEPTIDE-Y; LEPTIN RESISTANCE; PARAVENTRICULAR NUCLEUS; PROHORMONE CONVERTASES; MESSENGER-RNA; ER STRESS; GLUCOSE-HOMEOSTASIS	It was shown previously that abnormal prohormone processing or inactive proconverting enzymes that are responsible for this processing cause profound obesity. Our laboratory demonstrated earlier that in the diet-induced obesity (DIO) state, the appetite-suppressing neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) is reduced, yet the mRNA of its precursor protein proopiomelanocortin (POMC) remained unaltered. It was also shown that the DIO condition promotes the development of endoplasmic reticulum (ER) stress and leptin resistance. In the current study, using an in vivo model combined with in vitro experiments, we demonstrate that obesity-induced ER stress obstructs the post-translational processing of POMC by decreasing proconverting enzyme 2, which catalyzes the conversion of adrenocorticotropin to alpha-MSH, thereby decreasing alpha-MSH peptide production. This novel mechanism of ER stress affecting POMC processing in DIO highlights the importance of ER stress in regulating central energy balance in obesity.	[Cakir, Isin; Cyr, Nicole E.; Perello, Mario; Litvinov, Bogdan Patedakis; Romero, Amparo; Stuart, Ronald C.; Nillni, Eduardo A.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Endocrinol,Dept Med, Providence, RI 02907 USA; [Cakir, Isin; Nillni, Eduardo A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Nillni, EA (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Endocrinol, 55 Claverick St,3rd Floor,Rm 320, Providence, RI 02903 USA.	Eduardo_Nillni@Brown.edu		Romero-Pico, Amparo/0000-0001-5104-6998; Perello, Mario/0000-0003-2114-6765; cakir, isin/0000-0003-4293-7267	National Institutes of Health, NIDDK [R01 DK085916-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085916] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant R01 DK085916-01 (to E. A. N.).	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; BARNEA A, 1982, BRAIN RES, V232, P345, DOI 10.1016/0006-8993(82)90278-5; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brakch N, 1997, BIOCHEMISTRY-US, V36, P16309, DOI 10.1021/bi9714767; Challis BG, 2002, HUM MOL GENET, V11, P1997, DOI 10.1093/hmg/11.17.1997; Choi SJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1122, DOI 10.1152/ajpendo.00006.2010; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Cottrell EC, 2008, PHYSIOL BEHAV, V94, P17, DOI 10.1016/j.physbeh.2007.11.017; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; EMESON RB, 1986, J NEUROSCI, V6, P837; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Ernst MB, 2009, J NEUROSCI, V29, P11582, DOI 10.1523/JNEUROSCI.5712-08.2009; Furukawa H, 1999, DIABETES, V48, P1395, DOI 10.2337/diabetes.48.7.1395; Gamber KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030485; GRAMSCH C, 1980, BRAIN RES, V192, P109, DOI 10.1016/0006-8993(80)91012-4; Guan XM, 1998, NEUROREPORT, V9, P3415, DOI 10.1097/00001756-199810260-00015; Guo L, 2004, P NATL ACAD SCI USA, V101, P11797, DOI 10.1073/pnas.0403165101; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Huang XF, 2003, BRAIN RES, V992, P9, DOI 10.1016/j.brainres.2003.08.019; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Jansen E, 1997, BIOCHEM J, V328, P69, DOI 10.1042/bj3280069; Jing EX, 2004, ENDOCRINOLOGY, V145, P1503, DOI 10.1210/en.2003-0834; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Ladriere L, 2010, J CLIN ENDOCR METAB, V95, P1442, DOI 10.1210/jc.2009-2322; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Levin BE, 2003, AM J PHYSIOL-REG I, V285, pR1184, DOI 10.1152/ajpregu.00267.2003; Lloyd DJ, 2006, HUM MOL GENET, V15, P1884, DOI 10.1093/hmg/ddl111; Mandl J, 2009, TRENDS ENDOCRIN MET, V20, P194, DOI 10.1016/j.tem.2009.01.003; Mercer JG, 2005, BIOCHEM SOC T, V33, P1068, DOI [10.1042/BST0331068, 10.1042/BST20051068]; Miki T, 2009, DIABETES, V58, P2863, DOI 10.2337/db09-0158; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Muller L, 1997, J CELL BIOL, V139, P625, DOI 10.1083/jcb.139.3.625; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; NILLNI EA, 1995, J NEUROCHEM, V65, P2462; Nillni EA, 2002, J BIOL CHEM, V277, P48587, DOI 10.1074/jbc.M206702200; Nillni EA, 2007, ENDOCRINOLOGY, V148, P4191, DOI 10.1210/en.2007-0173; Nillni EA, 2010, FRONT NEUROENDOCRIN, V31, P134, DOI 10.1016/j.yfrne.2010.01.001; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; ORWOLL E, 1979, ENDOCRINOLOGY, V104, P1845, DOI 10.1210/endo-104-6-1845; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Paquet L, 1996, J NEUROSCI, V16, P964; Perello M, 2007, ENDOCRINOLOGY, V148, P4952, DOI 10.1210/en.2007-0522; Perello M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1348, DOI 10.1152/ajpendo.00466.2006; Perello M, 2006, ENDOCRINOLOGY, V147, P3296, DOI 10.1210/en.2005-1533; Perello M, 2006, ENDOCRINOLOGY, V147, P2705, DOI 10.1210/en.2005-1609; Perello M, 2010, AM J PHYSIOL-ENDOC M, V299, pE976, DOI 10.1152/ajpendo.00448.2010; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanchez VC, 2004, J CLIN INVEST, V114, P357, DOI 10.1172/jci200421620; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schulz C, 2012, ENDOCRINOLOGY, V153, P143, DOI 10.1210/en.2011-1586; Song JQ, 2012, INT J BIOL SCI, V8, P265, DOI 10.7150/ijbs.3660; Torri C, 2002, PEPTIDES, V23, P1063, DOI 10.1016/S0196-9781(02)00030-X; von Eggelkraut-Gottanka R, 2003, CHEMBIOCHEM, V4, P425, DOI 10.1002/cbic.200200546; Wang N, 2009, MOL CELL ENDOCRINOL, V307, P89, DOI 10.1016/j.mce.2009.03.001; Wiley JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009135; Wisse BE, 2007, SCIENCE, V318, P928, DOI 10.1126/science.1148032; Wisse BE, 2009, CELL METAB, V10, P241, DOI 10.1016/j.cmet.2009.09.003; Won JC, 2009, OBESITY, V17, P1861, DOI 10.1038/oby.2009.194; Xu AW, 2007, ENDOCRINOLOGY, V148, P72, DOI 10.1210/en.2006-1119; Xu Y, 2011, ANN NY ACAD SCI, V1243, P1, DOI 10.1111/j.1749-6632.2011.06248.x; Yu YH, 2009, BEHAV BRAIN RES, V205, P50, DOI 10.1016/j.bbr.2009.07.003	69	73	77	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17675	17688		10.1074/jbc.M113.475343	http://dx.doi.org/10.1074/jbc.M113.475343			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640886	Green Published, hybrid			2022-12-25	WOS:000320380600058
J	Saidi, O; Ben Mansour, N; O'Flaherty, M; Capewell, S; Critchley, JA; Ben Romdhane, H				Saidi, Olfa; Ben Mansour, Nadia; O'Flaherty, Martin; Capewell, Simon; Critchley, Julia A.; Ben Romdhane, Habiba			Analyzing Recent Coronary Heart Disease Mortality Trends in Tunisia between 1997 and 2009	PLOS ONE			English	Article							PREVENTION; DECREASE; DECLINE	Background: In Tunisia, Cardiovascular Diseases are the leading causes of death (30%), 70% of those are coronary heart disease (CHD) deaths and population studies have demonstrated that major risk factor levels are increasing. Objective: To explain recent CHD trends in Tunisia between 1997 and 2009. Methods: Data Sources: Published and unpublished data were identified by extensive searches, complemented with specifically designed surveys. Analysis: Data were integrated and analyzed using the previously validated IMPACT CHD policy model. Data items included: (i) number of CHD patients in specific groups (including acute coronary syndromes, congestive heart failure and chronic angina)(ii) uptake of specific medical and surgical treatments, and(iii) population trends in major cardiovascular risk factors (smoking, total cholesterol, systolic blood pressure (SBP), body mass index (BMI), diabetes and physical inactivity). Results: CHD mortality rates increased by 11.8% for men and 23.8% for women, resulting in 680 additional CHD deaths in 2009 compared with the 1997 baseline, after adjusting for population change. Almost all (98%) of this rise was explained by risk factor increases, though men and women differed. A large rise in total cholesterol level in men (0.73 mmol/L) generated 440 additional deaths. In women, a fall (-0.43 mmol/L), apparently avoided about 95 deaths. For SBP a rise in men (4 mmHg) generated 270 additional deaths. In women, a 2 mmHg fall avoided 65 deaths. BMI and diabetes increased substantially resulting respectively in 105 and 75 additional deaths. Increased treatment uptake prevented about 450 deaths in 2009. The most important contributions came from secondary prevention following Acute Myocardial Infarction (AMI) (95 fewer deaths), initial AMI treatments (90), antihypertensive medications (80) and unstable angina (75). Conclusions: Recent trends in CHD mortality mainly reflected increases in major modifiable risk factors, notably SBP and cholesterol, BMI and diabetes. Current prevention strategies are mainly focused on treatments but should become more comprehensive.	[Saidi, Olfa; Ben Mansour, Nadia; Ben Romdhane, Habiba] Fac Med Tunis Tunisia, Cardiovasc Epidemiol & Prevent Res Lab, Tunis, Tunisia; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Critchley, Julia A.] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England	University of Liverpool; St Georges University London	Ben Romdhane, H (corresponding author), Fac Med Tunis Tunisia, Cardiovasc Epidemiol & Prevent Res Lab, Tunis, Tunisia.	habibabr@yahoo.fr	Shao, Ruitai/AAU-7642-2021	O'Flaherty, Martin/0000-0001-8944-4131; Critchley, Julia/0000-0002-5248-4188	European Community's Seventh Framework Programme (FP7)-the MedCHAMPS project [223075]; United Kingdom (UK) MRC; UK Higher Education Funding Council; UK Medical Research Council; MRC [G0900847] Funding Source: UKRI; Medical Research Council [G0900847] Funding Source: researchfish	European Community's Seventh Framework Programme (FP7)-the MedCHAMPS project; United Kingdom (UK) MRC; UK Higher Education Funding Council; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 223075-the MedCHAMPS project. MOF was also supported by the United Kingdom (UK) MRC. JC and SC are supported by the UK Higher Education Funding Council. MOF is partly funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The MedCHAMPS team had access to all data sources and has the responsibility for the contents of the report and the decision to submit for publication.	[Anonymous], 2009, TUN EP STUD AC COR S; Ben Ali S, 2011, HTR20110218R1; Ben Romdhane H, 2001, CORONARY HEART DIS E, VI; Ben Romdhane H., 2002, OPT MEDITERRANEENNES, V41, P248; Ben Romdhane H, 2010, AR HLTH URB PROJ BAS; Bennett K, 2006, J EPIDEMIOL COMMUN H, V60, P322, DOI 10.1136/jech.2005.038638; Bouguerra R, 2007, EUR J CLIN NUTR, V61, P160, DOI 10.1038/sj.ejcn.1602478; Briggs A, 1999, BRIT MED J, V319, P120, DOI 10.1136/bmj.319.7202.120; Capewell S, 1999, EUR HEART J, V20, P1386, DOI 10.1053/euhj.1999.1631; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Critchley JA, 2002, EUR HEART J, V23, P110, DOI 10.1053/euhj.2001.2681; Elasmi M, 2009, REV EPIDEMIOL SANTE, V57, P87, DOI 10.1016/j.respe.2008.12.010; Epidemiological Transition and Health Impact in North Africa, 2006, TAHINA PROJ FIN REP; Fakhfakh R, 2002, B WORLD HEALTH ORGAN, V80, P350; Fakhfakh R, 2000, East Mediterr Health J, V6, P678; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002; Ghozzi H, 2010, ANN CARDIOL ANGEIOL, V59, P131, DOI 10.1016/j.ancard.2010.04.004; Gupta Rajeev, 2005, Indian Heart J, V57, P632; Hu FB, 2003, LIPIDS, V38, P103, DOI 10.1007/s11745-003-1038-4; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Lassoued O, 2012, TRENDS SECONDARY PRE, DOI [10.1016/j.gheart.2012.01.002, DOI 10.1016/J.GHEART.2012.01.002]; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; National Institute of Nutrition and Food Technology, 1998, TREND NUTR STAT TUN; National Institute of Statistics, 2009, TUN YEARLY STAT REP; National Institute of Statistics, 2005, HOUS CONS SURV, VB; National Institute of Statistics Tunisia, 1997, 40 NAT I STAT TUN; National Public Health Institute, 1998, EP CHRON RESP DIS TU; National Public Health Institute, 2011, DEATHS REG 2009; National Public Health Institute Tunisia, 2003, DEATHS REG 2001; Palmieri L, 2010, AM J PUBLIC HEALTH, V100, P684, DOI 10.2105/AJPH.2008.147173; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; The National Policy and Strategic, 2011, PLAN PREV MAN NONC D; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; World Health Organization, 2011, WHO FRAM CONV TOB CO	39	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63202	10.1371/journal.pone.0063202	http://dx.doi.org/10.1371/journal.pone.0063202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658808	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000321202100055
J	Girard, O; Bishop, DJ; Racinais, S				Girard, Olivier; Bishop, David J.; Racinais, Sebastien			Neuromuscular Adjustments of the Quadriceps Muscle after Repeated Cycling Sprints	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MAXIMAL VOLUNTARY CONTRACTIONS; HUMAN KNEE EXTENSORS; HUMAN ELBOW FLEXORS; HUMAN MOTOR CORTEX; TWITCH INTERPOLATION; SUPRASPINAL FATIGUE; VALID MEASURE; ACTIVATION; EXERCISE	Purpose: This study investigated the supraspinal processes of fatigue of the quadriceps muscle in response to repeated cycling sprints. Methods: Twelve active individuals performed 10 x 6-s "all-out'' sprints on a cycle ergometer (recovery = 30 s), followed 6 min later by 5 x 6-s sprints (recovery = 30 s). Transcranial magnetic and electrical femoral nerve stimulations during brief (5-s) and sustained (30-s) isometric contractions of the knee extensors were performed before and 3 min post-exercise. Results: Maximal strength of the knee extensors decreased during brief and sustained contractions (similar to 11% and 9%, respectively; P<0.001). Peripheral and cortical voluntary activation, motor evoked potential amplitude and silent period duration responses measured during briefs contractions were unaltered (P>0.05). While cortical voluntary activation declined (P<0.01) during the sustained maximal contraction in both test sessions, larger reductions occurred (P<0.05) after exercise. Lastly, resting twitch amplitude in response to both femoral nerve and cortical stimulations was largely (> 40%) reduced (P<0.001) following exercise. Conclusion: The capacity of the motor cortex to optimally drive the knee extensors following a repeated-sprint test was shown in sustained, but not brief, maximal isometric contractions. Additionally, peripheral factors were largely involved in the exercise-induced impairment in neuromuscular function, while corticospinal excitability was well-preserved.	[Girard, Olivier; Racinais, Sebastien] Aspetar, Qatar Orthopaed & Sports Med Hosp, Doha, Qatar; [Bishop, David J.] Inst Sport Exercise & Act Living, Melbourne, Vic, Australia; [Bishop, David J.] Sch Sport & Exercise Sci, Melbourne, Vic, Australia	Aspetar Orthopaedic & Sports Medicine Hospital	Girard, O (corresponding author), Aspetar, Qatar Orthopaed & Sports Med Hosp, Doha, Qatar.	oliv.girard@gmail.com	Racinais, Sebastien/N-3052-2019; Bishop, David John/X-9826-2019	Bishop, David John/0000-0002-6956-9188; girard, olivier/0000-0002-4797-182X				Akima H, 2005, INT J SPORTS MED, V26, P245, DOI 10.1055/s-2004-821000; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Allen GM, 1998, MUSCLE NERVE, V21, P318, DOI 10.1002/(SICI)1097-4598(199803)21:3<318::AID-MUS5>3.0.CO;2-D; Bishop D, 2004, MED SCI SPORT EXER, V36, P807, DOI 10.1249/01.MSS.0000126392.20025.17; BRASILNETO J, 1993, EXP BRAIN RES, V93, P181; de Haan A, 2009, J APPL PHYSIOL, V107, P355, DOI 10.1152/japplphysiol.91220.2008a; Fernandez-del-Olmo M, 2011, SCAND J MED SCI 0803; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Goodall S, 2009, EXP PHYSIOL, V94, P995, DOI 10.1113/expphysiol.2009.047902; Goodall S, 2012, J PHYSIOL-LONDON, V590, P2767, DOI 10.1113/jphysiol.2012.228890; Goodall S, 2010, J APPL PHYSIOL, V109, P1842, DOI 10.1152/japplphysiol.00458.2010; Herbert RD, 1999, J NEUROPHYSIOL, V82, P2271, DOI 10.1152/jn.1999.82.5.2271; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; Kalmar JM, 2006, J APPL PHYSIOL, V100, P1757, DOI 10.1152/japplphysiol.01347.2005; Mendez-Villanueva A, 2008, EUR J APPL PHYSIOL, V103, P411, DOI 10.1007/s00421-008-0723-9; Mendez-Villanueva A, 2007, MED SCI SPORT EXER, V39, P2219, DOI 10.1249/mss.0b013e31815669dc; Perrey S, 2010, EUR J APPL PHYSIOL, V109, P1027, DOI 10.1007/s00421-010-1445-3; Place N, 2008, J PHYSIOL-LONDON, V586, P2799, DOI 10.1113/jphysiol.2008.151910; Place N, 2007, MUSCLE NERVE, V35, P486, DOI 10.1002/mus.20714; Place N, 2010, EUR J APPL PHYSIOL, V110, P1, DOI 10.1007/s00421-010-1480-0; Racinais S, 2007, MED SCI SPORT EXER, V39, P268, DOI 10.1249/01.mss.0000251775.46460.cb; Racinais S, 2012, PSYCHOPHYSIOLOGY, V49, P853, DOI 10.1111/j.1469-8986.2012.01360.x; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; Sidhu SK, 2009, J APPL PHYSIOL, V106, P556, DOI 10.1152/japplphysiol.90911.2008; Sidhu SK, 2009, MUSCLE NERVE, V39, P186, DOI 10.1002/mus.21064; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Taylor JL, 2009, J APPL PHYSIOL, V107, P354, DOI 10.1152/japplphysiol.91220.2008; Taylor JL, 2000, J APPL PHYSIOL, V89, P305, DOI 10.1152/jappl.2000.89.1.305; Taylor JL, 1996, J PHYSIOL-LONDON, V490, P519, DOI 10.1113/jphysiol.1996.sp021163; Todd G, 2004, J APPL PHYSIOL, V97, P236, DOI 10.1152/japplphysiol.01336.2003; Todd G, 2003, J PHYSIOL-LONDON, V551, P661, DOI 10.1113/jphysiol.2003.044099; Todd G, 2007, J APPL PHYSIOL, V102, P1756, DOI 10.1152/japplphysiol.00962.2006; Yoon T, 2012, J APPL PHYSIOL, V112, P849, DOI 10.1152/japplphysiol.00799.2011	34	48	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61793	10.1371/journal.pone.0061793	http://dx.doi.org/10.1371/journal.pone.0061793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650503	Green Accepted, gold, Green Published			2022-12-25	WOS:000319167000020
J	Nguyen, HT; Merriman, TR; Black, MA				Hoang Tan Nguyen; Merriman, Tony R.; Black, Michael A.			CNVrd, a Read-Depth Algorithm for Assigning Copy-Number at the FCGR Locus: Population-Specific Tagging of Copy Number Variation at FCGR3B	PLOS ONE			English	Article							RISK-FACTOR; SUSCEPTIBILITY; ASSOCIATION; GENE; ACCURATE; DELETION; FORMAT	The extent of contribution from common gene copy number (CN) variants in human disease is currently unresolved. Part of the reason for this is the technical difficulty in directly measuring CN variation (CNV) using molecular methods, and the lack of single nucleotide polymorphisms (SNPs) that can tag complex CNV that has arisen multiple times on different SNP haplotypes. One CNV locus implicated in human disease is FCGR. Here we aimed to use next-generation sequencing (NGS) data from the 1000 Genomes Project to assign CN at FCGR3A and FCGR3B and to comprehensively assess the ability of SNPs to tag specific CN variants. A read-depth algorithm was developed (CNVrd) and validated on a subset of HapMap samples using CN assignments that had previously been determined using molecular and microarray methods. At 7 out of 9 other complex loci there was >90% concordance with microarray data. However, given that some prior knowledge of CN is required, the generalizability of CNVrd is limited and should be applied to other complex CNV loci with caution. Subsequently, CN was assigned et FCGR3B using CNVrd in a total of 952 samples from the 1000 Genomes Project, using three classes and SNPs that correlated with duplication were identified. The best tag SNP was observed in the Mexican-American sample set for duplication at FCGR3B. This SNP (rs117435514, r(2) = 0.79) also tagged similar duplication in Chinese and Japanese (r(2) = 0.35-0.60), but not in Caucasian or African. No tag SNP for duplication at FCGR3A or deletion at FCGR3B was identified in any population. We conclude that it is possible to tag CNV at the FCGR locus, but CN and SNPs have to be characterized and correlated on a population-specific basis.	[Hoang Tan Nguyen; Merriman, Tony R.; Black, Michael A.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Hoang Tan Nguyen] Univ Otago, Dept Math & Stat, Dunedin, New Zealand	University of Otago; University of Otago	Merriman, TR (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.	tony.merriman@otago.ac.nz	Black, Michael/F-1484-2010	Black, Michael/0000-0003-1174-6054; Merriman, Tony/0000-0003-0844-8726	Virtual Institute of Statistical Genetics; New Zealand Foundation of Research, Science and Technology [C04X0804]	Virtual Institute of Statistical Genetics; New Zealand Foundation of Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	The Virtual Institute of Statistical Genetics (www.visg.co.nz) is thanked for funding this research, including the PhD stipend of NH. VISG is supported by a Programme (C04X0804) from New Zealand Foundation of Research, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley RW, 2010, AM J GASTROENTEROL, V105, P354, DOI 10.1038/ajg.2009.582; Breunis WB, 2009, HUM MUTAT, V30, pE640, DOI 10.1002/humu.20997; Campbell CD, 2011, AM J HUM GENET, V88, P317, DOI 10.1016/j.ajhg.2011.02.004; Colobran R, 2010, CLIN EXP IMMUNOL, V162, P41, DOI 10.1111/j.1365-2249.2010.04224.x; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Cukier HN, 2009, ANAL BIOCHEM, V386, P288, DOI 10.1016/j.ab.2008.11.040; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Fernandez-Jimenez N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028910; Field SF, 2009, NAT MED, V15, P1115, DOI 10.1038/nm1009-1115; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hollox EJ, 2010, AM J GASTROENTEROL, V105, P360, DOI 10.1038/ajg.2009.573; Hollox EJ, 2009, HUM MUTAT, V30, P477, DOI 10.1002/humu.20911; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mamtani M, 2010, GENES IMMUN, V11, P155, DOI 10.1038/gene.2009.71; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; McKinney C, 2012, GENES IMMUN, V13, P458, DOI 10.1038/gene.2012.15; McKinney C, 2012, HUM MOL GENET, V21, P2370, DOI 10.1093/hmg/dds039; McKinney C, 2010, ANN RHEUM DIS, V69, P1711, DOI 10.1136/ard.2009.123588; Merikangas AK, 2009, TRENDS GENET, V25, P536, DOI 10.1016/j.tig.2009.10.006; Niederer HA, 2010, HUM MOL GENET, V19, P3282, DOI 10.1093/hmg/ddq216; Robinson JI, 2012, HUM MUTAT, V33, P741, DOI 10.1002/humu.22031; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Waszak SM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000988; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zhou XJ, 2010, INT IMMUNOL, V22, P45, DOI 10.1093/intimm/dxp113	36	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63219	10.1371/journal.pone.0063219	http://dx.doi.org/10.1371/journal.pone.0063219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646200	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300158
J	Stockert, J; Wolf, A; Kaddatz, K; Schnitzer, E; Finkernagel, F; Meissner, W; Muller-Brusselbach, S; Kracht, M; Muller, R				Stockert, Josefine; Wolf, Alexander; Kaddatz, Kerstin; Schnitzer, Evelyn; Finkernagel, Florian; Meissner, Wolfgang; Mueller-Bruesselbach, Sabine; Kracht, Michael; Mueller, Rolf			Regulation of TAK1/TAB1-Mediated IL-1 beta Signaling by Cytoplasmic PPAR beta/delta	PLOS ONE			English	Article							NF-KAPPA-B; PROLIFERATOR-ACTIVATED RECEPTORS; INDUCED NUCLEAR TRANSLOCATION; NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE TAK1; TNF-ALPHA; TGF-BETA; DELTA; EXPRESSION; GROWTH	The peroxisome proliferator-activated receptor subtypes PPAR alpha, PPAR beta/delta, PPAR gamma are members of the steroid hormone receptor superfamily with well-established functions in transcriptional regulation. Here, we describe an unexpected cytoplasmic function of PPAR beta/delta. Silencing of PPAR beta/delta expression interferes with the expression of a large subset of interleukin-1 beta (IL-1 beta)-induced target genes in HeLa cells, which is preceded by an inhibition of the IL-1 beta-induced phosphorylation of TAK1 and its downstream effectors, including the NF kappa B alpha inhibitor I kappa B alpha (NFKBIA) and the NF kappa B alpha subunit p65 (RELA). PPAR beta/delta enhances the interaction between TAK1 and the small heat-shock protein HSP27, a known positive modulator of TAK1-mediated IL-1 beta signaling. Consistent with these findings, PPAR beta/delta physically interacts with both the endogenous cytoplasmic TAK1/TAB1 complex and HSP27, and PPAR beta/delta overexpression increases the TAK1-induced transcriptional activity of NF kappa B. These observations suggest that PPAR beta/delta plays a role in the assembly of a cytoplasmic multi-protein complex containing TAK1, TAB1, HSP27 and PPAR beta/delta, and thereby participates in the NF kappa B response to IL-1 beta.	[Stockert, Josefine; Kaddatz, Kerstin; Schnitzer, Evelyn; Finkernagel, Florian; Meissner, Wolfgang; Mueller-Bruesselbach, Sabine; Mueller, Rolf] Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany; [Wolf, Alexander; Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmakol, Giessen, Germany	Philipps University Marburg; Justus Liebig University Giessen	Muller, R (corresponding author), Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany.	rmueller@imt.uni-marburg.de	Müller, Rolf/L-4997-2016	Müller, Rolf/0000-0003-3339-4248; Kracht, Michael/0000-0002-8501-043X	Deutsche Forschungsgemeinschaft [SFB-TRR17, MU601/13, SFB-TRR81, KR1143/7]; LOEWE research cluster "Tumor and Inflammation"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE research cluster "Tumor and Inflammation"	This work was supported by grants from the Deutsche Forschungsgemeinschaft to R.M. (SFB-TRR17 and MU601/13) and M.K. (SFB-TRR81 and KR1143/7) and by the LOEWE research cluster "Tumor and Inflammation". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016344; Alford KA, 2007, J BIOL CHEM, V282, P6232, DOI 10.1074/jbc.M610987200; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; BRUNETSIMIONI M, ONCOGENE, V28, P3332; Brunmair B, 2006, DIABETOLOGIA, V49, P2713, DOI 10.1007/s00125-006-0357-6; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Cao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050059; Chen R, 2012, P NATL ACAD SCI USA, V109, P14128, DOI 10.1073/pnas.1205246109; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Chong HC, 2009, J CELL BIOL, V184, P817, DOI 10.1083/jcb.200809028; Cristiano L, 2005, NEUROSCIENCE, V131, P577, DOI 10.1016/j.neuroscience.2004.11.008; Dempsey CE, 2000, BBA-GENE STRUCT EXPR, V1517, P46, DOI 10.1016/S0167-4781(00)00258-X; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Ding GL, 2006, J MOL CELL CARDIOL, V40, P821, DOI 10.1016/j.yjmcc.2006.03.422; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hoffmann E, 2005, J BIOL CHEM, V280, P9706, DOI 10.1074/jbc.M407071200; Holtmann H, 2001, J BIOL CHEM, V276, P3508, DOI 10.1074/jbc.M004376200; Kaddatz K, 2010, J BIOL CHEM, V285, P29469, DOI 10.1074/jbc.M110.142018; Kanakasabai S, 2010, IMMUNOLOGY, V130, P572, DOI 10.1111/j.1365-2567.2010.03261.x; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Knapinska AM, 2011, MOL CELL BIOL, V31, P1419, DOI 10.1128/MCB.00907-10; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lim H, 2002, ENDOCRINOLOGY, V143, P3207, DOI 10.1210/en.2002-220159; Ma Q, 2008, CELL SIGNAL, V20, P1044, DOI 10.1016/j.cellsig.2008.01.015; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Moreno R, 2010, NUCLEIC ACIDS RES, V38, P6029, DOI 10.1093/nar/gkq439; Muller-Brusselbach S, 2007, EMBO J, V26, P3686, DOI 10.1038/sj.emboj.7601803; Naruhn S, 2011, MOL PHARMACOL, V80, P828, DOI 10.1124/mol.111.074039; Naruhn S, 2010, MOL PHARMACOL, V77, P171, DOI 10.1124/mol.109.060541; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; Rival Y, 2002, EUR J PHARMACOL, V435, P143, DOI 10.1016/S0014-2999(01)01589-8; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Romanowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009701; Russo MP, 2002, AM J PHYSIOL-CELL PH, V283, pC347, DOI 10.1152/ajpcell.00166.2001; Sakai A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-2; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Schmitz ML, 2011, BBA-MOL CELL RES, V1813, P2165, DOI 10.1016/j.bbamcr.2011.06.019; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Stockert J, 2011, NUCLEIC ACIDS RES, V39, P119, DOI 10.1093/nar/gkq773; Sumanasekera WK, 2003, J BIOL CHEM, V278, P4467, DOI 10.1074/jbc.M211261200; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Takayama O, 2006, BRIT J CANCER, V95, P889, DOI 10.1038/sj.bjc.6603343; Tan NS, 2004, EMBO J, V23, P4211, DOI 10.1038/sj.emboj.7600437; Thiefes A, 2005, J BIOL CHEM, V280, P27728, DOI 10.1074/jbc.M411657200; Thiefes A, 2006, EMBO REP, V7, P838, DOI 10.1038/sj.embor.7400754; Umemoto T, 2012, GENES CELLS, V17, P576, DOI 10.1111/j.1365-2443.2012.01607.x; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Westergaard M, 2003, J INVEST DERMATOL, V121, P1104, DOI 10.1046/j.1523-1747.2003.12536.x; Wu YF, 2009, CELL SIGNAL, V21, P143, DOI 10.1016/j.cellsig.2008.10.001; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025; YANG X, 2011, PLOS ONE, V6, P1516, DOI DOI 10.1371/J0URNAL.P0NE.0025271.PUBMED:21966476; Zhou Bo, 2011, Zhonghua Shao Shang Za Zhi, V27, P446	65	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63011	10.1371/journal.pone.0063011	http://dx.doi.org/10.1371/journal.pone.0063011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646170	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300125
J	Wei, SJ; Joseph, T; Sim, AYL; Yurlova, L; Zolghadr, K; Lane, D; Verma, C; Ghadessy, F				Wei, Siau Jia; Joseph, Thomas; Sim, Adelene Y. L.; Yurlova, Larisa; Zolghadr, Kourosh; Lane, David; Verma, Chandra; Ghadessy, Farid			In Vitro Selection of Mutant HDM2 Resistant to Nutlin Inhibition	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PATHWAY; STAPLED P53 PEPTIDE; ZINC-FINGER DOMAIN; N-TERMINAL DOMAIN; PROTEIN INTERACTION; DRUG-RESISTANCE; CANCER-THERAPY; BINDING-SITE; FORCE-FIELD; WILD-TYPE	HDM2 binds to the p53 tumour suppressor and targets it for proteosomal degradation. Presently in clinical trials, the small molecule Nutlin-3A competitively binds to HDM2 and abrogates its repressive function. Using a novel in vitro selection methodology, we simulated the emergence of resistance by evolving HDM2 mutants capable of binding p53 in the presence of Nutlin concentrations that inhibit the wild-type HDM2-p53 interaction. The in vitro phenotypes were recapitulated in ex vivo assays measuring both p53 transactivation function and the direct p53-HDM2 interaction in the presence of Nutlin. Mutations conferring drug resistance were not confined to the N-terminal p53/Nutlin-binding domain, and were additionally seen in the acidic, zinc finger and RING domains. Mechanistic insights gleaned from this broad spectrum of mutations will aid in future drug design and further our understanding of the complex p53-HDM2 interaction.	[Wei, Siau Jia; Lane, David; Ghadessy, Farid] Agcy Sci Technol & Res, P53Lab, Singapore, Singapore; [Wei, Siau Jia; Joseph, Thomas; Sim, Adelene Y. L.; Verma, Chandra] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Yurlova, Larisa; Zolghadr, Kourosh] ChromoTek GmbH, Planegg Martinsried, Germany; [Verma, Chandra] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Verma, Chandra] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Verma, C (corresponding author), Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore.	chandra@bii.a-star.edu		Lane, David/0000-0003-0551-3545; Ghadessy, Farid/0000-0001-8559-903X	Agency for Science, Technology and Research (Singapore)	Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR))	This work was funded by the Agency for Science, Technology and Research (Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Aziz MH, 2011, ONCOGENE, V30, P4678, DOI 10.1038/onc.2011.185; Baek S, 2012, J AM CHEM SOC, V134, P103, DOI 10.1021/ja2090367; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Beroud C, 2003, HUM MUTAT, V21, P176, DOI 10.1002/humu.10187; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bothner B, 2001, J MOL BIOL, V314, P263, DOI 10.1006/jmbi.2001.5110; Brennan RC, 2011, CANCER RES, V71, P4205, DOI 10.1158/0008-5472.CAN-11-0058; Brown CJ, 2012, ACS CHEM BIOL, P53; Case D.A., 2022, AMBER 2020; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fen CX, 2007, J MOL BIOL, V371, P1238, DOI 10.1016/j.jmb.2007.05.099; Funston G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042642; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Guo TH, 2009, CLIN CANCER RES, V15, P6862, DOI 10.1158/1078-0432.CCR-09-1315; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; KASTAN MB, 1991, CANCER RES, V51, P6304; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; LUNA RMD, 1995, NATURE, V378, P203; Ma JH, 2006, BIOCHEMISTRY-US, V45, P9238, DOI 10.1021/bi060661u; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; McCoy MA, 2003, P NATL ACAD SCI USA, V100, P1645, DOI 10.1073/pnas.0334477100; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Noureddine MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000462; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Ray-Coquard I, 2012, LANCET ONCOL, V13, P1133, DOI 10.1016/S1470-2045(12)70474-6; Rew Y, 2012, J MED CHEM, V55, P4936, DOI 10.1021/jm300354j; Schlott T, 1997, J PATHOL, V182, P54; Secchiero P, 2011, CURR PHARM DESIGN, V17, P569, DOI 10.2174/138161211795222586; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shen H, 2008, CANCER RES, V68, P8260, DOI 10.1158/0008-5472.CAN-08-1901; Showalter SA, 2008, J AM CHEM SOC, V130, P6472, DOI 10.1021/ja800201j; TAKAHASHI T, 1992, CANCER RES, V52, P2340; Tamborini E, 2001, INT J CANCER, V92, P790, DOI 10.1002/ijc.1271; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Worrall Erin G, 2009, J Chem Biol, V2, P113, DOI 10.1007/s12154-009-0019-5; Worralll EG, 2010, J MOL BIOL, V398, P414, DOI 10.1016/j.jmb.2010.03.023; Yu GW, 2006, PROTEIN SCI, V15, P384, DOI 10.1110/ps.051927306; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zaccolo M, 1999, J MOL BIOL, V285, P775, DOI 10.1006/jmbi.1998.2262; Zhou M, 2000, LEUKEMIA, V14, P61, DOI 10.1038/sj.leu.2401619; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200	63	27	29	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62564	10.1371/journal.pone.0062564	http://dx.doi.org/10.1371/journal.pone.0062564			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23653682	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300076
J	Bozdag, S; Li, AG; Riddick, G; Kotliarov, Y; Baysan, M; Iwamoto, FM; Cam, MC; Kotliarova, S; Fine, HA				Bozdag, Serdar; Li, Aiguo; Riddick, Gregory; Kotliarov, Yuri; Baysan, Mehmet; Iwamoto, Fabio M.; Cam, Margaret C.; Kotliarova, Svetlana; Fine, Howard A.			Age-Specific Signatures of Glioblastoma at the Genomic, Genetic, and Epigenetic Levels	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; DNA METHYLATION; MOLECULAR SUBTYPES; RADIATION-THERAPY; GLIOMAS REVEALS; EXPRESSION; ANGIOGENESIS; MULTIFORME; SURVIVAL; TRIAL	Age is a powerful predictor of survival in glioblastoma multiforme (GBM) yet the biological basis for the difference in clinical outcome is mostly unknown. Discovering genes and pathways that would explain age-specific survival difference could generate opportunities for novel therapeutics for GBM. Here we have integrated gene expression, exon expression, microRNA expression, copy number alteration, SNP, whole exome sequence, and DNA methylation data sets of a cohort of GBM patients in The Cancer Genome Atlas (TCGA) project to discover age-specific signatures at the transcriptional, genetic, and epigenetic levels and validated our findings on the REMBRANDT data set. We found major age-specific signatures at all levels including age-specific hypermethylation in polycomb group protein target genes and the upregulation of angiogenesis-related genes in older GBMs. These age-specific differences in GBM, which are independent of molecular subtypes, may in part explain the preferential effects of anti-angiogenic agents in older GBM and pave the way to a better understanding of the unique biology and clinical behavior of older versus younger GBMs.	[Bozdag, Serdar; Li, Aiguo; Riddick, Gregory; Kotliarov, Yuri; Baysan, Mehmet; Iwamoto, Fabio M.; Cam, Margaret C.; Kotliarova, Svetlana; Fine, Howard A.] NINDS, Neurooncol Branch, NCI, NIH, Bethesda, MD 20892 USA; [Bozdag, Serdar] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA; [Kotliarov, Yuri] NHLBI, Ctr Human Immunol Autoimmun & Inflammat, NIH, Bethesda, MD 20892 USA; [Iwamoto, Fabio M.] Columbia Univ, Coll Phys & Surg, Neurol Inst New York, New York, NY USA; [Fine, Howard A.] NYU, Inst Canc, Langone Med Ctr, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Neurological Disorders & Stroke (NINDS); Marquette University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Columbia University; New York University; NYU Langone Medical Center	Bozdag, S (corresponding author), NINDS, Neurooncol Branch, NCI, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	serdar.bozdag@marquette.edu	Kotliarov, Yuri/B-6938-2017; baysan, mehmet/O-1710-2018	baysan, mehmet/0000-0001-7359-2965; Kotliarov, Yuri/0000-0002-6558-8883	National Institutes of Health (NIH), National Cancer Institute	National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Afra D, 2002, LANCET, V359, P1011; Ahuja N, 1998, CANCER RES, V58, P5489; Ahuja N, 2000, HISTOL HISTOPATHOL, V15, P835, DOI 10.14670/HH-15.835; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Benjamini Y, 2001, ANN STAT, V29, P1165; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BioDiscovery I, 2009, LOCATING SIGNIFICANT; Blanco S, 2007, MOL CELL BIOL, V27, P7273, DOI 10.1128/MCB.00025-07; Buckner JC, 2006, J CLIN ONCOL, V24, P3871, DOI 10.1200/JCO.2005.04.6979; Chi AS, 2009, ONCOLOGIST, V14, P621, DOI 10.1634/theoncologist.2008-0272; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dweep H, 2011, J BIOMEDICAL INFORM; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gorlia T, 2008, LANCET ONCOL, V9, P29, DOI 10.1016/S1470-2045(07)70384-4; Halperin EC, 1996, INT J RADIAT ONCOL, V34, P793, DOI 10.1016/0360-3016(95)02025-X; He LF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-39; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Kang J, 2008, ONCOGENE, V27, P3999, DOI 10.1038/onc.2008.15; Katoh M, 2005, ONCOL REP, V14, P1583; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Kesari S, 2011, SEMIN ONCOL, V38, pS2, DOI 10.1053/j.seminoncol.2011.09.005; Kim JH, 2011, BLOOD, V118, P2622, DOI 10.1182/blood-2010-08-299784; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Laffaire J, 2011, NEURO-ONCOLOGY, V13, P84, DOI 10.1093/neuonc/noq110; Lee H-H, 2009, NOVEL AGENT INHIBITS; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Li ZY, 2011, TUMOR BIOL, V32, P677, DOI 10.1007/s13277-011-0168-3; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Liu S, 2011, BIOCHIM BIOPHYS ACTA, V1801, P106; Lux Andreas, 2006, BMC Cardiovasc Disord, V6, P13, DOI 10.1186/1471-2261-6-13; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nghiemphu PL, 2009, NEUROLOGY, V72, P1217, DOI 10.1212/01.wnl.0000345668.03039.90; NicAmhlaoibh R, 2001, ONCOGENE, V20, P270, DOI 10.1038/sj.onc.1204075; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Noy P, 2010, MOL CELL BIOL, V30, P2120, DOI 10.1128/MCB.01511-09; Nutt CL, 2003, CANCER RES, V63, P1602; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Pez F, 2011, CANCER RES, V71, P1647, DOI 10.1158/0008-5472.CAN-10-1516; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; R Development Core Team R. F. F. S. C., 2008, R LANG ENV STAT COMP, V1; Rodriguez P, 2012, CARDIOVASC RES, V93, P232, DOI 10.1093/cvr/cvr296; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; SIMPSON JR, 1993, INT J RADIAT ONCOL, V26, P239, DOI 10.1016/0360-3016(93)90203-8; STEIN S, 1989, GERONTOLOGIST, V29, P224, DOI 10.1093/geront/29.2.224; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Tang M, 2011, P NATL ACAD SCI USA, V108, P15231, DOI 10.1073/pnas.1104662108; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Tso CL, 2006, CANCER RES, V66, P159, DOI 10.1158/0008-5472.CAN-05-0077; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wedding Ulrich, 2007, Cancer Control, V14, P44; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	64	42	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62982	10.1371/journal.pone.0062982	http://dx.doi.org/10.1371/journal.pone.0062982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658659	Green Published, gold			2022-12-25	WOS:000321662800071
J	Schwarzmaier, D; Foell, D; Weinhage, T; Varga, G; Dabritz, J				Schwarzmaier, David; Foell, Dirk; Weinhage, Toni; Varga, Georg; Daebritz, Jan			Peripheral Monocyte Functions and Activation in Patients with Quiescent Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BLOOD MONOCYTES; IMMUNODEFICIENCY; PATHOGENESIS; MACROPHAGES; EXPRESSION; IMMUNITY; RECEPTOR	Recent developments suggest a causal link between inflammation and impaired bacterial clearance in Crohn's disease (CD) due to alterations of intestinal macrophages. Studies suggest that excessive inflammation is the consequence of an underlying immunodeficiency rather than the primary cause of CD pathogenesis. We characterized phenotypic and functional features of peripheral blood monocytes of patients with quiescent CD (n = 18) and healthy controls (n = 19) by analyses of cell surface molecule expression, cell adherence, migration, chemotaxis, phagocytosis, oxidative burst, and cytokine expression and secretion with or without lipopolysaccharide (LPS) priming. Peripheral blood monocytes of patients with inactive CD showed normal expression of cell surface molecules (CD14, CD16, CD116), adherence to plastic surfaces, spontaneous migration, chemotaxis towards LTB4, phagocytosis of E. coli, and production of reactive oxygen species. Interestingly, peripheral blood monocytes of CD patients secreted higher levels of IL1 beta (p,. 05). Upon LPS priming we found a decreased release of IL10 (p<.05) and higher levels of CCL2 (p<.001) and CCL5 (p<.05). The expression and release of TNF alpha, IFN gamma, IL4, IL6, IL8, IL13, IL17, CXCL9, and CXCL10 were not altered compared to healthy controls. Based on our phenotypic and functional studies, peripheral blood monocytes from CD patients in clinical remission were not impaired compared to healthy controls. Our results highlight that defective innate immune mechanisms in CD seems to play a role in the (inflamed) intestinal mucosa rather than in peripheral blood.	[Schwarzmaier, David; Foell, Dirk; Weinhage, Toni; Varga, Georg; Daebritz, Jan] Univ Childrens Hosp Munster, Dept Pediat Rheumatol & Immunol, Munster, NRW, Germany; [Foell, Dirk; Daebritz, Jan] Univ Munster, Interdisciplinary Ctr Clin Res, D-48149 Munster, NRW, Germany; [Daebritz, Jan] Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Parkville, Vic, Australia	University of Munster; University of Munster; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Dabritz, J (corresponding author), Univ Childrens Hosp Munster, Dept Pediat Rheumatol & Immunol, Munster, NRW, Germany.	Jan.Daebritz@uni-muenster.de	Däbritz, Jan/GXG-1969-2022	Dabritz, Jan/0000-0003-4219-5283; Weinhage, Toni/0000-0003-4337-9260	Broad Medical Research Program (BMRP) [IBD0201]; German Research Foundation (DFG) [DA1161/4-1]; Innovative Medical Research Program of the University of Munster (IMF) [DA120904]	Broad Medical Research Program (BMRP); German Research Foundation (DFG)(German Research Foundation (DFG)); Innovative Medical Research Program of the University of Munster (IMF)	The study was supported by grants of the Broad Medical Research Program (BMRP Reference No. IBD0201, to DF and JD), the German Research Foundation (DFG Reference No. DA1161/4-1, to JD and DF), and the Innovative Medical Research Program of the University of Munster (IMF Reference No. DA120904, to JD and DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDASSANO RN, 1993, GASTROENTEROLOGY, V105, P60, DOI 10.1016/0016-5085(93)90010-A; BURGIO VL, 1995, GASTROENTEROLOGY, V109, P1029; Casanova JL, 2009, J EXP MED, V206, P1839, DOI 10.1084/jem.20091683; Dabritz J, 2011, AM J PHYSIOL-GASTR L, V300, pG823, DOI 10.1152/ajpgi.00115.2010; Folwaczny C, 2003, EUR J GASTROEN HEPAT, V15, P621, DOI 10.1097/00042737-200306000-00007; Goldstein JI, 2011, GASTROENTEROLOGY, V141, P208, DOI 10.1053/j.gastro.2011.03.060; GRIMM MC, 1995, CLIN EXP IMMUNOL, V100, P291, DOI 10.1111/j.1365-2249.1995.tb03667.x; Grip O, 2007, INFLAMM BOWEL DIS, V13, P566, DOI 10.1002/ibd.20025; Koch S, 2010, CLIN EXP IMMUNOL, V161, P332, DOI 10.1111/j.1365-2249.2010.04177.x; Korzenik JR, 2007, GUT, V56, P2, DOI 10.1136/gut.2006.095588; Liu ZX, 1997, SCAND J GASTROENTERO, V32, P1241, DOI 10.3109/00365529709028154; Marks DJB, 2011, CURR OPIN GASTROEN, V27, P328, DOI 10.1097/MOG.0b013e3283463b45; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; MEE A, 1980, J CLIN PATHOL, V33, P921, DOI 10.1136/jcp.33.10.921; MEE A, 1980, J CLIN PATHOL, V33, P917, DOI 10.1136/jcp.33.10.917; MIURA M, 1987, J CLIN LAB IMMUNOL, V24, P167; OKABE N, 1990, J CLIN LAB IMMUNOL, V32, P29; OKABE N, 1988, J CLIN LAB IMMUNOL, V25, P69; OKABE N, 1986, J CLIN LAB IMMUNOL, V21, P11; Sandborn WJ, 2002, GASTROENTEROLOGY, V122, P512, DOI 10.1053/gast.2002.31072; SEGAL AW, 1976, LANCET, V2, P219; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; WHORWELL PJ, 1981, DIGESTION, V22, P271, DOI 10.1159/000198668; Zhou L, 2009, CELL MOL LIFE SCI, V66, P192, DOI 10.1007/s00018-008-8308-7; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	25	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62761	10.1371/journal.pone.0062761	http://dx.doi.org/10.1371/journal.pone.0062761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658649	gold, Green Published			2022-12-25	WOS:000318343700072
J	Abahussin, M; Hayes, S; Edelhauser, H; Dawson, DG; Meek, KM				Abahussin, Mohammad; Hayes, Sally; Edelhauser, Henry; Dawson, Daniel G.; Meek, Keith M.			A Microscopy Study of the Structural Features of Post-LASIK Human Corneas	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; PHOTOREFRACTIVE KERATECTOMY; DISLOCATION	Purpose: To study the structural features of human post-LASIK corneas. Methods: A pair of post-mortem donor corneas, from a 55-year old patient who underwent uncomplicated LASIK surgery five years previously, were bisected and fixed in 4% paraformaldehyde. The right cornea and one half of the left cornea were processed for light microscopy and scanning electron microscopy. One half of the right cornea was also examined by transmission electron microscopy. Results: The flap-bed interface could be easily detected several years after LASIK and, although the flap appeared to be in close association with the stromal bed, there was a noticeable absence of reconnection between adjacent severed lamellae. Tissue gaps were evident at the flap margin, which once free of cellular components revealed the presence of a few bridging fibres. Conclusion: Examination of corneas five years after LASIK revealed evidence of primitive reparative scar development at the wound interface, but no reconnection of severed collagen lamellae. Such findings may explain the occurrence of flap dislocation following trauma in some patients months or years after surgery.	[Abahussin, Mohammad; Hayes, Sally; Meek, Keith M.] Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Res Grp, Cardiff CF10 3AX, S Glam, Wales; [Abahussin, Mohammad] King Saud Univ, Coll Appl Med Sci, Dept Optometry, Riyadh, Saudi Arabia; [Edelhauser, Henry; Dawson, Daniel G.] Emory Univ, Emory Eye Ctr, Atlanta, GA 30322 USA; [Dawson, Daniel G.] Univ Florida, Dept Ophthalmol, Gainesville, FL USA	Cardiff University; King Saud University; Emory University; State University System of Florida; University of Florida	Meek, KM (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Res Grp, Cardiff CF10 3AX, S Glam, Wales.	meekkm@cf.ac.uk		Hayes, Sally/0000-0001-8550-0108	United Kingdom Medical Research Council [G0600755]; King Saud University, Riyadh, Saudi Arabia; Royal Society-Wolfson Research Merit Award; MRC [MR/K000837/1, G0600755] Funding Source: UKRI; Medical Research Council [G0600755, MR/K000837/1] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); King Saud University, Riyadh, Saudi Arabia(King Saud University); Royal Society-Wolfson Research Merit Award(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a 5-year United Kingdom Medical Research Council Grant (G0600755 awarded to KMM). MA was the recipient of a scholarship from King Saud University, Riyadh, Saudi Arabia. KMM is a Royal Society-Wolfson Research Merit Award Holder. These funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amm M, 1996, J REFRACT SURG, V12, P758; Behrens A, 2000, AM J OPHTHALMOL, V129, P59, DOI 10.1016/S0002-9394(99)00269-X; Chan Colin C. K., 2006, International Ophthalmology Clinics, V46, P13, DOI 10.1097/00004397-200604630-00004; Dawson DG, 2005, ARCH OPHTHALMOL-CHIC, V123, P741, DOI 10.1001/archopht.123.6.741; Feltham MH, 2008, EYE, V22, P1117, DOI 10.1038/sj.eye.6702856; Hamill MB, 2002, J CATARACT REFR SURG, V28, P328, DOI 10.1016/S0886-3350(01)01248-2; Hayes S, 2007, ANAT REC, V290, P1542, DOI 10.1002/ar.20613; HOELTZEL DA, 1992, J BIOMECH ENG-T ASME, V114, P202, DOI 10.1115/1.2891373; Holt DG, 2012, J CATARACT REFR SURG, V38, P357, DOI 10.1016/j.jcrs.2011.10.024; Huang D, 1999, J REFRACT SURG, V15, P538; Kamma-Lorger CS, 2009, EXP EYE RES, V88, P953, DOI 10.1016/j.exer.2008.12.005; Kim HJ, 2010, J REFRACT SURG, V26, P447, DOI 10.3928/1081597X-20090710-03; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Park CK, 1999, J CATARACT REFR SURG, V25, P842, DOI 10.1016/S0886-3350(99)00047-4; Reinstein DZ, 2012, J REFRACT SURG, V28, P291, DOI 10.3928/1081597X-20120229-01; Roberts C, 2000, J REFRACT SURG, V16, P407; Schmack I, 2005, J REFRACT SURG, V21, P433	17	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63268	10.1371/journal.pone.0063268	http://dx.doi.org/10.1371/journal.pone.0063268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650559	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000319167000104
J	Kadouri, DE; To, K; Shanks, RMQ; Doi, Y				Kadouri, Daniel E.; To, Kevin; Shanks, Robert M. Q.; Doi, Yohei			Predatory Bacteria: A Potential Ally against Multidrug-Resistant Gram-Negative Pathogens	PLOS ONE			English	Article							BDELLOVIBRIO-BACTERIOVORUS; MICAVIBRIO-AERUGINOSAVORUS; BETA-LACTAMASE; SUSCEPTIBILITY; INFECTIONS; DIVERSITY; BIOFILMS; CLADE; GEN.	Multidrug-resistant (MDR) Gram-negative bacteria have emerged as a serious threat to human and animal health. Bdellovibrio spp. and Micavibrio spp. are Gram-negative bacteria that prey on other Gram-negative bacteria. In this study, the ability of Bdellovibrio bacteriovorus and Micavibrio aeruginosavorus to prey on MDR Gram-negative clinical strains was examined. Although the potential use of predatory bacteria to attack MDR pathogens has been suggested, the data supporting these claims is lacking. By conducting predation experiments we have established that predatory bacteria have the capacity to attack clinical strains of a variety of beta-lactamase-producing, MDR Gram-negative bacteria. Our observations indicate that predatory bacteria maintained their ability to prey on MDR bacteria regardless of their antimicrobial resistance, hence, might be used as therapeutic agents where other antimicrobial drugs fail.	[Kadouri, Daniel E.; To, Kevin] Univ Med & Dent New Jersey, Dept Oral Biol, Newark, NJ 07103 USA; [Shanks, Robert M. Q.] Univ Pittsburgh, Dept Ophthalmol, Campbell Lab Ophthalm Microbiol, Pittsburgh, PA 15260 USA; [Doi, Yohei] Univ Pittsburgh, Div Infect Dis, Sch Med, Pittsburgh, PA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kadouri, DE (corresponding author), Univ Med & Dent New Jersey, Dept Oral Biol, Newark, NJ 07103 USA.	kadourde@umdnj.edu	Shanks, Robert M. Q./AFO-0831-2022	Shanks, Robert M. Q./0000-0002-7699-5396; Doi, Yohei/0000-0002-9620-2525	Department of the ARMY USAMRAA [W81XWH-12-2-0067]; UMDNJ departmental start-up fund; National Institutes of Health [K22AI080584]; NIH [AI085570, EY08098]; Research to Prevent Blindness Career Development award; NATIONAL EYE INSTITUTE [P30EY008098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085570, K22AI080584] Funding Source: NIH RePORTER	Department of the ARMY USAMRAA; UMDNJ departmental start-up fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Career Development award(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by the Department of the ARMY USAMRAA #W81XWH-12-2-0067 and by UMDNJ departmental start-up fund to DEK. YD was supported in part through a career development award, the National Institutes of Health (K22AI080584). RMQS was supported by NIH grants AI085570, EY08098, and a Research to Prevent Blindness Career Development award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT SUS S; Dashiff A, 2011, J APPL MICROBIOL, V110, P431, DOI 10.1111/j.1365-2672.2010.04900.x; Davidov Y, 2004, INT J SYST EVOL MICR, V54, P1439, DOI 10.1099/ijs.0.02978-0; Davidov Y, 2006, ENVIRON MICROBIOL, V8, P2179, DOI 10.1111/j.1462-2920.2006.01101.x; Doi Y, 2009, ANTIMICROB AGENTS CH, V53, P3159, DOI 10.1128/AAC.00133-09; Dwidar M, 2012, BMB REP, V45, P71, DOI 10.5483/BMBRep.2012.45.2.71; Jurkevitch E, 2000, APPL ENVIRON MICROB, V66, P2365, DOI 10.1128/AEM.66.6.2365-2371.2000; Kadouri D, 2005, APPL ENVIRON MICROB, V71, P4044, DOI 10.1128/AEM.71.7.4044-4051.2005; Kadouri D, 2007, APPL ENVIRON MICROB, V73, P605, DOI 10.1128/AEM.01893-06; Kallen AJ, 2010, INFECT CONT HOSP EP, V31, pS51, DOI 10.1086/655996; Kim YA, 2012, CLIN INFECT DIS, V55, P224, DOI 10.1093/cid/cis387; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; LAMBINA V A, 1982, Mikrobiologiya, V51, P114; LAMBINA V A, 1983, Mikrobiologiya, V52, P777; Markelova NY, 2010, INT J HYG ENVIR HEAL, V213, P428, DOI 10.1016/j.ijheh.2010.08.004; Martin MO, 2002, J MOL MICROB BIOTECH, V4, P467; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Rogosky AM, 2006, CURR MICROBIOL, V52, P81, DOI 10.1007/s00284-005-0038-6; Sockett RE, 2004, NAT REV MICROBIOL, V2, P669, DOI 10.1038/nrmicro959; Sockett RE, 2009, ANNU REV MICROBIOL, V63, P523, DOI 10.1146/annurev.micro.091208.073346; STOLP H, 1963, ANTON VAN LEE J M S, V29, P217, DOI 10.1007/BF02046064; Tian GB, 2011, ANTIMICROB AGENTS CH, V55, P2710, DOI 10.1128/AAC.01660-10; Wang Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-453	23	101	101	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63397	10.1371/journal.pone.0063397	http://dx.doi.org/10.1371/journal.pone.0063397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650563	gold, Green Accepted, Green Published			2022-12-25	WOS:000319167000108
J	Olsen, JR; Oyan, AM; Rostad, K; Hellem, MR; Liu, J; Li, LS; Micklem, DR; Haugen, H; Lorens, JB; Rotter, V; Ke, XS; Lin, BY; Kalland, KH				Olsen, Jan Roger; Oyan, Anne Margrete; Rostad, Kari; Hellem, Margrete R.; Liu, Jie; Li, Lisha; Micklem, David R.; Haugen, Hallvard; Lorens, James B.; Rotter, Varda; Ke, Xi-Song; Lin, Biaoyang; Kalland, Karl-Henning			p63 Attenuates Epithelial to Mesenchymal Potential in an Experimental Prostate Cell Model	PLOS ONE			English	Article							LARGE GENE LISTS; CHIP-SEQ DATA; BINDING-SITES; IN-VITRO; EXPRESSION; CANCER; TRANSITION; GENOME; IDENTIFICATION; HISTONE	The transcription factor p63 is central for epithelial homeostasis and development. In our model of epithelial to mesenchymal transition (EMT) in human prostate cells, p63 was one of the most down-regulated transcription factors during EMT. We therefore investigated the role of p63 in EMT. Over-expression of the predominant epithelial isoform Delta Np63 alpha in mesenchymal type cells of the model led to gain of several epithelial characteristics without resulting in a complete mesenchymal to epithelial transition (MET). This was corroborated by a reciprocal effect when p63 was knocked down in epithelial EP156T cells. Global gene expression analyses showed that Delta Np63 alpha induced gene modules involved in both cell-to-cell and cell-to-extracellular-matrix junctions in mesenchymal type cells. Genome-wide analysis of p63 binding sites using ChIP-seq analyses confirmed binding of p63 to regulatory areas of genes associated with cell adhesion in prostate epithelial cells. DH1 and ZEB1 are two elemental factors in the control of EMT. Over-expression and knock-down of these factors, respectively, were not sufficient alone or in combination with Delta Np63 alpha to reverse completely the mesenchymal phenotype. The partial reversion of epithelial to mesenchymal transition might reflect the ability of Delta Np63 alpha, as a key co-ordinator of several epithelial gene expression modules, to reduce epithelial to mesenchymal plasticity (EMP). The utility of Delta Np63 alpha expression and the potential of reduced EMP in order to counteract metastasis warrant further investigation.	[Olsen, Jan Roger; Oyan, Anne Margrete; Rostad, Kari; Hellem, Margrete R.; Ke, Xi-Song; Kalland, Karl-Henning] Univ Bergen, Gade Inst, Bergen, Norway; [Oyan, Anne Margrete; Ke, Xi-Song; Kalland, Karl-Henning] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway; [Liu, Jie; Li, Lisha; Lin, Biaoyang] Zhejiang Univ, Zhejing Calif Int NanoSyst Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Micklem, David R.; Haugen, Hallvard; Lorens, James B.] BerGenBio AS, Bergen, Norway; [Haugen, Hallvard; Lorens, James B.] Univ Bergen, Dept Biomed, Bergen, Norway; [Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Lin, Biaoyang] Swedish Med Ctr, Seattle, WA USA; [Lin, Biaoyang] Univ Washington, Dept Urol, Seattle, WA 98195 USA	University of Bergen; University of Bergen; Haukeland University Hospital; Zhejiang University; University of Bergen; Weizmann Institute of Science; Swedish Medical Center; University of Washington; University of Washington Seattle	Kalland, KH (corresponding author), Univ Bergen, Gade Inst, Bergen, Norway.	Kalland@gades.uib.no	Lorens, James/B-9737-2017; Kalland, Karl-Henning/B-9445-2017; Lin, Biaoyang/AAA-1258-2020	Lorens, James/0000-0002-6782-3349; Kalland, Karl-Henning/0000-0003-4486-2334; Lin, Biaoyang/0000-0002-2189-0407; Micklem, David/0000-0003-2756-2591	Helse Vest [911626, 911555, 911747]; Bergen Medical Research Foundation and Einar Galtung DAsvig; Trond Mohn and Jan Einar Greve; Norwegian Cancer Society; Chinese NSFC [81230090]	Helse Vest; Bergen Medical Research Foundation and Einar Galtung DAsvig; Trond Mohn and Jan Einar Greve; Norwegian Cancer Society(Norwegian Cancer Society); Chinese NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Helse Vest (911626, 911555, 911747), the Bergen Medical Research Foundation and Einar Galtung DAsvig, Trond Mohn and Jan Einar Greve and the Norwegian Cancer Society and Chinese NSFC (81230090) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Coppola V., 2012, ONCOGENE; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gandellini P, 2012, CELL DEATH DIFFER; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Grisanzio C, 2008, J CELL BIOCHEM, V103, P1354, DOI 10.1002/jcb.21555; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hill L., 2012, INT J CANC; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Ke XS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-669; Ke XS, 2011, EXP CELL RES, V317, P234, DOI 10.1016/j.yexcr.2010.10.009; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li QW, 2008, NEOPLASIA, V10, P1444, DOI 10.1593/neo.08968; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; Mangiulli M, 2009, NUCLEIC ACIDS RES, V37, P6092, DOI 10.1093/nar/gkp674; McDade SS, 2012, NUCLEIC ACIDS RES, V40, P7190, DOI 10.1093/nar/gks389; Parsons JK, 2009, PROSTATE, V69, P559, DOI 10.1002/pros.20904; Petersen K, 2007, ANAL BIOCHEM, V366, P46, DOI 10.1016/j.ab.2007.03.013; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thepot A, 2010, INT J CANCER, V127, P2051, DOI 10.1002/ijc.25221; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Valastyan S, 2011, J CELL SCI, V124, P999, DOI 10.1242/jcs.081513; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	40	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62547	10.1371/journal.pone.0062547	http://dx.doi.org/10.1371/journal.pone.0062547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658742	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000056
J	Zhang, YJ; Lin, HF; Yang, ZH; Wang, J				Zhang, Yijia; Lin, Hongfei; Yang, Zhihao; Wang, Jian			Construction of Ontology Augmented Networks for Protein Complex Prediction	PLOS ONE			English	Article							ATTACHMENT BASED METHOD; FUNCTIONAL MODULES; ALGORITHM; CLIQUES	Protein complexes are of great importance in understanding the principles of cellular organization and function. The increase in available protein-protein interaction data, gene ontology and other resources make it possible to develop computational methods for protein complex prediction. Most existing methods focus mainly on the topological structure of protein-protein interaction networks, and largely ignore the gene ontology annotation information. In this article, we constructed ontology augmented networks with protein-protein interaction data and gene ontology, which effectively unified the topological structure of protein-protein interaction networks and the similarity of gene ontology annotations into unified distance measures. After constructing ontology augmented networks, a novel method (clustering based on ontology augmented networks) was proposed to predict protein complexes, which was capable of taking into account the topological structure of the protein-protein interaction network, as well as the similarity of gene ontology annotations. Our method was applied to two different yeast protein-protein interaction datasets and predicted many well-known complexes. The experimental results showed that (i) ontology augmented networks and the unified distance measure can effectively combine the structure closeness and gene ontology annotation similarity; (ii) our method is valuable in predicting protein complexes and has higher F1 and accuracy compared to other competing methods.	[Zhang, Yijia; Lin, Hongfei; Yang, Zhihao; Wang, Jian] Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Liaoning, Peoples R China	Dalian University of Technology	Zhang, YJ (corresponding author), Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Liaoning, Peoples R China.	zhyj@dlut.edu.cn			Natural Science Foundation of China [61272373, 61070098]; Doctoral Program Foundation of Institutions of Higher Education of China [20090041110002]; Fundamental Research Funds for the Central Universities [DUT10JS09]; Liaoning Province Doctor Startup Fund [20091015]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Liaoning Province Doctor Startup Fund	This work is supported by grant from the Natural Science Foundation of China (No. 61272373 and 61070098), Doctoral Program Foundation of Institutions of Higher Education of China (20090041110002), the Fundamental Research Funds for the Central Universities (No. DUT10JS09) and Liaoning Province Doctor Startup Fund (No. 20091015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Altaf-Ul-Amin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-207; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Chin CH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S25; Chua Hon Nian, 2008, Journal of Bioinformatics and Computational Biology, V6, P435, DOI 10.1142/S0219720008003497; Dongen SV, 2000, THESIS U UTRECHT; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Jung SH, 2010, BIOINFORMATICS, V26, P385, DOI 10.1093/bioinformatics/btp668; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Li M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-398; Li Xiao-Li, 2005, Genome Inform, V16, P260; Li XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S3; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tomita E, 2006, THEOR COMPUT SCI, V363, P28, DOI 10.1016/j.tcs.2006.06.015; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wang J, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-S1-S18; Wu M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-169; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; ZHOU YANG, 2009, PROC VLDB ENDOW, V2, P718, DOI [DOI 10.14778/1687627.1687709, 10.14778/1687627.1687709]	24	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62077	10.1371/journal.pone.0062077	http://dx.doi.org/10.1371/journal.pone.0062077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650509	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000028
J	Mull, CG; Lyons, K; Blasius, ME; Winkler, C; O'Sullivan, JB; Lowe, CG				Mull, Christopher G.; Lyons, Kady; Blasius, Mary E.; Winkler, Chuck; O'Sullivan, John B.; Lowe, Christopher G.			Evidence of Maternal Offloading of Organic Contaminants in White Sharks (Carcharodon carcharias)	PLOS ONE			English	Article							BREEDING GLAUCOUS GULLS; FINNED PILOT WHALES; ORGANOCHLORINE COMPOUNDS; SOUTHERN-CALIFORNIA; MARINE MAMMALS; KILLER WHALES; POLYCHLORINATED-BIPHENYLS; REPRODUCTIVE TRANSFER; DERMOCHELYS-CORIACEA; LEATHERBACK TURTLES	Organic contaminants were measured in young of the year (YOY) white sharks (Carcharodon carcharias) incidentally caught in southern California between 2005 and 2012 (n = 20) and were found to be unexpectedly high considering the young age and dietary preferences of young white sharks, suggesting these levels may be due to exposure in utero. To assess the potential contributions of dietary exposure to the observed levels, a five-parameter bioaccumulation model was used to estimate the total loads a newborn shark would potentially accumulate in one year from consuming contaminated prey from southern California. Maximum simulated dietary accumulation of DDTs and PCBs were 25.1 and 4.73 mu g/g wet weight (ww) liver, respectively. Observed Sigma DDT and Sigma PCB concentrations (95 +/- 91 mu g/g and 16 +/- 10 mu g/g ww, respectively) in a majority of YOY sharks were substantially higher than the model predictions suggesting an additional source of contaminant exposure beyond foraging. Maternal offloading of organic contaminants during reproduction has been noted in other apex predators, but this is the first evidence of transfer in a matrotrophic shark. While there are signs of white shark population recovery in the eastern Pacific, the long-term physiological and population level consequences of biomagnification and maternal offloading of environmental contaminants in white sharks is unclear.	[Mull, Christopher G.; Lyons, Kady; Blasius, Mary E.; Lowe, Christopher G.] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA; [Mull, Christopher G.; Blasius, Mary E.] Calif State Univ Long Beach, Inst Integrated Res Mat Environm & Soc, Long Beach, CA 90840 USA; [Winkler, Chuck] Southern Calif Marine Inst, Terminal Isl, CA USA; [O'Sullivan, John B.] Monterey Bay Aquarium, Monterey, CA USA	California State University System; California State University Long Beach; California State University System; California State University Long Beach; Monterey Bay Aquarium Research Institute	Mull, CG (corresponding author), Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA.	creeas@gmail.com			Monterey Bay Aquarium; University of Southern California Sea Grant; California Ocean Protection Council	Monterey Bay Aquarium; University of Southern California Sea Grant; California Ocean Protection Council	Funding for this project was provided, in part, by Monterey Bay Aquarium, University of Southern California Sea Grant and the California Ocean Protection Council. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDISON RF, 1987, CAN J FISH AQUAT SCI, V44, P782, DOI 10.1139/f87-095; AGUILAR A, 1994, ARCH ENVIRON CON TOX, V27, P546; Bargar TA, 2001, ENVIRON TOXICOL CHEM, V20, P61, DOI [10.1002/etc.5620200106, 10.1897/1551-5028(2001)020&lt;0061:MTOCCS&gt;2.0.CO;2]; Beckmen KB, 1999, SCI TOTAL ENVIRON, V231, P183, DOI 10.1016/S0048-9697(99)00094-7; Blasius ME, 2008, MAR POLLUT BULL, V56, P1973, DOI 10.1016/j.marpolbul.2008.08.011; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BORRELL A, 1995, ENVIRON POLLUT, V88, P283, DOI 10.1016/0269-7491(95)93441-2; Butler P.A., 1979, AQUAT TOXICOL, P212; Cailliet G.M., 1985, Memoirs of the Southern California Academy of Sciences, V9, P49; Carlisle AB, 2012, PLOS ONE, P7; Cochran JW, 1999, J CHROMATOGR A, V843, P323, DOI 10.1016/S0021-9673(99)00063-1; Connolly JP, 2002, CONT SHELF RES, V22, P1059, DOI 10.1016/S0278-4343(01)00113-3; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; Debier C, 2006, AQUAT TOXICOL, V80, P149, DOI 10.1016/j.aquatox.2006.08.002; Domeier M., 2012, GLOBAL PERSPECTIVES; Eganhouse RP, 2000, MAR CHEM, V70, P289, DOI 10.1016/S0304-4203(00)00034-7; Ezcurra Juan M., 2012, P3; Fair PA, 2010, SCI TOTAL ENVIRON, V408, P1577, DOI 10.1016/j.scitotenv.2009.12.021; Fisk AT, 2002, ECOLOGY, V83, P2162, DOI 10.1890/0012-9658(2002)083[2162:UACASI]2.0.CO;2; Francis MP, 1996, OBSERVATIONS PREGNAN; FRY DM, 1995, ENVIRON HEALTH PERSP, V103, P165, DOI 10.2307/3432528; Gelsleichter J, 2008, MAR POLLUT BULL, V56, P359, DOI 10.1016/j.marpolbul.2007.10.028; Gelsleichter J, 2010, CRC MAR BIOL SER, P491; Greig DJ, 2011, SCI TOTAL ENVIRON, V409, P3537, DOI 10.1016/j.scitotenv.2011.05.047; GUILLETTE LJ, 1995, ENVIRON HEALTH PERSP, V103, P31, DOI 10.2307/3432409; Guirlet E, 2010, CHEMOSPHERE, V79, P720, DOI 10.1016/j.chemosphere.2010.02.047; Hall Ailsa J., 2001, P523; Hickie BE, 1999, ENVIRON TOXICOL CHEM, V18, P2622, DOI [10.1897/1551-5028(1999)018&lt;2622:LPMFHC&gt;2.3.CO;2, 10.1002/etc.5620181132]; HOSE JE, 1989, ENVIRON POLLUT, V57, P139, DOI 10.1016/0269-7491(89)90006-7; Hussey NE, 2010, J ANIM ECOL, V79, P184, DOI 10.1111/j.1365-2656.2009.01623.x; Hussey NE, 2009, MAR ECOL PROG SER, V380, P199, DOI 10.3354/meps07918; Kim SK, 2012, PROCEEDINGS OF THE ASME PACIFIC RIM TECHNICAL CONFERENCE AND EXHIBITION ON PACKAGING AND INTEGRATION OF ELECTRONIC AND PHOTONIC SYSTEMS, MEMS AND NEMS 2011, VOL 2, P7; Klasing S., 2009, HLTH ADVISORY SAFE E, P42; Klimley A.P., 1985, Memoirs of the Southern California Academy of Sciences, V9, P15; LARSSON P, 1993, ENVIRON TOXICOL CHEM, V12, P855, DOI [10.1897/1552-8618(1993)12[855:RSALCA]2.0.CO;2, 10.1002/etc.5620120509]; Lee HJ, 2002, CONT SHELF RES, V22, P859, DOI 10.1016/S0278-4343(01)00108-X; Lowe CG, 2002, J EXP MAR BIOL ECOL, V278, P141, DOI 10.1016/S0022-0981(02)00331-3; Lowe CG, 2012, GLOBAL PERSPECTIVES; McKinney MA, 2011, ENVIRON SCI TECHNOL, V45, P896, DOI 10.1021/es102781b; MILLER MA, 1993, CAN J FISH AQUAT SCI, V50, P1405, DOI 10.1139/f93-161; Mongillo TM, 2012, MAR ECOL PROG SER, V453, P263, DOI 10.3354/meps09658; Mossner S, 1997, CHEMOSPHERE, V34, P1285, DOI 10.1016/S0045-6535(97)00426-8; Ross P, 1996, TOXICOLOGY, V112, P157, DOI 10.1016/0300-483X(96)03396-3; Ross PS, 2000, MAR POLLUT BULL, V40, P504, DOI 10.1016/S0025-326X(99)00233-7; Schlenk D, 2005, MAR POLLUT BULL, V50, P208, DOI 10.1016/j.marpolbul.2004.11.032; Serrano R, 2000, ARCH ENVIRON CON TOX, V38, P217, DOI 10.1007/s002449910029; Sonne Christian, 2010, Toxicological and Environmental Chemistry, V92, P969, DOI 10.1080/02772240903187221; Stewart KR, 2011, MAR POLLUT BULL, V62, P1396, DOI 10.1016/j.marpolbul.2011.04.042; SUBRAMANIAN A, 1987, MAR POLLUT BULL, V18, P643, DOI 10.1016/0025-326X(87)90397-3; Sumpter JP, 2009, PHILOS T R SOC A, V367, P3877, DOI 10.1098/rsta.2009.0106; TANABE S, 1994, SCI TOTAL ENVIRON, V154, P163, DOI 10.1016/0048-9697(94)90086-8; Team RDC, 2019, R LANG ENV STAT COMP; van de Merwe JP, 2011, AQUAT TOXICOL, V103, P199, DOI 10.1016/j.aquatox.2011.02.021; van de Merwe JP, 2010, MAR ECOL PROG SER, V403, P269, DOI 10.3354/meps08462; Verboven N, 2009, AUK, V126, P123, DOI 10.1525/auk.2009.08039; Verreault J, 2005, SCI TOTAL ENVIRON, V351, P369, DOI 10.1016/j.scitotenv.2004.10.031; Verreault J, 2006, ENVIRON POLLUT, V144, P1053, DOI 10.1016/j.envpol.2005.10.055; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Weng KC, 2007, MAR ECOL PROG SER, V338, P211, DOI 10.3354/meps338211; WETHERBEE BM, 1993, COPEIA, P416; Ylitalo GM, 2005, MAR POLLUT BULL, V50, P30, DOI 10.1016/j.marpolbul.2004.08.005; Ylitalo GM, 2001, SCI TOTAL ENVIRON, V281, P183, DOI 10.1016/S0048-9697(01)00846-4	62	47	49	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62886	10.1371/journal.pone.0062886	http://dx.doi.org/10.1371/journal.pone.0062886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646154	Green Published, gold			2022-12-25	WOS:000319077300108
J	Stojadinovic, O; Sawaya, A; Pastar, I; Tomic-Canic, M				Stojadinovic, Olivera; Sawaya, Andrew; Pastar, Irena; Tomic-Canic, Marjana			Glucocorticoid Receptor Localizes to Adherens Junctions at the Plasma Membrane of Keratinocytes	PLOS ONE			English	Article							EPIDERMAL-KERATINOCYTES; CELLS; INHIBITION; ALPHA; SKIN; EPITHELIALIZATION; MECHANISM	Glucocorticoids are important regulators of epidermal tissue homeostasis. As such, their clinical applications are widespread, ranging from inflammatory skin disorders to keloids and cancer. Glucocorticoids exert their effect by binding to glucocorticoid receptor (GR) which translocates to the nucleus and regulates gene expression (genomic effect). In addition, GR has rapid non-genomic effects that are mediated by cell signaling proteins and do not involve gene transcription. Although genomic effects of GR in the epidermis are well documented, the non- genomic effects are not completely understood. Therefore, we utilized immunostaining and immunoprecipitations to determine specific localization of the GR in human keratinocytes that may contribute to non-genomic effects of glucocorticoid action. Here we describe a novel finding of GR localization to the plasma membrane of keratinocytes. Immunocytochemistry showed co-localization of GR with alpha-catenin. Immunoprecipitation of the membranous fraction revealed an association of GR with alpha-catenin, confirming its localization to adherens junctions. We conclude that GR localization to adherens junctions of keratinocytes provides a new mechanism of non- genomic signaling by glucocorticoids which may have significant biological and clinical impact.	[Stojadinovic, Olivera; Sawaya, Andrew; Pastar, Irena; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program, Miami, FL 33136 USA; [Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Cellular & Mol Pharmacol Grad Program Biomed Sci, Miami, FL 33136 USA	University of Miami; University of Miami	Tomic-Canic, M (corresponding author), Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program, Miami, FL 33136 USA.	mtcanic@med.miami.edu	Pastar, Irena/AAD-3626-2020	Pastar, Irena/0000-0003-0197-6198	Department of Dermatology of the University of Miami	Department of Dermatology of the University of Miami	This grant was funded by the sources from the Department of Dermatology of the University of Miami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boldizsar F, 2010, IMMUNOBIOLOGY, V215, P521, DOI 10.1016/j.imbio.2009.10.003; Cirillo N, 2011, J CELL BIOCHEM, V112, P1499, DOI 10.1002/jcb.23081; Croxtall JD, 2000, BRIT J PHARMACOL, V130, P289, DOI 10.1038/sj.bjp.0703272; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; Gametchu B, 1999, STEROIDS, V64, P107, DOI 10.1016/S0039-128X(98)00097-X; Lee B, 2005, J MOL BIOL, V345, P1083, DOI 10.1016/j.jmb.2004.11.027; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Marino M, 2008, STEROIDS, V73, P853, DOI 10.1016/j.steroids.2007.12.003; ORCHINIK M, 1991, SCIENCE, V252, P1848, DOI 10.1126/science.2063198; Radoja N, 2000, MOL CELL BIOL, V20, P4328, DOI 10.1128/MCB.20.12.4328-4339.2000; RANDOLPH RK, 1993, J BIOL CHEM, V268, P9198; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Roozendaal B, 2010, J NEUROSCI, V30, P5037, DOI 10.1523/JNEUROSCI.5717-09.2010; Sevilla LM, 2010, MOL ENDOCRINOL, V24, P2166, DOI 10.1210/me.2010-0183; Song IH, 2006, MOL CELL ENDOCRINOL, V246, P142, DOI 10.1016/j.mce.2005.11.012; Stellacci E, 2009, EXP HEMATOL, V37, P559, DOI 10.1016/j.exphem.2009.02.005; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Terao M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025039; Tiganescu A, 2011, J INVEST DERMATOL, V131, P30, DOI 10.1038/jid.2010.257; Vukelic S, 2011, J BIOL CHEM, P286; Vukelic S, 2010, J BIOL CHEM, V285, P1980, DOI 10.1074/jbc.M109.016741; Xiao L, 2010, MOL ENDOCRINOL, V24, P497, DOI 10.1210/me.2009-0422; Yang J, 1996, MOL ENDOCRINOL, V10, P3, DOI 10.1210/me.10.1.3	24	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63453	10.1371/journal.pone.0063453	http://dx.doi.org/10.1371/journal.pone.0063453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646206	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300165
J	Ahnstedt, H; Cao, L; Krause, DN; Warfvinge, K; Saveland, H; Nilsson, OG; Edvinsson, L				Ahnstedt, Hilda; Cao, Lei; Krause, Diana N.; Warfvinge, Karin; Saveland, Hans; Nilsson, Ola G.; Edvinsson, Lars			Male-Female Differences in Upregulation of Vasoconstrictor Responses in Human Cerebral Arteries	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; ANGIOTENSIN-II; SUBARACHNOID HEMORRHAGE; B RECEPTORS; CONTRACTILE RECEPTORS; VASCULAR-RESPONSES; GENDER-DIFFERENCES; HYPERTENSIVE-RATS; SEX-DIFFERENCES; BLOOD-FLOW	Background and purpose: Male-female differences may significantly impact stroke prevention and treatment in men women, however underlying mechanisms for sexual dimorphism in stroke are not understood. We previously found males that cerebral ischemia upregulates contractile receptors in cerebral arteries, which is associated with lower flow. The present study investigates if cerebral arteries from men and women differ in cerebrovascular upregulation. Experimental approach: Freshly obtained human cerebral arteries were placed in organ culture, an established model studying receptor upregulation. 5-hydroxtryptamine type 1B (5-HT1B), angiotensin II type 1 (AT(1)) and endothelin-1 type and B (ETA and ETB) receptors were evaluated using wire myograph for contractile responses, real-time PCR for mRNA immunohistochemistry for receptor expression. Key results: Vascular sensitivity to angiotensin II and endothelin-1 was markedly lower in cultured cerebral arteries women as compared to men. ETB receptor-mediated contraction occurred in male but not female arteries. there were similar upregulation in mRNA and expression of 5-HT1B, AT(1), and E-TB receptors and in local expression of Ang II after organ culture. Conclusions and Implications: In spite of receptor upregulation after organ culture in both sexes, cerebral arteries women were significantly less responsive to vasoconstrictors angiotensin II and endothelin-1 as compared to arteries men. This suggests receptor coupling and/or signal transduction mechanisms involved in cerebrovascular contractility be suppressed in females. This is the first study to demonstrate sex differences in the vascular function of human arteries.	[Ahnstedt, Hilda; Cao, Lei; Warfvinge, Karin; Edvinsson, Lars] Lund Univ, Dept Clin Sci, Div Expt Vasc Res, Lund, Sweden; [Krause, Diana N.] Univ Calif Irvine, Dept Pharmacol, Sch Med, Irvine, CA 92717 USA; [Saveland, Hans; Nilsson, Ola G.] Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden	Lund University; University of California System; University of California Irvine; Lund University; Skane University Hospital	Ahnstedt, H (corresponding author), Lund Univ, Dept Clin Sci, Div Expt Vasc Res, Lund, Sweden.	hilda.ahnstedt@med.lu.se		Cao, Lei/0000-0002-9676-7366; Edvinsson, Lars/0000-0002-1805-1346	Swedish Heart Lung Association [2010225]; Swedish Research Council [2011-5414]	Swedish Heart Lung Association(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by grants from the Swedish Heart Lung Association (grant no. 2010225, http://www.hjart-lungfonden.se/ and the Swedish Research Council (grant no. 2011-5414, www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnstedt H, 2012, ACTA PHYSIOL, V205, P266, DOI 10.1111/j.1748-1716.2011.02392.x; Ahnstedt H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-5; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; Ansar S, 2013, BMC NEUROSC IN PRESS; Ansar S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-107; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Arnold AP, 2009, J NEUROENDOCRINOL, V21, P377, DOI 10.1111/j.1365-2826.2009.01831.x; Beg SAS, 2006, J CEREBR BLOOD F MET, V26, P846, DOI 10.1038/sj.jcbfm.9600236; CHENG DY, 1992, EUR J PHARMACOL, V215, P171, DOI 10.1016/0014-2999(92)90025-Y; David FL, 2002, BRAZ J MED BIOL RES, V35, P1061, DOI 10.1590/S0100-879X2002000900006; De Silva TM, 2009, STROKE, V40, P1091, DOI 10.1161/STROKEAHA.108.531707; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Edvinsson LIH, 2011, J CEREBR BLOOD F MET, V31, P1554, DOI 10.1038/jcbfm.2011.70; Forster A, 2009, STROKE, V40, P2428, DOI 10.1161/STROKEAHA.109.548750; Fu H, 2011, J HYPERTENS, V29, P2210, DOI 10.1097/HJH.0b013e32834bbb30; Geary GG, 1998, AM J PHYSIOL-HEART C, V275, pH292, DOI 10.1152/ajpheart.1998.275.1.H292; Gonzales RJ, 2005, AM J PHYSIOL-HEART C, V289, pH578, DOI 10.1152/ajpheart.00958.2004; Hansen-Schwartz J, 2002, NEUROSURGERY, V50, P127, DOI 10.1097/00006123-200201000-00021; Hansen-Schwartz J, 2003, NEUROSURGERY, V52, P1188, DOI 10.1227/01.NEU.0000058467.82442.64; Henriksson M, 2004, BRIT J PHARMACOL, V142, P1155, DOI 10.1038/sj.bjp.0705803; Henriksson M, 2003, STROKE, V34, P1479, DOI 10.1161/01.STR.0000072984.79136.79; Henriksson M, 2007, EXP BRAIN RES, V178, P470, DOI 10.1007/s00221-006-0753-7; HOGESTATT ED, 1983, ACTA PHYSIOL SCAND, V117, P49, DOI 10.1111/j.1748-1716.1983.tb07178.x; Hosomi N, 2005, NEUROSCIENCE, V134, P225, DOI 10.1016/j.neuroscience.2005.03.054; Hurn PD, 2003, STROKE, V34, P338, DOI 10.1161/01.STR.0000054051.88378.25; Kent DM, 2005, STROKE, V36, P62, DOI 10.1161/01.STR.0000150515.15576.29; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Liao SL, 2001, NEUROSCI LETT, V297, P159, DOI 10.1016/S0304-3940(00)01704-3; Maddahi A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-85; Mugge A, 1997, PHARMACOLOGY, V54, P162, DOI 10.1159/000139483; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nilsson T, 1997, NEUROSURGERY, V40, P346, DOI 10.1097/00006123-199702000-00023; Nilsson T, 1999, BRIT J PHARMACOL, V128, P1133, DOI 10.1038/sj.bjp.0702773; Ospina JA, 2003, AM J PHYSIOL-HEART C, V285, pH241, DOI 10.1152/ajpheart.00018.2003; Passaglia RCAT, 2000, BRIT J PHARMACOL, V130, P1092, DOI 10.1038/sj.bjp.0703389; Povlsen GK, 2012, EXP BRAIN R IN PRESS; Salom JB, 2001, J CEREBR BLOOD F MET, V21, P422, DOI 10.1097/00004647-200104000-00011; Silva-Antonialli MM, 2004, CARDIOVASC RES, V62, P587, DOI 10.1016/j.cardiores.2004.01.020; Turtzo LC, 2010, FUTUR NEUROL, V5, P47, DOI 10.2217/FNL.09.66; Vikman P, 2006, EUR J NEUROL, V13, P1324, DOI 10.1111/j.1468-1331.2006.01496.x; Zuern CS, 2009, SEMIN THROMB HEMOST, V35, P295, DOI 10.1055/s-0029-1222608	41	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62698	10.1371/journal.pone.0062698	http://dx.doi.org/10.1371/journal.pone.0062698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658641	Green Published, gold			2022-12-25	WOS:000321662800056
J	Arooj, M; Sakkiah, S; Kim, S; Arulalapperumal, V; Lee, KW				Arooj, Mahreen; Sakkiah, Sugunadevi; Kim, Songmi; Arulalapperumal, Venkatesh; Lee, Keun Woo			A Combination of Receptor-Based Pharmacophore Modeling & QM Techniques for Identification of Human Chymase Inhibitors	PLOS ONE			English	Article							MAST-CELL CHYMASE; ANGIOTENSIN-II; NONPEPTIDE INHIBITORS; DRUG DISCOVERY; DESIGN; DOCKING; POTENT; MECHANISMS; PROTEASES; TOPOLOGY	Inhibition of chymase is likely to divulge therapeutic ways for the treatment of cardiovascular diseases, and fibrotic disorders. To find novel and potent chymase inhibitors and to provide a new idea for drug design, we used both ligand-based and structure-based methods to perform the virtual screening(VS) of commercially available databases. Different pharmacophore models generated from various crystal structures of enzyme may depict diverse inhibitor binding modes. Therefore, multiple pharmacophore-based approach is applied in this study. X-ray crystallographic data of chymase in complex with different inhibitors were used to generate four structure-based pharmacophore models. One ligand-based pharmacophore model was also developed from experimentally known inhibitors. After successful validation, all pharmacophore models were employed in database screening to retrieve hits with novel chemical scaffolds. Drug-like hit compounds were subjected to molecular docking using GOLD and AutoDock. Finally four structurally diverse compounds with high GOLD score and binding affinity for several crystal structures of chymase were selected as final hits. Identification of final hits by three different pharmacophore models necessitates the use of multiple pharmacophore-based approach in VS process. Quantum mechanical calculation is also conducted for analysis of electrostatic characteristics of compounds which illustrates their significant role in driving the inhibitor to adopt a suitable bioactive conformation oriented in the active site of enzyme. In general, this study is used as example to illustrate how multiple pharmacophore approach can be useful in identifying structurally diverse hits which may bind to all possible bioactive conformations available in the active site of enzyme. The strategy used in the current study could be appropriate to design drugs for other enzymes as well.	[Arooj, Mahreen; Sakkiah, Sugunadevi; Kim, Songmi; Arulalapperumal, Venkatesh; Lee, Keun Woo] Gyeongsang Natl Univ GNU, Plant Mol Biol & Biotechnol Res Ctr PMBBRC, Syst & Synthet Agrobiotech Ctr SSAC, Div Appl Life Sci,Program BK21,Res Inst Nat Sci R, Jinju, South Korea	Gyeongsang National University	Lee, KW (corresponding author), Gyeongsang Natl Univ GNU, Plant Mol Biol & Biotechnol Res Ctr PMBBRC, Syst & Synthet Agrobiotech Ctr SSAC, Div Appl Life Sci,Program BK21,Res Inst Nat Sci R, Jinju, South Korea.	kwlee@gnu.ac.kr	Arooj, Mahreen/AAC-7565-2020	Sakkiah, Suguna Devi/0000-0002-8337-9348; Arooj, Mahreen/0000-0003-1975-5289	National Research Foundation of Korea (NRF) [2012R1A1A4A01013657, 2009-0081539, 2010-0029084]; Ministry of Education, Science and Technology (MEST) of Republic of Korea; Rural Development Administration (RDA) of Republic of Korea [PJ009486]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration (RDA) of Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by Basic Science Research Program (2012R1A1A4A01013657), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. And this work was also supported by the Next-Generation BioGreen 21 Program (PJ009486) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 2008, GENET MED, V10, P593, DOI [10.1097/GIM.0b013e3181804b9c, 10.1097GIM.0b013e3181804b9c]; Aoyama Y, 2000, BIOORG MED CHEM LETT, V10, P2397, DOI 10.1016/S0960-894X(00)00488-1; Aoyama Y, 2001, BIOORG MED CHEM LETT, V11, P1691, DOI 10.1016/S0960-894X(01)00264-5; Aoyama Y, 2001, BIOORGAN MED CHEM, V9, P3065, DOI 10.1016/S0968-0896(01)00209-7; Arooj M, 2011, INT J MOL SCI, V12, P9236, DOI 10.3390/ijms12129236; Boda K, 2007, J COMPUT AID MOL DES, V21, P311, DOI 10.1007/s10822-006-9099-2; Caughey GH, 2000, BBA-PROTEIN STRUCT M, V1480, P245, DOI 10.1016/S0167-4838(00)00076-5; de Garavilla L, 2005, J BIOL CHEM, V280, P18001, DOI 10.1074/jbc.M501302200; Dehez F, 2008, J AM CHEM SOC, V130, P12725, DOI 10.1021/ja8033087; Devereux M, 2009, J CHEM INF MODEL, V49, P1497, DOI 10.1021/ci900085d; Dickson M, 2004, NAT REV DRUG DISCOV, V3, P417, DOI 10.1038/nrd1382; Garcia-Garcia A, 2004, J ANTIMICROB CHEMOTH, V53, P65, DOI 10.1093/jac/dkh014; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; Greco MN, 2007, J MED CHEM, V50, P1727, DOI 10.1021/jm0700619; Huang XR, 2003, J AM SOC NEPHROL, V14, P1738, DOI 10.1097/01.ASN.0000071512.93927.4E; Iijima K, 1999, BIOORG MED CHEM LETT, V9, P413, DOI 10.1016/S0960-894X(99)00012-8; Kenny PW, 2009, J CHEM INF MODEL, V49, P1234, DOI 10.1021/ci9000234; Kervinen J, 2010, BIOCHEM PHARMACOL, V80, P1033, DOI 10.1016/j.bcp.2010.06.014; Khedkar SA, 2007, MED CHEM, V3, P187, DOI 10.2174/157340607780059521; Kim S, 2000, PHARMACOL REV, V52, P11; Koide Y, 2003, BIOORG MED CHEM LETT, V13, P25, DOI 10.1016/S0960-894X(02)00853-3; Kruger DM, 2011, ACS MED CHEM LETT, V2, P489, DOI 10.1021/ml100217h; Langer T, 2003, CURR OPIN DRUG DISC, V6, P370; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Levit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027990; Lindsay GA, 2010, ACS SYM SER, V1039, P35; Lo HY, 2011, BIOORG MED CHEM LETT, V21, P4533, DOI 10.1016/j.bmcl.2011.05.126; Nam K, 2008, RNA, V14, P1501, DOI 10.1261/rna.863108; Niwata S, 1997, J MED CHEM, V40, P2156, DOI 10.1021/jm960793t; Omoto Y, 2006, J IMMUNOL, V177, P8315, DOI 10.4049/jimmunol.177.12.8315; Panchmatia PM, 2010, J PHYS CHEM A, V114, P13381, DOI 10.1021/jp106358m; Schuster D, 2011, BIOORGANIC MED CHEM; Takai S, 2005, LETT DRUG DES DISCOV, V2, P19, DOI 10.2174/1570180053398433; Tiwari R, 2009, J CHEM INF MODEL, V49, P1581, DOI 10.1021/ci900031y; Tuccinardi T, 2010, J CHEM INF MODEL, V50, P1432, DOI 10.1021/ci100161z; Urata H, 1996, AM J HYPERTENS, V9, P277, DOI 10.1016/0895-7061(95)00349-5; Vainio MJ, 2009, J CHEM INF MODEL, V49, P492, DOI 10.1021/ci800315d; Vyas VK, 2013, J MOL GRAPHICS MODEL; Zhao WX, 2011, J CHEM INF MODEL, V51, P2147, DOI 10.1021/ci100511v	39	39	39	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e63030	10.1371/journal.pone.0063030	http://dx.doi.org/10.1371/journal.pone.0063030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658661	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700087
J	Haase, S; Hanssen, E; Matthews, K; Kalanon, M; de Koning-Ward, TF				Haase, Silvia; Hanssen, Eric; Matthews, Kathryn; Kalanon, Ming; de Koning-Ward, Tania F.			The Exported Protein PbCP1 Localises to Cleft-Like Structures in the Rodent Malaria Parasite Plasmodium berghei	PLOS ONE			English	Article							MEMBRANE-PROTEIN; TRAFFICKING; VIRULENCE; SURFACE; FAMILY; CYTOADHERENCE; ERYTHROCYTES; PFEMP1; EXPRESSION; INFECTION	Protein export into the host red blood cell is one of the key processes in the pathobiology of the malaria parasite Plasmodiumtrl falciparum, which extensively remodels the red blood cell to ensure its virulence and survival. In this study, we aimed to shed further light on the protein export mechanisms in the rodent malaria parasite P. berghei and provide further proof of the conserved nature of host cell remodeling in Plasmodium spp. Based on the presence of an export motif (R/KxLxE/Q/D) termed PEXEL (Plasmodium export element), we have generated transgenic P. berghei parasite lines expressing GFP chimera of putatively exported proteins and analysed one of the newly identified exported proteins in detail. This essential protein, termed PbCP1 (P. berghei Cleft-like Protein 1), harbours an atypical PEXEL motif (RxLxY) and is further characterised by two predicted transmembrane domains (2TMD) in the C-terminal end of the protein. We have functionally validated the unusual PEXEL motif in PbCP1 and analysed the role of the 2TMD region, which is required to recruit PbCP1 to discrete membranous structures in the red blood cell cytosol that have a convoluted, vesico-tubular morphology by electron microscopy. Importantly, this study reveals that rodent malaria species also induce modifications to their host red blood cell.	[Haase, Silvia; Matthews, Kathryn; Kalanon, Ming; de Koning-Ward, Tania F.] Deakin Univ, Sch Med, Waurn Ponds, Vic 3217, Australia; [Hanssen, Eric] Univ Melbourne, Inst Bio21, Electron Microscopy Unit, Parkville, Vic 3052, Australia	Deakin University; University of Melbourne	Haase, S (corresponding author), Deakin Univ, Sch Med, Waurn Ponds, Vic 3217, Australia.	haase@wehi.edu.au; taniad@deakin.edu.au	de Koning-Ward, Tania F/N-3572-2017; Hanssen, Eric/A-7217-2013	de Koning-Ward, Tania F/0000-0001-5810-8063; Hanssen, Eric/0000-0002-4064-1844; Haase, Silvia/0000-0003-0870-3715	Australian National Health and Medical Research Council [533811]; Deakin University; Alfred Deakin Fellowship Scheme; NHMRC	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Deakin University; Alfred Deakin Fellowship Scheme; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian National Health and Medical Research Council (533811) and Deakin University's Central Research Grants Scheme. S. H. acknowledges support from the Alfred Deakin Fellowship Scheme. TdKW is supported by an NHMRC Career Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bhattacharjee S, 2012, CELL, V148, P201, DOI 10.1016/j.cell.2011.10.051; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Braks JAM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj033; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Cunningham D, 2010, MOL BIOCHEM PARASIT, V170, P65, DOI 10.1016/j.molbiopara.2009.12.010; Curra C, 2012, TRAFFIC, V13, P388, DOI 10.1111/j.1600-0854.2011.01313.x; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; de Koning-Ward TF, 2000, ANNU REV MICROBIOL, V54, P157, DOI 10.1146/annurev.micro.54.1.157; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Dixon MWA, 2011, MOL MICROBIOL, V81, P982, DOI 10.1111/j.1365-2958.2011.07740.x; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001032; Gruring C, 2012, CELL HOST MICROBE, V12, P717, DOI 10.1016/j.chom.2012.09.010; Gruring C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1169; Haase S, 2010, CELL MICROBIOL, V12, P580, DOI 10.1111/j.1462-5822.2010.01455.x; Hanssen E, 2008, MOL MICROBIOL, V69, P938, DOI 10.1111/j.1365-2958.2008.06329.x; Hanssen E, 2008, MOL MICROBIOL, V67, P703, DOI 10.1111/j.1365-2958.2007.06063.x; Hanssen E, 2010, INT J PARASITOL, V40, P123, DOI 10.1016/j.ijpara.2009.09.004; Hawthorne PL, 2004, MOL BIOCHEM PARASIT, V136, P181, DOI 10.1016/j.molbiopara.2004.03.013; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Ingmundson A, 2012, MOL MICROBIOL, V83, P1229, DOI 10.1111/j.1365-2958.2012.08004.x; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; KILEJIAN A, 1979, P NATL ACAD SCI USA, V76, P4650, DOI 10.1073/pnas.76.9.4650; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; Lanzer M, 2006, INT J PARASITOL, V36, P23, DOI 10.1016/j.ijpara.2005.10.001; MacKenzie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002405; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Pasini EM, 2013, MOL CELL PROTEOMICS, V12, P426, DOI 10.1074/mcp.M112.021238; Sam-Yellowe TY, 2009, TRENDS PARASITOL, V25, P277, DOI 10.1016/j.pt.2009.03.009; Sam-Yellowe TY, 2004, GENOME RES, V14, P1052, DOI 10.1101/gr.2126104; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Sijwali PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010227; Spielmann T, 2006, MOL BIOL CELL, V17, P3613, DOI 10.1091/mbc.E06-04-0291; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Spycher C, 2003, J BIOL CHEM, V278, P35373, DOI 10.1074/jbc.M305851200; Spycher C, 2008, MOL MICROBIOL, V68, P1300, DOI 10.1111/j.1365-2958.2008.06235.x; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tilley L, 2008, TRAFFIC, V9, P187, DOI 10.1111/j.1600-0854.2007.00684.x; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; Wong W, 2011, P NATL ACAD SCI USA, V108, P9869, DOI 10.1073/pnas.1018927108	50	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61482	10.1371/journal.pone.0061482	http://dx.doi.org/10.1371/journal.pone.0061482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658610	gold, Green Published			2022-12-25	WOS:000318343700012
J	Stock, AK; Wascher, E; Beste, C				Stock, Ann-Kathrin; Wascher, Edmund; Beste, Christian			Differential Effects of Motor Efference Copies and Proprioceptive Information on Response Evaluation Processes	PLOS ONE			English	Article							MOVEMENT-RELATED POTENTIALS; SPATIAL ATTENTION; SPACE; BRAIN; SCALP; EEG; PERCEPTION; CORTEX; LINKS; COPY	It is well-kown that sensory information influences the way we execute motor responses. However, less is known about if and how sensory and motor information are integrated in the subsequent process of response evaluation. We used a modified Simon Task to investigate how these streams of information are integrated in response evaluation processes, applying an in-depth neurophysiological analysis of event-related potentials (ERPs), time-frequency decomposition and sLORETA. The results show that response evaluation processes are differentially modulated by afferent proprioceptive information and efference copies. While the influence of proprioceptive information is mediated via oscillations in different frequency bands, efference copy based information about the motor execution is specifically mediated via oscillations in the theta frequency band. Stages of visual perception and attention were not modulated by the interaction of proprioception and motor efference copies. Brain areas modulated by the interactive effects of proprioceptive and efference copy based information included the middle frontal gyrus and the supplementary motor area (SMA), suggesting that these areas integrate sensory information for the purpose of response evaluation. The results show how motor response evaluation processes are modulated by information about both the execution and the location of a response.	[Stock, Ann-Kathrin; Beste, Christian] Ruhr Univ Bochum, Inst Cognit Neurosci, Dept Biopsychol, Bochum, Germany; [Wascher, Edmund] Leibnitz Inst Arbeitsforsch TU Dortmund, Dortmund, Germany	Ruhr University Bochum	Stock, AK (corresponding author), Ruhr Univ Bochum, Inst Cognit Neurosci, Dept Biopsychol, Univ Str 150, Bochum, Germany.	Ann-Kathrin.Stock@rub.de	Stock, Ann-Kathrin/G-9536-2019; Stock, Ann-Kathrin/AAT-9168-2020; Wascher, Edmund/N-6848-2019; Wascher, Edmund/B-8457-2019	Stock, Ann-Kathrin/0000-0001-7113-4020; Stock, Ann-Kathrin/0000-0001-7113-4020; Wascher, Edmund/0000-0003-3616-9767	Deutsche Forschungsgemeinschaft (DFG) [BE4045/10-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a Grant from the Deutsche Forschungsgemeinschaft (DFG) BE4045/10-1 to C. B. Funder's website: www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain S, 2004, CLIN NEUROPHYSIOL, V115, P2014, DOI 10.1016/j.clinph.2004.04.013; ANGEL RW, 1976, NEUROLOGY, V26, P1164, DOI 10.1212/WNL.26.12.1164; Babiloni F, 2001, HUM BRAIN MAPP, V14, P197, DOI 10.1002/hbm.1052; Beaule V, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/627816; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Beste C, 2009, NEUROSCIENCE, V159, P143, DOI 10.1016/j.neuroscience.2008.12.030; Beste C, 2007, NEUROPSYCHOLOGIA, V45, P2922, DOI 10.1016/j.neuropsychologia.2007.06.004; Beste C, 2012, NEUROIMAGE, V62, P137, DOI 10.1016/j.neuroimage.2012.05.019; Beste C, 2010, J NEUROSCI, V30, P10727, DOI 10.1523/JNEUROSCI.2493-10.2010; Beste C, 2010, HUM BRAIN MAPP, V31, P621, DOI 10.1002/hbm.20892; Cui RQ, 1999, NEUROIMAGE, V9, P124, DOI 10.1006/nimg.1998.0388; Danielmeier C, 2009, PSYCHOPHYSIOLOGY, V46, P1288, DOI 10.1111/j.1469-8986.2009.00860.x; Diedrichsen J, 2006, CEREB CORTEX, V16, P1729, DOI 10.1093/cercor/bhj108; Eimer M, 2001, EXP BRAIN RES, V139, P398, DOI 10.1007/s002210100773; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Feldman AG, 2009, EXP BRAIN RES, V194, P39, DOI 10.1007/s00221-008-1667-3; FOGASSI L, 1992, EXP BRAIN RES, V89, P686, DOI 10.1007/BF00229894; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Fukui T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034985; Gonzalez CC, 2013, EXP BRAIN RES, V224, P189, DOI 10.1007/s00221-012-3298-y; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Gritsenko V, 2007, J NEUROPHYSIOL, V98, P1140, DOI 10.1152/jn.00162.2007; Gruendler TOJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025591; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Hallett M, 1994, Electromyogr Clin Neurophysiol, V34, P5; Heed T, 2012, NEURAL BASES MULTISE; Heed T, 2012, J EXP PSYCHOL HUMAN, V38, P386, DOI 10.1037/a0024059; Heed T, 2010, J COGNITIVE NEUROSCI, V22, P184, DOI 10.1162/jocn.2008.21168; Herz DM, 2012, NEUROIMAGE, V59, P3187, DOI 10.1016/j.neuroimage.2011.11.042; HOCHERMAN S, 1988, EXP BRAIN RES, V73, P256; Hoffmann S, 2012, NEUROSCI LETT, V506, P225, DOI 10.1016/j.neulet.2011.11.011; Hoffmann S, 2010, HUM BRAIN MAPP, V31, P1305, DOI 10.1002/hbm.20937; Holst E. von, 1954, British Journal of Animal Behaviour, V2, P89; IKEDA A, 1995, ELECTROEN CLIN NEURO, V95, P323, DOI 10.1016/0013-4694(95)00086-E; Kennett S, 2001, J COGNITIVE NEUROSCI, V13, P462, DOI 10.1162/08989290152001899; Kim C, 2012, BRAIN RES, V1444, P55, DOI 10.1016/j.brainres.2012.01.023; Leuthold H, 2011, ACTA PSYCHOL, V136, P203, DOI 10.1016/j.actpsy.2010.08.001; Lloyd DM, 2010, BRAIN COGNITION, V73, P102, DOI 10.1016/j.bandc.2010.03.006; Loayza FR, 2011, NEUROIMAGE, V55, P635, DOI 10.1016/j.neuroimage.2010.12.011; LOGAN GD, 1985, ACTA PSYCHOL, V60, P193, DOI 10.1016/0001-6918(85)90055-1; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mead LA, 2002, J INT NEUROPSYCH SOC, V8, P735, DOI 10.1017/S1355617702860015; Muller V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038931; NESHIGE R, 1988, BRAIN, V111, P719; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; NUNEZ PL, 1991, J CLIN NEUROPHYSIOL, V8, P397, DOI 10.1097/00004691-199110000-00005; Ocklenburg S, 2011, NEUROIMAGE, V55, P1771, DOI 10.1016/j.neuroimage.2011.01.035; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parsons LM, 1998, J NEUROSCI, V18, P6539; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; PERNIER J, 1988, ELECTROEN CLIN NEURO, V69, P385, DOI 10.1016/0013-4694(88)90009-0; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Peterburs J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021517; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; Praamstra P, 1996, ELECTROEN CLIN NEURO, V98, P468, DOI 10.1016/0013-4694(96)95643-6; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Roger C, 2010, NEUROIMAGE, V51, P391, DOI 10.1016/j.neuroimage.2010.02.005; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Semprini G, 2012, J MOTOR BEHAV, V44, P373, DOI 10.1080/00222895.2012.724476; Simon JR., 1990, ADV PSYCHOL, P31, DOI [10.1016/s0166-4115(08)61218-2, DOI 10.1016/S0166-4115(08)61218-2]; Spence C, 2000, J EXP PSYCHOL HUMAN, V26, P1298, DOI 10.1037//0096-1523.26.4.1298; Suchan B, 2003, NEUROSCI LETT, V350, P101, DOI 10.1016/S0304-3940(03)00879-6; TallonBaudry C, 1997, J NEUROSCI, V17, P722; TARKKA IM, 1991, J CLIN NEUROPHYSIOL, V8, P331, DOI 10.1097/00004691-199107010-00009; Therrien AS, 2011, NEUROPSYCHOLOGIA, V49, P2941, DOI 10.1016/j.neuropsychologia.2011.06.023; Tremblay P, 2011, NEUROIMAGE, V57, P1561, DOI 10.1016/j.neuroimage.2011.05.067; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; Vakalopoulos C, 2007, MED HYPOTHESES, V68, P574, DOI 10.1016/j.mehy.2006.08.013; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; WALLACE RJ, 1971, J EXP PSYCHOL, V88, P354, DOI 10.1037/h0030892; Wascher E, 2001, J EXP PSYCHOL HUMAN, V27, P731, DOI 10.1037//0096-1523.27.3.731; Wascher E, 2010, J NEUROPHYSIOL, V103, P1057, DOI 10.1152/jn.00376.2009; Wiegand K, 2007, PSYCHOL RES-PSYCH FO, V71, P401, DOI 10.1007/s00426-005-0027-1; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Yordanova J, 2004, NEUROIMAGE, V22, P590, DOI 10.1016/j.neuroimage.2004.01.040; Zhou Y, 2012, J NEUROSCI, V32, P8354, DOI 10.1523/JNEUROSCI.0829-12.2012	80	38	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62335	10.1371/journal.pone.0062335	http://dx.doi.org/10.1371/journal.pone.0062335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658624	gold, Green Published, Green Submitted			2022-12-25	WOS:000318343700048
J	Cardoso, AP; Pinto, ML; Pinto, AT; Oliveira, MI; Pinto, MT; Goncalves, R; Relvas, JB; Figueiredo, C; Seruca, R; Mantovani, A; Mareel, M; Barbosa, MA; Oliveira, MJ				Cardoso, A. P.; Pinto, M. L.; Pinto, A. T.; Oliveira, M. I.; Pinto, M. T.; Goncalves, R.; Relvas, J. B.; Figueiredo, C.; Seruca, R.; Mantovani, A.; Mareel, M.; Barbosa, M. A.; Oliveira, M. J.			Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y-1086, c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity	ONCOGENE			English	Article						tumor microenvironment; cancer cell invasion; macrophages; invasion-related signaling pathways; colon cancer; gastric cancer	TUMOR-CELL MIGRATION; PHOSPHOLIPASE C-GAMMA-1; GROWTH; INFILTRATION; METASTASIS; INFLAMMATION; INVASIVENESS; ANGIOGENESIS; PROGRESSION; CARCINOMA	The interactions between cancer cells and their microenvironment are crucial for malignant progression, as they modulate invasion-related activities. Tumor-associated macrophages are generally considered allies in the process of tumor progression in several types of cancer, although their role on gastric and colorectal carcinomas is still poorly understood. In this report, we studied the influence of primary human macrophages on gastric and colorectal cancer cells, considering invasion, motility/migration, proteolysis and activated intracellular signaling pathways. We demonstrated that macrophages stimulate cancer cell invasion, motility and migration, and that these effects depend on matrix metalloproteinase (MMP) activity and on the activation of epidermal growth factor receptor (EGFR) (at the residue Y-1086), PLC-gamma (phospholipase C-gamma) and Gab1 (GRB2-associated binding protein-1), as evidenced by siRNA (small interference RNA) experiments. Epidermal growth factor (EGF)-immunodepletion impaired macrophage-mediated cancer cell invasion and motility, suggesting that EGF is the pro-invasive and pro-motile factor produced by macrophages. Macrophages also induced gastric and colorectal cancer cell phosphorylation of Akt, c-Src and ERK1/2, and led to an increase of RhoA and Cdc42 activity. Interestingly, whereas macrophage-mediated cancer cell c-Src and ERK1/2 phosphorylation occurred downstream EGFR activation, Akt phosphorylation seems to be a parallel event, taking place in an EGFR-independent manner. The involvement of EGF, EGFR-downstream signaling partners and MMPs in macrophage-mediated invasion provides novel insights into the molecular crosstalk established between cancer cells and macrophages, opening new perspectives for the design of new and more efficient therapeutic strategies to counteract cancer cell invasion.	[Cardoso, A. P.; Pinto, M. L.; Pinto, A. T.; Oliveira, M. I.; Goncalves, R.; Barbosa, M. A.; Oliveira, M. J.] Univ Porto, Inst Biomed Engn, P-4150180 Oporto, Portugal; [Cardoso, A. P.; Pinto, A. T.] Univ Porto, Fac Engn, P-4150180 Oporto, Portugal; [Pinto, M. L.; Barbosa, M. A.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4150180 Oporto, Portugal; [Pinto, M. T.; Figueiredo, C.; Seruca, R.] Univ Porto, Inst Patol & Imunol Mol, P-4150180 Oporto, Portugal; [Relvas, J. B.] Univ Porto, Inst Biol Celular & Mol, P-4150180 Oporto, Portugal; [Relvas, J. B.] Univ Porto, Fac Med, Dept Biol Expt, P-4150180 Oporto, Portugal; [Figueiredo, C.; Seruca, R.; Oliveira, M. J.] Univ Porto, Fac Med, Dept Patol & Oncol, P-4150180 Oporto, Portugal; [Mantovani, A.] Humanitas Clin & Res Ctr, Rozzano, Italy; [Mantovani, A.] Univ Milan, BIOMETRA Dept, Milan, Italy; [Mareel, M.] Ghent Univ Hosp, Expt Cancerol Lab, Ghent, Belgium	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; IRCCS Humanitas Research Hospital; University of Milan; Ghent University; Ghent University Hospital	Oliveira, MJ (corresponding author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	mariajo@ineb.up.pt	Pinto, Marta T/J-2519-2013; Figueiredo, Ceu/B-8776-2008; Barbosa, Mário A/F-5964-2011; Cardoso, Ana P/G-2150-2017; Oliveira, Marta I A/M-9386-2013; Mantovani, Alberto/HCI-7449-2022; Pinto, Marta/AAE-4575-2020; Relvas, Joao B/A-1142-2008; Pinto, Ana/AAZ-8360-2020; Gonçalves, Raquel M/C-5940-2012; Oliveira, Maria Jose/K-3275-2013	Pinto, Marta T/0000-0002-8521-2904; Figueiredo, Ceu/0000-0001-5247-840X; Barbosa, Mário A/0000-0003-3568-7482; Cardoso, Ana P/0000-0003-1987-0316; Oliveira, Marta I A/0000-0002-0578-9202; Mantovani, Alberto/0000-0001-5578-236X; Pinto, Marta/0000-0002-5783-3965; Relvas, Joao B/0000-0001-7636-0924; Pinto, Ana/0000-0003-0974-2206; Gonçalves, Raquel M/0000-0003-2841-0485; Seruca, Raquel/0000-0002-8851-4166; Oliveira, Maria Jose/0000-0002-0724-0272	FCT [PTDC-SAU-ONC/112511/2009, SFRH/BD/74144/2010, SFRH/BD/81103/2011, SFRH/BPD/37090/2007]; COMPETE [FCOMP-01-0124-FEDER-010915]; Prize L'Oreal for Women Science (Foundation L'Oreal/FCT/UNESCO); European project DISC Regeneration [NMP3-LA-2008-213904]; AIRC; ERC; Italian Ministry of Health [RF2010]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); COMPETE; Prize L'Oreal for Women Science (Foundation L'Oreal/FCT/UNESCO)(L'Oreal Group); European project DISC Regeneration; AIRC(Fondazione AIRC per la ricerca sul cancro); ERC(European Research Council (ERC)European Commission); Italian Ministry of Health(Ministry of Health, Italy)	This work was financially supported by FCT (PTDC-SAU-ONC/112511/2009), COMPETE FCOMP-01-0124-FEDER-010915 and Prize L'Oreal for Women Science (Foundation L'Oreal/FCT/UNESCO). AP Cardoso is a PhD Fellow from the International Iberian Nanotechnology Laboratory (INL). AT Pinto and ML Pinto are PhD Fellows (SFRH/BD/74144/2010, SFRH/BD/81103/2011) and MI Oliveira a Postdoc Fellow (SFRH/BPD/37090/2007) from FCT. MJ Oliveira and MT Pinto are granted by Programa Ciencia2007-FCT. RGoncalves was funded by the European project DISC Regeneration, NMP3-LA-2008-213904 (FP7). A Mantovani is supported by AIRC, ERC and RF2010 Italian Ministry of Health.	Abella JV, 2010, J CELL SCI, V123, P1306, DOI 10.1242/jcs.062570; Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chou J, 2003, EXP CELL RES, V287, P47, DOI 10.1016/S0014-4827(03)00119-8; Coffelt SB, 2009, BBA-REV CANCER, V1796, P11, DOI 10.1016/j.bbcan.2009.02.004; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Foda HD, 2001, DRUG DISCOV TODAY, V6, P478, DOI 10.1016/S1359-6446(01)01752-4; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Green CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006713; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Hagemann T, 2007, CANCER CELL, V12, P300, DOI 10.1016/j.ccr.2007.10.005; Hakansson L, 1997, BRIT J CANCER, V75, P374, DOI 10.1038/bjc.1997.61; Humtsoe JO, 2010, ONCOGENE, V29, P1214, DOI 10.1038/onc.2009.419; Ishigami S, 2003, ANTICANCER RES, V23, P4079; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang JC, 2010, J SURG ONCOL, V102, P242, DOI 10.1002/jso.21617; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kuroda T, 2005, CLIN CANCER RES, V11, P7629, DOI 10.1158/1078-0432.CCR-05-0798; Leek RD, 1996, CANCER RES, V56, P4625; Liguori Manuela, 2011, Cancers (Basel), V3, P3740, DOI 10.3390/cancers3043740; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin EY, 2002, J MAMMARY GLAND BIOL, V7, P147, DOI 10.1023/A:1020399802795; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lombardo CR, 1995, BIOCHEMISTRY-US, V34, P16456, DOI 10.1021/bi00050a029; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mateus AR, 2007, HUM MOL GENET, V16, P1639, DOI 10.1093/hmg/ddm113; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Ohno S, 2003, ANTICANCER RES, V23, P5015; Ohta M, 2003, INT J ONCOL, V22, P773; Oliveira MJ, 2006, J BIOL CHEM, V281, P34888, DOI 10.1074/jbc.M607067200; Oliveira MI, 2012, EUR CELLS MATER, V24, P136, DOI 10.22203/eCM.v024a10; Oliveira MJ, 2005, J CANCER RES CLIN, V131, P49, DOI 10.1007/s00432-004-0601-8; Oliveira MJ, 2003, EMBO J, V22, P6161, DOI 10.1093/emboj/cdg586; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Piccolo E, 2002, ONCOGENE, V21, P6520, DOI 10.1038/sj.onc.1205821; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Sala G, 2008, CANCER RES, V68, P10187, DOI 10.1158/0008-5472.CAN-08-1181; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449	50	81	87	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 17	2014	33	16					2123	2133		10.1038/onc.2013.154	http://dx.doi.org/10.1038/onc.2013.154			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF3GH	23644655				2022-12-25	WOS:000334599100011
J	Arimori, T; Kawamoto, N; Shinya, S; Okazaki, N; Nakazawa, M; Miyatake, K; Fukamizo, T; Ueda, M; Tamada, T				Arimori, Takao; Kawamoto, Noriko; Shinya, Shoko; Okazaki, Nobuo; Nakazawa, Masami; Miyatake, Kazutaka; Fukamizo, Tamo; Ueda, Mitsuhiro; Tamada, Taro			Crystal Structures of the Catalytic Domain of a Novel Glycohydrolase Family 23 Chitinase from Ralstonia sp A-471 Reveals a Unique Arrangement of the Catalytic Residues for Inverting Chitin Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SEQUENCE SIMILARITIES; 2.0 ANGSTROM RESOLUTION; GOOSE-TYPE LYSOZYME; X-RAY-DIFFRACTION; GLYCOSYL HYDROLASES; HEVEA-BRASILIENSIS; ACTIVE-SITE; SUBSTRATE; COMPLEX; MECHANISMS	Chitinase C from Ralstonia sp. A-471 (Ra-ChiC) has a catalytic domain sequence similar to goose-type (G-type) lysozymes and, unlike other chitinases, belongs to glycohydrolase (GH) family 23. Using NMR spectroscopy, however, Ra-ChiC was found to interact only with the chitin dimer but not with the peptidoglycan fragment. Here we report the crystal structures of wild-type, E141Q, and E162Q of the catalytic domain of Ra-ChiC with or without chitin oligosaccharides. Ra-ChiC has a substrate-binding site including a tunnel-shaped cavity, which determines the substrate specificity. Mutation analyses based on this structural information indicated that a highly conserved Glu-141 acts as a catalytic acid, and that Asp-226 located at the roof of the tunnel activates a water molecule as a catalytic base. The unique arrangement of the catalytic residues makes a clear contrast to the other GH23 members and also to inverting GH19 chitinases.	[Arimori, Takao; Okazaki, Nobuo; Tamada, Taro] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Tokai, Ibaraki 3191195, Japan; [Kawamoto, Noriko; Nakazawa, Masami; Miyatake, Kazutaka; Ueda, Mitsuhiro] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 5998531, Japan; [Shinya, Shoko; Fukamizo, Tamo] Kinki Univ, Dept Adv Biosci, Nara, Nara 6318505, Japan	Japan Atomic Energy Agency; Osaka Metropolitan University; Kindai University (Kinki University)	Tamada, T (corresponding author), Japan Atom Energy Agcy, Quantum Beam Sci Directorate, 2-4 Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	tamada.taro@jaea.go.jp	Fukamizo, Tamo/AAY-7251-2020	Okazaki, Nobuo/0000-0003-3553-2894; Tamada, Taro/0000-0003-1419-8022; Arimori, Takao/0000-0002-6063-5572				Bokma E, 1997, FEBS LETT, V411, P161, DOI 10.1016/S0014-5793(97)00682-0; BOLLER T, 1983, PLANTA, V157, P22, DOI 10.1007/BF00394536; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Guerin DMA, 2002, J MOL BIOL, V316, P1061, DOI 10.1006/jmbi.2001.5404; HART PJ, 1995, J MOL BIOL, V248, P402, DOI 10.1006/jmbi.1995.0230; Helland R, 2009, CELL MOL LIFE SCI, V66, P2585, DOI 10.1007/s00018-009-0063-x; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HOLM L, 1994, FEBS LETT, V340, P129, DOI 10.1016/0014-5793(94)80187-8; Huet J, 2008, BIOCHEMISTRY-US, V47, P8283, DOI 10.1021/bi800655u; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Iseli B, 1996, FEBS LETT, V382, P186, DOI 10.1016/0014-5793(96)00174-3; JEKEL PA, 1991, EUR J BIOCHEM, V200, P123, DOI 10.1111/j.1432-1033.1991.tb21057.x; Karlsen S, 1996, ACTA CRYSTALLOGR D, V52, P105, DOI 10.1107/S0907444995008468; Kawamura S, 2006, J BIOCHEM, V140, P75, DOI 10.1093/jb/mvj125; Kezuka Y, 2006, J MOL BIOL, V358, P472, DOI 10.1016/j.jmb.2006.02.013; Kim SK, 2005, CARBOHYD POLYM, V62, P357, DOI 10.1016/j.carbpol.2005.08.012; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Monzingo AF, 1996, NAT STRUCT BIOL, V3, P133, DOI 10.1038/nsb0296-133; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muzzarelli RAA, 1999, EXS, V87, P293; Okazaki N, 2011, ACTA CRYSTALLOGR F, V67, P494, DOI 10.1107/S1744309111004751; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsiegla G, 1998, EMBO J, V17, P5551, DOI 10.1093/emboj/17.19.5551; Petersen L, 2009, J PHYS CHEM B, V113, P7331, DOI 10.1021/jp811470d; Song HK, 1996, ACTA CRYSTALLOGR D, V52, P289, DOI 10.1107/S0907444995009061; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; Tamada T, 2004, ACTA CRYSTALLOGR D, V60, P13, DOI 10.1107/S0907444903020778; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueda M, 2003, EUR J BIOCHEM, V270, P2513, DOI 10.1046/j.1432-1033.2003.03624.x; Ueda M, 2009, APPL MICROBIOL BIOT, V81, P1077, DOI 10.1007/s00253-008-1676-y; VANSCHELTINGA ACT, 1994, STRUCTURE, V2, P1181, DOI 10.1016/S0969-2126(94)00120-0; Watanabe T, 1999, MICROBIOL-SGM, V145, P3353, DOI 10.1099/00221287-145-12-3353; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Wohlkonig A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015388	45	26	29	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18696	18706		10.1074/jbc.M113.462135	http://dx.doi.org/10.1074/jbc.M113.462135			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658014	Green Published, hybrid			2022-12-25	WOS:000321335800006
J	Basurto-Islas, G; Grundke-Iqbal, I; Tung, YC; Liu, F; Iqbal, K				Basurto-Islas, Gustavo; Grundke-Iqbal, Inge; Tung, Yunn Chyn; Liu, Fei; Iqbal, Khalid			Activation of Asparaginyl Endopeptidase Leads to Tau Hyperphosphorylation in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; FOCAL CEREBRAL-ISCHEMIA; ABNORMAL HYPERPHOSPHORYLATION; OXIDATIVE STRESS; SET; LEGUMAIN; BRAIN; INHIBITORS; PHOSPHORYLATION; DEGRADATION	Neurofibrillary pathology of abnormally hyperphosphorylated Tau is a key lesion of Alzheimer disease and other tauopathies, and its density in the brain directly correlates with dementia. The phosphorylation of Tau is regulated by protein phosphatase 2A, which in turn is regulated by inhibitor 2, I-2(PP2A). In acidic conditions such as generated by brain ischemia and hypoxia, especially in association with hyperglycemia as in diabetes, I-2(PP2A) is cleaved by asparaginyl endopeptidase at Asn-175 into the N-terminal fragment (I-2(PP2A)) and the C-terminal fragment (I-2CTF). Both I-2NTF and I-2CTF are known to bind to the catalytic subunit of protein phosphatase 2A and inhibit its activity. Here we show that the level of activated asparaginyl endopeptidase is significantly increased, and this enzyme and I-2(PP2A) translocate, respectively, from neuronal lysosomes and nucleus to the cytoplasm where they interact and are associated with hyperphosphorylated Tau in Alzheimer disease brain. Asparaginyl endopeptidase from Alzheimer disease brain could cleave GST-I-2(PP2A), except when I-2(PP2A) was mutated at the cleavage site Asn-175 to Gln. Finally, an induction of acidosis by treatment with kainic acid or pH 6.0 medium activated asparaginyl endopeptidase and consequently produced the cleavage of I-2(PP2A), inhibition of protein phosphatase 2A, and hyperphosphorylation of Tau, and the knockdown of asparaginyl endopeptidase with siRNA abolished this pathway in SH-SY5Y cells. These findings suggest the involvement of brain acidosis in the etiopathogenesis of Alzheimer disease, and asparaginyl endopeptidase-I-2(PP2A)-protein phosphatase 2A-Tau hyperphosphorylation pathway as a therapeutic target.	[Basurto-Islas, Gustavo; Grundke-Iqbal, Inge; Tung, Yunn Chyn; Liu, Fei; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA	Institute for Basic Research in Developmental Disabilities	Iqbal, K (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	khalid.iqbal.ibr@gmail.com		Basurto-Islas, Gustavo/0000-0002-9401-140X	National Institutes of Health Grant [AG019158]; New York State Office of People with Developmental Disabilities; NATIONAL INSTITUTE ON AGING [R01AG019158] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Office of People with Developmental Disabilities; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG019158. This work was also supported by the New York State Office of People with Developmental Disabilities.	ADACHI Y, 1994, J BIOL CHEM, V269, P2258; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Andrade V, 2011, J HEPATOL, V55, P626, DOI 10.1016/j.jhep.2010.12.022; Arnaud L, 2011, FEBS LETT, V585, P2653, DOI 10.1016/j.febslet.2011.07.020; Back T, 2000, ANN NEUROL, V47, P485, DOI 10.1002/1531-8249(200004)47:4<485::AID-ANA12>3.3.CO;2-#; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Castellani RJ, 2004, AGEING RES REV, V3, P319, DOI 10.1016/j.arr.2004.01.002; CATALDO AM, 1990, BRAIN RES, V513, P181, DOI 10.1016/0006-8993(90)90456-L; CATALDO AM, 1991, P NATL ACAD SCI USA, V88, P10998, DOI 10.1073/pnas.88.24.10998; Chen JM, 2001, BIOL CHEM, V382, P777, DOI 10.1515/BC.2001.093; Chen JM, 2000, BIOCHEM J, V352, P327, DOI 10.1042/0264-6021:3520327; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Clerin V, 2008, ATHEROSCLEROSIS, V201, P53, DOI 10.1016/j.atherosclerosis.2008.01.016; Compagnone NA, 2000, MOL ENDOCRINOL, V14, P875, DOI 10.1210/me.14.6.875; Fang BY, 2010, INT J NEUROSCI, V120, P591, DOI 10.3109/00207454.2010.505353; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; Gong CX, 2001, BRAIN RES PROTOC, V6, P134, DOI 10.1016/S1385-299X(00)00046-5; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; Graham JM, 2001, CURRENT PROTOCOLS CE, V3, P1; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Halfon S, 1998, FEBS LETT, V438, P114, DOI 10.1016/S0014-5793(98)01281-2; Iqbal K, 2005, ANN NEUROL, V58, P748, DOI 10.1002/ana.20639; Ishizaki T, 2010, J CEREBR BLOOD F MET, V30, P1756, DOI 10.1038/jcbfm.2010.39; Katayose Y, 2000, J BIOL CHEM, V275, P9209, DOI 10.1074/jbc.275.13.9209; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Lam BD, 2012, CYTOM PART A, V81A, P81, DOI 10.1002/cyto.a.21153; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Liu C, 2003, CANCER RES, V63, P2957; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Miura Y, 2010, BIOL PHARM BULL, V33, P22, DOI 10.1248/bpb.33.22; MORGAN JM, 1994, J PATHOL, V174, P301, DOI 10.1002/path.1711740410; Morita Y, 2007, FEBS LETT, V581, P1417, DOI 10.1016/j.febslet.2007.02.064; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Pirchl M, 2009, NEUROPSYCHIATRIE, V23, P187; Pivtoraiko VN, 2009, ANTIOXID REDOX SIGN, V11, P481, DOI [10.1089/ars.2008.2263, 10.1089/ARS.2008.2263]; Pratt MR, 2009, CHEM BIOL, V16, P1001, DOI 10.1016/j.chembiol.2009.07.011; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Tsujio I, 2005, FEBS LETT, V579, P363, DOI 10.1016/j.febslet.2004.11.097; TURK B, 1993, BIOCHEMISTRY-US, V32, P375, DOI 10.1021/bi00052a046; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wang XC, 2010, FASEB J, V24, P4420, DOI 10.1096/fj.10-158477; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Wu BH, 2010, J BIOL CHEM, V285, P1790, DOI 10.1074/jbc.M109.049064; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; YATES CM, 1990, J NEUROCHEM, V55, P1624, DOI 10.1111/j.1471-4159.1990.tb04948.x	57	76	76	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17495	17507		10.1074/jbc.M112.446070	http://dx.doi.org/10.1074/jbc.M112.446070			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640887	Green Published, hybrid			2022-12-25	WOS:000320380600041
J	Gaitonde, P; Ramakrishnan, R; Chin, J; Kelleher, RJ; Bankert, RB; Balu-Iyer, SV				Gaitonde, Puneet; Ramakrishnan, Radha; Chin, Jamie; Kelleher, Raymond J., Jr.; Bankert, Richard B.; Balu-Iyer, Sathy V.			Exposure to Factor VIII Protein in the Presence of Phosphatidylserine Induces Hypo-responsiveness toward Factor VIII Challenge in Hemophilia A Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLEROGENIC DENDRITIC CELLS; REGULATORY T-CELL; TGF-BETA; TOLERANCE; INHIBITORS; IMMUNITY; MECHANISMS; THERAPY	Administration of recombinant factor VIII (FVIII), an important co-factor in blood clotting cascade, elicits unwanted anti-FVIII antibodies in hemophilia A (HA) patients. Previously, FVIII associated with phosphatidylserine (PS) showed significant reduction in the anti-FVIII antibody response in HA mice. The reduction in the immune response to FVIII-PS could be due either to a failure of the immune system to recognize the antigen (i.e. immunological ignorance) or to an active induction of an antigen-specific nonresponsiveness (i.e. immunological tolerance). If it were a result of tolerance, one would predict that pre-exposure to FVIII-PS would render the mice hypo-responsive to a subsequent FVIII challenge. Here, we have demonstrated that naive HA mice that were pretreated with FVIII-PS showed a significantly reduced FVIII immune response to further challenge with native FVIII and that this decreased responsiveness could be adoptively transferred to other mice. An increase in number of FoxP3-expressing CD4(+) regulatory T-cells (Treg) was observed for the FVIII-PS-immunized group as compared with animals that received FVIII alone, suggesting the involvement of Treg in PS-mediated hypo-responsiveness. The PS-mediated reduction in antibody response was reversed by the co-administration of function-blocking anti-TGF-beta antibody with FVIII-PS. The decreased response to FVIII induced by FVIII-PS was determined to be antigen-specific because the immune response to another non-cross-reactive antigen (ovalbumin) was not altered. These results are consistent with the notion that FVIII-PS is tolerogenic and suggest that immunization with this tolerogenic form of the protein could be a useful treatment option to minimize immunogenicity of FVIII and other protein-based therapeutics.	[Gaitonde, Puneet; Ramakrishnan, Radha; Chin, Jamie; Balu-Iyer, Sathy V.] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14214 USA; [Kelleher, Raymond J., Jr.; Bankert, Richard B.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Balu-Iyer, SV (corresponding author), SUNY Buffalo, Dept Pharmaceut Sci, 359 Kapoor Hall, Buffalo, NY 14214 USA.	svb@buffalo.edu	Ramakrishnan, Radha/AAC-2464-2020		National Institutes of Health [R01 HL-70227]; NATIONAL CANCER INSTITUTE [R01CA131407, R01CA108970] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL-70227 (to S. V. B.).	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gaitonde P, 2011, CLIN IMMUNOL, V138, P135, DOI 10.1016/j.clim.2010.10.006; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lollar P, 2001, ADV EXP MED BIOL, V489, P65; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Purohit VS, 2005, J BIOL CHEM, V280, P17593, DOI 10.1074/jbc.M500163200; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Ramani K, 2008, J PHARM SCI-US, V97, P1386, DOI 10.1002/jps.21102; Skupsky J, 2010, CURR OPIN MOL THER, V12, P509; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Su RJ, 2011, MOL THER, V19, P1896, DOI 10.1038/mt.2011.134; Sule G, 2012, HUM GENE THER, V23, P769, DOI 10.1089/hum.2011.225; VERBRUGGEN B, 1995, THROMB HAEMOSTASIS, V73, P247; Wan YY, 2008, J CLIN IMMUNOL, V28, P647, DOI 10.1007/s10875-008-9251-y; Waters B, 2009, J THROMB HAEMOST, V7, P1446, DOI 10.1111/j.1538-7836.2009.03538.x; Wiestner A, 2002, BLOOD, V100, P3426, DOI 10.1182/blood-2002-03-0765; Zhang AH, 2011, BLOOD, V117, P2223, DOI 10.1182/blood-2010-06-293324	20	22	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17051	17056		10.1074/jbc.C112.396325	http://dx.doi.org/10.1074/jbc.C112.396325			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23649621	Green Published, hybrid			2022-12-25	WOS:000320380600001
J	Wiseman, SL; Shimizu, Y; Palfrey, C; Nairn, AC				Wiseman, Shari L.; Shimizu, Yoshio; Palfrey, Clive; Nairn, Angus C.			Proteasomal Degradation of Eukaryotic Elongation Factor-2 Kinase (EF2K) Is Regulated by cAMP-PKA Signaling and the SCF beta TRCP Ubiquitin E3 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; TRANSLATIONAL CONTROL; MTOR INHIBITOR; PC12 CELLS; FACTOR-II; PHOSPHORYLATION; MEMORY; ACTIVATION; DEPTOR; GROWTH	Protein translation and degradation are critical for proper protein homeostasis, yet it remains unclear how these processes are dynamically regulated, or how they may directly balance or synergize with each other. An important translational control mechanism is the Ca2+/calmodulin-dependent phosphorylation of eukaryotic elongation factor-2 (eEF-2) by eukaryotic elongation factor-2 kinase (EF2K), which inhibits elongation of nascent polypeptide chains during translation. We previously described a reduction of EF2K activity in PC12 cells treated with NGF or forskolin. Here, we show that both forskolin- and IGF-1-mediated reductions of EF2K activity in PC12 cells are due to decreased EF2K protein levels, and this is attenuated by application of the proteasome inhibitor, MG132. We further demonstrate that proteasome-mediated degradation of EF2K occurs in response to A2A-type adenosine receptor stimulation, and that activation of protein kinase A (PKA) or phospho-mimetic mutation of the previously characterized PKA site, Ser-499, were sufficient to induce EF2K turnover in PC12 cells. A similar EF2K degradation mechanism was observed in primary neurons and HEK cells. Expression of a dominant-negative form of Cul1 in HEK cells demonstrated that EF2K levels are regulated by an SCF-type ubiquitin E3 ligase. Specifically, EF2K binds to the F-box proteins, beta TRCP1 and beta TRCP2, and beta TRCP regulates EF2K levels and polyubiquitylation. We propose that the proteasomal degradation of EF2K provides a mechanistic link between activity-dependent protein synthesis and degradation.	[Wiseman, Shari L.; Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; [Shimizu, Yoshio] Mannari Hosp, Dept Psychiat, Okayama 7000071, Japan; [Palfrey, Clive] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Yale University; University of Chicago	Nairn, AC (corresponding author), Yale Univ, Sch Med, Dept Psychiat, 34 Pk St, New Haven, CT 06508 USA.	angus.nairn@yale.edu		Nairn, Angus/0000-0002-7075-0195; Wiseman, Shari/0000-0001-7868-9723	National Institutes of Health [DA018343, DA10044, 1F31 DA029361]; State of Connecticut, Department of Mental Health and Addiction Services; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343, F31DA029361, P01DA010044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Connecticut, Department of Mental Health and Addiction Services; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA018343 and DA10044 (to A. C. N.) and 1F31 DA029361 (to S. L. W.). Support was also obtained from the State of Connecticut, Department of Mental Health and Addiction Services.	Arora S, 2005, CANCER RES, V65, P3806, DOI 10.1158/0008-5472.CAN-04-4036; Artinian J, 2008, EUR J NEUROSCI, V27, P3009, DOI 10.1111/j.1460-9568.2008.06262.x; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; BRADY MJ, 1990, J NEUROCHEM, V54, P1034, DOI 10.1111/j.1471-4159.1990.tb02354.x; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Diggle TA, 2001, BIOCHEM J, V353, P621, DOI 10.1042/0264-6021:3530621; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; Kruiswijk F, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002718; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; MACKIE KP, 1989, J BIOL CHEM, V264, P1748; Marin P, 1997, J NEUROSCI, V17, P3445; MITSUI K, 1993, J BIOL CHEM, V268, P13422; Nairn AC, 2001, PROG MOLEC, V27, P91; NAIRN AC, 1987, J BIOL CHEM, V262, P14265; PALFREY HC, 1987, J BIOL CHEM, V262, P9785; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; REDPATH NT, 1993, BIOCHEM J, V293, P31, DOI 10.1042/bj2930031; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Setoyama D, 2007, P NATL ACAD SCI USA, V104, P18001, DOI 10.1073/pnas.0706952104; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wiseman S. L., 2009, HDB CELL SIGNALING, P587; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029	39	13	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17803	17811		10.1074/jbc.M113.477182	http://dx.doi.org/10.1074/jbc.M113.477182			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640883	Green Published, hybrid			2022-12-25	WOS:000320380600069
J	Brotons, L; Aquilue, N; de Caceres, M; Fortin, MJ; Fall, A				Brotons, Lluis; Aquilue, Nuria; de Caceres, Miquel; Fortin, Marie-Josee; Fall, Andrew			How Fire History, Fire Suppression Practices and Climate Change Affect Wildfire Regimes in Mediterranean Landscapes	PLOS ONE			English	Article							CATALONIA NE SPAIN; MANAGEMENT STRATEGIES; BOREAL FORESTS; WILDLAND FIRE; MODELS; DYNAMICS; FUELS; RISK; REEXAMINATION; ECOSYSTEMS	Available data show that future changes in global change drivers may lead to an increasing impact of fires on terrestrial ecosystems worldwide. Yet, fire regime changes in highly humanised fire-prone regions are difficult to predict because fire effects may be heavily mediated by human activities We investigated the role of fire suppression strategies in synergy with climate change on the resulting fire regimes in Catalonia (north-eastern Spain). We used a spatially-explicit fire-succession model at the landscape level to test whether the use of different firefighting opportunities related to observed reductions in fire spread rates and effective fire sizes, and hence changes in the fire regime. We calibrated this model with data from a period with weak firefighting and later assess the potential for suppression strategies to modify fire regimes expected under different levels of climate change. When comparing simulations with observed fire statistics from an eleven-year period with firefighting strategies in place, our results showed that, at least in two of the three sub-regions analysed, the observed fire regime could not be reproduced unless taking into account the effects of fire suppression. Fire regime descriptors were highly dependent on climate change scenarios, with a general trend, under baseline scenarios without fire suppression, to large-scale increases in area burnt. Fire suppression strategies had a strong capacity to compensate for climate change effects. However, strong active fire suppression was necessary to accomplish such compensation, while more opportunistic fire suppression strategies derived from recent fire history only had a variable, but generally weak, potential for compensation of enhanced fire impacts under climate change. The concept of fire regime in the Mediterranean is probably better interpreted as a highly dynamic process in which the main determinants of fire are rapidly modified by changes in landscape, climate and socioeconomic factors such as fire suppression strategies.	[Brotons, Lluis; Aquilue, Nuria; de Caceres, Miquel] CTFC, Area Biodiversitat, Grp Ecol Paisatge, Solsona, Catalonia, Spain; [Brotons, Lluis; Aquilue, Nuria; de Caceres, Miquel] CREAF, Bellaterra, Spain; [Fortin, Marie-Josee] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Fall, Andrew] Simon Fraser Univ, Lasqueti, BC, Canada; [Fall, Andrew] Gowlland Technol Ltd, Lasqueti, BC, Canada	Centre Tecnologic Forestal de Catalunya (CTFC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Toronto; Simon Fraser University	Brotons, L (corresponding author), CTFC, Area Biodiversitat, Grp Ecol Paisatge, Solsona, Catalonia, Spain.	lluis.brotons@ctfc.cat	Aquilué, Núria/AAA-6149-2020; Brotons, Lluís/D-1570-2009; De Caceres, Miquel/I-1279-2016	Aquilué, Núria/0000-0001-7911-3144; Brotons, Lluís/0000-0002-4826-4457; De Caceres, Miquel/0000-0001-7132-2080	Spanish Ministry of Education and Science (MEC) [CGL2008-05506-C02-01/BOS, CGL2011-29539/BOS, CSD2008-00040]; Catalan government [2010 BE 272]; 'Beatriu de Pinos' Programme [2009 BP-B 00342]	Spanish Ministry of Education and Science (MEC)(Spanish Government); Catalan government; 'Beatriu de Pinos' Programme	This study has received financial support from the projects CGL2008-05506-C02-01/BOS, CGL2011-29539/BOS and Consolider Montes CSD2008-00040 granted by the Spanish Ministry of Education and Science (MEC). Additional funding to LB and MC was received from the Catalan government through projects 2010 BE 272 and the 'Beatriu de Pinos' Programme (2009 BP-B 00342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 01886174.	Arienti MC, 2006, CAN J FOREST RES, V36, P3155, DOI 10.1139/X06-188; BAKER WL, 1992, ECOLOGY, V73, P1879, DOI 10.2307/1940039; Bridge SRJ, 2005, FOREST SCI, V51, P41; Brotons L, 2005, J BIOGEOGR, V32, P789, DOI 10.1111/j.1365-2699.2004.01195.x; Castellnou M, 2009, P 5 C FOR ESP AV SPA; Cui W, 2008, INT J WILDLAND FIRE, V17, P234, DOI 10.1071/WF06145; Cumming SG, 2005, CAN J FOREST RES, V35, P772, DOI 10.1139/X04-174; DeWilde L, 2006, ECOSYSTEMS, V9, P1342, DOI 10.1007/s10021-006-0095-0; Diaz-Delgado R, 2004, LANDSCAPE ECOL, V19, P731, DOI 10.1007/s10980-005-0183-1; Diaz-Delgado R, 2004, INT J WILDLAND FIRE, V13, P89, DOI 10.1071/WF02051; Fall A, 2004, CAN J FOREST RES, V34, P310, DOI [10.1139/x03-143, 10.1139/X03-143]; Fall A, 2001, ECOL MODEL, V141, P1, DOI 10.1016/S0304-3800(01)00334-9; Flannigan MD, 2009, INT J WILDLAND FIRE, V18, P483, DOI 10.1071/WF08187; Gill AM, 2008, INT J WILDLAND FIRE, V17, P688, DOI 10.1071/WF07145; Gonzalez JR, 2007, EUR J FOREST RES, V126, P421, DOI 10.1007/s10342-006-0164-0; Gracia C, 2000, INVENTARI ECOLOGIC F; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hessl AE, 2011, PROG PHYS GEOG, V35, P393, DOI 10.1177/0309133311407654; Ibanez J. J., 2002, PERSPECTIVES TERRITO, V3, P10; James PMA, 2007, ECOSYSTEMS, V10, P1261, DOI 10.1007/s10021-007-9095-y; Keane RE, 2004, ECOL MODEL, V179, P3, DOI 10.1016/j.ecolmodel.2004.03.015; Keeley JE, 1999, SCIENCE, V284, P1829, DOI 10.1126/science.284.5421.1829; Lindenmayer DB, 2011, P NATL ACAD SCI USA, V108, P15887, DOI 10.1073/pnas.1110245108; Lloret F, 2007, ECOLOGY, V88, P2270, DOI 10.1890/06-1195.1; Lloret F, 2001, FOREST ECOL MANAG, V141, P155, DOI 10.1016/S0378-1127(00)00323-6; Loepfe L, 2011, ENVIRON MODELL SOFTW, V26, P1028, DOI 10.1016/j.envsoft.2011.02.015; Minnich RA, 2001, CONSERV BIOL, V15, P1549, DOI 10.1046/j.1523-1739.2001.01067.x; Miyanishi K, 2001, CAN J FOREST RES, V31, P1462, DOI 10.1139/cjfr-31-8-1462; Mladenoff DJ, 2004, ECOL MODEL, V180, P7, DOI 10.1016/j.ecolmodel.2004.03.016; Moghaddas JJ, 2007, INT J WILDLAND FIRE, V16, P673, DOI 10.1071/WF06066; Moreira F, 2011, J ENVIRON MANAGE, V92, P2389, DOI 10.1016/j.jenvman.2011.06.028; Moriondo M, 2006, CLIM RES, V31, P85, DOI 10.3354/cr031085; Moritz MA, 2003, ECOLOGY, V84, P351, DOI 10.1890/0012-9658(2003)084[0351:SAOCOS]2.0.CO;2; Mouillot F, 2003, LANDSCAPE ECOL, V18, P665, DOI 10.1023/B:LAND.0000004182.22525.a9; Pausas JG, 2012, GLOBAL ECOL BIOGEOGR; Pausas JG, 2011, CLIMATIC CHANGE, P1, DOI [10.1007/s10584-011-0060-6, DOI 10.1007/S10584-011-0060-6]; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Pechony O, 2010, P NATL ACAD SCI USA, V107, P19167, DOI 10.1073/pnas.1003669107; Peix J., 1999, FOC VERD 2 PROGRAMA; Pennanen J, 2002, FOREST ECOL MANAG, V164, P157, DOI 10.1016/S0378-1127(01)00608-9; Perry GLW, 2006, PROG PHYS GEOG, V30, P47, DOI 10.1191/0309133306pp469ra; Pinol J, 1998, CLIMATIC CHANGE, V38, P345, DOI 10.1023/A:1005316632105; Pinol J, 2005, ECOL MODEL, V183, P397, DOI 10.1016/j.ecolmodel.2004.09.001; Pinol J, 2007, ECOL MODEL, V207, P34, DOI 10.1016/j.ecolmodel.2007.03.020; Podur J, 2010, ECOL MODEL, V221, P1301, DOI 10.1016/j.ecolmodel.2010.01.013; Preisler HK, 2011, INT J WILDLAND FIRE, V20, P508, DOI 10.1071/WF09087; Rodrigo A, 2004, ECOLOGY, V85, P716, DOI 10.1890/02-0492; Rothermel R., 1972, MATH MODEL PREDICTIN; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Schoennagel T, 2008, INT J WILDLAND FIRE, V17, P742, DOI 10.1071/WF07146; Sharples JJ, 2010, ENVIRON MODELL SOFTW, V25, P1099, DOI 10.1016/j.envsoft.2010.03.016; Sturtevant BR, 2009, ECOSYSTEMS, V12, P445, DOI 10.1007/s10021-009-9234-8; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Telesca L, 2010, NAT HAZARD EARTH SYS, V10, P723, DOI 10.5194/nhess-10-723-2010; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Vallecillo S, 2009, ECOL APPL, V19, P538, DOI 10.1890/08-0348.1; Villanueva JA, 2004, TERCER INVENTARIO FO; Wang Z, 2010, SCIENCE, V330, P1663, DOI 10.1126/science.1197257; Ward PC, 2001, CAN J FOREST RES, V31, P1467, DOI 10.1139/cjfr-31-8-1467	60	118	120	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62392	10.1371/journal.pone.0062392	http://dx.doi.org/10.1371/journal.pone.0062392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658726	gold, Green Submitted, Green Published			2022-12-25	WOS:000321200500025
J	Buarque, DS; Braz, GRC; Martins, RM; Tanaka-Azevedo, AM; Gomes, CM; Oliveira, FAA; Schenkman, S; Tanaka, AS				Buarque, Diego S.; Braz, Gloria R. C.; Martins, Rafael M.; Tanaka-Azevedo, Anita M.; Gomes, Cicera M.; Oliveira, Felipe A. A.; Schenkman, Sergio; Tanaka, Aparecida S.			Differential Expression Profiles in the Midgut of Triatoma infestans Infected with Trypanosoma cruzi	PLOS ONE			English	Article							RHODNIUS-PROLIXUS; BLOODSUCKING BUG; SEQUENCE CHARACTERIZATION; BRASILIENSIS HEMIPTERA; THROMBIN INHIBITOR; SALIVARY-GLANDS; VECTOR; IDENTIFICATION; DATABASE; INSECT	Chagas disease, or American trypanosomiasis, is a parasitic disease caused by the protozoan Trypanosoma cruzi and is transmitted by insects from the Triatominae subfamily. To identify components involved in the protozoan-vector relationship, we constructed and analyzed cDNA libraries from RNA isolated from the midguts of uninfected and T. cruzi-infected Triatoma infestans, which are major vectors of Chagas disease. We generated approximately 440 high-quality Expressed Sequence Tags (ESTs) from each T. infestans midgut cDNA library. The sequences were grouped in 380 clusters, representing an average length of 664.78 base pairs (bp). Many clusters were not classified functionally, representing unknown transcripts. Several transcripts involved in different processes (e. g., detoxification) showed differential expression in response to T. cruzi infection. Lysozyme, cathepsin D, a nitrophorin-like protein and a putative 14 kDa protein were significantly upregulated upon infection, whereas thioredoxin reductase was downregulated. In addition, we identified several transcripts related to metabolic processes or immunity with unchanged expressions, including infestin, lipocalins and defensins. We also detected ESTs encoding juvenile hormone binding protein (JHBP), which seems to be involved in insect development and could be a target in control strategies for the vector. This work demonstrates differential gene expression upon T. cruzi infection in the midgut of T. infestans. These data expand the current knowledge regarding vector-parasite interactions for Chagas disease.	[Buarque, Diego S.; Oliveira, Felipe A. A.; Tanaka, Aparecida S.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biochem, Sao Paulo, Brazil; [Braz, Gloria R. C.] Univ Fed Rio de Janeiro, Inst Quim, Dept Biochem, Rio De Janeiro, Brazil; [Martins, Rafael M.] Inst Pasteur, Biol Host Parasite Interact Unit, Paris, France; [Tanaka-Azevedo, Anita M.; Gomes, Cicera M.] Inst Butantan, Lab Herpetol, Sao Paulo, Brazil; [Schenkman, Sergio] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP)	Tanaka, AS (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Biochem, Sao Paulo, Brazil.	tanaka.bioq@epm.br	Schenkman, Sergio/A-9227-2013; Tanaka, Aparecida/ADF-5338-2022; Azevedo, Anita M Tanaka/B-3429-2014; Tanaka, Aparecida S/L-8754-2017; Buarque, Diego S/C-9803-2012	Schenkman, Sergio/0000-0001-9353-8480; Azevedo, Anita M Tanaka/0000-0002-4694-4475; Tanaka, Aparecida S/0000-0001-9407-805X; miyazawa martins, rafael/0000-0001-7449-0696	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/03514-9, 2007/58973-3, 2012/00723-0, 2012/03657-8]; Conselho Nacional de Desenvolvimento Tecnologico (CNPq); INCT - Entomologia Molecular	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT - Entomologia Molecular	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Proc. no. 2005/03514-9; Proc no. 2007/58973-3; Proc. no. 2012/00723-0 and Proc. no. 2012/03657-8), Conselho Nacional de Desenvolvimento Tecnologico (CNPq), and INCT - Entomologia Molecular. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2007, MICROBE; Araujo CAC, 2006, INSECT BIOCHEM MOLEC, V36, P547, DOI 10.1016/j.ibmb.2006.04.003; Araujo RN, 2007, INT J PARASITOL, V37, P1351, DOI 10.1016/j.ijpara.2007.04.017; Ascenzi P, 2002, IUBMB LIFE, V53, P121, DOI [10.1080/10399710290039016, 10.1080/15216540211472]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assumpcao TCF, 2008, INSECT BIOCHEM MOLEC, V38, P213, DOI 10.1016/j.ibmb.2007.11.001; Avila ML, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-39; Balczun C, 2012, INSECT BIOCHEM MOLEC, V42, P240, DOI 10.1016/j.ibmb.2011.12.006; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Blanco E, 2002, CURRENT PROTOCOLS BI; Buarque DS, 2011, BIOCHEM BIOPH RES CO, V413, P241, DOI 10.1016/j.bbrc.2011.08.078; Bussacos ACM, 2011, J PROTEOMICS, V74, P1693, DOI 10.1016/j.jprot.2011.04.028; Campos ITN, 2004, FEBS LETT, V577, P512, DOI 10.1016/j.febslet.2004.10.052; Campos ITN, 2002, INSECT BIOCHEM MOLEC, V32, P991, DOI 10.1016/S0965-1748(02)00035-8; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; FuentesPrior P, 1997, P NATL ACAD SCI USA, V94, P11845, DOI 10.1073/pnas.94.22.11845; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Guo YJ, 2009, BIOINFORMATICS, V25, P1195, DOI 10.1093/bioinformatics/btp129; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kato H, 2010, INFECT GENET EVOL, V10, P184, DOI 10.1016/j.meegid.2009.10.012; Kollien AH, 1998, AM J TROP MED HYG, V59, P166, DOI 10.4269/ajtmh.1998.59.166; Kollien AH, 2003, ARCH INSECT BIOCHEM, V53, P134, DOI 10.1002/arch.10090; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez L, 2003, INSECT BIOCHEM MOLEC, V33, P439, DOI 10.1016/S0965-1748(03)00008-0; Lovato DV, 2011, EXP PARASITOL, V129, P362, DOI 10.1016/j.exppara.2011.09.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Medeiros MN, 2011, INSECT BIOCHEM MOLEC, V41, P823, DOI 10.1016/j.ibmb.2011.06.004; MELLO CB, 1995, J INVERTEBR PATHOL, V65, P261, DOI 10.1006/jipa.1995.1040; Mesquita RD, 2008, INFECT IMMUN, V76, P5543, DOI 10.1128/IAI.00683-08; Paes Marcia Cristina, 2011, Journal of Parasitology Research, V2011, DOI 10.1155/2011/174614; Piacenza L, 2012, ANTIOXID RE IN PRESS; Raj PA, 2002, FEMS MICROBIOL LETT, V206, P9, DOI 10.1111/j.1574-6968.2002.tb10979.x; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos A, 2007, INSECT BIOCHEM MOLEC, V37, P702, DOI 10.1016/j.ibmb.2007.04.004; Scharfstein Julio, 2008, V47, P140; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Ursic-Bedoya R, 2011, INSECT MOL BIOL, V20, P775, DOI 10.1111/j.1365-2583.2011.01107.x; Ursic-Bedoya RJ, 2008, J INSECT PHYSIOL, V54, P593, DOI 10.1016/j.jinsphys.2007.12.009; Ursic-Bedoya RJ, 2007, DEV COMP IMMUNOL, V31, P109, DOI 10.1016/j.dci.2006.05.008; Waniek PJ, 2011, VECTOR-BORNE ZOONOT, V11, P845, DOI 10.1089/vbz.2010.0020; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; [No title captured]; [No title captured]	51	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61203	10.1371/journal.pone.0061203	http://dx.doi.org/10.1371/journal.pone.0061203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658688	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500005
J	Morisset, D; Stebih, D; Milavec, M; Gruden, K; Zel, J				Morisset, Dany; Stebih, Dejan; Milavec, Mojca; Gruden, Kristina; Zel, Jana			Quantitative Analysis of Food and Feed Samples with Droplet Digital PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENETICALLY-MODIFIED ORGANISMS; MODIFIED MAIZE EVENTS; DNA COPY NUMBER; MULTIPLEX PCR; QUANTIFICATION	In this study, the applicability of droplet digital PCR (ddPCR) for routine analysis in food and feed samples was demonstrated with the quantification of genetically modified organisms (GMOs). Real-time quantitative polymerase chain reaction (qPCR) is currently used for quantitative molecular analysis of the presence of GMOs in products. However, its use is limited for detecting and quantifying very small numbers of DNA targets, as in some complex food and feed matrices. Using ddPCR duplex assay, we have measured the absolute numbers of MON810 transgene and hmg maize reference gene copies in DNA samples. Key performance parameters of the assay were determined. The ddPCR system is shown to offer precise absolute and relative quantification of targets, without the need for calibration curves. The sensitivity (five target DNA copies) of the ddPCR assay compares well with those of individual qPCR assays and of the chamber digital PCR (cdPCR) approach. It offers a dynamic range over four orders of magnitude, greater than that of cdPCR. Moreover, when compared to qPCR, the ddPCR assay showed better repeatability at low target concentrations and a greater tolerance to inhibitors. Finally, ddPCR throughput and cost are advantageous relative to those of qPCR for routine GMO quantification. It is thus concluded that ddPCR technology can be applied for routine quantification of GMOs, or any other domain where quantitative analysis of food and feed samples is needed.	[Morisset, Dany; Stebih, Dejan; Milavec, Mojca; Gruden, Kristina; Zel, Jana] Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia	National Institute of Biology - Slovenia	Morisset, D (corresponding author), Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia.	dany.morisset@nib.si	Gruden, kristina/AAI-6439-2020; Milavec, Mojca/AAM-2674-2020	Milavec, Mojca/0000-0002-5794-2109; Morisset, Dany/0000-0001-8967-9424; gruden, kristina/0000-0001-5906-8569	Slovenian Research Agency [P4 0165]; Slovenian Ministry of Economic Development and Technology, Metrology Institute (MIRS) [640118/2008/67]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Slovenian Ministry of Economic Development and Technology, Metrology Institute (MIRS)	The work was supported by the Slovenian Research Agency (grant Nos.: P4 0165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; We thank Prof. Dr. Roger Pain for reviewing the manuscript. This work was co-financed by the Slovenian Ministry of Economic Development and Technology, Metrology Institute (MIRS) in the frame of the contract no. 640118/2008/67 on performing activities as holder of the national standard MIRS/NIB/FITO for the amount of substance in food of plant origin..	Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027; Berdal KG, 2008, EUR FOOD RES TECHNOL, V227, P1149, DOI 10.1007/s00217-008-0830-1; Bhat S, 2009, ANAL BIOANAL CHEM, V394, P457, DOI 10.1007/s00216-009-2729-5; Burns MJ, 2010, EUR FOOD RES TECHNOL, V231, P353, DOI 10.1007/s00217-010-1277-8; Cankar K, 2008, ANAL BIOCHEM, V376, P189, DOI 10.1016/j.ab.2008.02.013; Cankar K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-37; Chaouachi M, 2008, J AGR FOOD CHEM, V56, P11596, DOI 10.1021/jf801482r; Codex Alimentarius Commission, 2010, GUIDELINES PERFORMAN; Corbisier P, 2010, ANAL BIOANAL CHEM, V396, P2143, DOI 10.1007/s00216-009-3200-3; Devonshire AS, 2012, METHODS IN PRESS; European Union Reference Laboratory for GM Food and Feed, 2006, CRL ASS VAL EV SPEC; European Union Reference Laboratory for GM Food and Feed, 2008, DEF MIN PERF REQ AN; Gruere G. P., 2007, AgBioForum, V10, P51; Heide BR, 2008, EUR FOOD RES TECHNOL, V227, P1125, DOI 10.1007/s00217-008-0828-8; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Holst-Jensen A, 2009, BIOTECHNOL ADV, V27, P1071, DOI 10.1016/j.biotechadv.2009.05.025; Hoorfar J, 2004, APMIS, V112, P808, DOI 10.1111/j.1600-0463.2004.apm11211-1207.x; International Organization for Standardization, 2005, 215702005 ISO; Lee D, 2010, FOOD CHEM, V118, P974, DOI 10.1016/j.foodchem.2008.05.118; Nadal A, 2006, ELECTROPHORESIS, V27, P3879, DOI 10.1002/elps.200600124; Peccoud J, 1996, BIOPHYS J, V71, P101, DOI 10.1016/S0006-3495(96)79205-6; Pekin D, 2011, LAB CHIP, V11, P2156, DOI 10.1039/c1lc20128j; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Pohl G, 2004, EXPERT REV MOL DIAGN, V4, P41, DOI 10.1586/14737159.4.1.41; Sanders R, 2011, ANAL CHEM, V83, P6474, DOI 10.1021/ac103230c; Settanni L, 2007, J MICROBIOL METH, V69, P1, DOI 10.1016/j.mimet.2006.12.008; Somma M., 2006, TRAINING COURSE ANAL; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Weighardt F., 2006, TRAINING COURSE ANAL, P1; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203	30	180	226	8	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62583	10.1371/journal.pone.0062583	http://dx.doi.org/10.1371/journal.pone.0062583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658750	gold, Green Published, Green Submitted			2022-12-25	WOS:000321200500031
J	Zhang, JM; Wang, Y; Miao, YJ; Zhang, Y; Wu, YN; Jia, LX; Qi, YF; Du, J				Zhang, Jun-Meng; Wang, Ying; Miao, Yan-Ju; Zhang, Yi; Wu, Yi-Na; Jia, Li-Xin; Qi, Yong-Fen; Du, Jie			Knockout of CD8 Delays Reendothelialization and Accelerates Neointima Formation in Injured Arteries of Mouse via TNF-alpha Inhibiting the Endothelial Cells Migration	PLOS ONE			English	Article							DRUG-ELUTING STENTS; RE-ENDOTHELIALIZATION; VASCULAR INJURY; RESTENOSIS; MODEL; HYPERPLASIA; EXPRESSION; THERAPY; GAMMA	Objective: Delayed or impaired reendothelialization is a major cause of stent thrombosis in the interventional treatment of coronary heart disease. T cells are involved in neointima formation of injured arteries. However, the regulated mechanism of reendothelialization and the role of CD8 T cell in reendothelialization are unclear. Methods and Results: Immunofluorescence staining showed that CD8 positive cells were increased in wire injured femoral artery of mice. On day 21 after injury, elastin staining showed that knockout of CD8 (CD8(-/-)) significantly increased intimal thickness and a ratio of intima to media by 1.8 folds and 1.9 folds respectively in injured arteries. Evans blue staining showed that knockout of CD8 delayed the reendothelialization area on day 7 after injury (18.8+/-0.5% versus 42.1+/-5.6%, p<0.05). In vitro, a migration assay revealed that CD8(-/-) T cells co-cultured with WT macrophages significantly inhibited the migration of the endothelial cells (ECs); compared to CD4(+) T cells, and CD8(+) T cells could promote the ECs migration. Furthermore, real-time PCR analysis showed that knockout of CD8 increased the level of tumor necrosis factor a (TNF-alpha) in injured arteries and cytometric bead cytokine array showed that TNF-alpha was elevated in cultured CD8(-/-) T cells. Finally, a wound-healing assay showed that recombinant TNF-alpha significantly inhibited the migration of ECs. Conclusion: Our study suggested that CD8(+) T cells could promote the reendothelialization and inhibit the neointima formation after the artery wire injury, and this effect is at least partly dependent on decreasing TNF-alpha production promoting ECs migration.	[Du, Jie] Capital Med Univ, Beijing An Zhen Hosp, Beijing, Peoples R China; Minist Educ, Inst Heart Lung & Blood Vessel Dis, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China	Capital Medical University	Du, J (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Beijing, Peoples R China.	jdu@bcm.edu		Wang, Ying/0000-0002-7852-386X; Zhang, Junmeng/0000-0003-4670-0670	Chinese Ministry of Science and Technology [2009CB522205, 2012CB517802]; National Science Foundation of China [81230006, 31090363]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1074]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was supported by grants from the Chinese Ministry of Science and Technology (2009CB522205, 2012CB517802), the National Science Foundation of China (81230006, 31090363) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai X, 2010, ARTERIOSCL THROM VAS, V30, P2467, DOI 10.1161/ATVBAHA.110.215723; Brunetti ND, 2008, CORONARY ARTERY DIS, V19, P133, DOI 10.1097/MCA.0b013e3282f3fbcb; Charalambous C, 2005, CANCER RES, V65, P10347, DOI 10.1158/0008-5472.CAN-05-0949; Cole DK, 2012, IMMUNOLOGY, V137, P139, DOI 10.1111/j.1365-2567.2012.03625.x; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Dimayuga PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020214; Dimayuga PC, 2005, ARTERIOSCL THROM VAS, V25, P2528, DOI 10.1161/01.ATV.0000190606.41121.00; Grassia G, 2009, CARDIOVASC RES, V84, P485, DOI 10.1093/cvr/cvp238; Han YL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035506, 10.1371/journal.pone.0048966]; HANCOCK WW, 1994, AM J PATHOL, V145, P1008; HANSSON GK, 1991, P NATL ACAD SCI USA, V88, P10530, DOI 10.1073/pnas.88.23.10530; Hutter R, 2003, CIRCULATION, V107, P1658, DOI 10.1161/01.CIR.0000058169.21850.CE; Indolfi C, 2005, AM J CARDIOL, V95, P1146, DOI 10.1016/j.amjcard.2005.01.040; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Kollum M, 2001, INT J RADIAT ONCOL, V50, P495, DOI 10.1016/S0360-3016(01)01497-3; Krasinski K, 2001, CIRCULATION, V104, P1754, DOI 10.1161/hc4001.098046; LANCKI DW, 1991, J IMMUNOL, V146, P3242; Larsen K, 2012, EUR HEART J, V33, P120, DOI 10.1093/eurheartj/ehr196; Li YL, 2012, ARTERIOSCL THROM VAS, V32, P1662, DOI 10.1161/ATVBAHA.112.249706; Ligresti G, 2011, ARTERIOSCL THROM VAS, V31, P1151, DOI 10.1161/ATVBAHA.111.223917; LINDNER V, 1993, CIRC RES, V73, P792, DOI 10.1161/01.RES.73.5.792; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Newsome LT, 2008, ANESTH ANALG, V107, P552, DOI 10.1213/ane.0b013e3181732049; Raber L, 2011, CIRCULATION, V123, P2819, DOI 10.1161/CIRCULATIONAHA.110.004762; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; Sakuma M, 2010, ARTERIOSCL THROM VAS, V30, P1196, DOI 10.1161/ATVBAHA.110.205559; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; Saxena A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051556; Takaoka M, 2010, ARTERIOSCL THROM VAS, V30, P1576, DOI 10.1161/ATVBAHA.110.207175; Tanaka H, 1996, ARTERIOSCL THROM VAS, V16, P12, DOI 10.1161/01.ATV.16.1.12; Tanaka T, 2004, AM J CARDIOL, V93, P1547, DOI 10.1016/j.amjcard.2004.02.070; Zheng SA, 2010, AM J PHYSIOL-CELL PH, V299, pC1485, DOI 10.1152/ajpcell.00173.2010; Zhu BH, 2002, ARTERIOSCL THROM VAS, V22, P450, DOI 10.1161/hq0302.105377; Zimmerman MA, 2002, AM J PHYSIOL-REG I, V283, pR505, DOI 10.1152/ajpregu.00033.2002	36	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62001	10.1371/journal.pone.0062001	http://dx.doi.org/10.1371/journal.pone.0062001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658704	gold, Green Published, Green Submitted			2022-12-25	WOS:000321200500015
J	Davis, FP; Eddy, SR				Davis, Fred P.; Eddy, Sean R.			Transcription Factors That Convert Adult Cell Identity Are Differentially Polycomb Repressed	PLOS ONE			English	Article							STEM-CELLS; MOUSE FIBROBLASTS; DNA METHYLATION; EXPRESSION; LIVER; BETA; ENHANCERS	Transcription factors that can convert adult cells of one type to another are usually discovered empirically by testing factors with a known developmental role in the target cell. Here we show that standard genomic methods (RNA-seq and ChIP-seq) can help identify these factors, as most are more strongly Polycomb repressed in the source cell and more highly expressed in the target cell. This criterion is an effective genome-wide screen that significantly enriches for factors that can transdifferentiate several mammalian cell types including neural stem cells, neurons, pancreatic islets, and hepatocytes. These results suggest that barriers between adult cell types, as depicted in Waddington's "epigenetic landscape'', consist in part of differentially Polycomb-repressed transcription factors. This genomic model of cell identity helps rationalize a growing number of transdifferentiation protocols and may help facilitate the engineering of cell identity for regenerative medicine.	[Davis, Fred P.; Eddy, Sean R.] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Davis, FP (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	davisf@janelia.hhmi.org		Davis, Fred/0000-0001-8294-1610; Eddy, Sean/0000-0001-6676-4706	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was funded by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2012, NATURE, V487, P249, DOI 10.1038/nature11173; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Ber I, 2003, J BIOL CHEM, V278, P31950, DOI 10.1074/jbc.M303127200; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Burke ZD, 2006, J CELL PHYSIOL, V206, P147, DOI 10.1002/jcp.20438; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Crews ST, 2009, CURR BIOL, V19, pR241, DOI 10.1016/j.cub.2009.01.015; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Gefen-Halevi S, 2010, CELL REPROGRAM, V12, P655, DOI 10.1089/cell.2010.0030; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hatcher CJ, 2000, DEV DYNAM, V219, P90, DOI 10.1002/1097-0177(200009)219:1<90::AID-DVDY1033>3.0.CO;2-L; Henry GL, 2012, NUCLEIC ACIDS RES, V40, P9691, DOI 10.1093/nar/gks671; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Holmberg J, 2012, NAT REV GENET, V13, P429, DOI 10.1038/nrg3209; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Lu M, 1997, J BIOL CHEM, V272, P28349, DOI 10.1074/jbc.272.45.28349; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Malarkey DE, 2005, TOXICOL PATHOL, V33, P27, DOI 10.1080/01926230590881826; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Nilsson J, 2010, CANCER RES, V70, P2020, DOI 10.1158/0008-5472.CAN-09-1677; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Sackett SD, 2009, HEPATOLOGY, V49, P920, DOI 10.1002/hep.22705; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Thorvaldsdottir H., 2012, BRIEFINGS BIOINFORMA; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Waddington C., 1957, STRATEGY GENES; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026729; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	64	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63407	10.1371/journal.pone.0063407	http://dx.doi.org/10.1371/journal.pone.0063407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650565	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000110
J	Malfitano, AM; Laezza, C; D'Alessandro, A; Procaccini, C; Saccomanni, G; Tuccinardi, T; Manera, C; Macchia, M; Matarese, G; Gazzerro, P; Bifulco, M				Malfitano, Anna Maria; Laezza, Chiara; D'Alessandro, Alba; Procaccini, Claudio; Saccomanni, Giuseppe; Tuccinardi, Tiziano; Manera, Clementina; Macchia, Marco; Matarese, Giuseppe; Gazzerro, Patrizia; Bifulco, Maurizio			Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis	PLOS ONE			English	Article							CANNABINOID RECEPTOR; BIOLOGICAL EVALUATION; RATIONAL DESIGN; LIGANDS; SYSTEM; 1,8-NAPHTHYRIDIN-4(1H)-ON-3-CARBOXAMIDE; ACTIVATION; EXPRESSION; ARVANIL; BRAIN	The efficacy of cannabinoids in the treatment of multiple sclerosis is widely documented; however their use is limited by psychoactivity mainly ascribed to the activation of the cannabinoid receptor CB1. Emerging findings support as alternative strategy in the treatment of neurodegenerative disorders, the application of compounds targeting the CB2 receptor, since likely unrelated to these side effects. Recently, a novel class of compounds, 1,8-naphthyridine, pyridine and quinoline derivatives have been demonstrated to show high CB2 receptor selectivity and affinity versus the CB1 receptor. Considering that the CB2 receptor is mainly expressed in cell and organs of the immune system, in this study we assessed the potential immune-modulatory effects of these compounds in activated lymphocytes isolated from MS patients with respect to healthy controls. These compounds blocked cell proliferation through a mechanism partially ascribed to the CB2 receptor, down-regulated TNF-alpha production and did not induce cell death. They also down-regulated Akt, Erk and NF-kB phosphorylation. Despite comparable effects observed in patients and healthy controls, these compounds, in particular, 1,8-naphthyridine and quinoline derivatives inhibited cell activation markers in MS patient derived lymphocytes more efficiently than in healthy control derived cells. Indeed, 1,8-naphthyridin-2-one derivative reduced the levels of Cox-2 in lymphocytes from patients whereas no effect was observed in control cells. Our findings suggest potential application of these drugs in neuro-inflammation, supporting further investigations of the effects of compounds in the therapy of MS, particularly on the aspects regarding activation and inflammation.	[Malfitano, Anna Maria; D'Alessandro, Alba; Gazzerro, Patrizia; Bifulco, Maurizio] Univ Salerno, Dipartimento Farm, I-84100 Salerno, Italy; [Malfitano, Anna Maria; D'Alessandro, Alba; Procaccini, Claudio; Matarese, Giuseppe; Bifulco, Maurizio] Univ Salern Fac Med, Dipartimento Med & Chirurg, Salerno, Italy; [Laezza, Chiara] Univ Napoli Federico II, Dipartimento Biol & Patol Cellulare & Mol, Consiglio Nazl Ric IEOS CNR, Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [Procaccini, Claudio; Matarese, Giuseppe] Univ Napoli Federico II, Dipartimento Biol & Patol Cellulare & Mol, Consiglio Nazl Ric IEOS CNR, Lab Immunol,Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [Saccomanni, Giuseppe; Tuccinardi, Tiziano; Manera, Clementina; Macchia, Marco] Univ Pisa, Dipartimento Farm, Pisa, Italy	University of Salerno; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Pisa	Bifulco, M (corresponding author), Univ Salerno, Dipartimento Farm, I-84100 Salerno, Italy.	mbifulco@unisa.it	Tuccinardi, Tiziano/M-1232-2015; Matarese, Giuseppe/AAO-4077-2021; Procaccini, Claudio/AAB-3696-2019; laez, chi/AAW-4437-2020	Tuccinardi, Tiziano/0000-0002-6205-4069; Matarese, Giuseppe/0000-0001-9429-0616; PROCACCINI, CLAUDIO/0000-0002-2184-0442; MANERA, CLEMENTINA/0000-0002-7379-5743; Bifulco, Maurizio/0000-0002-1771-4531; SACCOMANNI, GIUSEPPE/0000-0002-6230-1023; MACCHIA, MARCO/0000-0002-5565-2044; Malfitano, Anna Maria/0000-0002-6193-2835	FISM - Fondazione Italiana Sclerosi Multipla - Cod. [2009/R/3/C1]; Associazione Ricerca Medica Salernitana "ERMES''; FISM - Fondazione Italiana Sclerosi Multipla; EU Ideas Programme; ERC-Starting Independent Grant "menTORingTregs'' [310496]; Telethon-JDRF Grant [GJT08004]; FIRB MERIT Grant [RBNE08HWLZ]	FISM - Fondazione Italiana Sclerosi Multipla - Cod.(Fondazione Italiana Sclerosi Multipla (FISM)); Associazione Ricerca Medica Salernitana "ERMES''; FISM - Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); EU Ideas Programme; ERC-Starting Independent Grant "menTORingTregs''; Telethon-JDRF Grant(Fondazione Telethon); FIRB MERIT Grant	This study was supported by FISM - Fondazione Italiana Sclerosi Multipla - Cod. 2009/R/3/C1 (Grant to M.B.), and Associazione Ricerca Medica Salernitana "ERMES''. A.M.M. was supported by a fellowship from FISM - Fondazione Italiana Sclerosi Multipla. G.M. is supported by grants from the EU Ideas Programme, ERC-Starting Independent Grant "menTORingTregs'' n. 310496, Telethon-JDRF Grant n. GJT08004, FIRB MERIT Grant n. RBNE08HWLZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benavides A, 2009, J NAT PROD, V72, P813, DOI 10.1021/np8006205; Bifulco M, 2007, MULT SCLER J, V13, P133, DOI 10.1177/1352458506071303; Bifulco M, 2008, ENDOCR-RELAT CANCER, V15, P391, DOI 10.1677/ERC-07-0258; Chuchawankul S, 2004, INT IMMUNOPHARMACOL, V4, P265, DOI 10.1016/j.intimp.2003.12.011; Ferrarini PL, 2004, BIOORGAN MED CHEM, V12, P1921, DOI 10.1016/j.bmc.2004.01.035; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Hillard CJ, 2012, NEUROSCIENCE, V204, P207, DOI 10.1016/j.neuroscience.2011.11.020; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Jackson SJ, 2005, NEUROSCIENCE, V134, P261, DOI 10.1016/j.neuroscience.2005.02.045; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Lombard C, 2007, CLIN IMMUNOL, V122, P259, DOI 10.1016/j.clim.2006.11.002; Loria F, 2010, NEUROBIOL DIS, V37, P166, DOI 10.1016/j.nbd.2009.09.020; Malfitano AM, 2006, J NEUROIMMUNOL, V171, P110, DOI 10.1016/j.jneuroim.2005.09.005; Malfitano AM, 2007, IMMUNOL LETT, V109, P145, DOI 10.1016/j.imlet.2007.02.004; Malfitano AM, 2005, CNS NEUROL DISORD-DR, V4, P667, DOI 10.2174/156800705774933087; Malfitano AM, 2011, EXPERT OPIN THER TAR, V15, P297, DOI 10.1517/14728222.2011.553606; Malfitano Anna Maria, 2008, Neuropsychiatr Dis Treat, V4, P847; Manera C, 2006, J MED CHEM, V49, P5947, DOI 10.1021/jm0603466; Manera C, 2007, BIOORG MED CHEM LETT, V17, P6505, DOI 10.1016/j.bmcl.2007.09.089; Manera C, 2012, EUR J MED CHEM, V52, P284, DOI 10.1016/j.ejmech.2012.03.031; Manera C, 2009, J MED CHEM, V52, P3644, DOI 10.1021/jm801563d; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mestre L, 2009, MOL CELL NEUROSCI, V40, P258, DOI 10.1016/j.mcn.2008.10.015; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; Pertwee RG, 2009, BRIT J PHARMACOL, V156, P397, DOI 10.1111/j.1476-5381.2008.00048.x; Proto MC, 2012, J CELL PHYSIOL, V227, P250, DOI 10.1002/jcp.22727; Pryce G, 2003, BRAIN, V126, P2191, DOI 10.1093/brain/awg224; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740	31	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62511	10.1371/journal.pone.0062511	http://dx.doi.org/10.1371/journal.pone.0062511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658734	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000053
J	O'Brien, CL; Allison, GE; Grimpen, F; Pavli, P				O'Brien, Claire L.; Allison, Gwen E.; Grimpen, Florian; Pavli, Paul			Impact of Colonoscopy Bowel Preparation on Intestinal Microbiota	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; RIBOSOMAL-RNA GENES; GUT MICROBIOTA; DIVERSITY; COMMUNITY; BACTERIA; PRIMERS; ECOLOGY; DISEASE; FECES	The gut microbiota is important in maintaining human health, but numerous factors have the potential to alter its composition. Our aim was to examine the impact of a standard bowel preparation on the intestinal microbiota using two different techniques. Fifteen subjects undergoing colonoscopy consumed a bowel preparation comprised of 10 mg bisacodyl and 2 L polyethylene glycol. The microbiota of stool samples, collected one month before, one week before (precolonoscopy), and one week, one month, and three to six months after colonoscopy (post-colonoscopy) was evaluated. Two samples were taken three to six months apart from five healthy subjects who did not undergo colonoscopy. Universal primers targeting the V2-V3 region of the 16S rRNA gene were used to PCR amplify all samples for denaturing gradient gel electrophoresis (PCR-DGGE). Pre- and post-colonoscopy samples were compared using Dice's similarity coefficients. Three samples from ten subjects who underwent colonoscopy, and both samples from the five subjects who didn't, were used for high-throughput sequencing of the V1-V3 region of the 16S rRNA gene. Samples were curated and analysed in Mothur. Results of the DGGE analyses show that the fecal microbiota of a small number of subjects had short-term changes. High-throughput sequencing results indicated that the variation between the samples of subjects who underwent colonoscopy was no greater than the variation observed between samples from subjects who did not. We conclude that bowel preparation does not have a lasting effect on the composition of the intestinal microbiota for the majority of subjects.	[O'Brien, Claire L.; Allison, Gwen E.; Pavli, Paul] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Grimpen, Florian] Royal Brisbane & Womens Hosp, Dept Gastroenterol & Hepatol, Herston, Qld, Australia; [Allison, Gwen E.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [O'Brien, Claire L.; Pavli, Paul] Canberra Hosp, Gastroenterol & Hepatol Unit, Canberra, ACT, Australia	Australian National University; Royal Brisbane & Women's Hospital; Australian National University; Australian National University; Canberra Hospital	O'Brien, CL (corresponding author), Australian Natl Univ, Sch Med, Canberra, ACT, Australia.	Claire.Obrien@anu.edu.au	Allison, Gwen E/D-1163-2009; Pavli, Paul/GZL-0607-2022	O'Brien, Claire/0000-0003-1599-9913	Australian Post-Graduate Award scholarship	Australian Post-Graduate Award scholarship	This work was funded by an Australian Post-Graduate Award scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby MN, 2007, APPL ENVIRON MICROB, V73, P4532, DOI 10.1128/AEM.02956-06; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Harrell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032545; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lofmark S, 2006, J ANTIMICROB CHEMOTH, V58, P1160, DOI 10.1093/jac/dkl420; Mai V, 2006, GUT, V55, P1822, DOI 10.1136/gut.2006.108266; Maki T, 2008, AIR QUAL ATMOS HLTH, V1, P81, DOI 10.1007/s11869-008-0016-9; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Menees S, 2007, INFLAMM BOWEL DIS, V13, P12, DOI 10.1002/ibd.20049; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Swidsinski A, 2008, GASTROENTEROLOGY, V135, P568, DOI 10.1053/j.gastro.2008.04.017; Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; Tourlomousis P, 2010, MICROB ECOL, V59, P776, DOI 10.1007/s00248-009-9613-x; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Wang GCY, 1997, APPL ENVIRON MICROB, V63, P4645, DOI 10.1128/AEM.63.12.4645-4650.1997; Xing De-feng, 2006, Weishengwu Xuebao, V46, P331; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	32	66	67	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62815	10.1371/journal.pone.0062815	http://dx.doi.org/10.1371/journal.pone.0062815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650530	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000075
J	Park, CW; Yoon, BH; Park, JS; Jun, JK				Park, Chan-Wook; Yoon, Bo Hyun; Park, Joong Shin; Jun, Jong Kwan			A Fetal and an Intra-Amniotic Inflammatory Response Is More Severe in Preterm Labor than in Preterm PROM in the Context of Funisitis: Unexpected Observation in Human Gestations	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BLOOD-CELL COUNT; PREMATURE RUPTURE; AMNIOTIC-FLUID; CLINICAL-SIGNIFICANCE; INTACT MEMBRANES; INFECTION; WOMEN; CHORIOAMNIONITIS; DIAGNOSIS	Objective: Although intra-amniotic(IA) infection is present in both preterm labor and intact membranes(PTL) and preterm premature rupture of membranes(preterm-PROM), it is more common in preterm-PROM than in PTL. Microorganisms and their products in the amniotic-cavity can elicit an inflammatory-response in fetus as well as in amniotic-cavity in the progression of acute histologic chorioamnionitis(acute-HCA). A fundamental question is whether a fetal and an IA inflammatory-response is more severe in preterm-PROM than in PTL, in the same-context of acute-HCA with or without fetal-involvement. The purpose of current-study was to answer this-question. Study-Design: Study population consisted of 213 singleton preterm-gestations(, 34 weeks) delivered within 4 days of amniocentesis due to PTL(120 cases) or preterm-PROM(93 cases). The intensity of fetal and IA inflammatory-responses was compared between PTL and preterm-PROM, according to placental inflammatory conditions: 1) placenta without inflammatory-lesion; 2) acute-HCA without funisitis; 3) acute-HCA with funisitis. IA inflammatory response was assessed by amniotic-fluid(AF) matrix metalloproteinase-8(MMP-8), and fetal inflammatory response(FIR) by umbilical-cord plasma(UCP) C-reactive protein(CRP) at birth. Results: 1) Patients with preterm-PROM had higher rates of IA infection, acute-HCA, and acute-HCA with funisitis than those with PTL did(p<.01 for each); 2) there were no significant differences in the intensity of fetal and IA inflammatory-responses and the rate of cervical dilatation >= 3 cm or 4 cm between patients with PTL and those with preterm-PROM in the context of both placenta without inflammatory-lesion and acute-HCA without funisitis(p>.05 for each); 3) however, acute-HCA with funisitis was associated with a significantly higher median AF MMP-8 and UCP CRP concentration and higher rate of cervical dilatation >= 3 cm or 4 cm in PTL than in preterm-PROM(AF MMP-8, 675 ng/mlvs. 417 ng/ml; UCP CRP, 969 ng/mlvs. 397 ng/ml; each for p>.05), despite less common IA infection in PTL than in preterm-PROM(29% vs. 57%; p>.05). Conclusions: A fetal and an IA inflammatory-response is more severe in PTL than in preterm-PROM in the context of funisitis, despite less common IA infection. This unexpected observation may indicate the fundamental difference in the pathogenesis between PTL and preterm-PROM.	[Park, Chan-Wook; Yoon, Bo Hyun; Park, Joong Shin; Jun, Jong Kwan] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Seoul National University (SNU)	Park, CW (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	hwpark0803@gmail.com	PARK, Chan-Wook/G-3663-2013; Park, Joong Shin/D-5741-2012; Yoon, Bo Hyun/H-6344-2011	PARK, Chan-Wook/0000-0002-1290-6438; Park, Joong Shin/0000-0002-5246-0477; 	National Research Foundation of Korea (NRF); Korea government (MEST) [2009-0080429]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (number 2009-0080429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baergen R, 2005, MANUAL BENIRSCHKE KA, P279; Been JV, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.025; Benirschuke K, 2006, PATHOLOGY HUMAN PLAC; Blackwell SC, 1999, CURR OPIN OBSTET GYN, V11, P541, DOI 10.1097/00001703-199912000-00001; D'Alquen D, 2005, PEDIATR RES, V57, P263, DOI 10.1203/01.PDR.0000148713.48218.86; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2002, NUTR REV, V60, pS19, DOI 10.1301/00296640260130696; GOMEZ R, 1995, CLIN PERINATOL, V22, P281; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gomez R, 1997, INFECT DIS CLIN N AM, V11, P135, DOI 10.1016/S0891-5520(05)70347-0; HOROWITZ S, 1995, ACTA OBSTET GYN SCAN, V74, P132, DOI 10.3109/00016349509008922; Lee AJX, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.015; Lee SM, 2011, PLACENTA, V32, P516, DOI 10.1016/j.placenta.2011.03.012; Lee SE, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.006; MAZOR M, 1993, J REPROD MED, V38, P799; Murtha AP, 1996, AM J OBSTET GYNECOL, V175, P966, DOI 10.1016/S0002-9378(96)80033-0; NAEYE RL, 1982, EARLY HUM DEV, V6, P91, DOI 10.1016/0378-3782(82)90062-7; Oh KJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.035; Ovalle A, 2000, REV MED CHILE, V128, P985; Park JS, 2001, AM J OBSTET GYNECOL, V185, P1156, DOI 10.1067/mob.2001.117679; ROMERO R, 1990, AM J OBSTET GYNECOL, V163, P968, DOI 10.1016/0002-9378(90)91106-M; Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6; ROMERO R, 1988, CLIN OBSTET GYNECOL, V31, P553, DOI 10.1097/00003081-198809000-00006; ROMERO R, 1989, AM J OBSTET GYNECOL, V160, P1117, DOI 10.1016/0002-9378(89)90172-5; ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P817, DOI 10.1016/0002-9378(89)90409-2; Seong HS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.040; Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; VINTZILEOS AM, 1986, OBSTET GYNECOL, V68, P488; Yoon B H, 2003, J Matern Fetal Neonatal Med, V14, P85; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680; Yoon BH, 1996, OBSTET GYNECOL, V87, P231, DOI 10.1016/0029-7844(95)00380-0; Yoon BH, 1996, OBSTET GYNECOL, V88, P1034	35	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62521	10.1371/journal.pone.0062521	http://dx.doi.org/10.1371/journal.pone.0062521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658737	Green Submitted, Green Published, gold			2022-12-25	WOS:000319167000054
J	Parvathaneni, S; Stortchevoi, A; Sommers, JA; Brosh, RM; Sharma, S				Parvathaneni, Swetha; Stortchevoi, Alexei; Sommers, Joshua A.; Brosh, Robert M., Jr.; Sharma, Sudha			Human RECQ1 Interacts with Ku70/80 and Modulates DNA End-Joining of Double-Strand Breaks	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; REPAIR PATHWAY CHOICE; CELL-FREE-EXTRACTS; HOMOLOGOUS RECOMBINATION; WERNER PROTEIN; KU PROTEIN; POLY(ADP-RIBOSE) POLYMERASE-1; VERTEBRATE CELLS; MAMMALIAN-CELLS; APLF C2ORF13	Genomic instability is a known precursor to cancer and aging. The RecQ helicases are a highly conserved family of DNA-unwinding enzymes that play key roles in maintaining genome stability in all living organisms. Human RecQ homologs include RECQ1, BLM, WRN, RECQ4, and RECQ5 beta, three of which have been linked to diseases with elevated risk of cancer and growth defects (Bloom Syndrome and Rothmund-Thomson Syndrome) or premature aging (Werner Syndrome). RECQ1, the first RecQ helicase discovered and the most abundant in human cells, is the least well understood of the five human RecQ homologs. We have previously described that knockout of RECQ1 in mice or knockdown of its expression in human cells results in elevated frequency of spontaneous sister chromatid exchanges, chromosomal instability, increased load of DNA damage and heightened sensitivity to ionizing radiation. We have now obtained evidence implicating RECQ1 in the nonhomologous end-joining pathway of DNA double-strand break repair. We show that RECQ1 interacts directly with the Ku70/80 subunit of the DNA-PK complex, and depletion of RECQ1 results in reduced end-joining in cell free extracts. In vitro, RECQ1 binds and unwinds the Ku70/80-bound partial duplex DNA substrate efficiently. Linear DNA is co-bound by RECQ1 and Ku70/80, and DNA binding by Ku70/80 is modulated by RECQ1. Collectively, these results provide the first evidence for an interaction of RECQ1 with Ku70/80 and a role of the human RecQ helicase in double-strand break repair through nonhomologous end-joining.	[Parvathaneni, Swetha; Stortchevoi, Alexei; Sharma, Sudha] Howard Univ, Coll Med, Dept Biochem & Mol Biol, Washington, DC 20059 USA; [Sommers, Joshua A.; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	Howard University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sharma, S (corresponding author), Howard Univ, Coll Med, Dept Biochem & Mol Biol, Washington, DC 20059 USA.	sudha.sharma@howard.edu	Sharma, Sudha/AAV-6152-2021	Sharma, Sudha/0000-0003-2765-2482	NIH/NIGMS [5SC1GM093999-04]; NIH Intramural Research Program; National Institute on Aging; NIH/NIMHD [G12MD007597]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM093999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000753, ZIAAG000741, ZIAAG000752] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007597] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work is supported by NIH/NIGMS grant 5SC1GM093999-04 (to SS) and the NIH Intramural Research Program, National Institute on Aging (to RB). Howard University College of Medicine core facilities are supported by the NIH/NIMHD under Award Number G12MD007597. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2002, P NATL ACAD SCI USA, V99, P3758, DOI 10.1073/pnas.052545899; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Bekker-Jensen S, 2007, J BIOL CHEM, V282, P19638, DOI 10.1074/jbc.C700060200; Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602; Berti M, 2013, NAT STRUCT MOL BIOL; BLIER PR, 1993, J BIOL CHEM, V268, P7594; Bugreev DV, 2008, J BIOL CHEM, V283, P20231, DOI 10.1074/jbc.M801582200; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cooper MP, 2000, GENE DEV, V14, P907; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; de Oca RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007050; DEVRIES E, 1989, J MOL BIOL, V208, P65, DOI 10.1016/0022-2836(89)90088-0; Doherty KM, 2005, J BIOL CHEM, V280, P28085, DOI 10.1074/jbc.M500265200; Drouet J, 2005, J BIOL CHEM, V280, P7060, DOI 10.1074/jbc.M410746200; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521; Gottipati P, 2010, CANCER RES, V70, P5389, DOI 10.1158/0008-5472.CAN-09-4716; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Karmakar P, 2002, NUCLEIC ACIDS RES, V30, P3583, DOI 10.1093/nar/gkf482; Karmakar P, 2002, J BIOL CHEM, V277, P18291, DOI 10.1074/jbc.M111523200; Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Li BM, 2004, J BIOL CHEM, V279, P13659, DOI 10.1074/jbc.M311606200; Li BM, 2001, J BIOL CHEM, V276, P9896, DOI 10.1074/jbc.M008575200; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Macrae CJ, 2008, DNA REPAIR, V7, P292, DOI 10.1016/j.dnarep.2007.10.008; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; Mansour W.Y., 2010, NUCL ACIDS RES; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Nussenzweig A, 2007, CELL, V131, P223, DOI 10.1016/j.cell.2007.10.005; Oshima J, 2002, CANCER RES, V62, P547; PAILLARD S, 1991, NUCLEIC ACIDS RES, V19, P5619, DOI 10.1093/nar/19.20.5619; Popuri V, 2008, J BIOL CHEM, V283, P17766, DOI 10.1074/jbc.M709749200; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2008, CELL CYCLE, V7, P989, DOI 10.4161/cc.7.8.5707; Sharma S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001297; Sharma S, 2007, MOL CELL BIOL, V27, P1784, DOI 10.1128/MCB.01620-06; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Sharma S, 2012, DNA REPAIR, V11, P537, DOI 10.1016/j.dnarep.2012.04.003; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Singh DK, 2012, MUTAT RES-FUND MOL M, V736, P15, DOI 10.1016/j.mrfmmm.2011.06.002; Sun J, 2012, J BIOL CHEM, V287, P4936, DOI 10.1074/jbc.M111.306167; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; von Kobbe C, 2004, NUCLEIC ACIDS RES, V32, P4003, DOI 10.1093/nar/gkh721; von Kobbe C, 2003, MOL CELL BIOL, V23, P8601, DOI 10.1128/MCB.23.23.8601-8613.2003; Wang HC, 2003, NUCLEIC ACIDS RES, V31, P5377, DOI 10.1093/nar/gkg728; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Weinstock David M, 2007, Nat Cell Biol, V9, P978; Wu YL, 2010, DNA REPAIR, V9, P315, DOI 10.1016/j.dnarep.2009.12.010; Wyman C, 2004, DNA REPAIR, V3, P827, DOI 10.1016/j.dnarep.2004.03.037; Zhong Q, 2002, CANCER RES, V62, P3966; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	78	41	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62481	10.1371/journal.pone.0062481	http://dx.doi.org/10.1371/journal.pone.0062481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650516	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000050
J	Frickmann, H; Christner, M; Donat, M; Berger, A; Essig, A; Podbielski, A; Hagen, RM; Poppert, S				Frickmann, Hagen; Christner, Martin; Donat, Martina; Berger, Anja; Essig, Andreas; Podbielski, Andreas; Hagen, Ralf Matthias; Poppert, Sven			Rapid Discrimination of Haemophilus influenzae, H. parainfluenzae, and H. haemolyticus by Fluorescence In Situ Hybridization (FISH) and Two Matrix-Assisted Laser-Desorption-Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF-MS) Platforms	PLOS ONE			English	Article							OLIGONUCLEOTIDE PROBES; RESPIRATORY-TRACT; IDENTIFICATION; BACTERIA; NEISSERIA; STRAINS; MENINGITIS; AEGYPTIUS; SAMPLES; SPP.	Background: Due to considerable differences in pathogenicity, Haemophilus influenzae, H. parainfluenzae and H. haemolyticus have to be reliably discriminated in routine diagnostics. Retrospective analyses suggest frequent misidentifications of commensal H. haemolyticus as H. influenzae. In a multi-center approach, we assessed the suitability of fluorescence in situ hybridization (FISH) and matrix-assisted laser-desorption-ionization time-of-flight mass-spectrometry (MALDI-TOF-MS) for the identification of H. influenzae, H. parainfluenzae and H. haemolyticus to species level. Methodology: A strain collection of 84 Haemophilus spp. comprising 50 H. influenzae, 25 H. parainfluenzae, 7 H. haemolyticus, and 2 H. parahaemolyticus including 77 clinical isolates was analyzed by FISH with newly designed DNA probes, and two different MALDI-TOF-MS systems (Bruker, Shimadzu) with and without prior formic acid extraction. Principal Findings: Among the 84 Haemophilus strains analyzed, FISH led to 71 correct results (85%), 13 uninterpretable results (15%), and no misidentifications. Shimadzu MALDI-TOF-MS resulted in 59 correct identifications (70%), 19 uninterpretable results (23%), and 6 misidentifications (7%), using colony material applied directly. Bruker MALDI-TOF-MS with prior formic acid extraction led to 74 correct results (88%), 4 uninterpretable results (5%) and 6 misidentifications (7%). The Bruker MALDI-TOF-MS misidentifications could be resolved by the addition of a suitable H. haemolyticus reference spectrum to the system's database. In conclusion, no analyzed diagnostic procedure was free of errors. Diagnostic results have to be interpreted carefully and alternative tests should be applied in case of ambiguous test results on isolates from seriously ill patients.	[Frickmann, Hagen; Hagen, Ralf Matthias] German Armed Forces Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany; [Frickmann, Hagen; Donat, Martina; Podbielski, Andreas] Univ Rostock, Inst Med Microbiol Virol & Hyg, D-18055 Rostock, Germany; [Christner, Martin] Univ Hosp Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Berger, Anja] Bavarian Food & Hlth Author, Oberschleissheim, Germany; [Essig, Andreas] Univ Ulm, Inst Med Microbiol & Hyg, D-89069 Ulm, Germany; [Poppert, Sven] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Rostock; University of Hamburg; University Medical Center Hamburg-Eppendorf; Bavarian Health & Food Safety Authority; Ulm University; Bernhard Nocht Institut fur Tropenmedizin	Frickmann, H (corresponding author), German Armed Forces Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany.	Frickmann@bni-hamburg.de			German Ministry of Defense (MoD) [13K2-S-451215]	German Ministry of Defense (MoD)	The 16S rRNA gene sequencing of the Haemophilus spp. with conflicting results in FISH and MALDI-TOF-MS analysis was funded by the German Ministry of Defense (MoD), scientific project number 13K2-S-451215 "New development/evaluation of diagnostic molecular procedures for the proof of infectious agents and symptom-based diagnostic procedures for tropical infectious diseases.'' The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeldaim GMK, 2009, DIAGN MICR INFEC DIS, V64, P366, DOI 10.1016/j.diagmicrobio.2009.03.030; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Anderson R, 2012, J CLIN MICROBIOL, V50, P2462, DOI 10.1128/JCM.06575-11; BARBE G, 1994, J CLIN MICROBIOL, V32, P187; BRENNER DJ, 1988, J CLIN MICROBIOL, V26, P1524, DOI 10.1128/JCM.26.8.1524-1534.1988; Brook I, 2009, EUR ARCH OTO-RHINO-L, V266, P315, DOI 10.1007/s00405-008-0849-8; Cilia V, 1996, MOL BIOL EVOL, V13, P451, DOI 10.1093/oxfordjournals.molbev.a025606; Clinical and Laboratory Standards Institute, 2008, MM18A CLIN LAB STAND, P30; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Couturier MR, 2011, J CLIN MICROBIOL, V49, P1104, DOI 10.1128/JCM.01777-10; DarrasJoly C, 1997, CLIN INFECT DIS, V24, P1087, DOI 10.1086/513624; Dommerich S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030150; FADEN H, 1995, J INFECT DIS, V172, P132, DOI 10.1093/infdis/172.1.132; Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37; Frickmann H, 2011, EUR J MICROBIOL IMMU, V1, P289, DOI 10.1556/EuJMI.1.2011.4.4; Frickmann H, 2012, TROP MED INT HEALTH, V17, P1117, DOI 10.1111/j.1365-3156.2012.03024.x; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Haag AM, 1998, J MASS SPECTROM, V33, P750, DOI 10.1002/(SICI)1096-9888(199808)33:8<750::AID-JMS680>3.0.CO;2-1; Hendolin PH, 2000, J CLIN MICROBIOL, V38, P125; Hogardt M, 2000, J CLIN MICROBIOL, V38, P818, DOI 10.1128/JCM.38.2.818-825.2000; Hotomi M, 2010, AURIS NASUS LARYNX, V37, P594, DOI 10.1016/j.anl.2010.02.005; Justesen US, 2010, J CLIN MICROBIOL, V48, P946, DOI 10.1128/JCM.02075-09; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; Kilian M, 2002, MOL MICROBIOL, V46, P1367, DOI 10.1046/j.1365-2958.2002.03254.x; KILIAN M, 1974, ACTA PATH MICRO IM B, VB 82, P835; Kirkham LAS, 2010, J CLIN MICROBIOL, V48, P2557, DOI 10.1128/JCM.00069-10; Kumar Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-240; Lakner A, 2011, MYCOSIS, V55; Loy A, 2008, ENVIRON MICROBIOL, V10, P2894, DOI 10.1111/j.1462-2920.2008.01706.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; McCrea KW, 2008, J CLIN MICROBIOL, V46, P406, DOI 10.1128/JCM.01832-07; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Mukundan D, 2007, J CLIN MICROBIOL, V45, P3207, DOI 10.1128/JCM.00492-07; Munson E, 2002, EUR J CLIN MICROBIOL, V21, P196, DOI 10.1007/s10096-001-0688-7; Munson EL, 2007, J CLIN MICROBIOL, V45, P4051, DOI 10.1128/JCM.01663-07; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Nascimento-Carvalho C M, 2001, Braz J Infect Dis, V5, P87; Norskov-Lauritsen N, 2009, J BACTERIOL, V191, P822, DOI 10.1128/JB.00782-08; Olvera A, 2006, MICROBIOL-SGM, V152, P3683, DOI 10.1099/mic.0.29254-0; Peters RPH, 2006, J CLIN MICROBIOL, V44, P4186, DOI 10.1128/JCM.01085-06; PITTMAN M, 1953, J BACTERIOL, V65, P750, DOI 10.1128/JB.65.6.750-751.1953; Poppert S, 2005, J CLIN MICROBIOL, V43, P3390, DOI 10.1128/JCM.43.7.3390-3397.2005; Rennie RP, 2008, J CLIN MICROBIOL, V46, P2681, DOI 10.1128/JCM.00449-08; Tian GZ, 2012, BIOMED ENVIRON SCI, V25, P367, DOI 10.3967/0895-3988.2012.03.016; TOTTEN PA, 1995, INFECT IMMUN, V63, P4409, DOI 10.1128/IAI.63.11.4409-4416.1995; TURK DC, 1984, J MED MICROBIOL, V18, P1, DOI 10.1099/00222615-18-1-1; Valenza G, 2007, J CLIN MICROBIOL, V45, P3493, DOI 10.1128/JCM.00953-07; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; Wellinghausen N, 2005, J CLIN MICROBIOL, V43, P4070, DOI 10.1128/JCM.43.8.4070-4075.2005; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002; Wood-Baker R, 2012, BRIT J BIOMED SCI, V69, P37, DOI 10.1080/09674845.2012.11978244	51	36	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63222	10.1371/journal.pone.0063222	http://dx.doi.org/10.1371/journal.pone.0063222			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646201	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300159
J	Reynolds, RM; Phillips, PC				Reynolds, Rose M.; Phillips, Patrick C.			Natural Variation for Lifespan and Stress Response in the Nematode Caenorhabditis remanei	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; NUCLEOTIDE POLYMORPHISM; QUANTITATIVE VARIATION; WILD POPULATIONS; OXIDATIVE DAMAGE; RESISTANCE; GENETICS; ELEGANS; LONGEVITY; HERITABILITY	Genetic approaches (e. g. mutation, RNA interference) in model organisms, particularly the nematode Caenorhabditis elegans, have yielded a wealth of information on cellular processes that can influence lifespan. Although longevity mutants discovered in the lab are instructive of cellular physiology, lab studies might miss important genes that influence health and longevity in the wild. C. elegans has relatively low natural genetic variation and high levels of linkage disequilibrium, and thus is not optimal for studying natural variation in longevity. In contrast, its close relative C. remanei possesses very high levels of molecular genetic variation and low levels of linkage disequilibrium. To determine whether C. remanei may be a good model system for the study of natural genetic variation in aging, we evaluated levels of quantitative genetic variation for longevity and resistance to oxidative, heat and UV stress. Heritability (and the coefficient of additive genetic variation) was high for oxidative and heat stress resistance, low (but significant) for longevity, and essentially zero for UV stress response. Our results suggest that C. remanei may be a powerful system for studying natural genetic variation for longevity and oxidative and heat stress response, as well as an informative model for the study of functional relationships between longevity and stress response.	[Reynolds, Rose M.; Phillips, Patrick C.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA	University of Oregon	Phillips, PC (corresponding author), Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA.	pphil@uoregon.edu		Phillips, Patrick/0000-0001-7271-342X	National Institutes of Health [R03-AG029377, P01-AG022500]; Ellison Medical Foundation; National Institutes of Health (Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship) [AG032900]; NATIONAL INSTITUTE ON AGING [R03AG029377, F32AG032900, P01AG022500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health (Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work received funding support from the National Institutes of Health (R03-AG029377 and P01-AG022500 to PCP; Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship AG032900 to RMR), and the Ellison Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Baird SE, 1999, NEMATOLOGY, V1, P471, DOI 10.1163/156854199508478; Barker JSF, 1995, J EVOLUTION BIOL, V8, P689, DOI 10.1046/j.1420-9101.1995.8060689.x; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; Becker W. A, 1984, MANUAL QUANTITATIVE; Biteau B, 2011, EXP GERONTOL, V46, P349, DOI 10.1016/j.exger.2010.11.003; Cutter AD, 2006, GENETICS, V172, P171, DOI 10.1534/genetics.105.048207; Cutter AD, 2006, GENETICS, V174, P901, DOI 10.1534/genetics.106.061879; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Evans DS, 2011, AGEING RES REV, V10, P225, DOI 10.1016/j.arr.2010.04.001; Gaertner BE, 2010, GENET RES, V92, P331, DOI 10.1017/S0016672310000601; Gonzalez-Recio O, 2007, GENET SEL EVOL, V39, P391, DOI 10.1051/gse:2007010; Graustein A, 2002, GENETICS, V161, P99; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harshman LG, 1999, NEUROBIOL AGING, V20, P521, DOI 10.1016/S0197-4580(99)00091-3; HEGMANN JP, 1981, BEHAV GENET, V11, P103, DOI 10.1007/BF01065621; Hoffmann AA, 1998, EVOLUTION, V52, P1207, DOI [10.2307/2411250, 10.1111/j.1558-5646.1998.tb01847.x]; HOULE D, 1992, GENETICS, V130, P195; Imasheva AG, 1998, HEREDITY, V81, P246, DOI 10.1046/j.1365-2540.1998.00384.x; JOHNSON TE, 1986, BEHAV GENET, V16, P221, DOI 10.1007/BF01065487; Johnson TE, 2000, EXP GERONTOL, V35, P687, DOI 10.1016/S0531-5565(00)00138-8; Jovelin R, 2003, MOL ECOL, V12, P1325, DOI 10.1046/j.1365-294X.2003.01805.x; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; Narasimhan SD, 2009, CURR BIOL, V19, pR657, DOI 10.1016/j.cub.2009.06.013; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Petriv OI, 2004, J BIOL CHEM, V279, P19996, DOI 10.1074/jbc.M400207200; Phillips PC, 1998, BIOLOGY; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; ROSE MR, 1981, GENETICS, V97, P187; SAS Institute, 2002, SAS 9 1 3; SAS Institute Inc, 2004, GEN AN COMPL TRAITS, P292; Sivasundar A, 2003, GENETICS, V163, P147; TANAKA Y, 1993, HEREDITY, V70, P318, DOI 10.1038/hdy.1993.46; Tatar M, 1999, AM NAT, V154, pS67, DOI 10.1086/303284; Willi Y, 2010, EVOL ECOL RES, V12, P761; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Ziv E, 2011, AGEING RES REV, V10, P201, DOI 10.1016/j.arr.2010.09.002	42	16	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e58212	10.1371/journal.pone.0058212	http://dx.doi.org/10.1371/journal.pone.0058212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658604	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700002
J	Yang, SJ; Jan, YH; Gray, JP; Mishin, V; Heck, DE; Laskin, DL; Laskin, JD				Yang, Shaojun; Jan, Yi-Hua; Gray, Joshua P.; Mishin, Vladimir; Heck, Diane E.; Laskin, Debra L.; Laskin, Jeffrey D.			Sepiapterin Reductase Mediates Chemical Redox Cycling in Lung Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; THIOREDOXIN REDUCTASE; HYDROXYSTEROID DEHYDROGENASE; CYTOCHROME-P450 REDUCTASE; CARBONYL REDUCTASE; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; BINDING MODE; TETRAHYDROBIOPTERIN; PARAQUAT	In the lung, chemical redox cycling generates highly toxic reactive oxygen species that can cause alveolar inflammation and damage to the epithelium, as well as fibrosis. In this study, we identified a cytosolic NADPH-dependent redox cycling activity in mouse lung epithelial cells as sepiapterin reductase (SPR), an enzyme important for the biosynthesis of tetrahydrobiopterin. Human SPR was cloned and characterized. In addition to reducing sepiapterin, SPR mediated chemical redox cycling of bipyridinium herbicides and various quinones; this activity was greatest for 1,2-naphthoquinone followed by 9,10-phenanthrenequinone, 1,4-naphthoquinone, menadione, and 2,3-dimethyl-1,4-naphthoquinone. Whereas redox cycling chemicals inhibited sepiapterin reduction, sepiapterin had no effect on redox cycling. Additionally, inhibitors such as dicoumarol, N-acetylserotonin, and indomethacin blocked sepiapterin reduction, with no effect on redox cycling. Non-redox cycling quinones, including benzoquinone and phenylquinone, were competitive inhibitors of sepiapterin reduction but noncompetitive redox cycling inhibitors. Site-directed mutagenesis of the SPR C-terminal substrate-binding site (D257H) completely inhibited sepiapterin reduction but had minimal effects on redox cycling. These data indicate that SPR-mediated reduction of sepiapterin and redox cycling occur by distinct mechanisms. The identification of SPR as a key enzyme mediating chemical redox cycling suggests that it may be important in generating cytotoxic reactive oxygen species in the lung. This activity, together with inhibition of sepiapterin reduction by redox-active chemicals and consequent deficiencies in tetrahydrobiopterin, may contribute to tissue injury.	[Yang, Shaojun; Laskin, Jeffrey D.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, Piscataway, NJ 08854 USA; [Jan, Yi-Hua; Mishin, Vladimir; Laskin, Debra L.] Rutgers State Univ, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA; [Gray, Joshua P.] US Coast Guard Acad, Dept Sci, New London, CT 06320 USA; [Heck, Diane E.] New York Med Coll, Dept Environm Hlth Sci, Valhalla, NY 10595 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; New York Medical College	Laskin, JD (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, 170 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	jlaskin@eohsi.rutgers.edu		Gray, Joshua/0000-0002-9704-3845; Gray, Joshua/0000-0003-4146-7902; Laskin, Debra/0000-0003-1832-7311	National Institutes of Health [R01GM034310, R01ES004738, R01CA132624, U54AR055073, P30ES005022]; NATIONAL CANCER INSTITUTE [R01CA132624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR055073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022, R01ES004738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM034310, R01ES004738, R01CA132624, U54AR055073, and P30ES005022.	Agarwal A, 2011, CRIT REV BIOTECHNOL, V31, P264, DOI 10.3109/07388551.2010.527823; Auerbach G, 1997, EMBO J, V16, P7219, DOI 10.1093/emboj/16.24.7219; Backes WL, 2003, PHARMACOL THERAPEUT, V98, P221, DOI 10.1016/S0163-7258(03)00031-7; Barrett EG, 1998, AM J PHYSIOL-LUNG C, V275, pL1110, DOI 10.1152/ajplung.1998.275.6.L1110; Blau N, 2011, MOL GENET METAB, V104, pS2, DOI 10.1016/j.ymgme.2011.08.017; Bonafe L, 2001, AM J HUM GENET, V69, P269, DOI 10.1086/321970; Bonneh-Barkay D, 2005, MOL BRAIN RES, V134, P52, DOI 10.1016/j.molbrainres.2004.11.005; BUTLER J, 1993, BIOCHIM BIOPHYS ACTA, V1161, P73, DOI 10.1016/0167-4838(93)90198-Z; Cohen G. M., 1987, BR J CANC S, V8, P46; Crabtree MJ, 2011, NITRIC OXIDE-BIOL CH, V25, P81, DOI 10.1016/j.niox.2011.04.004; Curtius H C, 1984, Adv Neurol, V40, P463; Day BJ, 1999, P NATL ACAD SCI USA, V96, P12760, DOI 10.1073/pnas.96.22.12760; DICKER E, 1991, BIOCHEM PHARMACOL, V42, P529, DOI 10.1016/0006-2952(91)90315-V; Farrugia R, 2007, MOL GENET METAB, V90, P277, DOI 10.1016/j.ymgme.2006.10.013; FERRE J, 1988, CLIN CHIM ACTA, V174, P271, DOI 10.1016/0009-8981(88)90053-8; Fujimoto K, 2001, CHEM-BIOL INTERACT, V130, P825, DOI 10.1016/S0009-2797(00)00238-6; Fujimoto K, 1999, BBA-PROTEIN STRUCT M, V1431, P306, DOI 10.1016/S0167-4838(99)00054-0; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fussell KC, 2011, FREE RADICAL BIO MED, V50, P874, DOI 10.1016/j.freeradbiomed.2010.12.035; Gray JP, 2007, J BIOL CHEM, V282, P7939, DOI 10.1074/jbc.M611817200; Ham SW, 2004, BIOORG MED CHEM LETT, V14, P4103, DOI 10.1016/j.bmcl.2004.05.009; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Homma D, 2011, J BIOL CHEM, V286, P1445, DOI 10.1074/jbc.M110.159426; KATOH S, 1971, ARCH BIOCHEM BIOPHYS, V146, P202, DOI 10.1016/S0003-9861(71)80057-7; KIMBROUGH RD, 1970, TOXICOL APPL PHARM, V17, P679, DOI 10.1016/0041-008X(70)90042-6; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Kovacic P, 2009, REV ENVIRON CONTAM T, V201, P41, DOI 10.1007/978-1-4419-0032-6_2; KUBOTA S, 1977, J BIOCHEM-TOKYO, V81, P187, DOI 10.1093/oxfordjournals.jbchem.a131434; Mandel JS, 2012, REGUL TOXICOL PHARM, V62, P385, DOI 10.1016/j.yrtph.2011.10.004; Marin A, 1997, BRIT J CANCER, V76, P923, DOI 10.1038/bjc.1997.485; Matsunaga T, 2011, FREE RADICAL RES, V45, P848, DOI 10.3109/10715762.2011.585648; MAU BL, 1990, FREE RADICAL RES COM, V8, P365, DOI 10.3109/10715769009053370; Mishin VA, 2004, BIOCHEM PHARMACOL, V68, P747, DOI 10.1016/j.bcp.2004.05.004; O'Donnell BV, 1993, BIOCH J 1, V290, P41; Oppermann UCT, 1997, BIOCHEMISTRY-US, V36, P34, DOI 10.1021/bi961803v; Osman AM, 2003, J APPL TOXICOL, V23, P209, DOI 10.1002/jat.908; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Park HS, 2009, RESPIROLOGY, V14, P27, DOI 10.1111/j.1440-1843.2008.01447.x; Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010; RASHBASTEP J, 1994, MOL PHARMACOL, V45, P150; Roginsky VA, 1999, CHEM-BIOL INTERACT, V121, P177, DOI 10.1016/S0009-2797(99)00099-X; Shultz CA, 2011, CHEM RES TOXICOL, V24, P2153, DOI 10.1021/tx200294c; SMITH GK, 1992, J BIOL CHEM, V267, P5599; SUEOKA T, 1985, BIOCHIM BIOPHYS ACTA, V843, P193, DOI 10.1016/0304-4165(85)90139-4; Supangat S, 2006, J BIOL CHEM, V281, P2249, DOI 10.1074/jbc.M509343200; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Tanaka N, 1996, STRUCTURE, V4, P33, DOI 10.1016/S0969-2126(96)00007-X; TANI Y, 1994, NEUROSCI LETT, V181, P169, DOI 10.1016/0304-3940(94)90586-X; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Verbeekac MM, 2008, MOL GENET METAB, V94, P403, DOI 10.1016/j.ymgme.2008.04.003; Wang Y, 2010, MOL CANCER THER, V9, P1852, DOI 10.1158/1535-7163.MCT-09-1098; Wang Y, 2008, FREE RADICAL BIO MED, V44, P1169, DOI 10.1016/j.freeradbiomed.2007.12.013; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Wolff DJ, 1997, ARCH BIOCHEM BIOPHYS, V338, P73, DOI 10.1006/abbi.1996.9811; Yang S, 2006, AM J HUM GENET, V78, P575, DOI 10.1086/501372; YUBISUI T, 1980, J BIOL CHEM, V255, P2454; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	58	18	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19221	19237		10.1074/jbc.M112.402164	http://dx.doi.org/10.1074/jbc.M112.402164			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23640889	hybrid, Green Published			2022-12-25	WOS:000321335800055
J	Onal, M; Piemontese, M; Xiong, JH; Wang, YY; Han, L; Ye, SQ; Komatsu, M; Selig, M; Weinstein, RS; Zhao, HB; Jilka, RL; Almeida, M; Manolagas, SC; O'Brien, CA				Onal, Melda; Piemontese, Marilina; Xiong, Jinhu; Wang, Yiying; Han, Li; Ye, Shiqiao; Komatsu, Masaaki; Selig, Martin; Weinstein, Robert S.; Zhao, Haibo; Jilka, Robert L.; Almeida, Maria; Manolagas, Stavros C.; O'Brien, Charles A.			Suppression of Autophagy in Osteocytes Mimics Skeletal Aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRABECULAR BONE LOSS; OSTEOCLAST FORMATION; TARGETED DELETION; RANKL EXPRESSION; OXIDATIVE STRESS; BMP ANTAGONIST; MICE; CELLS; GENE; OSTEOPOROSIS	Bone mass declines with age but the mechanisms responsible remain unclear. Here we demonstrate that deletion of a conditional allele for Atg7, a gene essential for autophagy, from osteocytes caused low bone mass in 6-month-old male and female mice. Cancellous bone volume and cortical thickness were decreased, and cortical porosity increased, in conditional knock-out mice compared with control littermates. These changes were associated with low osteoclast number, osteoblast number, bone formation rate, and wall width in the cancellous bone of conditional knock-out mice. In addition, oxidative stress was higher in the bones of conditional knock-out mice as measured by reactive oxygen species levels in the bone marrow and by p66(shc) phosphorylation in L6 vertebra. Each of these changes has been previously demonstrated in the bones of old versus young adult mice. Thus, these results demonstrate that suppression of autophagy in osteocytes mimics, in many aspects, the impact of aging on the skeleton and suggest that a decline in autophagy with age may contribute to the low bone mass associated with aging.	[Onal, Melda; Piemontese, Marilina; Xiong, Jinhu; Wang, Yiying; Han, Li; Ye, Shiqiao; Weinstein, Robert S.; Zhao, Haibo; Jilka, Robert L.; Almeida, Maria; Manolagas, Stavros C.; O'Brien, Charles A.] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Onal, Melda; Piemontese, Marilina; Xiong, Jinhu; Wang, Yiying; Han, Li; Ye, Shiqiao; Weinstein, Robert S.; Zhao, Haibo; Jilka, Robert L.; Almeida, Maria; Manolagas, Stavros C.; O'Brien, Charles A.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Prot Metab Project, Tokyo 1568506, Japan; [Selig, Martin] Massachusetts Gen Hosp, Pathol Serv, Electron Microscopy Unit, Boston, MA 02114 USA; [Selig, Martin] Harvard Univ, Sch Med, Boston, MA 02114 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; Tokyo Metropolitan Institute of Medical Science; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	O'Brien, CA (corresponding author), Univ Arkansas Med Sci, 4301 W Markham St,MS 587, Little Rock, AR 72205 USA.	caobrien@uams.edu	O'Brien, Charles A./AAL-5078-2020; Ye, Shiqiao/N-2873-2015; xiong, jinhu/E-1849-2011; Liu, Juan/J-5155-2015; Zhao, Haibo/ABG-9729-2021; Komatsu, Masaaki/B-8321-2011	Ye, Shiqiao/0000-0003-1529-7102; Komatsu, Masaaki/0000-0001-7672-7722; ZHAO, HAIBO/0000-0003-0836-7555; Almeida, Maria/0000-0002-6722-9200; Piemontese, Marilina/0000-0002-9296-1348	National Institutes of Health [AG13918, AR049794]; Central Arkansas Veteran's Healthcare System [1I01BX000294]; UAMS Translational Research Institute [UL1RR029884]; UAMS tobacco settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central Arkansas Veteran's Healthcare System; UAMS Translational Research Institute; UAMS tobacco settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants AG13918 (to S. C. M.) and AR049794 (to C. A. O.) and the Central Arkansas Veteran's Healthcare System (Merit Review 1I01BX000294, to C. A. O.). Additional support was provided by the UAMS Translational Research Institute (UL1RR029884) and by UAMS tobacco settlement funds.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Deretic V, 2012, TRENDS CELL BIOL, V22, P397, DOI 10.1016/j.tcb.2012.04.008; Di Gregorio GB, 2001, J CLIN INVEST, V107, P803, DOI 10.1172/JCI11653; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Emerton KB, 2010, BONE, V46, P577, DOI 10.1016/j.bone.2009.11.006; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Galli C, 2008, ENDOCRINOLOGY, V149, P146, DOI 10.1210/en.2007-0734; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Jilka RL, 2013, BONE, V54, P264, DOI 10.1016/j.bone.2012.11.038; Jilka RL, 2010, AGING CELL, V9, P851, DOI 10.1111/j.1474-9726.2010.00616.x; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; Martin-Millan M, 2010, MOL ENDOCRINOL, V24, P323, DOI 10.1210/me.2009-0354; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Miao DS, 2004, ENDOCRINOLOGY, V145, P2046, DOI 10.1210/en.2003-1097; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; O'Brien CA, 2005, AM J PHYSIOL-ENDOC M, V289, pE784, DOI 10.1152/ajpendo.00029.2005; PARFITT AM, 1995, J BONE MINER RES, V10, P466; Riggs BL, 2008, J BONE MINER RES, V23, P205, DOI 10.1359/JBMR.071020; Salminen A, 2009, TRENDS MOL MED, V15, P217, DOI 10.1016/j.molmed.2009.03.004; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Shahnazari M, 2012, BONE, V50, P628, DOI 10.1016/j.bone.2011.11.010; Sheng MHC, 2013, BONE, V52, P133, DOI 10.1016/j.bone.2012.09.027; Silbermann M, 1987, Compr Gerontol A, V1, P45; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Vellai T, 2009, TRENDS CELL BIOL, V19, P487, DOI 10.1016/j.tcb.2009.07.007; Weinstein RS, 2010, AGING CELL, V9, P147, DOI 10.1111/j.1474-9726.2009.00545.x; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; XI H, 1993, TOXICOL APPL PHARM, V120, P29, DOI 10.1006/taap.1993.1083; Xia XC, 2010, J BONE MINER RES, V25, P2479, DOI 10.1002/jbmr.160; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yen WL, 2008, PHYSIOLOGY, V23, P248, DOI 10.1152/physiol.00013.2008; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	53	133	146	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17432	17440		10.1074/jbc.M112.444190	http://dx.doi.org/10.1074/jbc.M112.444190			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645674	hybrid, Green Published			2022-12-25	WOS:000320380600035
J	Yin, JJ; Sharma, S; Shumyak, SP; Wang, ZX; Zhou, ZW; Zhang, YD; Guo, PX; Li, CZ; Kanwar, JR; Yang, TX; Mohapatra, SS; Liu, WQ; Duan, W; Wang, JC; Li, Q; Zhang, XJ; Tan, J; Jia, L; Liang, J; Wei, MQ; Li, XT; Zhou, SF				Yin, Juan-Juan; Sharma, Sonali; Shumyak, Stepan P.; Wang, Zhi-Xin; Zhou, Zhi-Wei; Zhang, Yangde; Guo, Peixuan; Li, Chen-Zhong; Kanwar, Jagat R.; Yang, Tianxin; Mohapatra, Shyam S.; Liu, Wanqing; Duan, Wei; Wang, Jian-Cheng; Li, Qi; Zhang, Xueji; Tan, Jun; Jia, Lee; Liang, Jun; Wei, Ming Q.; Li, Xiaotian; Zhou, Shu-Feng			Synthesis and Biological Evaluation of Novel Folic Acid Receptor-Targeted, beta-Cyclodextrin-Based Drug Complexes for Cancer Treatment	PLOS ONE			English	Article							HUMAN CYTOCHROME-P450 2D6; CHINESE HERBAL MEDICINE; MOLECULAR DOCKING; DELIVERY SYSTEMS; FOLATE; DOXORUBICIN; BINDING; LIGAND; CARDIOTOXICITY; ANTHRACYCLINES	Drug targeting is an active area of research and nano-scaled drug delivery systems hold tremendous potential for the treatment of neoplasms. In this study, a novel cyclodextrin (CD)-based nanoparticle drug delivery system has been assembled and characterized for the therapy of folate receptor-positive [FR(+)] cancer. Water-soluble folic acid (FA)conjugated CD carriers (FACDs) were successfully synthesized and their structures were confirmed by 1D/2D nuclear magnetic resonance (NMR), matrix-assisted laser desorption ionization time-of-flight mass spectrometer (MALDI-TOF-MS), high performance liquid chromatography (HPLC), Fourier transform infrared spectroscopy (FTIR), and circular dichroism. Drug complexes of adamatane (Ada) and cytotoxic doxorubicin (Dox) with FACD were readily obtained by mixed solvent precipitation. The average size of FACD-Ada-Dox was 1.5-2.5 nm. The host-guest association constant K-a was 1,639 M-1 as determined by induced circular dichroism and the hydrophilicity of the FACDs was greatly enhanced compared to unmodified CD. Cellular uptake and FR binding competitive experiments demonstrated an efficient and preferentially targeted delivery of Dox into FR-positive tumor cells and a sustained drug release profile was seen in vitro. The delivery of Dox into FR(+) cancer cells via endocytosis was observed by confocal microscopy and drug uptake of the targeted nanoparticles was 8-fold greater than that of non-targeted drug complexes. Our docking results suggest that FA, FACD and FACD-Ada-Dox could bind human hedgehog interacting protein that contains a FR domain. Mouse cardiomyocytes as well as fibroblast treated with FACD-Ada-Dox had significantly lower levels of reactive oxygen species, with increased content of glutathione and glutathione peroxidase activity, indicating a reduced potential for Dox-induced cardiotoxicity. These results indicate that the targeted drug complex possesses high drug association and sustained drug release properties with good biocompatibility and physiological stability. The novel FA-conjugated beta-CD based drug complex might be promising as an anti-tumor treatment for FR(+) cancer.	[Yin, Juan-Juan; Sharma, Sonali; Shumyak, Stepan P.; Wang, Zhi-Xin; Zhou, Zhi-Wei; Liang, Jun; Zhou, Shu-Feng] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA; [Zhang, Yangde] Cent S Univ, Natl Hepatobiliary & Enter Surg Res Ctr, Changsha, Hunan, Peoples R China; [Guo, Peixuan] Univ Kentucky, Coll Pharm, Nanobiotechnol Ctr & Markey Canc Ctr, Lexington, KY USA; [Li, Chen-Zhong] Florida Int Univ, Nanobioengn & Bioelect Lab, Dept Biomed Engn, Miami, FL 33199 USA; [Kanwar, Jagat R.] Deakin Univ, Nanomed Lab Immunol & Mol Biomed Res LIMBR, Ctr Biotechnol & Interdisciplinary Biosci, Waurn Ponds, Vic, Australia; [Kanwar, Jagat R.] Deakin Univ, Inst Frontier Mat, Waurn Ponds, Vic, Australia; [Yang, Tianxin] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Yang, Tianxin] Salt Lake Vet Affairs Med Ctr, Salt Lake City, UT USA; [Mohapatra, Shyam S.] Univ S Florida, Nanomed Res Ctr, Tampa, FL USA; [Mohapatra, Shyam S.] Univ S Florida, Dept Internal Med, Div Translat Med, Morsani Coll Med, Tampa, FL 33612 USA; [Liu, Wanqing] Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, Indiana, PA USA; [Duan, Wei] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia; [Wang, Jian-Cheng; Jia, Lee] Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100871, Peoples R China; [Li, Qi] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Oncol, Shanghai, Peoples R China; [Zhang, Xueji] Univ Sci & Technol Beijing, Res Ctr Bioengineering & Sensing Technol, Beijing 100083, Peoples R China; [Tan, Jun] James A Haley Vet Adm Hosp, Tampa, FL USA; [Liang, Jun] Univ S Florida, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Morsani Coll Med, Tampa, FL USA; [Tan, Jun] Univ S Florida, Dept Psychiat & Behav Neurosci, Morsani Coll Med, Silver Child Dev Ctr,Rashid Lab Dev Neurobiol, Tampa, FL USA; [Liang, Jun] Fuzhou Univ, Coll Chem & Chem Engn, Canc Metastasis Alert & Prevent Ctr, Fuzhou 350002, Peoples R China; [Wei, Ming Q.] Griffith Univ, Griffith Hlth Inst, Div Mol & Gene Therapies, Sch Med Sci, Nathan, Qld 4111, Australia; [Li, Xiaotian] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Li, Xiaotian] Fudan Univ, Inst Biomed, Shanghai, Peoples R China	State University System of Florida; University of South Florida; Central South University; University of Kentucky; State University System of Florida; Florida International University; Deakin University; Deakin University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Purdue University System; Purdue University; Deakin University; Peking University; Shanghai University of Traditional Chinese Medicine; University of Science & Technology Beijing; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Fuzhou University; Griffith University; Menzies Health Institute Queensland; Fudan University; Fudan University	Zhou, SF (corresponding author), Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA.	szhou@health.usf.edu	zhang, xueji/ABE-6497-2020; Guo, Peixuan/AAE-2573-2022; zhou, zhiwei/J-7878-2015; Li, Chenzhong/F-5087-2016; wang, zhixin/GZH-2500-2022; Mohapatra, Shyam/C-2500-2012; zhang, xueji/B-1904-2010; Li, Xiaotian/ABI-3309-2020; Guo, Peixuan/I-7184-2015; Duan, Wei/A-5181-2015; Zhou, Shu-Feng/E-3166-2013	zhang, xueji/0000-0002-0035-3821; Guo, Peixuan/0000-0001-5706-2833; zhou, zhiwei/0000-0002-8227-2573; Li, Xiaotian/0000-0002-2051-4581; Duan, Wei/0000-0001-5782-9184; Zhou, Shu-Feng/0000-0002-5542-6119; Liu, Wanqing/0000-0001-7727-6900; JIA, LEE/0000-0001-6839-5545	College of Pharmacy, University of South Florida, Tampa, Florida	College of Pharmacy, University of South Florida, Tampa, Florida	Dr JJY is supported by a postdoctoral scholarship from the College of Pharmacy, University of South Florida, 12901 Bruce B Downs Blvd., Tampa, Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Bishop B, 2009, NAT STRUCT MOL BIOL, V16, P698, DOI 10.1038/nsmb.1607; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Chen G, 2011, CHEM SOC REV, V40, P2254, DOI 10.1039/c0cs00153h; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; Dickey JS, 2012, CURR MOL MED, V12, P763; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Fan J, 2012, SMALL; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gatenby RA, 2009, NATURE, V459, P508, DOI 10.1038/459508a; Granadero D, 2010, INT J MOL SCI, V11, P173, DOI 10.3390/ijms11010173; Hanusova V, 2011, DRUG METAB REV, V43, P540, DOI 10.3109/03602532.2011.609174; Hilgenbrink AR, 2005, J PHARM SCI-US, V94, P2135, DOI 10.1002/jps.20457; Hochdorffer K, 2012, J MED CHEM, V55, P7502, DOI 10.1021/jm300493m; Kizek R, 2012, PHARMACOL THERAPEUT, V133, P26, DOI 10.1016/j.pharmthera.2011.07.006; Kratz F, 2012, J CONTROL RELEASE, V164, P221, DOI 10.1016/j.jconrel.2012.05.045; Lammers T, 2012, J CONTROL RELEASE, V161, P175, DOI 10.1016/j.jconrel.2011.09.063; Legigan T, 2012, J MED CHEM, V55, P4516, DOI 10.1021/jm300348r; Menna P, 2012, EXPERT OPIN DRUG SAF, V11, pS21, DOI 10.1517/14740338.2011.589834; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mo SL, 2012, CURR PHARM BIOTECHNO, V13, P1640, DOI 10.2174/138920112800958779; Mo SL, 2012, COMB CHEM HIGH T SCR, V15, P36, DOI 10.2174/138620712798280826; Muro S, 2012, J CONTROL RELEASE, V164, P125, DOI 10.1016/j.jconrel.2012.05.052; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; PETTER RC, 1990, J AM CHEM SOC, V112, P3860, DOI 10.1021/ja00166a021; Roy PP, 2010, MOL SIMULAT, V36, P887, DOI 10.1080/08927022.2010.492834; Sabharanjak S, 2004, ADV DRUG DELIVER REV, V56, P1099, DOI 10.1016/j.addr.2004.01.010; Salas C, 2011, REV INVEST CLIN, V63, P53; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; WEITMAN SD, 1992, CANCER RES, V52, P3396; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yague E, 2005, BRIT J CANCER, V93, P973, DOI 10.1038/sj.bjc.6602821; Zhao XB, 2008, EXPERT OPIN DRUG DEL, V5, P309, DOI [10.1517/17425247.5.3.309, 10.1517/17425247.5.3.309 ]	38	51	52	2	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62289	10.1371/journal.pone.0062289	http://dx.doi.org/10.1371/journal.pone.0062289			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658721	Green Published, Green Submitted, gold			2022-12-25	WOS:000321200500022
J	Cui, HX; Zhang, WL; Hu, W; Liu, K; Wang, T; Ma, N; Liu, XH; Liu, YP; Jiang, YH				Cui, Huixia; Zhang, Wenlu; Hu, Wei; Liu, Kun; Wang, Tong; Ma, Nan; Liu, Xiaohui; Liu, Yunpeng; Jiang, Youhong			Recombinant Mammaglobin A Adenovirus-Infected Dendritic Cells Induce Mammaglobin A-Specific CD8(+) Cytotoxic T Lymphocytes against Breast Cancer Cells In Vitro	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CELLULAR IMMUNE-RESPONSES; VIRUS CORE ANTIGEN; INDUCED MATURATION; PERIPHERAL-BLOOD; ACTIVATION; GENERATION; VIVO; IDENTIFICATION; VACCINATION	Mammaglobin A (MGBA) is a novel breast cancer-associated antigen almost exclusively over-expressed in primary and metastatic human breast cancers, making it a potential therapeutic target for breast cancer. The development of dendritic cell (DC)-induced tumor antigen specific CD8(+) cytotoxic T lymphocytes (CTLs) may hold promise in cancer immunotherapy. In this study we constructed recombinant replication-defective adenoviral (Ad) vectors encoding MGBA and evaluated their ability to trigger anti-tumor immunity in vitro. DCs were isolated from the human peripheral blood monocyte cells (PBMCs) of two HLA-A33(+) healthy female volunteers, and infected with adenovirus carrying MGBA cDNA (Ad-MGBA). After that, the Ad-MGBA-infected DCs were used to stimulate CD8(+) CTLs in vitro and the latter was used for co-culture with breast cancer cell lines. The data revealed that infection with Ad-MGBA improved DC maturation and up-regulated the expression of costimulatory molecules and the secretion of interleukin-12 (IL-12), but down-regulated interleukin-10 (IL-10) secretion from DCs. Ad-MGBA-infected DC-stimulated CD8(+) CTLs displayed the highest cytotoxicity towards HLA-A33(+)/MGBA(+) breast cancer MDA-MB-415 cells compared with other CD8(+) CTL populations, and compared with the cytotoxicity towards HLA-A33(-)/MGBA(+) breast cancer HBL-100 cells and HLA-A33(-)/MGBA(-) breast cancer MDA-MB 231 cells. In addition, Ad-MGBA infected DC-stimulated CD8(+) CTLs showed a high level of IFN gamma secretion when stimulated with HLA-A33(+)/MGBA(+) breast cancer MDA-MB-415 cells, but not when stimulated with HLA-A33(-)/MGBA(+) HBL-100 and HLA-A33(-)/MGBA(-)MDA-MB-231 cells. In addition, killing of CD8(+) CTLs against breast cancer was in a major histocompability complex (MHC)-limited pattern. Finally, the data also determined the importance of TNF-alpha in activating DCs and T cells. These data together suggest that MGBA recombinant adenovirus-infected DCs could induce specific anti-tumor immunity against MGBA(+) breast cancers, which could provide a novel strategy in the immunotherapy of breast cancer.	[Cui, Huixia; Hu, Wei; Wang, Tong; Ma, Nan; Liu, Xiaohui; Jiang, Youhong] China Med Univ, Hosp 1, Canc Res Inst, Shenyang, Peoples R China; [Cui, Huixia; Liu, Kun] Liaoning Med Univ, Coll Nursing, Jinzhou, Peoples R China; [Zhang, Wenlu] Liaoning Med Univ, Hosp 1, Dept Oncol, Jinzhou, Peoples R China; [Liu, Yunpeng] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Peoples R China	China Medical University; Jinzhou Medical University; Jinzhou Medical University; China Medical University	Jiang, YH (corresponding author), China Med Univ, Hosp 1, Canc Res Inst, Shenyang, Peoples R China.	jiangyouhong2000@yahoo.com.cn			Science and Technology project of Liaoning Province [2011415052-3]; Youth Foundation of Liaoning Medical University [Y2012Z013]	Science and Technology project of Liaoning Province; Youth Foundation of Liaoning Medical University	This study was supported by grants from the Science and Technology project of Liaoning Province (No. 2011415052-3) and the Youth Foundation of Liaoning Medical University (No. Y2012Z013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Joudi FS, 2011, INDIAN J PATHOL MICR, V54, P284, DOI 10.4103/0377-4929.81596; Aline F, 2009, VACCINE, V27, P5284, DOI 10.1016/j.vaccine.2009.05.028; Balwin Jr AS, 1995, ANNU REV IMMUNOL, V14, P649; Basha HI, 2011, BREAST CANCER RES TR, V127, P81, DOI 10.1007/s10549-010-0975-z; Bernstein JL, 2005, CLIN CANCER RES, V11, P6528, DOI 10.1158/1078-0432.CCR-05-0415; Ceballos MP, 2011, CLIN BIOCHEM, V44, P1429, DOI 10.1016/j.clinbiochem.2011.08.1140; Chamoto K, 2003, CANCER SCI, V94, P924, DOI 10.1111/j.1349-7006.2003.tb01377.x; Chen BG, 1998, BLOOD, V91, P4652, DOI 10.1182/blood.V91.12.4652.412a03_4652_4661; Chen JH, 2012, WORLD J GASTROENTERO, V18, P1319, DOI 10.3748/wjg.v18.i12.1319; Chen XH, 2008, ACTA BIOCH BIOPH SIN, V40, P996, DOI 10.1111/j.1745-7270.2008.00487.x; Fleming TP, 2000, ANN NY ACAD SCI, V923, P78, DOI 10.1111/j.1749-6632.2000.tb05521.x; Garetto S, 2009, CYTOTHERAPY, V11, P1090, DOI 10.3109/14653240903164971; Ge CY, 2011, INT IMMUNOPHARMACOL, V11, P2200, DOI 10.1016/j.intimp.2011.10.001; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; He Dandan, 2010, CHINA CANC, V19, P108; Herrera OB, 2002, VACCINE, V21, P231, DOI 10.1016/S0264-410X(02)00448-6; Hirata N, 2011, CELL IMMUNOL, V266, P165, DOI 10.1016/j.cellimm.2010.09.012; Hirschowitz EA, 2000, GENE THER, V7, P1112, DOI 10.1038/sj.gt.3301210; Jaramillo A, 2004, BREAST CANCER RES TR, V88, P29, DOI 10.1007/s10549-004-8918-1; [进淑娟 Jin Shujuan], 2010, [军事医学科学院院刊, Bulletin of the Academy of Military Medical Sciences], V34, P440; Kim J, 2013, FOOD FUNCT, V4, P258, DOI 10.1039/c2fo30209h; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Li A, 2011, DNA CELL BIOL, V30, P883, DOI 10.1089/dna.2011.1222; Manna PP, 2003, BREAST CANCER RES TR, V79, P133, DOI 10.1023/A:1023323509888; Micheva I, 2004, CLIN IMMUNOL, V113, P310, DOI 10.1016/j.clim.2004.08.007; Mikhitarian K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-55; Miyazawa M, 2011, CANCER LETT, V305, P32, DOI 10.1016/j.canlet.2011.02.013; Morelli AE, 2000, J VIROL, V74, P9617, DOI 10.1128/JVI.74.20.9617-9628.2000; Narayanan K, 2004, JNCI-J NATL CANCER I, V96, P1388, DOI 10.1093/jnci/djh261; Noh YW, 2011, BIOMATERIALS, V32, P6254, DOI 10.1016/j.biomaterials.2011.05.013; Philpott NJ, 2004, P NATL ACAD SCI USA, V101, P6200, DOI 10.1073/pnas.0308368101; Smits ELJM, 2009, HUM GENE THER, V20, P1106, DOI 10.1089/hum.2009.145; Tian S, 2009, GENE THER, V16, P1260, DOI 10.1038/gt.2009.110; Tiriveedhi V, 2012, HUM IMMUNOL, V73, P11, DOI 10.1016/j.humimm.2011.10.017; Vujanovic L, 2009, CANCER IMMUNOL IMMUN, V58, P121, DOI 10.1007/s00262-008-0533-2; WATSON MA, 1994, CANCER RES, V54, P4598; Watson MA, 1996, CANCER RES, V56, P860; Wei CH, 2002, HUM IMMUNOL, V63, P821, DOI 10.1016/S0198-8859(02)00454-8; WeiPeng, 2011, VACCINE, V29, P3501, DOI 10.1016/j.vaccine.2011.02.027; Wierecky J, 2006, CANCER IMMUNOL IMMUN, V55, P63, DOI 10.1007/s00262-005-0673-6; Wintermeyer P, 2010, J VIRAL HEPATITIS, V17, P705, DOI 10.1111/j.1365-2893.2009.01228.x; Wu YG, 2010, MED ONCOL, V27, P736, DOI 10.1007/s12032-009-9277-x; Xie LH, 2008, CANCER IMMUNOL IMMUN, V57, P1029, DOI 10.1007/s00262-007-0434-9; Yoon SH, 2009, EXP MOL MED, V41, P161, DOI 10.3858/emm.2009.41.3.019; Young J W, 1999, Curr Opin Hematol, V6, P135, DOI 10.1097/00062752-199905000-00003	45	5	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63055	10.1371/journal.pone.0063055	http://dx.doi.org/10.1371/journal.pone.0063055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650543	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000088
J	Gallego, O; Specht, T; Brach, T; Kumar, A; Gavin, AC; Kaksonen, M				Gallego, Oriol; Specht, Tanja; Brach, Thorsten; Kumar, Arun; Gavin, Anne-Claude; Kaksonen, Marko			Detection and Characterization of Protein Interactions In Vivo by a Simple Live-Cell Imaging Method	PLOS ONE			English	Article							LIVING CELLS; SACCHAROMYCES-CEREVISIAE; YEAST; COMPLEMENTATION; DOMAINS	Over the last decades there has been an explosion of new methodologies to study protein complexes. However, most of the approaches currently used are based on in vitro assays (e.g. nuclear magnetic resonance, X-ray, electron microscopy, isothermal titration calorimetry etc). The accurate measurement of parameters that define protein complexes in a physiological context has been largely limited due to technical constrains. Here, we present PICT (Protein interactions from Imaging of Complexes after Translocation), a new method that provides a simple fluorescence microscopy readout for the study of protein complexes in living cells. We take advantage of the inducible dimerization of FK506-binding protein (FKBP) and FKBP-rapamycin binding (FRB) domain to translocate protein assemblies to membrane associated anchoring platforms in yeast. In this assay, GFP-tagged prey proteins interacting with the FRB-tagged bait will co-translocate to the FKBP-tagged anchor sites upon addition of rapamycin. The interactions are thus encoded into localization changes and can be detected by fluorescence live-cell imaging under different physiological conditions or upon perturbations. PICT can be automated for high-throughput studies and can be used to quantify dissociation rates of protein complexes in vivo. In this work we have used PICT to analyze protein-protein interactions from three biological pathways in the yeast Saccharomyces cerevisiae: Mitogen-activated protein kinase cascade (Ste5-Ste11-Ste50), exocytosis (exocyst complex) and endocytosis (Ede1-Syp1).	[Gallego, Oriol] IRB, Barcelona, Spain; [Gallego, Oriol; Specht, Tanja; Brach, Thorsten; Kumar, Arun; Gavin, Anne-Claude; Kaksonen, Marko] European Mol Biol Lab, Heidelberg, Germany	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; European Molecular Biology Laboratory (EMBL)	Kaksonen, M (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	kaksonen@embl.de	Gallego, Oriol/R-9559-2018; Gallego, Oriol/S-2933-2019	Gallego, Oriol/0000-0001-7479-2563; Gallego, Oriol/0000-0001-7479-2563; Brach, Thorsten/0000-0002-6740-4013; KUMAR, ARUN/0000-0001-8706-8558; Kaksonen, Marko/0000-0003-3645-7689; Gavin, Anne-Claude/0000-0003-4917-2340	Ramon y Cajal program of the Spanish government	Ramon y Cajal program of the Spanish government(Spanish Government)	OG is funded by the Ramon y Cajal program of the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Brach T, 2011, J CELL SCI, V124, P328, DOI 10.1242/jcs.078519; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Charbonnier S, 2008, BIOTECHNOL ANN REV, V14, P1, DOI 10.1016/S1387-2656(08)00001-X; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; CHOI KY, 1994, CELL, V78, P499; Gallego O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.87; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Knop M, 1999, AIDYEA399 3 0 CO 2 W; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Michnick SW, 2000, METHOD ENZYMOL, V328, P208, DOI 10.1016/S0076-6879(00)28399-7; Periasamy A, 1999, METHOD CELL BIOL, V58, P293; Rad MR, 1998, MOL GEN GENET, V259, P29, DOI 10.1007/s004380050785; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; Skruzny M, 2012, P NATL ACAD SCI USA, V109, pE2533, DOI 10.1073/pnas.1207011109; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Wehrman T, 2002, P NATL ACAD SCI USA, V99, P3469, DOI 10.1073/pnas.062043699; Young KH, 1998, BIOL REPROD, V58, P302, DOI 10.1095/biolreprod58.2.302; Ziolkowska NE, 2011, NAT STRUCT MOL BIOL, V18, P854, DOI 10.1038/nsmb.2080	23	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62195	10.1371/journal.pone.0062195	http://dx.doi.org/10.1371/journal.pone.0062195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658712	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000033
J	Han, M; Heppel, SC; Su, T; Bogs, J; Zu, YG; An, ZG; Rausch, T				Han, Mei; Heppel, Simon C.; Su, Tao; Bogs, Jochen; Zu, Yuangang; An, Zhigang; Rausch, Thomas			Enzyme Inhibitor Studies Reveal Complex Control of Methyl-D-Erythritol 4-Phosphate (MEP) Pathway Enzyme Expression in Catharanthus roseus	PLOS ONE			English	Article							METHYLERYTHRITOL PHOSPHATE-PATHWAY; 1-DEOXY-D-XYLULOSE 5-PHOSPHATE SYNTHASE; NON-MEVALONATE PATHWAY; INDOLE ALKALOID PRODUCTION; ISOPRENOID BIOSYNTHESIS; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; MUTANT REVEALS; ACCUMULATION; PLANTS	In Catharanthus roseus, the monoterpene moiety exerts a strong flux control for monoterpene indole alkaloid (MIA) formation. Monoterpene synthesis depends on the methyl-D-erythritol 4-phosphate (MEP) pathway. Here, we have explored the regulation of this pathway in response to developmental and environmental cues and in response to specific enzyme inhibitors. For the MEP pathway entry enzyme 1-deoxy-D-xylulose 5-phosphate synthase (DXS), a new (type I) DXS isoform, CrDXS1, has been cloned, which, in contrast to previous reports on type II CrDXS, was not transcriptionally activated by the transcription factor ORCA3. Regulation of the MEP pathway in response to metabolic perturbations has been explored using the enzyme inhibitors clomazone (precursor of 5-ketochlomazone, inhibitor of DXS) and fosmidomycin (inhibitor of deoxyxylulose 5-phosphate reductoisomerase (DXR)), respectively. Young leaves of non-flowering plants were exposed to both inhibitors, adopting a non-invasive in vivo technique. Transcripts and proteins of DXS (3 isoforms), DXR, and hydroxymethylbutenyl diphosphate synthase (HDS) were monitored, and protein stability was followed in isolated chloroplasts. Transcripts for DXS1 were repressed by both inhibitors, whereas transcripts for DXS2A& B, DXR and HDS increased after clomazone treatment but were barely affected by fosmidomycin treatment. DXS protein accumulated in response to both inhibitors, whereas DXR and HDS proteins were less affected. Fosmidomycin-induced accumulation of DXS protein indicated substantial posttranscriptional regulation. Furthermore, fosmidomycin effectively protected DXR against degradation in planta and in isolated chloroplasts. Thus our results suggest that DXR protein stability may be affected by substrate binding. In summary, the present results provide novel insight into the regulation of DXS expression in C. roseus in response to MEP-pathway perturbation.	[Han, Mei; Heppel, Simon C.; Su, Tao; Rausch, Thomas] Heidelberg Univ, Ctr Organismal Studies COS Heidelberg, Heidelberg, Germany; [Bogs, Jochen] Dienstleistungszentrum Landlicher Raum Rheinpfalz, Neustadt, Germany; [Zu, Yuangang; An, Zhigang] Northeast Forestry Univ, Minist Educ, Key Lab Forest Plant Ecol, Harbin, Peoples R China	Ruprecht Karls University Heidelberg; Northeast Forestry University - China	Rausch, T (corresponding author), Heidelberg Univ, Ctr Organismal Studies COS Heidelberg, Heidelberg, Germany.	thomas.rausch@cos.uni-heidelberg.de	SU, TAO/N-4904-2015; Han, Mei/O-6714-2015; Han, Mei/R-2144-2017	SU, TAO/0000-0003-4267-0574; Han, Mei/0000-0001-7073-7225	Heidelberg University Core; DAAD	Heidelberg University Core; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	Funding came from Heidelberg University Core Funding and a DAAD stipend to Mei Han. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argenta L. C., 1991, Revista Brasileira de Fisiologia Vegetal, V3, P69; Burlat V, 2004, PLANT J, V38, P131, DOI 10.1111/j.1365-313X.2004.02030.x; Carretero-Paulet L, 2006, PLANT MOL BIOL, V62, P683, DOI 10.1007/s11103-006-9051-9; Chahed K, 2000, PLANT PHYSIOL BIOCH, V38, P559, DOI 10.1016/S0981-9428(00)00781-6; Contin A, 1998, FEBS LETT, V434, P413, DOI 10.1016/S0014-5793(98)01022-9; Cordoba E, 2011, J EXP BOT, V62, P2023, DOI 10.1093/jxb/erq393; Cordoba E, 2009, J EXP BOT, V60, P2933, DOI 10.1093/jxb/erp190; Dubey VS, 2003, J BIOSCIENCES, V28, P637, DOI 10.1007/BF02703339; Dutta A, 2007, PLANT CELL REP, V26, P907, DOI 10.1007/s00299-007-0305-z; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; Facchini PJ, 2008, PLANT J, V54, P763, DOI 10.1111/j.1365-313X.2008.03438.x; Ferhatoglu Y, 2006, PESTIC BIOCHEM PHYS, V85, P7, DOI 10.1016/j.pestbp.2005.10.002; Flores-Perez U, 2008, PLANT CELL, V20, P1303, DOI 10.1105/tpc.108.058768; Floris M, 2009, INT J MOL SCI, V10, P3168, DOI 10.3390/ijms10073168; Floss DS, 2008, PLANT J, V56, P86, DOI 10.1111/j.1365-313X.2008.03575.x; Gil MJ, 2005, PLANT J, V44, P155, DOI 10.1111/j.1365-313X.2005.02517.x; Guevara-Garcia A, 2005, PLANT CELL, V17, P628, DOI 10.1105/tpc.104.028860; Hedhili Sabah, 2007, Phytochemistry Reviews, V6, P341, DOI 10.1007/s11101-006-9021-5; HELL R, 1990, PLANTA, V180, P603, DOI 10.1007/BF02411460; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Hemmerlin A, 2012, PROG LIPID RES, V51, P95, DOI 10.1016/j.plipres.2011.12.001; Hong SB, 2003, BIOTECHNOL PROGR, V19, P1105, DOI 10.1021/bp034031k; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; JULLIARD JH, 1991, P NATL ACAD SCI USA, V88, P2042, DOI 10.1073/pnas.88.6.2042; Kobayashi K, 2007, PLANT CELL PHYSIOL, V48, P322, DOI 10.1093/pcp/pcm005; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Loyola-Vargas Victor Manuel, 2007, Phytochemistry Reviews, V6, P307, DOI 10.1007/s11101-007-9064-2; Mahmoud SS, 2001, P NATL ACAD SCI USA, V98, P8915, DOI 10.1073/pnas.141237298; Mahroug Samira, 2007, Phytochemistry Reviews, V6, P363, DOI 10.1007/s11101-006-9017-1; Matsue Y, 2010, J ANTIBIOT, V63, P583, DOI 10.1038/ja.2010.100; Mincheva Z, 2005, PHYTOCHEMISTRY, V66, P1797, DOI 10.1016/j.phytochem.2005.06.002; Mueller C, 2000, BIOCHEM SOC T, V28, P792, DOI 10.1042/BST0280792; NORMAN MA, 1990, PLANT PHYSIOL, V92, P777, DOI 10.1104/pp.92.3.777; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; Okada A, 2007, PLANT MOL BIOL, V65, P177, DOI 10.1007/s11103-007-9207-2; Oudin Audrey, 2007, Phytochemistry Reviews, V6, P259, DOI 10.1007/s11101-006-9054-9; Oudin A, 2007, PLANT MOL BIOL, V65, P13, DOI 10.1007/s11103-007-9190-7; Paetzold H, 2010, MOL PLANT, V3, P904, DOI 10.1093/mp/ssq032; Pan QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043038; Peebles CAM, 2011, METAB ENG, V13, P234, DOI 10.1016/j.ymben.2010.11.005; Phillips MA, 2007, PLANT MOL BIOL, V65, P243, DOI 10.1007/s11103-007-9212-5; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Rischer H, 2006, P NATL ACAD SCI USA, V103, P5614, DOI 10.1073/pnas.0601027103; Rivasseau C, 2009, PLANT CELL ENVIRON, V32, P82, DOI 10.1111/j.1365-3040.2008.01903.x; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Rodriguez-Villalon A, 2009, PLANT J, V60, P424, DOI 10.1111/j.1365-313X.2009.03966.x; Sauret-Gueto S, 2006, PLANT PHYSIOL, V141, P75, DOI 10.1104/pp.106.079855; St-Pierre B, 1999, PLANT CELL, V11, P887, DOI 10.1105/tpc.11.5.887; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Umeda T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00009; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; van der Heijden R, 2004, CURR MED CHEM, V11, P607; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veau B, 2000, BBA-GENE STRUCT EXPR, V1517, P159, DOI 10.1016/S0167-4781(00)00240-2; Walter MH, 2002, PLANT J, V31, P243, DOI 10.1046/j.1365-313X.2002.01352.x; Walter MH, 2000, PLANT J, V21, P571, DOI 10.1046/j.1365-313x.2000.00708.x; Xiao YM, 2012, CELL, V149, P1525, DOI 10.1016/j.cell.2012.04.038; Zeidler J, 1998, Z NATURFORSCH C, V53, P980; Zybailov B, 2009, MOL CELL PROTEOMICS, V8, P1789, DOI 10.1074/mcp.M900104-MCP200	62	47	53	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62467	10.1371/journal.pone.0062467	http://dx.doi.org/10.1371/journal.pone.0062467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650515	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000048
J	Kong, XT; Peng, B; Yang, Y; Zhang, PZ; Qin, B; Han, DD; Wang, CJ; Dang, YJ; Liu, JO; Yu, L				Kong, Xiangtao; Peng, Bo; Yang, Yang; Zhang, Pingzhao; Qin, Bo; Han, Dingding; Wang, Chenji; Dang, Yongjun; Liu, Jun O.; Yu, Long			p53 Represses Transcription of RING Finger LIM Domain-Binding Protein RLIM through Sp1	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; TUMOR-SUPPRESSOR P53; WILD-TYPE P53; CELL-LINE; SINA GENE; ACTIVATION; APOPTOSIS; GROWTH; ALPHA; PHOSPHORYLATION	RLIM acts as a negative regulator of LIM-Homeodomain proteins either by recruiting Sin3A/Histone Deacetylase (HDAC) corepressor complex or through degradation of CLIM coactivator, thus playing an important role in embryonic development. Recent studies by different research groups have shown that RLIM acts as an X-encoded, dose-dependent inducer of X chromosome inactivation in mouse embryonic stem cells. However, until now, very little is known about the expression regulation of RLIM gene, and we tried to study the transctriptional regulation of RLIM gene. In the present study, we identified RLIM as a novel target of p53 and demonstrated that p53 repressed both mRNA and protein levels of RLIM. Expression of wild type p53, but not p53 mutants, led to repression of the RLIM promoter activity. We further identified four putative Sp1 elements (S1 to S4) on the RLIM promoter that are essential for p53-mediated repression of RLIM. Although p53 does not directly bind to the RLIM promoter, it physically interacts with and prevents the binding of Sp1 to the RLIM promoter. Thus, RLIM is a novel target of p53, and p53 exerts its inhibitory effect on RLIM expression by interfering with Sp1-mediated transcriptional activation on RLIM. Our results provided data to enlarge the knowledge of transcriptional regulation of RLIM and suggested a new pathway by which physiological and pathological activators of p53 may affect development.	[Kong, Xiangtao; Peng, Bo; Yang, Yang; Zhang, Pingzhao; Qin, Bo; Han, Dingding; Wang, Chenji; Yu, Long] Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Pingzhao; Yu, Long] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Dang, Yongjun; Liu, Jun O.] Johns Hopkins Sch Med, Dept Pharmacol, Baltimore, MD USA; [Liu, Jun O.] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA; [Qin, Bo] Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN USA	Fudan University; Fudan University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Mayo Clinic	Yu, L (corresponding author), Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	longyu@fudan.edu.cn	Han, Dingding/HGD-2042-2022; dang, yongjun/M-6531-2016	Han, Dingding/0000-0003-0963-6286; dang, yongjun/0000-0001-7237-1132	National 973 program of China [2004CB518605]; National 863 project of China [2006AA020501]; National Key Sci-Tech Special Project of China [2008ZX10002-020]; Project of the Shanghai Municipal Science and Technology Commission [03dz14086]	National 973 program of China(National Basic Research Program of China); National 863 project of China; National Key Sci-Tech Special Project of China; Project of the Shanghai Municipal Science and Technology Commission	This work was supported by the National 973 program of China (2004CB518605), the National 863 project of China (2006AA020501), the National Key Sci-Tech Special Project of China (2008ZX10002-020) and the Project of the Shanghai Municipal Science and Technology Commission (03dz14086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; BORELLINI F, 1993, J BIOL CHEM, V268, P7923; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Gu LB, 2004, J BIOL CHEM, V279, P52141, DOI 10.1074/jbc.M407915200; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Jin SK, 2001, J CELL SCI, V114, P4139; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kim E, 2003, ONCOGENE, V22, P7716, DOI 10.1038/sj.onc.1207155; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; Koutsodontis G, 2005, BIOCHEM J, V389, P443, DOI 10.1042/BJ20041980; Kramer OH, 2008, FASEB J, V22, P1369, DOI 10.1096/fj.06-8050com; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li BQ, 2001, J BIOL CHEM, V276, P29729, DOI 10.1074/jbc.M101167200; Linares-Cruz G, 1998, P NATL ACAD SCI USA, V95, P1131, DOI 10.1073/pnas.95.3.1131; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; Ohlsson C, 1998, ENDOCRINOLOGY, V139, P1101, DOI 10.1210/en.139.3.1101; Ostendorff HP, 2000, GENOMICS, V69, P120, DOI 10.1006/geno.2000.6311; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Wang LQ, 2001, J BIOL CHEM, V276, P43604, DOI 10.1074/jbc.M106570200; Zhan MC, 2005, J BIOL CHEM, V280, P4825, DOI 10.1074/jbc.M407450200; Zhang LL, 2000, CANCER RES, V60, P3655	31	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62832	10.1371/journal.pone.0062832	http://dx.doi.org/10.1371/journal.pone.0062832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650532	gold, Green Published, Green Submitted			2022-12-25	WOS:000319167000077
J	Lagha, M; Mayeuf-Louchart, A; Chang, T; Montarras, D; Rocancourt, D; Zalc, A; Kormish, J; Zaret, KS; Buckingham, ME; Relaix, F				Lagha, Mounia; Mayeuf-Louchart, Alicia; Chang, Ted; Montarras, Didier; Rocancourt, Didier; Zalc, Antoine; Kormish, Jay; Zaret, Kenneth S.; Buckingham, Margaret E.; Relaix, Frederic			Itm2a Is a Pax3 Target Gene, Expressed at Sites of Skeletal Muscle Formation In Vivo	PLOS ONE			English	Article							C-MET RECEPTOR; PROGENITOR CELLS; SATELLITE CELLS; STEM-CELL; ACTIVATION; PAX3-FKHR; MYOGENESIS; BRICHOS; DOMAIN; CRE	The paired-box homeodomain transcription factor Pax3 is a key regulator of the nervous system, neural crest and skeletal muscle development. Despite the important role of this transcription factor, very few direct target genes have been characterized. We show that Itm2a, which encodes a type 2 transmembrane protein, is a direct Pax3 target in vivo, by combining genetic approaches and in vivo chromatin immunoprecipitation assays. We have generated a conditional mutant allele for Itm2a, which is an imprinted gene, by flanking exons 2-4 with loxP sites and inserting an IRESnLacZ reporter in the 3' UTR of the gene. The LacZ reporter reproduces the expression profile of Itm2a, and allowed us to further characterize its expression at sites of myogenesis, in the dermomyotome and myotome of somites, and in limb buds, in the mouse embryo. We further show that Itm2a is not only expressed in adult muscle fibres but also in the satellite cells responsible for regeneration. Itm2a mutant mice are viable and fertile with no overt phenotype during skeletal muscle formation or regeneration. Potential compensatory mechanisms are discussed.	[Lagha, Mounia; Mayeuf-Louchart, Alicia; Montarras, Didier; Rocancourt, Didier; Buckingham, Margaret E.] Inst Pasteur, CNRS URA 2578, Dept Dev Biol, Paris, France; [Chang, Ted; Zalc, Antoine; Relaix, Frederic] UPMC Paris 06, UMR S 787, Paris, France; [Chang, Ted; Zalc, Antoine; Relaix, Frederic] INSERM, Avenir Team, Paris, France; [Chang, Ted; Zalc, Antoine; Relaix, Frederic] Inst Myol, Paris, France; [Kormish, Jay; Zaret, Kenneth S.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Pennsylvania	Buckingham, ME (corresponding author), Inst Pasteur, CNRS URA 2578, Dept Dev Biol, Paris, France.	margab@pasteur.fr; frelaix@gmail.com	Mayeuf-Louchart, Alicia/AAC-5102-2019; Lagha, Mounia/T-7351-2018	Mayeuf-Louchart, Alicia/0000-0002-3787-7450; Lagha, Mounia/0000-0002-7082-1950; Relaix, Frederic/0000-0003-1270-1472; Zalc, Antoine/0000-0001-6077-0996	INSERM Avenir Program; Association Francaise Contre les Myopathies (AFM); Association Institut de Myologie; Ligue Nationale Contre le Cancer (LNCC); Association pour la Recherche Contre le Cancer (ARC); Fondation pour la Recherche Medicale, Institut National du Cancer (INCa); European Union [241440]; Pasteur Institute; CNRS [URA 2578, 200720]; AFM; Optistem [223098]; Human Frontier Science Program (HFSP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036477] Funding Source: NIH RePORTER	INSERM Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise Contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Association Institut de Myologie; Ligue Nationale Contre le Cancer (LNCC)(Ligue nationale contre le cancer); Association pour la Recherche Contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Fondation pour la Recherche Medicale, Institut National du Cancer (INCa); European Union(European Commission); Pasteur Institute; CNRS(Centre National de la Recherche Scientifique (CNRS)); AFM(Association Francaise contre les Myopathies); Optistem; Human Frontier Science Program (HFSP)(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by funding to FR from the INSERM Avenir Program, Association Francaise Contre les Myopathies (AFM), Association Institut de Myologie, the Ligue Nationale Contre le Cancer (LNCC), Association pour la Recherche Contre le Cancer (ARC), Fondation pour la Recherche Medicale, Institut National du Cancer (INCa), and from the European Union Seventh Framework Programme in the project ENDOSTEM (grant agreement number 241440). MB's laboratory was supported by the Pasteur Institute and the CNRS (URA 2578) and by grants from the AFM and the EU 7th PCRD programmes, EuroSyStem (grant agreement number 200720) and Optistem (grant agreement number 223098). ML is currently the recipient of a Human Frontier Science Program (HFSP) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; Barber TD, 2002, GENOMICS, V79, P278, DOI 10.1006/geno.2002.6703; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Boeuf S, 2009, DIFFERENTIATION, V78, P108, DOI 10.1016/j.diff.2009.05.007; Brown CB, 2004, DEV BIOL, V267, P190, DOI 10.1016/j.ydbio.2003.10.024; Buckingham M, 2008, CURR OPIN GENET DEV, V18, P330, DOI 10.1016/j.gde.2008.06.005; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Chang THT, 2004, DEV BIOL, V269, P595, DOI 10.1016/j.ydbio.2004.02.013; Clerc P, 2006, CURR OPIN GENET DEV, V16, P246, DOI 10.1016/j.gde.2006.04.001; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cossu G, 1996, DEVELOPMENT, V122, P429; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Fleischer A, 2002, ONCOGENE, V21, P3181, DOI 10.1038/sj.onc.1205464; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Khan J, 1999, P NATL ACAD SCI USA, V96, P13264, DOI 10.1073/pnas.96.23.13264; Kirchner J, 1999, J EXP MED, V190, P217, DOI 10.1084/jem.190.2.217; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; Lagha M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-696; Lagha M, 2009, DEV CELL, V17, P892, DOI 10.1016/j.devcel.2009.10.021; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Mayanil CSK, 2001, J BIOL CHEM, V276, P49299, DOI 10.1074/jbc.M107933200; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mercado GE, 2007, CURR MOL MED, V7, P47, DOI 10.2174/156652407779940440; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Mulugeta S, 2007, AM J PHYSIOL-LUNG C, V293, pL720, DOI 10.1152/ajplung.00025.2007; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Pittois K, 1999, MAMM GENOME, V10, P54, DOI 10.1007/s003359900942; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; Rizzoti K, 2004, NAT GENET, V36, P247, DOI 10.1038/ng1309; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Soleimani VD, 2012, DEV CELL, V22, P1208, DOI 10.1016/j.devcel.2012.03.014; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tuckermann JP, 2000, J BONE MINER RES, V15, P1257, DOI 10.1359/jbmr.2000.15.7.1257; Van den Plas D, 2004, CELL BIOL INT, V28, P199, DOI 10.1016/j.cellbi.2003.11.019; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Willander H, 2011, FEBS J, V278, P3893, DOI 10.1111/j.1742-4658.2011.08209.x; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	46	20	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63143	10.1371/journal.pone.0063143	http://dx.doi.org/10.1371/journal.pone.0063143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650549	gold, Green Submitted, Green Published			2022-12-25	WOS:000319167000094
J	Marks, LR; Clementi, EA; Hakansson, AP				Marks, Laura R.; Clementi, Emily A.; Hakansson, Anders P.			Sensitization of Staphylococcus aureus to Methicillin and Other Antibiotics In Vitro and In Vivo in the Presence of HAMLET	PLOS ONE			English	Article							HUMAN ALPHA-LACTALBUMIN; HUMAN-MILK; EFFLUX PUMP; MULTIDRUG-RESISTANCE; BACTERICIDAL ACTIVITY; INTRACELLULAR PH; FOLDING VARIANT; VANCOMYCIN; MECHANISM; APOPTOSIS	HAMLET (human alpha-lactalbumin made lethal to tumor cells) is a protein-lipid complex from human milk with both tumoricidal and bactericidal activities. HAMLET exerts a rather specific bactericidal activity against some respiratory pathogens, with highest activity against Streptococcus pneumoniae, but lacks activity against most other bacterial pathogens, including Staphylococci. Still, ion transport associated with death in S. pneumoniae is also detected to a lower degree in insensitive organisms. In this study we demonstrate that HAMLET acts as an antimicrobial adjuvant that can increase the activity of a broad spectrum of antibiotics (methicillin, vancomycin, gentamicin and erythromycin) against multi-drug resistant Staphylococcus aureus, to a degree where they become sensitive to those same antibiotics, both in antimicrobial assays against planktonic and biofilm bacteria and in an in vivo model of nasopharyngeal colonization. We show that HAMLET exerts these effects specifically by dissipating the proton gradient and inducing a sodium-dependent calcium influx that partially depolarizes the plasma membrane, the same mechanism induced during pneumococcal death. These effects results in an increased cell associated binding and/or uptake of penicillin, gentamicin and vancomycin, especially in resistant stains. Finally, HAMLET inhibits the increased resistance of methicillin seen under antibiotic pressure and the bacteria do not become resistant to the adjuvant, which is a major advantageous feature of the molecule. These results highlight HAMLET as a novel antimicrobial adjuvant with the potential to increase the clinical usefulness of antibiotics against drug resistant strains of S. aureus.	[Marks, Laura R.; Clementi, Emily A.; Hakansson, Anders P.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Clementi, Emily A.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA; [Hakansson, Anders P.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hakansson, AP (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	andersh@buffalo.edu	Hakansson, Anders P/AAX-1225-2020; Hakansson, Anders/H-8190-2014	Hakansson, Anders P/0000-0002-2834-6009; Hakansson, Anders/0000-0002-2834-6009; Marks, Laura/0000-0002-5317-443X	Bill and Melinda Gates Foundation [53085]; JR Oishei Foundation; American Lung Association [RG-123721-N]; National Institutes of Health (NIDCR) [F31DC011218]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC011218] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); JR Oishei Foundation; American Lung Association; National Institutes of Health (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Bill and Melinda Gates Foundation (grant 53085), the JR Oishei Foundation, and The American Lung Association (Grant RG-123721-N) to APH, and National Institutes of Health (NIDCR) fellowship F31DC011218 to EAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; [Anonymous], 2011, B WORLD HEALTH ORGAN, V89, P88, DOI 10.2471/BLT.11.030211; Bakar NS, 2012, PAK J PHARM SCI, V25, P633; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Calfee DP, 2012, CURR OPIN INFECT DIS, V25, P385, DOI 10.1097/QCO.0b013e3283553441; Clementi EA, 2012, J BIOL CHEM, V287, P27168, DOI 10.1074/jbc.M112.371070; Corvini PFX, 2000, MICROBIOL-SGM, V146, P2671, DOI 10.1099/00221287-146-10-2671; Cottagnoud P, 2003, ANTIMICROB AGENTS CH, V47, P144, DOI 10.1128/AAC.47.1.144-147.2003; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; de Kraker MEA, 2011, ANTIMICROB AGENTS CH, V55, P1598, DOI 10.1128/AAC.01157-10; Fadli M, 2011, INT J ANTIMICROB AG, V38, P325, DOI 10.1016/j.ijantimicag.2011.05.005; Falcao-Silva VS, 2009, PHYTOTHER RES, V23, P1367, DOI 10.1002/ptr.2695; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Fuchs PC, 2002, J ANTIMICROB CHEMOTH, V49, P467, DOI 10.1093/jac/49.3.467; GLOTZER DJ, 1970, ARCH SURG-CHICAGO, V100, P589; Gould IM, 2012, INT J ANTIMICROB AG, V39, P96, DOI 10.1016/j.ijantimicag.2011.09.028; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 1999, EXP CELL RES, V246, P451, DOI 10.1006/excr.1998.4265; Hakansson A, 2000, MOL MICROBIOL, V35, P589, DOI 10.1046/j.1365-2958.2000.01728.x; Hakansson AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017717; Harigaya Y, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-287; HEINE WE, 1991, J NUTR, V121, P277, DOI 10.1093/jn/121.3.277; Jean SS, 2011, EXPERT OPIN PHARMACO, V12, P2145, DOI 10.1517/14656566.2011.599320; JENSEN RG, 1980, LIPIDS, V15, P345, DOI 10.1007/BF02533550; JENSEN RG, 1990, J DAIRY SCI, V73, P223, DOI 10.3168/jds.S0022-0302(90)78666-3; Kaatz GW, 2003, ANTIMICROB AGENTS CH, V47, P719, DOI 10.1128/AAC.47.2.719-726.2003; Kaatz GW, 2002, J ANTIMICROB CHEMOTH, V50, P833, DOI 10.1093/jac/dkf224; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Kristiansen JE, 2010, IN VIVO, V24, P751; Lemaire S, 2008, J BIOL CHEM, V283, P12769, DOI 10.1074/jbc.M800079200; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Lonnerdal B, 2004, ADV EXP MED BIOL, V554, P11; LONNERDAL B, 1985, AM J CLIN NUTR, V42, P1299; LOVELL DL, 1945, ARCH SURG-CHICAGO, V51, P78, DOI 10.1001/archsurg.1945.01230040083002; Mahamoud A, 2007, J ANTIMICROB CHEMOTH, V59, P1223, DOI 10.1093/jac/dkl493; Margolis E, 2009, J BACTERIOL, V191, P571, DOI 10.1128/JB.00950-08; Markham PN, 1996, ANTIMICROB AGENTS CH, V40, P2673, DOI 10.1128/AAC.40.11.2673; Marks LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043514; Marks LR, 2012, INFECT IMMUN, V80, P2744, DOI 10.1128/IAI.00488-12; Martins A, 2007, INT J ANTIMICROB AG, V29, P302, DOI 10.1016/j.ijantimicag.2006.10.012; McGavin MJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00066; MONTVILLE TJ, 1994, INT J FOOD MICROBIOL, V24, P53, DOI 10.1016/0168-1605(94)90106-6; MOSS B, 1948, LANCET, V254, P320; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Newburg DS, 2005, J NUTR, V135, P1308, DOI 10.1093/jn/135.5.1308; Newburg DS, 1999, CURR MED CHEM, V6, P117; Nobmann P, 2010, J APPL MICROBIOL, V108, P2152, DOI 10.1111/j.1365-2672.2009.04622.x; Nuryastuti T, 2009, APPL ENVIRON MICROB, V75, P6850, DOI 10.1128/AEM.00875-09; Parra-Ruiz J, 2010, ANTIMICROB AGENTS CH, V54, P4329, DOI 10.1128/AAC.00455-10; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Rafii F, 2008, ARCH MICROBIOL, V190, P417, DOI 10.1007/s00203-008-0385-3; Ramon-Garcia S, 2006, J ANTIMICROB CHEMOTH, V57, P252, DOI 10.1093/jac/dki436; Ramon-Garcia S, 2012, ANTIMICROB AGENTS CH, V56, P2074, DOI 10.1128/AAC.05946-11; Rand KH, 2004, ANTIMICROB AGENTS CH, V48, P2871, DOI 10.1128/AAC.48.8.2871-2875.2004; Reiter KC, 2012, DIAGN MICR INFEC DIS, V74, P101, DOI 10.1016/j.diagmicrobio.2012.05.034; Ricci V, 2006, ANTIMICROB AGENTS CH, V50, P38, DOI 10.1128/AAC.50.1.38-42.2006; ROE E, 1972, LANCET, V2, P109; Rose WE, 2009, J ANTIMICROB CHEMOTH, V63, P485, DOI 10.1093/jac/dkn513; Simor AE, 2011, LANCET INFECT DIS, V11, P952, DOI 10.1016/S1473-3099(11)70281-X; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; Tang HJ, 2011, INT J ANTIMICROB AG, V38, P46, DOI 10.1016/j.ijantimicag.2011.02.013; VARGA DT, 1961, J CLIN INVEST, V40, P2209, DOI 10.1172/JCI104447; Zhang Z, 2010, WORLD J GASTROENTERO, V16, P1279, DOI 10.3748/wjg.v16.i10.1279	70	50	51	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63158	10.1371/journal.pone.0063158	http://dx.doi.org/10.1371/journal.pone.0063158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650551	Green Published, gold			2022-12-25	WOS:000319167000096
J	Sparks, ME; Blackburn, MB; Kuhar, D; Gundersen-Rindal, DE				Sparks, Michael E.; Blackburn, Michael B.; Kuhar, Daniel; Gundersen-Rindal, Dawn E.			Transcriptome of the Lymantria dispar (Gypsy Moth) Larval Midgut in Response to Infection by Bacillus thuringiensis	PLOS ONE			English	Article							HELIOTHIS-VIRESCENS LEPIDOPTERA; ANTIMICROBIAL PEPTIDE; SPODOPTERA-EXIGUA; CRYSTAL PROTEINS; CRY1AB TOXIN; BOMBYX-MORI; PRE-PORE; VIRUS; RESISTANCE; MECHANISM	Transcriptomic profiles of the serious lepidopteran insect pest Lymantria dispar (gypsy moth) were characterized in the larval midgut in response to infection by Bacillus thuringiensis kurstaki, a biopesticide commonly used for its control. RNA-Seq approaches were used to define a set of 49,613 assembled transcript sequences, of which 838, 1,248 and 3,305 were respectively partitioned into high-, mid- and low-quality tiers on the basis of homology information. Digital gene expression profiles suggested genes differentially expressed at 24 hours post infection, and qRT-PCR analyses were performed for verification. The differentially expressed genes primarily associated with digestive function, including alpha-amylase, lipase and carboxypeptidase; immune response, including C-type lectin 4; developmental genes such as arylphorin; as well as a variety of binding proteins: cellular retinoic acid binding protein (lipid-binding), insulin-related peptide binding protein (protein-binding) and ovary C/EBPg transcription factor (nucleic acid-binding). This is the first study conducted to specifically investigate gypsy moth response to a bacterial infection challenge using large-scale sequencing technologies, and the results highlight important genes that could be involved in biopesticide resistance development or could serve as targets for biologically-based control mechanisms of this insect pest.	[Sparks, Michael E.; Blackburn, Michael B.; Kuhar, Daniel; Gundersen-Rindal, Dawn E.] USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA	United States Department of Agriculture (USDA)	Gundersen-Rindal, DE (corresponding author), USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA.	dawn.gundersen-rindal@ars.usda.gov		Sparks, Michael/0000-0001-6251-8559; Blackburn, Michael/0000-0001-5541-4831	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This research was funded by the United States Department of Agriculture and conducted by the authors as part of their duties. As employees of the US Department of Agriculture, the Federal Government was responsible for study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antony B, 2009, INSECT BIOCHEM MOLEC, V39, P90, DOI 10.1016/j.ibmb.2008.10.008; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Axen A, 1997, EUR J BIOCHEM, V247, P614, DOI 10.1111/j.1432-1033.1997.00614.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bell RA., 1981, USDA TECH B, P599; Blackburn MB, 2004, ARCH INSECT BIOCHEM, V55, P26, DOI 10.1002/arch.10119; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Candas M, 2003, MOL CELL PROTEOMICS, V2, P19, DOI 10.1074/mcp.M200069-MCP200; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Eddy Sean R, 2009, Genome Inform, V23, P205; FARRAR RR, 1995, J ENTOMOL SCI, V30, P29, DOI 10.18474/0749-8004-30.1.29; Federici BA, 1998, APPL ENVIRON MICROB, V64, P4368; Forcada C, 1999, ARCH INSECT BIOCHEM, V42, P51, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;51::AID-ARCH6&gt;3.0.CO;2-6; Gao K, 2012, J INVERTEBR PATHOL, V110, P83, DOI 10.1016/j.jip.2012.02.011; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Goto S, 2002, NUCLEIC ACIDS RES, V30, P402, DOI 10.1093/nar/30.1.402; Hagstrom AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037230; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; He WY, 2012, GENOMICS, V99, P169, DOI 10.1016/j.ygeno.2011.12.009; Hernandez-Martinez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012795; HOFTE H, 1989, MICROBIOL REV, V53, P242; Hwang J, 2011, J INVERTEBR PATHOL, V108, P194, DOI 10.1016/j.jip.2011.09.003; Jenkins JL, 2000, J BIOL CHEM, V275, P14423, DOI 10.1074/jbc.275.19.14423; Jimenez-Juarez N, 2008, PEPTIDES, V29, P318, DOI 10.1016/j.peptides.2007.09.026; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Leonard D.E., 1981, B US DEP AGR, V1584, P9; Lienard Marjorie A., 2010, Communicative & Integrative Biology, V3, P586, DOI 10.4161/cib.3.6.13177; Loeb MJ, 2001, J INSECT PHYSIOL, V47, P599, DOI 10.1016/S0022-1910(00)00150-5; Ma WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038151; Marrone Pamela G., 1993, P221; Martinez-Ramirez AC, 1999, BIOCONTROL SCI TECHN, V9, P239, DOI 10.1080/09583159929811; Melchionna R, 2012, J INVEST DERMATOL, V132, P1908, DOI 10.1038/jid.2012.51; Moreno-Habel DA, 2012, J INVERTEBR PATHOL, V110, P92, DOI 10.1016/j.jip.2012.02.007; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Oppert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034624; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Smit A, 1996, REPEATMASKER OPEN 30; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1337, DOI 10.1007/s00018-008-8330-9; Sparks ME, 2011, VIRUSES-BASEL, V3, P2339, DOI 10.3390/v3112339; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wang Y, 2007, DEV COMP IMMUNOL, V31, P1002, DOI 10.1016/j.dci.2007.01.001; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhu YC, 2011, J INVERTEBR PATHOL, V106, P296, DOI 10.1016/j.jip.2010.10.007	51	41	42	2	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61190	10.1371/journal.pone.0061190	http://dx.doi.org/10.1371/journal.pone.0061190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658687	Green Submitted, Green Published, gold			2022-12-25	WOS:000319167000008
J	Van Dijk, TC; Van Staalduinen, MA; Van der Sluijs, JP				Van Dijk, Tessa C.; Van Staalduinen, Marja A.; Van der Sluijs, Jeroen P.			Macro-Invertebrate Decline in Surface Water Polluted with Imidacloprid	PLOS ONE			English	Article							ACUTE TOXICITY; NEONICOTINOID INSECTICIDES; SYSTEMIC INSECTICIDE; RISK-ASSESSMENT; HONEY-BEES; PESTICIDES; EXPOSURE; FIPRONIL; ECOSYSTEMS	Imidacloprid is one of the most widely used insecticides in the world. Its concentration in surface water exceeds the water quality norms in many parts of the Netherlands. Several studies have demonstrated harmful effects of this neonicotinoid to a wide range of non-target species. Therefore we expected that surface water pollution with imidacloprid would negatively impact aquatic ecosystems. Availability of extensive monitoring data on the abundance of aquatic macro-invertebrate species, and on imidacloprid concentrations in surface water in the Netherlands enabled us to test this hypothesis. Our regression analysis showed a significant negative relationship (P<0.001) between macro-invertebrate abundance and imidacloprid concentration for all species pooled. A significant negative relationship was also found for the orders Amphipoda, Basommatophora, Diptera, Ephemeroptera and Isopoda, and for several species separately. The order Odonata had a negative relationship very close to the significance threshold of 0.05 (P <0.051). However, in accordance with previous research, a positive relationship was found for the order Actinedida. We used the monitoring field data to test whether the existing three water quality norms for imidacloprid in the Netherlands are protective in real conditions. Our data show that macrofauna abundance drops sharply between 13 and 67 ng l(-1). For aquatic ecosystem protection, two of the norms are not protective at all while the strictest norm of 13 ng l(-1) (MTR) seems somewhat protective. In addition to the existing experimental evidence on the negative effects of imidacloprid on invertebrate life, our study, based on data from large-scale field monitoring during multiple years, shows that serious concern about the far-reaching consequences of the abundant use of imidacloprid for aquatic ecosystems is justified.	[Van Dijk, Tessa C.; Van Staalduinen, Marja A.; Van der Sluijs, Jeroen P.] Univ Utrecht, Utrecht, Netherlands	Utrecht University	Van der Sluijs, JP (corresponding author), Univ Utrecht, Utrecht, Netherlands.	j.p.vandersluijs@uu.nl	van der Sluijs, Jeroen P/B-6302-2008	van der Sluijs, Jeroen P/0000-0002-1346-5953	TVD; MVS; Triodos Foundation's Support Fund for Independent Research on Bee Decline and Systemic Pesticides; Adessium Foundation (The Netherlands); Act Beyond Trust (Japan); Universiteit Utrecht (Netherlands); Stichting Triodos Foundation (The Netherlands); Gesellschaft fur Schmetterlingsschutz (Germany); Gravin van Bylandt Stichting (The Netherlands); Zukunft Stiftung Landwirtschaft (Germany); Beekeepers Union ABTB (Netherlands); Study Association Storm (Student Association Environmental Sciences Utrecht University)	TVD; MVS; Triodos Foundation's Support Fund for Independent Research on Bee Decline and Systemic Pesticides; Adessium Foundation (The Netherlands)(Netherlands Government); Act Beyond Trust (Japan); Universiteit Utrecht (Netherlands); Stichting Triodos Foundation (The Netherlands)(Netherlands Government); Gesellschaft fur Schmetterlingsschutz (Germany); Gravin van Bylandt Stichting (The Netherlands)(Netherlands Government); Zukunft Stiftung Landwirtschaft (Germany); Beekeepers Union ABTB (Netherlands); Study Association Storm (Student Association Environmental Sciences Utrecht University)	Financial support was given to TVD and MVS by the Triodos Foundation's Support Fund for Independent Research on Bee Decline and Systemic Pesticides. This Support Fund has been created from donations by Adessium Foundation (The Netherlands), Act Beyond Trust (Japan), Universiteit Utrecht (Netherlands), Stichting Triodos Foundation (The Netherlands), Gesellschaft fur Schmetterlingsschutz (Germany), M.A.O.C. Gravin van Bylandt Stichting (The Netherlands), Zukunft Stiftung Landwirtschaft (Germany), Beekeepers Union ABTB (Netherlands), Study Association Storm (Student Association Environmental Sciences Utrecht University) and citizens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Alexander AC, 2007, ENVIRON TOXICOL CHEM, V26, P1726, DOI 10.1897/07-015R.1; [Anonymous], DTSCH PEST ATL; [Anonymous], 2012, PESTICIDE PROPERTIES; [Anonymous], 2011, FINE CHEM IND BUSINE, DOI DOI 10.1002/9780470946404; Beketov MA, 2008, SCI TOTAL ENVIRON, V405, P96, DOI 10.1016/j.scitotenv.2008.07.001; Beketov MA, 2008, ARCH ENVIRON CON TOX, V55, P247, DOI 10.1007/s00244-007-9104-3; Beketov MA, 2008, ENVIRON TOXICOL CHEM, V27, P461, DOI 10.1897/07-322R.1; Bijkerk R., 2010, 201028 STICHT TOEG O; Bonada N, 2004, ENVIRON POLLUT, V132, P509, DOI 10.1016/j.envpol.2004.05.006; Bonmatin JM, 2005, ENVIRONMENTAL CHEMISTRY: GREEN CHEMISTRY AND POLLUTANTS IN ECOSYSTEMS, P483; Buckingham SD, 1997, J EXP BIOL, V200, P2685; Cairns John Jr., 1993, P10; Chen XD, 2009, ECOTOX ENVIRON SAFE, V73, P132; CJAM Posthuma-Doodeman, 2008, 6017160182008 RIVM P; Collier TK, 2003, HUM ECOL RISK ASSESS, V9, P259, DOI 10.1080/713609862; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Thuyet DQ, 2012, SCI TOTAL ENVIRON, V414, P515, DOI 10.1016/j.scitotenv.2011.10.051; De Snoo G. R., 2012, BESTRIJDINGSMIDDELEN; Deglise P, 2002, NEUROSCI LETT, V321, P13, DOI 10.1016/S0304-3940(01)02400-4; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dijk T. C., 2010, THESIS UTRECHT U UTR; Englert D, 2012, ENVIRON POLLUT, V167, P41, DOI 10.1016/j.envpol.2012.03.024; Felsot AS, 1998, B ENVIRON CONTAM TOX, V60, P363, DOI 10.1007/s001289900635; Feng SL, 2004, CHEMOSPHERE, V56, P457, DOI 10.1016/j.chemosphere.2004.02.010; Gupta S, 2002, B ENVIRON CONTAM TOX, V68, P502, DOI 10.1007/s001280283; GUSTAFSON DI, 1989, ENVIRON TOXICOL CHEM, V8, P339, DOI 10.1897/1552-8618(1989)8[339:GUSASM]2.0.CO;2; Haith DA, 2010, ENVIRON SCI TECHNOL, V44, P6496, DOI 10.1021/es101636y; Hayasaka D, 2012, ECOTOX ENVIRON SAFE, V80, P355, DOI 10.1016/j.ecoenv.2012.04.004; Hayasaka D, 2012, ECOTOXICOLOGY, V21, P421, DOI 10.1007/s10646-011-0802-2; Hayasaka D, 2012, ECOTOXICOLOGY, V21, P191, DOI 10.1007/s10646-011-0778-y; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Key P, 2007, ECOTOX ENVIRON SAFE, V68, P272, DOI 10.1016/j.ecoenv.2006.11.017; Kreutzweiser DP, 2008, B ENVIRON CONTAM TOX, V80, P211, DOI 10.1007/s00128-007-9347-8; Kreutzweiser D, 2007, ECOTOX ENVIRON SAFE, V68, P315, DOI 10.1016/j.ecoenv.2007.04.011; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Liess M, 2011, ECOTOXICOLOGY, V20, P1328, DOI 10.1007/s10646-011-0689-y; Loureiro S, 2010, ENVIRON TOXICOL CHEM, V29, P1716, DOI 10.1002/etc.198; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Maxim L, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014006; Maxim L, 2007, SCI TOTAL ENVIRON, V376, P1, DOI 10.1016/j.scitotenv.2006.12.052; Miranda GRB, 2011, HUM ECOL RISK ASSESS, V17, P981, DOI 10.1080/10807039.2011.588159; Mohr S, 2012, AQUAT TOXICOL, V110, P25, DOI 10.1016/j.aquatox.2011.11.016; Overmyer JP, 2005, B ENVIRON CONTAM TOX, V74, P872, DOI 10.1007/s00128-005-0662-7; Pestana JLT, 2010, CHEMOSPHERE, V78, P241, DOI 10.1016/j.chemosphere.2009.10.066; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Roberts T.R., 1999, METABOLIC PATHWAYS A, DOI [10.1039/9781847551375, DOI 10.1039/9781847551375-00937]; Roessink I, 2013, ENVIRON TOXICOL CHEM, V32, P1096, DOI 10.1002/etc.2201; Rose PH, 2012, ISSUES TOXICOL, V12, P184, DOI 10.1039/9781849733007-00184; Sanchez-Bayo F, 2012, J ENV ANAL TOXICOL S, VS4, pS4; Sanchez-Bayo F, 2009, ECOTOXICOLOGY, V18, P343, DOI 10.1007/s10646-008-0290-1; Sanchez-Bayo F, 2006, ENVIRON TOXICOL CHEM, V25, P1677, DOI 10.1897/05-404R.1; Sanchez-Bayo F, 2006, AQUAT TOXICOL, V78, P262, DOI 10.1016/j.aquatox.2006.03.009; Sardo AM, 2010, ARCH ENVIRON CON TOX, V58, P648, DOI 10.1007/s00244-010-9470-0; Selim HM, 2010, SOIL SCI, V175, P375, DOI 10.1097/SS.0b013e3181ebc9a2; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Stoughton SJ, 2008, ARCH ENVIRON CON TOX, V54, P662, DOI 10.1007/s00244-007-9073-6; Stuijfzand SC, 1999, ARCH ENVIRON CON TOX, V36, P186, DOI 10.1007/s002449900459; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Sur Robin, 2003, Bulletin of Insectology, V56, P35; Szczepaniec A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020018; Tennekes HA, 2011, J ENV ANAL TOXICOL S, VS4, pS4; Tennekes HA, 2010, TOXICOLOGY, V276, P1, DOI 10.1016/j.tox.2010.07.005; Tisler T, 2009, CHEMOSPHERE, V76, P907, DOI 10.1016/j.chemosphere.2009.05.002; TOMIZAWA M, 1992, J PESTIC SCI, V17, P231; Van Wijngaarden RPA, 2005, ECOTOXICOLOGY, V14, P355, DOI 10.1007/s10646-004-6371-x; Verdonschot PFM, 2010, GRAADMETERS AQUATISC; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Wu G, 2004, J ECON ENTOMOL, V97, P2057, DOI 10.1603/0022-0493-97.6.2057; Zeng CX, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.2001	73	253	261	10	225	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62374	10.1371/journal.pone.0062374	http://dx.doi.org/10.1371/journal.pone.0062374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650513	gold, Green Published			2022-12-25	WOS:000319167000043
J	Jepson, PD; Deaville, R; Acevedo-Whitehouse, K; Barnett, J; Brownlow, A; Brownell, RL; Clare, FC; Davison, N; Law, RJ; Loveridge, J; Macgregor, SK; Morris, S; Murphy, S; Penrose, R; Perkins, MW; Pinn, E; Seibel, H; Siebert, U; Sierra, E; Simpson, V; Tasker, ML; Tregenza, N; Cunningham, AA; Fernandez, A				Jepson, Paul D.; Deaville, Robert; Acevedo-Whitehouse, Karina; Barnett, James; Brownlow, Andrew; Brownell, Robert L., Jr.; Clare, Frances C.; Davison, Nick; Law, Robin J.; Loveridge, Jan; Macgregor, Shaheed K.; Morris, Steven; Murphy, Sinead; Penrose, Rod; Perkins, Matthew W.; Pinn, Eunice; Seibel, Henrike; Siebert, Ursula; Sierra, Eva; Simpson, Victor; Tasker, Mark L.; Tregenza, Nick; Cunningham, Andrew A.; Fernandez, Antonio			What Caused the UK's Largest Common Dolphin (Delphinus delphis) Mass Stranding Event?	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; PORPOISES PHOCOENA-PHOCOENA; GAS-BUBBLE LESIONS; TURSIOPS-TRUNCATUS; POLYCHLORINATED-BIPHENYLS; CETACEANS; SONAR; WHALES; MORTALITY; INFECTION	On 9 June 2008, the UK's largest mass stranding event (MSE) of short-beaked common dolphins (Delphinus delphis) occurred in Falmouth Bay, Cornwall. At least 26 dolphins died, and a similar number was refloated/herded back to sea. On necropsy, all dolphins were in good nutritive status with empty stomachs and no evidence of known infectious disease or acute physical injury. Auditory tissues were grossly normal (26/26) but had microscopic haemorrhages (5/5) and mild otitis media (1/5) in the freshest cases. Five lactating adult dolphins, one immature male, and one immature female tested were free of harmful algal toxins and had low chemical pollutant levels. Pathological evidence of mud/seawater inhalation (11/26), local tide cycle, and the relative lack of renal myoglobinuria (26/26) suggested MSE onset on a rising tide between 06: 30 and 08: 21 hrs (9 June). Potential causes excluded or considered highly unlikely included infectious disease, gas/fat embolism, boat strike, by-catch, predator attack, foraging unusually close to shore, chemical or algal toxin exposure, abnormal weather/climatic conditions, and high-intensity acoustic inputs from seismic airgun arrays or natural sources (e. g., earthquakes). International naval exercises did occur in close proximity to the MSE with the most intense part of the exercises (including mid-frequency sonars) occurring four days before the MSE and resuming with helicopter exercises on the morning of the MSE. The MSE may therefore have been a "two-stage process'' where a group of normally pelagic dolphins entered Falmouth Bay and, after 3-4 days in/around the Bay, a second acoustic/disturbance event occurred causing them to strand en masse. This spatial and temporal association with the MSE, previous associations between naval activities and cetacean MSEs, and an absence of other identifiable factors known to cause cetacean MSEs, indicates naval activity to be the most probable cause of the Falmouth Bay MSE.	[Jepson, Paul D.; Deaville, Robert; Clare, Frances C.; Macgregor, Shaheed K.; Murphy, Sinead; Perkins, Matthew W.; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Acevedo-Whitehouse, Karina] Autonomous Univ Queretaro, Sch Nat Sci, Unit Basic & Appl Microbiol, Queretaro, Mexico; [Barnett, James; Davison, Nick] Anim Hlth & Vet Labs Agcy Truro, Truro, Cornwall, England; [Brownlow, Andrew; Davison, Nick] Scottish Agr Coll, Inverness, Scotland; [Brownell, Robert L., Jr.] NOAA Fisheries, SW Fisheries Sci Ctr, Pacific Grove, CA USA; [Law, Robin J.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England; [Loveridge, Jan; Tregenza, Nick] Five Acres, Cornwall Wildlife Trust Marine Strandings Network, Truro, England; [Morris, Steven] Ctr Environm Fisheries & Aquaculture Sci, Weymouth, Dorset, England; [Penrose, Rod] Marine Environm Monitoring, Cardigan, Ceredigion, Wales; [Pinn, Eunice; Tasker, Mark L.] Joint Nat Conservat Comm, Aberdeen, Scotland; [Seibel, Henrike; Siebert, Ursula] Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Busum, Germany; [Sierra, Eva; Fernandez, Antonio] Univ Las Palmas Gran Canaria, Vet Sch Montana Cardones Arucas, Inst Anim Hlth, Histol & Pathol Unit, Gran Canaria, Spain; [Simpson, Victor] Wildlife Vet Invest Ctr, Truro, Cornwall, England	Zoological Society of London; Universidad Autonoma de Queretaro; Scottish Agricultural College; National Oceanic Atmospheric Admin (NOAA) - USA; Centre for Environment Fisheries & Aquaculture Science; Centre for Environment Fisheries & Aquaculture Science; University of Veterinary Medicine Hannover, Foundation; Universidad de Las Palmas de Gran Canaria	Jepson, PD (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	paul.jepson@ioz.ac.uk	Sierra, Eva/H-9352-2015; Brownlow, Andrew/ABA-4653-2020; Fernandez, Antonio/G-3448-2015; Cunningham, Andrew A/E-7536-2010; Brownlow, Andrew C/P-6593-2018	Sierra, Eva/0000-0003-3749-8845; Brownlow, Andrew/0000-0001-9885-7480; Fernandez, Antonio/0000-0001-5281-0521; Davison, Nicholas/0000-0001-7286-1836	UK Department for Environment, Food and Rural Affairs [CR0364]	UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This investigation was funded by the UK Department for Environment, Food and Rural Affairs under under a variation to contract number CR0364. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2001, INT J LEGAL MED, V114, P232, DOI 10.1007/s004140000170; [Anonymous], 2006, SCI SER TECH REPORT; [Anonymous], 2005, 200506 AOAC INT; Barnett J, 2009, VET REC, V165, P441, DOI 10.1136/vr.165.15.441; Birkun A, 1999, VET REC, V144, P85, DOI 10.1136/vr.144.4.85; Brophy J, 2009, SC61SM14 INT WHAL CO; Brownell Jr R.L., 2004, SC56E37 INT WHAL COM; Brownell RL, 2009, MAR MAMMAL SCI, V25, P639, DOI 10.1111/j.1748-7692.2009.00281.x; Brownell Robert L. Jr., 2008, Journal of Cetacean Research and Management, V10, P81; CEBELIN MS, 1980, HUM PATHOL, V11, P123, DOI 10.1016/S0046-8177(80)80129-8; Clark LS, 2006, J COMP PATHOL, V135, P208, DOI 10.1016/j.jcpa.2006.07.005; Cloeckaert A, 2000, CLIN DIAGN LAB IMMUN, V7, P835, DOI 10.1128/CDLI.7.5.835-839.2000; Cloeckaert A, 2001, MICROBES INFECT, V3, P729, DOI 10.1016/S1286-4579(01)01427-7; Cox T. M., 2005, Journal of Cetacean Research and Management, V7, P177; CWT/BDMLR, 2009, REP MASS STRAND COMM; Dabin W, 2008, MAR BIOL, V156, P127, DOI 10.1007/s00227-008-1070-4; Dana K, 2011, MAR TECHNOL SOC J, V45, P89, DOI 10.4031/MTSJ.45.6.5; Davison NJ, 2011, VET REC, V169, DOI 10.1136/vr.d2714; Davison NJ, 2009, VET REC, V165, P86, DOI 10.1136/vetrec.165.3.86; Deaville R, 2011, CSIP FINAL REPORT PE; Department of the Environment and Heritage, 2005, MAR BAY WHAL STRAND; Dudok van Heel W. H., 1962, Netherlands Journal of Sea Research, V1, P407, DOI 10.1016/0077-7579(62)90001-7; Evans PGH, 1991, HDB BRIT MAMMALS; Fernandez A, 2005, VET PATHOL, V42, P446, DOI 10.1354/vp.42-4-446; Filadelfo Ronald, 2009, Aquatic Mammals, V35, P435, DOI 10.1578/AM.35.4.2009.435; Foster G, 2002, VET MICROBIOL, V90, P563, DOI 10.1016/S0378-1135(02)00236-5; Frantzis A, 1998, NATURE, V392, P29, DOI 10.1038/32068; GERACI JR, 1978, OCEANUS, V21, P38; Geraci JR., 2005, MARINE MAMMALS ASHOR; Gerssen A, 2009, J CHROMATOGR A, V1216, P1421, DOI 10.1016/j.chroma.2008.12.099; Glanville Emma, 2003, Irish Naturalists' Journal, V27, P241; Herraez P, 2007, J WILDLIFE DIS, V43, P770, DOI 10.7589/0090-3558-43.4.770; Hess P, 2005, TRAC-TREND ANAL CHEM, V24, P358, DOI 10.1016/j.trac.2004.11.019; Hohn AA, 2005, NMFSSEFSC537 NOAA; Hooker SK, 2012, P ROY SOC B-BIOL SCI, V279, P1041, DOI 10.1098/rspb.2011.2088; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Jepson PD, 2005, ENVIRON TOXICOL CHEM, V24, P238, DOI 10.1897/03-663.1; Jepson PD, 2005, VET PATHOL, V42, P291, DOI 10.1354/vp.42-3-291; Jepson PD, 1998, VET REC, V143, P614, DOI 10.1136/vr.143.22.614; Jepson PD, 2006, POSTMORTEM RES FEASI; Jepson PD, 2006, CETACEAN STRANDINGS, P1; Jepson PD, 2009, INVESTIGATION COMMON; Ketten DR, 2000, SPR HDB AUD, V12, P43; Klinowska M, 1983, GEOMAGNETIC ORIENTAT; KUIKEN T, 1994, VET REC, V134, P81, DOI 10.1136/vr.134.4.81; Law R.J., 1994, COLLABORATIVE UK MAR, V97, P42; Murphy S, 2005, J MAMMAL, V86, P1247, DOI 10.1644/1545-1542(2005)86[1247:MSITMC]2.0.CO;2; Murphy S., 2005, Irish Naturalists' Journal, V28, P42; Murphy S., 2004, BIOL ECOLOGY COMMON; Murphy S, 2012, NAMCO SCI P IN PRESS; Murphy S, 2009, MAR ECOL PROG SER, V388, P273, DOI 10.3354/meps08129; Murray Tony, 2003, Irish Naturalists' Journal, V27, P240; Norman SA, 2004, NMFSNWR34 NOAA; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Odell D.K., 1987, Cetus, V7, P2; Parsons ECM, 2008, MAR POLLUT BULL, V56, P1248, DOI 10.1016/j.marpolbul.2008.04.025; Patenaude NJ, 2002, MAR MAMMAL SCI, V18, P309, DOI 10.1111/j.1748-7692.2002.tb01040.x; QUILLIAM MA, 1995, J AOAC INT, V78, P543; Raga JA, 2008, EMERG INFECT DIS, V14, P471, DOI 10.3201/eid1403.071230; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Rogan E, 1997, J ZOOL, V242, P217, DOI 10.1111/j.1469-7998.1997.tb05798.x; Ross HM, 1996, P ROY SOC B-BIOL SCI, V263, P283, DOI 10.1098/rspb.1996.0043; Schuknecht H., 1993, PATHOLOGY EAR, V2nd ed.; Siebert U, 2001, J COMP PATHOL, V124, P102, DOI 10.1053/jcpa.2000.0436; Southall BL, 2004, NMFSORP31 NOAA, P73; Spraker Terry R., 1993, P481; Sundaram B, 2006, J THEOR BIOL, V238, P764, DOI 10.1016/j.jtbi.2005.06.022; Turnbull BS, 1998, J COMP PATHOL, V118, P317, DOI 10.1016/S0021-9975(07)80007-7; Turner AD, 2009, J AOAC INT, V92, P190; United States Navy, 2007, HAW RANG CO IN PRESS; Viricel A, 2008, BEHAV ECOL SOCIOBIOL, V63, P173, DOI 10.1007/s00265-008-0648-7; Weilgart LS, 2007, CAN J ZOOL, V85, P1091, DOI 10.1139/Z07-101; Wiley David N., 2001, Aquatic Mammals, V27, P162; Wright AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055553; WURSIG B, 2002, ENCY MARINE MAMMALS, P794; Wursig Bernd, 1998, Aquatic Mammals, V24, P41; Yang WC, 2008, VET REC, V162, P184, DOI 10.1136/vr.162.6.184	77	37	38	4	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e60953	10.1371/journal.pone.0060953	http://dx.doi.org/10.1371/journal.pone.0060953			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646103	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300004
J	Jung, F; Stephan, KE; Backes, H; Moran, R; Gramer, M; Kumagai, T; Graf, R; Endepols, H; Tittgemeyer, M				Jung, Fabienne; Stephan, Klaas Enno; Backes, Heiko; Moran, Rosalyn; Gramer, Markus; Kumagai, Tetsuya; Graf, Rudolf; Endepols, Heike; Tittgemeyer, Marc			Mismatch Responses in the Awake Rat: Evidence from Epidural Recordings of Auditory Cortical Fields	PLOS ONE			English	Article							STIMULUS-SPECIFIC ADAPTATION; EVENT-RELATED POTENTIALS; NEGATIVITY MMN GENERATION; SENSORY MEMORY; FREQUENCY DISCRIMINATION; EVOKED-POTENTIALS; ANESTHETIZED RATS; CORTEX; PROBABILITY; DEVIANCE	Detecting sudden environmental changes is crucial for the survival of humans and animals. In the human auditory system the mismatch negativity (MMN), a component of auditory evoked potentials (AEPs), reflects the violation of predictable stimulus regularities, established by the previous auditory sequence. Given the considerable potentiality of the MMN for clinical applications, establishing valid animal models that allow for detailed investigation of its neurophysiological mechanisms is important. Rodent studies, so far almost exclusively under anesthesia, have not provided decisive evidence whether an MMN analogue exists in rats. This may be due to several factors, including the effect of anesthesia. We therefore used epidural recordings in awake black hooded rats, from two auditory cortical areas in both hemispheres, and with bandpass filtered noise stimuli that were optimized in frequency and duration for eliciting MMN in rats. Using a classical oddball paradigm with frequency deviants, we detected mismatch responses at all four electrodes in primary and secondary auditory cortex, with morphological and functional properties similar to those known in humans, i.e., large amplitude biphasic differences that increased in amplitude with decreasing deviant probability. These mismatch responses significantly diminished in a control condition that removed the predictive context while controlling for presentation rate of the deviants. While our present study does not allow for disambiguating precisely the relative contribution of adaptation and prediction error processing to the observed mismatch responses, it demonstrates that MMN-like potentials can be obtained in awake and unrestrained rats.	[Jung, Fabienne; Backes, Heiko; Gramer, Markus; Graf, Rudolf; Endepols, Heike; Tittgemeyer, Marc] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Stephan, Klaas Enno] Univ Zurich, Inst Biomed Engn, TNU, Zurich, Switzerland; [Stephan, Klaas Enno] Swiss Fed Inst Technol, Zurich, Switzerland; [Stephan, Klaas Enno] Univ Zurich, Lab Social & Neural Syst Res SNS, Zurich, Switzerland; [Stephan, Klaas Enno; Moran, Rosalyn] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Kumagai, Tetsuya] Osaka Univ, Grad Sch Med, Dept Neurosurg, Osaka, Japan	Max Planck Society; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of London; University College London; Osaka University	Jung, F (corresponding author), Max Planck Inst Neurol Res, Gleueler Str 50, D-50931 Cologne, Germany.	fabienne.jung@nf.mpg.de	Endepols, Heike/AAG-7794-2020	Endepols, Heike/0000-0002-6166-4818; Moran, Rosalyn/0000-0002-2736-2621; Stephan, Klaas Enno/0000-0002-8594-9092	German Research Foundation; clinical research group 219	German Research Foundation(German Research Foundation (DFG)); clinical research group 219	Funding of the German Research Foundation and the clinical research group 219 supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astikainen P, 2006, NEUROREPORT, V17, P1561, DOI 10.1097/01.wnr.0000233097.13032.7d; Astikainen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024208; Baldeweg T, 2006, INT J PSYCHOPHYSIOL, V59, P49, DOI 10.1016/j.ijpsycho.2005.07.014; Baldeweg T, 1999, ANN NEUROL, V45, P495, DOI 10.1002/1531-8249(199904)45:4<495::AID-ANA11>3.0.CO;2-M; BARTH DS, 1990, J NEUROPHYSIOL, V64, P1527, DOI 10.1152/jn.1990.64.5.1527; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BORG E, 1982, HEARING RES, V8, P101, DOI 10.1016/0378-5955(82)90069-7; Cheung SW, 2001, HEARING RES, V156, P115, DOI 10.1016/S0378-5955(01)00272-6; CSEPE V, 1995, EAR HEARING, V16, P91, DOI 10.1097/00003446-199502000-00007; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; Farley BJ, 2010, J NEUROSCI, V30, P16475, DOI 10.1523/JNEUROSCI.2793-10.2010; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gaese BH, 2001, J NEUROPHYSIOL, V86, P1062, DOI 10.1152/jn.2001.86.2.1062; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Garrido MI, 2009, NEUROIMAGE, V48, P269, DOI 10.1016/j.neuroimage.2009.06.034; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; IMADA T, 1993, ELECTROEN CLIN NEURO, V87, P144, DOI 10.1016/0013-4694(93)90120-K; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; JAVITT DC, 1994, BRAIN RES, V667, P192, DOI 10.1016/0006-8993(94)91496-6; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Javitt DC, 1998, EVOKED POTENTIAL, V108, P143, DOI 10.1016/S0168-5597(97)00073-7; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KRAUS N, 1994, J NEUROPHYSIOL, V72, P1270, DOI 10.1152/jn.1994.72.3.1270; Lazar R, 2003, HEARING RES, V181, P51, DOI 10.1016/S0378-5955(03)00166-7; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; Naatanen R, 2003, INT J PSYCHOPHYSIOL, V48, P179, DOI 10.1016/S0167-8760(03)00053-9; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; Naatanen R, 1992, ATTENTION BRAIN FUNC, P193; Naatanen R, PSYCHOL B, V125, P826; Nakamura T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00367; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Pincze Z, 2001, CLIN NEUROPHYSIOL, V112, P778, DOI 10.1016/S1388-2457(01)00509-0; Roger C, 2009, PSYCHOPHYSIOLOGY, V46, P1028, DOI 10.1111/j.1469-8986.2009.00840.x; Ruusuvirta T, 1998, NEUROSCI LETT, V248, P45, DOI 10.1016/S0304-3940(98)00330-9; Ruusuvirta T, 1996, NEUROREPORT, V7, P1266, DOI 10.1097/00001756-199605170-00009; Sabri M, 2001, COGNITIVE BRAIN RES, V12, P171, DOI 10.1016/S0926-6410(01)00026-X; SAMS M, 1985, ELECTROEN CLIN NEURO, V62, P437, DOI 10.1016/0168-5597(85)90054-1; Shelley AM, 1999, SCHIZOPHR RES, V37, P65, DOI 10.1016/S0920-9964(98)00138-8; SIMPSON GV, 1993, BRAIN RES, V602, P251, DOI 10.1016/0006-8993(93)90690-O; Sonnadara RR, 2006, BRAIN RES, V1071, P175, DOI 10.1016/j.brainres.2005.11.088; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Tikhonravov D, 2010, NEUROSCIENCE, V167, P1175, DOI 10.1016/j.neuroscience.2010.03.014; Tikhonravov D, 2008, BRAIN RES, V1203, P97, DOI 10.1016/j.brainres.2008.02.006; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Umbricht D, 2005, CLIN NEUROPHYSIOL, V116, P353, DOI 10.1016/j.clinph.2004.08.015; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; Winkler I, 1996, BRAIN RES, V742, P239, DOI 10.1016/S0006-8993(96)01008-6; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; ZURITA P, 1994, NEUROSCI RES, V19, P303, DOI 10.1016/0168-0102(94)90043-4	57	30	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63203	10.1371/journal.pone.0063203	http://dx.doi.org/10.1371/journal.pone.0063203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646197	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000319077300154
J	Sutherland, T; Downing, J; Miller, S; Bishai, DM; Butrick, E; Fathalla, MMF; Mourad-Youssif, M; Ojengbede, O; Nsima, D; Kahn, JG				Sutherland, Tori; Downing, Janelle; Miller, Suellen; Bishai, David M.; Butrick, Elizabeth; Fathalla, Mohamed M. F.; Mourad-Youssif, Mohammed; Ojengbede, Oladosu; Nsima, David; Kahn, James G.			Use of the Non-Pneumatic Anti-Shock Garment (NASG) for Life-Threatening Obstetric Hemorrhage: A Cost-Effectiveness Analysis in Egypt and Nigeria	PLOS ONE			English	Article							INTERVENTIONS	Objective: To assess the cost-effectiveness of a non-pneumatic anti-shock garment (NASG) for obstetric hemorrhage in tertiary hospitals in Egypt and Nigeria. Methods: We combined published data from pre-intervention/NASG-intervention clinical trials with costs from study sites. For each country, we used observed proportions of initial shock level (mild: mean arterial pressure [MAP] >60 mmHg; severe: MAP <= 60 mmHg) to define a standard population of 1,000 women presenting in shock. We examined three intervention scenarios: no women in shock receive the NASG, only women in severe shock receive the NASG, and all women in shock receive the NASG. Clinical data included frequencies of adverse health outcomes (mortality, severe morbidity, severe anemia), and interventions to manage bleeding (uterotonics, blood transfusions, hysterectomies). Costs (in 2010 international dollars) included the NASG, training, and clinical interventions. We compared costs and disability-adjusted life years (DALYs) across the intervention scenarios. Results: For 1000 women presenting in shock, providing the NASG to those in severe shock results in decreased mortality and morbidity, which averts 357 DALYs in Egypt and 2,063 DALYs in Nigeria. Differences in use of interventions result in net savings of $9,489 in Egypt (primarily due to reduced transfusions) and net costs of $6,460 in Nigeria, with a cost per DALY averted of $3.13. Results of providing the NASG for women in mild shock has smaller and uncertain effects due to few clinical events in this data set. Conclusion: Using the NASG for women in severe shock resulted in markedly improved health outcomes (2-2.9 DALYs averted per woman, primarily due to reduced mortality), with net savings or extremely low cost per DALY averted. This suggests that in resource-limited settings, the NASG is a very cost-effective intervention for women in severe hypovolemic shock. The effects of the NASG for mild shock are less certain.	[Sutherland, Tori] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Downing, Janelle; Kahn, James G.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Miller, Suellen; Butrick, Elizabeth] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Bixby Ctr Global Reprod Hlth & Policy, San Francisco, CA USA; [Bishai, David M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Fathalla, Mohamed M. F.] Assiut Univ, Fac Med, Womens Hlth Ctr, Dept Obstet & Gynecol, Assiut, Egypt; [Mourad-Youssif, Mohammed] El Galaa Matern Teaching Hosp, Dept Obstet & Gynecol, Cairo, Egypt; [Ojengbede, Oladosu] Univ Coll Hosp, Dept Obstet & Gynecol, Ibadan, Nigeria; [Nsima, David] Katsina Gen Hosp, Dept Obstet & Gynecol, Katsina, Nigeria	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); University of Ibadan; University College Hospital, Ibadan	Downing, J (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA.	janelle.downing@gmail.com	, David Bishai/GRO-4211-2022	Downing, Jae/0000-0002-2382-5537; Bishai, David/0000-0003-0714-9062				Acharya A., 2003, MAKING CHOICES HLTH; American College of Physicians (ACP), PRIM COST EFF AN; Atrash HK, 2006, MATERN CHILD HLTH J, V10, pS3, DOI 10.1007/s10995-006-0100-4; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Drummond MF, 2015, METHODS EC EVALUATIO; G?lmezoglu, 2009, WHO GUIDELINES MANAG; Galloway R, 2003, ANEMIA PREVENTIO 1 2; Goldie SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000264; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kidney E, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-2; Krahn MD, 1997, MED DECIS MAKING, V17, P142, DOI 10.1177/0272989X9701700204; Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x; Miller S, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-64; Miller S, 2010, INT J GYNECOL OBSTET, V109, P20, DOI 10.1016/j.ijgo.2009.11.016; Miller S, 2009, INT J GYNECOL OBSTET, V107, P121, DOI 10.1016/j.ijgo.2009.06.005; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-30; Ordi J, 2009, PLOS MED, V6, P174, DOI 10.1371/journal.pmed.1000036; Osobu-Asubiojo FBR, 2011, MERCHANTS BLOOD NEWS; PATH, 2011, AFF HIGH QUAL NONPN, P1; PPP, 2011, PPP CONV FACT GDP; Seligman B, 2006, EC ASSESSMENT INTERV; Sutherland T, 2010, INT J GYNECOL OBSTET, V108, P289, DOI 10.1016/j.ijgo.2009.11.007; UNICEF, GOAL 5 IMPR MAT HLTH, V5; United Nations, 2011, MILL DEV GOALS IND P; VANSLYKE DD, 1950, J BIOL CHEM, V183, P331; WHO, 2011, COMP NEW EM HLTH TEC	28	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62282	10.1371/journal.pone.0062282	http://dx.doi.org/10.1371/journal.pone.0062282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646124	Green Published, gold			2022-12-25	WOS:000319077300036
J	Zhang, WL; Fang, D; Xing, QC; Zhou, L; Jiang, B; Mu, WM				Zhang, Wenli; Fang, Dan; Xing, Qingchao; Zhou, Leon; Jiang, Bo; Mu, Wanmeng			Characterization of a Novel Metal-Dependent D-Psicose 3-Epimerase from Clostridium scindens 35704	PLOS ONE			English	Article							D-TAGATOSE 3-EPIMERASE; D-FRUCTOSE; AGROBACTERIUM-TUMEFACIENS; PSEUDOMONAS-CICHORII; CELLULOLYTICUM H10; CRYSTAL-STRUCTURES; D-ALLOSE; KETOHEXOSE; ISOMERASE; CLONING	The noncharacterized protein CLOSCI_02528 from Clostridium scindens ATCC 35704 was characterized as D-psicose 3-epimerase. The enzyme showed maximum activity at pH 7.5 and 60 degrees C. The half-life of the enzyme at 50 degrees C was 108 min, suggesting the enzyme was relatively thermostable. It was strictly metal-dependent and required Mn2+ as optimum cofactor for activity. In addition, Mn2+ improved the structural stability during both heat- and urea-induced unfolding. Using circular dichroism measurements, the apparent melting temperature (T-m) and the urea midtransition concentration (C-m) of metal-free enzyme were 64.4 degrees C and 2.68 M. By comparison, the Mn2+-bound enzyme showed higher T-m and C-m with 67.3 degrees C and 5.09 M. The Michaelis-Menten constant (K-m), turnover number (k(cat)), and catalytic efficiency (k(cat)/K-m) values for substrate D-psicose were estimated to be 28.3 mM, 1826.8 s(-1), and 64.5 mM(-1) s(-1), respectively. The enzyme could effectively produce D-psicose from D-fructose with the turnover ratio of 28%.	[Zhang, Wenli; Fang, Dan; Xing, Qingchao; Zhou, Leon; Jiang, Bo; Mu, Wanmeng] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Zhou, Leon] Roquette Amer, Keokuk, IA USA	Jiangnan University	Mu, WM (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	wmmu@jiangnan.edu.cn			NSFC Project [31171705, 21276001]; 973 Project [2012CB720802]; 863 Project [2011AA100904]; Fundamental Research Funds for the Central Universities [JUSRP51304A]; Support Project of Jiangsu Province [BE2011622, BE2011766, BE2010678, BE2010626]	NSFC Project(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China); 863 Project(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Support Project of Jiangsu Province	This work was supported by the NSFC Project (No. 31171705 and 21276001), the 973 Project (No. 2012CB720802), the 863 Project (No. 2011AA100904), the Fundamental Research Funds for the Central Universities (No. JUSRP51304A), and the Support Project of Jiangsu Province (No. BE2011622, BE2011766, BE2010678, and BE2010626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan HC, 2012, PROTEIN CELL, V3, P123, DOI 10.1007/s13238-012-2026-5; Choi JG, 2011, APPL ENVIRON MICROB, V77, P7316, DOI 10.1128/AEM.05566-11; Hayashi N, 2010, BIOSCI BIOTECH BIOCH, V74, P510, DOI 10.1271/bbb.90707; Iida T, 2008, J NUTR SCI VITAMINOL, V54, P511, DOI 10.3177/jnsv.54.511; Ishida Y, 1997, J FERMENT BIOENG, V83, P529, DOI 10.1016/S0922-338X(97)81132-4; ITOH H, 1995, J FERMENT BIOENG, V80, P101, DOI 10.1016/0922-338X(95)98186-O; ITOH H, 1994, BIOSCI BIOTECH BIOCH, V58, P2168, DOI 10.1271/bbb.58.2168; IZUMORI K, 1993, BIOSCI BIOTECH BIOCH, V57, P1037, DOI 10.1271/bbb.57.1037; Kim HJ, 2006, APPL ENVIRON MICROB, V72, P981, DOI 10.1128/AEM.72.2.981-985.2006; Kim K, 2006, J MOL BIOL, V361, P920, DOI 10.1016/j.jmb.2006.06.069; Lee DW, 2005, ARCH BIOCHEM BIOPHYS, V434, P333, DOI 10.1016/j.abb.2004.11.004; Lin CJ, 2010, J AGR FOOD CHEM, V58, P10431, DOI 10.1021/jf102063q; Mu WM, 2012, APPL MICROBIOL BIOT, V94, P1461, DOI 10.1007/s00253-012-4093-1; Mu WM, 2011, J AGR FOOD CHEM, V59, P7785, DOI 10.1021/jf201356q; Murata A, 2003, J BIOSCI BIOENG, V96, P89, DOI 10.1016/S1389-1723(03)90104-6; Oshima H, 2006, FOOD SCI TECHNOL RES, V12, P137, DOI 10.3136/fstr.12.137; Park CS, 2007, BIOTECHNOL LETT, V29, P1387, DOI 10.1007/s10529-007-9393-7; Rhimi M, 2006, BBA-GEN SUBJECTS, V1760, P191, DOI 10.1016/j.bbagen.2005.11.007; Sun Y, 2004, J AGR FOOD CHEM, V52, P1293, DOI 10.1021/jf030428s; Sun YX, 2005, J AGR FOOD CHEM, V53, P10205, DOI 10.1021/jf051565n; Suna S, 2007, TOXICOL LETT, V173, P107, DOI 10.1016/j.toxlet.2007.06.015; Takata MK, 2005, J BIOSCI BIOENG, V100, P511, DOI 10.1263/jbb.100.511; Takeshita K, 2000, J BIOSCI BIOENG, V90, P453, DOI [10.1263/jbb.90.453, 10.1016/S1389-1723(01)80018-9]; Yoshida H, 2007, J MOL BIOL, V374, P443, DOI 10.1016/j.jmb.2007.09.033; Zhang LT, 2009, BIOTECHNOL LETT, V31, P857, DOI 10.1007/s10529-009-9942-3; Zhu YM, 2012, BIOTECHNOL LETT, V34, P1901, DOI 10.1007/s10529-012-0986-4	26	35	44	7	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62987	10.1371/journal.pone.0062987	http://dx.doi.org/10.1371/journal.pone.0062987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646168	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300123
J	Liu, HS; Chapman, ER; Dean, C				Liu, Huisheng; Chapman, Edwin R.; Dean, Camin			"Self" versus "Non-Self" Connectivity Dictates Properties of Synaptic Transmission and Plasticity	PLOS ONE			English	Article							READILY RELEASABLE POOL; DENDRITIC PROTEIN-SYNTHESIS; HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; SYNAPTOTAGMIN-I; NEURONS; VESICLES; PROBABILITY; AUTAPSES; NEUROTRANSMISSION	Autapses are connections between a neuron and itself. These connections are morphologically similar to "normal" synapses between two different neurons, and thus were long thought to have similar properties of synaptic transmission. However, this has not been directly tested. Here, using a micro-island culture assay in which we can define the number of interconnected cells, we directly compared synaptic transmission in excitatory autapses and in two-neuron micronetworks consisting of two excitatory neurons, in which a neuron is connected to one other neuron and to itself. We discovered that autaptic synapses are optimized for maximal transmission, and exhibited enhanced EPSC amplitude, charge, and RRP size compared to interneuronal synapses. However, autapses are deficient in several aspects of synaptic plasticity. Short-term potentiation only became apparent when a neuron was connected to another neuron. This acquisition of plasticity only required reciprocal innervation with one other neuron; micronetworks consisting of just two interconnected neurons exhibited enhanced short-term plasticity in terms of paired pulse ratio (PPR) and release probability (Pr), compared to autapses. Interestingly, when a neuron was connected to another neuron, not only interneuronal synapses, but also the autaptic synapses on itself exhibited a trend toward enhanced short-term plasticity in terms of PPR and Pr. Thus neurons can distinguish whether they are connected via "self" or "non-self" synapses and have the ability to adjust their plasticity parameters when connected to other neurons.	[Liu, Huisheng; Chapman, Edwin R.; Dean, Camin] Univ Wisconsin, Dept Neurosci, Madison, WI 53715 USA; [Liu, Huisheng; Chapman, Edwin R.; Dean, Camin] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI USA; [Dean, Camin] ENI G, Gottingen, Germany	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Liu, HS (corresponding author), Univ Wisconsin, Dept Neurosci, Madison, WI 53715 USA.	hliu@Waisman.Wisc.Edu; c.dean@eni-g.de	889, CRC/L-1607-2018	889, CRC/0000-0002-6678-3138; Chapman, Edwin/0000-0001-9787-8140	National Institute of Health (NIH) [MH61876]; Epilepsy Foundation; Alexander von Humboldt Foundation; European Research Council (ERC) [SytActivity FP7 260916]; Deutsche Forschungsgemeinschaft (DFG) [SFB889, 1951/1-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Research Council (ERC)(European Research Council (ERC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a National Institute of Health (NIH) grant MH61876 to E.R.C., and by an Epilepsy Foundation grant, Sofja Kovalevskaja grant from the Alexander von Humboldt Foundation, European Research Council (ERC) starting grant SytActivity FP7 260916, and Deutsche Forschungsgemeinschaft (DFG) grants SFB889 and 1951/1-1 to C.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Bekkers JM, 2003, CURR BIOL, V13, pR433, DOI 10.1016/S0960-9822(03)00363-4; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bekkers JM, 2009, CURR BIOL, V19, pR296, DOI 10.1016/j.cub.2009.02.010; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; de Jong APH, 2012, J CELL BIOL, V197, P327, DOI 10.1083/jcb.201112135; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Feng J, 2002, J NEUROSCI, V22, P4372, DOI 10.1523/JNEUROSCI.22-11-04372.2002; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; Hosoi N, 2007, J NEUROSCI, V27, P14286, DOI 10.1523/JNEUROSCI.4122-07.2007; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Lubke J, 1996, J NEUROSCI, V16, P3209; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Saada R, 2009, CURR BIOL, V19, P479, DOI 10.1016/j.cub.2009.01.060; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Stevens CF, 2007, J NEUROPHYSIOL, V98, P3221, DOI 10.1152/jn.00857.2007; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tamas G, 1997, J NEUROSCI, V17, P6352; Tokuoka H, 2008, P NATL ACAD SCI USA, V105, P14656, DOI 10.1073/pnas.0805705105; Tyler WJ, 2006, J PHYSIOL-LONDON, V574, P787, DOI 10.1113/jphysiol.2006.111310; VANDERLO.H, 1972, BRAIN RES, V48, P355, DOI 10.1016/0006-8993(72)90189-8; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Zhang JC, 2005, BRAIN RES, V1050, P110, DOI 10.1016/j.brainres.2005.05.032; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	42	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62414	10.1371/journal.pone.0062414	http://dx.doi.org/10.1371/journal.pone.0062414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658626	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800042
J	Zucchini, C; Manara, MC; Pinca, RS; De Sanctis, P; Guerzoni, C; Sciandra, M; Lollini, PL; Cenacchi, G; Picci, P; Valvassori, L; Scotlandi, K				Zucchini, C.; Manara, M. C.; Pinca, R. S.; De Sanctis, P.; Guerzoni, C.; Sciandra, M.; Lollini, P-L; Cenacchi, G.; Picci, P.; Valvassori, L.; Scotlandi, K.			CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity	ONCOGENE			English	Article						CD99; osteosarcoma; cadherins; ezrin; ROCK2; ARP2/3	EWINGS-SARCOMA CELLS; RHO-KINASE-II; MOLECULAR-MECHANISMS; CANCER INVASION; ARP2/3 COMPLEX; IN-VIVO; C-SRC; EXPRESSION; ADHESION; EZRIN	CD99, a transmembrane protein encoded by MIC2 gene is involved in multiple cellular events including cell adhesion and migration, apoptosis, cell differentiation and regulation of protein trafficking either in physiological or pathological conditions. In osteosarcoma, CD99 is expressed at low levels and functions as a tumour suppressor. The full-length protein (CD99wt) and the short-form harbouring a deletion in the intracytoplasmic domain (CD99sh) have been associated with distinct functional outcomes with respect to tumour malignancy. In this study, we especially evaluated modulation of cell-cell contacts, reorganisation of the actin cytoskeleton and modulation of signalling pathways by comparing osteosarcoma cells characterised by different metastasis capabilities and CD99 expression, to identify molecular mechanisms responsible for metastasis. Our data indicate that forced expression of CD99wt induces recruitment of N-cadherin and beta-catenin to adherens junctions. In addition, transfection of CD99wt inhibits the expression of several molecules crucial to the remodelling of the actin cytoskeleton, such as ACTR2, ARPC1A, Rho-associated, coiled-coil containing protein kinase 2 (ROCK2) as well as ezrin, an ezrin/radixin/moesin family member that has been clearly associated with tumour progression and metastatic spread in osteosarcoma. Functional studies point to ROCK2 as a crucial intracellular mediator regulating osteosarcoma migration. By maintaining c-Src in an inactive conformation, CD99wt inhibits ROCK2 signalling and this leads to ezrin decrease at cell membrane while N-cadherin and b-catenin translocate to the plasma membrane and function as main molecular bridges for actin cytoskeleton. Taken together, we propose that the re-expression of CD99wt, which is generally present in osteoblasts but lost in osteosarcoma, through inhibition of c-Src and ROCK2 activity, manages to increase contact strength and reactivate stop-migration signals that counteract the otherwise dominant promigratory action of ezrin in osteosarcoma cells.	[Zucchini, C.; De Sanctis, P.; Lollini, P-L; Valvassori, L.] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Manara, M. C.; Pinca, R. S.; Sciandra, M.; Scotlandi, K.] CRS Dev Biomol Therapies, Bologna, Italy; [Manara, M. C.; Pinca, R. S.; Guerzoni, C.; Picci, P.; Scotlandi, K.] Ist Ortoped Rizzoli, Expt Oncol Lab, I-40136 Bologna, Italy; [Guerzoni, C.; Scotlandi, K.] Ist Ortoped Rizzoli, RIT Dept, STB, PROMETEO Lab, I-40136 Bologna, Italy; [Cenacchi, G.] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy	University of Bologna; IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli; University of Bologna	Scotlandi, K (corresponding author), Ist Ortoped Rizzoli, CRS Dev Biomol Therapies, Via Barbiano 1-10, I-40136 Bologna, Italy.	katia.scotlandi@ior.it	Scotlandi, Katia/J-9009-2016; Manara, Maria Cristina/K-3366-2018; Sciandra, Marika/C-8724-2018; De Sanctis, Paola/HCI-1421-2022; Lollini, Pier Luigi/A-7644-2008; Picci, Piero/J-5979-2016	Scotlandi, Katia/0000-0001-6114-9499; Manara, Maria Cristina/0000-0001-5686-720X; Sciandra, Marika/0000-0001-7147-6960; Lollini, Pier Luigi/0000-0003-1702-4108; Picci, Piero/0000-0002-8519-4101; CENACCHI, GIOVANNA/0000-0001-5824-3118	Italian Association for Cancer Research (AIRC) [IG10452]; Liddy Shriver Sarcoma Initiative; Ricerca Fondamentale Orientata (RFO)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Liddy Shriver Sarcoma Initiative; Ricerca Fondamentale Orientata (RFO)	We are in debt to Cristina Ghinelli for editing the manuscript and to Anming Meng, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China, for kindly providing the plasmid pCMV5-HA3-ROCK2. This work was supported by the Italian Association for Cancer Research (AIRC; IG10452 to K Scotlandi), the Liddy Shriver Sarcoma Initiative (international grant to K Scotlandi) and Ricerca Fondamentale Orientata (RFO 2010 to C Zucchini). Rosa Simona Pinca is a recipient of a fellowship from the Associazione Onlus 'il Pensatore: Matteo Amitrano' and 'Liberi di Vivere Luca Righi.'	Alberti I, 2002, FASEB J, V16, P1946, DOI 10.1096/fj.02-0049fje; Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Bernard G, 2000, EUR J IMMUNOL, V30, P3061, DOI 10.1002/1521-4141(200010)30:10<3061::AID-IMMU3061>3.0.CO;2-M; Bernard G, 1997, J IMMUNOL, V158, P2543; BERNARD G, 1995, J IMMUNOL, V154, P26; Borensztajn K, 2010, THROMB RES, V125, pE323, DOI 10.1016/j.thromres.2010.02.018; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; Bulut G, 2012, ONCOGENE, V31, P269, DOI 10.1038/onc.2011.245; Byun HJ, 2006, J BIOL CHEM, V281, P34833, DOI 10.1074/jbc.M605483200; Cai YP, 2010, J PATHOL, V220, P24, DOI 10.1002/path.2628; Cerisano V, 2004, ONCOGENE, V23, P5664, DOI 10.1038/sj.onc.1207741; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Dworzak MN, 1999, BRIT J HAEMATOL, V105, P690, DOI 10.1046/j.1365-2141.1999.01426.x; Dworzak MN, 2004, LEUKEMIA, V18, P703, DOI 10.1038/sj.leu.2403303; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Hahn JH, 1997, J IMMUNOL, V159, P2250; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Husak Z, 2010, J LEUKOCYTE BIOL, V88, P405, DOI 10.1189/jlb.0210097; Imbert AM, 2006, BLOOD, V108, P2578, DOI 10.1182/blood-2005-12-010827; Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167; Jiao XM, 2008, MOL BIOL CELL, V19, P1378, DOI 10.1091/mbc.E07-08-0753; Jung KC, 2003, FEBS LETT, V554, P478, DOI 10.1016/S0014-5793(03)01224-9; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Kashima T, 2003, INT J CANCER, V104, P147, DOI 10.1002/ijc.10931; Kashima T, 1999, AM J PATHOL, V155, P1549, DOI 10.1016/S0002-9440(10)65471-5; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kim C, 2009, CANCER RES TREAT, V41, P138, DOI 10.4143/crt.2009.41.3.138; Kim SH, 2000, BLOOD, V95, P294; Laurila E, 2009, GENE CHROMOSOME CANC, V48, P330, DOI 10.1002/gcc.20643; Lee EJ, 2003, EXP MOL MED, V35, P438, DOI 10.1038/emm.2003.57; Lee HH, 2010, J CELL SCI, V123, P3368, DOI 10.1242/jcs.071555; LEVY R, 1979, P NATL ACAD SCI USA, V76, P6552, DOI 10.1073/pnas.76.12.6552; Lock FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031423; Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Manara MC, 2006, MOL BIOL CELL, V17, P1910, DOI 10.1091/mbc.E05-10-0971; Nakamura H, 1996, J BONE MINER RES, V11, P1715; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Otsubo T, 2004, MODERN PATHOL, V17, P461, DOI 10.1038/modpathol.3800062; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Park HR, 2006, PATHOL RES PRACT, V202, P509, DOI 10.1016/j.prp.2006.01.015; Pettersen RD, 2001, J IMMUNOL, V166, P4931, DOI 10.4049/jimmunol.166.8.4931; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rivat C, 2004, ONCOGENE, V23, P3317, DOI 10.1038/sj.onc.1207437; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Schenkel AR, 2007, CELL COMMUN ADHES, V14, P227, DOI 10.1080/15419060701755966; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Scotlandi K, 2007, ONCOGENE, V26, P6604, DOI 10.1038/sj.onc.1210481; Sohn HW, 1998, AM J PATHOL, V153, P1937, DOI 10.1016/S0002-9440(10)65707-0; Vishnubhotla R, 2007, LAB INVEST, V87, P1149, DOI 10.1038/labinvest.3700674; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wong CCL, 2009, HEPATOLOGY, V49, P1583, DOI 10.1002/hep.22836; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684; Yu HF, 2011, FRONT BIOSCI-LANDMRK, V16, P1536, DOI 10.2741/3803; Zhang XJ, 2011, CELL MOL BIOL LETT, V16, P279, DOI 10.2478/s11658-011-0006-z; Zhang Y, 2009, J CELL SCI, V122, P2197, DOI 10.1242/jcs.040659; Zheng SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022439	63	34	34	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2014	33	15					1912	1921		10.1038/onc.2013.152	http://dx.doi.org/10.1038/onc.2013.152			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RK	23644663				2022-12-25	WOS:000334346300004
J	Dhamija, S; Winzen, R; Doerrie, A; Behrens, G; Kuehne, N; Schauerte, C; Neumann, E; Dittrich-Breiholz, O; Kracht, M; Holtmann, H				Dhamija, Sonam; Winzen, Reinhard; Doerrie, Anneke; Behrens, Gesine; Kuehne, Nancy; Schauerte, Celina; Neumann, Elena; Dittrich-Breiholz, Oliver; Kracht, Michael; Holtmann, Helmut			Interleukin-17 (IL-17) and IL-1 Activate Translation of Overlapping Sets of mRNAs, Including That of the Negative Regulator of Inflammation, MCPIP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENT; NF-KAPPA-B; INDUCED PROTEIN-1; GENE-EXPRESSION; 3'-UNTRANSLATED REGION; TRANSCRIPTION FACTOR; CYTOKINE; CELLS; IDENTIFICATION; STABILIZATION	Changes in gene expression during inflammation are in part caused by post-transcriptional mechanisms. A transcriptome-wide screen for changes in ribosome occupancy indicated that the inflammatory cytokine IL-17 activates translation of a group of mRNAs that overlaps partially with those affected similarly by IL-1. Included are mRNAs of I kappa B zeta and of MCPIP1, important regulators of the quality and course of immune and inflammatory responses. Evidence for increased ribosome association of these mRNAs was also obtained in LPS-activated RAW264.7 macrophages and human peripheral blood mononuclear cells. Like IL-1, IL-17 activated translation of I kappa B zeta mRNA by counteracting the function of a translational silencing element in its 3'-UTR defined previously. Translational silencing of MCPIP1 mRNA in unstimulated cells resulted from the combined suppressive activities of its 5'-UTR, which contains upstream open reading frames, and of its 3'-UTR, which silences independently of the 5'-UTR. Only the silencing function of the 3'-UTR was counteracted by IL-17 as well as by IL-1. Translational silencing by the 3'-UTR was dependent on a putative stem-loop-forming region previously associated with rapid degradation of the mRNA. The results suggest that translational control exerted by IL-1 and IL-17 plays an important role in the coordination of an inflammatory reaction.	[Dhamija, Sonam; Winzen, Reinhard; Doerrie, Anneke; Behrens, Gesine; Kuehne, Nancy; Schauerte, Celina; Dittrich-Breiholz, Oliver; Holtmann, Helmut] Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany; [Neumann, Elena] Univ Giessen, Kerckhoff Clin Bad Nauheim, Dept Internal Med & Rheumatol, D-61231 Bad Nauheim, Germany; [Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmacol, D-35392 Giessen, Germany	Hannover Medical School; Justus Liebig University Giessen; Kerckhoff Clinic; Justus Liebig University Giessen	Holtmann, H (corresponding author), Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany.	holtmann.helmut@mh-hannover.de	Neumann, Elena/A-1418-2011; Dhamija, Sonam/AAJ-2093-2020	Dhamija, Sonam/0000-0002-9569-2729; Kuhne, Nancy/0000-0002-9418-7296; Kracht, Michael/0000-0002-8501-043X	Deutsche Forschungsgemeinschaft [SFB 566/A10, SFB 566/Z2, Ho 1116/5]; Deutsche Krebshilfe	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by Grants SFB 566/A10, SFB 566/Z2, and Ho 1116/5 from the Deutsche Forschungsgemeinschaft and by a grant from the Deutsche Krebshilfe.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Cai XY, 1998, IMMUNOL LETT, V62, P51, DOI 10.1016/S0165-2478(98)00027-3; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Datta S, 2010, J IMMUNOL, V184, P1484, DOI 10.4049/jimmunol.0902423; Dhamija S, 2011, J BIOL CHEM, V286, P33279, DOI 10.1074/jbc.M111.264754; Dhamija S, 2010, J BIOL CHEM, V285, P29165, DOI 10.1074/jbc.M110.146365; Faour WH, 2003, J BIOL CHEM, V278, P26897, DOI 10.1074/jbc.M212790200; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Jura J, 2008, BBA-GENE REGUL MECH, V1779, P383, DOI 10.1016/j.bbagrm.2008.04.006; Kasza A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-14; Katz Y, 2001, ARTHRITIS RHEUM-US, V44, P2176, DOI 10.1002/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-182; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Maniati E, 2010, ONCOGENE, V29, P5653, DOI 10.1038/onc.2010.367; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Milner JD, 2011, CURR OPIN IMMUNOL, V23, P784, DOI 10.1016/j.coi.2011.09.006; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Neumann E, 2002, GENE THER, V9, P1508, DOI 10.1038/sj.gt.3301811; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Niu JL, 2009, CLIN SCI, V117, P95, DOI 10.1042/CS20080581; Ohba T, 2012, FEBS J, V279, P211, DOI 10.1111/j.1742-4658.2011.08416.x; Qi DF, 2011, J BIOL CHEM, V286, P41692, DOI 10.1074/jbc.M111.276006; Qi YF, 2010, FEBS LETT, V584, P3065, DOI 10.1016/j.febslet.2010.05.040; Rubsamen D, 2012, RNA, V18, P1910, DOI 10.1261/rna.033019.112; Ryzhakov G, 2011, J IMMUNOL, V187, P5357, DOI 10.4049/jimmunol.1100917; Skalniak L, 2009, FEBS J, V276, P5892, DOI 10.1111/j.1742-4658.2009.07273.x; Sparna T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-226; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tiedje C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002977; Watanabe S, 2007, BIOCHEM BIOPH RES CO, V356, P785, DOI 10.1016/j.bbrc.2007.03.044; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Xu NH, 1998, NUCLEIC ACIDS RES, V26, P558, DOI 10.1093/nar/26.2.558; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496	45	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19250	19259		10.1074/jbc.M113.452649	http://dx.doi.org/10.1074/jbc.M113.452649			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658019	Green Published, hybrid			2022-12-25	WOS:000321335800057
J	Moik, D; Bottcher, A; Makhina, T; Grashoff, C; Bulus, N; Zent, R; Fassler, R				Moik, Daniel; Boettcher, Anika; Makhina, Tatiana; Grashoff, Carsten; Bulus, Nada; Zent, Roy; Faessler, Reinhard			Mutations in the Paxillin-binding Site of Integrin-linked Kinase (ILK) Destabilize the Pseudokinase Domain and Cause Embryonic Lethality in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; ALPHA-PARVIN; MOLECULAR DISSECTION; STRUCTURAL BASIS; ADAPTER PROTEIN; IN-VITRO; VASCULOGENESIS; LOCALIZATION; COMPLEX; PINCH	Integrin-linked kinase (ILK) localizes to focal adhesions (FAs) where it regulates cell spreading, migration, and growth factor receptor signaling. Previous reports showed that overexpressed ILK in which Val(386) and Thr(387) were substituted with glycine residues (ILK-VT/GG) could neither interact with paxillin nor localize to FA in cells expressing endogenous wild-type ILK, implying that paxillin binding to ILK is required for its localization to FAs. Here, we show that introducing this mutation into the germ line of mice (ILK-VT/GG) caused vasculogenesis defects, resulting in a general developmental delay and death at around embryonic day 12.5. Fibroblasts isolated from ILK-VT/GG mice contained mutant ILK in FAs, showed normal adhesion to and spreading on extracellular matrix substrates but displayed impaired migration. Biochemical analysis revealed that VT/GG substitutions decreased ILK protein stability leading to decreased ILK levels and reduced binding to paxillin and alpha-parvin. Because paxillin depletion did not affect ILK localization to FAs, the embryonic lethality and the in vitro migration defects are likely due to the reduced levels of ILK-VT/GG and diminished binding to parvins.	[Moik, Daniel; Boettcher, Anika; Makhina, Tatiana; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Grashoff, Carsten] Max Planck Inst Biochem, Mechanotransduct Res Grp, D-82152 Martinsried, Germany; [Bulus, Nada; Zent, Roy] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN 37232 USA; [Zent, Roy] Vet Affairs Med Ctr, Dept Med, Nashville, TN 37232 USA	Max Planck Society; Max Planck Society; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Fassler, R (corresponding author), Max Planck Inst Biochem, Dept Mol Med, Klopferspitz 18, D-82152 Martinsried, Germany.	faessler@biochem.mpg.de			Max Planck Society; Veterans Affairs Merit Review Grants [1I01BX002196-01, DK075594, DK069221, DK083187]; O'Brien Center [DK79341-01]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079341, R01DK083187, R01DK075594] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002196] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); Veterans Affairs Merit Review Grants(US Department of Veterans Affairs); O'Brien Center; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Max Planck Society (to R. F.); Veterans Affairs Merit Review Grants 1I01BX002196-01, DK075594, DK069221, and DK083187; the O'Brien Center DK79341-01; and an American Heart Association established investigator award (to R. Z.).	Aoyagi Y, 2005, BIOCHEM BIOPH RES CO, V331, P1061, DOI 10.1016/j.bbrc.2005.03.225; Azimifar SB, 2012, J CELL SCI, V125, P435, DOI 10.1242/jcs.091652; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Boulter E, 2006, FASEB J, V20, P1489, DOI 10.1096/fj.05-4579fje; Chen D, 2004, AM J PHYSIOL-RENAL, V287, pF602, DOI 10.1152/ajprenal.00015.2004; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Friedrich EB, 2004, MOL CELL BIOL, V24, P8134, DOI 10.1128/MCB.24.18.8134-8144.2004; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Gao GH, 2004, J BIOL CHEM, V279, P8441, DOI 10.1074/jbc.M309808200; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; JAT PS, 1986, J VIROL, V59, P746, DOI 10.1128/JVI.59.3.746-750.1986; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Lorenz S, 2008, STRUCTURE, V16, P1521, DOI 10.1016/j.str.2008.08.007; MARTIN JS, 1995, ANN NY ACAD SCI, V752, P300, DOI 10.1111/j.1749-6632.1995.tb17439.x; Meyer M, 2012, J CELL SCI, V125, P5690, DOI 10.1242/jcs.108167; Moik DV, 2011, J CELL SCI, V124, P414, DOI 10.1242/jcs.075960; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Radovanac K, 2013, EMBO J, V32, P1409, DOI 10.1038/emboj.2013.90; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stanchi F, 2009, J CELL SCI, V122, P1800, DOI 10.1242/jcs.044602; Stiegler AL, 2012, J BIOL CHEM, V287, P32566, DOI 10.1074/jbc.M112.367342; Theiler K., 1989, HOUSE MOUSE ATLAS EM, P26; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Wade R, 2002, ONCOGENE, V21, P96, DOI 10.1038/sj.onc.1205013; Wang XX, 2008, J BIOL CHEM, V283, P21113, DOI 10.1074/jbc.M801270200; Wickstrom SA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005116; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Widmaier M, 2012, J CELL SCI, V125, P1839, DOI 10.1242/jcs.093864; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	39	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18863	18871		10.1074/jbc.M113.470476	http://dx.doi.org/10.1074/jbc.M113.470476			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658024	Green Published, hybrid			2022-12-25	WOS:000321335800024
J	Li, XN; Liu, X; Xu, WY; Zhou, P; Gao, P; Jiang, SS; Lobie, PE; Zhu, T				Li, Xiaoni; Liu, Xin; Xu, Weiyi; Zhou, Peng; Gao, Ping; Jiang, Songshan; Lobie, Peter E.; Zhu, Tao			c-MYC-regulated miR-23a/24-2/27a Cluster Promotes Mammary Carcinoma Cell Invasion and Hepatic Metastasis by Targeting Sprouty2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR RECEPTOR; BREAST-CANCER; MIR-23A-SIMILAR-TO-27A-SIMILAR-TO-24-2 CLUSTER; COMPUTATIONAL METHODS; TRANSCRIPTION FACTORS; MICRORNAS; ANGIOGENESIS; PROTEIN; EXPRESSION	Emerging evidence indicates that the miR-23a/24-2/27a cluster may possess a causal role in mammary tumorigenesis and function as a novel class of oncogenes. However, the regulatory mechanism of the miR-23a/24-2/27a cluster in mammary carcinoma cell invasion and migration is still largely unknown. We observed that the expression levels of miR-23a, miR-24-2 and miR-27a were significantly higher in breast cancer with lymph node metastasis, compared with that from patients without lymph node metastasis or normal tissue. Forced expression of the miR-23a/24-2/27a cluster promoted mammary carcinoma cell migration, invasion, and hepatic metastasis, through targeting Sprouty2 (SPRY2) and consequent activation of p44/42 MAPK. Epidermal growth factor induced the expression of the transcription factor c-MYC, which promoted the expression of mature miR-23a, miR-24-2, and miR-27a and subsequently decreased expression of SPRY2 and activated p44/42 MAPK to promote mammary carcinoma cell migration and invasion. We therefore suggest a novel link between epidermal growth factor and the miR-23a/24-2/27a cluster via the regulation of c-MYC, providing the potential for the miR-23a/24-2/27a cluster to be used as biomarker in the diagnosis and/or treatment of breast cancer.	[Li, Xiaoni; Liu, Xin; Gao, Ping; Zhu, Tao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Li, Xiaoni; Liu, Xin; Gao, Ping; Zhu, Tao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Xu, Weiyi; Zhou, Peng; Jiang, Songshan] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Weiyi; Zhou, Peng; Jiang, Songshan] Sun Yat Sen Univ, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Lobie, Peter E.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117456, Singapore; [Lobie, Peter E.] Natl Univ Singapore, Dept Pharmacol, Singapore 117456, Singapore; [Lobie, Peter E.] Natl Univ Singapore, Natl Canc Inst Singapore, Natl Univ Hlth Syst, Singapore 117456, Singapore	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Sun Yat Sen University; Sun Yat Sen University; National University of Singapore; National University of Singapore; National University of Singapore	Lobie, PE (corresponding author), Natl Univ Singapore, Ctr Life Sci, Canc Sci Inst Singapore, 03-06C,28 Med Dr, Singapore 117456, Singapore.	csipel@nus.edu.sg; zhut@ustc.edu.cn	Zhu, Tao/H-3495-2018		National Key Scientific Program of China [2012CB934002, 2010CB912804]; National Natural Science Foundation of China [30971492, 81272925]; Cancer Science Institute of Singapore; Senior Foreign Expert Plan [6DW2012340015J]; S&T Plan of Guangzhou [2012J4100082]	National Key Scientific Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cancer Science Institute of Singapore; Senior Foreign Expert Plan; S&T Plan of Guangzhou	This work was supported by National Key Scientific Program of China Grants 2012CB934002 and 2010CB912804, National Natural Science Foundation of China Grants 30971492 and 81272925, the Cancer Science Institute of Singapore and the Senior Foreign Expert Plan (Grant 6DW2012340015J), and the S&T Plan of Guangzhou (Grant 2012J4100082).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Bicknell R, 2004, ANNU REV PHARMACOL, V44, P219, DOI 10.1146/annurev.pharmtox.44.101802.121650; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Brandvold KA, 2000, ONCOGENE, V19, P2780, DOI 10.1038/sj.onc.1203589; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Ellis IO, 2003, PATHOLOGY GENETICS T, P9; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Evdokimova V, 2009, CELL CYCLE, V8, P2901, DOI 10.4161/cc.8.18.9537; Fitzgerald K, 2005, CURR OPIN DRUG DISC, V8, P557; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Guarneri V, 2009, ONCOLOGIST, V14, P645, DOI 10.1634/theoncologist.2009-0078; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Janda E, 2002, ONCOGENE, V21, P5148, DOI 10.1038/sj.onc.1205661; Jiang X, 2004, J THROMB HAEMOST, V2, P93, DOI 10.1111/j.1538-7836.2004.00545.x; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Martins PAD, 2010, CURR DRUG TARGETS, V11, P900, DOI 10.2174/138945010791591322; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Milanezi F, 2008, EXPERT REV MOL DIAGN, V8, P417, DOI 10.1586/14737159.8.4.417; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mukhina S, 2004, P NATL ACAD SCI USA, V101, P15166, DOI 10.1073/pnas.0405881101; Nanba D, 2008, J CELL PHYSIOL, V214, P465, DOI 10.1002/jcp.21233; Ngo CV, 2000, CELL GROWTH DIFFER, V11, P201; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Pawlicki JM, 2010, TRENDS CELL BIOL, V20, P52, DOI 10.1016/j.tcb.2009.10.004; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Qian PX, 2012, CANCER RES, V72, P6036, DOI 10.1158/0008-5472.CAN-12-1507; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Sakuma K, 2012, P NATL ACAD SCI USA, V109, P7776, DOI 10.1073/pnas.1111135109; Skaftnesmo KO, 2007, CURR PHARM BIOTECHNO, V8, P320, DOI 10.2174/138920107783018390; Tsuji T, 2008, CANCER RES, V68, P10377, DOI 10.1158/0008-5472.CAN-08-1444; Utsumi Toshiaki, 2007, Breast Cancer, V14, P194, DOI 10.2325/jbcs.959; van Cruijsen H, 2005, INT J CANCER, V117, P883, DOI 10.1002/ijc.21479; Watanabe Y, 2007, METHOD ENZYMOL, V427, P65, DOI 10.1016/S0076-6879(07)27004-1; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Yuan XY, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-65; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	66	114	121	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18121	18133		10.1074/jbc.M113.478560	http://dx.doi.org/10.1074/jbc.M113.478560			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649631	Green Published, hybrid			2022-12-25	WOS:000320721900018
J	Yang, XH; Li, L; Liang, J; Shi, L; Yang, JG; Yi, X; Zhang, D; Han, X; Yu, N; Shang, YF				Yang, Xiaohan; Li, Lei; Liang, Jing; Shi, Lei; Yang, Jianguo; Yi, Xia; Zhang, Di; Han, Xiao; Yu, Na; Shang, Yongfeng			Histone Acetyltransferase 1 Promotes Homologous Recombination in DNA Repair by Facilitating Histone Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; CHROMATIN REMODELING COMPLEX; SACCHAROMYCES-CEREVISIAE; VARIANT H3.3; IN-VIVO; ACTIVE CHROMATIN; BINDING PROTEIN; DAMAGE RESPONSE; CORE HISTONES; NUCLEOSOME	Faithful repair of DNA double-strand breaks is vital to the maintenance of genome integrity and proper cell functions. Histone modifications, such as reversible acetylation, phosphorylation, methylation, and ubiquitination, which collectively contribute to the establishment of distinct chromatin states, play important roles in the recruitment of repair factors to the sites of double-strand breaks. Here we report that histone acetyltransferase 1 (HAT1), a classical B type histone acetyltransferase responsible for acetylating the N-terminal tail of newly synthesized histone H4 in the cytoplasm, is a key regulator of DNA repair by homologous recombination in the nucleus. We found that HAT1 is required for the incorporation of H4K5/K12-acetylated H3.3 at sites of double-strand breaks through its HIRA-dependent histone turnover activity. Incorporated histones with specific chemical modifications facilitate subsequent recruitment of RAD51, a key repair factor in mammalian cells, to promote efficient homologous recombination. Significantly, depletion of HAT1 sensitized cells to DNA damage compromised the global chromatin structure, inhibited cell proliferation, and induced cell apoptosis. Our experiments uncovered a role for HAT1 in DNA repair in higher eukaryotic organisms and provide a mechanistic insight into the regulation of histone dynamics by HAT1.	[Yang, Xiaohan; Li, Lei; Liang, Jing; Yang, Jianguo; Yi, Xia; Zhang, Di; Han, Xiao; Yu, Na; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China; [Shi, Lei; Shang, Yongfeng] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, Tianjin 300070, Peoples R China	Peking University; Tianjin Medical University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	yshang@hsc.pku.edu.cn	Zhang, Di/AAE-2027-2021; Zhang, Di/AAD-6936-2021; Han, Xiao/A-1109-2017	Han, Xiao/0000-0002-5395-4022; Han, Xiao/0000-0002-6024-6286	National Natural Science Foundation of China [91219201, 81130048]; Ministry of Science and Technology of China grants (973 Program) [2011CB504204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China grants (973 Program)	This work was supported by National Natural Science Foundation of China Grants 91219201 and 81130048 (to Y. S.) and by Ministry of Science and Technology of China grants (973 Program: 2011CB504204; to Y. S.).	Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; ALTHAUS FR, 1992, J CELL SCI, V102, P663; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Barman HK, 2006, BIOCHEM BIOPH RES CO, V345, P1547, DOI 10.1016/j.bbrc.2006.05.079; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Benson LJ, 2007, J BIOL CHEM, V282, P836, DOI 10.1074/jbc.M607464200; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen DY, 2005, J CELL BIOL, V168, P41, DOI 10.1083/jcb.200407182; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Dunlop MH, 2011, J BIOL CHEM, V286, P37328, DOI 10.1074/jbc.M111.290015; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Ge ZQ, 2011, J BIOL CHEM, V286, P16790, DOI 10.1074/jbc.M110.216846; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; He J, 2012, J BIOL CHEM, V287, P31747, DOI 10.1074/jbc.M112.384750; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; HORWITZ SB, 1973, CANCER RES, V33, P2834; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; KLEIMAN NJ, 1990, CURR EYE RES, V9, P1185, DOI 10.3109/02713689009003475; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; Li Q, 2011, CANCER RES, V71, P6899, DOI 10.1158/0008-5472.CAN-11-1523; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Lorain S, 1998, MOL CELL BIOL, V18, P5546, DOI 10.1128/MCB.18.9.5546; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Parthun MR, 2007, ONCOGENE, V26, P5319, DOI 10.1038/sj.onc.1210602; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Qin S, 2006, MOL CELL BIOL, V26, P3649, DOI 10.1128/MCB.26.9.3649-3658.2006; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; SANDALTZOPOULOS R, 1994, NUCLEIC ACIDS RES, V22, P1511, DOI 10.1093/nar/22.8.1511; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Seiden-Long IM, 2006, ONCOGENE, V25, P91, DOI 10.1038/sj.onc.1209005; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Unnikrishnan A, 2010, NAT STRUCT MOL BIOL, V17, P430, DOI 10.1038/nsmb.1780; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Verzijlbergen KF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002284; Vidanes GM, 2005, CELL, V121, P973, DOI 10.1016/j.cell.2005.06.013; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Xiao J, 2001, J BIOL CHEM, V276, P6105, DOI 10.1074/jbc.M008893200; Yang XH, 2011, MOL CELL, V44, P39, DOI 10.1016/j.molcel.2011.07.032; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang Y, 2011, J BIOL CHEM, V286, P42414, DOI 10.1074/jbc.M111.271064	64	66	70	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18271	18282		10.1074/jbc.M113.473199	http://dx.doi.org/10.1074/jbc.M113.473199			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653357	Green Published, hybrid			2022-12-25	WOS:000320721900031
J	Shimizu, N; Nakajima, NI; Tsunematsu, T; Ogawa, I; Kawai, H; Hirayama, R; Fujimori, A; Yamada, A; Okayasu, R; Ishimaru, N; Takata, T; Kudo, Y				Shimizu, Natsumi; Nakajima, Nakako Izumi; Tsunematsu, Takaaki; Ogawa, Ikuko; Kawai, Hidehiko; Hirayama, Ryoichi; Fujimori, Akira; Yamada, Akiko; Okayasu, Ryuichi; Ishimaru, Naozumi; Takata, Takashi; Kudo, Yasusei			Selective Enhancing Effect of Early Mitotic Inhibitor 1 (Emi1) Depletion on the Sensitivity of Doxorubicin or X-ray Treatment in Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; RESISTANT PROSTATE-CANCER; DNA-REPLICATION; GENE-EXPRESSION; AURORA KINASE; UBIQUITIN LIGASE; GEMININ; CYCLE; CARCINOMA; COMPLEX	Chemotherapy and radiation in addition to surgery has proven useful in a number of different cancer types, but the effectiveness in normal tissue cannot be avoided in these therapies. To improve the effectiveness of these therapies selectively in cancer tissue is important for avoiding side effects. Early mitotic inhibitor 1 (Emi1) is known to have the function to inhibit anaphase-promoting complex/cyclosome ubiquitin ligase complex, which ubiquitylates the cell cycle-related proteins. It recently has been shown that Emi1 knockdown prevents transition from S to G(2) phase by down-regulating geminin via anaphase-promoting complex/cyclosome activation. At present, anticancer drugs for targeting DNA synthesis to interfere with rapidly dividing cells commonly are used. As Emi1 depletion interferes with completion of DNA synthesis in cancer cells, we thought that Emi1 knockdown might enhance the sensitivity for anticancer agents. Here, we confirmed that Emi1 siRNA induced polyploidy for preventing transition from S to G(2) phase in several cancer cell lines. Then, we treated Emi1 depleted cells with doxorubicin. Interestingly, increased apoptotic cells were observed after doxorubicin treatment in Emi1 siRNA-treated cancer cells. In addition, Emi1 depletion enhanced the sensitivity of x-ray irradiation in cancer cells. Importantly, synergistic effect of Emi1 knockdown in these combination therapies was not observed in normal cells. These results suggest that Emi1 siRNA can be a useful tool for enhancing of sensitivity of cancer cells to anticancer reagents and radiation.	[Shimizu, Natsumi; Tsunematsu, Takaaki; Takata, Takashi; Kudo, Yasusei] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima 7348553, Japan; [Nakajima, Nakako Izumi; Hirayama, Ryoichi; Fujimori, Akira; Okayasu, Ryuichi] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 2638555, Japan; [Nakajima, Nakako Izumi; Hirayama, Ryoichi; Fujimori, Akira; Okayasu, Ryuichi] Natl Inst Radiol Sci, Int Open Lab, Particle Therapy Mol Target Res Unit, Chiba 2638555, Japan; [Ogawa, Ikuko] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima 7348553, Japan; [Kawai, Hidehiko] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Radiobiol, Hiroshima 7348553, Japan; [Yamada, Akiko; Ishimaru, Naozumi; Kudo, Yasusei] Univ Tokushima, Grad Sch, Dept Oral Mol Pathol, Inst Hlth Biosci, Tokushima 7708504, Japan	Hiroshima University; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; Hiroshima University; Hiroshima University; Tokushima University	Kudo, Y (corresponding author), Univ Tokushima, Grad Sch, Dept Oral Mol Pathol, Inst Hlth Biosci, 3-18-15 Kuramoto, Tokushima 7708504, Japan.	yasusei@tokushima-u.ac.jp	Okayasu, Ryuichi/F-2071-2013	Okayasu, Ryuichi/0000-0001-5091-7210; Kudo, Yasusei/0000-0002-0392-7720; Kawai, Hidehiko/0000-0003-2213-7166	Ministry of Education, Culture, Sports, Science and Technology [23689074, 25670778, 21249088, 23390301, 24249067, 19-9, H23-A-43]; Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science [23-6562]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (23689074 and 25670778 (to Y. K.), 21249088 (to T. Takata), and 23390301 and 24249067 (to R. O.)), Grant-in-aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology (19-9, H23-A-43; to R. O.), and a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (23-6562; to T. Tsunematsu).	Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Dancey JE, 2012, CELL, V148, P409, DOI 10.1016/j.cell.2012.01.014; Di Fiore B, 2007, J CELL BIOL, V177, P425, DOI 10.1083/jcb.200611166; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Guan Z, 2007, CANCER RES, V67, P10436, DOI 10.1158/0008-5472.CAN-07-1379; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Gutgemann I, 2008, MODERN PATHOL, V21, P445, DOI 10.1038/modpathol.3801022; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Lehman NL, 2006, CELL CYCLE, V5, P1569, DOI 10.4161/cc.5.14.2925; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; MILAS L, 1994, CANCER RES, V54, P3506; Moretti L, 2011, INT J RADIAT ONCOL, V80, P1189, DOI 10.1016/j.ijrobp.2011.01.060; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Niermann KJ, 2011, RADIAT RES, V175, P444, DOI 10.1667/RR2317.1; Onozuka H, 2011, CANCER SCI, V102, P975, DOI 10.1111/j.1349-7006.2011.01880.x; Pagano M, 2003, CANCER CELL, V4, P251, DOI 10.1016/S1535-6108(03)00243-5; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; POMMIER Y, 1994, CANCER INVEST, V12, P530, DOI 10.3109/07357909409021413; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takimoto C. H., 2008, PRINCIPLES ONCOLOGIC, P1; Tao Y, 2007, BRIT J CANCER, V97, P1664, DOI 10.1038/sj.bjc.6604083; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; TISHLER RB, 1992, CANCER RES, V52, P3495; Verschuren EW, 2007, MOL CELL BIOL, V27, P7955, DOI 10.1128/MCB.00908-07; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yamasaki L, 2004, CURR OPIN CELL BIOL, V16, P623, DOI 10.1016/j.ceb.2004.08.005; Yokoyama K, 2003, INT J ONCOL, V22, P891; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Zhang AL, 2007, PROSTATE, V67, P1630, DOI 10.1002/pros.20638; Zhu WG, 2009, CANCER RES, V69, P4870, DOI 10.1158/0008-5472.CAN-08-4559	50	15	15	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17238	17252		10.1074/jbc.M112.446351	http://dx.doi.org/10.1074/jbc.M112.446351			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645673	Green Published, hybrid			2022-12-25	WOS:000320380600020
J	Herrador, A; Leon, S; Haguenauer-Tsapis, R; Vincent, O				Herrador, Antonio; Leon, Sebastien; Haguenauer-Tsapis, Rosine; Vincent, Olivier			A Mechanism for Protein Monoubiquitination Dependent on a trans-Acting Ubiquitin-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; ESCRT-I; RECRUITMENT; COMPLEX; YEAST; RECEPTOR; LIGASE	The length of the ubiquitin chain on a substrate dictates various functional outcomes, yet little is known about its regulation in vivo. The yeast arrestin-related protein Rim8/Art9 is monoubiquitinated in vivo by the Rsp5 ubiquitin ligase. This also requires Vps23, a protein that displays an ubiquitin-E2 variant (UEV) domain. Here, we report that binding of the UEV domain to Rim8 interferes with ubiquitin chain elongation and directs Rim8 monoubiquitination. We propose that Vps23 UEV competes with Rsp5 HECTN-lobe for binding to the first conjugated ubiquitin, thereby preventing polyubiquitination. These findings reveal a novel mechanism to control ubiquitin chain length on substrates in vivo.	[Herrador, Antonio; Vincent, Olivier] CSIC UAM, Inst Invest Biomed, Madrid 28029, Spain; [Leon, Sebastien; Haguenauer-Tsapis, Rosine] Univ Paris Diderot, Inst Jacques Monod, CNRS, UMR 7592,Sorbonne Paris Cite, F-75205 Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Vincent, O (corresponding author), CSIC UAM, Inst Invest Biomed, Arturo Duperier 4, Madrid 28029, Spain.	ovincent@iib.uam.es	vincent, Olivier/H-1620-2015; LEON, Sebastien/A-5441-2008	vincent, Olivier/0000-0003-4355-5367; LEON, Sebastien/0000-0002-2536-8595	Ministerio de Ciencia e Innovacion [BFU2008-02005]; Association pour la Recherche sur le Cancer (ARC) [SFI20101201844]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (BFU2008-02005; to O.V.) and the Association pour la Recherche sur le Cancer (ARC, Grant SFI20101201844; to S.L.).	Burgdorf S, 2004, J BIOL CHEM, V279, P17524, DOI 10.1074/jbc.M313703200; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Erpapazoglou Z, 2012, MOL BIOL CELL, V23, P2170, DOI 10.1091/mbc.E11-10-0891; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Herrador A, 2010, MOL CELL BIOL, V30, P897, DOI 10.1128/MCB.00132-09; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Kee Y, 2006, J BIOL CHEM, V281, P36724, DOI 10.1074/jbc.M608756200; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Ren XF, 2011, EMBO J, V30, P2130, DOI 10.1038/emboj.2011.122; Rose MD., 1990, METHODS YEAST GENETI; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Wang GL, 1999, MOL CELL BIOL, V19, P342; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484	21	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16206	16211		10.1074/jbc.C113.452250	http://dx.doi.org/10.1074/jbc.C113.452250			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23645667	Green Published, hybrid			2022-12-25	WOS:000320378900001
J	Zaremba-Niedzwiedzka, K; Andersson, SGE				Zaremba-Niedzwiedzka, Katarzyna; Andersson, Siv G. E.			No Ancient DNA Damage in Actinobacteria from the Neanderthal Bone	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; INSOLUBLE COLLAGEN; HYDROLYSIS; METAGENOMICS; PATTERNS; RESOURCE; PROTEASE	Background: The Neanderthal genome was recently sequenced using DNA extracted from a 38,000-year-old fossil. At the start of the project, the fraction of mammalian and bacterial DNA in the sample was estimated to be <6% and 9%, respectively. Treatment with restriction enzymes prior to sequencing increased the relative proportion of mammalian DNA to 15%, but the large majority of sequences remain uncharacterized. Principal Findings: Our taxonomic profiling of 3.95 Gb of Neanderthal DNA isolated from the Vindija Neanderthal Vi33.16 fossil showed that 90% of about 50,000 rRNA gene sequence reads were of bacterial origin, of which Actinobacteria accounted for more than 75%. Actinobacteria also represented more than 80% of the PCR-amplified 16S rRNA gene sequences from a cave sediment sample taken from the same G layer as the Neanderthal bone. However, phylogenetic analyses did not identify any sediment clones that were closely related to the bone-derived sequences. We analysed the patterns of nucleotide differences in the individual sequence reads compared to the assembled consensus sequences of the rRNA gene sequences. The typical ancient nucleotide substitution pattern with a majority of C to T changes indicative of DNA damage was observed for the Neanderthal rRNA gene sequences, but not for the Streptomyces-like rRNA gene sequences. Conclusions/Significance: Our analyses suggest that the Actinobacteria, and especially members of the Streptomycetales, contribute the majority of sequences in the DNA extracted from the Neanderthal fossil Vi33.16. The bacterial DNA showed no signs of damage, and we hypothesize that it was derived from bacteria that have been enriched inside the bone. The bioinformatic approach used here paves the way for future studies of microbial compositions and patterns of DNA damage in bacteria from archaeological bones. Such studies can help identify targeted measures to increase the relative amount of endogenous DNA in the sample.	[Zaremba-Niedzwiedzka, Katarzyna; Andersson, Siv G. E.] Uppsala Univ, Biomed Ctr, Dept Mol Evolut, Cell & Mol Biol Sci Life Lab, Uppsala, Sweden	Uppsala University	Andersson, SGE (corresponding author), Uppsala Univ, Biomed Ctr, Dept Mol Evolut, Cell & Mol Biol Sci Life Lab, Uppsala, Sweden.	Siv.Andersson@icm.uu.se		Zaremba-Niedzwiedzka, Katarzyna/0000-0003-1030-8212	Swedish Research Council [315-2004-6676]; Goran Gustafsson Foundation; Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Goran Gustafsson Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work has been supported by grants to SGEA from the Swedish Research Council (315-2004-6676), the Goran Gustafsson Foundation, and the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; CHILD AM, 1995, STUD CONSERV, V40, P19, DOI 10.2307/1506608; CHILD AM, 1995, J ARCHAEOL SCI, V22, P165, DOI 10.1006/jasc.1995.0018; Darling A. E., 2010, PLOS ONE, V5; ENSIGN JC, 1978, ANNU REV MICROBIOL, V32, P185, DOI 10.1146/annurev.mi.32.100178.001153; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guy L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003393; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Johnson SS, 2007, P NATL ACAD SCI USA, V104, P14401, DOI 10.1073/pnas.0706787104; KARPENKO HF, 1977, UKR BIOKHIM ZH+, V49, P76; KARPENKO HF, 1977, UKR BIOKHIM ZH+, V49, P80; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lomstein BA, 2012, NATURE, V484, P101, DOI 10.1038/nature10905; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; MISHUNIN IF, 1975, UKR BIOKHIM ZH+, V47, P226; Morono Y, 2011, P NATL ACAD SCI USA, V108, P18295, DOI 10.1073/pnas.1107763108; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rastogi R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-208; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Sawyer S, 2012, PLOS ONE, V7; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Tsyperovich A S, 1973, Ukr Biokhim Zh, V45, P151; Willerslev E, 2004, CURR BIOL, V14, pR9, DOI 10.1016/j.cub.2003.12.012	36	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62799	10.1371/journal.pone.0062799	http://dx.doi.org/10.1371/journal.pone.0062799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658776	Green Submitted, gold, Green Published			2022-12-25	WOS:000321202100042
J	Carmona, L; Pola, M; Gosliner, TM; Cervera, JL				Carmona, Leila; Pola, Marta; Gosliner, Terrence M.; Cervera, Juan Lucas			A Tale That Morphology Fails to Tell: A Molecular Phylogeny of Aeolidiidae (Aeolidida, Nudibranchia, Gastropoda)	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; OPISTHOBRANCHIA MOLLUSCA; BERGHIA-VERRUCICORNIS; EUTHYNEURA MOLLUSCA; SPECIES BOUNDARIES; MAXIMUM-LIKELIHOOD; FAMILY AEOLIDIIDAE; BABAKINA ROLLER; DNA-SEQUENCES; BIOGEOGRAPHY	Aeolidida is one of the largest clades of nudibranchs with at least 560 known species. However, its systematics has not been studied in a comprehensive manner. Phylogenetic analyses of larger clades such as Nudibranchia or Cladobranchia have usually included a poor sample of aeolids. Furthermore, phylogenetic studies at the family or generic level in Aeolidida are a few and far between. The first molecular phylogeny of the aeolid family Aeolidiidae is presented here. This study, the most comprehensive for Aeolidida to date, uses new sequences of two mitochondrial (COI and 16S) genes and one nuclear gene (H3). 251 specimens from members of seven families of Aeolidida, including 39 species of Aeolidiidae were studied. Excluding Pleurolidia juliae, Aeolidiidae is monophyletic. Our results resolve the systematic relationships within the Aeolidiidae at a generic level, requiring changes in the systematics of this family. Spurilla, Anteaeolidiella, Limenandra and Aeolidia are well-supported and monophyletic clades. Aeolidiella stephanieae is transferred to Berghia and Aeolidiopsis ransoni and Spurilla salaamica to Baeolidia, to maintain the monophyletic lineages reflected in this study. The systematics of Cerberilla remains unclear. Some species earlier attributed to Aeolidiella are now grouped in a previously unnamed clade that we designate as Bulbaeolidia gen. nov.	[Carmona, Leila; Cervera, Juan Lucas] Univ Cadiz, Fac Ciencias Mar & Ambientales, Dept Biol, Cadiz, Spain; [Pola, Marta] Autonomous Univ Madrid, Dept Biol Edificio Biol, E-28049 Madrid, Spain; [Gosliner, Terrence M.] Calif Acad Sci, Dept Invertebrate Zool, San Francisco, CA 94118 USA	Universidad de Cadiz; Autonomous University of Madrid; California Academy of Sciences	Carmona, L (corresponding author), Univ Cadiz, Fac Ciencias Mar & Ambientales, Dept Biol, Campus Excelencia Int Mar CEI MAR, Cadiz, Spain.	leila.carmona@uca.es	Pola, Marta/K-6054-2014; Cervera, Juan Lucas/D-9733-2018; Carmona, Leila/L-8021-2014	Cervera, Juan Lucas/0000-0002-8337-2867; Carmona, Leila/0000-0002-2070-4684	University of Cadiz; California Academy of Sciences; National Science Foundation [DEB 0329054]; Spanish Ministry of Economy and Competitiveness (Ministry of Sciences and Innovation) [CGL2006-05182/BOS, CTM2008-05228-E/MAR, CGL2010-17187]; Institut Menorqui d'Estudis, Balearic Is; Bermuda Zoological Society; AECID-PCI (Spanish Agency of International Cooperation and Development) [A/8688/07]	University of Cadiz; California Academy of Sciences; National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Economy and Competitiveness (Ministry of Sciences and Innovation); Institut Menorqui d'Estudis, Balearic Is; Bermuda Zoological Society; AECID-PCI (Spanish Agency of International Cooperation and Development)	This work is supported by the University of Cadiz, the California Academy of Sciences, the National Science Foundation DEB 0329054 to TMG, and grants from the Spanish Ministry of Economy and Competitiveness (includes the early Ministry of Sciences and Innovation) CGL2006-05182/BOS, CTM2008-05228-E/MAR and CGL2010-17187; Institut Menorqui d'Estudis, Balearic Is; Bermuda Zoological Society; AECID-PCI A/8688/07 (Spanish Agency of International Cooperation and Development) to JLC. The funders had no role in the study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2005, REG C P AM ZOO AQ AS, V43, P218; Avise John C., 2004, P1; Baba K, 1930, VENUS, V2, P117; Baba K, 1955, OPISTHOBRANCHIA SA S; Baba K., 1992, REP SADO MAR BIOL ST, V22, P29; BARNARD K. H., 1927, ANN S AFRICAN MUS, V25, P171; Bebbington A., 1968, Actes de la Societe Linneenne de Bordeaux, V105, P1; Behrens DW, 2008, INDOPACIFIC NUDIBRAN; Bergh R, 1888, REISEN ARCHIPEL PHIL, V3, P755; Bergh R, 1877, ZOOLOGISH BOT GESSEL, V26, P737; Bergh R, 1882, ZOOLOGISH BOT GESELL, V31, P7; Burn R, 1969, J MALACOLOGICAL SOC, V12, P64, DOI DOI 10.1080/00852988.1969.10673833; Burn R, 1966, J MALACOLOGICAL SOC, V10, P21; Burn R, 1964, JOURN CONCHYL CIV, P85; Burn Robert, 2006, Museum Victoria Science Reports, V10, P1; Carmona L, 2011, J MOLLUS STUD, V77, P417, DOI 10.1093/mollus/eyr029; CARROLL DJ, 1990, BIOL BULL, V179, P243, DOI 10.2307/1542315; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Debelius H, 2007, NUDIBRANCHS WORLD; Dinapoli Angela, 2007, Bonner Zoologische Beitraege, V55, P191; Dominguez M, 2008, ZOOL J LINN SOC-LOND, V153, P349, DOI 10.1111/j.1096-3642.2008.00390.x; Drummond A. J., 2009, GENEIOUS V4 6; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EDMUNDS M, 1969, Proceedings of the Malacological Society of London, V38, P451; EDMUNDS M, 1983, J MOLLUS STUD, V49, P185, DOI 10.1093/oxfordjournals.mollus.a065713; Eliot C, 1903, P ZOOL SOC LOND, V1903, P250; Eliot CNE, 1913, J COLL SCI IMP U TOK, V35, P1; Engel H., 1925, Bijdragen tot de Dierkunde, V24, P33; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frey MA, 2008, MOL PHYLOGENET EVOL, V48, P1067, DOI 10.1016/j.ympev.2008.05.009; GARCIA JC, 1985, J MOLLUS STUD, V51, P138; Garcia-Garcia FJ, 2008, OPISTOBRANQUIOS BRAS; GARCIAGOMEZ JC, 1990, J MOLLUS STUD, V56, P323, DOI 10.1093/mollus/56.3.323; Gobbeler K, 2011, THALASSAS, V27, P121; GOSLINER T M, 1985, Annals of the South African Museum, V95, P233; GOSLINER T M, 1990, Proceedings of the California Academy of Sciences, V47, P1; Gosliner TM, 2007, ZOOL J LINN SOC-LOND, V151, P671, DOI 10.1111/j.1096-3642.2007.00331.x; GOSLINER TM, 1979, PAC SCI, V33, P37; GOSLINER TM, 1991, VELIGER, V34, P97; Gosliner TM, 1981, ANN S AFR MUS, V82, P102; Grande C, 2004, MOL PHYLOGENET EVOL, V33, P378, DOI 10.1016/j.ympev.2004.06.008; Grande C, 2004, MOL BIOL EVOL, V21, P303, DOI 10.1093/molbev/msh016; Haefelfinger H. R., 1958, Vie et Milieu, V9, P418; Hamatani Iwao, 2000, Venus the Japanese Journal of Malacology, V59, P263; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jorger KM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-323; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KEMPF SC, 1991, J MOLLUS STUD, V57, P75, DOI 10.1093/mollus/57.Supplement_Part_4.75; Kempf SC, 2002, PHOTO BERGHIA VERRUC; Kempf SC, 1996, REG C P AM ZOO AQ AS; Kerstitch A., 1989, pi; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; MacFarland Frank Mace, 1909, Leland Stanford Junior University Publications University Series Stanford University Cal, VNo. 2; MACNAE WILLIAM, 1954, ANN NATAL MUS, V13, P1; MADDISON D. R., 2005, MACCLADE 4 V 4 08 OS; Malaquias MAE, 2009, J BIOGEOGR, V36, P1760, DOI 10.1111/j.1365-2699.2009.02118.x; Marcus E., 1967, Studies in Tropical Oceanography, VNo. 6, P1; Marcus E., 1961, VELIGER            S, V3, P1; MARCUS E., 1957, J LINNEAN SOC ZOOLOG, V43, P390, DOI DOI 10.1111/J.1096-3642.1957.TB01559.X; Marcus E. du B.-R., 1977, Journal moll Stud, V4, P1; Marcus Er., 1970, STUD FAUNA CURACAO, V33, P1; MARCUS ERNST, 1958, AMER MUS NOVITATES, V1906, P1; MARIN A, 1991, J MOLLUS STUD, V57, P87, DOI 10.1093/mollus/57.Supplement_Part_4.87; Martin Rainer, 2010, Open Marine Biology Journal, V4, P96, DOI 10.2174/1874450801004010096; MCDONALD G, 1975, Veliger, V17, P378; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Miller MC, 2001, J NAT HIST, V35, P629, DOI 10.1080/00222930152023081; Moore E, 2009, ZOOTAXA, P30, DOI 10.11646/zootaxa.2201.1.6; Moore EJ, 2011, MOL PHYLOGENET EVOL, V58, P116, DOI 10.1016/j.ympev.2010.11.008; Muniain Claudia, 1999, Avicennia, V10-11, P143; Nylander J. A. A., 2004, MRMODELTEST V2; Odhner N., 1968, TRAITE ZOOL, V5, P608; Odhner N., 1939, KONGELIGE NORSKE VID, V1, P1; Odhner N. H., 1937, Videnskabelige Meddelelser fra Dansk Naturhistorisk Forening i Kjobenhavn, V101, P253; Ornelas-Gatdula E, 2011, ZOOL J LINN SOC-LOND, V163, P1077, DOI 10.1111/j.1096-3642.2011.00749.x; Ortea J, 2004, REV ACAD CANAR CIENC, V15, P3; Padula V, 2010, NAUTILUS, V124, P175; Palumbi S., 1991, SIMPLE FOOLS GUIDE P; Pola M, 2008, B MAR SCI, V83, P391; Pola M, 2007, MOL PHYLOGENET EVOL, V43, P726, DOI 10.1016/j.ympev.2007.02.003; Pola M, 2010, MOL PHYLOGENET EVOL, V56, P931, DOI 10.1016/j.ympev.2010.05.003; PRUVOT-FOL. A., 1956, BULL MUS NATL HIST NAT, V28, P228; Pruvot-Fol A., 1953, Trav Inat sci Cherifien, VNo. 5, P1; Pruvot-Fol A, 1954, FAUNE FRANCE, V58; Reid DG, 2006, J BIOGEOGR, V33, P990, DOI 10.1111/j.1365-2699.2006.01469.x; RISBEC JEAN, 1928, FAUNE COLONIES FRANC, V2, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RUDMAN WB, 1982, ZOOL J LINN SOC-LOND, V74, P147, DOI 10.1111/j.1096-3642.1982.tb01146.x; RUDMAN WB, 1990, J MOLLUS STUD, V56, P505, DOI 10.1093/mollus/56.4.505; Schmekel L, 1982, OPISTHOBRANCHIA MITT; Schrodl M, 2011, THALASSAS, V27, P101; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stimpson W, 1855, P ACAD NAT SCI PHILA, V7, P385, DOI DOI 10.5962/BHL.TITLE.51445; Swennen C, 1961, ZOOLOGISCHE MEDEDELI, V38, P42; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tardy JP, 1965, B I OCEANOGRAPHIQUE, V65, p[1, 1]; Tardy JP, 1962, B I OCEANOGRAPHIQUE, V59, P1; Thollesson M, 1999, P ROY SOC B-BIOL SCI, V266, P75, DOI 10.1098/rspb.1999.0606; Trinchese S., 1878, Memorie Accademia Bologna, V(3), P405; Uribe Roberto A., 2012, Marine Biodiversity Records, V5, P1; Valde 'sA', 2006, CARIBBEAN SEA SLUGS; Valdes A, 2004, B MAR SCI, V75, P381; Vayssie` re A', 1888, ANN MUSEE HIST NATUR, V3, P1; Vayssiere A, 1913, MOLLUSQUES FRANCE RE, V1; Vonnemann V, 2005, J MOLLUS STUD, V71, P113, DOI 10.1093/mollus/eyi014; Waegele Heike, 2008, P385; Wagele H, 2004, ORG DIVERS EVOL, V4, P175, DOI 10.1016/j.ode.2004.03.002; Wagele H, 2003, SM S COMP E, P185; WAGELE H, 1990, ZOOL SCR, V19, P309, DOI 10.1111/j.1463-6409.1990.tb00261.x; Wagele H, 2000, ZOOL J LINN SOC-LOND, V130, P83, DOI 10.1006/zjls.1999.0214; Wagele Heike, 2005, Front Zool, V2, P3, DOI 10.1186/1742-9994-2-3; Wheeler QD, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P55; Willan Richard, 2006, Malacological Society of Australasia Newsletter, V130, P3; Williams ST, 2004, EVOLUTION, V58, P2227; Williams ST, 2003, MOL PHYLOGENET EVOL, V28, P60, DOI 10.1016/S1055-7903(03)00038-1; Wollscheid E, 1999, MOL PHYLOGENET EVOL, V13, P215, DOI 10.1006/mpev.1999.0664; Wollscheid-Lengeling E, 2001, ORG DIVERS EVOL, V1, P241, DOI 10.1078/1439-6092-00022	123	92	103	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63000	10.1371/journal.pone.0063000	http://dx.doi.org/10.1371/journal.pone.0063000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658794	Green Submitted, Green Published, gold			2022-12-25	WOS:000321200500051
J	Priede, IG; Bergstad, OA; Miller, PI; Vecchione, M; Gebruk, A; Falkenhaug, T; Billett, DSM; Craig, J; Dale, AC; Shields, MA; Tilstone, GH; Sutton, TT; Gooday, AJ; Inall, ME; Jones, DOB; Martinez-Vicente, V; Menezes, GM; Niedzielski, T; Sigurosson, P; Rothe, N; Rogacheva, A; Alt, CHS; Brand, T; Abell, R; Brierley, AS; Cousins, NJ; Crockard, D; Hoelzel, AR; Hoines, A; Letessier, TB; Read, JF; Shimmield, T; Cox, MJ; Galbraith, JK; Gordon, JDM; Horton, T; Neat, F; Lorance, P				Priede, Imants G.; Bergstad, Odd Aksel; Miller, Peter I.; Vecchione, Michael; Gebruk, Andrey; Falkenhaug, Tone; Billett, David S. M.; Craig, Jessica; Dale, Andrew C.; Shields, Mark A.; Tilstone, Gavin H.; Sutton, Tracey T.; Gooday, Andrew J.; Inall, Mark E.; Jones, Daniel O. B.; Martinez-Vicente, Victor; Menezes, Gui M.; Niedzielski, Tomasz; Sigurosson, Porsteinn; Rothe, Nina; Rogacheva, Antonina; Alt, Claudia H. S.; Brand, Timothy; Abell, Richard; Brierley, Andrew S.; Cousins, Nicola J.; Crockard, Deborah; Hoelzel, A. Rus; Hoines, Age; Letessier, Tom B.; Read, Jane F.; Shimmield, Tracy; Cox, Martin J.; Galbraith, John K.; Gordon, John D. M.; Horton, Tammy; Neat, Francis; Lorance, Pascal			Does Presence of a Mid-Ocean Ridge Enhance Biomass and Biodiversity?	PLOS ONE			English	Article							MID-ATLANTIC RIDGE; TEMPERATE NE ATLANTIC; DEEP-WATER FISH; NORTH-ATLANTIC; DEMERSAL FISH; SEA FISH; AREA; BIOLUMINESCENCE; SEAMOUNTS; PATTERNS	In contrast to generally sparse biological communities in open-ocean settings, seamounts and ridges are perceived as areas of elevated productivity and biodiversity capable of supporting commercial fisheries. We investigated the origin of this apparent biological enhancement over a segment of the North Mid-Atlantic Ridge (MAR) using sonar, corers, trawls, traps, and a remotely operated vehicle to survey habitat, biomass, and biodiversity. Satellite remote sensing provided information on flow patterns, thermal fronts, and primary production, while sediment traps measured export flux during 2007-2010. The MAR, 3,704,404 km 2 in area, accounts for 44.7% lower bathyal habitat (800-3500 m depth) in the North Atlantic and is dominated by fine soft sediment substrate (95% of area) on a series of flat terraces with intervening slopes either side of the ridge axis contributing to habitat heterogeneity. The MAR fauna comprises mainly species known from continental margins with no evidence of greater biodiversity. Primary production and export flux over the MAR were not enhanced compared with a nearby reference station over the Porcupine Abyssal Plain. Biomasses of benthic macrofauna and megafauna were similar to global averages at the same depths totalling an estimated 258.9 kt C over the entire lower bathyal north MAR. A hypothetical flat plain at 3500 m depth in place of the MAR would contain 85.6 kt C, implying an increase of 173.3 kt C attributable to the presence of the Ridge. This is approximately equal to 167 kt C of estimated pelagic biomass displaced by the volume of the MAR. There is no enhancement of biological productivity over the MAR; oceanic bathypelagic species are replaced by benthic fauna otherwise unable to survive in the mid ocean. We propose that globally sea floor elevation has no effect on deep sea biomass; pelagic plus benthic biomass is constant within a given surface productivity regime.	[Priede, Imants G.; Craig, Jessica; Shields, Mark A.; Cousins, Nicola J.; Crockard, Deborah] Univ Aberdeen, Inst Biol & Environm Sci, Oceanlab, Aberdeen, Scotland; [Bergstad, Odd Aksel; Falkenhaug, Tone] Inst Marine Res, Flodevigen, His, Norway; [Miller, Peter I.; Tilstone, Gavin H.; Martinez-Vicente, Victor] Plymouth Marine Lab, Remote Sensing Grp, Plymouth, Devon, England; [Vecchione, Michael] Smithsonian Inst, Natl Museum Nat Hist, Natl Systemat Lab, Natl Marine Fisheries Serv,NOAA, Washington, DC 20560 USA; [Gebruk, Andrey; Rogacheva, Antonina] Russian Acad Sci, PP Shirshov Inst Oceanol, Moscow, Russia; [Billett, David S. M.; Gooday, Andrew J.; Jones, Daniel O. B.; Rothe, Nina; Alt, Claudia H. S.; Read, Jane F.; Horton, Tammy] Natl Oceanog Ctr, Southampton, Hants, England; [Dale, Andrew C.; Inall, Mark E.; Brand, Timothy; Abell, Richard; Shimmield, Tracy; Gordon, John D. M.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Sutton, Tracey T.] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA USA; [Menezes, Gui M.] Univ Azores, Dept Oceanog & Fisheries, Horta, Faial, Portugal; [Niedzielski, Tomasz] Univ Wroclaw, Inst Geog & Reg Dev, Dept Geoinformat & Cartog, PL-50138 Wroclaw, Poland; [Sigurosson, Porsteinn] Marine Res Inst, IS-121 Reykjavik, Iceland; [Brierley, Andrew S.] Univ St Andrews, Scottish Oceans Inst, St Andrews KY16 9AJ, Fife, Scotland; [Hoelzel, A. Rus] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Hoines, Age] Inst Marine Res, N-5024 Bergen, Norway; [Letessier, Tom B.] Univ Western Australia, Oceans Inst, Ctr Marine Futures, Perth, WA 6009, Australia; [Cox, Martin J.] Australian Antarctic Div, Southern Ocean Ecosyst Change Dept, Kingston, Tas, Australia; [Galbraith, John K.] NOAA, Northeast Fisheries Sci Ctr, Woods Hole, MA USA; [Neat, Francis] Marine Scotland Sci, Marine Lab, Aberdeen, Scotland; [Lorance, Pascal] IFREMER, Ctr Atlantique, F-44311 Nantes 03, France	University of Aberdeen; Institute of Marine Research - Norway; Plymouth Marine Laboratory; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History; Russian Academy of Sciences; Shirshov Institute of Oceanology; NERC National Oceanography Centre; UHI Millennium Institute; William & Mary; Virginia Institute of Marine Science; Universidade dos Acores; University of Wroclaw; Marine & Freshwater Research Institute (MFRI); University of St Andrews; Durham University; Institute of Marine Research - Norway; University of Western Australia; Australian Antarctic Division; National Oceanic Atmospheric Admin (NOAA) - USA; Marine Scotland Science (MSS); Ifremer	Priede, IG (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Oceanlab, Aberdeen, Scotland.	i.g.priede@abdn.ac.uk	Dale, Andrew C/H-4847-2012; Kremenetskaia, Antonina/H-5654-2018; Menezes, Gui M./A-3956-2009; Gebruk, Andrey/A-9041-2016; Niedzielski, Tomasz/AAI-8985-2020; Letessier, Tom Bech/AAV-2759-2020; Jones, Daniel/A-3412-2009; Vicente, Victor Martinez/T-1207-2019; Gooday, Andrew/AAH-8991-2021; Horton, Tammy/G-3590-2010; Inall, Mark/I-4835-2014; Gooday, Andrew/ABB-4267-2020; Martinez-Vicente, Victor/F-5131-2010; Alt, Claudia/B-5439-2014; Miller, Peter I./E-4525-2013; Sutton, Tracey/AAW-7644-2021; Brierley, Andrew/G-8019-2011; Lorance, Pascal/F-4668-2011	Dale, Andrew C/0000-0002-9256-7770; Kremenetskaia, Antonina/0000-0001-8851-3318; Menezes, Gui M./0000-0003-0781-4579; Niedzielski, Tomasz/0000-0001-8236-9861; Letessier, Tom Bech/0000-0003-4011-0207; Jones, Daniel/0000-0001-5218-1649; Horton, Tammy/0000-0003-4250-1068; Inall, Mark/0000-0002-1624-4275; Gooday, Andrew/0000-0002-5661-7371; Martinez-Vicente, Victor/0000-0003-3492-583X; Miller, Peter I./0000-0002-5292-8789; Sutton, Tracey/0000-0002-5280-7071; Priede, Imants/0000-0002-5064-9751; Tilstone, Gavin/0000-0002-9347-1682; Craig, Jessica/0000-0003-3811-7362; Brierley, Andrew/0000-0002-6438-6892; Bergstad, Odd Aksel/0000-0002-4096-0896; Lorance, Pascal/0000-0002-6453-2925	UK Natural Environment Research Council [NE/C512961/1]; Census of Marine Life; NERC [NE/C512988/1, NE/C51297X/1, NE/C512996/1, pml010008, NE/C512961/1, NE/C51300X/1, NE/C513018/1, noc010009] Funding Source: UKRI; Natural Environment Research Council [NE/C512961/1, NE/C51300X/1, NE/C512988/1, pml010008, NE/C513018/1, NE/C51297X/1, noc010009, NE/C512996/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Census of Marine Life; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research was funded by the UK Natural Environment Research Council (http://www.nerc.ac.uk/) consortium grant number NE/C512961/1 for a project entitled: ECOMAR; Ecosystem of the Mid Atlantic Ridge at the Sub-Polar Front and Charlie Gibbs Fracture Zone. Funding was also provided by the Census of Marine Life (http://www.coml.org/). Other than selecting the project for funding and approving the resources required, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL MV, 1990, PHILOS T R SOC A, V331, P15, DOI 10.1098/rsta.1990.0053; Bergstad OA, 2012, DEEP-SEA RES PT I, V61, P74, DOI 10.1016/j.dsr.2011.12.002; Craig J, 2011, J MARINE SYST, V88, P563, DOI 10.1016/j.jmarsys.2011.07.006; Doel RE, 2006, J HIST GEOGR, V32, P605, DOI 10.1016/j.jhg.2005.10.011; Flach E, 1996, MAR ECOL PROG SER, V141, P55, DOI 10.3354/meps141055; Ganachaud A, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001333; GEBCO, 2010, GEN BATH CHART OC GE; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P383, DOI 10.1017/S0025315499002088; German CR, 1998, EARTH PLANET SC LETT, V160, P327, DOI 10.1016/S0012-821X(98)00093-4; GIERE O, 2003, ENERGY MASS TRANSFER, P211; Gillibrand EJV, 2007, MAR ECOL PROG SER, V341, P37, DOI 10.3354/meps341037; Gooday AJ, 2013, MAR BIOL RE IN PRESS; GORDON JDM, 1992, J MAR BIOL ASSOC UK, V72, P213, DOI 10.1017/S002531540004889X; Hareide NR, 2001, FISH RES, V51, P297, DOI 10.1016/S0165-7836(01)00253-3; Heezen B. C., 1957, PHYSIOGRAPHIC DIAGRA; HEEZEN BC, 1969, TECTONOPHYSICS, V8, P269, DOI 10.1016/0040-1951(69)90037-7; Heger A, 2008, DEEP-SEA RES PT II, V55, P126, DOI 10.1016/j.dsr2.2007.09.014; HUBBS CARL L., 1959, PACIFIC SCI, V13, P311; Hughes DJ, 2004, PROG OCEANOGR, V63, P29, DOI 10.1016/j.pocean.2004.09.002; Knutsen H, 2012, MAR ECOL PROG SER, V460, P233, DOI 10.3354/meps09728; Koppelmann R, 1999, MAR ECOL PROG SER, V179, P27, DOI 10.3354/meps179027; Kukuev EI, 2004, ARCH FISH MAR RES, V51, P215; Lampitt RS, 2010, DEEP-SEA RES PT II, V57, P1346, DOI 10.1016/j.dsr2.2010.01.011; Lampitt RS, 2001, PROG OCEANOGR, V50, P27, DOI 10.1016/S0079-6611(01)00047-7; Miller P, 2009, J MARINE SYST, V78, P327, DOI 10.1016/j.jmarsys.2008.11.019; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; MOREL A, 1991, PROG OCEANOGR, V26, P263, DOI 10.1016/0079-6611(91)90004-6; Mortensen PB, 2008, DEEP-SEA RES PT II, V55, P142, DOI 10.1016/j.dsr2.2007.09.018; Murray J, 1912, DEPTHS OCEAN; O'Leary BC, 2012, MAR POLICY, V36, P598, DOI 10.1016/j.marpol.2011.11.003; Opdal AF, 2008, DEEP-SEA RES PT II, V55, P45, DOI 10.1016/j.dsr2.2007.09.002; OSPAR, 2008, OSPAR CONV PROT MAR; Pollard RT, 2009, NATURE, V457, P577, DOI 10.1038/nature07716; Priede IG, 2012, INVERTEBR BIOL, V131, P244, DOI 10.1111/j.1744-7410.2012.00266.x; Priede IG, 2010, MAR ECOL-EVOL PERSP, V31, P247, DOI 10.1111/j.1439-0485.2009.00330.x; Read JF, 2010, DEEP-SEA RES PT I, V57, P307, DOI 10.1016/j.dsr.2009.11.010; Rex M. A, 2010, DEEP SEA BIODIVERSIT; ROE HSJ, 1988, HYDROBIOLOGIA, V167, P169, DOI 10.1007/BF00026303; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P226, DOI 10.1111/j.1439-0485.2010.00400.x; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Smyth TJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002784; St Laurent LC, 2007, NATURE, V448, P680, DOI 10.1038/nature06043; Storch D, 2012, NATURE, V488, P78, DOI 10.1038/nature11226; Sutton TT, 2008, DEEP-SEA RES PT II, V55, P161, DOI 10.1016/j.dsr2.2007.09.013; Taylor JR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049312; Tilstone G, 2009, DEEP-SEA RES PT II, V56, P918, DOI 10.1016/j.dsr2.2008.10.034; UNESCO, 2009, IOC TECHN SER, V84; Van Dover CL, 2000, ECOLOGY HYDROTHERMAL; Webb TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010223; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Wenneek TL, 2008, DEEP-SEA RES PT II, V55, P6, DOI 10.1016/j.dsr2.2007.09.017; White TA, 2011, HEREDITY, V106, P690, DOI 10.1038/hdy.2010.108; White TA, 2010, MOL ECOL, V19, P216, DOI 10.1111/j.1365-294X.2009.04446.x; Wolff GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020697	55	55	56	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61550	10.1371/journal.pone.0061550	http://dx.doi.org/10.1371/journal.pone.0061550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658696	Green Accepted, Green Published, gold			2022-12-25	WOS:000321200500009
J	George, J; Jenkins, NE; Blanford, S; Thomas, MB; Baker, TC				George, Justin; Jenkins, Nina E.; Blanford, Simon; Thomas, Matthew B.; Baker, Thomas C.			Malaria Mosquitoes Attracted by Fatal Fungus	PLOS ONE			English	Article							BEAUVERIA-BASSIANA; METARHIZIUM-ANISOPLIAE; ENTOMOPATHOGENIC FUNGUS; BIOLOGICAL-CONTROL; ANOPHELES-GAMBIAE; CULEX-QUINQUEFASCIATUS; MICROBIAL CONTROL; CARBON-DIOXIDE; INFECTION; COLEOPTERA	Insect-killing fungi such as Beauveria bassiana are being evaluated as possible active ingredients for use in novel biopesticides against mosquito vectors that transmit malaria. Fungal pathogens infect through contact and so applications of spores to surfaces such as walls, nets, or other resting sites provide possible routes to infect mosquitoes in and around domestic dwellings. However, some insects can detect and actively avoid fungal spores to reduce infection risk. If true for mosquitoes, such behavior could render the biopesticide approach ineffective. Here we find that the spores of B. bassiana are highly attractive to females of Anopheles stephensi, a major anopheline mosquito vector of human malaria in Asia. We further find that An. stephensi females are preferentially attracted to dead and dying caterpillars infected with B. bassiana, landing on them and subsequently becoming infected with the fungus. Females are also preferentially attracted to cloth sprayed with oil-formulated B. bassiana spores, with 95% of the attracted females becoming infected after a one-minute visit on the cloth. This is the first report of an insect being attracted to a lethal fungal pathogen. The exact mechanisms involved in this behavior remain unclear. Nonetheless, our results indicate that biopesticidal formulations comprising B. bassiana spores will be conducive to attraction and on-source visitation by malaria vectors.	[George, Justin; Jenkins, Nina E.; Blanford, Simon; Thomas, Matthew B.; Baker, Thomas C.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Blanford, Simon; Thomas, Matthew B.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Baker, TC (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	tcb10@psu.edu			Pennsylvania State Agricultural Experiment Station; Pennsylvania State University	Pennsylvania State Agricultural Experiment Station; Pennsylvania State University	The Pennsylvania State Agricultural Experiment Station and Pennsylvania State University funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SB, 2009, AM NAT, V174, P424, DOI 10.1086/603640; [Anonymous], 2012, PLOS NEGLECT TROP D, DOI DOI 10.1371/journal.pntd.0001793; [Anonymous], 2004, J INSECT SCI; Arthurs S, 2001, ECOL ENTOMOL, V26, P227, DOI 10.1046/j.1365-2311.2001.00317.x; Barbarin AM, 2012, J INVERTEBR PATHOL, V111, P82, DOI 10.1016/j.jip.2012.04.009; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Blanford S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023591; Carruthers RI, 1997, MEM ENTOMOL SOC CAN, P329, DOI 10.4039/entm129171329-1; Cator LJ, 2012, TRENDS PARASITOL, V28, P466, DOI 10.1016/j.pt.2012.08.004; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Farenhorst M, 2008, AM J TROP MED HYG, V78, P910, DOI 10.4269/ajtmh.2008.78.910; Farenhorst M, 2011, J MED ENTOMOL, V48, P305, DOI 10.1603/ME10134; Fernandes EKK, 2011, VET PARASITOL, V182, P307, DOI 10.1016/j.vetpar.2011.05.046; George J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-219; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; HALL DR, 1984, INSECT SCI APPL, V5, P335, DOI 10.1017/S1742758400008626; HARRIS P, 1969, SCIENCE, V164, P184, DOI 10.1126/science.164.3876.184; Howard AFV, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-87; JENKINS NE, 1998, BIOCONTROL NEWS INFO, V19, P21; Jones WE, 1996, ENVIRON ENTOMOL, V25, P481, DOI 10.1093/ee/25.2.481; Lecuona RE, 2005, J MED ENTOMOL, V42, P332, DOI 10.1603/0022-2585(2005)042[0332:MCOMDD]2.0.CO;2; Liu HP, 2008, BIOCONTROL SCI TECHN, V18, P565, DOI 10.1080/09583150802085331; Lomer CJ, 2001, ANNU REV ENTOMOL, V46, P667, DOI 10.1146/annurev.ento.46.1.667; Lynch PA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-383; Maehara N, 2007, J ECON ENTOMOL, V100, P49, DOI 10.1603/0022-0493(2007)100[49:MFATOB]2.0.CO;2; Maniania NK, 1998, BIOCONTROL, V43, P311, DOI 10.1023/A:1009939711555; Martel V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025658; Mburu DM, 2009, J INSECT PHYSIOL, V55, P774, DOI 10.1016/j.jinsphys.2009.04.015; Mburu DM, 2011, J EXP BIOL, V214, P956, DOI 10.1242/jeb.050419; Mnyone LL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-87; Muller GC, 2010, MED VET ENTOMOL, V24, P346, DOI 10.1111/j.1365-2915.2010.00876.x; Pedrini N, 2010, J ECON ENTOMOL, V103, P1094, DOI 10.1603/EC10072; Pedrini N, 2009, PLOS NEGLECT TROP D, V3, P1; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941; Scholte EJ, 2006, J INVERTEBR PATHOL, V91, P43, DOI 10.1016/j.jip.2005.10.006; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Seyoum E, 2002, J APPL ENTOMOL, V126, P119, DOI 10.1046/j.1439-0418.2002.00609.x; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; WAAGE JK, 1979, BIOL J LINN SOC, V12, P187, DOI 10.1111/j.1095-8312.1979.tb00055.x; WHO, 2011, WORLD MALARIA REPORT 2011, P1	44	28	30	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62632	10.1371/journal.pone.0062632	http://dx.doi.org/10.1371/journal.pone.0062632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658757	gold, Green Submitted, Green Published			2022-12-25	WOS:000319167000064
J	Delaney, NF; Kaczmarek, ME; Ward, LM; Swanson, PK; Lee, MC; Marx, CJ				Delaney, Nigel F.; Kaczmarek, Maria E.; Ward, Lewis M.; Swanson, Paige K.; Lee, Ming-Chun; Marx, Christopher J.			Development of an Optimized Medium, Strain and High-Throughput Culturing Methods for Methylobacterium extorquens	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; PSEUDOMONAS AM 1; MICROBIAL-GROWTH; C1 COMPOUNDS; MICROTITER PLATES; GENOME SEQUENCES; METHANOL; DEHYDROGENASE; ADAPTATION; OXIDATION	Methylobacterium extorquens strains are the best-studied methylotrophic model system, and their metabolism of single carbon compounds has been studied for over 50 years. Here we develop a new system for high-throughput batch culture of M. extorquens in microtiter plates by jointly optimizing the properties of the organism, the growth media and the culturing system. After removing cellulose synthase genes in M. extorquens strains AM1 and PA1 to prevent biofilm formation, we found that currently available lab automation equipment, integrated and managed by open source software, makes possible reliable estimates of the exponential growth rate. Using this system, we developed an optimized growth medium for M. extorquens using response surface methodologies. We found that media that used EDTA as a metal chelator inhibited growth and led to inconsistent culture conditions. In contrast, the new medium we developed with a PIPES buffer and metals chelated by citrate allowed for fast and more consistent growth rates. This new Methylobacterium PIPES ('MP') medium was also robust to large deviations in its component ingredients which avoided batch effects from experiments that used media prepared at different times. MP medium allows for faster and more consistent growth than other media used for M. extorquens.	[Delaney, Nigel F.; Kaczmarek, Maria E.; Ward, Lewis M.; Swanson, Paige K.; Lee, Ming-Chun; Marx, Christopher J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Marx, Christopher J.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Marx, CJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	cmarx@oeb.harvard.edu		Ward, Lewis/0000-0002-9290-2567	National Science Foundation (NSF); NSF CAREER grant [DEB-0845893]	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF CAREER grant(National Science Foundation (NSF)NSF - Office of the Director (OD))	NFD was supported by a National Science Foundation (NSF) graduate student fellowship and this research was funded by an NSF CAREER grant awarded to CJM (DEB-0845893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY C, 1964, BIOCHEM J, V92, P614, DOI 10.1042/bj0920614; Atlas RM., 2004, HDB MICROBIOLOGICAL; Blomberg A, 2011, CURR OPIN BIOTECH, V22, P94, DOI 10.1016/j.copbio.2010.10.013; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Box G.E.P., 2005, STAT EXPT DESIGN INN, V2nd ed.; CHAN HTC, 1992, FEMS MICROBIOL LETT, V96, P231, DOI 10.1111/j.1574-6968.1992.tb05422.x; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; CHOI J H, 1989, Korean Journal of Applied Microbiology and Bioengineering, V17, P392; Chou HH, 2012, CELL REP, V1, P133, DOI 10.1016/j.celrep.2011.12.003; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; DALES SL, 1995, BIOCHEM J, V312, P261, DOI 10.1042/bj3120261; Delaney NF, 2012, J LAB AUTOM; Dworkin M, 2006, PROKARYOTES HDB BIOL, P257; Hermann R, 2003, BIOTECHNOL BIOENG, V81, P178, DOI 10.1002/bit.10456; Kensy F, 2005, BIOTECHNOL BIOENG, V89, P698, DOI 10.1002/bit.20373; Kiefer P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007831; Kim P, 2003, WORLD J MICROB BIOT, V19, P357, DOI 10.1023/A:1023969629568; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Knief C, 2010, MICROB ECOL, V60, P440, DOI 10.1007/s00248-010-9725-3; LARGE PJ, 1961, BIOCHEM J, V81, P470, DOI 10.1042/bj0810470; Laukel M, 2003, EUR J BIOCHEM, V270, P325, DOI 10.1046/j.1432-1033.2003.03391.x; Lee MC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002651; Lee MC, 2009, EVOLUTION, V63, P2816, DOI 10.1111/j.1558-5646.2009.00757.x; Marx CJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-109; Marx CJ, 2012, J BACTERIOL, V194, P4746, DOI 10.1128/JB.01009-12; Marx Christopher J, 2008, BMC Res Notes, V1, P1, DOI 10.1186/1756-0500-1-1; Marx CJ, 2004, J BACTERIOL, V186, P2173, DOI 10.1128/JB.186.7.2173-2178.2004; Marx CJ, 2004, MICROBIOL-SGM, V150, P9, DOI 10.1099/mic.0.26587-0; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Marx CJ, 2001, MICROBIOL-SGM, V147, P2065, DOI 10.1099/00221287-147-8-2065; MCINTIRE WS, 1991, SCIENCE, V252, P817, DOI 10.1126/science.2028257; Mokhtari-Hosseini ZB, 2009, BIORESOURCE TECHNOL, V100, P2436, DOI 10.1016/j.biortech.2008.11.024; Mokhtari-Hosseini ZB, 2009, IRAN J CHEM CHEM ENG, V28; Morel F. M. M., 1993, PRINCIPLES APPL AQUA; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Overmann J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P80, DOI 10.1007/0-387-30741-9_5; PEEL D, 1961, BIOCHEM J, V81, P465, DOI 10.1042/bj0810465; Peyraud R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-189; Schmidt S, 2010, THESIS ETH ZURICH; Skovran E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014091; SPARKES A, 2010, AUTOM EXP, P2; TSUCHIYA Y, 1980, EUR J APPL MICROBIOL, V9, P121, DOI 10.1007/BF00503507; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Wu C. J., 2011, EXPT PLANNING ANAL O	46	72	76	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62957	10.1371/journal.pone.0062957	http://dx.doi.org/10.1371/journal.pone.0062957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646164	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300118
J	Phan, KD; Butler, SJ				Phan, Keith D.; Butler, Samantha J.			Bilaterally Symmetric Populations of Chicken dI1 (Commissural) Axons Cross the Floor Plate Independently of Each Other	PLOS ONE			English	Article							ROOF PLATE; GROWTH CONES; LIM KINASE; EXPRESSION PATTERNS; SONIC HEDGEHOG; CELL-ADHESION; BMP RECEPTOR; F-SPONDIN; NR-CAM; GUIDANCE	Axons use temporal and directional guidance cues at intermediate targets to set the rate and direction of growth towards their synaptic targets. Our recent studies have shown that disrupting the temporal guidance process, by unilaterally accelerating the rate at which spinal dI1 (commissural) axons grow, resulted in turning errors both in the ventral spinal cord and after crossing the floor plate. Here we investigate a mechanistic explanation for these defects: the accelerated dI1 axons arrive in the ventral spinal cord before necessary fasciculation cues from incoming dI1 axons from the opposite side of the spinal cord. The identification of such an interaction would support a model of selective fasciculation whereby the pioneering dI1 axons serve as guides for the processes of the bilaterally symmetrical population of dI1 neurons. To test this model, we first developed the ability to "double'' in ovo electroporate the embryonic chicken spinal cord to independently manipulate the rate of growth of the two bilateral populations of dI1 axons. Second, we examined the requirement for a putative bilateral interaction by unilaterally ablating the dI1 population in cultured explants of chicken embryonic spinal cord. Surprisingly, we find no evidence for a bilateral dI1 axon interaction, rather dI1 axons appear to project independently of each other.	[Phan, Keith D.; Butler, Samantha J.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California	Butler, SJ (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	butlersj@usc.edu			National Institutes of Health [NS 063999]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institutes of Health (NS 063999) to S.J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1984, DEV RAT SPINAL CORD; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Avraham O, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-21; Bak M, 2003, DEVELOPMENT, V130, P4999, DOI 10.1242/dev.00713; Bamburg JR, 2008, CURR BIOL, V18, pR273, DOI 10.1016/j.cub.2008.02.002; Bourikas D, 2005, NAT NEUROSCI, V8, P297, DOI 10.1038/nn1396; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Butler SJ, 2007, DEVELOPMENT, V134, P439, DOI 10.1242/dev.02762; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Endo M, 2003, J NEUROSCI, V23, P2527; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; Hazen VM, 2012, DEV BIOL, V367, P216, DOI 10.1016/j.ydbio.2012.05.014; Hazen VM, 2011, DEV BIOL, V356, P566, DOI 10.1016/j.ydbio.2011.06.017; Hazen VM, 2010, J VIS EXP; Helms AW, 1998, DEVELOPMENT, V125, P919; Helms AW, 2000, DEVELOPMENT, V127, P1185; HOLLEY JA, 1982, J COMP NEUROL, V205, P360, DOI 10.1002/cne.902050405; HOLLEY JA, 1982, J COMP NEUROL, V205, P371, DOI 10.1002/cne.902050406; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; Imondi R, 2001, DEVELOPMENT, V128, P4859; JACOBS JR, 1989, J NEUROSCI, V9, P2412; Kadison SR, 2006, J NEUROSCI, V26, P8909, DOI 10.1523/JNEUROSCI.1569-06.2006; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; KRUSHEL LA, 1993, NEUROSCIENCE, V53, P797, DOI 10.1016/0306-4522(93)90625-P; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Marsick BM, 2010, DEV NEUROBIOL, V70, P565, DOI 10.1002/dneu.20800; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; OPPENHEIM RW, 1988, J COMP NEUROL, V275, P159, DOI 10.1002/cne.902750202; Phan KD, 2010, J NEUROSCI, V30, P15430, DOI 10.1523/JNEUROSCI.4117-10.2010; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; RUEGG MA, 1989, EMBO J, V8, P55, DOI 10.1002/j.1460-2075.1989.tb03348.x; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Van Vactor D, 1998, CURR OPIN NEUROBIOL, V8, P80, DOI 10.1016/S0959-4388(98)80011-1; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wightman B, 1997, DEVELOPMENT, V124, P2571; Wilson SI, 2008, NEURON, V59, P413, DOI 10.1016/j.neuron.2008.07.020; Yamauchi K, 2008, DEVELOPMENT, V135, P1119, DOI 10.1242/dev.012989; Yamauchi K, 2013, DEVELOPMENT, V140, P333, DOI 10.1242/dev.089524	53	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62977	10.1371/journal.pone.0062977	http://dx.doi.org/10.1371/journal.pone.0062977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646165	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300120
J	Wang, T; Huang, XL; Huang, PY; Li, D; Lv, FJ; Zhang, Y; Zhou, LK; Yang, DY; Xie, P				Wang, Tao; Huang, Xiaolan; Huang, Peiyu; Li, Dan; Lv, Fajin; Zhang, Yong; Zhou, Linke; Yang, Deyu; Xie, Peng			Early-Stage Psychotherapy Produces Elevated Frontal White Matter Integrity in Adult Major Depressive Disorder	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; DORSOLATERAL PREFRONTAL CORTEX; ANTERIOR CINGULATE CORTEX; NEURAL MECHANISMS; COGNITIVE MODEL; MOOD DISORDERS; BRAIN; DIFFUSION; THERAPY; ABNORMALITIES	Background: Psychotherapy has demonstrated comparable efficacy to antidepressant medication in the treatment of major depressive disorder. Metabolic alterations in the MDD state and in response to treatment have been detected by functional imaging methods, but the underlying white matter microstructural changes remain unknown. The goal of this study is to apply diffusion tensor imaging techniques to investigate psychotherapy-specific responses in the white matter. Methods: Twenty-one of forty-five outpatients diagnosed with major depression underwent diffusion tensor imaging before and after a four-week course of guided imagery psychotherapy. We compared fractional anisotropy in depressed patients (n = 21) with healthy controls (n = 22), and before-after treatment, using whole brain voxel-wise analysis. Results: Post-treatment, depressed subjects showed a significant reduction in the 17-item Hamilton Depression Rating Scale. As compared to healthy controls, depressed subjects demonstrated significantly increased fractional anisotropy in the right thalamus. Psychopathological changes did not recover post-treatment, but a novel region of increased fractional anisotropy was discovered in the frontal lobe. Conclusions: At an early stage of psychotherapy, higher fractional anisotropy was detected in the frontal emotional regulation-associated region. This finding reveals that psychotherapy may induce white matter changes in the frontal lobe. This remodeling of frontal connections within mood regulation networks positively contributes to the "top-down'' mechanism of psychotherapy.	[Wang, Tao; Huang, Xiaolan; Huang, Peiyu; Li, Dan; Lv, Fajin; Zhang, Yong; Zhou, Linke; Yang, Deyu; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Wang, Tao; Huang, Xiaolan; Huang, Peiyu; Li, Dan; Zhang, Yong; Zhou, Linke; Yang, Deyu; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Wang, Tao; Zhou, Linke; Yang, Deyu; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Lv, Fajin] Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn			National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [31271189]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (973 Program, No: 2009CB918300) and the National Natural Science Foundation of China (Grant No. 31271189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 2008, AM J PSYCHIAT, V165, P238, DOI 10.1176/appi.ajp.2007.07050744; Alexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Blood AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013945; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Burke HM, 2005, PSYCHONEUROENDOCRINO, V30, P846, DOI 10.1016/j.psyneuen.2005.02.010; Clark L, 2009, ANNU REV NEUROSCI, V32, P57, DOI 10.1146/annurev.neuro.31.060407.125618; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Frodl T, 2010, BIOL PSYCHIAT, V67, P161, DOI 10.1016/j.biopsych.2009.08.022; GOLD SR, 1982, J CLIN PSYCHOL, V38, P312, DOI 10.1002/1097-4679(198204)38:2<312::AID-JCLP2270380213>3.0.CO;2-2; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hamilton J. P, 2012, AM J PSYCHIAT; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; JARVINEN PJ, 1981, J CLIN PSYCHOL, V37, P523, DOI 10.1002/1097-4679(198107)37:3<523::AID-JCLP2270370314>3.0.CO;2-O; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Kennedy SH, 2007, AM J PSYCHIAT, V164, P778, DOI 10.1176/appi.ajp.164.5.778; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kim JH, 2010, NEUROIMAGE, V49, P2375, DOI 10.1016/j.neuroimage.2009.10.016; Kim SD, 2005, CANCER NURS, V28, P79, DOI 10.1097/00002820-200501000-00012; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lisiecka D, 2011, INT J NEUROPSYCHOPH, V14, P521, DOI 10.1017/S1461145710001513; Martin SD, 2001, ARCH GEN PSYCHIAT, V58, P641, DOI 10.1001/archpsyc.58.7.641; Matousek Rose H, 2010, Complement Ther Clin Pract, V16, P13, DOI 10.1016/j.ctcp.2009.06.004; Merali Z, 2004, J NEUROSCI, V24, P1478, DOI 10.1523/JNEUROSCI.4734-03.2004; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nobuhara K, 2004, NEUROPSYCHOBIOLOGY, V50, P48, DOI 10.1159/000077941; Oishi K., 2010, MRI ATLAS HUMAN WHIT; Parker G, 2001, AM J PSYCHIAT, V158, P857, DOI 10.1176/appi.ajp.158.6.857; Peng HJ, 2012, J AFFECT DISORDERS, V136, P249, DOI 10.1016/j.jad.2011.12.006; Pilkington K, 2005, J AFFECT DISORDERS, V89, P13, DOI 10.1016/j.jad.2005.08.013; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rubia K, 2009, BIOL PSYCHOL, V82, P1, DOI 10.1016/j.biopsycho.2009.04.003; Sacher J, 2012, J AFFECT DISORDERS, V140, P142, DOI 10.1016/j.jad.2011.08.001; Schultz D, 2003, IMAGE HUM D, P343; Sexton CE, 2009, BIOL PSYCHIAT, V66, P814, DOI 10.1016/j.biopsych.2009.05.024; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Taylor WD, 2001, BIOL PSYCHIAT, V50, P179, DOI 10.1016/S0006-3223(01)01160-X; Thomas AJ, 2002, ANN NY ACAD SCI, V977, P333, DOI 10.1111/j.1749-6632.2002.tb04835.x; Thomason ME, 2011, ANNU REV CLIN PSYCHO, V7, P63, DOI 10.1146/annurev-clinpsy-032210-104507; van Dixhoorn J, 2005, EUR J CARDIOV PREV R, V12, P193, DOI 10.1097/00149831-200506000-00002; Watanabe Eri, 2005, BMC Complement Altern Med, V5, P21, DOI 10.1186/1472-6882-5-21; Young KA, 2004, AM J PSYCHIAT, V161, P1270, DOI 10.1176/appi.ajp.161.7.1270	56	23	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63081	10.1371/journal.pone.0063081	http://dx.doi.org/10.1371/journal.pone.0063081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646178	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300133
J	Zou, YJ; Yin, TL; Chen, SJ; Yang, J; Huang, WH				Zou, Yujie; Yin, Tailang; Chen, Shijing; Yang, Jing; Huang, Weihua			On-Chip Cryopreservation: A Novel Method for Ultra-Rapid Cryoprotectant-Free Cryopreservation of Small Amounts of Human Spermatozoa	PLOS ONE			English	Article							CHRONICALLY INFECTED WOMEN; LIQUID-NITROGEN SAMPLES; SPENT CULTURE-MEDIA; SPERM DNA INTEGRITY; VITRIFICATION; ZONA; TECHNOLOGY; OOCYTES; EMBRYOS; CYCLES	Cryopreservation of human spermatozoa free from cryoprotectant can avoid toxicity caused by highly concentrated cryoprotectant and a series of specific carriers have been previously explored, except for PDMS chip. Our study is aimed at exploring a novel device for ultra-rapid cryopreservation of small numbers of spermatozoa without cryoprotectant based on polydimethylsiloxane (PDMS) chips. Spermatozoa from 25 healthy men were involved in this study, comparing on-chip cryopreservation with different micro-channel height (group A: 10 mu m height, group B: 50 mu m height, group C: 100 mu m height) and conventional freezing (group D) in liquid nitrogen for 72 h. The viability, motility, DNA integrity by comet assay and acrosome integrity by fluorescein isothiocyanate-conjugated peanut agglutinin (FITC-PNA) staining of frozen-thawed spermatozoa of each group were compared. The motility and viability of post-thawed spermatozoa was significantly decreased than that of pre-freezing spermatozoa. There was no difference of viability and motility of frozen-thawed spermatozoa between group A and D, while viability and motility of group B and C decreased compared to group A. Comet assay showed that no matter for group A or D, there was no difference of CR, TL, TD and OTM between pre-frozen and post-thawed spermatozoa. There was no difference of CR, TL, TD and OTM of post-thawed spermatozoa between group A and group D neither, while spermatozoa DNA damage was more serious in group B and group C with increasing height of micro-channel compared with group A. The proportion of intact acrosome of post-thawed spermatozoa in group A was the highest when compared with group B and group C, though similar to that of group D. In conclusion, PDMS chip with 10 mu m height micro-channel is ideal for ultra-rapid cryopreservation of small quantity of spermatozoa without cryoprotectant.	[Zou, Yujie; Yin, Tailang; Yang, Jing] Wuhan Univ, Renmin Hosp, Reprod Med Ctr, Wuhan 430072, Peoples R China; [Yin, Tailang] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Ctr Reprod Med, Beijing 100871, Peoples R China; [Chen, Shijing; Huang, Weihua] Wuhan Univ, Coll Chem & Mol Sci, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China	Wuhan University; Peking University; Wuhan University	Yang, J (corresponding author), Wuhan Univ, Renmin Hosp, Reprod Med Ctr, Wuhan 430072, Peoples R China.	DrYangQing@hotmail.com; whhuang@whu.edu.cn			National Natural Science Foundation of China [30973196, 20975077, 31070995]; Science Fund for Creative Research Groups [20921062]; Program for New Century Excellent Talents in University [NCET-10-0611]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Groups(Science Fund for Creative Research Groups); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (No. 30973196, 20975077, 31070995), the Science Fund for Creative Research Groups (No. 20921062), and the Program for New Century Excellent Talents in University (NCET-10-0611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird DT, 2010, HUM REPROD UPDATE, V16, P590, DOI 10.1093/humupd/dmq023; Baumber J, 2003, J ANDROL, V24, P621; Cobo A, 2012, FERTIL STERIL, V97, P74, DOI 10.1016/j.fertnstert.2011.10.006; Desai NN, 2004, REPROD BIOMED ONLINE, V9, P47, DOI 10.1016/S1472-6483(10)62109-8; Donnelly ET, 2001, HUM REPROD, V16, P1191, DOI 10.1093/humrep/16.6.1191; Endo Y., 2011, Journal of Mammalian Ova Research, V28, P47, DOI 10.1274/jmor.28.47; Endo Y, 2012, REPROD BIOMED ONLINE, V24, P301, DOI 10.1016/j.rbmo.2011.11.016; Gandini L., 2006, Cell and Tissue Banking, V7, P91, DOI 10.1007/s10561-005-0275-8; Hsieh YY, 2000, FERTIL STERIL, V73, P694, DOI 10.1016/S0015-0282(99)00612-3; Isachenko Eugenia, 2003, Reprod Biomed Online, V6, P191; Isachenko V, 2005, REPROD BIOMED ONLINE, V10, P350, DOI 10.1016/S1472-6483(10)61795-6; Kalthur G, 2008, FERTIL STERIL, V89, P1723, DOI 10.1016/j.fertnstert.2007.06.087; Li S, 2010, JALA-J LAB AUTOM, V15, P99, DOI 10.1016/j.jala.2010.01.001; Nawroth F, 2002, FERTIL STERIL, V78, pS129, DOI 10.1016/S0015-0282(02)03725-1; Paasch U, 2004, BIOL REPROD, V71, P1828, DOI 10.1095/biolreprod.103.025627; Pukazhenthi B, 2002, CRYOBIOLOGY, V44, P288, DOI 10.1016/S0011-2240(02)00035-4; Reid CE, 2009, THERIOGENOLOGY, V71, P275, DOI 10.1016/j.theriogenology.2008.07.009; Gimenez JR, 2011, HUM REPROD, V26, pI45; Thomson LK, 2009, FERTIL STERIL, V92, P991, DOI 10.1016/j.fertnstert.2008.07.1747; Vajta G, 2011, HUM REPROD, V26, pI42, DOI 10.1093/humrep/26.s1.30; Valcarcel A, 1997, ANIM REPROD SCI, V45, P299, DOI 10.1016/S0378-4320(96)01586-2; Wheeler MB, 2007, THERIOGENOLOGY S1, P178; World Health Organization, 1999, WHO LAB MAN EX HUM S; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Ye YH, 2009, FERTIL STERIL, V92, P1002, DOI 10.1016/j.fertnstert.2008.07.1737; Yi CQ, 2006, ANAL CHIM ACTA, V560, P1, DOI 10.1016/j.aca.2005.12.037	26	37	41	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61593	10.1371/journal.pone.0061593	http://dx.doi.org/10.1371/journal.pone.0061593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646110	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300011
J	Lopez-Gomez, C; Pino-Angeles, A; Orpez-Zafra, T; Pinto-Medel, MJ; Oliver-Martos, B; Ortega-Pinazo, J; Arnaiz, C; Guijarro-Castro, C; Varade, J; Alvarez-Lafuente, R; Urcelay, E; Sanchez-Jimenez, F; Fernandez, O; Leyva, L				Lopez-Gomez, Carlos; Pino-Angeles, Almudena; Orpez-Zafra, Teresa; Jesus Pinto-Medel, Maria; Oliver-Martos, Begona; Ortega-Pinazo, Jesus; Arnaiz, Carlos; Guijarro-Castro, Cristina; Varade, Jezabel; Alvarez-Lafuente, Roberto; Urcelay, Elena; Sanchez-Jimenez, Francisca; Fernandez, Oscar; Leyva, Laura			Candidate Gene Study of TRAIL and TRAIL Receptors: Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients	PLOS ONE			English	Article							LIGAND TRAIL; PHARMACOGENOMIC ANALYSIS; APOPTOSIS; DEATH; SUSCEPTIBILITY; CANCER; CELLS; POLYMORPHISMS; EXPRESSION	TRAIL and TRAIL Receptor genes have been implicated in Multiple Sclerosis pathology as well as in the response to IFN beta therapy. The objective of our study was to evaluate the association of these genes in relation to the age at disease onset (AAO) and to the clinical response upon IFN beta treatment in Spanish MS patients. We carried out a candidate gene study of TRAIL, TRAILR-1, TRAILR-2, TRAILR-3 and TRAILR-4 genes. A total of 54 SNPs were analysed in 509 MS patients under IFN beta treatment, and an additional cohort of 226 MS patients was used to validate the results. Associations of rs1047275 in TRAILR-2 and rs7011559 in TRAILR-4 genes with AAO under an additive model did not withstand Bonferroni correction. In contrast, patients with the TRAILR-1 rs20576-CC genotype showed a better clinical response to IFN beta therapy compared with patients carrying the A-allele (recessive model: p = 8.88x10(-4), p(c) = 0.048, OR = 0.30). This SNP resulted in a non synonymous substitution of Glutamic acid to Alanine in position 228 (E228A), a change previously associated with susceptibility to different cancer types and risk of metastases, suggesting a lack of functionality of TRAILR-1. In order to unravel how this amino acid change in TRAILR-1 would affect to death signal, we performed a molecular modelling with both alleles. Neither TRAIL binding sites in the receptor nor the expression levels of TRAILR-1 in peripheral blood mononuclear cell subsets (monocytes, CD4+ and CD8+ T cells) were modified, suggesting that this SNP may be altering the death signal by some other mechanism. These findings show a role for TRAILR-1 gene variations in the clinical outcome of IFN beta therapy that might have relevance as a biomarker to predict the response to IFN beta in MS.	[Lopez-Gomez, Carlos; Orpez-Zafra, Teresa; Jesus Pinto-Medel, Maria; Oliver-Martos, Begona; Ortega-Pinazo, Jesus; Leyva, Laura] Hosp Reg Univ Carlos Haya, Clin Neurosci Inst, Res Lab, Malaga, Spain; [Pino-Angeles, Almudena; Sanchez-Jimenez, Francisca] Univ Malaga, Dept Mol Biol & Biochem, E-29071 Malaga, Spain; [Arnaiz, Carlos; Fernandez, Oscar] Hosp Reg Univ Carlos Haya, Clin Neurosci Inst, Dept Neurol, Malaga, Spain; [Guijarro-Castro, Cristina] Hosp Univ 12 Octubre, Dept Neurol, Madrid, Spain; [Varade, Jezabel; Alvarez-Lafuente, Roberto; Urcelay, Elena] Hosp Clin San Carlos, IdISSC, Multiple Sclerosis Unit, Madrid, Spain; [Pino-Angeles, Almudena; Sanchez-Jimenez, Francisca] CIBERER, Malaga, Spain; [Orpez-Zafra, Teresa; Jesus Pinto-Medel, Maria; Oliver-Martos, Begona; Guijarro-Castro, Cristina; Varade, Jezabel; Alvarez-Lafuente, Roberto; Urcelay, Elena; Fernandez, Oscar; Leyva, Laura] Red Espanola Esclerosis Multiple REEM RD 07 0060, Malaga, Spain	Hospital Carlos Haya; Universidad de Malaga; Hospital Carlos Haya; Hospital Universitario 12 de Octubre; Hospital Clinico San Carlos; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Leyva, L (corresponding author), Hosp Reg Univ Carlos Haya, Clin Neurosci Inst, Res Lab, Malaga, Spain.	leyvafer@gmail.com	varade, jezabel/B-2771-2017; Leyva, Laura/R-2187-2019; Alvarez-Lafuente, Roberto/AAJ-9980-2020; Jiménez, Francisca María Sánchez/H-2513-2015; Varadé, Jezabel/Z-5054-2019; Pino-Angeles, Almudena/L-4975-2014; López-Gómez, Carlos/C-8938-2009; Oliver-Martos, Begoña/U-5444-2019; Leyva, Laura/B-5574-2019	varade, jezabel/0000-0002-3964-110X; Leyva, Laura/0000-0003-0620-9625; Jiménez, Francisca María Sánchez/0000-0002-4958-6060; Varadé, Jezabel/0000-0002-3964-110X; Pino-Angeles, Almudena/0000-0002-8845-8686; López-Gómez, Carlos/0000-0003-2699-451X; Leyva, Laura/0000-0003-0620-9625; Alvarez-Lafuente, Roberto/0000-0002-3132-1486; Urcelay, Elena/0000-0001-8470-8396; Ortega-Pinazo, Jesus/0000-0002-2884-9239; Pinto Medel, Maria Jesus/0000-0002-1129-7415	Fondo de Investigacion Sanitaria & Fondo Europeo de Desarrollo Regional [PS09/01764]; Consejeria de Salud de la Junta de Andalucia [SAS07/0231]; Consejeria de Innovacion [P07-CTS-03223]	Fondo de Investigacion Sanitaria & Fondo Europeo de Desarrollo Regional; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Consejeria de Innovacion	The authors acknowledge the support from Fondo de Investigacion Sanitaria & Fondo Europeo de Desarrollo Regional (PS09/01764) and Consejeria de Salud de la Junta de Andalucia (SAS07/0231) to L. L., and from Consejeria de Innovacion (P07-CTS-03223) to OF. The authors would like to thank Biogen Idec Iberia S. L. for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas O, 2007, FRONT BIOSCI-LANDMRK, V12, P2912, DOI 10.2741/2281; Arbour N, 2005, MULT SCLER J, V11, P652, DOI 10.1191/1352458505ms1222oa; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barblu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032874; Byun E, 2008, ARCH NEUROL-CHICAGO, V65, P337, DOI 10.1001/archneurol.2008.47; Chen B, 2009, EUR J CANCER, V45, P2598, DOI 10.1016/j.ejca.2009.06.023; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Comabella M, 2009, ARCH NEUROL-CHICAGO, V66, P972, DOI 10.1001/archneurol.2009.150; Cunningham S, 2005, CLIN PHARMACOL THER, V78, P635, DOI 10.1016/j.clpt.2005.08.018; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doggrell SA, 2010, EXPERT OPIN PHARMACO, V11, P1225, DOI 10.1517/14656561003677390; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fernandez O, 2005, ACTA NEUROL SCAND, V112, P391, DOI 10.1111/j.1600-0404.2005.00415.x; Fernandez O, 2003, ACTA NEUROL SCAND, V107, P7, DOI 10.1034/j.1600-0404.2003.01350.x; Frank B, 2005, CARCINOGENESIS, V26, P1975, DOI 10.1093/carcin/bgi164; Frank B, 2006, CANCER EPIDEM BIOMAR, V15, P2002, DOI 10.1158/1055-9965.EPI-06-0053; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Hebb A.L., 2010, AUTOIMMUNE DIS, V2011; Ikeda T, 2010, J IMMUNOL, V185, P5259, DOI 10.4049/jimmunol.0902797; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kawade Y, 2003, J IMMUNOL METHODS, V278, P127, DOI 10.1016/S0022-1759(03)00203-5; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Kikuchi S, 2005, J NEUROIMMUNOL, V167, P170, DOI 10.1016/j.jneuroim.2005.06.021; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Langsenlehner T, 2008, PROSTATE, V68, P264, DOI 10.1002/pros.20682; Leyva L, 2005, J NEUROIMMUNOL, V163, P165, DOI 10.1016/j.jneuroim.2005.02.010; Lopez-Gomez G, 2011, PLOS ONE, V6; Lunemann JD, 2002, J IMMUNOL, V168, P4881, DOI 10.4049/jimmunol.168.10.4881; Matysiak M, 2002, BRAIN, V125, P2469, DOI 10.1093/brain/awf254; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McKeage K, 2008, CNS DRUGS, V22, P787, DOI 10.2165/00023210-200822090-00005; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Doherty C, 2009, PHARMACOGENOMICS, V10, P1177, DOI [10.2217/pgs.09.41, 10.2217/PGS.09.41]; Oliver B, 2009, J IMMUNOL METHODS, V351, P41, DOI 10.1016/j.jim.2009.09.005; Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740; Rozen S, 2000, Methods Mol Biol, V132, P365; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Sriram U, 2003, GENES IMMUN, V4, P147, DOI 10.1038/sj.gene.6363946; Valley CC, 2012, J BIOL CHEM, V287, P21265, DOI 10.1074/jbc.M111.306480; Van Weyenbergh J, 2001, J LEUKOCYTE BIOL, V70, P745; Villoslada P, 2002, J NEUROIMMUNOL, V130, P194, DOI 10.1016/S0165-5728(02)00215-1; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Weinstock-Guttman B, 2007, J NEUROIMMUNOL, V182, P236, DOI 10.1016/j.jneuroim.2006.10.011; Wergeland S, 2005, EUR J NEUROL, V12, P171, DOI 10.1111/j.1468-1331.2004.01102.x; WHO Expert Committee on Biological Standardization, 1985, WHO TECH REP SER, V725, P1; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wolf S, 2006, INT J CANCER, V118, P1831, DOI 10.1002/ijc.21502; Zula JA, 2011, P NATL ACAD SCI USA, V108, P19689, DOI 10.1073/pnas.1117347108	51	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62540	10.1371/journal.pone.0062540	http://dx.doi.org/10.1371/journal.pone.0062540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658636	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800050
J	Wang, E; Chong, K; Yu, M; Akhoundsadegh, N; Granville, DJ; Shapiro, J; McElwee, KJ				Wang, Eddy; Chong, Katy; Yu, Mei; Akhoundsadegh, Noushin; Granville, David J.; Shapiro, Jerry; McElwee, Kevin J.			Development of Autoimmune Hair Loss Disease Alopecia Areata Is Associated with Cardiac Dysfunction in C3H/HeJ Mice	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ADRENOCORTICOTROPIC HORMONE; ANDROGENETIC ALOPECIA; INTERLEUKIN (IL)-18; TROPONIN-I; HPA AXIS; EXPRESSION; IL-18; STRESS; GENE	Alopecia areata (AA) is a chronic autoimmune hair loss disease that affects several million men, women and children worldwide. Previous studies have suggested a link between autoimmunity, stress hormones, and increased cardiovascular disease risk. In the current study, histology, immunohistology, quantitative PCR (qPCR) and ELISAs were used to assess heart health in the C3H/HeJ mouse model for AA and heart tissue response to adrenocorticotropic hormone (ACTH) exposure. Mice with AA exhibited both atrial and ventricular hypertrophy, and increased collagen deposition compared to normal-haired littermates. QPCR revealed significant increases in Il18 (4.6-fold), IL18 receptor-1 (Il18r1; 2.8-fold) and IL18 binding protein (Il18bp; 5.2-fold) in AA hearts. Time course studies revealed a trend towards decreased Il18 in acute AA compared to controls while Il18r1, Il18bp and Casp1 showed similar trends to those of chronic AA affected mice. Immunohistochemistry showed localization of IL18 in chronic AA mouse atria. ELISA indicated cardiac troponin-I (cTnI) was elevated in the serum and significantly increased in AA heart tissue. Cultures of heart atria revealed differential gene expression between AA and control mice in response to ACTH. ACTH treatment induced significant increase in cTnI release into the culture medium in a dose-dependent manner for both AA and control mice. In conclusion, murine AA is associated with structural, biochemical, and gene expression changes consistent with cardiac hypertrophy in response to ACTH exposure.	[Wang, Eddy; Yu, Mei; Akhoundsadegh, Noushin; McElwee, Kevin J.] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Chong, Katy] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Granville, David J.] Univ British Columbia, Dept Pathol & Lab Med, James Hogg Res Ctr, Inst Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada; [Shapiro, Jerry] Vancouver Gen Hosp, Dept Dermatol & Skin Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	McElwee, KJ (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada.	kmcelwee@interchange.ubc.ca	Wang, Eddy Hsi Chun/AAD-2759-2019	Wang, Eddy Hsi Chun/0000-0001-7785-1442; McElwee, Kevin/0000-0003-1020-3832	Canadian Dermatology Foundation (CDF); Canadian Institutes of Health Research (CIHR) [MOP-82927]	Canadian Dermatology Foundation (CDF); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Dermatology Foundation (CDF) and the Canadian Institutes of Health Research (CIHR; MOP-82927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JE, 1993, CIRCULATION, V88, P101, DOI 10.1161/01.CIR.88.1.101; Aherrahrou Z, 2004, AM J PATHOL, V164, P1379, DOI 10.1016/S0002-9440(10)63224-5; Ahouansou S, 2007, EUR J DERMATOL, V17, P220; Alikhan A, 2011, J AM ACAD DERMATOL, V65, P473, DOI 10.1016/j.jaad.2010.11.061; Alkhalifah A, 2010, J AM ACAD DERMATOL, V62, P177, DOI 10.1016/j.jaad.2009.10.032; Arias-Santiago S, 2010, BRIT J DERMATOL, V162, P786, DOI 10.1111/j.1365-2133.2009.09588.x; Arias-Santiago S, 2010, J AM ACAD DERMATOL, V63, P420, DOI 10.1016/j.jaad.2009.10.018; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; Baran W, 2008, BIOMARKERS, V13, P52, DOI 10.1080/13547500701610273; Bauml MA, 2010, CLEV CLIN J MED, V77, P381, DOI 10.3949/ccjm.77a.09158; Biernacka A, 2011, AGING DIS, V2, P158; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Brade T, 2011, DEVELOPMENT, V138, P139, DOI 10.1242/dev.054239; Caulfield J B, 1997, Technol Health Care, V5, P95; Chandrasekar B, 2005, J BIOL CHEM, V280, P4553, DOI 10.1074/jbc.M411787200; Chang AN, 2008, BIOCHEM BIOPH RES CO, V369, P74, DOI 10.1016/j.bbrc.2007.12.081; Chu SY, 2012, BRIT J DERMATOL, V166, P525, DOI 10.1111/j.1365-2133.2011.10714.x; Chu SY, 2011, J AM ACAD DERMATOL; Dinarello CA, 2011, J INTERN MED, V269, P16, DOI 10.1111/j.1365-2796.2010.02313.x; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dinarello CA, 2001, ANN RHEUM DIS, V60, pIII18; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; dos Santos JC, 2008, INT IMMUNOPHARMACOL, V8, P1433, DOI 10.1016/j.intimp.2008.05.016; Duprez D, 1999, J HYPERTENS, V17, P1583, DOI 10.1097/00004872-199917110-00012; Eliakim-Raz N, 2008, CARDIOLOGY, V111, P202, DOI 10.1159/000121605; Evans JF, 2012, MOL CELL ENDOCRINOL, V355, P60, DOI 10.1016/j.mce.2012.01.019; Evers AWM, 2010, BRIT J DERMATOL, V163, P986, DOI 10.1111/j.1365-2133.2010.09984.x; Fix C, 2011, CYTOKINE, V53, P19, DOI 10.1016/j.cyto.2010.10.002; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Guo HW, 2011, MED HYPOTHESES, V76, P122, DOI 10.1016/j.mehy.2010.08.048; Guo HW, 2010, EXP DERMATOL, V19, P1020, DOI 10.1111/j.1600-0625.2010.01125.x; Gutersohn T, 2005, DERMATOLOGY, V211, P72, DOI 10.1159/000085583; Hirobe T, 2000, J EXP ZOOL, V286, P632, DOI 10.1002/(SICI)1097-010X(20000501)286:6<632::AID-JEZ10>3.0.CO;2-4; HOLZINGER C, 1995, CIRCULATION, V92, P2876, DOI 10.1161/01.CIR.92.10.2876; Isales CM, 2010, ANN NY ACAD SCI, V1192, P110, DOI 10.1111/j.1749-6632.2009.05231.x; ITO H, 1993, CIRCULATION, V87, P1715, DOI 10.1161/01.CIR.87.5.1715; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Ivandic BT, 1996, P NATL ACAD SCI USA, V93, P5483, DOI 10.1073/pnas.93.11.5483; Jefferis BJMH, 2011, ATHEROSCLEROSIS, V217, P227, DOI 10.1016/j.atherosclerosis.2011.03.015; Johansen C, 2007, J INVEST DERMATOL, V127, P2857, DOI 10.1038/sj.jid.5700922; Jokinen J, 2009, J AFFECT DISORDERS, V116, P88, DOI 10.1016/j.jad.2008.10.025; Kahai S, 2004, MATRIX BIOL, V23, P445, DOI 10.1016/j.matbio.2004.09.004; Kasumagic-Halilovic E, 2008, ACTA DERMATOVENER CR, V16, P123; LANG D, 1984, EUR J PEDIATR, V142, P121, DOI 10.1007/BF00445591; Lee D, 2010, EXP DERMATOL, V19, P145, DOI 10.1111/j.1600-0625.2009.00937.x; Leite SN, 2011, AN BRAS DERMATOL, V86, P681, DOI 10.1590/S0365-05962011000400009; Liao CH, 2010, J CLIN INVEST, V120, P242, DOI 10.1172/JCI39942; Lim W, 2006, AM J CRIT CARE, V15, P280; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorell BH, 2000, CIRCULATION, V102, P470; Luan Y, 2010, EUROPACE, V12, P1713, DOI 10.1093/europace/euq321; MADRI JA, 1988, AM J PATHOL, V132, P18; Mallat Z, 2004, FASEB J, V18, P1752, DOI 10.1096/fj.04-2426fje; Manolache L, 2007, J EUR ACAD DERMATOL, V21, P921, DOI 10.1111/j.1468-3083.2006.02106.x; McElwee KJ, 1998, J INVEST DERMATOL, V111, P797, DOI 10.1046/j.1523-1747.1998.00380.x; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; Miller WL, 2007, CIRCULATION, V116, P249, DOI 10.1161/CIRCULATIONAHA.107.694562; Mizuno Y, 2005, J HYPERTENS, V23, P411, DOI 10.1097/00004872-200502000-00024; Mustonen E, 2008, BIOCHEM BIOPH RES CO, V373, P186, DOI 10.1016/j.bbrc.2008.05.164; Naito Y, 2002, HEART, V88, P296, DOI 10.1136/heart.88.3.296; Nellessen U, 2006, CLIN CARDIOL, V29, P219, DOI 10.1002/clc.4960290510; O'Shaughnessy PJ, 2003, ENDOCRINOLOGY, V144, P3279, DOI 10.1210/en.2003-0277; Oiso N, 2011, DERMAT RES PRACT, V2011, DOI 10.1155/2011/518090; Otis M, 2007, J ENDOCRINOL, V193, P331, DOI 10.1677/JOE-07-0055; Pala M, 1998, Cardiologia, V43, P1375; Park HJ, 2007, J INVEST DERMATOL, V127, P1210, DOI 10.1038/sj.jid.5700703; Park JB, 2002, AM J HYPERTENS, V15, P164, DOI 10.1016/S0895-7061(01)02291-9; Petukhova L, 2011, DERMATOL THER, V24, P326, DOI 10.1111/j.1529-8019.2011.01411.x; Platis A, 2008, PERFUSION-UK, V23, P237, DOI 10.1177/0267659108101511; Porrello ER, 2008, CLIN EXP PHARMACOL P, V35, P1358, DOI 10.1111/j.1440-1681.2008.05036.x; Potier M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1237, DOI 10.1152/ajpendo.00451.2002; Ro Byung In, 1995, Journal of Dermatology (Tokyo), V22, P858; Rummery NM, 2002, J HYPERTENS, V20, P247, DOI 10.1097/00004872-200202000-00014; Searle J, 2011, MINERVA CARDIOANGIOL, V59, P203; Sekiyama A, 2005, IMMUNITY, V22, P669, DOI 10.1016/j.immuni.2005.04.006; Sekiyama Atsuo, 2005, J Med Invest, V52 Suppl, P236, DOI 10.2152/jmi.52.236; Sharma S, 2004, J CLIN PATHOL, V57, P1025, DOI 10.1136/jcp.2003.015420; Sharma VK, 1996, INT J DERMATOL, V35, P22, DOI 10.1111/j.1365-4362.1996.tb01610.x; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Stojanovich L, 2008, AUTOIMMUN REV, V7, P209, DOI 10.1016/j.autrev.2007.11.007; Tsai TF, 2011, J DERMATOL SCI, V63, P40, DOI 10.1016/j.jdermsci.2011.03.002; Van Kerckhoven R, 2000, CARDIOVASC RES, V46, P316, DOI 10.1016/S0008-6363(99)00427-7; Vena GA, 2010, DERMATOL THER, V23, P144, DOI 10.1111/j.1529-8019.2010.01308.x; Vogelzangs N, 2010, J CLIN ENDOCR METAB, V95, P4959, DOI 10.1210/jc.2010-0192; Walsh D, 1913, BRIT MED J, V1913, P1007; Wang E, 2011, DERMATOL THER, V24, P337, DOI 10.1111/j.1529-8019.2011.01416.x; Wang MJ, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e318160f215; Wang Shu-fei, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P237; WEN XI, 1985, CANCER RES, V45, P3974; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Woldbaek PR, 2005, AM J PHYSIOL-HEART C, V289, pH708, DOI 10.1152/ajpheart.01179.2004; Xiang Y, 1999, P NATL ACAD SCI USA, V96, P11537, DOI 10.1073/pnas.96.20.11537; Yu M, 2008, J INVEST DERMATOL, V128, P1797, DOI 10.1038/sj.jid.5701243; Zhang XQ, 2009, J INVEST DERMATOL, V129, P1527, DOI 10.1038/jid.2008.371	94	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62935	10.1371/journal.pone.0062935	http://dx.doi.org/10.1371/journal.pone.0062935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658656	gold, Green Submitted, Green Published			2022-12-25	WOS:000318343700080
J	Yogalingam, G; Hwang, S; Ferreira, JCB; Mochly-Rosen, D				Yogalingam, Gouri; Hwang, Sunhee; Ferreira, Julio C. B.; Mochly-Rosen, Daria			Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Phosphorylation by Protein Kinase C delta (PKC delta) Inhibits Mitochondria Elimination by Lysosomal-like Structures following Ischemia and Reoxygenation-induced Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; REPERFUSION INJURY; MITOPHAGY; AUTOPHAGY; ACTIVATION; PARKIN; RECEPTOR; TRANSLOCATION; MEMBRANE; CARDIOPROTECTION	After cardiac ischemia and reperfusion or reoxygenation (I/R), damaged mitochondria propagate tissue injury by promoting cell death. One possible mechanism to protect from I/R-induced injury is the elimination of damaged mitochondria by mitophagy. Here we identify new molecular events that lead to mitophagy using a cell culture model and whole hearts subjected to I/R. We found that I/R induces glyceraldehyde-3-phosphate dehydrogenase (GAPDH) association with mitochondria and promotes direct uptake of damaged mitochondria into multiorganellar lysosomal-like (LL) structures for elimination independently of the macroautophagy pathway. We also found that protein kinase C delta (PKC delta) inhibits GAPDH-driven mitophagy by phosphorylating the mitochondrially associated GAPDH at threonine 246 following I/R. Phosphorylated GAPDH promotes the accumulation of mitochondria at the periphery of LL structures, which coincides with increased mitochondrial permeability. Either inhibition of PKC delta or expression of a phosphorylation-defective GAPDH mutant during I/R promotes a reduction in mitochondrial mass and apoptosis, thus indicating rescued mitophagy. Taken together, we identified a GAPDH/PKC delta signaling switch, which is activated during oxidative stress to regulate the balance between cell survival by mitophagy and cell death due to accumulation of damaged mitochondria.	[Yogalingam, Gouri; Hwang, Sunhee; Ferreira, Julio C. B.; Mochly-Rosen, Daria] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Mochly-Rosen, D (corresponding author), CCSR, Rm 3145A,269 Campus Dr, Stanford, CA 94305 USA.	mochly@stanford.edu	Ferreira, Julio/L-4687-2019; Ferreira, Julio Cesar Batista/I-3177-2012; Ferreira, Julio Cesar Batista/AEU-0494-2022	Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Mochly-Rosen, Daria/0000-0002-6691-8733	National Institutes of Health [HL052141]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant HL052141 (to D. M. R.).	ASHMARINA LI, 1988, FEBS LETT, V231, P413, DOI 10.1016/0014-5793(88)80861-5; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Churchill EN, 2005, ARCH BIOCHEM BIOPHYS, V439, P194, DOI 10.1016/j.abb.2005.05.007; Churchill EN, 2005, CIRC RES, V97, P78, DOI 10.1161/01.RES.0000173896.32522.6e; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; CUERVO AM, 1994, J BIOL CHEM, V269, P26374; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; Farre JC, 2009, CURR OPIN CELL BIOL, V21, P522, DOI 10.1016/j.ceb.2009.04.015; Gao Y, 2006, J BIOL CHEM, V281, P18394, DOI 10.1074/jbc.M601112200; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; Gottlieb RA, 2011, AUTOPHAGY, V7, P1573, DOI 10.4161/auto.7.12.18175; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Honda HM, 2006, CARDIOVASC DRUG THER, V20, P425, DOI 10.1007/s10557-006-0642-0; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Hwang NR, 2009, BIOCHEM J, V423, P253, DOI 10.1042/BJ20090854; Ikeno F, 2007, CARDIOVASC RES, V73, P699, DOI 10.1016/j.cardiores.2006.12.011; Inagaki K, 2003, CIRCULATION, V108, P2304, DOI 10.1161/01.CIR.0000101682.24138.36; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kanki T, 2010, AUTOPHAGY, V6, P433, DOI 10.4161/auto.6.3.11420; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Mijaljica D, 2011, AUTOPHAGY, V7, P673, DOI 10.4161/auto.7.7.14733; MORERO RD, 1985, BIOCHEMISTRY-US, V24, P1904, DOI 10.1021/bi00329a015; Murriel CL, 2004, J BIOL CHEM, V279, P47985, DOI 10.1074/jbc.M405071200; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Okamoto K, 2009, AUTOPHAGY, V5, P1203, DOI 10.4161/auto.5.8.9830; Prasad A, 2009, CIRCULATION, V120, P2105, DOI 10.1161/CIRCULATIONAHA.108.814640; QIN SF, 1995, BIOCHEM J, V308, P347, DOI 10.1042/bj3080347; Qvit Nir, 2010, Drug Discov Today Dis Mech, V7, pe87, DOI 10.1016/j.ddmec.2010.07.001; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Sala-Mercado JA, 2010, CIRCULATION, V122, pS179, DOI 10.1161/CIRCULATIONAHA.109.928242; SCHIEVEN GL, 1993, J BIOL CHEM, V268, P16688; Sun Y, 2012, J BIOL CHEM, V287, P40652, DOI 10.1074/jbc.M112.419721; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wild P, 2010, NAT CELL BIOL, V12, P104, DOI 10.1038/ncb0210-104; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	54	76	76	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18947	18960		10.1074/jbc.M113.466870	http://dx.doi.org/10.1074/jbc.M113.466870			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23653351	Green Published, hybrid			2022-12-25	WOS:000321335800032
J	Doyle, TM; Jaentschke, B; Van Domselaar, G; Hashem, AM; Farnsworth, A; Forbes, NE; Li, CG; Wang, JZ; He, RT; Brown, EG; Li, XG				Doyle, Tracey M.; Jaentschke, Bozena; Van Domselaar, Gary; Hashem, Anwar M.; Farnsworth, Aaron; Forbes, Nicole E.; Li, Changgui; Wang, Junzhi; He, Runtao; Brown, Earl G.; Li, Xuguang			The Universal Epitope of Influenza A Viral Neuraminidase Fundamentally Contributes to Enzyme Activity and Viral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS NEURAMINIDASE; 3-DIMENSIONAL STRUCTURE; ANTIGENIC VARIATION; FLUOROMETRIC ASSAY; ANTIBODIES; GLYCOPROTEIN; SUBTYPES; FUSION; ENTRY; SYSTEM	The only universally conserved sequence among all influenza A viral neuraminidases is located between amino acids 222 and 230. However, the potential roles of these amino acids remain largely unknown. Through an array of experimental approaches including mutagenesis, reverse genetics, and growth kinetics, we found that this sequence could markedly affect viral replication. Additional experiments revealed that enzymes with mutations in this region demonstrated substantially decreased catalytic activity, substrate binding, and thermostability. Consistent with viral replication analyses and enzymatic studies, protein modeling suggests that these amino acids could either directly bind to the substrate or contribute to the formation of the active site in the enzyme. Collectively, these findings reveal the essential role of this unique region in enzyme function and viral growth, which provides the basis for evaluating the validity of this sequence as a potential target for antiviral intervention and vaccine development.	[Doyle, Tracey M.; Jaentschke, Bozena; Hashem, Anwar M.; Farnsworth, Aaron; Li, Xuguang] Hlth Canada, Ctr Vaccine Evaluat, Biol & Genet Therapies Directorate, Hlth Prod & Food Branch, Ottawa, ON K1A 0K9, Canada; [Van Domselaar, Gary; He, Runtao] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada; [Hashem, Anwar M.] King Abdulaziz Univ, Fac Med, Dept Med Microbiol & Parasitol, Jeddah 21413, Saudi Arabia; [Li, Changgui; Wang, Junzhi] Natl Inst Food & Drug Control, Beijing 100050, Peoples R China; [Doyle, Tracey M.; Hashem, Anwar M.; Forbes, Nicole E.; Brown, Earl G.; Li, Xuguang] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Doyle, Tracey M.; Hashem, Anwar M.; Forbes, Nicole E.; Brown, Earl G.; Li, Xuguang] Univ Ottawa, Ctr Emerging Pathogens Res, Ottawa, ON K1H 8M5, Canada	Health Canada; Public Health Agency of Canada; King Abdulaziz University; National Institute of Food & Drug Control - China; University of Ottawa; University of Ottawa	Li, XG (corresponding author), Hlth Canada, Sir FG Banting Res Ctr, Ctr Vaccine Evaluat, A-L 2201E,251 Sir Frederick Banting Driveway, Ottawa, ON K1A 0K9, Canada.	Sean.Li@hc-sc.gc.ca	Hashem, Anwar/E-9411-2011; Hashem, Anwar M/B-2301-2017	Hashem, Anwar M/0000-0002-8471-7011; Forbes, Nicole/0000-0002-2645-695X	Canadian Regulatory Strategy for Biotechnology; Canadian Institutes of Health Research Pandemic Preparedness Team Grant [TPA-90188]; Natural Sciences and Engineering Research Council of Canada; King Abdulaziz University through the Saudi Arabian Cultural Bureau in Canada	Canadian Regulatory Strategy for Biotechnology; Canadian Institutes of Health Research Pandemic Preparedness Team Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); King Abdulaziz University through the Saudi Arabian Cultural Bureau in Canada	This work was supported in part by the Canadian Regulatory Strategy for Biotechnology (to X. L.) and Canadian Institutes of Health Research Pandemic Preparedness Team Grant TPA-90188 (to E. G. B.).; Supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada.; Supported by a scholarship from King Abdulaziz University through the Saudi Arabian Cultural Bureau in Canada.	AIR GM, 1989, PROTEINS, V6, P341, DOI 10.1002/prot.340060402; BAKER AT, 1987, PROTEINS, V2, P111, DOI 10.1002/prot.340020205; Basak A, 2002, FEBS LETT, V514, P333, DOI 10.1016/S0014-5793(02)02394-3; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; COLMAN PM, 1987, NATURE, V326, P358, DOI 10.1038/326358a0; COLMAN PM, 1989, PHILOS T R SOC B, V323, P511, DOI 10.1098/rstb.1989.0028; COLMAN PM, 1992, IMMUNOL CELL BIOL, V70, P209, DOI 10.1038/icb.1992.26; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fuchs W, 2012, J VIROL, V86, P8002, DOI 10.1128/JVI.00690-12; Govorkova EA, 2013, CURR TOP MICROBIOL, V370, P273, DOI 10.1007/82_2011_198; Gravel C, 2010, VACCINE, V28, P5774, DOI 10.1016/j.vaccine.2010.06.075; GRIFFIN JA, 1983, VIROLOGY, V125, P324, DOI 10.1016/0042-6822(83)90205-2; Hashem AM, 2012, HUM VACC IMMUNOTHER, V8, P425, DOI 10.4161/hv.19109; Hashem AM, 2010, BIOCHEM BIOPH RES CO, V403, P247, DOI 10.1016/j.bbrc.2010.11.030; Hashem AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008350; Hatta Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001139; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Ilyushina NA, 2012, J VIROL, V86, P4724, DOI 10.1128/JVI.06774-11; Klenk H D, 1988, Adv Virus Res, V34, P247, DOI 10.1016/S0065-3527(08)60520-5; LAVER WG, 1984, MICROBIOL SCI, V1, P37; LIM WA, 1992, BIOCHEMISTRY-US, V31, P4324, DOI 10.1021/bi00132a025; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Liu Qinfang, 2009, J Mol Genet Med, V3, P225; Monera OD, 1996, PROTEIN ENG, V9, P353, DOI 10.1093/protein/9.4.353; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Su B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008495; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; WEBSTER RG, 1978, ANNU REV GENET, V12, P415, DOI 10.1146/annurev.ge.12.120178.002215; Wei CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004273; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102	43	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18283	18289		10.1074/jbc.M113.468884	http://dx.doi.org/10.1074/jbc.M113.468884			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645684	Green Published, hybrid			2022-12-25	WOS:000320721900032
J	Marion, JD; Roberts, CF; Call, RJ; Forbes, JL; Nelson, KT; Bell, JE; Bell, JK				Marion, James D.; Roberts, Charlotte F.; Call, R. Jason; Forbes, Jonathan L.; Nelson, Kristina T.; Bell, J. Ellis; Bell, Jessica K.			Mechanism of Endogenous Regulation of the Type I Interferon Response by Suppressor of I kappa B Kinase epsilon (SIKE), a Novel Substrate of TANK-binding Kinase 1 (TBK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; INNATE IMMUNE-RESPONSE; KINETIC MECHANISM; CRYSTAL-STRUCTURE; VIRUS-INFECTION; IKK-EPSILON; RIG-I; ACTIVATION; PHOSPHORYLATION; IRF-3	TANK-binding kinase 1 (TBK1) serves as a key convergence point in multiple innate immune signaling pathways. In response to receptor-mediated pathogen detection, TBK1 phosphorylation promotes production of pro-inflammatory cytokines and type I interferons. Increasingly, TBK1 dysregulation has been linked to autoimmune disorders and cancers, heightening the need to understand the regulatory controls of TBK1 activity. Here, we describe the mechanism by which suppressor of IKK epsilon (SIKE) inhibits TBK1-mediated phosphorylation of interferon regulatory factor 3 (IRF3), which is essential to type I interferon production. Kinetic analyses showed that SIKE not only inhibits IRF3 phosphorylation but is also a high affinity TBK1 substrate. With respect to IRF3 phosphorylation, SIKE functioned as a mixed-type inhibitor (K-i,K- app = 350 nM) rather than, given its status as a TBK1 substrate, as a competitive inhibitor. TBK1 phosphorylation of IRF3 and SIKE displayed negative cooperativity. Both substrates shared a similar K-m value at low substrate concentrations (similar to 50 nM) but deviated >8-fold at higher substrate concentrations (IRF3 = 3.5 mu M; SIKE = 0.4 mu M). TBK1-SIKE interactions were modulated by SIKE phosphorylation, clustered in the C-terminal portion of SIKE (Ser-133, -185, -187, -188, -190, and -198). These sites exhibited striking homology to the phosphorylation motif of IRF3. Mutagenic probing revealed that phosphorylation of Ser-185 controlled TBK1-SIKE interactions. Taken together, our studies demonstrate for the first time that SIKE functions as a TBK1 substrate and inhibits TBK1-mediated IRF3 phosphorylation by forming a high affinity TBK1-SIKE complex. These findings provide key insights into the endogenous control of a critical catalytic hub that is achieved not by direct repression of activity but by redirection of catalysis through substrate affinity.	[Marion, James D.; Roberts, Charlotte F.; Call, R. Jason; Forbes, Jonathan L.; Bell, Jessica K.] Virginia Commonwealth Univ, Biochem & Mol Biol Dept, Richmond, VA 23298 USA; [Nelson, Kristina T.] Virginia Commonwealth Univ, Dept Chem, Richmond, VA 23298 USA; [Bell, Jessica K.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA; [Bell, Jessica K.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23298 USA; [Bell, Jessica K.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Bell, J. Ellis] Univ Richmond, Dept Chem, Richmond, VA 23173 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Richmond	Bell, JK (corresponding author), Biochem & Mol Biol Dept, POB 980614, Richmond, VA 23298 USA.	jbell6@vcu.edu	Bell, Jessica/I-3893-2013	Bell, Jessica/0000-0003-1455-3274	Thomas F. and Kate Miller Jeffress Memorial Trust [J1016]	Thomas F. and Kate Miller Jeffress Memorial Trust	This work was supported by Thomas F. and Kate Miller Jeffress Memorial Trust Grant J1016 (to J. K. B.).	An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; BELL JE, 1976, J BIOL CHEM, V251, P3003; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Burke JR, 1998, J BIOL CHEM, V273, P12041, DOI 10.1074/jbc.273.20.12041; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; DALZIEL K, 1957, ACTA CHEM SCAND, V11, P1706, DOI 10.3891/acta.chem.scand.11-1706; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gleason CE, 2011, J BIOL CHEM, V286, P35663, DOI 10.1074/jbc.M111.267567; Grand EK, 2004, GENE CHROMOSOME CANC, V40, P78, DOI 10.1002/gcc.20023; Hammaker D, 2012, RHEUMATOLOGY, V51, P610, DOI 10.1093/rheumatology/ker154; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Huynh QK, 2002, J BIOL CHEM, V277, P12550, DOI 10.1074/jbc.M111526200; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Lin A, 2010, AM J PATHOL, V176, P108, DOI 10.2353/ajpath.2010.090256; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Ma XL, 2012, P NATL ACAD SCI USA, V109, P9378, DOI 10.1073/pnas.1121552109; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Munoz MC, 2009, J ENDOCRINOL, V201, P185, DOI 10.1677/JOE-08-0276; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Oganesyan G, 2008, J BIOL CHEM, V283, P802, DOI 10.1074/jbc.M704755200; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Paz S, 2006, CELL MOL BIOL, V52, P17, DOI 10.1170/T694; Peet GW, 1999, J BIOL CHEM, V274, P32655, DOI 10.1074/jbc.274.46.32655; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Radtke AL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030029; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shen RR, 2011, ONCOGENE, V30, P631, DOI 10.1038/onc.2010.493; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Wang BX, 2012, TRENDS IMMUNOL, V33, P190, DOI 10.1016/j.it.2012.01.004; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	52	16	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18612	18623		10.1074/jbc.M112.440859	http://dx.doi.org/10.1074/jbc.M112.440859			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649622	hybrid, Green Published			2022-12-25	WOS:000320721900060
J	Chung, D; Cha, M; Farkas, J; Westpheling, J				Chung, Daehwan; Cha, Minseok; Farkas, Joel; Westpheling, Janet			Construction of a Stable Replicating Shuttle Vector for Caldicellulosiruptor Species: Use for Extending Genetic Methodologies to Other Members of This Genus	PLOS ONE			English	Article							PLANT BIOMASS; SP-NOV.; BACTERIUM; PLASMID; TRANSFORMATION; DECONSTRUCTION; PRETREATMENT; RESTRICTION; CONVERSION; ENZYMES	The recalcitrance of plant biomass is the most important barrier to its economic conversion by microbes to products of interest. Thermophiles have special advantages for biomass conversion and members of the genus Caldicellulosiruptor are the most thermophilic cellulolytic microbes known. In this study, we report the construction of a replicating shuttle vector for Caldicellulosiruptor species based on pBAS2, the smaller of two native C. bescii plasmids. The entire plasmid was cloned into an E. coli cloning vector containing a pSC101 origin of replication and an apramycin resistance cassette for selection in E. coli. The wild-type C. bescii pyrF locus was cloned under the transcriptional control of the regulatory region of the ribosomal protein S30EA (Cbes2105), and the resulting vector was transformed into a new spontaneous deletion mutant in the pyrFA locus of C. bescii that allowed complementation with the pyrF gene alone. Plasmid DNA was methylated in vitro with a recently described cognate methyltransferase, M. CbeI, and transformants were selected for uracil prototrophy. The plasmid was stably maintained in low copy with selection but rapidly lost without selection. There was no evidence of DNA rearrangement during transformation and replication in C. bescii. A similar approach was used to screen for transformability of other members of this genus using M. CbeI to overcome restriction as a barrier and was successful for transformation of C. hydrothermalis, an attractive species for many applications. Plasmids containing a carbohydrate binding domain (CBM) and linker region from the C. bescii celA gene were maintained with selection and were structurally stable through transformation and replication in C. bescii and E. coli.	[Chung, Daehwan; Cha, Minseok; Farkas, Joel; Westpheling, Janet] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Chung, Daehwan; Cha, Minseok; Farkas, Joel; Westpheling, Janet] Oak Ridge Natl Lab, Dept Energy, BioEnergy Sci Ctr, Oak Ridge, TN USA	University System of Georgia; University of Georgia; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Westpheling, J (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	janwest@uga.edu			United States Department of Energy Bioenergy Research Center; Office of Biological and Environmental Research in the DOE Office of Science; predoctoral Graduate Training in Genetics grant [NIH 5T32GM007103-30]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007103] Funding Source: NIH RePORTER	United States Department of Energy Bioenergy Research Center(United States Department of Energy (DOE)); Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); predoctoral Graduate Training in Genetics grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The BioEnergy Science Center supported by a United States Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science. JF was supported in part by a predoctoral Graduate Training in Genetics grant (NIH 5T32GM007103-30) to the Genetics Department of the University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumer-Schuette SE, 2008, CURR OPIN BIOTECH, V19, P210, DOI 10.1016/j.copbio.2008.04.007; Blumer-Schuette SE, 2012, J BACTERIOL, V194, P4015, DOI 10.1128/JB.00266-12; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Bredholt S, 1999, INT J SYST BACTERIOL, V49, P991, DOI 10.1099/00207713-49-3-991; Chung D, 2013, J IND MICROBIOL BIOT, DOI [10.1007/s10295-10013-11244-z, DOI 10.1007/S10295-10013-11244-Z]; Chung DH, 2011, J IND MICROBIOL BIOT, V38, P1867, DOI 10.1007/s10295-011-0976-x; Chung D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043844; Clausen A, 2004, PLASMID, V52, P131, DOI 10.1016/j.plasmid.2004.06.001; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; ESPINOSA M, 1995, FEMS MICROBIOL LETT, V130, P111; Farkas JCD, 2012, J IND MICRO IN PRESS; GRUSS A, 1989, MICROBIOL REV, V53, P231, DOI 10.1128/MMBR.53.2.231-241.1989; Hamilton-Brehm SD, 2010, APPL ENVIRON MICROB, V76, P1014, DOI 10.1128/AEM.01903-09; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Huang CY, 1998, INT J SYST BACTERIOL, V48, P91, DOI 10.1099/00207713-48-1-91; IMANAKA T, 1982, J BACTERIOL, V149, P824, DOI 10.1128/JB.149.3.824-830.1982; Jennert KCB, 2000, MICROBIOL-SGM, V146, P3071, DOI 10.1099/00221287-146-12-3071; Karita S, 2001, BIOSCI BIOTECH BIOCH, V65, P226, DOI 10.1271/bbb.65.226; Kurusu Y, 2001, MAR BIOTECHNOL, V3, P96, DOI 10.1007/s101260000067; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Mai V, 1997, FEMS MICROBIOL LETT, V148, P163, DOI 10.1016/S0378-1097(97)00028-1; McCann MC, 2008, CURR OPIN PLANT BIOL, V11, P314, DOI 10.1016/j.pbi.2008.04.001; Miroshnichenko ML, 2008, INT J SYST EVOL MICR, V58, P1492, DOI 10.1099/ijs.0.65236-0; Negro MJ, 2003, APPL BIOCHEM BIOTECH, V105, P87, DOI 10.1385/ABAB:105:1-3:87; RAINEY FA, 1994, FEMS MICROBIOL LETT, V120, P263, DOI 10.1016/0378-1097(94)90481-2; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Sambrook J, 2001, MOL CLONING LAB MANU; SVETLICHNYI VA, 1990, MICROBIOLOGY+, V59, P598; Tripathi SA, 2010, APPL ENVIRON MICROB, V76, P6591, DOI 10.1128/AEM.01484-10; TSOI T V, 1987, Molekulyarnaya Genetika Mikrobiologiya i Virusologiya, P18; VanFossen AL, 2011, BIOTECHNOL BIOENG, V108, P1559, DOI 10.1002/bit.23093; Wilson DB, 2008, ANN NY ACAD SCI, V1125, P289, DOI 10.1196/annals.1419.026; Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009; Yang SJ, 2009, APPL ENVIRON MICROB, V75, P4762, DOI 10.1128/AEM.00236-09; Zhang YHP, 2007, BIOTECHNOL BIOENG, V97, P214, DOI 10.1002/bit.21386; Zwick ME, 2012, GENOME RES, V22, P1512, DOI 10.1101/gr.134437.111	38	47	47	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62881	10.1371/journal.pone.0062881	http://dx.doi.org/10.1371/journal.pone.0062881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658781	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100044
J	Knockel, J; Molina-Cruz, A; Fischer, E; Muratova, O; Haile, A; Barillas-Mury, C; Miller, LH				Knoeckel, Julia; Molina-Cruz, Alvaro; Fischer, Elizabeth; Muratova, Olga; Haile, Ashley; Barillas-Mury, Carolina; Miller, Louis H.			An Impossible Journey? The Development of Plasmodium falciparum NF54 in Culex quinquefasciatus	PLOS ONE			English	Article							COMPLEMENT-LIKE PROTEIN; HUMAN MALARIA PARASITES; VECTOR ANOPHELES-GAMBIAE; VALLEY FEVER VIRUS; OOKINETE INVASION; ENTOMOLOGIC INVESTIGATIONS; REFRACTORY STRAIN; MIDGUT EPITHELIUM; MOSQUITOS DIPTERA; FEEDING PATTERNS	Although Anopheles mosquitoes are the vectors for human Plasmodium spp., there are also other mosquito species-among them culicines (Culex spp., Aedes spp.)-present in malaria-endemic areas. Culicine mosquitoes transmit arboviruses and filarial worms to humans and are vectors for avian Plasmodium spp., but have never been observed to transmit human Plasmodium spp. When ingested by a culicine mosquito, parasites could either face an environment that does not allow development due to biologic incompatibility or be actively killed by the mosquito's immune system. In the latter case, the molecular mechanism of killing must be sufficiently powerful that Plasmodium is not able to overcome it. To investigate how human malaria parasites develop in culicine mosquitoes, we infected Culex quinquefasciatus with Plasmodium falciparum NF54 and monitored development of parasites in the blood bolus and midgut epithelium at different time points. Our results reveal that ookinetes develop in the midgut lumen of C. quinquefasciatus in slightly lower numbers than in Anopheles gambiae G3. After 30 hours, parasites have invaded the midgut and can be observed on the basal side of the midgut epithelium by confocal and transmission electron microscopy. Very few of the parasites in C. quinquefasciatus are alive, most of them are lysed. Eight days after the mosquito's blood meal, no oocysts can be found in C. quinquefasciatus. Our results suggest that the mosquito immune system could be involved in parasite killing early in development after ookinetes have crossed the midgut epithelium and come in contact with the mosquito hemolymph.	[Knoeckel, Julia; Molina-Cruz, Alvaro; Haile, Ashley; Barillas-Mury, Carolina; Miller, Louis H.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Fischer, Elizabeth] NIAID, Rocky Mt Labs, Elect Microscopy Unit, Res Technol Branch,NIH, Hamilton, MT 59840 USA; [Muratova, Olga] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Knockel, J (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	julia.knoeckel@gmail.com; lmiller@niaid.nih.gov		Vivian, Julia/0000-0001-6688-7714	National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000241, ZIAAI000947, ZICAI001052] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini A, 1999, PARASITOLOGY, V119, P331, DOI 10.1017/S0031182099004874; Arrighi RBG, 2005, J EXP BIOL, V208, P2497, DOI 10.1242/jeb.01664; Baton LA, 2007, J INVERTEBR PATHOL, V96, P244, DOI 10.1016/j.jip.2007.05.005; Baton LA, 2004, PARASITOLOGY, V129, P663, DOI 10.1017/S0031182004005979; Baton LA, 2012, INT J PARASITOL, V42, P249, DOI 10.1016/j.ijpara.2011.12.005; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007; BRIEGEL H, 1979, J MED ENTOMOL, V15, P235, DOI 10.1093/jmedent/15.3.235; CHEONG WH, 1963, SINGAP MED J, V4, P183; Clayton AM, 2013, DEV COMP IMMUNOL, V39, P323, DOI 10.1016/j.dci.2012.10.009; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Devenport Martin, 2005, P297; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Garver LS, 2008, DEV COMP IMMUNOL, V32, P519, DOI 10.1016/j.dci.2007.09.007; Garver LS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002737; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Gupta L, 2005, P NATL ACAD SCI USA, V102, P4010, DOI 10.1073/pnas.0409642102; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; HAYNES JD, 1976, NATURE, V263, P767, DOI 10.1038/263767a0; HUFF CG, 1965, EXP PARASITOL, V16, P107, DOI 10.1016/0014-4894(65)90036-6; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Jaswant Singh, 1955, Indian Journal of Malariology, V9, P71; Kwan JL, 2010, AM J TROP MED HYG, V83, P400, DOI 10.4269/ajtmh.2010.10-0076; LENSEN AHW, 1992, PARASITE IMMUNOL, V14, P471, DOI 10.1111/j.1365-3024.1992.tb00021.x; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Lindahl J, 2012, AM J TROP MED HYG, V87, P1076, DOI 10.4269/ajtmh.2012.12-0315; Mackay AJ, 2010, J MED ENTOMOL, V47, P238, DOI 10.1603/ME09168; Menge DM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-44; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Molina-Cruz A, 2012, P NATL ACAD SCI USA, V109, pE1957, DOI 10.1073/pnas.1121183109; Muturi EJ, 2008, PARASITOL RES, V102, P1329, DOI 10.1007/s00436-008-0914-7; Nacer A, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-33; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Norris LC, 2011, J VECTOR ECOL, V36, P411, DOI 10.1111/j.1948-7134.2011.00182.x; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Paskewitz SM, 2005, J MED ENTOMOL, V42, P712, DOI 10.1603/0022-2585(2005)042[0712:BTMRID]2.0.CO;2; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P242, DOI 10.1016/0035-9203(82)90289-9; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319; SAVAGE HM, 1993, AM J TROP MED HYG, V49, P38, DOI 10.4269/ajtmh.1993.49.38; Schneider D, 2000, SCIENCE, V288, P2376, DOI 10.1126/science.288.5475.2376; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Turell MJ, 2008, J MED ENTOMOL, V45, P102, DOI 10.1603/0022-2585(2008)45[102:VCOSAM]2.0.CO;2; Unlu I, 2010, J MED ENTOMOL, V47, P625, DOI 10.1603/ME09087; Varma M.G.L., 1989, GEOGRAPHICAL DISTRIB, P35; WARREN M., 1962, MOSQUITO NEWS, V22, P303; WEATHERSBY AB, 1968, J PARASITOL, V54, P1017, DOI 10.2307/3277137; WHARTON R. H., 1962, MOSQUITO NEWS, V22, P304; White G. B., 1989, GEOGRAPHICAL DISTRIB, P23; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Williamson KB, 1937, T ROYAL SOC TROPICAL, VXXXI; YOELI M, 1973, EXP PARASITOL, V34, P448, DOI 10.1016/0014-4894(73)90104-5	56	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63387	10.1371/journal.pone.0063387	http://dx.doi.org/10.1371/journal.pone.0063387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658824	Green Submitted, Green Published, gold			2022-12-25	WOS:000321202100065
J	Cheng, JCH; Yuan, A; Chen, JH; Lu, YC; Cho, KH; Wu, JK; Wu, CJ; Chang, YC; Yang, PC				Cheng, Jason Chia-Hsien; Yuan, Ang; Chen, Jyh-Horng; Lu, Yi-Chien; Cho, Kuan-Hung; Wu, Jian-Kuen; Wu, Chien-Jang; Chang, Yeun-Chung; Yang, Pan-Chyr			Early Detection of Lewis Lung Carcinoma Tumor Control by Irradiation Using Diffusion-Weighted and Dynamic Contrast-Enhanced MRI	PLOS ONE			English	Article							RADIATION-THERAPY; CANCER; RADIOTHERAPY; CHEMOTHERAPY; BIOMARKER	Purpose: To investigate the correlation between diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) derived parameters and radioresponsiveness of Lewis lung carcinoma (LLC) tumor. Materials and Methods: LLC tumor growth in C57BL/6 mouse limb was used for the experiment. The tumors were irradiated with 10 Gy x 5, or 30 Gy x 2 vs. sham irradiation. Fourteen tumors were subjected to DW-MRI and DCE-MRI pre-radiotherapy and weekly imaging after radiotherapy. The temporal changes in apparent diffusion coefficient (ADC) and DCE-MRI derived parameters (K-trans, k(ep), v(e), and v(p)) were correlated with tumor size, and were histologically compared with CD31 staining of resected tumors. Results: The 10 Gy x 5 dose inhibited tumor growth for a week, while 30 Gy x 2 controlled tumor growth for a 3-week observation period. One week after radiotherapy (week 2), irradiated tumors showed significantly higher values of ADC than untreated ones (10 Gy x 5, p = 0.004; 30 Gy x 2, p = 0.01). Significantly higher values of v(e) were shown earlier by 30 Gy x 2 vs. sham (p = 0.01) and 10 Gy x 5 vs. sham irradiation (p = 0.05). Sustained higher v(e) from 10 Gy x 5 compared to sham irradiated tumors was evident at week 3 (p = 0.016) and week 4 (p = 0.046). A 13.8% early increase in ADC for 30 Gy x 2 tumor group (p = 0.002) and a 16.5% increase for 10 Gy x 5 group were noted (p = 0.01) vs. sham irradiation (which showed a 2.2% decrease). No differences were found for K-trans, k(ep), or v(p). Both radiotherapy groups demonstrated significant reduction in microvessel counts. Conclusion: Early increase in ADC and ve correlated with tumor control by irradiation.	[Cheng, Jason Chia-Hsien] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10764, Taiwan; [Cheng, Jason Chia-Hsien] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Lu, Yi-Chien; Chang, Yeun-Chung] Natl Taiwan Univ, Coll Med, Dept Radiol, Taipei 10764, Taiwan; [Cheng, Jason Chia-Hsien; Chen, Jyh-Horng] Natl Taiwan Univ, Coll Elect Engn & Comp Sci, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Cheng, Jason Chia-Hsien] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Chang, Yeun-Chung] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Yuan, Ang; Yang, Pan-Chyr] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Cho, Kuan-Hung] Natl Yang Ming Univ, Instrumentat Resource Ctr, Taipei 112, Taiwan; [Wu, Jian-Kuen; Wu, Chien-Jang] Natl Taiwan Normal Univ, Inst Electroopt Sci & Technol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; National Taiwan Normal University	Chang, YC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Radiol, Taipei 10764, Taiwan.	ycc5566@ntu.edu.tw		CHANG, YEUN-CHUNG/0000-0001-9984-5713; CHENG, JASON CHIA-HSIEN/0000-0002-2007-0220; YUAN, ANG/0000-0002-5664-1339; YANG, PAN-CHYR/0000-0001-6330-6048	Department of Health, Taiwan, ROC [DOH102-TD-PB-111-TM009]; National Taiwan University Hospital [NTUH101-S1879, NTUH99-S1274]; National Science Council, Execute Yuan, Taiwan, ROC [NSC98-2627-B-002-016, NSC99-2627-B-002-007, NSC100-2627-B-002-005, NSC95-2627-B-002-013, NSC96-2627-B-002-007, NSC97-2627-B-002-003]	Department of Health, Taiwan, ROC; National Taiwan University Hospital(National Taiwan University); National Science Council, Execute Yuan, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by Department of Health, Taiwan, ROC (DOH102-TD-PB-111-TM009), National Taiwan University Hospital (NTUH101-S1879, NTUH99-S1274), National Science Council, Execute Yuan, Taiwan, ROC (NSC98-2627-B-002-016, NSC99-2627-B-002-007, NSC100-2627-B-002-005, NSC95-2627-B-002-013, NSC96-2627-B-002-007, NSC97-2627-B-002-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mamgani A, 2008, INT J RADIAT ONCOL, V72, P980, DOI 10.1016/j.ijrobp.2008.02.073; Bonekamp S, 2012, J MAGN RESON IMAGING, V35, P257, DOI 10.1002/jmri.22786; Camphausen K, 2001, CANCER RES, V61, P2207; Chang YC, 2012, J MAGN RESON IMAGING, V36, P387, DOI 10.1002/jmri.23660; Chikui T, 2012, J MAGN RESON IMAGING, V36, P589, DOI 10.1002/jmri.23704; Chou CH, 2012, ONCOGENE, V31, P458, DOI 10.1038/onc.2011.240; Connell PP, 2009, CANCER RES, V69, P383, DOI 10.1158/0008-5472.CAN-07-6871; Ding PR, 2012, ANN SURG, V256, P111, DOI 10.1097/SLA.0b013e31825b3a2b; Galban S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035857; KIM JH, 2012, EUR RADIOL; Lo SS, 2010, NAT REV CLIN ONCOL, V7, P44, DOI 10.1038/nrclinonc.2009.188; Loveless ME, 2012, NEOPLASIA, V14, P54, DOI 10.1593/neo.111478; Lovey J, 2003, STRAHLENTHER ONKOL, V179, P812, DOI 10.1007/s00066-003-1051-y; Michalski J, 2012, INT J RADIAT ONCOL, V83, pE363, DOI 10.1016/j.ijrobp.2011.12.070; Nougaret S, 2012, RADIOLOGY, V263, P409, DOI 10.1148/radiol.12111263; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Ovrebo KM, 2012, RADIOTHER ONCOL, V102, P429, DOI 10.1016/j.radonc.2011.11.013; Ovrebo KM, 2011, INT J RADIAT ONCOL, V81, P255, DOI 10.1016/j.ijrobp.2011.04.008; Quon H, 2012, SEMIN RADIAT ONCOL, V22, P220, DOI 10.1016/j.semradonc.2012.03.007; Sinkus R, 2012, EUR J CANCER, V48, P425, DOI 10.1016/j.ejca.2011.11.034; Stinauer MA, 2012, INT J RADIAT ONCOL, V83, pE613, DOI 10.1016/j.ijrobp.2012.02.008; Sun YS, 2011, AM J ROENTGENOL, V197, pW23, DOI 10.2214/AJR.10.4912; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thoeny HC, 2010, J MAGN RESON IMAGING, V32, P2, DOI 10.1002/jmri.22167; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Yabuuchi H, 2011, RADIOLOGY, V261, P598, DOI 10.1148/radiol.11101503	28	4	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62762	10.1371/journal.pone.0062762	http://dx.doi.org/10.1371/journal.pone.0062762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658769	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500036
J	Gao, JZ; Zhang, C; Fu, X; Yi, Q; Tian, FY; Ning, Q; Luo, XP				Gao, Jinzhi; Zhang, Cai; Fu, Xi; Yi, Qin; Tian, Fengyan; Ning, Qin; Luo, Xiaoping			Effects of Targeted Suppression of Glutaryl-CoA Dehydrogenase by Lentivirus-Mediated shRNA and Excessive Intake of Lysine on Apoptosis in Rat Striatal Neurons	PLOS ONE			English	Article							ACIDURIA TYPE-I; ACIDEMIA TYPE-I; BLOOD-BRAIN-BARRIER; 3-HYDROXYGLUTARIC ACID; MOUSE MODEL; YOUNG-RATS; ENERGY-METABOLISM; OXIDATIVE STRESS; CEREBRAL-CORTEX; DEFICIENCY	In glutaric aciduria type 1 (GA1), glutaryl-CoA dehydrogenase (GCDH) deficiency has been shown to be responsible for the accumulation of glutaric acid and striatal degeneration. However, the mechanisms by which GA1 induces striatal degeneration remain unclear. In this study, we aimed to establish a novel neuronal model of GA1 and to investigate the effects of GCDH deficiency and lysine-related metabolites on the viability of rat striatal neurons. Thus we constructed a lentiviral vector containing short hairpin RNA targeted against the GCDH gene expression (lentivirus-shRNA) in neurons. A virus containing a scrambled short hairpin RNA construct served as a control. Addition of lysine (5 mmol/L) was used to mimic hypermetabolism. Cell viability was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. Apoptosis was assessed using Hoechst33342 staining and Annexin V-PE/7-AAD staining. The mitochondrial membrane potential (MPP) was monitored using tetramethylrhodamine methyl ester. The expression levels of caspases 3, 8, and 9 were determined by Western blotting. We found that lentivirus-shRNA induced apoptosis and decreased MMP levels in neurons, and addition of 5 mmol/L lysine enhanced this effect markedly. Lentivirus-shRNA upregulated the protein levels of caspases 3 and 9 regardless of the presence of 5 mmol/L lysine. The expression level of caspase 8 was higher in neurons co-treated with lentivirus- shRNA and 5 mmol/L lysine than in control. Benzyloxy-carbonyl-Val-Ala-Asp(OMe)-fluoromethylketone, a pan-caspase inhibitor, blocked the apoptosis induced by lentivirus-shRNA and 5 mmol/L lysine to a great extent. These results indicate that the targeted suppression of GCDH by lentivirus-mediated shRNA and excessive intake of lysine may be a useful cell model of GA1. These also suggest that GA1-induced striatal degeneration is partially caspase-dependent.	[Gao, Jinzhi; Zhang, Cai; Fu, Xi; Yi, Qin; Tian, Fengyan; Luo, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pediat, Wuhan 430074, Peoples R China; [Ning, Qin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Infect Dis, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Luo, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pediat, Wuhan 430074, Peoples R China.	xpluo@tjh.tjmu.edu.cn	Zhang, Cai/AAO-8788-2021	Zhang, Cai/0000-0001-6005-0905; fu, xi/0000-0001-6928-4396	National Natural Science Foundation of China [81070699]; Twelfth Five-year National Science Supported Planning Project [2012BAI09B04]; Sector Fund from the Ministry of Health of China [201002006]; Innovation Team Development Plan of the Ministry of Education of China [IRT1131]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Twelfth Five-year National Science Supported Planning Project; Sector Fund from the Ministry of Health of China; Innovation Team Development Plan of the Ministry of Education of China	This study is supported by the National Natural Science Foundation of China (No.81070699) [X.L.], Twelfth Five-year National Science Supported Planning Project (No.2012BAI09B04) [X.L.], the Sector Fund from the Ministry of Health of China (No. 201002006) [X.L.], and Innovation Team Development Plan of the Ministry of Education of China (No. IRT1131) [Q.N.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr O, 2002, NEUROLOGY, V59, P1802, DOI 10.1212/01.WNL.0000036616.11962.3C; Bonthuis PJ, 2010, FRONT NEUROENDOCRIN, V31, P341, DOI 10.1016/j.yfrne.2010.05.001; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cao ZY, 2010, TOXICOL SCI, V114, P323, DOI 10.1093/toxsci/kfp312; Christensen E, 2004, J INHERIT METAB DIS, V27, P861, DOI 10.1023/B:BOLI.0000045770.93429.3c; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Coutant F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048644; D'Costa J, 2009, CURR OPIN MOL THER, V11, P554; Di Nunzio F, 2012, VACCINE, V30, P2499, DOI 10.1016/j.vaccine.2012.01.089; Dreyer JL, 2010, METHODS MOL BIOL, V614, P3, DOI 10.1007/978-1-60761-533-0_1; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Ferreira GC, 2007, INT J DEV NEUROSCI, V25, P391, DOI 10.1016/j.ijdevneu.2007.05.009; Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974; Frizzo MES, 2004, NEUROCHEM INT, V44, P345, DOI 10.1016/S0197-0186(03)00169-4; Funk CBR, 2005, BRAIN, V128, P711, DOI 10.1093/brain/awh401; Gerstner B, 2005, PEDIATR RES, V57, P771, DOI 10.1203/01.PDR.0000157727.21503.8D; Gokmen-Ozel H, 2012, J HUM NUTR DIET, V25, P514, DOI 10.1111/j.1365-277X.2012.01269.x; GOODMAN SI, 1975, BIOCHEM MED METAB B, V12, P12, DOI 10.1016/0006-2944(75)90091-5; Harper Scott Q., 2008, V442, P95, DOI 10.1007/978-1-59745-191-8_8; Harting I, 2009, BRAIN, V132, P1764, DOI 10.1093/brain/awp112; Hedlund GL, 2006, AM J MED GENET C, V142C, P86, DOI 10.1002/ajmg.c.30088; Hirst WD, 2003, MOL PHARMACOL, V64, P1295, DOI 10.1124/mol.64.6.1295; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Jafari P, 2011, MOL GENET METAB, V104, P425, DOI 10.1016/j.ymgme.2011.08.027; Joshi DC, 2011, JOVE-J VIS EXP, DOI 10.3791/2704; Kamate M, 2012, ANN INDIAN ACAD NEUR, V15, P31, DOI 10.4103/0972-2327.93273; Keyser B, 2008, BBA-MOL BASIS DIS, V1782, P385, DOI 10.1016/j.bbadis.2008.02.008; Keyser B, 2008, HUM MOL GENET, V17, P3854, DOI 10.1093/hmg/ddn284; Kolker S, 2006, BRAIN, V129, pE54, DOI 10.1093/brain/awl137; Kolker S, 2006, PEDIATR RES, V59, P840, DOI 10.1203/01.pdr.0000219387.79887.86; Kolker S, 2012, MOL GENET METAB, V107, P72, DOI 10.1016/j.ymgme.2012.03.021; Kolker S, 2011, J INHERIT METAB DIS, V34, P677, DOI 10.1007/s10545-011-9289-5; Koeller DM, 2004, J INHERIT METAB DIS, V27, P813, DOI 10.1023/B:BOLI.0000045763.52907.5e; Koeller DM, 2002, HUM MOL GENET, V11, P347, DOI 10.1093/hmg/11.4.347; Lamp J, 2011, J BIOL CHEM, V286, P17777, DOI 10.1074/jbc.M111.232744; Latini A, 2005, NEUROSCIENCE, V135, P111, DOI 10.1016/j.neuroscience.2005.05.013; Latini A, 2005, J INHERIT METAB DIS, V28, P57, DOI 10.1007/s10545-005-3677-7; Leipnitz G, 2005, INT J DEV NEUROSCI, V23, P695, DOI 10.1016/j.ijdevneu.2005.08.004; Lin X, 2006, CARCINOGENESIS, V27, P1538, DOI 10.1093/carcin/bgl002; Manilla P, 2005, HUM GENE THER, V16, P17, DOI 10.1089/hum.2005.16.17; Martin E, 2011, HUM MOL GENET, V20, P2422, DOI 10.1093/hmg/ddr148; Molles BE, 2006, J MOL NEUROSCI, V30, P105, DOI 10.1385/JMN:30:1:105; Moran M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009; Muhlhausen C, 2003, J INHERIT METAB DIS, V26, P713, DOI 10.1023/B:BOLI.0000005604.90621.e2; Olivera-Bravo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020831; Perez-Pinzon MA, 2012, J CEREBR BLOOD F MET, V32, P1362, DOI 10.1038/jcbfm.2012.32; Quincozes-Santos A, 2010, METAB BRAIN DIS, V25, P191, DOI 10.1007/s11011-010-9203-0; Rohn TT, 2010, APOPTOSIS, V15, P1403, DOI 10.1007/s10495-010-0463-2; Ruiz M, 2012, NEUROBIOL DIS, V48, P202, DOI 10.1016/j.nbd.2011.08.023; Sauer SW, 2010, BBA-MOL BASIS DIS, V1802, P552, DOI 10.1016/j.bbadis.2010.03.003; Sauer SW, 2006, J NEUROCHEM, V97, P899, DOI 10.1111/j.1471-4159.2006.03813.x; Sauer SW, 2005, J BIOL CHEM, V280, P21830, DOI 10.1074/jbc.M502845200; Schambach A, 2008, CURR GENE THER, V8, P474, DOI 10.2174/156652308786848049; Seredenina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022231; Sliva K, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-248; Tian FY, 2012, J HUAZHONG U SCI-MED, V32, P107, DOI 10.1007/s11596-012-0019-5; van der Watt G, 2010, MOL GENET METAB, V101, P178, DOI 10.1016/j.ymgme.2010.07.018; Wajner M, 2004, J INHERIT METAB DIS, V27, P825, DOI 10.1023/B:BOLI.0000045765.37043.fb; Wajner M, 2011, J BIOENERG BIOMEMBR, V43, P31, DOI 10.1007/s10863-011-9324-0; Yang LL, 2011, MED SCI MONITOR, V17, pPH55, DOI 10.12659/MSM.881834; Zafeiriou DI, 2000, NEUROPEDIATRICS, V31, P303, DOI 10.1055/s-2000-12943; Zinnanti WJ, 2007, J CLIN INVEST, V117, P3258, DOI 10.1172/JCI31617; Zinnanti WJ, 2006, BRAIN, V129, P899, DOI 10.1093/brain/awl009	63	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63084	10.1371/journal.pone.0063084	http://dx.doi.org/10.1371/journal.pone.0063084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658800	Green Published, Green Submitted, gold			2022-12-25	WOS:000321200500055
J	Iwata, M; Ochi, H; Asou, Y; Haro, H; Aikawa, T; Harada, Y; Nezu, Y; Yogo, T; Tagawa, M; Hara, Y				Iwata, Munetaka; Ochi, Hiroki; Asou, Yoshinori; Haro, Hirotaka; Aikawa, Takeshi; Harada, Yasuji; Nezu, Yoshinori; Yogo, Takuya; Tagawa, Masahiro; Hara, Yasushi			Variations in Gene and Protein Expression in Canine Chondrodystrophic Nucleus Pulposus Cells following Long-Term Three-Dimensional Culture	PLOS ONE			English	Article							INTERVERTEBRAL DISC CELLS; EXTRACELLULAR-MATRIX; ANULUS FIBROSUS; LUMBAR SPINE; CLASSIFICATION; DEGENERATION; BIOCHEMISTRY; METABOLISM; PHENOTYPE; PRODUCE	Intervertebral disc (IVD) degeneration greatly affects quality of life. The nucleus pulposus (NP) of chondrodystrophic dog breeds (CDBs) is similar to the human NP, because the cells disappear with age and are replaced by fibrochondrocyte-like cells. However, because IVD develops as early as within the first year of life, we used canines as a model to investigate in vitro the mechanisms underlying IVD degeneration. Specifically, we evaluated the potential of a three-dimensional (3D) culture of healthy NP as an in vitro model system to investigate the mechanisms of IVD degeneration. Agarose hydrogels were populated with healthy NP cells from beagles after performing magnetic resonance imaging, and mRNA expression profiles and pericellular extracellular matrix (ECM) protein distribution were determined. After 25 days of 3D culture, there was a tendency for redifferentiation into the native NP phenotype, and mRNA levels of Col2A1, COMP, and CK18 were not significantly different from those of freshly isolated cells. Our findings suggest that long-term 3D culture promoted chondrodystrophic NP redifferentiation through reconstruction of the pericellular microenvironment. Further, lipopolysaccharide (LPS) induced expression of TNF-alpha, MMP3, MMP13, VEGF, and PGES mRNA in the 3D cultures, creating a molecular milieu that mimics that of degenerated NP. These results suggest that this in vitro model represents a reliable and cost-effective tool for evaluating new therapies for disc degeneration.	[Iwata, Munetaka; Harada, Yasuji; Nezu, Yoshinori; Yogo, Takuya; Tagawa, Masahiro; Hara, Yasushi] Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Vet Sci, Div Vet Surg, Musashino, Tokyo, Japan; [Ochi, Hiroki] Nippon Vet & Life Sci Univ, Fac Vet Sci, Sch Vet Med, Lab Vet Microbiol, Musashino, Tokyo, Japan; [Asou, Yoshinori] Tokyo Med & Dent Univ, Dev Div Adv Orthoped Therapeut, Bunkyo Ku, Tokyo, Japan; [Haro, Hirotaka] Univ Yamanashi, Grad Sch Med & Engn, Dept Orthoped Surg, Chuo, Yamanashi, Japan; [Aikawa, Takeshi] Aikawa Vet Med Ctr, Tokyo, Japan; [Aikawa, Takeshi] Vet Surg Serv Japan, Shinjuku Ku, Tokyo, Japan	Nippon Veterinary & Life Science University; Nippon Veterinary & Life Science University; Tokyo Medical & Dental University (TMDU); University of Yamanashi	Ochi, H (corresponding author), Nippon Vet & Life Sci Univ, Fac Vet Sci, Sch Vet Med, Lab Vet Microbiol, 1-7-1 Kyonancho, Musashino, Tokyo, Japan.	ochi-vet@nvlu.ac.jp		Iwata, Munetaka/0000-0002-5561-4996	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar DJ, 1999, EXP CELL RES, V246, P129, DOI 10.1006/excr.1998.4287; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Aota Y, 2006, CELL TISSUE RES, V326, P787, DOI 10.1007/s00441-006-0225-1; Bjornsson S, 1998, ANAL BIOCHEM, V256, P229, DOI 10.1006/abio.1997.2494; BRAUND KG, 1975, RES VET SCI, V19, P167, DOI 10.1016/S0034-5288(18)33527-6; Cappello R, 2006, SPINE, V31, P873, DOI 10.1097/01.brs.0000209302.00820.fd; Cheng CC, 2009, J CELL PHYSIOL, V221, P668, DOI 10.1002/jcp.21904; Chou AI, 2006, SPINE, V31, P1875, DOI 10.1097/01.brs.0000229222.98051.9a; Doita M, 1996, SPINE, V21, P235, DOI 10.1097/00007632-199601150-00015; Gage E. D., 1975, Journal of the American Animal Hospital Association, V11, P167; Gruber H E, 2000, BMC Musculoskelet Disord, V1, P1, DOI 10.1186/1471-2474-1-1; HANSEN H J, 1952, Acta Orthop Scand Suppl, V11, P1; Horner HA, 2002, SPINE, V27, P1018, DOI 10.1097/00007632-200205150-00004; Hutton WC, 1999, SPINE, V24, P1507, DOI 10.1097/00007632-199908010-00002; Jimbo K, 2005, J NEUROSURG-SPINE, V2, P589, DOI 10.3171/spi.2005.2.5.0589; KANG JD, 1995, SPINE, V20, P2373, DOI 10.1097/00007632-199511001-00001; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; OEGEMA TR, 1993, CLIN SPORT MED, V12, P419; Oegema TR, 2002, BIOCHEM SOC T, V30, P839, DOI 10.1042/bst0300839; Ono T, 1951, MEDICINE BIOLOGY JAP, V19, P326; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; PRIESTER W A, 1976, Theriogenology, V6, P293, DOI 10.1016/0093-691X(76)90021-2; Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705; Sive JI, 2002, J CLIN PATHOL-MOL PA, V55, P91, DOI 10.1136/mp.55.2.91; Smits P, 2003, DEVELOPMENT, V130, P1135, DOI 10.1242/dev.00331; Specchia N, 2002, EUR SPINE J, V11, P145, DOI 10.1007/s00586-001-0361-y; Volck B, 2001, OSTEOARTHR CARTILAGE, V9, P203, DOI 10.1053/joca.2000.0377; Wang JY, 2001, SPINE, V26, P1747, DOI 10.1097/00007632-200108150-00003; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Wuertz K, 2009, J ORTHOP RES, V27, P1235, DOI 10.1002/jor.20867	30	21	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63120	10.1371/journal.pone.0063120	http://dx.doi.org/10.1371/journal.pone.0063120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658803	Green Submitted, gold, Green Published			2022-12-25	WOS:000321200500056
J	Arrubla, J; Neuner, I; Hahn, D; Boers, F; Shah, NJ				Arrubla, Jorge; Neuner, Irene; Hahn, David; Boers, Frank; Shah, N. Jon			Recording Visual Evoked Potentials and Auditory Evoked P300 at 9.4T Static Magnetic Field	PLOS ONE			English	Article							FOCAL CORTICAL DYSPLASIA; SIMULTANEOUS EEG-FMRI; BALLISTOCARDIOGRAM ARTIFACT; DYNAMICS; BRAIN; RESPONSES; NETWORKS	Simultaneous recording of electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) has shown a number of advantages that make this multimodal technique superior to fMRI alone. The feasibility of recording EEG at ultra-high static magnetic field up to 9.4T was recently demonstrated and promises to be implemented soon in fMRI studies at ultra high magnetic fields. Recording visual evoked potentials are expected to be amongst the most simple for simultaneous EEG/fMRI at ultra-high magnetic field due to the easy assessment of the visual cortex. Auditory evoked P300 measurements are of interest since it is believed that they represent the earliest stage of cognitive processing. In this study, we investigate the feasibility of recording visual evoked potentials and auditory evoked P300 in a 9.4T static magnetic field. For this purpose, EEG data were recorded from 26 healthy volunteers inside a 9.4T MR scanner using a 32-channel MR compatible EEG system. Visual stimulation and auditory oddball paradigm were presented in order to elicit evoked related potentials (ERP). Recordings made outside the scanner were performed using the same stimuli and EEG system for comparison purposes. We were able to retrieve visual P100 and auditory P300 evoked potentials at 9.4T static magnetic field after correction of the ballistocardiogram artefact using independent component analysis. The latencies of the ERPs recorded at 9.4T were not different from those recorded at 0T. The amplitudes of ERPs were higher at 9.4T when compared to recordings at 0T. Nevertheless, it seems that the increased amplitudes of the ERPs are due to the effect of the ultra-high field on the EEG recording system rather than alteration in the intrinsic processes that generate the electrophysiological responses.	[Arrubla, Jorge; Neuner, Irene; Hahn, David; Boers, Frank; Shah, N. Jon] Forschungszentrum Julich, INM 4, D-52425 Julich, Germany; [Neuner, Irene; Hahn, David] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Neuner, Irene; Shah, N. Jon] JARA BRAIN Translat Med, Aachen, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University	Arrubla, J (corresponding author), Forschungszentrum Julich, INM 4, D-52425 Julich, Germany.	j.arrubla@fz-juelich.de	Neuner, Irene/J-6619-2013; Shah, N. Jon/H-5849-2013	Shah, N. Jon/0000-0002-8151-6169; Neuner, Irene/0000-0002-5164-8873				Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Bagshaw AP, 2007, NEUROIMAGE, V38, P280, DOI 10.1016/j.neuroimage.2007.07.042; Blinowska K., 2009, COMPUT INTELL NEUROS, DOI DOI 10.1155/2009/813607; De Martino F, 2010, MAGN RESON IMAGING, V28, P1104, DOI 10.1016/j.mri.2009.12.026; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Debener S, 2008, INT J PSYCHOPHYSIOL, V67, P189, DOI 10.1016/j.ijpsycho.2007.05.015; Debener S, 2008, INT J PSYCHOPHYSIOL, V67, P159, DOI 10.1016/j.ijpsycho.2007.07.001; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; Debener S, 2011, CLIN NEUROPHYSIOL, V122, P217, DOI 10.1016/j.clinph.2010.07.008; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eichele T, 2005, P NATL ACAD SCI USA, V102, P17798, DOI 10.1073/pnas.0505508102; Heinrich A, 2013, RADIOLOGY, V266, P236, DOI 10.1148/radiol.12112172; Huiskamp GJM, 2005, P ANN INT IEEE EMBS, P3691, DOI 10.1109/IEMBS.2005.1617283; Juckel G, 2012, NEUROIMAGE, V60, P2027, DOI 10.1016/j.neuroimage.2012.02.019; Kim YH, 2011, EPILEPSIA, V52, P722, DOI 10.1111/j.1528-1167.2010.02950.x; Koike T, 2011, NEUROSCI RES, V69, P322, DOI 10.1016/j.neures.2010.12.018; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2012, NEUROIMAGE, V62, P962, DOI 10.1016/j.neuroimage.2012.01.033; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Neuner I, 2013, NEUROIMAGE, V68, P214, DOI 10.1016/j.neuroimage.2012.11.064; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Ostwald D, 2010, NEUROIMAGE, V49, P498, DOI 10.1016/j.neuroimage.2009.07.038; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Schlamann M, 2010, J MAGN RESON IMAGING, V31, P1061, DOI 10.1002/jmri.22065; Thornton R, 2011, ANN NEUROL, V70, P822, DOI 10.1002/ana.22535	30	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62915	10.1371/journal.pone.0062915	http://dx.doi.org/10.1371/journal.pone.0062915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650538	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000083
J	Chandrasekar, G; Vesterlund, L; Hultenby, K; Tapia-Paez, I; Kere, J				Chandrasekar, Gayathri; Vesterlund, Liselotte; Hultenby, Kjell; Tapia-Paez, Isabel; Kere, Juha			The Zebrafish Orthologue of the Dyslexia Candidate Gene DYX1C1 Is Essential for Cilia Growth and Function	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; IN-UTERO RNAI; DEVELOPMENTAL DYSLEXIA; NEURONAL MIGRATION; KUPFFERS VESICLE; JOUBERT-SYNDROME; DYNEIN ARMS; ASSOCIATION; BRAIN; DYSKINESIA	DYX1C1, a susceptibility gene for dyslexia, encodes a tetratricopeptide repeat domain containing protein that has been implicated in neuronal migration in rodent models. The developmental role of this gene remains unexplored. To understand the biological function(s) of zebrafish dyx1c1 during embryonic development, we cloned the zebrafish dyx1c1 and used morpholino-based knockdown strategy. Quantitative real-time PCR analysis revealed the presence of dyx1c1 transcripts in embryos, early larval stages and in a wide range of adult tissues. Using mRNA in situ hybridization, we show here that dyx1c1 is expressed in many ciliated tissues in zebrafish. Inhibition of dyx1c1 produced pleiotropic phenotypes characteristically associated with cilia defects such as body curvature, hydrocephalus, situs inversus and kidney cysts. We also demonstrate that in dyx1c1 morphants, cilia length is reduced in several organs including Kupffer's vesicle, pronephros, spinal canal and olfactory placode. Furthermore, electron microscopic analysis of cilia in dyx1c1 morphants revealed loss of both outer (ODA) and inner dynein arms (IDA) that have been shown to be required for cilia motility. Considering all these results, we propose an essential role for dyx1c1 in cilia growth and function.	[Chandrasekar, Gayathri; Vesterlund, Liselotte; Tapia-Paez, Isabel; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, Huddinge, Sweden; [Hultenby, Kjell] Karolinska Inst, Dept Lab Med, Clin Res Ctr, Stockholm, Sweden; [Kere, Juha] Univ Helsinki, Res Programs Unit, Helsinki & Mol Neurol Program, Folkhalsan Inst Genet, Helsinki, Finland; [Kere, Juha] Karolinska Inst, Sci Life Lab, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; University of Helsinki; Karolinska Institutet	Kere, J (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, Huddinge, Sweden.	juha.kere@ki.se	Tapia-Páez, Isabel/N-1210-2013; Tapia-Páez, Isabel/ABD-7197-2021; Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Vesterlund, Liselotte/0000-0003-3547-9288; Tapia-Paez, Isabel/0000-0002-0535-4233	Swedish Research Council; Swedish Royal Bank Tercentennial Foundation, Swedish Brain Foundation; Center for Biosciences and Sigrid Juselius Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Royal Bank Tercentennial Foundation, Swedish Brain Foundation; Center for Biosciences and Sigrid Juselius Foundation	This work was supported by Swedish Research Council (www.vr.se); Swedish Royal Bank Tercentennial Foundation, Swedish Brain Foundation (Hjarnfonden)(www.hjarnfonden.se); Knut and Alice Wallenberg Foundation (www.wallenberg.com); Center for Biosciences and Sigrid Juselius Foundation(www.sigridjuselius.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Ahmed NT, 2005, MOL BIOL CELL, V16, P5004, DOI 10.1091/mbc.E05-07-0627; Andrews W, 2006, DEVELOPMENT, V133, P2243, DOI 10.1242/dev.02379; Arellano JI, 2012, J COMP NEUROL, V520, P848, DOI 10.1002/cne.22793; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Balci S, 1999, AM J MED GENET, V82, P166, DOI 10.1002/(SICI)1096-8628(19990115)82:2<166::AID-AJMG13>3.0.CO;2-J; Bellini G, 2005, J MOL NEUROSCI, V27, P311, DOI 10.1385/JMN:27:3:311; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Breunig JJ, 2010, NAT NEUROSCI, V13, P654, DOI 10.1038/nn0610-654; Burbridge TJ, 2008, NEUROSCIENCE, V152, P723, DOI 10.1016/j.neuroscience.2008.01.020; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Chandrasekar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009678; Chen YX, 2009, J CANCER RES CLIN, V135, P1265, DOI 10.1007/s00432-009-0568-6; Cope NA, 2005, MOL PSYCHIATR, V10, P237, DOI 10.1038/sj.mp.4001596; Dahdouh F, 2009, PSYCHIAT GENET, V19, P59, DOI 10.1097/YPG.0b013e32832080e1; Darki F, 2012, BIOL PSYCHIAT, V72, P671, DOI 10.1016/j.biopsych.2012.05.008; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Gao CL, 2010, DEV DYNAM, V239, P2190, DOI 10.1002/dvdy.22355; Gorivodsky M, 2009, DEV BIOL, V325, P24, DOI 10.1016/j.ydbio.2008.09.019; GREENSTONE MA, 1984, ARCH DIS CHILD, V59, P481, DOI 10.1136/adc.59.5.481; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; HUMPHREYS P, 1990, ANN NEUROL, V28, P727, DOI 10.1002/ana.410280602; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; Ivliev AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035618; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Liang P, 1997, J CELL SCI, V110, P1431; Lim CKP, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-16; Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Marino C, 2007, GENES BRAIN BEHAV, V6, P640, DOI 10.1111/j.1601-183X.2006.00291.x; Marino C, 2005, EUR J HUM GENET, V13, P491, DOI 10.1038/sj.ejhg.5201356; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Massinen S, 2009, HUM MOL GENET, V18, P2802, DOI 10.1093/hmg/ddp215; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Meng HY, 2005, HUM GENET, V118, P87, DOI 10.1007/s00439-005-0017-9; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Obara T, 2006, J AM SOC NEPHROL, V17, P2706, DOI 10.1681/ASN.2006040412; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rosen GD, 2007, CEREB CORTEX, V17, P2562, DOI 10.1093/cercor/bhl162; Scerri TS, 2004, J MED GENET, V41, P853, DOI 10.1136/jmg.2004.018341; SCHIDLOW DV, 1994, ANN ALLERGY, V73, P457; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Szalkowski CE, 2011, GENES BRAIN BEHAV, V10, P244, DOI 10.1111/j.1601-183X.2010.00662.x; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; Tammimies K, 2013, BIOL PSYCHIAT, V73, P583, DOI 10.1016/j.biopsych.2012.08.012; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Threlkeld SW, 2007, BRAIN RES BULL, V71, P508, DOI 10.1016/j.brainresbull.2006.11.005; TORIKATA C, 1991, AM J PATHOL, V138, P341; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Venkatesh SK, 2011, BEHAV GENET, V41, P105, DOI 10.1007/s10519-010-9441-2; Wang Y, 2006, NEUROSCIENCE, V143, P515, DOI 10.1016/j.neuroscience.2006.08.022; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zhao CT, 2007, MECH DEVELOP, V124, P605, DOI 10.1016/j.mod.2007.04.004	77	40	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63123	10.1371/journal.pone.0063123	http://dx.doi.org/10.1371/journal.pone.0063123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650548	Green Submitted, Green Published, gold			2022-12-25	WOS:000319167000093
J	Chen, SA; Chen, JZ; Chen, LJ; Zhang, QA; Luo, XQ; Zhang, WH				Chen, Sheng'an; Chen, Jiazhen; Chen, Lianjun; Zhang, Qiao'an; Luo, Xiaoqun; Zhang, Wenhong			Mycobacterium tuberculosis Infection Is Associated with the Development of Erythema Nodosum and Nodular Vasculitis	PLOS ONE			English	Article							GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; SKIN-TEST; DIAGNOSIS; INDURATUM; PCR; DNA; PULMONARY; LEPROSUM; CHINA	Background: Mycobacterium tuberculosis (MTB) infection has been suggested to contribute to the pathogenesis of erythema nodosum (EN) and nodular vasculitis (NV), the classic forms of panniculitis. However, there is little evidence to demonstrate the presence of MTB in the skin lesions. This study is aimed at evaluating the association between MTB infection and the development of EN and NV in a Chinese population. Methods: A total of 107 patients (36 EN, 27 NV, and 44 others) with vasculitis and 40 control cases with other skin diseases were recruited and their skin lesion samples were subjected to real time polymerase chain reaction (PCR) analysis of the IS6110 and mpt64 gene fragments of MTB. Their blood mononuclear cells were tested for MTB antigen-specific IFN-gamma responses by QuantiFERON (R)-TB Gold In-Tube (IT) assays. Results: PCR analysis revealed that 7/23 (30.4%) and 7/18 (38.9%) of the EN and NV samples were positive for the IS6110 DNA, respectively, which were significantly higher than 3/34 (8.8%) of other vasculitis (OV) and 3/40 (7.5%) of the control samples (p<0.05). The nested Real-Time PCR assay indicated that 6/7 (86%) of the IS6110-positive EN samples, all of the IS6110-positive NV and control samples, but only 1/3 of the IS6110-positive OV samples, were positive for the mpt64 gene. Similarly, 19/32 (59.4%) of the EN patients, 20/26 (76.9%) of the NV patients, and 17/36 (47.2%) of the OV patients were positive for MTB antigen-specific IFN-gamma responses, which were significantly higher than 6/40 (15%) of the controls (p<0.05). Conclusion: Our data strongly suggest that MTB infection and active TB are associated with the development of NV and EN in Chinese.	[Chen, Sheng'an; Chen, Lianjun; Zhang, Qiao'an; Luo, Xiaoqun] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Chen, Jiazhen; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Luo, XQ (corresponding author), Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China.	xiaoqunluo09@gmail.com; zhangwenhong@fudan.edu.cn						Adhe Vijay, 2012, Indian J Dermatol, V57, P114, DOI 10.4103/0019-5154.94278; Angus J, 2007, BRIT J DERMATOL, V157, P1293, DOI 10.1111/j.1365-2133.2007.08227.x; Baselga E, 1997, ARCH DERMATOL, V133, P457, DOI 10.1001/archderm.133.4.457; Broccolo F, 2003, J CLIN MICROBIOL, V41, P4565, DOI 10.1128/JCM.41.10.4565-4572.2003; Burl S, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012287, 10.1371/journal.pone.0018185]; Chan CM, 1996, J CLIN PATHOL, V49, P290, DOI 10.1136/jcp.49.4.290; Cho KH, 1996, INT J DERMATOL, V35, P802, DOI 10.1111/j.1365-4362.1996.tb02979.x; Cuevas J, 2007, SEMIN CUTAN MED SURG, V26, P126, DOI 10.1016/j.sder.2007.02.010; El Khechine A, 2009, MICROBIOL-SGM, V155, P2384, DOI 10.1099/mic.0.026484-0; Feng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032652; Garcia-Porrua C, 2000, ARTHRITIS RHEUM, V43, P584, DOI 10.1002/1529-0131(200003)43:3<584::AID-ANR15>3.0.CO;2-6; Gilchrist H, 2010, DERMATOL THER, V23, P320, DOI 10.1111/j.1529-8019.2010.01332.x; Gupta SN, 2002, INT J DERMATOL, V41, P173, DOI 10.1046/j.1365-4362.2002.01390.x; Kalantri Y, 2009, INDIAN J EXP BIOL, V47, P463; KARAT ABA, 1968, BMJ-BRIT MED J, V4, P223, DOI 10.1136/bmj.4.5625.223; Lalvani A, 2010, ENFERM INFEC MICR CL, V28, P245, DOI 10.1016/j.eimc.2009.05.012; Mahan CS, 2011, INT J TUBERC LUNG D, V15, P174; Marker M, 2004, J DTSCH DERMATOL GES, V2, P215; Marker Michael, 2004, J Dtsch Dermatol Ges, V2, P206, DOI 10.1046/j.1439-0353.2004.03627.x; Mert A, 2004, SCAND J INFECT DIS, V36, P424, DOI 10.1080/00365540410027184; Mert A, 2004, J DERMATOL, V31, P66, DOI 10.1111/j.1346-8138.2004.tb00509.x; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Papagrigoraki A, 2010, EUR J DERMATOL, V20, P773, DOI 10.1684/ejd.2010.1116; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Requena L, 2007, SEMIN CUTAN MED SURG, V26, P114, DOI 10.1016/j.sder.2007.02.009; Sarveswari K N, 2001, Indian J Dermatol Venereol Leprol, V67, P287; Segura S, 2008, J AM ACAD DERMATOL, V59, P839, DOI 10.1016/j.jaad.2008.07.030; Sun L, 2010, CHINESE MED J-PEKING, V123, P2786, DOI 10.3760/cma.j.issn.0366-6999.2010.20.007; Takahashi T, 2008, J CLIN MICROBIOL, V46, P1708, DOI 10.1128/JCM.01200-07; Tan SH, 1999, INT J DERMATOL, V38, P122, DOI 10.1046/j.1365-4362.1999.00576.x; Tantisirin Ora, 2003, Journal of the Medical Association of Thailand, V86, P1095; Wan XF DL, 2006, CHIN J DERM VENEREOL, V20, P353; Wang T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-885; Yang YR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1110; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10; Zhao YL, 2012, EXP THER MED, V4, P949, DOI 10.3892/etm.2012.699	38	14	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62653	10.1371/journal.pone.0062653	http://dx.doi.org/10.1371/journal.pone.0062653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650522	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000066
J	Lee, YK; Hou, SW; Lee, CC; Hsu, CY; Huang, YS; Su, YC				Lee, Yi-Kung; Hou, Sheng-Wen; Lee, Ching-Chih; Hsu, Chen-Yang; Huang, Yung-Sung; Su, Yung-Cheng			Increased Risk of Dementia in Patients with Mild Traumatic Brain Injury: A Nationwide Cohort Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; PREVALENCE; ACCURACY	Background: It is known that the risk of dementia in patients with moderate to severe traumatic brain injury (TBI) is higher. However, the relationship between mild traumatic brain injury (mTBI) and dementia has never been established. Objectives: We investigated the incidences of dementia among patients with mTBI in Taiwan to evaluate if there is higher risk compared with general population. Methods: We utilized a sampled National Health Insurance (NHI) claims data containing one million beneficiaries. We followed all adult beneficiaries from January 1, 2005 till December 31, 2009 to see if they had been diagnosed with dementia. We further identify patients with mTBI and compared their risk of dementia with the general population. Results: We identified 28551 patients with mTBI and 692382 without. After controlled for age, gender, urbanization level, socioeconomic status, diabetes, hypertension, coronary artery disease, hyperlipidemia, history of alcohol intoxication, history of ischemic stroke, history of intracranial hemorrhage and Charlson Comorbidity Index Score, the adjusted hazard ratio is 3.26 (95% Confidence interval, 2.69-3.94). Conclusions: TBI is an independent significant risk factor of developing dementia even in the mild type.	[Lee, Yi-Kung; Su, Yung-Cheng] Buddhist Tzu Chi Dalin Gen Hosp, Emergency Dept, Chiayi, Taiwan; [Lee, Yi-Kung; Lee, Ching-Chih; Su, Yung-Cheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hou, Sheng-Wen] Shin Kong Wu Ho Mem Hosp, Emergency Dept, Taipei, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan; [Hsu, Chen-Yang] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan; [Huang, Yung-Sung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Neurol, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Tzu Chi University; Shin Kong Wu Ho Su Memorial Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Taiwan University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Su, YC (corresponding author), Buddhist Tzu Chi Dalin Gen Hosp, Emergency Dept, Chiayi, Taiwan.	drsu119@gmail.com						[Anonymous], 1994, AM PSYCHIAT ASS DIAG, V4th; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Corrada MM, 2008, NEUROLOGY, V71, P337, DOI 10.1212/01.wnl.0000310773.65918.cd; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fuh J-L., 2008, TAIWAN GERIATR GERON, V3, P169; Hebert LE, 2004, NEUROLOGY, V62, P2021, DOI 10.1212/01.WNL.0000129258.93137.4B; Howards PP, 2012, AM J EPIDEMIOL, V176, P506, DOI 10.1093/aje/kws127; Jawaid A, 2009, NEURODEGENER DIS, V6, P219, DOI 10.1159/000258704; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kovacic JC, 2012, MT SINAI J MED, V79, P664, DOI 10.1002/msj.21347; Lee CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035923; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Pouryamout L, 2012, DRUGS, V72, P789, DOI 10.2165/11631830-000000000-00000; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Sattler C, 2012, PSYCHIAT RES, V196, P90, DOI 10.1016/j.psychres.2011.11.012; Schmidt R, 2008, NEUROPSYCHIATRIE, V22, P1; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Shively S, 2012, ARCH NEUROL-CHICAGO, P1; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Tan ZS, 2003, ARCH INTERN MED, V163, P1053, DOI 10.1001/archinte.163.9.1053; Tang BL, 2009, CELL ADHES MIGR, V3, P118, DOI 10.4161/cam.3.1.7254; Xu WL, 2004, NEUROLOGY, V63, P1181, DOI 10.1212/01.WNL.0000140291.86406.D1	25	139	143	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62422	10.1371/journal.pone.0062422	http://dx.doi.org/10.1371/journal.pone.0062422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658727	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000044
J	Abe, H; Ueno, S; Takahashi, T; Tsumura, Y; Hasegawa, M				Abe, Harue; Ueno, Saneyoshi; Takahashi, Toshimori; Tsumura, Yoshihiko; Hasegawa, Masami			Resilient Plant-Bird Interactions in a Volcanic Island Ecosystem: Pollination of Japanese Camellia Mediated by the Japanese White-Eye	PLOS ONE			English	Article							PERAXILLA-TETRAPETALA LORANTHACEAE; POLLEN DISPERSAL; PRIMARY SUCCESSION; SEED DISPERSAL; GENETIC-STRUCTURE; RAIN-FOREST; JAPONICA L; POPULATIONS; FRAGMENTATION; COLONIZATION	Observations of interspecies interactions during volcanic activity provide important opportunities to study how organisms respond to environmental devastation. Japanese camellia (Camellia japonica L.) and its main avian pollinator, the Japanese White-eye (Zosterops japonica), offer an excellent example of such an interaction as key members of the biotic community on Miyake-jima, which erupted in 2000 and continues to emit volcanic gases. Both species exhibit higher resistance to volcanic damage than other species. We examined the effects of volcanic activity on this plant-pollinator system by estimating pollen flow and the genetic diversity of the next generation. The results showed that despite a decrease in Camellia flowers, the partitioning of allelic richness among mother-tree pollen pools and seeds decreased while the migration rate of pollen from outside the study plot and the pollen donor diversity within a fruit increased as the index of volcanic damage increased. In areas with low food (flower) density due to volcanic damage, Z. japonica ranged over larger areas to satisfy its energy needs rather than moving to areas with higher food density. Consequently, the genetic diversity of the seeds (the next plant generation) increased with the index of volcanic damage. The results were consistent with previously published data on the movement of Z. japonica based on radio tracking and the genetic diversity of Camellia pollen adhering to pollinators. Overall, our results indicated that compensation mechanisms ensured better pollination after volcanic disturbance.	[Abe, Harue] Niigata Univ, Fac Agr, Field Ctr Sustainable Agr & Forestry, Niigata, Japan; [Ueno, Saneyoshi; Tsumura, Yoshihiko] Forestry & Forest Prod Res Inst, Dept Forest Genet, Tree Genet Lab, Tsukuba, Ibaraki 305, Japan; [Takahashi, Toshimori] Utsunomiya Univ, Fac Agr, Satoyama Sci Res Ctr, Utsunomiya, Tochigi 321, Japan; [Hasegawa, Masami] Toho Univ, Lab Geog Ecol, Funabashi, Chiba 274, Japan	Niigata University; Forestry & Forest Products Research Institute - Japan; Utsunomiya University; Toho University	Abe, H (corresponding author), Niigata Univ, Fac Agr, Field Ctr Sustainable Agr & Forestry, 94-2 Koda, Niigata, Japan.	apodemusnyagis@gmail.com			Japanese Society for the Promotion of Science (JSPS)	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a fellowship from the Japanese Society for the Promotion of Science (JSPS) to HA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2012, INT BIOG SOC FRON S1, V4, P178; ABE H, 2007, THESIS TOHO U; Abe H, 2008, ECOL RES, V23, P141, DOI 10.1007/s11284-007-0345-4; Abe H, 2006, ECOL RES, V21, P732, DOI 10.1007/s11284-006-0179-5; Abe H, 2011, SINGLE-POLLEN GENOTYPING, P47, DOI 10.1007/978-4-431-53901-8_5; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; BRONSTEIN JL, 1995, BIOTROPICA, V27, P373, DOI 10.2307/2388922; Burgess VJ, 2006, NEW ZEAL J ECOL, V30, P179; Caballero A, 2010, CONSERV GENET, V11, P409, DOI 10.1007/s10592-009-0020-0; Chimera CG, 2010, BIOTROPICA, V42, P493, DOI 10.1111/j.1744-7429.2009.00610.x; COX PA, 1983, OIKOS, V41, P195, DOI 10.2307/3544263; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Dick CW, 2003, MOL ECOL, V12, P753, DOI 10.1046/j.1365-294X.2003.01760.x; Forestry and Forest Products Research Institute, 2006, 2003 2005 ANN REP RE; Fukue Y, 2007, J PLANT RES, V120, P413, DOI 10.1007/s10265-007-0078-z; Goudet J., 2000, FSTAT PROGRAM ESTIMA; Herrera Carlos M., 2002, P185; Jha S, 2010, P NATL ACAD SCI USA, V107, P13760, DOI 10.1073/pnas.1002490107; Kamijo T, 2002, FOLIA GEOBOT, V37, P71, DOI 10.1007/BF02803192; Kamijo T., 2003, GLOBAL ENV RES, V7, P69; Kamijo T, 2008, J DISASTER RES, V3, P226, DOI 10.20965/jdr.2008.p0226; KATO K, 2006, SINRINNKAGAKU, V46, P16; Katsuta M, 1999, CAMELLIA LINN CAMELL, P277; Kelly D, 2006, ECOL STUD-ANAL SYNTH, V186, P227; Kelly D, 2000, CONSERV BIOL SER, V4, P241; KIKKAWA J, 1981, Journal of the Yamashina Institute for Ornithology, V13, P60; KITAYAMA K, 1995, J VEG SCI, V6, P211, DOI 10.2307/3236216; Kunitake YK, 2004, PLANT SPEC BIOL, V19, P197, DOI 10.1111/j.1442-1984.2004.00115.x; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Levin D. A., 1974, EVOL BIOL, V7, P139, DOI DOI 10.1007/978-1-4615-6944-2_5; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MARUYAMA T, 1985, GENETICS, V111, P675; MEAGHER TR, 1986, AM NAT, V128, P199, DOI 10.1086/284554; Mimura M, 2009, MOL ECOL, V18, P4180, DOI 10.1111/j.1365-294X.2009.04350.x; Murphy DJ, 2003, NEW ZEAL J ECOL, V27, P11; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagamasu H, 2006, FLORA JAPAN A, VII, P394; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Perez-Figueroa A, 2009, CONSERV GENET, V10, P1097, DOI 10.1007/s10592-008-9718-7; RAMSEY MW, 1988, OECOLOGIA, V76, P119, DOI 10.1007/BF00379609; Rathcke BJ, 2000, ECOLOGY, V81, P1951; Schulke B, 2001, OECOLOGIA, V127, P239, DOI 10.1007/s004420000586; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Shanahan M., 2001, Journal of Biogeography, V28, P1365, DOI 10.1046/j.1365-2699.2001.00638.x; SHIBATA M, 1991, KURUME BRANCH ANN RE, V4, P182; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Stacy EA, 1996, AM NAT, V148, P275, DOI 10.1086/285925; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Suyama Y, 1996, GENES GENET SYST, V71, P145, DOI 10.1266/ggs.71.145; Takahashi T, 2008, J JPN I LANDSC ARCHI, V46, P7; Taniguchi F, 2012, BREEDING SCI, V62, P186, DOI 10.1270/jsbbs.62.186; Thornton IWB, 1996, J BIOGEOGR, V23, P577, DOI 10.1111/j.1365-2699.1996.tb00019.x; TSUYUZAKI S, 1995, J VEG SCI, V6, P517, DOI 10.2307/3236350; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Ueno S, 1999, MOL ECOL, V8, P335, DOI 10.1046/j.1365-294X.1999.00534.x; Ueno S, 2000, MOL ECOL, V9, P647, DOI 10.1046/j.1365-294x.2000.00891.x; Vandergast AG, 2004, MOL ECOL, V13, P1729, DOI 10.1111/j.1365-294X.2004.02179.x; Ward M, 2005, HEREDITY, V19, P1; WENDEL JF, 1985, AM J BOT, V72, P52, DOI 10.2307/2443568; YUMOTO T, 1988, Ecological Research, V3, P117, DOI 10.1007/BF02346934	61	5	6	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62696	10.1371/journal.pone.0062696	http://dx.doi.org/10.1371/journal.pone.0062696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646136	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300088
J	Jiang, XL; Liu, YJ; Li, WW; Zhao, L; Meng, F; Wang, YS; Tan, HR; Yang, H; Wei, CL; Wan, XC; Gao, LP; Xia, T				Jiang, Xiaolan; Liu, Yajun; Li, Weiwei; Zhao, Lei; Meng, Fei; Wang, Yunsheng; Tan, Huarong; Yang, Hua; Wei, Chaoling; Wan, Xiaochun; Gao, Liping; Xia, Tao			Tissue-Specific, Development-Dependent Phenolic Compounds Accumulation Profile and Gene Expression Pattern in Tea Plant [Camellia sinensis]	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTOR; GREEN TEA; PROANTHOCYANIDIN BIOSYNTHESIS; ANTHOCYANIDIN-REDUCTASE; FLAVONOID BIOSYNTHESIS; MEDICAGO-TRUNCATULA; ECTOPIC EXPRESSION; SEED COAT; ARABIDOPSIS; CATECHINS	Phenolic compounds in tea plant [Camellia sinensis (L.)] play a crucial role in dominating tea flavor and possess a number of key pharmacological benefits on human health. The present research aimed to study the profile of tissue-specific, development-dependent accumulation pattern of phenolic compounds in tea plant. A total of 50 phenolic compounds were identified qualitatively using liquid chromatography in tandem mass spectrometry technology. Of which 29 phenolic compounds were quantified based on their fragmentation behaviors. Most of the phenolic compounds were higher in the younger leaves than that in the stem and root, whereas the total amount of proanthocyanidins were unexpectedly higher in the root. The expression patterns of 63 structural and regulator genes involved in the shikimic acid, phenylpropanoid, and flavonoid pathways were analyzed by quantitative real-time polymerase chain reaction and cluster analysis. Based on the similarity of their expression patterns, the genes were classified into two main groups: C1 and C2; and the genes in group C1 had high relative expression level in the root or low in the bud and leaves. The expression patterns of genes in C2-2-1 and C2-2-2-1 groups were probably responsible for the development-dependent accumulation of phenolic compounds in the leaves. Enzymatic analysis suggested that the accumulation of catechins was influenced simultaneously by catabolism and anabolism. Further research is recommended to know the expression patterns of various genes and the reason for the variation in contents of different compounds in different growth stages and also in different organs.	[Jiang, Xiaolan; Zhao, Lei; Meng, Fei; Yang, Hua; Wei, Chaoling; Wan, Xiaochun; Xia, Tao] Anhui Agr Univ, Minist Educ China, Key Lab Tea Biochem & Biotechnol, Hefei, Anhui, Peoples R China; [Liu, Yajun; Li, Weiwei; Wang, Yunsheng; Gao, Liping] Anhui Agr Univ, Sch Life Sci, Hefei, Anhui, Peoples R China; [Tan, Huarong] Anhui Agr Univ, Ctr Biotechnol, Hefei, Anhui, Peoples R China	Anhui Agricultural University; Ministry of Education, China; Anhui Agricultural University; Anhui Agricultural University	Gao, LP (corresponding author), Anhui Agr Univ, Sch Life Sci, Hefei, Anhui, Peoples R China.	gaolp62@126.com; xiatao62@126.com			Natural Science Foundation of China [30972401, 31170647, 31170282, 31270730]; Natural Science Foundation of Anhui Province [11040606M73]; Collegiate Natural Science Foundation of Anhui Province [KJ2012A110]; Doctoral Program Foundation of Institutions of Higher Education of China [20093418110004]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1101]; Major Project of Chinese National Programmes for Fundamental Research and Development [2012CB722903]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Collegiate Natural Science Foundation of Anhui Province; Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Major Project of Chinese National Programmes for Fundamental Research and Development	This work was supported by the Natural Science Foundation of China (30972401, 31170647, 31170282 and 31270730), the Natural Science Foundation of Anhui Province (11040606M73), Collegiate Natural Science Foundation of Anhui Province (KJ2012A110), the Doctoral Program Foundation of Institutions of Higher Education of China (20093418110004), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1101) and the Major Project of Chinese National Programmes for Fundamental Research and Development (2012CB722903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2009, PLANT PHYSIOL, V151, P2028, DOI 10.1104/pp.109.146985; Ashihara H, 2010, PHYTOCHEMISTRY, V71, P559, DOI 10.1016/j.phytochem.2010.01.010; Ashihara H, 2010, PHYTOCHEMISTRY, V71, P47, DOI 10.1016/j.phytochem.2009.09.033; Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; Carretero-Paulet L, 2010, PLANT PHYSIOL, V153, P1398, DOI 10.1104/pp.110.153593; Chen HD, 2011, J CHROMATOGR A, V1218, P7297, DOI 10.1016/j.chroma.2011.08.056; Crespy V, 2004, J NUTR, V134, p3431S, DOI 10.1093/jn/134.12.3431S; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; Debeaujon I, 2001, PLANT CELL, V13, P853, DOI 10.1105/tpc.13.4.853; Del Rio D, 2004, J AGR FOOD CHEM, V52, P2807, DOI 10.1021/jf0354848; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Eungwanichayapant PD, 2009, PLANT PHYSIOL BIOCH, V47, P94, DOI 10.1016/j.plaphy.2008.11.002; Fernandez PL, 2000, ANALYST, V125, P421, DOI 10.1039/a909219f; FORREST GI, 1969, BIOCHEM J, V113, P741, DOI 10.1042/bj1130741; Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806; Goodman CD, 2004, PLANT CELL, V16, P1812, DOI 10.1105/tpc.022574; He Q, 2009, NAT PROD RES, V23, P93, DOI 10.1080/14786410801886682; HERTOG MGL, 1993, NUTR CANCER, V20, P21, DOI 10.1080/01635589309514267; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Kumar NS, 2009, J CHROMATOGR A, V1216, P4295, DOI 10.1016/j.chroma.2008.12.025; Kumar NS, 2005, J CHROMATOGR A, V1083, P223, DOI 10.1016/j.chroma.2005.06.013; Lakenbrink C, 1999, J AGR FOOD CHEM, V47, P4621, DOI 10.1021/jf9813081; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Lin LZ, 2008, J AGR FOOD CHEM, V56, P8130, DOI 10.1021/jf800986s; Liu YJ, 2012, J BIOL CHEM, V287, P44406, DOI 10.1074/jbc.M112.403071; Liu YJ, 2009, J AGR FOOD CHEM, V57, P10371, DOI 10.1021/jf902614n; Luo J, 2008, PLANT J, V56, P316, DOI 10.1111/j.1365-313X.2008.03597.x; Maeda-Yamamoto M, 2004, J IMMUNOL, V172, P4486, DOI 10.4049/jimmunol.172.7.4486; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Miranda M, 2007, MOL PLANT MICROBE IN, V20, P816, DOI 10.1094/MPMI-20-7-0816; Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176; Nakachi K, 2000, BIOFACTORS, V13, P49, DOI 10.1002/biof.5520130109; Natsume M, 2000, BIOSCI BIOTECH BIOCH, V64, P2581, DOI 10.1271/bbb.64.2581; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Nie ZhiYin, 2011, Journal of Tea Science, V31, P439; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Pang Y, 2013, PLANT PHYSL; Pang YZ, 2008, P NATL ACAD SCI USA, V105, P14210, DOI 10.1073/pnas.0805954105; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Park JS, 2004, PLANT SCI, V166, P953, DOI 10.1016/j.plantsci.2003.12.010; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Ryu OH, 2006, DIABETES RES CLIN PR, V71, P356, DOI 10.1016/j.diabres.2005.08.001; Santagati NA, 2008, J CHROMATOGR SCI, V46, P150, DOI 10.1093/chromsci/46.2.150; Setiawan VW, 2001, INT J CANCER, V92, P600, DOI 10.1002/ijc.1231; Sharma SB, 2005, PLANT J, V44, P62, DOI 10.1111/j.1365-313X.2005.02510.x; Shi CY, 2011, BMC GENOMICS, P12; Singh K, 2009, FUNCT INTEGR GENOMIC, V9, P125, DOI 10.1007/s10142-008-0092-9; Singh K, 2008, TREE PHYSIOL, V28, P1349, DOI 10.1093/treephys/28.9.1349; Singh K, 2009, TREE PHYSIOL, V29, P837, DOI 10.1093/treephys/tpp022; Soobrattee MA, 2006, BIOFACTORS, V27, P19, DOI 10.1002/biof.5520270103; Stracke R, 2010, NEW PHYTOL, V188, P985, DOI 10.1111/j.1469-8137.2010.03421.x; Sueoka N, 2001, ANN NY ACAD SCI, V928, P274; TAKEUCHI A, 1994, PLANT CELL PHYSIOL, V35, P1011; Tamagnone L, 1998, PLANT CELL, V10, P135, DOI 10.1105/tpc.10.2.135; Terrier N, 2009, PLANT PHYSIOL, V149, P1028, DOI 10.1104/pp.108.131862; Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011; Thompson EP, 2010, PLANT SIGNAL BEHAV, V5, P860, DOI 10.4161/psb.5.7.11894; Verdier J, 2012, P NATL ACAD SCI USA, V109, P1766, DOI 10.1073/pnas.1120916109; Wang J, 2000, J AGR FOOD CHEM, V48, P1657, DOI 10.1021/jf991035p; Wang YS, 2012, SCI HORTIC-AMSTERDAM, V141, P7, DOI 10.1016/j.scienta.2012.04.013; Wang YS, 2012, SCI HORTIC-AMSTERDAM, V133, P72, DOI 10.1016/j.scienta.2011.10.017; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Winkel-Shirley B, 2006, SCI FLAVONOIDS, P75; Wu XL, 2004, J AGR FOOD CHEM, V52, P7846, DOI 10.1021/jf0486850; Xie DY, 2004, ARCH BIOCHEM BIOPHYS, V422, P91, DOI 10.1016/j.abb.2003.12.011; Zhang XL, 2012, J SCI FOOD AGR, V92, P1533, DOI 10.1002/jsfa.4739; Zhao J, 2010, PLANT PHYSIOL, V153, P437, DOI 10.1104/pp.110.155432; Zhao J, 2009, PLANT CELL, V21, P2323, DOI 10.1105/tpc.109.067819; Zhao L, 2013, FUNCT INTEGR GENOMIC, V13, P75, DOI 10.1007/s10142-012-0301-4; Zheng XQ, 2008, AFR J BIOTECHNOL, V7, P3283	78	151	169	5	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62315	10.1371/journal.pone.0062315	http://dx.doi.org/10.1371/journal.pone.0062315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646127	gold, Green Submitted, Green Published			2022-12-25	WOS:000319077300040
J	Aschan, M; Fossheim, M; Greenacre, M; Primicerio, R				Aschan, Michaela; Fossheim, Maria; Greenacre, Michael; Primicerio, Raul			Change in Fish Community Structure in the Barents Sea	PLOS ONE			English	Article							CAPELIN MALLOTUS-VILLOSUS; HERRING CLUPEA-HARENGUS; CLIMATE-CHANGE; REGIME SHIFTS; CONTINENTAL-SHELF; ASSEMBLAGE STRUCTURE; TROPHIC CASCADES; DEMERSAL FISH; MARINE; ECOSYSTEMS	Change in oceanographic conditions causes structural alterations in marine fish communities, but this effect may go undetected as most monitoring programs until recently mainly have focused on oceanography and commercial species rather than on whole ecosystems. In this paper, the objective is to describe the spatial and temporal changes in the Barents Sea fish community in the period 1992-2004 while taking into consideration the observed abundance and biodiversity patterns for all 82 observed fish species. We found that the spatial structure of the Barents Sea fish community was determined by abiotic factors such as temperature and depth. The observed species clustered into a deep assemblage, a warm water southern assemblage, both associated with Atlantic water, and a cold water north-eastern assemblage associated with mixed water. The latitude of the cold water NE and warm water S assemblages varied from year to year, but no obvious northward migration was observed over time. In the period 1996-1999 we observed a significant reduction in total fish biomass, abundance, mean fish weight, and a change in community structure including an increase in the pelagic/demersal ratio. This change in community structure is probably due to extremely cold conditions in 1996 impacting on a fish community exposed to historically high fishing rates. After 1999 the fish community variables such as biomass, abundance, mean weight, P/D ratio as well as community composition did not return to levels of the early 90s, although fishing pressure and climatic conditions returned to earlier levels.	[Aschan, Michaela; Greenacre, Michael; Primicerio, Raul] Univ Tromso, Fac Biosci Fisheries & Econ, Tromso, Norway; [Fossheim, Maria] Inst Marine Res, Tromso, Norway; [Greenacre, Michael] Univ Pompeu Fabra, Dept Econ & Business, Barcelona, Spain	UiT The Arctic University of Tromso; Institute of Marine Research - Norway; Pompeu Fabra University	Aschan, M (corresponding author), Univ Tromso, Fac Biosci Fisheries & Econ, Tromso, Norway.	michaela.aschan@uit.no	Fossheim, Maria/B-7134-2014; Greenacre, Michael J/D-7401-2013	Greenacre, Michael J/0000-0002-0054-3131; Aschan, Michaela/0000-0002-9276-9321	Norwegian Ministry of Fisheries and Coastal Affairs; Norwegian Government through Norwegian Ministry of Fisheries and Coastal Affairs; Norwegian Government through Ministry of Education and Research; Spanish Ministry of Education [MTM2012-37195]	Norwegian Ministry of Fisheries and Coastal Affairs; Norwegian Government through Norwegian Ministry of Fisheries and Coastal Affairs; Norwegian Government through Ministry of Education and Research; Spanish Ministry of Education(Spanish Government)	The data were collected during the former annual shrimp survey conducted by the Norwegian Institute of Fisheries and Aquaculture (NIFA) and the Institute of Marine Research (IMR) in the Barents Sea from 1992 until 2004, and were funded by the Norwegian Ministry of Fisheries and Coastal Affairs. The scientific work was also funded by the Norwegian Government through the above mentioned ministry and through the Ministry of Education and Research. Michael Greenacre's research was partially funded by the BBVA Foundation in Madrid and a grant from the Spanish Ministry of Education MTM2012-37195. The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript.	[Anonymous], 2005, ARCTIC CLIMATE IMPAC; [Anonymous], 2010, IMR PINRO JOINT REPO, V4, P108; Asan Z, 2011, FUZZY SET SYST, V183, P57, DOI 10.1016/j.fss.2011.03.007; Aschan M, 1997, ICES COUNCIL M, V7, P23; Aschan M, 2009, DEEP-SEA RES PT II, V56, P2012, DOI 10.1016/j.dsr2.2008.11.012; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Bergstad OA, 1999, SARSIA, V84, P67, DOI 10.1080/00364827.1999.10420452; Bogstad B, 2008, IMR PINRO JOINT REPO; Burgos GE, 1989, BOTTOM FISH COMMUNIT; Byrkjedal I, 2007, POLAR RES, V26, P135, DOI 10.1111/J.1751-8369.2007.00030.x; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cheung WWL, 2008, MODELING PRESENT CLI; Choi JS, 2004, CAN J FISH AQUAT SCI, V61, P505, DOI 10.1139/F04-079; Collie JS, 2008, CAN J FISH AQUAT SCI, V65, P1352, DOI 10.1139/F08-048; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Dolgov A. V., 2005, Journal of Northwest Atlantic Fishery Science, V35, P495; Dolgov AV, 2007, ICES CM E, V31, P17; DOMMASNES A, 2002, FISHERIES CTR RES RE, P213; Drinkwater KF, 2011, PROG OCEANOGR, V90, P47, DOI 10.1016/j.pocean.2011.02.006; Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1203, DOI 10.1016/j.icesjms.2005.08.008; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Duplisea DE, 2005, ECOSYSTEMS, V8, P899, DOI 10.1007/s10021-005-0011-z; Ehrich S, 2009, FISH OCEANOGR, V18, P36, DOI 10.1111/j.1365-2419.2008.00495.x; Ekman S, 1953, BOREAL FAUNA N ATLAN, P100, DOI Sidgwick and Jackson; Ellingsen IH, 2008, CLIMATIC CHANGE, V87, P155, DOI 10.1007/s10584-007-9369-6; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fossheim A, 2006, MAR BIOL RES, V2, P260, DOI 10.1080/17451000600815698; Frank KT, 2007, TRENDS ECOL EVOL, V22, P236, DOI 10.1016/j.tree.2007.03.002; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; FROESE R, 2007, FISHBASE; Gaertner JC, 2005, MAR ECOL PROG SER, V297, P245, DOI 10.3354/meps297245; Gaertner JC, 2002, SCI MAR, V66, P221; Genner MJ, 2004, P ROY SOC B-BIOL SCI, V271, P655, DOI 10.1098/rspb.2003.2651; Gjosaeter H, 2008, FISKEN HAVET SAERN, V1, P200; Gjosaeter H, 2009, MAR BIOL RES, V5, P40, DOI 10.1080/17451000802454866; Greenacre M, 2013, FUZZY CODING CONSTRA; Hallfredsson EH, 2009, CAN J FISH AQUAT SCI, V66, P1693, DOI 10.1139/F09-105; Harbitz A, 1998, FISH RES, V37, P107, DOI 10.1016/S0165-7836(98)00130-1; Hjermann DO, 2007, P ROY SOC B-BIOL SCI, V274, P661, DOI 10.1098/rspb.2006.0069; Hovde SC, 2002, ICES J MAR SCI, V59, P421, DOI 10.1006/jmsc.2002.1171; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Hsieh CH, 2008, CAN J FISH AQUAT SCI, V65, P947, DOI 10.1139/F08-017; Hsieh CH, 2009, GLOBAL CHANGE BIOL, V15, P2137, DOI 10.1111/j.1365-2486.2009.01875.x; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; ICES, 2008, ICES CM 2008 ACOM; ICES (International Council for the Exploration of the Sea), 2011, REP ARCT FISH WORK G; Jennings S, 2010, J MARINE SYST, V79, P418, DOI 10.1016/j.jmarsys.2008.12.016; Johannesen E, 2012, ICES J MARINE SCI J; Johannesen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034924; Kaiser MJ, 2004, FISH RES, V69, P1, DOI 10.1016/j.fishres.2004.05.001; Krebs C. J., 2014, ECOLOGICAL METHODOLO; Lees K, 2006, FISH FISH, V7, P104, DOI 10.1111/j.1467-2979.2006.00215.x; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Levin SA, 2008, BIOSCIENCE, V58, P27, DOI 10.1641/B580107; Loeng H, 2007, DEEP-SEA RES PT II, V54, P2478, DOI 10.1016/j.dsr2.2007.08.013; Mahon R, 1998, CAN J FISH AQUAT SCI, V55, P1704, DOI 10.1139/cjfas-55-7-1704; Moreno JID, 2000, ICES J MAR SCI, V57, P1091, DOI 10.1006/jmsc.2000.0705; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; MURAWSKI SA, 1993, T AM FISH SOC, V122, P647, DOI 10.1577/1548-8659(1993)122<0647:CCAMFD>2.3.CO;2; NILSSEN EM, 1992, ICES MAR SC, V195, P331; Oksanen J., 2011, MULTIVARIATE ANAL EC, P1, DOI DOI 10.1016/0169-5347(88)90124-3; Olsen E, 2010, ICES J MAR SCI, V67, P87, DOI 10.1093/icesjms/fsp229; Overland J, 2008, PROG OCEANOGR, V77, P92, DOI 10.1016/j.pocean.2008.03.016; Pedersen T, 2008, MAR BIOL, V153, P1037, DOI 10.1007/s00227-007-0875-x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; Poulard JC, 2005, ICES J MAR SCI, V62, P1436, DOI 10.1016/j.icesjms.2005.04.017; R Development Core Team, 2009, R FDN STAT COMP; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Shackell NL, 2007, MAR ECOL PROG SER, V336, P235, DOI 10.3354/meps336235; Skogen M, 2007, FISKEN HAVET SAERN, V1, P191; Spielhagen RF, 2011, SCIENCE, V331, P450, DOI 10.1126/science.1197397; Stefansdottir L, 2010, FISH OCEANOGR, V19, P42, DOI 10.1111/j.1365-2419.2009.00527.x; Stige LC, 2010, P ROY SOC B-BIOL SCI, V277, P3411, DOI 10.1098/rspb.2010.0602; Yaragina N, 2009, DEEP SEA RES; Zenkewitch L, 1963, BIOL SEAS USSR	79	15	19	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62748	10.1371/journal.pone.0062748	http://dx.doi.org/10.1371/journal.pone.0062748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658646	Green Published, gold			2022-12-25	WOS:000321662800059
J	Pirman, DA; Efuet, E; Ding, XP; Pan, Y; Tan, L; Fischer, SM; DuBois, RN; Yang, PY				Pirman, David A.; Efuet, Ekem; Ding, Xiao-Ping; Pan, Yong; Tan, Lin; Fischer, Susan M.; DuBois, Raymond N.; Yang, Peiying			Changes in Cancer Cell Metabolism Revealed by Direct Sample Analysis with MALDI Mass Spectrometry	PLOS ONE			English	Article							INTERMEDIATE-PRESSURE MALDI; EICOSAPENTAENOIC ACID; TISSUE-SECTIONS; GROWTH; LUNG; LOCALIZATION; PHOSPHOLIPIDS; METABOANALYST; METASTASIS; SUBTYPES	Biomarker discovery using mass spectrometry (MS) has recently seen a significant increase in applications, mainly driven by the rapidly advancing field of metabolomics. Instrumental and data handling advancements have allowed for untargeted metabolite analyses which simultaneously interrogate multiple biochemical pathways to elucidate disease phenotypes and therapeutic mechanisms. Although most MS-based metabolomic approaches are coupled with liquid chromatography, a few recently published studies used matrix-assisted laser desorption (MALDI), allowing for rapid and direct sample analysis with minimal sample preparation. We and others have reported that prostaglandin E-3 (PGE(3)), derived from COX-2 metabolism of the omega-3 fatty acid eicosapentaenoic acid (EPA), inhibited the proliferation of human lung, colon and pancreatic cancer cells. However, how PGE(3) metabolism is regulated in cancer cells, particularly human non-small cell lung cancer (NSCLC) cells, is not fully understood. Here, we successfully used MALDI to identify differences in lipid metabolism between two human non-small-cell lung cancer (NSCLC) cell lines, A549 and H596, which could contribute to their differential response to EPA treatment. Analysis by MALDI-MS showed that the level of EPA incorporated into phospholipids in H596 cells was 4-fold higher than A549 cells. Intriguingly, H596 cells produced much less PGE(3) than A549 cells even though the expression of COX-2 was similar in these two cell lines. This appears to be due to the relatively lower expression of cytosolic phospholipase A(2) (cPLA(2)) in H596 cells than that of A549 cells. Additionally, the MALDI-MS approach was successfully used on tumor tissue extracts from a K-ras transgenic mouse model of lung cancer to enhance our understanding of the mechanism of action of EPA in the in vivo model. These results highlight the utility of combining a metabolomics workflow with MALDI-MS to identify the biomarkers that may regulate the metabolism of omega-3 fatty acids and ultimately affect their therapeutic potentials.	[Pirman, David A.; Tan, Lin; DuBois, Raymond N.; Yang, Peiying] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Efuet, Ekem; Ding, Xiao-Ping; Pan, Yong; Yang, Peiying] Univ Texas MD Anderson Canc Ctr, Dept Gen Oncol, Houston, TX 77030 USA; [Fischer, Susan M.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yang, PY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	pyang@mdanderson.org	DuBois, Raymond N./AAX-8869-2020		National Institutes of Health [CA144053-01A1]; NATIONAL CANCER INSTITUTE [R01CA144053, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant CA144053-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar NYR, 2010, ANAL CHEM, V82, P2621, DOI 10.1021/ac100113w; Balog J, 2010, ANAL CHEM, V82, P7343, DOI 10.1021/ac101283x; Benabdellah F, 2009, ANAL CHEM, V81, P5557, DOI 10.1021/ac9005364; Berry KAZ, 2011, J LIPID RES, V52, P1551, DOI 10.1194/jlr.M015750; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Castellino S, 2011, BIOANALYSIS, V3, P2427, DOI [10.4155/bio.11.232, 10.4155/BIO.11.232]; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cho Y-T, 2012, GENOMIC MED BIOMARKE, V4, P3; Cornett DS, 2008, ANAL CHEM, V80, P5648, DOI 10.1021/ac800617s; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Eberlin LS, 2012, CANCER RES, V72, P645, DOI 10.1158/0008-5472.CAN-11-2465; Eberlin LS, 2010, ANGEW CHEM INT EDIT, V49, P5953, DOI 10.1002/anie.201001452; Esquenazi E, 2008, MOL BIOSYST, V4, P562, DOI 10.1039/b720018h; FALCONER JS, 1994, BRIT J CANCER, V69, P826, DOI 10.1038/bjc.1994.161; Fehniger TE, 2011, ANAL CHEM, V83, P8329, DOI 10.1021/ac2014349; Gamez-Pozo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007731; Garrett TJ, 2007, INT J MASS SPECTROM, V260, P166, DOI 10.1016/j.ijms.2006.09.019; Garrett TJ, 2006, ANAL CHEM, V78, P2465, DOI 10.1021/ac0522761; Marko-Varga G, 2011, J PROTEOMICS, V74, P982, DOI 10.1016/j.jprot.2011.03.019; McDonnell LA, 2012, J PROTEOMICS, V75, P5113, DOI 10.1016/j.jprot.2012.05.016; Meding S, 2012, J PROTEOME RES, V11, P1996, DOI 10.1021/pr200784p; MINOURA T, 1988, CANCER RES, V48, P4790; Murphy RC, 2011, BBA-MOL CELL BIOL L, V1811, P970, DOI 10.1016/j.bbalip.2011.04.012; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Rohner TC, 2005, MECH AGEING DEV, V126, P177, DOI 10.1016/j.mad.2004.09.032; ROSE DP, 1995, JNCI-J NATL CANCER I, V87, P587, DOI 10.1093/jnci/87.8.587; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Shimma S, 2007, J CHROMATOGR B, V855, P98, DOI 10.1016/j.jchromb.2007.02.037; Stauber J, 2010, J AM SOC MASS SPECTR, V21, P338, DOI 10.1016/j.jasms.2009.09.016; Strupat K, 2009, J AM SOC MASS SPECTR, V20, P1451, DOI 10.1016/j.jasms.2009.04.013; Vanamala J, 2008, CARCINOGENESIS, V29, P790, DOI 10.1093/carcin/bgm256; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yang PY, 2006, PROSTAG LEUKOTR ESS, V75, P385, DOI 10.1016/j.plefa.2006.07.015; Yang PY, 2004, J LIPID RES, V45, P1030, DOI 10.1194/jlr.M300455-JLR200; Yang PY, 2002, ANAL BIOCHEM, V308, P168, DOI 10.1016/S0003-2697(02)00218-X	36	27	27	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61379	10.1371/journal.pone.0061379	http://dx.doi.org/10.1371/journal.pone.0061379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658609	Green Submitted, gold, Green Published			2022-12-25	WOS:000318343700009
J	Jiang, Y; Ding, Q; Xie, XL; Libby, RT; Lefebvre, V; Gan, L				Jiang, Ying; Ding, Qian; Xie, Xiaoling; Libby, Richard T.; Lefebvre, Veronique; Gan, Lin			Transcription Factors SOX4 and SOX11 Function Redundantly to Regulate the Development of Mouse Retinal Ganglion Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN FACTOR BRN-3B; NEURONAL DIFFERENTIATION; SYSTEM DEVELOPMENT; NERVOUS-SYSTEM; VISUAL-SYSTEM; MATH5; MICE; NEUROGENESIS; REQUIREMENT; EXPRESSION	SOX family proteins belong to the high-mobility-group (HMG) domain-containing transcription factors, and function as key players to regulate embryonic development and cell fate determination. The highly related group C Sox genes Sox4 and Sox11 are widely expressed in the development of mouse retina and share a similar expression pattern with each other in this process. Here, to investigate the roles of Sox4 and Sox11 in the retinal development, Sox4, Sox11, and Sox4/Sox11 conditional knock-out (CKO) mice with deletion of Sox4, Sox11, and Sox4/Sox11 in retinas were generated. Our studies demonstrated that targeted disruption of Sox4 or Sox11 in retinas caused a moderate reduction of generation of RGCs. However, a complete loss of RGCs was observed in Sox4/Sox11-null retinas, suggesting the two genes play similar roles in the development of RGCs. Our further analysis confirms that Sox4 and Sox11 function redundantly to regulate the generation of RGCs at early embryonic stages as well as the survival of RGCs at late embryonic stages. In addition, we demonstrated that loss of Math5 impairs the expression of Sox4 and Sox11 in the ganglion cell layer while deletion of Brn3b has no effect on the expression of Sox4 and Sox11. Taken together, these findings elucidate SoxC genes as essential contributors to maintain the survival of RGCs, and imply their intermediate position between Math5 and Brn3b in the genetic hierarchy of RGC development.	[Jiang, Ying; Ding, Qian; Xie, Xiaoling; Libby, Richard T.; Gan, Lin] Univ Rochester, Flaum Eye Inst, Rochester, NY 14642 USA; [Jiang, Ying; Ding, Qian; Xie, Xiaoling; Libby, Richard T.; Gan, Lin] Univ Rochester, Dept Ophthalmol, Rochester, NY 14642 USA; [Jiang, Ying] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Lefebvre, Veronique] Cleveland Clin, Lerner Inst, Cleveland, OH 44195 USA; [Gan, Lin] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China	University of Rochester; University of Rochester; University of Rochester; Cleveland Clinic Foundation; Hangzhou Normal University	Gan, L (corresponding author), Univ Rochester, Flaum Eye Inst, 601 Elmwood Ave,Box 659, Rochester, NY 14642 USA.	lin_gan@urmc.rochester.edu		Libby, Richard/0000-0003-2844-7632	National Natural Science Foundation of China [81271006]; Hangzhou City Health Science Foundation [20120633B01]; Research to Prevent Blindness Challenge Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054153] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hangzhou City Health Science Foundation; Research to Prevent Blindness Challenge Grant(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Natural Science Foundation of China Grant No. 81271006, and Hangzhou City Health Science Foundation Grant No. 20120633B01, and by a Research to Prevent Blindness Challenge Grant to the Department of Ophthalmology at the University of Rochester.	Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Brown NL, 1998, DEVELOPMENT, V125, P4821; Castillo SD, 2012, CANCER RES, V72, P176, DOI 10.1158/0008-5472.CAN-11-3506; Cheung M, 2000, MOL BRAIN RES, V79, P180, DOI 10.1016/S0169-328X(00)00109-1; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Farah MH, 2005, J COMP NEUROL, V489, P120, DOI 10.1002/cne.20615; Feng L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-36; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Hoser M, 2008, MOL CELL BIOL, V28, P4675, DOI 10.1128/MCB.00338-08; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Li YZ, 2012, ACTA BIOCH BIOPH SIN, V44, P660, DOI 10.1093/abbs/gms045; Lin L, 2011, DEV DYNAM, V240, P52, DOI 10.1002/dvdy.22489; Mu LF, 2012, J NEUROSCI, V32, P3067, DOI 10.1523/JNEUROSCI.4679-11.2012; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; Nissen-Meyer LSH, 2007, J CELL SCI, V120, P2785, DOI 10.1242/jcs.003855; NIXON RA, 1989, MOL BRAIN RES, V5, P93, DOI 10.1016/0169-328X(89)90001-6; Pan L, 2005, DEVELOPMENT, V132, P703, DOI 10.1242/dev.01646; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Penzo-Mendez A, 2007, GENESIS, V45, P776, DOI 10.1002/dvg.20358; PERRY VH, 1983, J COMP NEUROL, V219, P356, DOI 10.1002/cne.902190309; Potzner MR, 2010, DEVELOPMENT, V137, P775, DOI 10.1242/dev.042101; Sander B, 2011, SEMIN DIAGN PATHOL, V28, P245, DOI 10.1053/j.semdp.2011.02.010; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Thein DC, 2010, J NEUROCHEM, V115, P131, DOI 10.1111/j.1471-4159.2010.06910.x; Usui A, 2013, DEVELOPMENT, V140, P740, DOI 10.1242/dev.090274; Vaney DI, 2002, PROG BRAIN RES, V136, P239; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Wurm A, 2008, EXP EYE RES, V86, P895, DOI 10.1016/j.exer.2008.03.004; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	43	76	77	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18429	18438		10.1074/jbc.M113.478503	http://dx.doi.org/10.1074/jbc.M113.478503			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649630	Green Published, hybrid			2022-12-25	WOS:000320721900045
J	Kim, S; Cipolla, L; Guidetti, G; Okigaki, M; Jin, JG; Torti, M; Kunapuli, SP				Kim, Soochong; Cipolla, Lina; Guidetti, Gianni; Okigaki, Mitsuhiko; Jin, Jianguo; Torti, Mauro; Kunapuli, Satya P.			Distinct Role of Pyk2 in Mediating Thromboxane Generation Downstream of Both G(12/13) and Integrin alpha IIb beta 3 in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL TYROSINE KINASE; SRC FAMILY KINASES; PROTEIN-KINASE; ADHESION KINASE; MICE LACKING; DIFFERENTIAL REGULATION; THROMBUS FORMATION; 3-KINASE BETA; SHAPE CHANGE; ACTIVATION	Proline-rich tyrosine kinase 2 (Pyk2) is activated by various agonists in platelets. We evaluated the signaling mechanism and the functional role of Pyk2 in platelets by using pharmacological inhibitors and Pyk2-deficient platelets. We found that platelet aggregation and secretion in response to 2-methylthio-ADP (2-MeSADP) and AYPGKF were diminished in the presence of Pyk2 inhibitors or in Pyk2-deficient platelets, suggesting that Pyk2 plays a positive regulatory role in platelet functional responses. It has been shown that ADP-, but not thrombin-induced thromboxane (TxA(2)) generation depends on integrin signaling. Unlike ADP, thrombin activates G(12/13) pathways, and G(12/13) pathways can substitute for integrin signaling for TxA(2) generation. We found that Pyk2 was activated downstream of both G(12/13) and integrin-mediated pathways, and both 2-Me-SADP- and AYPGKF-induced TxA(2) generation was significantly diminished in Pyk2-deficient platelets. In addition, TxA(2) generation induced by co-stimulation of G(i) and G(z) pathways, which is dependent on integrin signaling, was inhibited by blocking Pyk2. Furthermore, inhibition of 2-MeSADP-induced TxA(2) generation by fibrinogen receptor antagonist was not rescued by co-stimulation of G(12/13) pathways in the presence of Pyk2 inhibitor. We conclude that Pyk2 is a common signaling effector downstream of both G(12/13) and integrin alpha IIb beta 3 signaling, which contributes to thromboxane generation.	[Kim, Soochong; Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Kim, Soochong; Jin, Jianguo; Kunapuli, Satya P.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Cipolla, Lina; Guidetti, Gianni; Torti, Mauro] Univ Pavia, Dept Biochem, I-27100 Pavia, Italy; [Okigaki, Mitsuhiko] Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto 6028566, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pavia; Kyoto Prefectural University of Medicine	Kunapuli, SP (corresponding author), Temple Univ, Sch Med, Dept Physiol, 3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu			National Institutes of Health [HL60683, HL93231]; American Heart Association [12SDG8980013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093231, R01HL060683, R01HL118593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL60683 and HL93231 (to S. P. K.) and American Heart Association Grant 12SDG8980013 (to S. K.).	Astier A, 1997, J BIOL CHEM, V272, P19719, DOI 10.1074/jbc.272.32.19719; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; Bauer M, 1999, BLOOD, V94, P1665, DOI 10.1182/blood.V94.5.1665.417k33_1665_1672; Bhavaraju K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016586; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Canobbio I, 2002, THROMB HAEMOSTASIS, V87, P509, DOI 10.1055/s-0037-1613032; Canobbio I, 2013, BLOOD, V121, P648, DOI 10.1182/blood-2012-06-438762; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; Consonni A, 2012, BLOOD, V119, P847, DOI 10.1182/blood-2011-07-364992; Dorsam RT, 2005, BLOOD, V105, P2749, DOI 10.1182/blood-2004-07-2821; Duan YL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-4; Duan YL, 2010, AM J RESP CELL MOL, V42, P491, DOI 10.1165/rcmb.2008-0469OC; Evangelista V, 2007, BLOOD, V109, P2461, DOI 10.1182/blood-2006-06-029082; Garcia A, 2007, BIOCHEM J, V404, P299, DOI 10.1042/BJ20061584; Garcia A, 2010, BIOCHEM J, V429, P369, DOI 10.1042/BJ20100166; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Hiregowdara D, 1997, J BIOL CHEM, V272, P10804; Hitchcock IS, 2008, BLOOD, V111, P596, DOI 10.1182/blood-2007-05-089680; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Jin JG, 2009, BIOCHEM PHARMACOL, V77, P835, DOI 10.1016/j.bcp.2008.11.017; Keogh RJ, 2002, BIOCHEM BIOPH RES CO, V294, P1001, DOI 10.1016/S0006-291X(02)00568-5; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Koziak K, 2001, BRIT J HAEMATOL, V114, P134, DOI 10.1046/j.1365-2141.2001.02894.x; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lipinski CA, 2010, EXPERT OPIN THER TAR, V14, P95, DOI 10.1517/14728220903473194; MALMSTEN C, 1977, BRIT J HAEMATOL, V35, P511, DOI 10.1111/j.1365-2141.1977.tb00617.x; Murugappan S, 2005, BLOOD, V106, P550, DOI 10.1182/blood-2004-12-4866; Murugappan S, 2009, BIOCHEM J, V417, P113, DOI 10.1042/BJ20080235; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Ohmori T, 2000, BIOCHEM J, V347, P561, DOI 10.1042/0264-6021:3470561; Ohmori T, 1999, THROMB RES, V93, P291, DOI 10.1016/S0049-3848(98)00188-1; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Raja S, 1997, J BIOL CHEM, V272, P10941; Sayed MR, 2000, J CELL PHYSIOL, V183, P314, DOI 10.1002/(SICI)1097-4652(200006)183:3<314::AID-JCP3>3.0.CO;2-J; Schoenwaelder SM, 2010, J BIOL CHEM, V285, P2886, DOI 10.1074/jbc.M109.029132; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Siciliano JC, 1996, J BIOL CHEM, V271, P28942, DOI 10.1074/jbc.271.46.28942; Soltoff SP, 1998, J BIOL CHEM, V273, P2653, DOI 10.1074/jbc.273.5.2653; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; Wang L, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-26; Wang ZY, 2001, HYPERTENSION, V37, P148, DOI 10.1161/01.HYP.37.1.148; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Zhu XD, 2008, AM J RESP CELL MOL, V39, P263, DOI 10.1165/rcmb.2008-0047OC	46	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18194	18203		10.1074/jbc.M113.461087	http://dx.doi.org/10.1074/jbc.M113.461087			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23640884	Green Published, hybrid			2022-12-25	WOS:000320721900024
J	Sakaki-Yumoto, M; Liu, JM; Ramalho-Santos, M; Yoshida, N; Derynck, R				Sakaki-Yumoto, Masayo; Liu, Jianming; Ramalho-Santos, Miguel; Yoshida, Nobuaki; Derynck, Rik			Smad2 Is Essential for Maintenance of the Human and Mouse Primed Pluripotent Stem Cell State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EMBRYONIC STEM; TGF-BETA RECEPTOR; HUMAN ES CELLS; GROWTH-FACTOR; MAINTAINS PLURIPOTENCY; TRANSCRIPTION FACTORS; SELF-RENEWAL; INDUCED DIFFERENTIATION; ENDODERM FORMATION; MH1 DOMAIN	Human embryonic stem cells and mouse epiblast stem cells represent a primed pluripotent stem cell state that requires TGF-beta/activin signaling. TGF-beta and/or activin are commonly thought to regulate transcription through both Smad2 and Smad3. However, the different contributions of these two Smads to primed pluripotency and the downstream events that they may regulate remain poorly understood. We addressed the individual roles of Smad2 and Smad3 in the maintenance of primed pluripotency. We found that Smad2, but not Smad3, is required to maintain the undifferentiated pluripotent state. We defined a Smad2 regulatory circuit in human embryonic stem cells and mouse epiblast stem cells, in which Smad2 acts through binding to regulatory promoter sequences to activate Nanog expression while in parallel repressing autocrine bone morphogenetic protein signaling. Increased autocrine bone morphogenetic protein signaling caused by Smad2 down-regulation leads to cell differentiation toward the trophectoderm, mesoderm, and germ cell lineages. Additionally, induction of Cdx2 expression, as a result of decreased Smad2 expression, leads to repression of Oct4 expression, which, together with the decreased Nanog expression, accelerates the loss of pluripotency. These findings reveal that Smad2 is a unique integrator of transcription and signaling events and is essential for the maintenance of the mouse and human primed pluripotent stem cell state.	[Sakaki-Yumoto, Masayo; Liu, Jianming; Ramalho-Santos, Miguel; Derynck, Rik] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Program Cell Biol, San Francisco, CA 94143 USA; [Sakaki-Yumoto, Masayo; Liu, Jianming; Ramalho-Santos, Miguel; Derynck, Rik] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Program Dev & Stem Cell Biol, San Francisco, CA 94143 USA; [Sakaki-Yumoto, Masayo; Liu, Jianming; Derynck, Rik] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Yoshida, Nobuaki] Univ Tokyo, Lab Dev Genet, Ctr Expt Med & Syst Biol, Inst Med Sci, Tokyo 1088639, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Tokyo	Derynck, R (corresponding author), Univ Calif San Francisco, Broad Ctr RMB 1027, 35 Med Ctr Way, San Francisco, CA 94143 USA.	rik.derynck@ucsf.edu	Ramalho-Santos, Miguel/L-9092-2018	Ramalho-Santos, Miguel/0000-0003-0177-5556	National Institutes of Health [R21 HL0923494]; CIRM New Stem Cell Lines Grant [RL-100669]; Union Internationale Contre le Cancer; Uehara Foundation; Program in Breakthrough Basic Research at University of California at San Francisco; American Heart Association; University of California at San Francisco; Muscular Dystrophy Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM New Stem Cell Lines Grant; Union Internationale Contre le Cancer; Uehara Foundation(Uehara Memorial Foundation); Program in Breakthrough Basic Research at University of California at San Francisco; American Heart Association(American Heart Association); University of California at San Francisco(University of California System); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 HL0923494 (to R. D.). This work was also supported by CIRM New Stem Cell Lines Grant RL-100669 (to M. R.-S.).; Supported by postdoctoral fellowships from the Union Internationale Contre le Cancer, the Uehara Foundation, and an award from the Program in Breakthrough Basic Research at University of California at San Francisco.; Supported by a postdoctoral fellowship from the American Heart Association, a University of California at San Francisco core exploratory award, and a Muscular Dystrophy Association development grant.	Avery S, 2010, STEM CELLS, V28, P863, DOI 10.1002/stem.409; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Blount AL, 2008, J BIOL CHEM, V283, P7016, DOI 10.1074/jbc.M709502200; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen LY, 2009, CELL RES, V19, P1052, DOI 10.1038/cr.2009.79; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Denissova NG, 2000, P NATL ACAD SCI USA, V97, P6397, DOI 10.1073/pnas.090099297; Dennler S, 1999, ONCOGENE, V18, P1643, DOI 10.1038/sj.onc.1202729; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frankenberg S, 2011, DEV CELL, V21, P1005, DOI 10.1016/j.devcel.2011.10.019; Furtado MB, 2008, GENE DEV, V22, P3037, DOI 10.1101/gad.1682108; Galvin KE, 2010, J BIOL CHEM, V285, P19747, DOI 10.1074/jbc.M109.077347; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Gronroos E, 2012, MOL CELL BIOL, V32, P2904, DOI 10.1128/MCB.00231-12; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Messerschmidt DM, 2010, DEV BIOL, V344, P129, DOI 10.1016/j.ydbio.2010.04.020; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Pereira PNG, 2012, DEVELOPMENT, V139, P3343, DOI 10.1242/dev.075465; Peterson AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036548; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Topper JN, 1998, P NATL ACAD SCI USA, V95, P9506, DOI 10.1073/pnas.95.16.9506; Tsuneyoshi N, 2012, GENE DEV, V26, P2471, DOI 10.1101/gad.201772.112; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yamamoto M, 2009, J CELL BIOL, V184, P323, DOI 10.1083/jcb.200808044; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	72	61	68	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18546	18560		10.1074/jbc.M112.446591	http://dx.doi.org/10.1074/jbc.M112.446591			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649632	Green Published, hybrid			2022-12-25	WOS:000320721900055
J	Tan, QL; Kerestes, H; Percy, MJ; Pietrofesa, R; Chen, L; Khurana, TS; Christofidou-Solomidou, M; Lappin, TRJ; Lee, FS				Tan, Qiulin; Kerestes, Heddy; Percy, Melanie J.; Pietrofesa, Ralph; Chen, Li; Khurana, Tejvir S.; Christofidou-Solomidou, Melpo; Lappin, Terence R. J.; Lee, Frank S.			Erythrocytosis and Pulmonary Hypertension in a Mouse Model of Human HIF2A Gain of Function Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTERIAL-HYPERTENSION; HYPOXIA; ERYTHROPOIETIN; CELLS; GENE; INACTIVATION; HIF-2-ALPHA; PATHWAY; MICE; POLYCYTHEMIA	The central pathway for oxygen-dependent control of red cell mass is the prolyl hydroxylase domain protein (PHD):hypoxia inducible factor (HIF) pathway. PHD site specifically prolyl hydroxylates the transcription factor HIF-alpha, thereby targeting the latter for degradation. Under hypoxia, this modification is attenuated, allowing stabilized HIF-alpha to activate target genes, including that for erythropoietin (EPO). Studies employing genetically modified mice point to Hif-2 alpha, one of two main Hif-alpha isoforms, as being the critical regulator of Epo in the adult mouse. More recently, erythrocytosis patients with heterozygous point mutations in the HIF2A gene have been identified; whether these mutations were polymorphisms unrelated to the phenotype could not be ruled out. In the present report, we characterize a mouse line bearing a G536W missense mutation in the Hif2a gene that corresponds to the first such human mutation identified (G537W). We obtained mice bearing both heterozygous and homozygous mutations at this locus. We find that these mice display, in a mutation dose-dependent manner, erythrocytosis and pulmonary hypertension with a high degree of penetrance. These findings firmly establish missense mutations in HIF-2 alpha as a cause of erythrocytosis, highlight the importance of this HIF-alpha isoform in erythropoiesis, and point to HIF-alpha consequences of HIF-2 alpha dysregulation.	[Tan, Qiulin; Kerestes, Heddy; Lee, Frank S.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Pietrofesa, Ralph; Christofidou-Solomidou, Melpo] Univ Penn, Perelman Sch Med, Div Pulm Allergy & Crit Care, Dept Med, Philadelphia, PA 19104 USA; [Chen, Li] Univ Penn, Perelman Sch Med, Dept Med, Div Cardiovasc Med, Philadelphia, PA 19104 USA; [Khurana, Tejvir S.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Khurana, Tejvir S.] Univ Penn, Perelman Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Percy, Melanie J.] Belfast City Hosp, Dept Haematol, Belfast BT9 7AB, Antrim, North Ireland; [Lappin, Terence R. J.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Belfast City Hospital; Queens University Belfast	Lee, FS (corresponding author), Univ Penn, Perelman Sch Med, 605 Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu		Lee, Frank/0000-0003-2511-1834	National Institutes of Health [R01-CA153347, P30-DK19525]; NATIONAL CANCER INSTITUTE [R01CA153347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA153347 (to F. S. L.) and P30-DK19525 (to the Penn Diabetes Endocrine Research Center).	Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Bushuev VI, 2006, HAEMATOLOGICA, V91, P744; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Diebold I, 2008, THROMB HAEMOSTASIS, V100, P984, DOI 10.1160/TH08-08-0524; Formenti F, 2011, FASEB J, V25, P2001, DOI 10.1096/fj.10-177378; Furlow PW, 2009, J BIOL CHEM, V284, P9050, DOI 10.1074/jbc.M808737200; Gale DP, 2008, BLOOD, V112, P919, DOI 10.1182/blood-2008-04-153718; Gordeuk VR, 2004, BLOOD, V103, P3924, DOI 10.1182/blood-2003-07-2535; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hickey MM, 2010, J CLIN INVEST, V120, P827, DOI 10.1172/JCI36362; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kwapiszewska G, 2008, CIRCULATION, V118, P1183, DOI 10.1161/CIRCULATIONAHA.107.761916; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lee FS, 2011, ANNU REV PATHOL-MECH, V6, P165, DOI 10.1146/annurev-pathol-011110-130321; Li XP, 2010, BLOOD CELL MOL DIS, V45, P9, DOI 10.1016/j.bcmd.2010.03.003; Lifshitz L, 2010, HAEMATOL-HEMATOL J, V95, P1823, DOI 10.3324/haematol.2010.025015; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Martini M, 2008, HAEMATOL-HEMATOL J, V93, P1068, DOI 10.3324/haematol.13210; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Nakagawa Y, 2009, BIOCHEM BIOPH RES CO, V382, P183, DOI 10.1016/j.bbrc.2009.03.004; Nemenoff RA, 2008, CIRC RES, V102, P1036, DOI 10.1161/CIRCRESAHA.107.169896; Percy MJ, 2008, BLOOD, V111, P5400, DOI 10.1182/blood-2008-02-137703; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Percy MJ, 2012, AM J HEMATOL, V87, P439, DOI 10.1002/ajh.23123; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Rankin EB, 2008, ONCOGENE, V27, P5354, DOI 10.1038/onc.2008.160; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Smith TG, 2006, PLOS MED, V3, P1178, DOI 10.1371/journal.pmed.0030290; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Teng XW, 2003, CIRC RES, V92, P1065, DOI 10.1161/01.RES.0000073999.07698.33; van Wijk R, 2010, HAEMATOL-HEMATOL J, V95, P829, DOI 10.3324/haematol.2009.017582; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; Weissmann N, 2005, THROMB HAEMOSTASIS, V94, P630, DOI 10.1160/TH05-02-0104; Wenger RH, 2010, AM J PHYSIOL-RENAL, V298, pF1287, DOI 10.1152/ajprenal.00736.2009; Xu WL, 2004, FASEB J, V18, P1746, DOI 10.1096/fj.04-2317fje; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yamashita T, 2008, BLOOD, V112, P1482, DOI 10.1182/blood-2007-11-122648; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200; Yoon D, 2011, AM J PHYSIOL-CELL PH, V300, pC1215, DOI 10.1152/ajpcell.00044.2011	52	76	80	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17134	17144		10.1074/jbc.M112.444059	http://dx.doi.org/10.1074/jbc.M112.444059			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640890	Green Published, hybrid			2022-12-25	WOS:000320380600011
J	Pieters, N; Koppen, G; Smeets, K; Napierska, D; Plusquin, M; De Prins, S; Van de Weghe, H; Nelen, V; Cox, B; Cuypers, A; Hoet, P; Schoeters, G; Nawrot, TS				Pieters, Nicky; Koppen, Gudrun; Smeets, Karen; Napierska, Dorota; Plusquin, Michelle; De Prins, Sofie; Van de Weghe, Hendrik; Nelen, Vera; Cox, Bianca; Cuypers, Ann; Hoet, Peter; Schoeters, Greet; Nawrot, Tim S.			Decreased Mitochondrial DNA Content in Association with Exposure to Polycyclic Aromatic Hydrocarbons in House Dust during Wintertime: From a Population Enquiry to Cell Culture	PLOS ONE			English	Article							INDOOR AIR; POLLUTANTS; DEPLETION; CHILDREN	Polycyclic aromatic hydrocarbons (PAHs) are widespread environmental pollutants that are formed in combustion processes. At the cellular level, exposure to PAHs causes oxidative stress and/or some of it congeners bind to DNA, which may interact with mitochondrial function. However, the influence of these pollutants on mitochondrial DNA (mtDNA) content remains largely unknown. We determined whether indoor exposure to PAHs is associated with mitochondrial damage as represented by blood mtDNA content. Blood mtDNA content (ratio mitochondrial/nuclear DNA copy number) was determined by real-time qPCR in 46 persons, both in winter and summer. Indoor PAH exposure was estimated by measuring PAHs in sedimented house dust, including 6 volatile PAHs and 8 non-volatile PAHs. Biomarkers of oxidative stress at the level of DNA and lipid peroxidation were measured. In addition to the epidemiologic enquiry, we exposed human TK6 cells during 24 h at various concentrations (range: 0 to 500 mu M) of benzo(a) pyrene and determined mtDNA content. Mean blood mtDNA content averaged (+/- SD) 0.95 +/- 0.185. The median PAH content amounted 554.1 ng/g dust (25th-75th percentile: 390.7-767.3) and 1385 ng/g dust (25th-75th percentile: 1000-1980) in winter for volatile and non-volatile PAHs respectively. Independent for gender, age, BMI and the consumption of grilled meat or fish, blood mtDNA content decreased by 9.85% (95% CI: -15.16 to -4.2; p = 0.002) for each doubling of non-volatile PAH content in the house dust in winter. The corresponding estimate for volatile PAHs was -7.3% (95% CI: -13.71 to -0.42; p = 0.04). Measurements of oxidative stress were not correlated with PAH exposure. During summer months no association was found between mtDNA content and PAH concentration. The ability of benzo(a)pyrene (range 0 mu M to 500 mu M) to lower mtDNA content was confirmed in vitro in human TK6 cells. Based on these findings, mtDNA content can be a target of PAH toxicity in humans.	[Pieters, Nicky; Smeets, Karen; Plusquin, Michelle; Cox, Bianca; Cuypers, Ann; Nawrot, Tim S.] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium; [Koppen, Gudrun; De Prins, Sofie; Van de Weghe, Hendrik; Schoeters, Greet] Vlaamse Instelling Technol Onderzoek, Environm Risk & Hlth Unit, B-2400 Mol, Belgium; [Napierska, Dorota; Hoet, Peter; Nawrot, Tim S.] Leuven Univ KU Leuven, Dept Publ Hlth & Primary Care, Louvain, Belgium; [De Prins, Sofie; Schoeters, Greet] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, B-2020 Antwerp, Belgium; [Nelen, Vera] Prov Inst Hyg, Environm & Hlth Unit, Antwerp, Belgium	Hasselt University; VITO; KU Leuven; University of Antwerp	Nawrot, TS (corresponding author), Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium.	tim.nawrot@uhasselt.be	, Karen/N-8133-2019; Koppen, Gudrun/Q-4011-2018; Cuypers, Ann JF/A-3142-2016; Cox, Bianca/A-9480-2015; Hoet, Peter/H-9987-2013; Nawrot, Tim/AAA-4531-2019; Cuypers, Ann/AAH-2053-2019	, Karen/0000-0001-9673-8824; Cuypers, Ann JF/0000-0002-0171-0245; Cox, Bianca/0000-0001-9824-6276; Hoet, Peter/0000-0002-0292-6603; Cuypers, Ann/0000-0002-0171-0245; Nawrot, Tim/0000-0002-3583-3593; Plusquin, Michelle/0000-0002-7271-9722; Schoeters, Greta/0000-0002-6556-4814	Flemish Administration for Environment (Leefmilieu, Natuur Energie); Flemish Scientific Fund [G.0.873.11.N.10/G029212N]; Bijzonder Onderzoeksfonds (BOF) UHasselt	Flemish Administration for Environment (Leefmilieu, Natuur Energie); Flemish Scientific Fund; Bijzonder Onderzoeksfonds (BOF) UHasselt	Study supported by the Flemish Administration for Environment (Leefmilieu, Natuur & Energie) and the Flemish Scientific Fund (G.0.873.11.N.10/G029212N) and Bijzonder Onderzoeksfonds (BOF) UHasselt. Tim Nawrot is holder of a grant from the European Research Council, ERC starting grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burstyn I, 2000, ANN OCCUP HYG, V44, P43, DOI 10.1093/annhyg/44.1.43; Cannino G, 2009, MITOCHONDRION, V9, P377, DOI 10.1016/j.mito.2009.08.009; Carugno M, 2011, ENV HLTH PERSPECT, V120; Choi YS, 2001, DIABETES RES CLIN PR, V54, pS3, DOI 10.1016/S0168-8227(01)00330-8; Chuang JC, 1999, J EXPO ANAL ENV EPID, V9, P85, DOI 10.1038/sj.jea.7500003; Cossarizza A, 2003, ANTIVIR THER, V8, P315; Fortune RG, 1999, ENVIRON HEALTH PERSP, V107, P721; Gevao B, 2007, ARCH ENVIRON CON TOX, V53, P503, DOI 10.1007/s00244-006-0261-6; Gianotti TF, 2008, OBESITY, V16, P1591, DOI 10.1038/oby.2008.253; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hou LF, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-48; Janssen BG, 2012, ENVIRON HEALTH PERSP, V120, P1346, DOI 10.1289/ehp.1104458; Langer S, 2010, ATMOS ENVIRON, V44, P2294, DOI 10.1016/j.atmosenv.2010.04.001; Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1007/BF02255913; Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000; Maertens RM, 2008, ENVIRON SCI TECHNOL, V42, P1747, DOI 10.1021/es702449c; Masayesva BG, 2006, CANCER EPIDEM BIOMAR, V15, P19, DOI 10.1158/1055-9965.EPI-05-0210; Meierhofer D, 2004, CARCINOGENESIS, V25, P1005, DOI 10.1093/carcin/bgh104; MENZIE CA, 1992, ENVIRON SCI TECHNOL, V26, P1278, DOI 10.1021/es00031a002; Mukerjee S, 1997, ENVIRON INT, V23, P657, DOI 10.1016/S0160-4120(97)00068-8; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461; NY ET, 1993, AM IND HYG ASSOC J, V54, P277, DOI 10.1202/0002-8894(1993)054<0277:TRBPAH>2.0.CO;2; Penning TM, 1999, CHEM RES TOXICOL, V12, P1, DOI 10.1021/tx980143n; Pleil JD, 2004, J CHROMATOGR A, V1033, P9, DOI 10.1016/j.chroma.2003.12.074; Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Srogi K, 2007, ENVIRON CHEM LETT, V5, P169, DOI 10.1007/s10311-007-0095-0; Stepanov I, 2009, CHEM RES TOXICOL, V22, P406, DOI 10.1021/tx800398x; Tabish AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034674; Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Whitehead T, 2011, J EXPO SCI ENV EPID, V21, P123, DOI 10.1038/jes.2009.68; Wilson NK, 2003, J EXPO ANAL ENV EPID, V13, P187, DOI 10.1038/sj.jea.7500270; Wong J, 2009, DIABETOLOGIA, V52, P1953, DOI 10.1007/s00125-009-1424-6; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454; Xie H, REDUCED MITOCHONDRIA; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955	43	56	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63208	10.1371/journal.pone.0063208	http://dx.doi.org/10.1371/journal.pone.0063208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658810	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100056
J	Cohen, LD; Zuchman, R; Sorokina, O; Muller, A; Dieterich, DC; Armstrong, JD; Ziv, T; Ziv, NE				Cohen, Laurie D.; Zuchman, Rina; Sorokina, Oksana; Mueller, Anke; Dieterich, Daniela C.; Armstrong, J. Douglas; Ziv, Tamar; Ziv, Noam E.			Metabolic Turnover of Synaptic Proteins: Kinetics, Interdependencies and Implications for Synaptic Maintenance	PLOS ONE			English	Article							MESSENGER-RNA; AXONAL-TRANSPORT; MOLECULAR-DYNAMICS; AMPA RECEPTORS; AMINO-ACIDS; SYNAPSIN-I; LOCALIZATION; TRANSLATION; TRAFFICKING; PROTEOME	Chemical synapses contain multitudes of proteins, which in common with all proteins, have finite lifetimes and therefore need to be continuously replaced. Given the huge numbers of synaptic connections typical neurons form, the demand to maintain the protein contents of these connections might be expected to place considerable metabolic demands on each neuron. Moreover, synaptic proteostasis might differ according to distance from global protein synthesis sites, the availability of distributed protein synthesis facilities, trafficking rates and synaptic protein dynamics. To date, the turnover kinetics of synaptic proteins have not been studied or analyzed systematically, and thus metabolic demands or the aforementioned relationships remain largely unknown. In the current study we used dynamic Stable Isotope Labeling with Amino acids in Cell culture (SILAC), mass spectrometry (MS), Fluorescent Non-Canonical Amino acid Tagging (FUNCAT), quantitative immunohistochemistry and bioinformatics to systematically measure the metabolic half-lives of hundreds of synaptic proteins, examine how these depend on their pre/postsynaptic affiliation or their association with particular molecular complexes, and assess the metabolic load of synaptic proteostasis. We found that nearly all synaptic proteins identified here exhibited half-lifetimes in the range of 2-5 days. Unexpectedly, metabolic turnover rates were not significantly different for presynaptic and postsynaptic proteins, or for proteins for which mRNAs are consistently found in dendrites. Some functionally or structurally related proteins exhibited very similar turnover rates, indicating that their biogenesis and degradation might be coupled, a possibility further supported by bioinformatics-based analyses. The relatively low turnover rates measured here (similar to 0.7% of synaptic protein content per hour) are in good agreement with imaging-based studies of synaptic protein trafficking, yet indicate that the metabolic load synaptic protein turnover places on individual neurons is very substantial.	[Cohen, Laurie D.; Ziv, Noam E.] Technion Israel Inst Technol, Technion Fac Med, Lorry Lokey Ctr Life Sci & Engn, Haifa, Israel; [Cohen, Laurie D.; Ziv, Noam E.] Technion Israel Inst Technol, Network Biol Res Labs, Lorry Lokey Ctr Life Sci & Engn, Haifa, Israel; [Zuchman, Rina; Ziv, Tamar] Technion Israel Inst Technol, Fac Biol, Smoler Prote Ctr, Haifa, Israel; [Sorokina, Oksana; Armstrong, J. Douglas] Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland; [Mueller, Anke; Dieterich, Daniela C.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Mueller, Anke; Dieterich, Daniela C.] Otto Von Guericke Univ, Inst Pharmacol & Toxicol, Magdeburg, Germany	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Edinburgh; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University	Ziv, NE (corresponding author), Technion Israel Inst Technol, Technion Fac Med, Lorry Lokey Ctr Life Sci & Engn, Haifa, Israel.	noamz@netvision.net.il	Sorokina, Oksana V/B-1800-2010; Ziv, Noam/ABA-6551-2020	Sorokina, Oksana V/0000-0002-6786-9945; Ziv, Noam/0000-0001-9197-326X; Dieterich, Daniela C./0000-0002-9880-1214; Ziv, Tamar/0000-0003-4299-7454; Armstrong, Douglas/0000-0002-5397-3864	United States Israel Binational Science Foundation [2007425]; European Union Seventh Framework Programme [HEALTH-F2-2009-241498]; Deutsch-Israelische-Projektkooperation German-Israeli Project Cooperation foundation	United States Israel Binational Science Foundation(US-Israel Binational Science Foundation); European Union Seventh Framework Programme(European Commission); Deutsch-Israelische-Projektkooperation German-Israeli Project Cooperation foundation	This work has received funding from the United States Israel Binational Science Foundation (2007425), the European Union Seventh Framework Programme under grant agreement nos. HEALTH-F2-2009-241498 ("EUROSPIN"), and the Deutsch-Israelische-Projektkooperation German-Israeli Project Cooperation foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Alvarez J, 2000, PROG NEUROBIOL, V62, P1, DOI 10.1016/S0301-0082(99)00062-3; Archibald K, 1998, NEUROPHARMACOLOGY, V37, P1345, DOI 10.1016/S0028-3908(98)00135-X; BAITINGER C, 1987, J NEUROSCI, V7, P3723; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Benson DL, 1997, NEUROREPORT, V8, P823, DOI 10.1097/00001756-199703030-00004; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011429; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brewer GJ, 1996, NEUROREPORT, V7, P1509, DOI 10.1097/00001756-199606170-00014; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Butko MT, 2012, NAT NEUROSCI, V15, P1742, DOI 10.1038/nn.3246; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Cajigas IJ, 2010, EMBO J, V29, P2746, DOI 10.1038/emboj.2010.173; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deglincerti A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120079; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Gerrow K, 2010, CURR OPIN NEUROBIOL, V20, P631, DOI 10.1016/j.conb.2010.06.010; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; Huang F, 2005, J NEUROSCI, V25, P7199, DOI 10.1523/JNEUROSCI.1779-05.2005; Iijima T, 2005, P NATL ACAD SCI USA, V102, P17190, DOI 10.1073/pnas.0504684102; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kalla S, 2006, J NEUROSCI, V26, P13054, DOI 10.1523/JNEUROSCI.4330-06.2006; Kaufman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040980; Kjoller C, 2000, NEUROCHEM INT, V37, P7, DOI 10.1016/S0197-0186(00)00008-5; KLEIMAN R, 1990, NEURON, V5, P821, DOI 10.1016/0896-6273(90)90341-C; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105; Link AJ, 2007, NAT PROTOC, V2, P1884, DOI 10.1038/nprot.2007.269; Mammen AL, 1997, J NEUROSCI, V17, P7351; Marom S, 2010, PROG NEUROBIOL, V90, P16, DOI 10.1016/j.pneurobio.2009.10.003; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Milner E, 2006, MOL CELL PROTEOMICS, V5, P357, DOI 10.1074/mcp.M500241-MCP200; Minerbi A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000136; Mondin M, 2011, J NEUROSCI, V31, P13500, DOI 10.1523/JNEUROSCI.6439-10.2011; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; PETRUCCI TC, 1991, J NEUROSCI, V11, P2938; Pielot Rainer, 2012, Front Synaptic Neurosci, V4, P1, DOI 10.3389/fnsyn.2012.00001; Pontrello Crystal G, 2009, Open Neurosci J, V3, P67; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Ribrault C, 2011, J NEUROSCI, V31, P17590, DOI 10.1523/JNEUROSCI.4065-11.2011; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Scott DA, 2011, NEURON, V70, P441, DOI 10.1016/j.neuron.2011.03.022; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Specht CG, 2008, BIOESSAYS, V30, P1062, DOI 10.1002/bies.20831; Spellman DS, 2008, MOL CELL PROTEOMICS, V7, P1067, DOI 10.1074/mcp.M700387-MCP200; Staras K, 2007, TRENDS NEUROSCI, V30, P292, DOI 10.1016/j.tins.2007.04.005; Staras Kevin, 2010, Front Synaptic Neurosci, V2, P20, DOI 10.3389/fnsyn.2010.00020; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; STEWARD O, 1982, J NEUROSCI, V2, P284; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Tsuriel S, 2009, J NEUROSCI, V29, P351, DOI 10.1523/JNEUROSCI.4777-08.2009; VALLEE RB, 1991, ANNU REV NEUROSCI, V14, P59, DOI 10.1146/annurev.ne.14.030191.000423; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Zeidan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042314; Zhang GA, 2012, J NEUROSCI, V32, P599, DOI 10.1523/JNEUROSCI.2463-11.2012; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370; Zukin RS, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.014.2009	85	120	121	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63191	10.1371/journal.pone.0063191	http://dx.doi.org/10.1371/journal.pone.0063191			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658807	Green Submitted, gold, Green Published			2022-12-25	WOS:000321200500059
J	Zhang, GT; Tsang, CM; Deng, W; Yip, YL; Lui, VWY; Wong, SCC; Cheung, ALM; Hau, PM; Zeng, MS; Lung, ML; Chen, HL; Lo, KW; Takada, K; Tsao, SW				Zhang, Guitao; Tsang, Chi Man; Deng, Wen; Yip, Yim Ling; Lui, Vivian Wai-Yan; Wong, Sze Chuen Cesar; Cheung, Annie Lai-Man; Hau, Pok Man; Zeng, Musheng; Lung, Maria Li; Chen, Honglin; Lo, Kwok Wai; Takada, Kenzo; Tsao, Sai Wah			Enhanced IL-6/IL-6R Signaling Promotes Growth and Malignant Properties in EBV-Infected Premalignant and Cancerous Nasopharyngeal Epithelial Cells	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; STAT3 ACTIVATION; GENE-EXPRESSION; IN-VITRO; IL-6; CARCINOMA; LMP1; TRANSCRIPTION; INFLAMMATION; RECEPTOR	Nasopharyngeal carcinoma (NPC) is etiologically associated with Epstein-Barr virus (EBV) infection. However, the exact role of EBV in NPC pathogenesis remains elusive. Activation of signal transducer and activator of transcription 3 (STAT3) is common in human cancers including NPC and plays an important role in the pathogenesis and progression of human cancers. Interleukin-6 (IL-6), a major inflammatory cytokine, is a potent activator of STAT3. In this study, we report that EBV-infected immortalized nasopharyngeal epithelial (NPE) cells often acquire an enhanced response to IL-6-induced STAT3 activation to promote their growth and invasive properties. Interestingly, this enhanced IL-6/STAT3 response was mediated by overexpression of IL-6 receptor (IL-6R). Furthermore, IL-6R overexpression enhanced IL-6-induced STAT3 activation in uninfected immortalized NPE cells in vitro, and promoted growth and tumorigenicity of EBV-positive NPC cell line (C666-1) in vivo. Moreover, it is shown for the first time that IL-6R was overexpressed in clinical specimens of NPC. IL-6 expression could also be strongly detected in the stromal cells of NPC and a higher circulating level of IL-6 was found in the sera of advance-staged NPC patients compared to the control subjects. Therefore, IL-6R overexpression, coupled with enhanced IL6/STAT3 signaling may facilitate the malignant transformation of EBV-infected premalignant NPE cells into cancer cells, and enhance malignant properties of NPC cells.	[Zhang, Guitao; Tsang, Chi Man; Deng, Wen; Yip, Yim Ling; Cheung, Annie Lai-Man; Hau, Pok Man; Tsao, Sai Wah] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Zhang, Guitao] Capital Med Univ, Dept Anat Histol & Embryol, Beijing, Peoples R China; [Lui, Vivian Wai-Yan] Univ Pittsburgh, Sch Med, Dept Otoloaryngol, Pittsburgh, PA USA; [Wong, Sze Chuen Cesar] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China; [Zeng, Musheng] Sun Yat Sen Univ, Inst Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Lung, Maria Li] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Chen, Honglin] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Lo, Kwok Wai] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Takada, Kenzo] Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido, Japan	University of Hong Kong; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hong Kong Polytechnic University; State Key Lab Oncology South China; Sun Yat Sen University; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Hokkaido University	Tsao, SW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	gswtsao@hkucc.hku.hk	Lui, Vivian W. Y./I-5458-2016; Deng, Wen/M-5208-2019; Chen, Honglin/C-4224-2009; Lung, Maria Li/C-4495-2009; /C-4230-2009	Lui, Vivian W. Y./0000-0001-6918-1573; Chen, Honglin/0000-0001-5108-8338; Lung, Maria Li/0000-0003-2559-3626; /0000-0003-3217-1456; WONG, Sze Chuen Cesar/0000-0003-0058-140X	GRF; Hong Kong Research Grant Council [776608M, 779810M, 780911M]; RGC sponsored Area of Excellence Theme [AoE/M-06/08]; Pittsburgh Foundation, USA; Career 512 Development Program of the Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer [5P50CA097190-05]; Head and Neck Cancer SPORE Developmental Research Award [5P50CA097007]	GRF; Hong Kong Research Grant Council(Hong Kong Research Grants Council); RGC sponsored Area of Excellence Theme; Pittsburgh Foundation, USA; Career 512 Development Program of the Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer; Head and Neck Cancer SPORE Developmental Research Award	This project is funded by GRF grants awarded by the Hong Kong Research Grant Council (Grant number: 776608M; 779810M; 780911M to SWT) and the RGC sponsored Area of Excellence Theme (Grant number: AoE/M-06/08 to MLL). VWL is supported by the Patricia L. Knebel Fund of the Pittsburgh Foundation, USA, the Career 512 Development Program of the Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer (5P50CA097190-05), the Head and Neck Cancer SPORE Developmental Research Award (5P50CA097007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1987, CANCER RES, V47, P3239; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bronte-Tinkew DM, 2009, CANCER RES, V69, P632, DOI 10.1158/0008-5472.CAN-08-1191; BROOKS L, 1992, J VIROL, V66, P2689, DOI 10.1128/JVI.66.5.2689-2697.1992; Buettner M, 2006, VIRCHOWS ARCH, V449, P513, DOI 10.1007/s00428-006-0294-2; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chen HL, 2003, J VIROL, V77, P4139, DOI 10.1128/JVI.77.7.4139-4148.2003; Chen HL, 2001, J VIROL, V75, P2929, DOI 10.1128/JVI.75.6.2929-2937.2001; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Eliopoulos AG, 1997, ONCOGENE, V14, P2899, DOI 10.1038/sj.onc.1201258; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Gourzones C, 2012, SEMINARS CANC BIOL, V22, P127; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li HM, 2006, INT J CANCER, V119, P1567, DOI 10.1002/ijc.22032; Liu YP, 2008, INT J MOL MED, V21, P153; Lo AKF, 2003, LAB INVEST, V83, P697, DOI 10.1097/01.LAB.0000067480.44925.10; Lo AKF, 2006, NEOPLASIA, V8, P173, DOI 10.1593/neo.05625; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lui VWY, 2009, CARCINOGENESIS, V30, P2085, DOI 10.1093/carcin/bgp253; Lui VWY, 2009, INT J CANCER, V125, P1884, DOI 10.1002/ijc.24567; Ma N, 2008, INT J CANCER, V122, P2517, DOI 10.1002/ijc.23415; Man CH, 2012, J PATHOL, V226, P471, DOI 10.1002/path.2997; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Raab-Traub N, 1992, Semin Cancer Biol, V3, P297; Tsang CM, 2012, P NATL ACAD SCI USA, V109, pE3473, DOI 10.1073/pnas.1202637109; Tsang CM, 2010, INT J CANCER, V127, P1570, DOI 10.1002/ijc.25173; Tsao SW, 2012, SEMIN CANCER BIOL, V22, P137, DOI 10.1016/j.semcancer.2012.02.004; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	33	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62284	10.1371/journal.pone.0062284	http://dx.doi.org/10.1371/journal.pone.0062284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658720	Green Published, Green Accepted, gold			2022-12-25	WOS:000319167000038
J	Amos, W				Amos, William			Variation in Heterozygosity Predicts Variation in Human Substitution Rates between Populations, Individuals and Genomic Regions	PLOS ONE			English	Article							MICROSATELLITE MUTATION-RATE; DEMOGRAPHIC HISTORY; GENETIC DIVERSITY; EUKARYOTES; BOTTLENECK; HYPOTHESIS; FAMILIES; CLUSTERS; SEQUENCE; HOTSPOTS	The "heterozygote instability" (HI) hypothesis suggests that gene conversion events focused on heterozygous sites during meiosis locally increase the mutation rate, but this hypothesis remains largely untested. As humans left Africa they lost variability, which, if HI operates, should have reduced the mutation rate in non-Africans. Relative substitution rates were quantified in diverse humans using aligned whole genome sequences from the 1,000 genomes project. Substitution rate is consistently greater in Africans than in non-Africans, but only in diploid regions of the genome, consistent with a role for heterozygosity. Analysing the same data partitioned into a series of non-overlapping 2 Mb windows reveals a strong, nonlinear correlation between the amount of heterozygosity lost "out of Africa" and the difference in substitution rate between Africans and non-Africans. Putative recent mutations, derived variants that occur only once among the 80 human chromosomes sampled, occur preferentially at the centre of 2 Kb windows that have elevated heterozygosity compared both with the same region in a closely related population and with an immediately adjacent region in the same population. More than half of all substitutions appear attributable to variation in heterozygosity. This observation provides strong support for HI with implications for many branches of evolutionary biology.	Univ Cambridge, Dept Zool, Cambridge, Cambs, England	University of Cambridge	Amos, W (corresponding author), Univ Cambridge, Dept Zool, Cambridge, Cambs, England.	w.amos@zoo.cam.ac.uk						Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amos W, 2010, P R SOC B, V277, P131, DOI 10.1098/rspb.2009.1473; Amos W, 2011, P ROY SOC B-BIOL SCI, V278, P1587, DOI 10.1098/rspb.2010.2056; Amos W, 2011, J MOL EVOL, V72, P215, DOI 10.1007/s00239-010-9423-2; Amos W, 2010, P ROY SOC B-BIOL SCI, V277, P1443, DOI 10.1098/rspb.2009.1757; Amos W, 2010, BIOESSAYS, V32, P82, DOI 10.1002/bies.200900108; Amos W, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-72; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; Bromham L, 2011, PHILOS T R SOC B, V366, P2503, DOI 10.1098/rstb.2011.0014; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Drake JW, 2007, CRIT REV BIOCHEM MOL, V42, P247, DOI 10.1080/10409230701495631; Drake JW, 2005, P NATL ACAD SCI USA, V102, P12849, DOI 10.1073/pnas.0503009102; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Gravel S, 2011, P NATL ACAD SCI US; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gronlund F, 2009, TRENDS GENET, V25, P523; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Kimura M., 1983, NEUTRAL THEORY EVOLU; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; McConnell R, 2007, GENETICS, V177, P1499, DOI 10.1534/genetics.107.076067; NAG DK, 1995, GENETICS, V141, P75; Ninio J, 1996, MOL GEN GENET, V251, P503, DOI 10.1007/BF02173638; Nishant KT, 2009, BIOESSAYS, V31, P912, DOI 10.1002/bies.200900017; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Rogozin IB, 2003, MUTAT RES-REV MUTAT, V544, P65, DOI 10.1016/S1383-5742(03)00032-2; ROMANOVSKY MG, 1992, GENETIKA+, V28, P88; Schrider DR, 2011, CURR BIOL, V21, P1051, DOI 10.1016/j.cub.2011.05.013; Schug MD, 1997, NAT GENET, V15, P99, DOI 10.1038/ng0197-99; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TAJIMA F, 1993, GENETICS, V135, P599; Tenaillon MI, 2008, J EVOLUTION BIOL, V21, P541, DOI 10.1111/j.1420-9101.2007.01490.x; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Woodruff RC, 1989, BIOL J LINN SOC, V36, P281	37	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63048	10.1371/journal.pone.0063048	http://dx.doi.org/10.1371/journal.pone.0063048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646173	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300128
J	Lai, CH; Liu, XX; Tian, CL; Wu, FM				Lai, Chaohua; Liu, Xiaoxi; Tian, Changlin; Wu, Fangming			Integrin alpha 1 Has a Long Helix, Extending from the Transmembrane Region to the Cytoplasmic Tail in Detergent Micelles	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; EXTRACELLULAR SEGMENT; NMR; COMPLEX; DOMAIN; SUBUNIT; ACTIVATION; MECHANISM; BINDING	Integrin proteins are very important adhesion receptors that mediate cell-cell and cell-extracellular matrix interactions. They play essential roles in cell signaling and the regulation of cellular shape, motility, and the cell cycle. Here, the transmembrane and cytoplasmic (TMC) domains of integrin alpha 1 and beta 1 were over-expressed and purified in detergent micelles. The structure and backbone relaxations of alpha 1-TMC in LDAO micelles were determined and analyzed using solution NMR. A long helix, extending from the transmembrane region to the cytoplasmic tail, was observed in alpha 1-TMC. Structural comparisons of alpha 1-TMC with reported alpha IIb-TMC domains indicated different conformations in the transmembrane regions and cytoplasmic tails. An NMR titration experiment indicated weak interactions between alpha 1-TMC and beta 1-TMC through several alpha 1-TMC residues located at its N-terminal juxta-transmembrane region and C-terminal extended helix region.	[Lai, Chaohua; Liu, Xiaoxi; Tian, Changlin] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Lai, Chaohua; Liu, Xiaoxi; Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Tian, Changlin; Wu, Fangming] Chinese Acad Sci, High Field Magnet Lab, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Tian, CL (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	cltian@ustc.edu.cn; fmwu@hmfl.ac.cn	Tian, Changlin/P-1469-2014		Chinese National High-Tech Research Grant [2006AA02A321]; National Natural Science Foundation of China [30970577, 31100538]	Chinese National High-Tech Research Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese National High-Tech Research Grant (2006AA02A321) and the National Natural Science Foundation of China (30970577) to CT, and the National Natural Science Foundation of China (31100538) to FW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abair TD, 2008, BLOOD, V112, P3242, DOI 10.1182/blood-2007-12-126433; Ahrens IG, 2006, EXP CELL RES, V312, P925, DOI 10.1016/j.yexcr.2005.11.036; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ekholm E, 2002, AM J PATHOL, V160, P1779, DOI 10.1016/S0002-9440(10)61124-8; Gardner H A, 1999, Curr Rheumatol Rep, V1, P28, DOI 10.1007/s11926-999-0021-5; Gottschalk KE, 2005, STRUCTURE, V13, P703, DOI 10.1016/j.str.2005.02.014; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kalli AC, 2010, STRUCTURE, V18, P1280, DOI 10.1016/j.str.2010.07.012; Karpusas M, 2003, J MOL BIOL, V327, P1031, DOI 10.1016/S0022-2836(03)00203-1; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Loster K, 2001, BIOCHEM J, V356, P233, DOI 10.1042/0264-6021:3560233; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P631, DOI 10.1021/bi201435d; McBrien NA, 2006, INVEST OPHTH VIS SCI, V47, P4674, DOI 10.1167/iovs.05-1150; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Metcalf DG, 2009, J MOL BIOL, V392, P1087, DOI 10.1016/j.jmb.2009.06.032; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Rentala S, 2010, ASIAN J ANDROL, V12, P548, DOI 10.1038/aja.2010.20; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smerling C, 2007, EXP CELL RES, V313, P3153, DOI 10.1016/j.yexcr.2007.06.003; Suk JE, 2012, J AM CHEM SOC, V134, P9030, DOI 10.1021/ja304247f; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Vossmeyer D, 2000, EXP CELL RES, V256, P321, DOI 10.1006/excr.2000.4831; Vossmeyer D, 2002, J BIOL CHEM, V277, P4636, DOI 10.1074/jbc.M105415200; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Weljie AM, 2002, P NATL ACAD SCI USA, V99, P5878, DOI 10.1073/pnas.092515799; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	44	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62954	10.1371/journal.pone.0062954	http://dx.doi.org/10.1371/journal.pone.0062954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646163	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300117
J	Sheppard, HM; Ussher, JE; Verdon, D; Chen, J; Taylor, JA; Dunbar, PR				Sheppard, Hilary M.; Ussher, James E.; Verdon, Daniel; Chen, Jennifer; Taylor, John A.; Dunbar, P. Rod			Recombinant Adeno-Associated Virus Serotype 6 Efficiently Transduces Primary Human Melanocytes	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; GROWTH-FACTOR RECEPTOR; PHASE-I TRIAL; GENE-TRANSFER; TRANSFORMED PHENOTYPE; MELANOMA METASTASES; SIALIC-ACID; CELL-LINES; EXPRESSION; VECTOR	The study of melanocyte biology is important to understand their role in health and disease. However, current methods of gene transfer into melanocytes are limited by safety or efficacy. Recombinant adeno-associated virus (rAAV) has been extensively investigated as a gene therapy vector, is safe and is associated with persistent transgene expression without genome integration. There are twelve serotypes and many capsid variants of rAAV. However, a comparative study to determine which rAAV is most efficient at transducing primary human melanocytes has not been conducted. We therefore sought to determine the optimum rAAV variant for use in the in vitro transduction of primary human melanocytes, which could also be informative to future in vivo studies. We have screened eight variants of rAAV for their ability to transduce primary human melanocytes and identified rAAV6 as the optimal serotype, transducing 7-78% of cells. No increase in transduction was seen with rAAV6 tyrosine capsid mutants. The number of cells expressing the transgene peaked at 6-12 days post-infection, and transduced cells were still detectable at day 28. Therefore rAAV6 should be considered as a non-integrating vector for the transduction of primary human melanocytes.	[Sheppard, Hilary M.; Ussher, James E.; Verdon, Daniel; Chen, Jennifer; Taylor, John A.; Dunbar, P. Rod] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Sheppard, Hilary M.; Taylor, John A.; Dunbar, P. Rod] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand	University of Auckland; University of Auckland	Sheppard, HM (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	h.sheppard@auckland.ac.nz	Ussher, James/O-4493-2019; Dunbar, Rod/C-2570-2012	Ussher, James/0000-0001-9222-7680; Dunbar, Rod/0000-0001-9626-2600; Verdon, Daniel/0000-0001-6060-0065; Sheppard, Hilary/0000-0003-1147-4618	Health Research Council of New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery, NZ	Health Research Council of New Zealand(Health Research Council of New Zealand); Maurice Wilkins Centre for Molecular Biodiscovery, NZ	This research was conducted during the tenure of a Clinical Research Training Fellowship from the Health Research Council of New Zealand (J.U.). The authors also acknowledge funding from the Maurice Wilkins Centre for Molecular Biodiscovery, NZ (http://www.mauricewilkinscentre.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINO AP, 1981, J EXP MED, V154, P1764, DOI 10.1084/jem.154.6.1764; Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; BENNETT DC, 1985, J CELL SCI, V77, P167; BERTHIERVERGNES O, 1990, PIGM CELL RES, V3, P55, DOI 10.1111/j.1600-0749.1990.tb00323.x; Brantly ML, 2006, HUM GENE THER, V17, P1177, DOI 10.1089/hum.2006.17.1177; Brantly ML, 2009, P NATL ACAD SCI USA, V106, P16363, DOI 10.1073/pnas.0904514106; Breckpot K, 2007, GENE THER, V14, P847, DOI 10.1038/sj.gt.3302947; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Chen JL, 2000, J IMMUNOL, V165, P948, DOI 10.4049/jimmunol.165.2.948; Coleman AB, 1998, J INVEST DERMATOL, V110, P793, DOI 10.1046/j.1523-1747.1998.00166.x; Conner SR, 2003, J BIOL CHEM, V278, P34548, DOI 10.1074/jbc.M305797200; Dunlap S, 2004, J INVEST DERMATOL, V122, P549, DOI 10.1046/j.0022-202X.2004.22214.x; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Flotte T, 1996, HUM GENE THER, V7, P1145, DOI 10.1089/hum.1996.7.9-1145; Flotte TR, 2003, HUM GENE THER, V14, P1079, DOI 10.1089/104303403322124792; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Gargiulo A, 2009, MOL THER, V17, P1347, DOI 10.1038/mt.2009.112; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hamm A, 2002, TISSUE ENG, V8, P235, DOI 10.1089/107632702753725003; Hamoen KE, 2001, MELANOMA RES, V11, P89, DOI 10.1097/00008390-200104000-00002; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; HOUGHTON AN, 1987, J EXP MED, V165, P812, DOI 10.1084/jem.165.3.812; JIMBOW K, 1975, J CELL BIOL, V66, P663, DOI 10.1083/jcb.66.3.663; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Li W, 2008, MOL THER, V16, P1252, DOI 10.1038/mt.2008.100; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Locke M, 2011, TISSUE ENG PART C-ME, V17, P949, DOI [10.1089/ten.tec.2011.0153, 10.1089/ten.TEC.2011.0153]; Manno CS, 2003, BLOOD, V101, P2963, DOI 10.1182/blood-2002-10-3296; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mirmohammadsadegh A, 2005, J INVEST DERMATOL, V125, P392, DOI 10.1111/j.0022-202X.2005.23772.x; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Nesbit M, 1999, ONCOGENE, V18, P6469, DOI 10.1038/sj.onc.1203066; Ng R, 2010, J VIROL, V84, P12945, DOI 10.1128/JVI.01235-10; PIEPKORN M, 1995, IN VITRO CELL DEV-AN, V31, P536; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Qiao CP, 2010, HUM GENE THER, V21, P1343, DOI 10.1089/hum.2010.003; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; Rabinowitz JE, 1998, CURR OPIN BIOTECH, V9, P470, DOI 10.1016/S0958-1669(98)80031-1; Rohr UP, 2002, J VIROL METHODS, V105, P265, DOI 10.1016/S0166-0934(02)00117-9; Schiaffino MV, 2002, HUM GENE THER, V13, P947, DOI 10.1089/10430340252939050; Schmidt M, 2008, J VIROL, V82, P1399, DOI 10.1128/JVI.02012-07; Smith RH, 2008, GENE THER, V15, P817, DOI 10.1038/gt.2008.55; Snyder RO, 2005, CURR GENE THER, V5, P311, DOI 10.2174/1566523054065066; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Taylor KL, 2011, DEVELOPMENT, V138, P3579, DOI 10.1242/dev.064014; Thomas CE, 2004, J VIROL, V78, P3110, DOI 10.1128/JVI.78.6.3110-3122.2004; Ussher JE, 2010, HUM GENE THER, V21, P1675, DOI 10.1089/hum.2010.087; Van Gele M, 2008, J INVEST DERMATOL, V128, P2474, DOI 10.1038/jid.2008.100; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vogl A, 2005, J INVEST DERMATOL, V124, P401, DOI 10.1111/j.0022-202X.2004.23603.x; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; Weber M, 2003, MOL THER, V7, P774, DOI 10.1016/S1525-0016(03)00098-4; Weller ML, 2010, NAT MED, V16, P662, DOI 10.1038/nm.2145; Wu Z, 2006, J VIROL, V80, P11393, DOI 10.1128/JVI.01288-06; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06; Yang GS, 2002, J VIROL, V76, P7651, DOI 10.1128/JVI.76.15.7651-7660.2002; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	62	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62753	10.1371/journal.pone.0062753	http://dx.doi.org/10.1371/journal.pone.0062753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646140	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300093
J	Vizzini, A; Bonura, A; Parrinello, D; Sanfratello, MA; Longo, V; Colombo, P				Vizzini, Aiti; Bonura, Angela; Parrinello, Daniela; Sanfratello, Maria Antonietta; Longo, Valeria; Colombo, Paolo			LPS Challenge Regulates Gene Expression and Tissue Localization of a Ciona intestinalis Gene through an Alternative Polyadenylation Mechanism	PLOS ONE			English	Article							MESSENGER-RNA POLYADENYLATION; INFLAMMATORY-LIKE REACTION; SYSTEM; PROLIFERATION; TUNICATA; COLLAGEN; PHARYNX; CLONING	A subtractive hybridization strategy for the identification of differentially expressed genes was performed between LPS-challenged and naive Ciona intestinalis. This strategy allowed the characterization of two transcripts (Ci8short and Ci8long) generated by the use of two Alternative Polyadenylation sites. The Ci8long transcript contains a protein domain with relevant homology to several components of the Receptor Transporting Protein (RTP) family not present in the Ci8short mRNA. By means of Real Time PCR and Northern Blot, the Ci8short and Ci8long transcripts showed a different pattern of gene expression with the Ci8short mRNA being strongly activated after LPS injection in the pharynx. In situ hybridization analysis demonstrated that the activation of the APA site also influenced the tissue localization of the Ci8short transcript. This analysis showed that the Ci8long mRNA was expressed in hemocytes meanwhile the Ci8short mRNA was highly transcribed also in vessel endothelial cells and in the epithelium of pharynx. These findings demonstrated that regulation of gene expression based on different polyadenylation sites is an ancestral powerful strategy influencing both the level of expression and tissue distribution of alternative transcripts.	[Vizzini, Aiti; Parrinello, Daniela; Sanfratello, Maria Antonietta] Dipartimento Sci & Tecnol Biol Chim & Farmaceut, Palermo, Italy; [Bonura, Angela; Longo, Valeria; Colombo, Paolo] CNR, Ist Biomed & Immunol Mol Alberto Monroy, Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR)	Colombo, P (corresponding author), CNR, Ist Biomed & Immunol Mol Alberto Monroy, Palermo, Italy.	paolo.colombo@ibim.cnr.it	Colombo, Paolo/ABD-2985-2020; Bonura, Angela/AAY-6091-2020; Colombo, Paolo/O-7284-2019	Colombo, Paolo/0000-0002-0908-1359; VIZZINI, Aiti/0000-0002-0786-7294; LONGO, VALERIA/0000-0002-8328-0698; BONURA, ANGELA/0000-0002-7006-9279	Bando Prin; MIUR Progetto PRIN	Bando Prin; MIUR Progetto PRIN(Ministry of Education, Universities and Research (MIUR))	This work was supported by Bando Prin 2010-2011, and by a grant from: MIUR Progetto PRIN 2010-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonura A, 2010, CELL TISSUE RES, V342, P411, DOI 10.1007/s00441-010-1072-7; Bonura A, 2009, MOL IMMUNOL, V46, P2389, DOI 10.1016/j.molimm.2009.04.035; Cammarata M, 2008, CELL TISSUE RES, V333, P481, DOI 10.1007/s00441-008-0649-x; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Giacomelli S, 2012, FISH SHELLFISH IMMUN, V33, P946, DOI 10.1016/j.fsi.2012.08.003; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Lutz CS, 2011, WIRES RNA, V2, P22, DOI 10.1002/wrna.47; Mainland J, 2012, ADV EXP MED BIOL, V744, P75, DOI 10.1007/978-1-4614-2364-5_7; MARTINUCCI GB, 1988, TISSUE CELL, V20, P119, DOI 10.1016/0040-8166(88)90012-2; PARRINELLO N, 1984, BIOL BULL, V167, P238, DOI 10.2307/1541351; PARRINELLO N, 1984, BIOL BULL, V167, P229, DOI 10.2307/1541350; PARRINELLO N, 1981, DEV COMP IMMUNOL, V5, P33, DOI 10.1016/S0145-305X(81)80005-5; Parrinello N., 2010, CELL TISSUE RES; Parrinello N, 2008, CELL TISSUE RES, V334, P305, DOI 10.1007/s00441-008-0695-4; Parrinello N, 2007, CELL TISSUE RES, V329, P379, DOI 10.1007/s00441-007-0415-5; Pinto MR, 2003, J IMMUNOL, V171, P5521, DOI 10.4049/jimmunol.171.10.5521; RAFTOS DA, 1991, P NATL ACAD SCI USA, V88, P9518, DOI 10.1073/pnas.88.21.9518; RAFTOS DA, 1991, IMMUNOL CELL BIOL, V69, P225, DOI 10.1038/icb.1991.33; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Vizzini A, 2002, BBA-GENE STRUCT EXPR, V1577, P38, DOI 10.1016/S0167-4781(02)00403-7; Vizzini A, 2008, DEV COMP IMMUNOL, V32, P682, DOI 10.1016/j.dci.2007.10.006; Vizzini A, 2012, FISH SHELLFISH IMMUN, V32, P101, DOI 10.1016/j.fsi.2011.10.028; Yang Q, 2010, P NATL ACAD SCI USA, V107, P10062, DOI 10.1073/pnas.1000848107	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63235	10.1371/journal.pone.0063235	http://dx.doi.org/10.1371/journal.pone.0063235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646203	Green Submitted, gold, Green Published			2022-12-25	WOS:000319077300161
J	Zhang, CY; Lu, XJ; Du, XQ; Jian, J; Shu, L; Ma, Y				Zhang, Chun-Ying; Lu, Xiao-Jun; Du, Xiao-Qing; Jian, Jun; Shu, Ling; Ma, Ying			Phylogenetic and Evolutionary Analysis of Chinese Leishmania Isolates Based on Multilocus Sequence Typing	PLOS ONE			English	Article							DONOVANI COMPLEX; EPIDEMIOLOGY; POPULATIONS; GENOTYPES; GENETICS; TAXONOMY; STRAINS	Leishmaniasis is a debilitating infectious disease that has a variety of clinical forms. In China, visceral leishmaniasis (VL) is the most common symptom, and L. donovani and/or L. infantum are the likely pathogens. In this study, multilocus sequence typing (MLST) of five enzyme-coding genes (fh, g6pdh, icd, mpi, pgd) and two conserved genes (hsp70, lack) was used to investigate the phylogenetic relationships of Chinese Leishmania strains. Concatenated alignment of the nucleotide sequences of the seven genes was analyzed and phylogenetic trees were constructed using neighbor-joining and maximum parsimony models. A set of additional sequences from 25 strains (24 strains belong to the L. donovani complex and one strain belongs to L. gerbilli) were retrieved from GenBank to infer the molecular evolutionary history of Leishmania from China and other endemic areas worldwide. Phylogenetic analyses consolidated Chinese Leishmania into four groups: (i) one clade A population comprised 13 isolates from different foci in China, which were pathogenic to humans and canines. This population was subdivided into two subclades, clade A1 and clade A2, which comprised sister organisms to the remaining members of the worldwide L. donovani complex; (ii) a population in clade B consisted of one reference strain of L. turanica and five Chinese strains from Xinjiang; (iii) clade C (SELF-7 and EJNI-154) formed a population that was closely related to clade B, and both isolates were identified as L. gerbilli; and (iv) the final group, clade D, included Sauroleishmania (LIZRD and KXG-E) and was distinct from the other strains. We hypothesize that the phylogeny of Chinese Leishmania is associated with the geographical origins rather than with the clinical forms (VL or CL) of leishmaniasis. To conclude, this study provides further molecular information on Chinese Leishmania isolates and the Chinese isolates appear to have a more complex evolutionary history than previously thought.	[Zhang, Chun-Ying; Lu, Xiao-Jun; Du, Xiao-Qing; Jian, Jun; Shu, Ling; Ma, Ying] Sichuan Univ, West China Hosp, Dept Lab Med, Div Clin Microbiol, Chengdu 610064, Peoples R China	Sichuan University	Ma, Y (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Div Clin Microbiol, Chengdu 610064, Peoples R China.	majiying72@hotmail.com			National Nature Science Foundations of China [81071425]	National Nature Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundations of China(81071425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; Cao DP, 2011, PARASITOL RES, V109, P163, DOI 10.1007/s00436-010-2239-6; Cruz I, 2006, INDIAN J MED RES, V123, P357; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Fraga J, 2010, INFECT GENET EVOL, V10, P238, DOI 10.1016/j.meegid.2009.11.007; Gonzalez-Aseguinolaza G, 1999, EUR J BIOCHEM, V259, P909, DOI 10.1046/j.1432-1327.1999.00122.x; Guan Li-Ren, 2009, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V27, P394; Guan LiRen, 2000, Endemic Diseases Bulletin, V15, P49; Guan LiRen, 2003, Chinese Journal of Parasitology and Parasitic Diseases, V21, P285; Guan LR, 1982, CHINESE J EPIDEMIOLO, V4, P261; Hu Y.D., 1976, STUDY EPIDEMIC DIS C, V3, P225; Kuhls K, 2005, MICROBES INFECT, V7, P1224, DOI 10.1016/j.micinf.2005.04.009; Kuhls K, 2007, MICROBES INFECT, V9, P334, DOI 10.1016/j.micinf.2006.12.009; Lu Dian-mei, 2001, Chinese Journal of Parasitology and Parasitic Diseases, V19, P290; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Mauricio IL, 2006, INT J PARASITOL, V36, P757, DOI 10.1016/j.ijpara.2006.03.006; Ochsenreither S, 2006, J CLIN MICROBIOL, V44, P495, DOI 10.1128/JCM.44.2.495-503.2006; Osman Y., 2011, Endemic Diseases Bulletin / Di Fang Bing Tong Bao, V26, P3; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reale S, 2010, TRANSBOUND EMERG DIS, V57, P37, DOI 10.1111/j.1865-1682.2010.01131.x; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; Schonian G, 2011, PARASITOLOGY, V138, P405, DOI 10.1017/S0031182010001538; Schonian G, 2008, TRENDS PARASITOL, V24, P135, DOI 10.1016/j.pt.2007.12.006; Schonian G, 2010, TRENDS PARASITOL, V26, P466, DOI 10.1016/j.pt.2010.06.013; Schonian G, 1996, MOL BIOCHEM PARASIT, V77, P19, DOI 10.1016/0166-6851(96)02572-8; Segatto M, 2012, MEM I OSWALDO CRUZ, V107, P39, DOI 10.1590/S0074-02762012000100006; Sun K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-75; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tintaya KWQ, 2004, J INFECT DIS, V189, P1035, DOI 10.1086/382049; Tsukayama P, 2009, INT J PARASITOL, V39, P355, DOI 10.1016/j.ijpara.2008.08.004; Waki K, 2007, EUKARYOT CELL, V6, P198, DOI 10.1128/EC.00282-06; Wang JY, 2010, PARASITOL INT, V59, P331, DOI 10.1016/j.parint.2010.04.002; Wang Y, 2010, PARASITOL RES, V106, P1385, DOI 10.1007/s00436-010-1814-1; Yan Lei, 1995, Endemic Diseases Bulletin, V10, P4; Yang BB, 2010, PARASITOL RES, V107, P1049, DOI 10.1007/s00436-010-1969-9; Zemanova E, 2007, INT J PARASITOL, V37, P149, DOI 10.1016/j.ijpara.2006.08.008; Zhou XD, 2009, INT J ORAL SCI, V1, P1	40	28	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63124	10.1371/journal.pone.0063124	http://dx.doi.org/10.1371/journal.pone.0063124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646184	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300139
J	Juang, JH; Shen, CR; Wang, JJ; Kuo, CH; Chien, YW; Kuo, HY; Chen, FR; Chen, MH; Yen, TC; Tsai, ZT				Juang, Jyuhn-Huarng; Shen, Chia-Rui; Wang, Jiun-Jie; Kuo, Chien-Hung; Chien, Yu-Wen; Kuo, Hsiao-Yunn; Chen, Fu-Rong; Chen, Ming H.; Yen, Tzu-Chen; Tsai, Zei-Tsan			Magnetic Resonance Imaging of Mouse Islet Grafts Labeled with Novel Chitosan-Coated Superparamagnetic Iron Oxide Nanoparticles	PLOS ONE			English	Article							PANCREATIC-ISLETS; IN-VIVO; TRANSPLANTED ISLETS; DIABETES-MELLITUS; LIVER; MRI; PARTICLES; SURVIVAL	Object: To better understand the fate of islet isografts and allografts, we utilized a magnetic resonance (MR) imaging technique to monitor mouse islets labeled with a novel MR contrast agent, chitosan-coated superparamagnetic iron oxide (CSPIO) nanoparticles. Materials and Methods: After being incubated with and without CSPIO (10 mu g/ml), C57BL/6 mouse islets were examined under transmission electron microscope (TEM) and their insulin secretion was measured. Cytotoxicity was examined in alpha (alpha TC1) and beta (NIT-1 and beta TC) cell lines as well as islets. C57BL/6 mice were used as donors and inbred C57BL/6 and Balb/c mice were used as recipients of islet transplantation. Three hundred islets were transplanted under the left kidney capsule of each mouse and then MR was performed in the recipients periodically. At the end of study, the islet graft was removed for histology and TEM studies. Results: After incubation of mouse islets with CSPIO (10 mu g/mL), TEM showed CSPIO in endocytotic vesicles of alpha- and beta-cells at 8 h. Incubation with CSPIO did not affect insulin secretion from islets and death rates of alpha TC1, NIT-1 and beta TC cell lines as well as islets. After syngeneic and allogeneic transplantation, grafts of CSPIO-labeled islets were visualized on MR scans as persistent hypointense areas. At 8 weeks after syngeneic transplantation and 31 days after allogeneic transplantation, histology of CSPIO-labeled islet grafts showed colocalized insulin and iron staining in the same areas but the size of allografts decreased with time. TEM with elementary iron mapping demonstrated CSPIO distributed in the cytoplasm of islet cells, which maintained intact ultrastructure. Conclusion: Our results indicate that after syngeneic and allogeneic transplantation, islets labeled with CSPIO nanoparticles can be effectively and safely imaged by MR.	[Juang, Jyuhn-Huarng; Chien, Yu-Wen] Chang Gung Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Tao Yuan, Taiwan; [Juang, Jyuhn-Huarng; Chien, Yu-Wen] Chang Gung Univ, Coll Med, Dept Med, Tao Yuan, Taiwan; [Shen, Chia-Rui; Kuo, Hsiao-Yunn] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Shen, Chia-Rui; Yen, Tzu-Chen; Tsai, Zei-Tsan] Chang Gung Mem Hosp, Mol Imaging Ctr, Tao Yuan, Taiwan; [Wang, Jiun-Jie; Yen, Tzu-Chen] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Kuo, Chien-Hung] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chen, Fu-Rong] Natl Tsing Hua Univ, Ctr Transmiss Microscopy, Hsinchu, Taiwan; [Chen, Ming H.] Univ Alberta, Surg Med Res Inst, Edmonton, AB, Canada; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; National Tsing Hua University; University of Alberta; Chang Gung Memorial Hospital	Juang, JH (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Tao Yuan, Taiwan.	jjuang@adm.cgmh.org.tw; zeitsan@ms9.hinet.net	Chou, Jung-Chuan/I-5924-2019	Chou, Jung-Chuan/0000-0002-8829-3404; Wang, Jiun-Jie/0000-0002-2422-9059; Shen, Chia-Rui/0000-0002-8386-3965; CHEN, Fu-Rong/0000-0003-4707-6590	Chang Gung Memorial Hospital [CMRPG370361-2, CMRPG370871-2, CMRPG391701-2]; National Science Council of Taiwan, ROC [NSC 96-2314-B-182A-039-MY3, 99-2314-B-182A-010-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Chang Gung Memorial Hospital (CMRPG370361-2, CMRPG370871-2, CMRPG391701-2) and the National Science Council (NSC 96-2314-B-182A-039-MY3, 99-2314-B-182A-010-MY3) of Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkova Z, 2005, TRANSPL P, V37, P3496, DOI 10.1016/j.transproceed.2005.09.052; Berkova Z, 2008, TRANSPLANTATION, V85, P155, DOI 10.1097/01.tp.0000297247.08627.ff; Briley-Saebo KC, 2006, INVEST RADIOL, V41, P560, DOI 10.1097/01.rli.0000221321.90261.09; Brillet PY, 2005, EUR RADIOL, V15, P1369, DOI 10.1007/s00330-004-2586-8; Cher T, 2010, APPL RADIOL, V39, P26; Di Gialleonardo V, 2012, ENDOCR REV, V33, P892, DOI 10.1210/er.2011-1041; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Evgenov NV, 2008, TRANSPLANTATION, V85, P1091, DOI 10.1097/TP.0b013e31816b183e; Evgenov NV, 2006, DIABETES, V55, P2419, DOI 10.2337/db06-0484; Evgenov NV, 2006, NAT MED, V12, P144, DOI 10.1038/nm1316; Gaglia JL, 2011, J CLIN INVEST, V121, P442, DOI 10.1172/JCI44339; Hathout E, 2009, PEDIATR TRANSPLANT, V13, P892, DOI 10.1111/j.1399-3046.2008.01088.x; Ichii H, 2005, AM J TRANSPLANT, V5, P1635, DOI 10.1111/j.1600-6143.2005.00913.x; Jiao Y, 2008, ANAT REC, V291, P1684, DOI 10.1002/ar.20770; Jirak D, 2004, MAGN RESON MED, V52, P1228, DOI 10.1002/mrm.20282; Juang JH, 2010, TRANSPL P, V42, P4217, DOI 10.1016/j.transproceed.2010.09.089; Juang JH, 2010, TRANSPL P, V42, P2104, DOI 10.1016/j.transproceed.2010.05.103; Juang JH, 2001, CELL TRANSPLANT, V10, P277, DOI 10.3727/000000001783986738; Kriz J, 2008, TRANSPL P, V40, P444, DOI 10.1016/j.transproceed.2008.02.018; Kriz J, 2005, TRANSPLANTATION, V80, P1596, DOI 10.1097/01.tp.0000183959.73681.b9; Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b; Malosio ML, 2009, AM J TRANSPLANT, V9, P2372, DOI 10.1111/j.1600-6143.2009.02791.x; Marzola P, 2009, CONTRAST MEDIA MOL I, V4, P135, DOI 10.1002/cmmi.274; Medarova Z, 2009, NAT REV ENDOCRINOL, V5, P444, DOI 10.1038/nrendo.2009.130; Medarova Z, 2009, TRANSPLANTATION, V87, P1659, DOI 10.1097/TP.0b013e3181a5cbc0; Meloche RM, 2007, WORLD J GASTROENTERO, V13, P6347, DOI 10.3748/wjg.13.6347; Muller K, 2007, BIOMATERIALS, V28, P1629, DOI 10.1016/j.biomaterials.2006.12.002; Paty BW, 2004, TRANSPLANTATION, V77, P1133, DOI 10.1097/01.TP.0000113231.90613.0E; ROSS DD, 1989, CANCER RES, V49, P3776; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Saudek F, 2010, TRANSPLANTATION, V90, P1602, DOI 10.1097/TP.0b013e3181ffba5e; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Tai JH, 2006, DIABETES, V55, P2931, DOI 10.2337/db06-0393; Toso C, 2008, AM J TRANSPLANT, V8, P701, DOI 10.1111/j.1600-6143.2007.02120.x; Tsai ZT, 2010, J MAGN MAGN MATER, V322, P208, DOI 10.1016/j.jmmm.2009.08.049; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Zhang SZ, 2009, PANCREAS, V38, P293, DOI 10.1097/MPA.0b013e318190d77a	38	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62626	10.1371/journal.pone.0062626	http://dx.doi.org/10.1371/journal.pone.0062626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658638	gold, Green Published, Green Submitted			2022-12-25	WOS:000321662800052
J	Kim, W; Tengra, FK; Young, Z; Shong, J; Marchand, N; Chan, HK; Pangule, RC; Parra, M; Dordick, JS; Plawsky, JL; Collins, CH				Kim, Wooseong; Tengra, Farah K.; Young, Zachary; Shong, Jasmine; Marchand, Nicholas; Chan, Hon Kit; Pangule, Ravindra C.; Parra, Macarena; Dordick, Jonathan S.; Plawsky, Joel L.; Collins, Cynthia H.			Spaceflight Promotes Biofilm Formation by Pseudomonas aeruginosa	PLOS ONE			English	Article							SHEAR MODELED MICROGRAVITY; MULTICELLULAR STRUCTURES; ESCHERICHIA-COLI; GENE-EXPRESSION; IV PILI; MOTILITY; GROWTH; VIRULENCE; FLAGELLAR; SYSTEM	Understanding the effects of spaceflight on microbial communities is crucial for the success of long-term, manned space missions. Surface-associated bacterial communities, known as biofilms, were abundant on the Mir space station and continue to be a challenge on the International Space Station. The health and safety hazards linked to the development of biofilms are of particular concern due to the suppression of immune function observed during spaceflight. While planktonic cultures of microbes have indicated that spaceflight can lead to increases in growth and virulence, the effects of spaceflight on biofilm development and physiology remain unclear. To address this issue, Pseudomonas aeruginosa was cultured during two Space Shuttle Atlantis missions: STS-132 and STS-135, and the biofilms formed during spaceflight were characterized. Spaceflight was observed to increase the number of viable cells, biofilm biomass, and thickness relative to normal gravity controls. Moreover, the biofilms formed during spaceflight exhibited a column-and-canopy structure that has not been observed on Earth. The increase in the amount of biofilms and the formation of the novel architecture during spaceflight were observed to be independent of carbon source and phosphate concentrations in the media. However, flagella-driven motility was shown to be essential for the formation of this biofilm architecture during spaceflight. These findings represent the first evidence that spaceflight affects community-level behaviors of bacteria and highlight the importance of understanding how both harmful and beneficial human-microbe interactions may be altered during spaceflight.	[Kim, Wooseong; Tengra, Farah K.; Young, Zachary; Shong, Jasmine; Marchand, Nicholas; Chan, Hon Kit; Pangule, Ravindra C.; Dordick, Jonathan S.; Plawsky, Joel L.; Collins, Cynthia H.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Kim, Wooseong; Tengra, Farah K.; Shong, Jasmine; Marchand, Nicholas; Pangule, Ravindra C.; Dordick, Jonathan S.; Collins, Cynthia H.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA; [Parra, Macarena] Lockheed Martin, Ames Res Ctr, Moffett Field, CA USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Lockheed Martin; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Collins, CH (corresponding author), Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA.	ccollins@rpi.edu	Young, Zachary D/V-5031-2017; Kim, Wooseong/AAQ-3221-2020; Kim, Wooseong/A-9256-2017	Young, Zachary D/0000-0002-3781-1101; Kim, Wooseong/0000-0002-4597-8374; Kim, Wooseong/0000-0002-4597-8374; Collins, Cynthia/0000-0003-1647-860X	NASA [NNX09AI70G]	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by NASA Grant NNX09AI70G to CHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Benoit MR, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/046007; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; Castaneda RJ., 2007, J EXP MICROBIOL IMMU, V11, P23; Crabbe A, 2008, ENVIRON MICROBIOL, V10, P2098, DOI 10.1111/j.1462-2920.2008.01631.x; Crabbe A, 2011, APPL ENVIRON MICROB, V77, P1221, DOI 10.1128/AEM.01582-10; Crabbe A, 2010, ENVIRON MICROBIOL, V12, P1545, DOI 10.1111/j.1462-2920.2010.02184.x; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; England LS, 2003, BBA-GEN SUBJECTS, V1624, P76, DOI 10.1016/j.bbagen.2003.09.012; Gu JD, 1998, INT BIODETER BIODEGR, V41, P25, DOI 10.1016/S0964-8305(97)00070-X; Guadarrama S, 2005, Gravit Space Biol Bull, V18, P85; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harmsen M, 2010, FEMS IMMUNOL MED MIC, V59, P253, DOI 10.1111/j.1574-695X.2010.00690.x; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Hogardt M, 2004, MICROBIOL-SGM, V150, P843, DOI 10.1099/mic.0.26703-0; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Klaus D, 1997, MICROBIOL-SGM, V143, P449, DOI 10.1099/00221287-143-2-449; Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Lynch SV, 2006, APPL ENVIRON MICROB, V72, P7701, DOI 10.1128/AEM.01294-06; Marcu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015361; McLean RJC, 2001, FEMS MICROBIOL LETT, V195, P115, DOI 10.1016/S0378-1097(00)00549-8; Merritt JH, 2005, CURR PROTOC MICROBIO, V1; Nelson Emily S, 2004, J Gravit Physiol, V11, P1; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x; Sternberg Claus, 2006, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b02s00; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; Storrs-Mabilat M, 2001, STUDY MICROBIAL DETE; Toutain CM, 2005, J BACTERIOL, V187, P771, DOI 10.1128/JB.187.2.771-777.2005; Videla HA, 2005, INT MICROBIOL, V8, P169; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Wilson JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003923	34	111	123	8	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62437	10.1371/journal.pone.0062437	http://dx.doi.org/10.1371/journal.pone.0062437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658630	Green Submitted, Green Published, gold			2022-12-25	WOS:000321662800045
J	Modi, KK; Sendtner, M; Pahan, K				Modi, Khushbu K.; Sendtner, Michael; Pahan, Kalipada			Up-regulation of Ciliary Neurotrophic Factor in Astrocytes by Aspirin IMPLICATIONS FOR REMYELINATION IN MULTIPLE SCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLARY ACIDIC PROTEIN; LIPID-LOWERING DRUG; NEUTRAL SPHINGOMYELINASE; CNTF; DISEASE; CELLS; GEMFIBROZIL; NEURONS; KINASE; CAMP	Ciliary neurotrophic factor (CNTF) is a promyelinating trophic factor, and the mechanisms by which CNTF expression could be increased in the brain are poorly understood. Acetylsalicylic acid (aspirin) is one of the most widely used analgesics. Interestingly, aspirin increased mRNA and protein expression of CNTF in primary mouse and human astrocytes in a dose- and time-dependent manner. Aspirin induced the activation of protein kinase A (PKA) but not protein kinase C (PKC). H-89, an inhibitor of PKA, abrogated aspirin-induced expression of CNTF. The activation of cAMP-response element-binding protein (CREB), but not NF-kappa B, by aspirin, the abrogation of aspirin-induced expression of CNTF by siRNA knockdown of CREB, the presence of a consensus cAMP-response element in the promoter of CNTF, and the recruitment of CREB and CREB-binding protein to the CNTF promoter by aspirin suggest that aspirin increases the expression of the Cntf gene via the activation of CREB. Furthermore, we demonstrate that aspirin-induced astroglial CNTF was also functionally active and that supernatants of aspirin-treated astrocytes of wild type, but not Cntf null, mice increased myelin-associated proteins in oligodendrocytes and protected oligodendrocytes from TNF-alpha insult. These results highlight a new and novel myelinogenic property of aspirin, which may be of benefit for multiple sclerosis and other demyelinating disorders.	[Modi, Khushbu K.; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Sendtner, Michael] Univ Wurzburg, Inst Clin Neurobiol, D-97078 Wurzburg, Germany; [Pahan, Kalipada] Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL 60612 USA	Rush University; University of Wurzburg; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 West Harrison St,Ste Cohn 320, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu	Sendtner, Michael/J-1542-2012; Sendtner, Michael/M-8137-2014	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974	National Institutes of Health [AT6681]; Veteran Affairs Merit Award [I01BX002174]; National Center for Complementary & Integrative Health [R01AT006681] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Affairs Merit Award; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant AT6681. This work was also supported by Veteran Affairs Merit Award I01BX002174.	Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696; Aubin N, 1998, J NEUROCHEM, V71, P1635, DOI 10.1046/j.1471-4159.1998.71041635.x; Bae MK, 2006, BBA-MOL CELL RES, V1763, P282, DOI 10.1016/j.bbamcr.2006.01.005; BARRES BA, 1993, DEVELOPMENT, V118, P283; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; BUDD JS, 1993, J ROY SOC MED, V86, P261; Corbett GT, 2012, J IMMUNOL, V189, P1002, DOI 10.4049/jimmunol.1102624; Dhaunchak AS, 2011, J NEUROSCI, V31, P14961, DOI 10.1523/JNEUROSCI.2097-11.2011; Emerich DF, 2006, CURR GENE THER, V6, P147, DOI 10.2174/156652306775515547; Ghosh A, 2012, J BIOL CHEM, V287, P38922, DOI 10.1074/jbc.M112.365148; Ghosh A, 2012, J BIOL CHEM, V287, P27189, DOI 10.1074/jbc.M112.346932; Giess R, 2002, ARCH NEUROL-CHICAGO, V59, P407, DOI 10.1001/archneur.59.3.407; HAFLER DA, 1989, IMMUNOL TODAY, V10, P104, DOI 10.1016/0167-5699(89)90236-3; Ito Y, 2006, P NATL ACAD SCI USA, V103, P7871, DOI 10.1073/pnas.0602332103; Jana A, 2007, J NEUROIMMUNE PHARM, V2, P184, DOI 10.1007/s11481-007-9066-2; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; Kuhlmann T, 2006, AM J PATHOL, V169, P584, DOI 10.2353/ajpath.2006.051086; LAUDANNO OM, 1987, AM J MED, V83, P43, DOI 10.1016/0002-9343(87)90850-3; Leung FW, 2008, DIGEST DIS SCI, V53, P2604, DOI 10.1007/s10620-007-0178-6; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Linker RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007624; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; Lu ZQ, 2009, J NEUROIMMUNOL, V206, P58, DOI 10.1016/j.jneuroim.2008.10.014; Mao LM, 2007, BRAIN RES BULL, V72, P302, DOI 10.1016/j.brainresbull.2007.01.009; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; Pahan K, 2010, J NEUROIMMUNE PHARM, V5, P165, DOI 10.1007/s11481-010-9219-6; Riedel W, 2003, MOL CELL BIOCHEM, V247, P83, DOI 10.1023/A:1024142400835; Stankoff B, 2002, J NEUROSCI, V22, P9221; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; TAYLOR SS, 1995, FASEB J, V9, P1255, DOI 10.1096/fasebj.9.13.7557015; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99	37	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18533	18545		10.1074/jbc.M112.447268	http://dx.doi.org/10.1074/jbc.M112.447268			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653362	Green Published, hybrid			2022-12-25	WOS:000320721900054
J	Zebda, N; Tian, YF; Tian, XY; Gawlak, G; Higginbotham, K; Reynolds, AB; Birukova, AA; Birukov, KG				Zebda, Noureddine; Tian, Yufeng; Tian, Xinyong; Gawlak, Grzegorz; Higginbotham, Katherine; Reynolds, Albert B.; Birukova, Anna A.; Birukov, Konstantin G.			Interaction of p190RhoGAP with C-terminal Domain of p120-catenin Modulates Endothelial Cytoskeleton and Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-FAMILY GTPASES; CELL-CELL ADHESION; P120 CATENIN; E-CADHERIN; VE-CADHERIN; OXIDIZED PHOSPHOLIPIDS; BARRIER; PHOSPHORYLATION; ACTIVATION; RAC	p120-catenin is a multidomain intracellular protein, which mediates a number of cellular functions, including stabilization of cell-cell transmembrane cadherin complexes as well as regulation of actin dynamics associated with barrier function, lamellipodia formation, and cell migration via modulation of the activities of small GTPAses. One mechanism involves p120 catenin interaction with Rho GTPase activating protein (p190RhoGAP), leading to p190RhoGAP recruitment to cell periphery and local inhibition of Rho activity. In this study, we have identified a stretch of 23 amino acids within the C-terminal domain of p120 catenin as the minimal sequence responsible for the recruitment of p190RhoGAP (herein referred to as CRAD; catenin-RhoGAP association domain). Expression of the p120-catenin truncated mutant lacking the CRAD in endothelial cells attenuated effects of barrier protective oxidized phospholipid, OxPAPC. This effect was accompanied by inhibition of membrane translocation of p190RhoGAP, increased Rho signaling, as well as suppressed activation of Rac1 and its cytoskeletal effectors PAK1 (p21-activated kinase 1) and cortactin. Expression of p120 catenin-truncated mutant lacking CRAD also delayed the recovery process after thrombin-induced endothelial barrier disruption. Concomitantly, RhoA activation and downstream signaling were sustained for a longer period of time, whereas Rac signaling was inhibited. These data demonstrate a critical role for p120-catenin (amino acids 820-843) domain in the p120-cateninp 190RhoGAP signaling complex assembly, membrane targeting, and stimulation of p190RhoGAP activity toward inhibition of the Rho pathway and reciprocal up-regulation of Rac signaling critical for endothelial barrier regulation.	[Zebda, Noureddine; Tian, Yufeng; Tian, Xinyong; Gawlak, Grzegorz; Higginbotham, Katherine; Birukova, Anna A.; Birukov, Konstantin G.] Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, Chicago, IL 60637 USA; [Reynolds, Albert B.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA	University of Chicago; Vanderbilt University	Birukov, KG (corresponding author), Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, 5841 S Maryland Ave,Off N-611, Chicago, IL 60637 USA.	kbirukov@medicine.bsd.uchicago.edu	Birukov, Konstantin/FJB-5755-2022		National Institutes of Health [HL087823, HL076259, HL107920, HL089257, CA05724]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089257, R01HL087823, R56HL107920, R01HL107920, R01HL076259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL087823 and HL076259 (to K. G. B.); HL107920 and HL089257 (to A. A. B.); and CA05724 (to A. B. R.).	Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008; Birukova AA, 2012, J CELL PHYSIOL, V227, P3405, DOI 10.1002/jcp.24041; Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011; Birukova AA, 2011, J CELL PHYSIOL, V226, P2052, DOI 10.1002/jcp.22543; Carnahan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015747; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Fukumoto Y, 2008, EXP CELL RES, V314, P52, DOI 10.1016/j.yexcr.2007.07.024; Gentil-dit-Maurin A, 2010, EXP CELL RES, V316, P2587, DOI 10.1016/j.yexcr.2010.06.015; Grosheva I, 2001, J CELL SCI, V114, P695; Hatanaka K, 2011, AM J PHYSIOL-HEART C, V300, pH162, DOI 10.1152/ajpheart.00650.2010; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Konstantoulaki M, 2003, AM J PHYSIOL-LUNG C, V285, pL434, DOI 10.1152/ajplung.00075.2003; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Oas RG, 2010, CIRC RES, V106, P941, DOI 10.1161/CIRCRESAHA.109.207753; Ozaki C, 2010, CELL STRUCT FUNCT, V35, P81, DOI 10.1247/csf.10009; Peifer M, 2003, J CELL BIOL, V163, P437, DOI 10.1083/jcb.200310090; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Smalley-Freed WG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019880; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; Starosta V, 2012, AM J RESP CELL MOL, V46, P331, DOI 10.1165/rcmb.2011-0153OC; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Wang YL, 2011, J IMMUNOL, V186, P3180, DOI 10.4049/jimmunol.1001252; Wei J, 2005, MOL CELL, V17, P23, DOI 10.1016/j.molcel.2004.11.024; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Xiao K, 2007, BBA-MOL CELL RES, V1773, P8, DOI 10.1016/j.bbamcr.2006.07.005; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022	39	50	51	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18290	18299		10.1074/jbc.M112.432757	http://dx.doi.org/10.1074/jbc.M112.432757			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653363	Green Published, hybrid			2022-12-25	WOS:000320721900033
J	Kubota, S; Fukumoto, Y; Aoyama, K; Ishibashi, K; Yuki, R; Morinaga, T; Honda, T; Yamaguchi, N; Kuga, T; Tomonaga, T; Yamaguchi, N				Kubota, Sho; Fukumoto, Yasunori; Aoyama, Kazumasa; Ishibashi, Kenichi; Yuki, Ryuzaburo; Morinaga, Takao; Honda, Takuya; Yamaguchi, Noritaka; Kuga, Takahisa; Tomonaga, Takeshi; Yamaguchi, Naoto			Phosphorylation of KRAB-associated Protein 1 (KAP1) at Tyr-449, Tyr-458, and Tyr-517 by Nuclear Tyrosine Kinases Inhibits the Association of KAP1 and Heterochromatin Protein 1 alpha (HP1 alpha) with Heterochromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; DOUBLE-STRAND BREAKS; SRC-FAMILY KINASES; HP1 PROTEINS; HISTONE H3; C-SRC; SIGNAL-TRANSDUCTION; IONIZING-RADIATION; GROWTH-FACTOR; HUMAN GENOME	Protein tyrosine phosphorylation regulates a wide range of cellular processes at the plasma membrane. Recently, we showed that nuclear tyrosine phosphorylation by Src family kinases (SFKs) induces chromatin structural changes. In this study, we identify KRAB-associated protein 1 (KAP1/TIF1 beta/TRIM28), a component of heterochromatin, as a nuclear tyrosine-phosphorylated protein. Tyrosine phosphorylation of KAP1 is induced by several tyrosine kinases, such as Src, Lyn, Abl, and Brk. Among SFKs, Src strongly induces tyrosine phosphorylation of KAP1. Nucleus-targeted Lyn potentiates tyrosine phosphorylation of KAP1 compared with intact Lyn, but neither intact Fyn nor nucleus-targeted Fyn phosphorylates KAP1. Substitution of the three tyrosine residues Tyr-449/Tyr-458/Tyr517, located close to the HP1 binding-motif, into phenylalanine ablates tyrosine phosphorylation of KAP1. Immunostaining and chromatin fractionation show that Src and Lyn decrease the association of KAP1 with heterochromatin in a kinase activity-dependent manner. KAP1 knockdown impairs the association of HP1 alpha with heterochromatin, because HP1 alpha associates with KAP1 in heterochromatin. Intriguingly, tyrosine phosphorylation of KAP1 decreases the association of HP1 alpha with heterochromatin, which is inhibited by replacement of endogenous KAP1 with its phenylalanine mutant (KAP1-Y449F/Y458F/Y517F, KAP1-3YF). In DNA damage, KAP1-3YF repressed transcription of p21. These results suggest that nucleus-localized tyrosine kinases, including SFKs, phosphorylate KAP1 at Tyr-449/Tyr-458/Tyr-517 and inhibit the association of KAP1 and HP1 alpha with heterochromatin.	[Kubota, Sho; Fukumoto, Yasunori; Aoyama, Kazumasa; Ishibashi, Kenichi; Yuki, Ryuzaburo; Morinaga, Takao; Honda, Takuya; Yamaguchi, Noritaka; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chuo Ku, Chiba 2608675, Japan; [Kuga, Takahisa; Tomonaga, Takeshi] Natl Inst Biomed Innovat, Lab Proteome Res, Osaka 5670085, Japan	Chiba University; National Institute of Health Sciences - Japan	Yamaguchi, N (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	nyama@faculty.chiba-u.jp	Kuga, Takahisa/AAX-9334-2020	Kubota, Sho/0000-0001-6119-1259; Honda, Takuya/0000-0002-7141-0088	Global Center for Education and Research in Immune Regulation and Treatment (G-COE) Program from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Special Funds for Education and Research (Development of SPECT Probes for Pharmaceutical Innovation) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [24659622, 24790184] Funding Source: KAKEN	Global Center for Education and Research in Immune Regulation and Treatment (G-COE) Program from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Special Funds for Education and Research (Development of SPECT Probes for Pharmaceutical Innovation) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research, the Global Center for Education and Research in Immune Regulation and Treatment (G-COE) Program, and Special Funds for Education and Research (Development of SPECT Probes for Pharmaceutical Innovation) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Amanchy R, 2009, MOL ONCOL, V3, P439, DOI 10.1016/j.molonc.2009.07.001; Aoyama K, 2011, EXP CELL RES, V317, P2874, DOI 10.1016/j.yexcr.2011.09.013; Baldeyron C, 2011, J CELL BIOL, V193, P81, DOI 10.1083/jcb.201101030; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Cammas F, 2000, DEVELOPMENT, V127, P2955; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Cans C, 2000, BIOCHEM PHARMACOL, V60, P1203, DOI 10.1016/S0006-2952(00)00434-2; Chang CW, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-61; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Delfino FJ, 2006, BIOCHEM J, V399, P141, DOI 10.1042/BJ20060194; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Herkert B, 2010, J CELL BIOL, V188, P905, DOI 10.1083/jcb.200908103; Hirao A, 1997, EMBO J, V16, P2342, DOI 10.1093/emboj/16.9.2342; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ikeda K, 2008, EXP CELL RES, V314, P3392, DOI 10.1016/j.yexcr.2008.08.019; Ishibashi K, 2013, J CELL SCI, V126, P625, DOI 10.1242/jcs.116277; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Iwama A, 1996, EMBO J, V15, P5866, DOI 10.1002/j.1460-2075.1996.tb00973.x; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kharbanda S, 1996, CANCER RES, V56, P3617; Kuga T, 2008, EXP CELL RES, V314, P2040, DOI 10.1016/j.yexcr.2008.03.018; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LAW CL, 1994, J BIOL CHEM, V269, P12310; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Lee DH, 2012, EMBO J, V31, P2403, DOI 10.1038/emboj.2012.86; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mera A, 1999, J BIOL CHEM, V274, P15766, DOI 10.1074/jbc.274.22.15766; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nakayama Y, 2005, EXP CELL RES, V304, P570, DOI 10.1016/j.yexcr.2004.11.027; Nakayama Y, 2006, EXP CELL RES, V312, P2252, DOI 10.1016/j.yexcr.2006.03.021; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Obata Y, 2010, J CELL SCI, V123, P2649, DOI 10.1242/jcs.066266; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tada J, 1999, BLOOD, V93, P3723, DOI 10.1182/blood.V93.11.3723.411k02_3723_3735; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Tamura T, 2000, INT IMMUNOL, V12, P1205, DOI 10.1093/intimm/12.8.1205; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; White D, 2012, MOL CANCER RES, V10, P401, DOI 10.1158/1541-7786.MCR-11-0134; Yamaguchi N, 2001, J CELL SCI, V114, P1631; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; Zeng W, 2010, EPIGENETICS-US, V5, P287, DOI 10.4161/epi.5.4.11683; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	68	34	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17871	17883		10.1074/jbc.M112.437756	http://dx.doi.org/10.1074/jbc.M112.437756			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645696	Green Published, hybrid			2022-12-25	WOS:000320380600075
J	Popova, EY; Grigoryev, SA; Fan, YH; Skoultchi, AI; Zhang, SS; Barnstable, CJ				Popova, Evgenya Y.; Grigoryev, Sergei A.; Fan, Yuhong; Skoultchi, Arthur I.; Zhang, Samuel S.; Barnstable, Colin J.			Developmentally Regulated Linker Histone H1c Promotes Heterochromatin Condensation and Mediates Structural Integrity of Rod Photoreceptors in Mouse Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME REPEAT LENGTH; CHROMATIN-STRUCTURE; GENE-EXPRESSION; MYOGENIC DIFFERENTIATION; VARIANT OVEREXPRESSION; CELL-DIFFERENTIATION; CEREBRAL-CORTEX; ACTIVATION; PROTEINS; REVEALS	Mature rod photoreceptor cells contain very small nuclei with tightly condensed heterochromatin. We observed that during mouse rod maturation, the nucleosomal repeat length increases from 190 bp at postnatal day 1 to 206 bp in the adult retina. At the same time, the total level of linker histone H1 increased reaching the ratio of 1.3 molecules of total H1 per nucleosome, mostly via a dramatic increase in H1c. Genetic elimination of the histone H1c gene is functionally compensated by other histone variants. However, retinas in H1c/H1e/H1(0) triple knock-outs have photoreceptors with bigger nuclei, decreased heterochromatin area, and notable morphological changes suggesting that the process of chromatin condensation and rod cell structural integrity are partly impaired. In triple knock-outs, nuclear chromatin exposed several epigenetic histone modification marks masked in the wild type chromatin. Dramatic changes in exposure of a repressive chromatin mark, H3K9me2, indicate that during development linker histone plays a role in establishing the facultative heterochromatin territory and architecture in the nucleus. During retina development, the H1c gene and its promoter acquired epigenetic patterns typical of rod-specific genes. Our data suggest that histone H1c gene expression is developmentally up-regulated to promote facultative heterochromatin in mature rod photoreceptors.	[Popova, Evgenya Y.; Zhang, Samuel S.; Barnstable, Colin J.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 17033 USA; [Grigoryev, Sergei A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Fan, Yuhong] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Fan, Yuhong] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Skoultchi, Arthur I.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Zhang, Samuel S.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore 168751, Singapore	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Yeshiva University; Albert Einstein College of Medicine; National University of Singapore; Singapore National Eye Center	Zhang, SS (corresponding author), Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 17033 USA.	ssz3@psu.edu; cbarnstable@hmc.psu.edu	Barnstable, Colin/ABB-4822-2021; Barnstable, Colin/GLU-9219-2022	Barnstable, Colin/0000-0002-7011-4068	National Institutes of Health [EY013865, CA079057, GM085261]; Macula Vision Research Foundation; National Science Foundation Grant [MCB-1021681]; NATIONAL CANCER INSTITUTE [R56CA079057, R01CA079057] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macula Vision Research Foundation; National Science Foundation Grant(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY013865 (to C. J. B.), CA079057 (to A. I. S.), and GM085261 (to Y. F.), a grant from the Macula Vision Research Foundation (to C. J. B.), and National Science Foundation Grant MCB-1021681 (to S. A. G.).	Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; ATHEY BD, 1990, J CELL BIOL, V111, P795, DOI 10.1083/jcb.111.3.795; BATES DL, 1981, NUCLEIC ACIDS RES, V9, P5883, DOI 10.1093/nar/9.22.5883; BERKOWITZ EM, 1983, J NEUROCHEM, V41, P516, DOI 10.1111/j.1471-4159.1983.tb04769.x; Bhattacharjee RN, 2001, MOL CELL BIOL, V21, P5417, DOI 10.1128/MCB.21.16.5417-5425.2001; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Brown DT, 1996, NUCLEIC ACIDS RES, V24, P486, DOI 10.1093/nar/24.3.486; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2004, METHOD ENZYMOL, V377, P85; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Gilbert N, 2003, EMBO J, V22, P5540, DOI 10.1093/emboj/cdg520; Grigoryev SA, 2006, CHROMOSOME RES, V14, P53, DOI 10.1007/s10577-005-1021-6; Grigoryev SA, 2004, J CELL SCI, V117, P6153, DOI 10.1242/cs.01537; Grigoryev SA, 2012, EXP CELL RES, V318, P1448, DOI 10.1016/j.yexcr.2012.02.014; Gunjan A, 1999, J BIOL CHEM, V274, P37950, DOI 10.1074/jbc.274.53.37950; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; HUANG HC, 1984, J BIOL CHEM, V259, P4237; Istomina NE, 2003, MOL CELL BIOL, V23, P6455, DOI 10.1128/MCB.23.18.6455-6468.2003; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; JAEGER AW, 1982, EMBO J, V1, P811, DOI 10.1002/j.1460-2075.1982.tb01252.x; Jeno L, 1975, Mikroskopie, V31, P1; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kamieniarz K, 2012, GENE DEV, V26, P797, DOI 10.1101/gad.182014.111; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Kizilyaprak C, 2011, NUCLEUS-AUSTIN, V2, P444, DOI 10.4161/nucl.2.5.17843; Kizilyaprak C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011039; Koop R, 2003, EMBO J, V22, P588, DOI 10.1093/emboj/cdg052; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Li JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002879; Lu XW, 2013, SCIENCE, V340, P78, DOI 10.1126/science.1234654; Lu XW, 2009, GENE DEV, V23, P452, DOI 10.1101/gad.1749309; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; Medrzycki M., 2012, J VIS EXP, V19, P3577; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Morrow EM, 1998, TRENDS CELL BIOL, V8, P353, DOI 10.1016/S0962-8924(98)01341-5; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Vicent GP, 2011, GENE DEV, V25, P845, DOI 10.1101/gad.621811; PEARSON EC, 1984, EUR J BIOCHEM, V144, P353, DOI 10.1111/j.1432-1033.1984.tb08471.x; Popova EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046867; Popova EY, 2009, CHROMOSOME RES, V17, P47, DOI 10.1007/s10577-008-9005-y; Popova EY, 2006, EXP HEMATOL, V34, P453, DOI 10.1016/j.exphem.2006.01.003; Rawlings JS, 2011, EMBO J, V30, P263, DOI 10.1038/emboj.2010.314; Sekeri-Pataryas KE, 2007, ANN NY ACAD SCI, V1100, P361, DOI 10.1196/annals.1395.039; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; THOMAS JO, 1977, CELL, V10, P633, DOI 10.1016/0092-8674(77)90096-4; WEINTRAUB H, 1978, NUCLEIC ACIDS RES, V5, P1179, DOI 10.1093/nar/5.4.1179; WEINTRAUB H, 1984, CELL, V38, P17, DOI 10.1016/0092-8674(84)90522-1; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Yellajoshyula D, 2006, P NATL ACAD SCI USA, V103, P18568, DOI 10.1073/pnas.0606478103; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zhang LB, 2011, GENE DEV, V25, P119, DOI 10.1101/gad.1998711; Zhang SSM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-48; Zhang SSM, 2004, INVEST OPHTH VIS SCI, V45, P2407, DOI 10.1167/iovs.04-0003; Zhang YZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002691	69	40	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17895	17907		10.1074/jbc.M113.452144	http://dx.doi.org/10.1074/jbc.M113.452144			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645681	Green Published, hybrid			2022-12-25	WOS:000320380600077
J	Spitzen, J; Spoor, CW; Grieco, F; ter Braak, C; Beeuwkes, J; van Brugge, SP; Kranenbarg, S; Noldus, LPJJ; van Leeuwen, JL; Takken, W				Spitzen, Jeroen; Spoor, Cornelis W.; Grieco, Fabrizio; ter Braak, Cajo; Beeuwkes, Jacob; van Brugge, Sjaak P.; Kranenbarg, Sander; Noldus, Lucas P. J. J.; van Leeuwen, Johan L.; Takken, Willem			A 3D Analysis of Flight Behavior of Anopheles gambiae sensu stricto Malaria Mosquitoes in Response to Human Odor and Heat	PLOS ONE			English	Article							FEMALE CULEX-QUINQUEFASCIATUS; FINE-SCALE STRUCTURE; MM-X TRAPS; CARBON-DIOXIDE; UPWIND FLIGHT; HOST ODOR; PHEROMONE PLUMES; TSETSE-FLIES; ORIENTATION; DIPTERA	Female mosquitoes use odor and heat as cues to navigate to a suitable landing site on their blood host. The way these cues affect flight behavior and modulate anemotactic responses, however, is poorly understood. We studied in-flight behavioral responses of females of the nocturnal malaria mosquito Anopheles gambiae sensu stricto to human odor and heat. Flight-path characteristics in a wind tunnel (flow 20 cm/s) were quantified in three dimensions. With wind as the only stimulus (control), short and close to straight upwind flights were recorded. With heat alone, flights were similarly short and direct. The presence of human odor, in contrast, caused prolonged and highly convoluted flight patterns. The combination of odor+heat resulted in longer flights with more landings on the source than to either cue alone. Flight speed was greatest (mean groundspeed 27.2 cm/s) for odor+heat. Odor alone resulted in decreased flight speed when mosquitoes arrived within 30 cm of the source whereas mosquitoes exposed to odor+heat maintained a high flight speed while flying in the odor plume, until they arrived within 15 cm of the source. Human odor evoked an increase in crosswind flights with an additive effect of heat at close range (<15 cm) to the source. This was found for both horizontal and vertical flight components. However, mosquitoes nevertheless made upwind progress when flying in the odor+heat generated plume, suggesting that mosquitoes scan their environment intensively while they progress upwind towards their host. These observations may help to improve the efficacy of trapping systems for malaria mosquitoes by (1) optimizing the site of odor release relative to trap entry and (2) adding a heat source which enhances a landing response.	[Spitzen, Jeroen; Beeuwkes, Jacob; Takken, Willem] Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands; [Spoor, Cornelis W.; Kranenbarg, Sander; van Leeuwen, Johan L.] Wageningen Univ, Expt Zool Grp, NL-6700 AP Wageningen, Netherlands; [Grieco, Fabrizio] Noldus Informat Technol BV, Wageningen, Netherlands; [ter Braak, Cajo] Wageningen UR, Dept Math & Stat Methods, Biometris, Wageningen, Netherlands; [van Brugge, Sjaak P.] Wageningen Univ, Facil Serv, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Takken, W (corresponding author), Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands.	willem.takken@wur.nl	Spitzen, Jeroen/B-3098-2012; van Leeuwen, Johan L/B-7897-2011; van Leeuwen, Johan/N-3437-2019; Braak, Cajo J. F. ter/G-7006-2011	Spitzen, Jeroen/0000-0003-0455-7511; van Leeuwen, Johan/0000-0002-4433-880X; Braak, Cajo J. F. ter/0000-0002-0414-8745	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH) [121]	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH#121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkenius A, 2010, J EXP BIOL, V213, P3741, DOI 10.1242/jeb.043760; Bhasin A, 2001, MED VET ENTOMOL, V15, P147, DOI 10.1046/j.1365-2915.2001.00285.x; Braks MAH, 2005, MEASURING BEHAV 2005; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Carde RT, 2010, ECOL CONT VECTOR-BOR, V2, P115; Carde RT., 1995, CHEM ECOLOGY INSECTS; Cooperband MF, 2006, MED VET ENTOMOL, V20, P11, DOI 10.1111/j.1365-2915.2006.00613.x; Cummins B, 2012, PLOS COMPUTATIONAL B, V8, DOI [10.1371/journal.pcbi.1002500, DOI 10.1371/J0URNAL.PCBI.1002500)]; David C.T., 1989, P17; David C.T., 1986, P49; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Dekker T, 2011, J EXP BIOL, V214, P3480, DOI 10.1242/jeb.055186; Faiman R, 2011, ACTA TROP, V120, P110, DOI 10.1016/j.actatropica.2011.06.015; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; GIBSON G, 1988, PHYSIOL ENTOMOL, V13, P29, DOI 10.1111/j.1365-3032.1988.tb00906.x; GIBSON G, 1991, PHYSIOL ENTOMOL, V16, P47, DOI 10.1111/j.1365-3032.1991.tb00542.x; GIBSON G, 1995, PHYSIOL ENTOMOL, V20, P224, DOI 10.1111/j.1365-3032.1995.tb00005.x; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; GILLIES MT, 1970, B ENTOMOL RES, V60, P225, DOI 10.1017/S000748530004075X; Healy TP, 2000, MED VET ENTOMOL, V14, P195, DOI 10.1046/j.1365-2915.2000.00238.x; Healy TP, 2002, MED VET ENTOMOL, V16, P126, DOI 10.1046/j.1365-2915.2002.00353.x; Howlett F. M., 1910, Parasitology Cambridge, V3; KELLOG F. E., 1962, CANADIAN ENTOMOL, V94, P1009; Krcmar S, 2005, J VECTOR ECOL, V30, P133; Laarman J. J., 1958, Tropical and Geographical Medicine Amsterdam, V10, P293; Lacey ES, 2011, MED VET ENTOMOL, V25, P94, DOI 10.1111/j.1365-2915.2010.00921.x; Lacey ES, 2012, PHYSIOL ENTOMOL, V37, P153, DOI 10.1111/j.1365-3032.2011.00829.x; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; MAFRANETO A, 1995, PHYSIOL ENTOMOL, V20, P117, DOI 10.1111/j.1365-3032.1995.tb00808.x; MAFRANETO A, 1995, PHYSIOL ENTOMOL, V20, P229, DOI 10.1111/j.1365-3032.1995.tb00006.x; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Olanga EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-6; PETERSON DG, 1951, B ENTOMOL RES, V42, P535, DOI 10.1017/S0007485300028935; Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2; Smallegange RC, 2010, J MED ENTOMOL, V47, P338, DOI 10.1603/ME09015; Spitzen J, 2008, MEAS BEH 6 INT C MEA, P133; Stewart FJ, 2010, J EXP BIOL, V213, P1886, DOI 10.1242/jeb.026526; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; Takken W, 1997, J INSECT BEHAV, V10, P395, DOI 10.1007/BF02765606; Verhulst NO, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, DOI 10.1371/J0URNAL.P0NE.0028991)]; VICKERS NJ, 1994, P NATL ACAD SCI USA, V91, P5756, DOI 10.1073/pnas.91.13.5756; VISSER JH, 1978, ENTOMOL EXP APPL, V24, P738, DOI 10.1007/BF02385130; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; Webster B, 2012, PHYSIOL ENTOMOL, V37, P10, DOI 10.1111/j.1365-3032.2011.00791.x; Williams CR, 2006, J AM MOSQUITO CONTR, V22, P641, DOI 10.2987/8756-971X(2006)22[641:LAFAOS]2.0.CO;2	48	64	65	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62995	10.1371/journal.pone.0062995	http://dx.doi.org/10.1371/journal.pone.0062995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658792	Green Published, Green Submitted, gold			2022-12-25	WOS:000321200500049
J	Arribas-Gonzalez, E; Alonso-Torres, P; Aragon, C; Lopez-Corcuera, B				Arribas-Gonzalez, Esther; Alonso-Torres, Pablo; Aragon, Carmen; Lopez-Corcuera, Beatriz			Calnexin-Assisted Biogenesis of the Neuronal Glycine Transporter 2 (GlyT2)	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; STARTLE DISEASE; PLASMA-MEMBRANE; GLUCOSIDASE-II; PROTEIN; HYPEREKPLEXIA; MUTATIONS; ER; SLC6A5	The neuronal transporter GlyT2 is a polytopic, 12-transmembrane domain, plasma membrane glycoprotein involved in the removal and recycling of synaptic glycine from inhibitory synapses. Mutations in the human GlyT2 gene (SLC6A5) that cause deficient glycine transport or defective GlyT2 trafficking are the second most common cause of hyperekplexia or startle disease. In this study we examined several aspects of GlyT2 biogenesis that involve the endoplasmic reticulum chaperone calnexin (CNX). CNX binds transiently to an intermediate under-glycosylated transporter precursor and facilitates GlyT2 processing. In cells expressing GlyT2, transporter accumulation and transport activity were attenuated by siRNA-mediated CNX knockdown and enhanced by CNX overexpression. GlyT2 binding to CNX was mediated by glycan and polypeptide-based interactions as revealed by pharmacological approaches and the behavior of GlyT2 N-glycan-deficient mutants. Moreover, transporter folding appeared to be stabilized by N-glycans. Co-expression of CNX and a fully non-glycosylated mutant rescues glycine transport but not mutant surface expression. Hence, CNX discriminates between different conformational states of GlyT2 displaying a lectin-independent chaperone activity. GlyT2 wild-type and mutant transporters were finally degraded in the lysosome. Our findings provide further insight into GlyT2 biogenesis, and a useful framework for the study of newly synthesized GlyT2 transporters bearing hyperekplexia mutations.	[Arribas-Gonzalez, Esther; Alonso-Torres, Pablo; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, CSIC, Dept Biol Mol, Madrid, Spain; [Arribas-Gonzalez, Esther; Alonso-Torres, Pablo; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Aragon, Carmen; Lopez-Corcuera, Beatriz] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain; [Arribas-Gonzalez, Esther; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, IdiPAZ Hosp Univ La Paz, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Madrid; Hospital Universitario La Paz	Lopez-Corcuera, B (corresponding author), Univ Autonoma Madrid, CSIC, Dept Biol Mol, Madrid, Spain.	blopez@cbm.uam.es	Aragon, Carmen/K-9783-2014; Corcuera, Beatriz López/D-5188-2009	Aragon, Carmen/0000-0001-8287-9386; Corcuera, Beatriz López/0000-0002-0383-4241; Arribas Gonzalez, Esther/0000-0001-6579-3396	Spanish 'Direccion General de Ensenanza Superior e Investigacion Cientifica' [BFU2005-05931/BMC, BIO2005-05786]; Ministerio de Ciencia e Innovacion [SAF2008-05436]; Comunidad Autonoma de Madrid [11/BCB/010, S-SAL-0253/2006]; Ministerio de Economia y Competitividad [SAF2011-28674]; CIBERER [U-751/U-753]; Fundacion Ramon Areces	Spanish 'Direccion General de Ensenanza Superior e Investigacion Cientifica'; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Ministerio de Economia y Competitividad(Spanish Government); CIBERER; Fundacion Ramon Areces	This work was supported by the Spanish 'Direccion General de Ensenanza Superior e Investigacion Cientifica' (BFU2005-05931/BMC and BIO2005-05786), 'Ministerio de Ciencia e Innovacion' (SAF2008-05436), 'Comunidad Autonoma de Madrid' (11/BCB/010 and S-SAL-0253/2006), Ministerio de Economia y Competitividad (SAF2011-28674), CIBERER (intramural project U-751/U-753), by an institutional grant from the 'Fundacion Ramon Areces'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon C, 2005, TRENDS PHARMACOL SCI, V26, P283, DOI 10.1016/j.tips.2005.04.007; Aragon C, 2003, EUR J PHARMACOL, V479, P249, DOI 10.1016/j.ejphar.2003.08.074; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Carta E, 2012, J BIOL CHEM, V287, P28975, DOI 10.1074/jbc.M112.372094; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Compain P., 2007, IMINOSUGARS SYNTHESI; de Juan-Sanz J, 2011, TRAFFIC, V12, P1850, DOI 10.1111/j.1600-0854.2011.01278.x; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Esapa CT, 2005, HUM MOL GENET, V14, P295, DOI 10.1093/hmg/ddi026; Eulenburg V, 2006, BIOCHEM BIOPH RES CO, V348, P400, DOI 10.1016/j.bbrc.2006.07.080; Freeze H, 2010, CURRENT PROTOCOLS IM; Gimenez C, 2012, J BIOL CHEM, V287, P28986, DOI 10.1074/jbc.M111.319244; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Jimenez E, 2011, J BIOL CHEM, V286, P10712, DOI 10.1074/jbc.M110.167056; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; KAUSHAL GP, 1990, J BIOL CHEM, V265, P16271; Korkhov VM, 2008, J MOL BIOL, V378, P337, DOI 10.1016/j.jmb.2008.02.056; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Lopez-Corcuera B, 2001, J BIOL CHEM, V276, P43463, DOI 10.1074/jbc.M107438200; Lopez-Corcuera B, 1998, J NEUROCHEM, V71, P2211; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Martinez-Maza R, 2001, J BIOL CHEM, V276, P2168, DOI 10.1074/jbc.M006774200; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Morello JP, 2001, BIOCHEMISTRY-US, V40, P6766, DOI 10.1021/bi002699r; Nunez E, 2008, J NEUROCHEM, V105, P2080, DOI 10.1111/j.1471-4159.2008.05292.x; Nunez E, 2009, TRAFFIC, V10, P829, DOI 10.1111/j.1600-0854.2009.00911.x; OLIVARES L, 1994, J BIOL CHEM, V269, P28400; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Perez-Siles G, 2012, BIOCHEM J, V442, P323, DOI 10.1042/BJ20110247; Perez-Siles G, 2011, J NEUROCHEM, V118, P195, DOI 10.1111/j.1471-4159.2011.07309.x; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Rousseau F, 2008, J NEUROSCI, V28, P9755, DOI 10.1523/JNEUROSCI.0509-08.2008; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Solda T, 2007, MOL CELL, V27, P238, DOI 10.1016/j.molcel.2007.05.032; SUHREN O, 1966, J NEUROL SCI, V3, P577, DOI 10.1016/0022-510X(66)90047-5; Tate CG, 1999, BIOCHEM SOC T, V27, P932, DOI 10.1042/bst0270932; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x	52	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63230	10.1371/journal.pone.0063230	http://dx.doi.org/10.1371/journal.pone.0063230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650557	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000102
J	Alpert, MH; Alford, S				Alpert, Michael H.; Alford, Simon			Synaptic NMDA Receptor-Dependent Ca2+ Entry Drives Membrane Potential and Ca2+ Oscillations in Spinal Ventral Horn Neurons	PLOS ONE			English	Article							METHYL-D-ASPARTATE; POTASSIUM CHANNELS; ELECTROPHYSIOLOGICAL PROPERTIES; RETICULOSPINAL NEURONS; CALCIUM-CHANNELS; SK CHANNELS; LATE AFTERHYPERPOLARIZATION; VOLTAGE OSCILLATIONS; PATTERN GENERATION; FICTIVE LOCOMOTION	During vertebrate locomotion, spinal neurons act as oscillators when initiated by glutamate release from descending systems. Activation of NMDA receptors initiates Ca2+-mediated intrinsic membrane potential oscillations in central pattern generator (CPG) neurons. NMDA receptor-dependent intrinsic oscillations require Ca2+-dependent K+ (K(Ca)2) channels for burst termination. However, the location of Ca2+ entry mediating K(Ca)2 channel activation, and type of Ca2+ channel - which includes NMDA receptors and voltage-gated Ca2+ channels (VGCCs) - remains elusive. NMDA receptor-dependent Ca2+ entry necessitates presynaptic release of glutamate, implying a location at active synapses within dendrites, whereas VGCC-dependent Ca2+ entry is not similarly constrained. Where Ca2+ enters relative to K(Ca)2 channels is crucial to information processing of synaptic inputs necessary to coordinate locomotion. We demonstrate that Ca2+ permeating NMDA receptors is the dominant source of Ca2+ during NMDA-dependent oscillations in lamprey spinal neurons. This Ca2+ entry is synaptically located, NMDA receptor-dependent, and sufficient to activate K(Ca)2 channels at excitatory interneuron synapses onto other CPG neurons. Selective blockade of VGCCs reduces whole-cell Ca2+ entry but leaves membrane potential and Ca2+ oscillations unaffected. Furthermore, repetitive oscillations are prevented by fast, but not slow, Ca2+ chelation. Taken together, these results demonstrate that K(Ca)2 channels are closely located to NMDA receptor-dependent Ca2+ entry. The close spatial relationship between NMDA receptors and K(Ca)2 channels provides an intrinsic mechanism whereby synaptic excitation both excites and subsequently inhibits ventral horn neurons of the spinal motor system. This places the components necessary for oscillation generation, and hence locomotion, at glutamatergic synapses.	[Alpert, Michael H.; Alford, Simon] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Alford, S (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	sta@uic.edu		Alford, Simon/0000-0002-0454-4246	National Institutes of Health [RO1 MH 084874]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institutes of Health Grant RO1 MH 084874; http://www.nimh.nih.gov/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER EM, 1991, J NEUROSCI, V11, P1496; ALFORD S, 1990, BRAIN RES, V506, P297, DOI 10.1016/0006-8993(90)91266-J; Alford S, 2003, NEUROSCIENTIST, V9, P217, DOI 10.1177/1073858403009003014; ALFORD S, 1989, J NEUROSCI, V9, P2792; AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; BACSKAI BJ, 1995, NEURON, V14, P19, DOI 10.1016/0896-6273(95)90237-6; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; BRODIN L, 1988, ARCH ITAL BIOL, V126, P317; BUCHANAN JT, 1993, J NEUROPHYSIOL, V70, P2313, DOI 10.1152/jn.1993.70.6.2313; BUCHANAN JT, 1989, J NEUROPHYSIOL, V62, P59, DOI 10.1152/jn.1989.62.1.59; BUCHANAN JT, 1982, J NEUROPHYSIOL, V47, P948, DOI 10.1152/jn.1982.47.5.948; BUCHANAN JT, 1987, BRAIN RES, V408, P321, DOI 10.1016/0006-8993(87)90397-0; Buchanan JT, 2001, PROG NEUROBIOL, V63, P441, DOI 10.1016/S0301-0082(00)00050-2; BUCHANAN JT, 1982, J NEUROPHYSIOL, V47, P961, DOI 10.1152/jn.1982.47.5.961; BUCHANAN JT, 1987, SCIENCE, V236, P312, DOI 10.1126/science.3563512; Bussieres N, 1999, BRAIN RES, V847, P175, DOI 10.1016/S0006-8993(99)02002-8; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cangiano L, 2002, J NEUROPHYSIOL, V88, P289, DOI 10.1152/jn.2002.88.1.289; Di Prisco GV, 2004, J NEUROPHYSIOL, V92, P1796, DOI 10.1152/jn.00138.2004; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; ElManira A, 1997, J NEUROPHYSIOL, V78, P1334; ELMANIRA A, 1994, J NEUROPHYSIOL, V72, P1852, DOI 10.1152/jn.1994.72.4.1852; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Faber ESL, 2010, J PHYSIOL-LONDON, V588, P1281, DOI 10.1113/jphysiol.2009.185645; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Guertin PA, 1998, J NEUROPHYSIOL, V80, P3380, DOI 10.1152/jn.1998.80.6.3380; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Han P, 2007, J NEUROSCI, V27, P13192, DOI 10.1523/JNEUROSCI.1279-07.2007; Harris-Warrick RM, 2002, CURR OPIN NEUROBIOL, V12, P646, DOI 10.1016/S0959-4388(02)00377-X; Herlitze S, 2003, J BIOENERG BIOMEMBR, V35, P621, DOI 10.1023/B:JOBB.0000008027.19384.c0; Hess D, 2001, P NATL ACAD SCI USA, V98, P5276, DOI 10.1073/pnas.091096198; HILL R, 1992, NEUROREPORT, V3, P943, DOI 10.1097/00001756-199210000-00032; HILL RH, 1989, BRAIN RES, V499, P388, DOI 10.1016/0006-8993(89)90790-7; HOCHMAN S, 1994, J NEUROPHYSIOL, V72, P2559, DOI 10.1152/jn.1994.72.5.2559; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V398, P575, DOI 10.1113/jphysiol.1988.sp017058; Huss M, 2007, J NEUROPHYSIOL, V97, P2696, DOI 10.1152/jn.00528.2006; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Isope P, 2012, CEREBELLUM, V11, P651, DOI 10.1007/s12311-010-0195-4; KASICKI S, 1989, BRAIN RES, V484, P203, DOI 10.1016/0006-8993(89)90363-6; Kettunen P, 2002, J NEUROSCI, V22, P1868, DOI 10.1523/JNEUROSCI.22-05-01868.2002; Krieger P, 2000, J NEUROSCI, V20, P5382, DOI 10.1523/JNEUROSCI.20-14-05382.2000; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; Li X, 2007, J NEUROPHYSIOL, V97, P3314, DOI 10.1152/jn.01068.2006; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P569, DOI 10.1113/jphysiol.1981.sp013764; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCCLELLAN AD, 1988, BRAIN RES, V457, P338, DOI 10.1016/0006-8993(88)90704-4; McClellan AD, 2008, J NEUROSCI, V28, P650, DOI 10.1523/JNEUROSCI.3840-07.2008; MEER DP, 1992, NEUROSCI LETT, V143, P1, DOI 10.1016/0304-3940(92)90219-W; MILLS LR, 1994, J NEUROSCI, V14, P6815; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; MOORE LE, 1995, BIOPHYS J, V68, P96, DOI 10.1016/S0006-3495(95)80163-3; Moore LE, 1999, J NEUROSCI, V19, P8271; Nanou E, 2013, J NEUROPHYS IN PRESS; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; REGEHR WG, 1992, J NEUROSCI, V12, P4202; Sah P, 1996, J NEUROSCI, V16, P4537; Shah MM, 2002, J NEUROPHYSIOL, V87, P2983, DOI 10.1152/jn.2002.87.6.2983; Sirota MG, 2000, EUR J NEUROSCI, V12, P4081, DOI 10.1046/j.1460-9568.2000.00301.x; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stackman RW, 2002, J NEUROSCI, V22, P10163; Takahashi M, 2001, J PHYSIOL-LONDON, V532, P323, DOI 10.1111/j.1469-7793.2001.0323f.x; Tognoli E, 2009, PROG NEUROBIOL, V87, P31, DOI 10.1016/j.pneurobio.2008.09.014; WALL MJ, 1995, J PHYSIOL-LONDON, V487, P557, DOI 10.1113/jphysiol.1995.sp020900; WALLEN P, 1989, J NEUROPHYSIOL, V61, P759, DOI 10.1152/jn.1989.61.4.759; WALLEN P, 1987, J NEUROSCI, V7, P2745; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Wikstrom MA, 1998, EUR J NEUROSCI, V10, P1528; WILLIAMS TL, 1990, J NEUROPHYSIOL, V64, P862, DOI 10.1152/jn.1990.64.3.862; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	79	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63154	10.1371/journal.pone.0063154	http://dx.doi.org/10.1371/journal.pone.0063154			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646190	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300145
J	Boccardi, V; Esposito, A; Rizzo, MR; Marfella, R; Barbieri, M; Paolisso, G				Boccardi, Virginia; Esposito, Antonietta; Rizzo, Maria Rosaria; Marfella, Raffaele; Barbieri, Michelangela; Paolisso, Giuseppe			Mediterranean Diet, Telomere Maintenance and Health Status among Elderly	PLOS ONE			English	Article							LIFE-STYLE FACTORS; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; LENGTH; ASSOCIATION; ADHERENCE; SURVIVAL; PATTERNS; STRESS; CANCER	Leukocyte telomere length (LTL) and rate of telomere shortening are known biomarkers of aging while, numerous studies showed that Mediterranean diet (MD) may boost longevity. We studied association between telomere length, telomerase activity and different adherence to MD and its effects on healthy status. The study was conducted in 217 elderly subjects stratified according Mediterranean diet score (MDS) in low adherence (MDS <= 3), medium adherence (MDS 4-5) and high adherence (MDS >= 6) groups. LTL was measured by quantitative polymerase chain reaction and telomerase activity by a PCR-ELISA protocol. High adherence group showed longer LTL (p = 0.003) and higher telomerase activity (p = 0.013) compared to others. Linear regression analysis including age, gender, smoking habit and MDS showed that MDS was independently associated with LTL (p = 0.024) and telomerase activity levels (p = 0.006). Telomerase activity was independently associated with LTL (p = 0.007) and negatively modulated by inflammation and oxidative stress. Indeed, telomerase levels were associated with healthy status independently of multiple covariates (p = 0.048). These results support a novel role of MD in promoting health-span suggesting that telomere maintenance, rather than LTL variability is the major determinant of healthy status among elderly.	[Boccardi, Virginia; Esposito, Antonietta; Rizzo, Maria Rosaria; Marfella, Raffaele; Barbieri, Michelangela; Paolisso, Giuseppe] Univ Naples 2, Dept Internal Med Surg Neurol Metab Dis & Geriatr, Naples, Italy	Universita della Campania Vanvitelli	Paolisso, G (corresponding author), Univ Naples 2, Dept Internal Med Surg Neurol Metab Dis & Geriatr, Naples, Italy.	giuseppe.paolisso@unina2.it	Rizzo, Maria Rosaria/AHH-3649-2022; Boccardi, Virginia/K-2630-2016; Marfella, Raffaele/AAH-2595-2019; Rizzo, Maria/HGD-6576-2022; rizzo, maria rosaria R/J-1968-2016; Barbieri, Michelangela/K-2192-2016; paolisso, giuseppe/AAP-8516-2020	Rizzo, Maria Rosaria/0000-0002-1023-4260; Boccardi, Virginia/0000-0003-2134-1122; Marfella, Raffaele/0000-0003-3960-9270; rizzo, maria rosaria R/0000-0002-1023-4260; Barbieri, Michelangela/0000-0002-9223-5792; paolisso, giuseppe/0000-0002-2137-455X				Anderson AL, 2011, J AM DIET ASSOC, V111, P84, DOI 10.1016/j.jada.2010.10.012; de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245; de Jesus BB, 2011, AGING CELL, V10, P604, DOI 10.1111/j.1474-9726.2011.00700.x; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Boccardi V, 2012, EMBO MOL MED, V4, P685, DOI 10.1002/emmm.201200246; Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Dai J, 2008, AM J CLIN NUTR, V88, P1364, DOI 10.3945/ajcn.2008.26528; Dai J, 2008, CIRCULATION, V117, P169, DOI 10.1161/CIRCULATIONAHA.107.710699; Daubenmier J, 2012, PSYCHONEUROENDOCRINO, V37, P917, DOI 10.1016/j.psyneuen.2011.10.008; Donate LE, 2011, PHILOS T R SOC B, V366, P76, DOI 10.1098/rstb.2010.0291; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Haveman-Nies A, 2003, AGE AGEING, V32, P427, DOI 10.1093/ageing/32.4.427; Hu FB, 2003, AM J CLIN NUTR, V78, p544S, DOI 10.1093/ajcn/78.3.544S; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Kimura M, 2007, AM J PHYSIOL-REG I, V293, pR2210, DOI 10.1152/ajpregu.00615.2007; Kouris-Blazos A, 1999, BRIT J NUTR, V82, P57, DOI 10.1017/S0007114599001129; MAHONEY F I, 1965, Md State Med J, V14, P61; MARIN C, 2011, AGE DORDR, V34, P1309; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; Nettleton JA, 2008, AM J CLIN NUTR, V88, P1405, DOI 10.3945/ajcn.2008.26429; Oeseburg H, 2010, PFLUG ARCH EUR J PHY, V459, P259, DOI 10.1007/s00424-009-0728-1; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Paul L, 2011, J NUTR BIOCHEM, V22, P895, DOI 10.1016/j.jnutbio.2010.12.001; Serrano AL, 2004, CIRC RES, V94, P575, DOI 10.1161/01.RES.0000122141.18795.9C; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Terry DF, 2008, J GERONTOL A-BIOL, V63, P809, DOI 10.1093/gerona/63.8.809; Terry DF, 2008, ARCH INTERN MED, V168, P277, DOI 10.1001/archinternmed.2007.75; Trichopoulou A, 2004, PUBLIC HEALTH NUTR, V7, P943, DOI 10.1079/PHN2004558; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	36	113	115	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62781	10.1371/journal.pone.0062781	http://dx.doi.org/10.1371/journal.pone.0062781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646142	gold, Green Submitted, Green Published			2022-12-25	WOS:000319077300095
J	Costantini, F; Carlesi, L; Abbiati, M				Costantini, Federica; Carlesi, Lorenzo; Abbiati, Marco			Quantifying Spatial Genetic Structuring in Mesophotic Populations of the Precious Coral Corallium rubrum	PLOS ONE			English	Article							MEDITERRANEAN RED CORAL; SEA; CONNECTIVITY; CONSERVATION; BIODIVERSITY; INFERENCE; SOFTWARE; MARKERS; ISSUES; G(ST)	While shallow water red coral populations have been overharvested in the past, nowadays, commercial harvesting shifted its pressure on mesophotic organisms. An understanding of red coral population structure, particularly larval dispersal patterns and connectivity among harvested populations is paramount to the viability of the species. In order to determine patterns of genetic spatial structuring of deep water Corallium rubrum populations, for the first time, colonies found between 58-118 m depth within the Tyrrhenian Sea were collected and analyzed. Ten microsatellite loci and two regions of mitochondrial DNA (mtMSH and mtC) were used to quantify patterns of genetic diversity within populations and to define population structuring at spatial scales from tens of metres to hundreds of kilometres. Microsatellites showed heterozygote deficiencies in all populations. Significant levels of genetic differentiation were observed at all investigated spatial scales, suggesting that populations are likely to be isolated. This differentiation may by the results of biological interactions, occurring within a small spatial scale and/or abiotic factors acting at a larger scale. Mitochondrial markers revealed significant genetic structuring at spatial scales greater then 100 km showing the occurrence of a barrier to gene flow between northern and southern Tyrrhenian populations. These findings provide support for the establishment of marine protected areas in the deep sea and off-shore reefs, in order to effectively maintain genetic diversity of mesophotic red coral populations.	[Costantini, Federica; Carlesi, Lorenzo; Abbiati, Marco] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Ctr Interdipartimentale Ric Sci Ambientali, CoNISMa, Ravenna, Italy; [Abbiati, Marco] ISMAR CNR, Bologna, Italy	CoNISMa; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Costantini, F (corresponding author), Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Ctr Interdipartimentale Ric Sci Ambientali, CoNISMa, Ravenna, Italy.	federica.costantini@unibo.it	COSTANTINI, FEDERICA/ABH-9194-2020; CNR, Ismar/P-1247-2014	COSTANTINI, FEDERICA/0000-0002-8813-1923; Abbiati, Marco/0000-0002-2426-4524; CNR, Ismar/0000-0001-5351-1486	Italian Ministry of Environment; Assegno di Ricerca of the University of Bologna; MIUR	Italian Ministry of Environment; Assegno di Ricerca of the University of Bologna; MIUR(Ministry of Education, Universities and Research (MIUR))	This study is part of a research project "Study of red coral deep dwelling populations: structure, demography and genetics'' supported by a grant form the Italian Ministry of Environment and by an Assegno di Ricerca of the University of Bologna to FC. This study was partially funded by MIUR (PRIN 2011 project on "Coastal bioconstructions: structure, function and management"). The Ministry had a role, through founding, in data collection and analysis.	Addamo AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050215; ARTALE V, 1994, J GEOPHYS RES-OCEANS, V99, P14127, DOI 10.1029/94JC00284; Aurelle D, 2011, GENETICA, V139, P855, DOI 10.1007/s10709-011-9589-6; BELKHIR K, 2004, GENETIX V 4 0 LOGICI; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bo M, 2011, ITAL J ZOOL, V78, P231, DOI 10.1080/11250001003652619; Bo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016357; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; Bramanti L, 2013, GLOBAL CHANGE BIOL, V19, P1897, DOI 10.1111/gcb.12171; Bramanti L, 2009, ECOL MODEL, V220, P2851, DOI 10.1016/j.ecolmodel.2009.01.031; Calderon I, 2006, J EXP MAR BIOL ECOL, V336, P184, DOI 10.1016/j.jembe.2006.05.006; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2010, BIODIVERS CONSERV, V19, P153, DOI 10.1007/s10531-009-9712-5; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Corriero G, 1997, MAR ECOL-P S Z N I, V18, P147, DOI 10.1111/j.1439-0485.1997.tb00433.x; Costantini F, 2007, MOL ECOL, V16, P5168, DOI 10.1111/j.1365-294X.2007.03579.x; Costantini F, 2003, BIOL MARINA MEDITERR, V10, P73; Costantini F, 2007, MAR ECOL PROG SER, V340, P109, DOI 10.3354/meps340109; Costantini F, 2006, MOL ECOL NOTES, V6, P521, DOI 10.1111/j.1471-8286.2006.01305.x; Costantini F, 2011, CORAL REEFS, V30, P991, DOI 10.1007/s00338-011-0771-1; Costantini F, 2010, MAR ECOL-EVOL PERSP, V31, P261, DOI 10.1111/j.1439-0485.2009.00333.x; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; DCT R, 2008, LANG ENV STAT COMP; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; France Scott C., 2001, Bulletin of the Biological Society of Washington, P110; Freiwald A, 2009, OCEANOGRAPHY, V22, P58, DOI 10.5670/oceanog.2009.06; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Gori A, 2012, BIOGEOSCIENCES DISCU, V9, P19053; Gori A, 2011, MAR BIOL, V158, P1721, DOI 10.1007/s00227-011-1686-7; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kendall M.G., 1977, ADV THEORY STAT, V4th ed.; Ledoux JB, 2010, MOL ECOL, V19, P4204, DOI 10.1111/j.1365-294X.2010.04814.x; Ledoux JB, 2010, MOL ECOL, V19, P675, DOI 10.1111/j.1365-294X.2009.04516.x; Lepard AB, 2003, ANAL VARIATION MITOC; Linares C, 2012, CONSERV BIOL, V26, P88, DOI 10.1111/j.1523-1739.2011.01795.x; MANTEL N, 1967, CANCER RES, V27, P209; Miller K, 2010, MAR ECOL-EVOL PERSP, V31, P144, DOI 10.1111/j.1439-0485.2010.00380.x; Miller K, 2011, TLS-TIMES LIT SUPPL, P6; Nei M., 1987, MOL EVOLUTIONARY GEN; Palumbi SR, 2012, EVOL ECOL, V26, P317, DOI 10.1007/s10682-011-9517-3; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rossi S, 2008, MAR BIOL, V154, P533, DOI 10.1007/s00227-008-0947-6; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Santangelo G, 2001, AQUAT CONSERV, V11, P253, DOI 10.1002/aqc.451; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsounis G, 2013, MAR POLICY, V39, P361, DOI 10.1016/j.marpol.2012.12.010; Tsounis G, 2010, OCEANOGR MAR BIOL, V48, P161, DOI 10.1201/EBK1439821169-c3; Uda K, 2011, GENE, V476, P27, DOI 10.1016/j.gene.2011.01.019; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; VIGHI M, 1972, VIE MILIEU A BIOL MA, V23, P21; Weinberg S., 1979, Contributions to Zoology, V49, P16; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323	67	21	21	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61546	10.1371/journal.pone.0061546	http://dx.doi.org/10.1371/journal.pone.0061546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646109	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300010
J	Itoh, TQ; Matsumoto, A; Tanimura, T				Itoh, Taichi Q.; Matsumoto, Akira; Tanimura, Teiichi			C-Terminal Binding Protein (CtBP) Activates the Expression of E-Box Clock Genes with CLOCK/CYCLE in Drosophila	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; TRANSCRIPTIONAL REPRESSION; COACTIVATOR; TAKEOUT; NEURONS; PDP1-EPSILON; COREPRESSOR; OSCILLATOR; PHENOTYPES; REVEALS	In Drosophila, CLOCK/CYCLE heterodimer (CLK/CYC) is the primary activator of circadian clock genes that contain the E-box sequence in their promoter regions (hereafter referred to as "E-box clock genes''). Although extensive studies have investigated the feedback regulation of clock genes, little is known regarding other factors acting with CLK/CYC. Here we show that Drosophila C-terminal binding protein (dCtBP), a transcriptional co-factor, is involved in the regulation of the E-box clock genes. In vivo overexpression of dCtBP in clock cells lengthened or abolished circadian locomotor rhythm with upregulation of a subset of the E-box clock genes, period (per), vrille (vri), and PAR domain protein 1 epsilon (Pdp1 epsilon). Co-expression of dCtBP with CLK in vitro also increased the promoter activity of per, vri, Pdp1 epsilon and cwo depending on the amount of dCtBP expression, whereas no effect was observed without CLK. The activation of these clock genes in vitro was not observed when we used mutated dCtBP which carries amino acid substitutions in NAD(+) domain. These results suggest that dCtBP generally acts as a putative co-activator of CLK/CYC through the E-box sequence.	[Itoh, Taichi Q.; Tanimura, Teiichi] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Matsumoto, Akira] Juntendo Univ, Sch Med, Dept Biol, Chiba, Japan	Kyushu University; Juntendo University	Tanimura, T (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	tanimura@kyudai.jp	Itoh, Taichi/AAV-1976-2021	Itoh, Taichi/0000-0003-0794-1711	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [24570199] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to TT and AM, and the Japan Society for the Promotion of Science (JSPS) to TQI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Benito J, 2007, J NEUROSCI, V27, P2539, DOI 10.1523/JNEUROSCI.4870-06.2007; Benito J, 2010, P NATL ACAD SCI USA, V107, P2544, DOI 10.1073/pnas.0906422107; Bhambhani C, 2011, EMBO J, V30, P2031, DOI 10.1038/emboj.2011.100; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Hardin PE, 2006, CURR OPIN NEUROBIOL, V16, P686, DOI 10.1016/j.conb.2006.09.001; Hung HC, 2007, J BIOL CHEM, V282, P31349, DOI 10.1074/jbc.M702319200; Itoh TQ, 2011, APPL ENTOMOL ZOOL, V46, P391, DOI 10.1007/s13355-011-0052-z; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Kuppuswamy M, 2007, MOL CELL BIOL, V28, P259; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lim C, 2007, MOL CELL BIOL, V27, P4876, DOI 10.1128/MCB.02155-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mani-Telang P, 2007, FEBS LETT, V581, P5241, DOI 10.1016/j.febslet.2007.10.011; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Matsumoto A, 2011, BIOTECHNIQUES, V51, P55, DOI 10.2144/000113705; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; Pili-Floury S, 2004, J BIOL CHEM, V279, P12848, DOI 10.1074/jbc.M313324200; Poortinga G, 1998, EMBO J, V17, P2067, DOI 10.1093/emboj/17.7.2067; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Tomioka K, 2010, CELL MOL LIFE SCI, V67, P1397, DOI 10.1007/s00018-009-0232-y; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353	39	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63113	10.1371/journal.pone.0063113	http://dx.doi.org/10.1371/journal.pone.0063113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646183	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300138
J	Smircich, P; Forteza, D; El-Sayed, NM; Garat, B				Smircich, Pablo; Forteza, Diego; El-Sayed, Najib M.; Garat, Beatriz			Genomic Analysis of Sequence-Dependent DNA Curvature in Leishmania	PLOS ONE			English	Article							GENE-EXPRESSION; 3'-UNTRANSLATED REGION; RNA GENE; DEVELOPMENTAL REGULATION; REPLICATION ORIGINS; TRANSCRIPTION; ORGANIZATION; ELEMENTS; IDENTIFICATION; TERMINATION	Leishmania major is a flagellated protozoan parasite of medical importance. Like other members of the Trypanosomatidae family, it possesses unique mechanisms of gene expression such as constitutive polycistronic transcription of directional gene clusters, gene amplification, mRNA trans-splicing, and extensive editing of mitochondrial transcripts. The molecular signals underlying most of these processes remain under investigation. In order to investigate the role of DNA secondary structure signals in gene expression, we carried out a genome-wide in silico analysis of the intrinsic DNA curvature. The L. major genome revealed a lower frequency of high intrinsic curvature regions as well as inter- and intra- chromosomal distribution heterogeneity, when compared to prokaryotic and eukaryotic organisms. Using a novel method aimed at detecting region-integrated intrinsic curvature (RIIC), high DNA curvature was found to be associated with regions implicated in transcription initiation. Those include divergent strand-switch regions between directional gene clusters and regions linked to markers of active transcription initiation such as acetylated H3 histone, TRF4 and SNAP50. These findings suggest a role for DNA curvature in transcription initiation in Leishmania supporting the relevance of DNA secondary structures signals.	[Smircich, Pablo; Forteza, Diego; Garat, Beatriz] Fac Ciencias, Lab Interacc Mol, Montevideo, Uruguay; [Smircich, Pablo] Fac Med, Dept Genet, Montevideo, Uruguay; [El-Sayed, Najib M.] Univ Maryland Coll Pk, Dept Cell Biol & Mol Genet, College Pk, MD USA; [El-Sayed, Najib M.] Univ Maryland Coll Pk, Ctr Bioinformat & Computat Biol, College Pk, MD USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Garat, B (corresponding author), Fac Ciencias, Lab Interacc Mol, Montevideo, Uruguay.	bgarat@fcien.edu.uy	El-Sayed, Najib M.A./K-7266-2015	El-Sayed, Najib M.A./0000-0001-7970-3312; Smircich, Pablo/0000-0002-3856-3920; Garat, Beatriz/0000-0003-2679-8244	Fondo Clemente Estable (Agencia Nacional de Investigacion e Innovacion); Comision Sectorial de Investigacion Cientifica (Universidad de la Republica); Programa de Desarrollo de Ciencias Basicas; PhD fellowship (Agencia Nacional de Investigacion e Innovacion); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094773] Funding Source: NIH RePORTER	Fondo Clemente Estable (Agencia Nacional de Investigacion e Innovacion); Comision Sectorial de Investigacion Cientifica (Universidad de la Republica); Programa de Desarrollo de Ciencias Basicas; PhD fellowship (Agencia Nacional de Investigacion e Innovacion); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Fondo Clemente Estable (Agencia Nacional de Investigacion e Innovacion); Comision Sectorial de Investigacion Cientifica (Universidad de la Republica) and Programa de Desarrollo de Ciencias Basicas. PS received a PhD fellowship (Agencia Nacional de Investigacion e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaui V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001021; AGAMI R, 1994, NUCLEIC ACIDS RES, V22, P1959, DOI 10.1093/nar/22.11.1959; Alcolea PJ, 2011, J EUKARYOT MICROBIOL, V58, P352, DOI 10.1111/j.1550-7408.2011.00549.x; Alcolea PJ, 2009, GENOMICS, V93, P551, DOI 10.1016/j.ygeno.2009.01.007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANTON H, 1999, CALCULUS NEW HORIZON, V32, P1130; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Boucher N, 2004, NUCLEIC ACIDS RES, V32, P2925, DOI 10.1093/nar/gkh617; Boucher N, 2002, J BIOL CHEM, V277, P19511, DOI 10.1074/jbc.M200500200; Bringaud F, 2007, PLOS PATHOG, V3, P1291, DOI 10.1371/journal.ppat.0030136; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Casagrande L, 2005, INT J PARASITOL, V35, P973, DOI 10.1016/j.ijpara.2005.04.004; Choi J, 2012, PARASITE IMMUNOL, V34, P72, DOI 10.1111/j.1365-3024.2011.01347.x; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Cuervo P, 2010, J PROTEOMICS, V73, P845, DOI 10.1016/j.jprot.2009.12.012; Daenen F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-332; Das A, 2008, EUKARYOT CELL, V7, P429, DOI 10.1128/EC.00297-07; Depledge DP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000476; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Duhagon MA, 2011, GENE, V487, P29, DOI 10.1016/j.gene.2011.07.022; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Gabrielian A, 1997, FEBS LETT, V406, P69, DOI 10.1016/S0014-5793(97)00236-6; Ghedin E, 2004, MOL BIOCHEM PARASIT, V134, P183, DOI 10.1016/j.molbiopara.2003.11.012; Ghedira K, 2011, INFECT GENET EVOL, V11, P769, DOI 10.1016/j.meegid.2010.10.015; Gimenes F, 2008, GENET MOL RES, V7, P549, DOI 10.4238/vol7-2gmr461; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kiyama R, 2002, FEBS LETT, V523, P7, DOI 10.1016/S0014-5793(02)02937-X; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Liu HD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-72; Marilley M, 2000, MOL GEN GENET, V263, P854, DOI 10.1007/s004380000253; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Martinez-Calvillo S, 2004, EUKARYOT CELL, V3, P506, DOI 10.1128/EC.3.2.506-517.2004; Martinez-Calvillo S, 2001, MOL BIOCHEM PARASIT, V116, P147, DOI 10.1016/S0166-6851(01)00310-3; Martinez-Calvillo S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525241; McDonagh PD, 2000, NUCLEIC ACIDS RES, V28, P2800, DOI 10.1093/nar/28.14.2800; McNicoll F, 2005, J BIOL CHEM, V280, P35238, DOI 10.1074/jbc.M507511200; Mukherjee A, 2011, NUCLEIC ACIDS RES, V39, P7499, DOI 10.1093/nar/gkr494; Nilsson D, 2005, EXP PARASITOL, V109, P143, DOI 10.1016/j.exppara.2004.12.004; NTAMBI JM, 1984, MOL BIOCHEM PARASIT, V12, P273, DOI 10.1016/0166-6851(84)90084-7; Ohyama T., 2005, DNA CONFORMATION TRA; Padilla-Mejia NE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-232; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Potaman VN, 2005, MOL B INT U, P3; Puechberty J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-57; Quijada L, 2000, MOL BIOCHEM PARASIT, V110, P79, DOI 10.1016/S0166-6851(00)00258-9; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rana T, 2011, J BIOL CHEM, V286, P6614, DOI 10.1074/jbc.M110.181735; Requena JM, 1997, MOL BIOCHEM PARASIT, V84, P101, DOI 10.1016/S0166-6851(96)02785-5; Requena JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-263; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Rochette A, 2009, MOL BIOCHEM PARASIT, V165, P32, DOI 10.1016/j.molbiopara.2008.12.012; SAITO RM, 1994, EMBO J, V13, P5460, DOI 10.1002/j.1460-2075.1994.tb06881.x; Smith M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-240; Stempliuk VD, 2002, INT J PARASITOL, V32, P437, DOI 10.1016/S0020-7519(01)00371-X; Sturm NR, 1999, MOL CELL BIOL, V19, P1595; Thomas S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-152; Tosato V, 2001, CURR GENET, V40, P186, DOI 10.1007/s002940100246; Tsigankov P, 2012, PARASITOLOGY, V139, P1146, DOI 10.1017/S0031182012000157; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115; van Luenen HGAM, 2012, CELL, V150, P909, DOI 10.1016/j.cell.2012.07.030; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P4201, DOI 10.1093/nar/gkg469; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; Zilka A, 2001, J BIOL CHEM, V276, P47922, DOI 10.1074/jbc.M108271200	67	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63068	10.1371/journal.pone.0063068	http://dx.doi.org/10.1371/journal.pone.0063068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646176	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300131
J	Brady, RA; Mocca, CP; Prabhakara, R; Plaut, RD; Shirtliff, ME; Merkel, TJ; Burns, DL				Brady, Rebecca A.; Mocca, Christopher P.; Prabhakara, Ranjani; Plaut, Roger D.; Shirtliff, Mark E.; Merkel, Tod J.; Burns, Drusilla L.			Evaluation of Genetically Inactivated Alpha Toxin for Protection in Multiple Mouse Models of Staphylococcus aureus Infection	PLOS ONE			English	Article							CLUMPING FACTOR-A; NASAL CARRIAGE; INDUCED MASTITIS; GENE-EXPRESSION; IMMUNE-RESPONSE; BINDING PROTEIN; VACCINE; IMMUNIZATION; IDENTIFICATION; COLONIZATION	Staphylococcus aureus is a major human pathogen and a leading cause of nosocomial and community-acquired infections. Development of a vaccine against this pathogen is an important goal. While S. aureus protective antigens have been identified in the literature, the majority have only been tested in a single animal model of disease. We wished to evaluate the ability of one S. aureus vaccine antigen to protect in multiple mouse models, thus assessing whether protection in one model translates to protection in other models encompassing the full breadth of infections the pathogen can cause. We chose to focus on genetically inactivated alpha toxin mutant HlaH35L. We evaluated the protection afforded by this antigen in three models of infection using the same vaccine dose, regimen, route of immunization, adjuvant, and challenge strain. When mice were immunized with HlaH35L and challenged via a skin and soft tissue infection model, HlaH35L immunization led to a less severe infection and decreased S. aureus levels at the challenge site when compared to controls. Challenge of HlaH35L-immunized mice using a systemic infection model resulted in a limited, but statistically significant decrease in bacterial colonization as compared to that observed with control mice. In contrast, in a prosthetic implant model of chronic biofilm infection, there was no significant difference in bacterial levels when compared to controls. These results demonstrate that vaccines may confer protection against one form of S. aureus disease without conferring protection against other disease presentations and thus underscore a significant challenge in S. aureus vaccine development.	[Brady, Rebecca A.; Mocca, Christopher P.; Prabhakara, Ranjani; Plaut, Roger D.; Merkel, Tod J.; Burns, Drusilla L.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA; [Shirtliff, Mark E.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Shirtliff, Mark E.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	US Food & Drug Administration (FDA); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Burns, DL (corresponding author), US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA.	drusilla.burns@fda.hhs.gov	Shirtliff, Mark E/H-2563-2017; Plaut, Roger D./B-2340-2013	Shirtliff, Mark E/0000-0002-8913-3445; Plaut, Roger D./0000-0002-0883-972X	Center for Biologics Evaluation and Research; Food and Drug Administration; National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01AI69568, ARRA AI69568]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007540, R01AI069568, N01AI095359] Funding Source: NIH RePORTER	Center for Biologics Evaluation and Research(United States Department of Health & Human Services); Food and Drug Administration(United States Department of Health & Human Services); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Center for Biologics Evaluation and Research, Food and Drug Administration, and by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (grants R01AI69568 and ARRA AI69568 to MES). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adhikari RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038567; Anderson AS, 2012, J INFECT DIS, V205, P1688, DOI 10.1093/infdis/jis272; Arrecubieta C, 2008, J INFECT DIS, V198, P571, DOI 10.1086/590210; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Brady RA, 2011, INFECT IMMUN, V79, P1797, DOI 10.1128/IAI.00451-10; Brouillette E, 2002, VACCINE, V20, P2348, DOI 10.1016/S0264-410X(02)00100-7; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Cook J, 2009, HUM VACCINES, V5, P254, DOI 10.4161/hv.5.4.6765; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Gening ML, 2010, INFECT IMMUN, V78, P764, DOI 10.1128/IAI.01093-09; Glowalla E, 2009, INFECT IMMUN, V77, P2719, DOI 10.1128/IAI.00617-08; Gong R, 2010, CLIN VACCINE IMMUNOL, V17, P1746, DOI 10.1128/CVI.00162-10; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Ho MM, 2006, HUM VACCINES, V2, P89, DOI 10.4161/hv.2755; Hu DL, 2009, VACCINE, V27, P4867, DOI 10.1016/j.vaccine.2009.04.053; Hume EBH, 2000, INFECT IMMUN, V68, P6052, DOI 10.1128/IAI.68.10.6052-6055.2000; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Josefsson E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002206; Joshi A, 2012, HUM VACC IMMUNOTHER, V8, P336, DOI DOI 10.4161/HV.18946; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kim HK, 2010, J EXP MED, V207, P1863, DOI 10.1084/jem.20092514; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Krespi YP, 2012, AM J OTOLARYNG, V33, P572, DOI 10.1016/j.amjoto.2012.02.002; Li D, 2008, J ORTHOP RES, V26, P96, DOI 10.1002/jor.20452; MAMO W, 1994, FEMS IMMUNOL MED MIC, V10, P47, DOI 10.1111/j.1574-695X.1994.tb00010.x; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Narita K, 2008, FEMS IMMUNOL MED MIC, V52, P389, DOI 10.1111/j.1574-695X.2008.00384.x; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P402, DOI 10.1016/j.ijmm.2010.04.015; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Prabhakara R, 2013, INFECT IMMUN; Prabhakara R, 2011, INFECT IMMUN, V79, P1789, DOI 10.1128/IAI.01386-10; Rauch S, 2012, INFECT IMMUN, V80, P3721, DOI 10.1128/IAI.00442-12; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Schaffer AC, 2006, INFECT IMMUN, V74, P2145, DOI 10.1128/IAI.74.4.2145-2153.2006; Shannon O, 2006, SCAND J IMMUNOL, V63, P184, DOI 10.1111/j.1365-3083.2006.01735.x; Shkreta L, 2004, VACCINE, V23, P114, DOI 10.1016/j.vaccine.2004.05.002; STEMMER WPC, 1992, BIOTECHNIQUES, V13, P214; Ster C, 2010, VET IMMUNOL IMMUNOP, V136, P311, DOI 10.1016/j.vetimm.2010.03.010; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Zhou H, 2006, VACCINE, V24, P4830, DOI 10.1016/j.vaccine.2006.03.020	46	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e63040	10.1371/journal.pone.0063040	http://dx.doi.org/10.1371/journal.pone.0063040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658662	Green Submitted, Green Published, gold			2022-12-25	WOS:000321662800074
J	Gobron, N; Waszczak, C; Simon, M; Hiard, S; Boivin, S; Charif, D; Ducamp, A; Wenes, E; Budar, F				Gobron, Nicolas; Waszczak, Cezary; Simon, Matthieu; Hiard, Sophie; Boivin, Stephane; Charif, Delphine; Ducamp, Aloise; Wenes, Estelle; Budar, Francoise			A Cryptic Cytoplasmic Male Sterility Unveils a Possible Gynodioecious Past for Arabidopsis thaliana	PLOS ONE			English	Article							MITOCHONDRIAL GENOMES; SELF-COMPATIBILITY; NUCLEAR; EVOLUTION; FERTILITY; DNA; INCOMPATIBILITY; SELECTION; ALIGNMENT; CONFLICT	Gynodioecy, the coexistence of hermaphrodites and females (i.e. male-sterile plants) in natural plant populations, most often results from polymorphism at genetic loci involved in a particular interaction between the nuclear and cytoplasmic genetic compartments (cytonuclear epistasis): cytoplasmic male sterility (CMS). Although CMS clearly contributes to the coevolution of involved nuclear loci and cytoplasmic genomes in gynodioecious species, the occurrence of CMS genetic factors in the absence of sexual polymorphism (cryptic CMS) is not easily detected and rarely taken in consideration. We found cryptic CMS in the model plant Arabidopsis thaliana after crossing distantly related accessions, Sha and Mr-0. Male sterility resulted from an interaction between the Sha cytoplasm and two Mr-0 genomic regions located on chromosome 1 and chromosome 3. Additional accessions with either nuclear sterility maintainers or sterilizing cytoplasms were identified from crosses with either Sha or Mr-0. By comparing two very closely related cytoplasms with different male-sterility inducing abilities, we identified a novel mitochondrial ORF, named orf117Sha, that is most likely the sterilizing factor of the Sha cytoplasm. The presence of orf117Sha was investigated in worldwide natural accessions. It was found mainly associated with a single chlorotype in accessions belonging to a clade predominantly originating from Central Asia. More than one-third of accessions from this clade carried orf117Sha, indicating that the sterilizing-inducing cytoplasm had spread in this lineage. We also report the coexistence of the sterilizing cytoplasm with a non-sterilizing cytoplasm at a small, local scale in a natural population; in addition a correlation between cytotype and nuclear haplotype was detected in this population. Our results suggest that this CMS system induced sexual polymorphism in A. thaliana populations, at the time when the species was mainly outcrossing.	[Gobron, Nicolas; Waszczak, Cezary; Simon, Matthieu; Hiard, Sophie; Boivin, Stephane; Charif, Delphine; Ducamp, Aloise; Wenes, Estelle; Budar, Francoise] INRA, UMR1318, IJPB, F-78026 Versailles, France; [Gobron, Nicolas; Waszczak, Cezary; Simon, Matthieu; Hiard, Sophie; Boivin, Stephane; Charif, Delphine; Ducamp, Aloise; Wenes, Estelle; Budar, Francoise] AgroParisTech, IJPB, Versailles, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Budar, F (corresponding author), INRA, UMR1318, IJPB, F-78026 Versailles, France.	Francoise.Budar@versailles.inra.fr	BUDAR, Françoise/G-1221-2013; Waszczak, Cezary/AAA-8882-2019	BUDAR, Françoise/0000-0002-4328-5670; Waszczak, Cezary/0000-0002-5978-7560; BOIVIN, Stephane/0000-0002-4084-2312	French Ministry in charge of Research; VERT Marie Curie Early Training Site	French Ministry in charge of Research; VERT Marie Curie Early Training Site	NG was funded by the French Ministry in charge of Research. CW was funded by the VERT Marie Curie Early Training Site. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashutosh, 2008, PLANT CELL PHYSIOL, V49, P284, DOI 10.1093/pcp/pcm182; Bailey MF, 2003, AM NAT, V161, P762, DOI 10.1086/374803; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Boggs NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000426; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2010, PHILOS T R SOC B, V365, P1815, DOI 10.1098/rstb.2009.0304; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Bouchez D, 1996, PLANT MOL BIOL REP, V14, P115, DOI 10.1007/BF02684900; Budar F, 2003, GENETICA, V117, P3, DOI 10.1023/A:1022381016145; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Caruso CM, 2012, TRENDS PLANT SCI, V17, P638, DOI 10.1016/j.tplants.2012.06.006; Case AL, 2008, EVOLUTION, V62, P1026, DOI 10.1111/j.1558-5646.2008.00360.x; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Darwin C, 1877, EFFECTS CROSS SELF F; Davila JI, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-64; Delph LF, 2007, TRENDS ECOL EVOL, V22, P17, DOI 10.1016/j.tree.2006.09.013; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Drouaud J, 2011, METHODS MOL BIOL, V745, P223, DOI 10.1007/978-1-61779-129-1_14; Ducos E, 2001, PLANT J, V26, P171, DOI 10.1046/j.1365-313x.2001.01017.x; Dufay M, 2007, HEREDITY, V99, P349, DOI 10.1038/sj.hdy.6801009; Fishman L, 2006, EVOLUTION, V60, P1372, DOI 10.1111/j.0014-3820.2006.tb01216.x; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Giancola S, 2007, THEOR APPL GENET, V114, P1333, DOI 10.1007/s00122-007-0520-6; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Jacobs MS, 2003, AM NAT, V161, P837, DOI 10.1086/375174; Knoop V, 2004, CURR GENET, V46, P123, DOI 10.1007/s00294-004-0522-8; Kronholm I, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-33; Kubo T, 2011, CRIT REV PLANT SCI, V30, P378, DOI 10.1080/07352689.2011.587727; Kumar P, 2012, J EXP BOT, V63, P2921, DOI 10.1093/jxb/err459; Leppala J, 2011, EVOLUTION, V65, P2959, DOI 10.1111/j.1558-5646.2011.01361.x; LEWIS D., 1941, NEW PHYTOT, V40, P56, DOI 10.1111/j.1469-8137.1941.tb07028.x; LHomme Y, 1997, CURR GENET, V31, P325, DOI 10.1007/s002940050212; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Moison M, 2010, PLANT J, V63, P728, DOI 10.1111/j.1365-313X.2010.04275.x; Nasrallah JB, 2002, SCIENCE, V296, P305, DOI 10.1126/science.296.5566.305; Nasrallah ME, 2004, P NATL ACAD SCI USA, V101, P16070, DOI 10.1073/pnas.0406970101; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Scotti N., 2001, Plant Molecular Biology Reporter, V19, P67, DOI 10.1007/BF02824080; Shimizu KK, 2008, MOL ECOL, V17, P704, DOI 10.1111/j.1365-294X.2007.03605.x; Shimizu KK, 2004, SCIENCE, V306, P2081, DOI 10.1126/science.1103776; Silveira AB, 2013, PLOS GENET IN PRESS; Simon M, 2012, PLANT J, V69, P1094, DOI 10.1111/j.1365-313X.2011.04852.x; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Smith LM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002164; Tang CL, 2007, SCIENCE, V317, P1070, DOI 10.1126/science.1143153; Tang HV, 1996, PLANT J, V10, P123, DOI 10.1046/j.1365-313X.1996.10010123.x; Touzet P, 2012, ADV BOT RES, V63, P71, DOI 10.1016/B978-0-12-394279-1.00004-1; van Wyhe J, 2006, NOTES REC ROY SOC, V60, P87, DOI 10.1098/rsnr.2005.0128; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wen LY, 2003, GENETICS, V165, P771; Yamagishi H, 2001, THEOR APPL GENET, V103, P725, DOI 10.1007/s001220100614	58	22	22	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62450	10.1371/journal.pone.0062450	http://dx.doi.org/10.1371/journal.pone.0062450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658632	gold, Green Published, Green Submitted			2022-12-25	WOS:000321662800047
J	Palova-Jelinkova, L; Danova, K; Drasarova, H; Dvorak, M; Funda, DP; Fundova, P; Kotrbova-Kozak, A; Cerna, M; Kamanova, J; Martin, SF; Freudenberg, M; Tuckova, L				Palova-Jelinkova, Lenka; Danova, Klara; Drasarova, Hana; Dvorak, Milos; Funda, David P.; Fundova, Petra; Kotrbova-Kozak, Anna; Cerna, Marie; Kamanova, Jana; Martin, Stefan F.; Freudenberg, Marina; Tuckova, Ludmila			Pepsin Digest of Wheat Gliadin Fraction Increases Production of IL-1 beta via TLR4/MyD88/TRIF/MAPK/NF-kappa B Signaling Pathway and an NLRP3 Inflammasome Activation	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; CELIAC-DISEASE; DIFFERENTIAL REQUIREMENT; CASPASE-1 ACTIVATION; BLOOD MONOCYTES; IMMUNE-RESPONSE; NITRIC-OXIDE; GLUTEN; INNATE; SECRETION	Celiac disease (CD) is a gluten-responsive, chronic inflammatory enteropathy. IL-1 cytokine family members IL-1 beta and IL-18 have been associated with the inflammatory conditions in CD patients. However, the mechanisms of IL-1 molecule activation in CD have not yet been elucidated. We show in this study that peripheral blood mononuclear cells (PBMC) and monocytes from celiac patients responded to pepsin digest of wheat gliadin fraction (PDWGF) by a robust secretion of IL-1 beta and IL-1 alpha and a slightly elevated production of IL-18. The analysis of the upstream mechanisms underlying PDWGF-induced IL-1 beta production in celiac PBMC show that PDWGF-induced de novo pro-IL-1 beta synthesis, followed by a caspase-1 dependent processing and the secretion of mature IL-1 beta. This was promoted by K+ efflux and oxidative stress, and was independent of P2X7 receptor signaling. The PDWGF-induced IL-1 beta release was dependent on Nod-like receptor family containing pyrin domain 3 (NLRP3) and apoptosis-associated speck like protein (ASC) as shown by stimulation of bone marrow derived dendritic cells (BMDC) from NLRP3(-/-) and ASC(-/-) knockout mice. Moreover, treatment of human PBMC as well as MyD88(-/-) and Toll-interleukin-1 receptor domain-containing adaptor-inducing interferon-beta (TRIF)(-/-) BMDC illustrated that prior to the activation of caspase-1, the PDWGF-triggered signal constitutes the activation of the MyD88/TRIF/MAPK/NF-kappa B pathway. Moreover, our results indicate that the combined action of TLR2 and TLR4 may be required for optimal induction of IL-1 beta in response to PDWGF. Thus, innate immune pathways, such as TLR2/4/MyD88/TRIF/MAPK/NF-kB and an NLRP3 inflammasome activation are involved in wheat proteins signaling and may play an important role in the pathogenesis of CD.	[Palova-Jelinkova, Lenka; Danova, Klara; Drasarova, Hana; Funda, David P.; Fundova, Petra; Kamanova, Jana; Tuckova, Ludmila] Acad Sci Czech Republ, Inst Microbiol, Dept Immunol, Prague, Czech Republic; [Dvorak, Milos] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Kotrbova-Kozak, Anna; Cerna, Marie] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Martin, Stefan F.] Univ Med Ctr Freiburg, Dept Dermatol, Allergy Res Grp, Freiburg, Germany; [Freudenberg, Marina] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; University of Freiburg; Max Planck Society	Palova-Jelinkova, L (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Dept Immunol, Prague, Czech Republic.	lenicka@biomed.cas.cz	Fundova, Petra/J-8670-2014; Kotrbova Kozak, Anna/HFZ-7610-2022; Funda, David/J-8669-2014; Kamanova, Jana/Q-4477-2017; Dvorak, Milos/Q-2942-2016; Drasarova, Hana/M-4238-2014; Černá, Marie/G-8372-2016	Kamanova, Jana/0000-0001-6574-4404; Dvorak, Milos/0000-0002-3043-8711; Černá, Marie/0000-0002-1208-5588; Funda, David/0000-0001-8327-6931; Freudenberg, Marina Alexandra/0000-0001-5894-1805	Grant Agency of the Czech Republic [310/09/1640, 310/07/0414]; Institutional Research Concept [RVO: 61388971]; Charles University through University Research Centre [UNCE 204015]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Institutional Research Concept; Charles University through University Research Centre	This work was supported by grants from the Grant Agency of the Czech Republic (no. 310/09/1640, 310/07/0414) and by Institutional Research Concept RVO: 61388971. A.K.K. gratefully acknowledges support of the Charles University through University Research Centre program UNCE 204015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam R, 2011, J IMMUNOL, V186, P2714, DOI 10.4049/jimmunol.1002657; Garrote JA, 2008, J PEDIATR GASTR NUTR, V47, pS27, DOI 10.1097/MPG.0b013e3181818fb9; Barone MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017039; Beckett CG, 1999, EUR J GASTROEN HEPAT, V11, P529, DOI 10.1097/00042737-199905000-00011; Chartrand LJ, 1997, J AM DIET ASSOC, V97, P612, DOI 10.1016/S0002-8223(97)00156-9; Chladkova B, 2011, J CELL MOL MED, V15, P938, DOI 10.1111/j.1582-4934.2010.01066.x; Cinova J, 2007, J CLIN IMMUNOL, V27, P201, DOI 10.1007/s10875-006-9061-z; Cseh A, 2011, DIGEST DIS SCI, V56, P792, DOI 10.1007/s10620-010-1363-6; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Freudenberg MA, 2008, IMMUNOBIOLOGY, V213, P193, DOI 10.1016/j.imbio.2007.11.008; Harris KM, 2008, J IMMUNOL, V181, P4457, DOI 10.4049/jimmunol.181.7.4457; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Junker Y, 2012, J EXP MED, V209, P2395, DOI 10.1084/jem.20102660; Kalliomaki M, 2012, J PEDIATR GASTR NUTR, V54, P727, DOI 10.1097/MPG.0b013e318241cfa8; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Lammers KM, 2003, GASTROENTEROLOGY, V135, P194; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Londei M, 2005, MOL IMMUNOL, V42, P913, DOI 10.1016/j.molimm.2004.12.005; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Manavalan JS, 2010, HUM IMMUNOL, V71, P50, DOI 10.1016/j.humimm.2009.09.351; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Matysiak-Budnik T, 2003, GASTROENTEROLOGY, V125, P696, DOI 10.1016/S0016-5085(03)01049-7; Mazzarella G, 2003, GUT, V52, P57, DOI 10.1136/gut.52.1.57; McCoy AJ, 2010, J IMMUNOL, V185, P7077, DOI 10.4049/jimmunol.1002165; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Nikulina M, 2004, J IMMUNOL, V173, P1925, DOI 10.4049/jimmunol.173.3.1925; Palova-Jelinkova L, 2005, J IMMUNOL, V175, P7038, DOI 10.4049/jimmunol.175.10.7038; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432; Pontillo A, 2011, AM J GASTROENTEROL, V106, P539, DOI 10.1038/ajg.2010.474; Salvati VM, 2002, GUT, V50, P186, DOI 10.1136/gut.50.2.186; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Stepniak D, 2006, HUM IMMUNOL, V67, P460, DOI 10.1016/j.humimm.2006.03.011; Szebeni B, 2007, J PEDIATR GASTR NUTR, V45, P187, DOI 10.1097/MPG.0b013e318064514a; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Tuckova L, 2000, J LEUKOCYTE BIOL, V67, P312, DOI 10.1002/jlb.67.3.312; Ward JR, 2010, J BIOL CHEM, V285, P23145, DOI 10.1074/jbc.M109.072793	47	82	86	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62426	10.1371/journal.pone.0062426	http://dx.doi.org/10.1371/journal.pone.0062426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658628	gold, Green Published, Green Submitted			2022-12-25	WOS:000321662800044
J	Wang, WQ; Cheng, HY; Song, SQ				Wang, Wei-Qing; Cheng, Hong-Yan; Song, Song-Quan			Development of a Threshold Model to Predict Germination of Populus tomentosa Seeds after Harvest and Storage under Ambient Condition	PLOS ONE			English	Article							HYDROTHERMAL TIME; RIPARIAN COTTONWOODS; INSTREAM FLOWS; TEMPERATURE; RIVER; DECLINE; SALICACEAE; DISPERSAL; EXPLAINS; LEGUMES	Effects of temperature, storage time and their combination on germination of aspen (Populus tomentosa) seeds were investigated. Aspen seeds were germinated at 5 to 30 degrees C at 5 degrees C intervals after storage for a period of time under 28 degrees C and 75% relative humidity. The effect of temperature on aspen seed germination could not be effectively described by the thermal time (TT) model, which underestimated the germination rate at 5 degrees C and poorly predicted the time courses of germination at 10, 20, 25 and 30 degrees C. A modified TT model (MTT) which assumed a two-phased linear relationship between germination rate and temperature was more accurate in predicting the germination rate and percentage and had a higher likelihood of being correct than the TT model. The maximum lifetime threshold (MLT) model accurately described the effect of storage time on seed germination across all the germination temperatures. An aging thermal time (ATT) model combining both the TT and MLT models was developed to describe the effect of both temperature and storage time on seed germination. When the ATT model was applied to germination data across all the temperatures and storage times, it produced a relatively poor fit. Adjusting the ATT model to separately fit germination data at low and high temperatures in the suboptimal range increased the models accuracy for predicting seed germination. Both the MLT and ATT models indicate that germination of aspen seeds have distinct physiological responses to temperature within a suboptimal range.	[Wang, Wei-Qing; Cheng, Hong-Yan; Song, Song-Quan] Chinese Acad Sci, Inst Bot, Key Lab Plant Resource, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Song, SQ (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resource, Beijing, Peoples R China.	sqsong@ibcas.ac.cn			National Science and Technology Support Program [2012BAC01B05]; National Science Foundation of China [30870223]	National Science and Technology Support Program; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funds for this study were provided by the National Science and Technology Support Program (2012BAC01B05) and National Science Foundation of China (30870223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alvarado V, 2002, PLANT CELL ENVIRON, V25, P1061, DOI 10.1046/j.1365-3040.2002.00894.x; Bloomberg M, 2009, SEED SCI RES, V19, P171, DOI 10.1017/S0960258509990031; Borset O., 1960, Scottish Forestry, V14, P68; Braatne JH, 2007, RIVER RES APPL, V23, P247, DOI 10.1002/rra.978; Bradford KJ, 1994, SEED SCI RES, V4, P63, DOI 10.1017/S0960258500002038; BRADFORD KJ, 1993, J EXP BOT, V44, P1225, DOI 10.1093/jxb/44.7.1225; Chantre GR, 2009, ANN BOT-LONDON, V103, P1291, DOI 10.1093/aob/mcp070; COVELL S, 1986, J EXP BOT, V37, P705, DOI 10.1093/jxb/37.5.705; ELLIS RH, 1988, J EXP BOT, V39, P935, DOI 10.1093/jxb/39.7.935; Fang CF, 2006, FLORA CHINA, P17; Forcella F, 2000, FIELD CROP RES, V67, P123, DOI 10.1016/S0378-4290(00)00088-5; GARCIAHUIDOBRO J, 1982, J EXP BOT, V33, P297, DOI 10.1093/jxb/33.2.297; Gonzalez E, 2010, TREES-STRUCT FUNCT, V24, P151, DOI 10.1007/s00468-009-0388-y; Grundy AC, 2000, NEW PHYTOL, V148, P433, DOI 10.1046/j.1469-8137.2000.00778.x; Guilloy-Froget H, 2002, WETLANDS, V22, P478, DOI 10.1672/0277-5212(2002)022[0478:DGASOP]2.0.CO;2; Hardegree SP, 1999, ENVIRON EXP BOT, V41, P209, DOI 10.1016/S0098-8472(99)00004-0; Hardegree SP, 1999, J RANGE MANAGE, V52, P83, DOI 10.2307/4003496; Hardegree SP, 2008, ENVIRON EXP BOT, V62, P120, DOI 10.1016/j.envexpbot.2007.07.010; Hardegree SP, 2006, ANN BOT-LONDON, V97, P1115, DOI 10.1093/aob/mcl071; International Seed Testing Association, 1999, SEED SCI TECHNOL, V27, P47; Karrenberg S, 2003, AM J BOT, V90, P749, DOI 10.3732/ajb.90.5.749; Kebreab E, 1999, J EXP BOT, V50, P655, DOI 10.1093/jexbot/50.334.655; Kobayashi K, 2000, AGRON J, V92, P345, DOI 10.1007/s100870050043; McDonald CK, 2002, AUST J EXP AGR, V42, P407, DOI 10.1071/EA00188; Merritt DM, 2000, REGUL RIVER, V16, P543, DOI 10.1002/1099-1646(200011/12)16:6&lt;543::AID-RRR590&gt;3.0.CO;2-N; Moss EH, 1937, BOT GAZ, V99, P529; Probert RJ, 1992, SEEDS ECOLOGY REGENE; R Development Core Team, 2007, R LANG ENV STAT COMP; ROOD SB, 1989, CAN J BOT, V67, P1744, DOI 10.1139/b89-221; ROOD SB, 1995, CAN J BOT, V73, P1250, DOI 10.1139/b95-136; Rood SB, 1998, WETLANDS, V18, P557, DOI 10.1007/BF03161672; Rowse HR, 2003, NEW PHYTOL, V158, P101, DOI 10.1046/j.1469-8137.2003.00707.x; VANSPLUNDER I, 1995, ACTA BOT NEERL, V44, P269; Windauer LB, 2012, ANN BOT-LONDON, V109, P265, DOI 10.1093/aob/mcr242	35	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62868	10.1371/journal.pone.0062868	http://dx.doi.org/10.1371/journal.pone.0062868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658654	Green Published, gold			2022-12-25	WOS:000318343700077
J	Ackermann, MA; Patel, PD; Valenti, J; Takagi, Y; Homsher, E; Sellers, JR; Kontrogianni-Konstantopoulos, A				Ackermann, Maegen A.; Patel, Puja D.; Valenti, Jane; Takagi, Yasuharu; Homsher, Earl; Sellers, James R.; Kontrogianni-Konstantopoulos, Aikaterini			Loss of actomyosin regulation in distal arthrogryposis myopathy due to mutant myosin binding protein-C slow	FASEB JOURNAL			English	Article						actin; contractility; MYBPC1; skeletal muscle	RABBIT SKELETAL-MUSCLE; MYBP-C; CARDIAC MYOSIN; THICK FILAMENT; F-ACTIN; DOMAIN; MUTATIONS; ISOFORM; SITE; CONTRACTION	Myosin binding protein C (MyBP-C) is expressed in striated muscles, where it plays key roles in the modulation of actomyosin cross-bridges. Slow MyBP-C (sMyBP-C) consists of multiple variants sharing common domains but also containing unique segments within the NH2 and COOH termini. Two missense mutations in the NH2 terminus (W236R) and COOH terminus (Y856H) of sMyBP-C have been causally linked to the development of distal arthrogryposis-1 (DA-1), a severe skeletal muscle disorder. Using a combination of in vitro binding and motility assays, we show that the COOH terminus mediates binding of sMyBP-C to thick filaments, while the NH2 terminus modulates the formation of actomyosin cross-bridges in a variant-specific manner. Consistent with this, a recombinant NH2-terminal peptide that excludes residues 34-59 reduces the sliding velocity of actin filaments past myosin heads from 9.0 +/- 1.3 to 5.7 +/- 1.0 m/s at 0.1 M, while a recombinant peptide that excludes residues 21-59 fails to do so. Notably, the actomyosin regulatory properties of sMyBP-C are completely abolished by the presence of the DA-1 mutations. In summary, our studies are the first to show that the NH2 and COOH termini of sMyBP-C have distinct functions, which are regulated by differential splicing, and are compromized by the presence of missense point mutations linked to muscle disease.Ackermann, M. A., Patel, P. D., Valenti, J., Takagi, Y., Homsher, E., Sellers, J. R., Kontrogiannni-Konstantopoulos, A. Loss of actomyosin regulation in distal arthrogryposis myopathy due to mutant myosin binding protein-C slow.	[Ackermann, Maegen A.; Patel, Puja D.; Valenti, Jane; Kontrogianni-Konstantopoulos, Aikaterini] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Takagi, Yasuharu; Sellers, James R.] NHLBI, NIH, Bethesda, MD 20892 USA; [Homsher, Earl] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kontrogianni-Konstantopoulos, A (corresponding author), Univ Maryland, Sch Med, 108 N Greene St, Baltimore, MD 21201 USA.	akons001@umaryland.edu		Patel, Puja/0000-0002-7595-1340	U.S. National Institutes of Health (NIH) [R01-AR-52768]; NIH (intramural funds from National Heart, Lung, and Blood Institute); NIH [F32-AR-058079]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001786, K99HL116778, ZIAHL006174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR058079, R01AR052768] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (intramural funds from National Heart, Lung, and Blood Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research has been supported by grants to A. K. K. from the U.S. National Institutes of Health (NIH; R01-AR-52768), to J.R.S from the NIH (intramural funds from National Heart, Lung, and Blood Institute), and to M. A. A. from the NIH (F32-AR-058079).	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ackermann MA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/636403; Ackermann MA, 2011, J PROTEOME RES, V10, P4547, DOI 10.1021/pr200355w; Ackermann MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/652065; Ackermann MA, 2009, MOL BIOL CELL, V20, P2963, DOI 10.1091/mbc.E08-12-1251; Alyonycheva TN, 1997, J BIOL CHEM, V272, P20866, DOI 10.1074/jbc.272.33.20866; Borzok MA, 2007, J BIOL CHEM, V282, P32384, DOI 10.1074/jbc.M704089200; de Tombe PP, 2006, CIRC RES, V98, P1234, DOI 10.1161/01.RES.0000225873.63162.c4; EINHEBER S, 1990, P NATL ACAD SCI USA, V87, P2157, DOI 10.1073/pnas.87.6.2157; Flashman E, 2007, BIOCHEM J, V401, P97, DOI 10.1042/BJ20060500; Gautel M, 1998, CIRC RES, V82, P124; Gilbert R, 1996, J CELL SCI, V109, P101; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Gurnett CA, 2010, HUM MOL GENET, V19, P1165, DOI 10.1093/hmg/ddp587; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; HOMSHER E, 1993, ADV EXP MED BIOL, V332, P279; Homsher E, 1993, ADV EXP MED BIOL, V332, P289; James J, 2011, J BIOL CHEM, V286, P9913, DOI 10.1074/jbc.R110.171801; Jana SS, 2009, J BIOL CHEM, V284, P11563, DOI 10.1074/jbc.M806574200; Kensler RW, 2011, J STRUCT BIOL, V174, P44, DOI 10.1016/j.jsb.2010.12.003; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Markus B, 2012, HUM MUTAT, V33, P1435, DOI 10.1002/humu.22122; Martyn DA, 2004, J MOL CELL CARDIOL, V37, P813, DOI 10.1016/j.yjmcc.2004.07.005; McClellan G, 2004, J MOL CELL CARDIOL, V37, P823, DOI 10.1016/j.yjmcc.2004.05.023; MOOS C, 1978, J MOL BIOL, V124, P571, DOI 10.1016/0022-2836(78)90172-9; MOOS C, 1975, J MOL BIOL, V97, P1, DOI 10.1016/S0022-2836(75)80017-9; Oakley CE, 2007, INT J BIOCHEM CELL B, V39, P2161, DOI 10.1016/j.biocel.2006.12.008; OKAGAKI T, 1993, J CELL BIOL, V123, P619, DOI 10.1083/jcb.123.3.619; Ratti J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.156646; Rybakova IN, 2011, J BIOL CHEM, V286, P2008, DOI 10.1074/jbc.M110.170605; Sellers J. R., 2001, CURR PROTOC CELL BIO, V13; SELLERS JR, 1991, J CELL SCI, P67; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; Vydyanath A, 2012, J MUSCLE RES CELL M, V33, P61, DOI 10.1007/s10974-012-9286-9; Wang F, 2000, BIOCHEMISTRY-US, V39, P5555, DOI 10.1021/bi000133x; WEBER FE, 1993, EUR J BIOCHEM, V216, P661, DOI 10.1111/j.1432-1033.1993.tb18186.x; Welikson RE, 2002, J CELL SCI, V115, P3517; YASUDA M, 1995, J MOL CELL CARDIOL, V27, P2275, DOI 10.1016/S0022-2828(95)91731-4	41	27	27	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3217	3228		10.1096/fj.13-228882	http://dx.doi.org/10.1096/fj.13-228882			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23657818	Green Published			2022-12-25	WOS:000329877600027
J	Liu, XH; Wu, Y; Yao, S; Levine, AC; Kirschenbaum, A; Collier, L; Bauman, WA; Cardozo, CP				Liu, Xin-Hua; Wu, Yong; Yao, Shen; Levine, Alice C.; Kirschenbaum, Alexander; Collier, Lauren; Bauman, William A.; Cardozo, Christopher P.			Androgens Up-regulate Transcription of the Notch Inhibitor Numb in C2C12 Myoblasts via Wnt/beta-Catenin Signaling to T Cell Factor Elements in the Numb Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; MYOGENIC DIFFERENTIATION; SKELETAL-MUSCLE; WNT; ACTIVATION; RECEPTOR; FATE; STEM; COMPLEX; PROTEIN	Androgen signaling via the androgen receptor is a key pathway that contributes to development, cell fate decisions, and differentiation, including that of myogenic progenitors. Androgens and synthetic steroids have well established anabolic actions on skeletal muscle. Wnt and Notch signaling pathways are also essential to myogenic cell fate decisions during development and tissue repair. However, the interactions among these pathways are largely unknown. Androgenic regulation of Wnt signaling has been reported. Nandrolone, an anabolic steroid, has been shown to inhibit Notch signaling and up-regulate Numb, a Notch inhibitor. To elucidate the mechanisms of interaction between nandrolone and Wnt/Notch signaling, we investigated the effects of nandrolone on Numb expression and Wnt signaling and determined the roles of Wnt signaling in nandrolone-induced Numb expression in C2C12 myoblasts. Nandrolone increased Numb mRNA and protein levels and T cell factor (Tcf) transcriptional activity via inhibition of glycogen synthase kinase 3 beta. Up-regulation of Numb expression by nandrolone was blocked by the Wnt inhibitors, sFRP1 and DKK1, whereas Wnt3a increased Numbm RNA and protein expression. In addition, we observed that the proximal promoter of the Numb gene had functional Tcf binding elements to which beta-catenin was recruited in a manner enhanced by both nandrolone and Wnt3a. Moreover, site-directed mutagenesis indicated that the Tcf binding sites in the Numb promoter are required for the nandrolone-induced Numb transcriptional activation in this cell line. These results reveal a novel molecular mechanism underlying up-regulation of Numb transcription with a critical role for increased canonical Wnt signaling. In addition, the data identify Numb as a novel target gene of the Wnt signaling pathway by which Wnts would be able to inhibit Notch signaling.	[Liu, Xin-Hua; Wu, Yong; Collier, Lauren; Bauman, William A.; Cardozo, Christopher P.] James J Peter Vet Affairs Med Ctr, Natl Ctr Excellence Med Consequences Spinal Cord, Bronx, NY 10468 USA; [Yao, Shen; Levine, Alice C.; Bauman, William A.; Cardozo, Christopher P.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Kirschenbaum, Alexander] Mt Sinai Sch Med, Dept Urol, New York, NY 10029 USA; [Bauman, William A.; Cardozo, Christopher P.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Cardozo, CP (corresponding author), James J Peter Vet Affairs Med Ctr, 130 West Kingsbridge Rd, Bronx, NY 10468 USA.	chris.cardozo@mssm.edu	Cardozo, Christopher/R-6021-2019	Cardozo, Christopher/0000-0003-4013-2537; Levine, Alice/0000-0002-0634-4133	Veterans Health Administration, Rehabilitation Research and Development Service [B4162C, F7756R, F6997R]	Veterans Health Administration, Rehabilitation Research and Development Service(US Department of Veterans Affairs)	This work was supported by the Veterans Health Administration, Rehabilitation Research and Development Service Grants B4162C, F7756R, and F6997R.	Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Carter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-221; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Gregory CM, 2003, SPINAL CORD, V41, P23, DOI 10.1038/sj.sc.3101370; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Jory A, 2009, STEM CELLS, V27, P2769, DOI 10.1002/stem.220; Katoh M, 2006, INT J MOL MED, V18, P517; Kicman AT, 2008, BRIT J PHARMACOL, V154, P502, DOI 10.1038/bjp.2008.165; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kwon C, 2011, NAT CELL BIOL, V13, P1244, DOI 10.1038/ncb2313; Lange C, 2011, NEUROSCI LETT, V488, P36, DOI 10.1016/j.neulet.2010.10.076; Liu XH, 2007, ANN NY ACAD SCI, V1116, P423, DOI 10.1196/annals.1402.017; Liu XH, 2007, CANCER RES, V67, P5747, DOI 10.1158/0008-5472.CAN-07-0478; Liu XH, 2012, J ANDROL, V33, P1216, DOI 10.2164/jandrol.112.016428; Liu XH, 2011, BIOCHEM BIOPH RES CO, V414, P165, DOI 10.1016/j.bbrc.2011.09.048; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo D, 2005, SEMIN CELL DEV BIOL, V16, P612, DOI 10.1016/j.semcdb.2005.07.002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Munoz-Descalzo S, 2012, BIOESSAYS, V34, P110, DOI 10.1002/bies.201100102; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Pawlowski JE, 2002, J BIOL CHEM, V277, P20702, DOI 10.1074/jbc.M200545200; Shahi P, 2011, STEM CELLS, V29, P678, DOI 10.1002/stem.606; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Singh R, 2003, ENDOCRINOLOGY, V144, P5081, DOI 10.1210/en.2003-0741; Singh R, 2009, ENDOCRINOLOGY, V150, P1259, DOI 10.1210/en.2008-0858; Sinha-Hikim I, 2006, J CLIN ENDOCR METAB, V91, P3024, DOI 10.1210/jc.2006-0357; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Taylor DC, 1999, AM J SPORT MED, V27, P718, DOI 10.1177/03635465990270060601; Truica CI, 2000, CANCER RES, V60, P4709; van Noort M, 2002, EXP CELL RES, V276, P264, DOI 10.1006/excr.2002.5520; Wimalawansa SM, 1999, J APPL PHYSIOL, V86, P1841, DOI 10.1152/jappl.1999.86.6.1841; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Zhao WD, 2008, ENDOCRINOLOGY, V149, P5449, DOI 10.1210/en.2008-0664; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X	47	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					17990	17998		10.1074/jbc.M113.478487	http://dx.doi.org/10.1074/jbc.M113.478487			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649620	hybrid, Green Published			2022-12-25	WOS:000320721900006
J	Sharma, A; Diecke, S; Zhang, WY; Lan, F; He, CJ; Mordwinkin, NM; Chua, KF; Wu, JC				Sharma, Amit; Diecke, Sebastian; Zhang, Wendy Y.; Lan, Feng; He, Chunjiang; Mordwinkin, Nicholas M.; Chua, Katrin F.; Wu, Joseph C.			The Role of SIRT6 Protein in Aging and Reprogramming of Human Induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN; DISEASE; STRESS; MICE; AGE; DEACETYLATION; FIBROBLASTS; SENESCENCE; EXPRESSION; CHROMATIN	Aging is known to be the single most important risk factor for multiple diseases. Sirtuin 6, or SIRT6, has recently been identified as a critical regulator of transcription, genome stability, telomere integrity, DNA repair, and metabolic homeostasis. A knockout mouse model of SIRT6 has displayed dramatic phenotypes of accelerated aging. In keeping with its role in aging, we demonstrated that human dermal fibroblasts (HDFs) from older human subjects were more resistant to reprogramming by classic Yamanaka factors than those from younger human subjects, but the addition of SIRT6 during reprogramming improved such efficiency in older HDFs substantially. Despite the importance of SIRT6, little is known about the molecular mechanism of its regulation. We show, for the first, time posttranscriptional regulation of SIRT6 by miR-766 and inverse correlation in the expression of this microRNA in HDFs from different age groups. Our results suggest that SIRT6 regulates miR-766 transcription via a feedback regulatory loop, which has implications for the modulation of SIRT6 expression in reprogramming of aging cells.	[Sharma, Amit; Diecke, Sebastian; Zhang, Wendy Y.; Lan, Feng; He, Chunjiang; Mordwinkin, Nicholas M.; Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Chua, Katrin F.; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Chua, Katrin F.] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Wu, JC (corresponding author), Lorry I Lokey Stem Cell Res Bldg,265 Campus Dr,Rm, Stanford, CA 94305 USA.	joewu@stanford.edu	Lan, Feng/I-2023-2012; Wu, Joseph/H-1067-2013; He, Chunjiang/N-4316-2016	Lan, Feng/0000-0002-9038-4014; Wu, Joseph/0000-0002-6068-8041; Mordwinkin, Nicholas/0000-0002-3019-0170; He, Chunjiang/0000-0002-4868-331X	National Institutes of Health [DP2 OD004437, RC1 HL099117, R01 HL113006, P01 GM099130, UO1 HL099776]; CIRM [RB3-05129]; DFG (German Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099117, U01HL099776, R01HL113006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099130] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); DFG (German Research Foundation)(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants DP2 OD004437, RC1 HL099117, R01 HL113006, P01 GM099130, UO1 HL099776, and CIRM RB3-05129 (to J. C. W.). This work was also supported by DFG (German Research Foundation) (to S. D.).	Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Alt EU, 2012, STEM CELL RES, V8, P215, DOI 10.1016/j.scr.2011.11.002; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Chen LH, 2010, AGEING RES REV, V9, pS59, DOI 10.1016/j.arr.2010.08.002; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Fernandez-Hernando C, 2011, ARTERIOSCL THROM VAS, V31, P2378, DOI 10.1161/ATVBAHA.111.226688; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gorospe M, 2011, TRENDS GENET, V27, P233, DOI 10.1016/j.tig.2011.03.005; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; HARMAN D, 1991, P NATL ACAD SCI USA, V88, P5360, DOI 10.1073/pnas.88.12.5360; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kawahara TLA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002153; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Lee YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045633; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Tat PA, 2011, CELL REPROGRAM, V13, P331, DOI 10.1089/cell.2011.0002; Tennen RI, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1443; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wilson KD, 2010, CANCER RES, V70, P5539, DOI 10.1158/0008-5472.CAN-09-4238; Wu JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000164; Yamakuchi M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00068; Yoshida Y, 2010, CIRCULATION, V122, P80, DOI 10.1161/CIRCULATIONAHA.109.881433; Yu JM, 2011, AGING CELL, V10, P66, DOI 10.1111/j.1474-9726.2010.00646.x	38	96	105	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18439	18447		10.1074/jbc.M112.405928	http://dx.doi.org/10.1074/jbc.M112.405928			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653361	Green Published, hybrid			2022-12-25	WOS:000320721900046
J	Levas, SJ; Grottoli, AG; Hughes, A; Osburn, CL; Matsui, Y				Levas, Stephen J.; Grottoli, Andrea G.; Hughes, Adam; Osburn, Christopher L.; Matsui, Yohei			Physiological and Biogeochemical Traits of Bleaching and Recovery in the Mounding Species of Coral Porites lobata: Implications for Resilience in Mouding Corals	PLOS ONE			English	Article							ORGANIC-MATTER RELEASE; EASTERN PACIFIC CORALS; REEF CORALS; MONTASTREA-ANNULARIS; SCLERACTINIAN CORAL; CLIMATE-CHANGE; STYLOPHORA-PISTILLATA; SKELETAL DELTA-C-13; THERMAL TOLERANCE; MORTALITY RISK	Mounding corals survive bleaching events in greater numbers than branching corals. However, no study to date has determined the underlying physiological and biogeochemical trait(s) that are responsible for mounding coral holobiont resilience to bleaching. Furthermore, the potential of dissolved organic carbon (DOC) as a source of fixed carbon to bleached corals has never been determined. Here, Porites lobata corals were experimentally bleached for 23 days and then allowed to recover for 0, 1, 5, and 11 months. At each recovery interval a suite of analyses were performed to assess their recovery (photosynthesis, respiration, chlorophyll a, energy reserves, tissue biomass, calcification, delta C-13 of the skeletal, delta C-13, and delta N-15 of the animal host and endosymbiont fractions). Furthermore, at 0 months of recovery, the assimilation of photosynthetically acquired and zooplankton-feeding acquired carbon into the animal host, endosymbiont, skeleton, and coral-mediated DOC were measured via C-13-pulse-chase labeling. During the first month of recovery, energy reserves and tissue biomass in bleached corals were maintained despite reductions in chlorophyll a, photosynthesis, and the assimilation of photosynthetically fixed carbon. At the same time, P. lobata corals catabolized carbon acquired from zooplankton and seemed to take up DOC as a source of fixed carbon. All variables that were negatively affected by bleaching recovered within 5 to 11 months. Thus, bleaching resilience in the mounding coral P. lobata is driven by its ability to actively catabolize zooplankton-acquired carbon and seemingly utilize DOC as a significant fixed carbon source, facilitating the maintenance of energy reserves and tissue biomass. With the frequency and intensity of bleaching events expected to increase over the next century, coral diversity on future reefs may favor not only mounding morphologies but species like P. lobata, which have the ability to utilize heterotrophic sources of fixed carbon that minimize the impact of bleaching and promote fast recovery.	[Levas, Stephen J.; Grottoli, Andrea G.; Matsui, Yohei] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Hughes, Adam] Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Osburn, Christopher L.] Naval Res Lab, Div Chem, Washington, DC USA	University System of Ohio; Ohio State University; UHI Millennium Institute; United States Department of Defense; United States Navy; Naval Research Laboratory	Levas, SJ (corresponding author), Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA.	levas.1@osu.edu	Hughes, Adam D/J-7867-2013; Hughes, Adam D/L-1088-2016; Grottoli, Andrea/C-9736-2009; Levas, Stephen/AAA-6774-2020	Osburn, Christopher/0000-0002-9334-4202	National Science Foundation divisions of Biological Oceanography [0542415]; Chemical Oceanography [0610487]; Mellon Foundation; Ford Foundation Diversity Fellowship; Direct For Biological Sciences [1041124] Funding Source: National Science Foundation	National Science Foundation divisions of Biological Oceanography(National Science Foundation (NSF)); Chemical Oceanography(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Mellon Foundation; Ford Foundation Diversity Fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Science Foundation divisions of Biological Oceanography (Grant No. 0542415) and Chemical Oceanography (Grant No. 0610487) (http://www.nsf.gov), the Mellon Foundation (http://www.mellon.org), and the Ford Foundation Diversity Fellowship (http://sites.nationalacademies.org/pga/fordfellowships/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch-Gottlib L, 2002, J BIOCH PHYS METH, V50, P187; Al-Horani FA, 2003, J EXP MAR BIOL ECOL, V288, P1, DOI 10.1016/S0022-0981(02)00578-6; Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Barnes DJ, 1999, CORAL REEFS, V18, P213, DOI 10.1007/s003380050185; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Borell EM, 2008, J EXP MAR BIOL ECOL, V364, P116, DOI 10.1016/j.jembe.2008.07.033; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; CHALKER BE, 1975, PROC R SOC SER B-BIO, V190, P323, DOI 10.1098/rspb.1975.0096; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Cortes J, 1998, REV BIOL TROP, V46, P55; CROSSLAND CJ, 1987, CORAL REEFS, V6, P35, DOI 10.1007/BF00302210; D'Croz L, 2001, B MAR SCI, V69, P203; Dinsdale EA, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P231, DOI 10.1007/978-94-007-0114-4_16; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dunne RP, 2001, CORAL REEFS, V20, P201; Edmunds PJ, 2008, B MAR SCI, V83, P453; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; Ferrier-Pages C, 1998, MAR ECOL PROG SER, V172, P265, DOI 10.3354/meps172265; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; FITT WK, 1993, CORAL REEFS, V12, P57, DOI 10.1007/BF00302102; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; GOREAU TJ, 1990, CORAL REEFS, V8, P211, DOI 10.1007/BF00265013; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Grottoli AG, 2002, GEOCHIM COSMOCHIM AC, V66, P1955, DOI 10.1016/S0016-7037(01)00901-2; Grottoli AG, 1999, CORAL REEFS, V18, P29, DOI 10.1007/s003380050150; Grover R, 2003, LIMNOL OCEANOGR, V48, P2266, DOI 10.4319/lo.2003.48.6.2266; Guest JR, 2010, PLOS ONE, V7, P8; GUZMAN HM, 1993, REV BIOL TROP, V41, P535; Haas AF, 2010, J EXP MAR BIOL ECOL, V389, P53, DOI 10.1016/j.jembe.2010.03.018; Haas AF, 2010, MAR ECOL PROG SER, V409, P27, DOI 10.3354/meps08631; Heikoop JM, 2000, MAR POLLUT BULL, V40, P628, DOI 10.1016/S0025-326X(00)00006-0; Hoegh-Guldberg O, 2004, MAR ECOL PROG SER, V280, P105, DOI 10.3354/meps280105; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Hueerkamp C, 2001, B MAR SCI, V69, P215; Hughes AD, 2010, MAR ECOL PROG SER, V420, P91, DOI 10.3354/meps08866; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jimenez IM, 2012, LIMNOL OCEANOGR, V57, P1816, DOI 10.4319/lo.2012.57.6.1816; Jokiel P.L., 1978, Monographs on Oceanographic Methodology, P529; JOKIEL PL, 1977, MAR BIOL, V43, P201, DOI 10.1007/BF00402312; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LEDER JJ, 1991, CORAL REEFS, V10, P19, DOI 10.1007/BF00301902; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; LEWIS JB, 1976, MAR BIOL, V36, P147, DOI 10.1007/BF00388437; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Lucas JM, 1997, J EXP BIOL, V200, P2653; MARSH J A JR, 1970, Ecology (Washington D C), V51, P255, DOI 10.2307/1933661; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2004, MAR BIOL, V144, P1239, DOI 10.1007/s00227-003-1271-9; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Muller-Parker G., 1994, Pacific Science, V48, P273; Muscatine L., 1994, Pacific Science, V48, P304; Muscatine L, 2005, P NATL ACAD SCI USA, V102, P1525, DOI 10.1073/pnas.0408921102; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; MUSCATINE L, 1989, MAR BIOL, V100, P185, DOI 10.1007/BF00391957; Naumann MS, 2010, CORAL REEFS, V29, P649, DOI 10.1007/s00338-010-0612-7; Niggl W, 2008, 1 EVIDENCE CORAL BLE, P905; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Osburn CL, 2007, LIMNOL OCEANOGR-METH, V5, P296, DOI 10.4319/lom.2007.5.296; Palardy JE, 2008, J EXP MAR BIOL ECOL, V367, P180, DOI 10.1016/j.jembe.2008.09.015; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rodrigues LJ, 2006, GEOCHIM COSMOCHIM AC, V70, P2781, DOI 10.1016/j.gca.2006.02.014; Sheppard A, 2008, IUCN 2012 IUCN RED L; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Suzuki A, 2000, GEOCHEM J, V34, P321, DOI 10.2343/geochemj.34.321; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4; Tambutte E, 1996, J EXP BIOL, V199, P1029; Tanaka Y, 2008, B MAR SCI, V82, P237; Tanaka Y, 2007, LIMNOL OCEANOGR, V52, P1139, DOI 10.4319/lo.2007.52.3.1139; Tanaka Y, 2009, J EXP MAR BIOL ECOL, V377, P101, DOI 10.1016/j.jembe.2009.06.023; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Thornhill DJ, 2011, PLOS ONE, V6, P13; Tremblay P, 2012, MAR ECOL PROG SER, V453, P63, DOI 10.3354/meps09640; Ulstrup KE, 2011, AQUAT BIOL, V12, P241, DOI 10.3354/ab00338; van Duyl FC, 2001, AQUAT MICROB ECOL, V24, P17, DOI 10.3354/ame024017; van Woesik R, 2012, CORAL REEFS, V31, P633, DOI 10.1007/s00338-012-0911-2; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Wang JT, 2012, ZOOL STUD, V51, P137; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; Wild C, 2008, MAR ECOL PROG SER, V372, P67, DOI 10.3354/meps07724; Wilkinson C, 2008, STATUS CORAL REEFS W; Yamazaki A, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001697	96	72	73	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63267	10.1371/journal.pone.0063267	http://dx.doi.org/10.1371/journal.pone.0063267			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658817	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500065
J	Mahen, R; Hattori, H; Lee, M; Sharma, P; Jeyasekharan, AD; Venkitaraman, AR				Mahen, Robert; Hattori, Hiroyoshi; Lee, Miyoung; Sharma, Pooja; Jeyasekharan, Anand D.; Venkitaraman, Ashok R.			A-Type Lamins Maintain the Positional Stability of DNA Damage Repair Foci in Mammalian Nuclei	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; GILFORD PROGERIA SYNDROME; ORGANIZATION; RECOMBINATION; MOBILITY; CELLS; CHROMOSOMES; EXPRESSION; DYNAMICS; PATHWAY	A-type lamins encoded by LMNA form a structural fibrillar meshwork within the mammalian nucleus. How this nuclear organization may influence the execution of biological processes involving DNA transactions remains unclear. Here, we characterize changes in the dynamics and biochemical interactions of lamin A/C after DNA damage. We find that DNA breakage reduces the mobility of nucleoplasmic GFP-lamin A throughout the nucleus as measured by dynamic fluorescence imaging and spectroscopy in living cells, suggestive of incorporation into stable macromolecular complexes, but does not induce the focal accumulation of GFP-lamin A at damage sites. Using a proximity ligation assay and biochemical analyses, we show that lamin A engages chromatin via histone H2AX and its phosphorylated form (gamma H2AX) induced by DNA damage, and that these interactions are enhanced after DNA damage. Finally, we use three-dimensional time-lapse imaging to show that LMNA inactivation significantly reduces the positional stability of DNA repair foci in living cells. This defect is partially rescued by the stable expression of GFP-lamin A. Thus collectively, our findings suggest that the dynamic structural meshwork formed by A-type lamins anchors sites of DNA repair in mammalian nuclei, providing fresh insight into the control of DNA transactions by nuclear structural organization.	[Mahen, Robert; Hattori, Hiroyoshi; Lee, Miyoung; Sharma, Pooja; Jeyasekharan, Anand D.; Venkitaraman, Ashok R.] Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge, England		Venkitaraman, AR (corresponding author), Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge, England.	arv22@hutchison-mrc.cam.ac.uk	Jeyasekharan, Anand/O-3398-2019; Lee, MiYoung/G-3748-2014	Mahen, Robert/0000-0002-4748-3690; Jeyasekharan, Anand/0000-0001-9816-6137	Medical Research Council; GIA-Cancer Cell Unit (RG); Wellcome Trust (RG); MRC [G1001522, G0600332, MC_UU_12022/8, MC_U105359877, G1001521] Funding Source: UKRI; Medical Research Council [MC_UU_12022/8, MC_U105359877, G0600332, G1001522, G1001521] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GIA-Cancer Cell Unit (RG); Wellcome Trust (RG)(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Medical Research Council (http://www.mrc.ac.uk/index.htm) and the GIA-Cancer Cell Unit (RG) and the The Wellcome Trust (http://www.wellcome.ac.uk/) (RG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Broers JLV, 1999, J CELL SCI, V112, P3463; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Dechat T, 2010, COLD SH Q B, V75, P533, DOI 10.1101/sqb.2010.75.018; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Goldberg M, 1999, P NATL ACAD SCI USA, V96, P2852, DOI 10.1073/pnas.96.6.2852; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gonzalez-Suarez I, 2011, EMBO J, V30, P3383, DOI 10.1038/emboj.2011.225; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; HOZAK P, 1995, J CELL SCI, V108, P635; Jahn D, 2012, NUCLEUS-AUSTIN, V3, P463, DOI 10.4161/nucl.21676; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Lee DC, 2009, EXP CELL RES, V315, P996, DOI 10.1016/j.yexcr.2009.01.003; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Mahen R, 2011, P NATL ACAD SCI USA, V108, P9310, DOI 10.1073/pnas.1101112108; Manju K, 2006, J CELL SCI, V119, P2704, DOI 10.1242/jcs.03009; Mattout A, 2007, J CELL SCI, V120, P77, DOI 10.1242/jcs.03325; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Zgheib O, 2009, MOL CELL BIOL, V29, P1050, DOI 10.1128/MCB.01011-08	37	36	39	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61893	10.1371/journal.pone.0061893	http://dx.doi.org/10.1371/journal.pone.0061893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658700	Green Published, Green Submitted, gold			2022-12-25	WOS:000321200500013
J	Cohen, D; Cassel, RS; Saint-Georges, C; Mahdhaoui, A; Laznik, MC; Apicella, F; Muratori, P; Maestro, S; Muratori, F; Chetouani, M				Cohen, David; Cassel, Raquel S.; Saint-Georges, Catherine; Mahdhaoui, Ammar; Laznik, Marie-Christine; Apicella, Fabio; Muratori, Pietro; Maestro, Sandra; Muratori, Filippo; Chetouani, Mohamed			Do Parentese Prosody and Fathers' Involvement in Interacting Facilitate Social Interaction in Infants Who Later Develop Autism?	PLOS ONE			English	Article							CHILD-DIRECTED SPEECH; PHYSIOLOGICAL PRECURSORS; SPECTRUM DISORDER; COMMUNICATION; SYNCHRONY; RESPONSES; RECOGNITION; PREFERENCES; PREDICTORS; PERCEPTION	Background: Whether development of autism impacts the interactive process between an infant and his/her parents remains an unexplored issue. Methodology and Principal Findings: Using computational analysis taking into account synchronic behaviors and emotional prosody (parentese), we assessed the course of infants' responses to parents' type of speech in home movies from typically developing (TD) infants and infants who will subsequently develop autism aged less than 18 months. Our findings indicate: that parentese was significantly associated with infant responses to parental vocalizations involving orientation towards other people and with infant receptive behaviours; that parents of infants developing autism displayed more intense solicitations that were rich in parentese; that fathers of infants developing autism spoke to their infants more than fathers of TD infants; and that fathers' vocalizations were significantly associated with intersubjective responses and active behaviours in infants who subsequently developed autism. Conclusion: The parents of infants who will later develop autism change their interactive pattern of behaviour by both increasing parentese and father's involvement in interacting with infants; both are significantly associated with infant's social responses. We stress the possible therapeutic implications of these findings and its implication for Dean Falk's theory regarding pre-linguistic evolution in early hominins.	[Cohen, David; Cassel, Raquel S.; Saint-Georges, Catherine] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Dept Child & Adolescent Psychiat, Paris, France; [Cohen, David; Cassel, Raquel S.; Saint-Georges, Catherine; Mahdhaoui, Ammar; Chetouani, Mohamed] Univ Paris 06, Ctr Natl Rech Sci UMR 7222, Inst Syst Intelligents & Robot, Paris, France; [Laznik, Marie-Christine] Assoc Sante Mentale 13Eme, Dept Child & Adolescent Psychiat, Paris, France; [Apicella, Fabio; Muratori, Pietro; Maestro, Sandra; Muratori, Filippo] Univ Pisa, Stella Maris Sci Inst, Div Child Neurol & Psychiat, Calambrone, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; IRCCS Fondazione Stella Maris; University of Pisa	Cohen, D (corresponding author), Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Dept Child & Adolescent Psychiat, Paris, France.	david.cohen@psl.aphp.fr	Bargagna, Stefania/AAB-7603-2019; CHETOUANI, Mohamed/F-5854-2010; Maestro, Sandra/AAB-9297-2022; Muratori, Pietro/J-3538-2016; Muratori, Filippo/K-3187-2018; Maestro, Sandra/AAA-7386-2021; Apicella, Fabio/ABF-4304-2020; Muratori, Pietro/AAH-9232-2021	Bargagna, Stefania/0000-0001-6430-9494; CHETOUANI, Mohamed/0000-0002-2920-4539; Maestro, Sandra/0000-0003-3929-1573; Muratori, Pietro/0000-0001-7779-779X; Muratori, Filippo/0000-0001-9598-0096; Maestro, Sandra/0000-0003-3929-1573; Apicella, Fabio/0000-0001-7390-3241; Muratori, Pietro/0000-0001-7779-779X	Italian Ministry of Instruction, University, and Research; Fondation de France [2008005170]; Universite Pierre et Marie Curie; European Commission [288241]; fund "Entreprendre pour aider"	Italian Ministry of Instruction, University, and Research(Ministry of Education, Universities and Research (MIUR)); Fondation de France(Fondation de France); Universite Pierre et Marie Curie; European Commission(European CommissionEuropean Commission Joint Research Centre); fund "Entreprendre pour aider"	The Pisa "home video in autism" project was supported by grants PRIN 2003-2005 and PRIN 2005-2007 from the Italian Ministry of Instruction, University, and Research. The current study was supported by a grant (no2008005170) from the Fondation de France given to MC and DC, by the Universite Pierre et Marie Curie (Projet Emergence 2010) the European Commission (FP7: Michelangelo under grant agreement no 288241), and the fund "Entreprendre pour aider". The funding agencies and the University were not involved in the study design, collection, analysis and interpretation of data, writing of the paper, or the decision to submit for publication.	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Atzil S, 2012, J AM ACAD CHILD PSY, V51, P798, DOI 10.1016/j.jaac.2012.06.008; Bickerton D, 2002, TRANSITION LANGUAGE, P207; Boddaert N, 2004, AM J PSYCHIAT, V161, P2117, DOI 10.1176/appi.ajp.161.11.2117; Braarud HC, 2008, SOC DEV, V17, P1074, DOI 10.1111/j.1467-9507.2007.00455.x; Cassel RS, INTERACTION STUDIES; Chaby L, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P950, DOI 10.1109/SocialCom-PASSAT.2012.111; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Crown CL, 2002, J PSYCHOLINGUIST RES, V31, P1, DOI 10.1023/A:1014301303616; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Elsabbagh M, 2010, TRENDS COGN SCI, V14, P81, DOI 10.1016/j.tics.2009.12.005; Falk D, 2004, BEHAV BRAIN SCI, V27, P491; Falk D, 2004, BEHAV BRAIN SCI, V27, P83; Falk D, 2009, FINDINGS OUR TONGUES; Feldman R, 2006, DEV PSYCHOL, V42, P175, DOI 10.1037/0012-1649.42.1.175; Feldman R, 2007, J CHILD PSYCHOL PSYC, V48, P329, DOI 10.1111/j.1469-7610.2006.01701.x; FERNALD A, 1987, INFANT BEHAV DEV, V10, P279, DOI 10.1016/0163-6383(87)90017-8; Fivaz-Depeursinge E, 1996, New Dir Child Dev, P27; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Goldstein MH, 2009, CHILD DEV, V80, P636, DOI 10.1111/j.1467-8624.2009.01287.x; Groen W, 2008, J AUTISM DEV DISORD, V38, P1819, DOI 10.1007/s10803-008-0572-8; Groenen M., 1996, LEROI GOURHAN ESSENC; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; Guinchat V, 2012, RES AUTISM SPECT DIS, V6, P589, DOI 10.1016/j.rasd.2011.10.005; HIRSHPASEK K, 1987, COGNITION, V26, P269, DOI 10.1016/S0010-0277(87)80002-1; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Laznik M, 2005, COMMENCEMENT ETAIT V; Mahdhaoui A, 2011, INT J METH PSYCH RES, V20, pE6, DOI 10.1002/mpr.332; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Muratori F, 2011, RES AUTISM SPECT DIS, V5, P408, DOI 10.1016/j.rasd.2010.06.003; Niwano K, 2003, PSYCHOL REP, V92, P481, DOI 10.2466/PR0.92.2.481-487; Paul R, 2007, J SPEECH LANG HEAR R, V50, P1350, DOI 10.1044/1092-4388(2007/094); Plooij FX., 1984, BEHAV DEV FREE LIVIN; Ramchandani PG, 2013, J CHILD PSYCHOL PSYC, V54, P56, DOI 10.1111/j.1469-7610.2012.02583.x; Rutter M., 2003, AUTISM DIAGNOSTIC IN, DOI DOI 10.1002/aur.1329; Saint-Georges C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022393; Saint-Georges C, 2010, RES AUTISM SPECT DIS, V4, P355, DOI 10.1016/j.rasd.2009.10.017; Schopler E, 1998, CHILDHOOD AUTISM RAT; Schuller B, 2007, P INTERSPEECH; Small Meredith, 1998, OUR BABIES OURSELVES; STONE WL, 1994, ARCH PEDIAT ADOL MED, V148, P174, DOI 10.1001/archpedi.1994.02170020060010; Stormark KM, 2004, INFANT BEHAV DEV, V27, P195, DOI 10.1016/j.infbeh.2003.09.004; Toth K, 2006, J AUTISM DEV DISORD, V36, P993, DOI 10.1007/s10803-006-0137-7; Viaux-Savelon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030935; Wan MW, 2013, J CHILD PSYCHOL PSYC, V54, P763, DOI 10.1111/jcpp.12032; Wan MW, 2012, RES DEV DISABIL, V33, P924, DOI 10.1016/j.ridd.2011.12.011; Warlaumont AS, 2009, P 32 ANN C COGN SCI, P121; Watson LR, 2012, J AUTISM DEV DISORD, V42, P1616, DOI 10.1007/s10803-011-1401-z; Watson LR, 2010, J SPEECH LANG HEAR R, V53, P1052, DOI 10.1044/1092-4388(2009/09-0096); Werner E, 2000, J AUTISM DEV DISORD, V30, P157, DOI 10.1023/A:1005463707029; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	55	68	70	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61402	10.1371/journal.pone.0061402	http://dx.doi.org/10.1371/journal.pone.0061402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23650498	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000013
J	Golubchik, T; Batty, EM; Miller, RR; Farr, H; Young, BC; Larner-Svensson, H; Fung, R; Godwin, H; Knox, K; Votintseva, A; Everitt, RG; Street, T; Cule, M; Ip, CLC; Didelot, X; Peto, TEA; Harding, RM; Wilson, DJ; Crook, DW; Bowden, R				Golubchik, Tanya; Batty, Elizabeth M.; Miller, Ruth R.; Farr, Helen; Young, Bernadette C.; Larner-Svensson, Hanna; Fung, Rowena; Godwin, Heather; Knox, Kyle; Votintseva, Antonina; Everitt, Richard G.; Street, Teresa; Cule, Madeleine; Ip, Camilla L. C.; Didelot, Xavier; Peto, Timothy E. A.; Harding, Rosalind M.; Wilson, Daniel J.; Crook, Derrick W.; Bowden, Rory			Within-Host Evolution of Staphylococcus aureus during Asymptomatic Carriage	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; NASAL CARRIAGE; LINKAGE DISEQUILIBRIUM; NUCLEOTIDE-SEQUENCE; RECOMBINATION; DYNAMICS; BACTEREMIA; POPULATION; PROTEIN	Background: Staphylococcus aureus is a major cause of healthcare associated mortality, but like many important bacterial pathogens, it is a common constituent of the normal human body flora. Around a third of healthy adults are carriers. Recent evidence suggests that evolution of S. aureus during nasal carriage may be associated with progression to invasive disease. However, a more detailed understanding of within-host evolution under natural conditions is required to appreciate the evolutionary and mechanistic reasons why commensal bacteria such as S. aureus cause disease. Therefore we examined in detail the evolutionary dynamics of normal, asymptomatic carriage. Sequencing a total of 131 genomes across 13 singly colonized hosts using the Illumina platform, we investigated diversity, selection, population dynamics and transmission during the short-term evolution of S. aureus. Principal Findings: We characterized the processes by which the raw material for evolution is generated: micro-mutation (point mutation and small insertions/deletions), macro-mutation (large insertions/deletions) and the loss or acquisition of mobile elements (plasmids and bacteriophages). Through an analysis of synonymous, non-synonymous and intergenic mutations we discovered a fitness landscape dominated by purifying selection, with rare examples of adaptive change in genes encoding surface-anchored proteins and an enterotoxin. We found evidence for dramatic, hundred-fold fluctuations in the size of the within-host population over time, which we related to the cycle of colonization and clearance. Using a newly-developed population genetics approach to detect recent transmission among hosts, we revealed evidence for recent transmission between some of our subjects, including a husband and wife both carrying populations of methicillin-resistant S. aureus (MRSA). Significance: This investigation begins to paint a picture of the within-host evolution of an important bacterial pathogen during its prevailing natural state, asymptomatic carriage. These results also have wider significance as a benchmark for future systematic studies of evolution during invasive S. aureus disease.	[Golubchik, Tanya; Batty, Elizabeth M.; Street, Teresa; Cule, Madeleine; Ip, Camilla L. C.; Didelot, Xavier; Bowden, Rory] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Miller, Ruth R.; Farr, Helen; Young, Bernadette C.; Fung, Rowena; Votintseva, Antonina; Everitt, Richard G.; Peto, Timothy E. A.; Wilson, Daniel J.; Crook, Derrick W.] Univ Oxford, Nuffield Dept Clin Med, Div Expt Med, Oxford, England; [Miller, Ruth R.; Farr, Helen; Larner-Svensson, Hanna; Fung, Rowena; Votintseva, Antonina; Peto, Timothy E. A.; Crook, Derrick W.; Bowden, Rory] Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford, England; [Larner-Svensson, Hanna; Wilson, Daniel J.; Bowden, Rory] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Godwin, Heather] Natl Hlth Serv Trust, Oxford Univ Hosp, Oxford, England; [Knox, Kyle] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Harding, Rosalind M.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford	Wilson, DJ (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Div Expt Med, Oxford, England.	daniel.wilson@ndm.ox.ac.uk; bowden@stats.ox.ac.uk	Young, Bernadette Carmel/AAB-4157-2019; Wilson, Daniel J/AAE-8975-2019; Golubchik, Tanya/B-4226-2018; Didelot, Xavier/P-4282-2019; Didelot, Xavier/H-1608-2013	Young, Bernadette Carmel/0000-0001-6071-6770; Wilson, Daniel J/0000-0002-0940-3311; Golubchik, Tanya/0000-0003-2765-9828; Didelot, Xavier/0000-0003-1885-500X; Didelot, Xavier/0000-0003-1885-500X; Everitt, Richard/0000-0002-0822-5648; peto, tim/0000-0003-3477-8307; Batty, Liz/0000-0001-8559-452X	Oxford National Institute for Health Research (NIHR) Biomedical Research Centre; United Kingdom Clinical Research Collaboration (UKCRC) Modernising Medical Microbiology Consortium; UKCRC Translational Infection Research Initiative; Medical Research Council, Biotechnology and Biological Sciences Research Council; National Institute for Health Research on behalf of the Department of Health [G0800778]; Wellcome Trust [087646/Z/08/Z, 090532/Z/09/Z]; MRC [MR/K010174/1, G0800778] Funding Source: UKRI; Medical Research Council [G0600719B, MR/K010174/1, MR/K010174/1B, G0800778] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10047, NF-SI-0508-10279, ACF-2009-13-009] Funding Source: researchfish	Oxford National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); United Kingdom Clinical Research Collaboration (UKCRC) Modernising Medical Microbiology Consortium; UKCRC Translational Infection Research Initiative; Medical Research Council, Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research on behalf of the Department of Health; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Oxford National Institute for Health Research (NIHR) Biomedical Research Centre and the United Kingdom Clinical Research Collaboration (UKCRC) Modernising Medical Microbiology Consortium, the latter funded under the UKCRC Translational Infection Research Initiative supported by Medical Research Council, Biotechnology and Biological Sciences Research Council and the National Institute for Health Research on behalf of the Department of Health (Grant G0800778) and the Wellcome Trust (Grant 087646/Z/08/Z). The authors acknowledge the support of Wellcome Trust core funding (Grant 090532/Z/09/Z). TEP and DWC are NIHR Oxford Biomedical Research Centre senior investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Achtman M, 2012, PHILOS T R SOC B, V367, P860, DOI 10.1098/rstb.2011.0303; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Castillo-Ramirez S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002129; CATCHPOLE I, 1988, J GEN MICROBIOL, V134, P697; Cespedes C, 2005, J INFECT DIS, V191, P444, DOI 10.1086/427240; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Cordova SP, 2004, J HOSP INFECT, V56, P22, DOI 10.1016/j.jhin.2003.10.009; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Das I, 2007, J HOSP INFECT, V65, P117, DOI 10.1016/j.jhin.2006.09.022; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; DIDELOT X, GENOME RES UNPUB; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Drake JW, 1998, GENETICS, V148, P1667; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Goerke C, 2004, J INFECT DIS, V189, P724, DOI 10.1086/381502; Goerke C, 2007, ENVIRON MICROBIOL, V9, P3134, DOI 10.1111/j.1462-2920.2007.01423.x; Goerke C, 2006, MOL MICROBIOL, V61, P1673, DOI 10.1111/j.1365-2958.2006.05354.x; Griffiths RC, 2003, THEOR POPUL BIOL, V64, P241, DOI 10.1016/S0040-5809(03)00075-3; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; HUDSON RR, 1985, GENETICS, V111, P147; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; MacKinnon MM, 2000, J HOSP INFECT, V46, P216, DOI [10.1053/jhin.2000.0807, 10.1016/S0195-6701(00)90807-7]; McAdam PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024301; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean G, 2002, GENETICS, V160, P1231; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Meunier J, 2001, MOL BIOL EVOL, V18, P2132, DOI 10.1093/oxfordjournals.molbev.a003756; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Moxon ER, 2005, TRENDS MICROBIOL, V13, P563, DOI 10.1016/j.tim.2005.10.004; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Nandi T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000845; NICOLAISEN LA, 2012, MOL BIOL EV IN PRESS; Panton PN, 1932, LANCET, V1, P506; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; SANFORD MD, 1994, CLIN INFECT DIS, V19, P1123, DOI 10.1093/clinids/19.6.1123; SCHAEFFER SW, 1993, GENETICS, V135, P541; SLATKIN M, 1991, GENETICS, V129, P555; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sokal R. R., 1981, BIOMETRY; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Tacconelli E, 2004, J ANTIMICROB CHEMOTH, V53, P474, DOI 10.1093/jac/dkh107; VandenBergh MFQ, 1999, J CLIN MICROBIOL, V37, P3133, DOI 10.1128/JCM.37.10.3133-3140.1999; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Vriens MR, 2005, INFECT CONT HOSP EP, V26, P629, DOI 10.1086/502592; Wakeley J, 2004, MOL ECOL, V13, P865, DOI 10.1111/j.1365-294X.2004.02086.x; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wilson DJ, 2006, GENETICS, V172, P1411, DOI 10.1534/genetics.105.044917; WILSON DJ, 2012, PLOS PATHOG IN PRESS; World Health Organization, 2011, WHO MORT DAT ICD 10; World Health Organization, 2008, GLOB BURD DIS 2004 U; Wright S, 1931, GENETICS, V16, P0097; Wyllie DH, 2007, J HOSP INFECT, V67, P301, DOI 10.1016/j.jhin.2007.08.018; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	81	141	143	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61319	10.1371/journal.pone.0061319	http://dx.doi.org/10.1371/journal.pone.0061319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658690	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000319167000009
J	Haralambieva, IH; Oberg, AL; Ovsyannikova, IG; Kennedy, RB; Grill, DE; Middha, S; Bot, BM; Wang, VW; Smith, DI; Jacobson, RM; Poland, GA				Haralambieva, Iana H.; Oberg, Ann L.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Grill, Diane E.; Middha, Sumit; Bot, Brian M.; Wang, Vivian W.; Smith, David I.; Jacobson, Robert M.; Poland, Gregory A.			Genome-Wide Characterization of Transcriptional Patterns in High and Low Antibody Responders to Rubella Vaccination	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; GENE-EXPRESSION; CYTOKINE PRODUCTION; MEASLES; POLYMORPHISMS; ASSOCIATIONS; CELLS; MUMPS; VACCINOMICS; MICROARRAY	Immune responses to current rubella vaccines demonstrate significant inter-individual variability. We performed mRNA-Seq profiling on PBMCs from high and low antibody responders to rubella vaccination to delineate transcriptional differences upon viral stimulation. Generalized linear models were used to assess the per gene fold change (FC) for stimulated versus unstimulated samples or the interaction between outcome and stimulation. Model results were evaluated by both FC and p-value. Pathway analysis and self-contained gene set tests were performed for assessment of gene group effects. Of 17,566 detected genes, we identified 1,080 highly significant differentially expressed genes upon viral stimulation (p<1.00E(-15), FDR<1.00E(-14)), including various immune function and inflammation-related genes, genes involved in cell signaling, cell regulation and transcription, and genes with unknown function. Analysis by immune outcome and stimulation status identified 27 genes (p <= 0.0006 and FDR <= 0.30) that responded differently to viral stimulation in high vs. low antibody responders, including major histocompatibility complex (MHC) class I genes (HLA-A, HLA-B and B2M with p = 0.0001, p = 0.0005 and p = 0.0002, respectively), and two genes related to innate immunity and inflammation (EMR3 and MEFV with p = 1.46E(-08) and p = 0.0004, respectively). Pathway and gene set analysis also revealed transcriptional differences in antigen presentation and innate/inflammatory gene sets and pathways between high and low responders. Using mRNA-Seq genome-wide transcriptional profiling, we identified antigen presentation and innate/inflammatory genes that may assist in explaining rubella vaccine-induced immune response variations. Such information may provide new scientific insights into vaccine-induced immunity useful in rational vaccine development and immune response monitoring.	[Haralambieva, Iana H.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Jacobson, Robert M.; Poland, Gregory A.] Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA; [Haralambieva, Iana H.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Jacobson, Robert M.; Poland, Gregory A.] Mayo Clin, Program Translat Immunovirol & Biodef, Rochester, MN USA; [Oberg, Ann L.; Grill, Diane E.; Middha, Sumit] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Jacobson, Robert M.; Poland, Gregory A.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA; [Bot, Brian M.] Sage Bionetworks, Seattle, WA USA; [Wang, Vivian W.; Smith, David I.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA.	poland.gregory@mayo.edu		Middha, Sumit/0000-0003-4135-6268; Jacobson, Robert/0000-0002-6355-8752; Kennedy, Rick/0000-0001-6164-4967; Bot, Brian/0000-0002-2412-6826	National Institutes of Health (NIH) [AI33144, AI48793 501]; National Institute of Aging [R01 AG034676]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033144, R01AI048793, R37AI048793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding support was provided by National Institutes of Health (NIH) grants AI33144, AI48793 501 (which recently received a MERIT Award), and recruitment was made possible by the Rochester Epidemiology Project (Grant Number R01 AG034676) from the National Institute of Aging. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo MP, 2008, VIROLOGY, V370, P1, DOI 10.1016/j.virol.2007.08.003; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boulland ML, 2007, BLOOD, V110, P220, DOI 10.1182/blood-2006-07-036210; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Dhiman N, 2008, TISSUE ANTIGENS, V72, P211, DOI 10.1111/j.1399-0039.2008.01097.x; Dhiman N, 2010, CYTOKINE, V50, P24, DOI 10.1016/j.cyto.2009.12.002; Dhiman N, 2010, IMMUNOGENETICS, V62, P197, DOI 10.1007/s00251-010-0423-6; Dhiman N, 2009, EXPERT REV VACCINES, V8, P963, DOI [10.1586/erv.09.67, 10.1586/ERV.09.67]; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Fridley BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012693; FROME EL, 1985, AM J EPIDEMIOL, V121, P309, DOI 10.1093/oxfordjournals.aje.a114001; Haralambieva IH, 2010, FUTURE MICROBIOL, V5, P1757, DOI [10.2217/fmb.10.146, 10.2217/FMB.10.146]; Haralambieva IH, 2010, J MED VIROL, V82, P1966, DOI 10.1002/jmv.21899; Haralambieva IH, 2010, HUM IMMUNOL, V71, P383, DOI 10.1016/j.humimm.2010.01.004; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Kanazawa N, 2012, J DERMATOL SCI, V66, P183, DOI 10.1016/j.jdermsci.2012.01.004; Lawrence T, 2007, BIOCHEM SOC T, V35, P270, DOI 10.1042/BST0350270; Lee J, 2011, CANCER INFORM, V10, P205, DOI 10.4137/CIN.S7473; Leonardi S, 2009, VACCINE, V27, P6030, DOI 10.1016/j.vaccine.2009.07.099; Linge HM, 2008, ANTIMICROB AGENTS CH, V52, P2599, DOI 10.1128/AAC.00028-08; Matmati M, 2007, J LEUKOCYTE BIOL, V81, P440, DOI 10.1189/jlb.0406276; McCullagh P, 1983, GEN LINEAR MODELS 19; Mo XY, 2007, J MED VIROL, V79, P1783, DOI 10.1002/jmv.20942; Oberg AL, 2012, BMC GENOMICS, V13, P2, DOI 10.1186/1471-2164-13-304; Oberg AL, 2011, J IMMUNOL METHODS, V366, P69, DOI 10.1016/j.jim.2011.01.011; Ovsyannikova IG, 2006, J INFECT DIS, V193, P655, DOI 10.1086/500144; Ovsyannikova IG, 2004, HUM IMMUNOL, V65, P1506, DOI 10.1016/j.humimm.2004.07.001; Ovsyannikova IG, 2007, VACCINE, V25, P3090, DOI 10.1016/j.vaccine.2007.01.020; Ovsyannikova IG, 2007, CLIN VACCINE IMMUNOL, V14, P115, DOI 10.1128/CVI.00247-06; Ovsyannikova IG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011806; Ovsyannikova IG, 2010, HUM GENET, V127, P207, DOI 10.1007/s00439-009-0763-1; Ovsyannikova IG, 2010, J INFECT DIS, V201, P207, DOI 10.1086/649588; Ovsyannikova IG, 2009, VACCINE, V27, P6926, DOI 10.1016/j.vaccine.2009.08.109; Ovsyannikova IG, 2009, VACCINE, V27, P3359, DOI 10.1016/j.vaccine.2009.01.079; Ovsyannikova IG, 2009, VACCINE, V27, P3349, DOI 10.1016/j.vaccine.2009.01.080; Pankratz VS, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-48; Peng XX, 2009, CURR OPIN MICROBIOL, V12, P432, DOI 10.1016/j.mib.2009.06.003; Poland GA, 2007, CLIN PHARMACOL THER, V82, P653, DOI 10.1038/sj.clpt.6100415; Poland GA, 2011, OMICS, V15, P625, DOI 10.1089/omi.2011.0032; R Development Core Team, 2011, R LANG ENV STAT COMP; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romeo PH, 2002, ADV EXP MED BIOL, V515, P49; Stacey M, 2001, J BIOL CHEM, V276, P18863, DOI 10.1074/jbc.M101147200; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tan PL, 2001, VACCINE, V19, P2434, DOI 10.1016/S0264-410X(00)00468-0; Thibault S, 2009, VIROLOGY, V389, P20, DOI 10.1016/j.virol.2009.04.019; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107	53	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62149	10.1371/journal.pone.0062149	http://dx.doi.org/10.1371/journal.pone.0062149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658707	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000031
J	Ludt, S; Urban, E; Eckardt, J; Wache, S; Broge, B; Kaufmann-Kolle, P; Heller, G; Miksch, A; Glassen, K; Hermann, K; Bolter, R; Ose, D; Campbell, SM; Wensing, M; Szecsenyi, J				Ludt, Sabine; Urban, Elisabeth; Eckardt, Joerg; Wache, Stefanie; Broge, Bjoern; Kaufmann-Kolle, Petra; Heller, Guenther; Miksch, Antje; Glassen, Katharina; Hermann, Katja; Boelter, Regine; Ose, Dominik; Campbell, Stephen M.; Wensing, Michel; Szecsenyi, Joachim			Evaluating the Quality of Colorectal Cancer Care across the Interface of Healthcare Sectors	PLOS ONE			English	Article							INDICATORS; FRAMEWORK; UK	Colorectal cancer (CRC) has a high prevalence in western countries. Diagnosis and treatment of CRC is complex and requires multidisciplinary collaboration across the interface of health care sectors. In Germany, a new nationwide established program aims to provide quality information of healthcare delivery across different sectors. Within this context, this study describes the development of a set of quality indicators charting the whole pathway of CRC-care including data specifications that are necessary to operationalize these indicators before practice testing. Methods: Indicators were developed following a systematic 10 step modified 'RAND/UCLA Appropriateness Method' which involved a multidisciplinary panel of thirteen participants. For each indicator in the final set, data specifications relating to sources of quality information, data collection procedures, analysis and feedback were described. Results: The final indicator set included 52 indicators covering diagnostic procedures (11 indicators), therapeutic management (28 indicators) and follow-up (6 indicators). In addition, 7 indicators represented patient perspectives. Primary surgical tumor resection and pre-operative radiation (rectum carcinoma only) were perceived as most useful tracer procedures initiating quality data collection. To assess the quality of CRC care across sectors, various data sources were identified: medical records, administrative inpatient and outpatient data, sickness-funds billing code systems and patient survey. Conclusion: In Germany, a set of 52 quality indicators, covering necessary aspects across the interfaces and pathways relevant to CRC-care has been developed. Combining different sectors and sources of health care in quality assessment is an innovative and challenging approach but reflects better the reality of the patient pathway and experience of CRC-care.	[Ludt, Sabine; Urban, Elisabeth; Miksch, Antje; Glassen, Katharina; Hermann, Katja; Boelter, Regine; Ose, Dominik; Campbell, Stephen M.; Wensing, Michel; Szecsenyi, Joachim] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Eckardt, Joerg; Wache, Stefanie; Broge, Bjoern; Kaufmann-Kolle, Petra; Heller, Guenther; Szecsenyi, Joachim] AQUA Inst Appl Qual Improvement & Res Healthcare, Gottingen, Germany; [Campbell, Stephen M.] Univ Manchester, Inst Populat Hlth, Ctr Primary Care, Manchester, Lancs, England; [Wensing, Michel] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands	Ruprecht Karls University Heidelberg; University of Manchester; Radboud University Nijmegen	Ludt, S (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	sabine.ludt@med.uni-heidelberg.de	Wensing, Michel/H-8113-2014; Ose, Dominik/L-4250-2019; Ose, Dominik J/F-7691-2013	Wensing, Michel/0000-0001-6569-8137; Ose, Dominik/0000-0002-5079-2152; Ose, Dominik J/0000-0002-5079-2152; Glassen, Ronald/0000-0003-3195-5718; Campbell, Stephen/0000-0002-2328-4136	Federal Joint Committee (G-BA) under the German Social Code; Federal Joint Committee	Federal Joint Committee (G-BA) under the German Social Code; Federal Joint Committee	The SQG program and the work of the AQUA-Institute in this field are funded by the Federal Joint Committee (G-BA) under the German Social Code Book V, 137a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JS is a director and shareholder of the AQUA-institute which is responsible for the development of the SQG program by contract with the Federal Joint Committee. SL, EU, AM, KG, KH, RB, and DO are employees of the department of General Practice and Health Services Research at the University Hospital of Heidelberg. The department is a contract partner of the AQUA-Institute. SMC is an expert in the field of indicator development and has a contract with the department of General Practice and Health Services Research. BB, JE, SW, PK-K and GH are employees and MW's institute has a contract with the AQUAinstitute. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	*AM MED ASS, 2010, MEAS TEST PROT PHYS; [Anonymous], 2010, GERMAN POLICY STUDIE; *AQUA I, 2012, CROSS SECT QUAL HLTH; Arah OA, 2006, INT J QUAL HEALTH C, V18, P5, DOI 10.1093/intqhc/mzl024; ARDEN M, 2011, BMJ, V343; Busse R, 2009, HEALTH AFFAIR, V28, pW294, DOI 10.1377/hlthaff.28.2.w294; Campbell SM, 2004, QUAL SAF HEALTH CARE, V13, P428, DOI 10.1136/qshc.2003.007815; Campbell SM, 2002, QUAL SAF HEALTH CARE, V11, P358, DOI 10.1136/qhc.11.4.358; Campbell SM, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-85; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Demetter P, 2011, ACTA GASTRO-ENT BELG, V74, P445; Dente K, 2009, NAT MED, V15, P825, DOI 10.1038/nm0809-825; DERSCHULENBURG JM, 2010, EUR J HEALTH ECON, V10, P21; Desch CE, 2008, J CLIN ONCOL, V26, P3631, DOI 10.1200/JCO.2008.16.5068; Dixon E, 2009, J SURG RES, V156, P32, DOI 10.1016/j.jss.2009.03.084; Elwyn G, 2007, BRIT MED J, V335, P1021, DOI 10.1136/bmj.39339.490301.AD; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fitch K., 2001, RAND UCLA APPR METH; Heller G, 2007, JAMA-J AM MED ASSOC, V297, P1983, DOI 10.1001/jama.297.18.1983; Hermens RPMG, 2006, LUNG CANCER, V54, P117, DOI 10.1016/j.lungcan.2006.07.001; Institute of Medicine (US) Committee, 2001, CROSSING QUALITY CHA, P1, DOI [DOI 10.17226/10027, 10.17226/10027]; Kotter T, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-21; Kube R, 2009, ONKOLOGIE, V32, P25, DOI 10.1159/000185572; Malin JL, 2000, CANCER-AM CANCER SOC, V88, P701, DOI 10.1002/(SICI)1097-0142(20000201)88:3<701::AID-CNCR29>3.0.CO;2-V; Marshall MN, 2003, QUAL SAF HEALTH CARE, V12, P8, DOI 10.1136/qhc.12.1.8; McGory ML, 2006, J NATL CANCER I, V98, P1623, DOI 10.1093/jnci/djj438; *ORG EC CO DEV, 2012, OECD HLTH DAT 2012; Patwardhan Meenal B, 2006, Evid Rep Technol Assess (Full Rep), P1; Pena A, 2010, INT J QUAL HEALTH C, V22, P201, DOI 10.1093/intqhc/mzq018; Prosnitz RG, 2006, CANCER-AM CANCER SOC, V107, P2352, DOI 10.1002/cncr.22278; Rubin HR, 2001, INT J QUAL HEALTH C, V13, P489, DOI 10.1093/intqhc/13.6.489; Schmiegel W, 2004, Z GASTROENTEROL, V42, P1129, DOI 10.1055/s-2004-813699; Spinks T, 2012, CANCER-AM CANCER SOC, V118, P2571, DOI 10.1002/cncr.26536; Steel N, 2004, QUAL SAF HEALTH CARE, V13, P260, DOI 10.1136/qshc.2004.010280; Szecsenyi J, 2012, INT J QUAL HEALTH C, V24, P101, DOI 10.1093/intqhc/mzr086; Uphoff EPMM, 2012, CANCER NURS, V35, P29, DOI 10.1097/NCC.0b013e318210e3a2; van Gijn W, 2010, Eur J Surg Oncol, V36 Suppl 1, pS23, DOI 10.1016/j.ejso.2010.06.026; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Wollersheim H, 2007, NETH J MED, V65, P15	41	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e60947	10.1371/journal.pone.0060947	http://dx.doi.org/10.1371/journal.pone.0060947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23658684	Green Submitted, Green Published, gold			2022-12-25	WOS:000319167000006
J	Yu, Q; Su, YK; Lu, B; Ma, Y; Zhao, XQ; Yang, XM; Dong, HY; Liu, Y; Lian, LL; Wan, L; Wu, YM; Wan, KL				Yu, Qin; Su, Yunkai; Lu, Bing; Ma, Yan; Zhao, Xiuqin; Yang, Xiaomin; Dong, Haiyan; Liu, Yao; Lian, Lulu; Wan, Li; Wu, Yimou; Wan, Kanglin			Genetic Diversity of Mycobacterium tuberculosis Isolates from Inner Mongolia, China	PLOS ONE			English	Article							BEIJING FAMILY; MOLECULAR EPIDEMIOLOGY; STRAINS; GENOTYPE; RESISTANT	Background: Tuberculosis (TB) is a serious public health problem in China, and within China, Inner Mongolia has a high prevalence area of TB. Though studies on the genetic diversity of Mycobacterium tuberculosis (MTB) have been reported in many provinces, there are no such studies to date in Inner Mongolia. In this study, we investigated the genetic diversity of MTB in Inner Mongolia. Methodology/Principal Findings: In this study, we analyzed 372 clinical MTB isolates with 22-loci mycobacterial interspersed repetitive unit and variable-number tandem repeats (MIRU-VNTR), spoligotyping, large sequence polymorphism (LSP), and NTF region analysis to understand the TB genotypes prevalent in Inner Mongolia. We found that the Beijing family was the most prevalent genotype (85.48%, 318/372), and the "modern'' sublineage accounted for 76.73% (244/318) of the isolates. Our data also showed that there was no statistically significant association between the two major nationalities and the Beijing genotype (chi(2) = 3.612, P = 0.057; P > 0.05). Conclusion/Significance: The Beijing genotype is the most prevalent family of M. tuberculosis in Inner Mongolia, and we do not find any correlation between the Beijing genotype and the major nationalities.	[Yu, Qin; Lu, Bing; Zhao, Xiuqin; Dong, Haiyan; Lian, Lulu; Wan, Li; Wan, Kanglin] Chinese Ctr Dis Control & Prevention, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Yu, Qin; Lian, Lulu; Wu, Yimou; Wan, Kanglin] Univ South China, Pathogen Biol Inst, Hengyang, Hunan, Peoples R China; [Su, Yunkai; Ma, Yan; Yang, Xiaomin; Liu, Yao] Inner Mongolia Inst TB Control & Prevent, Hohhot, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of South China	Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevention, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	wankanglin@icdc.cn			project "Transmission Mode of Tuberculosis'' of the National Key Program of Mega Infectious Disease [2008ZX100/03-010-02]; project of the State Key Laboratory for Infectious Disease Prevention and Control [2011SKLID208]	project "Transmission Mode of Tuberculosis'' of the National Key Program of Mega Infectious Disease; project of the State Key Laboratory for Infectious Disease Prevention and Control	This work was funded by the project "Transmission Mode of Tuberculosis'' (2008ZX100/03-010-02) of the National Key Program of Mega Infectious Disease and by the project of the State Key Laboratory for Infectious Disease Prevention and Control (2011SKLID208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Chai Li-Quan, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P785; Dong HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033904; Dong HY, 2010, J CLIN MICROBIOL, V48, P4102, DOI 10.1128/JCM.00549-10; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jiao WW, 2007, CHINESE MED J-PEKING, V120, P814, DOI 10.1097/00029330-200705010-00014; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kang HY, 2010, J MED MICROBIOL, V59, P1191, DOI 10.1099/jmm.0.022103-0; Kurepina N. E., 1998, Tubercle and Lung Disease, V79, P31, DOI 10.1054/tuld.1998.0003; Lawson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038409; Liu Q, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-288; Maeda S, 2010, INT J TUBERC LUNG D, V14, P1201; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; Mokrousov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041318; Nagai Y, 2012, JPN J INFECT DIS, V65, P341, DOI 10.7883/yoken.65.341; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; The national tuberculosis epidemiology sampling technology steering group, 1992, CHIN J TUBERC RESP D, V15, P69; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Wang JA, 2011, J CLIN MICROBIOL, V49, P1354, DOI 10.1128/JCM.02274-10; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; WHO, 2010, GLOB TUB CONTR 2010; Zhao CL, 2010, INNER MONGOLIA MINOR	30	15	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e57660	10.1371/journal.pone.0057660	http://dx.doi.org/10.1371/journal.pone.0057660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658680	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000003
J	Ameri, K; Rajah, AM; Nguyen, V; Sanders, TA; Jahangiri, A; DeLay, M; Donne, M; Choi, HJ; Tormos, KV; Yeghiazarians, Y; Jeffrey, SS; Rinaudo, PF; Rowitch, DH; Aghi, M; Maltepe, E				Ameri, Kurosh; Rajah, Anthony M.; Vien Nguyen; Sanders, Timothy A.; Jahangiri, Arman; DeLay, Michael; Donne, Matthew; Choi, Hwa J.; Tormos, Kathryn V.; Yeghiazarians, Yerem; Jeffrey, Stefanie S.; Rinaudo, Paolo F.; Rowitch, David H.; Aghi, Manish; Maltepe, Emin			Nuclear Localization of the Mitochondrial Factor HIGD1A during Metabolic Stress	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; CARBONIC-ANHYDRASE-IX; TUMOR-CELL SURVIVAL; BCL-2 FAMILY-MEMBER; GENE-EXPRESSION; PROTEIN BNIP3; CYTOCHROME-C; MYOCARDIAL-ISCHEMIA; MICROARRAY ANALYSIS; DNA-BINDING	Cellular stress responses are frequently governed by the subcellular localization of critical effector proteins. Apoptosis-inducing Factor (AIF) or Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH), for example, can translocate from mitochondria to the nucleus, where they modulate apoptotic death pathways. Hypoxia-inducible gene domain 1A (HIGD1A) is a mitochondrial protein regulated by Hypoxia-inducible Factor-1 alpha (HIF1 alpha). Here we show that while HIGD1A resides in mitochondria during physiological hypoxia, severe metabolic stress, such as glucose starvation coupled with hypoxia, in addition to DNA damage induced by etoposide, triggers its nuclear accumulation. We show that nuclear localization of HIGD1A overlaps with that of AIF, and is dependent on the presence of BAX and BAK. Furthermore, we show that AIF and HIGD1A physically interact. Additionally, we demonstrate that nuclear HIGD1A is a potential marker of metabolic stress in vivo, frequently observed in diverse pathological states such as myocardial infarction, hypoxic-ischemic encephalopathy (HIE), and different types of cancer. In summary, we demonstrate a novel nuclear localization of HIGD1A that is commonly observed in human disease processes in vivo.	[Ameri, Kurosh; Rajah, Anthony M.; Vien Nguyen; Sanders, Timothy A.; Choi, Hwa J.; Tormos, Kathryn V.; Rowitch, David H.; Maltepe, Emin] Univ Calif San Francisco, Dept Pediat Neonatol, San Francisco, CA 94143 USA; [Jahangiri, Arman; DeLay, Michael; Aghi, Manish] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Donne, Matthew] Univ Calif San Francisco, Dept Dev & Stem Cell Biol, San Francisco, CA 94143 USA; [Yeghiazarians, Yerem; Maltepe, Emin] Univ Calif San Francisco, Dept Med Cardiol, San Francisco, CA 94143 USA; [Jeffrey, Stefanie S.] Stanford Univ, Sch Med, Dept Surg, Palo Alto, CA 94304 USA; [Rinaudo, Paolo F.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco	Maltepe, E (corresponding author), Univ Calif San Francisco, Dept Pediat Neonatol, San Francisco, CA 94143 USA.	emin.maltepe@ucsf.edu		Jeffrey, Stefanie/0000-0003-4478-2764; Rowitch, David/0000-0002-0079-0060	Department of Pediatrics, UCSF; NIH [HL087754, HD072455, T32HD007470]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062803, T32HD007470, R01HD072455] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS064167] Funding Source: NIH RePORTER	Department of Pediatrics, UCSF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by Department of Pediatrics, UCSF and by NIH (HL087754, HD072455, T32HD007470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri K, 2010, BRIT J CANCER, V102, P561, DOI 10.1038/sj.bjc.6605491; An HJ, 2011, BBA-MOL CELL RES, V1813, P2088, DOI 10.1016/j.bbamcr.2011.07.017; Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Azam S, 2008, J BIOL CHEM, V283, P30632, DOI 10.1074/jbc.M801401200; Bacon AL, 2007, ONCOGENE, V26, P132, DOI 10.1038/sj.onc.1209761; Bedo G, 2005, INT J DEV BIOL, V49, P431, DOI 10.1387/ijdb.041901gb; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Burton TR, 2009, J NEUROSCI, V29, P4189, DOI 10.1523/JNEUROSCI.5747-08.2009; Burton TR, 2006, INT J CANCER, V118, P1660, DOI 10.1002/ijc.21547; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Cheung ECC, 2005, J NEUROSCI, V25, P1324, DOI 10.1523/JNEUROSCI.4261-04.2005; Choi HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056949; Dai RP, 2008, J BIOL CHEM, V283, P26894, DOI 10.1074/jbc.M804307200; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Delay M, 2012, CLIN CANCER RES, V18, P2930, DOI 10.1158/1078-0432.CCR-11-2390; Denko N, 2000, CLIN CANCER RES, V6, P480; Dong DZ, 2005, CANCER RES, V65, P5785, DOI 10.1158/0008-5472.CAN-05-0754; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gallo LI, 2011, J BIOL CHEM, V286, P30152, DOI 10.1074/jbc.M111.256610; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Hayashi H, 2012, FASEB J, V26, P2306, DOI 10.1096/fj.11-196063; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jin K, 2002, NEUROCHEM RES, V27, P1105, DOI 10.1023/A:1020913123054; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kim C, 2006, BIOCHEM BIOPH RES CO, V341, P1237, DOI 10.1016/j.bbrc.2006.01.087; Kubli DA, 2008, AM J PHYSIOL-HEART C, V295, pH2025, DOI 10.1152/ajpheart.00552.2008; Lipton SA, 2002, CELL, V111, P147, DOI 10.1016/S0092-8674(02)01046-2; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Maltepe E, 2009, PEDIATR RES, V65, P261, DOI 10.1203/PDR.0b013e31818fc83f; MANSUR NR, 1993, NUCLEIC ACIDS RES, V21, P993, DOI 10.1093/nar/21.4.993; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; McIntyre A, 2012, CLIN CANCER RES, V18, P3100, DOI 10.1158/1078-0432.CCR-11-1877; Nagel S, 2010, ANTIOXID REDOX SIGN, V12, P481, DOI 10.1089/ars.2009.2711; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Ochiai D, 2011, BIOCHEM BIOPH RES CO, V415, P445, DOI 10.1016/j.bbrc.2011.10.089; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Papandreou I, 2005, CANCER RES, V65, P3171, DOI 10.1158/0008-5472.CAN-04-3395; Park SK, 2003, MOL CELL BIOL, V23, P4959, DOI 10.1128/MCB.23.14.4959-4971.2003; Potter C, 2004, CELL CYCLE, V3, P164; RONAI Z, 1993, INT J BIOCHEM, V25, P1073, DOI 10.1016/0020-711X(93)90123-V; Salnikow K, 2003, CANCER RES, V63, P3524; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Schmidt-Kastner R, 2004, BRAIN RES, V1001, P133, DOI 10.1016/j.brainres.2003.11.065; Semenza GL, 2000, ADV EXP MED BIOL, V475, P123; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Takahashi E, 2008, AM J PHYSIOL-HEART C, V294, pH2507, DOI 10.1152/ajpheart.00168.2008; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Wang J, 2006, P NATL ACAD SCI USA, V103, P10636, DOI 10.1073/pnas.0604194103; Watanabe M, 2009, INT J CANCER, V124, P55, DOI 10.1002/ijc.23897; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Yasuda M, 1998, J BIOL CHEM, V273, P12415, DOI 10.1074/jbc.273.20.12415; Yeghiazarians Y, 2012, CYTOTHERAPY, V14, P223, DOI 10.3109/14653249.2011.623690; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhang K, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00005; Zhang XP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034126; Zhao SP, 2010, J NEUROSCI RES, V88, P1727, DOI 10.1002/jnr.22338	69	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62758	10.1371/journal.pone.0062758	http://dx.doi.org/10.1371/journal.pone.0062758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646141	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300094
J	Wijnans, L; Dieleman, J; Voordouw, B; Sturkenboom, M				Wijnans, Leonoor; Dieleman, Jeanne; Voordouw, Bettie; Sturkenboom, Miriam			Effectiveness of MF59 (TM) Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands	PLOS ONE			English	Article							PATIENT RECORDS; INFECTIONS; ENGLAND	Background: The aim of the present study was to estimate the effectiveness of the MF59 (TM)-adjuvanted influenza A(H1N1)pdm09 vaccine against medically attended influenza-like illness and RT-PCR confirmed influenza in the at-risk population and persons over 60 in the Netherlands. Methods: We conducted a retrospective cohort study in a Dutch based GP medical record database between 30 November 2009 and 1 March 2010 to estimate the vaccine effectiveness against influenza-like illness. Within the cohort we nested a test negative case-control study to estimate the effectiveness against laboratory confirmed influenza. Results: The crude effectiveness in preventing diagnosed or possible influenza-like illness was 17.3% (95%CI: -8.5%-36.9%). Of the measured covariates, age, the severity of disease and health seeking behaviour through devised proxies confounded the association between vaccination and influenza-like illness. The adjusted vaccine effectiveness was 20.8% (95%CI: -5.4%, 40.5%) and varied significantly by age, being highest in adults up to 50 years (59%, 95%CI: 23%, 78%), and non-detectable in adults over 50 years. The number of cases in the nested case control study was too limited to validly estimate the VE against confirmed influenza. Conclusions: With our study we demonstrated that the approach of combining a cohort study in a primary health care database with field sampling is a feasible and useful option to monitor VE of influenza vaccines in the future.	[Wijnans, Leonoor; Dieleman, Jeanne; Sturkenboom, Miriam] Erasmus MC, Rotterdam, Netherlands; [Wijnans, Leonoor; Voordouw, Bettie] Med Evaluat Board, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC	Wijnans, L (corresponding author), Erasmus MC, Rotterdam, Netherlands.	e.wijnans@erasmusmc.nl			European Centre for Disease Control and Prevention (ECDC)	European Centre for Disease Control and Prevention (ECDC)	This work has been undertaken as part of a European Centre for Disease Control and Prevention (ECDC) funded project "I-MOVE''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews N, 2011, J INFECT DIS, V203, P32, DOI 10.1093/infdis/jiq014; Castilla J, 2011, VACCINE, V29, P5919, DOI 10.1016/j.vaccine.2011.06.063; Coordination Group for Mutual Recognition and Decentralised Procedures Human, 2009, COR SPC TRIV INFL VA; European Medicines Agency, 2010, SUMM PROD CHAR FOC I; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hardelid P, 2011, EUROSURVEILLANCE, V16, P12; Johansen K, 2009, EUROSURVEILLANCE, V14, P12; Monto AS, 2009, VACCINE, V27, P5043, DOI 10.1016/j.vaccine.2009.06.032; Ortqvist A, 2011, CLIN INFECT DIS, V52, P1203, DOI 10.1093/cid/cir182; Pelat C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019621; Puig-Barbera J, 2010, VACCINE, V28, P7460, DOI 10.1016/j.vaccine.2010.09.042; Savulescu C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-899; Simpson CR, 2010, HEALTH TECHNOL ASSES, V14, P323, DOI 10.3310/hta14340-05; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Song JY, 2011, VACCINE, V29, P1395, DOI 10.1016/j.vaccine.2010.12.050; Steens A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-196; Uphoff H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019932; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; VANDERLEI J, 1993, ANN INTERN MED, V119, P1036, DOI 10.7326/0003-4819-119-10-199311150-00011; Vlug AE, 1999, METHOD INFORM MED, V38, P339; Voordouw BCG, 2006, ARCH INTERN MED, V166, P1980, DOI 10.1001/archinte.166.18.1980; Wichmann O, 2010, EUROSURVEILLANCE, V15, P2	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63156	10.1371/journal.pone.0063156	http://dx.doi.org/10.1371/journal.pone.0063156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646191	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300146
J	Perovic, VR; Muller, CP; Niman, HL; Veljkovic, N; Dietrich, U; Tosic, DD; Glisic, S; Veljkovic, V				Perovic, Vladimir R.; Muller, Claude P.; Niman, Henry L.; Veljkovic, Nevena; Dietrich, Ursula; Tosic, Dusan D.; Glisic, Sanja; Veljkovic, Veljko			Novel Phylogenetic Algorithm to Monitor Human Tropism in Egyptian H5N1-HPAIV Reveals Evolution toward Efficient Human-to-Human Transmission	PLOS ONE			English	Article							AVIAN INFLUENZA H5N1; RECEPTOR-BINDING; A VIRUSES; HEMAGGLUTININ; IDENTIFICATION; MUTATIONS; SEQUENCES; DOMAIN	Years of endemic infections with highly pathogenic avian influenza (HPAI) A subtype H5N1 virus in poultry and high numbers of infections in humans provide ample opportunity in Egypt for H5N1-HPAIV to develop pandemic potential. In an effort to better understand the viral determinants that facilitate human infections of the Egyptian H5N1-HPAIVvirus, we developed a new phylogenetic algorithm based on a new distance measure derived from the informational spectrum method (ISM). This new approach, which describes functional aspects of the evolution of the hemagglutinin subunit 1 (HA1), revealed a growing group G2 of H5N1-HPAIV in Egypt after 2009 that acquired new informational spectrum (IS) properties suggestive of an increased human tropism and pandemic potential. While in 2006 all viruses in Egypt belonged to the G1 group, by 2011 these viruses were virtually replaced by G2 viruses. All of the G2 viruses displayed four characteristic mutations (D43N, S120(D,N), (S,L)129 Delta and I151T), three of which were previously reported to increase binding to the human receptor. Already in 2006-2008 G2 viruses were significantly (p<0.02) more often found in humans than expected from their overall prevalence and this further increased in 2009-2011 (p<0.007). Our approach also identified viruses that acquired additional mutations that we predict to further enhance their human tropism. The extensive evolution of Egyptian H5N1-HPAIV towards a preferential human tropism underlines an urgent need to closely monitor these viruses with respect to molecular determinants of virulence.	[Perovic, Vladimir R.; Veljkovic, Nevena; Glisic, Sanja; Veljkovic, Veljko] Univ Belgrade, Inst Nucl Sci Vinca, Ctr Multidisciplinary Res, Belgrade, Serbia; [Muller, Claude P.] Inst Immunol, Ctr Rech Publ Sante, Lab Natl Sante, Luxembourg, Luxembourg; [Niman, Henry L.] Recombinom Inc, Pittsburgh, PA USA; [Dietrich, Ursula] Inst Biomed Res, Frankfurt, Germany; [Tosic, Dusan D.] Univ Belgrade, Fac Math, Belgrade, Serbia	University of Belgrade; Luxembourg Institute of Health; University of Belgrade	Muller, CP (corresponding author), Inst Immunol, Ctr Rech Publ Sante, Lab Natl Sante, Luxembourg, Luxembourg.	claude.muller@crp-sante.lu	Glisic, Sanja/AAE-8590-2019; Dietrich, Ursula/AAD-5704-2020	Glisic, Sanja/0000-0001-5691-1055; Dietrich, Ursula/0000-0003-2491-4758; Perovic, Vladimir/0000-0002-3700-6452; Veljkovic, Nevena/0000-0001-6562-5800	Ministry of Science and Technological Development of the Republic of Serbia [173001]; Ministry of Foreign Affairs, Luxembourg	Ministry of Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); Ministry of Foreign Affairs, Luxembourg	This work was supported by the Ministry of Science and Technological Development of the Republic of Serbia (Grant no. 173001, www.mpn.gov.rs) and the Ministry of Foreign Affairs, Luxembourg. They had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	Abdel-Moneim AS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-283; Abdelwhab E.M., 2010, SEQUENCING, DOI [DOI 10.1155/2010/450823, 10.1155/2010/450823]; Aly MM, 2008, AVIAN DIS, V52, P269, DOI 10.1637/8166-103007-Reg.1; Arafa A, 2010, AVIAN DIS, V54, P345, DOI 10.1637/8927-051509-ResNote.1; Bahgat MM, 2009, J VIROL METHODS, V159, P244, DOI 10.1016/j.jviromet.2009.04.008; Cao ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038126; Cattoli G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004842; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; David WM, 2001, BIOINFORMATICS SEQUE, P6; Epstein S, 2012, J INFECT DIS, V205, P4, DOI 10.1093/infdis/jir692; FELSENSTEIN J, 1973, SYST ZOOL, V22, P240, DOI 10.2307/2412304; Feng DF, 1996, METHOD ENZYMOL, V266, P368; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Garcia JM, 2009, PLOS MED, V6; Hu HX, 2012, J VIROL, V86, P2978, DOI 10.1128/JVI.06665-11; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kayali G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017730; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kongchanagul A, 2008, J GEN VIROL, V89, P1805, DOI 10.1099/vir.0.2008/002469-0; Li Z, 2011, ARCH VIROL, V156, P1803, DOI 10.1007/s00705-011-1056-2; Lycett SJ, 2009, J VIROL, V83, P9901, DOI 10.1128/JVI.00608-09; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Mau B, 1996, 961 U WISC MAD STAT; Saad MD, 2007, EMERG INFECT DIS, V13, P1120, DOI 10.3201/eid1307.061222; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sankoff D, 1983, TIME WARPS STRING ED, P253; Su Y, 2008, ARCH VIROL, V153, P2253, DOI 10.1007/s00705-008-0255-y; Veljkovic N, 2008, CURR PROTEIN PEPT SC, V9, P493, DOI 10.2174/138920308785915245; Veljkovic V, 2007, CURR MED CHEM, V14, P441, DOI 10.2174/092986707779941014; VELJKOVIC V, 1985, IEEE T BIO-MED ENG, V32, P337, DOI 10.1109/TBME.1985.325549; VELJKOVIC V, 1973, PHYS LETT A, VA 45, P41, DOI 10.1016/0375-9601(73)90497-0; VELJKOVIC V, 1972, PHYS REV LETT, V29, P105, DOI 10.1103/PhysRevLett.29.105; Veljkovic V., 1980, THEORETICAL APPROACH; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-62; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-21; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; [WHO] World Health Organization, INFL HUM AN INT HAI; World Health Organization (WHO), 2011, AV NEW REC A H5N1 CA; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yong E, 2012, NATURE	43	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61572	10.1371/journal.pone.0061572	http://dx.doi.org/10.1371/journal.pone.0061572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658611	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700013
J	Schierack, P; Rodiger, S; Kuhl, C; Hiemann, R; Roggenbuck, D; Li, G; Weinreich, J; Berger, E; Nolan, LK; Nicholson, B; Romer, A; Frommel, U; Wieler, LH; Schroder, C				Schierack, Peter; Roediger, Stefan; Kuhl, Christoph; Hiemann, Rico; Roggenbuck, Dirk; Li, Ganwu; Weinreich, Joerg; Berger, Enrico; Nolan, Lisa K.; Nicholson, Bryon; Roemer, Antje; Froemmel, Ulrike; Wieler, Lothar H.; Schroeder, Christian			Porcine E. coli: Virulence-Associated Genes, Resistance Genes and Adhesion and Probiotic Activity Tested by a New Screening Method	PLOS ONE			English	Article							INTESTINAL ESCHERICHIA-COLI; FIELD GEL-ELECTROPHORESIS; STRAIN NISSLE-1917; ANTIMICROBIAL RESISTANCE; COMPARATIVE GENOMICS; EPITHELIAL-CELLS; DNA-SEQUENCE; IN-VITRO; SWINE; COLONIZATION	We established an automated screening method to characterize adhesion of Escherichia coli to intestinal porcine epithelial cells (IPEC-J2) and their probiotic activity against infection by enteropathogenic E. coli (EPEC). 104 intestinal E. coli isolates from domestic pigs were tested by PCR for the occurrence of virulence-associated genes, genes coding for resistances to antimicrobial agents and metals, and for phylogenetic origin by PCR. Adhesion rates and probiotic activity were examined for correlation with the presence of these genes. Finally, data were compared with those from 93 E. coli isolates from wild boars. Isolates from domestic pigs carried a broad variety of all tested genes and showed great diversity in gene patterns. Adhesions varied with a maximum of 18.3 or 24.2 mean bacteria adherence per epithelial cell after 2 or 6 hours respectively. Most isolates from domestic pigs and wild boars showed low adherence, with no correlation between adhesion/probiotic activity and E. coli genes or gene clusters. The gene sfa/foc, encoding for a subunit of F1C fimbriae did show a positive correlative association with adherence and probiotic activity; however E. coli isolates from wild boars with the sfa/foc gene showed less adhesion and probiotic activity than E. coli with the sfa/foc gene isolated from domestic pigs after 6 hour incubation. In conclusion, screening porcine E. coli for virulence associated genes genes, adhesion to intestinal epithelial cells, and probiotic activity revealed a single important adhesion factor, several probiotic candidates, and showed important differences between E. coli of domestic pigs and wild boars.	[Schierack, Peter; Roediger, Stefan; Kuhl, Christoph; Hiemann, Rico; Roggenbuck, Dirk; Weinreich, Joerg; Berger, Enrico; Froemmel, Ulrike; Schroeder, Christian] Hsch Lausitz FH, Fak Nat Wissensch, Senftenberg, Germany; [Li, Ganwu; Nolan, Lisa K.; Nicholson, Bryon] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [Roemer, Antje] Fed Off Consumer Protect & Food Safety, Berlin, Germany; [Wieler, Lothar H.] Free Univ Berlin, Inst Mikrobiol & Tierseuchen, Berlin, Germany	Brandenburg University of Technology Cottbus; Iowa State University; Free University of Berlin	Schierack, P (corresponding author), Hsch Lausitz FH, Fak Nat Wissensch, Senftenberg, Germany.	Peter.Schierack@HS-Lausitz.de	Rödiger, Stefan J/G-6107-2016; Rödiger, Stefan/O-4633-2019; Li, Ganwu/AAC-7423-2020	Rödiger, Stefan J/0000-0002-1441-6512; Rödiger, Stefan/0000-0002-1441-6512; Wieler, Lothar H./0000-0003-4365-3717; Roggenbuck, Dirk/0000-0002-6861-6827	InnoProfile [IP 03 IP 611]; Bundesministerium f (A) over tilde1/4r Bildung und Forschung (BMBF, Germany); Collaborative Research Group "Nutrition and intestinal microbiota - host interactions in the pig" [(SFB) 852]; Deutsche Forschungsgemeinschaft (DFG)	InnoProfile; Bundesministerium f (A) over tilde1/4r Bildung und Forschung (BMBF, Germany)(Federal Ministry of Education & Research (BMBF)); Collaborative Research Group "Nutrition and intestinal microbiota - host interactions in the pig"; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by InnoProfile IP 03 IP 611 funded by the Bundesministerium f (A) over tilde1/4r Bildung und Forschung (BMBF, Germany) and by Collaborative Research Group (SFB) 852 "Nutrition and intestinal microbiota - host interactions in the pig" funded by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoefer A, 2004, FEMS IMMUNOL MED MIC, V40, P223, DOI 10.1016/S0928-8244(03)00368-7; Barth S, 2007, BERL MUNCH TIERARZTL, V120, P307, DOI 10.2376/0005-9366-120-307; Bass L, 1999, ANTIMICROB AGENTS CH, V43, P2925, DOI 10.1128/AAC.43.12.2925; Bean DC, 2009, ANTIMICROB AGENTS CH, V53, P1088, DOI 10.1128/AAC.00800-08; Bjorkman J, 2000, DRUG RESIST UPDATE, V3, P237, DOI 10.1054/drup.2000.0147; Boerlin P, 2005, APPL ENVIRON MICROB, V71, P6753, DOI 10.1128/AEM.71.11.6753-6761.2005; Borkow G, 2004, FASEB J, V18, P1728, DOI 10.1096/fj.04-2029fje; Boudeau J, 2003, ALIMENT PHARM THER, V18, P45, DOI 10.1046/j.1365-2036.2003.01638.x; Chen J, 1998, LETT APPL MICROBIOL, V27, P369, DOI 10.1046/j.1472-765X.1998.00445.x; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; DIORIO C, 1995, J BACTERIOL, V177, P2050, DOI 10.1128/jb.177.8.2050-2056.1995; Egerer K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2949; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2009, ENV MICROBIOL REP, V1, P510, DOI 10.1111/j.1758-2229.2009.00058.x; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Grossmann K, 2011, CYTOM PART A, V79A, P118, DOI 10.1002/cyto.a.21009; Guenther S, 2010, VET MICROBIOL, V142, P352, DOI 10.1016/j.vetmic.2009.10.004; Henker J, 2008, PEDIATR INFECT DIS J, V27, P494, DOI 10.1097/INF.0b013e318169034c; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Huebner C, 2011, APPL ENVIRON MICROB, V77, P2541, DOI 10.1128/AEM.01601-10; Johnson AM, 2009, J BACTERIOL, V191, P178, DOI 10.1128/JB.00822-08; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2006, ANTIMICROB AGENTS CH, V50, P3929, DOI 10.1128/AAC.00569-06; Johnson TJ, 2010, INFECT IMMUN, V78, P1931, DOI 10.1128/IAI.01174-09; Johnson TJ, 2005, ANTIMICROB AGENTS CH, V49, P4681, DOI 10.1128/AAC.49.11.4681-4688.2005; Johnson TJ, 2004, AVIAN DIS, V48, P351, DOI 10.1637/7121; Kivity S, 2012, CLIN RHEUMATOL, V31, P503, DOI 10.1007/s10067-011-1884-1; Kleta S, 2006, J APPL MICROBIOL, V101, P1357, DOI 10.1111/j.1365-2672.2006.03019.x; Kleta S, 2008, THESIS HUMBOLDT U BE; Krammer HJ, 2006, Z GASTROENTEROL, V44, P651, DOI 10.1055/s-2006-926909; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Lasaro MA, 2009, APPL ENVIRON MICROB, V75, P246, DOI 10.1128/AEM.01144-08; Liesegang A, 2002, INT J MED MICROBIOL, V291, P645, DOI 10.1078/1438-4221-00180; Merlino J, 1996, J CLIN MICROBIOL, V34, P1788, DOI 10.1128/JCM.34.7.1788-1793.1996; Monteiro C, 2009, ENVIRON MICROBIOL, V11, P1105, DOI 10.1111/j.1462-2920.2008.01840.x; Moon HW, 1999, J VET DIAGN INVEST, V11, P557, DOI 10.1177/104063879901100617; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Osek J, 1999, VET MICROBIOL, V68, P209, DOI 10.1016/S0378-1135(99)00109-1; Rodiger S, 2012, ADV BIOCHEM ENG BIOT, V23; Rodiger S, 2012, J STAT SOFTW, V49, P1; Roggenbuck D, 2011, CLIN CHIM ACTA, V412, P2011, DOI 10.1016/j.cca.2011.07.005; Romer A, 2012, VET MICROBIOL, V17, P122; Romer A, 2009, THESIS FREIE U BERLI; Runge R, 2012, INT J RADIAT BIOL, V88, P439, DOI 10.3109/09553002.2012.658468; Sanders ME, 2008, CLIN INFECT DIS, V46, pS58, DOI 10.1086/523341; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Schierack P, 2008, ENVIRON MICROBIOL, V10, P1742, DOI 10.1111/j.1462-2920.2008.01595.x; Schierack P, 2007, MICROBIOL-SGM, V153, P3830, DOI 10.1099/mic.0.2007/010173-0; Schierack P, 2011, APPL ENVIRON MICROB, V77, P8451, DOI 10.1128/AEM.05289-11; Schierack P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014712; Schierack P, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-18; Schierack P, 2009, APPL ENVIRON MICROB, V75, P695, DOI 10.1128/AEM.01650-08; Schroeder B, 2006, DIGEST DIS SCI, V51, P724, DOI 10.1007/s10620-006-3198-8; Schultz M, 2004, CLIN DIAGN LAB IMMUN, V11, P372, DOI 10.1128/CDLI.11.2.372-378.2004; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; von Buenau R, 2005, J DAIRY SCI, V88, P317, DOI 10.3168/jds.S0022-0302(05)72690-4; WINKLE S, 1979, MIKROBIOLOGISCHE SER; ZHU C, 1994, INFECT IMMUN, V62, P4153, DOI 10.1128/IAI.62.10.4153-4159.1994; Zihler A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-264	59	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e59242	10.1371/journal.pone.0059242	http://dx.doi.org/10.1371/journal.pone.0059242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658605	Green Submitted, Green Published, gold			2022-12-25	WOS:000318343700003
J	Volodyaev, IV; Krasilnikova, EN; Ivanovsky, RN				Volodyaev, Ilya V.; Krasilnikova, Elena N.; Ivanovsky, Ruslan N.			CO2 Mediated Interaction in Yeast Stimulates Budding and Growth on Minimal Media	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; CELL COMMUNICATION; ADENYLYL-CYCLASE; BACTERIA; VIRULENCE; COLONIES; MEIOSIS	Here we show that carbon dioxide (CO2) stimulates budding and shortens the lag-period of Saccharomyces cerevisiae cultures, grown on specific weak media. CO2 can be both exogenous and secreted by another growing yeast culture. We also show that this effect can be observed only in the lag-period, and demonstrate minimal doses and duration of culture exposition to CO2. Opposite to the effects of CO2 sensitivity, previously shown for pathogens, where increased concentration of CO2 suppressed mitosis and stimulated cell differentiation and invasion, here it stimulates budding and culture growth.	[Volodyaev, Ilya V.; Krasilnikova, Elena N.; Ivanovsky, Ruslan N.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Microbiol, Moscow, Russia	Lomonosov Moscow State University	Volodyaev, IV (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Microbiol, Moscow, Russia.	ivolodyaev@gmail.com						Acs L., 1932, CENTR F BAKT 1, V120, P216; Audubert R, 1939, T FARADAY SOC, V35, P0197, DOI 10.1039/tf9393500197; Bahn YS, 2005, CURR BIOL, V15, P2013, DOI 10.1016/j.cub.2005.09.047; Baron M., 1930, PLANTA, V10, P28, DOI 10.1007/BF01911536; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; CREANOR J, 1982, J CELL SCI, V58, P263; FOWELL RR, 1969, YEASTS, V1, P303; Frank G, 1931, NATURWISSENSCHAFTEN, V19, P659, DOI DOI 10.1007/BF01516035; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gurwitsch A., 1932, MITOGENETISCHE STRAH; Hall RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001193; Hammer A, 2006, BIOCHEM J, V396, P215, DOI 10.1042/BJ20060372; Hayashi M, 1998, YEAST, V14, P905; Hogan DA, 2006, EUKARYOT CELL, V5, P613, DOI 10.1128/EC.5.4.613-619.2006; Hollaender A, 1937, EXPT STUDY PROBLEM M; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Mitchell AP, 2005, CURR BIOL, V15, pR934, DOI 10.1016/j.cub.2005.10.064; Nekrasov K, 2010, 10 INT C PATT REC IM, P335; NOVAK B, 1988, J CELL SCI, V89, P433; Ohkuni K, 1998, YEAST, V14, P623, DOI 10.1002/(SICI)1097-0061(199805)14:7<623::AID-YEA264>3.3.CO;2-4; OURA E, 1980, J GEN MICROBIOL, V118, P51; Palkova Z, 2000, J CELL SCI, V113, P1923; Palkova Z, 1997, NATURE, V390, P532, DOI 10.1038/37398; QUICKENDEN TI, 1976, PHOTOCHEM PHOTOBIOL, V23, P201, DOI 10.1111/j.1751-1097.1976.tb07242.x; Rahn O., 1936, INVISIBLE RAD ORGANI; Ras G., 1931, CENTR BACT 1, V123, P257; Sharabi K, 2009, J CELL MOL MED, V13, P4304, DOI 10.1111/j.1582-4934.2009.00952.x; Trushin MV, 2004, MICROBIOL RES, V159, P1, DOI 10.1016/j.micres.2003.11.001; TUTHILL JOHN B., 1933, ARCH MIKROBIOL, V4, P565, DOI 10.1007/BF00407562; UENO T, 1964, Nihon Seirigaku Zasshi, V26, P156; Visick KL, 2005, J BACTERIOL, V187, P5507, DOI 10.1128/JB.187.16.5507-5519.2005; Wuster A, 2010, MOL BIOSYST, V6, P134, DOI 10.1039/b913579k	33	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62808	10.1371/journal.pone.0062808	http://dx.doi.org/10.1371/journal.pone.0062808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658652	Green Submitted, gold, Green Published			2022-12-25	WOS:000318343700075
J	Hoffmann, DC; Willenborg, S; Koch, M; Zwolanek, D; Muller, S; Becker, AKA; Metzger, S; Ehrbar, M; Kurschat, P; Hellmich, M; Hubbell, JA; Eming, SA				Hoffmann, Daniel C.; Willenborg, Sebastian; Koch, Manuel; Zwolanek, Daniela; Mueller, Stefan; Becker, Ann-Kathrin A.; Metzger, Stephanie; Ehrbar, Martin; Kurschat, Peter; Hellmich, Martin; Hubbell, Jeffrey A.; Eming, Sabine A.			Proteolytic Processing Regulates Placental Growth Factor Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL MIGRATION; HEPARIN-BINDING; VEGF-A; NEUROPILIN-1 BINDS; STRUCTURAL BASIS; TYROSINE KINASE; RECEPTOR; ANGIOGENESIS; INHIBITION; GENE	Placental growth factor (PlGF) is a critical mediator of blood vessel formation, yet mechanisms of its action and regulation are incompletely understood. Here we demonstrate that proteolytic processing regulates the biological activity of PlGF. Specifically, we show that plasmin processing of PlGF-2 yields a protease-resistant core fragment comprising the vascular endothelial growth factor receptor-1 binding site but lacking the carboxyl-terminal domain encoding the heparin-binding domain and an 8-amino acid peptide encoded by exon 7. We have identified plasmin cleavage sites, generated a truncated PlGF118 isoform mimicking plasmin-processed PlGF, and explored its biological function in comparison with that of PlGF-1 and -2. The angiogenic responses induced by the diverse PlGF forms were distinct. Whereas PlGF-2 increased endothelial cell chemotaxis, vascular sprouting, and granulation tissue formation upon skin injury, these activities were abrogated following plasmin digestion. Investigation of PlGF/Neuropilin-1 binding and function suggests a critical role for heparin-binding domain/Neuropilin-1 interaction and its regulation by plasmin processing. Collectively, here we provide new mechanistic insights into the regulation of PlGF-2/Neuropilin-1-mediated tissue vascularization and growth.	[Hoffmann, Daniel C.; Willenborg, Sebastian; Kurschat, Peter; Eming, Sabine A.] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Koch, Manuel; Zwolanek, Daniela; Becker, Ann-Kathrin A.] Univ Cologne, Inst Dent Res & Oral Musculoskeletal Biol, Ctr Biochem, D-50937 Cologne, Germany; [Koch, Manuel; Mueller, Stefan; Eming, Sabine A.] Univ Cologne, Ctr Mol Med Cologne, D-50937 Cologne, Germany; [Hellmich, Martin] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50937 Cologne, Germany; [Eming, Sabine A.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50937 Cologne, Germany; [Metzger, Stephanie; Ehrbar, Martin] Univ Zurich Hosp, Dept Obstet, CH-8091 Zurich, Switzerland; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Eming, SA (corresponding author), Univ Cologne, Dept Dermatol, Kerpenerstr 62, D-50937 Cologne, Germany.	sabine.eming@uni-koeln.de	Zwolanek, Daniela/AAN-8767-2020; Ehrbar, Martin/O-4130-2019; Koch, Manuel/AAG-9914-2021; Hubbell, Jeffrey A/A-9266-2008; Ehrbar, Martin/F-4578-2012	Ehrbar, Martin/0000-0003-2707-4870; Koch, Manuel/0000-0002-2962-7814; Hubbell, Jeffrey A/0000-0003-0276-5456; Ehrbar, Martin/0000-0003-2707-4870; Hellmich, Martin/0000-0001-5174-928X	European Union [NMP-LA-2008-214402]; Deutsche Forschungsgemeinschaft [SFB 829, SFB 832]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant Angioscaff NMP-LA-2008-214402 (to S. A. E., M. E., and J. A. H.) from the European Union and Deutsche Forschungsgemeinschaft Grants SFB 829 (to S. A. E., P. K., and M. K.) and SFB 832 (to M. K.).	Abu-Ghazaleh R, 2001, BIOCHEM J, V360, P255, DOI 10.1042/0264-6021:3600255; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cebe-Suarez S, 2008, FASEB J, V22, P3078, DOI 10.1096/fj.08-107219; Cianfarani F, 2006, AM J PATHOL, V169, P1167, DOI 10.2353/ajpath.2006.051314; DiPalma T, 1996, MAMM GENOME, V7, P6, DOI 10.1007/s003359900003; Eming SA, 2006, J INVEST DERMATOL, V126, P2731, DOI 10.1038/sj.jid.5700474; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; HAUSER S, 1993, GROWTH FACTORS, V9, P259, DOI 10.3109/08977199308991586; Herzog B, 2011, MOL BIOL CELL, V22, P2766, DOI 10.1091/mbc.E09-12-1061; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Iwasaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024872; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Lauer G, 2000, J INVEST DERMATOL, V115, P12, DOI 10.1046/j.1523-1747.2000.00036.x; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Maes C, 2006, J CLIN INVEST, V116, P1230, DOI 10.1172/JCI26772; MAGLIONE D, 1993, ONCOGENE, V8, P925; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Migdal M, 1998, J BIOL CHEM, V273, P22272, DOI 10.1074/jbc.273.35.22272; Oura H, 2003, BLOOD, V101, P560, DOI 10.1182/blood-2002-05-1516; Palolahti M, 1993, Exp Dermatol, V2, P29, DOI 10.1111/j.1600-0625.1993.tb00196.x; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Parker MW, 2012, J BIOL CHEM, V287, P11082, DOI 10.1074/jbc.M111.331140; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Roth D, 2006, AM J PATHOL, V168, P670, DOI 10.2353/ajpath.2006.050372; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sawano A, 1996, CELL GROWTH DIFFER, V7, P213; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; Vander Kooi CW, 2007, P NATL ACAD SCI USA, V104, P6152, DOI 10.1073/pnas.0700043104; von Wronski MA, 2006, J BIOL CHEM, V281, P5702, DOI 10.1074/jbc.M511941200; Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694; Zachary IC, 2011, BIOCHEM SOC T, V39, P1583, DOI 10.1042/BST20110697	43	14	15	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					17976	17989		10.1074/jbc.M113.451831	http://dx.doi.org/10.1074/jbc.M113.451831			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645683	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000320721900005
J	Bijveld, MMC; van Genderen, MM; Hoeben, FP; Katzin, AA; van Nispen, RMA; Riemslag, FCC; Kappers, AML				Bijveld, Mieke M. C.; van Genderen, Maria M.; Hoeben, Frank P.; Katzin, Amir A.; van Nispen, Ruth M. A.; Riemslag, Frans C. C.; Kappers, Astrid M. L.			Assessment of Night Vision Problems in Patients with Congenital Stationary Night Blindness	PLOS ONE			English	Article							ISLAND EYE DISEASE; INDEPENDENT MOBILITY; LOW LUMINANCE; MUTATIONS; CONE; ELECTRORETINOGRAM; ABNORMALITIES; NYCTALOPIN; CACNA1F; MOUSE	Congenital Stationary Night Blindness (CSNB) is a retinal disorder caused by a signal transmission defect between photoreceptors and bipolar cells. CSNB can be subdivided in CSNB2 (rod signal transmission reduced) and CSNB1 (rod signal transmission absent). The present study is the first in which night vision problems are assessed in CSNB patients in a systematic way, with the purpose of improving rehabilitation for these patients. We assessed the night vision problems of 13 CSNB2 patients and 9 CSNB1 patients by means of a questionnaire on low luminance situations. We furthermore investigated their dark adapted visual functions by the Goldmann Weekers dark adaptation curve, a dark adapted static visual field, and a two-dimensional version of the "Light Lab". In the latter test, a digital image of a living room with objects was projected on a screen. While increasing the luminance of the image, we asked the patients to report on detection and recognition of objects. The questionnaire showed that the CSNB2 patients hardly experienced any night vision problems, while all CSNB1 patients experienced some problems although they generally did not describe them as severe. The three scotopic tests showed minimally to moderately decreased dark adapted visual functions in the CSNB2 patients, with differences between patients. In contrast, the dark adapted visual functions of the CSNB1 patients were more severely affected, but showed almost no differences between patients. The results from the "2D Light Lab showed that all CSNB1 patients were blind at low intensities (equal to starlight), but quickly regained vision at higher intensities (full moonlight). Just above their dark adapted thresholds both CSNB1 and CSNB2 patients had normal visual fields. From the results we conclude that night vision problems in CSNB, in contrast to what the name suggests, are not conspicuous and generally not disabling.	[Bijveld, Mieke M. C.; van Genderen, Maria M.; Hoeben, Frank P.; Katzin, Amir A.; Riemslag, Frans C. C.] Bartimeus Inst Visually Impaired, Zeist, Netherlands; [Bijveld, Mieke M. C.; Kappers, Astrid M. L.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst, Amsterdam, Netherlands; [van Nispen, Ruth M. A.] Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [van Nispen, Ruth M. A.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Riemslag, Frans C. C.] Rotterdam Eye Hosp, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Rotterdam Eye Hospital	Bijveld, MMC (corresponding author), Bartimeus Inst Visually Impaired, Zeist, Netherlands.	mbijveld@bartimeus.nl		van Nispen, Ruth M.A./0000-0003-1227-1177	ODAS Stichting	ODAS Stichting	This study is partially funded by ODAS Stichting: http://www.odasstichting.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allen LE, 2003, BRIT J OPHTHALMOL, V87, P1413, DOI 10.1136/bjo.87.11.1413; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bijveld M, 2013, OPHTHALMOLO IN PRESS; Boycott KM, 2000, CAN J OPHTHALMOL, V35, P204, DOI 10.1016/S0008-4182(00)80031-9; Bradshaw K, 2004, DOC OPHTHALMOL, V108, P135, DOI 10.1023/B:DOOP.0000036786.22179.44; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; CORNELISSEN FW, 1995, VISION RES, V35, P161, DOI 10.1016/0042-6989(94)00183-M; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; ESTERMAN B, 1982, OPHTHALMOLOGY, V89, P1226; Finger RP, 2011, INVEST OPHTH VIS SCI, V52, P8241, DOI 10.1167/iovs.11-7858; GLASS IA, 1993, J MED GENET, V30, P1044, DOI 10.1136/jmg.30.12.1044; Gregg RG, 2007, J NEUROPHYSIOL, V98, P3023, DOI 10.1152/jn.00608.2007; HAWKSWORTH NR, 1995, BRIT J OPHTHALMOL, V79, P424, DOI 10.1136/bjo.79.5.424; Hope CI, 2005, CLIN EXP OPHTHALMOL, V33, P129, DOI 10.1111/j.1442-9071.2005.00987.x; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Littink KW, 2009, INVEST OPHTH VIS SCI, V50, P2344, DOI 10.1167/iovs.08-2553; Makous W, 1998, VISION RES PRACTICAL, P1; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Nakamura M, 2001, INVEST OPHTH VIS SCI, V42, P1610; Owsley C, 2006, INVEST OPHTH VIS SCI, V47, P528, DOI 10.1167/iovs.05-1222; PEARCE WG, 1990, CAN J OPHTHALMOL, V25, P3; Peters A. Y., 2000, Documenta Ophthalmologica, V101, P1, DOI 10.1023/A:1002765024774; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Riemslag FCC, 2009, DOC OPHTHALMOL, V119, P1, DOI 10.1007/s10633-008-9161-6; Rotenstreich Y, 2004, OPHTHALMOLOGY, V111, P1222, DOI 10.1016/j.ophtha.2003.10.025; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; TREMBLAY F, 1995, VISION RES, V35, P2383, DOI 10.1016/0042-6989(95)00006-L; Turano KA, 2002, INVEST OPHTH VIS SCI, V43, P2874; Turano KA, 1999, INVEST OPHTH VIS SCI, V40, P865; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067	34	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62927	10.1371/journal.pone.0062927	http://dx.doi.org/10.1371/journal.pone.0062927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658786	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100047
J	Chai, JT; Digby, JE; Ruparelia, N; Jefferson, A; Handa, A; Choudhury, RP				Chai, Joshua T.; Digby, Janet E.; Ruparelia, Neil; Jefferson, Andrew; Handa, Ashok; Choudhury, Robin P.			Nicotinic Acid Receptor GPR109A Is Down-Regulated in Human Macrophage-Derived Foam Cells	PLOS ONE			English	Article							EXTENDED-RELEASE NIACIN; PROTEIN-COUPLED RECEPTOR; PPAR-GAMMA; CHOLESTEROL EFFLUX; ARTERIAL BIOLOGY; IN-VITRO; PUMA-G; ATHEROSCLEROSIS; EXPRESSION; ADIPOPHILIN	Nicotinic acid (NA) regresses atherosclerosis in human imaging studies and reduces atherosclerosis in mice, mediated by myeloid cells, independent of lipoproteins. Since GPR109A is expressed by human monocytes, we hypothesized that NA may drive cholesterol efflux from foam cells. In THP-1 cells NA suppressed LPS-induced mRNA transcription of MCP-1 by 76.6 +/- 12.2% (P<0.01) and TNF alpha by 56.1 +/- 11.5% (P<0.01), yet restored LPS-induced suppression of PPAR gamma-transcription by 536.5 +/- 46.4% (P<0.001) and its downstream effector CD36 by 116.8 +/- 19.8% (P<0.01). Whilst direct PPAR gamma-agonism promoted cholesterol efflux from THP-1 derived foam cells by 37.7 +/- 3.1% (P<0.01) and stimulated transcription of LXR alpha by 87.9 +/- 9.5% (P<0.001) and ABCG1 by 101.2 +/- 15.5% (P<0.01), NA showed no effect in foam cells on either cholesterol efflux or key RCT genes transcription. Upon foam cell induction, NA lost its effect on PPAR gamma and cAMP pathways, since its receptor, GPR109A, was down-regulated by foam cell transformation. This observation was confirmed in explanted human carotid plaques. In conclusion, despite NA's anti-inflammatory effect on human macrophages, it has no effect on foam cells in reverse cholesterol transport; due to GPR109A down-regulation.	[Chai, Joshua T.; Digby, Janet E.; Ruparelia, Neil; Jefferson, Andrew; Choudhury, Robin P.] Univ Oxford, Div Cardiovasc Med, Oxford, England; [Handa, Ashok] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England	University of Oxford; University of Oxford	Choudhury, RP (corresponding author), Univ Oxford, Div Cardiovasc Med, Oxford, England.	robin.choudhury@cardiov.ox.ac.uk			British Heart Foundation; MRC [MR/K00266X/1] Funding Source: UKRI; Medical Research Council [MR/K00266X/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors' laboratory is supported by the British Heart Foundation; RPC is a Wellcome Trust Senior Research Fellow in Clinical Science; JTC is an MRC Clinical Research Training Fellow; the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL R, 1955, ARCH BIOCHEM BIOPHYS, V54, P558, DOI 10.1016/0003-9861(55)90070-9; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Bruckert E, 2010, ATHEROSCLEROSIS, V210, P353, DOI 10.1016/j.atherosclerosis.2009.12.023; Buechler C, 2001, BBA-MOL CELL BIOL L, V1532, P97, DOI 10.1016/S1388-1981(01)00121-4; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; CASHINHEMPHILL L, 1990, JAMA-J AM MED ASSOC, V264, P3013, DOI 10.1001/jama.264.23.3013; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P582, DOI 10.1161/ATVBAHA.111.236315; Digby JE, 2010, ATHEROSCLEROSIS, V209, P89, DOI 10.1016/j.atherosclerosis.2009.08.045; FATEMI SH, 1986, BIOMED BIOCHIM ACTA, V45, P539; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Kajita K, 2004, DIABETES RES CLIN PR, V66, pS79, DOI 10.1016/j.diabres.2003.09.022; Knowles HJ, 2006, BIOCHEM PHARMACOL, V71, P646, DOI 10.1016/j.bcp.2005.11.019; Kritharides L, 1998, ARTERIOSCL THROM VAS, V18, P1589, DOI 10.1161/01.ATV.18.10.1589; LACASA D, 1986, FEBS LETT, V202, P260, DOI 10.1016/0014-5793(86)80698-6; Lavigne PM, 2012, J AM COLL CARDIOL, V59, pE1687, DOI 10.1016/S0735-1097(12)61688-X; Lee JMS, 2009, J AM COLL CARDIOL, V54, P1787, DOI 10.1016/j.jacc.2009.06.036; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Masuda R, 2005, J NEUROSCI RES, V80, P501, DOI 10.1002/jnr.20464; Nuotio K, 2007, STROKE, V38, P1791, DOI 10.1161/STROKEAHA.106.478867; Offermanns S, 2006, TRENDS PHARMACOL SCI, V27, P384, DOI 10.1016/j.tips.2006.05.008; Offermanns S, 2011, PHARMACOL REV, V63, P269, DOI 10.1124/pr.110.003301; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ozasa H, 2011, ATHEROSCLEROSIS, V219, P141, DOI 10.1016/j.atherosclerosis.2011.07.113; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plutzky J, 2011, CIRC RES, V108, P1002, DOI 10.1161/CIRCRESAHA.110.226860; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Robinet P, 2010, J LIPID RES, V51, P3364, DOI 10.1194/jlr.D007336; Rosenson RS, 2012, AM HEART J, V164, P672, DOI 10.1016/j.ahj.2012.06.023; Rubic T, 2004, BIOCHEM PHARMACOL, V67, P411, DOI 10.1016/j.bcp.2003.09.014; Samoilova M, 2010, J NEUROCHEM, V113, P826, DOI 10.1111/j.1471-4159.2010.06645.x; SENIOR B, 1968, NATURE, V219, P83, DOI 10.1038/219083a0; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Taylor AJ, 2006, CURR MED RES OPIN, V22, P2243, DOI 10.1185/030079906X148508; Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Villines TC, 2012, CURR ATHEROSCLER REP, V14, P49, DOI 10.1007/s11883-011-0212-1; Villines TC, 2010, J AM COLL CARDIOL, V55, P2721, DOI 10.1016/j.jacc.2010.03.017; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wang XK, 1999, FEBS LETT, V462, P145, DOI 10.1016/S0014-5793(99)01521-5; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Wu ZH, 2009, PHARMACOLOGY, V84, P282, DOI 10.1159/000242999; Ye JP, 2008, BIOCHEM BIOPH RES CO, V374, P405, DOI 10.1016/j.bbrc.2008.07.068; Zhang YY, 2005, BIOCHEM BIOPH RES CO, V334, P729, DOI 10.1016/j.bbrc.2005.06.141	54	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62934	10.1371/journal.pone.0062934	http://dx.doi.org/10.1371/journal.pone.0062934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658787	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500045
J	Zhu, Z; Wang, JN; Sun, Z; Sun, XR; Wang, ZN; Xu, HM				Zhu, Zhi; Wang, Jinou; Sun, Zhe; Sun, Xuren; Wang, Zhenning; Xu, Huimian			Flotillin2 Expression Correlates with HER2 Levels and Poor Prognosis in Gastric Cancer	PLOS ONE			English	Article							BREAST-CANCER; DEOXYRIBONUCLEOSIDE KINASE; SURVIVAL; PROTEIN; MICROARRAYS; MELANOMA	Objective: Flotillin gene is known as a tumor promoter or suppressor, depending on the tumor type or tumor stage. We aimed to investigate the clinical significance of flotillin2 protein expression in gastric cancer. Methods: We examined flotillin2 and erbB2 levels in tissue microarray of 282 gastric cancer samples and analyzed the association between flotillin2 levels, clinicopathologic factors and prognosis. The regulation of erbB2 by flotillin2 was examined with flotillin2 siRNA-transfected gastric cancer cells. Results: Flotillin2 partially co-localized with erbB2 at the plasma membrane as detected by confocal microscopy, levels of erbB2 were reduced after flotillin knockdown in SGC-7901 cancer cells, and the expression of flotillin2 was positively correlated with that of erbB2. In non-neoplastic gastric mucosa, flotillin2 was not expressed in the epithelial compartment. In gastric cancer, positive staining of flotillin2 was shown in 129 (45.7%) of 282 cases, also, it was significantly associated with a Lauren grade, histologic type, lymphovascular invasion and tumor location. Moreover, survival analysis showed that flotillin2 expression was an independent prognostic factor of poor survival (p<0.001). Conclusions: These results indicate that a positive correlation exists between flotillin2 and erbB2 expression levels, flotillin2 maybe involved in the stabilization of erbB2 at the plasma membrane, flotillin2 is significantly correlated with cancer progression and poor prognosis in gastric cancer.	[Zhu, Zhi; Sun, Zhe; Wang, Zhenning; Xu, Huimian] China Med Univ, Hosp 1, Dept Gen Surg, Dept Surg Oncol, Shenyang, Peoples R China; [Wang, Jinou] China Med Univ, Dept Pathol, Shengjing Hosp, Shenyang, Peoples R China; [Sun, Xuren] China Med Univ, Hosp 1, Dept Digest, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Xu, HM (corresponding author), China Med Univ, Hosp 1, Dept Gen Surg, Dept Surg Oncol, Shenyang, Peoples R China.	xuhuimian@126.com	Gao, Peng/B-8031-2013; wang, zhen ning/E-1878-2011	wang, zhen ning/0000-0003-0557-3097	National Natural Science Foundation of China [81272718]; Young Scholars' Research Fund for the Doctoral Program of Higher Education of China [20122104120008]; Fund for Scientific Research of the First Hospital of China Medical University [FSFH1208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Scholars' Research Fund for the Doctoral Program of Higher Education of China; Fund for Scientific Research of the First Hospital of China Medical University	This work was supported by grants from the National Natural Science Foundation of China (81272718), Young Scholars' Research Fund for the Doctoral Program of Higher Education of China (20122104120008) and Fund for Scientific Research of the First Hospital of China Medical University (FSFH1208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaddii M, 2012, J BIOL CHEM, V287, P7265, DOI 10.1074/jbc.M111.287599; Berger T, 2012, ONCOGENE; Doherty SD, 2006, MELANOMA RES, V16, P461, DOI 10.1097/01.cmr.0000222592.75858.20; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Heskamp S, 2012, J NUCL MED, V53, P146, DOI 10.2967/jnumed.111.093047; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Punyadeera C, 2005, CELL MOL LIFE SCI, V62, P239, DOI 10.1007/s00018-004-4435-y; Pust S., 2012, ONCOGENE; Pust S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008844; Sasaki Y, 2008, MOL CANCER RES, V6, P395, DOI 10.1158/1541-7786.MCR-07-0108; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Takano N, 2002, CANCER LETT, V176, P129, DOI 10.1016/S0304-3835(01)00739-X; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Tomasovic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029739; Untch M, 2011, J CLIN ONCOL, V29, P3351, DOI 10.1200/JCO.2010.31.4930; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Zhao F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-479; Zhu Z, 2011, CANCER BIOL THER, V11, P874, DOI 10.4161/cbt.11.10.15182; Zhu Z, 2010, ANTICANCER RES, V30, P2641	21	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62365	10.1371/journal.pone.0062365	http://dx.doi.org/10.1371/journal.pone.0062365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658725	Green Published, Green Submitted, gold			2022-12-25	WOS:000321200500024
J	Kassambara, A; Schoenhals, M; Moreaux, J; Veyrune, JL; Reme, T; Goldschmidt, H; Hose, D; Klein, B				Kassambara, Alboukadel; Schoenhals, Matthieu; Moreaux, Jerome; Veyrune, Jean-Luc; Reme, Thierry; Goldschmidt, Hartmut; Hose, Dirk; Klein, Bernard			Inhibition of DEPDC1A, a Bad Prognostic Marker in Multiple Myeloma, Delays Growth and Induces Mature Plasma Cell Markers in Malignant Plasma Cells	PLOS ONE			English	Article							RISK-ADAPTED TREATMENT; GENE-EXPRESSION; MOLECULAR CLASSIFICATION; UP-REGULATION; MODEL; SIGNATURE; SURVIVAL; PREDICTION; PROTEIN; CANCER	High throughput DNA microarray has made it possible to outline genes whose expression in malignant plasma cells is associated with short overall survival of patients with Multiple Myeloma (MM). A further step is to elucidate the mechanisms encoded by these genes yielding to drug resistance and/or patients' short survival. We focus here on the biological role of the DEP (for Disheveled, EGL-10, Pleckstrin) domain contained protein 1A (DEPDC1A), a poorly known protein encoded by DEPDC1A gene, whose high expression in malignant plasma cells is associated with short survival of patients. Using conditional lentiviral vector delivery of DEPDC1A shRNA, we report that DEPDC1A knockdown delayed the growth of human myeloma cell lines (HMCLs), with a block in G2 phase of the cell cycle, p53 phosphorylation and stabilization, and p21(Cip1) accumulation. DEPDC1A knockdown also resulted in increased expression of mature plasma cell markers, including CXCR4, IL6-R and CD38. Thus DEPDC1A could contribute to the plasmablast features of MMCs found in some patients with adverse prognosis, blocking the differentiation of malignant plasma cells and promoting cell cycle.	[Kassambara, Alboukadel; Schoenhals, Matthieu; Reme, Thierry; Klein, Bernard] INSERM, U1040, Montpellier, France; [Moreaux, Jerome; Veyrune, Jean-Luc; Klein, Bernard] CHU Montpellier, Inst Res Biotherapy, Montpellier, France; [Goldschmidt, Hartmut; Hose, Dirk] Univ Klinikum Heidelberg, Med Klin 5, Heidelberg, Germany; [Goldschmidt, Hartmut; Hose, Dirk] Natl Ctr Tumorerkrankungen, Heidelberg, Germany; [Klein, Bernard] Univ Montpellier I, UFR Med, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Universite de Montpellier	Klein, B (corresponding author), INSERM, U1040, Montpellier, France.	bernard.klein@inserm.fr	moreaux, jerome/HGA-5649-2022; Goldschmidt, Hartmut/AAL-8069-2021; Schoenhals, Matthieu/AGC-8822-2022; J, Moreaux/ABA-2974-2021	J, Moreaux/0000-0002-5717-3207	ARC (Paris France) [SL220110603450]; European Community; Tumorzentrum Heidelberg/Mannheim, Germany; Deutsche Krebshilfe, Bonn, Germany; Deutsche Forschungsgemeinschaft, Bonn, Germany [Transregio TRR79]	ARC (Paris France); European Community(European Commission); Tumorzentrum Heidelberg/Mannheim, Germany; Deutsche Krebshilfe, Bonn, Germany(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG))	This work was supported by grants from ARC (SL220110603450, Paris France), the European Community (FP7-OVERMYR), the Tumorzentrum Heidelberg/Mannheim, Germany, and the Deutsche Krebshilfe, Bonn, Germany, the Deutsche Forschungsgemeinschaft, Transregio TRR79, Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Barlogie B, 2006, BLOOD, V107, P2633, DOI 10.1182/blood-2005-10-4084; Carrour TL, 2010, OPEN BIOINFORMATICS, V4, P5, DOI [10.2174/1875036201004010005, DOI 10.2174/1875036201004010005]; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Chiron D, 2012, BRIT J HAEMATOL, V156, P679, DOI 10.1111/j.1365-2141.2011.08904.x; Christensen JH, 2012, HAEMATOL-HEMATOL J, V97, pE18, DOI 10.3324/haematol.2011.043125; Cremer FW, 2005, GENE CHROMOSOME CANC, V44, P194, DOI 10.1002/gcc.20231; De Vos J, 2002, ONCOGENE, V21, P6848, DOI 10.1038/sj.onc.1205868; Decaux O, 2008, J CLIN ONCOL, V26, P4798, DOI 10.1200/JCO.2007.13.8545; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Greipp PR, 1998, BLOOD, V91, P2501, DOI 10.1182/blood.V91.7.2501.2501_2501_2507; GREIPP PR, 1985, BLOOD, V65, P305; Gu ZJ, 2000, LEUKEMIA, V14, P188, DOI 10.1038/sj.leu.2401632; Harada Y, 2010, CANCER RES, V70, P5829, DOI 10.1158/0008-5472.CAN-10-0255; Hill R, 2010, CELL CYCLE, V9, P3460, DOI 10.4161/cc.9.17.13043; Hose D, 2011, HAEMATOL-HEMATOL J, V96, P87, DOI 10.3324/haematol.2010.030296; Hose D, 2009, BLOOD, V113, P4331, DOI 10.1182/blood-2008-09-178350; Jego G, 1999, BLOOD, V94, P701, DOI 10.1182/blood.V94.2.701.414k16_701_712; Jourdan M, 2005, EUR CYTOKINE NETW, V16, P57; Jourdan M, 2011, J IMMUNOL, V187, P3931, DOI 10.4049/jimmunol.1101230; Jourdan M, 2009, BLOOD, V114, P5173, DOI 10.1182/blood-2009-07-235960; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Kanehira M, 2007, ONCOGENE, V26, P6448, DOI 10.1038/sj.onc.1210466; Kassambara A, 2012, HAEMATOL-HEMATOL J, V97, P622, DOI 10.3324/haematol.2011.046821; Kim D, 2012, LEUKEMIA, V26, P2530, DOI 10.1038/leu.2012.140; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Lemee F, 2010, P NATL ACAD SCI USA, V107, P13390, DOI 10.1073/pnas.0910759107; Lupo A, 2011, INT J BIOCHEM CELL B, V43, P470, DOI 10.1016/j.biocel.2010.12.020; Medugno L, 2005, GENE, V359, P35, DOI 10.1016/j.gene.2005.06.021; Moreaux J, 2005, BLOOD, V106, P1021, DOI 10.1182/blood-2004-11-4512; Moreaux J, 2011, HAEMATOL-HEMATOL J, V96, P574, DOI 10.3324/haematol.2010.033456; OKAYAMA H, 2011, CANC RES; Pillaire MJ, 2010, ONCOGENE, V29, P876, DOI 10.1038/onc.2009.378; Rebouissou C, 1998, BLOOD, V91, P4727, DOI 10.1182/blood.V91.12.4727.412k35_4727_4737; Reme T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-16; Seckinger A, 2009, ONCOGENE, V28, P3866, DOI 10.1038/onc.2009.257; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; ZHANG XG, 1994, BLOOD, V83, P3654	44	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62752	10.1371/journal.pone.0062752	http://dx.doi.org/10.1371/journal.pone.0062752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646139	Green Published, gold			2022-12-25	WOS:000319077300092
J	Heydari, H; Wee, WY; Lokanathan, N; Hari, R; Yusoff, AM; Beh, CY; Yazdi, AH; Wong, GJ; Ngeow, YF; Choo, SW				Heydari, Hamed; Wee, Wei Yee; Lokanathan, Naline; Hari, Ranjeev; Yusoff, Aini Mohamed; Beh, Ching Yew; Yazdi, Amir Hessam; Wong, Guat Jah; Ngeow, Yun Fong; Choo, Siew Woh			MabsBase: A Mycobacterium abscessus Genome and Annotation Database	PLOS ONE			English	Article							SEQUENCE; MASSILIENSE; INFECTION; BOLLETII	Mycobacterium abscessus is a rapidly growing non-tuberculous mycobacterial species that has been associated with a wide spectrum of human infections. As the classification and biology of this organism is still not well understood, comparative genomic analysis on members of this species may provide further insights on their taxonomy, phylogeny, pathogenicity and other information that may contribute to better management of infections. The MabsBase described in this paper is a user-friendly database providing access to whole-genome sequences of newly discovered M. abscessus strains as well as resources for whole-genome annotations and computational predictions, to support the expanding scientific community interested in M. abscessus research. The MabsBase is freely available at http://mabscessus.um.edu.my.	[Ngeow, Yun Fong] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Heydari, Hamed; Wee, Wei Yee; Lokanathan, Naline; Hari, Ranjeev; Yusoff, Aini Mohamed; Beh, Ching Yew; Yazdi, Amir Hessam; Wong, Guat Jah; Choo, Siew Woh] Univ Malaya, Fac Dent, Dent Res & Training Unit, Kuala Lumpur, Malaysia; [Heydari, Hamed] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Software Engn, Kuala Lumpur, Malaysia; [Yazdi, Amir Hessam] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Comp Syst & Technol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Choo, SW (corresponding author), Univ Malaya, Fac Dent, Dent Res & Training Unit, Kuala Lumpur, Malaysia.	lchoo@um.edu.my	Choo, Siew Woh/E-3406-2010; NGEOW, YUN FONG/B-9237-2010	Ngeow, Yun Fong/0000-0002-1011-762X	Ministry of Higher Education; University of Malaya, Malaysia [UM.C/HIR/MOHE/08, UM.C/625/1/HIR/004]	Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); University of Malaya, Malaysia(Universiti Malaya)	This work was supported by the Ministry of Higher Education and University of Malaya [grant numbers UM.C/HIR/MOHE/08, UM.C/625/1/HIR/004], Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Choo SW, 2012, J BACTERIOL, V194, P5724, DOI 10.1128/JB.01407-12; Choo SW, 2012, J BACTERIOL, V194, P5128, DOI 10.1128/JB.01096-12; Choo SW, 2012, J BACTERIOL, V194, P4778, DOI 10.1128/JB.01043-12; Choo SW, 2012, J BACTERIOL, V194, P3278, DOI 10.1128/JB.00492-12; Esther CR, 2010, J CYST FIBROS, V9, P117, DOI 10.1016/j.jcf.2009.12.001; GRIFFITH DE, 1993, AM REV RESPIR DIS, V147, P1271, DOI 10.1164/ajrccm/147.5.1271; Kim HY, 2010, MICROBIOL IMMUNOL, V54, P347, DOI 10.1111/j.1348-0421.2010.00221.x; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; KUSUNOKI S, 1992, INT J SYST BACTERIOL, V42, P240, DOI 10.1099/00207713-42-2-240; Laing C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-461; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Meyer F, 2009, NUCLEIC ACIDS RES, V37, P6643, DOI 10.1093/nar/gkp698; MOORE M, 1953, J INVEST DERMATOL, V20, P133, DOI 10.1038/jid.1953.18; Ngeow YF, 2012, J BACTERIOL, V194, P6662, DOI 10.1128/JB.01846-12; Ngeow YF, 2012, J BACTERIOL, V194, P6002, DOI 10.1128/JB.01455-12; Ngeow YF, 2012, J BACTERIOL, V194, P4786, DOI 10.1128/JB.01104-12; Ngeow YF, 2012, J BACTERIOL, V194, P4125, DOI 10.1128/JB.00712-12; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Sanguinetti M, 2001, J CLIN MICROBIOL, V39, P816, DOI 10.1128/JCM.39.2.816-819.2001; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Varshney RK, 2012, FIELD CROP RES, V126, P171, DOI 10.1016/j.fcr.2011.10.008; Wong VL, 2012, J BACTERIOL, V194, P4475, DOI 10.1128/JB.00916-12; Yakrus MA, 2001, J CLIN MICROBIOL, V39, P4103, DOI 10.1128/JCM.39.11.4103-4110.2001; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	28	25	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62443	10.1371/journal.pone.0062443	http://dx.doi.org/10.1371/journal.pone.0062443			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658631	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800046
J	Jauregui, AR; Savalia, D; Lowry, VK; Farrell, CM; Wathelet, MG				Jauregui, Andrew R.; Savalia, Dhruti; Lowry, Virginia K.; Farrell, Cara M.; Wathelet, Marc G.			Identification of Residues of SARS-CoV nsp1 That Differentially Affect Inhibition of Gene Expression and Antiviral Signaling	PLOS ONE			English	Article							I INTERFERON; CORONAVIRUS; PROTEIN; INDUCTION; DOMAIN	An epidemic of Severe Acute Respiratory Syndrome (SARS) led to the identification of an associated coronavirus, SARS-CoV. This virus evades the host innate immune response in part through the expression of its non-structural protein (nsp) 1, which inhibits both host gene expression and virus-and interferon (IFN)-dependent signaling. Thus, nsp1 is a promising target for drugs, as inhibition of nsp1 would make SARS-CoV more susceptible to the host antiviral defenses. To gain a better understanding of nsp1 mode of action, we generated and analyzed 38 mutants of the SARS-CoV nsp1, targeting 62 solvent exposed residues out of the 180 amino acid protein. From this work, we identified six classes of mutants that abolished, attenuated or increased nsp1 inhibition of host gene expression and/or antiviral signaling. Each class of mutants clustered on SARS-CoV nsp1 surface and suggested nsp1 interacts with distinct host factors to exert its inhibitory activities. Identification of the nsp1 residues critical for its activities and the pathways involved in these activities should help in the design of drugs targeting nsp1. Significantly, several point mutants increased the inhibitory activity of nsp1, suggesting that coronaviruses could evolve a greater ability to evade the host response through mutations of such residues.	[Jauregui, Andrew R.; Savalia, Dhruti; Lowry, Virginia K.; Farrell, Cara M.; Wathelet, Marc G.] Lovelace Resp Res Inst, Program Infect Dis, Albuquerque, NM USA; [Wathelet, Marc G.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico	Wathelet, MG (corresponding author), Lovelace Resp Res Inst, Program Infect Dis, Albuquerque, NM USA.	mwathelet@lrri.org			National Institutes of Health [RO1 HL084171, HL084171-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants RO1 HL084171 and HL084171-S1 to MGW ( http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Agol VI, 2010, NAT REV MICROBIOL, V8, P867, DOI 10.1038/nrmicro2452; Almeida MS, 2007, J VIROL, V81, P3151, DOI 10.1128/JVI.01939-06; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Fang XN, 2007, J MED VIROL, V79, P1431, DOI 10.1002/jmv.20953; Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Harlow E., 1988, ANTIBODIES LAB MANUA; Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Li SW, 2011, J GEN VIROL, V92, P1127, DOI 10.1099/vir.0.028936-0; Lu XL, 2011, VIRUS GENES, V42, P37, DOI 10.1007/s11262-010-0544-x; Minakshi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008342; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Osterhaus ADME, 2004, PHILOS T ROY SOC B, V359, P1081, DOI 10.1098/rstb.2004.1489; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Pfefferle S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002331; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030802; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Wang YJ, 2010, INFECT GENET EVOL, V10, P919, DOI 10.1016/j.meegid.2010.05.014; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wevers BA, 2009, CLIN LAB MED, V29, P715, DOI 10.1016/j.cll.2009.07.007; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Yang HM, 2002, EUR J BIOCHEM, V269, P6142, DOI 10.1046/j.1432-1033.2002.03330.x; Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109	45	54	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62416	10.1371/journal.pone.0062416	http://dx.doi.org/10.1371/journal.pone.0062416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658627	gold, Green Published, Green Submitted			2022-12-25	WOS:000321662800043
J	Kempf, C; Staudt, T; Bingen, P; Horstmann, H; Engelhardt, J; Hell, SW; Kuner, T				Kempf, Christian; Staudt, Thorsten; Bingen, Pit; Horstmann, Heinz; Engelhardt, Johann; Hell, Stefan W.; Kuner, Thomas			Tissue Multicolor STED Nanoscopy of Presynaptic Proteins in the Calyx of Held	PLOS ONE			English	Article							GTP-BINDING PROTEIN; ACTIVE ZONE; SYNAPTIC VESICLES; RELEASE; RECONSTRUCTION; LOCALIZATION; MICROSCOPY; POOL	The calyx of Held, a large glutamatergic terminal in the mammalian auditory brainstem has been extensively employed to study presynaptic structure and function in the central nervous system. Nevertheless, the nanoarchitecture of presynaptic proteins and subcellular components in the calyx terminal and its relation to functional properties of synaptic transmission is only poorly understood. Here, we use stimulated emission depletion (STED) nanoscopy of calyces in thin sections of aldehyde-fixed rat brain tissue to visualize immuno-labeled synaptic proteins including VGluT1, synaptophysin, Rab3A and synapsin with a lateral resolution of approximately 40 nm. Excitation multiplexing of suitable fluorescent dyes deciphered the spatial arrangement of the presynaptic phospho-protein synapsin relative to synaptic vesicles labeled with anti-VGluT1. Both predominantly occupied the same focal volume, yet may exist in exclusive domains containing either VGluT1 or synapsin immunoreactivity. While the latter have been observed with diffraction-limited fluorescence microscopy, STED microscopy for the first time revealed VGluT1-positive domains lacking synapsins. This observation supports the hypothesis that molecularly and structurally distinct synaptic vesicle pools operate in presynaptic nerve terminals.	[Kempf, Christian; Horstmann, Heinz; Kuner, Thomas] Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany; [Staudt, Thorsten; Bingen, Pit; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany; [Staudt, Thorsten; Bingen, Pit; Engelhardt, Johann; Hell, Stefan W.] Heidelberg Univ, Bioquant Ctr, Heidelberg, Germany; [Staudt, Thorsten; Bingen, Pit; Engelhardt, Johann; Hell, Stefan W.] German Canc Res Ctr, Opt Nanoscopy Div, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Kuner, T (corresponding author), Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany.	kuner@uni-heidelberg.de			CellNetworks Cluster of Excellence [EXC81]	CellNetworks Cluster of Excellence	This work has been partially supported by the CellNetworks Cluster of Excellence (EXC81, T.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ayelet O, 2012, J NEUROCHEM, V120, P248, DOI 10.1111/j.1471-4159.2011.07579.x; Billups B, 2005, NEUROSCI LETT, V382, P66, DOI 10.1016/j.neulet.2005.02.071; Borst JGG, 2012, ANNU REV PHYSIOL, V74, P199, DOI 10.1146/annurev-physiol-020911-153236; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Denker A, 2010, FRONTIERS SYNAPTIC N, V2; Denker A, 2011, P NATL ACAD SCI USA, V108, P17183, DOI 10.1073/pnas.1112690108; Dondzillo A, 2010, J COMP NEUROL, V518, P1008, DOI 10.1002/cne.22260; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; MIZOGUCHI A, 1990, J BIOL CHEM, V265, P11872; Pavlos Nathan J, 2011, Small GTPases, V2, P77; Punge A, 2008, MICROSC RES TECHNIQ, V71, P644, DOI 10.1002/jemt.20602; Satzler K, 2002, J NEUROSCI, V22, P10567; Schmidt R, 2008, NAT METHODS, V5, P539, DOI 10.1038/nmeth.1214; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Vasileva M, 2012, EUROPEAN J NEUROSCIE; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; Welzel O, 2011, BIOPHYS J, V100, P593, DOI 10.1016/j.bpj.2010.12.3706	22	25	25	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62893	10.1371/journal.pone.0062893	http://dx.doi.org/10.1371/journal.pone.0062893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658655	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700079
J	Hurst, JH; Dohlman, HG				Hurst, Jillian H.; Dohlman, Henrik G.			Dynamic Ubiquitination of the Mitogen-activated Protein Kinase Kinase (MAPKK) Ste7 Determines Mitogen-activated Protein Kinase (MAPK) Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PHEROMONE RESPONSE PATHWAY; SIGNALING SPECIFICITY; DEUBIQUITINATING ENZYMES; FILAMENTOUS-GROWTH; INVASIVE GROWTH; POSTTRANSLATIONAL MODIFICATIONS; FEEDBACK PHOSPHORYLATION; DIFFERENTIAL REGULATION; CAENORHABDITIS-ELEGANS	Ubiquitination is a post-translational modification that tags proteins for proteasomal degradation. In addition, there is a growing appreciation that ubiquitination can influence protein activity and localization. Ste7 is a prototype MAPKK in yeast that participates in both the pheromone signaling and nutrient deprivation/invasive growth pathways. We have shown previously that Ste7 is ubiquitinated upon pheromone stimulation. Here, we show that the Skp1/Cullin/F-box ubiquitin ligase SCFCdc4 and the ubiquitin protease Ubp3 regulate Ste7 ubiquitination and signal specificity. Using purified components, we demonstrate that SCFCdc4 ubiquitinates Ste7 directly. Using gene deletion mutants, we show that SCFCdc4 and Ubp3 have opposing effects on Ste7 ubiquitination. Although SCFCdc4 is necessary for proper activation of the pheromone MAPK Fus3, Ubp3 is needed to limit activation of the invasive growth MAPK Kss1. Finally, we show that Fus3 phosphorylates Ubp3 directly and that phosphorylation of Ubp3 is necessary to limit Kss1 activation. These results reveal a feedback loop wherein one MAPK limits the ubiquitination of an upstream MAPKK and thereby prevents spurious activation of a second competing MAPK.	[Hurst, Jillian H.; Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, 3049 Genet Med Bldg,Campus Box 7260, Chapel Hill, NC 27599 USA.	henrik_dohlman@med.unc.edu		Hurst, Jillian/0000-0001-5079-9920; Dohlman, Henrik/0000-0003-2443-0729	National Institutes of Health Ruth L. Kirschstein National Research Service Award [GM096597]; NIGMS [R01-GM059167]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096597, R01GM059167] Funding Source: NIH RePORTER	National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Ruth L. Kirschstein National Research Service Award GM096597 (to J. H. H.) and Grant R01-GM059167 from NIGMS (to H. G. D.).	Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; BARDWELL L, 1994, DEV BIOL, V166, P363, DOI 10.1006/dbio.1994.1323; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; Bruckner S, 2004, CURR GENET, V46, P331, DOI 10.1007/s00294-004-0545-1; Cappell SD, 2011, J BIOL CHEM, V286, P14852, DOI 10.1074/jbc.M110.195073; Cappell SD, 2010, MOL CELL, V38, P746, DOI 10.1016/j.molcel.2010.05.026; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chasse SA, 2004, METHOD ENZYMOL, V389, P399; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; DRISCOLL JJ, 2012, SEMIN HEMATOL, V49, P277, DOI DOI 10.1053/j.seminhematol.2012.04.002; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Errede B, 1993, CURR OPIN CELL BIOL, V5, P254, DOI 10.1016/0955-0674(93)90112-4; Farley FW, 1999, GENETICS, V151, P1425; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fischer JA, 2002, BIOESSAYS, V24, P13, DOI 10.1002/bies.10030; Gagiano M, 2002, FEMS YEAST RES, V2, P433, DOI 10.1016/S1567-1356(02)00133-2; Garrenton LS, 2006, GENE DEV, V20, P1946, DOI 10.1101/gad.1413706; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; Garrenton LS, 2009, MOL CELL BIOL, V29, P582, DOI 10.1128/MCB.01019-08; Garrison TR, 1999, J BIOL CHEM, V274, P36387, DOI 10.1074/jbc.274.51.36387; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; Hao N, 2007, ONCOGENE, V26, P3254, DOI 10.1038/sj.onc.1210416; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hao N, 2012, MOL BIOL CELL, V23, P3899, DOI 10.1091/mbc.E12-04-0333; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Inuzuka H, 2010, ONCOTARGET, V1, P685; Jung YS, 2012, FEBS LETT, V586, P1397, DOI 10.1016/j.febslet.2012.03.052; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; LEVIN DE, 1995, CURR OPIN CELL BIOL, V7, P197, DOI 10.1016/0955-0674(95)80028-X; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; Mao P, 2010, J BIOL CHEM, V285, P37542, DOI 10.1074/jbc.M110.170175; Maruyama S, 2001, GENOMICS, V78, P214, DOI 10.1006/geno.2001.6658; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Mocciaro A, 2012, J CELL SCI, V125, P255, DOI 10.1242/jcs.091199; Molina M, 2010, YEAST, V27, P503, DOI 10.1002/yea.1791; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Palecek SP, 2002, MICROBIOL-SGM, V148, P893, DOI 10.1099/00221287-148-4-893; Parnell SC, 2005, BIOCHEMISTRY-US, V44, P8159, DOI 10.1021/bi0503091; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; Posas F, 1998, CURR OPIN MICROBIOL, V1, P175, DOI 10.1016/S1369-5274(98)80008-8; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Randles L, 2012, FRONT BIOSCI-LANDMRK, V17, P2140, DOI 10.2741/4042; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Silverman JS, 2012, TRENDS BIOCHEM SCI, V37, P66, DOI 10.1016/j.tibs.2011.10.004; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sole C, 2011, EMBO J, V30, P3274, DOI 10.1038/emboj.2011.227; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Wang GC, 2012, CHIN J CANCER, V31, P169, DOI 10.5732/cjc.011.10319; Wang Y., 2002, J BIOL CHEM; Wang YQ, 2006, J BIOL CHEM, V281, P1964, DOI 10.1074/jbc.M508985200; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Wang YQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007456; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Whelan JT, 2012, J CELL PHYSIOL, V227, P1235, DOI 10.1002/jcp.22899; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wing SS, 2003, INT J BIOCHEM CELL B, V35, P590, DOI 10.1016/S1357-2725(02)00392-8; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Yang WL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003197; Yang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055833; Yoon S, 2003, J BIOL CHEM, V278, P2131, DOI 10.1074/jbc.M209905200; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200	89	13	13	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18660	18671		10.1074/jbc.M113.475707	http://dx.doi.org/10.1074/jbc.M113.475707			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23645675	hybrid, Green Published			2022-12-25	WOS:000321335800003
J	Chertova, E; Bergamaschi, C; Chertov, O; Sowder, R; Bear, J; Roser, JD; Beach, RK; Lifson, JD; Felber, BK; Pavlakis, GN				Chertova, Elena; Bergamaschi, Cristina; Chertov, Oleg; Sowder, Raymond; Bear, Jenifer; Roser, James D.; Beach, Rachel K.; Lifson, Jeffrey D.; Felber, Barbara K.; Pavlakis, George N.			Characterization and Favorable in Vivo Properties of Heterodimeric Soluble IL-15 center dot IL-15R alpha Cytokine Compared to IL-15 Monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD8(+) T-CELLS; RECEPTOR-ALPHA-CHAIN; NATURAL-KILLER-CELLS; SIGNAL PEPTIDE; INTERLEUKIN (IL)-15; ESTABLISHED TUMORS; TRANS PRESENTATION; NONHUMAN-PRIMATES; RHESUS MACAQUES; CD4(+) CELLS	Interleukin-15 (IL-15), a 114-amino acid cytokine related to IL-2, regulates immune homeostasis and the fate of many lymphocyte subsets. We reported that, in the blood of mice and humans, IL-15 is present as a heterodimer associated with soluble IL-15 receptor alpha (sIL-15R alpha). Here, we show efficient production of this noncovalently linked but stable heterodimer in clonal human HEK293 cells and release of the processed IL-15 center dot sIL-15R alpha heterodimer in the medium. Purification of the IL-15 and sIL-15R alpha polypeptides allowed identification of the proteolytic cleavage site of IL-15R alpha and characterization of multiple glycosylation sites. Administration of the IL-15 center dot sIL-15R alpha heterodimer reconstituted from purified subunits resulted in sustained plasma IL-15 levels and in robust expansion of NK and T cells in mice, demonstrating pharmacokinetics and in vivo bioactivity superior to single chain IL-15. These identified properties of heterodimeric IL-15 provide a strong rationale for the evaluation of this molecule for clinical applications.	[Chertova, Elena; Sowder, Raymond; Roser, James D.; Lifson, Jeffrey D.] Frederick Natl Lab, AIDS & Canc Virus Program, Ft Detrick, MD 21702 USA; [Chertov, Oleg] Frederick Natl Lab, Prot Chem Lab, Adv Technol Program, SAIC Frederick Inc, Ft Detrick, MD 21702 USA; [Bergamaschi, Cristina; Beach, Rachel K.; Pavlakis, George N.] NCI, Ctr Canc Res, Vaccine Branch, Human Retrovirus Sect, Frederick, MD 21702 USA; [Bear, Jenifer; Beach, Rachel K.; Felber, Barbara K.] NCI, Ctr Canc Res, Vaccine Branch, Human Retrovirus Pathogenesis Sect, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pavlakis, GN (corresponding author), NCI, Ctr Canc Res, Vaccine Branch, Human Retrovirus Sect, Frederick, MD 21702 USA.	pavlakig@mail.nih.gov			Intramural Research Program, National Cancer Institute, National Institutes of Health (NCI/National Institutes of Health); National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010750, ZIABC010350, ZIABC010334] Funding Source: NIH RePORTER	Intramural Research Program, National Cancer Institute, National Institutes of Health (NCI/National Institutes of Health); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program, National Cancer Institute, National Institutes of Health (NCI/National Institutes of Health) and federal funds from the National Cancer Institute, National Institutes of Health, under contract number HHSN261200800001E.	ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; Bamford RN, 1998, J IMMUNOL, V160, P4418; Beq S, 2009, BLOOD, V114, P816, DOI 10.1182/blood-2008-11-191288; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Bergamaschi C, 2008, J BIOL CHEM, V283, P4189, DOI 10.1074/jbc.M705725200; Bergamaschi C, 2012, BLOOD, V120, pE1, DOI 10.1182/blood-2011-10-384362; Bergamaschi C, 2009, J IMMUNOL, V183, P3064, DOI 10.4049/jimmunol.0900693; Berger C, 2009, BLOOD, V114, P2417, DOI 10.1182/blood-2008-12-189266; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Chamorey AL, 2002, EUR CYTOKINE NETW, V13, P154; Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x; Chirifu M, 2007, NAT IMMUNOL, V8, P1001, DOI 10.1038/ni1492; Croce M, 2012, IMMUNOTHERAPY-UK, V4, P957, DOI [10.2217/IMT.12.92, 10.2217/imt.12.92]; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Dubois S, 1999, J BIOL CHEM, V274, P26978, DOI 10.1074/jbc.274.38.26978; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Duitman EH, 2008, MOL CELL BIOL, V28, P4851, DOI 10.1128/MCB.02178-07; Epardaud M, 2008, CANCER RES, V68, P2972, DOI 10.1158/0008-5472.CAN-08-0045; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; Gonzalez-Alvaro I, 2003, CLIN EXP RHEUMATOL, V21, P639; GRIBBEN JG, 1990, LANCET, V335, P434, DOI 10.1016/0140-6736(90)90665-R; Han KP, 2011, CYTOKINE, V56, P804, DOI 10.1016/j.cyto.2011.09.028; Jalah R, 2007, DNA CELL BIOL, V26, P827, DOI 10.1089/dna.2007.0645; Karpusas M, 1998, CELL MOL LIFE SCI, V54, P1203, DOI 10.1007/s000180050248; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Kurys G, 2000, J BIOL CHEM, V275, P30653, DOI 10.1074/jbc.M002373200; Lugli E, 2010, BLOOD, V116, P3238, DOI 10.1182/blood-2010-03-275438; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Onu A, 1997, J IMMUNOL, V158, P255; Perales MA, 2012, BLOOD, V120, P4882, DOI 10.1182/blood-2012-06-437236; Picker LJ, 2006, J CLIN INVEST, V116, P1514, DOI 10.1172/JCI27564; Querol S, 1999, HAEMATOLOGICA, V84, P493; Rentzos M, 2006, J NEUROL SCI, V241, P25, DOI 10.1016/j.jns.2005.10.003; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Rubinstein MP, 2002, J IMMUNOL, V169, P4928, DOI 10.4049/jimmunol.169.9.4928; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sneller MC, 2011, BLOOD, V118, P6845, DOI 10.1182/blood-2011-09-377804; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; Tagaya Y, 1997, P NATL ACAD SCI USA, V94, P14444, DOI 10.1073/pnas.94.26.14444; TAKEUCHI M, 1991, Glycobiology, V1, P337, DOI 10.1093/glycob/1.4.337; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359; Vyas VV, 2012, BIOTECHNOL PROGR, V28, P497, DOI 10.1002/btpr.746; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Waldmann TA, 2011, BLOOD, V117, P4787, DOI 10.1182/blood-2010-10-311456; Zhang ML, 2009, P NATL ACAD SCI USA, V106, P7513, DOI 10.1073/pnas.0902637106; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	60	66	80	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18093	18103		10.1074/jbc.M113.461756	http://dx.doi.org/10.1074/jbc.M113.461756			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649624	Green Published, hybrid			2022-12-25	WOS:000320721900015
J	Silva, PN; Altamentova, SM; Kilkenny, DM; Rocheleau, JV				Silva, Pamuditha N.; Altamentova, Svetlana M.; Kilkenny, Dawn M.; Rocheleau, Jonathan V.			Fibroblast Growth Factor Receptor Like-1 (FGFRL1) Interacts with SHP-1 Phosphatase at Insulin Secretory Granules and Induces Beta-cell ERK1/2 Protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL EXPRESSION; FLUORESCENT PROTEIN; DYNAMICS; MOUSE; PROLIFERATION; TRAFFICKING; PATHWAY; PHOGRIN; ATLAS	FGFRL1 is a newly identified member of the fibroblast growth factor receptor (FGFR) family expressed in adult pancreas. Unlike canonical FGFRs that initiate signaling via tyrosine kinase domains, the short intracellular sequence of FGFRL1 consists of a putative Src homology domain-2 (SH2)-binding motif adjacent to a histidine-rich C terminus. As a consequence of nonexistent kinase domains, FGFRL1 has been postulated to act as a decoy receptor to inhibit canonical FGFR ligand-induced signaling. In pancreatic islet beta-cells, canonical FGFR1 signaling affects metabolism and insulin processing. This study determined beta-cell expression of FGFRL1 as well as consequent effects on FGFR1 signaling and biological responses. We confirmed FGFRL1 expression at the plasma membrane and within distinct intracellular granules of both primary beta-cells and beta TC3 cells. Fluorescent protein-tagged FGFRL1 (RL1) induced a significant ligand-independent increase in MAPK signaling. Removal of the histidine-rich domain (RL1-Delta His) or entire intracellular sequence (RL1-Delta C) resulted in greater retention at the plasma membrane and significantly reduced ligand-independent ERK1/2 responses. The SHP-1 phosphatase was identified as an RL1-binding substrate. Point mutation of the SH2-binding motif reduced the ability of FGFRL1 to bind SHP-1 and activate ERK1/2 but did not affect receptor localization to insulin secretory granules. Finally, overexpression of RL1 increased cellular insulin content and matrix adhesion. Overall, these data suggest that FGFRL1 does not function as a decoy receptor in beta-cells, but rather it enhances ERK1/2 signaling through association of SHP-1 with the receptor's intracellular SH2-binding motif.	[Silva, Pamuditha N.; Kilkenny, Dawn M.; Rocheleau, Jonathan V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Altamentova, Svetlana M.; Rocheleau, Jonathan V.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 2M9, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Kilkenny, DM (corresponding author), Univ Toronto, Rosebrugh Bldg,164 Coll St,Rm 407, Toronto, ON M5G 1L7, Canada.	dawn.kilkenny@utoronto.ca; jon.rocheleau@utoronto.ca		Rocheleau, Jonathan/0000-0002-1760-2564	Canadian Institutes of Health Research Bridge Fund Grant [NMD106997]; Natural Sciences and Engineering Research Council of Canada Discovery Grant; Novo-Nordisk student scholarship from the University of Toronto Faculty of Medicine Banting; Novo-Nordisk student scholarship from the University of Toronto Faculty of Medicine Banting and Best Diabetes Centre	Canadian Institutes of Health Research Bridge Fund Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Novo-Nordisk student scholarship from the University of Toronto Faculty of Medicine Banting; Novo-Nordisk student scholarship from the University of Toronto Faculty of Medicine Banting and Best Diabetes Centre	This work was supported by Canadian Institutes of Health Research Bridge Fund Grant NMD106997 (to J. V. R. and D. M. K.), a Natural Sciences and Engineering Research Council of Canada Discovery Grant (to J. V. R.), and a Novo-Nordisk student scholarship from the University of Toronto Faculty of Medicine Banting and Best Diabetes Centre (to P. N. S.). The confocal microscope used in these studies was purchased using a CFI Leaders Opportunity Fund Grant (to J. V. R.).	Aksamitiene E, 2010, CELL SIGNAL, V22, P1369, DOI 10.1016/j.cellsig.2010.05.006; Albrecht DS, 2008, CHEM-BIOL INTERACT, V171, P89, DOI 10.1016/j.cbi.2007.09.001; Arany E, 2000, PEDIATR RES, V48, P389, DOI 10.1203/00006450-200009000-00023; Bapat S, 2001, FEBS LETT, V499, P21, DOI 10.1016/S0014-5793(01)02511-X; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Beazely MA, 2009, J BIOL CHEM, V284, P8054, DOI 10.1074/jbc.M805384200; Burren OS, 2011, NUCLEIC ACIDS RES, V39, pD997, DOI 10.1093/nar/gkq912; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dichmann DS, 2003, DEV DYNAM, V226, P663, DOI 10.1002/dvdy.10270; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Haugsten EM, 2005, J CELL SCI, V118, P3869, DOI 10.1242/jcs.02509; Hiriart M, 2001, ISRAEL MED ASSOC J, V3, P114; Hughes SE, 1997, J HISTOCHEM CYTOCHEM, V45, P1005, DOI 10.1177/002215549704500710; HUTTON JC, 1983, BIOCHEM J, V210, P297, DOI 10.1042/bj2100297; Kilkenny DM, 2008, MOL ENDOCRINOL, V22, P196, DOI 10.1210/me.2007-0241; Kim I, 2001, BBA-GENE STRUCT EXPR, V1518, P152, DOI 10.1016/S0167-4781(00)00282-7; MANDERS EMM, 1992, J CELL SCI, V103, P857; Micou M. K., 2012, LAB COURSE TISSUE EN; Ming AYK, 2012, J BIOL CHEM, V287, P19997, DOI 10.1074/jbc.M111.325670; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Pouli AE, 1998, BIOCHEM J, V333, P193, DOI 10.1042/bj3330193; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Rankin MM, 2010, ISLETS, V2, P345, DOI 10.4161/isl.2.6.13376; Rieckmann T, 2008, EXP CELL RES, V314, P1071, DOI 10.1016/j.yexcr.2007.10.029; Rieckmann T, 2009, BBA-MOL BASIS DIS, V1792, P112, DOI 10.1016/j.bbadis.2008.11.006; Rivas-Carrillo JD, 2006, CELL TRANSPLANT, V15, P939, DOI 10.3727/000000006783981323; Seymour PA, 2012, DEVELOPMENT, V139, P3363, DOI 10.1242/dev.078733; Sleeman M, 2001, GENE, V271, P171, DOI 10.1016/S0378-1119(01)00518-2; Steinberg F, 2010, J BIOL CHEM, V285, P2193, DOI 10.1074/jbc.M109.058248; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suckalel J, 2010, TRENDS ENDOCRIN MET, V21, P599, DOI 10.1016/j.tem.2010.06.003; Sun MY, 2012, BIOPHYS J, V103, P2379, DOI 10.1016/j.bpj.2012.10.028; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tapinos N, 2005, P NATL ACAD SCI USA, V102, P9188, DOI 10.1073/pnas.0501196102; Trueb B, 2003, J BIOL CHEM, V278, P33857, DOI 10.1074/jbc.M300281200; Trueb B, 2011, CELL MOL LIFE SCI, V68, P951, DOI 10.1007/s00018-010-0576-3; Wang W, 2011, J CELL BIOCHEM, V112, P2062, DOI 10.1002/jcb.23125; Wasmeier C, 1996, J BIOL CHEM, V271, P18161, DOI 10.1074/jbc.271.30.18161; Wiedemann M, 2000, GENOMICS, V69, P275, DOI 10.1006/geno.2000.6332; Xu XF, 2011, MECH DEVELOP, V128, P412, DOI 10.1016/j.mod.2011.08.001; Zhen Y, 2007, ONCOGENE, V26, P6372, DOI 10.1038/sj.onc.1210473; Zhuang L, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-33; Zinchuk O, 2004, CELL TISSUE RES, V317, P265, DOI 10.1007/s00441-004-0919-1	45	36	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17859	17870		10.1074/jbc.M112.440677	http://dx.doi.org/10.1074/jbc.M112.440677			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640895	Green Published, hybrid			2022-12-25	WOS:000320380600074
J	Ren, XF; Nevo, E; Sun, DF; Sun, GL				Ren, Xifeng; Nevo, Eviatar; Sun, Dongfa; Sun, Genlou			Tibet as a Potential Domestication Center of Cultivated Barley of China	PLOS ONE			English	Article							GRAIN PROTEIN-CONTENT; GENETIC DIVERSITY ANALYSIS; WILD CLOSE RELATIVES; THIOREDOXIN; SEQUENCE; ORIGIN; EAST; EVOLUTION; POLYMORPHISM; POPULATIONS	The importance of wild barley from Qinghai-Tibet Plateau in the origin and domestication of cultivated barley has long been underestimated. Population-based phylogenetic analyses were performed to study the origin and genetic diversity of Chinese domesticated barley, and address the possibility that the Tibetan region in China was an independent center of barley domestication. Wild barley (Hordeum vulgare ssp. spontaneum) populations from Southwest Asia, Central Asia, and Tibet along with domesticated barley from China were analyzed using two nuclear genes. Our results showed that Tibetan wild barley distinctly diverged from Southwest Asian (Near East) wild barley, that Central Asian wild barley is related to Southwest Asian wild barley, and that Chinese domesticated barley shares the same haplotypes with Tibetan wild barley. Phylogenetic analysis showed a close relationship between Chinese domesticated barley and the Tibetan wild barley, suggesting that Tibetan wild barley was the ancestor of Chinese domesticated barley. Our results favor the polyphyletic origin for cultivated barley.	[Ren, Xifeng; Sun, Dongfa; Sun, Genlou] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Ren, Xifeng; Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada; [Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel	Huazhong Agricultural University; Saint Marys University - Canada; University of Haifa	Sun, DF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	sundongfa1@mail.hzau.edu.cn; genlou.sun@smu.ca			National Natural Science Foundation of China [31228017]; Postdoctoral Science Foundation [2012M511627]; earmarked fund for China Agriculture Research System [CARS-5]; Natural Sciences and Engineering Research Council of Canada [238425]; Senate Research Grant at Saint Mary's University, Canada	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation(China Postdoctoral Science Foundation); earmarked fund for China Agriculture Research System; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Senate Research Grant at Saint Mary's University, Canada	This project was supported in part by the National Natural Science Foundation of China (31228017), the Postdoctoral Science Foundation (2012M511627), an earmarked fund for China Agriculture Research System (CARS-5), a discovery grant (238425) from the Natural Sciences and Engineering Research Council of Canada, and a Senate Research Grant at Saint Mary's University, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhaguvel P, 2007, ANN BOT-LONDON, V100, P1009, DOI 10.1093/aob/mcm129; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Balmer Y, 2006, P NATL ACAD SCI USA, V103, P2988, DOI 10.1073/pnas.0511040103; Bjornstad A, 2010, CROP SCI, V50, P1579, DOI 10.2135/cropsci2009.12.0719; BUCHANAN BB, 1994, ARCH BIOCHEM BIOPHYS, V314, P257, DOI 10.1006/abbi.1994.1439; Dai F, 2012, P NATL ACAD SCI USA, V109, P16969, DOI 10.1073/pnas.1215265109; Distelfeld A, 2008, MOL BREEDING, V22, P25, DOI 10.1007/s11032-007-9153-3; Ellis RP, 2000, J EXP BOT, V51, P9, DOI 10.1093/jexbot/51.342.9; Emebiri LC, 2005, J CEREAL SCI, V41, P107, DOI 10.1016/j.jcs.2004.08.012; Feng Zong-Yun, 2006, Acta Genetica Sinica, V33, P917, DOI 10.1016/S0379-4172(06)60126-1; FU YX, 1993, GENETICS, V133, P693; Gelhaye E, 2004, PLANT PHYSIOL BIOCH, V42, P265, DOI 10.1016/j.plaphy.2004.03.002; Harlan J. R., 1971, Barley genetics II. Proceedings of Second International Barley Genetics Symposium. Washington State University, Pulman, 1970., P45; Harlan J. R., 1976, Evolution of crop plants., P93; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Ivandic V, 2002, PLANT MOL BIOL, V48, P511, DOI 10.1023/A:1014875800036; Jamar C, 2010, J PLANT PHYSIOL, V167, P497, DOI 10.1016/j.jplph.2009.10.014; Jin XL, 2011, J CEREAL SCI, V53, P59, DOI 10.1016/j.jcs.2010.09.006; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; Juttner J, 2000, EUR J BIOCHEM, V267, P7109, DOI 10.1046/j.1432-1327.2000.01811.x; KAHLER AL, 1981, THEOR APPL GENET, V59, P101, DOI 10.1007/BF00285898; Kakeda K, 2009, BREEDING SCI, V59, P595, DOI 10.1270/jsbbs.59.595; Kilian B, 2006, MOL GENET GENOMICS, V276, P230, DOI 10.1007/s00438-006-0136-6; Maeso I, 2012, GENOME BIOL EVOL, V4, P486, DOI 10.1093/gbe/evs022; MAROOF MAS, 1994, P NATL ACAD SCI USA, V91, P5466, DOI 10.1073/pnas.91.12.5466; Molina-Cano JL, 2005, THEOR APPL GENET, V110, P613, DOI 10.1007/s00122-004-1878-3; Molina-Cano JL, 2002, BARLEY SCI RECENT AD; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Nevo E, 2004, CEREAL GENOMICS, P135; NEVO E, 1986, BIOL J LINN SOC, V27, P355, DOI 10.1111/j.1095-8312.1986.tb01742.x; NEVO E, 1984, EUPHYTICA, V33, P737, DOI 10.1007/BF00021901; Nevo E, 2013, ADV BARLEY SCI, P1, DOI 10.1007/978-94-007-4682-4_1; Nevo Eviatar, 2006, Plant Genetic Resources Characterization and Utilization, V4, P36, DOI 10.1079/PGR2006108; Nuruzzaman M, 2008, MOL GENET GENOMICS, V280, P139, DOI 10.1007/s00438-008-0351-4; Orabi J, 2009, PLANT BREEDING, V128, P606, DOI 10.1111/j.1439-0523.2009.01637.x; Raines C, 2005, J EXP BOT, V56, pIV, DOI 10.1093/jxb/eri183; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Rozas J., 2005, DNA SEQUENCE POLYMOR; Saisho D, 2007, GENETICS, V177, P1765, DOI 10.1534/genetics.107.079491; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; See D, 2002, CROP SCI, V42, P680, DOI 10.2135/cropsci2002.0680; Shao QQ, 1975, ACTA GENET SIN, V2, P123; Shao QQ, 1982, WILD BARLEY TIBET, P1; Stein N, 2001, PLANT BREEDING, V120, P354, DOI 10.1046/j.1439-0523.2001.00615.x; Swofford D, 2003, PAUP VERSION 4 BETA; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHASHI R, 1955, ADV GENET, V7, P227, DOI 10.1016/S0065-2660(08)60097-8; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Vavilov N. I., 1926, B APPL BOT GEN PB, V14, P1; Vavilov NI, 1951, CHRON BOT, V13, P1, DOI DOI 10.1097/00010694-195112000-00018; von Bothmer R., 2011, BARLEY PRODUCTION IM, P14, DOI DOI 10.1002/9780470958636.CH2; von Bothmer R, 1985, SVERIGES UTSADESFORE, V95, P71; VONBOTHMER R, 1995, SYSTEMATIC ECOGEOGRA, V7; Wang AH, 2009, CR BIOL, V332, P393, DOI 10.1016/j.crvi.2008.11.007; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; XU T, 1982, Acta Genetica Sinica, V9, P440; XU TW, 1986, P CHIN BARL SCI, P34; Xu TW, 1985, BARLEY NEWSLET, V29, P105; Xu TW, 1975, ACTA GENET SIN, V2, P129; Xu TW, 1984, J SICHUAN AGR COLL, V2, P11; Yang J. L., 1985, Sveriges Utsadesforenings Tidskrift, V95, P71; Yang ShiDong, 2008, Agricultural Sciences in China, V7, P796, DOI 10.1016/S1671-2927(08)60116-9; YAO Z, 1982, Acta Genetica Sinica, V9, P160; Yin YQ, 2003, THEOR APPL GENET, V107, P837, DOI 10.1007/s00122-003-1328-7; ZHANG QF, 1990, P NATL ACAD SCI USA, V87, P8741, DOI 10.1073/pnas.87.22.8741; ZHANG QF, 1994, GENOME, V37, P631, DOI 10.1139/g94-090; ZHANG QF, 1992, THEOR APPL GENET, V84, P682, DOI 10.1007/BF00224168; Zhang Qifa, 1992, Acta Genetica Sinica, V19, P236; ZHOU Z, 1981, Acta Genetica Sinica, V8, P344; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	72	28	38	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62700	10.1371/journal.pone.0062700	http://dx.doi.org/10.1371/journal.pone.0062700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658764	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100034
J	Brenner, C; Bomans, K; Habicht, J; Simon, MM; Wallich, R				Brenner, Christiane; Bomans, Katharina; Habicht, Jueri; Simon, Markus M.; Wallich, Reinhard			Mapping the Ligand-Binding Region of Borrelia hermsii Fibronectin-Binding Protein	PLOS ONE			English	Article							BORNE RELAPSING FEVER; HUMAN-COMPLEMENT REGULATORS; OUTER-MEMBRANE PROTEIN; H-LIKE PROTEIN-1; SURFACE PROTEIN; FUNCTIONAL-CHARACTERIZATION; SPIROCHETAL LIPOPROTEINS; EXTRACELLULAR-MATRIX; C4B-BINDING PROTEIN; ANTIGENIC VARIATION	Many pathogenic microorganisms express fibronectin-binding molecules that facilitate their adherence to the extracellular matrix and/or entry into mammalian cells. We have previously described a Borrelia recurrentis gene, cihC that encodes a 40-kDa surface receptor for both, fibronectin and the complement inhibitors C4bp and C1-Inh. We now provide evidence for the expression of a group of highly homologues surface proteins, termed FbpA, in three B. hermsii isolates and two tick-borne relapsing fever spirochetes, B. parkeri and B. turicatae. When expressed in Escherichia coli or B. burgdorferi, four out of five proteins were shown to selectively bind fibronectin, whereas none of five proteins were able to bind the human complement regulators, C4bp and C1-Inh. By applying deletion mutants of the B. hermsii fibronectin-binding proteins a putative high-affinity binding site for fibronectin was mapped to its central region. In addition, the fibronectin-binding proteins of B. hermsii were found to share sequence homology with BBK32 of the Lyme disease spirochete B. burgdorferi with similar function suggesting its involvement in persistence and/or virulence of relapsing fever spirochetes.	[Brenner, Christiane; Bomans, Katharina; Habicht, Jueri; Simon, Markus M.; Wallich, Reinhard] Heidelberg Univ, Inst Immunol, Infect Immunol Grp, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Wallich, R (corresponding author), Heidelberg Univ, Inst Immunol, Infect Immunol Grp, Neuenheimer Feld 305, Heidelberg, Germany.	wallich@uni-hd.de		Glosse, Katharina/0000-0002-5517-5786	Grimminger-Stiftung fur Zoonosenforschung	Grimminger-Stiftung fur Zoonosenforschung	The authors are indebted for the financial support of the Grimminger-Stiftung fur Zoonosenforschung to Dr. Wallich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOUR AG, 1990, ANNU REV MICROBIOL, V44, P155, DOI 10.1146/annurev.mi.44.100190.001103; BARBOUR AG, 1991, INFECT IMMUN, V59, P390, DOI 10.1128/IAI.59.1.390-397.1991; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Boyle EC, 2003, CURR OPIN CELL BIOL, V15, P633, DOI 10.1016/S0955-0674(03)00099-1; Brinkman MB, 2008, INFECT IMMUN, V76, P1848, DOI 10.1128/IAI.01424-07; Brissette CA, 2008, INFECT IMMUN; Cutler SJ, 1997, INT J SYST BACTERIOL, V47, P958, DOI 10.1099/00207713-47-4-958; Davis H, 2002, PEDIATR INFECT DIS J, V21, P703, DOI 10.1097/00006454-200207000-00020; Dworkin MS, 1998, CLIN INFECT DIS, V26, P122, DOI 10.1086/516273; Fikrig E, 2000, J IMMUNOL, V164, P5344, DOI 10.4049/jimmunol.164.10.5344; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Grab DJ, 1998, BBA-MOL BASIS DIS, V1407, P135, DOI 10.1016/S0925-4439(98)00038-6; GREINER M, 1995, J IMMUNOL METHODS, V185, P123, DOI 10.1016/0022-1759(95)00121-P; Grosskinsky S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000698; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; Hovis KM, 2006, INFECT IMMUN, V74, P2007, DOI 10.1128/IAI.74.4.2007-2014.2006; Hovis KM, 2004, J BACTERIOL, V186, P2612, DOI 10.1128/JB.186.9.2612-2618.2004; Hyde JA, 2011, MOL MICROBIOLOGY; JOH HJ, 1994, BIOCHEMISTRY-US, V33, P6086, DOI 10.1021/bi00186a007; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Kraiczy P, 2004, J BIOL CHEM, V279, P2421, DOI 10.1074/jbc.M308343200; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; KUHN S, 1995, J IMMUNOL, V155, P5663; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meri T, 2006, INFECT IMMUN, V74, P4157, DOI 10.1128/IAI.00007-06; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Naito M, 1998, J BIOL CHEM, V273, P2905, DOI 10.1074/jbc.273.5.2905; Norman MU, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000169; Ozeri V, 1996, EMBO J, V15, P989, DOI 10.1002/j.1460-2075.1996.tb00435.x; Porcella SF, 2005, INFECT IMMUN, V73, P6647, DOI 10.1128/IAI.73.10.6647-6658.2005; Probert WS, 1998, MOL MICROBIOL, V30, P1003, DOI 10.1046/j.1365-2958.1998.01127.x; Probert WS, 2001, INFECT IMMUN, V69, P4129, DOI 10.1128/IAI.69.6.4129-4133.2001; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Rawlings J A, 1995, Tex Med, V91, P56; Rossmann E, 2007, J IMMUNOL, V178, P7292, DOI 10.4049/jimmunol.178.11.7292; Schorey JS, 1996, MOL MICROBIOL, V21, P321, DOI 10.1046/j.1365-2958.1996.6381353.x; Schott M, 2010, INFECT IMMUN, V78, P2199, DOI 10.1128/IAI.00089-10; Schwan TG, 2005, J CLIN MICROBIOL, V43, P3851, DOI 10.1128/JCM.43.8.3851-3859.2005; Schwan TG, 2007, EMERG INFECT DIS, V13, P436, DOI 10.3201/eid1303.060958; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699; Walker RL, 2002, J CLIN MICROBIOL, V40, P1558, DOI 10.1128/JCM.40.4.1558-1562.2002; Wallich R, 2005, INFECT IMMUN, V73, P2351, DOI 10.1128/IAI.73.4.2351-2359.2005; WESTERLUND B, 1993, MOL MICROBIOL, V9, P687, DOI 10.1111/j.1365-2958.1993.tb01729.x; Whitney MS, 2007, VET CLIN PATH, V36, P212, DOI 10.1111/j.1939-165X.2007.tb00213.x; Zuckert WR, 2004, INFECT IMMUN, V72, P1463, DOI 10.1128/IAI.72.3.1463-1469.2004; Zuckert WR, 1999, INFECT IMMUN, V67, P3257	53	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63437	10.1371/journal.pone.0063437	http://dx.doi.org/10.1371/journal.pone.0063437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658828	Green Published, Green Submitted, gold			2022-12-25	WOS:000321200500070
J	Ulrich, CT; Fung, C; Vatter, H; Setzer, M; Gueresir, E; Seifert, V; Beck, J; Raabe, A				Ulrich, Christian T.; Fung, Christian; Vatter, Hartmut; Setzer, Matthias; Gueresir, Erdem; Seifert, Volker; Beck, Juergen; Raabe, Andreas			Occurrence of Vasospasm and Infarction in Relation to a Focal Monitoring Sensor in Patients after SAH: Placing a Bet when Placing a Probe?	PLOS ONE			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; CEREBRAL VASOSPASM; BEDSIDE MICRODIALYSIS; INTRACRANIAL ANEURYSMS; NEUROLOGICAL DEFICITS; SYMPTOMATIC VASOSPASM; TRANSCRANIAL DOPPLER; ARTERIAL SPASM; PREDICTORS; PREVENTION	Introduction: Vasospastic brain infarction is a devastating complication of aneurysmal subarachnoid hemorrhage (SAH). Using a probe for invasive monitoring of brain tissue oxygenation or blood flow is highly focal and may miss the site of cerebral vasospasm (CVS). Probe placement is based on the assumption that the spasm will occur either at the dependent vessel territory of the parent artery of the ruptured aneurysm or at the artery exposed to the focal thick blood clot. We investigated the likelihood of a focal monitoring sensor being placed in vasospasm or infarction territory on a hypothetical basis. Methods: From our database we retrospectively selected consecutive SAH patients with angiographically proven (day 7-14) severe CVS (narrowing of vessel lumen >50%). Depending on the aneurysm location we applied a standard protocol of probe placement to detect the most probable site of severe CVS or infarction. We analyzed whether the placement was congruent with existing CVS/infarction. Results: We analyzed 100 patients after SAH caused by aneurysms located in the following locations: MCA (n = 14), ICA (n = 30), A1CA (n = 4), AcoA or A2CA (n = 33), and VBA (n = 19). Sensor location corresponded with CVS territory in 93% of MCA, 87% of ICA, 76% of AcoA or A2CA, but only 50% of A1CA and 42% of VBA aneurysms. The focal probe was located inside the infarction territory in 95% of ICA, 89% of MCA, 78% of ACoA or A2CA, 50% of A1CA and 23% of VBA aneurysms. Conclusion: The probability that a single focal probe will be situated in the territory of severe CVS and infarction varies. It seems to be reasonably accurate for MCA and ICA aneurysms, but not for ACA or VBA aneurysms.	[Ulrich, Christian T.; Fung, Christian; Beck, Juergen; Raabe, Andreas] Univ Hosp Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland; [Vatter, Hartmut; Setzer, Matthias; Gueresir, Erdem; Seifert, Volker] Goethe Univ Frankfurt, Dept Neurosurg, D-60054 Frankfurt, Germany	University of Bern; University Hospital of Bern; Goethe University Frankfurt	Ulrich, CT (corresponding author), Univ Hosp Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland.	christian.ulrich@insel.ch	Setzer, Matthias/P-3266-2014; Güresir, Erdem/AAL-4484-2020; Güresir, Erdem/AAV-7224-2021	Güresir, Erdem/0000-0001-8319-0847; Beck, Jurgen/0000-0002-7687-6098	Bern University Hospital; Goethe University Frankfurt/Main	Bern University Hospital; Goethe University Frankfurt/Main	This work was supported by the Bern University Hospital and Goethe University Frankfurt/Main. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bonilha L, 2001, ARQ NEURO-PSIQUIAT, V59, P676, DOI 10.1590/S0004-282X2001000500004; BOTTERELL EH, 1956, J NEUROSURG, V13, P1, DOI 10.3171/jns.1956.13.1.0001; Carrera E, 2009, NEUROSURGERY, V65, P316, DOI 10.1227/01.NEU.0000349209.69973.88; Charpentier C, 1999, STROKE, V30, P1402, DOI 10.1161/01.STR.30.7.1402; Fergusen S, 2007, NEUROSURGERY, V60, P658, DOI 10.1227/01.NEU.0000255396.23280.31; FINDLAY JM, 1991, CEREBROVAS BRAIN MET, V3, P336; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; GRAF CJ, 1974, STROKE, V5, P557, DOI 10.1161/01.STR.5.4.557; Harrod CG, 2005, NEUROSURGERY, V56, P633, DOI 10.1227/01.NEU.0000156644.45384.92; Kivisaari RP, 2001, AM J NEURORADIOL, V22, P1143; Kreiter KT, 2009, STROKE, V40, P2362, DOI 10.1161/STROKEAHA.109.547331; Lasner TM, 1997, J NEUROSURG, V87, P381, DOI 10.3171/jns.1997.87.3.0381; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; McGirt MJ, 2004, NEUROSURGERY, V54, P1369, DOI 10.1227/01.NEU.0000125016.37332.50; McGirt MJ, 2003, J NEUROSURG, V98, P1222, DOI 10.3171/jns.2003.98.6.1222; Raabe A, 2005, J NEUROSURG, V103, P974, DOI 10.3171/jns.2005.103.6.0974; RABB CH, 1994, ACTA NEUROCHIR, V127, P27, DOI 10.1007/BF01808542; Rabinstein AA, 2005, STROKE, V36, P992, DOI 10.1161/01.STR.0000163090.59350.5a; Rabinstein AA, 2004, AM J NEURORADIOL, V25, P1778; Rabinstein AA, 2004, STROKE, V35, P1862, DOI 10.1161/01.STR.0000133132.76983.8e; SAITO I, 1979, Neurologia Medico-Chirurgica, V19, P103, DOI 10.2176/nmc.19.103; Sarrafzadeh A, 2003, STROKE, V34, P1382, DOI 10.1161/01.STR.0000074036.97859.02; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Suarez JI, 2002, CRIT CARE MED, V30, P1348, DOI 10.1097/00003246-200206000-00035; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Vajkoczy P, 2005, J NEUROSURG, V103, P9, DOI 10.3171/jns.2005.103.1.0009; Vajkoczy P, 2003, J NEUROSURG, V98, P1227, DOI 10.3171/jns.2003.98.6.1227; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Weidauer S, 2007, STROKE, V38, P1831, DOI 10.1161/STROKEAHA.106.477976; Weir B, 1998, SUBARACHNOID HEMORRH; WILKINS RH, 1986, NEUROSURGERY, V18, P808, DOI 10.1227/00006123-198606000-00026; WILKINS RH, 1980, NEUROSURGERY, V6, P198, DOI 10.1227/00006123-198002000-00016; Yanaka K, 2001, DRUGS TODAY, V37, P573, DOI 10.1358/dot.2001.37.8.844172; ZABRAMSKI JM, 1986, NEUROSURGERY, V18, P1	35	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62754	10.1371/journal.pone.0062754	http://dx.doi.org/10.1371/journal.pone.0062754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658768	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500035
J	Giroud, S; Frare, C; Strijkstra, A; Boerema, A; Arnold, W; Ruf, T				Giroud, Sylvain; Frare, Carla; Strijkstra, Arjen; Boerema, Ate; Arnold, Walter; Ruf, Thomas			Membrane Phospholipid Fatty Acid Composition Regulates Cardiac SERCA Activity in a Hibernator, the Syrian Hamster (Mesocricetus auratus)	PLOS ONE			English	Article							SQUIRRELS SPERMOPHILUS-LATERALIS; SARCOPLASMIC-RETICULUM; GROUND-SQUIRRELS; DAILY TORPOR; CA-2+-ATPASE ACTIVITY; MARMOTA-FLAVIVENTRIS; ADAPTIVE-MECHANISMS; BODY-TEMPERATURE; CALCIUM-UPTAKE; MAMMALS	Polyunsaturated fatty acids (PUFA) have strong effects on hibernation and daily torpor. Increased dietary uptake of PUFA of the n-6 class, particularly of Linoleic acid (LA, C18:2 n-6) lengthens torpor bout duration and enables animals to reach lower body temperatures (T-b) and metabolic rates. As previously hypothesized, this well-known influence of PUFA may be mediated via effects of the membrane fatty acid composition on sarcoplasmic reticulum (SR) Ca2+- ATPase 2a (SERCA) in the heart of hibernators. We tested the hypotheses that high proportions of n-6 PUFA in general, or specifically high proportions of LA (C18:2 n-6) in SR phospholipids (PL) should be associated with increased cardiac SERCA activity, and should allow animals to reach lower minimum T-b in torpor. We measured activity of SERCA from hearts of hibernating and non-hibernating Syrian hamsters (Mesocricetus auratus) in vitro at 35 degrees C. Further, we determined the PL fatty acid composition of the SR membrane of these hearts. We found that SERCA activity strongly increased as the proportion of LA in SR PL increased but was negatively affected by the content of Docosahexaenoic acid (DHA; C22:6 n-3). SR PL from hibernating hamsters were characterized by high proportions of LA and low proportions of DHA. As a result, SERCA activity was significantly higher during entrance into torpor and in torpor compared to inter-bout arousal. Also, animals with increased SERCA activity reached lower T-b during torpor. Interestingly, a subgroup of hamsters which never entered torpor but remained euthermic throughout winter displayed a phenotype similar to animals in summer. This was characterized by lower proportions of LA and increased proportions of DHA in SR membranes, which is apparently incompatible with torpor. We conclude that the PUFA composition of SR membranes affects cardiac function via modulating SERCA activity, and hence determines the minimum T-b tolerated by hibernators.	[Giroud, Sylvain; Frare, Carla; Arnold, Walter; Ruf, Thomas] Univ Vet Med, Dept Integrat Biol & Evolut, Res Inst Wildlife Ecol, Vienna, Austria; [Strijkstra, Arjen] Univ Groningen, Univ Med Ctr Groningen, Dept Chronobiol, Groningen, Netherlands; [Strijkstra, Arjen] Univ Groningen, Univ Med Ctr Groningen, Dept Mol Neurobiol, Groningen, Netherlands; [Strijkstra, Arjen; Boerema, Ate] Univ Groningen, Dept Chronobiol, Groningen, Netherlands; [Strijkstra, Arjen] Univ Appl Sci Van Hall Larenstein, Leeuwarden, Netherlands; [Boerema, Ate] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands	University of Veterinary Medicine Vienna; University of Groningen; University of Groningen; University of Groningen; Wageningen University & Research; University of Groningen	Giroud, S (corresponding author), Univ Vet Med, Dept Integrat Biol & Evolut, Res Inst Wildlife Ecol, Vienna, Austria.	sylvain.giroud@vetmeduni.ac.at	Arnold, Walter/C-3394-2013; Giroud, Sylvain/AAG-6430-2019; Boerema, A.S./W-9810-2018	Arnold, Walter/0000-0001-6785-5685; Giroud, Sylvain/0000-0001-6621-7462; Boerema, A.S./0000-0002-4771-5156; Frare, Carla/0000-0001-8822-5893; Ruf, Thomas/0000-0002-9235-7079	University of Veterinary Medicine Vienna (Austria)	University of Veterinary Medicine Vienna (Austria)	SG and this research work were financially supported by a postdoctoral fellowship of the University of Veterinary Medicine Vienna (Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia RC, 1979, CHEM ZOOL, V11; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Arnold W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018641; BELKE DD, 1991, CRYOBIOLOGY, V28, P354, DOI 10.1016/0011-2240(91)90042-M; BELKE DD, 1987, J THERM BIOL, V12, P53, DOI 10.1016/0306-4565(87)90035-0; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Boerema A. S, 2012, THESIS U GRONINGEN N; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauch KM, 2005, PHYSIOL GENOMICS, V23, P227, DOI 10.1152/physiolgenomics.00076.2005; Braulke LJ, 2010, CRYOBIOLOGY, V60, P198, DOI 10.1016/j.cryobiol.2009.11.001; Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; Bruns U, 2000, LIFE IN THE COLD, P215; Chritie WW, 1996, LIPID ANAL; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; EDER K, 1995, J CHROMATOGR B, V671, P113, DOI 10.1016/0378-4347(95)00142-6; Elvert R, 2005, J EXP BIOL, V208, P1373, DOI 10.1242/jeb.01546; FLORANT GL, 1993, AM J PHYSIOL, V264, pR747, DOI 10.1152/ajpregu.1993.264.4.R747; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRANK CL, 1992, PHYSIOL ZOOL, V65, P906, DOI 10.1086/physzool.65.5.30158549; FRANK CL, 1995, J COMP PHYSIOL B, V164, P536; Frank CL, 2004, 12 INT HIB S BIOL PA, P71; GEISER F, 1993, CAN J ZOOL, V71, P1182, DOI 10.1139/z93-161; GEISER F, 1995, PHYSIOL ZOOL, V68, P935, DOI 10.1086/physzool.68.6.30163788; GEISER F, 1987, AM J PHYSIOL, V252, pR897, DOI 10.1152/ajpregu.1987.252.5.R897; Geiser F, 2007, NATURWISSENSCHAFTEN, V94, P319, DOI 10.1007/s00114-006-0193-z; Grossfield A, 2006, P NATL ACAD SCI USA, V103, P4888, DOI 10.1073/pnas.0508352103; Hampton M, 2010, AM J PHYSIOL-REG I, V299, pR1478, DOI 10.1152/ajpregu.00273.2010; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; Hill VL, 2000, PHYSIOL BEHAV, V68, P431, DOI 10.1016/S0031-9384(99)00177-8; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Johansson BW, 1996, CARDIOVASC RES, V31, P826, DOI 10.1016/S0008-6363(95)00192-1; Leaf A, 2003, PHARMACOL THERAPEUT, V98, P355, DOI 10.1016/S0163-7258(03)00039-1; LINDEMANN JP, 1983, J BIOL CHEM, V258, P464; Liu B, 1997, AM J PHYSIOL-REG I, V272, pR1121, DOI 10.1152/ajpregu.1997.272.4.R1121; LYMAN CHARLES P., 1960, BULL MUS COMP ZOOL HARVARD UNIV, V124, P353; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Milsom WK, 1999, COMP BIOCHEM PHYS A, V124, P383, DOI 10.1016/S1095-6433(99)00130-0; MROSOVSKY N, 1978, STRATEGIES COLD NATU, P21; Oklejewicz M, 2001, J COMP PHYSIOL B, V171, P431; Ortmann S, 2000, AM J PHYSIOL-REG I, V278, pR698, DOI 10.1152/ajpregu.2000.278.3.R698; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; R Development Core Team, 2009, R FDN STAT COMP; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Ruf T, 2008, AM J PHYSIOL-REG I, V294, pR1044, DOI 10.1152/ajpregu.00688.2007; SIMONIDES WS, 1990, ANAL BIOCHEM, V191, P321, DOI 10.1016/0003-2697(90)90226-Y; STRUMWASSER F, 1959, AM J PHYSIOL, V196, P15, DOI 10.1152/ajplegacy.1958.196.1.15; SWANSON JE, 1989, J NUTR, V119, P364, DOI 10.1093/jn/119.3.364; TAFFET GE, 1993, J MEMBRANE BIOL, V131, P35, DOI 10.1007/BF02258532; Talaei F, 2011, J EXP BIOL, V214, P1276, DOI 10.1242/jeb.052704; THORP CR, 1994, PHYSIOL ZOOL, V67, P1213, DOI 10.1086/physzool.67.5.30163890; Ushio H, 1997, COMP BIOCHEM PHYS B, V118, P681, DOI 10.1016/S0305-0491(97)00229-0; Wang SQ, 2002, J EXP BIOL, V205, P2957; Yatani A, 2004, AM J PHYSIOL-HEART C, V286, pH2219, DOI 10.1152/ajpheart.01096.2003; YEAGLE PL, 1989, FASEB J, V3, P1833, DOI 10.1096/fasebj.3.7.2469614; [No title captured]	55	62	64	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63111	10.1371/journal.pone.0063111	http://dx.doi.org/10.1371/journal.pone.0063111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650545	gold, Green Published, Green Submitted			2022-12-25	WOS:000319167000090
J	Gravina, HD; Antonelli, L; Gazzinelli, RT; Ropert, C				Gravina, Humberto D.; Antonelli, Lis; Gazzinelli, Ricardo T.; Ropert, Catherine			Differential Use of TLR2 and TLR9 in the Regulation of Immune Responses during the Infection with Trypanosoma cruzi	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; DENDRITIC CELLS; CUTTING EDGE; SIGNALING PATHWAYS; GAMMA-INTERFERON; ACTIVATION; MACROPHAGES; EXPRESSION; MICE; COOPERATION	Pathogens express ligands for several TLRs that may play a role in the induction or control of the inflammatory response during infection. Concerning Trypanosoma cruzi, the agent of Chagas disease, we have previously characterized glycosylphosphatidylinositol (GPI) anchored mucin-like glycoproteins (tGPI-mucin) and unmethylated CpG DNA sequences as TLR2 and TLR9 agonists, respectively. Here we sought to determine how these TLRs may modulate the inflammatory response in the following cell populations: F4/80(+)CD11b(+) (macrophages), F4/80(low)CD11b(+) (monocytes) and MHCII+ CD11-c(high) (dendritic cells). For this purpose, TLR2(-/-) and TLR9(-/-) mice were infected with Y strain of T. cruzi and different immunological parameters were evaluated. According to our previous data, a crucial role of TLR9 was evidenced in the establishment of Th1 response, whereas TLR2 appeared to act as immunoregulator in the early stage of infection. More precisely, we demonstrated here that TLR2 was mainly used by F4/80(+)CD11b(+) cells for the production of TNF-alpha. In the absence of TLR2, an increased production of IL-12/IL-23p40 and IFN-gamma was noted suggesting that TLR2 negatively controls the Th1 response. In contrast, TLR9 was committed to IL-12/IL-23p40 production by MHCII(+)CD11c(high) cells that constitute the main source of IL-12/IL-23p40 during infection. Importantly, a down-regulation of TLR9 response was observed in F4/80(+)CD11b(+) and F4/80(low)CD11b(+) populations that correlated with the decreased TLR9 expression level in these cells. Interestingly, these cells recovered their capacity to respond to TLR9 agonist when MHCII(+)CD11c(high) cells were impeded from producing IL-12/IL-23p40, thereby indicating possible cross-talk between these populations. The differential use of TLR2 and TLR9 by the immune cells during the acute phase of the infection explains why TLR9-but not TLR2-deficient mice are susceptible to T. cruzi infection.	[Antonelli, Lis; Gazzinelli, Ricardo T.; Ropert, Catherine] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Gravina, Humberto D.; Gazzinelli, Ricardo T.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Gazzinelli, Ricardo T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; University of Massachusetts System; University of Massachusetts Worcester	Ropert, C (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	cropert@hotmail.com	Ropert, Catherine/AAL-7302-2021; Antonelli, Lis/G-2907-2012; Gravina, H D/F-2831-2016; Antonelli, Lis/R-4910-2019; Antonelli, Guido/K-7915-2016; Ropert, Catherine/G-2463-2012	Ropert, Catherine/0000-0002-3077-714X; Gravina, H D/0000-0002-5006-8869; Antonelli, Lis/0000-0002-4969-8812; Gazzinelli, Ricardo/0000-0003-2427-7699	Rede Mineira de Biomoleculas - Fundacao de Amparo as Pesquisa do Estado de Minas Gerais (FAPEMIG); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV) - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Atlantic Philanthropies Program of Clinical Discovery from the Ludwig Institute of Cancer Research	Rede Mineira de Biomoleculas - Fundacao de Amparo as Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV) - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Atlantic Philanthropies Program of Clinical Discovery from the Ludwig Institute of Cancer Research	This study was funded by Rede Mineira de Biomoleculas - Fundacao de Amparo as Pesquisa do Estado de Minas Gerais (FAPEMIG), the Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV) - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and by the Atlantic Philanthropies Program of Clinical Discovery from the Ludwig Institute of Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2006, J IMMUNOL, V176, P5788, DOI 10.4049/jimmunol.176.10.5788; Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Bartholomeu DC, 2008, J IMMUNOL, V181, P1333, DOI 10.4049/jimmunol.181.2.1333; Bhan U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009896; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Cardillo F, 1996, INFECT IMMUN, V64, P128, DOI 10.1128/IAI.64.1.128-134.1996; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Ford AQ, 2009, J IMMUNOL S, V182, P79; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; Hou BD, 2011, P NATL ACAD SCI USA, V108, P278, DOI 10.1073/pnas.1011549108; Hunter CA, 1997, J IMMUNOL, V158, P3311; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Krummen M, 2010, J LEUKOCYTE BIOL, V88, P189, DOI 10.1189/jlb.0408228; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lee KS, 2007, CELL IMMUNOL, V245, P103, DOI 10.1016/j.cellimm.2007.04.003; Lima ESL, 2007, INFECT IMMUN, V65, P457; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Mellett M, 2011, J IMMUNOL, V186, P4925, DOI 10.4049/jimmunol.1002739; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Ouyang XS, 2007, BIOCHEM BIOPH RES CO, V354, P1045, DOI 10.1016/j.bbrc.2007.01.090; Pompei L, 2007, J IMMUNOL, V178, P5192, DOI 10.4049/jimmunol.178.8.5192; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Rodrigues Mauricio M., 2012, Journal of Parasitology Research, P507874, DOI 10.1155/2012/507874; Ropert C, 2004, J ENDOTOXIN RES, V10, P425, DOI 10.1179/096805104225006507; Sengupta D, 2010, J IMMUNOL, V184, P956, DOI 10.4049/jimmunol.0902008; Sieve AN, 2010, EUR J IMMUNOL, V40, P2236, DOI 10.1002/eji.200939759; Silva GK, 2010, J IMMUNOL, V184, P1148, DOI 10.4049/jimmunol.0902254; SILVA JS, 1995, INFECT IMMUN, V63, P4862, DOI 10.1128/IAI.63.12.4862-4867.1995; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Wang J, 2009, MICROBES INFECT, V11, P321, DOI 10.1016/j.micinf.2008.12.011; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713	41	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63100	10.1371/journal.pone.0063100	http://dx.doi.org/10.1371/journal.pone.0063100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650544	Green Submitted, Green Published, gold			2022-12-25	WOS:000319167000089
J	Vincelette, RL; Roth, CC; McConnell, MP; Payne, JA; Beier, HT; Ibey, BL				Vincelette, Rebecca L.; Roth, Caleb C.; McConnell, Maureen P.; Payne, Jason A.; Beier, Hope T.; Ibey, Bennett L.			Thresholds for Phosphatidylserine Externalization in Chinese Hamster Ovarian Cells following Exposure to Nanosecond Pulsed Electrical Fields (nsPEF)	PLOS ONE			English	Article							PLASMA-MEMBRANE PERMEABILIZATION; ERYTHROCYTE-MEMBRANE; MAMMALIAN-CELLS; ELECTROPORATION; PHOSPHOLIPIDS; SUBMICROSECOND; TRANSLOCATION; MECHANISMS; TISSUES	High-amplitude, MV/m, nanosecond pulsed electric fields (nsPEF) have been hypothesized to cause nanoporation of the plasma membrane. Phosphatidylserine (PS) externalization has been observed on the outer leaflet of the membrane shortly after nsPEF exposure, suggesting local structural changes in the membrane. In this study, we utilized fluorescently-tagged Annexin V to observe the externalization of PS on the plasma membrane of isolated Chinese Hamster Ovary (CHO) cells following exposure to nsPEF. A series of experiments were performed to determine the dosimetric trends of PS expression caused by nsPEF as a function of pulse duration, tau, delivered field strength, E-D, and pulse number, n. To accurately estimate dose thresholds for cellular response, data were reduced to a set of binary responses and ED50s were estimated using Probit analysis. Probit analysis results revealed that PS externalization followed the non-linear trend of (tau*E-D(2))(-1) for high amplitudes, but failed to predict low amplitude responses. A second set of experiments was performed to determine the nsPEF parameters necessary to cause observable calcium uptake, using cells preloaded with calcium green (CaGr), and membrane permeability, using FM1-43 dye. Calcium influx and FM1-43 uptake were found to always be observed at lower nsPEF exposure parameters compared to PS externalization. These findings suggest that multiple, higher amplitude and longer pulse exposures may generate pores of larger diameter enabling lateral diffusion of PS; whereas, smaller pores induced by fewer, lower amplitude and short pulse width exposures may only allow extracellular calcium and FM1-43 uptake.	[Vincelette, Rebecca L.; Beier, Hope T.] CNR, Ft Sam Houston, TX USA; [Roth, Caleb C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol Sci, San Antonio, TX 78229 USA; [McConnell, Maureen P.; Payne, Jason A.; Ibey, Bennett L.] Air Force Res Lab, Radio Frequency Bioeffects Branch, Ft Sam Houston, TX USA	University of Texas System; University of Texas Health San Antonio	Ibey, BL (corresponding author), Air Force Res Lab, Radio Frequency Bioeffects Branch, Ft Sam Houston, TX USA.	BennettIbey@gmail.com	Roth, Caleb/Y-1487-2019	Roth, Caleb/0000-0001-8962-1097; Beier, Hope/0000-0002-6291-118X	Air Force Office of Scientific Research [AFOSR-LRIR 09RH09COR]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This study was supported by a grant from the Air Force Office of Scientific Research (AFOSR-LRIR 09RH09COR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, PHYS BIOL, V3, P233; Cain C. P., 1996, USAF TECHNICAL REPOR; *CLIPP CONTR INC, 2005, DIEL CONST REF GUID; DRESSLER V, 1983, BIOCHIM BIOPHYS ACTA, V732, P304, DOI 10.1016/0005-2736(83)90216-X; Finney D.J., 1971, PROBIT ANAL; Foster KR, 1998, BIOELECTROMAGNETICS, V19, P420, DOI 10.1002/(SICI)1521-186X(1998)19:7<420::AID-BEM3>3.0.CO;2-3; Haest CWM, 1997, BBA-BIOMEMBRANES, V1325, P17, DOI 10.1016/S0005-2736(96)00239-8; HIBINO M, 1993, BIOPHYS J, V64, P1789, DOI 10.1016/S0006-3495(93)81550-9; Hu Q, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031902; Ibey BL, 2010, BBA-GEN SUBJECTS, V1800, P1210, DOI 10.1016/j.bbagen.2010.07.008; Ibey BL, 2010, BIOELECTROCHEMISTRY, V79, P114, DOI 10.1016/j.bioelechem.2010.01.001; Ibey BL, 2009, BIOELECTROMAGNETICS, V30, P92, DOI 10.1002/bem.20451; Kim JM, 2005, J MICROMECH MICROENG, V15, P543, DOI 10.1088/0960-1317/15/3/015; Krassowska W, 2007, BIOPHYS J, V92, P404, DOI 10.1529/biophysj.106.094235; Levine ZA, 2010, J MEMBRANE BIOL; Neumann E., 1989, ELECTROPORATION ELEC; Pakhomov AG, 2010, ADV ELECTROPORATION; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Saulis G, 1999, Biomed Sci Instrum, V35, P409; Schoenbach KH, 2007, IEEE T DIELECT EL IN, V14, P1088, DOI 10.1109/TDEI.2007.4339468; Schoenbach KH, 2002, IEEE T PLASMA SCI, V30, P293, DOI 10.1109/TPS.2002.1003873; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Smith KC, BIOCH BIOPHYSICAL RE, V412, P8; Smith KC, 2008, BIOPHYS J, V95, P1547, DOI 10.1529/biophysj.107.121921; Sun YH, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2187970; Taflove A., 1995, COMPUTATIONAL ELECTR; Teissie J, 1999, ADV DRUG DELIVER REV, V35, P3, DOI 10.1016/S0169-409X(98)00060-X; TEKLE E, 1991, P NATL ACAD SCI USA, V88, P4230, DOI 10.1073/pnas.88.10.4230; Tekle E, 2001, BIOPHYS J, V81, P960, DOI 10.1016/S0006-3495(01)75754-2; Vasilkoski Z, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021904; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Vernier PT, 2008, BIOELECTROCHEMISTRY, V73, P1, DOI 10.1016/j.bioelechem.2008.02.003; Vernier PT, 2006, J AM CHEM SOC, V128, P6288, DOI 10.1021/ja0588306; Vernier PT, 2004, FEBS LETT, V572, P103, DOI 10.1016/j.febslet.2004.07.021; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; Weaver JC, 2000, IEEE T PLASMA SCI, V28, P24, DOI 10.1109/27.842820; Weaver JC, 2003, IEEE T DIELECT EL IN, V10, P754, DOI 10.1109/TDEI.2003.1237325; Wu Y, 2011, BIOCHEMISTRY-US, V50, P7493, DOI 10.1021/bi2006288; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; Zaharoff DA, 2008, EXP BIOL MED, V233, P94, DOI 10.3181/0704-RM-113; Zimmeramann U, 1996, EFFECT HIGH INTENSIT	44	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e63122	10.1371/journal.pone.0063122	http://dx.doi.org/10.1371/journal.pone.0063122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658665	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800077
J	van den Berg, SAA; Heemskerk, MM; Geerling, JJ; van Klinken, JB; Schaap, FG; Bijland, S; Berbee, JFP; van Harmelen, VJA; Pronk, ACM; Schreurs, M; Havekes, LM; Rensen, PCN; van Dijk, KW				van den Berg, Sjoerd A. A.; Heemskerk, Mattijs M.; Geerling, Janine J.; van Klinken, Jan-Bert; Schaap, Frank G.; Bijland, Silvia; Berbee, Jimmy F. P.; van Harmelen, Vanessa J. A.; Pronk, Amanda C. M.; Schreurs, Marijke; Havekes, Louis M.; Rensen, Patrick C. N.; van Dijk, Ko Willems			Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake	FASEB JOURNAL			English	Article						APOA5; central nervous system; hyperphagia; triglyceride metabolism	CENTRAL-NERVOUS-SYSTEM; DENSITY LIPOPROTEIN-TRIGLYCERIDE; LDL-RECEPTOR; RICH LIPOPROTEINS; GENE-EXPRESSION; LIPID DROPLETS; EARLY PHASE; APOC-III; IN-VITRO; BLOOD	Mutations in apolipoprotein A5 (APOA5) have been associated with hypertriglyceridemia in humans and mice. This has been attributed to a stimulating role for APOA5 in lipoprotein lipase-mediated triglyceride hydrolysis and hepatic clearance of lipoprotein remnant particles. However, because of the low APOA5 plasma abundance, we investigated an additional signaling role for APOA5 in high-fat diet (HFD)-induced obesity. Wild-type (WT) and Apoa5(-/-) mice fed a chow diet showed no difference in body weight or 24-h food intake (Apoa5(-/-), 4.5 +/- 0.6 g; WT, 4.2 +/- 0.5 g), while Apoa5(-/-) mice fed an HFD ate more in 24 h (Apoa5(-/-), 2.8 +/- 0.4 g; WT, 2.5 +/- 0.3 g, P<0.05) and became more obese than WT mice. Also, intravenous injection of APOA5-loaded VLDL-like particles lowered food intake (VLDL control, 0.26 +/- 0.04 g; VLDL+APOA5, 0.11 +/- 0.07 g, P<0.01). In addition, the HFD-induced hyperphagia of Apoa5(-/-) mice was prevented by adenovirus-mediated hepatic overexpression of APOA5. Finally, intracerebroventricular injection of APOA5 reduced food intake compared to injection of the same mouse with artificial cerebral spinal fluid (0.40 +/- 0.11 g; APOA5, 0.23 +/- 0.08 g, P<0.01). These data indicate that the increased HFD-induced obesity of Apoa5(-/-) mice as compared to WT mice is at least partly explained by hyperphagia and that APOA5 plays a role in the central regulation of food intake.Van den Berg, S. A. A., Heemskerk, M. M., Geerling, J. J., van Klinken, J.-B., Schaap, F. G., Bijland, S., Berbee, J. F. P., van Harmelen, V. J. A., Pronk, A. C. M., Schreurs, M., Havekes, L. M., Rensen, P. C. N., van Dijk, K. W. Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake.	[van den Berg, Sjoerd A. A.; Heemskerk, Mattijs M.; van Klinken, Jan-Bert; Bijland, Silvia; van Harmelen, Vanessa J. A.; Pronk, Amanda C. M.; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [van den Berg, Sjoerd A. A.; Heemskerk, Mattijs M.; Geerling, Janine J.; van Klinken, Jan-Bert; Berbee, Jimmy F. P.; van Harmelen, Vanessa J. A.; Pronk, Amanda C. M.; Havekes, Louis M.; Rensen, Patrick C. N.; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, NL-2300 RC Leiden, Netherlands; [Geerling, Janine J.; Berbee, Jimmy F. P.; Havekes, Louis M.; Rensen, Patrick C. N.; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2300 RC Leiden, Netherlands; [Schaap, Frank G.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Berbee, Jimmy F. P.] Univ Patras, Sch Med, Dept Med, Pharmacol Unit, Rion, Greece; [Schreurs, Marijke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Mol Genet Grp,Med Biol Div, Groningen, Netherlands; [Havekes, Louis M.] Dutch Org Tech Sci Res TNO Qual Life, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Patras; University of Groningen	Heemskerk, MM (corresponding author), Leiden Univ, Med Ctr, Rm S03-46,POB 9600,Albinusdreef 2,S4-P, NL-2300 RC Leiden, Netherlands.	m.m.heemskerk@lumc.nl	Rensen, Patrick C.N./D-7176-2018; van Dijk, Ko Willems/AAT-4681-2021; van den Berg, Sjoerd A/R-9541-2018; van Dijk, Ko Willems/A-1798-2008	Rensen, Patrick C.N./0000-0002-8455-4988; van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; Schaap, Frank/0000-0002-1597-572X; van den Berg, Sjoerd/0000-0001-8967-376X; van Harmelen, Vanessa/0000-0003-0111-9858; van den Berg, Sjoerd/0000-0001-5937-7505	Center of Medical Systems Biology (CMSB); Netherlands Consortium for Systems Biology (NCSB); Netherlands Diabetes Foundation [DFN2007.00.010]; Netherlands Heart Foundation [2009T038]	Center of Medical Systems Biology (CMSB); Netherlands Consortium for Systems Biology (NCSB); Netherlands Diabetes Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was supported by grants from the Center of Medical Systems Biology (CMSB), the Netherlands Consortium for Systems Biology (NCSB) established by The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO), and the Netherlands Diabetes Foundation (DFN2007.00.010 to P.C.N.R.). P.C.N.R. is an established investigator of the Netherlands Heart Foundation (grant 2009T038). Furthermore, the authors thank Rick Havinga (University Medical Center Groningen, Groningen, The Netherlands) for surgical and analytical assistance.	Austin MA, 2000, CIRCULATION, V101, P2777, DOI 10.1161/01.CIR.101.24.2777; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Candela P, 2008, ENDOTHELIUM-J ENDOTH, V15, P254, DOI 10.1080/10623320802487759; Chan DC, 2006, ARTERIOSCL THROM VAS, V26, P590, DOI 10.1161/01.ATV.0000203519.25116.54; Chan DC, 2004, CLIN SCI, V107, P233, DOI 10.1042/CS20040109; Chen ES, 2010, LIPIDS, V45, P511, DOI 10.1007/s11745-010-3426-z; Coomans CP, 2011, DIABETES, V60, P3132, DOI 10.2337/db10-1100; Coomans CP, 2011, J LIPID RES, V52, P1712, DOI 10.1194/jlr.M015396; Corella D, 2007, J MOL MED-JMM, V85, P119, DOI 10.1007/s00109-006-0147-0; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; Dehouck B, 1997, J CELL BIOL, V138, P877, DOI 10.1083/jcb.138.4.877; Demeester N, 2000, J LIPID RES, V41, P963; Dhurandhar NV, 2002, J NUTR, V132, P3155, DOI 10.1093/jn/131.10.3155; Dichlberger A, 2007, J LIPID RES, V48, P1451, DOI 10.1194/jlr.C600026-JLR200; Forte TM, 2009, J LIPID RES, V50, pS150, DOI 10.1194/jlr.R800050-JLR200; Fox PT, 2002, NAT REV NEUROSCI, V3, P319, DOI 10.1038/nrn789; FUJIMOTO K, 1993, J CLIN INVEST, V91, P1830, DOI 10.1172/JCI116395; Genoux A, 2005, ARTERIOSCL THROM VAS, V25, P1186, DOI 10.1161/01.ATV.0000163841.85333.83; Gerritsen G, 2005, J LIPID RES, V46, P1466, DOI 10.1194/jlr.M400479-JLR200; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Glatzle J, 2004, AM J PHYSIOL-REG I, V287, pR354, DOI 10.1152/ajpregu.00705.2003; Gotoh K, 2006, AM J PHYSIOL-REG I, V290, pR202, DOI 10.1152/ajpregu.00502.2005; Grosskopf I, 2005, ARTERIOSCL THROM VAS, V25, P2573, DOI 10.1161/01.ATV.0000186189.26141.12; Guardiola M, 2012, NUTR METAB CARDIOVAS, V22, P756, DOI 10.1016/j.numecd.2010.12.003; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847; Hishida A, 2012, ENDOCR J, V59, P589, DOI 10.1507/endocrj.EJ11-0310; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Horvatovich K, 2011, INT J PEDIATR OBES, V6, pE318, DOI 10.3109/17477166.2010.490268; Ishihara M, 2005, J LIPID RES, V46, P2015, DOI 10.1194/jlr.D500018-JLR200; Karagiannides I, 2008, FEBS J, V275, P4796, DOI 10.1111/j.1742-4658.2008.06619.x; Kim JY, 2006, J AM COLL NUTR, V25, P340, DOI 10.1080/07315724.2006.10719544; Koch S, 2001, J LIPID RES, V42, P1143; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Merkel M, 2005, J CLIN INVEST, V115, P2694, DOI 10.1172/JCI26712; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Moreno-Luna R, 2007, J CLIN ENDOCR METAB, V92, P2280, DOI 10.1210/jc.2006-1802; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullier A, 2010, J COMP NEUROL, V518, P943, DOI 10.1002/cne.22273; Nelbach L, 2008, J LIPID RES, V49, P572, DOI 10.1194/jlr.M700281-JLR200; O'Brien PJ, 2005, CLIN CHEM, V51, P351, DOI 10.1373/clinchem.2004.040824; OKUMURA T, 1994, GASTROENTEROLOGY, V107, P1861, DOI 10.1016/0016-5085(94)90833-8; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Ponten F, 2011, J INTERN MED, V270, P428, DOI 10.1111/j.1365-2796.2011.02427.x; Pruneta-Deloche V, 2005, ATHEROSCLEROSIS, V181, P403, DOI 10.1016/j.atherosclerosis.2005.01.034; Rensen PCN, 1997, J LIPID RES, V38, P1070; Sanchez-Moreno C, 2011, J NUTR, V141, P380, DOI 10.3945/jn.110.130344; Schaap FG, 2004, J BIOL CHEM, V279, P27941, DOI 10.1074/jbc.M403240200; Schaap FG, 2006, J LIPID RES, V47, P2333, DOI 10.1194/jlr.M500533-JLR200; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Schwinkendorf DR, 2011, INT J OBESITY, V35, P336, DOI 10.1038/ijo.2010.159; Shen L, 2008, DIABETES, V57, P2092, DOI 10.2337/db08-0291; Shimogori T, 2010, NAT NEUROSCI, V13, P767, DOI 10.1038/nn.2545; Shu X, 2008, J LIPID RES, V49, P1670, DOI 10.1194/jlr.M800111-JLR200; Shu X, 2010, BBA-MOL CELL BIOL L, V1801, P605, DOI 10.1016/j.bbalip.2010.02.004; Smith CE, 2010, OBESITY, V18, P327, DOI 10.1038/oby.2009.216; So PW, 2005, INT J OBESITY, V29, P603, DOI 10.1038/sj.ijo.0802917; Tiller G, 2009, ENDOCRINOLOGY, V150, P5373, DOI 10.1210/en.2009-0488; van der Hoogt CC, 2006, BBA-MOL CELL BIOL L, V1761, P213, DOI 10.1016/j.bbalip.2006.01.002; van der Vliet HN, 2001, J BIOL CHEM, V276, P44512, DOI 10.1074/jbc.M106888200; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; von Eckardstein A, 2009, CURR OPIN LIPIDOL, V20, P197, DOI 10.1097/MOL.0b013e32832afd63; Weinberg RB, 2003, J BIOL CHEM, V278, P34438, DOI 10.1074/jbc.M303784200; Whigham LD, 2006, AM J PHYSIOL-REG I, V290, pR190, DOI 10.1152/ajpregu.00479.2005; Wolfgang MJ, 2006, J BIOL CHEM, V281, P37265, DOI 10.1074/jbc.R600016200; Yang L, 2012, J LIPID RES, V53, P1245, DOI 10.1194/jlr.R024117; Zheng XY, 2012, BIOL CHEM, V393, P161, DOI 10.1515/hsz-2011-0259; Ziotopoulou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE838, DOI 10.1152/ajpendo.2000.279.4.E838	72	10	10	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3354	3362		10.1096/fj.12-225367	http://dx.doi.org/10.1096/fj.12-225367			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23650188				2022-12-25	WOS:000329877600040
J	Denoel, M; Perez, A; Cornet, Y; Ficetola, GF				Denoel, Mathieu; Perez, Amelie; Cornet, Yves; Ficetola, Gentile Francesco			Similar Local and Landscape Processes Affect Both a Common and a Rare Newt Species	PLOS ONE			English	Article							TRITURUS-CRISTATUS; MODEL SELECTION; HABITAT DETERMINANTS; AMPHIBIAN OCCURRENCE; BEHAVIORAL ECOLOGY; MICROHABITAT USE; POND; CONSERVATION; FISH; TERRESTRIAL	Although rare species are often the focus of conservation measures, more common species may experience similar decline and suffer from the same threatening processes. We tested this hypothesis by examining, through an information-theoretic approach, the importance of ecological processes at multiple scales in the great crested newt Triturus cristatus, regionally endangered and protected in Europe, and the more common smooth newt, Lissotriton vulgaris. Both species were similarly affected by the same processes, i.e. suitability of aquatic and terrestrial components of their habitat at different scales, connectivity among breeding sites, and the presence of introduced fish. T. cristatus depended more on water depth and aquatic vegetation than L. vulgaris. The results show that environmental pressures threaten both common and rare species, and therefore the more widespread species should not be neglected in conservation programs. Because environmental trends are leading to a deterioration of aquatic and terrestrial habitat features required by newt populations, populations of the common species may follow the fate of the rarest species. This could have substantial conservation implications because of the numerical importance of common species in ecosystems and because commonness could be a transient state moving towards rarity. On the other hand, in agreement with the umbrella species concept, targeting conservation efforts on the most demanding species would also protect part of the populations of the most common species.	[Denoel, Mathieu; Perez, Amelie] Univ Liege, Dept Ecol & Evolut Biol, Behav Biol Unit, Lab Fish & Amphibian Ethol, Liege, Belgium; [Cornet, Yves] Univ Liege, Geomat Unit, Liege, Belgium; [Ficetola, Gentile Francesco] Univ Milano Bicocca, Dept Environm Sci, Milan, Italy	University of Liege; University of Liege; University of Milano-Bicocca	Denoel, M (corresponding author), Univ Liege, Dept Ecol & Evolut Biol, Behav Biol Unit, Lab Fish & Amphibian Ethol, Liege, Belgium.	Mathieu.Denoel@ulg.ac.be	Ficetola, Gentile Francesco/A-2813-2008	Ficetola, Gentile Francesco/0000-0003-3414-5155; Denoel, Mathieu/0000-0002-3586-8323	University of Milano-Bicocca; public grant of Service Public de Wallonie; Contrat de riviere du sous-bassin hydrographique de la Vesdre, F.R.S. - FNRS (Credit au chercheur) [1.5.040.10]; Fonds Speciaux pour la Recherche (University of Liege) [C11/23]	University of Milano-Bicocca; public grant of Service Public de Wallonie; Contrat de riviere du sous-bassin hydrographique de la Vesdre, F.R.S. - FNRS (Credit au chercheur)(Fonds de la Recherche Scientifique - FNRS); Fonds Speciaux pour la Recherche (University of Liege)(University of Liege)	MD is a Research Associate at the F.R.S. - Fonds de la Recherche Scientifique (Belgium). GFF was funded by a scholarship of the University of Milano-Bicocca. This research benefited from a public grant of Service Public de Wallonie, Contrat de riviere du sous-bassin hydrographique de la Vesdre, F.R.S. - FNRS (Credit au chercheur 1.5.040.10) and Fonds Speciaux pour la Recherche (C11/23 - University of Liege). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Arntzen JW, 2002, J HERPETOL, V36, P272, DOI 10.1670/0022-1511(2002)036[0272:TFECOT]2.0.CO;2; Arntzen JW, 2008, IUCN RED LIST THREAT; BEEBEE T J C, 1985, Amphibia-Reptilia, V6, P35, DOI 10.1163/156853885X00164; Bonardi A, 2011, BIOL CONSERV, V144, P2328, DOI 10.1016/j.biocon.2011.06.011; Boothby J., 1998, PONDS POND LANDSCAPE, P1; Branton M, 2011, CONSERV BIOL, V25, P9, DOI 10.1111/j.1523-1739.2010.01606.x; BRAZ E, 1994, ARCH HYDROBIOL, V131, P129; Breheny, 2020, PACKAGE VISREGR PACK; COOKE AS, 1976, J ZOOL, V178, P223; Curado N, 2011, BIOL CONSERV, V144, P1610, DOI 10.1016/j.biocon.2011.02.011; Denoel M, 2005, CONSERV BIOL, V19, P162, DOI 10.1111/j.1523-1739.2005.00001.x; Denoel M, 2003, BELG J ZOOL, V133, P95; Denoel M, 2009, BIOL CONSERV, V142, P509, DOI 10.1016/j.biocon.2008.11.008; Denoel M, 2008, AQUAT CONSERV, V18, P714, DOI 10.1002/aqc.853; Denoel M, 2007, ECOL APPL, V17, P302, DOI 10.1890/1051-0761(2007)017[0302:LTANC]2.0.CO;2; Denoel Mathieu, 2004, Bulletin de la Societe Herpetologique de France, V111-112, P49; Denoel M, 2006, BIOL CONSERV, V130, P495, DOI 10.1016/j.biocon.2006.01.009; Denoel M, 2012, BIODIVERS CONSERV, V21, P2887, DOI 10.1007/s10531-012-0343-x; DOLMEN D, 1982, Fauna Norvegica Series A, V3, P12; Edgar P., 2005, ACTION PLAN CONSERVA; Egea-Serrano A, 2011, ECOTOXICOLOGY, V20, P1246, DOI 10.1007/s10646-011-0673-6; Ficetola GF, 2011, DIVERS DISTRIB, V17, P1141, DOI 10.1111/j.1472-4642.2011.00797.x; Ficetola GF, 2011, ECOL APPL, V21, P1272, DOI 10.1890/10-0431.1; Ficetola GF, 2009, CONSERV BIOL, V23, P114, DOI 10.1111/j.1523-1739.2008.01081.x; Ficetola GF, 2004, BIOL CONSERV, V119, P219, DOI 10.1016/j.biocon.2003.11.004; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Gaston KJ, 2011, BIOSCIENCE, V61, P354, DOI 10.1525/bio.2011.61.5.4; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Gent T, 2001, RANA, V4, P295; Griffiths RA, 2010, BIOL CONSERV, V143, P485, DOI 10.1016/j.biocon.2009.11.017; Gustafson DH, 2009, J HERPETOL, V43, P300, DOI 10.1670/07-216R1.1; Halley JM, 1996, J APPL ECOL, V33, P455, DOI 10.2307/2404977; Hartel T, 2007, HYDROBIOLOGIA, V583, P173, DOI 10.1007/s10750-006-0490-8; Hartel T, 2010, ENVIRON CONSERV, V37, P195, DOI 10.1017/S037689291000055X; Hartel T, 2010, BIOL CONSERV, V143, P1118, DOI 10.1016/j.biocon.2010.02.006; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Jehle R, 2005, J EVOLUTION BIOL, V18, P619, DOI 10.1111/j.1420-9101.2004.00864.x; Jehle R, 2000, HERPETOL J, V10, P137; Jehle R., 2011, CRESTED NEWT DWINDLI; Johnson PTJ, 2011, CONSERV BIOL, V25, P556, DOI 10.1111/j.1523-1739.2010.01645.x; Joly P, 2001, CONSERV BIOL, V15, P239, DOI 10.1046/j.1523-1739.2001.99200.x; Kopecky O, 2010, AMPHIBIA-REPTILIA, V31, P109, DOI 10.1163/156853810790457821; Lambeck RJ, 1997, CONSERV BIOL, V11, P849, DOI 10.1046/j.1523-1739.1997.96319.x; Leu T, 2009, AMPHIBIA-REPTILIA, V30, P290, DOI 10.1163/156853809788201153; Lindenmayer DB, 2002, CONSERV BIOL, V16, P338, DOI 10.1046/j.1523-1739.2002.00450.x; Maletzky A, 2007, ANN LIMNOL-INT J LIM, V43, P107, DOI 10.1051/limn/2007017; Malmgren JC, 2002, HERPETOL J, V12, P29; Marnell F, 1998, J ZOOL, V244, P1; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; Meyer A., 2009, AMPHIBIENS REPTILES, P257; MIAUD C, 1994, COPEIA, P535; MIAUD C, 1993, J ZOOL, V231, P575, DOI 10.1111/j.1469-7998.1993.tb01939.x; Monello RJ, 2001, J HERPETOL, V35, P350, DOI 10.2307/1566132; Perret N, 2003, J ANIM ECOL, V72, P567, DOI 10.1046/j.1365-2656.2003.00726.x; Piha H, 2007, ECOL APPL, V17, P2298, DOI 10.1890/06-1509.1; Rannap R, 2009, HYDROBIOLOGIA, V634, P87, DOI 10.1007/s10750-009-9884-8; Rannap R, 2009, DIVERS DISTRIB, V15, P692, DOI 10.1111/j.1472-4642.2009.00575.x; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Schabetsberger R, 2004, BIOL CONSERV, V117, P95, DOI 10.1016/S0006-3207(03)00268-4; Schmidt B, 2005, LISTA ROSSA SPECIE M; Schmidt BR, 2005, J EVOLUTION BIOL, V18, P415, DOI 10.1111/j.1420-9101.2004.00822.x; Semlitsch RD, 2008, J WILDLIFE MANAGE, V72, P260, DOI 10.2193/2007-082; Skei JK, 2006, AMPHIBIA-REPTILIA, V27, P309, DOI 10.1163/156853806778189972; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Sztatecsny M, 2004, HERPETOL J, V14, P89; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; Vredenburg VT, 2004, P NATL ACAD SCI USA, V101, P7646, DOI 10.1073/pnas.0402321101; Wagner N, 2011, AMPHIBIA-REPTILIA, V32, P323, DOI 10.1163/017353711X579768; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wilbur HM, 1997, ECOLOGY, V78, P2279, DOI 10.1890/0012-9658(1997)078[2279:EEOFWC]2.0.CO;2; Winandy L, 2013, ETHOLOGY, V119, P121, DOI 10.1111/eth.12043; Wood PJ, 2003, AREA, V35, P206, DOI 10.1111/1475-4762.00249; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x	78	42	42	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62727	10.1371/journal.pone.0062727	http://dx.doi.org/10.1371/journal.pone.0062727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658765	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100035
J	Fan, LL; Song, B; Sun, GP; Ma, T; Zhong, F; Wei, W				Fan, Lulu; Song, Bing; Sun, Guoping; Ma, Tai; Zhong, Fei; Wei, Wei			Endoplasmic Reticulum Stress-Induced Resistance to Doxorubicin Is Reversed by Paeonol Treatment in Human Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; APOPTOSIS INDUCTION; CANCER; CYCLOOXYGENASE-2; LINES; ANTIPROLIFERATION; CISPLATIN; THERAPY; BIOLOGY	Background: Endoplasmic reticulum stress (ER stress) is generally activated in solid tumors and results in tumor cell antiapoptosis and drug resistance. Paeonol (Pae, 2-hydroxy-4-methoxyacetophenone), is a natural product extracted from the root of Paeonia Suffruticosa Andrew. Although Pae displays anti-neoplastic activity and increases the efficacy of chemotherapeutic drugs in various cell lines and in animal models, studies related to the effect of Pae on ER stress-induced resistance to chemotherapeutic agents in hepatocellular carcinoma (HCC) are poorly understood. Methodology/Principal Findings: In this study, we investigated the effect of the endoplasmic reticulum (ER) stress response during resistance of human hepatocellular carcinoma cells to doxorubicin. Treatment with the ER stress-inducer tunicamycin (TM) before the addition of doxorubicin reduced the rate of apoptosis induced by doxorubicin. Interestingly, co-pretreatment with tunicamycin and Pae significantly increased apoptosis induced by doxorubicin. Furthermore, induction of ER stress resulted in increasing expression of COX-2 concomitant with inactivation of Akt and up-regulation of the proapoptotic transcription factor CHOP (GADD153) in HepG2 cells. These cellular changes in gene expression and Akt activation may be an important resistance mechanism against doxorubicin in hepatocellular carcinoma cells undergoing ER stress. However, co-pretreatment with tunicamycin and Pae decreased the expression of COX-2 and levels of activation of Akt as well as increasing the levels of CHOP in HCC cells. Conclusions/Significance: Our results demonstrate that Pae reverses ER stress-induced resistance to doxorubicin in human hepatocellular carcinoma cells by targeting COX-2 mediated inactivation of PI3K/AKT/CHOP.	[Fan, Lulu; Sun, Guoping; Ma, Tai; Zhong, Fei] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Anhui, Peoples R China; [Song, Bing] Anhui Med Univ, Affiliated Hosp 1, Dept Cardiovasol, Hefei, Anhui, Peoples R China; [Wei, Wei] Anhui Med Univ, Inst Clin Pharmacol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Sun, GP (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Anhui, Peoples R China.	sunguoping@ahmu.edu.cn			Natural Science Foundation of China [81071986]; Research Fund for the Dectoral Program of Higher Education [20113420110002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Dectoral Program of Higher Education	This work was supported by the Natural Science Foundation of China (No. 81071986) and Research Fund for the Dectoral Program of Higher Education (NO. 20113420110002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catalano RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019209; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; Diehl JA, 2011, GASTROENTEROLOGY, V141, P38, DOI 10.1053/j.gastro.2011.05.018; Hersey P, 2008, PIGM CELL MELANOMA R, V21, P358, DOI 10.1111/j.1755-148X.2008.00467.x; Hinz B, 2002, J PHARMACOL EXP THER, V300, P367, DOI 10.1124/jpet.300.2.367; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Jiang S P, 1994, Zhongguo Zhong Yao Za Zhi, V19, P311; Kanaoka S, 2007, ADV CLIN CHEM, V43, P59, DOI 10.1016/S0065-2423(06)43002-X; Kapoor A, 2009, CLIN LIVER DIS, V13, P581, DOI 10.1016/j.cld.2009.07.004; Lee HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012358; Lencioni R, 2010, ONCOLOGIST, V15, P42, DOI 10.1634/theoncologist.2010-S4-42; Li N, 2010, WORLD J GASTROENTERO, V16, P4483, DOI 10.3748/wjg.v16.i35.4483; Liao ZX, 2007, DRUGS, V67, P821, DOI 10.2165/00003495-200767060-00001; Mendizabal M, 2009, MED CLIN N AM, V93, P885, DOI 10.1016/j.mcna.2009.03.004; Merquiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024660; Mujcic H, 2009, RADIOTHER ONCOL, V92, P450, DOI 10.1016/j.radonc.2009.08.017; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Riley CM, 1989, J CHROMATOGR, V489, P427; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Sun GP, 2008, DIS ESOPHAGUS, V21, P723, DOI 10.1111/j.1442-2050.2008.00840.x; Sun GP, 2008, EUR J PHARMACOL, V584, P246, DOI 10.1016/j.ejphar.2008.02.016; Wan XA, 2008, DIGEST LIVER DIS, V40, P531, DOI 10.1016/j.dld.2008.01.012; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Xu SP, 2007, ACTA PHARMACOL SIN, V28, P869, DOI 10.1111/j.1745-7254.2007.00564.x; Xu SP, 2007, WORLD J GASTROENTERO, V13, P250, DOI 10.3748/wjg.v13.i2.250; 孙言才, 2004, [中成药, Chinese Traditional Patent Medicine], V26, P579	30	44	53	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62627	10.1371/journal.pone.0062627	http://dx.doi.org/10.1371/journal.pone.0062627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658755	Green Submitted, Green Published, gold			2022-12-25	WOS:000321202100023
J	Gelderblom, M; Neumann, M; Ludewig, P; Bernreuther, C; Krasemann, S; Arunachalam, P; Gerloff, C; Glatzel, M; Magnus, T				Gelderblom, Mathias; Neumann, Melanie; Ludewig, Peter; Bernreuther, Christian; Krasemann, Susanne; Arunachalam, Priyadharshini; Gerloff, Christian; Glatzel, Markus; Magnus, Tim			Deficiency in Serine Protease Inhibitor Neuroserpin Exacerbates Ischemic Brain Injury by Increased Postischemic Inflammation	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; FOCAL CEREBRAL-ISCHEMIA; NECROSIS-FACTOR-ALPHA; MICROGLIAL ACTIVATION; STROKE; NEURONS; ACCUMULATION; ASSOCIATION; ALTEPLASE; BARRIER	The only approved pharmacological treatment for ischemic stroke is intravenous administration of plasminogen activator (tPA) to re-canalize the occluded cerebral vessel. Not only reperfusion but also tPA itself can induce an inflammatory response. Microglia are the innate immune cells of the central nervous system and the first immune cells to become activated in stroke. Neuroserpin, an endogenous inhibitor of tPA, is up-regulated following cerebral ischemia. To examine neuroserpin-dependent mechanisms of neuroprotection in stroke, we studied neuroserpin deficient (Ns(-/-)) mice in an animal model of temporal focal ischemic stroke. Infarct size and neurological outcome were worse in neuroserpin deficient mice even though the fibrinolytic activity in the ischemic brain was increased. The increased infarct size was paralleled by a selective increase in proinflammatory microglia activation in Ns(-/-) mice. Our results show excessive microglial activation in Ns(-/-) mice mediated by an increased activity of tPA. This activation results in a worse outcome further underscoring the potential detrimental proinflammatory effects of tPA.	[Gelderblom, Mathias; Ludewig, Peter; Arunachalam, Priyadharshini; Gerloff, Christian; Magnus, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Neumann, Melanie; Bernreuther, Christian; Krasemann, Susanne; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Magnus, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	t.magnus@uke.de	Glatzel, Markus/V-8844-2019; Glatzel, Markus/G-3356-2011	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817; Gerloff, Christian/0000-0002-6484-8882; Krasemann, Susanne/0000-0001-8795-818X	Landesexzellenzinitiative Hamburg; ERANET/NANOSTROKE	Landesexzellenzinitiative Hamburg; ERANET/NANOSTROKE	This work was supported by grants from the Landesexzellenzinitiative Hamburg (M.G., T.M. and C.G) and ERANET/NANOSTROKE (T.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; Cole JW, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-37; Copin JC, 2011, EUR J NEUROSCI, V34, P1085, DOI 10.1111/j.1460-9568.2011.07843.x; del Zoppo GJ, 2007, STROKE, V38, P646, DOI 10.1161/01.STR.0000254477.34231.cb; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Galliciotti G, 2007, AM J PATHOL, V170, P1305, DOI 10.2353/ajpath.2007.060910; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Osterwalder T, 1998, J BIOL CHEM, V273, P2312, DOI 10.1074/jbc.273.4.2312; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; Rodriguez-Gonzalez R, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-58; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Siao CJ, 2003, J NEUROSCI, V23, P3234; Siao CJ, 2002, J NEUROSCI, V22, P3352; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Tjarnlund-Wolf A, 2011, J NEUROL, V258, P1885, DOI 10.1007/s00415-011-6022-0; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yepes M, 2000, BLOOD, V96, P569; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; Zhang C, 2009, J CEREBR BLOOD F MET, V29, P1946, DOI 10.1038/jcbfm.2009.174; Zhang C, 2009, AM J PATHOL, V174, P586, DOI 10.2353/ajpath.2009.080661	32	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63118	10.1371/journal.pone.0063118	http://dx.doi.org/10.1371/journal.pone.0063118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658802	gold, Green Published, Green Submitted			2022-12-25	WOS:000321202100053
J	Mirabella, G; Iaconelli, S; Modugno, N; Giannini, G; Lena, F; Cantore, G				Mirabella, Giovanni; Iaconelli, Sara; Modugno, Nicola; Giannini, Giorgio; Lena, Francesco; Cantore, Gianpaolo			Stimulation of Subthalamic Nuclei Restores a Near Normal Planning Strategy in Parkinson's Patients	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; CHOICE-REACTION-TIME; OF-NO-RETURN; RESPONSE-INHIBITION; AIMING MOVEMENTS; DISEASE; EXECUTION; MEDICATION; SEQUENCES; SIGNS	A fundamental function of the motor system is to gather key information from the environment in order to implement behavioral strategies appropriate to the context. Although several lines of evidence indicate that Parkinson's disease affects the ability to modify behavior according to task requirements, it is currently unknown whether deep brain stimulation (DBS) of the subthalamic nucleus (STN) affects context-related planning. To explore this issue, we asked 12 Parkinson's patients with bilateral STN DBS and 13 healthy subjects to execute similar arm reaching movements in two different paradigms: go-only and countermanding tasks. In the former task patients had to perform speeded reaching movements to a peripheral target. In contrast, in the countermanding task participants had to perform the same reaches unless an infrequent and unpredictable stop-signal was shown during the reaction time (RT) indicating that they should withhold the ongoing action. We compared the performance of Parkinson's patients in different DBS conditions. We found that patients with both DBS-ON behaved similarly to healthy subjects, in that RTs of no-stop trial increased while movement times (MTs) decreased with respect to those of go-only-trials. However, when both DBS were off, both RTs and MTs were longer in no-stop trials than in go-only trials. These findings indicate that bilateral DBS of STN can partially restore the appropriate motor strategy according to the given cognitive contexts.	[Mirabella, Giovanni; Iaconelli, Sara; Modugno, Nicola; Giannini, Giorgio; Lena, Francesco; Cantore, Gianpaolo] Ist Neurol Mediterraneo Neuromed, Dept Neurosci, Pozzilli, IS, Italy; [Mirabella, Giovanni] Univ Roma La Sapienza, Dept Physiol & Pharmacol V Erspamer, I-00185 Rome, Italy	IRCCS Neuromed; Sapienza University Rome	Mirabella, G (corresponding author), Ist Neurol Mediterraneo Neuromed, Dept Neurosci, Pozzilli, IS, Italy.	giovanni.mirabella@uniroma1.it	modugno, nicola/AAN-8889-2020; lena, francesco/AAE-3229-2020; Mirabella, Giovanni/AAB-2818-2019; Modugno, Nicola/AAB-3527-2019	modugno, nicola/0000-0001-5243-1775; lena, francesco/0000-0001-5528-319X; Mirabella, Giovanni/0000-0002-4405-2609; 	Italian Ministry of Work, Health and Social Policies (Bando Giovani ricercatori); Italian Ministry of University and Research [2008_RBFNLH_005]	Italian Ministry of Work, Health and Social Policies (Bando Giovani ricercatori); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This research was supported by (i) the Italian Ministry of Work, Health and Social Policies (Bando Giovani ricercatori 2007 to GM); (ii) Italian Ministry of University and Research (PRIN n.2008_RBFNLH_005 to GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JJ, 2000, J EXP PSYCHOL HUMAN, V26, P295, DOI 10.1037/0096-1523.26.1.295; AGOSTINO R, 1992, BRAIN, V115, P1481, DOI 10.1093/brain/115.5.1481; Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; BENECKE R, 1987, BRAIN, V110, P361, DOI 10.1093/brain/110.2.361; Brown LA, 2007, NEUROSCI LETT, V418, P292, DOI 10.1016/j.neulet.2007.03.040; Cavanagh JF, 2011, NAT NEUROSCI, V14, P1462, DOI 10.1038/nn.2925; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Doan JB, 2010, BEHAV BRAIN RES, V214, P135, DOI 10.1016/j.bbr.2010.05.006; EIDELBERG D, 1990, MOVEMENT DISORD, V5, P203, DOI 10.1002/mds.870050304; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Garcia L, 2005, TRENDS NEUROSCI, V28, P209, DOI 10.1016/j.tins.2005.02.005; HENRY FM, 1960, RES QUART, V31, P448, DOI 10.1080/10671188.1960.10762052; Khan MA, 2006, Q J EXP PSYCHOL, V59, P524, DOI 10.1080/02724980443000809; Klapp ST, 1996, REACTION TIME ANAL C, P13; Leis BC, 2005, EXP NEUROL, V194, P393, DOI 10.1016/j.expneurol.2005.02.014; Levitt H, 1971, J ACOUST SOC AM S, V49; Logan G. D., 1981, ATTENTION PERFORM, VIX, P205; Lopiano L, 2003, EUR NEUROL, V50, P94, DOI 10.1159/000072506; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; Mirabella G, 2012, CEREB CORTEX, V22, P1124, DOI 10.1093/cercor/bhr187; Mirabella G, 2009, EXP BRAIN RES, V192, P199, DOI 10.1007/s00221-008-1570-y; Mirabella G, 2006, EXP BRAIN RES, V174, P240, DOI 10.1007/s00221-006-0456-0; Mirabella G, 2008, COGN NEUROPSYCHOL, V25, P996, DOI 10.1080/02643290802003216; Moro E, 1999, NEUROLOGY, V53, P85, DOI 10.1212/WNL.53.1.85; MUNGAS D, 1991, GERIATRICS, V46, P54; OSMAN A, 1990, J EXP PSYCHOL HUMAN, V16, P183, DOI 10.1037/0096-1523.16.1.183; OSMAN A, 1986, J EXP PSYCHOL HUMAN, V12, P243, DOI 10.1037/0096-1523.12.3.243; Rand MK, 2002, EXP BRAIN RES, V143, P383, DOI 10.1007/s00221-002-1000-5; Ray NJ, 2009, NEUROPSYCHOLOGIA, V47, P2828, DOI 10.1016/j.neuropsychologia.2009.06.011; ROSENBAUM DA, 1987, J EXP PSYCHOL HUMAN, V13, P193, DOI 10.1037/0096-1523.13.2.193; Scangos KW, 2010, J NEUROSCI, V30, P1968, DOI 10.1523/JNEUROSCI.4509-09.2010; Smiley-Oyen AL, 2007, J MOTOR BEHAV, V39, P103, DOI 10.3200/JMBR.39.2.103-114; Stancanello J, 2008, MED PHYS, V35, P3069, DOI 10.1118/1.2936229; Stancanello J, 2006, MED PHYS, V33, P1603, DOI 10.1118/1.2198588; STELMACH GE, 1987, INT J NEUROSCI, V36, P55, DOI 10.3109/00207458709002139; Sternberg S, 1978, LATENCY DURATION RAP, P117; Stuphorn V, 2006, NAT NEUROSCI, V9, P925, DOI 10.1038/nn1714; Sturman MM, 2008, MOVEMENT DISORD, V23, P866, DOI 10.1002/mds.21979; Swann N, 2011, J NEUROSCI, V31, P5721, DOI 10.1523/JNEUROSCI.6135-10.2011; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Toth C, 2004, MOVEMENT DISORD, V19, P151, DOI 10.1002/mds.10685; van den Wildenberg WPM, 2006, J COGNITIVE NEUROSCI, V18, P626, DOI 10.1162/jocn.2006.18.4.626; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Vindras P, 2005, EXP BRAIN RES, V160, P141, DOI 10.1007/s00221-004-1995-x; Weiss P, 1997, BRAIN, V120, P91, DOI 10.1093/brain/120.1.91; Wylie SA, 2010, BRAIN, V133, P3611, DOI 10.1093/brain/awq239; Zandbelt BB, 2011, BIOL PSYCHIAT, V70, P1151, DOI 10.1016/j.biopsych.2011.07.028; Zandbelt BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013848	50	54	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62793	10.1371/journal.pone.0062793	http://dx.doi.org/10.1371/journal.pone.0062793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658775	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100041
J	Deng, W; Putkey, JA; Li, RH				Deng, Wei; Putkey, John A.; Li, Renhao			Calmodulin Adopts an Extended Conformation when Interacting with L-Selectin in Membranes	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; TARGET RECOGNITION; CYTOPLASMIC DOMAIN; BILAYER THICKNESS; CONVERTING ENZYME; CRYSTAL-STRUCTURE; PEPTIDE COMPLEX; BINDING DOMAIN; CROSS-LINKING; KINASE-II	Calmodulin, an intracellular calcium-binding protein, is thought to regulate ectodomain shedding of many membrane proteins, but the underlying molecular mechanism has remained unclear. Basing on a solution structure of calcium-loaded calmodulin in complex with a L-selectin fragment that contains a portion of its transmembrane domain, Gifford et al. (University of Calgary) recently suggested that calmodulin regulates L-selectin shedding by binding directly to a portion of the L-selectin transmembrane domain in a compact conformation. Using fluorescently labeled calmodulin, we show however that calmodulin adopts a distinctly different and much more extended conformation when it binds to the CLS peptide (i.e. the entire transmembrane and cytoplasmic domains of L-selectin) reconstituted in the phosphatidylcholine liposome with micromolar dissociation constant and in a calcium-independent manner. Calmodulin adopts a similarly extended conformation in a ternary complex with the N-terminal FERM domain of moesin and CLS reconstituted in the phospholipid liposome that mimics the native membrane environment. These results indicate that calmodulin does not bind directly to the transmembrane domain of L-selectin. Understanding the association of calmodulin with L-selectin helps to shed light on the mechanisms underlying regulation of ectodomain shedding.	[Deng, Wei; Li, Renhao] Emory Univ, Sch Med, Dept Pediat, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA; [Putkey, John A.] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Emory University; University of Texas System; University of Texas Health Science Center Houston	Li, RH (corresponding author), Emory Univ, Sch Med, Dept Pediat, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA.	renhao.li@emory.edu	Li, Renhao/B-1257-2012	Li, Renhao/0000-0002-5806-5080	NIH [GM084175]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084175] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM084175. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFSHAR M, 1994, J MOL BIOL, V244, P554, DOI 10.1006/jmbi.1994.1752; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Blobel CP, 2002, INFLAMM RES, V51, P83, DOI 10.1007/BF02684007; Chattopadhyay S, 2005, J BIOL CHEM, V280, P33847, DOI 10.1074/jbc.M501718200; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Deng W, 2011, J MOL BIOL, V411, P220, DOI 10.1016/j.jmb.2011.05.041; Diaz-Rodriguez E, 2000, BIOCHEM J, V346, P359, DOI 10.1042/0264-6021:3460359; Dong JY, 2000, J BIOL CHEM, V275, P557, DOI 10.1074/jbc.275.1.557; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; Gardiner EE, 2004, BLOOD, V104, P3611, DOI 10.1182/blood-2004-04-1549; Gawrisch K, 2007, EUR BIOPHYS J BIOPHY, V36, P281, DOI 10.1007/s00249-007-0142-6; Gifford JL, 2012, J BIOL CHEM, V287, P26513, DOI 10.1074/jbc.M112.373373; Gopalan V, 1997, J MOL BIOL, V267, P765, DOI 10.1006/jmbi.1997.0907; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Holt A, 2010, EUR BIOPHYS J BIOPHY, V39, P609, DOI 10.1007/s00249-009-0567-1; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Ivetic A, 2004, BIOCHEM SOC T, V32, P1118, DOI 10.1042/BST0321118; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Killock DJ, 2009, J BIOL CHEM, V284, P8824, DOI 10.1074/jbc.M806983200; Kleerekoper QK, 2009, J BIOL CHEM, V284, P7455, DOI 10.1074/jbc.M808067200; Kurokawa H, 2001, J MOL BIOL, V312, P59, DOI 10.1006/jmbi.2001.4822; LAKOWICZ JR, 1983, J BIOL CHEM, V258, P5519; Lambert DW, 2008, FEBS LETT, V582, P385, DOI 10.1016/j.febslet.2007.11.085; LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Luo SZ, 2007, BLOOD, V109, P603, DOI 10.1182/blood-2006-05-024091; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; MATSUMOTO S, 1975, BIOCHEMISTRY-US, V14, P214, DOI 10.1021/bi00673a004; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PALECANDA A, 1992, EUR J IMMUNOL, V22, P1279, DOI 10.1002/eji.1830220524; PERSECHINI A, 1988, J BIOL CHEM, V263, P12175; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Schlondorff J, 1999, J CELL SCI, V112, P3603; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; SIMON SI, 1995, J IMMUNOL, V155, P1502; Srinivasan S, 2011, BBA-BIOMEMBRANES, V1808, P1709, DOI 10.1016/j.bbamem.2011.02.006; Walcheck B, 1996, NATURE, V380, P720, DOI 10.1038/380720a0; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; WEINSTEIN H, 1994, ANNU REV PHYSIOL, V56, P213, DOI 10.1146/annurev.ph.56.030194.001241; Wong MX, 2004, FEBS LETT, V568, P70, DOI 10.1016/j.febslet.2004.04.094; WU PG, 1994, BIOCHEMISTRY-US, V33, P10457, DOI 10.1021/bi00200a029; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Xiong LW, 2005, J BIOL CHEM, V280, P7070, DOI 10.1074/jbc.M410558200; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; Zhao LC, 2001, J BIOL CHEM, V276, P30631, DOI 10.1074/jbc.M103748200	62	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62861	10.1371/journal.pone.0062861	http://dx.doi.org/10.1371/journal.pone.0062861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658780	Green Published, Green Submitted, gold			2022-12-25	WOS:000321200500042
J	O'Flaherty, JT; Wooten, RE; Samuel, MP; Thomas, MJ; Levine, EA; Case, LD; Akman, SA; Edwards, IJ				O'Flaherty, Joseph T.; Wooten, Rhonda E.; Samuel, Michael P.; Thomas, Michael J.; Levine, Edward A.; Case, L. Douglas; Akman, Steven A.; Edwards, Iris J.			Fatty Acid Metabolites in Rapidly Proliferating Breast Cancer	PLOS ONE			English	Article							COX-2 EXPRESSION; LINOLEIC-ACID; PROGNOSTIC PARAMETERS; DUCTAL CARCINOMA; NUDE-MICE; PROSTAGLANDIN; CELLS; SURVIVAL; CYCLOOXYGENASE-2; LIPOXYGENASES	Purpose: Breast cancers that over-express a lipoxygenase or cyclooxygenase are associated with poor survival possibly because they overproduce metabolites that alter the cancer's malignant behaviors. However, these metabolites and behaviors have not been identified. We here identify which metabolites among those that stimulate breast cancer cell proliferation in vitro are associated with rapidly proliferating breast cancer. Experimental Design: We used selective ion monitoring-mass spectrometry to quantify in the cancer and normal breast tissue of 27 patients metabolites that stimulate (15-, 12-, 5-hydroxy-, and 5-oxo-eicosatetraenoate, 13-hydroxy-octadecaenoate [HODE]) or inhibit (prostaglandin [PG]E-2 and D-2) breast cancer cell proliferation. We then related their levels to each cancer's proliferation rate as defined by its Mib1 score. Results: 13-HODE was the only metabolite strongly, significantly, and positively associated with Mib1 scores. It was similarly associated with aggressive grade and a key component of grade, mitosis, and also trended to be associated with lymph node metastasis. PGE(2) and PGD(2) trended to be negatively associated with these markers. No other metabolite in cancer and no metabolite in normal tissue had this profile of associations. Conclusions: Our data fit a model wherein the overproduction of 13-HODE by 15- lipoxygenase-1 shortens breast cancer survival by stimulating its cells to proliferate and possibly metastasize; no other oxygenase-metabolite pathway, including cyclooxygenase-PGE(2)/D-2 pathways, uses this specific mechanism to shorten survival.	[O'Flaherty, Joseph T.] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC USA; [Wooten, Rhonda E.; Samuel, Michael P.; Thomas, Michael J.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Levine, Edward A.] Wake Forest Sch Med, Dept Surg Oncol, Winston Salem, NC USA; [Case, L. Douglas] Wake Forest Sch Med, Dept Publ Hlth Sci, Winston Salem, NC USA; [Akman, Steven A.] Wake Forest Sch Med, Dept Hematol & Oncol & Canc Biol, Winston Salem, NC USA; [Edwards, Iris J.] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Edwards, IJ (corresponding author), Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA.	iedwards@wakehealth.edu			Golfers Against Cancer; NSF [BIR-9414018]; NIH Shared Instrumentation Program [1S10RR13875]; National Institutes of Health [P01 CA106742, R01 CA 115958, U10 CA081851, P30 CA12197, U1O CA76001, R01 AI064609, R01 CA135288]; NATIONAL CANCER INSTITUTE [U10CA081851, U10CA076001, R01CA115958, P30CA012197, P01CA106742, R01CA135288] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064609] Funding Source: NIH RePORTER	Golfers Against Cancer; NSF(National Science Foundation (NSF)); NIH Shared Instrumentation Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Golfers Against Cancer and National Institutes of Health (grant numbers P01 CA106742, R01 CA 115958, U10 CA081851, P30 CA12197, U1O CA76001, R01 AI064609, and R01 CA135288); the Quattro II mass spectrometer was acquired using funds from the NSF (BIR-9414018, MJT) and the 600 MHz Bruker NMR was purchased in part with funds from the NIH Shared Instrumentation Program (1S10RR13875, MJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avis I, 2001, FASEB J, V15, P2007, DOI 10.1096/fj.00-0866fje; Bardia A, 2011, BREAST CANCER RES TR, V126, P149, DOI 10.1007/s10549-010-1074-x; Barisik NO, 2011, MED ONCOL, V28, P703, DOI 10.1007/s12032-010-9503-6; BENNETT A, 1989, BRIT J CANCER, V59, P268, DOI 10.1038/bjc.1989.56; Brash AR, 1999, ADV EXP MED BIOL, V447, P29; Brueggemeier RW, 1999, CANCER LETT, V140, P27, DOI 10.1016/S0304-3835(99)00050-6; Caly M, 2004, ANTICANCER RES, V24, P3283; Connolly JM, 1996, NUTR CANCER, V25, P231, DOI 10.1080/01635589609514447; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Edwards IJ, 2004, CLIN CANCER RES, V10, P8275, DOI 10.1158/1078-0432.CCR-04-1357; Fentiman I S, 1984, Mol Biol Med, V2, P81; FULTON AM, 1986, INVAS METAST, V6, P83; FUNK CD, 1983, BIOCHIM BIOPHYS ACTA, V754, P57; Hamberg M, 1998, ARCH BIOCHEM BIOPHYS, V349, P376, DOI 10.1006/abbi.1997.0443; Holmes MD, 2011, BREAST CANCER RES TR, V130, P657, DOI 10.1007/s10549-011-1651-7; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Jiang WG, 2006, PROSTAG LEUKOTR ESS, V74, P235, DOI 10.1016/j.plefa.2006.01.009; Jiang WG, 2006, PROSTAG LEUKOTR ESS, V74, P125, DOI 10.1016/j.plefa.2005.10.005; Jiang WG, 2003, PROSTAG LEUKOTR ESS, V69, P275, DOI 10.1016/S0952-3278(03)00110-8; KARMALI RA, 1983, BRIT J CANCER, V48, P689, DOI 10.1038/bjc.1983.251; Kawakami Y, 2009, PROSTAG LEUKOTR ESS, V80, P239, DOI 10.1016/j.plefa.2009.04.006; Kelavkar Uddhav, 2006, J Carcinog, V5, P9, DOI 10.1186/1477-3163-5-9; Kelavkar Uddhav, 2002, Curr Urol Rep, V3, P207, DOI 10.1007/s11934-002-0066-8; Kelly LM, 2003, EUR J SURG ONCOL, V29, P707, DOI 10.1016/j.ejso.2003.07.001; Kerlikowske K, 2010, JNCI-J NATL CANCER I, V102, P627, DOI 10.1093/jnci/djq101; KORT WJ, 1992, PROSTAG LEUKOTR ESS, V45, P319, DOI 10.1016/0952-3278(92)90090-6; Liu XH, 1996, CANCER LETT, V109, P223, DOI 10.1016/S0304-3835(96)04462-X; Mohammad A M, 2006, Indian J Cancer, V43, P163; Nassar A, 2007, APPL IMMUNOHISTO M M, V15, P255, DOI 10.1097/01.pai.0000213130.63417.b3; Nie D, 2007, FRONT BIOSCI, V12, P1574, DOI 10.2741/2170; O'Flaherty JT, 2005, BBA-MOL CELL BIOL L, V1736, P228, DOI 10.1016/j.bbalip.2005.08.009; Offersen BV, 2008, ACTA ONCOL, V47, P618, DOI 10.1080/02841860801958295; OFLAHERTY JT, 1985, PROSTA LEUKOTR MED, V17, P199, DOI 10.1016/0262-1746(85)90107-6; OFLAHERTY JT, 1994, BBA-GEN SUBJECTS, V1201, P505, DOI 10.1016/0304-4165(94)90083-3; Park BW, 2012, BREAST CANCER RES TR, V133, P741, DOI 10.1007/s10549-012-1971-2; PLANCHON P, 1995, LIFE SCI, V57, P1233, DOI 10.1016/0024-3205(95)02069-U; Reno F, 2004, PROSTAG OTH LIPID M, V73, P237, DOI 10.1016/j.prostaglandins.2004.03.002; Schneider C, 2011, CANCER METAST REV, V30, P277, DOI 10.1007/s10555-011-9310-3; Tong WG, 2002, BIOCHEM BIOPH RES CO, V296, P942, DOI 10.1016/S0006-291X(02)02014-4; Vangaveti V, 2010, THER ADV ENDOCRINOL, V1, P51, DOI 10.1177/2042018810375656; Wecksler AT, 2008, BIOCHEMISTRY-US, V47, P7364, DOI 10.1021/bi800550n; Wernli KJ, 2011, PHARMACOEPIDEM DR S, V20, P131, DOI 10.1002/pds.2064; Wulfing P, 2003, J CANCER RES CLIN, V129, P375, DOI 10.1007/s00432-003-0459-1; Zeeneldin A. A., 2009, Indian Journal of Cancer, V46, P54, DOI 10.4103/0019-509X.48597	44	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63076	10.1371/journal.pone.0063076	http://dx.doi.org/10.1371/journal.pone.0063076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658799	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500054
J	Leblanc, L; Rubinoff, D; Wright, MG				Leblanc, Luc; Rubinoff, Daniel; Wright, Mark G.			Conservation Implications of Changes in Endemic Hawaiian Drosophilidae Diversity across Land Use Gradients	PLOS ONE			English	Article							PICTURE-WINGED DROSOPHILA; DIPTERA-DROSOPHILIDAE; RAIN-FOREST; TEPHRITIDAE; ATTRACTION	Endemic Hawaiian Drosophilidae, a radiation of nearly 1000 species including 13 federally listed as endangered, occur mostly in intact native forest, 500-1500 m above sea level. But their persistence in disturbed forest and agricultural areas has not been documented. Thus, control efforts for agricultural pests may impact endemic species if previously undocumented refugia in agricultural areas may play a role in their conservation. To quantify whether invasive plants and agriculture habitats may harbor endemic Drosophilidae, we established standardized trapping arrays, with traps typically designed to control invasive fruit flies (Tephritidae), with 81 sites across native, disturbed and agricultural land use gradients on the islands of Hawai'i and Maui. We collected and identified, to species level, over 22,000 specimens. We found 121 of the possible 292 species expected to occur in the sampled areas, and the majority (91%) of the captured specimens belonged to 24 common species. Species diversity and numbers were greatest in the native forest, but 55% of the species occurred in the invasive strawberry guava belt and plantation forest, adjacent to and almost 500 m from native forest, and 22 species were collected in orchards and nonnative forest as far as 10 km from native habitats. Their persistence outside of native forest suggests that more careful management of disturbed forest and a reassessment of its conservation value are in order. Conservation efforts and assessments of native forest integrity should include the subset of species restricted to intact native forest, since these species are highly localized and particularly sensitive. Additionally, future efforts to control invasive pest fruit flies should consider the nontarget impacts of maintaining traps in and near native forest. This survey project demonstrates the utility of thorough biotic surveys and taxonomic expertise in developing both sensitive species lists and baseline diversity indices for future conservation and monitoring efforts.	[Leblanc, Luc; Rubinoff, Daniel; Wright, Mark G.] Univ Hawaii, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA	University of Hawaii System	Rubinoff, D (corresponding author), Univ Hawaii, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA.	rubinoff@hawaii.edu		Wright, Mark/0000-0002-1643-7560	U.S. Department of Agriculture-Agricultural Research Service through a Specific Cooperative Agreement with University of Hawaii CTAHR [0500-00044-016-07]; Study of Attraction of Nontarget Organisms to Fruit Fly Female Attractants and Male Lures in Hawaii; USDA-National Institute of Food and Agriculture Agreement [58-5320-9430]; Hatch projects [HAW00942-H, HAW00956-H]; College of Tropical Agriculture and Human Resources; University of Hawaii at Manoa	U.S. Department of Agriculture-Agricultural Research Service through a Specific Cooperative Agreement with University of Hawaii CTAHR; Study of Attraction of Nontarget Organisms to Fruit Fly Female Attractants and Male Lures in Hawaii; USDA-National Institute of Food and Agriculture Agreement; Hatch projects(United States Department of Agriculture (USDA)); College of Tropical Agriculture and Human Resources; University of Hawaii at Manoa	This study was made possible with funding from U.S. Department of Agriculture-Agricultural Research Service through a Specific Cooperative Agreement with University of Hawaii CTAHR under Project Number: 0500-00044-016-07, "Study of Attraction of Nontarget Organisms to Fruit Fly Female Attractants and Male Lures in Hawaii''. Additional research funding was provided by USDA-National Institute of Food and Agriculture Agreement No. 58-5320-9430, and Hatch projects HAW00942-H and HAW00956-H, administered by the College of Tropical Agriculture and Human Resources, University of Hawaii at Manoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazelet CS, 2011, LANDSCAPE ECOL, V26, P341, DOI 10.1007/s10980-010-9557-z; Carson H. L., 1970, ESSAYS EVOLUTION GEN, P437, DOI DOI 10.1007/978-1-4615-9585-4_15; Carson HL, 1986, P 3 C NAT SCI HAW VO, P3; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Foote David, 1995, P368; Fosberg FT, 1972, 10 PAC SCI C; Gerrish G, 1992, 85 U HAW MAN; HARDY DE, 1965, SERIES SCHIZOPHORA, V12; Heed WB, 1968, U TEXAS PUBLICATIONS, V6818, P387; HOWARTH F G, 1990, Bishop Museum Occasional Papers, V30, P4; Kaneshiro Kenneth Y., 1993, American Entomologist, V39, P23; Kaneshiro Kenneth Y., 1997, Pacific Science, V51, P450; KANESHIRO KY, 1983, ANNU REV ENTOMOL, V28, P161, DOI 10.1146/annurev.en.28.010183.001113; KANESHIRO KY, 1977, DROS INFORM SERV, V52, P85; Kitching RL, 2004, J BIOGEOGR, V31, P1185, DOI 10.1111/j.1365-2699.2004.01096.x; Krushelnycky Paul D., 2005, Proceedings of the Hawaiian Entomological Society, V37, P1; Leblanc Luc, 2009, Proceedings of the Hawaiian Entomological Society, V41, P121; Leblanc L, 2010, ENVIRON ENTOMOL, V39, P989, DOI 10.1603/EN09287; Leblanc L, 2009, ENVIRON ENTOMOL, V38, P1446, DOI 10.1603/022.038.0513; Magnacca KN, 2008, ZOOTAXA, P1; Magnacca KN, 2012, ZOOTAXA, P1; Magnacca KN, 2009, U CALIF PUBL ENTOMOL, V130; Meyer WM, 2011, SOIL BIOL BIOCHEM, V43, P206, DOI 10.1016/j.soilbio.2010.10.005; MONTGOMERY SL, 1975, P HAWAII ENTOMOL SOC, V22, P65; Muir C, 2008, MOL PHYLOGENET EVOL, V47, P1173, DOI 10.1016/j.ympev.2008.02.007; O'Grady P.M., 2010, Bishop Museum Occasional Papers, V108, P1; O'Grady P, 2008, BIOL LETTERS, V4, P195, DOI 10.1098/rsbl.2007.0575; Paulay G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019916; PIMM SL, 1994, PHILOS T ROY SOC B, V344, P27, DOI 10.1098/rstb.1994.0047; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Rubinoff D, 2001, CONSERV BIOL, V15, P1374, DOI 10.1046/j.1523-1739.2001.00176.x; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Vargas RI, 2008, AREAWIDE PEST MANAGEMENT: THEORY AND IMPLEMENTATION, P300, DOI 10.1079/9781845933722.0300; Vorsino AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051885; [No title captured]	35	4	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62464	10.1371/journal.pone.0062464	http://dx.doi.org/10.1371/journal.pone.0062464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650514	gold, Green Submitted, Green Published			2022-12-25	WOS:000319167000047
J	McInnes, L; Jones, FA; Orme, CDL; Sobkowiak, B; Barraclough, TG; Chase, MW; Govaerts, R; Soltis, DE; Soltis, PS; Savolainen, V				McInnes, Lynsey; Jones, F. Andrew; Orme, C. David L.; Sobkowiak, Benjamin; Barraclough, Timothy G.; Chase, Mark W.; Govaerts, Rafael; Soltis, Douglas E.; Soltis, Pamela S.; Savolainen, Vincent			Do Global Diversity Patterns of Vertebrates Reflect Those of Monocots?	PLOS ONE			English	Article							SPECIES RICHNESS; PLANT DIVERSITY; GEOGRAPHIC PATTERNS; WOODY PLANT; CONSERVATION; HOTSPOTS; BIODIVERSITY; EVOLUTION; LAND; DIVERSIFICATION	Few studies of global diversity gradients in plants exist, largely because the data are not available for all species involved. Instead, most global studies have focussed on vertebrates, as these taxa have historically been associated with the most complete data. Here, we address this shortfall by first investigating global diversity gradients in monocots, a morphologically and functionally diverse clade representing a quarter of flowering plant diversity, and then assessing congruence between monocot and vertebrate diversity patterns. To do this, we create a new dataset that merges biomelevel associations for all monocot genera with country-level associations for almost all similar to 70,000 species. We then assess the evidence for direct versus indirect effects of this plant diversity on vertebrate diversity using a combination of linear regression and structural equation modelling (SEM). Finally, we also calculate overlap of diversity hotspots for monocots and each vertebrate taxon. Monocots follow a latitudinal gradient although with pockets of extra-tropical diversity, mirroring patterns in vertebrates. Monocot diversity is positively associated with vertebrate diversity, but the strength of correlation varies depending on the clades being compared. Monocot diversity explains marginal amounts of variance (< 10%) after environmental factors have been accounted for. However, correlations remain among model residuals, and SEMs apparently reveal some direct effects of monocot richness. Our results suggest that collinear responses to environmental gradients are behind much of the congruence observed, but that there is some evidence for direct effects of producer diversity on consumer diversity. Much remains to be done before broad-scale diversity gradients among taxa are fully explained. Our dataset of monocot distributions will aid in this endeavour.	[McInnes, Lynsey; Jones, F. Andrew; Orme, C. David L.; Sobkowiak, Benjamin; Barraclough, Timothy G.; Savolainen, Vincent] Imperial Coll London, Div Ecol & Evolut, Ascot, Berks, England; [Chase, Mark W.; Govaerts, Rafael; Savolainen, Vincent] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Soltis, Douglas E.] Univ Florida, Dept Biol, Gainesville, FL USA; [Soltis, Pamela S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	Imperial College London; Royal Botanic Gardens, Kew; State University System of Florida; University of Florida; State University System of Florida; University of Florida	McInnes, L (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	lynsey.mcinnes@gmail.com; v.savolainen@imperial.ac.uk	Chase, Mark W/A-6642-2011; Sobkowiak, Ben/GYD-7396-2022; Soltis, Pamela S/L-5184-2015; Soltis, Douglas/L-5957-2015; Soltis, Pamela S/GNH-5557-2022	Sobkowiak, Ben/0000-0002-1382-1137; Soltis, Pamela S/0000-0001-9310-8659; Savolainen, Vincent/0000-0001-5350-9984; Barraclough, Timothy/0000-0002-8084-2640; BUNNEFELD, LYNSEY/0000-0002-9226-7153	Leverhulme Trust [ID20070432]; United States National Science Foundation [EF-0431266]; Royal Society [15927]; European Research Council [16675]; Natural Environment Research Council [NE/F002769/1]; NERC [NE/I013776/1, NE/F002769/1] Funding Source: UKRI; Natural Environment Research Council [NE/I013776/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); United States National Science Foundation(National Science Foundation (NSF)); Royal Society(Royal Society of London); European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by Leverhulme Trust: ID20070432 (http://www.leverhulme.ac.uk/), United States National Science Foundation: EF- 0431266 (www.nsf.gov); Royal Society: 15927 (royalsociety.org); European Research Council: 16675 (erc.europa.eu); Natural Environment Research Council: NE/F002769/1 (www.nerc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2011, TAXON, V60, P403, DOI 10.1002/tax.602010; Barthlott W, 2007, ERDKUNDE, V61, P305, DOI 10.3112/erdkunde.2007.04.01; Benzing D.H., 1990, VASCULAR EPIPHYTES G; Bouchenak-Khelladi Y, 2009, GLOBAL CHANGE BIOL, V15, P2397, DOI 10.1111/j.1365-2486.2009.01860.x; Brummitt R.K., 2001, WORLD GEOGRAPHIC SCH, V2; Cantino PD, 2007, TAXON, V56, P822, DOI 10.2307/25065865; Carwardine J, 2008, P NATL ACAD SCI USA, V105, P11446, DOI 10.1073/pnas.0707157105; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; Cooper N, 2010, AM NAT, V175, P727, DOI 10.1086/652466; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Govaerts R, 2004, TAXON, V53, P144, DOI 10.2307/4135499; Gravendeel B, 2004, PHILOS T ROY SOC B, V359, P1523, DOI 10.1098/rstb.2004.1529; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; Hawkins BA, 2011, J BIOGEOGR, V38, P1253, DOI 10.1111/j.1365-2699.2011.02490.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kisel Y, 2011, PHILOS T R SOC B, V366, P2514, DOI 10.1098/rstb.2011.0022; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P327, DOI 10.1111/j.1466-8238.2007.00379.x; Kissling WD, 2012, GLOBAL ECOL BIOGEOGR, V21, P909, DOI 10.1111/j.1466-8238.2011.00728.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nicholson E, 2006, ECOL LETT, V9, P1049, DOI 10.1111/j.1461-0248.2006.00956.x; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Qian H, 2008, ECOL LETT, V11, P547, DOI 10.1111/j.1461-0248.2008.01168.x; R Development Core Team, 2021, R PROJECT STAT COMPU; Raven P.H., 2005, BIOL PLANTS; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schuldt A, 2009, ECOGRAPHY, V32, P1019, DOI 10.1111/j.1600-0587.2009.05973.x; Sommer JH, 2010, P ROY SOC B-BIOL SCI, V277, P2271, DOI 10.1098/rspb.2010.0120; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; USGS, 2003, GLOB 30 ARC 2 EL DAT; Wang ZH, 2011, P ROY SOC B-BIOL SCI, V278, P2122, DOI 10.1098/rspb.2010.1897	50	8	9	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e56979	10.1371/journal.pone.0056979	http://dx.doi.org/10.1371/journal.pone.0056979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658679	Green Submitted, Green Published, gold			2022-12-25	WOS:000319167000002
J	Vazquez-Marrufo, M; Gonzalez-Rosa, JJ; Galvao-Carmona, A; Hidalgo-Munoz, A; Borges, M; Pena, JLR; Izquierdo, G				Vazquez-Marrufo, Manuel; Gonzalez-Rosa, Javier J.; Galvao-Carmona, Alejandro; Hidalgo-Munoz, Antonio; Borges, Monica; Ruiz Pena, Juan Luis; Izquierdo, Guillermo			Retest Reliability of Individual P3 Topography Assessed by High Density Electroencephalography	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; TEMPORAL STABILITY; TASK-DIFFICULTY; DETERMINANTS; LATENCY; YOUNG; ERPS	Background: Some controversy remains about the potential applicability of cognitive potentials for evaluating the cerebral activity associated with cognitive capacity. A fundamental requirement is that these neurophysiological parameters show a high level of stability over time. Previous studies have shown that the reliability of diverse parameters of the P3 component (latency and amplitude) ranges between moderate and high. However, few studies have paid attention to the retest reliability of the P3 topography in groups or individuals. Considering that changes in P3 topography have been related to different pathologies and healthy aging, the main objective of this article was to evaluate in a longitudinal study (two sessions) the reliability of P3 topography in a group and at the individual level. Results: The correlation between sessions for P3 topography in the grand average of groups was high (r = 0.977, p<0.001). The within-subject correlation values ranged from 0.626 to 0.981 (mean: 0.888). In the between-subjects topography comparisons, the correlation was always lower for comparisons between different subjects than for within-subjects correlations in the first session but not in the second session. Conclusions: The present study shows that P3 topography is highly reliable for group analysis (comprising the same subjects) in different sessions. The results also confirmed that retest reliability for individual P3 maps is suitable for follow-up studies for a particular subject. Moreover, P3 topography appears to be a specific marker considering that the betweensubjects correlations were lower than the within-subject correlations. However, P3 topography appears more similar between subjects in the second session, demonstrating that is modulated by experience. Possible clinical applications of all these results are discussed.	[Vazquez-Marrufo, Manuel; Galvao-Carmona, Alejandro; Hidalgo-Munoz, Antonio] Univ Seville, Fac Psychol, Dept Expt Psychol, Seville, Spain; [Borges, Monica; Ruiz Pena, Juan Luis; Izquierdo, Guillermo] Virgen Macarena Hosp, Multiple Sclerosis Unit, Seville, Spain; [Gonzalez-Rosa, Javier J.] Tech Univ Madrid UPM, Ctr Biomed Technol CTB, Lab Clin Neurosci, Madrid, Spain	University of Sevilla; Hospital Universitario Virgen Macarena; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB)	Vazquez-Marrufo, M (corresponding author), Univ Seville, Fac Psychol, Dept Expt Psychol, Seville, Spain.	marrufo@us.es	Hidalgo-Muñoz, Antonio R./ABG-5286-2020; Galvao-Carmona, Alejandro/A-1725-2015; Gonzalez-Rosa, Javier J./K-1291-2014; Marrufo, Manuel Vazquez/Y-8460-2019	Galvao-Carmona, Alejandro/0000-0002-5126-1273; Gonzalez-Rosa, Javier J./0000-0002-5609-1103; Marrufo, Manuel Vazquez/0000-0002-0456-7165; Borges Guerra, Monica/0000-0002-4258-2390; Hidalgo-Munoz, Antonio R/0000-0002-0457-5114	Ministerio de Economia, Gobierno de Espana [SEJ2007-65343]; Asociacion Neuroinvest	Ministerio de Economia, Gobierno de Espana; Asociacion Neuroinvest	Funding came from Ministerio de Economia, Gobierno de Espana, SEJ2007-65343, Asociacion Neuroinvest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JE, 1994, INT J PSYCHOPHYSIOL, V17, P35, DOI 10.1016/0167-8760(94)90053-1; BURGESS A, 1993, ELECTROEN CLIN NEURO, V86, P219, DOI 10.1016/0013-4694(93)90101-Z; Burgess AP, 1997, INT J PSYCHOPHYSIOL, V26, P113, DOI 10.1016/S0167-8760(97)00759-9; Cassidy SM, 2012, PSYCHOPHYSIOLOGY, V49, P659, DOI 10.1111/j.1469-8986.2011.01349.x; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; DUSTMAN RE, 1963, SCIENCE, V142, P1480, DOI 10.1126/science.142.3598.1480; DUSTMAN RE, 1965, ELECTROEN CLIN NEURO, V19, P570, DOI 10.1016/0013-4694(65)90242-7; Fallgatter AJ, 2002, J CLIN NEUROPHYSIOL, V19, P61, DOI 10.1097/00004691-200201000-00008; GOODIN D, 1994, ELECTROEN CLIN NEURO, V91, P18, DOI 10.1016/0013-4694(94)90014-0; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gruendler TOJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025591; Hagen GF, 2006, INT J PSYCHOPHYSIOL, V59, P8, DOI 10.1016/j.ijpsycho.2005.08.003; Helmstadter G. C., 1964, PRINCIPLES PSYCHOL M; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; KARNISKI W, 1989, ELECTROEN CLIN NEURO, V72, P373, DOI 10.1016/0013-4694(89)90043-6; KILENY PR, 1987, EAR HEARING, V8, P110, DOI 10.1097/00003446-198704000-00008; Kinoshita S, 1996, PHYSIOL BEHAV, V60, P1087, DOI 10.1016/0031-9384(96)00130-8; LEWIS GW, 1984, INT J NEUROSCI, V25, P131, DOI 10.3109/00207458408985595; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Neuhaus AH, 2010, INT J PSYCHOPHYSIOL, V76, P72, DOI 10.1016/j.ijpsycho.2010.02.005; Nuwer MR, 1999, EEG CL N SU, V50, P150; POLICH J, 1986, PSYCHOPHYSIOLOGY, V23, P590, DOI 10.1111/j.1469-8986.1986.tb00677.x; POLICH J, 1986, ELECTROEN CLIN NEURO, V65, P236, DOI 10.1016/0168-5597(86)90059-6; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; POLICH J, 1987, ELECTROEN CLIN NEURO, V68, P311, DOI 10.1016/0168-5597(87)90052-9; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Pratt H, 2000, CLIN NEUROPHYSIOL, V111, P1425, DOI 10.1016/S1388-2457(00)00344-8; Sandman CA, 2000, CLIN NEUROPHYSIOL, V111, P1427, DOI 10.1016/S1388-2457(00)00320-5; SEGALOWITZ SJ, 1993, PSYCHOPHYSIOLOGY, V30, P451, DOI 10.1111/j.1469-8986.1993.tb02068.x; SKLARE DA, 1984, ELECTROEN CLIN NEURO, V59, P420, DOI 10.1016/0168-5597(84)90043-1; Smit DJA, 2007, TWIN RES HUM GENET, V10, P335, DOI 10.1375/twin.10.2.335; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012; Walhovd KB, 2002, INT J PSYCHOPHYSIOL, V46, P29, DOI 10.1016/S0167-8760(02)00039-9; ZAMRINI EY, 1991, INT J NEUROSCI, V61, P113, DOI 10.3109/00207459108986279	34	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62523	10.1371/journal.pone.0062523	http://dx.doi.org/10.1371/journal.pone.0062523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658739	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000055
J	Cameron, EK; Proctor, HC; Bayne, EM				Cameron, Erin K.; Proctor, Heather C.; Bayne, Erin M.			Effects of an Ecosystem Engineer on Belowground Movement of Microarthropods	PLOS ONE			English	Article							EARTHWORM DENDROBAENA-OCTAEDRA; ORIBATID MITE; INVASIVE EARTHWORMS; PINE FOREST; SOIL FAUNA; DISPERSAL; COLLEMBOLA; COMMUNITY; ABUNDANCE; PLANT	Ecosystem engineers affect other species by changing physical environments. Such changes may influence movement of organisms, particularly belowground where soil permeability can restrict dispersal. We investigated whether earthworms, iconic ecosystem engineers, influence microarthropod movement. Our experiment tested whether movement is affected by tunnels (i.e., burrows), earthworm excreta (mucus, castings), or earthworms themselves. Earthworm burrows form tunnel networks that may facilitate movement. This effect may be enhanced by excreta, which could provide resources for microarthropods moving along the network. Earthworms may also promote movement via phoresy. Conversely, negative effects could occur if earthworms alter predator-prey relationships or change competitive interactions between microarthropods. We used microcosms consisting of a box connecting a "source'' container in which microarthropods were present and a "destination'' container filled with autoclaved soil. Treatments were set up within the boxes, which also contained autoclaved soil, as follows: 1) control with no burrows; 2) artificial burrows with no excreta; 3) abandoned burrows with excreta but no earthworms; and 4) earthworms (Lumbricus rubellus) present in burrows. Half of the replicates were sampled once after eight days, while the other half were sampled repeatedly to examine movement over time. Rather than performing classical pairwise comparisons to test our hypotheses, we used AIC(c) to assess support for three competing models (presence of tunnels, excreta, and earthworms). More individuals of Collembola, Mesostigmata, and all microarthropods together dispersed when tunnels were present. Models that included excreta and earthworms were less well supported. Total numbers of dispersing Oribatida and Prostigmata+Astigmata were not well explained by any models tested. Further research is needed to examine the impact of soil structure and ecosystem engineering on movement belowground, as the substantial increase in movement of some microarthropods when corridors were present suggests these factors can strongly affect colonization and community assembly.	[Cameron, Erin K.; Proctor, Heather C.; Bayne, Erin M.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Cameron, EK (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ecameron@ualberta.ca	Proctor, Heather C./A-2677-2014	Proctor, Heather C./0000-0002-4920-9556; Bayne, Erin/0000-0002-0679-4521	NSERC; EMB; NSERC Vanier Canada Graduate Scholarship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); EMB; NSERC Vanier Canada Graduate Scholarship	This research was supported by NSERC Discovery Grants to HCP and EMB and a NSERC Vanier Canada Graduate Scholarship to EKC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badano EI, 2006, OIKOS, V115, P369, DOI 10.1111/j.2006.0030-1299.15132.x; Bohlen PJ, 2004, FRONT ECOL ENVIRON, V2, P427, DOI 10.1890/1540-9295(2004)002[0427:NIEAAO]2.0.CO;2; Bouche MB, 1977, ECOL B STOCKHOLM, V25, P122, DOI DOI 10.2307/20112572; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cameron EK, 2013, SOIL BIOL BIOCHEM, V57, P334, DOI 10.1016/j.soilbio.2012.07.010; Commito JA, 2005, J EXP MAR BIOL ECOL, V316, P133, DOI 10.1016/j.jembe.2004.10.010; Cuddington K, 2004, ECOL MODEL, V178, P335, DOI 10.1016/j.ecolmodel.2004.03.010; Dayton CM, 1998, AM STAT, V52, P144, DOI 10.2307/2685473; Dighton J, 1997, APPL SOIL ECOL, V5, P109, DOI 10.1016/S0929-1393(96)00137-0; Ducarme X, 2004, PEDOBIOLOGIA, V48, P139, DOI 10.1016/j.pedobi.2003.10.002; Edwards CA, 1967, PROGR SOIL BIOL, V1966, P585; Eisenhauer N, 2010, PEDOBIOLOGIA, V53, P343, DOI 10.1016/j.pedobi.2010.04.003; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Gabay O, 2012, PLANT ECOL, V213, P685, DOI 10.1007/s11258-012-0033-5; GATES G E, 1970, Megadrilogica, V1, P1; GATES G E, 1982, Megadrilogica, V4, P12; Gilbert F, 1998, P ROY SOC B-BIOL SCI, V265, P577, DOI 10.1098/rspb.1998.0333; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Gutierrez Lopez Monica, 2009, Pedobiologia, V52, P163, DOI 10.1016/j.pedobi.2008.08.001; Gutierrez-Lopez M, 2011, SOIL BIOL BIOCHEM, V43, P55, DOI 10.1016/j.soilbio.2010.09.010; Hendrix PF, 2008, ANNU REV ECOL EVOL S, V39, P593, DOI 10.1146/annurev.ecolsys.39.110707.173426; Hoyle M, 2007, ECOL MODEL, V202, P441, DOI 10.1016/j.ecolmodel.2006.11.008; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KACZMAREK W, 1978, PEDOBIOLOGIA, V18, P434; Loss SR, 2011, CONSERV BIOL, V25, P983, DOI 10.1111/j.1523-1739.2011.01719.x; MACFADYEN A, 1961, J ANIM ECOL, V30, P171, DOI 10.2307/2120; MacMillan K, 2009, SOIL BIOL BIOCHEM, V41, P1483, DOI 10.1016/j.soilbio.2009.04.007; Maerz JC, 2009, CONSERV BIOL, V23, P975, DOI 10.1111/j.1523-1739.2009.01167.x; Maraun M, 2000, ECOGRAPHY, V23, P374, DOI 10.1111/j.1600-0587.2000.tb00294.x; Maraun M, 2003, SOIL BIOL BIOCHEM, V35, P1387, DOI 10.1016/S0038-0717(03)00218-9; McLean M, 1998, APPL SOIL ECOL, V7, P125, DOI 10.1016/S0929-1393(97)00041-3; McLean MA, 2000, SOIL BIOL BIOCHEM, V32, P1671, DOI 10.1016/S0038-0717(00)00083-3; Migge-Kleian S, 2006, BIOL INVASIONS, V8, P1275, DOI 10.1007/s10530-006-9021-9; MITCHELL R, 1970, AM NAT, V104, P425, DOI 10.1086/282677; Nielsen UN, 2008, SOIL BIOL BIOCHEM, V40, P1538, DOI 10.1016/j.soilbio.2007.12.029; Nuzzo VA, 2009, CONSERV BIOL, V23, P966, DOI 10.1111/j.1523-1739.2009.01168.x; Ojala R, 2001, PEDOBIOLOGIA, V45, P443, DOI 10.1078/0031-4056-00098; Ransom TS, 2011, OECOLOGIA, V165, P745, DOI 10.1007/s00442-010-1775-1; Regnier E, 2008, J APPL ECOL, V45, P1621, DOI 10.1111/j.1365-2664.2008.01489.x; Reynolds J.W., 1994, GLOB BIODIVERS, V4, P11; Salmon S, 2005, SOIL BIOL BIOCHEM, V37, P487, DOI 10.1016/j.soilbio.2004.08.011; Salmon S, 2004, BIOL FERT SOILS, V40, P323, DOI 10.1007/s00374-004-0782-y; Salmon S, 2001, BIOL FERT SOILS, V34, P304, DOI 10.1007/s003740100407; Salmon S, 1999, SOIL BIOL BIOCHEM, V31, P1161, DOI 10.1016/S0038-0717(99)00034-6; SHAPIRO DI, 1995, J NEMATOL, V27, P21; Sjogren M, 1997, PEDOBIOLOGIA, V41, P506; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Vreeken-Buijs MJ, 1998, SOIL BIOL BIOCHEM, V30, P97, DOI 10.1016/S0038-0717(97)00064-3; Wardle DA, 2002, COMMUNITIES ECOSYSTE	51	10	11	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62796	10.1371/journal.pone.0062796	http://dx.doi.org/10.1371/journal.pone.0062796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646146	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300099
J	Liu, JB; Ma, J				Liu, Junbo; Ma, Jun			Uncovering a Dynamic Feature of the Transcriptional Regulatory Network for Anterior-Posterior Patterning in the Drosophila Embryo	PLOS ONE			English	Article							SEGMENTATION GENE HUNCHBACK; BICOID MORPHOGEN GRADIENT; DIFFERENTIAL REGULATION; POSITIONAL INFORMATION; CONTROL ELEMENTS; EXPRESSION; KRUPPEL; PROTEIN; PRECISION; ESTABLISHMENT	Anterior-posterior (AP) patterning in the Drosophila embryo is dependent on the Bicoid (Bcd) morphogen gradient. However, most target genes of Bcd also require additional inputs to establish their expression domains, reflective of the operation of a cross-regulatory network and contributions of other maternal signals. This is in contrast to hunchback (hb), which has an anterior expression domain driven by an enhancer that appears to respond primarily to the Bcd input. To gain a better understanding of the regulatory logic of the AP patterning network, we perform quantitative studies that specifically investigate the dynamics of hb transcription during development. We show that Bcd-dependent hb transcription, monitored by the intron-containing nascent transcripts near the P2 promoter, is turned off quickly-on the order of a few minutes-upon entering the interphase of nuclear cycle 14A. This shutdown contrasts with earlier cycles during which active hb transcription can persist until the moment when the nucleus enters mitosis. The shutdown takes place at a time when the nuclear Bcd gradient profile in the embryo remains largely intact, suggesting that this is a process likely subject to control of a currently unknown regulatory mechanism. We suggest that this dynamic feature offers a window of opportunity for hb to faithfully interpret, and directly benefit from, Bcd gradient properties, including its scaling properties, to help craft a robust AP patterning outcome.	[Liu, Junbo; Ma, Jun] Cincinnati Childrens Res Fdn, Div Biomed Informat, Cincinnati, OH USA; [Ma, Jun] Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Ma, J (corresponding author), Cincinnati Childrens Res Fdn, Div Biomed Informat, Cincinnati, OH USA.	jun.ma@cchmc.org	Ma, Jun/GLT-4809-2022	Ma, Jun/0000-0002-1609-3294	National Science Foundation [IOS-0843424]; National Institutes of Health [1R01GM101373]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101373] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation (IOS-0843424), and National Institutes of Health (1R01GM101373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardehali MB, 2009, NAT STRUCT MOL BIOL, V16, P1123, DOI 10.1038/nsmb1109-1123; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Ben-Zvi D, 2011, CURR OPIN GENET DEV, V21, P704, DOI 10.1016/j.gde.2011.07.011; BENDER M, 1988, DEV GENET, V9, P715, DOI 10.1002/dvg.1020090604; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Bothma JP, 2011, CURR BIOL, V21, P1571, DOI 10.1016/j.cub.2011.08.019; Cheung D, 2011, DEVELOPMENT, V138, P2741, DOI 10.1242/dev.064402; Clyde DE, 2003, NATURE, V426, P849, DOI 10.1038/nature02189; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; de Lachapelle AM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.7; DENG J, PLOS ONE, V5; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Erickson JW, 2007, PLOS BIOL, V5, P2821, DOI 10.1371/journal.pbio.0050332; FOE VE, 1983, J CELL SCI, V61, P31; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Fung JC, 1998, J CELL BIOL, V141, P5, DOI 10.1083/jcb.141.1.5; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Gunawardena S, 2000, CURR BIOL, V10, P285, DOI 10.1016/S0960-9822(00)00360-2; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; HE F, 2013, PLOS ONE IN PRESS; He F, 2008, DEV CELL, V15, P558, DOI 10.1016/j.devcel.2008.09.004; He F, 2012, BIOINFORMATICS, V28, P970, DOI 10.1093/bioinformatics/bts068; He F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019122; He F, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-80; He F, 2010, BIOPHYS J, V99, P697, DOI 10.1016/j.bpj.2010.04.073; HOCH M, 1991, EMBO J, V10, P2267, DOI 10.1002/j.1460-2075.1991.tb07763.x; HOCH M, 1990, EMBO J, V9, P2587, DOI 10.1002/j.1460-2075.1990.tb07440.x; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Howard M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208103; HULSKAMP M, 1994, GENETICS, V138, P125; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; JACOB Y, 1991, P NATL ACAD SCI USA, V88, P5912, DOI 10.1073/pnas.88.13.5912; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2007, MECH DEVELOP, V124, P108, DOI 10.1016/j.mod.2006.11.001; Jaeger J, 2011, CELL MOL LIFE SCI, V68, P243, DOI 10.1007/s00018-010-0536-y; KRAUT R, 1991, DEVELOPMENT, V111, P611; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; Le Goff L, 2011, SCIENCE, V331, P1141, DOI 10.1126/science.1203270; Liu JB, 2011, FLY, V5, P242, DOI 10.4161/fly.5.3.15837; Liu JB, 2011, NAT CELL BIOL, V13, P22, DOI 10.1038/ncb2141; Lott SE, 2007, P NATL ACAD SCI USA, V104, P10926, DOI 10.1073/pnas.0701359104; Lu XM, 2009, DEVELOPMENT, V136, P2101, DOI 10.1242/dev.034421; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; McCleland ML, 2009, J CELL BIOL, V187, P7, DOI 10.1083/jcb.200906191; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Patel NH, 2002, NATURE, V415, P748, DOI 10.1038/415748a; PERRY MW, 2012, CURR BIOL; Porcher A, 2010, DEVELOPMENT, V137, P2795, DOI 10.1242/dev.051300; SCHRODER C, 1988, EMBO J, V7, P2881, DOI 10.1002/j.1460-2075.1988.tb03145.x; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; Surkova S, 2013, DEV BIOL, V376, P99, DOI 10.1016/j.ydbio.2013.01.008; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; TREISMAN J, 1989, NATURE, V341, P335, DOI 10.1038/341335a0; Tsurumi A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002086; Vakulenko S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.168102; Werz C, 2005, DEVELOPMENT, V132, P5343, DOI 10.1242/dev.02150; Wilkie GS, 1999, CURR BIOL, V9, P1263, DOI 10.1016/S0960-9822(99)80509-0; Wimmer EA, 2000, SCIENCE, V287, P2476, DOI 10.1126/science.287.5462.2476; Wu XL, 2001, DEV BIOL, V237, P79, DOI 10.1006/dbio.2001.0355; Wunderlich Z, 2011, CURR OPIN GENET DEV, V21, P711, DOI 10.1016/j.gde.2011.07.005; Yu D, 2008, CURR BIOL, V18, P868, DOI 10.1016/j.cub.2008.05.050	73	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62641	10.1371/journal.pone.0062641	http://dx.doi.org/10.1371/journal.pone.0062641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646132	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300084
J	Maria, M; Henriksen, M; Madsen, L; Dalsgaard, I				Maria, Maya; Henriksen, Mihalyi; Madsen, Lone; Dalsgaard, Inger			Effect of Hydrogen Peroxide on Immersion Challenge of Rainbow Trout Fry with Flavobacterium psychrophilum	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS; EXPERIMENTAL-INFECTION; ATLANTIC SALMON; STRESS-RESPONSE; FISH; TOXICITY; EXPOSURE; TEMPERATURE; FEVER; SALAR	An experimental model for immersion challenge of rainbow trout fry (Oncorhynchus mykiss) with Flavobacterium psychrophilum, the causative agent of rainbow trout fry syndrome and bacterial cold water disease was established in the present study. Although injection-based infection models are reliable and produce high levels of mortality attempts to establish a reproducible immersion model have been less successful. Various concentrations of hydrogen peroxide (H2O2) were evaluated before being used as a pre-treatment stressor prior to immersion exposure to F. psychrophilum. H2O2 accelerated the onset of mortality and increased mortality approximately two-fold; from 9.1% to 19.2% and from 14.7% to 30.3% in two separate experiments. Clinical signs observed in the infected fish corresponded to symptoms characteristically seen during natural outbreaks. These findings indicate that pre-treatment with H2O2 can increase the level of mortality in rainbow trout fry after exposure to F. psychrophilum.	[Maria, Maya; Henriksen, Mihalyi; Madsen, Lone; Dalsgaard, Inger] Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark	Technical University of Denmark	Henriksen, M (corresponding author), Tech Univ Denmark, Natl Vet Inst, Bulowsvej 27, Frederiksberg C, Denmark.	mmah@vet.dtu.dk		Madsen, Lone/0000-0001-8435-9827; Dalsgaard, Inger/0000-0003-2066-1060	Danish Council of Strategic Research [2101-080017]	Danish Council of Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was performed as a part of the Danish Fish Immunology Research Centre and Network (DAFINET; www.dafinet.dk) supported by the Danish Council of Strategic Research (grant 2101-080017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend D.F., 1981, FISH BIOL SERODIAGNO, V49, P447; Aoki M, 2005, DIS AQUAT ORGAN, V67, P73, DOI 10.3354/dao067073; Arndt RE, 1997, J WORLD AQUACULT SOC, V28, P150, DOI 10.1111/j.1749-7345.1997.tb00850.x; Avendano-Herrera R, 2006, AQUACULTURE, V257, P104, DOI 10.1016/j.aquaculture.2006.02.043; Borg AF, 1960, AM ASSOC ADV SCI PUB, V8, P1; Bowers JM, 2002, J VET PHARMACOL THER, V25, P311, DOI 10.1046/j.1365-2885.2002.00413.x; Bruno D. W., 1994, Aquaculture International, V2, P10, DOI 10.1007/BF00118529; Bruno DW, 1992, EUR ASS FISH PATHOL, V12, P215; Busch S, 2003, VET PARASITOL, V117, P117, DOI 10.1016/j.vetpar.2003.07.018; Chua FHC, THESIS U STIRLING ST; COVERT JB, 1977, NATURE, V267, P43, DOI 10.1038/267043a0; Decostere A, 2000, RES VET SCI, V69, P165, DOI 10.1053/rvsc.2000.0408; Gaikowski MP, 1999, AQUACULTURE, V178, P191, DOI 10.1016/S0044-8486(99)00123-4; Garcia C, 2000, DIS AQUAT ORGAN, V42, P191, DOI 10.3354/dao042191; Grans A, 2012, J FISH BIOL, V81, P1111, DOI 10.1111/j.1095-8649.2012.03333.x; Harper C, 2009, ILAR J, V50, P387, DOI 10.1093/ilar.50.4.387; Holt RA, 1988, THESIS OREGON STATE; Kiemer MCB, 1997, AQUACULTURE, V153, P181, DOI 10.1016/S0044-8486(97)00037-9; Lorenzen E., 1991, Bulletin of the European Association of Fish Pathologists, V11, P77; Madetoja J, 2000, DIS AQUAT ORGAN, V43, P27, DOI 10.3354/dao043027; Madsen L, 1999, DIS AQUAT ORGAN, V36, P169, DOI 10.3354/dao036169; Nematollahi A, 2003, J FISH DIS, V26, P563, DOI 10.1046/j.1365-2761.2003.00488.x; Pedersen LF, 2010, 2182010 DTU; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rach JJ, 1997, PROG FISH CULT, V59, P41, DOI 10.1577/1548-8640(1997)059&lt;0041:EOSLSA&gt;2.3.CO;2; Raida MK, 2007, DIS AQUAT ORGAN, V77, P41, DOI 10.3354/dao01808; RANGDALE RE, 1995, THESIS U STIRLING ST; Roque A, 2010, AQUACULTURE, V304, P104, DOI 10.1016/j.aquaculture.2010.03.024; Sortkjaer O, 2000, 7900206 DFU, P206; Speare DJ, 1997, CAN J FISH AQUAT SCI, V54, P2653, DOI 10.1139/cjfas-54-11-2653; Svendsen L. M., 2010, 2192010 DTU NAT I AQ; Thomas-Jinu S, 2004, J FISH DIS, V27, P23, DOI 10.1046/j.1365-2761.2003.00504.x; Tort MJ, 2002, J AQUAT ANIM HEALTH, V14, P95, DOI 10.1577/1548-8667(2002)014&lt;0095:ATEOIH&gt;2.0.CO;2; TOYAMA T, 1994, FISH PATHOL, V29, P271, DOI 10.3147/jsfp.29.271; Wiklund T, 2000, J APPL MICROBIOL, V88, P299, DOI 10.1046/j.1365-2672.2000.00959.x	35	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62590	10.1371/journal.pone.0062590	http://dx.doi.org/10.1371/journal.pone.0062590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646130	Green Submitted, gold, Green Published			2022-12-25	WOS:000319077300081
J	Calven, J; Yudina, Y; Uller, L				Calven, Jenny; Yudina, Yuliana; Uller, Lena			Rhinovirus and dsRNA Induce RIG-I-Like Receptors and Expression of Interferon beta and lambda(1) in Human Bronchial Smooth Muscle Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; THYMIC STROMAL LYMPHOPOIETIN; AIRWAY EPITHELIAL-CELLS; ASTHMA EXACERBATIONS; SECONDARY NECROSIS; ANTIVIRAL RESPONSE; INFECTION; RECOGNITION; TLR3	Rhinovirus (RV) infections cause exacerbations and development of severe asthma highlighting the importance of antiviral interferon (IFN) defence by airway cells. Little is known about bronchial smooth muscle cell (BSMC) production of IFNs and whether BSMCs have dsRNA-sensing receptors besides TLR3. dsRNA is a rhinoviral replication intermediate and necrotic cell effect mimic that mediates innate immune responses in bronchial epithelial cells. We have explored dsRNA-evoked IFN-beta and IFN-lambda(1) production in human BSMCs and potential involvement of TLR3 and RIG-I-like receptors (RLRs). Primary BSMCs were stimulated with 0.1-10 mu g/ml dsRNA, 0.1-1 mu g/ml dsRNA in complex with the transfection agent LyoVec (dsRNA/LyoVec; selectively activating cytosolic RLRs) or infected with 0.05-0.5 MOI RV1B. Both dsRNA stimuli evoked early (3 h), concentration-dependent IFN-b and IFN-lambda(1) mRNA expression, which with dsRNA/LyoVec was much greater, and with dsRNA was much less, after 24 h. The effects were inhibited by dexamethasone. Further, dsRNA and dsRNA/LyoVec concentration-dependently upregulated RIG-I and MDA5 mRNA and protein. dsRNA and particularly dsRNA/LyoVec caused IFN-b and IFN-lambda(1) protein production (24 h). dsRNA-but not dsRNA/LyoVec-induced IFN expression was partly inhibited by chloroquine that suppresses endosomal TLR3 activation. RV1B dose-dependently increased BSMC expression of RIG-I, MDA5, IFN-b, and IFN-lambda(1) mRNA. We suggest that BSMCs express functional RLRs and that both RLRs and TLR3 are involved in viral stimulus-induced BSMC expression of IFN-b and IFN-lambda(1).	[Calven, Jenny; Yudina, Yuliana; Uller, Lena] Lund Univ, Dept Expt Med Sci, Unit Resp Immunopharmacol, Lund, Sweden	Lund University	Uller, L (corresponding author), Lund Univ, Dept Expt Med Sci, Unit Resp Immunopharmacol, Lund, Sweden.	lena.uller@med.lu.se			Swedish Medical Research Council, Vinnova; Swedish Heart and Lung foundation	Swedish Medical Research Council, Vinnova; Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation)	This study was funded by the Swedish Medical Research Council, Vinnova, Swedish Heart and Lung foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedke N, 2009, J IMMUNOL, V182, P3660, DOI 10.4049/jimmunol.0802471; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Calven J, 2012, J INNATE IMMUN, V4, P86, DOI 10.1159/000329131; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Cooper PR, 2009, AM J PHYSIOL-LUNG C, V297, pL530, DOI 10.1152/ajplung.00133.2009; Damera G, 2009, PULM PHARMACOL THER, V22, P353, DOI 10.1016/j.pupt.2008.12.006; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Gern JE, 2012, AM J RESP CRIT CARE, V185, P468, DOI 10.1164/rccm.201112-2195ED; JOHNSTON SL, 1993, J CLIN MICROBIOL, V31, P111, DOI 10.1128/JCM.31.1.111-117.1993; Joubert P, 2005, J ALLERGY CLIN IMMUN, V116, P713, DOI 10.1016/j.jaci.2005.05.042; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Leung TF, 2010, CHEST, V137, P348, DOI 10.1378/chest.09-1250; Lim DM, 2011, AM J PHYSIOL-GASTR L, V301, pG91, DOI 10.1152/ajpgi.00471.2010; Liu JJ, 2012, EXP HEMATOL, V40, P330, DOI 10.1016/j.exphem.2011.12.002; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lopez-Souza N, 2009, J ALLERGY CLIN IMMUN, V123, P1384, DOI 10.1016/j.jaci.2009.03.010; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Miller EK, 2012, AM J RESP CRIT CARE, V185, P508, DOI 10.1164/rccm.201108-1462OC; Niimi K, 2007, J IMMUNOL, V178, P489, DOI 10.4049/jimmunol.178.1.489; Oliver BGG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-71; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Persson CGA, 2008, PULM PHARMACOL THER, V21, P1, DOI 10.1016/j.pupt.2006.10.017; Pritchard AL, 2012, J IMMUNOL, V188, P5898, DOI 10.4049/jimmunol.1103507; Rodel J, 2001, FEMS IMMUNOL MED MIC, V32, P9; Roth M, 2010, ANN ALLERG ASTHMA IM, V104, P152, DOI 10.1016/j.anai.2009.11.022; Rydell-Tormanen K, 2006, EUR RESPIR J, V28, P268, DOI 10.1183/09031936.06.00126905; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Solarewicz-Madejek K, 2009, CLIN EXP ALLERGY, V39, P845, DOI 10.1111/j.1365-2222.2009.03244.x; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Takeda N, 2009, CLIN EXP ALLERGY, V39, P1018, DOI 10.1111/j.1365-2222.2009.03238.x; Tliba O, 2003, J BIOL CHEM, V278, P50615, DOI 10.1074/jbc.M303680200; Uller L, 2004, AM J RESP CRIT CARE, V170, P742, DOI 10.1164/rccm.200402-240OC; Uller L, 2010, THORAX, V65, P626, DOI 10.1136/thx.2009.125930; Van Ly David, 2011, J Allergy (Cairo), V2011, P457169, DOI 10.1155/2011/457169; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2002, EUR RESPIR J, V19, P68, DOI 10.1183/09031936.02.00226302	45	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62718	10.1371/journal.pone.0062718	http://dx.doi.org/10.1371/journal.pone.0062718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658644	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800057
J	Dalai, S; Pakrashi, S; Chandrasekaran, N; Mukherjee, A				Dalai, Swayamprava; Pakrashi, Sunandan; Chandrasekaran, Natarajan; Mukherjee, Amitava			Acute Toxicity of TiO2 Nanoparticles to Ceriodaphnia dubia under Visible Light and Dark Conditions in a Freshwater System	PLOS ONE			English	Article							DAPHNIA-MAGNA; TITANIUM-DIOXIDE; ENGINEERED NANOPARTICLES; OXIDE NANOPARTICLES; CYTOTOXICITY; ECOTOXICITY; BEHAVIOR; AGGREGATION; PARTICLES; ALGAE	The ever increasing industrial and consumer applications of titanium dioxide nanoparticles (TiO2 NPs) raise concern over the possible risk associated with their environmental exposure. Still, the knowledge regarding nanoparticle behavior in a freshwater ecosystem is lacking. The current study focuses on the toxicity of TiO2 NPs towards Ceriodaphnia dubia (a dominant daphnid isolated from the freshwater) under two different conditions; (1) light and dark photoperiod (16:8 h) and (2) continuous dark conditions, for a period of 48 h. An increase in toxicity was observed with an increase in the concentration, until a certain threshold level (under both photoperiod and dark conditions), and beyond which, reduction was noted. The decrease in toxicity would have resulted from the aggregation and settling of NPs, making them less bioavailable. The oxidative stress was one of the major contributors towards cytotoxicity under both photoperiod and dark conditions. The slow depuration of TiO2 NPs under the photoperiod conditions confirmed a higher NP bioaccumulation and thus a higher bioconcentration factor (BCF) compared to dark conditions. The transmission electron micrographs confirmed the bioaccumulation of NPs and damage of tissues in the gut lining.	[Dalai, Swayamprava; Pakrashi, Sunandan; Chandrasekaran, Natarajan; Mukherjee, Amitava] VIT Univ, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Mukherjee, A (corresponding author), VIT Univ, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India.	amitav@vit.ac.in	Dalai, Swayamprava/AAD-8677-2021; Mukherjee, Amitava/H-5560-2011; Chandrasekaran, Natarajan/F-2312-2018	Mukherjee, Amitava/0000-0001-8682-4278; Chandrasekaran, Natarajan/0000-0002-0586-134X; Dalai, Swayamprava/0000-0001-5311-4763	VIT University	VIT University	The study is funded by institutional support from VIT University (www.vit.ac.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiano I, 2012, ENVIRON TOXICOL CHEM, V31, P2564, DOI 10.1002/etc.1981; Bennett SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048719; Bundschuh M, 2011, CHEMOSPHERE, V85, P1563, DOI 10.1016/j.chemosphere.2011.07.060; Dabrunz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020112; Dalai S, 2012, TOXICOL RES-UK, V1, P116, DOI 10.1039/c2tx00012a; Fenoglio I, 2009, CHEM-EUR J, V15, P4614, DOI 10.1002/chem.200802542; Frohlich E, 2009, J TOXICOL SCI, V34, P363; Gomes RL, 2004, ENVIRON TOXICOL CHEM, V23, P105, DOI 10.1897/02-613; Handy RD, 2012, ENVIRON TOXICOL CHEM, V31, P15, DOI 10.1002/etc.706; Heinlaan M, 2011, WATER RES, V45, P179, DOI 10.1016/j.watres.2010.08.026; Hong JL, 2006, J BIOSCI BIOENG, V101, P185, DOI 10.1263/jbb.101.185; Hund-Rinke K, 2006, ENVIRON SCI POLLUT R, V13, P225, DOI 10.1065/espr2006.06.311; Hussain M, 2010, CHEM ENG J, V157, P45, DOI 10.1016/j.cej.2009.10.043; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kim KT, 2010, SCI TOTAL ENVIRON, V408, P2268, DOI 10.1016/j.scitotenv.2010.01.041; Leung TY, 2008, WATER RES, V42, P4827, DOI 10.1016/j.watres.2008.08.031; Lewinski NA, 2010, ENVIRON SCI TECHNOL, V44, P1841, DOI 10.1021/es902728a; Lipovsky A, 2012, PHOTOCHEM PHOTOBIOL, V88, P14, DOI 10.1111/j.1751-1097.2011.01015.x; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; Lovern SB, 2006, ENVIRON TOXICOL CHEM, V25, P1132, DOI 10.1897/05-278R.1; Marcone GPS, 2012, J HAZARD MATER, V211, P436, DOI 10.1016/j.jhazmat.2011.12.075; Mendonca E, 2011, J HAZARD MATER, V186, P265, DOI 10.1016/j.jhazmat.2010.10.115; Miller RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030321, 10.1371/journal.pone.0033885]; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nowack B, 2007, ENVIRON POLLUT, V150, P5, DOI 10.1016/j.envpol.2007.06.006; OECD, 2004, TEST 202 DAPHN SP AC, DOI [10.1787/9789264069947-en, DOI 10.1787/9789264069947-EN]; Pinheiro T, 2013, NUCL INSTRUM METH B, V306, P117, DOI 10.1016/j.nimb.2012.12.049; Robertson PKJ, 2012, J HAZARD MATER, V211, P161, DOI 10.1016/j.jhazmat.2011.11.058; Rothen-Rutishauser Barbara, 2007, Part Fibre Toxicol, V4, P9; Sayes CM, 2006, TOXICOL SCI, V92, P174, DOI 10.1093/toxsci/kfj197; Scientific Committee on Emerging or Newly-Identified Health Risks, 2007, OP SCI ASP EX PROP D; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Sharma VK, 2009, J ENVIRON SCI HEAL A, V44, P1485, DOI 10.1080/10934520903263231; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Warheit DB, 2007, TOXICOL LETT, V171, P99, DOI 10.1016/j.toxlet.2007.04.008; Wiench K, 2009, CHEMOSPHERE, V76, P1356, DOI 10.1016/j.chemosphere.2009.06.025; WINTERBOURN CC, 1975, J LAB CLIN MED, V85, P337; Zhu XS, 2010, CHEMOSPHERE, V78, P209, DOI 10.1016/j.chemosphere.2009.11.013	40	38	39	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62970	10.1371/journal.pone.0062970	http://dx.doi.org/10.1371/journal.pone.0062970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658658	Green Published, Green Submitted, gold			2022-12-25	WOS:000321662800070
J	Coumans, FAW; van Dalum, G; Beck, M; Terstappen, LWMM				Coumans, Frank A. W.; van Dalum, Guus; Beck, Markus; Terstappen, Leon W. M. M.			Filtration Parameters Influencing Circulating Tumor Cell Enrichment from Whole Blood	PLOS ONE			English	Article							CANCER-PATIENTS; PERIPHERAL-BLOOD; BREAST-CANCER; HUMAN NEUTROPHILS; PROSTATE-CANCER; LUNG-CANCER; FLOW; SUSPENSIONS; SURVIVAL; ENUMERATION	Filtration can achieve circulating tumor cell (CTC) enrichment from blood. Key parameters such as flow-rate, applied pressure, and fixation, vary largely between assays and their influence is not well understood. Here, we used a filtration system, to monitor these parameters and determine their relationships. Whole blood, or its components, with and without spiked tumor cells were filtered through track-etched filters. We characterize cells passing through filter pores by their apparent viscosity; the viscosity of a fluid that would pass with the same flow. We measured a ratio of 5 center dot 10(4):10(2):1 for the apparent viscosities of 15 mu m diameter MDA-231 cells, 10 mu m white cells and 90 fl red cells passing through a 5 mu m pore. Fixation increases the pressure needed to pass cells through 8 mu m pores 25-fold and halves the recovery of spiked tumor cells. Filtration should be performed on unfixed samples at a pressure of similar to 10 mbar for a 1 cm(2) track-etched filter with 5 mu m pores. At this pressure MDA-231 cells move through the filter in 1 hour. If fixation is needed for sample preservation, a gentle fixative should be selected. The difference in apparent viscosity between CTC and blood cells is key in optimizing recovery of CTC.	[Coumans, Frank A. W.; van Dalum, Guus; Beck, Markus; Terstappen, Leon W. M. M.] Univ Twente, MIRA Inst, NL-7500 AE Enschede, Netherlands	University of Twente	Terstappen, LWMM (corresponding author), Univ Twente, MIRA Inst, POB 217, NL-7500 AE Enschede, Netherlands.	l.w.m.m.terstappen@utwente.nl	terstappen, leon/O-4923-2018	terstappen, leon/0000-0001-5944-3787; Beck, Markus/0000-0003-1298-4775	Veridex LLC; European Research Council	Veridex LLC; European Research Council(European Research Council (ERC)European Commission)	This work was supported by Veridex LLC (http://www.veridex.com/). MB was supported by a European Research Council starting grant (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2011, ISOLATION CIRCULATIN; Alix-Panabieres C, 2005, CLIN CHEM, V51, P1538, DOI 10.1373/clinchem.2005.049445; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; BAGGE U, 1977, ADV MICROCIRCULAT, V7, P18; CHIEN S, 1983, BIORHEOLOGY, V20, P11; Chung YK, 2011, BIOSENS BIOELECTRON, V26, P2520, DOI 10.1016/j.bios.2010.10.048; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Coumans FAW, 2013, METHODS MOL BIOL CIR; Coumans FAW, 2013, PLOS ONE IN PRESS; Coumans FAW, 2012, CLIN CANCER RES, V18, P5711, DOI 10.1158/1078-0432.CCR-12-1585; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; DAGAN Z, 1983, CHEM ENG SCI, V38, P583, DOI 10.1016/0009-2509(83)80118-3; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Desitter I, 2011, ANTICANCER RES, V31, P427; Dharmasiri U, 2011, ANAL CHEM, V83, P2301, DOI 10.1021/ac103172y; DONG C, 1988, J BIOMECH ENG-T ASME, V110, P27, DOI 10.1115/1.3108402; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; EVANS E, 1984, BLOOD, V64, P1028; FRANK RS, 1990, J BIOMECH ENG-T ASME, V112, P277, DOI 10.1115/1.2891185; Hiltermann TJN, 2012, ANN ONCOL, V23, P2937, DOI 10.1093/annonc/mds138; HOCHMUTH RM, 1990, BIORHEOLOGY, V27, P817; Holdich R, 2006, PHILOS T ROY SOC A, V364, P161, DOI 10.1098/rsta.2005.1090; Hou HW, 2009, BIOMED MICRODEVICES, V11, P557, DOI 10.1007/s10544-008-9262-8; Hsieh HB, 2006, BIOSENS BIOELECTRON, V21, P1893, DOI 10.1016/j.bios.2005.12.024; JONES JG, 1984, BRIT J HAEMATOL, V57, P457, DOI 10.1111/j.1365-2141.1984.tb02920.x; Kahn HJ, 2004, BREAST CANCER RES TR, V86, P237, DOI 10.1023/B:BREA.0000036897.92513.72; KHATO J, 1979, TOHOKU J EXP MED, V128, P273, DOI 10.1620/tjem.128.273; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Kuiper S, 2002, J MEMBRANE SCI, V196, P149, DOI 10.1016/S0376-7388(01)00552-X; Lee G.R., 1993, WINTROBES CLIN HEMAT, V9th; Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008; Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105; Matsusaka S, 2010, CANCER SCI, V101, P1067, DOI 10.1111/j.1349-7006.2010.01492.x; MERRILL EW, 1969, PHYSIOL REV, V49, P863, DOI 10.1152/physrev.1969.49.4.863; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; NEEDHAM D, 1990, J BIOMECH ENG-T ASME, V112, P269, DOI 10.1115/1.2891184; Ntouroupi TG, 2008, BRIT J CANCER, V99, P789, DOI 10.1038/sj.bjc.6604545; Rao C, 2011, INT J ONCOL, V38, P755, DOI 10.3892/ijo.2011.896; Rao CG, 2005, INT J ONCOL, V27, P49; ROMSDAHL MM, 1965, JAMA-J AM MED ASSOC, V193, P1087; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; SEAL SH, 1964, CANCER, V17, P637, DOI 10.1002/1097-0142(196405)17:5<637::AID-CNCR2820170512>3.0.CO;2-I; SKALAK R, 1987, BIORHEOLOGY, V24, P35; SKALAK R, 1983, BIORHEOLOGY, V20, P41; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Tan SJ, 2010, BIOSENS BIOELECTRON, V26, P1701, DOI 10.1016/j.bios.2010.07.054; Tan SJ, 2009, BIOMED MICRODEVICES, V11, P883, DOI 10.1007/s10544-009-9305-9; TSAI MA, 1993, BIOPHYS J, V65, P2078, DOI 10.1016/S0006-3495(93)81238-4; VALBERG PA, 1985, J CELL BIOL, V101, P130, DOI 10.1083/jcb.101.1.130; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; WEISS L, 1989, CELL BIOPHYS, V14, P187, DOI 10.1007/BF02797133; YEUNG A, 1989, BIOPHYS J, V56, P139, DOI 10.1016/S0006-3495(89)82659-1; Zheng S, 2007, J CHROMATOGR A, V1162, P154, DOI 10.1016/j.chroma.2007.05.064; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3	55	73	79	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61774	10.1371/journal.pone.0061774	http://dx.doi.org/10.1371/journal.pone.0061774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658615	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700021
J	Yang, L; Niu, HJ; Gao, XJ; Wang, QS; Han, G; Cao, LM; Cai, CQ; Weiler, J; Yin, HF				Yang, Lu; Niu, Hongjing; Gao, Xianjun; Wang, Qingsong; Han, Gang; Cao, Limin; Cai, Chunquan; Weiler, Jan; Yin, Haifang			Effective Exon Skipping and Dystrophin Restoration by 2 '-O-Methoxyethyl Antisense Oligonucleotide in Dystrophin-Deficient Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; CELL-PENETRATING PEPTIDE; NECROSIS-FACTOR-ALPHA; PHASE-II TRIAL; MESSENGER-RNA; CUSTIRSEN OGX-011; SPLICE-CORRECTION; APOLIPOPROTEIN-B; PROSTATE-CANCER; MUSCLE-CELLS	Antisense oligonucleotide (AO)-mediated exon-skipping therapy is one of the most promising therapeutic strategies for Duchenne Muscular Dystrophy (DMD) and several AO chemistries have been rigorously investigated. In this report, we focused on the effect of 2'-O-methoxyethyl oligonucleotides (MOE) on exon skipping in cultured mdx myoblasts and mice. Efficient dose-dependent skipping of targeted exon 23 was achieved in myoblasts with MOE AOs of different lengths and backbone chemistries. Furthermore, we established that 25-mer MOE phosphorothioate (PS) AOs provided the greatest exon-skipping efficacy. When compared with 2'O methyl phosphorothioate (2'OmePS) AOs, 25-mer MOE (PS) AOs also showed higher exon-skipping activity in vitro and in mdx mice after intramuscular injections. Characterization of uptake in vitro corroborated with exon-skipping results, suggesting that increased uptake of 25-mer MOE PS AOs might partly contribute to the difference in exon-skipping activity observed in vitro and in mdx mice. Our findings demonstrate the substantial potential for MOE PS AOs as an alternative option for the treatment of DMD.	[Yang, Lu; Niu, Hongjing; Gao, Xianjun; Wang, Qingsong; Han, Gang; Cao, Limin; Cai, Chunquan; Yin, Haifang] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China; [Weiler, Jan] Novartis Inst BioMed Res Inc, NIBR Biol Ctr, Cambridge, MA USA	Tianjin Medical University; Novartis	Yin, HF (corresponding author), Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China.	haifangyin@tmu.edu.cn			National Natural Science Foundation of China [81101340]; Research Fund for the Doctoral Program of Higher Education of China [20111202110002]; Program for New Century Excellent Talents [NCET-10-0957]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China (Grant No. 81101340), Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20111202110002) and Program for New Century Excellent Talents (NCET-10-0957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Akdim F, 2010, J AM COLL CARDIOL, V55, P1611, DOI 10.1016/j.jacc.2009.11.069; Arechavala-Gomeza V, 2007, HUM GENE THER, V18, P798, DOI 10.1089/hum.2006.061; Chi KN, 2005, J NATL CANCER I, V97, P1287, DOI 10.1093/jnci/dji252; Chia S, 2009, CLIN CANCER RES, V15, P708, DOI 10.1158/1078-0432.CCR-08-1159; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; El-Andaloussi S, 2007, MOL THER, V15, P1820, DOI 10.1038/sj.mt.6300255; Geary RS, 2003, DRUG METAB DISPOS, V31, P1419, DOI 10.1124/dmd.31.11.1419; Geary RS, 2001, J PHARMACOL EXP THER, V296, P890; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Heemskerk H, 2009, ANN NY ACAD SCI, V1175, P71, DOI 10.1111/j.1749-6632.2009.04973.x; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Kastelein JJP, 2006, CIRCULATION, V114, P1729, DOI 10.1161/CIRCULATIONAHA.105.606442; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Laskin JJ, 2012, J THORAC ONCOL, V7, P579, DOI 10.1097/JTO.0b013e31823f459c; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; Manoharan M, 1999, BBA-GENE STRUCT EXPR, V1489, P117, DOI 10.1016/S0167-4781(99)00138-4; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Moulton HM, 2012, METHODS MOL BIOL, V867, P407, DOI 10.1007/978-1-61779-767-5_26; Mountoni F, 2011, NAT REV, V10, P621; NATT F, 2000, Patent No. 2000240734; Natt F, Patents, Patent No. [CAN 132:279477, 132279477]; Natt F, Patents, Patent No. [EP 991-19768, 99119768]; Natt F, Patents, Patent No. [US 981-68447, 98168447]; Saad F, 2011, CLIN CANCER RES, V17, P5765, DOI 10.1158/1078-0432.CCR-11-0859; Sazani P, 2002, NAT BIOTECHNOL, V20, P1228, DOI 10.1038/nbt759; Sewell KL, 2002, J PHARMACOL EXP THER, V303, P1334, DOI 10.1124/jpet.102.036749; van Deutekom JCT, 2001, HUM MOL GENET, V10, P1547, DOI 10.1093/hmg/10.15.1547; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wang QS, 2010, J GENE MED, V12, P354, DOI 10.1002/jgm.1446; Wilton SD, 1999, NEUROMUSCULAR DISORD, V9, P330, DOI 10.1016/S0960-8966(99)00010-3; Wood MJA, 2010, BRAIN, V133, P957, DOI 10.1093/brain/awq002; Yin HF, 2008, MOL THER, V16, P38, DOI 10.1038/sj.mt.6300329; Yin HF, 2010, MOL THER, V18, P819, DOI 10.1038/mt.2009.310; Yin HF, 2009, HUM MOL GENET, V18, P4405, DOI 10.1093/hmg/ddp395; Yin H, 2008, HUM MOL GENET, V17, P3909, DOI 10.1093/hmg/ddn293; Yu RZ, 2007, DRUG METAB DISPOS, V35, P460, DOI 10.1124/dmd.106.012401; Yu RZ, 2001, J PHARMACOL EXP THER, V296, P388	40	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61584	10.1371/journal.pone.0061584	http://dx.doi.org/10.1371/journal.pone.0061584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658612	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700016
J	Cushman, I; Cushman, SM; Potter, PM; Casey, PJ				Cushman, Ian; Cushman, Stephanie M.; Potter, Philip M.; Casey, Patrick J.			Control of RhoA Methylation by Carboxylesterase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; ISOPRENYLCYSTEINE CARBOXYLMETHYLTRANSFERASE; PROTEIN PRENYLATION; CANCER-CELLS; METHYLTRANSFERASE; RAS; GTPASES; LOCALIZATION; ACTIVATION; ESTERASE	A number of proteins that play key roles in cell signaling are post-translationally modified by the prenylation pathway. The final step in this pathway is methylation of the carboxyl terminus of the prenylated protein by isoprenylcysteine carboxylmethyltransferase. Due to the impact of methylation on Rho function, we sought to determine if the process was reversible and hence could control Rho function in a dynamic fashion. Elevating isoprenylcysteine carboxylmethyltransferase activity in cells has profound effects on MDA-MB-231 cell morphology, implying the presence of a pool of unmethylated prenyl proteins in these cells under normal conditions. Using a knockdown approach, we identified a specific esterase, carboxylesterase 1, whose function had a clear impact not only on the methylation status of RhoA but also RhoA activation and cell morphology. These data provide compelling evidence that C-terminal modification of prenyl proteins, rather than being purely a constitutive process, can serve as a point of regulation of function for this important class of protein.	[Cushman, Ian; Casey, Patrick J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Cushman, Stephanie M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Potter, Philip M.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Cushman, Ian; Casey, Patrick J.] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore	Duke University; Duke University; St Jude Children's Research Hospital; National University of Singapore	Casey, PJ (corresponding author), Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore.	patrick.casey@duke-nus.edu.sg	; Potter, Philip/J-4515-2013	Casey, Patrick/0000-0002-7366-9309; Potter, Philip/0000-0001-8922-8535	American Lebanese and Syrian Associated Charities; St. Jude Children's Research Hospital	American Lebanese and Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital	This work was supported by the by the American Lebanese and Syrian Associated Charities and the St. Jude Children's Research Hospital.	Ashby MN, 1998, CURR OPIN LIPIDOL, V9, P99, DOI 10.1097/00041433-199804000-00004; Backlund PS, 1997, J BIOL CHEM, V272, P33175, DOI 10.1074/jbc.272.52.33175; Baron RA, 2007, BIOCHEMISTRY-US, V46, P554, DOI 10.1021/bi060344n; Baron Rudi A., 2004, BMC Biochemistry, V5, P19, DOI 10.1186/1471-2091-5-19; Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Brusehaber E, 2009, BIOORGAN MED CHEM, V17, P7878, DOI 10.1016/j.bmc.2009.10.033; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Cushman I, 2011, CELL ADHES MIGR, V5, P11, DOI 10.4161/cam.5.1.13196; Cushman I, 2009, J BIOL CHEM, V284, P27964, DOI 10.1074/jbc.M109.025296; Deem AK, 2006, GENE, V380, P159, DOI 10.1016/j.gene.2006.05.023; Doll RJ, 2004, CURR OPIN DRUG DISC, V7, P478; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; GLOMSET JA, 1994, ANNU REV CELL BIOL, V10, P181, DOI 10.1146/annurev.cellbio.10.1.181; Harrington EO, 2004, AM J PHYSIOL-LUNG C, V287, pL1091, DOI 10.1152/ajplung.00421.2003; Holmes RS, 2010, MAMM GENOME, V21, P427, DOI 10.1007/s00335-010-9284-4; Jayaram B, 2011, ISLETS, V3, P48, DOI 10.4161/isl.3.2.15016; Lu Q, 2004, CIRC RES, V94, P306, DOI 10.1161/01.RES.0000113923.85084.C1; Meigs T. E., 2005, J BIOL CHEM; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Morton CL, 2000, MOL BIOTECHNOL, V16, P193, DOI 10.1385/MB:16:3:193; Oboh OT, 2008, J BIOCHEM MOL TOXIC, V22, P51, DOI 10.1002/jbt.20214; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Ross MK, 2007, J BIOCHEM MOL TOXIC, V21, P187, DOI 10.1002/jbt.20178; Rounds S., 2008, T AM CLIN CLIMAT ASS, V119, P167; Rounds Sharon, 2008, Trans Am Clin Climatol Assoc, V119, P155; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Winter-Vann AM, 2005, P NATL ACAD SCI USA, V102, P4336, DOI 10.1073/pnas.0408107102; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Young S. G., 2001, ENZYMES, V21, P156; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	34	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19177	19183		10.1074/jbc.M113.467407	http://dx.doi.org/10.1074/jbc.M113.467407			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658012	Green Published, hybrid			2022-12-25	WOS:000321335800051
J	Ames, RM; MacPherson, JI; Pinney, JW; Lovell, SC; Robertson, DL				Ames, Ryan M.; MacPherson, Jamie I.; Pinney, John W.; Lovell, Simon C.; Robertson, David L.			Modular Biological Function Is Most Effectively Captured by Combining Molecular Interaction Data Types	PLOS ONE			English	Article							GENE ONTOLOGY; DISCOVERY; NETWORKS	Large-scale molecular interaction data sets have the potential to provide a comprehensive, system-wide understanding of biological function. Although individual molecules can be promiscuous in terms of their contribution to function, molecular functions emerge from the specific interactions of molecules giving rise to modular organisation. As functions often derive from a range of mechanisms, we demonstrate that they are best studied using networks derived from different sources. Implementing a graph partitioning algorithm we identify subnetworks in yeast protein-protein interaction (PPI), genetic interaction and gene co-regulation networks. Among these subnetworks we identify cohesive subgraphs that we expect to represent functional modules in the different data types. We demonstrate significant overlap between the subgraphs generated from the different data types and show these overlaps can represent related functions as represented by the Gene Ontology (GO). Next, we investigate the correspondence between our subgraphs and the Gene Ontology. This revealed varying degrees of coverage of the biological process, molecular function and cellular component ontologies, dependent on the data type. For example, subgraphs from the PPI show enrichment for 84%, 58% and 93% of annotated GO terms, respectively. Integrating the interaction data into a combined network increases the coverage of GO. Furthermore, the different annotation types of GO are not predominantly associated with one of the interaction data types. Collectively our results demonstrate that successful capture of functional relationships by network data depends on both the specific biological function being characterised and the type of network data being used. We identify functions that require integrated information to be accurately represented, demonstrating the limitations of individual data types. Combining interaction subnetworks across data types is therefore essential for fully understanding the complex and emergent nature of biological function.	[Ames, Ryan M.; MacPherson, Jamie I.; Lovell, Simon C.; Robertson, David L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Pinney, John W.] Univ London Imperial Coll Sci Technol & Med, Ctr Integrat Syst Biol & Bioinformat, Div Mol Biosci, London, England	University of Manchester; Imperial College London	Ames, RM (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	ryan.ames@manchester.ac.uk		Lovell, Simon/0000-0002-4092-8458; Ames, Ryan/0000-0002-1432-5629	Biotechnology and Biological Sciences Research Council (BBSRC) CASE studentship; Pfizer	Biotechnology and Biological Sciences Research Council (BBSRC) CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer)	JIM was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) CASE studentship with industry partner Pfizer and RMA by a BBSRC studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dutkowski J, 2013, NAT BIOTECHNOL, V31, P38, DOI 10.1038/nbt.2463; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Karypis G, 1998, SIAM J SCI COMPUT, V20, P359, DOI 10.1137/S1064827595287997; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Michaut M, 2011, PLOS COMPUTATIONAL B, V7; Mostafavi S, 2012, PROTEOMICS, V12, P1687, DOI 10.1002/pmic.201100607; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Srivas R, 2011, NAT PROTOC, V6, P1308, DOI 10.1038/nprot.2011.368; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Wang JX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S10; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Xiao Guanghua, 2005, Journal of Bioinformatics and Computational Biology, V3, P1371, DOI 10.1142/S0219720005001612; Zainudin S, 2008, ISDA 2008: EIGHTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS DESIGN AND APPLICATIONS, VOL 2, PROCEEDINGS, P557, DOI 10.1109/ISDA.2008.183; Zhou XD, 2011, IEEE INT C BIO BIO W, P235, DOI 10.1109/BIBMW.2011.6112380	28	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62670	10.1371/journal.pone.0062670	http://dx.doi.org/10.1371/journal.pone.0062670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658761	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000321202100030
J	Cai, M; Dai, H; Qiu, YY; Zhao, Y; Zhang, RY; Chu, MJ; Dai, JC; Hu, ZB; Shen, HB; Chen, F				Cai, Min; Dai, Hui; Qiu, Yongyong; Zhao, Yang; Zhang, Ruyang; Chu, Minjie; Dai, Juncheng; Hu, Zhibin; Shen, Hongbing; Chen, Feng			SNP Set Association Analysis for Genome-Wide Association Studies	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; CANCER SUSCEPTIBILITY LOCI; LUNG-CANCER; GENE; MULTIPLE; SURVIVAL; DISEASE; VARIANT; TESTS	Genome-wide association study (GWAS) is a promising approach for identifying common genetic variants of the diseases on the basis of millions of single nucleotide polymorphisms (SNPs). In order to avoid low power caused by overmuch correction for multiple comparisons in single locus association study, some methods have been proposed by grouping SNPs together into a SNP set based on genomic features, then testing the joint effect of the SNP set. We compare the performances of principal component analysis (PCA), supervised principal component analysis (SPCA), kernel principal component analysis (KPCA), and sliced inverse regression (SIR). Simulated SNP sets are generated under scenarios of 0, 1 and >= 2 causal SNPs model. Our simulation results show that all of these methods can control the type I error at the nominal significance level. SPCA is always more powerful than the other methods at different settings of linkage disequilibrium structures and minor allele frequency of the simulated datasets. We also apply these four methods to a real GWAS of non-small cell lung cancer (NSCLC) in Han Chinese population	[Cai, Min; Dai, Hui; Qiu, Yongyong; Zhao, Yang; Zhang, Ruyang; Chu, Minjie; Dai, Juncheng; Hu, Zhibin; Shen, Hongbing; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Clin Epidemiol Sect, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Chen, F (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	fengchen@njmu.edu.cn		Chen, Feng/0000-0002-2699-7190	National Natural Science Foundation of China [81072389, 30901232]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [11KJA330001, 10KJA33034]; Research Fund for the Doctoral Program of Higher Education of China [211323411002]; Research and the Innovation Project for College Graduates of Jiangsu Province [CXZZ11_0733]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research and the Innovation Project for College Graduates of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (grant numbers 81072389 to FC, 30901232 to YZ), Key Grant of Natural Science Foundation of the Jiangsu Higher Education Institutions of China (11KJA330001 and 10KJA33034), the Research Fund for the Doctoral Program of Higher Education of China (211323411002), the Research and the Innovation Project for College Graduates of Jiangsu Province (CXZZ11_0733) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or prepararion of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Beyene J, 2009, GENET EPIDEMIOL, V33, pS105, DOI 10.1002/gepi.20481; Buil Alfonso, 2009, BMC Proc, V3 Suppl 7, pS130; Butkiewicz D, 2012, INT J CANCER, V131, pE1100, DOI 10.1002/ijc.27596; Chen X, 2008, BIOINFORMATICS, V24, P2474, DOI 10.1093/bioinformatics/btn458; Chen X, 2010, GENET EPIDEMIOL, V34, P716, DOI 10.1002/gepi.20532; Dong J, 2012, NAT GENET, V44, P895, DOI 10.1038/ng.2351; Gao QS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-75; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hendricks AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040925; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Li Ang, 2005, Zhonghua Yi Xue Za Zhi, V85, P2623; Li KerChau, 1991, J AM STAT ASSOC, V86, P316; Liao WY, 2012, J THORAC ONCOL, V7, P973, DOI 10.1097/JTO.0b013e31824fe98c; Liu PY, 2010, CANCER EPIDEM BIOMAR, V19, P517, DOI 10.1158/1055-9965.EPI-09-0791; Liu ZQ, 2005, J BIOMED BIOTECHNOL, P155, DOI 10.1155/JBB.2005.155; Lo SH, 2008, P NATL ACAD SCI USA, V105, P12387, DOI 10.1073/pnas.0805242105; Ma SG, 2011, BRIEF BIOINFORM, V12, P714, DOI 10.1093/bib/bbq090; McKeen HD, 2011, BIOCHEM SOC T, V39, P663, DOI 10.1042/BST0390663; Montana G, 2005, BIOINFORMATICS, V21, P4309, DOI 10.1093/bioinformatics/bti689; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Orr N, 2012, NAT GENET, V44, P1182, DOI 10.1038/ng.2417; Peng QQ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-6; Qiao B, 2009, BMC P S7, V3, pS132; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266; Wang Xuexia, 2009, BMC Proc, V3 Suppl 7, pS28; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Zhao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044978; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	37	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62495	10.1371/journal.pone.0062495	http://dx.doi.org/10.1371/journal.pone.0062495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658731	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100010
J	Eappen, AG; Smith, RC; Jacobs-Lorena, M				Eappen, Abraham G.; Smith, Ryan C.; Jacobs-Lorena, Marcelo			Enterobacter-Activated Mosquito Immune Responses to Plasmodium Involve Activation of SRPN6 in Anopheles stephensi	PLOS ONE			English	Article							COMPLEMENT-LIKE PROTEIN; GRAM-NEGATIVE-BACTERIA; AEDES-AEGYPTI; SPOROGONIC DEVELOPMENT; PERITROPHIC MATRIX; GAMBIAE MOSQUITOS; MALARIA PARASITES; VECTOR; SYSTEM; INFECTION	Successful development of Plasmodium in the mosquito is essential for the transmission of malaria. A major bottleneck in parasite numbers occurs during midgut invasion, partly as a consequence of the complex interactions between the endogenous microbiota and the mosquito immune response. We previously identified SRPN6 as an immune component which restricts Plasmodium berghei development in the mosquito. Here we demonstrate that SRPN6 is differentially activated by bacteria in Anopheles stephensi, but only when bacteria exposure occurs on the lumenal surface of the midgut epithelium. Our data indicate that AsSRPN6 is strongly induced following exposure to Enterobacter cloacae, a common component of the mosquito midgut microbiota. We conclude that AsSRPN6 is a vital component of the E. cloacae-mediated immune response that restricts Plasmodium development in the mosquito An. stephensi.	[Eappen, Abraham G.; Smith, Ryan C.; Jacobs-Lorena, Marcelo] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Jacobs-Lorena, M (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD USA.	mlorena@jhsph.edu	Smith, Ryan C./H-9360-2019	Smith, Ryan C./0000-0003-0245-2265	National Research Service Award [F32AI088835]; Johns Hopkins Malaria Research Institute pilot grant; National Institutes of Health/National Institute of Allergy and Infectious Diseases [R01AI031478]; Calvin S. and Helen H. Lang Post-Doctoral Fellowship; Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; National Institutes of Health Grant [RR00052]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI088835, R01AI031478] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Research Institute pilot grant; National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Calvin S. and Helen H. Lang Post-Doctoral Fellowship; Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a National Research Service Award F32AI088835 (to R.C.S.), a Johns Hopkins Malaria Research Institute pilot grant (to M.J.L.), and by grant R01AI031478 (to M.J.L.) from the National Institutes of Health/National Institute of Allergy and Infectious Diseases. Additional support was provided by a Calvin S. and Helen H. Lang Post-Doctoral Fellowship (to R.C.S) and from the Johns Hopkins Malaria Research Institute and the Bloomberg Family Foundation. Supply of human blood was supported by National Institutes of Health Grant RR00052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2004, J BIOL CHEM, V279, P5573, DOI 10.1074/jbc.M307582200; Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; An CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048689; An CJ, 2011, CELL MOL LIFE SCI, V68, P1929, DOI 10.1007/s00018-010-0543-z; Augustin R, 2009, DEV COMP IMMUNOL, V33, P830, DOI 10.1016/j.dci.2009.01.009; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007; Ceraul SM, 2011, INFECT IMMUN, V79, P321, DOI 10.1128/IAI.00362-10; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Edwards MJ, 1997, INSECT BIOCHEM MOLEC, V27, P1063, DOI 10.1016/S0965-1748(97)00093-3; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Ghosh A, 2000, PARASITOL TODAY, V16, P196, DOI 10.1016/S0169-4758(99)01626-9; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Lowenberger CA, 1999, EXP PARASITOL, V91, P59, DOI 10.1006/expr.1999.4350; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Moskalyk LA, 1996, INSECT MOL BIOL, V5, P261, DOI 10.1111/j.1365-2583.1996.tb00100.x; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Opota O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002259; Pinto SB, 2008, CELL MICROBIOL, V10, P891, DOI 10.1111/j.1462-5822.2007.01091.x; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Richman AM, 1997, EMBO J, V16, P6114, DOI 10.1093/emboj/16.20.6114; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Shao L, 2001, ARCH INSECT BIOCHEM, V47, P119, DOI 10.1002/arch.1042; SINDEN RE, 1985, PARASITOLOGY, V91, P227, DOI 10.1017/S0031182000057334; Sinden RE, 2007, PLOS PATHOG, V3, P2005, DOI 10.1371/journal.ppat.0030195; Smith RC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002965; Srinivasan P, 2004, J BIOL CHEM, V279, P5581, DOI 10.1074/jbc.M307587200; Vizioli J, 2001, P NATL ACAD SCI USA, V98, P12630, DOI 10.1073/pnas.221466798; Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Warr E, 2008, INSECT MOL BIOL, V17, P39, DOI 10.1111/j.1365-2583.2008.00778.x; Whitten MMA, 2006, PARASITE IMMUNOL, V28, P121, DOI 10.1111/j.1365-3024.2006.00804.x; Zou Z, 2010, IMMUNITY, V32, P41, DOI 10.1016/j.immuni.2009.11.011	43	39	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62937	10.1371/journal.pone.0062937	http://dx.doi.org/10.1371/journal.pone.0062937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658788	Green Published, gold			2022-12-25	WOS:000321202100048
J	Luo, Q; Wang, Q; Lu, ZX; Liu, JA				Luo, Qing; Wang, Qi; Lu, Zuxun; Liu, Junan			Evaluation of Responsiveness of Community Health Services in Urban China: A Quantitative Study in Wuhan City	PLOS ONE			English	Article							SYSTEM; PHYSICIANS; CARE	Background: With the objective of the national health services systems reform to move care to the community, community health services (CHS) are becoming the gateways of the health system in China. This study aims to evaluate the levels and distributions of the responsiveness of CHS in urban China and identify the relevant features to provide the government with policy advice on the improvement of CHS responsiveness. Methods: A total of 872 face-to-face interviews were conducted in community health centers (CHCs) from 2007 to 2009. Indicators of responsiveness that were recommended by the World Health Organization were adopted, and non-conditional logistic regression analysis was performed to explore the factors associated with the levels and distributions of the responsiveness of CHS. Results: The responsiveness scored at a fairly 'good' level of 7.45, 7.45, and 7.46 for CHS in years 2007, 2008, and 2009, respectively. The representative responsiveness inequality indexes were 0.097, 0.101, and 0.109, respectively, indicating the moderately balanced distributions of responsiveness in these three years. During this period, the scores of responsiveness elements were highest at 7.44 to 8.34 in "dignity'', "communication'', and "social support'', while lowest at 6.76 to 7.54 in "autonomy'', "confidentiality'', and "basic amenities''. The results of the logistic regression analysis suggested that five elements (OR value), namely, "dignity'' (1.414-3.345), "communication'' (1.218-3.655), "basic amenities'' (1.251-2.362), "prompt attention'' (1.098-1.590), and "autonomy'' (1.416-2.173), had significant associations with CHS responsiveness. Conclusions: The responsiveness of CHS in Wuhan City was fairly good but still requires further improvement, particularly on the working conditions of CHCs and communication skills trainings among CHS workers.	[Luo, Qing; Lu, Zuxun; Liu, Junan] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan 430074, Hubei Province, Peoples R China; [Luo, Qing; Lu, Zuxun; Liu, Junan] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, JA (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan 430074, Hubei Province, Peoples R China.	lja10_11@163.com		Luo, Qing/0000-0003-1643-0307; Liu, Junan/0000-0003-1740-1161				[Anonymous], GPE DISCUSSION PAPER, V37; CARDOZO RN, 1965, J MARKETING RES, V2, P244, DOI 10.2307/3150182; Darby C, 2001, GPE DISCUSSION PAPER, V23; De Silva A, GPE DISCUSSION PAPER, V21; de Silva A, 2000, GPE DISCUSSION PAPER, V32; Forouzan AS, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-325; Gostin L, 2003, DOMAINS HLTH RESPONS; Gouveia Giselle Campozana, 2005, Cad. Saúde Pública, V21, pS109, DOI 10.1590/S0102-311X2005000700012; Hsu CC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-72; HULKA BS, 1970, MED CARE, V8, P429, DOI 10.1097/00005650-197009000-00010; Jamar S D, 1994, South Univ Law Rev, V22, P1; Jiang Q, 2002, CHINESE HLTH SERVICE, V168, P324; Ma Q., 2009, CHIN PRIM HLTH CARE, V23, P26; Mann Jonathan M, 1994, Health Hum Rights, V1, P6; MOH, 2011, NAT MED SERV RES JAN; MURPHYCULLEN CL, 1984, SOC SCI MED, V19, P163, DOI 10.1016/0277-9536(84)90283-1; Navarro V, 2001, INT J HEALTH SERV, V31, P23, DOI 10.2190/3LM8-A37Q-FKJ4-TE0R; Njeru MK, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-243; Peltzer K, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-117; Peng Dan, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P158; Qu J, 2001, HLTH EC RES, V5, P9; Satistics Bureau of Wuhan Municipality, 2010, WUH STAT YB 2010, P264; Savedoff W., 2003, HLTH SYSTEMS PERFORM; Smith C, 1992, Qual Assur Health Care, V4, P171; Valentine NB, 2000, GPE DISCUSSION PAPER, V22; Valentine N, 2008, SOC SCI MED, V66, P1939, DOI 10.1016/j.socscimed.2007.12.002; Wang X., 2008, CHIN PRIM HLTH CARE, V22, P18; World Health Organization, 2000, HLTH SYST IMPR PERF; Yan Y., 2009, CHIN J SOC MED, V26, P184; Yang D., 2005, CHIN GEN PRACT, V8, P359; Zhang J., 2007, CHIN PRIM HLTH CARE, V21, P28	31	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62923	10.1371/journal.pone.0062923	http://dx.doi.org/10.1371/journal.pone.0062923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175AF	23658785	Green Published, Green Submitted, gold			2022-12-25	WOS:000321200500044
J	Wang, BR; Choi, IY; Kim, KJ; Kwon, YD				Wang, Bo-Ram; Choi, In Young; Kim, Kwang-Jum; Kwon, Young Dae			Use of Traditional Korean Medicine by Patients with Musculoskeletal Disorders	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; UNITED-STATES; COMPLEMENTARY; ADULTS; PREVALENCE; PATTERNS; CARE; DETERMINANTS; POPULATION; THERAPIES	Background: South Korea has maintained a dual healthcare delivery system that incorporates both traditional Korean and Western medicine. In this research, we identified the determinants of the frequency of using traditional Korean medicine among musculoskeletal patients, who are known to be the most frequent users of complementary and alternative medicine. Methods: In this research, we reviewed 2 consecutive years of nationally representative survey data from the 2008 and 2009 Korea Health Panel Survey. We analyzed the utilization of outpatient services by musculoskeletal patients within 12 months of the 2009 survey date. A two-part model was used because some patients did not use traditional Korean medicine and skewness was present in the data on traditional Korean medicine use. In the first part, logistic regression analysis was performed to investigate the use of traditional Korean medicine. In the second part, multiple regression analysis was performed to analyze the frequency of traditional Korean medicine usage among the subjects who visited traditional Korean medical institutions. Results: The frequency of traditional Korean medicine usage was positively associated with ages of 40-49 years and over 60, restrictions on daily life, a greater number of chronic diseases, not being hospitalized, and more frequent visits (more than five times) to conventional hospitals or clinics for musculoskeletal disorders. Conclusions: The important determinants of the frequency of traditional Korean medicine usage were age, activity restrictions, the number of chronic diseases, hospitalization history, and the number of visits to conventional hospitals for musculoskeletal disorders. The results contribute to our understanding of the characteristics of traditional Korean medicine users and may be used as a basic resource for related policymaking by government officials and medical professionals.	[Wang, Bo-Ram; Choi, In Young; Kim, Kwang-Jum; Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea; [Wang, Bo-Ram; Choi, In Young; Kim, Kwang-Jum] Catholic Univ Korea, Grad Sch Healthcare Management & Policy, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Kwon, YD (corresponding author), Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea.	snukyd1@naver.com	Kwon, Young Dae/T-1591-2017	Kwon, Young Dae/0000-0002-8781-6832				ADAMS EK, 1991, HEALTH SERV RES, V26, P583; Al-Windi A, 2004, COMPLEMENT THER MED, V12, P99, DOI 10.1016/j.ctim.2004.09.007; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Barnes Patricia M, 2004, Adv Data, P1; Branch L, 1981, J Community Health, V7, P80, DOI 10.1007/BF01323227; Burke A, 2006, J ALTERN COMPLEM MED, V12, P639, DOI 10.1089/acm.2006.12.639; Caswell AM, 2002, J BACK MUSCULOSKELET, V16, P121, DOI 10.3233/BMR-2002-16402; Conboy L, 2005, J ALTERN COMPLEM MED, V11, P977, DOI 10.1089/acm.2005.11.977; Duan N., 1983, J BUS STAT, V1, P115, DOI DOI 10.2307/1391852; Egede LE, 2002, DIABETES CARE, V25, P324, DOI 10.2337/diacare.25.2.324; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Garrow D, 2006, J ALTERN COMPLEM MED, V12, P895, DOI 10.1089/acm.2006.12.895; Gha YS, 2007, RES I HEALTHCARE POL, V5, P51; Goldstein MS, 2005, EVID-BASED COMPL ALT, V2, P557, DOI 10.1093/ecam/neh138; Graham RE, 2005, J NATL MED ASSOC, V97, P535; Hanssen B, 2005, SCAND J PRIM HEALTH, V23, P57, DOI 10.1080/02813430510018419; Honda K, 2005, PREV MED, V40, P46, DOI 10.1016/j.ypmed.2004.05.001; Hori S, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-14; Kim HJ, 2003, J KOREAN GERIATR SOC, V7, P295; Kim Jinhyun, 2007, [Society of Preventive Korean Medicine, 대한예방한의학회지], V11, P139; Kim Myunghwa, 2010, J Prev Med Public Health, V43, P496, DOI 10.3961/jpmph.2010.43.6.496; Ko SJ, 2011, 3 C KOR HLTH PAN, P267; Korea Health Industry Development Institute (KHIDI), 2012, MED RES STAT HDB 201; Korea Institute for Health and Social Affairs, 2010, HLTH WELFARE ISSUE F, V58, P1; Korea Institute for Health and Social Affairs (KIHASA), STUD DES; Korea Ministry of Health & Welfare, 2011, NAT SURV OR MED UT H; Lachenbruch PA, 2002, STAT METHODS MED RES, V11, P297, DOI 10.1191/0962280202sm289ra; 이윤정, 2007, [Journal of Korean Academy of Community Health Nursing, 지역사회간호학회지], V18, P102; Lane P M, 1988, J Health Care Mark, V8, P5; Lawrence Dana J, 2007, Chiropr Osteopat, V15, P2, DOI 10.1186/1746-1340-15-2; Lee J, 2011, J KOREAN ACAD NURS, V41, P18, DOI 10.4040/jkan.2011.41.1.18; Lee Sang jeong, 2009, [Journal of Industrial Property, 산업재산권], V29, P1; Lim MK, 2005, COMPLEMENT THER MED, V13, P16, DOI 10.1016/j.ctim.2004.11.002; MacLennan AH, 1996, LANCET, V347, P569, DOI 10.1016/S0140-6736(96)91271-4; MacPherson H, 2006, COMPLEMENT THER MED, V14, P20, DOI 10.1016/j.ctim.2005.07.006; Molassiotis A, 2005, ANN ONCOL, V16, P655, DOI 10.1093/annonc/mdi110; Muhajarine N, 2000, CAN J PUBLIC HEALTH, V91, P449, DOI 10.1007/BF03404827; NCCAM. NIH, NCCAM NCCAM HIST CHR; Ock SM, 2009, J KOREAN MED SCI, V24, P1, DOI 10.3346/jkms.2009.24.1.1; Owens JE, 1999, J ALTERN COMPLEM MED, V5, P529, DOI 10.1089/acm.1999.5.529; Park AJ, 2003, KOREAN J RURAL MED, V28, P107; Pinchuck T, 1984, MED BEGINNERS; Reilly D, 1999, INT S COMM 10 ANN AS, P61; Saper RB, 2004, ALTERN THER HEALTH M, V10, P44; Shin WY, 2011, J AEROSPACE MED CTR, V58, P43; Son AHK, 1999, SOC SCI MED, V49, P543, DOI 10.1016/S0277-9536(99)00151-3; STURM R, 1995, HEALTH SERV RES, V30, P319; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.0407; Vos L, 2010, MARK INTELL PLAN, V28, P349, DOI 10.1108/02634501011041462; Yamashita H, 2002, COMPLEMENT THER MED, V10, P84, DOI 10.1054/ctim.2002.0519; 김성영, 2012, [The Korean Journal of Health Service Management, 보건의료산업학회지], V6, P27; Yoo Jong Hyang, 2011, [Journal of Physiology & Pathology in Korean Medicine, 동의생리병리학회지], V25, P582; Yoon BB, 2007, RES I HEALTHCARE POL, V5, P29; Yoon TH, 2005, KOREAN J FAM MED, V26, P203; 이백휴, 2011, [THE KOREAN SOCIETY OF LAW AND MEDICINE, 의료법학], V12, P123	55	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63209	10.1371/journal.pone.0063209	http://dx.doi.org/10.1371/journal.pone.0063209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658811	Green Submitted, Green Published, gold			2022-12-25	WOS:000321200500061
J	Chen, TY; Chen, DY; Wen, HW; Ou, JL; Chiou, SS; Chen, JM; Wong, ML; Hsu, WL				Chen, Tzu-Yen; Chen, Da-Yuan; Wen, Hsiao-Wei; Ou, Jun-Lin; Chiou, Shyan-Song; Chen, Jo-Mei; Wong, Min-Liang; Hsu, Wei-Li			Inhibition of Enveloped Viruses Infectivity by Curcumin	PLOS ONE			English	Article							KAPPA-B; GENE-EXPRESSION; APOPTOSIS; CELLS; INDUCTION; MEMBRANE; KINASE; REPLICATION; INTEGRASE; PATHWAY	Curcumin, a natural compound and ingredient in curry, has antiinflammatory, antioxidant, and anticarcinogenic properties. Previously, we reported that curcumin abrogated influenza virus infectivity by inhibiting hemagglutination (HA) activity. This study demonstrates a novel mechanism by which curcumin inhibits the infectivity of enveloped viruses. In all analyzed enveloped viruses, including the influenza virus, curcumin inhibited plaque formation. In contrast, the nonenveloped enterovirus 71 remained unaffected by curcumin treatment. We evaluated the effects of curcumin on the membrane structure using fluorescent dye (sulforhodamine B; SRB)-containing liposomes that mimic the viral envelope. Curcumin treatment induced the leakage of SRB from these liposomes and the addition of the influenza virus reduced the leakage, indicating that curcumin disrupts the integrity of the membranes of viral envelopes and of liposomes. When testing liposomes of various diameters, we detected higher levels of SRB leakage from the smaller-sized liposomes than from the larger liposomes. Interestingly, the curcumin concentration required to reduce plaque formation was lower for the influenza virus (approximately 100 nm in diameter) than for the pseudorabies virus (approximately 180 nm) and the vaccinia virus (roughly 335 x 200 x 200 nm). These data provide insights on the molecular antiviral mechanisms of curcumin and its potential use as an antiviral agent for enveloped viruses.	[Chen, Tzu-Yen; Wong, Min-Liang] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Chen, Da-Yuan; Ou, Jun-Lin; Chiou, Shyan-Song; Chen, Jo-Mei; Hsu, Wei-Li] Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan; [Wen, Hsiao-Wei] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Hsu, WL (corresponding author), Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan.	wlhsu@dragon.nchu.edu.tw	Chen, Da-Yuan/GLR-1178-2022; Hsu, Wei-Li/CAF-3821-2022	Chen, Da-Yuan/0000-0002-1957-3330; Hsu, Wei-Li/0000-0002-1392-163X; Wen, Hsiao-Wei/0000-0003-3427-1768	National Science Council [98-2313-B-005-015-MY3, 101-2321-B-005-005]; National Chung-Hsing University [TCVGH-NCHU1017612]; National Science Council, Taiwan [101-2321-B-005-005, 98-2313- B-005-015-MY3]	National Science Council(Ministry of Science and Technology, Taiwan); National Chung-Hsing University; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Science Council (98-2313-B-005-015-MY3, 101-2321-B-005-005) and National Chung-Hsing University (TCVGH-NCHU1017612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Kuan-Hsun Lin for the technique support. This study was supported partially by National Science Council, Taiwan (98-2313- B-005-015-MY3, 101-2321-B-005-005) and National Chung-Hsing University (TCVGH-NCHU1017612).	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Anuchapreeda S, 2002, BIOCHEM PHARMACOL, V64, P573, DOI 10.1016/S0006-2952(02)01224-8; Bernard N., 1996, FUNDAMENTAL VIROLOGY; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; BROUET I, 1995, BIOCHEM BIOPH RES CO, V206, P533, DOI 10.1006/bbrc.1995.1076; Chaudhury LR, 2003, J CELL BIOCHEM, V89, P1, DOI 10.1002/jcb.10495; Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]; Chen DY, 2010, FOOD CHEM, V119, P1346, DOI 10.1016/j.foodchem.2009.09.011; DONATUS IA, 1990, BIOCHEM PHARMACOL, V39, P1869, DOI 10.1016/0006-2952(90)90603-I; Dutta K, 2009, J NEUROIMMUNE PHARM, V4, P328, DOI 10.1007/s11481-009-9158-2; FUJII T, 1979, BIOCHEM PHARMACOL, V28, P613; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Ingolfsson HI, 2007, BIOCHEMISTRY-US, V46, P10384, DOI 10.1021/bi701013n; Jana NR, 2004, J BIOL CHEM, V279, P11680, DOI 10.1074/jbc.M310369200; Jaruga E, 1998, EXP CELL RES, V245, P303, DOI 10.1006/excr.1998.4225; Jaruga E, 1998, FEBS LETT, V433, P287, DOI 10.1016/S0014-5793(98)00919-3; Kim K, 2010, FEBS LETT, V584, P707, DOI 10.1016/j.febslet.2009.12.019; Knipe DM, 2007, FIELDS VIROLOGY; Kutluay SB, 2008, VIROLOGY, V373, P239, DOI 10.1016/j.virol.2007.11.028; Li Y, 2003, AM J PATHOL, V163, P1167, DOI 10.1016/S0002-9440(10)63476-1; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; MAZUMDER A, 1995, BIOCHEM PHARMACOL, V49, P1165, DOI 10.1016/0006-2952(95)98514-A; Mazur I, 2007, CELL MICROBIOL, V9, P1683, DOI 10.1111/j.1462-5822.2007.00902.x; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; Rechtman MM, 2010, FEBS LETT, V584, P2485, DOI 10.1016/j.febslet.2010.04.067; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Si XN, 2007, J VIROL, V81, P3142, DOI 10.1128/JVI.02028-06; Squires MS, 2003, BIOCHEM PHARMACOL, V65, P361, DOI 10.1016/S0006-2952(02)01517-4; Sreejayan Rao MN, 1997, J PHARM PHARMACOL, V49, P105; Sui Z, 1993, Bioorg Med Chem, V1, P415, DOI 10.1016/S0968-0896(00)82152-5; Vajragupta O, 2005, BIOORG MED CHEM LETT, V15, P3364, DOI 10.1016/j.bmcl.2005.05.032; Wen HW, 2005, ANAL BIOANAL CHEM, V382, P1217, DOI 10.1007/s00216-005-3292-3	32	85	88	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62482	10.1371/journal.pone.0062482	http://dx.doi.org/10.1371/journal.pone.0062482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658730	gold, Green Published, Green Submitted			2022-12-25	WOS:000319167000051
J	Veatch-Blohm, ME; Roche, BM; Campbell, M				Veatch-Blohm, Maren E.; Roche, Bernadette M.; Campbell, MaryJean			Evidence for Cross-Tolerance to Nutrient Deficiency in Three Disjunct Populations of Arabidopsis lyrata ssp lyrata in Response to Substrate Calcium to Magnesium Ratio	PLOS ONE			English	Article							CARBONIFEROUS LIMESTONE SOILS; PHENOTYPIC PLASTICITY; LOCAL ADAPTATION; SERPENTINE TOLERANCE; ADJACENT SERPENTINE; GRANITE OUTCROPS; USE EFFICIENCY; FESTUCA-RUBRA; CA/MG RATIO; SOUTH-WALES	Species with widespread distributions that grow in varied habitats may consist of ecotypes adapted to a particular habitat, or may exhibit cross-tolerance that enables them to exploit a variety of habitats. Populations of Arabidopsis lyrata ssp. lyrata (L.) O'Kane & Al-Shehbaz grow in a wide variety of edaphic settings including serpentine soil, limestone sand, and alluvial flood plains. While all three of these environments share some stressors, a crucial difference among these environments is soil calcium to magnesium ratio, which ranges from 25:1 in the limestone sand to 0.2:1 in serpentine soil. The three populations found on these substrates were subjected to three different Ca to Mg ratios under controlled environmental conditions during germination and rosette growth. Response to Ca to Mg ratio was evaluated through germination success and radicle growth rate, rosette growth rate, and the content of Ca and Mg in the rosette. All three populations were particularly efficient in fueling growth under nutrient deficiency, with the highest nutrient efficiency ratio for Ca under Ca deficiency and for Mg under Mg deficiency. Although the serpentine population had significantly higher leaf Ca to Mg ratio than the limestone or flood plain populations under all three Ca to Mg ratios, this increase did not result in any advantage in growth or appearance of the serpentine plants, during early life stages before the onset of flowering, even in the high Mg substrate. The three populations showed no population by substrate interaction for any of the parameters measured indicating that these populations may have cross-tolerance to substrate Ca to Mg ratio.	[Veatch-Blohm, Maren E.; Roche, Bernadette M.; Campbell, MaryJean] Loyola Univ Maryland, Dept Biol, Baltimore, MD USA	Loyola University Maryland	Veatch-Blohm, ME (corresponding author), Loyola Univ Maryland, Dept Biol, Baltimore, MD USA.	mblohm@loyola.edu			Loyola University Maryland	Loyola University Maryland	Funding provided by Loyola University Maryland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anacker BL, 2011, EVOLUTION, V65, P365, DOI 10.1111/j.1558-5646.2010.01114.x; [Anonymous], 1989, JMP VERS 8; Asemaneh T, 2007, PLANT SOIL, V293, P49, DOI 10.1007/s11104-006-9147-7; Baligar VC, 2001, COMMUN SOIL SCI PLAN, V32, P921, DOI 10.1081/CSS-100104098; Baythavong BS, 2011, AM NAT, V178, P75, DOI 10.1086/660281; Bennington CC, 2012, J ECOL, V100, P841, DOI 10.1111/j.1365-2745.2012.01984.x; Bert V, 2000, NEW PHYTOL, V146, P225, DOI 10.1046/j.1469-8137.2000.00634.x; Bischoff A, 2010, OIKOS, V119, P445, DOI 10.1111/j.1600-0706.2009.17776.x; Bogeat-Triboulot MB, 2007, PLANT PHYSIOL, V143, P876, DOI 10.1104/pp.106.088708; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Bradshaw HD, 2005, NEW PHYTOL, V167, P81, DOI 10.1111/j.1469-8137.2005.01408.x; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Briscoe LRE, 2009, RHODORA, V111, P1, DOI 10.3119/07-31.1; Chaney RL, 2008, PLANT SOIL, V311, P131, DOI 10.1007/s11104-008-9664-7; Clauss MJ, 2006, J CHEM ECOL, V32, P2351, DOI 10.1007/s10886-006-9150-8; COOPER A, 1976, J ECOL, V64, P147, DOI 10.2307/2258687; COOPER A, 1974, J ECOL, V62, P179, DOI 10.2307/2258887; Enoki T, 1997, ECOL RES, V12, P191, DOI 10.1007/BF02523784; Epstein E., 2005, MINERAL NUTR PLANTS, P31; Galloway LF, 2000, EVOLUTION, V54, P1173, DOI 10.1111/j.0014-3820.2000.tb00552.x; Ghasemi R, 2009, ENVIRON EXP BOT, V67, P260, DOI 10.1016/j.envexpbot.2009.06.016; Going BM, 2009, OECOLOGIA, V159, P839, DOI 10.1007/s00442-008-1264-y; GRUSAK MA, 1994, PLANT PHYSIOL, V104, P649, DOI 10.1104/pp.104.2.649; Harris R. C, 2009, OPUSCULA PHILOLICHEN, V6, P149; Harrison S, 2010, ECOLOGY, V91, P2141, DOI 10.1890/09-0742.1; HART R, 1980, ECOLOGY, V61, P688, DOI 10.2307/1937434; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; JOHNSTON WR, 1981, J ECOL, V69, P855, DOI 10.2307/2259641; JOHNSTON WR, 1984, NEW PHYTOL, V96, P95, DOI 10.1111/j.1469-8137.1984.tb03546.x; Kataeva MN, 2004, GEODERMA, V122, P257, DOI 10.1016/j.geoderma.2004.01.012; KHAN H, 1994, ESTUARIES, V17, P345, DOI 10.2307/1352668; Kingsolver JG, 2002, TRENDS ECOL EVOL, V17, P540, DOI 10.1016/S0169-5347(02)02641-1; Kooijman AM, 2005, CATENA, V59, P55, DOI 10.1016/j.catena.2004.05.004; Lloyd MW, 2011, CASTANEA, V76, P28, DOI 10.2179/10-002.1; Loe G, 2007, OIKOS, V116, P134, DOI 10.1111/j.2006.0030-1299.15022.x; Lombini A, 2003, J PLANT PHYSIOL, V160, P1451, DOI 10.1078/0176-1617-01002; Lortie CJ, 1996, INT J PLANT SCI, V157, P484, DOI 10.1086/297365; LYON GL, 1971, J ECOL, V59, P421, DOI 10.2307/2258322; Mable BK, 2007, MOL ECOL, V16, P3565, DOI 10.1111/j.1365-294X.2007.03416.x; Mable BK, 2005, EVOLUTION, V59, P1437, DOI 10.1111/j.0014-3820.2005.tb01794.x; MAGUIRE JAMES D., 1962, CROP SCI, V2, P176, DOI 10.2135/cropsci1962.0011183X000200020033x; MAIN JL, 1974, AM J BOT, V61, P931, DOI 10.2307/2441983; MAIN JL, 1981, AM MIDL NAT, V105, P196, DOI 10.2307/2425026; Marques L, 2004, NEW PHYTOL, V164, P289, DOI 10.1111/j.1469-8137.2004.01178.x; MARRS RH, 1976, J ECOL, V64, P953, DOI 10.2307/2258817; McGahan DG, 2009, SOIL SCI SOC AM J, V73, P2087, DOI 10.2136/sssaj2008.0087; Mitchell-Olds T, 2001, TRENDS ECOL EVOL, V16, P693, DOI 10.1016/S0169-5347(01)02291-1; Mleczek M, 2012, INT J PHYTOREMEDIAT, V14, P75, DOI 10.1080/15226514.2011.573824; Murren CJ, 2006, ECOLOGY, V87, P2591, DOI 10.1890/0012-9658(2006)87[2591:IACEOM]2.0.CO;2; MUSTART PJ, 1993, ECOLOGY, V74, P1490, DOI 10.2307/1940077; O'Dell RE, 2006, PLANT SOIL, V280, P49, DOI 10.1007/s11104-005-3502-y; OKane SL, 1997, NOVON, V7, P323, DOI 10.2307/3391949; Olsen KG, 2001, J CHEM EDUC, V78, P941, DOI 10.1021/ed078p941; Palm E, 2012, FUNCT PLANT BIOL, V39, P679, DOI 10.1071/FP12059; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pomper KW, 2004, J AM SOC HORTIC SCI, V129, P890, DOI 10.21273/JASHS.129.6.0890; Pope N, 2010, RHODORA, V112, P105, DOI 10.3119/09-02.1; Powell KI, 2009, INT J PLANT SCI, V170, P918, DOI 10.1086/600140; Proctor J, 1999, TRENDS ECOL EVOL, V14, P334, DOI 10.1016/S0169-5347(99)01698-5; Rajakaruna N, 2003, NEW PHYTOL, V157, P93, DOI 10.1046/j.1469-8137.2003.00648.x; Rasband WS, 1997, IMAGEJ; REEVES RD, 1984, NEW PHYTOL, V98, P191; Reiss C, 1994, EXPT PLANT PHYSL, P24; Riihimaki M, 2004, AM J BOT, V91, P1036, DOI 10.3732/ajb.91.7.1036; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Schlotterer C, 2002, CURR OPIN GENET DEV, V12, P683, DOI 10.1016/S0959-437X(02)00349-0; SHAW AJ, 1991, AM J BOT, V78, P1487, DOI 10.2307/2444973; SHEWRY PR, 1975, J APPL ECOL, V12, P381, DOI 10.2307/2401740; SILANDER JA, 1985, EVOLUTION, V39, P1034, DOI 10.1111/j.1558-5646.1985.tb00445.x; SINGH SP, 1992, J VEG SCI, V3, P573, DOI 10.2307/3235823; SPENCE D. H. N., 1963, JOUR ECOL, V51, P333, DOI 10.2307/2257688; SULTAN SE, 1993, EVOLUTION, V47, P1050, DOI [10.2307/2409974, 10.1111/j.1558-5646.1993.tb02134.x]; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Turner TL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003183; Veatch-Blohm ME, 2011, CASTANEA, V76, P199, DOI 10.2179/10-003.1; Walck JL, 1999, AM J BOT, V86, P820, DOI 10.2307/2656703; WOODELL SRJ, 1975, B TORREY BOT CLUB, V102, P232, DOI 10.2307/2484139; Wright JW, 2007, NEW PHYTOL, V173, P354, DOI 10.1111/j.1469-8137.2006.01925.x	78	5	5	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63117	10.1371/journal.pone.0063117	http://dx.doi.org/10.1371/journal.pone.0063117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650547	gold, Green Published, Green Submitted			2022-12-25	WOS:000319167000092
J	Kurlbaum, M; Mulek, M; Hogger, P				Kurlbaum, Max; Muelek, Melanie; Hoegger, Petra			Facilitated Uptake of a Bioactive Metabolite of Maritime Pine Bark Extract (Pycnogenol) into Human Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; GLUCOSE-TRANSPORTER; MASS-SPECTROMETRY; ANTIOXIDANT ACTIVITY; URINARY METABOLITES; GLUTATHIONE; QUERCETIN; POLYPHENOLS; BINDING; PHARMACOKINETICS	Many plant secondary metabolites exhibit some degree of biological activity in humans. It is a common observation that individual plant-derived compounds in vivo are present in the nanomolar concentration range at which they usually fail to display measurable activity in vitro. While it is debatable that compounds detected in plasma are not the key effectors of bioactivity, an alternative hypothesis may take into consideration that measurable concentrations also reside in compartments other than plasma. We analysed the binding of constituents and the metabolite delta-(3,4-dihydroxy-phenyl)-gamma-valerolactone (M1), that had been previously detected in plasma samples of human consumers of pine bark extract Pycnogenol, to human erythrocytes. We found that caffeic acid, taxifolin, and ferulic acid passively bind to red blood cells, but only the bioactive metabolite M1 revealed pronounced accumulation. The partitioning of M1 into erythrocytes was significantly diminished at higher concentrations of M1 and in the presence of glucose, suggesting a facilitated transport of M1 via GLUT-1 transporter. This concept was further supported by structural similarities between the natural substrate alpha-D-glucose and the S-isomer of M1. After cellular uptake, M1 underwent further metabolism by conjugation with glutathione. We present strong indication for a transporter-mediated accumulation of a flavonoid metabolite in human erythrocytes and subsequent formation of a novel glutathione adduct. The physiologic role of the adduct remains to be elucidated.	[Kurlbaum, Max; Muelek, Melanie; Hoegger, Petra] Univ Wurzburg, Inst Pharm & Lebensmittelchem, D-97070 Wurzburg, Germany	University of Wurzburg	Hogger, P (corresponding author), Univ Wurzburg, Inst Pharm & Lebensmittelchem, D-97070 Wurzburg, Germany.	hogger@pzlc.uni-wuerzburg.de	Kurlbaum, Max/ABV-8275-2022		German Research Foundation (DFG); University of Wurzburg in the funding programme Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg in the funding programme Open Access Publishing	This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso GL, 2007, J BIOL PHYS, V33, P485, DOI 10.1007/s10867-008-9104-1; Awad HM, 2003, CHEM RES TOXICOL, V16, P822, DOI 10.1021/tx020079g; AWASTHI YC, 1983, BRIT J HAEMATOL, V55, P419, DOI 10.1111/j.1365-2141.1983.tb02156.x; BAILLIE TA, 1993, BIOL MASS SPECTROM, V22, P319, DOI 10.1002/bms.1200220602; Biasutto L, 2010, MOLECULES, V15, P6570, DOI 10.3390/molecules15096570; Boots AW, 2005, BIOCHEM BIOPH RES CO, V338, P923, DOI 10.1016/j.bbrc.2005.10.031; Castro-Perez J, 2005, RAPID COMMUN MASS SP, V19, P798, DOI 10.1002/rcm.1855; Cunningham P, 2006, J BIOL CHEM, V281, P5797, DOI 10.1074/jbc.M509422200; DAS NP, 1971, BIOCHEM PHARMACOL, V20, P3435, DOI 10.1016/0006-2952(71)90449-7; Duweler KG, 2000, PHARMAZIE, V55, P364; Fan HT, 2001, BRIT J PHARMACOL, V133, P1096, DOI 10.1038/sj.bjp.0704159; GALBRAITH DA, 1980, BIOCHEM J, V191, P63, DOI 10.1042/bj1910063; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Grimm T, 2004, FREE RADICAL BIO MED, V36, P811, DOI 10.1016/j.freeradbiomed.2003.12.017; Grimm Tanja, 2006, BMC Clin Pharmacol, V6, P4, DOI 10.1186/1472-6904-6-4; Grimm Tanja, 2006, J Inflamm (Lond), V3, P1, DOI 10.1186/1476-9255-3-1; Hapner CD, 2010, CHEM-BIOL INTERACT, V186, P275, DOI 10.1016/j.cbi.2010.05.010; Highley MS, 1996, PHARM RES-DORDR, V13, P186, DOI 10.1023/A:1016074627293; Hinderling PH, 1997, PHARMACOL REV, V49, P279; JACOBS H, 2011, FREE RADIC BIOL MED, DOI DOI 10.1016/J.FREERADBI0MED.2011.09.013; Kalsi KK, 2008, PFLUG ARCH EUR J PHY, V456, P991, DOI 10.1007/s00424-008-0459-8; Koren E, 2010, EXP BIOL MED, V235, P689, DOI 10.1258/ebm.2010.009370; Kurlbaum M, 2011, J PHARMACEUT BIOMED, V54, P127, DOI 10.1016/j.jpba.2010.07.038; LAGERQUIST HC, 2003, J BIOCHEM BIOPH METH, V55, P127; Leitch JM, 2009, AM J PHYSIOL-CELL PH, V296, pC151, DOI 10.1152/ajpcell.00359.2008; Li C, 2000, CHEM RES TOXICOL, V13, P177, DOI 10.1021/tx9901837; Li CA, 2001, CHEM RES TOXICOL, V14, P702, DOI 10.1021/tx0002536; Maimoona A, 2011, J ETHNOPHARMACOL, V133, P261, DOI 10.1016/j.jep.2010.10.041; *MAR PIN EXTR, 2011, US PHARM, P1196; MARCUS CJ, 1978, ARCH BIOCHEM BIOPHYS, V188, P287, DOI 10.1016/S0003-9861(78)80011-3; Martial S, 1996, AM J PHYSIOL-RENAL, V271, pF1264, DOI 10.1152/ajprenal.1996.271.6.F1264; Martin HJ, 2003, CHEM-BIOL INTERACT, V146, P225, DOI 10.1016/j.cbi.2003.06.001; Montel-Hagen A, 2008, CELL, V132, P1039, DOI 10.1016/j.cell.2008.01.042; Montel-Hagen A, 2009, CURR OPIN HEMATOL, V16, P165, DOI 10.1097/MOH.0b013e328329905c; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Packer L, 1999, FREE RADICAL BIO MED, V27, P704, DOI 10.1016/S0891-5849(99)00090-8; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; Perez A, 2011, BIOCHEMISTRY-US, V50, P8834, DOI 10.1021/bi200748b; Raja MM, 2003, J BIOL CHEM, V278, P49154, DOI 10.1074/jbc.M306881200; RAPPOLD M, 2010, THESIS U WURZBURG WU, P11; Rohdewald P, 2002, INT J CLIN PHARM TH, V40, P158; SALAUZE D, 1994, COMP HAEMATOL INT, V4, P34, DOI 10.1007/BF00368264; Sana TR, 2008, J CHROMATOGR B, V871, P314, DOI 10.1016/j.jchromb.2008.04.030; Schrijvers D, 2003, CLIN PHARMACOKINET, V42, P779, DOI 10.2165/00003088-200342090-00001; Sugano K, 2010, NAT REV DRUG DISCOV, V9, P597, DOI 10.1038/nrd3187; Thorens B, 1996, AM J PHYSIOL-GASTR L, V270, pG541, DOI 10.1152/ajpgi.1996.270.4.G541; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Uhlenhut K, 2012, FREE RADICAL BIO MED, V53, P305, DOI 10.1016/j.freeradbiomed.2012.04.013; van Bladeren PJ, 2000, CHEM-BIOL INTERACT, V129, P61, DOI 10.1016/S0009-2797(00)00214-3; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Yang BX, 2001, J BIOL CHEM, V276, P624, DOI 10.1074/jbc.M008664200; Yu SX, 2005, RAPID COMMUN MASS SP, V19, P250, DOI 10.1002/rcm.1777; Zhang JZ, 1999, ARCH BIOCHEM BIOPHYS, V372, P173, DOI 10.1006/abbi.1999.1489; Zhang JZ, 2001, AM J PHYSIOL-CELL PH, V280, pC1277, DOI 10.1152/ajpcell.2001.280.5.C1277	55	23	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63197	10.1371/journal.pone.0063197	http://dx.doi.org/10.1371/journal.pone.0063197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646194	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300151
J	Leon, LJ; Pasupuleti, N; Gorin, F; Carraway, KL				Leon, Leonardo J.; Pasupuleti, Nagarekha; Gorin, Fredric; Carraway, Kermit L., III			A Cell-Permeant Amiloride Derivative Induces Caspase-Independent, AIF-Mediated Programmed Necrotic Death of Breast Cancer Cells	PLOS ONE			English	Article							EXCHANGE INHIBITION; GLIOBLASTOMA CELLS; NA+/H+ EXCHANGER; APOPTOSIS; MECHANISMS; AUTOPHAGY; MACROPINOCYTOSIS; ACTIVATION; INDUCTION; DIVERSITY	Amiloride is a potassium-sparing diuretic that has been used as an anti-kaliuretic for the chronic management of hypertension and heart failure. Several studies have identified a potential anti-cancer role for amiloride, however the mechanisms underlying its anti-tumor effects remain to be fully delineated. Our group previously demonstrated that amiloride triggers caspase-independent cytotoxic cell death in human glioblastoma cell lines but not in primary astrocytes. To delineate the cellular mechanisms underlying amiloride's anti-cancer cytotoxicity, cell permeant and cell impermeant derivatives of amiloride were synthesized that exhibit markedly different potencies in cancer cell death assays. Here we compare the cytotoxicities of 5-benzylglycinyl amiloride (UCD38B) and its free acid 5-glycinyl amiloride (UCD74A) toward human breast cancer cells. UCD74A exhibits poor cell permeability and has very little cytotoxic activity, while UCD38B is cell permeant and induces the caspase-independent death of proliferating and non-proliferating breast cancer cells. UCD38B treatment of human breast cancer cells promotes autophagy reflected in LC3 conversion, and induces the dramatic swelling of the endoplasmic reticulum, however these events do not appear to be the cause of cell death. Surprisingly, UCD38B but not UCD74A induces efficient AIF translocation from the mitochondria to the nucleus, and AIF function is necessary for the efficient induction of cancer cell death. Our observations indicate that UCD38B induces programmed necrosis through AIF translocation, and suggest that its cytosolic accessibility may facilitate drug action.	[Leon, Leonardo J.; Carraway, Kermit L., III] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Pasupuleti, Nagarekha; Gorin, Fredric] UC Davis Sch Med, Dept Neurol, Sacramento, CA USA; [Leon, Leonardo J.; Gorin, Fredric; Carraway, Kermit L., III] UC Davis Sch Med, UC Davis Comprehens Canc Ctr, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Carraway, KL (corresponding author), Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA.	klcarraway@ucdavis.edu	gorin, fredric a/GSJ-0273-2022; Pasupuleti, Nagarekha/B-5763-2015		Komen for Cure [KG090626]; NIH grant [NS060880]; Department of Defense Breast Cancer Research Program [W81XWH-10-1-0138]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060880] Funding Source: NIH RePORTER	Komen for Cure(Susan G. Komen Breast Cancer Foundation); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grant KG090626 from Komen for Cure (Carraway), NIH grant NS060880 (Gorin), and predoctoral fellowship W81XWH-10-1-0138 from the Department of Defense Breast Cancer Research Program (Leon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Delavallee L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432; Deng JY, 2009, CHEM RES TOXICOL, V22, P1817, DOI 10.1021/tx9002275; Garcia-Canero R, 1999, TOXICOL LETT, V106, P215, DOI 10.1016/S0378-4274(99)00072-7; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Harley W, 2010, BRAIN RES, V1363, P159, DOI 10.1016/j.brainres.2010.09.059; Hegde M, 2004, J PHARMACOL EXP THER, V310, P67, DOI 10.1124/jpet.103.065029; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Lorenzo HK, 2007, DRUG RESIST UPDATE, V10, P235, DOI 10.1016/j.drup.2007.11.001; Mandlekar S, 2000, CANCER RES, V60, P6601; Massey AP, 2012, BIOORG MED CHEM LETT, V22, P2635, DOI 10.1016/j.bmcl.2011.12.123; Matthews H, 2011, INT J CANCER, V129, P2051, DOI 10.1002/ijc.26156; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Overmeyer JH, 2008, MOL CANCER RES, V6, P965, DOI 10.1158/1541-7786.MCR-07-2036; Overmeyer JH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-69; Palandoken H, 2005, J PHARMACOL EXP THER, V312, P961, DOI 10.1124/jpet.104.076984; Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342; Rich IN, 2000, BLOOD, V95, P1427, DOI 10.1182/blood.V95.4.1427.004k48_1427_1434; Samadder P, 2009, BIOCHEM CELL BIOL, V87, P401, DOI [10.1139/O08-147, 10.1139/o08-147]; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Wilson TR, 2006, ANN ONCOL, V17, pX315, DOI 10.1093/annonc/mdl280; Xu XS, 2007, J NEUROCHEM, V103, P2004, DOI 10.1111/j.1471-4159.2007.04884.x; Yang XK, 2011, J GASTROEN HEPATOL, V26, P364, DOI 10.1111/j.1440-1746.2010.06382.x; Yang XK, 2010, CANCER LETT, V295, P198, DOI 10.1016/j.canlet.2010.03.001; Yichuan Wang, 2011, SCI SIGNAL, pP4; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9	35	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63038	10.1371/journal.pone.0063038	http://dx.doi.org/10.1371/journal.pone.0063038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646172	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300127
J	Matsuki, T; Pedron, T; Regnault, B; Mulet, C; Hara, T; Sansonetti, PJ				Matsuki, Takahiro; Pedron, Thierry; Regnault, Beatrice; Mulet, Celine; Hara, Taeko; Sansonetti, Philippe J.			Epithelial Cell Proliferation Arrest Induced by Lactate and Acetate from Lactobacillus casei and Bifidobacterium breve	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GUT MICROBIOTA; INTESTINAL MICROBIOTA; ESCHERICHIA-COLI; CYCLE ARREST; GERM-FREE; EXPRESSION; RECEPTOR; MODULATE; CANCER	In an attempt to identify and characterize how symbiotic bacteria of the gut microbiota affect the molecular and cellular mechanisms of epithelial homeostasis, intestinal epithelial cells were co-cultured with either Lactobacillus or Bifidobacterium as bona fide symbionts to examine potential gene modulations. In addition to genes involved in the innate immune response, genes encoding check-point molecules controlling the cell cycle were among the most modulated in the course of these interactions. In the m-ICcl2 murine cell line, genes encoding cyclin E1 and cyclin D1 were strongly down regulated by L. casei and B. breve respectively. Cell proliferation arrest was accordingly confirmed. Short chain fatty acids (SCFA) were the effectors of this modulation, alone or in conjunction with the acidic pH they generated. These results demonstrate that the production of SCFAs, a characteristic of these symbiotic microorganisms, is potentially an essential regulatory effector of epithelial proliferation in the gut.	[Matsuki, Takahiro; Pedron, Thierry; Mulet, Celine; Sansonetti, Philippe J.] Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France; [Pedron, Thierry; Mulet, Celine; Sansonetti, Philippe J.] Inst Pasteur, INSERM, U786, F-75724 Paris, France; [Sansonetti, Philippe J.] Coll France, Chaire Microbiol & Malad Infect, F-75231 Paris, France; [Regnault, Beatrice] Inst Pasteur, Genopole, Paris, France; [Matsuki, Takahiro; Hara, Taeko] Yakult Cent Inst Microbiol Res, Tokyo, Japan	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France; Yakult Honsha Company, Limited	Sansonetti, PJ (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France.	philippe.sansonetti@pasteur.fr		REGNAULT, Beatrice/0000-0002-3914-1914	European Research Council; Danone Research; Yakult Research	European Research Council(European Research Council (ERC)European Commission); Danone Research(Danone Nutricia); Yakult Research	This work was supported by the European Research Council and from grants from Danone Research and Yakult Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Takahiro Matsuki and Taeko Hara are employees of Yakult Central Institute for Microbiological Research. Danone Research provided a grant for this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Azcarate-Peril MA, 2011, AM J PHYSIOL-GASTR L, V301, pG401, DOI 10.1152/ajpgi.00110.2011; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Boidot R, 2012, CANCER RES, V72, P939, DOI 10.1158/0008-5472.CAN-11-2474; Bordonaro M, 2008, CELL CYCLE, V7, P1178, DOI 10.4161/cc.7.9.5818; BROWN D, 2012, AM J PHYSL IN PRESS; Bruno MEC, 2005, J IMMUNOL, V174, P7278, DOI 10.4049/jimmunol.174.11.7278; Chang YJ, 2006, CELL MICROBIOL, V8, P1740, DOI 10.1111/j.1462-5822.2006.00743.x; CHU SY, 1995, P NATL ACAD SCI USA, V92, P3303, DOI 10.1073/pnas.92.8.3303; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cover TL, 2003, CANCER RES, V63, P951; Faith JJ, 2010, ISME J, V4, P1094, DOI 10.1038/ismej.2010.110; Fernandez MI, 2003, IMMUNITY, V18, P739, DOI 10.1016/S1074-7613(03)00122-5; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gartel AL, 2003, ONCOL RES, V13, P405; Gray MC, 2011, CELL MICROBIOL, V13, P123, DOI 10.1111/j.1462-5822.2010.01525.x; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; KAETZEL CS, 1991, P NATL ACAD SCI USA, V88, P8796, DOI 10.1073/pnas.88.19.8796; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Keeney KM, 2011, CURR OPIN MICROBIOL, V14, P92, DOI 10.1016/j.mib.2010.12.012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; LUPTON JR, 1993, J NUTR, V123, P1522, DOI 10.1093/jn/123.9.1522; Matsumoto K, 2010, J BIOSCI BIOENG, V110, P547, DOI 10.1016/j.jbiosc.2010.05.016; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Morinaga N, 2008, CELL MICROBIOL, V10, P921, DOI 10.1111/j.1462-5822.2007.01094.x; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Ohnmacht C, 2011, CELL MICROBIOL, V13, P653, DOI 10.1111/j.1462-5822.2011.01577.x; Olsen L, 2005, AM J PHYSIOL-GASTR L, V289, pG220, DOI 10.1152/ajpgi.00449.2004; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Samba-Louaka A, 2009, FUTURE MICROBIOL, V4, P867, DOI [10.2217/fmb.09.60, 10.2217/FMB.09.60]; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; SAVAGE DC, 1981, APPL ENVIRON MICROB, V42, P996, DOI 10.1128/AEM.42.6.996-1001.1981; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sengupta S, 2006, J GASTROEN HEPATOL, V21, P209, DOI 10.1111/j.1440-1746.2006.04213.x; Tien MT, 2006, J IMMUNOL, V176, P1228, DOI 10.4049/jimmunol.176.2.1228; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Turpin W, 2010, INT J FOOD MICROBIOL, V143, P87, DOI 10.1016/j.ijfoodmicro.2010.07.032; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002	48	58	62	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63053	10.1371/journal.pone.0063053	http://dx.doi.org/10.1371/journal.pone.0063053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646174	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300129
J	Oikonomou, G; Teixeira, AGV; Foditsch, C; Bicalho, ML; Machado, VS; Bicalho, RC				Oikonomou, Georgios; Teixeira, Andre Gustavo Vieira; Foditsch, Carla; Bicalho, Marcela Lucas; Machado, Vinicius Silva; Bicalho, Rodrigo Carvalho			Fecal Microbial Diversity in Pre-Weaned Dairy Calves as Described by Pyrosequencing of Metagenomic 16S rDNA. Associations of Faecalibacterium Species with Health and Growth	PLOS ONE			English	Article							FED MILK REPLACERS; INTESTINAL MICROBIOTA; SYMBIOTIC BACTERIA	In this study, we use barcoded pyrosequencing of the 16S rRNA gene to characterize the fecal microbiota of neonatal calves and identify possible relationships of certain microbiota profiles with health and weight gain. Fecal samples were obtained weekly from 61 calves from birth until weaning (seventh week of the calves' life). Firmicutes was the most prevalent phylum, with a prevalence ranging from 63.84% to 81.90%, followed by Bacteroidetes (8.36% to 23.93%), Proteobacteria (3.72% to 9.75%), Fusobacteria (0.76% to 5.67%), and Actinobacteria (1.02% to 2.35%). Chao1 index gradually increased from the first to the seventh postnatal week. Chao1 index was lower during the third, fourth, and fifth week of life in calves that suffered from pneumonia and were treated with antibiotics. Diarrhea incidence during the first four weeks of the calves' life was also associated with a reduction of microbial diversity during the third week of life. Increased fecal microbial diversity after the second week of life was associated with higher weight gain. Using discriminant analysis we were able to show differences in the microbiota profiles between different weeks of life, between high and low weight gain groups of calves, and between calves affected and not affected with diarrhea during the first four weeks life. The prevalence of Faecalibacterium spp. in the first week of life was associated with weight gain and the incidence of diarrhea, with higher prevalence being associated with higher weight gain and less diarrhea. Representative sequences from Faecalibacterium spp. were closely affiliated to Faecalibacterium prausnitzii. Results presented here provide new information regarding the intestinal microbiota of neonatal calves and its association with health and growth. Fecal microbial diversity was associated with calf age, disease status and growth rates. Results suggesting a possible beneficial effect of Faecalibacterium spp. on health and growth are promising.	[Oikonomou, Georgios; Teixeira, Andre Gustavo Vieira; Foditsch, Carla; Bicalho, Marcela Lucas; Machado, Vinicius Silva; Bicalho, Rodrigo Carvalho] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University	Bicalho, RC (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Teixeira, Andre Gustavo/B-2177-2017	Teixeira, Andre Gustavo/0000-0002-8620-1422	United States Department of Agriculture/National Institute of Food and Agriculture Federal Formula Funds [NYC-478838, NE-1028]	United States Department of Agriculture/National Institute of Food and Agriculture Federal Formula Funds	Funding was provided by United States Department of Agriculture/National Institute of Food and Agriculture Federal Formula Funds project NYC-478838 hatch/multistate project NE-1028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bach A, 2007, J DAIRY SCI, V90, P3028, DOI 10.3168/jds.2006-761; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Balamurugan R, 2010, BRIT J NUTR, V103, P335, DOI 10.1017/S0007114509992182; Baldwin RL, 2000, J ANIM SCI, V78, P771; Carroll IM, 2012, NEUROGASTROENT MOTIL, V24, P521, DOI 10.1111/j.1365-2982.2012.01891.x; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Donovan DC, 2002, J DAIRY SCI, V85, P947, DOI 10.3168/jds.S0022-0302(02)74153-2; Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150; Edrington TS, 2012, J DAIRY SCI, V95, P4519, DOI 10.3168/jds.2011-5119; Guan LL, 2008, FEMS MICROBIOL LETT, V288, P85, DOI 10.1111/j.1574-6968.2008.01343.x; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Maynard L.A., 1979, ANIM NUTR; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mentschel J, 2001, ARCH ANIM NUTR, V55, P85, DOI 10.1080/17450390109386185; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Oikonomou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047671; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Schwiertz A, 2010, J PEDIATR-US, V157, P240, DOI 10.1016/j.jpeds.2010.02.046; Soberon F, 2012, J DAIRY SCI, V95, P783, DOI 10.3168/jds.2011-4391; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Sun YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq872; Timmerman HM, 2005, J DAIRY SCI, V88, P2154, DOI 10.3168/jds.S0022-0302(05)72891-5; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Wu S., 2012, METAGENOMICS, V1, P1	33	162	173	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63157	10.1371/journal.pone.0063157	http://dx.doi.org/10.1371/journal.pone.0063157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646192	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300147
J	Smelt, MJ; de Haan, BJ; Bron, PA; van Swam, I; Meijerink, M; Wells, JM; Kleerebezem, M; Faas, MM; de Vos, P				Smelt, Maaike J.; de Haan, Bart J.; Bron, Peter A.; van Swam, Iris; Meijerink, Marjolein; Wells, Jerry M.; Kleerebezem, Michiel; Faas, Marijke M.; de Vos, Paul			The Impact of Lactobacillus plantarum WCFS1 Teichoic Acid D-Alanylation on the Generation of Effector and Regulatory T-cells in Healthy Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LIPOTEICHOIC ACID; DOUBLE-BLIND; DENDRITIC CELLS; MAINTAINING REMISSION; ACIDOPHILUS DEFICIENT; ULCERATIVE-COLITIS; PROBIOTIC THERAPY; RESPONSES; GG	To date it remains unclear how probiotics affect the immune system. Bacterial envelope components may play an essential role, as these are the first to establish bacterial-host cell interactions. Teichoic acids (TAs), and especially lipoteichoic acids, are the most pro-inflammatory components of the gram-positive bacterial envelope. This effect is dependent on D-alanyl substitution of the TA backbone and interactions with TLR2 on host cells. Although the pro-inflammatory properties of TAs have been established in vitro, it remains unclear how TAs affect immunomodulation in vivo. In this study, we investigated the role of TA D-alanylation on L. plantarum-induced intestinal and systemic immunomodulation in vivo. For this, we compared the effect of L. plantarum WCFS1 and its TA D-Alanylation negative derivative (dltX-D) on the distribution of dendritic cell and T cell populations and responses in healthy mice. We demonstrated that the majority of the L. plantarum-induced in vivo immunomodulatory effects were dependent on D-alanylation (D-Ala), as some L. plantarum WCFS1-induced immune changes were not observed in the dltX-D-treated group and some were only observed after treatment with dltX-D. Strikingly, not only pro-inflammatory immune responses were abolished in the absence of D-Ala substitution, but also anti-inflammatory responses, such as the L. plantarum-induced generation of regulatory T cells in the spleen. With this study we provide insight in host-microbe interactions, by demonstrating the involvement of D-alanylation of TAs on the bacterial membrane in intestinal and systemic immunomodulation in healthy mice.	[Smelt, Maaike J.; Bron, Peter A.; van Swam, Iris; Meijerink, Marjolein; Wells, Jerry M.; Kleerebezem, Michiel; de Vos, Paul] Top Inst Food & Nutr, Wageningen, Netherlands; [Smelt, Maaike J.; de Haan, Bart J.; Faas, Marijke M.; de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Smelt, Maaike J.; de Haan, Bart J.; Faas, Marijke M.; de Vos, Paul] Univ Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Bron, Peter A.; van Swam, Iris; Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands; [Meijerink, Marjolein; Wells, Jerry M.; Kleerebezem, Michiel] Wageningen Univ, Dept Host Microbe Interact Grp, NL-6700 AP Wageningen, Netherlands; [Bron, Peter A.] Kluyver Ctr Fermentat & Genom, Delft, Netherlands	Top Institute Food & Nutrition; University of Groningen; University of Groningen; NIZO Food Research; Wageningen University & Research	de Vos, P (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	p.de.vos@umcg.nl	Kleerebezem, Michiel/AAT-2078-2021; de Vos, Paul/A-3170-2013; Meijerink, Marjolein/B-9258-2014	Meijerink, Marjolein/0000-0003-3994-9785; de vos, paul/0000-0001-9618-2408; Kleerebezem, Michiel/0000-0001-8552-2235	Top Institute Food and Nutrition, Wageningen, The Netherlands	Top Institute Food and Nutrition, Wageningen, The Netherlands(Netherlands Government)	This work was supported by a project from the Top Institute Food and Nutrition, Wageningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Boge T, 2009, VACCINE, V27, P5677, DOI 10.1016/j.vaccine.2009.06.094; Bron PA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-123; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; CAMPBELL LK, 1978, INFECT IMMUN, V22, P842, DOI 10.1128/IAI.22.3.842-851.1978; Chen Q, 2009, J IMMUNOL, V183, P4458, DOI 10.4049/jimmunol.0901465; Claes IJJ, 2010, CLIN EXP IMMUNOL, V162, P306, DOI 10.1111/j.1365-2249.2010.04228.x; Davidson LE, 2011, EUR J CLIN NUTR, V65, P501, DOI 10.1038/ejcn.2010.289; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Foligne B, 2006, DIGEST DIS SCI, V51, P390, DOI 10.1007/s10620-006-3143-x; Foligne B, 2007, GASTROENTEROLOGY, V133, P862, DOI 10.1053/j.gastro.2007.06.018; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9; Gosselink MP, 2004, DIS COLON RECTUM, V47, P876, DOI 10.1007/s10350-004-0525-z; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Guandalini S, 2002, DIGEST LIVER DIS, V34, pS63, DOI 10.1016/S1590-8658(02)80167-0; Guandalini S, 2010, J PEDIATR GASTR NUTR, V51, P24, DOI 10.1097/MPG.0b013e3181ca4d95; Hansson GC, 2010, GUT MICROBES, V1, P51, DOI 10.4161/gmic.1.1.10470; Hatakka K, 2001, BMJ-BRIT MED J, V322, P1327, DOI 10.1136/bmj.322.7298.1327; Hirose Y, 2010, MICROBIOL IMMUNOL, V54, P143, DOI 10.1111/j.1348-0421.2009.00189.x; Hojsak I, 2010, PEDIATRICS, V125, pE1171, DOI 10.1542/peds.2009-2568; Isolauri E, 2000, CLIN EXP ALLERGY, V30, P1604, DOI 10.1046/j.1365-2222.2000.00943.x; Jacobo P, 2011, REPRODUCTION, V141, P249, DOI 10.1530/REP-10-0362; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kang SS, 2011, MOL IMMUNOL, V48, P2170, DOI 10.1016/j.molimm.2011.07.009; Khazaie K, 2012, P NATL ACAD SCI USA, V109, P10462, DOI 10.1073/pnas.1207230109; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; KNOX KW, 1972, INFECT IMMUN, V6, P43, DOI 10.1128/IAI.6.1.43-49.1972; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Marco ML, 2007, APPL ENVIRON MICROB, V73, P124, DOI 10.1128/AEM.01475-06; Marco ML, 2006, CURR OPIN BIOTECH, V17, P204, DOI 10.1016/j.copbio.2006.02.005; Matsumoto S, 2005, CLIN EXP IMMUNOL, V140, P417, DOI 10.1111/j.1365-2249.2005.02790.x; Meijer K, 2010, CURR OPIN CLIN NUTR, V13, P715, DOI 10.1097/MCO.0b013e32833eebe5; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Miettinen M, 1998, INFECT IMMUN, V66, P6058, DOI 10.1128/IAI.66.12.6058-6062.1998; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; Mohamadzadeh M, 2011, P NATL ACAD SCI USA, V108, P4623, DOI 10.1073/pnas.1005066107; Morath S, 2005, J ENDOTOXIN RES, V11, P348, DOI 10.1179/096805105X67328; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Niers LEM, 2005, CLIN EXP ALLERGY, V35, P1481, DOI 10.1111/j.1365-2222.2005.02375.x; O'Flaherty S, 2010, GUT MICROBES, V1, P293, DOI 10.4161/gmic.1.5.12924; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; Paineau D, 2008, FEMS IMMUNOL MED MIC, V53, P107, DOI 10.1111/j.1574-695X.2008.00413.x; Palumbo E, 2006, J BACTERIOL, V188, P3709, DOI 10.1128/JB.188.10.3709-3715.2006; Remus DM, 2011, EUR J PHARMACOL, V668, pS33, DOI 10.1016/j.ejphar.2011.07.012; Rockel C, 2011, IMMUNOBIOLOGY, V216, P316, DOI 10.1016/j.imbio.2010.08.001; Ryu YH, 2009, INT IMMUNOPHARMACOL, V9, P127, DOI 10.1016/j.intimp.2008.10.014; Saber R, 2011, IMMUNOTHERAPY-UK, V3, P337, DOI 10.2217/IMT.10.119; Smelt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047244; So JS, 2008, MOL IMMUNOL, V45, P2690, DOI 10.1016/j.molimm.2007.12.010; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tsilingiri K, 2012, GUT, V61, P1007, DOI 10.1136/gutjnl-2011-300971; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Tursi A, 2004, MED SCI MONITOR, V10, pPI126; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van der Waaij LA, 2005, INFLAMM BOWEL DIS, V11, P865, DOI 10.1097/01.mib.0000179212.80778.d3; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; Vaughan EE, 2002, ANTON LEEUW INT J G, V82, P341, DOI 10.1023/A:1020672724450; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001; Yamazaki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018833; Zadeh M, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-7; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	75	37	39	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63099	10.1371/journal.pone.0063099	http://dx.doi.org/10.1371/journal.pone.0063099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646181	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300136
J	Hernandez, M; Guerrero, GD; Cecilia, JM; Garcia, JM; Inuggi, A; Jbabdi, S; Behrens, TEJ; Sotiropoulos, SN				Hernandez, Moises; Guerrero, Gines D.; Cecilia, Jose M.; Garcia, Jose M.; Inuggi, Alberto; Jbabdi, Saad; Behrens, Timothy E. J.; Sotiropoulos, Stamatios N.			Accelerating Fibre Orientation Estimation from Diffusion Weighted Magnetic Resonance Imaging Using GPUs	PLOS ONE			English	Article							TRACTOGRAPHY; GRAPHICS; BRAIN; CONNECTIVITY; TENSOR; TESLA	With the performance of central processing units (CPUs) having effectively reached a limit, parallel processing offers an alternative for applications with high computational demands. Modern graphics processing units (GPUs) are massively parallel processors that can execute simultaneously thousands of light-weight processes. In this study, we propose and implement a parallel GPU-based design of a popular method that is used for the analysis of brain magnetic resonance imaging (MRI). More specifically, we are concerned with a model-based approach for extracting tissue structural information from diffusion-weighted (DW) MRI data. DW-MRI offers, through tractography approaches, the only way to study brain structural connectivity, non-invasively and in-vivo. We parallelise the Bayesian inference framework for the ball & stick model, as it is implemented in the tractography toolbox of the popular FSL software package (University of Oxford). For our implementation, we utilise the Compute Unified Device Architecture (CUDA) programming model. We show that the parameter estimation, performed through Markov Chain Monte Carlo (MCMC), is accelerated by at least two orders of magnitude, when comparing a single GPU with the respective sequential single-core CPU version. We also illustrate similar speed-up factors (up to 120x) when comparing a multi-GPU with a multi-CPU implementation.	[Hernandez, Moises; Guerrero, Gines D.; Garcia, Jose M.] Univ Murcia, Dept Comp Sci, Murcia, Spain; [Cecilia, Jose M.] Catholic Univ Murcia, Dept Comp Sci, Murcia, Spain; [Inuggi, Alberto] Basque Ctr Cognit Brain & Language, San Sebastian, Spain; [Hernandez, Moises; Jbabdi, Saad; Behrens, Timothy E. J.; Sotiropoulos, Stamatios N.] Univ Oxford, Ctr Funct MRI Brain FMRIB, Oxford, England	University of Murcia; Universidad Catolica de Murcia; University of Oxford	Hernandez, M (corresponding author), Univ Murcia, Dept Comp Sci, Murcia, Spain.	moises.hernandez@um.es	Sotiropoulos, Stamatios/I-1163-2019; Inuggi, Alberto/AAF-8510-2019; Inuggi, Alberto/K-6261-2014; Garcia, Jose M/J-5734-2017; Cecilia, Jose Maria/G-3177-2015	Sotiropoulos, Stamatios/0000-0003-4735-5776; Inuggi, Alberto/0000-0002-8840-5197; Inuggi, Alberto/0000-0002-8840-5197; Garcia, Jose M/0000-0002-6388-2835; Cecilia, Jose Maria/0000-0001-5648-214X; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892; Behrens, Timothy/0000-0003-0048-1177; Jbabdi, Saad/0000-0003-3234-5639	Fundacion Seneca (Agencia Regional de Ciencia y Tecnologia, Region de Murcia) [15290/PI/2010]; European Commission FEDER (Fonds Europeen de Developpement Regional) [TIN2009-14475-C04, TIN2012-31345]; Human Connectome Project from the 16 National Institutes of Health Institutes and Centers [1U54MH091657-01]; Spanish Ministerio de Educacion y Ciencia; Medical Research Council [G0800578] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; MRC [G0800578] Funding Source: UKRI	Fundacion Seneca (Agencia Regional de Ciencia y Tecnologia, Region de Murcia)(Fundacion Seneca); European Commission FEDER (Fonds Europeen de Developpement Regional); Human Connectome Project from the 16 National Institutes of Health Institutes and Centers; Spanish Ministerio de Educacion y Ciencia(Spanish Government); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by Fundacion Seneca (Agencia Regional de Ciencia y Tecnologia, Region de Murcia) under grant 15290/PI/2010, and by the Spanish Ministerio de Educacion y Ciencia and European Commission FEDER (Fonds Europeen de Developpement Regional) under grants TIN2009-14475-C04 and TIN2012-31345. Funding also comes from the Human Connectome Project (1U54MH091657-01) from the 16 National Institutes of Health Institutes and Centers that support the NIH Blueprint for Neuroscience Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieu C, 2003, MACH LEARN, V50, P5, DOI 10.1023/A:1020281327116; [Anonymous], 2012, NVIDIA CUDA C PROGR; [Anonymous], 2012, CUDA C BEST PRACT GU; Asanovic K., 2006, LANDSCAPE PARALLEL C; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Behrens TEJ, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P333, DOI 10.1016/B978-0-12-374709-9.00015-8; Cecilia JM, 2012, J PARALLEL IN PRESS; Che S, 2008, J PARALLEL DISTR COM, V68, P1370, DOI 10.1016/j.jpdc.2008.05.014; Chen W, 2009, IEEE T VIS COMPUT GR, V15, P1433, DOI 10.1109/TVCG.2009.112; Chi JR, 2011, IEEE T BIO-MED ENG, V58, P1789, DOI 10.1109/TBME.2011.2116020; Clark CA, 2003, NEUROIMAGE, V20, P1601, DOI 10.1016/j.neuroimage.2003.07.022; Garland M, 2008, IEEE MICRO, V28, P13, DOI 10.1109/MM.2008.57; Hernandez M., 2012, Proceedings of the 2012 20th Euromicro International Conference on Parallel, Distributed and Network-Based Processing (PDP 2012), P622, DOI 10.1109/PDP.2012.46; Hwu WW., 2011, GPU COMPUTING GEMS; Jbabdi S, 2012, MAGN RESON MED, V68, P1846, DOI 10.1002/mrm.24204; Jeong WK, 2007, IEEE T VIS COMPUT GR, V13, P1480, DOI 10.1109/TVCG.2007.70571; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Jones DK., 2011, DIFFUSION MRI THEORY; Karimi K, 2011, PERFORMANCE COMP CUD; Keckler SW, 2011, IEEE MICRO, V31, P7, DOI 10.1109/MM.2011.89; Khronos OpenCL Working Group, 2012, OPENCL SPECIFICATION; Kohn A, 2009, P SPIE MED IM VIS IM, V7261; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lindholm E, 2008, IEEE MICRO, V28, P39, DOI 10.1109/MM.2008.31; Mittmann A, 2011, J DIGIT IMAGING, V24, P339, DOI 10.1007/s10278-009-9266-9; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Murphy M, 2012, IEEE T MED IMAGING, V31, P1250, DOI 10.1109/TMI.2012.2188039; NVIDIA, 2012, NVIDIAS NEXT GEN CUD; NVIDIA Corporation, 2011, TESL M2090 DUAL SLOT; NVIDIA Corporation, 2009, NVIDIAS NEXT GENERAT; NVIDIA Corporation, 2010, TESL M2050 TESL M207; Owens JD, 2008, P IEEE, V96, P879, DOI 10.1109/JPROC.2008.917757; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Petrovic V, 2007, IEEE T VISUALIZATION, V13, P742; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Platform Computing IBM, 2010, PLATF LSF 8 HPC WORK; Press W. H., 1992, ART SCI COMPUTING; Seunarine KK, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P55, DOI 10.1016/B978-0-12-374709-9.00004-3; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sorensen TS, 2008, IEEE T MED IMAGING, V27, P538, DOI 10.1109/TMI.2007.909834; Sotiropoulos SN, 2012, NEUROIMAGE, V60, P1412, DOI 10.1016/j.neuroimage.2012.01.056; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Stone SS, 2008, J PARALLEL DISTR COM, V68, P1307, DOI 10.1016/j.jpdc.2008.05.013; Sun Microsystems, 2007, SUN N1 GRID ENG 6 1; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Whitehead N., 2011, PRECISION PERFORMANC; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Xu M, 2012, IEEE SYM PARA DISTR, P742, DOI 10.1109/IPDPSW.2012.92	52	92	92	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e61892	10.1371/journal.pone.0061892	http://dx.doi.org/10.1371/journal.pone.0061892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658616	Green Published, gold			2022-12-25	WOS:000321662800016
J	Kim, G; Jang, MS; Son, YM; Seo, MJ; Ji, SY; Han, SH; Jung, ID; Park, YM; Jung, HJ; Yun, CH				Kim, Girak; Jang, Mi Seon; Son, Young Min; Seo, Min Ji; Ji, Sang Yun; Han, Seung Hyun; Jung, In Duk; Park, Yeong-Min; Jung, Hyun Jung; Yun, Cheol-Heui			Curcumin Inhibits CD4(+) T Cell Activation, but Augments CD69 Expression and TGF-beta 1-Mediated Generation of Regulatory T Cells at Late Phase	PLOS ONE			English	Article							NF-KAPPA-B; DENDRITIC CELLS; LYMPHOCYTE-PROLIFERATION; ANTIGEN CD69; MODULATION; PATHWAY; S1P(1); BETA; AUTOIMMUNE; INDUCTION	Background: Curcumin is a promising candidate for a natural medicinal agent to treat chronic inflammatory diseases. Although CD4(+) T cells have been implicated in the pathogenesis of chronic inflammation, whether curcumin directly regulates CD4(+) T cells has not been definitively established. Here, we showed curcumin-mediated regulation of CD2/CD3/CD28-initiated CD4(+) T cell activation in vitro. Methodology/Principal Findings: Primary human CD4(+) T cells were stimulated with anti-CD2/CD3/CD28 antibody-coated beads as an in vitro surrogate system for antigen presenting cell-T cell interaction and treated with curcumin. We found that curcumin suppresses CD2/CD3/CD28-initiated CD4(+) T cell activation by inhibiting cell proliferation, differentiation and cytokine production. On the other hand, curcumin attenuated the spontaneous decline of CD69 expression and indirectly increased expression of CCR7, L-selectin and Transforming growth factor-beta 1 (TGF-beta 1) at the late phase of CD2/CD3/CD28-initiated T cell activation. Curcumin-mediated up-regulation of CD69 at late phase was associated with ERK1/2 signaling. Furthermore, TGF-beta 1 was involved in curcumin-mediated regulation of T cell activation and late-phase generation of regulatory T cells. Conclusions/Significance: Curcumin not merely blocks, but regulates CD2/CD3/CD28-initiated CD4(+) T cell activation by augmenting CD69, CCR7, L-selectin and TGF-beta 1 expression followed by regulatory T cell generation. These results suggest that curcumin could directly reduce T cell-dependent inflammatory stress by modulating CD4(+) T cell activation at multiple levels.	[Kim, Girak; Jang, Mi Seon; Son, Young Min; Seo, Min Ji; Ji, Sang Yun] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Girak; Jang, Mi Seon; Son, Young Min; Seo, Min Ji; Ji, Sang Yun] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Han, Seung Hyun] Seoul Natl Univ, Dept Oral Microbiol & Immunol, Program BK21, Seoul, South Korea; [Han, Seung Hyun] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul, South Korea; [Jung, In Duk; Park, Yeong-Min] Konkuk Univ, Coll Med, Seoul, South Korea; [Ji, Sang Yun; Jung, Hyun Jung] Natl Inst Anim Sci, Suwon, Gyeonggi Do, South Korea; [Yun, Cheol-Heui] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea; [Yun, Cheol-Heui] Seoul Natl Univ, World Class Univ Biomodulat Major, Dept Agr Biotechnol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Konkuk University; Konkuk University Medical Center; National Institute of Animal Science, Republic of Korea; Seoul National University (SNU); Seoul National University (SNU)	Yun, CH (corresponding author), Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea.	cyun@snu.ac.kr	YUN, Cheol-Heui/AAR-2775-2020	YUN, Cheol-Heui/0000-0002-0041-2887; KIM, Girak/0000-0003-2613-1140	National Research Foundation (NRF) [2010-0027222, 2010-0003291, R31-10056]; Rural Development Administration [PJ008127012011]; R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	National Research Foundation (NRF); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	This work was supported by Basic Science Research Program through the National Research Foundation (NRF) (2010-0027222, 2010-0003291 World Class University program (R31-10056)) and a grant from the Next-Generation BioGreen 21 Program (PJ008127012011), Rural Development Administration and by R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Castellanos MD, 2002, EUR J IMMUNOL, V32, P3108; Castellanos MD, 1997, J IMMUNOL, V159, P5463; Churchill M, 2000, J SURG RES, V89, P169, DOI 10.1006/jsre.2000.5826; Cipriani B, 2001, J IMMUNOL, V167, P3454, DOI 10.4049/jimmunol.167.6.3454; Cong YZ, 2009, EUR J IMMUNOL, V39, P3134, DOI 10.1002/eji.200939052; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Esplugues E, 2003, J EXP MED, V197, P1093, DOI 10.1084/jem.20021337; Fahey AJ, 2007, J CELL MOL MED, V11, P1129, DOI 10.1111/j.1582-4934.2007.00089.x; Forward NA, 2011, BIOCHEM BIOPH RES CO, V407, P801, DOI 10.1016/j.bbrc.2011.03.103; Gandhi R, 2010, J IMMUNOL, V184, P4620, DOI 10.4049/jimmunol.0903329; Goronzy JJ, 2001, TRENDS IMMUNOL, V22, P251, DOI 10.1016/S1471-4906(00)01841-X; Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Ishikawa S, 1998, J IMMUNOL, V161, P1267; Jagetia GC, 2007, J CLIN IMMUNOL, V27, P19, DOI 10.1007/s10875-006-9066-7; Jeong YI, 2009, J BIOL CHEM, V284, P3700, DOI 10.1074/jbc.M807328200; Kang BY, 1999, BRIT J PHARMACOL, V128, P380, DOI 10.1038/sj.bjp.0702803; Kim GY, 2005, J IMMUNOL, V174, P8116, DOI 10.4049/jimmunol.174.12.8116; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Li Xinjian, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P137; Liang G, 2009, J CELL MOL MED, V13, P3370, DOI 10.1111/j.1582-4934.2009.00711.x; Maccario R, 2005, HAEMATOLOGICA, V90, P516; Martin P, 2010, J ALLERGY CLIN IMMUN; Martin P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001825; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; Natarajan C, 2002, J IMMUNOL, V168, P6506, DOI 10.4049/jimmunol.168.12.6506; Ortiz AM, 2002, RHEUMATOL INT, V21, P182, DOI 10.1007/s00296-001-0161-z; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Ranjan D, 1998, J SURG RES, V77, P174, DOI 10.1006/jsre.1998.5374; Ranjan D, 2004, J SURG RES, V121, P171, DOI 10.1016/j.jss.2004.04.004; Rogers NM, 2010, CLIN EXP IMMUNOL, V162, P460, DOI 10.1111/j.1365-2249.2010.04232.x; Saldanha-Araujo F, 2011, J CELL MOL MED; Sancho D, 1999, BLOOD, V93, P886, DOI 10.1182/blood.V93.3.886.403k10_886_896; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Seo MJ, 2011, MOL IMMUNOL, V48, P1744, DOI 10.1016/j.molimm.2011.04.018; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; TaylorFishwick DA, 1995, EUR J IMMUNOL, V25, P3215, DOI 10.1002/eji.1830251203; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Villalba M, 2000, EUR J IMMUNOL, V30, P1587, DOI 10.1002/1521-4141(200006)30:6<1587::AID-IMMU1587>3.0.CO;2-T; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Yadav VS, 2005, IMMUNOPHARM IMMUNOT, V27, P485, DOI 10.1080/08923970500242244; YASNI S, 1993, J NUTR SCI VITAMINOL, V39, P345, DOI 10.3177/jnsv.39.345	48	20	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62300	10.1371/journal.pone.0062300	http://dx.doi.org/10.1371/journal.pone.0062300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658623	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700047
J	Yang, CK; Yen, P				Yang, Chi-Kai; Yen, Pauline			Differential Translation of Dazap1 Transcripts during Spermatogenesis	PLOS ONE			English	Article							RNA-BINDING PROTEINS; MESSENGER-RNA; GENE-EXPRESSION; GERM-CELLS; IN-VIVO; DAZL; TESTIS; IDENTIFICATION; SPERMIOGENESIS; SEQUENCE	Deleted in AZoospermia Associated Protein 1 (DAZAP1) is a ubiquitous hnRNP protein that has been implicated in RNA transcription, splicing, and translation. It is highly expressed in testes, predominantly in late stage spermatocytes and postmeiotic spermatids. Dazap1 deficiency in mice results in growth retardation and spermatogenic arrest. The gene produces two major transcripts of 2.4 and 1.8 kb, designated Dazap1-L and Dazap1-S, respectively. Results of our previous RNA in situ hybridization and immunostaining suggested translational regulation of the Dazap1 transcripts during spermatogenesis. The main objectives of the study were to determine the origin of the two Dazap1 transcripts and to investigate whether they were similarly translated. Our Northern and 3' RACE analyses showed that the two transcripts were generated through alternative polyadenylation. In mouse testes, the levels of both transcripts were low at postnatal day 12 (P12), increased significantly at P18, and reached maximum at P27. Sucrose gradient analyses showed that at P12 both transcripts were actively translated. Afterward, an increasing portion of Dazap1-S became associated with the translationally inactive mRNPs, and the translational repression was accompanied by an increase in the length of its poly(A) tail. A much smaller portion of Dazap1-L was also sequestered to mRNPs as testes matured, but there was no changes in its poly(A) tail length. Using RNA pull-down followed by mass spectrometry, we identified DAZL, a germ-cell specific translation regulator, as one of the proteins that bound to the 3'UTR region specific for Dazap1-L. We further showed that DAZL preferentially bound to Dazap1-L in testis lysates and stimulated the translation of a reporter gene carrying Dazap1-L 3'UTR. In summary, our study shows that the translation of the two Dazap1 transcripts is differentially regulated. It also provides a new example of translational repression associated with poly(A) tail elongation during spermatogenesis.	[Yang, Chi-Kai; Yen, Pauline] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Yang, Chi-Kai; Yen, Pauline] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan	Yen, P (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	pyen@ibms.sinica.edu.tw			National Science Council [96-2311-B-001-026-MY3]; Academia Sinica in Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica in Taiwan(Academia Sinica - Taiwan)	This work was supported by the National Science Council (grant number 96-2311-B-001-026-MY3) and the Academia Sinica in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAER BW, 1980, P NATL ACAD SCI-BIOL, V77, P1890, DOI 10.1073/pnas.77.4.1890; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; BRAUN RE, 1989, GENE DEV, V3, P793, DOI 10.1101/gad.3.6.793; Braun RE, 1998, SEMIN CELL DEV BIOL, V9, P483, DOI 10.1006/scdb.1998.0226; Braun RE, 2000, INT J ANDROL, V23, P92, DOI 10.1046/j.1365-2605.2000.00027.x; Brook M, 2009, REPRODUCTION, V137, P595, DOI 10.1530/REP-08-0524; Chen J, 2011, GENE DEV, V25, P755, DOI 10.1101/gad.2028911; Chi MN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004900; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Dai T, 2001, BMC Genomics, V2, P6, DOI 10.1186/1471-2164-2-6; Davies HG, 2000, DEV BIOL, V221, P87, DOI 10.1006/dbio.2000.9658; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Fox M, 2005, GENOMICS, V85, P92, DOI 10.1016/j.ygeno.2004.10.003; FUJIMOTO H, 1988, Molecular Reproduction and Development, V1, P27, DOI 10.1002/mrd.1080010106; Goina E, 2008, MOL CELL BIOL, V28, P3850, DOI 10.1128/MCB.02253-07; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Hsu LCL, 2008, RNA, V14, P1814, DOI 10.1261/rna.1152808; Iguchi N, 2006, P NATL ACAD SCI USA, V103, P7712, DOI 10.1073/pnas.0510999103; Janicke A, 2012, RNA, V18, P1289, DOI 10.1261/rna.031898.111; Jenkins HT, 2011, P NATL ACAD SCI USA, V108, P18266, DOI 10.1073/pnas.1105211108; Jiao XF, 2002, BIOL REPROD, V66, P475, DOI 10.1095/biolreprod66.2.475; Kini HK, 2010, J CLIN INVEST, V120, P3090, DOI 10.1172/JCI44091; Kleene KC, 2003, CYTOGENET GENOME RES, V103, P217, DOI 10.1159/000076807; KLEENE KC, 1993, DEV BIOL, V159, P720, DOI 10.1006/dbio.1993.1277; KLEENE KC, 1989, DEVELOPMENT, V106, P367; Kleene KC, 2003, EXP CELL RES, V291, P101, DOI 10.1016/S0014-4827(03)00339-2; KLEENE KC, 1984, DEV BIOL, V105, P71, DOI 10.1016/0012-1606(84)90262-8; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Lee K, 1995, P NATL ACAD SCI USA, V92, P12451, DOI 10.1073/pnas.92.26.12451; Lin YT, 2006, RNA, V12, P1486, DOI 10.1261/rna.42206; Liu DL, 2007, NUCLEIC ACIDS RES, V35, P234, DOI 10.1093/nar/gkl919; Maegawa S, 2002, GENES CELLS, V7, P971, DOI 10.1046/j.1365-2443.2002.00576.x; Pastor T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023349; Pero R, 2003, MOL REPROD DEV, V66, P1, DOI 10.1002/mrd.10322; Prima V, 2005, LEUKEMIA, V19, P806, DOI 10.1038/sj.leu.2403684; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Reynolds N, 2007, RNA, V13, P974, DOI 10.1261/rna.465507; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sambrook J, 2001, MOL CLONING LAB MANU; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Skoko N, 2008, FEBS LETT, V582, P2231, DOI 10.1016/j.febslet.2008.05.018; Smith RWP, 2011, RNA, V17, P1282, DOI 10.1261/rna.2717711; Tsui SL, 2000, GENOMICS, V65, P266, DOI 10.1006/geno.2000.6169; Tsui SL, 2000, BIOL REPROD, V62, P1655, DOI 10.1095/biolreprod62.6.1655; Vangompel Michael J W, 2011, Spermatogenesis, V1, P36; Venables JP, 2001, NUCLEIC ACIDS RES, V29, P2479, DOI 10.1093/nar/29.12.2479; Vera Y, 2002, J ANDROL, V23, P622; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Xu MG, 2007, BIOL REPROD, V76, P1025, DOI 10.1095/biolreprod.107.060079; Yanagiya A, 2010, J CLIN INVEST, V120, P3389, DOI 10.1172/JCI43350; Yen PH, 2004, INT J ANDROL, V27, P125, DOI 10.1111/j.1365-2605.2004.00469.x; Yen PH, 1996, HUM MOL GENET, V5, P2013, DOI 10.1093/hmg/5.12.2013; Yuki Y, 2004, CANCER SCI, V95, P503, DOI 10.1111/j.1349-7006.2004.tb03240.x; Zeng M, 2009, MOL BIOL REP, V36, P2399, DOI 10.1007/s11033-009-9470-1; Zhong J, 1999, NAT GENET, V22, P171, DOI 10.1038/9684	60	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e60873	10.1371/journal.pone.0060873	http://dx.doi.org/10.1371/journal.pone.0060873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658607	Green Submitted, Green Published, gold			2022-12-25	WOS:000318343700007
J	Wang, N; Zimmerman, K; Raab, RW; McKown, RL; Hutnik, CML; Talla, V; Tyler, MF; Lee, JK; Laurie, GW				Wang, Ningning; Zimmerman, Keith; Raab, Ronald W.; McKown, Robert L.; Hutnik, Cindy M. L.; Talla, Venu; Tyler, Milton F.; Lee, Jae K.; Laurie, Gordon W.			Lacritin Rescues Stressed Epithelia via Rapid Forkhead Box O3 (FOXO3)-associated Autophagy That Restores Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSECRETORY MITOGEN LACRITIN; DRY EYE; NEGATIVE REGULATOR; PROTEOMIC ANALYSES; SIGNALING PATHWAY; BINDING-PROTEIN; LACRIMAL GLAND; CELLS; DEGRADATION; DISEASE	Homeostasis is essential for cell survival. However, homeostatic regulation of surface epithelia is poorly understood. The eye surface, lacking the cornified barrier of skin, provides an excellent model. Tears cover the surface of the eye and are deficient in dry eye, the most common eye disease affecting at least 5% of the world's population. Only a tiny fraction of the tear proteome appears to be affected, including lacritin, an epithelium-selective mitogen that promotes basal tearing when topically applied to rabbit eyes. Here we show that homeostasis of cultured corneal epithelia is entirely lacritin-dependent and elucidate the mechanism as a rapid autophagic flux to promptly restore cellular metabolism and mitochondrial fusion in keeping with the short residence time of lacritin on the eye. Accelerated flux appears to be derived from lacritin-stimulated acetylation of FOXO3 as a novel ligand for ATG101 and coupling of stress-acetylated FOXO1 with ATG7(which remains uncoupled without lacritin) and be sufficient to selectively divert huntingtin mutant Htt103Q aggregates largely without affecting non-aggregated Htt25Q. This is in keeping with stress as a prerequisite for lacritin-stimulated autophagy. Lacritin targets the cell surface proteoglycan syndecan-1 via its C-terminal amino acids Leu(108)-Leu(109)-Phe(112) and is also available in saliva, plasma, and lung lavage. Thus, lacritin may promote epithelial homeostasis widely.	[Wang, Ningning; Zimmerman, Keith; Talla, Venu; Tyler, Milton F.; Laurie, Gordon W.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA; [Lee, Jae K.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Lee, Jae K.] Univ Virginia, Dept Syst & Informat Engn, Charlottesville, VA 22908 USA; [Laurie, Gordon W.] Univ Virginia, Dept Ophthalmol, Charlottesville, VA 22908 USA; [Raab, Ronald W.; McKown, Robert L.] James Madison Univ, Dept Integrated Sci & Technol, Harrisonburg, VA 22807 USA; [Hutnik, Cindy M. L.] Univ Western Ontario, Dept Ophthalmol, London, ON N6A 4V2, Canada	University of Virginia; University of Virginia; University of Virginia; University of Virginia; James Madison University; Western University (University of Western Ontario)	Laurie, GW (corresponding author), Univ Virginia, Dept Cell Biol, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	glaurie@virginia.edu	Laurie, Gordon W/A-5244-2008	Laurie, Gordon W/0000-0002-5311-2650; Talla, Venu/0000-0002-5695-7536; Tyler IV, Milton/0000-0002-9870-0755	National Institutes of Health [RO1 EY013143, EY018222]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013143, R01EY018222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 EY013143 and EY018222 (to G. W. L.).	Barabino S, 2012, PROG RETIN EYE RES, V31, P271, DOI 10.1016/j.preteyeres.2012.02.003; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Chen LY, 2011, J PROTEOME RES, V10, P4876, DOI 10.1021/pr2004874; Ciani B, 2003, J BIOL CHEM, V278, P37409, DOI 10.1074/jbc.M307416200; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fleiszig SMJ, 2003, INFECT IMMUN, V71, P3866, DOI 10.1128/IAI.71.7.3866-3874.2003; Green-Church KB, 2008, MOL VIS, V14, P291; Grzelkowska-Kowalczyk K, 2010, CELL MOL BIOL LETT, V15, P13, DOI 10.2478/s11658-009-0033-1; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Herok GH, 2009, CURR EYE RES, V34, P589, DOI 10.1080/02713680902972366; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Kakazu A, 2004, INVEST OPHTH VIS SCI, V45, P3485, DOI 10.1167/iovs.04-0372; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Koo BS, 2005, J PROTEOME RES, V4, P719, DOI 10.1021/pr0498133; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lamark T, 2010, CURR OPIN CELL BIOL, V22, P192, DOI 10.1016/j.ceb.2009.11.002; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Lara-Pezzi E, 2007, J CELL BIOL, V179, P1205, DOI 10.1083/jcb.200704179; Laurie GW, 2008, OPTOMETRY VISION SCI, V85, P643, DOI 10.1097/OPX.0b013e318181ae73; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; LOHMANDER LS, 1979, J BIOL CHEM, V254, P551; Ma PS, 2008, EXP EYE RES, V86, P457, DOI 10.1016/j.exer.2007.01.025; Ma PS, 2006, J CELL BIOL, V174, P1097, DOI 10.1083/jcb.200511134; Malik SA, 2011, CELL CYCLE, V10, P2917, DOI 10.4161/cc.10.17.17067; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; McKown RL, 2009, EXP EYE RES, V88, P848, DOI 10.1016/j.exer.2008.09.002; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nichols JJ, 2009, CORNEA, V28, P1109, DOI 10.1097/ICO.0b013e3181a2ad81; Ozyildirim AM, 2005, INVEST OPHTH VIS SCI, V46, P1572, DOI 10.1167/iovs.04-1380; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Porter D, 2003, P NATL ACAD SCI USA, V100, P10931, DOI 10.1073/pnas.1932980100; Qi H, 2008, EXP EYE RES, V87, P580, DOI 10.1016/j.exer.2008.09.012; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; RIGGS TR, 1948, J BIOL CHEM, V172, P539; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Sanghi S, 2001, J MOL BIOL, V310, P127, DOI 10.1006/jmbi.2001.4748; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schenk S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-41; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Seifert K, 2012, INVEST OPHTH VIS SCI, V53, P6610, DOI 10.1167/iovs.11-8729; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Sinha RA, 2012, J CLIN INVEST, V122, P2428, DOI 10.1172/JCI60580; Srinivasan S, 2012, INVEST OPHTH VIS SCI, V53, P5052, DOI 10.1167/iovs.11-9022; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; van Grevenynghe J, 2008, NAT MED, V14, P266, DOI 10.1038/nm1728; Velez VF, 2013, INVEST OPHTH VIS SCI, V54, P2123, DOI 10.1167/iovs.12-11488; Wang JH, 2006, J CELL BIOL, V174, P689, DOI 10.1083/jcb.200605140; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Wu ZH, 2007, J BIOL CHEM, V282, P22414, DOI 10.1074/jbc.M702321200; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yoon K, 2008, CELL DEATH DIFFER, V15, P730, DOI 10.1038/sj.cdd.4402304; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang YH, 2013, J BIOL CHEM, V288, P12090, DOI 10.1074/jbc.M112.422717; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zheng XF, 2010, CORNEA, V29, P1048, DOI 10.1097/ICO.0b013e3181cf98ff; Zhou L, 2009, J PROTEOME RES, V8, P4889, DOI 10.1021/pr900686s	72	36	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18146	18161		10.1074/jbc.M112.436584	http://dx.doi.org/10.1074/jbc.M112.436584			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23640897	hybrid, Green Published			2022-12-25	WOS:000320721900020
J	Xu, XM; Kobayashi, S; Chen, K; Timm, D; Volden, P; Huang, Y; Gulick, J; Yue, ZY; Robbins, J; Epstein, PN; Liang, QR				Xu, Xianmin; Kobayashi, Satoru; Chen, Kai; Timm, Derek; Volden, Paul; Huang, Yuan; Gulick, James; Yue, Zhenyu; Robbins, Jeffrey; Epstein, Paul N.; Liang, Qiangrong			Diminished Autophagy Limits Cardiac Injury in Mouse Models of Type 1 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INDUCED CARDIOMYOCYTE INJURY; HIGH-RISK PATIENTS; VITAMIN-E; CARDIOVASCULAR EVENTS; OXIDATIVE STRESS; HEMODYNAMIC STRESS; PATHOGENIC ROLE; HEART-FAILURE; DEATH PLAYS	Cardiac autophagy is inhibited in type 1 diabetes. However, it remains unknown if the reduced autophagy contributes to the pathogenesis of diabetic cardiomyopathy. We addressed this question using mouse models with gain-and loss-of-autophagy. Autophagic flux was inhibited in diabetic hearts when measured at multiple time points after diabetes induction by streptozotocin as assessed by protein levels of microtubule-associated protein light chain 3 form 2 (LC3-II) or GFP-LC3 puncta in the absence and presence of the lysosome inhibitor bafilomycin A1. Autophagy in diabetic hearts was further reduced in beclin 1- or Atg16-deficient mice but was restored partially or completely by overexpression of beclin 1 to different levels. Surprisingly, diabetes-induced cardiac damage was substantially attenuated in beclin 1- and Atg16-deficient mice as shown by improved cardiac function as well as reduced levels of oxidative stress, interstitial fibrosis, and myocyte apoptosis. In contrast, diabetic cardiac damage was dose-dependently exacerbated by beclin 1 overexpression. The cardioprotective effects of autophagy deficiency were reproduced in OVE26 diabetic mice. These effects were associated with partially restored mitophagy and increased expression and mitochondrial localization of Rab9, an essential regulator of a non-canonical alternative autophagic pathway. Together, these findings demonstrate that the diminished autophagy is an adaptive response that limits cardiac dysfunction in type 1 diabetes, presumably through up-regulation of alternative autophagy and mitophagy.	[Xu, Xianmin; Kobayashi, Satoru; Chen, Kai; Timm, Derek; Volden, Paul; Huang, Yuan; Liang, Qiangrong] Univ S Dakota, Sanford Sch Med, Cardiovasc Hlth Res Ctr, Dept Internal Med, Sioux Falls, SD 57104 USA; [Robbins, Jeffrey] Cincinnati Childrens Hosp Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA; [Yue, Zhenyu] Mt Sinai Sch Med, Dept Neurol & Neurosci, New York, NY 10029 USA; [Epstein, Paul N.] Univ Louisville, Dept Pediat & Pharmacol, Louisville, KY 40202 USA; [Epstein, Paul N.] Univ Louisville, Dept Toxicol, Louisville, KY 40202 USA	University of South Dakota; Cincinnati Children's Hospital Medical Center; Icahn School of Medicine at Mount Sinai; University of Louisville; University of Louisville	Liang, QR (corresponding author), NY Inst Technol, Dept Biomed Sci, Coll Osteopath Med, Old Westbury, NY 11568 USA.	qliang03@nyit.edu		Epstein, Paul/0000-0002-7006-8954	American Diabetes Association [1-09-CD-09]; Juvenile Diabetes Research Foundation; National Institutes of Health National Center for Research Resources [5P20RR017662-10]; NIGMS [8 P20 GM103455-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017662] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103455] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Career Development Grant 1-09-CD-09) from the American Diabetes Association. Parts of this study were presented at the 71st and 72nd Scientific Sessions of the American Diabetes Association, San Diego, California, June 24-28, 2011 and in Philadelphia, PA, June 8-12, 2012.; Supported by an Advanced Postdoctoral Fellowship from the Juvenile Diabetes Research Foundation.; We thank Dr. Herbert W. Virgin from the Washington University School of Medicine for generous donation of the ATG16L1-HM mice and Dr. Noboru Mizushima from Tokyo Medical and Dental University for the GFP-LC3 mice. We are grateful to the Physiology Core Facility at the Sanford Research/USD for performing echocardiographic and hemodynamic measurements. We also thank the Imaging Core Facility for assistance with confocal microscopy. These core facilities are supported by National Institutes of Health National Center for Research Resources Grant 5P20RR017662-10 and NIGMS Grant 8 P20 GM103455-10.	Akazawa H, 2004, J BIOL CHEM, V279, P41095, DOI 10.1074/jbc.M313084200; BELL DSH, 1995, DIABETES CARE, V18, P708, DOI 10.2337/diacare.18.5.708; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Fiordaliso F, 2004, J MOL CELL CARDIOL, V37, P959, DOI 10.1016/j.yjmcc.2004.07.008; Fujimoto K, 2009, J BIOL CHEM, V284, P27664, DOI 10.1074/jbc.M109.041616; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hamacher-Brady A, 2006, CARDIOVASC DRUG THER, V20, P445, DOI 10.1007/s10557-006-0583-7; Hur KY, 2010, DIABETES OBES METAB, V12, P20, DOI 10.1111/j.1463-1326.2010.01278.x; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5; Juenemann K, 2012, INT J CELL BIOL; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kobayashi S, 2007, J BIOL CHEM, V282, P21945, DOI 10.1074/jbc.M703048200; Kobayashi S, 2012, AUTOPHAGY, V8, P577, DOI 10.4161/auto.18980; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Liang QR, 2002, DIABETES, V51, P174, DOI 10.2337/diabetes.51.1.174; Lonn E, 2002, DIABETES CARE, V25, P1919, DOI 10.2337/diacare.25.11.1919; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Lu LH, 2009, INT J CARDIOL, V134, P82, DOI 10.1016/j.ijcard.2008.01.043; Maloyan A, 2009, CIRC RES, V104, P1021, DOI 10.1161/CIRCRESAHA.108.193516; Martinet W, 2007, TRENDS MOL MED, V13, P482, DOI 10.1016/j.molmed.2007.08.004; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Meijer AJ, 2007, AUTOPHAGY, V3, P523; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Sacco M, 2003, DIABETES CARE, V26, P3264, DOI 10.2337/diacare.26.12.3264; Saeedi R, 2008, AM J PHYSIOL-HEART C, V294, pH2497, DOI 10.1152/ajpheart.00873.2007; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Takagi H, 2007, ANTIOXID REDOX SIGN, V9, P1373, DOI 10.1089/ars.2007.1689; Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105; Terman A, 2005, CARDIOVASC RES, V68, P355, DOI 10.1016/j.cardiores.2005.08.014; Thomson DM, 2009, J PHYSIOL-LONDON, V587, P2077, DOI 10.1113/jphysiol.2008.166512; Wold LE, 2005, ACTA PHARMACOL SIN, V26, P908, DOI 10.1111/j.1745-7254.2005.00146.x; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336; Ye G, 2003, DIABETES, V52, P777, DOI 10.2337/diabetes.52.3.777; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	57	175	193	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18077	18092		10.1074/jbc.M113.474650	http://dx.doi.org/10.1074/jbc.M113.474650			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23658055	Green Published, hybrid			2022-12-25	WOS:000320721900014
J	Sakuma, M; Imada, K; Okumura, Y; Uchiya, K; Yamashita, N; Ogawa, K; Hijikata, A; Shirai, T; Homma, M; Nikai, T				Sakuma, Mayuko; Imada, Katsumi; Okumura, Yoshiyuki; Uchiya, Kei-ichi; Yamashita, Nobuo; Ogawa, Kenji; Hijikata, Atsushi; Shirai, Tsuyoshi; Homma, Michio; Nikai, Toshiaki			X-ray Structure Analysis and Characterization of AFUEI, an Elastase Inhibitor from Aspergillus fumigatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGLIN-C; MOLECULAR-STRUCTURE; PROTEINASE; PURIFICATION; STABILITY; PROTEASES; ALIGNMENT; SOFTWARE; CRYSTAL; COMPLEX	Elastase from Aspergillus sp. is an important factor for aspergillosis. AFUEI is an inhibitor of the elastase derived from Aspergillus fumigatus. AFUEI is a member of the I78 inhibitor family and has a high inhibitory activity against elastases of Aspergillus fumigatus and Aspergillus flavus, human neutrophil elastase and bovine chymotrypsin, but does not inhibit bovine trypsin. Here we report the crystal structure of AFUEI in two crystal forms. AFUEI is a wedge-shaped protein composed of an extended loop and a scaffold protein core. The structure of AFUEI shows remarkable similarity to serine protease inhibitors of the potato inhibitor I family, although they are classified into different inhibitor families. A structural comparison with the potato I family inhibitors suggests that the extended loop of AFUEI corresponds to the binding loop of the potato inhibitor I family, and AFUEI inhibits its cognate proteases through the same mechanism as the potato I family inhibitors.	[Sakuma, Mayuko; Homma, Michio] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Imada, Katsumi] Osaka Univ, Grad Sch Sci, Dept Macromol Sci, Toyonaka, Osaka 5600043, Japan; [Okumura, Yoshiyuki; Uchiya, Kei-ichi; Nikai, Toshiaki] Meijo Univ, Fac Pharm, Dept Microbiol, Tempaku Ku, Nagoya, Aichi 4688503, Japan; [Yamashita, Nobuo] Hakutsuru Sake Brewing Co Ltd, Higashinada Ku, Kobe, Hyogo 6580041, Japan; [Ogawa, Kenji] Higashi Nagoya Natl Hosp, Dept Pulm Med, Meito Ku, Nagoya, Aichi 4658620, Japan; [Hijikata, Atsushi; Shirai, Tsuyoshi] Nagahama Inst Biosci & Technol, Fac Biosci, Nagahama 5260829, Japan	Nagoya University; Osaka University; Meijo University	Homma, M (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	g44416a@cc.nagoya-u.ac.jp		Imada, Katsumi/0000-0003-1342-8885; Hijikata, Atsushi/0000-0003-4297-8368; Shirai, Tsuyoshi/0000-0002-2506-5738	Ministry of Education, Science, and Culture of Japan; Japan Science and Technology Corporation; Specially Promoted Research of Meijo University Research Institute; Yakult Co. Ltd.; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [24590164] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Specially Promoted Research of Meijo University Research Institute; Yakult Co. Ltd.; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Science, and Culture of Japan and from the Japan Science and Technology Corporation (to M. H.) and for Specially Promoted Research of Meijo University Research Institute and from the Yakult Co. Ltd. (to T. N.). This work was also supported by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to A. H. and T. S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alp S, 2008, J BASIC MICROB, V48, P331, DOI 10.1002/jobm.200700349; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BETZEL C, 1993, FEBS LETT, V317, P185, DOI 10.1016/0014-5793(93)81273-3; BOUCHARA JP, 1995, TRENDS MICROBIOL, V3, P327, DOI 10.1016/S0966-842X(00)88965-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai ML, 2002, BIOCHEMISTRY-US, V41, P9572, DOI 10.1021/bi0258952; Cierpicki T, 2000, J MOL BIOL, V302, P1179, DOI 10.1006/jmbi.2000.4116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEINSTEIN G, 1973, BIOCHIM BIOPHYS ACTA, V309, P196, DOI 10.1016/0005-2744(73)90331-8; FRIGERIO F, 1992, J MOL BIOL, V225, P107, DOI 10.1016/0022-2836(92)91029-O; GERTLER A, 1971, BIOCHIM BIOPHYS ACTA, V235, P378, DOI 10.1016/0005-2744(71)90217-8; Hijikata A, 2011, PROTEINS, V79, P1868, DOI 10.1002/prot.23011; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; Huma Habib, 2007, Biotechnology and Molecular Biology Reviews, V2, P068; JACKSON SE, 1994, BIOCHEMISTRY-US, V33, P13880, DOI 10.1021/bi00250a042; Koizumi M, 2008, J SYNCHROTRON RADIAT, V15, P308, DOI 10.1107/S0909049507060670; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Leslie A. G. W., 1992, CRYSTALLOGRAPHY, V26, P27; MCPHALEN CA, 1987, BIOCHEMISTRY-US, V26, P261, DOI 10.1021/bi00375a036; MCPHALEN CA, 1988, BIOCHEMISTRY-US, V27, P6582, DOI 10.1021/bi00417a058; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Morya VK, 2012, APPL BIOCHEM BIOTECH, V166, P243, DOI 10.1007/s12010-011-9420-y; NIKAI T, 1977, YAKUGAKU ZASSHI, V97, P507, DOI 10.1248/yakushi1947.97.5_507; Okumura Yoshiyuki, 2008, Nihon Ishinkin Gakkai Zasshi, V49, P87, DOI 10.3314/jjmm.49.87; Okumura Yoshiyuki, 2006, Nihon Ishinkin Gakkai Zasshi, V47, P219; Okumura Y, 2008, J MED MICROBIOL, V57, P803, DOI 10.1099/jmm.0.47789-0; Okumura Yoshiyuki, 2007, Nihon Ishinkin Gakkai Zasshi, V48, P13, DOI 10.3314/jjmm.48.13; Radisky ES, 2005, BIOCHEMISTRY-US, V44, P6823, DOI 10.1021/bi047301w; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Rawlings ND, 2010, BIOCHIMIE, V92, P1463, DOI 10.1016/j.biochi.2010.04.013; Taguchi S, 1997, J MOL EVOL, V44, P542, DOI 10.1007/PL00006178; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020950; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wojtaszek J, 2006, COMP BIOCHEM PHYS B, V143, P465, DOI 10.1016/j.cbpb.2005.12.023; Yamashita N, 2011, J BIOSCI BIOENG, V112, P114, DOI 10.1016/j.jbiosc.2011.03.020; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	40	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17451	17459		10.1074/jbc.M112.433987	http://dx.doi.org/10.1074/jbc.M112.433987			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640894	Green Published, hybrid			2022-12-25	WOS:000320380600037
J	Cummings, AC; Torstenson, E; Davis, MF; D'Aoust, LN; Scott, WK; Pericak-Vance, MA; Bush, WS; Haines, JL				Cummings, Anna C.; Torstenson, Eric; Davis, Mary F.; D'Aoust, Laura N.; Scott, William K.; Pericak-Vance, Margaret A.; Bush, William S.; Haines, Jonathan L.			Evaluating Power and Type 1 Error in Large Pedigree Analyses of Binary Traits	PLOS ONE			English	Article							ONSET ALZHEIMER-DISEASE; LINKAGE ANALYSIS; DISEQUILIBRIUM TEST; GENERAL PEDIGREES; ASSOCIATION; AMISH; POPULATION; DEMENTIA; ALLEGRO; SCREEN	Studying population isolates with large, complex pedigrees has many advantages for discovering genetic susceptibility loci; however, statistical analyses can be computationally challenging. Allelic association tests need to be corrected for relatedness among study participants, and linkage analyses require subdividing and simplifying the pedigree structures. We have extended GenomeSIMLA to simulate SNP data in complex pedigree structures based on an Amish pedigree to generate the same structure and distribution of sampled individuals. We evaluated type 1 error rates when no disease SNP was simulated and power when disease SNPs with recessive, additive, and dominant modes of inheritance and odds ratios of 1.1, 1.5, 2.0, and 5.0 were simulated. We generated subpedigrees with a maximum bit-size of 24 using PedCut and performed two-point and multipoint linkage using Merlin. We also ran MQLS on the subpedigrees and unified pedigree. We saw no inflation of type 1 error when running MQLS on either the whole pedigrees or the sub-pedigrees, and we saw low type 1 error for two-point and multipoint linkage. Power was reduced when running MQLS on the subpedigrees versus the whole pedigree, and power was low for two-point and multipoint linkage analyses of the subpedigrees. These data suggest that MQLS has appropriate type 1 error rates in our Amish pedigree structure, and while type 1 error does not seem to be affected when dividing the pedigree prior to linkage analysis, power to detect linkage is diminished when the pedigree is divided.	[Cummings, Anna C.; Torstenson, Eric; Davis, Mary F.; D'Aoust, Laura N.; Bush, William S.; Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Scott, William K.; Pericak-Vance, Margaret A.] Univ Miami, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL 33136 USA; [Scott, William K.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA	Vanderbilt University; University of Miami; University of Miami	Haines, JL (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, 221 Kirkland Hall, Nashville, TN 37235 USA.	jonathan@chgr.mc.vanderbilt.edu	Haines, Jonathan/C-3374-2012; Bush, William/N-1369-2019	Haines, Jonathan/0000-0002-4351-4728; Bush, William/0000-0002-9729-6519; Scott, William/0000-0001-9336-6404	National Institutes of Health [AG019085, AG019726]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, T32GM080178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019085, R01AG019726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health grants AG019085 (to JLH and MPV) and AG019726 (to WKS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Agarwala R, 2003, AM J MED GENET C, V121C, P32, DOI 10.1002/ajmg.c.20004; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Cummings AC, 2012, ANN HUM GENET, V76, P342, DOI 10.1111/j.1469-1809.2012.00721.x; Cummings AC, 2011, ANN HUM GENET, V75, P351, DOI 10.1111/j.1469-1809.2011.00643.x; Edwards TL, 2008, LECT NOTES COMPUT SC, V4973, P24, DOI 10.1007/978-3-540-78757-0_3; Fishelson M, 2005, HUM HERED, V59, P41, DOI 10.1159/000084736; Fishelson M, 2004, J COMPUT BIOL, V11, P263, DOI 10.1089/1066527041410409; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hahs DW, 2006, AM J MED GENET B, V141B, P160, DOI 10.1002/ajmg.b.30257; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lee SL, 2008, ANN HUM GENET, V72, P621, DOI 10.1111/j.1469-1809.2008.00452.x; Liu F, 2006, ANN HUM GENET, V70, P965, DOI 10.1111/j.1469-1809.2006.00279.x; Liu F, 2008, EUR J HUM GENET, V16, P854, DOI 10.1038/ejhg.2008.24; Liu F, 2007, AM J HUM GENET, V81, P17, DOI 10.1086/518720; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; McArdle PF, 2007, HUM HERED, V64, P234, DOI 10.1159/000103861; McCauley JL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-19; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106	27	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62615	10.1371/journal.pone.0062615	http://dx.doi.org/10.1371/journal.pone.0062615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658753	gold, Green Published, Green Submitted			2022-12-25	WOS:000321202100020
J	Givnish, TJ; Bean, GJ; Ames, M; Lyon, SP; Sytsma, KJ				Givnish, Thomas J.; Bean, Gregory J.; Ames, Mercedes; Lyon, Stephanie P.; Sytsma, Kenneth J.			Phylogeny, Floral Evolution, and Inter-Island Dispersal in Hawaiian Clermontia (Campanulaceae) Based on ISSR Variation and Plastid Spacer Sequences	PLOS ONE			English	Article							GIANT LOBELIAS; GENETIC-RELATIONSHIPS; ADAPTIVE RADIATION; AFLP MARKERS; INFERENCE; BIOGEOGRAPHY; DIVERGENCE; ACCURACY; DIVERSIFICATION; LOBELIOIDEAE	Previous studies based on DNA restriction-site and sequence variation have shown that the Hawaiian lobeliads are monophyletic and that the two largest genera, Cyanea and Clermontia, diverged from each other ca. 9.7 Mya. Sequence divergence among species of Clermontia is quite limited, however, and extensive hybridization is suspected, which has interfered with production of a well-resolved molecular phylogeny for the genus. Clermontia is of considerable interest because several species posses petal-like sepals, raising the question of whether such a homeotic mutation has arisen once or several times. In addition, morphological and molecular studies have implied different patterns of inter-island dispersal within the genus. Here we use nuclear ISSRs (inter-simple sequence repeat polymorphisms) and five plastid non-coding sequences to derive biparental and maternal phylogenies for Clermontia. Our findings imply that (1) Clermontia is not monophyletic, with Cl. pyrularia nested within Cyanea and apparently an intergeneric hybrid; (2) the earliest divergent clades within Clermontia are native to Kauai, then Oahu, then Maui, supporting the progression rule of dispersal down the chain toward progressively younger islands, although that rule is violated in later-evolving taxa in the ISSR tree; (3) almost no sequence divergence among several Clermontia species in 4.5 kb of rapidly evolving plastid DNA; (4) several apparent cases of hybridization/introgression or incomplete lineage sorting (i.e., Cl. oblongifolia, peleana, persicifolia, pyrularia, samuelii, tuberculata), based on extensive conflict between the ISSR and plastid phylogenies; and (5) two origins and two losses of petaloid sepals, or-perhaps more plausibly-a single origin and two losses of this homeotic mutation, with its introgression into Cl. persicifolia. Our phylogenies are better resolved and geographically more informative than others based on ITS and 5S-NTS sequences and nuclear SNPs, but agree with them in supporting Clermontia's origin on Kauai or some older island and dispersal down the chain subsequently.	[Givnish, Thomas J.; Bean, Gregory J.; Lyon, Stephanie P.; Sytsma, Kenneth J.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Bean, Gregory J.] Chesterfield Village Res Ctr, Chesterfield Village, MO USA; [Ames, Mercedes] Promega North Amer, Fitchburg, WI USA	University of Wisconsin System; University of Wisconsin Madison	Givnish, TJ (corresponding author), Univ Wisconsin, Dept Bot, Madison, WI 53706 USA.	givnish@wisc.edu		Lyon, Stephanie/0000-0002-9950-1977	National Science Foundation (NSF) [DEB-9509550, DEB-0431233, DEB-0830836]; Division Of Environmental Biology [0830036] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by National Science Foundation (NSF) grants DEB-9509550 to TJG and KJS, DEB-0431233 to KJS, and DEB-0830836 to TJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2008, MOL PHYLOGENET EVOL, V46, P1, DOI 10.1016/j.ympev.2007.06.015; Antonelli A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-82; Bacon CD, 2011, TAXON, V60, P733, DOI 10.1002/tax.603009; Beardsley PM, 2003, EVOLUTION, V57, P1397, DOI 10.1111/j.0014-3820.2003.tb00347.x; Brant SV, 2000, J PARASITOL, V86, P545, DOI 10.1645/0022-3395(2000)086[0545:POSOTG]2.0.CO;2; Cacho NI, 2010, AM J BOT, V97, P493, DOI 10.3732/ajb.0900090; Carlquist S., 1970, HAWAII NATURAL HIST; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; Clague DA, 1987, VOLCANISM HAWAII, V1350, P5; Clague David A., 1996, P35; Dasmahapatra KK, 2009, HEREDITY, V103, P168, DOI 10.1038/hdy.2009.25; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Esselman EJ, 2000, AM J BOT, V87, P591, DOI 10.2307/2656603; Fang DQ, 1997, THEOR APPL GENET, V95, P211, DOI 10.1007/s001220050550; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FARRIS JS, 1969, SYST ZOOL, V18, P374, DOI 10.2307/2412182; Funk V. A., 1995, P379; Garcia-Pereira MJ, 2011, J EVOLUTION BIOL, V24, P2346, DOI 10.1111/j.1420-9101.2011.02361.x; Gaudeul M, 2012, AM J BOT, V99, P68, DOI 10.3732/ajb.1100321; Givnish Thomas J., 1995, P288; Givnish Thomas J., 1998, P281; Givnish TJ, 2010, TAXON, V59, P1326, DOI 10.1002/tax.595003; Givnish TJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-3; Givnish TJ, 2009, P ROY SOC B-BIOL SCI, V276, P407, DOI 10.1098/rspb.2008.1204; GIVNISH TJ, 1994, P NATL ACAD SCI USA, V91, P2810, DOI 10.1073/pnas.91.7.2810; Givnish TJ, 2004, AM J BOT, V91, P228, DOI 10.3732/ajb.91.2.228; Hipp AL, 2004, SYST BIOL, V53, P81, DOI 10.1080/10635150490264752; Hofer KA, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-26; Ipek M, 2006, GENOME, V49, P1246, DOI 10.1139/G06-092; Jabaily RS, 2013, BOT J LINN SOC, V171, P201, DOI 10.1111/j.1095-8339.2012.01307.x; Garcia-Pereira MJ, 2010, MOL BIOL EVOL, V27, P988, DOI 10.1093/molbev/msp315; Koopman WJM, 2005, SYST BIOL, V54, P197, DOI 10.1080/10635150590924181; Kropf M, 2003, MOL ECOL, V12, P931, DOI 10.1046/j.1365-294X.2003.01781.x; Kropf M, 2009, MOL ECOL, V18, P697, DOI 10.1111/j.1365-294X.2008.04053.x; Lammers T.G., 1999, MANUAL FLOWERING PLA, P420; LAMMERS TG, 1992, ANN MO BOT GARD, V79, P388, DOI 10.2307/2399776; LAMMERS TG, 1991, SYSTEMATIC BOT MONOG, V32, P1, DOI DOI 10.2307/25027798; Lammers Thomas G., 1995, P338; MABBERLEY D J, 1974, Kew Bulletin, V29, P535, DOI 10.2307/4108000; MABBERLEY DJ, 1975, NEW PHYTOL, V74, P365, DOI 10.1111/j.1469-8137.1975.tb02623.x; MADDISON D. R., 2005, MACCLADE 4 ANAL PHYL; Martin JP, 2000, THEOR APPL GENET, V101, P1234, DOI 10.1007/s001220051602; Miller M.A., 2010, CIPRES PORTALS; Montgomery RA, 2008, FUNCT PLANT BIOL, V35, P595, DOI 10.1071/FP08031; Mort ME, 2003, TAXON, V52, P511, DOI 10.2307/3647449; Pagel M., 2007, BAYESTRAITS VERSION; Pellmyr O, 2007, MOL PHYLOGENET EVOL, V43, P493, DOI 10.1016/j.ympev.2006.12.015; Pillon Y, 2012, SOC STUD EV 2012  M; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price Jonathan Paul, 2004, Pacific Science, V58, P27, DOI 10.1353/psc.2004.0008; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ren TH, 2011, GENOME, V54, P316, DOI [10.1139/G10-121, 10.1139/g10-121]; Richardson JE, 2003, EVOLUTION, V57, P816; Rieseberg LH, 1996, MOL ECOL, V5, P99, DOI 10.1111/j.1365-294X.1996.tb00295.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schenk MF, 2008, TREE GENET GENOMES, V4, P911, DOI 10.1007/s11295-008-0162-0; Spooner DM, 2005, TAXON, V54, P43, DOI 10.2307/25065301; Stamatakis A, 2005, LECT NOTES COMPUT SC, V3606, P288, DOI 10.1007/11535294_25; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stuessy TF, 2003, BASIC APPL ECOL, V4, P287, DOI 10.1078/1439-1791-00160; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; THORMANN CE, 1994, THEOR APPL GENET, V88, P973, DOI 10.1007/BF00220804; Tsumura Y, 1996, THEOR APPL GENET, V92, P40, DOI 10.1007/BF00222949; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016728; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/10635150116801; Zwickl D., 2006, GARLI GENETIC ALGORI	68	15	16	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62566	10.1371/journal.pone.0062566	http://dx.doi.org/10.1371/journal.pone.0062566			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658747	Green Published, gold			2022-12-25	WOS:000321200500030
J	Marret, S; Marchand-Martin, L; Picaud, JC; Hascoet, JM; Arnaud, C; Roze, JC; Truffert, P; Larroque, B; Kaminski, M; Ancei, PY				Marret, Stephane; Marchand-Martin, Laetitia; Picaud, Jean-Charles; Hascoet, Jean-Michel; Arnaud, Catherine; Roze, Jean-Christophe; Truffert, Patrick; Larroque, Beatrice; Kaminski, Monique; Ancei, Pierre-Yves		EPIPAGE Study Grp	Brain Injury in Very Preterm Children and Neurosensory and Cognitive Disabilities during Childhood: The EPIPAGE Cohort Study	PLOS ONE			English	Article							PREMATURELY BORN CHILDREN; CEREBRAL-PALSY; ULTRASOUND ABNORMALITIES; GESTATIONAL-AGE; INFANTS; BIRTH; PREVALENCE; ATTAINMENT; MORTALITY; OUTCOMES	Objective: To investigate the association of motor and cognitive/learning deficiencies and overall disabilities in very preterm (VPT) children and their relations to gestational age (GA) and brain lesions. Design, Setting, and Participants: EPIPAGE is a longitudinal population-based cohort study of children born before 33 weeks' gestation (WG) in 9 French regions in 1997-1998. Cumulating data from all follow up stages, neurodevelopmental outcomes were available for 90% of the 2480 VPT survivors at 8 years. Main outcomes were association of motor and cognitive deficiencies and existence of at least one deficiency (motor, cognitive, behavioral/ psychiatric, epileptic, visual, and/or hearing deficiencies) in three GA groups (24-26, 27-28, and 29-32WG) and four groups of brain lesions (none, minor, moderate, or severe). Results: VPT had high rates of motor (14%) and cognitive (31%) deficiencies. Only 6% had an isolated motor deficiency, 23% an isolated cognitive one and 8% both types. This rate reached 20% among extremely preterm. Psychiatric disorders and epilepsy were observed in 6% and 2% of children, respectively. The risks of at least one severe or moderate deficiency were 11 and 29%. These risks increased as GA decreased; only 36% of children born extremely preterm had no reported deficiency. Among children with major white matter injury (WMI), deficiency rates reached 71% at 24-26WG, 88% at 2728WG, and 80% at 29-32WG; more than 40% had associated motor and cognitive deficiencies. By contrast, isolated cognitive deficiency was the most frequent problem among children without major lesions. Conclusions: In VPT, the lower the GA, the higher the neurodisability rate. Cerebral palsy is common. Impaired cognitive development is more frequent. Its occurrence in case without WMI or early motor disorders makes long-term follow up necessary. The strong association between motor impairments, when they exist, and later cognitive dysfunction supports the hypothesis of a common origin of these difficulties.	[Marret, Stephane] Univ Rouen, Rouen Univ Hosp, Dept Neonatal Med, Rouen, France; [Marret, Stephane] Univ Rouen, Inst Biomed Res & Innovat, Reg INSERM Team, ERI 28,NeoVasc, Rouen, France; [Marchand-Martin, Laetitia; Larroque, Beatrice; Kaminski, Monique; Ancei, Pierre-Yves] Hop Tenon, INSERM, UMR S953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Paris, France; [Marchand-Martin, Laetitia; Larroque, Beatrice; Kaminski, Monique; Ancei, Pierre-Yves] Univ Paris 06, UMR S 953, Paris, France; [Picaud, Jean-Charles] Hosp Civils, Hop Croix Rousse, Dept Neonatal, Lyon, France; [Hascoet, Jean-Michel] Neonatal Dept, Nancy, France; [Arnaud, Catherine] Univ Toulouse 3, INSERM, UMR U558, Res Unit Perinatal Epidemiol Child Hlth & Dev, F-31062 Toulouse, France; [Truffert, Patrick] Hop Jeanne de Flandres, Dept Neonatal Med, Lille, France; [Roze, Jean-Christophe] Nantes Univ Hosp, Dept Neonatal Med, Nantes, France	CHU de Rouen; Universite de Rouen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Lille - ISITE; CHU Lille; Nantes Universite; CHU de Nantes	Marret, S (corresponding author), Univ Rouen, Rouen Univ Hosp, Dept Neonatal Med, Rouen, France.	stephane.marret@chu-rouen.fr	Blondel, Beatrice/G-5011-2017; Rozé, Jean-Christophe/AAS-1314-2021; EGO, Anne/G-7071-2011; ARNAUD, Catherine/AAC-5646-2019	EGO, Anne/0000-0002-1025-910X; ARNAUD, Catherine/0000-0002-4002-802X; Roze, Jean-Christophe/0000-0003-3367-512X; burguet, antoine/0000-0001-5140-2884; breart, gerard/0000-0003-3142-9128; ANCEL, pierre-yves/0000-0001-9632-7494; Marret, Stephane/0000-0002-2858-148X; Marchand-Martin, Laetitia/0000-0002-8036-8387; CAMBONIE, GILLES/0000-0002-1360-7915; pierrat, veronique/0000-0001-7435-5144	INSERM (National Institute of Health and Medical Research); Directorate General for Health at the Ministry for Social Affairs, Merck-Sharp and Dohme-Chibret; Medical Research Foundation; "Hospital Program for Clinical Research" of the French Ministry of Health [AOM01117, 2004/054/HP]; Wyeth Foundation for Children and Adolescents; FEDER "European Funds for Regional Development" of Haute-Normandie; Merck-Sharp; Dohme-Chibret	INSERM (National Institute of Health and Medical Research)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Directorate General for Health at the Ministry for Social Affairs, Merck-Sharp and Dohme-Chibret; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); "Hospital Program for Clinical Research" of the French Ministry of Health; Wyeth Foundation for Children and Adolescents; FEDER "European Funds for Regional Development" of Haute-Normandie; Merck-Sharp(Merck & Company); Dohme-Chibret	The EPIPAGE study was supprted by grants from INSERM (National Institute of Health and Medical Research), the Directorate General for Health at the Ministry for Social Affairs, Merck-Sharp and Dohme-Chibret, the Medical Research Foundation, and "Hospital Program for Clinical Research 2001 noAOM01117" of the French Ministry of Health. The 8-year follow-up was supported by the "Hospital Program for Clinical Research 2004/054/HP" of the French Ministry of Health, the Wyeth Foundation for Children and Adolescents, and the FEDER "European Funds for Regional Development" of Haute-Normandie 2010-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In particular, the commercial funder (Merck-Sharp and Dohme-Chibret) does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ancel PY, 2006, PEDIATRICS, V117, P828, DOI 10.1542/peds.2005-0091; Arnaud C, 2007, ARCH PEDIAT ADOL MED, V161, P1053, DOI 10.1001/archpedi.161.11.1053; Ball G, 2012, CEREB CORTEX, V22, P1016, DOI 10.1093/cercor/bhr176; Beaino G, 2011, ACTA PAEDIATR, V100, P370, DOI 10.1111/j.1651-2227.2010.02064.x; Beiano G, 2010, DEV MED CHILD NEUROL, V52, pe119; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Blakemore SJ, 2010, NEURON, V65, P744, DOI 10.1016/j.neuron.2010.03.004; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; De Vries LS, 2004, J PEDIATR-US, V144, P815, DOI 10.1016/j.jpeds.2004.03.034; Doyle LW, 2009, OBSTET GYNECOL, V113, P1327, DOI 10.1097/AOG.0b013e3181a60495; Foix-L'Helias L, 2008, BJOG-INT J OBSTET GY, V115, P275, DOI 10.1111/j.1471-0528.2007.01566.x; Gozzo Y, 2009, NEUROIMAGE, V48, P458, DOI 10.1016/j.neuroimage.2009.06.046; Himmelmann K, 2010, ACTA PAEDIATR, V99, P1337, DOI 10.1111/j.1651-2227.2010.01819.x; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Johnson S, 2011, PEDIATR RES, V69, p11R, DOI 10.1203/PDR.0b013e318212faa0; KAUFMANN AS, 1983, KAUFMANN ASSESSMENT; Kuban KCK, 2009, J CHILD NEUROL, V24, P63, DOI [10.1177/0883073808121048, 10.1177/0883073808321048]; Langen M, 2012, CORTEX, V48, P183, DOI 10.1016/j.cortex.2011.05.018; Larroque B, 2003, J PEDIATR-US, V143, P477, DOI 10.1067/S0022-3476(03)00417-7; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Larroque B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021361; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Peterson BS, 2002, PEDIATRICS, V110, P1153, DOI 10.1542/peds.110.6.1153; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Schipul SE, 2012, CEREB CORTEX, V22, P937, DOI 10.1093/cercor/bhr162; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; van Haastert IC, 2011, J PEDIATR-US, V159, P86, DOI 10.1016/j.jpeds.2010.12.053; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Weisglas-Kuperus N, 2009, ARCH DIS CHILD-FETAL, V94, pF196, DOI 10.1136/adc.2007.135095; Wolke D, 1999, DEV MED CHILD NEUROL, V41, P94, DOI 10.1017/S0012162299000201	32	99	104	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62683	10.1371/journal.pone.0062683	http://dx.doi.org/10.1371/journal.pone.0062683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658763	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500033
J	Van Daele, CM; De Meyer, T; De Buyzere, ML; Gillebert, TC; Denil, SLIJ; Bekaert, S; Chirinos, JA; Segers, P; De Backer, GG; De Bacquer, D; Rietzschel, ER				Van Daele, Caroline M.; De Meyer, Tim; De Buyzere, Marc L.; Gillebert, Thierry C.; Denil, Simon L. I. J.; Bekaert, Sofie; Chirinos, Julio A.; Segers, Patrick; De Backer, Guy G.; De Bacquer, Dirk; Rietzschel, Ernst R.		Asklepios Investigators	Addition of a Novel, Protective Family History Category Allows Better Profiling of Cardiovascular Risk and Atherosclerotic Burden in the General Population. The Asklepios Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MIDDLE-AGED ADULTS; LOW-DENSITY-LIPOPROTEIN; INTIMA-MEDIA THICKNESS; MYOCARDIAL-INFARCTION; PARENTAL-HISTORY; STROKE; HEALTH; STATEMENT; MEDICINE	Objectives: Whereas the importance of family history (FH) is widely recognized in cardiovascular risk assessment, its full potential could be underutilized, when applied with its current simple guidelines-based definition (cFH): presence of premature cardiovascular disease (CVD) in a first-degree relative. We tested the added value of a new, extended family history definition (eFH), also taking into account later onset of disease, second-degree relatives and number of affected relatives, on profiling cardiovascular risk and atherosclerotic burden in the general population. Design: longitudinal population study. Setting: random, representative population sample from Erpe-Mere and Nieuwerkerken (Belgium, primary care). Subjects: 2524 male/female volunteers, aged 35-55 years, free from overt CVD. Main outcome measures: Subjects were extensively phenotyped including presence of atherosclerosis (ultrasound) and a newly developed FH questionnaire (4 generations). Results: Compared to cFH, eFH was superior in predicting an adverse risk profile (glycemic state, elevated blood pressure, lipid abnormalities, presence of metabolic syndrome components) and presence of atherosclerosis (all age & sex-adjusted p<0.05). Unlike cFH, eFH remained a significant predictor of subclinical atherosclerosis after adjusting for confounders. Most relations with eFH were not graded but showed clear informational breakpoints, with absence of CVD (including late onset) in any first-degree relative being a negative predictor of atherosclerosis, and a particularly interesting phenotype for further study. Conclusions: A novel, extended FH definition is superior to the conventional definition in profiling cardiovascular risk and atherosclerotic burden in the general population. There remain clear opportunities to refine and increase the performance and informational content of this simple, readily-available inexpensive tool.	[Van Daele, Caroline M.; De Buyzere, Marc L.; Gillebert, Thierry C.; Rietzschel, Ernst R.] Ghent Univ Hosp, Dept Cardiovasc Dis, Ghent, Belgium; [De Meyer, Tim; Denil, Simon L. I. J.] Univ Ghent, Fac Biosci Engn, Dept Math Modelling Stat & Bioinformat, B-9000 Ghent, Belgium; [Bekaert, Sofie] Ghent Univ Hosp, Clin Res Ctr Ghent, Bimetra, Ghent, Belgium; [Chirinos, Julio A.] Philadelphia VA Med Ctr, Philadelphia, PA USA; [Chirinos, Julio A.] Univ Penn, Philadelphia, PA 19104 USA; [Segers, Patrick] Univ Ghent, Inst Biomed Technol IbiTech, B-9000 Ghent, Belgium; [De Backer, Guy G.; De Bacquer, Dirk; Rietzschel, Ernst R.] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University Hospital; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Ghent University; Ghent University	Van Daele, CM (corresponding author), Ghent Univ Hosp, Dept Cardiovasc Dis, Ghent, Belgium.	Caroline.Vandaele@UGent.be	De Bacquer, Dirk/HGU-3191-2022; De Backer, Guy/AAI-4607-2021; Gillebert, Thierry C/F-5551-2014; Segers, Patrick/AAA-7844-2020; De Meyer, Tim/D-3892-2011	Gillebert, Thierry C/0000-0002-3832-919X; Segers, Patrick/0000-0003-3870-3409; De Meyer, Tim/0000-0003-2994-9693; De Bacquer, Dirk/0000-0002-3202-7238	Fund for Scientific Research - Flanders (FWO) [G042703, G083810N]	Fund for Scientific Research - Flanders (FWO)(FWO)	The Asklepios Study is supported by the Fund for Scientific Research - Flanders (FWO research grants G042703 and G083810N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresdottir MB, 2002, EUR HEART J, V23, P1655, DOI 10.1053/euhj.2002.3235; Assimes TL, 2011, J AM COLL CARDIOL, V57, P628, DOI 10.1016/j.jacc.2010.09.036; Banerjee A, 2012, INT J CLIN PRACT, V66, P536, DOI 10.1111/j.1742-1241.2012.02908.x; BARRETTCONNOR E, 1984, CIRCULATION, V69, P1065, DOI 10.1161/01.CIR.69.6.1065; Bensen JT, 1999, GENET EPIDEMIOL, V17, P141, DOI 10.1002/(SICI)1098-2272(1999)17:2<141::AID-GEPI4>3.0.CO;2-Q; Berg AO, 2012, ANN INTERN MED, V156, P315, DOI 10.7326/0003-4819-156-4-201202210-00012; Berg AO, 2009, ANN INTERN MED, V151, P872, DOI [10.7326/0000605-200912150-00165, 10.7326/0003-4819-151-12-200912150-00165]; Chow CK, 2011, J AM COLL CARDIOL, V57, P619, DOI 10.1016/j.jacc.2010.07.054; de Giorgis T, 2009, J HYPERTENS, V27, P822, DOI 10.1097/HJH.0b013e328325d81b; De Meyer T, 2012, ARTERIOSCL THROM VAS, V32, P3076, DOI 10.1161/ATVBAHA.112.300341; DEBACKER G, 1986, AM HEART J, V112, P478, DOI 10.1016/0002-8703(86)90510-7; Elis A, 2008, EUR J CARDIOV PREV R, V15, P325, DOI 10.1097/HJR.0b013e3282f50ed8; Ford ES, 2005, AM J PREV MED, V29, P57, DOI 10.1016/j.amepre.2005.07.018; Frezzo TM, 2003, GENET MED, V5, P84, DOI 10.1097/01.GIM.0000055197.23822.5E; Friedlander Y, 2001, ATHEROSCLEROSIS, V156, P201, DOI 10.1016/S0021-9150(00)00635-3; Gabioud A, 2012, INT J CARDI IN PRESS; Gaeta G, 2000, NEW ENGL J MED, V343, P840, DOI 10.1056/NEJM200009213431203; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hamer M, 2009, J HYPERTENS, V27, P1966, DOI 10.1097/HJH.0b013e32832f0d6f; HELLER RF, 1983, J EPIDEMIOL COMMUN H, V37, P29, DOI 10.1136/jech.37.1.29; Kinra S, 2003, HEART, V89, P834, DOI 10.1136/heart.89.8.834; Kip KE, 2002, AM J PREV MED, V22, P258, DOI 10.1016/S0749-3797(02)00416-6; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; Langlois MR, 2008, ARTERIOSCL THROM VAS, V28, P1563, DOI 10.1161/ATVBAHA.108.167346; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Mills JD, 2002, ARTERIOSCL THROM VAS, V22, P704, DOI 10.1161/hq0402.105902; Murabito JM, 2005, JAMA-J AM MED ASSOC, V294, P3117, DOI 10.1001/jama.294.24.3117; Nasir K, 2004, CIRCULATION, V110, P2150, DOI 10.1161/01.CIR.0000144464.11080.14; Pankow JS, 1997, THROMB HAEMOSTASIS, V77, P87; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Qureshi N, 2012, ANN INTERN MED, V156, P253, DOI 10.7326/0003-4819-156-4-201202210-00002; Rietzschel ER, 2008, HYPERTENSION, V52, P535, DOI 10.1161/HYPERTENSIONAHA.108.114439; Rietzschel ER, 2007, EUR J CARDIOV PREV R, V14, P179, DOI 10.1097/HJR.0b013e328012c380; Scheuner MT, 2006, GENET MED, V8, P491, DOI 10.1097/01.gim.0000232582.91028.03; Scheuner MT, 2006, GENET MED, V8, P525, DOI 10.1097/01.gim.0000232480.00293.00; Scheuner MT, 2008, GENET MED, V10, P879, DOI 10.1097/GIM.0b013e31818e639b; Scheuner MT, 1997, AM J MED GENET, V71, P315, DOI 10.1002/(SICI)1096-8628(19970822)71:3<315::AID-AJMG12>3.0.CO;2-N; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; Silberberg J, 1999, GENET EPIDEMIOL, V16, P344, DOI 10.1002/(SICI)1098-2272(1999)16:4<344::AID-GEPI2>3.0.CO;2-Q; Silberberg JS, 1998, AM J EPIDEMIOL, V147, P1123; Silberberg JS, 1998, AM J EPIDEMIOL, V147, P1133; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; Vermeersch SJ, 2007, J HUM HYPERTENS, V21, P976, DOI 10.1038/sj.jhh.1002251; Viera AJ, 2005, FAM MED, V37, P360; Waters D, 2010, CARDIOLOGY; Williams RR, 2001, AM J CARDIOL, V87, P129, DOI 10.1016/S0002-9149(00)01303-5; Wilson BJ, 2009, ANN INTERN MED, V151, P878, DOI [10.7326/0000605-200912150-00177, 10.7326/0003-4819-151-12-200912150-00177]; Wong LSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023118; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	52	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63185	10.1371/journal.pone.0063185	http://dx.doi.org/10.1371/journal.pone.0063185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658806	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500058
J	Fischer, M; Grundke, I; Sohr, S; Quaas, M; Hoffmann, S; Knorck, A; Gumhold, C; Rother, K				Fischer, Martin; Grundke, Inga; Sohr, Sindy; Quaas, Marianne; Hoffmann, Saskia; Knoerck, Arne; Gumhold, Catalina; Rother, Karen			p53 and Cell Cycle Dependent Transcription of kinesin family member 23 (KIF23) Is Controlled Via a CHR Promoter Element Bound by DREAM and MMB Complexes	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P53; DNA-DAMAGE; B-MYB; REPRESS TRANSCRIPTION; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; P53-REGULATED GENES; G(2)/M GENES; PROTEIN; BINDING	The microtubule-dependent molecular motor KIF23 (Kinesin family member 23) is one of two components of the centralspindlin complex assembled during late stages of mitosis. Formation of this complex is known as an essential step for cytokinesis. Here, we identified KIF23 as a new transcriptional target gene of the tumor suppressor protein p53. We showed that p53 reduces expression of KIF23 on the mRNA as well as the protein level in different cell types. Promoter reporter assays revealed that this repression results from downregulation of KIF23 promoter activity. CDK inhibitor p21(WAF1/CIP1) was shown to be necessary to mediate p53-dependent repression. Furthermore, we identified the highly conserved cell cycle genes homology region (CHR) in the KIF23 promoter to be strictly required for p53-dependent repression as well as for cell cycle-dependent expression of KIF23. Cell cycle-and p53-dependent regulation of KIF23 appeared to be controlled by differential binding of DREAM and MMB complexes to the CHR element. With this study, we describe a new mechanism for transcriptional regulation of KIF23. Considering the strongly supporting function of KIF23 in cytokinesis, its p53-dependent repression may contribute to the prevention of uncontrolled cell growth.	[Fischer, Martin; Grundke, Inga; Sohr, Sindy; Quaas, Marianne; Hoffmann, Saskia] Univ Leipzig, Sch Med, D-04109 Leipzig, Germany; [Knoerck, Arne; Gumhold, Catalina; Rother, Karen] Univ Saarland, Med Ctr, Ctr Human & Mol Biol, Dept Med Biochem & Mol Biol, Homburg, Germany	Leipzig University; Saarland University	Rother, K (corresponding author), Univ Saarland, Med Ctr, Ctr Human & Mol Biol, Dept Med Biochem & Mol Biol, Homburg, Germany.	karen.rother@uks.eu	Fischer, Martin/I-4825-2014; Rother, Karen/GQI-3786-2022	Fischer, Martin/0000-0002-3429-1876; Quaas, Marianne/0000-0002-2781-1968; Hoffmann, Saskia/0000-0003-4835-0504	Freistaat Sachsen; Medical School at the University of Leipzig; Fonds der Chemische Industrie; Forschungsausschuss of the Saarland University	Freistaat Sachsen; Medical School at the University of Leipzig; Fonds der Chemische Industrie; Forschungsausschuss of the Saarland University	MQ is recipient of graduate fellowship awarded by the Freistaat Sachsen, SS was supported by a junior research grant and IG was the recipient of thesis support grant awarded by the Medical School at the University of Leipzig. This work was supported by grants from the Fonds der Chemische Industrie and the Forschungsausschuss of the Saarland University (to KR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Barboza JA, 2006, P NATL ACAD SCI USA, V103, P19842, DOI 10.1073/pnas.0606343104; Bashir T, 2005, NAT CELL BIOL, V7, P779, DOI 10.1038/ncb0805-779; Basile V, 2006, J BIOL CHEM, V281, P2347, DOI 10.1074/jbc.M507712200; Bohlig L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464916; Bohlig L, 2011, NUCLEIC ACIDS RES, V39, P440, DOI 10.1093/nar/gkq796; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Calvisi DF, 2011, HEPATOLOGY, V53, P1226, DOI 10.1002/hep.24174; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Esteve PO, 2005, P NATL ACAD SCI USA, V102, P1000, DOI 10.1073/pnas.0407729102; Fukasawa K, 2008, BBA-REV CANCER, V1786, P15, DOI 10.1016/j.bbcan.2008.04.002; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Helmbold H, 2009, ONCOGENE, V28, P3456, DOI 10.1038/onc.2009.222; Hutterer A, 2009, CURR BIOL, V19, P2043, DOI 10.1016/j.cub.2009.10.050; Imbriano C, 2012, BBA-REV CANCER, V1825, P131, DOI 10.1016/j.bbcan.2011.11.001; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; KASTAN MB, 1991, CANCER RES, V51, P6304; Knight AS, 2009, ONCOGENE, V28, P1737, DOI 10.1038/onc.2009.22; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; Kuriyama R, 2002, J CELL BIOL, V156, P783, DOI 10.1083/jcb.200109090; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Maeda Y, 2006, BIOCHEM J, V400, P303, DOI 10.1042/BJ20060614; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mannefeld M, 2009, CANCER RES, V69, P4073, DOI 10.1158/0008-5472.CAN-08-4156; Muller GA, 2012, NUCLEIC ACIDS RES, V40, P1561, DOI 10.1093/nar/gkr793; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Mukhina S, 2007, DEV CELL, V13, P554, DOI 10.1016/j.devcel.2007.08.003; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Pavicic-Kaltenbrunner V, 2007, MOL BIOL CELL, V18, P4992, DOI 10.1091/mbc.E07-05-0468; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Pietrzak M, 2008, BIOL CHEM, V389, P383, DOI 10.1515/BC.2008.039; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Quaas M, 2012, CELL CYCLE, V11, P4661, DOI 10.4161/cc.22917; Reichert N, 2010, MOL CELL BIOL, V30, P2896, DOI 10.1128/MCB.00028-10; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Saville MK, 1998, ONCOGENE, V17, P2679, DOI 10.1038/sj.onc.1202503; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Schuldt A, 2010, NAT REV MOL CELL BIO, V11, P602, DOI 10.1038/nrm2965; Scian MJ, 2008, ONCOGENE, V27, P2583, DOI 10.1038/sj.onc.1210898; Seguin L, 2009, MOL CELL BIOL, V29, P570, DOI 10.1128/MCB.01275-08; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Sohr S, 2008, CELL CYCLE, V7, P3448, DOI 10.4161/cc.7.21.7014; Sohr S, 2011, CELL CYCLE, V10, P3758, DOI 10.4161/cc.10.21.17946; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Takahashi S, 2012, J NEURO-ONCOL, V106, P519, DOI 10.1007/s11060-011-0706-2; Tavner F, 2007, ONCOGENE, V26, P2727, DOI 10.1038/sj.onc.1210087; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Valk K, 2010, ONCOLOGY-BASEL, V79, P283, DOI 10.1159/000322116; van Bodegom D, 2010, BBA-GENE REGUL MECH, V1799, P502, DOI 10.1016/j.bbagrm.2010.04.001; Wang SM, 2011, CLIN CANCER RES, V17, P6040, DOI 10.1158/1078-0432.CCR-11-0557; Wasner M, 2003, GENE, V312, P225, DOI 10.1016/S0378-1119(03)00618-8; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517	64	35	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63187	10.1371/journal.pone.0063187	http://dx.doi.org/10.1371/journal.pone.0063187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650552	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000319167000097
J	Maguire, SE; Schmidt, MF; White, DJ				Maguire, Sarah E.; Schmidt, Marc F.; White, David J.			Social Brains in Context: Lesions Targeted to the Song Control System in Female Cowbirds Affect Their Social Network	PLOS ONE			English	Article							BROWN-HEADED COWBIRDS; MALE COMPETITION; SERINUS-CANARIA; HVC; PERCEPTION; SIGNALS; SELECTIVITY; MECHANISMS; RESPONSES; DISPLAYS	Social experiences can organize physiological, neural, and reproductive function, but there are few experimental preparations that allow one to study the effect individuals have in structuring their social environment. We examined the connections between mechanisms underlying individual behavior and social dynamics in flocks of brown-headed cowbirds (Molothrus ater). We conducted targeted inactivations of the neural song control system in female subjects. Playback tests revealed that the lesions affected females' song preferences: lesioned females were no longer selective for high quality conspecific song. Instead, they reacted to all cowbird songs vigorously. When lesioned females were introduced into mixed-sex captive flocks, they were less likely to form strong pair-bonds, and they no longer showed preferences for dominant males. This in turn created a cascade of effects through the groups. Social network analyses showed that the introduction of the lesioned females created instabilities in the social structure: males in the groups changed their dominance status and their courtship patterns, and even the competitive behavior of other female group-mates was affected. These results reveal that inactivation of the song control system in female cowbirds not only affects individual behavior, but also exerts widespread effects on the stability of the entire social system.	[Maguire, Sarah E.; Schmidt, Marc F.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Maguire, Sarah E.; Schmidt, Marc F.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [White, David J.] Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada	University of Pennsylvania; University of Pennsylvania; Wilfrid Laurier University	White, DJ (corresponding author), Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada.	dwhite@wlu.ca	Schmidt, Marc/B-1597-2008		National Science Foundation (NSF) [1021801]; National Institutes of Health (NIH) [DC006102]; NSF IGERT Traineeship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006102] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF IGERT Traineeship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Work was supported by National Science Foundation (NSF) 1021801 (DJW), National Institutes of Health (NIH) DC006102 (MFS) and an NSF IGERT Traineeship (SEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andalman AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025461; BRENOWITZ EA, 1991, SCIENCE, V251, P303, DOI 10.1126/science.1987645; Burt JM, 2000, J NEUROBIOL, V42, P1, DOI 10.1002/(SICI)1097-4695(200001)42:1<1::AID-NEU1>3.0.CO;2-6; Cardin JA, 2005, J NEUROPHYSIOL, V93, P2157, DOI 10.1152/jn.01001.2004; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Cooper BG, 2004, SCIENCE, V303, P544, DOI 10.1126/science.1091099; COX CR, 1977, AM NAT, V111, P317, DOI 10.1086/283163; Del Negro C, 1998, BEHAV BRAIN RES, V96, P151, DOI 10.1016/S0166-4328(98)00009-6; Del Negro C, 2000, BEHAV NEUROSCI, V114, P526; DUFTY AM, 1986, BEHAV ECOL SOCIOBIOL, V19, P49, DOI 10.1007/BF00303842; Freed-Brown SG, 2006, BEHAVIOUR, V143, P1293, DOI 10.1163/156853906778987533; Gersick AS, 2012, ANIM BEHAV, V83, P1171, DOI 10.1016/j.anbehav.2012.02.005; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Halle F, 2002, J NEUROBIOL, V52, P1, DOI 10.1002/neu.10058; King AP, 2003, ANIM BEHAV, V66, P817, DOI 10.1006/anbe.2003.2280; KING AP, 1986, ETHOLOGY, V72, P89; KING AP, 1983, Z TIERPSYCHOL, V63, P37; Knudsen DP, 2010, BRAIN LANG, V115, P59, DOI 10.1016/j.bandl.2009.09.008; Leitner S, 2002, J NEUROBIOL, V52, P294, DOI 10.1002/neu.10085; Mendez JM, 2012, J NEUROPHYSIOL, V107, P2971, DOI 10.1152/jn.00646.2011; Miller JL, 2008, ANIM BEHAV, V76, P931, DOI 10.1016/j.anbehav.2008.05.011; Mooney R, 2009, LEARN MEMORY, V16, P655, DOI 10.1101/lm.1065209; Riters LV, 2003, BRAIN RES, V978, P91, DOI 10.1016/S0006-8993(03)02771-9; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Smith VA, 2000, ANIM BEHAV, V60, P599, DOI 10.1006/anbe.2000.1531; Snowdon C.T., 1997, SOCIAL INFLUENCES VO, DOI [10.1017/CBO9780511758843, DOI 10.1017/CBO9780511758843]; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; WATSON PJ, 1990, BEHAV ECOL SOCIOBIOL, V26, P77; WEST MJ, 1985, Z TIERPSYCHOL, V70, P225; WEST MJ, 1988, NATURE, V334, P244, DOI 10.1038/334244a0; White DJ, 2010, BEHAV ECOL, V21, P211, DOI 10.1093/beheco/arp178; White DJ, 2010, ANIM BEHAV, V79, P385, DOI 10.1016/j.anbehav.2009.11.014; Woolley SMN, 2010, DEV NEUROBIOL, V70, P235, DOI 10.1002/dneu.20783	34	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63239	10.1371/journal.pone.0063239	http://dx.doi.org/10.1371/journal.pone.0063239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650558	Green Submitted, Green Published, gold			2022-12-25	WOS:000319167000103
J	Maier, C; Schubert, A; Sanchez, MMB; Weinbauer, MG; Watremez, P; Gattuso, JP				Maier, Cornelia; Schubert, Alexander; Sanchez, Maria M. Berzunza; Weinbauer, Markus G.; Watremez, Pierre; Gattuso, Jean-Pierre			End of the Century pCO(2) Levels Do Not Impact Calcification in Mediterranean Cold-Water Corals	PLOS ONE			English	Article							OCEAN ACIDIFICATION; LOPHELIA-PERTUSA; REEFS; DEEP; GROWTH; CARBON; SEA; RATES; CO2; PHOTOSYNTHESIS	Ocean acidification caused by anthropogenic uptake of CO2 is perceived to be a major threat to calcifying organisms. Cold-water corals were thought to be strongly affected by a decrease in ocean pH due to their abundance in deep and cold waters which, in contrast to tropical coral reef waters, will soon become corrosive to calcium carbonate. Calcification rates of two Mediterranean cold-water coral species, Lophelia pertusa and Madrepora oculata, were measured under variable partial pressure of CO2 (pCO(2)) that ranged between 380 mu atm for present-day conditions and 930 matm for the end of the century. The present study addressed both short- and long-term responses by repeatedly determining calcification rates on the same specimens over a period of 9 months. Besides studying the direct, short-term response to elevated pCO(2) levels, the study aimed to elucidate the potential for acclimation of calcification of cold-water corals to ocean acidification. Net calcification of both species was unaffected by the levels of pCO(2) investigated and revealed no short-term shock and, therefore, no long-term acclimation in calcification to changes in the carbonate chemistry. There was an effect of time during repeated experiments with increasing net calcification rates for both species, however, as this pattern was found in all treatments, there is no indication that acclimation of calcification to ocean acidification occurred. The use of controls (initial and ambient net calcification rates) indicated that this increase was not caused by acclimation in calcification response to higher pCO(2). An extrapolation of these data suggests that calcification of these two cold-water corals will not be affected by the pCO(2) level projected at the end of the century.	[Maier, Cornelia; Schubert, Alexander; Sanchez, Maria M. Berzunza; Weinbauer, Markus G.; Gattuso, Jean-Pierre] CNRS, Inst Natl Sci Univers, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Maier, Cornelia; Schubert, Alexander; Sanchez, Maria M. Berzunza; Weinbauer, Markus G.; Gattuso, Jean-Pierre] Univ Paris 06, Observ Oceanol Villefranche, Villefranche Sur Mer, France; [Watremez, Pierre] Agence Aires Marines Protegees, Brest, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Maier, C (corresponding author), CNRS, Inst Natl Sci Univers, Lab Oceanog Villefranche, Villefranche Sur Mer, France.	maier.conny@gmail.com	Gattuso, Jean-Pierre/AAG-8643-2019; Gattuso, Jean-Pierre/E-6631-2010; Weinbauer, Markus/ABC-7017-2020	Gattuso, Jean-Pierre/0000-0002-4533-4114; Gattuso, Jean-Pierre/0000-0002-4533-4114; Weinbauer, Markus/0000-0002-7697-5571; Maier, Cornelia/0000-0002-2162-0677	European Commission through a Marie-Curie Fellowship [220299]; project COMP via the Prince Albert II of Monaco Foundation; German Academic Exchange Service (DAAD); European Community's Seventh Framework Programme FP7 [211384]	European Commission through a Marie-Curie Fellowship; project COMP via the Prince Albert II of Monaco Foundation; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); European Community's Seventh Framework Programme FP7(European Commission)	Financial support was provided by the European Commission through a Marie-Curie Fellowship to CM (MECCA, project no 220299) and the project COMP via the Prince Albert II of Monaco Foundation, the German Academic Exchange Service (DAAD). This work is a contribution to the 'European Project on Ocean Acidification' (EPOCA) which received funding from the European Community's Seventh Framework Programme FP7/2007-2013) under grant agreement no. 211384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R., 2011, J MAR BIOL, V2011, P1, DOI [10.1155/2011/473615, DOI 10.1155/2011/473615]; CHISHOLM JRM, 1991, LIMNOL OCEANOGR, V36, P1232, DOI 10.4319/lo.1991.36.6.1232; DAVIES PS, 1989, MAR BIOL, V101, P389; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabry VJ, 2008, SCIENCE, V320, P1020, DOI 10.1126/science.1157130; Fiorini S, 2011, J PHYCOL, V47, P1281, DOI 10.1111/j.1529-8817.2011.01080.x; Form AU, 2012, GLOBAL CHANGE BIOL, V18, P843, DOI 10.1111/j.1365-2486.2011.02583.x; Freiwald A, 2009, OCEANOGRAPHY, V22, P58, DOI 10.5670/oceanog.2009.06; Gagnon AC, 2012, EARTH PLANET SC LETT, V329, P150, DOI 10.1016/j.epsl.2012.03.005; Gattuso JP, 1999, AM ZOOL, V39, P160; Gattuso JP, 1999, P NATL ACAD SCI USA, V96, P13017, DOI 10.1073/pnas.96.23.13017; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Kleypas JA, 2001, INT J EARTH SCI, V90, P426, DOI 10.1007/s005310000125; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Lavigne H., 2011, SEACARB SEAWATER CAR; Maier C, 2012, P ROY SOC B-BIOL SCI, V279, P1716, DOI 10.1098/rspb.2011.1763; Maier C, 2011, BIOGEOSCIENCES, V8, P2609, DOI 10.5194/bg-8-2609-2011; Maier C, 2009, BIOGEOSCIENCES, V6, P1671, DOI 10.5194/bg-6-1671-2009; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; McCulloch M, 2012, GEOCHIM COSMOCHIM AC, V87, P21, DOI 10.1016/j.gca.2012.03.027; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Orejas C, 2008, CORAL REEFS, V27, P255, DOI 10.1007/s00338-007-0350-7; Orejas C, 2011, MAR ECOL PROG SER, V429, P57, DOI 10.3354/meps09104; Orr J.C., 2011, OCEAN ACIDIFICATION, V1, P41; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Plattner GK, 2001, TELLUS B, V53, P564, DOI 10.1034/j.1600-0889.2001.530504.x; Reynaud S, 2007, GEOCHIM COSMOCHIM AC, V71, P354, DOI 10.1016/j.gca.2006.09.009; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Ries JB, 2010, CORAL REEFS, V29, P661, DOI 10.1007/s00338-010-0632-3; Ries JB, 2009, GEOLOGY, V37; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rodolfo-Metalpa R, 2010, BIOGEOSCIENCES, V7, P289, DOI 10.5194/bg-7-289-2010; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Taviani M, 2005, ERLANGEN EARTH C SER, P137, DOI 10.1007/3-540-27673-4_7; Thresher RE, 2011, MAR ECOL PROG SER, V442, P87, DOI 10.3354/meps09400; Touratier F, 2011, DEEP-SEA RES PT I, V58, P1, DOI 10.1016/j.dsr.2010.10.002; Wolf-Gladrow DA, 2007, MAR CHEM, V106, P287, DOI 10.1016/j.marchem.2007.01.006; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343	47	44	44	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62655	10.1371/journal.pone.0062655	http://dx.doi.org/10.1371/journal.pone.0062655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646133	gold, Green Submitted, Green Published			2022-12-25	WOS:000319077300085
J	Thiem, U; Lamsfuss, R; Gunther, S; Schumacher, J; Baker, C; Endres, HG; Zacher, J; Burmester, GR; Pientka, L				Thiem, Ulrich; Lamsfuss, Rainer; Guenther, Sven; Schumacher, Jochen; Baeker, Christian; Endres, Heinz G.; Zacher, Josef; Burmester, Gerd R.; Pientka, Ludger			Prevalence of Self-Reported Pain, Joint Complaints and Knee or Hip Complaints in Adults Aged >= 40 Years: A Cross- Sectional Survey in Herne, Germany	PLOS ONE			English	Article							UNIVERSITY OSTEOARTHRITIS INDEX; GIESSENER BESCHWERDEBOGEN GBB; WESTERN-ONTARIO-UNIVERSITY; HEALTH-STATUS; OLDER-ADULTS; POPULATION REQUIREMENT; MUSCULOSKELETAL PAIN; REPLACEMENT SURGERY; DISABILITY; PEOPLE	Background: Pain and musculoskeletal complaints are among the most common symptoms in the general population. Despite their epidemiological, clinical and health economic importance, prevalence data on pain and musculoskeletal complaints for Germany are scarce. Methods: A cross-sectional survey of a random sample of citizens of Herne, Germany, aged >= 40 years was performed. A detailed self-complete postal questionnaire was used, followed by a short reminder questionnaire and telephone contacts for those not responding. The questionnaire contained 66 items, mainly addressing pain of any site, musculoskeletal complaints of any site and of knee and hip, pain intensities, the Western Ontario MacMaster Universities (WOMAC) index, medication, health care utilization, comorbidities, and quality of life. Results: The response rate was 57.8% (4,527 of 7,828 individuals). Survey participants were on average 1.3 years older, and the proportion of women among responders tended to be greater than in the population sample. There was no age difference between the population sample and 2,221 participants filling out the detailed questionnaire. The following standardized prevalences were assessed: current pain: 59.7%, pain within the past four weeks: 74.5%, current joint complaints: 49.3%, joint complaints within the past four weeks and twelve month: 62.8% and 67.4%, respectively, knee as the site predominantly affected: 30.9%, knee bilateral: 9.7%, hip: 15.2%, hip bilateral: 3.5%, knee and hip: 5.5%. Pain and musculoskeletal complaints were significantly more often reported by women. A typical relationship of pain and joint complaints to age could be found, i.e. increasing prevalences with increasing age categories, with a drop in the highest age groups. In general, pain and joint pain were associated with comorbidity and body mass index as well as quality of life. Conclusions: Our data confirm findings of other recent national as well as European surveys. The high site specific prevalences of knee and hip complaints underline the necessity to further investigate characteristics and consequences of pain and symptomatic osteoarthritis of these joints in adults in Germany.	[Thiem, Ulrich; Lamsfuss, Rainer; Guenther, Sven; Baeker, Christian; Pientka, Ludger] Ruhr Univ Bochum, Dept Geriatr, Marienhosp Herne, Herne, Germany; [Thiem, Ulrich; Endres, Heinz G.] Ruhr Univ Bochum, Dept Med Informat Biometry & Epidemiol, Bochum, Germany; [Schumacher, Jochen] Univ Duisburg Essen, Alfried Krupp Krankenhaus Steele, Dept Internal Med, Essen, Germany; [Zacher, Josef] HELIOS Klinikum Berlin Buch, Dept Orthoped, Berlin, Germany; [Burmester, Gerd R.] Univ Berlin, Charite Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany	Ruhr University Bochum; Ruhr University Bochum; University of Duisburg Essen; Helios Kliniken; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Thiem, U (corresponding author), Ruhr Univ Bochum, Dept Geriatr, Marienhosp Herne, Herne, Germany.	ulrich.thiem@rub.de	Burmester, Gerd R./AAY-7514-2020; Günther, Sven/P-4177-2017; GÜNTHER, Sven/W-7090-2019	Günther, Sven/0000-0001-8388-6131; GÜNTHER, Sven/0000-0001-8388-6131	"Forschungskolleg Geriatrie" grant from the Robert Bosch Foundation, Stuttgart, Germany; MSD Sharp & Dohme, Haar, Germany; initiative "Stark gegen der Schmerz e.V."	"Forschungskolleg Geriatrie" grant from the Robert Bosch Foundation, Stuttgart, Germany; MSD Sharp & Dohme, Haar, Germany; initiative "Stark gegen der Schmerz e.V."	In 2005 and 2006, U. Thiem and J. Schumacher were supported by a "Forschungskolleg Geriatrie" grant from the Robert Bosch Foundation, Stuttgart, Germany. The study was supported by an unrestricted research grant of MSD Sharp & Dohme, Haar, Germany, and the initiative "Stark gegen der Schmerz e.V.". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson J, 2006, ANN RHEUM DIS, V65, P520, DOI 10.1136/ard.2005.037317; Bellach BM., 2000, BUNDESGESUNDHEITSBLA, V43, P424, DOI 10.1007/s001030070048; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bergman S, 2001, J RHEUMATOL, V28, P1369; Birrell F, 2005, RHEUMATOLOGY, V44, P337, DOI 10.1093/rheumatology/keh458; Bitton Ryan, 2009, Am J Manag Care, V15, pS230; Chrubasik S, 1998, EUR J ANAESTH, V15, P397, DOI 10.1097/00003643-199807000-00004; Cimmino MA, 2001, CLIN EXP RHEUMATOL, V19, P35; Dawson J, 2004, RHEUMATOLOGY, V43, P497, DOI 10.1093/rheumatology/keh086; Donald IP, 2004, RHEUMATOLOGY, V43, P1256, DOI 10.1093/rheumatology/keh298; Frankel S, 1999, LANCET, V353, P1304, DOI 10.1016/S0140-6736(98)06451-4; Gunzelmann T, 2002, SCHMERZ, V16, P249, DOI 10.1007/s00482-002-0136-3; Horvath G, 2006, INT ORTHOP, V30, P118, DOI 10.1007/s00264-005-0033-3; Hunter DJ, 2006, BMJ-BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639; Jinks C, 2002, PAIN, V100, P55, DOI 10.1016/S0304-3959(02)00239-7; Juni P, 2003, RHEUMATOLOGY, V42, P516, DOI 10.1093/rheumatology/keg196; Keenan AM, 2006, ARTHRIT RHEUM-ARTHR, V55, P757, DOI 10.1002/art.22239; Kidd BL, 2006, PAIN, V123, P6, DOI 10.1016/j.pain.2006.04.009; Kohlmann T, 2003, SCHMERZ, V17, P405, DOI 10.1007/s00482-003-0250-x; Kohlmann T, 1991, Schmerz, V5, P208, DOI 10.1007/BF02527799; Merx H, 2007, Z ORTHOP UNFALLCHIR, V145, P421, DOI 10.1055/s-2007-965552; Meyer N, 2002, GESUNDHEITSWESEN, V64, P329, DOI 10.1055/s-2002-32178; Miro J, 2007, EUR J PAIN, V11, P83, DOI 10.1016/j.ejpain.2006.01.001; O'Reilly SC, 1998, BRIT J RHEUMATOL, V37, P870; Odding E, 1998, ANN RHEUM DIS, V57, P203, DOI 10.1136/ard.57.4.203; OReilly SC, 1996, ANN RHEUM DIS, V55, P931, DOI 10.1136/ard.55.12.931; Petersson IF, 1997, ANN RHEUM DIS, V56, P493, DOI 10.1136/ard.56.8.493; Picavet HSJ, 2003, ANN RHEUM DIS, V62, P644, DOI 10.1136/ard.62.7.644; RASPE A, 1994, SOZ PRAVENTIV MED, V39, P379, DOI 10.1007/BF01299669; Schneider S, 2005, ORTHOPADE, V34, P782, DOI 10.1007/s00132-005-0812-y; Schumacher J, 1999, SCHMERZ, V13, P375, DOI 10.1007/s004820050215; Statistisches Bundesamt, 2008, GES KRANKH 2002 2004; Stucki G, 1996, Z RHEUMATOL, V55, P40; Thiem U, 2008, Z RHEUMATOL, V67, P432, DOI 10.1007/s00393-008-0306-5; Thomas E, 2004, PAIN, V110, P361, DOI 10.1016/j.pain.2004.04.017; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646	36	36	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e60753	10.1371/journal.pone.0060753	http://dx.doi.org/10.1371/journal.pone.0060753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646102	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300003
J	Wang, X; Chang, SM; Yu, GR; Rao, ZT				Wang, Xin; Chang, Shi-min; Yu, Guang-rong; Rao, Zhi-tao			Clinical Value of the Ottawa Ankle Rules for Diagnosis of Fractures in Acute Ankle Injuries	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DECISION RULES; EMERGENCY-DEPARTMENT; EXCLUDE FRACTURES; FOOT RULES; IMPLEMENTATION; RADIOGRAPHY; VALIDATION; ACCURACY; CHILDREN	Background: The Ottawa ankle rules (OAR) are clinical decision guidelines used to identify whether patients with ankle injuries need to undergo radiography. The OAR have been proven that their application reduces unnecessary radiography. They have nearly perfect sensitivity for identifying clinically significant ankle fractures. Objectives: The purpose of this study was to assess the applicability of the OAR in China, to examine their accuracy for the diagnosis of fractures in patients with acute ankle sprains, and to assess their clinical utility for the detection of occult fractures. Methods: In this prospective study, patients with acute ankle injuries were enrolled during a 6-month period. The eligible patients were examined by emergency orthopedic specialists using the OAR, and then underwent ankle radiography. The results of examination using the OAR were compared with the radiographic results to assess the accuracy of the OAR for ankle fractures. Patients with OAR results highly suggestive of fracture, but no evidence of a fracture on radiographs, were advised to undergo 3-dimensional computed tomography (3D-CT). Results: 183 patients with ankle injuries were enrolled in the study and 63 of these injuries involved fractures. The pooled sensitivity, specificity, positive predictive value and negative predictive value of the OAR for detection of fractures of the ankle were 96.8%, 45.8%, 48.4% and 96.5%, respectively. Our results suggest that clinical application of the OAR could decrease unnecessary radiographs by 31.1%. Of the 21 patients with positive OAR results and negative radiographic findings who underwent 3D-CT examination, five had occult fractures of the lateral malleolus. Conclusions: The OAR are applicable in the Chinese population, and have high sensitivity and modest specificity for the diagnosis of fractures associated with acute ankle injury. They may detect some occult fractures of the malleoli that are not visible on radiographs.	[Wang, Xin; Chang, Shi-min; Yu, Guang-rong; Rao, Zhi-tao] Tongji Univ, Sch Med, Tongji Hosp, Dept Orthoped, Shanghai 200092, Peoples R China	Tongji University	Wang, X (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Dept Orthoped, Shanghai 200092, Peoples R China.	wangxin1681@126.com						Auleley Guy-Robert, 1997, JAMA (Journal of the American Medical Association), V277, P1935, DOI 10.1001/jama.277.24.1935; Bachmann LM, 2003, BMJ-BRIT MED J, V326, P417, DOI 10.1136/bmj.326.7386.417; Bessen T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3056; Blackham JEJ, 2008, EMERG MED J, V25, P750, DOI 10.1136/emj.2008.057877; Can U, 2008, SWISS MED WKLY, V138, P292, DOI 10.57187/smw.2008.12061; Canagasabey MD, 2011, EMERG MED J, V28, P838, DOI 10.1136/emj.2009.088286; Chandra A, 2001, UNFALLCHIRURG, V104, P617, DOI 10.1007/s001130170092; COCKSHOTT WP, 1983, CAN MED ASSOC J, V129, P129; Derksen RJ, 2005, AM J EMERG MED, V23, P725, DOI 10.1016/j.ajem.2005.02.054; Dowling S, 2009, ACAD EMERG MED, V16, P277, DOI 10.1111/j.1553-2712.2008.00333.x; Fiesseler F, 2004, AM J EMERG MED, V22, P145, DOI 10.1016/j.ajem.2004.02.001; Glas AS, 2002, CAN MED ASSOC J, V166, P727; GRATTON MC, 1990, ANN EMERG MED, V19, P497, DOI 10.1016/S0196-0644(05)82175-4; Gravel J, 2010, ACAD EMERG MED, V17, P859, DOI 10.1111/j.1553-2712.2010.00731.x; Heyworth J, 2003, BRIT J SPORT MED, V37, P194, DOI 10.1136/bjsm.37.3.194; Knudsen R, 2010, DAN MED BULL, V57; Leddy JJ, 2002, MED SCI SPORT EXER, V34, P57, DOI 10.1097/00005768-200201000-00010; LUCCHESI GM, 1995, ANN EMERG MED, V26, P1, DOI 10.1016/S0196-0644(95)70229-6; PIGMAN EC, 1994, ANN EMERG MED, V24, P41, DOI 10.1016/S0196-0644(94)70160-1; Plint AC, 1999, ACAD EMERG MED, V6, P1005, DOI 10.1111/j.1553-2712.1999.tb01183.x; Stiell I, 1996, CAN FAM PHYSICIAN, V42, P478; STIELL I, 1995, BRIT MED J, V311, P594, DOI 10.1136/bmj.311.7005.594; Stiell IG, 2007, ACAD EMERG MED, V14, P955, DOI 10.1197/j.aem.2007.06.039; STIELL IG, 1993, JAMA-J AM MED ASSOC, V269, P1127, DOI 10.1001/jama.269.9.1127; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; Yuen MC, 2001, AM J EMERG MED, V19, P429, DOI 10.1053/ajem.2001.24474	27	14	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63228	10.1371/journal.pone.0063228	http://dx.doi.org/10.1371/journal.pone.0063228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646202	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300160
J	Matsushita, Y; Sakamoto, K; Tamamura, Y; Shibata, Y; Minamizato, T; Kihara, T; Ito, M; Katsube, K; Hiraoka, S; Koseki, H; Harada, K; Yamaguchi, A				Matsushita, Yuki; Sakamoto, Kei; Tamamura, Yoshihiro; Shibata, Yasuaki; Minamizato, Tokutaro; Kihara, Tasuku; Ito, Masako; Katsube, Ken-ichi; Hiraoka, Shuichi; Koseki, Haruhiko; Harada, Kiyoshi; Yamaguchi, Akira			CCN3 Protein Participates in Bone Regeneration as an Inhibitory Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRILL-HOLE INJURY; MORPHOGENETIC PROTEINS; OSTEOBLAST DIFFERENTIATION; NOV CCN3; SIGNALING PATHWAYS; CAUSES OSTEOPENIA; HUMAN FRACTURES; WILMS-TUMORS; IN-VITRO; EXPRESSION	CCN3, a member of the CCN protein family, inhibits osteoblast differentiation in vitro. However, the role of CCN3 in bone regeneration has not been well elucidated. In this study, we investigated the role of CCN3 in bone regeneration. We identified the Ccn3 gene by microarray analysis as a highly expressed gene at the early phase of bone regeneration in a mouse bone regeneration model. We confirmed the up-regulation of Ccn3 at the early phase of bone regeneration by RT-PCR, Western blot, and immunofluorescence analyses. Ccn3 transgenic mice, in which Ccn3 expression was driven by 2.3-kb Col1a1 promoter, showed osteopenia compared with wild-type mice, but Ccn3 knock-out mice showed no skeletal changes compared with wild-type mice. We analyzed the bone regeneration process in Ccn3 transgenic mice and Ccn3 knock-out mice by microcomputed tomography and histological analyses. Bone regeneration in Ccn3 knock-out mice was accelerated compared with that in wild-type mice. The mRNA expression levels of osteoblast-related genes (Runx2, Sp7, Col1a1, Alpl, and Bglap) in Ccn3 knock-out mice were up-regulated earlier than those in wildtype mice, as demonstrated by RT-PCR. Bone regeneration in Ccn3 transgenic mice showed no significant changes compared with that in wild-type mice. Phosphorylation of Smad1/5 was highly up-regulated at bone regeneration sites in Ccn3 KO mice compared with wild-type mice. These results indicate that CCN3 is up-regulated in the early phase of bone regeneration and acts as a negative regulator for bone regeneration. This study may contribute to the development of new strategies for bone regeneration therapy.	[Matsushita, Yuki; Sakamoto, Kei; Tamamura, Yoshihiro; Katsube, Ken-ichi; Yamaguchi, Akira] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Oral Pathol, Tokyo 1138549, Japan; [Matsushita, Yuki; Kihara, Tasuku; Harada, Kiyoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Maxillofacial Surg, Tokyo 1138549, Japan; [Matsushita, Yuki; Yamaguchi, Akira] Tokyo Med & Dent Univ, Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo 1138549, Japan; [Tamamura, Yoshihiro] Mukogawa Womens Univ, Dept Hlth & Sports Sci, Nishinomiya, Hyogo 6638137, Japan; [Shibata, Yasuaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Pathol, Nagasaki 8528588, Japan; [Minamizato, Tokutaro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Nagasaki 8528588, Japan; [Ito, Masako] Nagasaki Univ Hosp, Med Work Life Balance Ctr, Nagasaki 8528588, Japan; [Hiraoka, Shuichi] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo 200045, Japan; [Koseki, Haruhiko] RIKEN Res Ctr Allergy & Immunol, Lab Dev Genet, Yokohama, Kanagawa 1578535, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Mukogawa Women's University; Nagasaki University; Nagasaki University; Nagasaki University; National Center for Child Health & Development - Japan; RIKEN	Yamaguchi, A (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Sect Oral Pathol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	akira.mpa@tmd.ac.jp	Koseki, Haruhiko/I-3825-2014; Matsushita, Yuki/H-3188-2015; Yamaguchi, Akira/AAX-9286-2020	Koseki, Haruhiko/0000-0001-8424-5854; Matsushita, Yuki/0000-0001-9577-3249; 	Japan Society for the Promotion of Science [21659420, 22249061, 23659854]; Ministry of Health, Labor, and Welfare [21040101]; Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo Medical and Dental University; Grants-in-Aid for Scientific Research [23592696] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo Medical and Dental University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 21659420, 22249061, and 23659854 from the Japan Society for the Promotion of Science and Health and Labor Sciences Research Grant 21040101 from the Ministry of Health, Labor, and Welfare (to A. Y.) and by the Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo Medical and Dental University.	BOSTROM MPG, 1995, J ORTHOPAED RES, V13, P357, DOI 10.1002/jor.1100130309; Burren CP, 1999, J CLIN ENDOCR METAB, V84, P1096; Canalis E, 2010, ENDOCRINOLOGY, V151, P221, DOI 10.1210/en.2009-0574; Chevalier G, 1998, AM J PATHOL, V152, P1563; Dean DB, 2010, J ANAT, V216, P625, DOI 10.1111/j.1469-7580.2010.01214.x; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Ellis PD, 2000, ARTERIOSCL THROM VAS, V20, P1912, DOI 10.1161/01.ATV.20.8.1912; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Gupta R, 2007, SCIENCE, V316, P590, DOI 10.1126/science.1136031; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Haque T, 2008, BONE, V42, P1144, DOI 10.1016/j.bone.2008.01.028; Heath E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-18; Ito M, 2005, J BONE MINER RES, V20, P1828, DOI 10.1359/JBMR.050610; Janune D, 2011, FEBS LETT, V585, P3033, DOI 10.1016/j.febslet.2011.08.024; Katae Y, 2009, J ORTHOP RES, V27, P1652, DOI 10.1002/jor.20920; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katsube K, 2001, Brain Res Gene Expr Patterns, V1, P61; Katsube K, 2009, J CELL COMMUN SIGNAL, V3, P135, DOI 10.1007/s12079-009-0059-1; Katsuki Y, 2008, BIOCHEM BIOPH RES CO, V368, P808, DOI 10.1016/j.bbrc.2008.02.010; Kawaki H, 2011, BONE, V49, P975, DOI 10.1016/j.bone.2011.06.033; Kloen P, 2012, BONE, V51, P59, DOI 10.1016/j.bone.2012.03.032; Kobayashi H, 2000, BIOCHEM BIOPH RES CO, V273, P630, DOI 10.1006/bbrc.2000.2981; KREBSBACH PH, 1993, MOL CELL BIOL, V13, P5168, DOI 10.1128/MCB.13.9.5168; Kubota S, 2012, JPN DENT SCI REV, V48, P101, DOI 10.1016/j.jdsr.2012.02.002; Kwong FNK, 2009, INT ORTHOP, V33, P281, DOI 10.1007/s00264-008-0691-z; Lafont J, 2005, J BONE MINER RES, V20, P2213, DOI 10.1359/JBMR.050818; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Macsai CE, 2012, BONE, V50, P1081, DOI 10.1016/j.bone.2012.02.013; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; Monfoulet L, 2010, CALCIFIED TISSUE INT, V86, P72, DOI 10.1007/s00223-009-9314-y; Nakase T, 2006, J BONE MINER METAB, V24, P425, DOI 10.1007/s00774-006-0718-8; Natarajan D, 2000, DEV DYNAM, V219, P417, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1058>3.0.CO;2-2; Ouellet V, 2012, J CELL COMMUN SIGNAL, V6, P73, DOI 10.1007/s12079-012-0161-7; Ouellet V, 2011, AM J PATHOL, V178, P2377, DOI 10.1016/j.ajpath.2011.01.033; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Pereira RC, 2000, ENDOCRINOLOGY, V141, P4558, DOI 10.1210/en.141.12.4558; Rydziel S, 2007, J BIOL CHEM, V282, P19762, DOI 10.1074/jbc.M700212200; Shimoyama T, 2010, ARTERIOSCL THROM VAS, V30, P675, DOI 10.1161/ATVBAHA.110.203356; SORET J, 1989, J VIROL, V63, P1803, DOI 10.1128/JVI.63.4.1803-1807.1989; Su BY, 1998, CR ACAD SCI III-VIE, V321, P883, DOI 10.1016/S0764-4469(99)80002-X; Subramaniam MM, 2008, VIRCHOWS ARCH, V452, P33, DOI 10.1007/s00428-007-0523-3; Tanaka K, 2010, BONE, V47, P1006, DOI 10.1016/j.bone.2010.08.016; Uchida S, 2000, BONE, V27, P81, DOI 10.1016/S8756-3282(00)00293-3; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Yamaguchi A, 2008, JPN DENT SCI REV, V44, P48, DOI 10.1016/j.jdsr.2007.11.003; Yeger H, 2007, J CELL COMMUN SIGNAL, V1, P159, DOI 10.1007/s12079-008-0022-6; Yoshimura Y, 2001, J BONE MINER RES, V16, P876, DOI 10.1359/jbmr.2001.16.5.876	50	35	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19973	19985		10.1074/jbc.M113.454652	http://dx.doi.org/10.1074/jbc.M113.454652			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23653360	hybrid, Green Published			2022-12-25	WOS:000321515800062
J	Guo, L; Ai, JT; Zheng, Z; Howatt, DA; Daugherty, A; Huang, B; Li, XA				Guo, Ling; Ai, Junting; Zheng, Zhong; Howatt, Deborah A.; Daugherty, Alan; Huang, Bin; Li, Xiang-An			High Density Lipoprotein Protects against Polymicrobe-induced Sepsis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; NECROSIS-FACTOR RELEASE; SCAVENGER RECEPTOR; SR-BI; CECAL LIGATION; UNITED-STATES; ENDOTOXIN; HDL; LIPOPOLYSACCHARIDE; CHYLOMICRONS	HDL has been considered to be a protective factor in sepsis; however, most contributing studies were conducted using the endotoxic animal model, and evidence from clinically relevant septic animal models remains limited and controversial. Furthermore, little is known about the roles of HDL in sepsis other than LPS neutralization. In this study, we employed cecal ligation and puncture (CLP), a clinically relevant septic animal model, and utilized apoA-I knock-out (KO) and transgenic mice to elucidate the roles of HDL in sepsis. ApoA-I-KO mice were more susceptible to CLP-induced septic death as shown by the 47.1% survival of apoA-I-KO mice versus the 76.7% survival of C57BL/6J (B6) mice (p = 0.038). ApoA-I-KO mice had exacerbated inflammatory cytokine production during sepsis compared with B6 mice. Further study indicated that serum from apoA-I-KO mice displayed less capacity for LPS neutralization compared with serum from B6 mice. In addition, apoA-I-KO mice had less LPS clearance, reduced corticosterone generation, and impaired leukocyte recruitment in sepsis. In contrast to apoA-I-KO mice, apoA-I transgenic mice were moderately resistant to CLP-induced septic death compared with B6 mice. In conclusion, our findings reveal multiple protective roles of HDL in CLP-induced sepsis. In addition to its well established role in neutralization of LPS, HDL exerts its protection against sepsis through promoting LPS clearance and modulating corticosterone production and leukocyte recruitment. Our study supports efforts to raise HDL levels as a therapeutic approach for sepsis.	[Guo, Ling; Ai, Junting; Zheng, Zhong; Li, Xiang-An] Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY 40536 USA; [Ai, Junting; Zheng, Zhong; Li, Xiang-An] Univ Kentucky, Coll Med, Grad Ctr Nutr Sci, Lexington, KY 40536 USA; [Howatt, Deborah A.; Daugherty, Alan; Li, Xiang-An] Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Huang, Bin] Univ Kentucky, Coll Med, Kentucky Canc Registry, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Li, XA (corresponding author), Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY 40536 USA.	xli2@email.uky.edu	Daugherty, Alan/C-8282-2009	Daugherty, Alan/0000-0003-2093-3775	National Institutes of Health from NIGMS [R01 GM085231, R01 GM085231-2S1, R01 GM085231-5S1]; Children's Miracle Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085231] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Children's Miracle Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM085231, R01 GM085231-2S1, and R01 GM085231-5S1 from NIGMS (to X.-A. L.). This work was also supported by a grant from the Children's Miracle Network.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; Cai L, 2008, J CLIN INVEST, V118, P364, DOI 10.1172/JCI31539; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; CUE JI, 1994, ARCH SURG-CHICAGO, V129, P193; Dai LJ, 2010, J LIPID RES, V51, P2695, DOI 10.1194/jlr.M008086; Echtenacher B, 2001, INFECT IMMUN, V69, P7271, DOI 10.1128/IAI.69.12.7172-7276.2001; EISENBERG S, 1984, J LIPID RES, V25, P1017; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; Feng H, 2010, J BIOL CHEM, V285, P25154, DOI 10.1074/jbc.M110.116897; Guo L, 2009, J BIOL CHEM, V284, P19826, DOI 10.1074/jbc.M109.020933; HARRIS HW, 1993, J CLIN INVEST, V91, P1028, DOI 10.1172/JCI116259; HARRIS HW, 1990, J CLIN INVEST, V86, P696, DOI 10.1172/JCI114765; Hoekstra M, 2008, J LIPID RES, V49, P738, DOI 10.1194/jlr.M700475-JLR200; HUBSCH AP, 1993, CIRC SHOCK, V40, P14; Ji AL, 2012, J LIPID RES, V53, P446, DOI 10.1194/jlr.M017079; Lee RP, 2007, RES NURS HEALTH, V30, P250, DOI 10.1002/nur.20187; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mineo C, 2012, CIRC RES, V111, P1079, DOI 10.1161/CIRCRESAHA.111.258673; Munford RS, 2005, J ENDOTOXIN RES, V11, P69, DOI 10.1179/096805105X35161; Murch O, 2007, INTENS CARE MED, V33, P13, DOI 10.1007/s00134-006-0432-y; Ocuin LM, 2011, J LEUKOCYTE BIOL, V89, P423, DOI 10.1189/jlb.0810479; Pajkrt D, 1996, J EXP MED, V184, P1601, DOI 10.1084/jem.184.5.1601; PARKER TS, 1995, INFECT IMMUN, V63, P253, DOI 10.1128/IAI.63.1.253-258.1995; Pavlou E., 2008, CRIT CARE, DOI [10.1186/cc6422, DOI 10.1186/CC6422]; Plump AS, 1996, J CLIN INVEST, V97, P2660, DOI 10.1172/JCI118716; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; QUEZADO ZMN, 1995, J PHARMACOL EXP THER, V272, P604; READ TE, 1993, INFECT IMMUN, V61, P3496, DOI 10.1128/IAI.61.8.3496-3502.1993; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Sessler Curtis N, 2004, Curr Opin Crit Care, V10, P354, DOI 10.1097/01.ccx.0000139363.76068.7b; Sorci-Thomas MG, 2012, BBA-MOL CELL BIOL L, V1821, P502, DOI 10.1016/j.bbalip.2011.08.019; Suzuki M, 2010, CIRCULATION, V122, P1919, DOI 10.1161/CIRCULATIONAHA.110.961193; Tsai MH, 2009, J HEPATOL, V50, P906, DOI 10.1016/j.jhep.2008.12.024; ULEVITCH RJ, 1981, J CLIN INVEST, V67, P827, DOI 10.1172/JCI110100; ULEVITCH RJ, 1979, J CLIN INVEST, V64, P1516, DOI 10.1172/JCI109610; van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51; Vishnyakova TG, 2003, J BIOL CHEM, V278, P22771, DOI 10.1074/jbc.M211032200; Wang L, 2010, CYTOKINE, V49, P194, DOI 10.1016/j.cyto.2009.08.008; Wilhelm AJ, 2009, ARTERIOSCL THROM VAS, V29, P843, DOI 10.1161/ATVBAHA.108.183442; WILLIAMSON R, 1992, P NATL ACAD SCI USA, V89, P7134, DOI 10.1073/pnas.89.15.7134; Yurdakul P, 2011, AM J PATHOL, V179, P23, DOI 10.1016/j.ajpath.2011.03.009; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhang ZH, 2009, AM J PHYSIOL-HEART C, V297, pH866, DOI 10.1152/ajpheart.01232.2008	49	85	90	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					17947	17953		10.1074/jbc.M112.442699	http://dx.doi.org/10.1074/jbc.M112.442699			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23658016	Green Published, hybrid			2022-12-25	WOS:000320721900002
J	Valdes, JJ; Schwarz, A; de Vaca, IC; Calvo, E; Pedra, JHF; Guallar, V; Kotsyfakis, M				Valdes, James J.; Schwarz, Alexandra; Cabeza de Vaca, Israel; Calvo, Eric; Pedra, Joao H. F.; Guallar, Victor; Kotsyfakis, Michalis			Tryptogalinin Is a Tick Kunitz Serine Protease Inhibitor with a Unique Intrinsic Disorder	PLOS ONE			English	Article							MAST-CELL TRYPTASE; SOFT TICK; IXODES-SCAPULARIS; STRUCTURE PREDICTION; SIALOSTATIN-L; DOCKING; SIALOME; SERVER; EVOLUTION; SEQUENCE	Background: A salivary proteome-transcriptome project on the hard tick Ixodes scapularis revealed that Kunitz peptides are the most abundant salivary proteins. Ticks use Kunitz peptides (among other salivary proteins) to combat host defense mechanisms and to obtain a blood meal. Most of these Kunitz peptides, however, remain functionally uncharacterized, thus limiting our knowledge about their biochemical interactions. Results: We discovered an unusual cysteine motif in a Kunitz peptide. This peptide inhibits several serine proteases with high affinity and was named tryptogalinin due to its high affinity for beta-tryptase. Compared with other functionally described peptides from the Acari subclass, we showed that tryptogalinin is phylogenetically related to a Kunitz peptide from Rhipicephalus appendiculatus, also reported to have a high affinity for b-tryptase. Using homology-based modeling (and other protein prediction programs) we were able to model and explain the multifaceted function of tryptogalinin. The N-terminus of the modeled tryptogalinin is detached from the rest of the peptide and exhibits intrinsic disorder allowing an increased flexibility for its high affinity with its inhibiting partners (i.e., serine proteases). Conclusions: By incorporating experimental and computational methods our data not only describes the function of a Kunitz peptide from Ixodes scapularis, but also allows us to hypothesize about the molecular basis of this function at the atomic level.	[Valdes, James J.; Schwarz, Alexandra; Kotsyfakis, Michalis] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Cabeza de Vaca, Israel; Guallar, Victor] Barcelona Supercomp Ctr, Res Program Computat Biol, Inst Res Biomed BSC IRB, Joint Barcelona Supercomp Ctr, Barcelona, Spain; [Cabeza de Vaca, Israel; Guallar, Victor] ICREA, Barcelona, Spain; [Calvo, Eric] NIAID, Vector Biol Sect, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Pedra, Joao H. F.] Univ Calif Riverside, Ctr Dis Vector Res, Riverside, CA 92521 USA; [Pedra, Joao H. F.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); ICREA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Riverside; University of California System; University of California Riverside	Valdes, JJ (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	valdjj@gmail.com	Valdés, James/G-9812-2014; Calvo, Eric/ABB-4935-2021; Kotsyfakis, Michail/G-9525-2014; Guallar, Victor/B-1579-2013	Valdés, James/0000-0002-0237-8061; Calvo, Eric/0000-0001-7880-2730; Kotsyfakis, Michail/0000-0002-7526-1876; Guallar, Victor/0000-0002-4580-1114; Pedra, Joao/0000-0001-8740-2667	European Social Fund; state budget of the Czech Republic; Grant Agency of the Czech Republic [P302/11/P798]; Ministry of Education, Youth and Sports of the Czech Republic [LH12002]; Academy of Sciences of the Czech Republic; European Project [ERC-2009-Adg 25027-PELE]; Academy of Sciences of the Czech Republic [Z60220518, P502/12/2409]; European Union [PIRG07-GA-2010-268177]; National Institutes of Health, USA;  [CZ.1.07/2.3.00/30.0032]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093653] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); European Project; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); European Union(European Commission); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	JJV was sponsored by project CZ.1.07/2.3.00/30.0032, co-financed by the European Social Fund and the state budget of the Czech Republic. AS was funded by the Grant Agency of the Czech Republic (Grant No. P302/11/P798) and the Ministry of Education, Youth and Sports of the Czech Republic (KONTAKT II grant no. LH12002), and MK received support from the Academy of Sciences of the Czech Republic (Jan Evangelista Purkyne Fellowship). Computational resources were provided by the Barcelona Supercomputing Center and the work was supported by the ERC-2009-Adg 25027-PELE European Project. The authors also want to acknowledge the financial support of the Academy of Sciences of the Czech Republic (grant no. Z60220518 and P502/12/2409), the 7th Framework Program of the European Union (Marie Curie Reintegration grant, grant no. PIRG07-GA-2010-268177). Because Extramural Funds from the National Institutes of Health, USA, supported this work and because EC is a government employee, this is also considered a government work (in the USA public domain). Notwithstanding any other agreements, the NIH reserves the right to provide the work to PubMed Central for display and use by the public. PubMed Central may tag or modify the work consistent with its customary practices. Rights can be established outside of the USA subject to a government use license.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alim MA, 2012, INSECT BIOCHEM MOLEC, V42, P925, DOI 10.1016/j.ibmb.2012.09.005; Balzar S, 2011, AM J RESP CRIT CARE, V183, P299, DOI 10.1164/rccm.201002-0295OC; Basdevant N, 2007, J PHYS CHEM B, V111, P9390, DOI 10.1021/jp0727190; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chmelar J, 2012, J PROTEOMICS, V75, P3842, DOI 10.1016/j.jprot.2012.04.026; Chmelar J, 2011, BLOOD, V117, P736, DOI 10.1182/blood-2010-06-293241; Chmelar J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-233; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Dai SX, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-4; DiMarco S, 1997, STRUCTURE, V5, P1465; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Eswar N., 2001, CURRENT PROTOCOLS PR; Ferre F, 2006, NUCLEIC ACIDS RES, V34, pW182, DOI 10.1093/nar/gkl189; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; Francischetti IMB, 2008, INSECT BIOCHEM MOLEC, V38, P1, DOI 10.1016/j.ibmb.2007.09.009; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Francischetti IMB, 2008, J PROTEOMICS, V71, P493, DOI 10.1016/j.jprot.2008.07.006; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Heyman P, 2010, EXPERT REV ANTI-INFE, V8, P33, DOI 10.1586/ERI.09.118; Joubert AM, 1998, EXP APPL ACAROL, V22, P603, DOI 10.1023/A:1006198713791; KARCZEWSKI J, 1994, J BIOL CHEM, V269, P6702; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kotsyfakis M, 2008, J IMMUNOL, V181, P5209, DOI 10.4049/jimmunol.181.8.5209; Kotsyfakis M, 2007, J BIOL CHEM, V282, P29256, DOI 10.1074/jbc.M703143200; Kotsyfakis M, 2006, J BIOL CHEM, V281, P26298, DOI 10.1074/jbc.M513010200; Kotsyfakis M, 2010, MOL MICROBIOL, V77, P456, DOI 10.1111/j.1365-2958.2010.07220.x; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Kunitz M, 1936, J GEN PHYSIOL, V19, P991, DOI 10.1085/jgp.19.6.991; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Li X, 2007, PROTEINS, V66, P824, DOI 10.1002/prot.21125; Lima CA, 2010, VET PARASITOL, V167, P279, DOI 10.1016/j.vetpar.2009.09.030; Ma DY, 2009, MOL CELL PROTEOMICS, V8, P2071, DOI 10.1074/mcp.M900186-MCP200; Macedo-Ribeiro S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001624; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P22, DOI 10.1016/j.ibmb.2007.09.002; Mans BJ, 2002, J BIOL CHEM, V277, P21371, DOI 10.1074/jbc.M112060200; Masone D, 2012, PROTEINS, V80, P818, DOI 10.1002/prot.23239; Paesen GC, 2007, J MOL BIOL, V368, P1172, DOI 10.1016/j.jmb.2007.03.011; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Payne V, 2004, ANAESTHESIA, V59, P695, DOI 10.1111/j.1365-2044.2004.03757.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ranasinghe S, 2013, DEV COMP IMMUNOL, V39, P219, DOI 10.1016/j.dci.2012.10.005; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Rost Burkhard, 1994, Current Opinion in Biotechnology, V5, P372, DOI 10.1016/0958-1669(94)90045-0; Sa-Nunes A, 2009, J IMMUNOL, V182, P7422, DOI 10.4049/jimmunol.0900075; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schaschke N, 2001, CHEM BIOL, V8, P313, DOI 10.1016/S1074-5521(01)00011-4; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sommerhoff CP, 2000, BBA-PROTEIN STRUCT M, V1477, P75, DOI 10.1016/S0167-4838(99)00265-4; Sommerhoff CP, 2009, BIOL CHEM H-S, V375, P685; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Tsujimoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029964; Valenzuela JG, 1999, BIOCHEMISTRY-US, V38, P11209, DOI 10.1021/bi990761i; Valenzuela JG, 2002, J EXP BIOL, V205, P2843; Vallat BK, 2009, PROTEINS, V76, P930, DOI 10.1002/prot.22401; WAXMAN L, 1990, SCIENCE, V248, P593, DOI 10.1126/science.2333510; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028000; Xu XQ, 2008, MOL CELL PROTEOMICS, V7, P582, DOI 10.1074/mcp.M700497-MCP200; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	79	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62562	10.1371/journal.pone.0062562	http://dx.doi.org/10.1371/journal.pone.0062562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658744	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100017
J	Budimir, N; de Haan, A; Meijerhof, T; Waijer, S; Boon, L; Gostick, E; Price, DA; Wilschut, J; Huckriede, A				Budimir, Natalija; de Haan, Aalzen; Meijerhof, Tjarko; Waijer, Simke; Boon, Louis; Gostick, Emma; Price, David A.; Wilschut, Jan; Huckriede, Anke			Critical Role of TLR7 Signaling in the Priming of Cross-Protective Cytotoxic T Lymphocyte Responses by a Whole Inactivated Influenza Virus Vaccine	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; ANTIGEN-PRESENTING CELLS; RIG-I; ANTIVIRAL RESPONSES; ANTIBODY-RESPONSE; IMMUNE-RESPONSES; INFECTION; CD8(+); ACTIVATION; INDUCTION	Current influenza vaccines fail to induce protection against antigenically distinct virus strains. Accordingly, there is a need for the development of cross-protective vaccines. Previously, we and others have shown that vaccination with whole inactivated virus (WIV) induces cross-protective cellular immunity in mice. To probe the mechanistic basis for this finding, we investigated the role of TLR7, a receptor for single-stranded RNA, in induction of cross-protection. Vaccination of TLR7-/- mice with influenza WIV failed to protect against a lethal heterosubtypic challenge; in contrast, wild-type mice were fully protected. The lack of protection in TLR7-/- mice was associated with high viral load and a relative paucity of influenza-specific CD8+ cytotoxic T lymphocyte (CTL) responses. Dendritic cells (DCs) from TLR7-/- mice were unable to cross-present WIV-derived antigen to influenza-specific CTLs in vitro. Similarly, TLR7-/- DCs failed to mature and become activated in response to WIV, as determined by the assessment of surface marker expression and cytokine production. Plasmacytoid DCs (pDCs) derived from wild-type mice responded directly to WIV while purified conventional DCs (cDCs) did not respond to WIV in isolation, but were responsive in mixed pDC/cDC cultures. Depletion of pDCs prior to and during WIV immunization resulted in reduced numbers of influenza-specific CTLs and impaired protection from heterosubtypic challenge. Thus, TLR7 plays a critical role in the induction of cross-protective immunity upon vaccination with WIV. The initial target cells for WIV appear to be pDCs which by direct or indirect mechanisms promote activation of robust CTL responses against conserved influenza epitopes.	[Budimir, Natalija; de Haan, Aalzen; Meijerhof, Tjarko; Waijer, Simke; Wilschut, Jan; Huckriede, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, Groningen, Netherlands; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Gostick, Emma; Price, David A.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales	University of Groningen; Bioceros B.V.; Cardiff University	Huckriede, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, Groningen, Netherlands.	a.l.w.huckriede@umcg.nl	Price, David A/C-7876-2013; Boon, Laurence/HCI-3629-2022; Huckriede, Anke/P-3558-2019	Price, David A/0000-0001-9416-2737; Huckriede, Anke/0000-0002-2646-5143; Boon, Louis/0000-0002-0937-9171; Waijer, Simke W/0000-0003-1717-0463	TI Pharma grant [T4-214-1]; Jan Kornelis de Cock Stichting grant; Wellcome Trust [100326/Z/12/Z] Funding Source: researchfish	TI Pharma grant; Jan Kornelis de Cock Stichting grant; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was financially supported by TI Pharma grant (T4-214-1) and Jan Kornelis de Cock Stichting grant (http://www.decockstichting.nl/subsidies.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 0120050158 EUR PHARM; Aoshi T, 2011, CURR OPIN VIROLGY, V1, P1; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Budimir N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030898; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; den Haan JMM, 2001, CURR OPIN IMMUNOL, V13, P437, DOI 10.1016/S0952-7915(00)00238-7; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Furuya Y, 2010, J VIROL, V84, P4212, DOI 10.1128/JVI.02508-09; Geeraedts F, 2010, AAPS J, V12, P215, DOI 10.1208/s12248-010-9179-z; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Gil-Torregrosa BC, 2004, EUR J IMMUNOL, V34, P398, DOI 10.1002/eji.200324508; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Hickman-Miller HD, 2006, NAT IMMUNOL, V7, P125, DOI 10.1038/ni0206-125; Hoeffel G, 2007, IMMUNITY, V27, P481, DOI 10.1016/j.immuni.2007.07.021; Ichinohe T, 2010, EXPERT REV VACCINES, V9, P1315, DOI 10.1586/ERV.10.118; Jelinek I, 2011, J IMMUNOL, V186, P2422, DOI 10.4049/jimmunol.1002845; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Kratky W, 2011, P NATL ACAD SCI USA, V108, P17414, DOI 10.1073/pnas.1108945108; Lattanzi L, 2011, IMMUNOBIOLOGY, V216, P537, DOI 10.1016/j.imbio.2010.10.003; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Mouries J, 2008, BLOOD, V112, P3713, DOI 10.1182/blood-2008-03-146290; Ni K, 1997, IMMUNOL CELL BIOL, V75, P223, DOI 10.1038/icb.1997.35; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Qi H, 2003, INFECT IMMUN, V71, P3337, DOI 10.1128/IAI.71.6.3337-3342.2003; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Sawai T, 2008, IMMUNOLOGY, V124, P155, DOI 10.1111/j.1365-2567.2007.02745.x; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Spadaro F, 2012, BLOOD, V119, P1407, DOI 10.1182/blood-2011-06-363564; Storni T, 2002, J IMMUNOL, V168, P2880, DOI 10.4049/jimmunol.168.6.2880; Wagner H, 2009, ADV DRUG DELIVER REV, V61, P243, DOI 10.1016/j.addr.2008.12.010; Watts C, 2010, CURR OPIN IMMUNOL, V22, P124, DOI 10.1016/j.coi.2009.12.005	46	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63163	10.1371/journal.pone.0063163	http://dx.doi.org/10.1371/journal.pone.0063163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658804	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000321200500057
J	Muhle, C; Huttner, HB; Walter, S; Reichel, M; Canneva, F; Lewczuk, P; Gulbins, E; Kornhuber, J				Muehle, Christiane; Huttner, Hagen B.; Walter, Silke; Reichel, Martin; Canneva, Fabio; Lewczuk, Piotr; Gulbins, Erich; Kornhuber, Johannes			Characterization of Acid Sphingomyelinase Activity in Human Cerebrospinal Fluid	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; SECRETORY SPHINGOMYELINASE; ALZHEIMERS-DISEASE; LYSOSOMAL SPHINGOMYELINASE; SPHINGOSINE 1-PHOSPHATE; ENZYME-ACTIVITY; CERAMIDE; APOPTOSIS; MICE; EXPRESSION	Background: As a key enzyme in sphingolipid metabolism, acid sphingomyelinase (ASM) is involved in the regulation of cell fate and signaling via hydrolysis of sphingomyelin to form ceramide. While increased activity of the lysosomal form has been associated with various pathological conditions, there are few studies on secretory ASM limited only to cell models, plasma or serum. Methods: An optimized assay based on a fluorescent substrate was applied to measure the ASM activity in cerebrospinal fluid (CSF) collected from mice and from 42 patients who were classified as controls based on normal routine CSF values. Results: We have detected ASM activity in human CSF, established a sensitive quantitative assay and characterized the enzyme's properties. The enzyme resembles plasmatic ASM including protein stability and Zn2+-dependence but the assays differ considerably in the optimal detergent concentration. Significantly increased activities in the CSF of ASM transgenic mice and undetectable levels in ASM knock-out mice prove that the measured ASM activity originates from the ASM-encoding gene SMPD1. CSF localized ASM activities were comparable to corresponding serum ASM levels at their respective optimal reaction conditions, but no correlation was observed. The large variance in ASM activity was independent of sex, age or analyzed routine CSF parameters. Conclusions: Human and mouse CSF contain detectable levels of secretory ASM, which are unrelated to serum ASM activities. Further investigations in humans and in animal models will help to elucidate the role of this enzyme in human disease and to assess its value as a potential biomarker for disease type, severity, progress or therapeutic success.	[Muehle, Christiane; Reichel, Martin; Lewczuk, Piotr; Kornhuber, Johannes] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Huttner, Hagen B.] Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany; [Walter, Silke] Univ Saarland, Dept Neurol, Homburg, Germany; [Canneva, Fabio] Univ Erlangen Nurnberg, Franz Penzoldt Ctr, D-91054 Erlangen, Germany; [Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Saarland University; University of Erlangen Nuremberg; University of Duisburg Essen	Muhle, C (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany.	christiane.muehle@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014; Gulbins, Erich/L-6989-2014; MÃhle, Christiane/AAE-7043-2019	Kornhuber, Johannes/0000-0002-8096-3987; Gulbins, Erich/0000-0002-3117-1342; Muhle, Christiane/0000-0001-7517-9154; Reichel, Martin/0000-0001-7886-2784; Walter, Silke/0000-0002-1176-2911	DFG [KO 947/11-1, GU 335/23-1]	DFG(German Research Foundation (DFG))	The work was supported by DFG (www.dfg.de) grant KO 947/11-1 and GU 335/23-1 (to JK and EG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenz C, 2010, CELL PHYSIOL BIOCHEM, V26, P1, DOI 10.1159/000315100; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; BOWSER PA, 1978, J INVEST DERMATOL, V70, P331, DOI 10.1111/1523-1747.ep12543516; Carmody W. R., 1961, J CHEM EDUC, V38, P559, DOI DOI 10.1021/ED038P559; Clarke CJ, 2011, ADV ENZYME REGUL, V51, P51, DOI 10.1016/j.advenzreg.2010.09.016; Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9; Filippov V, 2012, J ALZHEIMERS DIS, V29, P537, DOI 10.3233/JAD-2011-111202; Fujii S, 2004, BIOL PHARM BULL, V27, P1725, DOI 10.1248/bpb.27.1725; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; JONES CS, 1981, BIOCHEM J, V195, P373, DOI 10.1042/bj1950373; Kinnunen PKJ, 2002, TRENDS CARDIOVAS MED, V12, P37, DOI 10.1016/S1050-1738(01)00143-8; Kornhuber J, 2005, J NEURAL TRANSM, V112, P1583, DOI 10.1007/s00702-005-0374-5; Kornhuber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023852; Kornhuber J, 2010, CELL PHYSIOL BIOCHEM, V26, P9, DOI 10.1159/000315101; KORNHUBER ME, 1986, J NEUROSCI METH, V17, P63, DOI 10.1016/0165-0270(86)90035-X; Krstic D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-151; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; Lewczuk P, 2009, J NEURAL TRANSM, V116, P1163, DOI 10.1007/s00702-009-0277-y; Liu L, 2008, J VIS EXP, V21; Marathe S, 2000, HUM MOL GENET, V9, P1967, DOI 10.1093/hmg/9.13.1967; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Mielke MM, 2011, J ALZHEIMERS DIS, V27, P259, DOI 10.3233/JAD-2011-110405; Mikati MA, 2008, EPILEPSY RES, V81, P161, DOI 10.1016/j.eplepsyres.2008.05.009; Qiu HW, 2003, J BIOL CHEM, V278, P32744, DOI 10.1074/jbc.M303022200; Reichel M, 2011, ALCOHOL CLIN EXP RES, V35, P1852, DOI 10.1111/j.1530-0277.2011.01529.x; Reichel M, 2010, ALCOHOL CLIN EXP RES, V34, P46, DOI 10.1111/j.1530-0277.2009.01064.x; Rhein C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035467; Sacket SJ, 2009, ACTA PHARMACOL SIN, V30, P1454, DOI 10.1038/aps.2009.136; Satoi H, 2005, NEUROSCIENCE, V130, P657, DOI 10.1016/j.neuroscience.2004.08.056; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Schuchman EH, 2007, J INHERIT METAB DIS, V30, P654, DOI 10.1007/s10545-007-0632-9; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Takahashi I, 2000, TOHOKU J EXP MED, V192, P61, DOI 10.1620/tjem.192.61; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Vanderstichele H, 2012, ALZHEIMERS DEMENT, V8, P65, DOI 10.1016/j.jalz.2011.07.004; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Zhang Y, 2009, BBA-BIOMEMBRANES, V1788, P178, DOI 10.1016/j.bbamem.2008.07.030	41	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62912	10.1371/journal.pone.0062912	http://dx.doi.org/10.1371/journal.pone.0062912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658784	gold, Green Published			2022-12-25	WOS:000321200500043
J	Mak, GK; Antle, MC; Dyck, RH; Weiss, S				Mak, Gloria K. y; Antle, Michael C.; Dyck, Richard H.; Weiss, Samuel			Bi-Parental Care Contributes to Sexually Dimorphic Neural Cell Genesis in the Adult Mammalian Brain	PLOS ONE			English	Article							WATER MAZE TASK; SPATIAL WORKING-MEMORY; LONG-TERM POTENTIATION; MATERNAL-CARE; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; ESTROUS-CYCLE; STEM-CELLS; STIMULATED NEUROGENESIS; SYNAPTIC PLASTICITY	Early life events can modulate brain development to produce persistent physiological and behavioural phenotypes that are transmissible across generations. However, whether neural precursor cells are altered by early life events, to produce persistent and transmissible behavioural changes, is unknown. Here, we show that bi-parental care, in early life, increases neural cell genesis in the adult rodent brain in a sexually dimorphic manner. Bi-parentally raised male mice display enhanced adult dentate gyrus neurogenesis, which improves hippocampal neurogenesis-dependent learning and memory. Female mice display enhanced adult white matter oligodendrocyte production, which increases proficiency in bilateral motor coordination and preference for social investigation. Surprisingly, single parent-raised male and female offspring, whose fathers and mothers received bi-parental care, respectively, display a similar enhancement in adult neural cell genesis and phenotypic behaviour. Therefore, neural plasticity and behavioural effects due to bi-parental care persist throughout life and are transmitted to the next generation.	[Mak, Gloria K. y; Dyck, Richard H.; Weiss, Samuel] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Fac Med, Calgary, AB, Canada; [Antle, Michael C.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Fac Med, Calgary, AB, Canada; [Antle, Michael C.; Dyck, Richard H.] Univ Calgary, Hotchkiss Brain Inst, Fac Arts, Dept Psychol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Weiss, S (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Fac Med, Calgary, AB, Canada.	weiss@ucalgary.ca		Antle, Michael/0000-0001-5178-4683; Dyck, Richard/0000-0002-3254-8332	Canadian Institutes of Health Research and studentship; Alberta Innovates Health Solutions	Canadian Institutes of Health Research and studentship; Alberta Innovates Health Solutions	This work was funded by the Canadian Institutes of Health Research and studentship (GKM) and scientist (SW) awards from Alberta Innovates Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the mnauscript.	Antle MC, 2007, J BIOL RHYTHM, V22, P524, DOI 10.1177/0748730407306882; Arai JA, 2009, J NEUROSCI, V29, P1496, DOI 10.1523/JNEUROSCI.5057-08.2009; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Berry B, 1997, BEHAV NEUROSCI, V111, P267, DOI 10.1037/0735-7044.111.2.267; Bonzano L, 2008, J NEUROSCI, V28, P3227, DOI 10.1523/JNEUROSCI.4076-07.2008; Branchi I, 2006, J NEUROSCI RES, V83, P965, DOI 10.1002/jnr.20789; Branchi I, 2009, NEUROSCI BIOBEHAV R, V33, P551, DOI 10.1016/j.neubiorev.2008.03.011; Bredy TW, 2003, EUR J NEUROSCI, V18, P2903, DOI 10.1111/j.1460-9568.2003.02965.x; Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2; Buss C, 2007, J NEUROSCI, V27, P2592, DOI 10.1523/JNEUROSCI.3252-06.2007; Cameron N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002210; Carter DB, 2002, COMPARATIVE MED, V52, P452; Cerghet M, 2009, J NEUROL SCI, V286, P76, DOI 10.1016/j.jns.2009.06.039; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2010, DEV PSYCHOBIOL, V52, P299, DOI 10.1002/dev.20436; Champagne FA, 2009, NEUROSCI BIOBEHAV R, V33, P593, DOI 10.1016/j.neubiorev.2007.10.009; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Curley JP, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.025.2009; D'Amato FR, 2011, HIPPOCAMPUS, V21, P298, DOI 10.1002/hipo.20750; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Fairless AH, 2008, BRAIN RES, V1230, P211, DOI 10.1016/j.brainres.2008.07.025; Frick KM, 2000, NEUROREPORT, V11, P3461, DOI 10.1097/00001756-200011090-00013; FRYE CA, 1995, PHYSIOL BEHAV, V57, P5, DOI 10.1016/0031-9384(94)00197-D; Fugger HN, 1998, HORM BEHAV, V34, P163, DOI 10.1006/hbeh.1998.1475; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Hernandez-Rabaza V, 2009, NEUROSCIENCE, V159, P59, DOI 10.1016/j.neuroscience.2008.11.054; Hodes GE, 2010, J PHARMACOL EXP THER, V332, P266, DOI 10.1124/jpet.109.158717; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; Kerr AL, 2010, NEUROSCIENCE, V171, P214, DOI 10.1016/j.neuroscience.2010.08.008; KIERNAN JA, 1984, J MICROSC-OXFORD, V134, P25, DOI 10.1111/j.1365-2818.1984.tb00501.x; Lagace DC, 2007, HIPPOCAMPUS, V17, P175, DOI 10.1002/hipo.20265; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Liu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030803; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Mak GK, 2010, NAT NEUROSCI, V13, P753, DOI 10.1038/nn.2550; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; Markham JA, 2009, BRAIN RES, V1288, P9, DOI 10.1016/j.brainres.2009.06.087; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; MOORE CL, 1979, J COMP PHYSIOL PSYCH, V93, P677, DOI 10.1037/h0077599; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Mychasiuk R, 2012, BEHAV BRAIN RES, V228, P294, DOI 10.1016/j.bbr.2011.11.036; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; O'Hearn K, 2008, DEV PSYCHOPATHOL, V20, P1103, DOI 10.1017/S0954579408000527; Oomen CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003675; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049622; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050455; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; POLEY W, 1974, ANIM LEARN BEHAV, V2, P241, DOI 10.3758/BF03199187; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1006, DOI 10.1037/0735-7044.117.5.1006; Richards S, 2012, BEHAV BRAIN RES, V231, P86, DOI 10.1016/j.bbr.2012.02.043; Rissanen A, 1999, NEUROREPORT, V10, P1369, DOI 10.1097/00001756-199904260-00039; Rizzi S, 2011, BRAIN RES, V1415, P23, DOI 10.1016/j.brainres.2011.08.007; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Seri B, 2006, CEREB CORTEX, V16, pI103, DOI 10.1093/cercor/bhk027; Sgado P, 2006, P NATL ACAD SCI USA, V103, P15242, DOI 10.1073/pnas.0602116103; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Stackman RW, 1997, NEUROBIOL LEARN MEM, V67, P167, DOI 10.1006/nlme.1996.3753; Stone SSD, 2011, HIPPOCAMPUS, V21, P1348, DOI 10.1002/hipo.20845; Tang AC, 2003, J NEUROSCI, V23, P8254; Tang AC, 2006, P NATL ACAD SCI USA, V103, P15716, DOI 10.1073/pnas.0607374103; van Gaalen MM, 2000, BEHAV BRAIN RES, V115, P95, DOI 10.1016/S0166-4328(00)00240-0; van Hasselt FN, 2012, J NEUROENDOCRINOL, V24, P331, DOI 10.1111/j.1365-2826.2011.02233.x; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wachs TD, 2006, ANN NY ACAD SCI, V1094, P28, DOI 10.1196/annals.1376.004; Warren SG, 1997, BEHAV NEUROSCI, V111, P259, DOI 10.1037/0735-7044.111.2.259; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Whitaker J, 2009, LAB ANIMAL, V38, P24, DOI 10.1038/laban0109-24; WHITTEN WK, 1959, J ENDOCRINOL, V18, P102, DOI 10.1677/joe.0.0180102; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Zakharova E, 2012, BEHAV BRAIN RES, V230, P92, DOI 10.1016/j.bbr.2012.01.052; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhu ZL, 2004, J NEUROSCI RES, V78, P837, DOI 10.1002/jnr.20338	85	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62701	10.1371/journal.pone.0062701	http://dx.doi.org/10.1371/journal.pone.0062701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650527	Green Submitted, Green Published, gold			2022-12-25	WOS:000319167000072
J	Sabo, JK; Aumann, TD; Kilpatrick, TJ; Cate, HS				Sabo, Jennifer K.; Aumann, Tim D.; Kilpatrick, Trevor J.; Cate, Holly S.			Investigation of Sequential Growth Factor Delivery during Cuprizone Challenge in Mice Aimed to Enhance Oligodendrogliogenesis and Myelin Repair	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FACTOR-I; OLIGODENDROCYTE LINEAGE; INDUCED DEMYELINATION; MULTIPLE-SCLEROSIS; TRANSGENIC MICE; CELL-SURVIVAL; IGF-I; REMYELINATION; DIFFERENTIATION	Repair in multiple sclerosis involves remyelination, a process in which axons are provided with a new myelin sheath by new oligodendrocytes. Bone morphogenic proteins (BMPs) are a family of growth factors that have been shown to influence the response of oligodendrocyte progenitor cells (OPCs) in vivo during demyelination and remyelination in the adult brain. We have previously shown that BMP4 infusion increases numbers of OPCs during cuprizone-induced demyelination, while infusion of Noggin, an endogenenous antagonist of BMP4 increases numbers of mature oligodendrocytes and remyelinated axons following recovery. Additional studies have shown that insulin-like growth factor-1 (IGF-1) promotes the survival of OPCs during cuprizone-induced demyelination. Based on these data, we investigated whether myelin repair could be further enhanced by sequential infusion of these agents firstly, BMP4 to increase OPC numbers, followed by either Noggin or IGF-1 to increase the differentiation and survival of the newly generated OPCs. We identified that sequential delivery of BMP4 and IGF-1 during cuprizone challenge increased the number of mature oligodendrocytes and decreased astrocyte numbers following recovery compared with vehicle infused mice, but did not alter remyelination. However, sequential delivery of BMP4 and Noggin during cuprizone challenge did not alter numbers of oligodendrocytes or astrocytes in the corpus callosum compared with vehicle infused mice. Furthermore, electron microscopy analysis revealed no change in average myelin thickness in the corpus callosum between vehicle infused and BMP4-Noggin infused mice. Our results suggest that while single delivery of Noggin or IGF-1 increased the production of mature oligodendrocytes in vivo in the context of demyelination, only Noggin infusion promoted remyelination. Thus, sequential delivery of BMP4 and Noggin or IGF-1 does not further enhance myelin repair above what occurs with delivery of Noggin alone.	[Sabo, Jennifer K.; Kilpatrick, Trevor J.; Cate, Holly S.] Univ Melbourne, Neurosci Res Ctr, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Sabo, Jennifer K.; Aumann, Tim D.; Kilpatrick, Trevor J.; Cate, Holly S.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Cate, HS (corresponding author), Univ Melbourne, Neurosci Res Ctr, Dept Anat & Neurosci, Melbourne, Vic, Australia.	hcate@unimelb.edu.au		Kilpatrick, Trevor/0000-0003-3999-085X; Cate, Holly/0000-0001-6392-9640	National Health and Medical Research Council of Australia (NHMRC); Multiple Sclerosis Research Australia (MSRA); Holloway Family Trust; Victorian Operational Infrastructure Support Program	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Multiple Sclerosis Research Australia (MSRA); Holloway Family Trust; Victorian Operational Infrastructure Support Program	This work was supported by the National Health and Medical Research Council of Australia (NHMRC), Multiple Sclerosis Research Australia (MSRA), the Holloway Family Trust and the Victorian Operational Infrastructure Support Program. J.K.S. was supported by a MSRA Postgraduate Scholarship and H.S.C. was supported by NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Armstrong RC, 2002, J NEUROSCI, V22, P8574; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Binder MD, 2008, J NEUROSCI, V28, P5195, DOI 10.1523/JNEUROSCI.1180-08.2008; Cannella B, 2000, AM J PATHOL, V157, P933, DOI 10.1016/S0002-9440(10)64606-8; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; Cate HS, 2010, J NEUROCHEM, V115, P11, DOI 10.1111/j.1471-4159.2010.06660.x; Dummula K, 2011, J NEUROSCI, V31, P12068, DOI 10.1523/JNEUROSCI.0013-11.2011; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Frank JA, 2002, MULT SCLER, V8, P24, DOI 10.1191/1352458502ms768oa; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Genoud S, 2005, J NEUROIMMUNOL, V168, P40, DOI 10.1016/j.jneuroim.2005.06.033; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Kuhl NM, 2002, J NEUROSCI RES, V69, P207, DOI 10.1002/jnr.10293; Mason JL, 2000, J NEUROSCI, V20, P5703, DOI 10.1523/JNEUROSCI.20-15-05703.2000; Mason JL, 2003, J NEUROSCI, V23, P7710; Mukherjee A, 2008, MOL ENDOCRINOL, V22, P1238, DOI 10.1210/me.2008-0001; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; O'Leary MT, 2002, MOL CELL NEUROSCI, V19, P32, DOI 10.1006/mcne.2001.1062; Pang Y, 2007, GLIA, V55, P1099, DOI 10.1002/glia.20530; Peters I, 2006, J AM SOC NEPHROL, V17, P1644, DOI 10.1681/ASN.2005111209; Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097; Sabo JK, 2011, J NEUROSCI, V31, P4504, DOI 10.1523/JNEUROSCI.5859-10.2011; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Song K, 2011, INJURY, V42, P796, DOI 10.1016/j.injury.2011.02.003; Tengood JE, 2011, TISSUE ENG PT A, V17, P1181, DOI [10.1089/ten.tea.2010.0551, 10.1089/ten.TEA.2010.0551]; VonDran MW, 2011, J NEUROSCI, V31, P14182, DOI 10.1523/JNEUROSCI.6595-10.2011; Wahdan-Alaswad RS, 2010, CANCER RES, V70, P9106, DOI 10.1158/0008-5472.CAN-10-1119; YAO DL, 1995, P NATL ACAD SCI USA, V92, P6190, DOI 10.1073/pnas.92.13.6190; YE P, 1995, J NEUROSCI, V15, P7344; Zhu SG, 2010, J IMMUNOL, V184, P2348, DOI 10.4049/jimmunol.0902371	34	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63415	10.1371/journal.pone.0063415	http://dx.doi.org/10.1371/journal.pone.0063415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650566	Green Published, gold			2022-12-25	WOS:000319167000111
J	Spronk, M; Vogel, EK; Jonkman, LM				Spronk, Marjolein; Vogel, Edward K.; Jonkman, Lisa M.			No Behavioral or ERP Evidence for a Developmental Lag in Visual Working Memory Capacity or Filtering in Adolescents and Adults with ADHD	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY-DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; SELECTIVE ATTENTION; IRRELEVANT INFORMATION; DEFAULT NETWORK; NEURAL MEASURES; AGE-DIFFERENCES; CHILDREN	Attention-deficit/hyperactivity disorder (ADHD) patients have both working memory (WM) and attention problems. Good attention skills are important for WM performance; individuals have higher WM capacity when being able to prevent storage of irrelevant information through efficient filtering. Since it is unknown how filtering ability is associated with WM performance in ADHD, this was investigated in the present study. A visuospatial working memory (VSWM) change detection task with distracting stimuli was administered to adolescents (12-16 years old) and adults (20-46 years old) with and without ADHD matched on education/IQ. Besides performance, contralateral delay activity (CDA) was measured; a neural correlate of the number of targets and distracters encoded and maintained in WM during the retention interval. Performance data showed similar WM-load, WM-distracter interference and developmental effects in ADHD and control groups. Adolescents' performance on the WM task deteriorated more than that of adults in the presence of distracters and with higher WM-load, irrespective of Diagnosis. The CDA data suggested that initially all groups encoded/maintained distracting information, but only adults were able to bounce this information from memory later in the retention interval, leading to better WM performance. The only effect of Diagnosis was a smaller CDA in adolescents and adults with ADHD than in age/IQ-matched controls when maintaining a low 1-item load, which was possibly related to an inability to keep attention focused at cued stimuli with low task demands. Overall, the development of filtering efficiency and VSWM storage capacity in adolescents with ADHD was not different from that in typically developing peers.	[Spronk, Marjolein; Jonkman, Lisa M.] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Vogel, Edward K.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	Maastricht University; University of Oregon	Jonkman, LM (corresponding author), Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands.	l.jonkman@maastrichtuniversity.nl	Vogel, Edward K/AAW-9466-2021		Netherlands Organization of Scientific Research (NWO) [400-05-132]	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Netherlands Organization of Scientific Research (NWO), Open Competition programme, grant number 400-05-132 awarded to L.M. Jonkman (http://www.nwo.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 2003, MANUAL ASEBA ADULT F; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arend AM, 2011, J COGNITIVE NEUROSCI, V23, P4048, DOI 10.1162/jocn_a_00068; Barkley RA, 1998, SCI AM, V279, P66, DOI 10.1038/scientificamerican0998-66; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 1996, J ATTEN DISORD, V1, P41, DOI DOI 10.1177/108705479600100104; Biederman J, 1996, J AM ACAD CHILD PSY, V35, P343, DOI 10.1097/00004583-199603000-00016; Biederman J, 2008, DEV NEUROPSYCHOL, V33, P44, DOI 10.1080/87565640701729755; Boonstra AM, 2005, PSYCHOL MED, V35, P1097, DOI 10.1017/S003329170500499X; Brodeur DA, 2001, J ABNORM CHILD PSYCH, V29, P229, DOI 10.1023/A:1010381731658; Carr L, 2010, J CLIN CHILD ADOLESC, V39, P726, DOI 10.1080/15374416.2010.517168; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Chamberlain SR, 2011, BIOL PSYCHIAT, V69, P1192, DOI 10.1016/j.biopsych.2010.08.019; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Clark L, 2007, BIOL PSYCHIAT, V61, P1395, DOI 10.1016/j.biopsych.2006.07.020; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Cowan N, 2010, DEVELOPMENTAL SCI, V13, P120, DOI 10.1111/j.1467-7687.2009.00864.x; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Delvenne JF, 2011, PSYCHOPHYSIOLOGY, V48, P333, DOI 10.1111/j.1469-8986.2010.01079.x; Dige N, 2010, J ATTEN DISORD, V13, P677, DOI 10.1177/1087054709347245; Doehnert M, 2010, BIOL PSYCHIAT, V67, P608, DOI 10.1016/j.biopsych.2009.07.038; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Forster S, 2007, PSYCHOL SCI, V18, P377, DOI 10.1111/j.1467-9280.2007.01908.x; Friedman-Hill SR, 2010, COGNITION, V115, P93, DOI 10.1016/j.cognition.2009.11.013; Fukuda K, 2009, J NEUROSCI, V29, P8726, DOI 10.1523/JNEUROSCI.2145-09.2009; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gomarus HK, 2009, CLIN NEUROPHYSIOL, V120, P60, DOI 10.1016/j.clinph.2008.10.018; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Jeyakumar SLE, 2004, EDUC PSYCHOL MEAS, V64, P71, DOI 10.1177/0013164403258407; Jonkman LM, 2004, CLIN NEUROPHYSIOL, V115, P1537, DOI 10.1016/j.clinph.2004.01.022; Jonkman LM, 1999, PSYCHOPHYSIOLOGY, V36, P419; Jonkman LM, 1997, BIOL PSYCHIAT, V41, P595, DOI 10.1016/S0006-3223(96)00073-X; Jost K, 2011, CEREB CORTEX, V21, P1147, DOI 10.1093/cercor/bhq185; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Kofler MJ, 2010, J ABNORM CHILD PSYCH, V38, P149, DOI 10.1007/s10802-009-9357-6; Kooij JJS, 2005, PSYCHOL MED, V35, P817, DOI 10.1017/S003329170400337X; Kuo BC, 2012, J COGNITIVE NEUROSCI, V24, P51, DOI 10.1162/jocn_a_00087; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; Lee EY, 2010, BRAIN, V133, P2677, DOI 10.1093/brain/awq197; Lewis-Peacock JA, 2012, J COGNITIVE NEUROSCI, V24, P61, DOI 10.1162/jocn_a_00140; Lui M, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-12; Luna B, 2010, BRAIN COGNITION, V72, P101, DOI 10.1016/j.bandc.2009.08.005; Mariani MA, 1997, DEV NEUROPSYCHOL, V13, P111, DOI 10.1080/87565649709540671; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; McVay JC, 2009, PSYCHON B REV, V16, P857, DOI 10.3758/PBR.16.5.857; Peterson BS, 2009, AM J PSYCHIAT, V166, P1286, DOI 10.1176/appi.ajp.2009.08050724; Polanczyk G, 2008, CHILD ADOLESC PSYCHI, V17, pvii; Polanczyk G, 2008, CHILD ADOL PSYCH CL, V17, P245, DOI 10.1016/j.chc.2007.11.006; Rapport LJ, 2001, CLIN NEUROPSYCHOL, V15, P479, DOI 10.1076/clin.15.4.479.1878; Riggs KJ, 2006, J EXP CHILD PSYCHOL, V95, P18, DOI 10.1016/j.jecp.2006.03.009; Rogers M, 2011, CHILD NEUROPSYCHOL, V17, P444, DOI 10.1080/09297049.2010.544648; Romer D, 2011, DEVELOPMENTAL SCI, V14, P1119, DOI 10.1111/j.1467-7687.2011.01061.x; Romer D, 2009, NEUROPSYCHOLOGIA, V47, P2916, DOI 10.1016/j.neuropsychologia.2009.06.019; Rommelse NNJ, 2008, J NEURAL TRANSM, V115, P249, DOI 10.1007/s00702-007-0865-7; Sander MC, 2011, CEREB CORTEX, V21, P2809, DOI 10.1093/cercor/bhr076; Sandrini M, 2008, NEUROPSYCHOLOGIA, V46, P2056, DOI 10.1016/j.neuropsychologia.2008.02.003; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Sowerby P, 2011, J ATTEN DISORD, V15, P461, DOI 10.1177/1087054710370674; Spreen O, 1998, COMPENDIUM NEUROPSYC; Spronk M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042262; Tian LX, 2008, BRAIN DEV-JPN, V30, P342, DOI 10.1016/j.braindev.2007.10.005; Tillman C, 2011, DEV NEUROPSYCHOL, V36, P181, DOI 10.1080/87565641.2010.549981; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D., 1997, WECHSLER ADULT INTEL; Westerberg H, 2004, CHILD NEUROPSYCHOL, V10, P155, DOI 10.1080/09297040490911014	74	20	20	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62673	10.1371/journal.pone.0062673	http://dx.doi.org/10.1371/journal.pone.0062673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23650525	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000070
J	Urabe, J; Suzuki, T; Nishita, T; Makino, W				Urabe, Jotaro; Suzuki, Takao; Nishita, Tatsuki; Makino, Wataru			Immediate Ecological Impacts of the 2011 Tohoku Earthquake Tsunami on Intertidal Flat Communities	PLOS ONE			English	Article							QUALITY; FAUNA	Following the Great East Japan Earthquake in 2011, a large tsunami developed and struck the Pacific coast of eastern Japan. To assess the immediate impacts of the tsunami on coastal communities, changes in taxon composition and richness of macrobenthic animals before and after the tsunami were examined at nine intertidal flats in Sendai Bay and the Sanriku Ria coast. The results showed that 30-80% of taxa indigenously inhabiting intertidal flats disappeared after the tsunami. Among animal types, endobenthic and sessile epibenthic animals were more vulnerable to the tsunami than mobile epibenthic animals like shore crabs and snails. For all the intertidal flats examined, animals that were originally dwellers in lower tidal zones and not recorded before the tsunami were also found right after the tsunami, indicating that the tsunami not only took away many benthic taxa from the intertidal flats but also brought in some taxa from elsewhere. However, overall changes in taxon community composition were greater for intertidal flats that experienced larger inundation heights. These results showed that the ecological impacts of the tsunami were proportional to the physical impacts as gauged by wave height and that mobile epibenthic animals were less vulnerable to the tsunami.	[Urabe, Jotaro; Suzuki, Takao; Nishita, Tatsuki; Makino, Wataru] Tohoku Univ, Grad Sch Life Sci, Div Ecol & Evolutionary Biol, Sendai, Miyagi, Japan	Tohoku University	Urabe, J (corresponding author), Tohoku Univ, Grad Sch Life Sci, Div Ecol & Evolutionary Biol, Sendai, Miyagi, Japan.	urabe@m.tohoku.ac.jp	Urabe, Jotaro/ABI-7692-2020; Urabe, Jotaro/A-6256-2012	Urabe, Jotaro/0000-0001-5111-687X; Urabe, Jotaro/0000-0001-5111-687X	Mitsui & Co., Ltd. Environment Fund [F11-F1-020]; Tohoku Ecosystem-Associated Marine Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [24570018] Funding Source: KAKEN	Mitsui & Co., Ltd. Environment Fund; Tohoku Ecosystem-Associated Marine Science; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by Mitsui & Co., Ltd. Environment Fund (F11-F1-020), and research project funds, Tohoku Ecosystem-Associated Marine Science, from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balthis WL, 2006, ENVIRON MONIT ASSESS, V119, P367, DOI 10.1007/s10661-005-9031-6; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cyranoski D, 2012, NATURE, V483, P141, DOI 10.1038/483141a; Diez JM, 2012, FRONT ECOL ENVIRON, V10, P249, DOI 10.1890/110137; Fujioka Y, 2008, P 11 INT COR REEF S, P1225; Jan FGBL, 2007, SEDIMENT GEOL, V199, P1, DOI 10.1016/j.sedgeo.2006.12.007; Jaramillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035348; Kanaya Gen, 2012, Japanese Journal of Benthology, V67, P20; Kanaya G, 2011, ESTUAR COAST SHELF S, V92, P169, DOI 10.1016/j.ecss.2010.12.029; Krishnankutty N, 2006, CURR SCI INDIA, V90, P772; Legendre P, 1998, NUMERICAL ECOLOGY; Lomovasky BJ, 2011, J SEA RES, V65, P205, DOI 10.1016/j.seares.2010.10.002; Mallin MA, 1999, ECOL APPL, V9, P350, DOI 10.1890/1051-0761(1999)009[0350:HEOWQA]2.0.CO;2; Mori N, 2012, COAST ENG J, V54, DOI 10.1142/S0578563412500015; Noda A, 2007, SEDIMENT GEOL, V200, P314, DOI 10.1016/j.sedgeo.2007.01.010; Norio O, 2011, INT J DISAST RISK SC, V2, P34, DOI 10.1007/s13753-011-0004-9; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schlacher TA, 2011, ESTUAR COAST, V34, P937, DOI 10.1007/s12237-010-9354-6; Suzuki Takao, 2010, Plankton & Benthos Research, V5, P221; Thibault KM, 2008, P NATL ACAD SCI USA, V105, P3410, DOI 10.1073/pnas.0712282105; Whanpetch N, 2010, ESTUAR COAST SHELF S, V87, P246, DOI 10.1016/j.ecss.2010.01.001	21	65	66	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62779	10.1371/journal.pone.0062779	http://dx.doi.org/10.1371/journal.pone.0062779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650529	Green Submitted, Green Published, gold			2022-12-25	WOS:000319167000074
J	Wolff, JO; Nentwig, W; Gorb, SN				Wolff, Jonas O.; Nentwig, Wolfgang; Gorb, Stanislav N.			The Great Silk Alternative: Multiple Co-Evolution of Web Loss and Sticky Hairs in Spiders	PLOS ONE			English	Article							ARANEAE; EVOLUTION; SENSILLA; CAPTURE	Spiders are the most important terrestrial predators among arthropods. Their ecological success is reflected by a high biodiversity and the conquest of nearly every terrestrial habitat. Spiders are closely associated with silk, a material, often seen to be responsible for their great ecological success and gaining high attention in life sciences. However, it is often overlooked that more than half of all Recent spider species have abandoned web building or never developed such an adaptation. These species must have found other, more economic solutions for prey capture and retention, compensating the higher energy costs of increased locomotion activity. Here we show that hairy adhesive pads (scopulae) are closely associated with the convergent evolution of a vagrant life style, resulting in highly diversified lineages of at least, equal importance as the derived web building taxa. Previous studies often highlighted the idea that scopulae have the primary function of assisting locomotion, neglecting the fact that only the distal most pads (claw tufts) are suitable for those purposes. The former observations, that scopulae are used in prey capture, are largely overlooked. Our results suggest the scopulae evolved as a substitute for silk in controlling prey and that the claw tufts are, in most cases, a secondary development. Evolutionary trends towards specialized claw tufts and their composition from a low number of enlarged setae to a dense array of slender ones, as well as the secondary loss of those pads are discussed further. Hypotheses about the origin of the adhesive setae and their diversification throughout evolution are provided.	[Wolff, Jonas O.; Gorb, Stanislav N.] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Nentwig, Wolfgang] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland	University of Kiel; University of Bern	Wolff, JO (corresponding author), Univ Kiel, Inst Zool, D-24098 Kiel, Germany.	jwolff@zoologie.uni-kiel.de	Nentwig, Wolfgang/A-6624-2011	Wolff, Jonas/0000-0003-2326-0326	German Science Foundation (DFG) Initiative "Bionik" [GO995/7-1]	German Science Foundation (DFG) Initiative "Bionik"(German Research Foundation (DFG))	This work was supported by the German Science Foundation (DFG) Initiative "Bionik" (DFG grant GO995/7-1 to SNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2013, J ZOOL SYST EVOL RES, V51, P100, DOI 10.1111/jzs.12007; Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100; Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106; Briceno RD, 2012, NATURWISSENSCHAFTEN, V99, P337, DOI 10.1007/s00114-012-0901-9; Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025; Coddington JA, 2005, SPIDERS N AM IDENTIF, P18; Dunlop JA, 1995, NETH J ZOOL, V45, P513; FOELIX R, 1984, Revue Arachnologique, V5, P329; Foelix R. F., 2011, BIOL SPIDERS; Foelix R.F., 1975, P 6 INT AR C 1974, P156; FOELIX RF, 1970, J EXP ZOOL, V175, P99, DOI 10.1002/jez.1401750106; FORSTER RR, 1970, SPIDERS NZ 3; Gamble T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035982, 10.1371/journal.pone.0039429]; Gasparetto A, 2008, 066201 EUR SPAC AG A; Gertsch W.J., 1975, American Museum Novitates, VNo. 2580, P1; Gorb SN, 2001, NATURWISSENSCHAFTEN, V88, P530, DOI 10.1007/s00114-001-0274-y; Hawthorn AC, 2003, J EXP BIOL, V206, P3905, DOI 10.1242/jeb.00618; HENSCHEL JR, 1995, J NAT HIST, V29, P137, DOI 10.1080/00222939500770071; Hill DE, 2006, JUMPING SPIDER FEET, P1; HOMANN H, 1957, NATURWISSENSCHAFTEN, V44, P318, DOI 10.1007/BF00630926; Jager P, 2012, ARACHN MITT, V43, P5; Jeffree CE, 1986, INSECTS PLANT SURFAC, P23; Jocque R, 2005, ACTA ZOOL BULGAR, V1, P125; Joque R., 2007, SPIDER FAMILIES WORL; Kesel AB, 2003, J EXP BIOL, V206, P2733, DOI 10.1242/jeb.00478; Li YS, 2012, ROBOTICA, V30, P79, DOI 10.1017/S0263574711000373; Logunov Dmitri V., 1996, Bulletin of the British Arachnological Society, V10, P171; Maddison W.P., 2008, MESQUITE MODULAR SYS; MELCHERS MECHTHILD, 1967, Z MORPHOL OKOL TIERE, V58, P321, DOI 10.1007/BF00407384; Miller G.L., 1988, Bulletin of the British Arachnological Society, V7, P213; NENTWIG W, 1986, OECOLOGIA, V68, P595, DOI 10.1007/BF00378777; Nentwig W, 2012, ARANEAE SPIDERS EURO; Nentwig W, 2013, SPIDER ECOP IN PRESS; Niederegger S, 2006, J COMP PHYSIOL A, V192, P1223, DOI 10.1007/s00359-006-0157-y; Opell B, 2008, BIOL J LINN SOC, V62, P443; Peattie AM, 2007, P NATL ACAD SCI USA, V104, P18595, DOI 10.1073/pnas.0707591104; Peattie AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020485; Pekar S, 2011, NATURWISSENSCHAFTEN, V98, P593, DOI 10.1007/s00114-011-0804-1; PENNEY D, 2011, MONOGRAPH SERIES, V1; PEREZMILES F, 1994, J ARACHNOL, V22, P46; Platnick N.I., 1975, American Museum Novitates, VNo. 2575, P1; Platnick NI, 2012, WORLD SPIDER CATLOG; PRESTWICH KN, 1977, COMP BIOCHEM PHYS A, V57, P321, DOI 10.1016/0300-9629(77)90199-2; Pretto I, 2008, J BIONIC ENG, V5, P98, DOI 10.1016/S1672-6529(08)60079-7; Pugno N., 2011, PHYS PROPERTIES CERA, P111; R Development Core Team, 2011, R LANG ENV STAT COMP; RAVEN RJ, 1986, J ARACHNOL, V14, P357; Roscoe D.T., 1991, Bulletin of the British Arachnological Society, V8, P224; Rovner J.S., 1978, Symposia of the Zoological Society of London, P99; ROVNER JS, 1980, J ARACHNOL, V8, P201; Sahni V, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1019; Sameoto D, 2014, J ADHES SCI TECHNOL, V28, P354, DOI 10.1080/01694243.2012.693809; SPECK J, 1982, J COMP PHYSIOL, V148, P187, DOI 10.1007/BF00619125; TANAKA K, 1989, OECOLOGIA, V81, P459, DOI 10.1007/BF00378952; TURNBULL AL, 1973, ANNU REV ENTOMOL, V18, P305, DOI 10.1146/annurev.en.18.010173.001513; Ubick D, 2005, J ARACHNOL, V33, P63, DOI 10.1636/H03-24; Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221; Wolff JO, 2013, SCI REP IN PRESS; Wolff JO, 2012, ARTHROPOD STRUCT DEV, V41, P419, DOI 10.1016/j.asd.2012.04.004; Wolff JO, 2012, J EXP BIOL, V215, P179, DOI 10.1242/jeb.061507	61	38	39	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62682	10.1371/journal.pone.0062682	http://dx.doi.org/10.1371/journal.pone.0062682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650526	Green Published, gold			2022-12-25	WOS:000319167000071
J	Yu, Y; Wang, YS; Tong, Q; Liu, X; Su, F; Quan, FS; Guo, ZK; Zhang, Y				Yu, Yuan; Wang, Yongsheng; Tong, Qi; Liu, Xu; Su, Feng; Quan, Fusheng; Guo, Zekun; Zhang, Yong			A Site-Specific Recombinase-Based Method to Produce Antibiotic Selectable Marker Free Transgenic Cattle	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; PHAGE PHI-C31 INTEGRASE; PLURIPOTENT STEM-CELLS; NUCLEAR TRANSFER EMBRYOS; IN-VITRO DEVELOPMENT; CRE RECOMBINASE; STAPHYLOCOCCUS-AUREUS; HUMAN BETA-DEFENSIN-3; MAMMALIAN-CELLS; GENE-EXPRESSION	Antibiotic selectable marker genes have been widely used to generate transgenic animals. Once transgenic animals have been obtained, the selectable marker is no longer necessary but raises public concerns regarding biological safety. The aim of this study was to prepare competent antibiotic selectable marker free transgenic cells for somatic cell nuclear transfer (SCNT). PhiC31 intergrase was used to insert a transgene cassette into a "safe harbor'' in the bovine genome. Then, Cre recombinase was employed to excise the selectable marker under the monitoring of a fluorescent double reporter. By visually tracking the phenotypic switch from red to green fluorescence, antibiotic selectable marker free cells were easily detected and sorted by fluorescence-activated cell sorting. For safety, we used phiC31 mRNA and cell-permeant Cre protein in this study. When used as donor nuclei for SCNT, these safe harbor integrated marker-free transgenic cells supported a similar developmental competence of SCNT embryos compared with that of non-transgenic cells. After embryo transfer, antibiotic selectable marker free transgenic cattle were generated and anti-bacterial recombinant human b-defensin-3 in milk was detected during their lactation period. Thus, this approach offers a rapid and safe alternative to produce antibiotic selectable marker free transgenic farm animals, thereby making it a valuable tool to promote the healthy development and welfare of transgenic farm animals.	[Yu, Yuan; Wang, Yongsheng; Tong, Qi; Liu, Xu; Su, Feng; Quan, Fusheng; Guo, Zekun; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China.	zhangynwsuaf@gmail.com	Yu, Yuan/ABI-3655-2020; Zhang, Yong/K-7945-2016	Zhang, Yong/0000-0001-8642-4071	National Major Project for Production of Transgenic Breeding [2011ZX08007- 004]; National High Technology Research and Development Program of China (863 Program) [2011AA100303]	National Major Project for Production of Transgenic Breeding; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National Major Project for Production of Transgenic Breeding (No. 2011ZX08007- 004) and the National High Technology Research and Development Program of China (863 Program) (No. 2011AA100303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arat S, 2002, BIOL REPROD, V66, P1768, DOI 10.1095/biolreprod66.6.1768; Baba Y, 2005, MICROBIOL IMMUNOL, V49, P559, DOI 10.1111/j.1348-0421.2005.tb03753.x; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Bannerman DD, 2004, CLIN DIAGN LAB IMMUN, V11, P463, DOI 10.1128/CDLI.11.3.463-472.2004; Batchelder CA, 2005, CLONING STEM CELLS, V7, P238, DOI 10.1089/clo.2005.7.238; Bhak JS, 2006, ANIM REPROD SCI, V92, P37, DOI 10.1016/j.anireprosci.2005.04.016; Bordignon V, 2003, BIOL REPROD, V68, P2013, DOI 10.1095/biolreprod.102.010066; Brophy B, 2003, NAT BIOTECHNOL, V21, P157, DOI 10.1038/nbt783; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Chen SH, 2002, BIOL REPROD, V67, P1488, DOI 10.1095/biolreprod.102.006981; Chen XJ, 2005, J DERMATOL SCI, V40, P123, DOI 10.1016/j.jdermsci.2005.03.014; Clark AJ, 1997, NUCLEIC ACIDS RES, V25, P1009, DOI 10.1093/nar/25.5.1009; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; DALE EC, 1991, P NATL ACAD SCI USA, V88, P10558, DOI 10.1073/pnas.88.23.10558; Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007; Dobie KW, 1996, P NATL ACAD SCI USA, V93, P6659, DOI 10.1073/pnas.93.13.6659; Dunsche A, 2002, EUR J ORAL SCI, V110, P121, DOI 10.1034/j.1600-0722.2002.11186.x; Edwards JL, 2003, AM J REPROD IMMUNOL, V50, P113, DOI 10.1034/j.1600-0897.2003.00064.x; Endo S, 2002, PLANT J, V30, P115, DOI 10.1046/j.1365-313X.2002.01272.x; Gorman C, 2000, CURR OPIN BIOTECH, V11, P455, DOI 10.1016/S0958-1669(00)00127-0; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Heyman Y., 2002, Cloning and Stem Cells, V4, P47, DOI 10.1089/153623002753632048; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Huang SS, 2004, TRANSGENIC RES, V13, P451, DOI 10.1007/s11248-004-1453-3; Huber RC, 2011, TRANSGENIC RES; Hyun S, 2003, BIOL REPROD, V69, P1060, DOI 10.1095/biolreprod.102.014886; Iamtham S, 2000, NAT BIOTECHNOL, V18, P1172, DOI 10.1038/81161; Ishikawa Y, 2006, J GENE MED, V8, P646, DOI 10.1002/jgm.891; Joly S, 2004, J CLIN MICROBIOL, V42, P1024, DOI 10.1128/JCM.42.3.1024-1029.2004; Jura J, 2007, J ANIM FEED SCI, V16, P636, DOI 10.22358/jafs/66820/2007; Karow M, 2011, STEM CELLS, V29, P1696, DOI 10.1002/stem.730; Kerr DE, 2001, NAT BIOTECHNOL, V19, P66, DOI 10.1038/83540; Kind A, 2008, TRANSGENIC RES, V17, P1025, DOI 10.1007/s11248-008-9206-3; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Krepulat F, 2005, ONCOGENE, V24, P4645, DOI 10.1038/sj.onc.1208557; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Li B, 2010, J BIOTECHNOL, V145, P206, DOI 10.1016/j.jbiotec.2009.11.010; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Lim KT, 2007, THERIOGENOLOGY, V67, P293, DOI 10.1016/j.theriogenology.2006.07.011; Liu J, 2006, GENE THER, V13, P1188, DOI 10.1038/sj.gt.3302789; Liu J, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-31; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Ma QW, 2006, BIOCHEM BIOPH RES CO, V345, P984, DOI 10.1016/j.bbrc.2006.04.145; Maga EA, 2006, FOODBORNE PATHOG DIS, V3, P384, DOI 10.1089/fpd.2006.3.384; Midorikawa K, 2003, INFECT IMMUN, V71, P3730, DOI 10.1128/IAI.71.7.3730-3739.2003; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Nolden L, 2006, NAT METHODS, V3, P461, DOI 10.1038/NMETH884; Oback Bjorn, 2002, Cloning and Stem Cells, V4, P147, DOI 10.1089/153623002320253328; Ortiz-Urda S, 2002, NAT MED, V8, P1166, DOI 10.1038/nm766; Ou HL, 2009, FEBS J, V276, P155, DOI 10.1111/j.1742-4658.2008.06762.x; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Pilbrough W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008432; Qu LJ, 2012, J GENET GENOMICS, V39, P217, DOI 10.1016/j.jgg.2012.03.004; Quenneville SP, 2004, MOL THER, V10, P679, DOI 10.1016/j.ymthe.2004.05.034; Ramirez A, 2001, GENETICS, V158, P341; Rizos D, 2005, THERIOGENOLOGY, V63, P939, DOI 10.1016/j.theriogenology.2004.05.008; Roh S, 2000, REPROD FERT DEVELOP, V12, P1, DOI 10.1071/RD00021; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Sendai Y, 2006, TRANSPLANTATION, V81, P760, DOI 10.1097/01.tp.0000190422.66657.f1; Shin MR, 2002, MOL REPROD DEV, V62, P74, DOI 10.1002/mrd.10069; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; TAKAHASHI Y, 1992, THERIOGENOLOGY, V37, P963, DOI 10.1016/0093-691X(92)90096-A; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; VANDEURSEN J, 1995, P NATL ACAD SCI USA, V92, P7376, DOI 10.1073/pnas.92.16.7376; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wang S, 2009, THERIOGENOLOGY, V72, P535, DOI 10.1016/j.theriogenology.2009.04.009; Wang YS, 2011, CELL REPROGRAM, V13, P297, DOI 10.1089/cell.2010.0098; Wheeler MB, 2007, TRENDS BIOTECHNOL, V25, P204, DOI 10.1016/j.tibtech.2007.03.006; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wuensch A, 2007, BIOL REPROD, V76, P983, DOI 10.1095/biolreprod.106.058776; Xu YY, 2008, GENE, V419, P70, DOI 10.1016/j.gene.2008.04.020; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Ye L, 2010, P NATL ACAD SCI USA, V107, P19467, DOI 10.1073/pnas.1012677107; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zakhartchenko V, 2001, MOL REPROD DEV, V60, P362, DOI 10.1002/mrd.1098; Zhang Y, 2009, TRANSGENIC RES, V18, P607, DOI 10.1007/s11248-009-9251-6	79	25	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62457	10.1371/journal.pone.0062457	http://dx.doi.org/10.1371/journal.pone.0062457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658729	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000046
J	Branchi, I; Santarelli, S; Capoccia, S; Poggini, S; D'Andrea, I; Cirulli, F; Alleva, E				Branchi, Igor; Santarelli, Sara; Capoccia, Sara; Poggini, Silvia; D'Andrea, Ivana; Cirulli, Francesca; Alleva, Enrico			Antidepressant Treatment Outcome Depends on the Quality of the Living Environment: A Pre-Clinical Investigation in Mice	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; DEPRESSION-LIKE BEHAVIORS; ELEMENT-BINDING PROTEIN; CHRONIC FLUOXETINE; MESSENGER-RNA; SOCIOECONOMIC-STATUS; TREATMENT RESPONSE; RAT-BRAIN; STRESS; EXPRESSION	Antidepressants represent the standard treatment for major depression. However, their efficacy is variable and incomplete. A growing number of studies suggest that the environment plays a major role in determining the efficacy of these drugs, specifically of selective serotonin reuptake inhibitors (SSRI). A recent hypothesis posits that the increase in serotonin levels induced by SSRI may not affect mood per se, but enhances neural plasticity and, consequently, renders the individual more susceptible to the influence of the environment. Thus, SSRI administration in a favorable environment would lead to a reduction of symptoms, while in a stressful environment might lead to a worse prognosis. To test this hypothesis, we treated C57BL/6 adult male mice with chronic fluoxetine while exposing them to either (i) an enriched environment, after exposure to a chronic stress period aimed at inducing a depression-like phenotype, or (ii) a stressful environment. Anhedonia, brain BDNF and circulating corticosterone levels, considered endophenotypes of depression, were investigated. Mice treated with fluoxetine in an enriched condition improved their depression-like phenotype compared to controls, displaying higher saccharin preference, higher brain BDNF levels and reduced corticosterone levels. By contrast, when chronic fluoxetine administration occurred in a stressful condition, mice showed a more distinct worsening of the depression-like profile, displaying a faster decrease of saccharin preference, lower brain BDNF levels and increased corticosterone levels. Our findings suggest that the effect of SSRI on depression-like phenotypes in mice is not determined by the drug per se but is induced by the drug and driven by the environment. These findings may be helpful to explain variable effects of SSRI found in clinical practice and to device strategies aimed at enhancing their efficacy by means of controlling environmental conditions.	[Branchi, Igor; Santarelli, Sara; Capoccia, Sara; Poggini, Silvia; Cirulli, Francesca; Alleva, Enrico] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Branchi, Igor] Univ Zurich, Inst Anat, Zurich, Switzerland; [D'Andrea, Ivana] Neuromed Insitute Technol Pk, Dept Neuro & Cardiovasc Pathol, Pozzilli, Italy	Istituto Superiore di Sanita (ISS); University of Zurich; IRCCS Neuromed	Branchi, I (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	branchi@iss.it	Cirulli, Francesca/B-1581-2013; Poggini, Silvia/H-9286-2018; Branchi, Igor/N-9897-2017	Cirulli, Francesca/0000-0001-9440-1873; Poggini, Silvia/0000-0002-3711-3725; Branchi, Igor/0000-0003-4484-3598; Alleva, Enrico/0000-0002-9633-7657	Italian Ministry of Health; EU; Marie Curie IEF fellowship [302881 - Acronym: MODELMOOD]	Italian Ministry of Health(Ministry of Health, Italy); EU(European Commission); Marie Curie IEF fellowship(European Commission)	Funding for this study was provided by the Italian Ministry of Health, Ricerca Finalizzata 2009, Fasc. 12AF to FC and Ricerca Finalizzata 2008, Fasc. 10BF to EA, and Fondazione Veronesi 2012 to FC. IB was supported by EU, Marie Curie IEF fellowship for Experienced Researcher n: 302881 - Acronym: MODELMOOD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alboni S, 2010, EUR J PHARMACOL, V643, P180, DOI 10.1016/j.ejphar.2010.06.028; Altieri M, 2004, BRAIN RES, V1000, P148, DOI 10.1016/j.brainres.2003.12.028; Anacker C, 2011, PSYCHONEUROENDOCRINO, V36, P415, DOI 10.1016/j.psyneuen.2010.03.007; Angell M, 2008, JAMA-J AM MED ASSOC, V300, P1069, DOI 10.1001/jama.300.9.1069; Balak N, 2007, EUR J NEUROL, V14, pE9, DOI 10.1111/j.1468-1331.2006.01570.x; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Berry A, 2012, PSYCHONEUROENDOCRINO, V37, P762, DOI 10.1016/j.psyneuen.2011.09.007; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Branchi I, 2011, PSYCHONEUROENDOCRINO, V36, P339, DOI 10.1016/j.psyneuen.2010.08.011; Branchi I, 2010, PSYCHONEUROENDOCRINO, V35, P743, DOI 10.1016/j.psyneuen.2009.10.016; Brenes JC, 2009, BEHAV BRAIN RES, V198, P199, DOI 10.1016/j.bbr.2008.10.036; Brummett BH, 2008, BEHAV GENET, V38, P34, DOI 10.1007/s10519-007-9172-1; Chourbaji S, 2012, NEUROSCIENCE, V220, P267, DOI 10.1016/j.neuroscience.2012.06.016; Chourbaji S, 2008, STRESS, V11, P170, DOI 10.1080/10253890701560119; Chourbaji S, 2011, NEUROSCI BIOBEHAV R, V35, P599, DOI 10.1016/j.neubiorev.2010.07.003; Cirulli F, 2009, FRONT NEUROENDOCRIN, V30, P379, DOI 10.1016/j.yfrne.2009.05.002; Cohen A, 2006, ARCH GEN PSYCHIAT, V63, P50, DOI 10.1001/archpsyc.63.1.50; Cohen A, 2009, SOC PSYCH PSYCH EPID, V44, P272, DOI 10.1007/s00127-008-0436-8; Conti AC, 2002, J NEUROSCI, V22, P3262, DOI 10.1523/JNEUROSCI.22-08-03262.2002; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Eley TC, 2004, MOL PSYCHIATR, V9, P908, DOI 10.1038/sj.mp.4001546; Feifel David, 2008, Psychiatry (Edgmont), V5, P35; Fountoulakis KN, 2011, INT J NEUROPSYCHOPH, V14, P405, DOI 10.1017/S1461145710000957; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Goekint M, 2011, NEUROSCI LETT, V494, P150, DOI 10.1016/j.neulet.2011.03.001; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hellweg R, 2008, PHARMACOPSYCHIATRY, V41, P66, DOI 10.1055/s-2007-1004594; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Homberg JR, 2012, BEHAV BRAIN SCI, V35, P368, DOI 10.1017/S0140525X1200101X; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; Jacobsen JPR, 2006, BRAIN RES, V1110, P221, DOI 10.1016/j.brainres.2006.06.077; Jacobsen JPR, 2004, BRAIN RES, V1024, P183, DOI 10.1016/j.brainres.2004.07.065; Karpova NN, 2011, SCIENCE, V334, P1731, DOI 10.1126/science.1214592; Kirsch I, 2010, EMPERORS NEW DRUGS E; Kirsch I, 2002, PREV TREAT, V5; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kiser D, 2011, NEUROSCI BIOBEHAV RE; Knapska E, 2006, LEARN MEMORY, V13, P192, DOI 10.1101/lm.54706; Kozisek ME, 2008, PHARMACOL THERAPEUT, V117, P30, DOI 10.1016/j.pharmthera.2007.07.001; Kramer, 1994, LISTENING PROZAC PSY; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McAllister-Williams RH, 2008, EVID-BASED MENT HEAL, V11, P66, DOI 10.1136/ebmh.11.3.66; Mechan AO, 2009, J NEUROSCI METH, V180, P43, DOI 10.1016/j.jneumeth.2009.02.018; Miro X, 2002, NEUROPHARMACOLOGY, V43, P1148, DOI 10.1016/S0028-3908(02)00220-4; Moncrieff J, 2005, BMJ-BRIT MED J, V331, P155, DOI 10.1136/bmj.331.7509.155; Moncrieff J, 2003, INT J METH PSYCH RES, V12, P117, DOI 10.1002/mpr.148; Moncrieff J, 2005, COCHRANE LIB, P4; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Nibuya M, 1996, J NEUROSCI, V16, P2365; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Pariante CM, 2004, PSYCHONEUROENDOCRINO, V29, P423, DOI 10.1016/j.psyneuen.2003.10.009; Prendergast Mark A, 2002, Med Sci Monit, V8, pBR385; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; Rygula R, 2006, BEHAV PHARMACOL, V17, P19, DOI 10.1097/01.fbp.0000186631.53851.71; Sammut S, 2002, PHYSIOL BEHAV, V75, P765, DOI 10.1016/S0031-9384(02)00677-7; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Shen QY, 2010, BIOL PSYCHIAT, V68, P512, DOI 10.1016/j.biopsych.2010.04.024; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Tonissaar M, 2008, PROG NEURO-PSYCHOPH, V32, P164, DOI 10.1016/j.pnpbp.2007.08.001; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Uys JDK, 2006, NEUROSCIENCE, V137, P619, DOI 10.1016/j.neuroscience.2005.08.089; Weber CC, 2006, NEUROPSYCHOPHARMACOL, V31, P2443, DOI 10.1038/sj.npp.1301076; Wiles N., 2012, LANCET; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; World Health Organization, 2010, EQUI HLTH; World Health Organization, 2008, GLOB BURD DIS 2004 U; Zetterstrom TSC, 1999, NEUROPHARMACOLOGY, V38, P1063, DOI 10.1016/S0028-3908(99)00022-2	72	68	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62226	10.1371/journal.pone.0062226	http://dx.doi.org/10.1371/journal.pone.0062226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23653679	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300031
J	Gangappa, SN; Maurya, JP; Yadav, V; Chattopadhyay, S				Gangappa, Sreeramaiah N.; Maurya, Jay P.; Yadav, Vandana; Chattopadhyay, Sudip			The Regulation of the Z- and G-Box Containing Promoters by Light Signaling Components, SPA1 and MYC2, in Arabidopsis	PLOS ONE			English	Article							MEDIATED PHOTOMORPHOGENIC GROWTH; TRANSCRIPTION-FACTOR; HIGHER-PLANTS; GENE-EXPRESSION; SEEDLING DEVELOPMENT; PHYTOCHROME; HY5; PROTEIN; COP1; TRANSDUCTION	Although many transcription factors and regulatory proteins have been identified and functionally characterized in light signaling pathways, photoperception to transcription remains largely fragmented. The Z-box is one of the LREs (Light responsive elements) that plays important role in the regulation of transcription during light-controlled Arabidopsis seedling development. The involvement of photoreceptors in the modulation of the activity of the Z-box containing promoters has been demonstrated. However, the role of downstream signaling components such as SPA1 and MYC2/ZBF1, which are functionally interrelated, remains unknown. In this study, we have investigated the regulation of the Z-box containing synthetic and native promoters by SPA1 and MYC2 by using stable transgenic lines. Our studies suggest that SPA1 negatively regulates the expression of CAB1 native promoter. MYC2 negatively regulates the activity of Z- and/or Gbox containing synthetic as well as native promoters irrespective of light quality. Moreover, MYC2 negatively regulates the expression of Z/G-NOS101-GUS even in the darkness. Furthermore, analyses of tissue specific expression in adult plants suggest that MYC2 strongly regulates the activity of Z-and G-box containing promoters specifically in leaves and stems. In roots, whereas MYC2 positively regulates the activity of the Z-box containing synthetic promoter, it does not seem to control the activity of the G-box containing promoters. Taken together, these results provide insights into SPA1-and MYC2mediated transcriptional regulation of the Z- and G-box containing promoters in light signaling pathways.	[Gangappa, Sreeramaiah N.; Maurya, Jay P.; Chattopadhyay, Sudip] Natl Inst Technol, Durgapur, India; [Yadav, Vandana; Chattopadhyay, Sudip] Natl Inst Plant Genome Res, New Delhi, India	National Institute of Technology (NIT System); National Institute of Technology Durgapur; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Chattopadhyay, S (corresponding author), Natl Inst Technol, Durgapur, India.	sudipchatto@gmail.com	Gangappa, Sreeramaiah N/B-3005-2011; Gangappa, Sreeramaiah/I-9873-2014; Gangappa, Sreeramaiah N/AAL-3822-2020; Maurya, Jay Prakash/AAT-4001-2020; Chattopadhyay, Sudip/P-8491-2014	Gangappa, Sreeramaiah/0000-0003-1087-1523; Maurya, Jay Prakash/0000-0002-5105-7133; Gangappa, Sreeramaiah N./0000-0003-2171-1066	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work is supported by J.C. Bose National Fellowship Award Grant from Department of Science and Technology, Government of India (http://www.dst.gov.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Arguello-Astorga G, 1998, ANNU REV PLANT PHYS, V49, P525, DOI 10.1146/annurev.arplant.49.1.525; Bhatia S, 2008, PLANT PHYSIOL, V147, P169, DOI 10.1104/pp.108.118174; Chattopadhyay S, 1998, PLANT J, V15, P69, DOI 10.1046/j.1365-313X.1998.00180.x; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Chen M, 2011, TRENDS CELL BIOL, V21, P664, DOI 10.1016/j.tcb.2011.07.002; Deng XW, 1999, SEMIN CELL DEV BIOL, V10, P121, DOI 10.1006/scdb.1999.0287; DONALD RGK, 1990, EMBO J, V9, P1717, DOI 10.1002/j.1460-2075.1990.tb08295.x; Gangappa SN, 2010, PLANT SIGNAL BEHAV, V5, P1650, DOI 10.4161/psb.5.12.13981; Gangappa SN, 2010, PLANT PHYSIOL, V154, P1210, DOI 10.1104/pp.110.163717; GILMARTIN PM, 1990, PLANT CELL, V2, P369, DOI 10.1105/tpc.2.5.369; HA SB, 1988, P NATL ACAD SCI USA, V85, P8017, DOI 10.1073/pnas.85.21.8017; Hoecker U, 1998, PLANT CELL, V10, P19, DOI 10.1105/tpc.10.1.19; Hoecker U, 2001, J BIOL CHEM, V276, P38173; Hoecker U, 1999, SCIENCE, V284, P496, DOI 10.1126/science.284.5413.496; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; KUHLEMEIER C, 1987, ANNU REV PLANT PHYS, V38, P221; Kushwaha R, 2008, PLANT CELL, V20, P1747, DOI 10.1105/tpc.107.057612; Laubinger S, 2004, PLANT CELL, V16, P2293, DOI 10.1105/tpc.104.024216; Laubinger S, 2003, PLANT J, V35, P373, DOI 10.1046/j.1365-313X.2003.01813.x; Laubinger S, 2006, DEVELOPMENT, V133, P3213, DOI 10.1242/dev.02481; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Mallappa C, 2008, J BIOL CHEM, V283, P35772, DOI 10.1074/jbc.M803437200; Mallappa C, 2006, J BIOL CHEM, V281, P22190, DOI 10.1074/jbc.M601172200; MANZARA T, 1991, PLANT CELL, V3, P1305, DOI 10.1105/tpc.3.12.1305; MCNELLIS TW, 1995, PLANT CELL, V7, P1749, DOI 10.1105/tpc.7.11.1749; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; MITRA A, 1989, MOL GEN GENET, V215, P294, DOI 10.1007/BF00339731; Mol J, 1996, CRIT REV PLANT SCI, V15, P525, DOI 10.1080/07352689609382369; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Prasad VBR, 2012, MECH DEVELOP, V129, P298, DOI 10.1016/j.mod.2012.06.004; Puente P, 1996, EMBO J, V15, P3732, DOI 10.1002/j.1460-2075.1996.tb00743.x; Saijo Y, 2003, GENE DEV, V17, P2642, DOI 10.1101/gad.1122903; Salisbury FJ, 2007, PLANT J, V50, P429, DOI 10.1111/j.1365-313X.2007.03059.x; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Shin J, 2012, PLANT CELL, V24, P2470, DOI 10.1105/tpc.111.095430; Sibout R, 2006, PLOS GENET, V2, P1898, DOI 10.1371/journal.pgen.0020202; Singh A, 2012, J BIOL CHEM, V287, P25995, DOI 10.1074/jbc.M111.333906; Singh KB, 1998, PLANT PHYSIOL, V118, P1111, DOI 10.1104/pp.118.4.1111; Tepperman JM, 2001, P NATL ACAD SCI USA, V98, P9437, DOI 10.1073/pnas.161300998; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; THOMPSON WF, 1991, ANNU REV PLANT PHYS, V42, P423, DOI 10.1146/annurev.pp.42.060191.002231; Tobin Elaine M., 1994, Seminars in Cell Biology, V5, P335, DOI 10.1006/scel.1994.1040; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Yadav V, 2002, PLANT J, V31, P741, DOI 10.1046/j.1365-313X.2002.01395.x; Yang JP, 2005, PLANT J, V43, P131, DOI 10.1111/j.1365-313X.2005.02433.x; Yang JP, 2005, PLANT CELL, V17, P804, DOI 10.1105/tpc.104.030205	50	21	23	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62194	10.1371/journal.pone.0062194	http://dx.doi.org/10.1371/journal.pone.0062194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646119	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300029
J	Chandler, JA; James, PM				Chandler, James Angus; James, Pamela M.			Discovery of Trypanosomatid Parasites in Globally Distributed Drosophila Species	PLOS ONE			English	Article							INSECT TRYPANOSOMATIDS; COSTA-RICA; HETEROPTERA; WOLBACHIA; DENGUE; MODEL; DIVERSITY; EVOLUTION; INFECTION; SYMBIONT	Microbial parasites of animals include bacteria, viruses, and various unicellular eukaryotes. Because of the difficulty in studying these microorganisms in both humans and disease vectors, laboratory models are commonly used for experimental analysis of host-parasite interactions. Drosophila is one such model that has made significant contributions to our knowledge of bacterial, fungal, and viral infections. Despite this, less is known about other potential parasites associated with natural Drosophila populations. Here, we surveyed sixteen Drosophila populations comprising thirteen species from four continents and Hawaii and found that they are associated with an extensive diversity of trypanosomatids (Euglenozoa, Kinetoplastea). Phylogenetic analysis finds that Drosophila-associated trypanosomatids are closely related to taxa that are responsible for various types of leishmaniases and more distantly related to the taxa responsible for human African trypanosomiasis and Chagas disease. We suggest that Drosophila may provide a powerful system for studying the interactions between trypanosomatids and their hosts.	[Chandler, James Angus] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Chandler, JA (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	jschandler@ucdavis.edu			UC-Davis Center for Population Biology Graduate Student Research Award; UC-Davis President's Undergraduate Fellowship; NSF [IOS-0815141]; REU; Alfred P. Sloan Foundation grant	UC-Davis Center for Population Biology Graduate Student Research Award; UC-Davis President's Undergraduate Fellowship; NSF(National Science Foundation (NSF)); REU; Alfred P. Sloan Foundation grant	This work was supported by a UC-Davis Center for Population Biology Graduate Student Research Award to JAC, a UC-Davis President's Undergraduate Fellowship to PMJ, NSF grant IOS-0815141 and REU supplement to Artyom Kopp, and an Alfred P. Sloan Foundation grant to Jonathan A. Eisen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Boulanger N, 2001, INSECT BIOCHEM MOLEC, V31, P129, DOI 10.1016/S0965-1748(00)00096-5; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; Brandt SM, 2008, GENETICS, V180, P1671, DOI 10.1534/genetics.108.089748; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chandler JA, 2012, APPL ENVIRON MICROB, V78, P7327, DOI 10.1128/AEM.01741-12; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chatton E, 1908, CR HEBD ACAD SCI, V64, P3; Crompton DWT, 2010, WORK OV GLOB IMP NEG, Vix; Ebbert MA, 2001, J INVERTEBR PATHOL, V77, P27, DOI 10.1006/jipa.2000.4989; Farikou O, 2010, INFECT GENET EVOL, V10, P115, DOI 10.1016/j.meegid.2009.10.008; FERNANDES AP, 1993, P NATL ACAD SCI USA, V90, P11608, DOI 10.1073/pnas.90.24.11608; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jirku M, 2012, J EUKARYOTIC MICROBI; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Mackay TEC, 2006, ANNU REV GENOM HUM G, V7, P339, DOI 10.1146/annurev.genom.7.080505.115758; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; Markow T. A., 2006, DROSOPHILA GUIDE SPE; Maslov DA, 2007, J EUKARYOT MICROBIOL, V54, P57, DOI 10.1111/j.1550-7408.2006.00150.x; Maslov DA, 2013, TRENDS PARASITOL, V29, P43, DOI 10.1016/j.pt.2012.11.001; Maslov DA, 2010, J EUKARYOT MICROBIOL, V57, P177, DOI 10.1111/j.1550-7408.2009.00464.x; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; MCGHEE RB, 1980, MICROBIOL REV, V44, P140, DOI 10.1128/MMBR.44.1.140-173.1980; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Newman T, 2011, EXPERT OPIN DRUG DIS, V6, P129, DOI 10.1517/17460441.2011.549124; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Podlipaev S, 2001, INT J PARASITOL, V31, P648, DOI 10.1016/S0020-7519(01)00139-4; Podlipaev SA, 1990, LEN P ZOOL I USSR AC; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2014, TRACER V1 6; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rogers GB, 2011, J CYST FIBROS, V10, P387, DOI 10.1016/j.jcf.2011.06.014; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROWTON ED, 1978, J PROTOZOOL, V25, P232, DOI 10.1111/j.1550-7408.1978.tb04402.x; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneider D, 2000, SCIENCE, V288, P2376, DOI 10.1126/science.288.5475.2376; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; VICKERMAN K, 1988, BIOL CELL, V64, P109, DOI 10.1016/0248-4900(88)90070-6; Votypka J, 2012, PROTIST, V163, P616, DOI 10.1016/j.protis.2011.12.004; Votypka J, 2012, INT J PARASITOL, V42, P489, DOI 10.1016/j.ijpara.2012.03.007; Votypka J, 2010, MOL PHYLOGENET EVOL, V54, P243, DOI 10.1016/j.ympev.2009.10.014; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Westenberger SJ, 2004, PARASITOLOGY, V129, P537, DOI 10.1017/S003118200400592X; Wilfert L, 2011, PARASITOLOGY, V138, P858, DOI 10.1017/S0031182011000485; Yurchenko VY, 2006, PARASITOLOGY, V133, P537, DOI 10.1017/S0031182006000746	57	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e61937	10.1371/journal.pone.0061937	http://dx.doi.org/10.1371/journal.pone.0061937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658617	gold, Green Submitted, Green Published			2022-12-25	WOS:000321662800017
J	Remenyi, J; van den Bosch, MWM; Palygin, O; Mistry, RB; McKenzie, C; Macdonald, A; Hutvagner, G; Arthur, JSC; Frenguelli, BG; Pankratov, Y				Remenyi, Judit; van den Bosch, Mirjam W. M.; Palygin, Oleg; Mistry, Rajen B.; McKenzie, Colin; Macdonald, Andrew; Hutvagner, Gyorgy; Arthur, J. Simon C.; Frenguelli, Bruno G.; Pankratov, Yuriy			miR-132/212 Knockout Mice Reveal Roles for These miRNAs in Regulating Cortical Synaptic Transmission and Plasticity	PLOS ONE			English	Article							COCAINE INTAKE; MICRORNA; CREB; MSK1; ACTIVATION; EXPRESSION; PHOSPHORYLATION; TRANSCRIPTION; HIPPOCAMPUS; GENERATION	miR-132 and miR-212 are two closely related miRNAs encoded in the same intron of a small non-coding gene, which have been suggested to play roles in both immune and neuronal function. We describe here the generation and initial characterisation of a miR-132/212 double knockout mouse. These mice were viable and fertile with no overt adverse phenotype. Analysis of innate immune responses, including TLR-induced cytokine production and IFN beta induction in response to viral infection of primary fibroblasts did not reveal any phenotype in the knockouts. In contrast, the loss of miR-132 and miR-212, while not overtly affecting neuronal morphology, did affect synaptic function. In both hippocampal and neocortical slices miR-132/212 knockout reduced basal synaptic transmission, without affecting paired-pulse facilitation. Hippocampal long-term potentiation (LTP) induced by tetanic stimulation was not affected by miR-132/212 deletion, whilst theta burst LTP was enhanced. In contrast, neocortical theta burst-induced LTP was inhibited by loss of miR-132/212. Together these results indicate that miR-132 and/or miR-212 play a significant role in synaptic function, possibly by regulating the number of postsynaptic AMPA receptors under basal conditions and during activity-dependent synaptic plasticity.	[Remenyi, Judit; Hutvagner, Gyorgy] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat, Dundee, Scotland; [van den Bosch, Mirjam W. M.; Arthur, J. Simon C.] Univ Dundee, MRC Prot Phosphorylat Unit, Coll Life Sci, Dundee, Scotland; [Palygin, Oleg; Mistry, Rajen B.; McKenzie, Colin; Frenguelli, Bruno G.; Pankratov, Yuriy] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Macdonald, Andrew] Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Arthur, J. Simon C.] Univ Dundee, Div Cell Signalling & Immunol, Coll Life Sci, Dundee, Scotland	University of Dundee; University of Dundee; University of Warwick; University of Leeds; University of Dundee	Arthur, JSC (corresponding author), Univ Dundee, MRC Prot Phosphorylat Unit, Coll Life Sci, Dundee, Scotland.	j.s.c.arthur@dundee.ac.uk; B.G.Frenguelli@warwick.ac.uk; Y.Pankratov@warwick.ac.uk	Palygin, Oleg/AAT-3047-2020; Frenguelli, Bruno/C-5007-2015	Palygin, Oleg/0000-0002-3680-5527; Frenguelli, Bruno/0000-0001-7214-3172; Macdonald, Andrew/0000-0002-5978-4693; Arthur, Simon/0000-0002-8135-1958; Hutvagner, Gyorgy/0000-0002-7231-9446	Medical Research Council; Biotechnology and Biological Sciences Research Council; Wellcome Trust; European Union Sixth Framework Programme (FP6, SIROCCO); BBSRC [BB/F021445/1] Funding Source: UKRI; MRC [MC_U127081014] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F021445/1] Funding Source: researchfish; Medical Research Council [MC_U127081014] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); European Union Sixth Framework Programme (FP6, SIROCCO); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Medical Research Council, Biotechnology and Biological Sciences Research Council, Wellcome Trust and European Union Sixth Framework Programme (FP6, SIROCCO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Clovis YM, 2012, DEVELOPMENT, V139, P3332, DOI 10.1242/dev.078063; Correa SAL, 2012, J NEUROSCI, V32, P13039, DOI 10.1523/JNEUROSCI.0930-12.2012; Darragh J, 2010, BIOCHEM J, V425, P595, DOI 10.1042/BJ20091062; Delaney KR, 2002, CURR PROTOC NEUROSCI; Deplagne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018645; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Frenguelli BG, 2007, J NEUROCHEM, V101, P1400, DOI 10.1111/j.1471-4159.2006.04425.x; Hansen KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015497; Ho VM, 2011, SCIENCE, V334, P623, DOI 10.1126/science.1209236; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lambert TJ, 2011, PLOS ONE, V5; Lee HK, 2011, SEMIN CELL DEV BIOL, V22, P514, DOI 10.1016/j.semcdb.2011.06.007; Luikart BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019077; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Molnar V, 2012, CELL MOL LIFE SCI, V69, P793, DOI 10.1007/s00018-011-0786-3; Monk CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013669; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; O'Neill LAJ, 2009, IMMUNITY, V31, P854, DOI 10.1016/j.immuni.2009.11.004; Pankratov Y, 2007, J GEN PHYSIOL, V129, P257, DOI 10.1085/jgp.200609693; Pankratov YV, 2003, BIOPHYS J, V85, P3375, DOI 10.1016/S0006-3495(03)74757-2; Pathania M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038174; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tognini P, 2011, NAT NEUROSCI, V14, P1237, DOI 10.1038/nn.2920; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wingate AD, 2009, GENESIS, V47, P688, DOI 10.1002/dvg.20548; Zaragoza R, 2010, BIOCHEM J, V428, P451, DOI 10.1042/BJ20091091	48	103	106	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62509	10.1371/journal.pone.0062509	http://dx.doi.org/10.1371/journal.pone.0062509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658634	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700060
J	Spindler, MJ; Burmeister, BT; Huang, Y; Hsiao, EC; Salomonis, N; Scott, MJ; Srivastava, D; Carnegie, GK; Conklin, BR				Spindler, Matthew J.; Burmeister, Brian T.; Huang, Yu; Hsiao, Edward C.; Salomonis, Nathan; Scott, Mark J.; Srivastava, Deepak; Carnegie, Graeme K.; Conklin, Bruce R.			AKAP13 Rho-GEF and PKD-Binding Domain Deficient Mice Develop Normally but Have an Abnormal Response to beta-Adrenergic-Induced Cardiac Hypertrophy	PLOS ONE			English	Article							PROTEIN-KINASE-A; INDUCED CARDIOMYOCYTE HYPERTROPHY; EXCHANGE FACTOR AKAP13; ANCHORING PROTEIN; SIGNALING COMPLEX; CELL INVASIVENESS; HEART-FAILURE; BREAST-CANCER; RECEPTOR; MOUSE	Background: A-kinase anchoring proteins (AKAPs) are scaffolding molecules that coordinate and integrate G-protein signaling events to regulate development, physiology, and disease. One family member, AKAP13, encodes for multiple protein isoforms that contain binding sites for protein kinase A (PKA) and D (PKD) and an active Rho-guanine nucleotide exchange factor (Rho-GEF) domain. In mice, AKAP13 is required for development as null embryos die by embryonic day 10.5 with cardiovascular phenotypes. Additionally, the AKAP13 Rho-GEF and PKD-binding domains mediate cardiomyocyte hypertrophy in cell culture. However, the requirements for the Rho-GEF and PKD-binding domains during development and cardiac hypertrophy are unknown. Methodology/Principal Findings: To determine if these AKAP13 protein domains are required for development, we used gene-trap events to create mutant mice that lacked the Rho-GEF and/or the protein kinase D-binding domains. Surprisingly, heterozygous matings produced mutant mice at Mendelian ratios that had normal viability and fertility. The adult mutant mice also had normal cardiac structure and electrocardiograms. To determine the role of these domains during beta-adrenergic-induced cardiac hypertrophy, we stressed the mice with isoproterenol. We found that heart size was increased similarly in mice lacking the Rho-GEF and PKD-binding domains and wild-type controls. However, the mutant hearts had abnormal cardiac contractility as measured by fractional shortening and ejection fraction. Conclusions: These results indicate that the Rho-GEF and PKD-binding domains of AKAP13 are not required for mouse development, normal cardiac architecture, or beta-adrenergic-induced cardiac hypertrophic remodeling. However, these domains regulate aspects of beta-adrenergic-induced cardiac hypertrophy.	[Spindler, Matthew J.; Huang, Yu; Scott, Mark J.; Srivastava, Deepak; Conklin, Bruce R.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Spindler, Matthew J.; Conklin, Bruce R.] Univ Calif San Francisco, Grad Program Pharmaceut Sci & Pharmacogen, San Francisco, CA 94143 USA; [Burmeister, Brian T.; Carnegie, Graeme K.] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Hsiao, Edward C.] Univ Calif San Francisco, Dept Med, Div Endocrinol & Metab, San Francisco, CA USA; [Hsiao, Edward C.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Salomonis, Nathan] Calif Pacif Med Ctr Res Inst, San Francisco, CA USA; [Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; California Pacific Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Spindler, MJ (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA USA.	mspindler@gladstone.ucsf.edu	Conklin, Bruce/E-4738-2019	Conklin, Bruce/0000-0003-1463-6061	National Institutes of Health [RO1 HL60664, UO1 HL100406, 7 K08 AR056299-02, P01HL089707]; University of Illinois at Chicago Department of Cardiology [5T32HL072742-09]; American Heart Association Western States Predoctoral Fellowship [0715027Y]; National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences Grant [UL1TR000050]; California Institute of Regenerative Medicine; Younger Family Foundation; L.K. Whittier Foundation; Eugene Roddenberry Foundation; National Center for Research Resources [RR18928]; American Heart Association [11SDG5230003]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060664, T32HL072742, U01HL100406, P01HL089707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR056299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Chicago Department of Cardiology; American Heart Association Western States Predoctoral Fellowship; National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences Grant; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Younger Family Foundation; L.K. Whittier Foundation; Eugene Roddenberry Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health grants RO1 HL60664 and UO1 HL100406 (to BRC), 7 K08 AR056299-02 (to ECH), and T32 Training Grant 5T32HL072742-09 through the University of Illinois at Chicago Department of Cardiology (BTB). Fellowship support was provided by the American Heart Association Western States Predoctoral Fellowship 0715027Y (to MJSpindler). GKC received funding from the American Heart Association Grant 11SDG5230003 and the National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences Grant UL1TR000050. DS received funding from the National Institutes of Health grant P01HL089707, the California Institute of Regenerative Medicine, the Younger Family Foundation, the L.K. Whittier Foundation and the Eugene Roddenberry Foundation. The J. David Gladstone Institutes received support from a National Center for Research Resources Grant RR18928. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Azorsa DO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-25; Bonuccelli G, 2009, AM J PATHOL, V174, P1650, DOI 10.2353/ajpath.2009.080648; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Burmeister BT, 2012, J BIOL CHEM, V287, P40535, DOI 10.1074/jbc.M112.385641; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2004, EMBO J, V23, P2811, DOI 10.1038/sj.emboj.7600287; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Edwards HV, 2012, BIOCHEM J, V446, P437, DOI 10.1042/BJ20120570; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Fujita P. A., 2010, NUCL ACIDS RES; Gelman IH, 2000, HISTOCHEM J, V32, P13, DOI 10.1023/A:1003950027529; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hu JK, 2010, CLIN EXP MED, V10, P41, DOI 10.1007/s10238-009-0065-x; Jaehnig EJ, 2006, MOL CELL BIOL, V26, P9315, DOI 10.1128/MCB.00482-06; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Kino T, 2006, J BIOL CHEM, V281, P9118, DOI 10.1074/jbc.M509339200; Klingbeil P, 2001, MECH DEVELOP, V100, P323, DOI 10.1016/S0925-4773(00)00527-X; Klussmann E, 2001, FEBS LETT, V507, P264, DOI 10.1016/S0014-5793(01)02995-7; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; Mayers CM, 2010, J BIOL CHEM, V285, P12344, DOI 10.1074/jbc.M110.106856; MCCARTNEY S, 1995, J BIOL CHEM, V270, P9327, DOI 10.1074/jbc.270.16.9327; McConnell BK, 2009, J BIOL CHEM, V284, P1583, DOI 10.1074/jbc.M806321200; Newhall KJ, 2006, CURR BIOL, V16, P321, DOI 10.1016/j.cub.2005.12.031; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; Nuyens D, 2001, NAT MED, V7, P1021, DOI 10.1038/nm0901-1021; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Pare GC, 2005, J CELL SCI, V118, P5637, DOI 10.1242/jcs.02675; Porchia F, 2008, J RECEPT SIG TRANSD, V28, P265, DOI [10.1080/10799890802084515, 10.1080/10799890802084515 ]; Raeker MO, 2010, DEV BIOL, V337, P432, DOI 10.1016/j.ydbio.2009.11.018; Rawe VY, 2004, DEV BIOL, V276, P253, DOI 10.1016/j.ydbio.2004.07.043; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubino D, 1998, ONCOGENE, V16, P2513, DOI 10.1038/sj.onc.1201783; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Shibolet O, 2007, J BIOL CHEM, V282, P35308, DOI 10.1074/jbc.M704426200; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Su B, 2010, J BIOL CHEM, V285, P4578, DOI 10.1074/jbc.M109.073494; Tanabe S, 2004, METHOD ENZYMOL, V390, P285; Tingley WG, 2007, P NATL ACAD SCI USA, V104, P8461, DOI 10.1073/pnas.0610393104; TOKSOZ D, 1994, ONCOGENE, V9, P621; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Vitart V, 2010, HUM MOL GENET, V19, P4304, DOI 10.1093/hmg/ddq349; Weiser DC, 2007, GENE DEV, V21, P1559, DOI 10.1101/gad.1535007; Wirtenberger M, 2006, CARCINOGENESIS, V27, P593, DOI 10.1093/carcin/bgi245; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yin ZR, 2008, CIRCULATION, V117, P1414, DOI 10.1161/CIRCULATIONAHA.107.759233; Zhang Y, 2007, AM J PHYSIOL-HEART C, V292, pH1187, DOI 10.1152/ajpheart.00895.2006; Zou YZ, 1999, J BIOL CHEM, V274, P9760, DOI 10.1074/jbc.274.14.9760	63	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62705	10.1371/journal.pone.0062705	http://dx.doi.org/10.1371/journal.pone.0062705			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658642	gold, Green Published, Green Submitted			2022-12-25	WOS:000318343700066
J	Papp-Wallace, KM; Taracila, MA; Gatta, JA; Ohuchi, N; Bonomo, RA; Nukaga, M				Papp-Wallace, Krisztina M.; Taracila, Magdalena A.; Gatta, Julian A.; Ohuchi, Nozomi; Bonomo, Robert A.; Nukaga, Michiyoshi			Insights into beta-Lactamases from Burkholderia Species, Two Phylogenetically Related yet Distinct Resistance Determinants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM INFECTION; SITE OMEGA LOOP; PSEUDOMONAS-AERUGINOSA; NOSOCOMIAL OUTBREAK; ESCHERICHIA-COLI; CEPACIA; PSEUDOMALLEI; KPC-2; MELIOIDOSIS; CEFTAZIDIME	Burkholderia cepacia complex and Burkholderia pseudomallei are opportunistic human pathogens. Resistance to beta-lactams among Burkholderia spp. is attributable to expression of beta-lactamases (e. g. PenA in B. cepacia complex and PenI in B. pseudomallei). Phylogenetic comparisons reveal that PenA and PenI are highly related. However, the analyses presented here reveal that PenA is an inhibitor-resistant carbapenemase, most similar to KPC-2 (the most clinically significant serine carbapenemase), whereas PenI is an extended spectrum beta-lactamase. PenA hydrolyzes beta-lactams with k(cat) values ranging from 0.38 +/- 0.04 to 460 +/- 46 s(-1) and possesses high k(cat)/k(inact) values of 2000, 1500, and 75 for beta-lactamase inhibitors. PenI demonstrates the highest k(cat) value for cefotaxime of 9.0 +/- 0.9 s(-1). Crystal structure determination of PenA and PenI reveals important differences that aid in understanding their contrasting phenotypes. Changes in the positioning of conserved catalytic residues (e.g. Lys-73, Ser-130, and Tyr-105) as well as altered anchoring and decreased occupancy of the deacylation water explain the lower k(cat) values of PenI. The crystal structure of PenA with imipenem docked into the active site suggests why this carbapenem is hydrolyzed and the important role of Arg220, which was functionally confirmed by mutagenesis and biochemical characterization. Conversely, the conformation of Tyr-105 hindered docking of imipenem into the active site of PenI. The structural and biochemical analyses of PenA and PenI provide key insights into the hydrolytic mechanisms of beta-lactamases, which can lead to the rational design of novel agents against these pathogens.	[Papp-Wallace, Krisztina M.; Taracila, Magdalena A.; Gatta, Julian A.; Bonomo, Robert A.] Louis Stokes Cleveland Dept Vet Affairs, Res Serv, Cleveland, OH 44106 USA; [Papp-Wallace, Krisztina M.; Taracila, Magdalena A.; Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Ohuchi, Nozomi; Nukaga, Michiyoshi] Josai Int Univ, Togane City, Chiba 2838555, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Bonomo, RA (corresponding author), 10701 East Blvd, Cleveland, OH 44106 USA.	robert.bonomo@med.va.gov	Papp-Wallace, Krisztina/L-2923-2019	Papp-Wallace, Krisztina/0000-0002-9976-7898	National Institutes of Health, NIAID [R01 AI100560, R01 AI063517]; Veterans Affairs Career Development Program; Cleveland Department of Veterans Affairs; Veterans Affairs Merit Review Program; Geriatric Research Education and Clinical Center [VISN 10]; Japan Society for the Promotion of Science (KAKENHI) [22590401]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063517, R01AI100560] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs Career Development Program; Cleveland Department of Veterans Affairs; Veterans Affairs Merit Review Program(US Department of Veterans Affairs); Geriatric Research Education and Clinical Center; Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI100560 and R01 AI063517 from NIAID (to R. A. B.). This work was also supported by the Veterans Affairs Career Development Program (to K. M. P.-W.), by funds and/or facilities provided by the Cleveland Department of Veterans Affairs, the Veterans Affairs Merit Review Program, Geriatric Research Education and Clinical Center Grant VISN 10 (to R. A. B.), and Japan Society for the Promotion of Science Grant-in-aid for Scientific Research (KAKENHI) Grant 22590401 (to M. N.). This work has been performed under the approval of the Photon Factory Program Advisory Committee (Proposal No. 2010G584).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Aldhous P, 2005, NATURE, V434, P692, DOI 10.1038/434692a; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Avgeri SG, 2009, INT J ANTIMICROB AG, V33, P394, DOI 10.1016/j.ijantimicag.2008.09.010; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chantratita N, 2011, P NATL ACAD SCI USA, V108, P17165, DOI 10.1073/pnas.1111020108; CHARNAS RL, 1981, BIOCHEMISTRY-US, V20, P2732, DOI 10.1021/bi00513a005; Cheung TKM, 2002, ANTIMICROB AGENTS CH, V46, P1132, DOI 10.1128/AAC.46.4.1132-1135.2002; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Clinical Laboratory Standards Institute, 2006, M07A7 CLSI; da Silva RM, 2012, EXPERT OPIN BIOL TH, V12, P663, DOI 10.1517/14712598.2012.681369; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Diller DJ, 2003, J MED CHEM, V46, P4638, DOI 10.1021/jm020503a; Diller DJ, 2001, PROTEINS, V43, P113, DOI 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T; Dolan SA, 2011, INFECT CONT HOSP EP, V32, P804, DOI 10.1086/660876; Douce RW, 2008, INFECT CONT HOSP EP, V29, P364, DOI 10.1086/533543; Drawz SM, 2011, PROTEIN SCI, V20, P941, DOI 10.1002/pro.612; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; EASTON CJ, 1982, BIOCHEMISTRY-US, V21, P2857, DOI 10.1021/bi00541a008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falade OO, 2008, NEW ENGL J MED, V359, P628, DOI 10.1056/NEJMcps0708803; Frase H, 2009, J BIOL CHEM, V284, P29509, DOI 10.1074/jbc.M109.011262; Girlich D, 2010, ANTIMICROB AGENTS CH, V54, P328, DOI 10.1128/AAC.00961-09; GODFREY AJ, 1991, ANTIMICROB AGENTS CH, V35, P1635, DOI 10.1128/AAC.35.8.1635; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Henriques I, 2004, ANTIMICROB AGENTS CH, V48, P2321, DOI 10.1128/AAC.48.6.2321-2324.2004; Heo ST, 2008, J HOSP INFECT, V70, P241, DOI 10.1016/j.jhin.2008.07.019; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Holmes A, 1998, EMERG INFECT DIS, V4, P221, DOI 10.3201/eid0402.980209; Kattan JN, 2008, CLIN MICROBIOL INFEC, V14, P1102, DOI 10.1111/j.1469-0691.2008.02101.x; Ke W, 2007, BIOCHEMISTRY-US, V46, P5732, DOI 10.1021/bi700300u; KOPONEN MA, 1991, ARCH INTERN MED, V151, P605, DOI 10.1001/archinte.151.3.605; Lee CS, 2008, J HOSP INFECT, V68, P280, DOI 10.1016/j.jhin.2008.01.002; Lin S, 1998, BIOCHEM J, V333, P395, DOI 10.1042/bj3330395; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2005, Chron Respir Dis, V2, P209, DOI 10.1191/1479972305cd053ra; Martin M, 2012, ANAESTHESIST, V61, P25, DOI 10.1007/s00101-011-1954-4; Martin M, 2011, J HOSP INFECT, V77, P267, DOI 10.1016/j.jhin.2010.10.004; Martins IS, 2010, INFECT CONT HOSP EP, V31, P516, DOI 10.1086/651667; Memish ZA, 2009, AM J INFECT CONTROL, V37, P431, DOI 10.1016/j.ajic.2006.10.002; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; Molina-Cabrillana J, 2006, INFECT CONT HOSP EP, V27, P1281, DOI 10.1086/508845; Moreira BM, 2005, J HOSP INFECT, V60, P51, DOI 10.1016/j.jhin.2004.09.036; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; Nukaga M, 2008, J AM CHEM SOC, V130, P12656, DOI 10.1021/ja7111146; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALZKILL T, 1994, MOL MICROBIOL, V12, P217, DOI 10.1111/j.1365-2958.1994.tb01011.x; Papp-Wallace KM, 2012, ANTIMICROB AGENTS CH, V56, P4428, DOI 10.1128/AAC.05769-11; Papp-Wallace KM, 2010, PROTEIN SCI, V19, P1714, DOI 10.1002/pro.454; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P2867, DOI 10.1128/AAC.00197-10; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P890, DOI 10.1128/AAC.00693-09; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Petrosino JF, 1996, J BACTERIOL, V178, P1821, DOI 10.1128/jb.178.7.1821-1828.1996; Poirel L, 2001, ANTIMICROB AGENTS CH, V45, P2598, DOI 10.1128/AAC.45.9.2598-2603.2001; Poirel L, 2009, ANTIMICROB AGENTS CH, V53, P876, DOI 10.1128/AAC.00946-08; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rao SN, 2007, J CHEM INF MODEL, V47, P2159, DOI 10.1021/ci6004299; Rholl DA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00139; Rosengarten D, 2010, INFECT CONT HOSP EP, V31, P769, DOI 10.1086/653611; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S0108767307043930, 10.1107/S2053229614024218]; Sturenburg E, 2004, J ANTIMICROB CHEMOTH, V54, P406, DOI 10.1093/jac/dkh334; Suarez-Moreno ZR, 2012, MICROB ECOL, V63, P249, DOI 10.1007/s00248-011-9929-1; Sunenshine R, 2009, CLIN INFECT DIS, V48, P1580, DOI 10.1086/598938; Trepanier S, 1997, ANTIMICROB AGENTS CH, V41, P2399, DOI 10.1128/AAC.41.11.2399; Tribuddharat C, 2003, ANTIMICROB AGENTS CH, V47, P2082, DOI 10.1128/AAC.47.7.2082-2087.2003; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Winkler ML, 2013, J MED CHEM, V56, P1084, DOI 10.1021/jm301490d; Wooten MD, 2001, JCR-J CLIN RHEUMATOL, V7, P242, DOI 10.1097/00124743-200108000-00010; Wuthiekanun Vanaporn, 2006, Expert Rev Anti Infect Ther, V4, P445, DOI 10.1586/14787210.4.3.445; Yang CJ, 2008, J HOSP INFECT, V69, P398, DOI 10.1016/j.jhin.2008.03.011; ZAFARALLA G, 1992, BIOCHEMISTRY-US, V31, P3847, DOI 10.1021/bi00130a016	77	46	46	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19090	19102		10.1074/jbc.M113.458315	http://dx.doi.org/10.1074/jbc.M113.458315			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658015	Green Published, hybrid			2022-12-25	WOS:000321335800044
J	Buck, TM; Plavchak, L; Roy, A; Donnelly, BF; Kashlan, OB; Kleyman, TR; Subramanya, AR; Brodsky, JL				Buck, Teresa M.; Plavchak, Lindsay; Roy, Ankita; Donnelly, Bridget F.; Kashlan, Ossama B.; Kleyman, Thomas R.; Subramanya, Arohan R.; Brodsky, Jeffrey L.			The Lhs1/GRP170 Chaperones Facilitate the Endoplasmic Reticulum-associated Degradation of the Epithelial Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-EXCHANGE FACTOR; HEAT-SHOCK PROTEINS; NA+ CHANNEL; MOLECULAR CHAPERONES; MISFOLDED GLYCOPROTEINS; HSP70 CHAPERONES; QUALITY-CONTROL; MECHANISTICALLY DISTINCT	The epithelial sodium channel, ENaC, plays a critical role in maintaining salt and water homeostasis, and not surprisingly defects in ENaC function are associated with disease. Like many other membrane-spanning proteins, this trimeric protein complex folds and assembles inefficiently in the endoplasmic reticulum (ER), which results in a substantial percentage of the channel being targeted for ER-associated degradation (ERAD). Because the spectrum of factors that facilitates the degradation of ENaC is incomplete, we developed yeast expression systems for each ENaC subunit. We discovered that a conserved Hsp70-like chaperone, Lhs1, is required for maximal turnover of the ENaC alpha subunit. By expressing Lhs1 ATP binding mutants, we also found that the nucleotide exchange properties of this chaperone are dispensable for ENaC degradation. Consistent with the precipitation of an Lhs1-alpha ENaC complex, Lhs1 holdase activity was instead most likely required to support the ERAD of alpha ENaC. Moreover, a complex containing the mammalian Lhs1 homolog GRP170 and alpha ENaC co-precipitated, and GRP170 also facilitated ENaC degradation in human, HEK293 cells, and in a Xenopus oocyte expression system. In both yeast and higher cell types, the effect of Lhs1 on the ERAD of alpha ENaC was selective for the unglycosylated form of the protein. These data establish the first evidence that Lhs1/Grp170 chaperones can act as mediators of ERAD substrate selection.	[Buck, Teresa M.; Plavchak, Lindsay; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Roy, Ankita; Donnelly, Bridget F.; Kashlan, Ossama B.; Kleyman, Thomas R.; Subramanya, Arohan R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Subramanya, Arohan R.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, A320 Langley Hall,4249 5th Ave, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Subramanya, Arohan R./AAN-5217-2020	Subramanya, Arohan R./0000-0002-2609-7643; Buck, Teresa/0000-0002-9013-9756; ROY, ANKITA/0000-0002-3032-6365	National Institutes of Health [K01DK090195, DK65161, GM75061, DK79307]; United States Department of Veterans Affairs; University of Pittsburgh George O'Brien Kidney Research Center; American Heart Association [10BGIA3890010]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065161, P30DK079307, R01DK065161, K01DK090195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs); University of Pittsburgh George O'Brien Kidney Research Center; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants K01DK090195 (to T. M. B.), DK65161 (to T. K.), GM75061 (to J. L. B.), and DK79307 (to the University of Pittsburgh George O'Brien Kidney Research Center).; Supported by a Mid-level Career Development Award from the United States Department of Veterans Affairs, pilot funds from the University of Pittsburgh George O'Brien Kidney Research Center, and by James A. Shaver Fund of the American Heart Association Grant 10BGIA3890010.	Adams A., 1998, METHODS YEAST GENETI, V1997; Adams CM, 1997, J BIOL CHEM, V272, P27295, DOI 10.1074/jbc.272.43.27295; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Andreasson C, 2010, J BIOL CHEM, V285, P12445, DOI 10.1074/jbc.M109.096735; Asher C, 1996, AM J PHYSIOL-CELL PH, V271, pC605, DOI 10.1152/ajpcell.1996.271.2.C605; Baxter BK, 1996, MOL CELL BIOL, V16, P6444; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Buck TM, 2007, SEMIN CELL DEV BIOL, V18, P751, DOI 10.1016/j.semcdb.2007.09.001; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Chanoux RA, 2012, J BIOL CHEM, V287, P19255, DOI 10.1074/jbc.M112.357756; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Craven RA, 1996, EMBO J, V15, P2640, DOI 10.1002/j.1460-2075.1996.tb00624.x; de Keyzer J, 2009, J BIOL CHEM, V284, P31564, DOI 10.1074/jbc.M109.055160; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Gelling CL, 2012, GENETICS, V192, P889, DOI 10.1534/genetics.112.143487; Giodini A, 2008, EMBO J, V27, P201, DOI 10.1038/sj.emboj.7601941; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Grubb S, 2012, MOL BIOL CELL, V23, P520, DOI 10.1091/mbc.E11-08-0704; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Gusarova V, 2001, J BIOL CHEM, V276, P24891, DOI 10.1074/jbc.M100633200; Hale SJ, 2010, J BIOL CHEM, V285, P21600, DOI 10.1074/jbc.M110.111211; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hebert DN, 2012, TRENDS BIOCHEM SCI, V37, P404, DOI 10.1016/j.tibs.2012.07.005; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Hutt DM, 2012, J BIOL CHEM, V287, P21914, DOI 10.1074/jbc.M112.339788; Ismail N, 2006, CELL, V126, P237, DOI 10.1016/j.cell.2006.07.001; JORDAN R, 1995, J BIOL CHEM, V270, P4563, DOI 10.1074/jbc.270.9.4563; Kabani M, 2002, FEBS LETT, V531, P339, DOI 10.1016/S0014-5793(02)03570-6; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Kashlan OB, 2012, EXP CELL RES, V318, P1011, DOI 10.1016/j.yexcr.2012.02.024; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; LIBEREK K, 1995, P NATL ACAD SCI USA, V92, P6224, DOI 10.1073/pnas.92.14.6224; LIN HY, 1993, MOL BIOL CELL, V4, P1109, DOI 10.1091/mbc.4.11.1109; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller GM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M707339200; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Needham PG, 2011, J BIOL CHEM, V286, P43611, DOI 10.1074/jbc.M111.288928; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Park J, 2003, BIOCHEMISTRY-US, V42, P14893, DOI 10.1021/bi030122e; Park JE, 2006, CANCER RES, V66, P1161, DOI 10.1158/0008-5472.CAN-05-2609; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Prince LS, 1999, AM J PHYSIOL-CELL PH, V276, pC1346, DOI 10.1152/ajpcell.1999.276.6.C1346; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; RASMUSSEN SW, 1994, YEAST, V10, pS69, DOI 10.1002/yea.320100009; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Saris N, 1997, J CELL BIOL, V137, P813, DOI 10.1083/jcb.137.4.813; Schmidt BZ, 2005, AM J PHYSIOL-GASTR L, V289, pG444, DOI 10.1152/ajpgi.00237.2004; Scott CM, 2007, MOL BIOL CELL, V18, P3776, DOI 10.1091/mbc.E07-01-0034; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681; Soundararajan R, 2012, MOL CELL ENDOCRINOL, V350, P242, DOI 10.1016/j.mce.2011.11.003; Soundararajan R, 2010, J BIOL CHEM, V285, P30363, DOI 10.1074/jbc.R110.155341; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Tams JW, 1999, BBA-PROTEIN STRUCT M, V1432, P214, DOI 10.1016/S0167-4838(99)00103-X; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Teckman JH, 1996, J BIOL CHEM, V271, P13215, DOI 10.1074/jbc.271.22.13215; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; Weisz OA, 2000, J BIOL CHEM, V275, P39886, DOI 10.1074/jbc.M003822200; Weitzmann A, 2006, FEBS LETT, V580, P5237, DOI 10.1016/j.febslet.2006.08.055; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wolf DH, 2005, CURR TOP MICROBIOL, V300, P41; Yan M, 2011, BIOCHEM J, V438, P447, DOI 10.1042/BJ20110500; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zhang Yimao, 2002, Methods Mol Med, V70, P257; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	116	37	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18366	18380		10.1074/jbc.M113.469882	http://dx.doi.org/10.1074/jbc.M113.469882			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645669	Green Published, hybrid			2022-12-25	WOS:000320721900040
J	Esposito, G; Garvey, M; Alverdi, V; Pettirossi, F; Corazza, A; Fogolari, F; Polano, M; Mangione, PP; Giorgetti, S; Stoppini, M; Rekas, A; Bellotti, V; Heck, AJR; Carver, JA				Esposito, Gennaro; Garvey, Megan; Alverdi, Vera; Pettirossi, Fabio; Corazza, Alessandra; Fogolari, Federico; Polano, Maurizio; Mangione, P. Patrizia; Giorgetti, Sofia; Stoppini, Monica; Rekas, Agata; Bellotti, Vittorio; Heck, Albert J. R.; Carver, John A.			Monitoring the Interaction between beta(2)-Microglobulin and the Molecular Chaperone alpha B-crystallin by NMR and Mass Spectrometry alpha B-CRYSTALLIN DISSOCIATES beta(2)-MICROGLOBULIN OLIGOMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; HEAT-SHOCK PROTEINS; SOLVENT PERTURBATION; COMMON MECHANISM; IN-VITRO; AGGREGATION; BETA-2-MICROGLOBULIN; SPECTROSCOPY; EXTENSION; BINDING	The interaction at neutral pH between wild-type and a variant form (R3A) of the amyloid fibril-forming protein beta(2)-microglobulin (beta 2m) and the molecular chaperone alpha B-crystallin was investigated by thioflavin T fluorescence, NMR spectroscopy, and mass spectrometry. Fibril formation of R3A beta 2m was potently prevented by alpha B-crystallin. alpha B-crystallin also prevented the unfolding and nonfibrillar aggregation of R3A beta 2m. From analysis of the NMR spectra collected at various R3A beta 2m to alpha B-crystallin molar subunit ratios, it is concluded that the structured beta-sheet core and the apical loops of R3A beta 2m interact in a nonspecific manner with the alpha B-crystallin. Complementary information was derived from NMR diffusion coefficient measurements of wild-type beta 2m at a 100-fold concentration excess with respect to alpha B-crystallin. Mass spectrometry acquired in the native state showed that the onset of wild-type beta 2m oligomerization was effectively reduced by alpha B-crystallin. Furthermore, and most importantly, alpha B-crystallin reversibly dissociated beta 2m oligomers formed spontaneously in aged samples. These results, coupled with our previous studies, highlight the potent effectiveness of alpha B-crystallin in preventing beta 2m aggregation at the various stages of its aggregation pathway. Our findings are highly relevant to the emerging view that molecular chaperone action is intimately involved in the prevention of in vivo amyloid fibril formation.	[Esposito, Gennaro; Alverdi, Vera; Pettirossi, Fabio; Corazza, Alessandra; Fogolari, Federico; Polano, Maurizio] Univ Udine, Dept Sci Med & Biol, I-33100 Udine, Italy; [Garvey, Megan; Carver, John A.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Mangione, P. Patrizia; Giorgetti, Sofia; Stoppini, Monica; Bellotti, Vittorio] Univ Pavia, Ist Biochim, Dipartimento Med Mol, I-27100 Pavia, Italy; [Mangione, P. Patrizia; Bellotti, Vittorio] UCL, Div Med, Ctr Amyloidosis & Acute Phase Prot, Wolfson Drug Discovery Unit, London NW3 2PF, England; [Rekas, Agata] Australian Nucl Sci & Technol Org, Natl Deuterat Facil, Lucas Heights, NSW 2522, Australia; [Heck, Albert J. R.] Univ Utrecht, Dept Biomol Mass Spectrometry & Prote, Bijvoet Ctr Biomol Res, NL-3584 CA Utrecht, Netherlands; [Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands	University of Udine; University of Adelaide; University of Pavia; University of London; University College London; Australian Nuclear Science & Technology Organisation; Utrecht University; Utrecht University	Esposito, G (corresponding author), Univ Udine, Dept Sci Med & Biol, Ple Kolbe 4, I-33100 Udine, Italy.	rino.esposito@uniud.it	Garvey, Megan/J-9334-2013; Giorgetti, Sofia/AAD-4341-2019; Garvey, Megan/C-9137-2015; Polano, Maurizio/AAB-9679-2020; Bellotti, Vittorio/A-6201-2014; Heck, Albert/D-7098-2011; Carver, John Adrian/J-3825-2014; Corazza, Alessandra/AGB-1457-2022	Giorgetti, Sofia/0000-0001-9438-6511; Polano, Maurizio/0000-0002-6101-1382; Bellotti, Vittorio/0000-0001-8678-662X; Heck, Albert/0000-0002-2405-4404; Carver, John Adrian/0000-0002-2441-8108; Corazza, Alessandra/0000-0003-2272-1928; Mangione, Palma/0000-0003-0260-1400; Fogolari, Federico/0000-0001-9862-250X	Italian Ministry of Education (MIUR) [PRIN N. 20083ERXWS, FIRB N. RBRN07BMCT, FIRB N. RBFR109EOS]; Fondazione Cariplo Project [2011-2096, MR/K000187/1]; European Union Grant [LSHM-CT-2006-037525-EURAMY]; National Health and Medical Research Council of Australia; Australian Research Council; MRC [MR/K000187/1] Funding Source: UKRI; Medical Research Council [MR/K000187/1] Funding Source: researchfish	Italian Ministry of Education (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo Project(Fondazione Cariplo); European Union Grant; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Italian Ministry of Education (MIUR) Grants PRIN N. 20083ERXWS, FIRB N. RBRN07BMCT, and FIRB N. RBFR109EOS, Fondazione Cariplo Project 2011-2096, Strategic Award MR/K000187/1, European Union Grant LSHM-CT-2006-037525-EURAMY, the National Health and Medical Research Council of Australia, and the Australian Research Council.	Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Bellotti V, 1998, EUR J BIOCHEM, V258, P61, DOI 10.1046/j.1432-1327.1998.2580061.x; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Binger KJ, 2013, FASEB J, V27, P1214, DOI 10.1096/fj.12-220657; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; CARVER JA, 1992, FEBS LETT, V311, P143, DOI 10.1016/0014-5793(92)81386-Z; Carver JA, 1999, PROG RETIN EYE RES, V18, P431, DOI 10.1016/S1350-9462(98)00027-5; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; Carver JA, 1998, INT J BIOL MACROMOL, V22, P197, DOI 10.1016/S0141-8130(98)00017-8; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Corazza A, 2004, J BIOL CHEM, V279, P9176, DOI 10.1074/jbc.M310779200; Dehle FC, 2010, CELL STRESS CHAPERON, V15, P1013, DOI 10.1007/s12192-010-0212-z; Devlin GL, 2003, J BIOL CHEM, V278, P48644, DOI 10.1074/jbc.M308376200; Eakin CM, 2002, BIOCHEMISTRY-US, V41, P10646, DOI 10.1021/bi025944a; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Ecroyd H, 2008, FEBS J, V275, P935, DOI 10.1111/j.1742-4658.2008.06257.x; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; ESPOSITO G, 1992, J MOL BIOL, V224, P659, DOI 10.1016/0022-2836(92)90551-T; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Floege J, 2001, KIDNEY INT, V59, pS164, DOI 10.1046/j.1523-1755.2001.59780164.x; Garvey M, 2013, BIOCHEM BIOPH RES CO, V433, P276, DOI 10.1016/j.bbrc.2013.02.073; Garvey M, 2011, BIOPOLYMERS, V95, P376, DOI 10.1002/bip.21584; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hatters DM, 2001, J BIOL CHEM, V276, P33755, DOI 10.1074/jbc.M105285200; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jehle S, 2009, J MOL BIOL, V385, P1481, DOI 10.1016/j.jmb.2008.10.097; Jerschow A, 1998, J MAGN RESON, V132, P13, DOI 10.1006/jmre.1998.1400; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kudva YC, 1997, FEBS LETT, V416, P117, DOI 10.1016/S0014-5793(97)01180-0; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791; Meehan S, 2007, J MOL BIOL, V372, P470, DOI 10.1016/j.jmb.2007.06.060; Molinari H, 1997, BIOPHYS J, V73, P382, DOI 10.1016/S0006-3495(97)78078-0; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Piazza R, 2006, EUR BIOPHYS J BIOPHY, V35, P439, DOI 10.1007/s00249-006-0051-0; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Rekas A, 2007, FEBS J, V274, P6290, DOI 10.1111/j.1742-4658.2007.06144.x; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Sun TX, 1998, J BIOL CHEM, V273, P286, DOI 10.1074/jbc.273.1.286; Treweek TM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001046; Treweek TM, 2003, AUST J CHEM, V56, P357, DOI 10.1071/CH03031; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; van Duijn E, 2005, NAT METHODS, V2, P371, DOI 10.1038/nmeth753; Verdone G, 2002, PROTEIN SCI, V11, P487, DOI 10.1110/ps.29002; Villanueva J, 2004, PROTEIN SCI, V13, P797, DOI 10.1110/ps.03445704; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yamamoto S, 2005, BBA-PROTEINS PROTEOM, V1753, P4, DOI 10.1016/j.bbapap.2005.09.006; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	71	29	29	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17844	17858		10.1074/jbc.M112.448639	http://dx.doi.org/10.1074/jbc.M112.448639			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645685	Green Published, hybrid			2022-12-25	WOS:000320380600073
J	Leidgens, S; Bullough, KZ; Shi, HF; Li, FM; Shakoury-Elizeh, M; Yabe, T; Subramanian, P; Hsu, E; Natarajan, N; Nandal, A; Stemmler, TL; Philpott, CC				Leidgens, Sebastien; Bullough, Kimberly Z.; Shi, Haifeng; Li, Fengmin; Shakoury-Elizeh, Minoo; Yabe, Toshiki; Subramanian, Poorna; Hsu, Emory; Natarajan, Navin; Nandal, Anjali; Stemmler, Timothy L.; Philpott, Caroline C.			Each Member of the Poly-r(C)-binding Protein 1 (PCBP) Family Exhibits Iron Chaperone Activity toward Ferritin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; BINDING-PROTEIN; SACCHAROMYCES-CEREVISIAE; HOMEOSTASIS; GENE; HYDROXYLASE; PATHWAY; YEAST	The mechanisms through which iron-dependent enzymes receive their metal cofactors are largely unknown. Poly r(C)-binding protein 1 (PCBP1) is an iron chaperone for ferritin; both PCBP1 and its paralog PCBP2 are required for iron delivery to the prolyl hydroxylase that regulates HIF1. Here we show that PCBP2 is also an iron chaperone for ferritin. Co-expression of PCBP2 and human ferritins in yeast activated the iron deficiency response and increased iron deposition into ferritin. Depletion of PCBP2 in Huh7 cells diminished iron incorporation into ferritin. Both PCBP1 and PCBP2 were co-immunoprecipitated with ferritin in HEK293 cells, and expression of both PCBPs was required for ferritin complex formation in cells. PCBP1 and -2 exhibited high affinity binding to ferritin in vitro. Mammalian genomes encode 4 PCBPs, including the minimally expressed PCBPs 3 and 4. Expression of PCBP3 and -4 in yeast activated the iron deficiency response, but only PCBP3 exhibited strong interactions with ferritin. Expression of PCBP1 and ferritin in an iron-sensitive, ccc1 yeast strain intensified the toxic effects of iron, whereas expression of PCBP4 protected the cells from iron toxicity. Thus, PCBP1 and -2 form a complex for iron delivery to ferritin, and all PCBPs may share iron chaperone activity.	[Leidgens, Sebastien; Bullough, Kimberly Z.; Shi, Haifeng; Li, Fengmin; Shakoury-Elizeh, Minoo; Yabe, Toshiki; Hsu, Emory; Natarajan, Navin; Nandal, Anjali; Philpott, Caroline C.] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Subramanian, Poorna; Stemmler, Timothy L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Hsu, Emory] NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Wayne State University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA	Philpott, CC (corresponding author), NIDDK, Genet & Metab Sect, Liver Dis Branch, NIH, Bldg 10,Rm 9B-16,10 Ctr Dr, Bethesda, MD 20892 USA.	carolinep@intra.niddk.nih.gov	Nandal, Anjali/A-5376-2013; Li, Fengmin/K-8740-2012; Yabe-Wada, Toshiki/D-2420-2013; Li, Fengmin/J-5721-2013	Li, Fengmin/0000-0002-2144-3498; Yabe-Wada, Toshiki/0000-0002-6208-0590; Stemmler, Timothy/0000-0002-6298-088X	Intramural Research Program of the NIDDK, National Institutes of Health; National Institutes of Health [DK068139]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054510, R01DK068139] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25870851] Funding Source: KAKEN	Intramural Research Program of the NIDDK, National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Intramural Research Program of the NIDDK, National Institutes of Health.; Supported by the National Institutes of Health Grant DK068139.	Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; Bou-Abdallah F, 2002, BIOCHEMISTRY-US, V41, P11184, DOI 10.1021/bi020215g; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chkheidze AN, 1999, MOL CELL BIOL, V19, P4572; Choi HS, 2007, FASEB J, V21, P3963, DOI 10.1096/fj.07-8561com; Gao CY, 2000, BIOTECHNIQUES, V29, P1226, DOI 10.2144/00296st02; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Li YJ, 2012, CELL METAB, V15, P895, DOI 10.1016/j.cmet.2012.04.021; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; Rang DH, 2012, GENE, V501, P33, DOI 10.1016/j.gene.2012.04.001; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Scoumanne A, 2011, NUCLEIC ACIDS RES, V39, P213, DOI 10.1093/nar/gkq778; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; SHERMAN F, 1991, P3; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Zhu JH, 2000, MOL CELL BIOL, V20, P5602, DOI 10.1128/MCB.20.15.5602-5618.2000	28	115	118	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17791	17802		10.1074/jbc.M113.460253	http://dx.doi.org/10.1074/jbc.M113.460253			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640898	Green Published, hybrid			2022-12-25	WOS:000320380600068
J	Dong, XJ; Pan, RL; Zhang, H; Yang, C; Shao, JZ; Xiang, LX				Dong, Xuejun; Pan, Ruolang; Zhang, Hui; Yang, Chao; Shao, Jianzhong; Xiang, Lixin			Modification of Histone Acetylation Facilitates Hepatic Differentiation of Human Bone Marrow Mesenchymal Stem Cells	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; HEPATOCYTE-LIKE CELLS; DEACETYLASE INHIBITORS; PROGENITOR CELLS; STROMAL CELLS; PLASTICITY; PROLIFERATION; INDUCTION	The multi-potentiality of mesenchymal stem cells makes them excellent options for future tissue engineering and clinical therapy, including liver injury. In this study, we investigated the effects of valproic acid (VPA), a direct inhibitor of histone deacetylase (HDAC), on the hepatic differentiation of human bone marrow mesenchymal stem cells (BMMSCs). The cells were found to differentiate into a more homogeneous hepatocyte-like population when pretreated with 5 mM VPA for 72 h. The expression of liver-specific markers was significantly upregulated in the VPA-treated group at the mRNA and protein levels. VPA treatment also significantly enhanced the hepatic functions of the differentiated cells, including glycogen storage, cytochrome P450 activity, AFP and ALB synthesis, and urea production. Further analysis showed that treatment with 5 mM of VPA for 72 h greatly improved the histones H3 and H4 acetylation. These results demonstrated that VPA could considerably improve the hepatic differentiation of human BMMSCs, probably because the chromatin-acetylated state changes upon VPA treatment through its HDAC inhibitory effect. Thus, this study provides a direct research model for producing human hepatocytes for clinical purposes.	[Dong, Xuejun; Zhang, Hui; Yang, Chao] Zhejiang Univ, Shaoxing Hosp, Shaoxing Peoples Hosp, Shaoxing, Zhejiang, Peoples R China; [Pan, Ruolang; Shao, Jianzhong; Xiang, Lixin] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Ruolang; Shao, Jianzhong] Key Lab Cell & Gene Engn Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Zhang, Hui; Yang, Chao] Wenzhou Med Coll, Sch Lab Med & Life Sci, Wenzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Wenzhou Medical University	Shao, JZ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	shaojz@zju.edu.cn; xianglx@zju.edu.cn			Science and Technology Foundation of Ministry of Health of the People's Republic of China [WKJ2007-2-037]; National Basic Research Program of China [2012CB967900]; Key Discipline of Shaoxing Province [GJSX-010-003]; Key Discipline of Zhejiang Province [GJSX-010-003]; Key Science and Technology Innovation Team of Zhejiang Province [2010R50048]; Shaoxing key project for Science and technology [2007A23008, 2005141]; grant of medicine and health key project of Zhejiang Province	Science and Technology Foundation of Ministry of Health of the People's Republic of China; National Basic Research Program of China(National Basic Research Program of China); Key Discipline of Shaoxing Province; Key Discipline of Zhejiang Province; Key Science and Technology Innovation Team of Zhejiang Province; Shaoxing key project for Science and technology; grant of medicine and health key project of Zhejiang Province	This work was supported by the grant of medicine and health key project of Zhejiang Province, Science and Technology Foundation of Ministry of Health of the People's Republic of China WKJ2007-2-037; National Basic Research Program of China 2012CB967900; Key Disciplines of Shaoxing and Zhejiang Province GJSX-010-003; Key Science and Technology Innovation Team of Zhejiang Province (2010R50048); Shaoxing key project for Science and technology 2007A23008 and 2005141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanian AR, 2007, J CELL BIOCHEM, V100, P362, DOI 10.1002/jcb.21029; Bedada FB, 2006, CELL CYCLE, V5, P223, DOI 10.4161/cc.5.3.2364; Bernardo ME, 2007, CONNECT TISSUE RES, V48, P132, DOI 10.1080/03008200701228464; Chen JH, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-71; Chen Y, 2007, J CELL BIOCHEM, V102, P52, DOI 10.1002/jcb.21275; Chen Y, 2009, J CELL MOL MED, V13, P2582, DOI 10.1111/j.1582-4934.2008.00471.x; Cho HH, 2005, J CELL BIOCHEM, V96, P533, DOI 10.1002/jcb.20544; Horwitz EM, 2003, ARCH MED RES, V34, P600, DOI 10.1016/j.arcmed.2003.09.006; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Kawamura T, 2005, J BIOL CHEM, V280, P19682, DOI 10.1074/jbc.M412428200; KOEBE HG, 1994, INT J ARTIF ORGANS, V17, P95, DOI 10.1177/039139889401700207; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Lehrmann H, 2002, ADV CANCER RES, V86, P41, DOI 10.1016/S0065-230X(02)86002-X; Luk JM, 2005, J IMMUNOL METHODS, V305, P39, DOI 10.1016/j.jim.2005.07.006; Nussler A, 2006, J HEPATOL, V45, P144, DOI 10.1016/j.jhep.2006.04.002; Oh SH, 2007, GASTROENTEROLOGY, V132, P1077, DOI 10.1053/j.gastro.2007.01.001; Pan RL, 2008, CYTOTHERAPY, V10, P668, DOI 10.1080/14653240802360704; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quesenberry PJ, 2005, EXP HEMATOL, V33, P389, DOI 10.1016/j.exphem.2004.11.005; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Snykers S, 2006, TOXICOL SCI, V94, P330, DOI 10.1093/toxsci/kfl058; Turhan AG, 2003, TRANSFUS CLIN BIOL, V10, P103, DOI 10.1016/S1246-7820(03)00040-5; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9	24	23	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63405	10.1371/journal.pone.0063405	http://dx.doi.org/10.1371/journal.pone.0063405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658825	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500067
J	Huang, YH; Wu, HY; Wu, KM; Liu, TT; Liou, RF; Tsai, SF; Shiao, MS; Ho, LT; Tzean, SS; Yang, UC				Huang, Yen-Hua; Wu, Hung-Yi; Wu, Keh-Ming; Liu, Tze-Tze; Liou, Ruey-Fen; Tsai, Shih-Feng; Shiao, Ming-Shi; Ho, Low-Tone; Tzean, Shean-Shong; Yang, Ueng-Cheng			Generation and Analysis of the Expressed Sequence Tags from the Mycelium of Ganoderma lucidum	PLOS ONE			English	Article							C HEME LYASE; ANTITUMOR ACTIVITIES; INTRON DEFINITION; CYTOCHROME-C; PREDICTION; IMPORT; SITE; POLYSACCHARIDES; HYDROPHOBINS; ANNOTATION	Ganoderma lucidum (G. lucidum) is a medicinal mushroom renowned in East Asia for its potential biological effects. To enable a systematic exploration of the genes associated with the various phenotypes of the fungus, the genome consortium of G. lucidum has carried out an expressed sequence tag (EST) sequencing project. Using a Sanger sequencing based approach, 47,285 ESTs were obtained from in vitro cultures of G. lucidum mycelium of various durations. These ESTs were further clustered and merged into 7,774 non-redundant expressed loci. The features of these expressed contigs were explored in terms of over-representation, alternative splicing, and natural antisense transcripts. Our results provide an invaluable information resource for exploring the G. lucidum transcriptome and its regulation. Many cases of the genes over-represented in fast-growing dikaryotic mycelium are closely related to growth, such as cell wall and bioactive compound synthesis. In addition, the EST-genome alignments containing putative cassette exons and retained introns were manually curated and then used to make inferences about the predominating splice-site recognition mechanism of G. lucidum. Moreover, a number of putative antisense transcripts have been pinpointed, from which we noticed that two cases are likely to reveal hitherto undiscovered biological pathways. To allow users to access the data and the initial analysis of the results of this project, a dedicated web site has been created at http://csb2.ym.edu.tw/est/.	[Huang, Yen-Hua] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Biochem, Taipei 112, Taiwan; [Wu, Keh-Ming; Liu, Tze-Tze; Tsai, Shih-Feng] Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei 112, Taiwan; [Yang, Ueng-Cheng] Natl Yang Ming Univ, Coll Life Sci, Inst Biomed Informat, Taipei 112, Taiwan; [Huang, Yen-Hua; Yang, Ueng-Cheng] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Wu, Hung-Yi; Liou, Ruey-Fen; Tzean, Shean-Shong] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Shiao, Ming-Shi; Ho, Low-Tone] Taipei Vet Gen Hosp, Med Res & Educ Dept, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; Taipei Veterans General Hospital	Tzean, SS (corresponding author), Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan.	sst@ntu.edu.tw; yang@ym.edu.tw		LIOU, RUEY-FEN/0000-0001-7799-9287	Taipei Veterans General Hospital (Taiwan, Republic of China) [VGH92-378]; National Science Council (Taiwan, Republic of China) [NSC99-3112-B-010-019]	Taipei Veterans General Hospital (Taiwan, Republic of China)(Taipei Veterans General Hospital); National Science Council (Taiwan, Republic of China)(Ministry of Science and Technology, Taiwan)	This project was supported by VGH92-378 from the Taipei Veterans General Hospital (http://www.vghtpe.gov.tw/) (Taiwan, Republic of China) and also by NSC99-3112-B-010-019 from the National Science Council (http://web1.nsc.gov.tw/) (Taiwan, Republic of China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2004, AM J HUM GENET, V74, P83, DOI 10.1086/381039; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bidon N, 2001, GENE, V274, P253, DOI 10.1016/S0378-1119(01)00598-4; Boisson M, 2001, EMBO J, V20, P1010, DOI 10.1093/emboj/20.5.1010; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Clegg N, 2004, PROSTATE, V60, P227, DOI 10.1002/pros.20055; De Young MP, 2002, IN VIVO, V16, P239; DUMONT ME, 1991, MOL CELL BIOL, V11, P5487, DOI 10.1128/MCB.11.11.5487; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Eyras E, 2004, GENOME RES, V14, P976, DOI 10.1101/gr.1862204; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Hajjaj H, 2005, APPL ENVIRON MICROB, V71, P3653, DOI 10.1128/AEM.71.7.3653-3658.2005; Harrow J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-201; Huang Zhi Gang, 2006, Chin J Dig Dis, V7, P97, DOI 10.1111/j.1443-9573.2006.00254.x; Hutu DP, 2008, MOL BIOL CELL, V19, P2642, DOI 10.1091/mbc.E07-12-1226; Jensen Britt G, 2010, BMC Res Notes, V3, P344, DOI 10.1186/1756-0500-3-344; Jones SJM, 2006, ANNU REV GENOM HUM G, V7, P315, DOI 10.1146/annurev.genom.7.080505.115745; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Liang CZ, 2009, GENOME RES, V19, P1912, DOI 10.1101/gr.088997.108; LILL R, 1992, EMBO J, V11, P449, DOI 10.1002/j.1460-2075.1992.tb05074.x; Liu DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036146; Luo Hongmei, 2010, Chin Med, V5, P9, DOI 10.1186/1749-8546-5-9; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; Meng Ling-xin, 2007, Zhonghua Wei Chang Wai Ke Za Zhi, V10, P169; Milewski S, 2006, YEAST, V23, P1, DOI 10.1002/yea.1337; Moore MJ, 2002, CELL, V108, P431, DOI 10.1016/S0092-8674(02)00645-1; Moriwaki K, 2010, WORLD J HEPATOL, V2, P151, DOI 10.4254/wjh.v2.i4.151; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Potter SC, 2004, GENOME RES, V14, P934, DOI 10.1101/gr.1859804; Romfo CM, 2000, MOL CELL BIOL, V20, P7955, DOI 10.1128/MCB.20.21.7955-7970.2000; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sanodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717, DOI 10.2174/138920109789978757; SHIAO MS, 1987, J NAT PROD, V50, P886, DOI 10.1021/np50053a019; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smith CA, 2008, CURR GENET, V54, P241, DOI 10.1007/s00294-008-0215-9; SONE Y, 1985, AGR BIOL CHEM TOKYO, V49, P2641, DOI 10.1080/00021369.1985.10867134; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Stalker J, 2004, GENOME RES, V14, P951, DOI 10.1101/gr.1863004; TALERICO M, 1994, MOL CELL BIOL, V14, P3434, DOI 10.1128/MCB.14.5.3434; TALERICO M, 1990, MOL CELL BIOL, V10, P6299, DOI 10.1128/MCB.10.12.6299; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; van Wetter MA, 2000, MOL MICROBIOL, V36, P201, DOI 10.1046/j.1365-2958.2000.01848.x; Wang BC, 1991, CULTURAL ATLAS SOME; Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;699::AID-IJC12&gt;3.0.CO;2-5; Wang YY, 2002, BIOORGAN MED CHEM, V10, P1057, DOI 10.1016/S0968-0896(01)00377-7; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Wessels JGH, 1997, ADV MICROB PHYSIOL, V38, P1; Xing Y, 2004, GENOME RES, V14, P426, DOI 10.1101/gr.1304504; Yang FC, 1998, PROCESS BIOCHEM, V33, P547, DOI 10.1016/S0032-9592(98)00023-5; Ye LB, 2008, CARBOHYD RES, V343, P746, DOI 10.1016/j.carres.2007.12.004; Yousef GM, 2004, BRIT J CANCER, V90, P167, DOI 10.1038/sj.bjc.6601451	59	8	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61127	10.1371/journal.pone.0061127	http://dx.doi.org/10.1371/journal.pone.0061127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658685	Green Published, Green Submitted, gold			2022-12-25	WOS:000321200500004
J	Bhasin, MK; Dusek, JA; Chang, BH; Joseph, MG; Denninger, JW; Fricchione, GL; Benson, H; Libermann, TA				Bhasin, Manoj K.; Dusek, Jeffery A.; Chang, Bei-Hung; Joseph, Marie G.; Denninger, John W.; Fricchione, Gregory L.; Benson, Herbert; Libermann, Towia A.			Relaxation Response Induces Temporal Transcriptome Changes in Energy Metabolism, Insulin Secretion and Inflammatory Pathways	PLOS ONE			English	Article							PROTEIN REFERENCE DATABASE; SET ENRICHMENT ANALYSIS; NF-KAPPA-B; NITRIC-OXIDE; OXIDATIVE-STRESS; PSYCHOLOGICAL STRESS; RISK-FACTORS; GENOME-WIDE; EXPRESSION; MEDITATION	The relaxation response (RR) is the counterpart of the stress response. Millennia-old practices evoking the RR include meditation, yoga and repetitive prayer. Although RR elicitation is an effective therapeutic intervention that counteracts the adverse clinical effects of stress in disorders including hypertension, anxiety, insomnia and aging, the underlying molecular mechanisms that explain these clinical benefits remain undetermined. To assess rapid time-dependent (temporal) genomic changes during one session of RR practice among healthy practitioners with years of RR practice and also in novices before and after 8 weeks of RR training, we measured the transcriptome in peripheral blood prior to, immediately after, and 15 minutes after listening to an RR-eliciting or a health education CD. Both short-term and long-term practitioners evoked significant temporal gene expression changes with greater significance in the latter as compared to novices. RR practice enhanced expression of genes associated with energy metabolism, mitochondrial function, insulin secretion and telomere maintenance, and reduced expression of genes linked to inflammatory response and stress-related pathways. Interactive network analyses of RR-affected pathways identified mitochondrial ATP synthase and insulin (INS) as top upregulated critical molecules (focus hubs) and NF-kappa B pathway genes as top downregulated focus hubs. Our results for the first time indicate that RR elicitation, particularly after long-term practice, may evoke its downstream health benefits by improving mitochondrial energy production and utilization and thus promoting mitochondrial resiliency through upregulation of ATPase and insulin function. Mitochondrial resiliency might also be promoted by RR-induced downregulation of NF-kappa B-associated upstream and downstream targets that mitigates stress.	[Bhasin, Manoj K.; Denninger, John W.; Fricchione, Gregory L.; Benson, Herbert; Libermann, Towia A.] Massachusetts Gen Hosp, Benson Henry Inst Mind Body Med, Boston, MA 02114 USA; [Denninger, John W.; Fricchione, Gregory L.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Benson, Herbert] Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp, Boston, MA USA; [Bhasin, Manoj K.; Libermann, Towia A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Bhasin, Manoj K.; Joseph, Marie G.; Libermann, Towia A.] Beth Israel Deaconess Med Ctr, BIDMC Genom & Prote Ctr, Boston, MA 02215 USA; [Dusek, Jeffery A.] Abbott NW Hosp, Inst Hlth & Healing, Minneapolis, MN 55407 USA; [Chang, Bei-Hung] VA Boston Healthcare Syst, Boston, MA USA; [Chang, Bei-Hung] Boston Univ, Dept Hlth Policy & Management, Sch Publ Hlth, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University	Libermann, TA (corresponding author), Massachusetts Gen Hosp, Benson Henry Inst Mind Body Med, Boston, MA 02114 USA.	tliberma@bidmc.harvard.edu		Chang, Bei-Hung/0000-0001-9632-9713; Dusek, Jeffery/0000-0001-9581-0564; Libermann, Towia/0000-0002-4006-8179; Bhasin, Manoj/0000-0001-5172-420X	Centers for Disease Control and Prevention (CDC) [H75/CCH123424, R01 DP000339]; National Center for Complementary and Alternative Medicine (NCCAM) [RO1 AT006464-01]; NCRR, National Institutes of Health (The Harvard-Thorndike GCRC) [M01 RR01032]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [R01DP000339] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006464] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001032] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCRR, National Institutes of Health (The Harvard-Thorndike GCRC); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was funded by grants H75/CCH123424 and R01 DP000339 from the Centers for Disease Control and Prevention (CDC) (HB), RO1 AT006464-01 from the National Center for Complementary and Alternative Medicine (NCCAM) (HB) and grant M01 RR01032 from the NCRR, National Institutes of Health (The Harvard-Thorndike GCRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2007, ANN NY ACAD SCI, V1113, P256, DOI 10.1196/annals.1391.015; Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; ALEXANDER CN, 1989, J PERS SOC PSYCHOL, V57, P950, DOI 10.1037/0022-3514.57.6.950; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Antoni MH, 2012, BIOL PSYCHIAT, V71, P366, DOI 10.1016/j.biopsych.2011.10.007; ARCHER S, 1993, FASEB J, V7, P349, DOI 10.1096/fasebj.7.2.8440411; Astin JA, 2002, ARTHRIT RHEUM-ARTHR, V47, P291, DOI 10.1002/art.10416; BENSON H, 1978, PSYCHOTHER PSYCHOSOM, V30, P229, DOI 10.1159/000287304; BENSON H, 1974, PSYCHIATRY, V37, P37, DOI 10.1080/00332747.1974.11023785; Benson H., 1975, RELAXATION RESPONSE; Benson H., 2011, RELAXATION REVOLUTIO; Bierhaus A, 2004, PEDIATR NEPHROL, V19, P1189, DOI 10.1007/s00467-004-1603-0; Black D.S., 2012, PSYCHONEUROENDOCRINO; Chang BH, 2011, PSYCHOSOMATICS, V52, P550, DOI 10.1016/j.psym.2011.05.001; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Dusek JA, 2006, MED SCI MONITOR, V12, pCR1; Dusek JA, 2008, J ALTERN COMPLEM MED, V14, P129, DOI 10.1089/acm.2007.0623; Dusek Jeffery A, 2009, Minn Med, V92, P47; Dusek JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002576; Epel E, 2009, ANN NY ACAD SCI, V1172, P34, DOI 10.1111/j.1749-6632.2009.04414.x; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; FREEMAN BA, 1995, AM J PHYSIOL-LUNG C, V268, pL697, DOI 10.1152/ajplung.1995.268.5.L697; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Galvin Jennifer A, 2006, Complement Ther Clin Pract, V12, P186, DOI 10.1016/j.ctcp.2006.02.004; Hasegawa Y, 2012, CIRCULATION, V125, P1122, DOI 10.1161/CIRCULATIONAHA.111.054346; Hegde SV, 2011, DIABETES CARE, V34, P2208, DOI 10.2337/dc10-2430; HOFFMAN DW, 1980, J NEUROCHEM, V34, P1785, DOI 10.1111/j.1471-4159.1980.tb11279.x; Hofmann MA, 1999, DIABETOLOGIA, V42, P222, DOI 10.1007/s001250051142; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; JACOBS GD, 1993, BEHAV MODIF, V17, P498, DOI 10.1177/01454455930174005; Jacobs GD, 1996, AM J MED, V100, P212, DOI 10.1016/S0002-9343(97)89461-2; Jacobs TL, 2011, PSYCHONEUROENDOCRINO, V36, P664, DOI 10.1016/j.psyneuen.2010.09.010; Jayapandian M, 2007, NUCLEIC ACIDS RES, V35, pD566, DOI 10.1093/nar/gkl859; Lazar SW, 2000, NEUROREPORT, V11, P1581, DOI 10.1097/00001756-200005150-00041; LEONE AM, 1994, BIOCHEM BIOPH RES CO, V201, P883, DOI 10.1006/bbrc.1994.1784; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Mitchell Brett M, 2002, Biol Res Nurs, V4, P16, DOI 10.1177/1099800402004001003; MORIN CM, 1992, SLEEP, V15, P302, DOI 10.1093/sleep/15.4.302; Morita K, 2005, NEUROSCI LETT, V381, P57, DOI 10.1016/j.neulet.2005.01.081; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nagabhushan M, 2001, BRAIN BEHAV IMMUN, V15, P78, DOI 10.1006/brbi.2000.0589; Nakao M, 2001, PSYCHOTHER PSYCHOSOM, V70, P50, DOI 10.1159/000056225; Peng CK, 2004, INT J CARDIOL, V95, P19, DOI 10.1016/j.ijcard.2003.02.006; Perron NR, 2013, J BIOENERG BIOMEMBR, V45, P101, DOI 10.1007/s10863-012-9477-5; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Saleh MC, 2008, DIABETES-METAB RES, V24, P392, DOI 10.1002/dmrr.819; Segman RH, 2010, MOL PSYCHIATR, V15, P93, DOI 10.1038/mp.2009.65; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stefano GB, 2001, INT J MOL MED, V7, P119; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tamashiro KLK, 2011, ANN NY ACAD SCI, V1231, P46, DOI 10.1111/j.1749-6632.2011.06134.x; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; WALLACE RK, 1971, AM J PHYSIOL, V221, P795, DOI 10.1152/ajplegacy.1971.221.3.795; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697	69	137	137	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62817	10.1371/journal.pone.0062817	http://dx.doi.org/10.1371/journal.pone.0062817			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650531	Green Submitted, Green Published, gold			2022-12-25	WOS:000319167000076
J	de Moraes, ACF; Carvalho, HB; Rey-Lopez, JP; Gracia-Marco, L; Beghin, L; Kafatos, A; Jimenez-Pavon, D; Molnar, D; De Henauw, S; Manios, Y; Widhalm, K; Ruiz, JR; Ortega, FB; Sjostrom, M; Polito, A; Pedrero-Chamizo, R; Marcos, A; Gottrand, F; Moreno, LA				Ferreira de Moraes, Augusto Cesar; Carvalho, Heraclito Barbosa; Rey-Lopez, Juan Pablo; Gracia-Marco, Luis; Beghin, Laurent; Kafatos, Anthony; Jimenez-Pavon, David; Molnar, Denes; De Henauw, Stefaan; Manios, Yannis; Widhalm, Kurt; Ruiz, Jonatan R.; Ortega, Francisco B.; Sjostrom, Michael; Polito, Angela; Pedrero-Chamizo, Raquel; Marcos, Ascension; Gottrand, Frederic; Moreno, Luis A.			Independent and Combined Effects of Physical Activity and Sedentary Behavior on Blood Pressure in Adolescents: Gender Differences in Two Cross-Sectional Studies	PLOS ONE			English	Article							EUROPEAN ADOLESCENTS; RISK-FACTORS; LIFE-STYLE; SOCIOECONOMIC-STATUS; BONE MASS; TIME; DETERMINANTS; FITNESS; CHILDREN; HEALTH	Objectives: To examine the independent and combined association of physical activity (PA) and sedentary behavior (SB) on both systolic (SBP) and diastolic blood pressure (DBP) in adolescents from two observational studies. Methods: Participants from two cross-sectional studies, one conducted in Europe (n = 3,308; HELENA study) and the other in Brazil (n = 991; BRACAH study), were selected by complex sampling. Systolic and diastolic blood pressure (outcomes), PA and SB, both independently and combined, and potential confounders were analyzed. Associations were examined by multilevel linear regression. Results: Performing the recommended amount of PA (>= 60 min/d) attenuated the effect of SB on DBP in BRACAH study girls and in boys from both studies. In contrast, PA did not attenuate the effects of SB on the SBP of girls in the HELENA study. The combination of less than recommended levels of PA with 2-4 h/d of sedentary behavior was found to be associated with increased SBP in boys from both studies. Conclusions: Meeting current PA recommendations could mediate the association between SB and DBP in both sexes. In boys, the joint effect of low levels of PA and excessive sedentary activity increases SBP levels. Longitudinal studies are required to confirm these findings.	[Ferreira de Moraes, Augusto Cesar; Carvalho, Heraclito Barbosa; Rey-Lopez, Juan Pablo; Moreno, Luis A.] Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Carlos, SP, Brazil; [Ferreira de Moraes, Augusto Cesar] Pontificia Univ Catolica Parana PUCPR, GEPECIN Sci Nutr Grp Res, Curitiba, Parana, Brazil; [Ferreira de Moraes, Augusto Cesar; Rey-Lopez, Juan Pablo; Gracia-Marco, Luis; Jimenez-Pavon, David; Moreno, Luis A.] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev, Zaragoza, Spain; [Moreno, Luis A.] Univ Zaragoza, Sch Hlth Sci, Zaragoza, Spain; [Beghin, Laurent; Gottrand, Frederic] Unite Inserm U995, Lille, France; [Beghin, Laurent; Gottrand, Frederic] Univ Lille Nord France, Lille, France; [Kafatos, Anthony] Univ Crete, Sch Med, Prevent Med & Nutr Unit, Iraklion, Crete, Greece; [Jimenez-Pavon, David; Ruiz, Jonatan R.; Ortega, Francisco B.] Univ Granada, Sch Sport Sci, Dept Phys Educ & Sports, PROFITH Grp, Granada, Spain; [Molnar, Denes] Univ Pecs, Fac Med, Dept Paediat, Pecs, Hungary; [De Henauw, Stefaan] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Manios, Yannis] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Widhalm, Kurt] Med Univ Vienna, Dept Pediat, Div Nutr & Metab, Vienna, Austria; [Ruiz, Jonatan R.; Ortega, Francisco B.; Sjostrom, Michael] Karolinska Inst, Dept Biosci, Unit Prevent Nutr, Stockholm, Sweden; [Polito, Angela] Natl Inst Food & Nutr Res, Rome, Italy; [Pedrero-Chamizo, Raquel] Univ Politecn Madrid, Madrid, Spain; [Marcos, Ascension] Spanish Natl Res Council, Food Sci & Technol & Nutr Inst, Dept Metab & Nutr, Immunonutr Res Grp, Madrid, Spain; [Gracia-Marco, Luis] Univ Exeter, Sch Sport & Hlth Sci, Exeter, Devon, England; [Beghin, Laurent; Gottrand, Frederic] Ctr Invest Clin, Inserm CH& U, CIC 9301, Lille, France; [Ferreira de Moraes, Augusto Cesar] Univ Estadual Paulista, GICRAF Sci Res Grp Related Phys Act, Sao Paulo, Brazil	Universidade de Sao Paulo; Pontificia Universidade Catolica do Parana; University of Zaragoza; University of Zaragoza; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; University of Crete; University of Granada; University of Pecs; Ghent University; Harokopio University Athens; Medical University of Vienna; Karolinska Institutet; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Universidad Politecnica de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); University of Exeter; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universidade Estadual Paulista	de Moraes, ACF (corresponding author), Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Carlos, SP, Brazil.	augustocesar.demoraes@usp.br	Gracia-Marco, Luis/A-8845-2018; Gracia-Marco, Luis/R-4899-2019; Ortega, Francisco B/B-4002-2010; Manios, Yannis/AAM-8953-2021; Polito, Angela/B-1363-2016; gottrand, frederic F/G-7370-2015; RUIZ, JONATAN R/M-1338-2015; Carvalho, Heráclito/C-1334-2012; Jiménez-Pavón, David/AAA-2970-2020; Molnár, Dénes/AAB-6820-2022; Polito, Angela/AAO-1596-2020; Jiménez-Pavón, David/M-9005-2015; BEGHIN, Laurent R/D-4294-2011; Pedrero-Chamizo, Raquel/Z-3738-2019; Moreno, Luis/S-1780-2019; Ortega, Francisco B./AAG-5195-2021; Sanchez, Ascension Marcos/K-4965-2014; Ferreira De Moraes, Augusto César/D-2198-2009	Gracia-Marco, Luis/0000-0002-4020-0256; Gracia-Marco, Luis/0000-0002-4020-0256; Ortega, Francisco B/0000-0003-2001-1121; Manios, Yannis/0000-0001-6486-114X; Polito, Angela/0000-0003-4898-796X; gottrand, frederic F/0000-0002-5290-0436; RUIZ, JONATAN R/0000-0002-7548-7138; Carvalho, Heráclito/0000-0002-7037-5655; Jiménez-Pavón, David/0000-0002-8977-4744; Polito, Angela/0000-0003-4898-796X; Jiménez-Pavón, David/0000-0002-8977-4744; BEGHIN, Laurent R/0000-0001-5369-3910; Moreno, Luis/0000-0003-0454-653X; Ortega, Francisco B./0000-0003-2001-1121; Sanchez, Ascension Marcos/0000-0002-8022-9563; Ferreira De Moraes, Augusto César/0000-0002-5763-435X; Rey Lopez, Juan Pablo/0000-0002-7201-2006; Pedrero-Chamizo, Raquel/0000-0002-3866-4692	European Community [FOOD-CT-2005-007034]; Spanish Ministry of Health: Maternal, Child Health and Development Network [RD08/0072]; Spanish Ministry of Education [EX-2008-0641]; Swedish Heart-Lung Foundation [20090635]; Sao Paulo State Research Foundation (FAPESP) [2011/11137-1, 2011/20662-2]	European Community(European Commission); Spanish Ministry of Health: Maternal, Child Health and Development Network(Spanish Government); Spanish Ministry of Education(Spanish Government); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The HELENA Study received financial support from the European Community Sixth RTD Framework Programme (contract FOOD-CT-2005-007034). The writing group takes sole responsibility for the content of this article. This study was also supported by grants from the Spanish Ministry of Health: Maternal, Child Health and Development Network (number RD08/0072), the Spanish Ministry of Education (EX-2008-0641) and the Swedish Heart-Lung Foundation (20090635). The BRACAH survey received no funding. ACFM received a scholarship from the Sao Paulo State Research Foundation (FAPESP: proc. 2011/11137-1 and 2011/20662-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEP, 2006, BRAZ CRIT EC CLASS; Beaglehole R, 2010, LANCET, V376, P1619, DOI 10.1016/S0140-6736(10)61929-0; Bringolf-Isler B, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-50; Christofaro DGD, 2013, SCAND J MED SCI SPOR, V23, P317, DOI 10.1111/j.1600-0838.2011.01382.x; CLELAND V, 2011, BR J SPORTS MED; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; DEMORAES AC, 2012, APPETITE; Christofaro DGD, 2009, ARQ BRAS CARDIOL, V92, P9, DOI 10.1590/S0066-782X2009000100003; Ding D, 2011, AM J PREV MED, V41, P442, DOI 10.1016/j.amepre.2011.06.036; Dodd LJ, 2010, PREV MED, V51, P73, DOI 10.1016/j.ypmed.2010.04.005; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Edwardson CL, 2010, PSYCHOL SPORT EXERC, V11, P522, DOI 10.1016/j.psychsport.2010.05.001; Ekelund U, 2004, AM J CLIN NUTR, V80, P584; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; de Moraes ACF, 2011, CLINICS, V66, P1149, DOI 10.1590/S1807-59322011000700005; Gracia-Marco L, 2012, J ADOLESCENT HEALTH, V50, P484, DOI 10.1016/j.jadohealth.2011.08.018; Gracia-Marco L, 2011, AM J PREV MED, V40, P599, DOI 10.1016/j.amepre.2011.03.001; Hagstromer M, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.182; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Iliescu C, 2008, INT J OBESITY, V32, pS19, DOI 10.1038/ijo.2008.178; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Pavon DJ, 2010, NUTR HOSP, V25, P311, DOI 10.3305/nh.2010.25.2.4596; Kingwell BA, 2000, FASEB J, V14, P1685, DOI 10.1096/fj.99-0896rev; LAUER RM, 1989, PEDIATRICS, V84, P633; Lazarou C, 2009, J HUM HYPERTENS, V23, P456, DOI 10.1038/jhh.2008.151; Malcon MC, 2003, REV SAUDE PUBL, V37, P1, DOI 10.1590/S0034-89102003000100003; Marmot M, 2009, INT J PUBLIC HEALTH, V54, P125, DOI 10.1007/s00038-009-5402-z; Martinez-Gomez D, 2012, ATHEROSCLEROSIS, V221, P260, DOI 10.1016/j.atherosclerosis.2011.12.032; Martinez-Gomez D, 2011, ARCH DIS CHILD, V96, P240, DOI 10.1136/adc.2010.187161; Martinez-Gomez D, 2010, REV ESP CARDIOL, V63, P277, DOI 10.1016/S0300-8932(10)70086-5; Moreno LA, 2008, INT J OBESITY, V32, pS4, DOI 10.1038/ijo.2008.177; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Parker BA, 2010, EUR J APPL PHYSIOL, V110, P235, DOI 10.1007/s00421-010-1506-7; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Rey-Lopez JP, 2011, EUR J PUBLIC HEALTH, V21, P151, DOI 10.1093/eurpub/ckq035; REYLOPEZ JP, 2012, PEDIAT OBES; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Roux AVD, 2008, J EPIDEMIOL COMMUN H, V62, P957, DOI 10.1136/jech.2007.064311; Ruiz JR, 2011, AM J EPIDEMIOL, V174, P173, DOI 10.1093/aje/kwr068; Seabra AF, 2008, CAD SAUDE PUBLICA, V24, P721, DOI 10.1590/S0102-311X2008000400002; Sirard JR, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-82; Snijders T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Topouchian JA, 2006, BLOOD PRESS MONIT, V11, P165, DOI 10.1097/01.mbp.0000209078.17246.34; TRILK J, 2012, CLUSTER ANAL PHYS AC; Tsioufis C, 2011, EUR J PUBLIC HEALTH, V21, P63, DOI 10.1093/eurpub/ckq006; *US, 2008, KEY GUID CHILDR AD; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Wijndaele K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020058; Zago Anderson Saranz, 2006, Arq. Bras. Cardiol., V87, pe264, DOI 10.1590/S0066-782X2006001900029	52	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62006	10.1371/journal.pone.0062006	http://dx.doi.org/10.1371/journal.pone.0062006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23650506	Green Submitted, Green Published, gold			2022-12-25	WOS:000319167000025
J	Kujala, MV; Tornqvist, H; Somppi, S; Hanninen, L; Krause, CM; Vainio, O; Kujala, J				Kujala, Miiamaaria V.; Tornqvist, Heini; Somppi, Sanni; Hanninen, Laura; Krause, Christina M.; Vainio, Outi; Kujala, Jan			Reactivity of Dogs' Brain Oscillations to Visual Stimuli Measured with Non-Invasive Electroencephalography	PLOS ONE			English	Article							MONKEY MOTOR CORTEX; RHYTHMIC ACTIVITY; AWAKE CHIMPANZEE; MEMORY PROCESSES; ALPHA-RHYTHM; RESPONSES; TASK; CAT; SYNCHRONIZATION; ATTENTION	Studying cognition of domestic dogs has gone through a renaissance within the last decades. However, although the behavioral studies of dogs are beginning to be common in the field of animal cognition, the neural events underlying cognition remain unknown. Here, we employed a non-invasive electroencephalography, with adhesive electrodes attached to the top of the skin, to measure brain activity of from 8 domestic dogs (Canis familiaris) while they stayed still to observe photos of dog and human faces. Spontaneous oscillatory activity of the dogs, peaking in the sensors over the parieto-occipital cortex, was suppressed statistically significantly during visual task compared with resting activity at the frequency of 15-30 Hz. Moreover, a stimulus-induced low-frequency (similar to 2-6 Hz) suppression locked to the stimulus onset was evident at the frontal sensors, possibly reflecting a motor rhythm guiding the exploratory eye movements. The results suggest task-related reactivity of the macroscopic oscillatory activity in the dog brain. To our knowledge, the study is the first to reveal non-invasively measured reactivity of brain electrophysiological oscillations in healthy dogs, and it has been based purely on positive operant conditional training, without the need for movement restriction or medication.	[Kujala, Miiamaaria V.; Kujala, Jan] INSERM, Lyon Neurosci Res Ctr, CNRS UMR5292, U1028, F-69500 Bron, France; [Kujala, Miiamaaria V.; Tornqvist, Heini; Somppi, Sanni; Vainio, Outi] Univ Helsinki, Fac Vet Med, Dept Equine & Small Anim Med, Helsinki, Finland; [Kujala, Miiamaaria V.] Aalto Univ, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Tornqvist, Heini; Somppi, Sanni; Hanninen, Laura; Vainio, Outi] Univ Helsinki, Fac Vet Med, Res Ctr Anim Welf, Helsinki, Finland; [Tornqvist, Heini; Krause, Christina M.] Univ Helsinki, Fac Behav Sci, Inst Behav Sci, Helsinki, Finland; [Hanninen, Laura] Univ Helsinki, Fac Vet Med, Dept Prod Anim Med, Helsinki, Finland; [Kujala, Jan] Aalto Univ, OV Lounasmaa Lab, Brain Res Unit, Espoo, Finland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Helsinki; Aalto University; University of Helsinki; University of Helsinki; University of Helsinki; Aalto University	Kujala, MV (corresponding author), INSERM, Lyon Neurosci Res Ctr, CNRS UMR5292, U1028, F-69500 Bron, France.	miiamaaria.kujala@helsinki.fi	Hänninen, Laura Talvikki/E-6683-2011; Kujala, Jan/J-3092-2012	Hänninen, Laura Talvikki/0000-0001-5118-8451; Kujala, Jan/0000-0002-3056-753X; Kujala, Miiamaaria/0000-0002-1377-2187; Vainio, Outi Maritta/0000-0003-3467-2246	Academy of Finland [137931, 115215, 137511]; University of Helsinki; Foundations' Post Doc Pool (Kone Foundation); BRAHE neuroscience collaboration between the Aalto University; Finnish Cultural Foundation; Advancement of Technology Foundation; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); University of Helsinki; Foundations' Post Doc Pool (Kone Foundation); BRAHE neuroscience collaboration between the Aalto University; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Advancement of Technology Foundation; Emil Aaltonen Foundation	This study was supported by the Academy of Finland (project #137931 to OV; #115215 and #137511 to CMK), research grant from the University of Helsinki, Foundations' Post Doc Pool (Kone Foundation), BRAHE neuroscience collaboration between the Aalto University and the University of Helsinki, Finnish Cultural Foundation, Advancement of Technology Foundation and Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Bekisz M, 2003, EUR J NEUROSCI, V17, P421, DOI 10.1046/j.1460-9568.2003.02454.x; Bekisz Marek, 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P175; Berns GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038027; BICHSEL P, 1988, J VET INTERN MED, V2, P145, DOI 10.1111/j.1939-1676.1988.tb02811.x; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Bosman CA, 2009, J NEUROSCI, V29, P9471, DOI 10.1523/JNEUROSCI.1193-09.2009; BOUYER JJ, 1981, ELECTROEN CLIN NEURO, V51, P244, DOI 10.1016/0013-4694(81)90138-3; BOUYER JJ, 1987, NEUROSCIENCE, V22, P863, DOI 10.1016/0306-4522(87)92965-4; BUTTERWORTH G, 1980, INT J BEHAV DEV, V3, P253, DOI 10.1177/016502548000300303; Caton R, 1875, BRIT MED J, V2, P278, DOI DOI 10.1080/00029238.1970.11080764; CHATILA M, 1992, ELECTROEN CLIN NEURO, V83, P217, DOI 10.1016/0013-4694(92)90147-A; DASILVA FHL, 1977, NEUROSCI LETT, V6, P237, DOI 10.1016/0304-3940(77)90024-6; Fukushima H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013366; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gevins A, 1998, HUM FACTORS, V40, P79, DOI 10.1518/001872098779480578; GOKHBLIT I. I., 1958, BIULL EKSPTL BIOL I MED [TRANSL], V46, P790, DOI 10.1007/BF00837789; Guo K, 2010, PERCEPTION, V39, P533, DOI 10.1068/p6517; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Hanninen L, 2008, APPL ANIM BEHAV SCI, V111, P235, DOI 10.1016/j.applanim.2007.06.009; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B., 1998, EVOL COMMUN, V2, P137; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; Howell TJ, 2012, BEHAV PROCESS, V89, P8, DOI 10.1016/j.beproc.2011.09.009; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Jackson A, 2002, J PHYSIOL-LONDON, V541, P685, DOI 10.1113/jphysiol.2001.015099; Jensen O., 2010, MEG INTRO METHODS, P156; Kaminski J, 2008, ANIM COGN, V11, P367, DOI 10.1007/s10071-007-0124-1; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 1997, INT J PSYCHOPHYSIOL, V26, P319, DOI 10.1016/S0167-8760(97)00773-3; Krause CM, 2006, PROG BRAIN RES, V159, P197, DOI 10.1016/S0079-6123(06)59013-2; Krause CM, 2010, INT J PSYCHOPHYSIOL, V77, P305, DOI 10.1016/j.ijpsycho.2010.06.203; Kronland-Martinet R, 1987, INT J PATTERN RECOGN, V1, P273, DOI DOI 10.1142/S0218001487000205; Kujala J, 2012, CEREB CORTEX, V22, P2305, DOI 10.1093/cercor/bhr307; Kujala MV, 2009, HUM BRAIN MAPP, V30, P3910, DOI 10.1002/hbm.20816; Laaksonen H, 2008, NEUROIMAGE, V42, P207, DOI 10.1016/j.neuroimage.2008.04.175; Liljestrom M, 2005, NEUROIMAGE, V25, P734, DOI 10.1016/j.neuroimage.2004.11.034; Lima B, 2010, CEREB CORTEX, V20, P1556, DOI 10.1093/cercor/bhp218; LOPESDASILVA FH, 1970, ELECTROEN CLIN NEURO, V29, P246, DOI 10.1016/0013-4694(70)90137-9; LOPESDASILVA FH, 1970, ELECTROEN CLIN NEURO, V29, P260, DOI 10.1016/0013-4694(70)90138-0; LOPESDASILVA FH, 1973, ELECTROEN CLIN NEURO, V35, P627, DOI 10.1016/0013-4694(73)90216-2; Medendorp WP, 2007, CEREB CORTEX, V17, P2364, DOI 10.1093/cercor/bhl145; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Pellegrino FC, 2004, CLIN NEUROPHYSIOL, V115, P477, DOI 10.1016/S1388-2457(03)00347-X; PFURTSCHELLER G, 1994, INT J PSYCHOPHYSIOL, V16, P147, DOI 10.1016/0167-8760(89)90041-X; Range F, 2007, CURR BIOL, V17, P868, DOI 10.1016/j.cub.2007.04.026; Salenius S, 1995, ELECTROEN CLIN NEURO, V95, P453, DOI 10.1016/0013-4694(95)00155-7; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; Sams M, 1997, NEUROSCIENCE, V77, P49, DOI 10.1016/S0306-4522(96)00419-8; Somppi S, 2012, ANIM COGN, V15, P163, DOI 10.1007/s10071-011-0442-1; STERIADE M, 1990, ELECTROEN CLIN NEURO, V76, P481, DOI 10.1016/0013-4694(90)90001-Z; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tanskanen T, 2007, NEUROIMAGE, V35, P1636, DOI 10.1016/j.neuroimage.2007.01.023; Tomasello M, 2009, SCIENCE, V325, P1213, DOI 10.1126/science.1179670; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Tornqvist H, 2012, 3 CAN SCI FOR BARC; Ueno A, 2010, BIOL LETTERS, V6, P311, DOI 10.1098/rsbl.2009.0864; Ueno A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001442; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wrobel A, 2000, ACTA NEUROBIOL EXP, V60, P247	63	23	23	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61818	10.1371/journal.pone.0061818	http://dx.doi.org/10.1371/journal.pone.0061818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650504	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000021
J	Armananzas, R; Alonso-Nanclares, L; DeFelipe-Oroquieta, J; Kastanauskaite, A; de Sola, RG; DeFelipe, J; Bielza, C; Larranaga, P				Armananzas, Ruben; Alonso-Nanclares, Lidia; DeFelipe-Oroquieta, Jesus; Kastanauskaite, Asta; de Sola, Rafael G.; DeFelipe, Javier; Bielza, Concha; Larranaga, Pedro			Machine Learning Approach for the Outcome Prediction of Temporal Lobe Epilepsy Surgery	PLOS ONE			English	Article							THICKNESS; LOBECTOMY; SCLEROSIS	Epilepsy surgery is effective in reducing both the number and frequency of seizures, particularly in temporal lobe epilepsy (TLE). Nevertheless, a significant proportion of these patients continue suffering seizures after surgery. Here we used a machine learning approach to predict the outcome of epilepsy surgery based on supervised classification data mining taking into account not only the common clinical variables, but also pathological and neuropsychological evaluations. We have generated models capable of predicting whether a patient with TLE secondary to hippocampal sclerosis will fully recover from epilepsy or not. The machine learning analysis revealed that outcome could be predicted with an estimated accuracy of almost 90% using some clinical and neuropsychological features. Importantly, not all the features were needed to perform the prediction; some of them proved to be irrelevant to the prognosis. Personality style was found to be one of the key features to predict the outcome. Although we examined relatively few cases, findings were verified across all data, showing that the machine learning approach described in the present study may be a powerful method. Since neuropsychological assessment of epileptic patients is a standard protocol in the pre-surgical evaluation, we propose to include these specific psychological tests and machine learning tools to improve the selection of candidates for epilepsy surgery.	[Armananzas, Ruben; Bielza, Concha; Larranaga, Pedro] Univ Politecn Madrid, Dept Inteligencia Artificial, Madrid, Spain; [Alonso-Nanclares, Lidia; Kastanauskaite, Asta; DeFelipe, Javier] Univ Politecn Madrid, Lab Cajal Circuitos Corticales, Madrid, Spain; [Alonso-Nanclares, Lidia; Kastanauskaite, Asta; DeFelipe, Javier] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Alonso-Nanclares, Lidia; Kastanauskaite, Asta; DeFelipe, Javier] CIberNed, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [DeFelipe-Oroquieta, Jesus] Univ Camilo Jose Cela, Dept Psicol & Eduac, Madrid, Spain; [de Sola, Rafael G.] Hosp Univ Princesa, Dept Neurosurg, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED; Camilo Jose Cela University; Hospital de La Princesa	Armananzas, R (corresponding author), Univ Politecn Madrid, Dept Inteligencia Artificial, Madrid, Spain.	r.armananzas@upm.es	DEFELIPE, JAVIER/D-1195-2014; Kastanauskaite, Asta/AAD-3330-2019; Alonso-Nanclares, Lidia/K-6330-2013; Kastanauskaite, Asta/H-4676-2015; Armañanzas, Rubén/O-7403-2019; Bielza, Concha/F-9277-2013; Armañanzas, Rubén/C-2735-2013; Larranaga, Pedro/F-9293-2013	DEFELIPE, JAVIER/0000-0001-5484-0660; Kastanauskaite, Asta/0000-0001-8192-3402; Alonso-Nanclares, Lidia/0000-0003-2649-7097; Kastanauskaite, Asta/0000-0001-8192-3402; Armañanzas, Rubén/0000-0003-4049-0000; Bielza, Concha/0000-0001-7109-2668; Armañanzas, Rubén/0000-0003-4049-0000; Larranaga, Pedro/0000-0003-0652-9872; G. Sola, Rafael/0000-0002-0063-9301	Centre for Networked Biomedical Research into Neurodegenerative Diseases (CIBERNED) [CB06/05/0066]; Spanish Ministry of Economy and Competitiveness [SAF2009-09394]; Juan de la Cierva postdoctoral fellowship; Cajal Blue Brain Project, Spanish partner of the Blue Brain Project initiative from EPFL;  [TIN2010-20900-C04-04]	Centre for Networked Biomedical Research into Neurodegenerative Diseases (CIBERNED); Spanish Ministry of Economy and Competitiveness(Spanish Government); Juan de la Cierva postdoctoral fellowship(Instituto de Salud Carlos III); Cajal Blue Brain Project, Spanish partner of the Blue Brain Project initiative from EPFL; 	This work was supported by grants from the following entities: Centre for Networked Biomedical Research into Neurodegenerative Diseases (CIBERNED, CB06/05/0066 to JDF), the Spanish Ministry of Economy and Competitiveness (grants SAF2009-09394 to JDF; Juan de la Cierva postdoctoral fellowship to RA; TIN2010-20900-C04-04 and the Cajal Blue Brain Project, Spanish partner of the Blue Brain Project initiative from EPFL, to JDF, PL and CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma N, 2003, EPILEPSIA, V44, P408, DOI 10.1046/j.1528-1157.2003.24502.x; Arle JE, 1999, J NEUROSURG, V90, P998, DOI 10.3171/jns.1999.90.6.0998; Armananzas R., 2012, CONSENSUS POLICIES S; Armananzas R, 2012, COMPUT METH PROG BIO, V108, P442, DOI 10.1016/j.cmpb.2011.11.011; Aull-Watschinger S, 2008, EPILEPSIA, V49, P1308, DOI 10.1111/j.1528-1167.2008.01732.x; Choi YY, 2008, J NEUROSCI, V28, P10323, DOI 10.1523/JNEUROSCI.3259-08.2008; de Felipe-Oroquieta J, 2007, RORSCHACHIANA, V28, P3; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Engel Jerome Jr., 1993, P989; Engel Jr J., 1987, SURG TREATMENT EPILE, P553; Exner J, 1990, RORSCH WORKSH ASH; Exner J, 1993, RORSCHACH COMPREHENS; Exner J, 1991, RORSCHACH COMPREHENS; FALCONER MA, 1974, LANCET, V2, P767; Garcia-Bilbao A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-43; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Grigsby J, 1998, EPILEPSIA, V39, P61, DOI 10.1111/j.1528-1157.1998.tb01275.x; Honavar M, 1997, GREENFIELDS NEUROPAT, P931; Jones-Gotman M, 2010, EPILEPSY BEHAV, V18, P3, DOI 10.1016/j.yebeh.2010.02.019; Lacruz ME, 2004, J NEUROL NEUROSUR PS, V75, P600, DOI 10.1136/jnnp.2003.020248; Larranaga P, 2006, BRIEF BIOINFORM, V7, P86, DOI 10.1093/bib/bbk007; Lin JJ, 2007, CEREB CORTEX, V17, P2007, DOI 10.1093/cercor/bhl109; McIntosh AM, 2001, EPILEPSIA, V42, P1288, DOI 10.1046/j.1528-1157.2001.02001.x; MELDRUM B.S., 1992, GREENFIELDS NEUROPAT, P1246; Moore W, 1994, MACHINE LEARNING P, P190, DOI [10.1016/B978-1-55860-335-6.50031-3, DOI 10.1016/B978-1-55860-335-6.50031-3]; Narr KL, 2007, CEREB CORTEX, V17, P2163, DOI 10.1093/cercor/bhl125; Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309; Pepe MS, 2004, STAT EVALUATION MED; Sola RG, 2005, REV NEUROLOGIA, V41, P4; Spencer Dennis D., 1993, P583; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Thom M, 2010, ANN NEUROL, V68, P424, DOI 10.1002/ana.22142; Wechsler D, 1997, WESCHSLER ADULT INTE; Wechsler D., 1981, WECHSLER INTELLIGENC, V3rd; Wieser Heinz-Gregor, 1993, P49; World Medical Association (WMA), 2008, DECL HELS; Yu HY, 2009, SEIZURE-EUR J EPILEP, V18, P639, DOI 10.1016/j.seizure.2009.07.009	38	25	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62819	10.1371/journal.pone.0062819	http://dx.doi.org/10.1371/journal.pone.0062819			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646148	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300101
J	Cheng, SF; Tsai, MS; Huang, CL; Huang, YP; Chen, IH; Lin, NS; Hsu, YH; Tsai, CH; Cheng, CP				Cheng, Shun-Fang; Tsai, Meng-Shan; Huang, Chia-Lin; Huang, Ying-Ping; Chen, I-Hsuan; Lin, Na-Sheng; Hsu, Yau-Heiu; Tsai, Ching-Hsiu; Cheng, Chi-Ping			Ser/Thr Kinase-Like Protein of Nicotiana benthamiana Is Involved in the Cell-to-Cell Movement of Bamboo mosaic virus	PLOS ONE			English	Article							TRIPLE-GENE-BLOCK; N-TERMINAL REGION; VIRAL MOVEMENT; COAT PROTEIN; IN-VITRO; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; REPLICATION PROTEIN; P-33 REPLICATION; RNA-BINDING	To investigate the plant genes affected by Bamboo mosaic virus (BaMV) infection, we applied a cDNA-amplified fragment length polymorphism technique to screen genes with differential expression. A serine/threonine kinase-like (NbSTKL) gene of Nicotiana benthamiana is upregulated after BaMV infection. NbSTKL contains the homologous domain of Ser/Thr kinase. Knocking down the expression of NbSTKL by virus-induced gene silencing reduced the accumulation of BaMV in the inoculated leaves but not in the protoplasts. The spread of GFP-expressing BaMV in the inoculated leaves is also impeded by a reduced expression of NbSTKL. These data imply that NbSTKL facilitates the cell-to-cell movement of BaMV. The subcellular localization of NbSTKL is mainly on the cell membrane, which has been confirmed by mutagenesis and fractionation experiments. Combined with the results showing that active site mutation of NbSTKL does not change its subcellular localization but significantly affects BaMV accumulation, we conclude that NbSTKL may regulate BaMV movement on the cell membrane by its kinase-like activity. Moreover, the transient expression of NbSTKL does not significantly affect the accumulation of Cucumber mosaic virus (CMV) and Potato virus X (PVX); thus, NbSTKL might be a specific protein facilitating BaMV movement.	[Tsai, Meng-Shan; Cheng, Chi-Ping] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Cheng, Shun-Fang; Huang, Chia-Lin; Huang, Ying-Ping; Chen, I-Hsuan; Hsu, Yau-Heiu; Tsai, Ching-Hsiu] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Lin, Na-Sheng] Acad Sinica, Inst Plant & Microbial Biol, Nankang, Taiwan	Tzu Chi University; National Chung Hsing University; Academia Sinica - Taiwan	Tsai, CH (corresponding author), Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan.	chtsai1@dragon.nchu.edu.tw; cp1103@mail.tcu.edu.tw			National Science Council [NSC 97-2313-B-320-001-MY3, NSC 99-2321-B-005-003-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council NSC 97-2313-B-320-001-MY3 and NSC 99-2321-B-005-003-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Modena NA, 2008, VIRUS RES, V137, P16, DOI 10.1016/j.virusres.2008.04.007; Beachy RN, 2000, TRAFFIC, V1, P540, DOI 10.1034/j.1600-0854.2000.010703.x; Champagne J, 2007, MOL PLANT MICROBE IN, V20, P648, DOI 10.1094/MPMI-20-6-0648; Chang BY, 1997, J GEN VIROL, V78, P1175, DOI 10.1099/0022-1317-78-5-1175; Cheng SF, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-286; Chowda-Reddy RV, 2008, VIRUS RES, V135, P115, DOI 10.1016/j.virusres.2008.02.014; Guenoune-Gelbart D, 2008, MOL PLANT MICROBE IN, V21, P335, DOI 10.1094/MPMI-21-3-0335; Heinlein M, 1998, PLANT CELL, V10, P1107, DOI 10.1105/tpc.10.7.1107; Karger EM, 2003, J GEN VIROL, V84, P727, DOI 10.1099/vir.0.18972-0; Kleinow T, 2009, VIROLOGY, V390, P89, DOI 10.1016/j.virol.2009.04.018; Lan P, 2010, MOL PLANT MICROBE IN, V23, P903, DOI 10.1094/MPMI-23-7-0903; Lee CC, 2011, J VIROL, V85, P12022, DOI 10.1128/JVI.05595-11; Lee JY, 2005, PLANT CELL, V17, P2817, DOI 10.1105/tpc.105.034330; Lee JY, 2001, TRENDS MICROBIOL, V9, P5, DOI 10.1016/S0966-842X(00)01901-6; Lewsey M, 2009, MOL PLANT MICROBE IN, V22, P642, DOI 10.1094/MPMI-22-6-0642; Li YI, 1998, J VIROL, V72, P10093, DOI 10.1128/JVI.72.12.10093-10099.1998; Li YI, 2001, J VIROL, V75, P782, DOI 10.1128/JVI.75.2.782-788.2001; Lin JW, 2007, NUCLEIC ACIDS RES, V35, P424, DOI 10.1093/nar/gkl1061; Lin MK, 2004, J GEN VIROL, V85, P251, DOI 10.1099/vir.0.19442-0; LIN NS, 1994, J GEN VIROL, V75, P2513, DOI 10.1099/0022-1317-75-9-2513; Lucas WJ, 2006, VIROLOGY, V344, P169, DOI 10.1016/j.virol.2005.09.026; Martin-Belmonte F, 2000, BIOCHEMISTRY-US, V39, P1083, DOI 10.1021/bi992132e; Mas P, 1999, J CELL BIOL, V147, P945, DOI 10.1083/jcb.147.5.945; Matsushita Y, 2003, J GEN VIROL, V84, P497, DOI 10.1099/vir.0.18839-0; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; Meng L, 2010, P NATL ACAD SCI USA, V107, P3900, DOI 10.1073/pnas.0913759107; Munter S., 2006, SCI STKE, V2006, pre5, DOI DOI 10.1126/STKE.3352006RE5; Ouko MO, 2010, PLANT J, V62, P829, DOI 10.1111/j.1365-313X.2010.04195.x; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Schoelz JE, 2011, MOL PLANT, V4, P813, DOI 10.1093/mp/ssr070; Shapka N, 2005, VIROLOGY, V343, P65, DOI 10.1016/j.virol.2005.08.006; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Stork J, 2005, VIROLOGY, V343, P79, DOI 10.1016/j.virol.2005.08.005; Trutnyeva K, 2005, VIROLOGY, V332, P563, DOI 10.1016/j.virol.2004.11.040; Tsai CH, 1999, J VIROL, V73, P2703, DOI 10.1128/JVI.73.4.2703-2709.1999; Verchot-Lubicz J, 2010, MOL PLANT MICROBE IN, V23, P1231, DOI 10.1094/MPMI-04-10-0086; Waigmann E, 2000, EMBO J, V19, P4875, DOI 10.1093/emboj/19.18.4875; Yalovsky S, 1999, TRENDS PLANT SCI, V4, P439, DOI 10.1016/S1360-1385(99)01492-2; YEH CC, 1993, COUNCIL AGR PLANT PR, V1, P275; Zayakina O, 2008, MOL PLANT PATHOL, V9, P37, DOI [10.1111/J.1364-3703.2007.00445.X, 10.1111/j.1364-3703.2007.00445.x]	41	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62907	10.1371/journal.pone.0062907	http://dx.doi.org/10.1371/journal.pone.0062907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646157	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300111
J	LeBlanc, KH; Maidment, NT; Ostlund, SB				LeBlanc, Kimberly H.; Maidment, Nigel T.; Ostlund, Sean B.			Repeated Cocaine Exposure Facilitates the Expression of Incentive Motivation and Induces Habitual Control in Rats	PLOS ONE			English	Article							INDUCED BEHAVIORAL SENSITIZATION; PAVLOVIAN-INSTRUMENTAL TRANSFER; ENHANCED DOPAMINE EFFLUX; SENSORY-SPECIFIC SATIETY; NUCLEUS-ACCUMBENS SHELL; ADDICTION-LIKE BEHAVIOR; FREELY MOVING RATS; EXTRACELLULAR DOPAMINE; D-AMPHETAMINE; DORSAL STRIATUM	There is growing evidence that mere exposure to drugs can induce long-term alterations in the neural systems that mediate reward processing, motivation, and behavioral control, potentially causing the pathological pursuit of drugs that characterizes the addicted state. The incentive sensitization theory proposes that drug exposure potentiates the influence of reward-paired cues on behavior. It has also been suggested that drug exposure biases action selection towards the automatic execution of habits and away from more deliberate goal-directed control. The current study investigated whether rats given repeated exposure to peripherally administered cocaine would show alterations in incentive motivation (assayed using the Pavlovian-to-instrumental transfer (PIT) paradigm) or habit formation (assayed using sensitivity to reward devaluation). After instrumental and Pavlovian training for food pellet rewards, rats were given 6 daily injections of cocaine (15 mg/ kg, IP) or saline, followed by a 10-d period of rest. Consistent with the incentive sensitization theory, cocaine-treated rats showed stronger cue-evoked lever pressing than saline-treated rats during the PIT test. The same rats were then trained on a new instrumental action with a new food pellet reward before undergoing a reward devaluation testing. Although saline-treated rats exhibited sensitivity to reward devaluation, indicative of goal-directed performance, cocaine-treated rats were insensitive to this treatment, suggesting a reliance on habitual processes. These findings, when taken together, indicate that repeated exposure to cocaine can cause broad alterations in behavioral control, spanning both motivational and action selection processes, and could therefore help explain aberrations of decision-making that underlie drug addiction.	[LeBlanc, Kimberly H.; Maidment, Nigel T.; Ostlund, Sean B.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [LeBlanc, Kimberly H.; Maidment, Nigel T.; Ostlund, Sean B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	LeBlanc, KH (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.	kahathaway@ucla.edu	Ostlund, Sean/D-6000-2017	LeBlanc, Kimberly/0000-0002-9333-5963	NIDA [T32-DA024635, DA09359, DA05010, DA029035]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA024635, R01DA009359, R01DA029035] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by Grant DA029035 to SO, Grants DA09359 and DA05010 to NM, and training fellowship T32-DA024635 to KL, all from NIDA (http://www.drugabuse.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMOTO K, 1990, BRAIN RES, V507, P344, DOI 10.1016/0006-8993(90)90295-M; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Belin D, 2009, BIOL PSYCHIAT, V65, P863, DOI 10.1016/j.biopsych.2008.05.031; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; BERRIDGE KC, 1991, APPETITE, V16, P103, DOI 10.1016/0195-6663(91)90036-R; CADOR M, 1995, NEUROSCIENCE, V65, P385, DOI 10.1016/0306-4522(94)00524-9; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Clark JJ, 2004, PHARMACOL BIOCHEM BE, V78, P691, DOI 10.1016/j.pbb.2004.05.002; De Luca MA, 2011, PSYCHOPHARMACOLOGY, V216, P345, DOI 10.1007/s00213-011-2220-9; De Vries TJ, 1998, EUR J NEUROSCI, V10, P3565, DOI 10.1046/j.1460-9568.1998.00368.x; de Wit S, 2009, J EXP PSYCHOL ANIM B, V35, P382, DOI 10.1037/a0014793; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dickinson A, 2002, Q J EXP PSYCHOL-B, V55, P331, DOI 10.1080/0272499024400016; Dickinson A, 2000, BEHAV NEUROSCI, V114, P468, DOI 10.1037/0735-7044.114.3.468; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fiorino DF, 1999, J NEUROSCI, V19, P456, DOI 10.1523/JNEUROSCI.19-01-00456.1999; Fiorino DF, 1999, PSYCHOPHARMACOLOGY, V142, P200, DOI 10.1007/s002130050880; Harmer CJ, 1998, BEHAV PHARMACOL, V9, P299; Harmer CJ, 1999, NEUROSCIENCE, V90, P119, DOI 10.1016/S0306-4522(98)00464-3; Hemby SE, 1997, PSYCHOPHARMACOLOGY, V133, P7, DOI 10.1007/s002130050365; HETHERINGTON M, 1989, APPETITE, V12, P57, DOI 10.1016/0195-6663(89)90068-8; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; HORGER BA, 1992, PSYCHOPHARMACOLOGY, V107, P271, DOI 10.1007/BF02245147; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ito R, 2002, J NEUROSCI, V22, P6247; KALIVAS PW, 1993, J NEUROSCI, V13, P266; Kantor L, 1999, J NEUROSCI, V19, P3801; Klein ED, 2007, LEARN MOTIV, V38, P44, DOI 10.1016/j.lmot.2006.07.004; KUCZENSKI R, 1991, J NEUROSCI, V11, P2703; LeBlanc KH, 2012, BEHAV NEUROSCI, V126, P681, DOI 10.1037/a0029534; Lex A, 2008, LEARN MEMORY, V15, P483, DOI 10.1101/lm.978708; MAYFIELD RD, 1992, BRAIN RES, V573, P331, DOI 10.1016/0006-8993(92)90783-6; Mendez IA, 2009, BEHAV BRAIN RES, V201, P74, DOI 10.1016/j.bbr.2009.01.034; Mendrek A, 1998, PSYCHOPHARMACOLOGY, V135, P416, DOI 10.1007/s002130050530; Miles FJ, 2003, BEHAV NEUROSCI, V117, P927, DOI 10.1037/0735-7044.117.5.927; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Nocjar C, 2002, BEHAV BRAIN RES, V128, P189, DOI 10.1016/S0166-4328(01)00321-7; Nordquist RE, 2007, EUR NEUROPSYCHOPHARM, V17, P532, DOI 10.1016/j.euroneuro.2006.12.005; OSTLUND SB, 2010, FRONT INTEGR NEUROSC, P4; Ostlund SB, 2012, NEUROPSYCHOPHARMACOL, V37, P508, DOI 10.1038/npp.2011.217; Ostlund Sean B, 2008, Drug Discov Today Dis Models, V5, P235; Ostlund SB, 2011, J NEUROSCI, V31, P200, DOI 10.1523/JNEUROSCI.4759-10.2011; Pierce RC, 2010, NEUROSCI BIOBEHAV R, V35, P212, DOI 10.1016/j.neubiorev.2010.01.007; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; PIERCE RC, 1995, J PHARMACOL EXP THER, V275, P1019; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; POST RM, 1981, LIFE SCI, V28, P755, DOI 10.1016/0024-3205(81)90157-0; Ranaldi R, 2009, PHARMACOL BIOCHEM BE, V91, P351, DOI 10.1016/j.pbb.2008.08.006; RESCORLA RA, 1994, ANIM LEARN BEHAV, V22, P27, DOI 10.3758/BF03199953; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Robinson TE, 1998, NEUROSCI BIOBEHAV R, V22, P347, DOI 10.1016/S0149-7634(97)00020-1; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Saddoris MP, 2011, EUR J NEUROSCI, V33, P2274, DOI 10.1111/j.1460-9568.2011.07683.x; Schoenbaum G, 2005, CEREB CORTEX, V15, P1162, DOI 10.1093/cercor/bhh216; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shiflett MW, 2012, PSYCHOPHARMACOLOGY, V223, P361, DOI 10.1007/s00213-012-2724-y; SORG BA, 1993, J PHARMACOL EXP THER, V266, P424; Stefanski R, 1999, EUR J PHARMACOL, V371, P123, DOI 10.1016/S0014-2999(99)00094-1; Suto N, 2002, NEUROPSYCHOPHARMACOL, V27, P970, DOI 10.1016/S0893-133X(02)00379-2; Taylor JR, 2001, BIOL PSYCHIAT, V50, P137, DOI 10.1016/S0006-3223(01)01106-4; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Vezina P, 2002, J NEUROSCI, V22, P4654, DOI 10.1523/JNEUROSCI.22-11-04654.2002; Wassum KM, 2011, LEARN MEMORY, V18, P475, DOI 10.1101/lm.2229311; WEISS SRB, 1989, PHARMACOL BIOCHEM BE, V34, P655, DOI 10.1016/S0091-3057(89)80001-2; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; WILSON JM, 1994, BRAIN RES, V668, P39, DOI 10.1016/0006-8993(94)90508-8; Wiltgen BJ, 2007, EUR J NEUROSCI, V25, P2491, DOI 10.1111/j.1460-9568.2007.05487.x; Wyvell CL, 2001, J NEUROSCI, V21, P7831, DOI 10.1523/JNEUROSCI.21-19-07831.2001; Xie XH, 2012, PSYCHOPHARMACOLOGY, V223, P271, DOI 10.1007/s00213-012-2715-z; Young PT, 1940, J GEN PSYCHOL, V22, P33, DOI 10.1080/00221309.1940.10544318; Zapata A, 2010, J NEUROSCI, V30, P15457, DOI 10.1523/JNEUROSCI.4072-10.2010	80	70	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61355	10.1371/journal.pone.0061355	http://dx.doi.org/10.1371/journal.pone.0061355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646106	Green Published, gold			2022-12-25	WOS:000319077300007
J	Leunert, F; Grossart, HP; Gerhardt, V; Eckert, W				Leunert, Franziska; Grossart, Hans-Peter; Gerhardt, Volkmar; Eckert, Werner			Toxicant Induced Changes on Delayed Fluorescence Decay Kinetics of Cyanobacteria and Green Algae: A Rapid and Sensitive Biotest	PLOS ONE			English	Article							PHOTOSYSTEM-II; MICROCYSTIS-AERUGINOSA; ELECTRON-TRANSPORT; UNICELLULAR ALGAE; CHLOROPHYLL-A; TOXICITY; GROWTH; COPPER; LIGHT; LUMINESCENCE	Algal tests have developed into routine tools for testing toxicity of pollutants in aquatic environments. Meanwhile, in addition to algal growth rates, an increasing number of fluorescence based methods are used for rapid and sensitive toxicity measures. The present study stresses the suitability of delayed fluorescence (DF) as a promising parameter for biotests. DF is based on the recombination fluorescence at the reaction centre of photosystem II, which is emitted only by photosynthetically active cells. We analyzed the effects of three chemicals (3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU), 3,5 Dichlorophenol (3,5 DCP) and copper) on the shape of the DF decay kinetics for potential use in phytoplankton toxicity tests. The short incubation tests were done with four phytoplankton species, with special emphasis on the cyanobacterium Microcystis aeruginosa. All species exhibited a high sensitivity to DCMU, but cyanobacteria were more affected by copper and less by 3,5 DCP than the tested green algae. Analyses of changes in the DF decay curve in response to the added chemicals indicated the feasibility of the DF decay approach as a rapid and sensitive testing tool.	[Leunert, Franziska; Grossart, Hans-Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Stechlin, Germany; [Grossart, Hans-Peter] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Gerhardt, Volkmar] Univ Regensburg, Dept Phys, D-93053 Regensburg, Germany; [Eckert, Werner] Israel Oceanog & Limnol Res, Yigal Allon Kinneret Limnol Lab, Migdal, Israel	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Potsdam; University of Regensburg; Israel Oceanographic & Limnological Research Institute	Leunert, F (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Stechlin, Germany.	leunert@igb-berlin.de	Eckert, Werner/AAP-9335-2021	Eckert, Werner/0000-0002-2361-6911	Deutsche Forschungsgemeinschaft [PA1655/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (PA1655/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEMA DMM, 1978, HYDROBIOLOGIA, V59, P125, DOI 10.1007/BF00020773; [Anonymous], OECD GUIDELINES TEST, P221; Berden-Zrimec M, 2007, CENT EUR J BIOL, V2, P169, DOI 10.2478/s11535-007-0014-1; BLANCK H, 1984, ECOTOX ENVIRON SAFE, V8, P339, DOI 10.1016/0147-6513(84)90003-4; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CONRAD R, 1993, J APPL PHYCOL, V5, P505, DOI 10.1007/BF02182509; de Kuhn RM, 2006, WATER RES, V40, P2695, DOI 10.1016/j.watres.2006.04.045; Deniz F, 2011, B ENVIRON CONTAM TOX, V87, P11, DOI 10.1007/s00128-011-0300-5; DESAI TS, 1983, BIOCHIM BIOPHYS ACTA, V724, P485, DOI 10.1016/0005-2728(83)90109-3; Dziallas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025569; Eisentraeger A, 2003, ECOTOX ENVIRON SAFE, V54, P346, DOI 10.1016/S0147-6513(02)00099-4; Escher BI, 2008, J ENVIRON MONITOR, V10, P622, DOI 10.1039/b800951a; FERNANDES JC, 1991, BOT REV, V57, P246, DOI 10.1007/BF02858564; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Friedrich G, 2009, LIMNOLOGICA, V39, P14, DOI 10.1016/j.limno.2008.03.006; FUJITA Y, 1987, PLANT CELL PHYSIOL, V28, P283; Gerhardt V., 1998, Limnologica, V28, P313; Gerhardt V, 1989, DORTMUNDER BEITRAGE, V37, P87; Gerhardt V, 1993, ENTWICKLUNG IMPLEMEN; Goltsev V, 2003, J THEOR BIOL, V225, P171, DOI 10.1016/S0022-5193(03)00236-4; Greisberger S, 2007, J PHYCOL, V43, P1108, DOI 10.1111/j.1529-8817.2007.00404.x; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Hakanson L, 2003, ECOL MODEL, V169, P179, DOI 10.1016/S0304-3800(03)00269-2; HENNING M, 1991, INT REV GES HYDROBIO, V76, P37, DOI 10.1002/iroh.19910760105; HIDEG E, 1991, PHOTOSYNTH RES, V29, P107, DOI 10.1007/BF00035381; HIRANO M, 1980, Photosynthesis Research, V1, P149, DOI 10.1007/BF00020594; ID, 1996, METH US FREEZ DRI 2F; Istanovics V, 2005, FRESHWATER BIOL, V50, P1950, DOI 10.1111/j.1365-2427.2005.01442.x; JOLIOT P, 1971, PHOTOCHEM PHOTOBIOL, V14, P287, DOI 10.1111/j.1751-1097.1971.tb06174.x; Juneau P, 2001, CHEMOSPHERE, V45, P589, DOI 10.1016/S0045-6535(01)00034-0; Jursinic P.A., 1986, LIGHT EMISSION PLANT, V1st ed., P291; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Katsumata M, 2006, WATER RES, V40, P3393, DOI 10.1016/j.watres.2006.07.016; Katsumata M, 2009, B ENVIRON CONTAM TOX, V83, P484, DOI 10.1007/s00128-009-9826-1; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; LI WKW, 1994, LIMNOL OCEANOGR, V39, P169, DOI 10.4319/lo.1994.39.1.0169; Lombardi AT, 2011, PHOTOSYNTH RES, V108, P77, DOI 10.1007/s11120-011-9655-z; Marten M, 2002, FIELD SCREENING EUROPE 2001, P221; MELLVIG S, 1986, PHYSIOL PLANTARUM, V68, P180, DOI 10.1111/j.1399-3054.1986.tb01912.x; MOHANTY N, 1989, PLANT PHYSIOL, V90, P175, DOI 10.1104/pp.90.1.175; Morgan E.L., 1984, P75; OECD, 2011, OECD GUID TEST CHEM, DOI 10.1787/9789264069923-en; OECD (Organization for Economic Cooperation and Development), 2016, GUID TEST CHEM; PARSONS TR, 1963, J MAR RES, V21, P155; PETERSON HG, 1994, AQUAT TOXICOL, V28, P275, DOI 10.1016/0166-445X(94)90038-8; PUTT M, 1987, CAN J FISH AQUAT SCI, V44, P2144, DOI 10.1139/f87-263; Qian HF, 2010, AQUAT TOXICOL, V99, P405, DOI 10.1016/j.aquatox.2010.05.018; Rojickova-Padrtova R, 1999, CHEMOSPHERE, V38, P3329, DOI 10.1016/S0045-6535(98)00566-9; SANDMANN G, 1980, PLANT PHYSIOL, V66, P797, DOI 10.1104/pp.66.5.797; SCHAFER H, 1994, ECOTOX ENVIRON SAFE, V27, P64, DOI 10.1006/eesa.1994.1007; SCHERER S, 1990, TRENDS BIOCHEM SCI, V15, P458, DOI 10.1016/0968-0004(90)90296-N; Schreiber U, 2002, PHOTOSYNTH RES, V74, P317, DOI 10.1023/A:1021276003145; Schwarzenbach RP, 2010, ANNU REV ENV RESOUR, V35, P109, DOI 10.1146/annurev-environ-100809-125342; Shao CY, 2002, APPL ENVIRON MICROB, V68, P5026, DOI 10.1128/AEM.68.10.5026-5033.2002; Sherry ND, 2001, DEEP-SEA RES PT II, V48, P1263, DOI 10.1016/S0967-0645(00)00138-7; Streeb C, 2002, CURRENT TOPICS PLANT, V3, P131; STREHLER BL, 1951, J GEN PHYSIOL, V34, P809, DOI 10.1085/jgp.34.6.809; Thompson JA, 1997, CHEMOSPHERE, V35, P2027, DOI 10.1016/S0045-6535(97)00226-9; Vallotton N, 2008, ENVIRON TOXICOL CHEM, V27, P1399, DOI 10.1897/07-197; WANGBERG SA, 1988, ECOTOX ENVIRON SAFE, V16, P72, DOI 10.1016/0147-6513(88)90018-8; Wood AM., 2005, ALGAL CULTURING TECH, P269, DOI DOI 10.1016/B978-012088426-1/50019-6; Yacobi YZ, 1998, WATER RES, V32, P2577, DOI 10.1016/S0043-1354(98)00032-3; ZEHNDER A, 1960, CAN J MICROBIOL, V6, P645, DOI 10.1139/m60-077	63	14	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63127	10.1371/journal.pone.0063127	http://dx.doi.org/10.1371/journal.pone.0063127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646185	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300140
J	Lin, AHY; Li, RWS; Ho, EYW; Leung, GPH; Leung, SWS; Vanhoutte, PM; Man, RYK				Lin, Amanda H. Y.; Li, Rachel W. S.; Ho, Eva Y. W.; Leung, George P. H.; Leung, Susan W. S.; Vanhoutte, Paul M.; Man, Ricky Y. K.			Differential Ligand Binding Affinities of Human Estrogen Receptor-alpha Isoforms	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; ER-ALPHA; MEMBRANE LOCALIZATION; CANCER-CELLS; VARIANT; 17-BETA-ESTRADIOL; BETA; ACTIVATION; EXPRESSION	Rapid non-genomic effects of 17 beta-estradiol are elicited by the activation of different estrogen receptor-alpha isoforms. Presence of surface binding sites for estrogen have been identified in cells transfected with full-length estrogen receptor-alpha 66 (ER66) and the truncated isoforms, estrogen receptor-alpha 46 (ER46) and estrogen receptor-alpha 36 (ER36). However, the binding affinities of the membrane estrogen receptors (mERs) remain unknown due to the difficulty of developing of stable mER-transfected cell lines with sufficient mER density, which has largely hampered biochemical binding studies. The present study utilized cell-free expression systems to determine the binding affinities of 17 beta-estradiol to mERs, and the relationship among palmitoylation, membrane insertion and binding affinities. Saturation binding assays of human mERs revealed that [H-3]-17 beta-estradiol bound ER66 and ER46 with K-d values of 68.81 and 60.72 pM, respectively, whereas ER36 displayed no specific binding within the tested concentration range. Inhibition of palmitoylation or removal of the nanolipoprotein particles, used as membrane substitute, reduced the binding affinities of ER66 and ER46 to 17b-estradiol. Moreover, ER66 and ER46 bound differentially with some estrogen receptor agonists and antagonists, and phytoestrogens. In particular, the classical estrogen receptor antagonist, ICI 182,780, had a higher affinity for ER66 than ER46. In summary, the present study defines the binding affinities for human estrogen receptor-alpha isoforms, and demonstrates that ER66 and ER46 show characteristics of mERs. The present data also indicates that palmitoylation and membrane insertion of mERs are important for proper receptor conformation allowing 17 beta-estradiol binding. The differential binding of ER66 and ER46 with certain compounds substantiates the prospect of developing mER-selective drugs.	[Lin, Amanda H. Y.; Li, Rachel W. S.; Ho, Eva Y. W.; Leung, George P. H.; Leung, Susan W. S.; Vanhoutte, Paul M.; Man, Ricky Y. K.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Man, RYK (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Pokfulam, Hong Kong, Peoples R China.	rykman@hkucc.hku.hk	Lin, Amanda/C-6964-2014		General Research Fund of the Research Grant Council of Hong Kong [HKU 772307M]	General Research Fund of the Research Grant Council of Hong Kong	The work was supported by the General Research Fund (HKU 772307M) of the Research Grant Council of Hong Kong (http://www.ugc.edu.hk/eng/rgc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Acconcia F, 2004, BIOCHEM BIOPH RES CO, V316, P878, DOI 10.1016/j.bbrc.2004.02.129; ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; Billon-Gales A, 2009, P NATL ACAD SCI USA, V106, P2053, DOI 10.1073/pnas.0808742106; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Compton DR, 2004, J MED CHEM, V47, P5872, DOI 10.1021/jm049631k; Figtree GA, 2003, CIRCULATION, V107, P120, DOI 10.1161/01.CIR.0000043805.11780.F5; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; Ho KJ, 2002, ARTERIOSCL THROM VAS, V22, P1952, DOI 10.1161/01.ATV.0000041200.85946.4A; Hulme E. C., 1992, RECEPTOR LIGAND INTE, P63; JIANG SY, 1992, JNCI-J NATL CANCER I, V84, P580, DOI 10.1093/jnci/84.8.580; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Katzen F, 2008, J PROTEOME RES, V7, P3535, DOI 10.1021/pr800265f; Katzen F, 2009, TRENDS BIOTECHNOL, V27, P455, DOI 10.1016/j.tibtech.2009.05.005; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Keung W, 2005, BRIT J PHARMACOL, V146, P1148, DOI 10.1038/sj.bjp.0706422; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; KUSHNER PJ, 1990, MOL ENDOCRINOL, V4, P1465, DOI 10.1210/mend-4-10-1465; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Lin AHY, 2011, PHARMACOL RES, V63, P181, DOI 10.1016/j.phrs.2010.11.007; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; Lin SL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-102; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Morello KC, 2002, CRIT REV ONCOL HEMAT, V43, P63, DOI 10.1016/S1040-8428(02)00022-7; MURDOCH FE, 1991, MOL CELL ENDOCRINOL, V78, pC103, DOI 10.1016/0303-7207(91)90114-8; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; PAPPAS TC, 1995, FASEB J, V9, P404, DOI 10.1096/fasebj.9.5.7896011; PIETRAS RJ, 1977, NATURE, V265, P69, DOI 10.1038/265069a0; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; SALOMONSSON M, 1994, J STEROID BIOCHEM, V50, P313, DOI 10.1016/0960-0760(94)90137-6; Schults JR, 1988, BIOPHARMACEUTICAL ST, P21; Simoncini T, 2004, STEROIDS, V69, P537, DOI 10.1016/j.steroids.2004.05.009; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; Sun J, 2002, ENDOCRINOLOGY, V143, P941, DOI 10.1210/en.143.3.941; SZEGO CM, 1967, P NATL ACAD SCI USA, V58, P1711, DOI 10.1073/pnas.58.4.1711; Teoh H, 2000, MOL CELL BIOCHEM, V207, P65, DOI 10.1023/A:1007090113551; TESARIK J, 1995, J CLIN ENDOCR METAB, V80, P1438, DOI 10.1210/jc.80.4.1438; Vera R, 2005, J PHARMACOL EXP THER, V314, P1300, DOI 10.1124/jpet.105.085530; WAKELING AE, 1991, CANCER RES, V51, P3867; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; WEBB P, 1992, MOL ENDOCRINOL, V6, P157, DOI 10.1210/me.6.2.157; Wells J. W., 1992, RECEPTOR LIGAND INTE, P289; Xu YC, 2006, MOL CELL BIOCHEM, V287, P61, DOI 10.1007/s11010-005-9061-y	54	62	64	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63199	10.1371/journal.pone.0063199	http://dx.doi.org/10.1371/journal.pone.0063199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646196	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300153
J	Qaisar, U; Luo, LM; Haley, CL; Brady, SF; Carty, NL; Colmer-Hamood, JA; Hamood, AN				Qaisar, Uzma; Luo, Liming; Haley, Cecily L.; Brady, Sean F.; Carty, Nancy L.; Colmer-Hamood, Jane A.; Hamood, Abdul N.			The pvc Operon Regulates the Expression of the Pseudomonas aeruginosa Fimbrial Chaperone/Usher Pathway (Cup) Genes	PLOS ONE			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; BACTERIAL BIOFILMS; PROTEIN; PTXR; SIDEROPHORES; PATHOGENESIS; INVOLVEMENT; SEQUENCE; VARIANTS	The Pseudomonas aeruginosa fimbrial structures encoded by the cup gene clusters (cupB and cupC) contribute to its attachment to abiotic surfaces and biofilm formation. The P. aeruginosa pvcABCD gene cluster encodes enzymes that synthesize a novel isonitrile functionalized cumarin, paerucumarin. Paerucumarin has already been characterized chemically, but this is the first report elucidating its role in bacterial biology. We examined the relationship between the pvc operon and the cup gene clusters in the P. aeruginosa strain MPAO1. Mutations within the pvc genes compromised biofilm development and significantly reduced the expression of cupB1-6 and cupC1-3, as well as different genes of the cupB/cupC two-component regulatory systems, roc1/roc2. Adjacent to pvc is the transcriptional regulator ptxR. A ptxR mutation in MPAO1 significantly reduced the expression of the pvc genes, the cupB/cupC genes, and the roc1/roc2 genes. Overexpression of the intact chromosomally-encoded pvc operon by a ptxR plasmid significantly enhanced cupB2, cupC2, rocS1, and rocS2 expression and biofilm development. Exogenously added paerucumarin significantly increased the expression of cupB2, cupC2, rocS1 and rocS2 in the pvcA mutant. Our results suggest that pvc influences P. aeruginosa biofilm development through the cup gene clusters in a pathway that involves paerucumarin, PtxR, and different cup regulators.	[Qaisar, Uzma; Luo, Liming; Haley, Cecily L.; Carty, Nancy L.; Colmer-Hamood, Jane A.; Hamood, Abdul N.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Immunol & Mol Microbiol, Lubbock, TX 79430 USA; [Brady, Sean F.] Rockefeller Univ, Lab Genetically Encoded Small Mol, New York, NY 10021 USA; [Brady, Sean F.] Howard Hughes Med Inst, New York, NY USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Rockefeller University; Howard Hughes Medical Institute	Hamood, AN (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Immunol & Mol Microbiol, Lubbock, TX 79430 USA.	abdul.hamood@ttuhsc.edu	Qaisar, Uzma/AAE-9041-2019		National Institutes of Health (NIH) [R21 AI090169-01, NIH R01 AI-33386, NIH P30 DK089507]; Northeast Biodefense Center [U54-A1057158]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R21AI090169, R01AI033386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants National Institutes of Health (NIH) R21 AI090169-01 and NIH R01 AI-33386 to ANH and a Northeast Biodefense Center grant U54-A1057158 to SFB. Strains PW4830, PW4832, PW4833, PW7672, and PW6105 were made available through grant NIH P30 DK089507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; [Anonymous], 2010, MANDELL DOUGLAS BENN; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Brady SF, 2007, J AM CHEM SOC, V129, P12102, DOI 10.1021/ja075492v; Brady SF, 2005, ANGEW CHEM INT EDIT, V44, P7045, DOI 10.1002/anie.200501942; Branski LK, 2009, SURG INFECT, V10, P389, DOI 10.1089/sur.2009.024; BUDZIKIEWICZ H, 1993, FEMS MICROBIOL LETT, V104, P209, DOI 10.1111/j.1574-6968.1993.tb05868.x; Carty NL, 2006, MOL MICROBIOL, V61, P782, DOI 10.1111/j.1365-2958.2006.05269.x; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Clarke-Pearson MF, 2008, J BACTERIOL, V190, P6927, DOI 10.1128/JB.00801-08; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Doring G, 2008, VACCINE, V26, P1011, DOI 10.1016/j.vaccine.2007.12.007; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Drake EJ, 2008, J MOL BIOL, V384, P193, DOI 10.1016/j.jmb.2008.09.027; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Filloux A, 2004, PSEUDOMONAS, VOL 1: GENOMICS, LIFE STYLE AND MOLECULAR ARCHITECTURE, P721; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11; Giraud C, 2011, ENVIRON MICROBIOL, V13, P666, DOI 10.1111/j.1462-2920.2010.02372.x; Gonzalez JE, 2003, MICROBIOL MOL BIOL R, V67, P574, DOI 10.1128/MMBR.67.4.574-592.2003; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hamood AN, 1996, MOL MICROBIOL, V21, P97, DOI 10.1046/j.1365-2958.1996.6251337.x; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Homoe P, 2009, EUR ARCH OTO-RHINO-L, V266, P1533, DOI 10.1007/s00405-009-0940-9; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; Lochowska A, 2001, J BIOL CHEM, V276, P2098, DOI 10.1074/jbc.M007192200; LOCHT C, 1992, EMBO J, V11, P3175, DOI 10.1002/j.1460-2075.1992.tb05394.x; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Merkel TJ, 1998, J BACTERIOL, V180, P1682, DOI 10.1128/JB.180.7.1682-1690.1998; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Mikkelsen H, 2011, ENVIRON MICROBIOL, V13, P1666, DOI 10.1111/j.1462-2920.2011.02495.x; Mikkelsen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006018; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ruer S, 2007, J BACTERIOL, V189, P3547, DOI 10.1128/JB.00093-07; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Sivaneson M, 2011, MOL MICROBIOL, V79, P1353, DOI 10.1111/j.1365-2958.2010.07527.x; SMITH AW, 1989, NUCLEIC ACIDS RES, V17, P10509, DOI 10.1093/nar/17.24.10509; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Stintzi A, 1999, J BACTERIOL, V181, P4118, DOI 10.1128/JB.181.13.4118-4124.1999; Stintzi A, 1996, MICROBIOL-SGM, V142, P1181, DOI 10.1099/13500872-142-5-1181; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tacconelli E, 2009, J HOSP INFECT, V72, P97, DOI 10.1016/j.jhin.2008.12.012; Thanassi DG, 2005, MOL MEMBR BIOL, V22, P63, DOI 10.1080/09687860500063290; Tran PL, 2012, ANTIMICROB AGENTS CH, V56, P972, DOI 10.1128/AAC.05680-11; Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898; van Delden C, 2004, PSEUDOMONAS, VOL 2: VIRULENCE AND GENE REGULATION, P3; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005	67	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62735	10.1371/journal.pone.0062735	http://dx.doi.org/10.1371/journal.pone.0062735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646138	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300091
J	Shinohara, M; Shinohara, A				Shinohara, Miki; Shinohara, Akira			Multiple Pathways Suppress Non-Allelic Homologous Recombination during Meiosis in Saccharomyces cerevisiae	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; BREAK-INDUCED REPLICATION; MEIOTIC GENE CONVERSION; DOUBLE-STRAND BREAKS; DNA-DAMAGE; CROSSING-OVER; CROSSOVER INTERFERENCE; HOLLIDAY JUNCTIONS; SLIDING CLAMP; MUTS HOMOLOG	Recombination during meiosis in the form of crossover events promotes the segregation of homologous chromosomes by providing the only physical linkage between these chromosomes. Recombination occurs not only between allelic sites but also between non-allelic (ectopic) sites. Ectopic recombination is often suppressed to prevent non-productive linkages. In this study, we examined the effects of various mutations in genes involved in meiotic recombination on ectopic recombination during meiosis. RAD24, a DNA damage checkpoint clamp-loader gene, suppressed ectopic recombination in wild type in the same pathway as RAD51. In the absence of RAD24, a meiosis-specific recA homolog, DMC1, suppressed the recombination. Homology search and strand exchange in ectopic recombination occurred when either the RAD51 or the DMC1 recA homolog was absent, but was promoted by RAD52. Unexpectedly, the zip1 mutant, which is defective in chromosome synapsis, showed a decrease, rather than an increase, in ectopic recombination. Our results provide evidence for two types of ectopic recombination: one that occurs in wild-type cells and a second that occurs predominantly when the checkpoint pathway is inactivated.	[Shinohara, Miki; Shinohara, Akira] Osaka Univ, Inst Prot Res, Div Integrated Prot Funct, Suita, Osaka 565, Japan; [Shinohara, Miki; Shinohara, Akira] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Suita, Osaka, Japan	Osaka University; Osaka University	Shinohara, M (corresponding author), Osaka Univ, Inst Prot Res, Div Integrated Prot Funct, Suita, Osaka 565, Japan.	mikis@protein.osaka-u.ac.jp; ashino@protein.osaka-u.ac.jp	Shinohara, Miki/E-7151-2013	Shinohara, Miki/0000-0002-7413-8235	Ministry of Education, Science, Sport and Culture; Asahi-Glass Science Foundation; Uehara Science Foundation; Mochida Medical Science Foundation; Takeda Science Foundation; Japanese Society for the Promotion of Science through the "Next Generation World-Leading Researchers'' program; Council for Science and Technology Policy	Ministry of Education, Science, Sport and Culture; Asahi-Glass Science Foundation; Uehara Science Foundation(Uehara Memorial Foundation); Mochida Medical Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Society for the Promotion of Science through the "Next Generation World-Leading Researchers'' program; Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP))	This work was supported by a Grant-in-Aid from the Ministry of Education, Science, Sport and Culture to AS and MS, as well as grants from the Asahi-Glass Science Foundation, the Uehara Science Foundation, the Mochida Medical Science Foundation and the Takeda Science Foundation to AS. MS was supported by the Japanese Society for the Promotion of Science through the "Next Generation World-Leading Researchers'' program, initiated by the Council for Science and Technology Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Goldfarb T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000520; Goldman ASH, 2000, P NATL ACAD SCI USA, V97, P9537, DOI 10.1073/pnas.97.17.9537; Goldman ASH, 1996, GENETICS, V144, P43; Grushcow JM, 1999, GENETICS, V153, P607; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; JINKSROBERTSON S, 1985, P NATL ACAD SCI USA, V82, P3350, DOI 10.1073/pnas.82.10.3350; KADYK LC, 1992, GENETICS, V132, P387; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Klein HL, 1997, GENETICS, V147, P1533; KUPIEC M, 1988, MOL CELL BIOL, V8, P2942, DOI 10.1128/MCB.8.7.2942; Kurzbauer MT, 2012, PLANT CELL, V24, P2058, DOI 10.1105/tpc.112.098459; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; LICHTEN M, 1987, GENETICS, V115, P233; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Malkova A, 2001, GENE DEV, V15, P1055, DOI 10.1101/gad.875901; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; McMahill MS, 2007, PLOS BIOL, V5, P2589, DOI 10.1371/journal.pbio.0050299; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; SASANUMA H, 2013, NAT COMMS IN PRESS; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 2003, GENETICS, V164, P855; Shinohara M, 1997, GENETICS, V147, P1545; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Signon L, 2001, MOL CELL BIOL, V21, P2048, DOI 10.1128/MCB.21.6.2048-2056.2001; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Thompson DA, 1999, GENETICS, V153, P621; Tsubouchi H, 2004, GENETICS, V168, P1219, DOI 10.1534/genetics.103.025700; Tsubouchi T, 2006, DEV CELL, V10, P809, DOI 10.1016/j.devcel.2006.04.003; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	63	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63144	10.1371/journal.pone.0063144	http://dx.doi.org/10.1371/journal.pone.0063144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646187	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300142
J	Bryant, RA; McGrath, C; Felmingham, KL				Bryant, Richard A.; McGrath, Chloe; Felmingham, Kim L.			The Roles of Noradrenergic and Glucocorticoid Activation in the Development of Intrusive Memories	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; DECLARATIVE MEMORY; STRESS-DISORDER; SEX-DIFFERENCES; CONSOLIDATION; CORTISOL; AMYGDALA; HUMANS; WOMEN; AXIS	Intrusive memories are a common feature of many psychological disorders. Recent evidence has potentially extended cognitive models of intrusions by identifying the role of biological markers of arousal at the time of consolidation in subsequent memory for emotional events. This study investigated the role of arousal during consolidation in the development of intrusive memories. Seventy-eight university students (37 men and 41 women) viewed 20 negative and 20 neutral images. Half the participants then underwent a cold pressor test (High Stress), immersing their hand in ice water, while the remaining participants immersed their hand in warm water (Low Stress). Samples of salivary alpha-amylase (sAA) and cortisol were collected from participants at baseline and following the stressor challenge. Participants completed a delayed free recall test and intrusion questionnaires two days later. Participants in the High Stress condition reported more intrusions of negative images than participants in the Low Stress condition. An interaction variable in a linear regression of increased noradrenergic and cortisol values predicted intrusive memories of emotional stimuli for men but not women. These findings are consistent with recent evidence of the combined effects of noradrenaline and corticoid responses to stress on emotional memories, and also with increasing evidence of gender differences in how stress hormones influence formation of emotional memories. These findings point to possible mechanisms by which development of intrusions may be prevented after consolidation of traumatic experiences.	[Bryant, Richard A.; McGrath, Chloe] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Felmingham, Kim L.] Univ Tasmania, Sch Psychol, Hobart, Tas, Australia	University of New South Wales Sydney; University of Tasmania	Bryant, RA (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	r.bryant@unsw.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X	Australian Research Council [DP110105274]	Australian Research Council(Australian Research Council)	This project was funded by an Australian Research Council Discovery grant (DP110105274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie HC, 2006, PSYCHONEUROENDOCRINO, V31, P187, DOI 10.1016/j.psyneuen.2005.06.008; Abercrombie HC, 2003, BEHAV NEUROSCI, V117, P505, DOI 10.1037/0735-7044.117.3.505; Andreano JM, 2006, PSYCHOL SCI, V17, P466, DOI 10.1111/j.1467-9280.2006.01729.x; Andreano JM, 2008, PSYCHONEUROENDOCRINO, V33, P874, DOI 10.1016/j.psyneuen.2008.03.009; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Bryant RA, 2011, J AFFECT DISORDERS, V131, P398, DOI 10.1016/j.jad.2010.10.049; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cahill L, 1996, CURR OPIN NEUROBIOL, V6, P237, DOI 10.1016/S0959-4388(96)80078-X; Cahill L, 2001, TRENDS NEUROSCI, V24, P578, DOI 10.1016/S0166-2236(00)01885-3; Chatterton RT, 1996, CLIN PHYSIOL, V16, P433, DOI 10.1111/j.1475-097X.1996.tb00731.x; Clark D.A., 2005, INTRUSIVE THOUGHTS C; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlert U, 2006, J CLIN ENDOCR METAB, V91, P5130, DOI 10.1210/jc.2006-0461; Erickson K, 2003, NEUROSCI BIOBEHAV R, V27, P233, DOI 10.1016/S0149-7634(03)00033-2; Felmingham K.L., 2012, PSYCHONEUROENDOCRINO; Felmingham KL, 2012, BIOL PSYCHOL, V89, P539, DOI 10.1016/j.biopsycho.2011.12.006; Ferree NK, 2009, CONSCIOUS COGN, V18, P126, DOI 10.1016/j.concog.2008.11.008; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; Hagenaars MA, 2010, MEMORY, V18, P76, DOI 10.1080/09658210903476522; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Katanje E, 2006, PSYCHONEUROENDOCRINO, V31, P151; Klinger E., 1996, LEA SER PER CLIN PSY, P3; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Kukolja J, 2011, PSYCHOL MED, V41, P2167, DOI 10.1017/S0033291711000183; Kukolja J, 2008, J NEUROSCI, V28, P12868, DOI 10.1523/JNEUROSCI.3592-08.2008; Lang PJ, 2008, INT AFFECTIVE PICTUR; Lupien SJ, 1999, BEHAV NEUROSCI, V113, P420, DOI 10.1037/0735-7044.113.3.420; McGaugh JL, 2009, PSYCHOPHARMACOLOGY, V202, P3, DOI 10.1007/s00213-008-1285-6; Roca CA, 2003, J CLIN ENDOCR METAB, V88, P3057, DOI 10.1210/jc.2002-021570; Rohleder N, 2009, INT J PSYCHOPHYSIOL, V72, P74, DOI 10.1016/j.ijpsycho.2008.03.010; Roozendaal B, 2002, EUR J NEUROSCI, V15, P553, DOI 10.1046/j.0953-816x.2001.01876.x; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Segal SK, 2009, PSYCHONEUROENDOCRINO, V34, P1263, DOI 10.1016/j.psyneuen.2009.04.020; van Stegeren AH, 2005, NEUROIMAGE, V24, P898, DOI 10.1016/j.neuroimage.2004.09.011; Wenzlaff EM, 2000, ANNU REV PSYCHOL, V51, P59, DOI 10.1146/annurev.psych.51.1.59; Wolf OT, 2009, BRAIN RES, V1293, P142, DOI 10.1016/j.brainres.2009.04.013	42	39	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62675	10.1371/journal.pone.0062675	http://dx.doi.org/10.1371/journal.pone.0062675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658640	gold, Green Submitted, Green Published			2022-12-25	WOS:000321662800054
J	Neuman, Y; Assaf, D; Cohen, Y; Last, M; Argamon, S; Howard, N; Frieder, O				Neuman, Yair; Assaf, Dan; Cohen, Yohai; Last, Mark; Argamon, Shlomo; Howard, Newton; Frieder, Ophir			Metaphor Identification in Large Texts Corpora	PLOS ONE			English	Article							LANGUAGE; COMPREHENSION; DESIGN; CORPUS	Identifying metaphorical language-use (e.g., sweet child) is one of the challenges facing natural language processing. This paper describes three novel algorithms for automatic metaphor identification. The algorithms are variations of the same core algorithm. We evaluate the algorithms on two corpora of Reuters and the New York Times articles. The paper presents the most comprehensive study of metaphor identification in terms of scope of metaphorical phrases and annotated corpora size. Algorithms' performance in identifying linguistic phrases as metaphorical or literal has been compared to human judgment. Overall, the algorithms outperform the state-of-the-art algorithm with 71% precision and 27% averaged improvement in prediction over the base-rate of metaphors in the corpus.	[Neuman, Yair; Assaf, Dan] Ben Gurion Univ Negev, Dept Educ, IL-84105 Beer Sheva, Israel; [Cohen, Yohai] Gilasio Coding Ltd, Tel Aviv, Israel; [Last, Mark] Ben Gurion Univ Negev, Dept Informat Syst, IL-84105 Beer Sheva, Israel; [Argamon, Shlomo] IIT, Dept Comp Sci, Chicago, IL 60616 USA; [Howard, Newton] MIT, Synthet Intelligence Lab, Boston, MA USA; [Frieder, Ophir] Georgetown Univ, Dept Comp Sci, Washington, DC USA	Ben Gurion University; Ben Gurion University; Illinois Institute of Technology; Massachusetts Institute of Technology (MIT); Georgetown University	Neuman, Y (corresponding author), Ben Gurion Univ Negev, Dept Educ, IL-84105 Beer Sheva, Israel.	yneuman@bgu.ac.il	Argamon, Shlomo/AAM-4515-2020; Last, Mark/AAF-8443-2020	Howard, Newton/0000-0002-8503-3973	Intelligence Advanced Research Projects Activity (IARPA) via Department of Defense US Army Research Laboratory [W911NF-12-C-0021]	Intelligence Advanced Research Projects Activity (IARPA) via Department of Defense US Army Research Laboratory	This work is supported by the Intelligence Advanced Research Projects Activity (IARPA) via Department of Defense US Army Research Laboratory contract number W911NF-12-C-0021. The U.S. Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright annotation thereon. Disclaimer: The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of IARPA, DoD/ARL, or the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaf D, 2013, P IEEE S SE IN PRESS; Banea Carmen, 2011, P 9 INT C COMP SEM I, P25; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Birke Julia, 2006, EACL 2006 11 C EUR C; Birke Julia, 2007, P WORKSH COMP APPR F, P21; Cardillo ER, 2010, BEHAV RES METHODS, V42, P651, DOI 10.3758/BRM.42.3.651; Davies M, 2009, INT J CORPUS LINGUIS, V14, P159, DOI 10.1075/ijcl.14.2.02dav; De Marneffe M.-C., 2008, COL 2008 P WORKSH CR; Dolan W. B., 1995, P REPR ACQ LEX KNOWL, P27; Fass D., 1991, Computational Linguistics, V17, P49; Gibbs RW, 2004, J PRAGMATICS, V36, P1189, DOI 10.1016/j.pragma.2003.10.009; Goatly A, 1997, LANGUAGE METAPHORS; Gruber T, 2008, J WEB SEMANT, V6, P4, DOI 10.1016/j.websem.2007.11.011; Hashimoto C, 2009, LANG RESOUR EVAL, V43, P355, DOI 10.1007/s10579-009-9104-1; Hoey M, 1995, LEXICAL PRIMING NEW; January D, 2007, COGNITION, V104, P417, DOI 10.1016/j.cognition.2006.07.008; Just MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008622; Kintsch W, 2000, PSYCHON B REV, V7, P257, DOI 10.3758/BF03212981; Klepousniotou E, 2008, J EXP PSYCHOL LEARN, V34, P1534, DOI 10.1037/a0013012; Krishnakumaran S., 2007, P WORKSHOP COMPUTATI, P13; Lakoff G., 2003, METAPHORS WE LIVE; Lakoff G., 1999, PHILOS FLESH; Levy P., 2011, SEMANTIC SPHERE 1; Lewis DD, 2004, J MACH LEARN RES, V5, P361; Light M, 2002, COGNITIVE SCI, V26, P269, DOI 10.1207/s15516709cog2603_4; MARTIN JH, 1992, COGNITIVE SCI, V16, P233, DOI 10.1207/s15516709cog1602_4; Mason ZJ, 2004, COMPUT LINGUIST, V30, P23, DOI 10.1162/089120104773633376; Murphy GL, 1996, COGNITION, V60, P173, DOI 10.1016/0010-0277(96)00711-1; Navigli R, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1459352.1459355; Neuman Y, 2013, INFORM FUSI IN PRESS, DOI DOI 10.1016/J.INFFUS.2012.02.001.IN; Neuman Y, 2012, INTEGR PSYCHOL BEHAV, V46, P129, DOI 10.1007/s12124-011-9165-8; Neuman Y, 2009, INFORM SCIENCES, V179, P2719, DOI 10.1016/j.ins.2009.04.011; Nissim M, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P56; Pinker S., 2007, PUBLIC POLICY RES, V14, P59; Shutova E., 2012, COMPUTIONAL IN PRESS, V2, P301, DOI [10.1162/COLI_a_00124, DOI 10.1162/C0LI_A_00124]; Shutova E, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P688; Thibodeau PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016782; Toutanova K, 2003, HLT-NAACL 2003: HUMAN LANGUAGE TECHNOLOGY CONFERENCE OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE MAIN CONFERENCE, P252, DOI 10.3115/1073445.1073478; Turney Peter, 2011, P C EMP METH NAT LAN, P680; WILKS Y, 1978, ARTIF INTELL, V11, P197, DOI 10.1016/0004-3702(78)90001-2; WILKS Y, 1975, ARTIF INTELL, V6, P53, DOI 10.1016/0004-3702(75)90016-8	42	49	53	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62343	10.1371/journal.pone.0062343	http://dx.doi.org/10.1371/journal.pone.0062343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	181JC	23658625	Green Published, Green Submitted, gold			2022-12-25	WOS:000321662800037
J	Wen, PC; Verhalen, B; Wilkens, S; Mchaourab, HS; Tajkhorshid, E				Wen, Po-Chao; Verhalen, Brandy; Wilkens, Stephan; Mchaourab, Hassane S.; Tajkhorshid, Emad			On the Origin of Large Flexibility of P-glycoprotein in the Inward-facing State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; BACTERIAL ABC TRANSPORTER; NUCLEOTIDE-BINDING DOMAIN; ATP-BINDING; MULTIDRUG TRANSPORTER; TRANSMEMBRANE DOMAINS; MALTOSE TRANSPORTER; ALTERNATING ACCESS; GATING HINGE; DRUG-BINDING	P-glycoprotein (Pgp) is one of the most biomedically relevant transporters in the ATP binding cassette (ABC) superfamily due to its involvement in developing multidrug resistance in cancer cells. Employing molecular dynamics simulations and double electron-electron resonance spectroscopy, we have investigated the structural dynamics of membrane-bound Pgp in the inward-facing state and found that Pgp adopts an unexpectedly wide range of conformations, highlighted by the degree of separation between the two nucleotide-binding domains (NBDs). The distance between the two NBDs in the equilibrium simulations covers a range of at least 20 angstrom, including, both, more open and more closed NBD configurations than the crystal structure. The double electron-electron resonance measurements on spin-labeled Pgp mutants also show wide distributions covering both longer and shorter distances than those observed in the crystal structure. Based on structural and sequence analyses, we propose that the transmembrane domains of Pgp might be more flexible than other structurally known ABC exporters. The structural flexibility of Pgp demonstrated here is not only in close agreement with, but also helps rationalize, the reported high NBD fluctuations in several ABC exporters and possibly represents a fundamental difference in the transport mechanism between ABC exporters and ABC importers. In addition, during the simulations we have captured partial entrance of a lipid molecule from the bilayer into the lumen of Pgp, reaching the putative drug binding site. The location of the protruding lipid suggests a putative pathway for direct drug recruitment from the membrane.	[Wen, Po-Chao; Tajkhorshid, Emad] Univ Illinois, Coll Med, Dept Biochem, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Wen, Po-Chao; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Verhalen, Brandy; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA; [Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Vanderbilt University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Mchaourab, HS (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA.	hassane.mchaourab@vanderbilt.edu; emad@life.illinois.edu	Tajkhorshid, Emad/AAN-8323-2021; Wen, Po-Chao/I-5031-2014; Wen, Po-Chao/Q-5293-2019	Wen, Po-Chao/0000-0002-6049-6904; Wen, Po-Chao/0000-0002-6049-6904; Tajkhorshid, Emad/0000-0001-8434-1010	National Institutes of Health [U54-GM087519, R01-CA100246, R01-GM086749, P41-GM104601, 5T32NS007491-12]; NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086749, R01GM058600, P41GM104601, U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants U54-GM087519 (to H. S. M. and E. T.), R01-CA100246 (to W. S.), R01-GM086749 (to E. T.), P41-GM104601 (to E. T.), and 5T32NS007491-12 (to B. V.).	Abraham I, 2010, BIOCHEM PHARMACOL, V80, P1497, DOI 10.1016/j.bcp.2010.08.001; Abulrob ANG, 1999, BIOCHEM BIOPH RES CO, V262, P121, DOI 10.1006/bbrc.1999.1120; Aittoniemi J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000762; Al-Shawi MK, 2011, ESSAYS BIOCHEM, V50, P63, DOI [10.1042/BSE0500063, 10.1042/bse0500063]; Al-Shawi MK, 2005, J BIOENERG BIOMEMBR, V37, P489, DOI 10.1007/s10863-005-9497-5; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Becker JP, 2010, J PHYS CHEM B, V114, P15948, DOI 10.1021/jp1038392; Becker JP, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-3; Bessadok A, 2011, J BIOL CHEM, V286, P3552, DOI 10.1074/jbc.M110.155200; Bikadi Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025815; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Bosch I, 1997, BIOCHEMISTRY-US, V36, P5685, DOI 10.1021/bi962728r; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen ZS, 2011, FEBS J, V278, P3226, DOI 10.1111/j.1742-4658.2011.08235.x; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Di Ianni ME, 2012, J CHEM INF MODEL, V52, P3325, DOI 10.1021/ci300423q; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Dolghih E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002083; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Globisch C, 2008, CHEMMEDCHEM, V3, P280, DOI 10.1002/cmdc.200700249; Gualdesi MS, 2012, EUR J PHARM SCI, V47, P965, DOI 10.1016/j.ejps.2012.10.002; Gyimesi G, 2011, BBA-BIOMEMBRANES, V1808, P2954, DOI 10.1016/j.bbamem.2011.07.038; Ho BK, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-14; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Holland I. B., 2003, ABC PROTEINS BACTERI; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Ivetac A, 2008, EUR BIOPHYS J BIOPHY, V37, P403, DOI 10.1007/s00249-007-0225-4; Ivetac A, 2007, BIOCHEMISTRY-US, V46, P2767, DOI 10.1021/bi0622571; Jabeen I, 2012, J MED CHEM, V55, P3261, DOI 10.1021/jm201705f; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jones PM, 2012, J PHYS CHEM A, V116, P3004, DOI 10.1021/jp211139s; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kandt C, 2010, PROTEINS, V78, P738, DOI 10.1002/prot.22606; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Klepsch F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002036; Korkhov VM, 2012, FEBS LETT, V586, P972, DOI 10.1016/j.febslet.2012.02.042; Liu M, 2013, J BIOMOL STRUCT DYN, V31, P612, DOI 10.1080/07391102.2012.706079; Liu RH, 2000, BIOCHEMISTRY-US, V39, P14927, DOI 10.1021/bi0018786; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; O'Mara ML, 2007, FEBS LETT, V581, P4217, DOI 10.1016/j.febslet.2007.07.069; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Oliveira ASF, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002128; Oloo EO, 2004, J BIOL CHEM, V279, P45013, DOI 10.1074/jbc.M405084200; Omote H, 2004, BIOCHEMISTRY-US, V43, P3917, DOI 10.1021/bi035365l; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Pajeva IK, 2009, FEBS J, V276, P7016, DOI 10.1111/j.1742-4658.2009.07415.x; Palmeira A, 2012, BIOCHEM PHARMACOL, V83, P57, DOI 10.1016/j.bcp.2011.10.004; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Qu Q, 2001, BIOCHEMISTRY-US, V40, P1413, DOI 10.1021/bi002035h; Ravna AW, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-33; Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456; Rosenberg MF, 2003, J BIOL CHEM, V278, P8294, DOI 10.1074/jbc.M211758200; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Siarheyeva A, 2007, BIOCHEMISTRY-US, V46, P3075, DOI 10.1021/bi062109a; Singh DV, 2013, J MOL MODEL, V19, P227, DOI 10.1007/s00894-012-1535-8; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Oliveira AS, 2011, PROTEINS, V79, P1977, DOI 10.1002/prot.23023; Sonne J, 2007, BIOPHYS J, V92, P2727, DOI 10.1529/biophysj.106.097972; St-Pierre JF, 2012, J PHYS CHEM B, V116, P2934, DOI 10.1021/jp209126c; Storm J, 2007, BIOCHEMISTRY-US, V46, P9899, DOI 10.1021/bi700447p; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tombline G, 2006, ARCH BIOCHEM BIOPHYS, V445, P124, DOI 10.1016/j.abb.2005.11.004; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wen PC, 2011, BIOPHYS J, V101, P680, DOI 10.1016/j.bpj.2011.06.031; Wise JG, 2012, BIOCHEMISTRY-US, V51, P5125, DOI 10.1021/bi300299z; Yamaguchi H, 2012, BIOINFORMATION, V8, P1066, DOI 10.6026/97320630081066; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhao XQ, 2012, MOL PHARMACOL, V82, P47, DOI 10.1124/mol.111.076299; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	84	94	96	0	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19211	19220		10.1074/jbc.M113.450114	http://dx.doi.org/10.1074/jbc.M113.450114			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658020	hybrid, Green Published			2022-12-25	WOS:000321335800054
J	Williamson, DM; Elferich, J; Ramakrishnan, P; Thomas, G; Shinde, U				Williamson, Danielle M.; Elferich, Johannes; Ramakrishnan, Parvathy; Thomas, Gary; Shinde, Ujwal			The Mechanism by Which a Propeptide-encoded pH Sensor Regulates Spatiotemporal Activation of Furin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROPROTEIN CONVERTASE 1/3; INTRAMOLECULAR CHAPERONE; CIRCULAR-DICHROISM; ENDOPLASMIC-RETICULUM; ENZYME ACTIVATION; PRO-DOMAIN; CLEAVAGE; STABILITY; PEPTIDES	The proprotein convertase furin requires the pH gradient of the secretory pathway to regulate its multistep, compartment-specific autocatalytic activation. Although His-69 within the furin prodomain serves as the pH sensor that detects transport of the propeptide-enzyme complex to the trans-Golgi network, where it promotes cleavage and release of the inhibitory propeptide, a mechanistic understanding of how His-69 protonation mediates furin activation remains unclear. Here we employ biophysical, biochemical, and computational approaches to elucidate the mechanism underlying the pH-dependent activation of furin. Structural analyses and binding experiments comparing the wild-type furin propeptide with a nonprotonatable His-69 -> Leu mutant that blocks furin activation in vivo revealed protonation of His-69 reduces both the thermodynamic stability of the propeptide as well as its affinity for furin at pH 6.0. Structural modeling combined with mathematical modeling and molecular dynamic simulations suggested that His-69 does not directly contribute to the propeptide-enzyme interface but, rather, triggers movement of a loop region in the propeptide that modulates access to the cleavage site and, thus, allows for the tight pH regulation of furin activation. Our work establishes a mechanism by which His-69 functions as a pH sensor that regulates compartment-specific furin activation and provides insights into how other convertases and proteases may regulate their precise spatiotemporal activation.	[Williamson, Danielle M.; Elferich, Johannes; Ramakrishnan, Parvathy; Shinde, Ujwal] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Thomas, Gary] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shinde, U (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	shindeu@ohsu.edu		Elferich, Johannes/0000-0002-9911-706X	National Institutes of Health [CA151564]; National Science Foundation [MCB0746589]; American Heart Foundation; American Heart Association [12PRE11470005]; Div Of Molecular and Cellular Bioscience [0746589] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA151564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK096752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Foundation(American Heart Association); American Heart Association(American Heart Association); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health training grant (to D. M. W.) and National Institutes of Health Grant CA151564 (to G. T.). This work was also supported by National Science Foundation CAREER Award MCB0746589 and a grant in aid from the American Heart Foundation (to U. S.) and by American Heart Association Predoctoral Training Grant 12PRE11470005 (to J. E.).	Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; Basak A, 2003, BIOCHEM J, V373, P231, DOI 10.1042/BJ20030120; BASAK A, 1994, INT J PEPT PROT RES, V44, P253; Bhattacharjya S, 2001, PROTEIN SCI, V10, P934, DOI 10.1110/ps.41301; Bhattacharjya S, 2007, BIOPOLYMERS, V86, P329, DOI 10.1002/bip.20748; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS CL, 1992, J MOL BIOL, V227, P375, DOI 10.1016/0022-2836(92)90893-O; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; DAGGETT V, 1992, P NATL ACAD SCI USA, V89, P5142, DOI 10.1073/pnas.89.11.5142; DAGGETT V, 1993, J MOL BIOL, V232, P600, DOI 10.1006/jmbi.1993.1414; Day R, 1998, J BIOL CHEM, V273, P829, DOI 10.1074/jbc.273.2.829; Dhar P, 2004, BIOINFORMATICS, V20, P1319, DOI 10.1093/bioinformatics/bth067; Dillon SL, 2012, J MOL BIOL, V423, P47, DOI 10.1016/j.jmb.2012.06.023; Dufour EK, 2005, PROTEIN SCI, V14, P303, DOI 10.1110/ps.04843305; Elferich J., 2013, FASEB J IN PRESS; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenfield NJ, 2006, NAT PROTOC, V1, P2733, DOI 10.1038/nprot.2006.229; Greenfield NJ, 2006, NAT PROTOC, V1, P2891, DOI 10.1038/nprot.2006.244; JEAN F, 1993, BIOCHEM J, V292, P891, DOI 10.1042/bj2920891; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kim WJ, 2012, MOL CELL BIOL, V32, P3382, DOI 10.1128/MCB.06331-11; LAKOWICZ JR, 1983, BIOCHEMISTRY-US, V22, P1741, DOI 10.1021/bi00277a001; LEDUC R, 1992, J BIOL CHEM, V267, P14304; Marie-Claire C, 2001, J MOL BIOL, V305, P151, DOI 10.1006/jmbi.2000.4233; Nair SK, 2005, J MOL ENDOCRINOL, V35, P211, DOI 10.1677/jme.1.01830; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; REHEMTULLA A, 1992, P NATL ACAD SCI USA, V89, P8235, DOI 10.1073/pnas.89.17.8235; Salimi NL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000689; SAWICKI CA, 1976, J BIOL CHEM, V251, P1533; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; SHINDE U, 1993, P NATL ACAD SCI USA, V90, P6924, DOI 10.1073/pnas.90.15.6924; Shinde U, 2000, SEMIN CELL DEV BIOL, V11, P35, DOI 10.1006/scdb.1999.0349; SHINDE U, 1993, TRENDS BIOCHEM SCI, V18, P442, DOI 10.1016/0968-0004(93)90146-E; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Subbian E, 2005, J MOL BIOL, V347, P367, DOI 10.1016/j.jmb.2005.01.028; Subbian E, 2004, BIOCHEMISTRY-US, V43, P14348, DOI 10.1021/bi048397x; Tanco S, 2010, J BIOL CHEM, V285, P18385, DOI 10.1074/jbc.M109.060350; Tangrea MA, 2002, J MOL BIOL, V320, P801, DOI 10.1016/S0022-2836(02)00543-0; Tangrea MA, 2001, BIOCHEMISTRY-US, V40, P5488, DOI 10.1021/bi0026472; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829	47	16	16	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19154	19165		10.1074/jbc.M112.442681	http://dx.doi.org/10.1074/jbc.M112.442681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23653353	Green Published, hybrid			2022-12-25	WOS:000321335800049
J	Baba, K; Morimoto, H; Imaoka, S				Baba, Kazunobu; Morimoto, Haruka; Imaoka, Susumu			Seven in Absentia Homolog 2 (Siah2) Protein Is a Regulator of NF-E2-related Factor 2 (Nrf2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; E3 LIGASE SIAH2; OXIDATIVE STRESS; UBIQUITIN LIGASE; RESPONSE ELEMENT; GENE-EXPRESSION; PROLYL-HYDROXYLASES; SIGNALING PATHWAYS; NITRIC-OXIDE; INDUCTION	Under pathological conditions such as ischemia-reperfusion, Nrf2 acts as a key regulator of cellular oxidative response. Provided that Nrf2 is sensitive to hypoxia during ischemia, Nrf2 may affect reactive oxygen species metabolism during reoxygenation. In this study, hypoxia suppressed Nrf2 protein, and its hypoxic suppression was not recovered with knockdown of the Nrf2 repressor Keap1. Moreover, an Nrf2 mutant lacking the Keap1 binding domain was suppressed under hypoxia, suggesting that Keap1 does not contribute to hypoxic Nrf2 suppression. HIF-1 alpha and Siah2 are both key regulators of hypoxic responses. Hypoxia induced the Siah2 protein. Although inhibition or knockdown of Siah2 prevented the suppression of Nrf2, knockdown of HIF-1 alpha did not. Moreover, Siah2 interacted with Nrf2 through a binding motif, suggesting that Siah2 contributes to the suppression of Nrf2. Some cytosolic kinases also play important roles in Nrf2 regulation. In this study, PKC phosphorylates serine residues of Nrf2 during hypoxia. Knockdown of Siah2 rescued hypoxic decreases in an Nrf2 mutant that mimicked phosphorylation at serine 40 or lacked this phosphorylation site, suggesting that Siah2 contributes to the degradation of Nrf2 irrespective of its phosphorylation status. Moreover, knockdown of Siah2 attenuated ubiquitination of the Nrf2 mutant, suggesting that association of Siah2 with Nrf2 causes proteasome-mediated degradation of Nrf2.	[Imaoka, Susumu] Kwansei Gakuin Univ, Sch Sci & Technol, Res Ctr Environm Biosci, Sanda, Hyogo 6691337, Japan; Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda, Hyogo 6691337, Japan	Kwansei Gakuin University; Kwansei Gakuin University	Imaoka, S (corresponding author), Kwansei Gakuin Univ, Sch Sci & Technol, Res Ctr Environm Biosci, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	imaoka@kwansei.ac.jp			Japan Society for the Promotion of Science; Hyogo Science and Technology Association; Ministry of Education, Culture, Sports, Science and Technology; Kwansei Gakuin University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hyogo Science and Technology Association; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kwansei Gakuin University(Kwansei Gakuin University)	This work was supported in part by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science, a grant-in aid from the Hyogo Science and Technology Association, the Support Project to Assist Private Universities in Developing Bases from the Ministry of Education, Culture, Sports, Science and Technology, and by a grant-in-aid from Kwansei Gakuin University.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chen CW, 2009, IEEE T CIRC SYST VID, V19, P1, DOI 10.1109/TCSVT.2009.2012413; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Devling TWP, 2005, P NATL ACAD SCI USA, V102, P7280, DOI 10.1073/pnas.0501475102; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Jansen MPHM, 2009, BREAST CANCER RES TR, V116, P263, DOI 10.1007/s10549-008-0125-z; Jing Y, 2012, TOXICOL SCI, V125, P10, DOI 10.1093/toxsci/kfr256; Kang KW, 2002, NITRIC OXIDE-BIOL CH, V7, P244, DOI 10.1016/S1089-8603(02)00117-9; Kaur C, 2008, CLIN OPHTHALMOL, V2, P879, DOI 10.2147/opth.s3361; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; Kubo T, 2004, BIOCHEM BIOPH RES CO, V318, P1006, DOI 10.1016/j.bbrc.2004.04.125; Maxwell PH, 2001, ADV EXP MED BIOL, V502, P365; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Mo C, 2012, J BIOL CHEM, V287, P19242, DOI 10.1074/jbc.M112.349936; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2007, BIOCHEM J, V401, P217, DOI 10.1042/BJ20061135; Niture SK, 2009, J CELL SCI, V122, P4452, DOI 10.1242/jcs.058537; Osada M, 2002, J BIOL CHEM, V277, P23367, DOI 10.1074/jbc.M112413200; Ristoiu V, 2011, PAIN, V152, P936, DOI 10.1016/j.pain.2011.02.024; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shah M, 2009, PIGM CELL MELANOMA R, V22, P799, DOI 10.1111/j.1755-148X.2009.00628.x; Tschuch C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-60; Ueda K, 2008, FEBS LETT, V582, P2357, DOI 10.1016/j.febslet.2008.05.040; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Yu R, 1999, J BIOL CHEM, V274, P27545, DOI 10.1074/jbc.274.39.27545; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	36	36	40	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18393	18405		10.1074/jbc.M112.438762	http://dx.doi.org/10.1074/jbc.M112.438762			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645672	Green Published, hybrid			2022-12-25	WOS:000320721900042
J	Rauhala, L; Hamalainen, L; Salonen, P; Bart, G; Tammi, M; Pasonen-Seppanen, S; Tammi, R				Rauhala, Leena; Hamalainen, Lasse; Salonen, Pauliina; Bart, Genevieve; Tammi, Markku; Pasonen-Seppanen, Sanna; Tammi, Raija			Low Dose Ultraviolet B Irradiation Increases Hyaluronan Synthesis in Epidermal Keratinocytes via Sequential Induction of Hyaluronan Synthases Has1-3 Mediated by p38 and Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN SKIN; PERMEABILITY BARRIER; ORGANOTYPIC CULTURES; DERMAL COMPARTMENTS; MOUSE EPIDERMIS; CELL CARCINOMA; RETINOIC ACID; UP-REGULATION; TGF-BETA	Hyaluronan, a major epidermal extracellular matrix component, responds strongly to different kinds of injuries. This also occurs by UV radiation, but the mechanisms involved are poorly understood. The effects of a single ultraviolet B (UVB) exposure on hyaluronan content and molecular mass, and expression of genes involved in hyaluronan metabolism were defined in monolayer and differentiated, organotypic three-dimensional cultures of rat epidermal keratinocytes. The signals regulating the response were characterized using specific inhibitors and Western blotting. In monolayer cultures, UVB increased hyaluronan synthase Has1 mRNA already 4 h postexposure, with a return to control level by 24 h. In contrast, Has2 and Has3 were persistently elevated from 8 h onward. Silencing of Has2 and especially Has3 decreased the UVB-induced accumulation of hyaluronan. p38 and Ca2+/calmodulin-dependent protein kinase II pathways were found to be involved in the UVB-induced up-regulation of Has2 and Has3 expression, respectively, and their inhibition reduced hyaluronan deposition. However, the expressions of the hyaluronan-degrading enzymes Hyal1 and Hyal2 and the hyaluronan receptor Cd44 were also up-regulated by UVB. In organotypic cultures, UVB treatment also resulted in increased expression of both Has and Hyal genes and shifted hyaluronan toward a smaller size range. Histochemical stainings indicated localized losses of hyaluronan in the epidermis. The data show that exposure of keratinocytes to acute, low dose UVB increases hyaluronan synthesis via up-regulation of Has2 and Has3. The simultaneously enhanced catabolism of hyaluronan demonstrates the complexity of the UVB-induced changes. Nevertheless, enhanced hyaluronan metabolism is an important part of the adaptation of keratinocytes to radiation injury.	[Rauhala, Leena; Hamalainen, Lasse; Salonen, Pauliina; Bart, Genevieve; Tammi, Markku; Pasonen-Seppanen, Sanna; Tammi, Raija] Univ Eastern Finland, Sch Med, Inst Biomed Anat, Kuopio 70211, Finland	University of Eastern Finland	Rauhala, L (corresponding author), Univ Eastern Finland, Sch Med, Inst Biomed Anat, Kuopio Campus,Yliopistonranta 1 E,POB 1627, Kuopio 70211, Finland.	leena.rauhala@uef.fi	Tammi, Markku/AAQ-7878-2021	Bart, Genevieve/0000-0001-9809-150X; Hamalainen, Lasse/0000-0003-1649-1150	Tekes; Cancer Center of the University of Eastern Finland; Juselius Foundation	Tekes(Finnish Funding Agency for Technology & Innovation (TEKES)); Cancer Center of the University of Eastern Finland; Juselius Foundation	This work was supported by grants from Tekes (to R. T.), the Cancer Center of the University of Eastern Finland (to R. T. and M. T.), and the Juselius Foundation (to R. T. and M. T.).	Adler V, 1996, CARCINOGENESIS, V17, P2073, DOI 10.1093/carcin/17.9.2073; Agren UM, 1997, FREE RADICAL BIO MED, V23, P996, DOI 10.1016/S0891-5849(97)00098-1; Ajani G, 2007, EXP CELL RES, V313, P3005, DOI 10.1016/j.yexcr.2007.04.021; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614; BADEN HP, 1983, J INVEST DERMATOL, V80, P124, DOI 10.1111/1523-1747.ep12532899; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Bito T, 2010, EXP DERMATOL, V19, P654, DOI 10.1111/j.1600-0625.2010.01084.x; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenner M, 2005, BRIT J DERMATOL, V153, P733, DOI 10.1111/j.1365-2133.2005.06780.x; Calikoglu E, 2006, PHOTOCHEM PHOTOBIOL, V82, P1342, DOI 10.1562/2006-02-10-RA-801; Caskey RC, 2013, CELL TISSUE RES, V351, P117, DOI 10.1007/s00441-012-1504-7; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Ducale AE, 2005, AM J PHYSIOL-GASTR L, V289, pG462, DOI 10.1152/ajpgi.00494.2004; Esser PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041340; Hasova M, 2011, ARCH DERMATOL RES, V303, P277, DOI 10.1007/s00403-011-1146-8; Heck DE, 2003, J BIOL CHEM, V278, P22432, DOI 10.1074/jbc.C300048200; Heldin P, 2008, CONNECT TISSUE RES, V49, P215, DOI 10.1080/03008200802143323; Hiltunen ELJ, 2002, CANCER RES, V62, P6410; Hong SP, 2008, J INVEST DERMATOL, V128, P2880, DOI 10.1038/jid.2008.169; Hwang YP, 2011, J DERMATOL SCI, V63, P93, DOI 10.1016/j.jdermsci.2011.04.008; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 2008, SEMIN CANCER BIOL, V18, P268, DOI 10.1016/j.semcancer.2008.03.006; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Jost M, 2000, EUR J DERMATOL, V10, P505; Kakizaki I, 2008, ARCH BIOCHEM BIOPHYS, V471, P85, DOI 10.1016/j.abb.2007.12.004; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; Karvinen S, 2003, BRIT J DERMATOL, V148, P86, DOI 10.1046/j.1365-2133.2003.05028.x; Kim DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010290; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Lee SE, 2010, CLIN EXP DERMATOL, V35, P650, DOI 10.1111/j.1365-2230.2009.03699.x; Li YH, 2006, INT J MOL MED, V18, P713; Mack JA, 2012, J INVEST DERMATOL, V132, P198, DOI 10.1038/jid.2011.248; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Masaki H, 2009, J INVEST DERM SYMP P, V14, P50, DOI 10.1038/jidsymp.2009.12; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; Maytin EV, 2004, AM J PATHOL, V165, P1331, DOI 10.1016/S0002-9440(10)63391-3; Monslow J, 2009, J INVEST DERMATOL, V129, P2046, DOI 10.1038/jid.2009.9; Monzon ME, 2010, J BIOL CHEM, V285, P26126, DOI 10.1074/jbc.M110.135194; Mouchet N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010776; Nitzki F, 2010, CANCER RES, V70, P2739, DOI 10.1158/0008-5472.CAN-09-3743; Oikari S, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P39; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pasonen-Seppanen S, 2001, HISTOCHEM CELL BIOL, V116, P287, DOI 10.1007/s004180100312; Pasonen-Seppanen S, 2012, HISTOCHEM CELL BIOL, V137, P107, DOI 10.1007/s00418-011-0883-2; Pasonen-Seppanen SM, 2008, J INVEST DERMATOL, V128, P797, DOI 10.1038/sj.jid.5701098; Passi A, 2004, EXP CELL RES, V296, P123, DOI 10.1016/j.yexer.2004.01.031; Pauloin T, 2009, MOL VIS, V15, P577; Peus D, 1999, J INVEST DERMATOL, V112, P751, DOI 10.1046/j.1523-1747.1999.00584.x; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramamurthi A, 2003, J BIOMED MATER RES A, V66A, P317, DOI 10.1002/jbm.a.10588; REED RK, 1988, ACTA PHYSIOL SCAND, V134, P405, DOI 10.1111/j.1748-1716.1988.tb08508.x; Rezvani HR, 2007, J BIOL CHEM, V282, P16413, DOI 10.1074/jbc.M611397200; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Rilla K, 2013, J BIOL CHEM, V288, P5973, DOI 10.1074/jbc.M112.443879; Rock K, 2011, J BIOL CHEM, V286, P18268, DOI 10.1074/jbc.M110.201665; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Schindler EM, 2009, CANCER RES, V69, P4648, DOI 10.1158/0008-5472.CAN-08-4455; Schulz T, 2007, J BIOL CHEM, V282, P20999, DOI 10.1074/jbc.M700915200; Siiskonen H, 2011, J HISTOCHEM CYTOCHEM, V59, P908, DOI 10.1369/0022155411417874; Spicer Andrew P, 2004, Birth Defects Res C Embryo Today, V72, P89, DOI 10.1002/bdrc.20006; Stern R, 2008, CLIN DERMATOL, V26, P106, DOI 10.1016/j.clindermatol.2007.09.013; Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200; Suhonen TM, 2003, EUR J PHARM SCI, V20, P107, DOI 10.1016/S0928-0987(03)00176-3; TAKAHASHI Y, 1995, J DERMATOL SCI, V10, P139, DOI 10.1016/0923-1811(95)00396-A; TAMMI R, 1991, J INVEST DERMATOL, V97, P126, DOI 10.1111/1523-1747.ep12478553; Tammi R, 1998, J BIOL CHEM, V273, P28878, DOI 10.1074/jbc.273.44.28878; Tammi R, 2005, J INVEST DERMATOL, V124, P898, DOI 10.1111/j.0022-202X.2005.23697.x; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; TAMMI R, 1988, J INVEST DERMATOL, V90, P412, DOI 10.1111/1523-1747.ep12456530; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Tammi RH, 2000, HISTOCHEM CELL BIOL, V113, P265, DOI 10.1007/s004180000128; Tanimoto K, 2001, CONNECT TISSUE RES, V42, P187, DOI 10.3109/03008200109005649; Tobiishi M, 2011, J DERMATOL SCI, V64, P31, DOI 10.1016/j.jdermsci.2011.06.006; Tuhkanen AL, 1997, J INVEST DERMATOL, V109, P213, DOI 10.1111/1523-1747.ep12319402; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Van Laethem A, 2009, PHOTOCH PHOTOBIO SCI, V8, P299, DOI 10.1039/b813346h; WANG C, 1992, HISTOCHEMISTRY, V98, P105, DOI 10.1007/BF00717001; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Wright SC, 1997, FASEB J, V11, P843, DOI 10.1096/fasebj.11.11.9285482; Xu YR, 2006, AM J PATHOL, V169, P823, DOI 10.2353/ajpath.2006.050449; Xu YR, 2009, J CELL BIOCHEM, V107, P873, DOI 10.1002/jcb.22195; YANAGISHITA M, 1989, METHOD ENZYMOL, V179, P435; Yasul H, 2006, BIOCHEM BIOPH RES CO, V347, P83, DOI 10.1016/j.bbrc.2006.06.046; Zhang QS, 2001, INT J ONCOL, V19, P1057; Zhong JL, 2011, PHOTOCHEM PHOTOBIOL, V87, P1092, DOI 10.1111/j.1751-1097.2011.00963.x	91	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					17999	18012		10.1074/jbc.M113.472530	http://dx.doi.org/10.1074/jbc.M113.472530			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645665	hybrid, Green Published			2022-12-25	WOS:000320721900007
J	Erat, MC; Sladek, B; Campbell, ID; Vakonakis, I				Erat, Michele C.; Sladek, Barbara; Campbell, Iain D.; Vakonakis, Ioannis			Structural Analysis of Collagen Type I Interactions with Human Fibronectin Reveals a Cooperative Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GELATIN-BINDING; CRYSTAL-STRUCTURE; CRYSTALLOGRAPHIC STRUCTURE; (6)F1(1)F2(2)F2 FRAGMENT; 6 MODULES; DOMAIN; SITES; SCATTERING; IDENTIFICATION; COMPLEXES	Despite its biological importance, the interaction between fibronectin (FN) and collagen, two abundant and crucial tissue components, has not been well characterized on a structural level. Here, we analyzed the four interactions formed between epitopes of collagen type I and the collagen-binding fragment (gelatin-binding domain (GBD)) of human FN using solution NMR, fluorescence, and small angle x-ray scattering methods. Collagen association with FN modules (8-9)FnI occurs through a conserved structural mechanism but exhibits a 400-fold disparity in affinity between collagen sites. This disparity is reduced in the full-length GBD, as (6)FnI(1-2)FnII(7)FnI binds a specific collagen epitope next to the weakest (8-9)FnI-binding site. The cooperative engagement of all GBD modules with collagen results in four broadly equipotent FN-collagen interaction sites. Collagen association stabilizes a distinct monomeric GBD conformation in solution, giving further evidence to the view that FN fragments form well defined functional and structural units.	[Erat, Michele C.; Sladek, Barbara; Campbell, Iain D.; Vakonakis, Ioannis] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Vakonakis, I (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	ioannis.vakonakis@bioch.ox.ac.uk			Marie Curie Fellowship under European Commission Framework Programme 7 [235532]; Royal Society research grant [RG100227]; BBSRC [BB/J008265/1];  [088497/Z/09/Z]; Biotechnology and Biological Sciences Research Council [BB/J008265/1] Funding Source: researchfish; Medical Research Council [G0900052] Funding Source: researchfish; MRC [G0900052] Funding Source: UKRI	Marie Curie Fellowship under European Commission Framework Programme 7; Royal Society research grant(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by Marie Curie Fellowship 235532 under European Commission Framework Programme 7 and by Royal Society research grant RG100227.; Wellcome Trust Research Career Development Fellow supported by Grant 088497/Z/09/Z and BBSRC Project Grant BB/J008265/1. To whom correspondence should be addressed: Dept. of Biochemistry, University of Oxford, South Parks Rd., Oxford OX1 3QU, United Kingdom. Tel.: 44-1865-613362; Fax: 44-1865-613201; E-mail: ioannis.vakonakis@bioch.ox.ac.uk.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Atkin KE, 2010, J BIOL CHEM, V285, P36977, DOI 10.1074/jbc.M110.156935; BALIAN G, 1980, J BIOL CHEM, V255, P3234; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; BLUMENSTOCK FA, 1993, J LEUKOCYTE BIOL, V54, P56, DOI 10.1002/jlb.54.1.56; Campbell ID, 1998, NAT STRUCT BIOL, V5, P496, DOI 10.1038/733; DESSAU W, 1978, BIOCHEM J, V169, P55, DOI 10.1042/bj1690055; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Erat MC, 2010, J BIOL CHEM, V285, P33764, DOI 10.1074/jbc.M110.139394; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; ERICKSON HP, 1981, J CELL BIOL, V91, P673, DOI 10.1083/jcb.91.3.673; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Holmes DF, 2010, J MOL BIOL, V399, P9, DOI 10.1016/j.jmb.2010.04.008; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; Hynes RO, 1990, FIBRONECTINS; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200; KLEINMAN HK, 1976, BIOCHEM BIOPH RES CO, V72, P426, DOI 10.1016/S0006-291X(76)80060-5; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LACELLE P, 1990, BLOOD, V75, P470; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; LITVINOVICH SV, 1991, J MOL BIOL, V217, P563, DOI 10.1016/0022-2836(91)90758-X; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; Millard CJ, 2005, FEBS LETT, V579, P4529, DOI 10.1016/j.febslet.2005.05.082; Pagett A, 2005, BIOCHEMISTRY-US, V44, P14682, DOI 10.1021/bi050937i; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	49	52	52	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17441	17450		10.1074/jbc.M113.469841	http://dx.doi.org/10.1074/jbc.M113.469841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23653354	Green Published, hybrid			2022-12-25	WOS:000320380600036
J	McCarthy, RC; Kosman, DJ				McCarthy, Ryan C.; Kosman, Daniel J.			Ferroportin and Exocytoplasmic Ferroxidase Activity Are Required for Brain Microvascular Endothelial Cell Iron Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED CERULOPLASMIN; CENTRAL-NERVOUS-SYSTEM; EXPRESSION; HEPHAESTIN; ASTROCYTES; COPPER; OLIGODENDROCYTES; ACCUMULATION; METABOLISM; STABILITY	The mechanism(s) of iron flux across the brain microvasculature endothelial cells (BMVEC) of the blood-brain barrier remains unknown. Although both hephaestin (Hp) and the ferrous iron permease ferroportin (Fpn) have been identified in BMVEC, their roles in iron efflux have not been examined. Using a human BMVEC line (hBMVEC), we have demonstrated that these proteins are required for iron efflux from these cells. Expression of both Hp and Fpn protein was confirmed in hBMVEC by immunoblot and indirect immunofluorescence; we show that hBMVEC express soluble ceruloplasmin (Cp) transcript as well. Depletion of endogenous Hp and Cp via copper chelation leads to the reduction of hBMVEC Fpn protein levels as well as a complete inhibition of Fe-59 efflux. Both hBMVEC Fpn protein and Fe-59 efflux activity are restored upon incubation with 6.6 nM soluble plasma Cp. These results are independent of the source of cell iron, whether delivered as transferrinor non-transferrin-bound Fe-59. Our results demonstrate that iron efflux from hBMVEC Fpn requires the action of an exocytoplasmic ferroxidase, which can be either endogenous Hp or extracellular Cp.	[McCarthy, Ryan C.; Kosman, Daniel J.] SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), SUNY Buffalo, Dept Biochem, Farber Hall Rm 140,3435 Main St,Bldg 26, Buffalo, NY 14214 USA.	camkos@buffalo.edu			National Institutes of Health [DK053820]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053820, R56DK053820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grant DK053820 from the National Institutes of Health (to D. J. K.) and a predoctoral fellowship from the American Heart Association (to R. C. M.).	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Anderson GJ, 2009, CELL MOL LIFE SCI, V66, P3241, DOI 10.1007/s00018-009-0051-1; Chen HJ, 2009, J CELL BIOCHEM, V107, P803, DOI 10.1002/jcb.22178; Chung B, 2009, J NUTR, V139, P1457, DOI 10.3945/jn.108.102905; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; De Domenico I, 2007, MOL BIOL CELL, V18, P2569, DOI 10.1091/mbc.E07-01-0060; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Dringen R, 2007, NEUROCHEM RES, V32, P1884, DOI 10.1007/s11064-007-9375-0; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Ganz T, 2005, CELL METAB, V1, P155, DOI 10.1016/j.cmet.2005.02.005; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Greenough MA, 2013, NEUROCHEM INT, V62, P540, DOI 10.1016/j.neuint.2012.08.014; Han O, 2007, J CELL BIOCHEM, V101, P1000, DOI 10.1002/jcb.21392; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Klomp LWJ, 1996, HUM MOL GENET, V5, P1989, DOI 10.1093/hmg/5.12.1989; Klomp LWJ, 1996, J CLIN INVEST, V98, P207, DOI 10.1172/JCI118768; Kono S, 2010, BBA-MOL BASIS DIS, V1802, P968, DOI 10.1016/j.bbadis.2010.07.011; Leipuviene R, 2007, CELL MOL LIFE SCI, V64, P2945, DOI 10.1007/s00018-007-7198-4; Marques L, 2012, BLOOD CELL MOL DIS, V48, P110, DOI 10.1016/j.bcmd.2011.11.005; McCarthy RC, 2012, BIOMETALS, V25, P665, DOI 10.1007/s10534-012-9538-6; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Nittis T, 2004, J BIOL CHEM, V279, P25696, DOI 10.1074/jbc.M401151200; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Prohaska JR, 2005, J NEUROCHEM, V93, P698, DOI 10.1111/j.1471-4159.2005.03091.x; Qian ZM, 2007, J CELL BIOCHEM, V102, P1225, DOI 10.1002/jcb.21352; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Salvador GA, 2010, BIOFACTORS, V36, P103, DOI 10.1002/biof.80; Schulz K, 2011, J NEUROSCI, V31, P13301, DOI 10.1523/JNEUROSCI.2838-11.2011; Sedlak E, 2008, BIOPHYS J, V94, P1384, DOI 10.1529/biophysj.107.113696; Skjorringe T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00169; Slany A, 2010, J PROTEOME RES, V9, P6, DOI 10.1021/pr900057t; Thomas C, 2004, GUT, V53, P44, DOI 10.1136/gut.53.1.44; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Wang J, 2007, EUR J NEUROSCI, V25, P2766, DOI 10.1111/j.1460-9568.2007.05515.x; Wolkow N, 2012, AM J PATHOL, V180, P1614, DOI 10.1016/j.ajpath.2011.12.041; Wu LJC, 2004, BRAIN RES, V1001, P108, DOI 10.1016/j.brainres.2003.10.066; Yang WM, 2011, CELL MOL NEUROBIOL, V31, P93, DOI 10.1007/s10571-010-9558-0	40	53	54	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17932	17940		10.1074/jbc.M113.455428	http://dx.doi.org/10.1074/jbc.M113.455428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640881	hybrid, Green Published			2022-12-25	WOS:000320380600080
J	Bockelmann, AC; Tams, V; Ploog, J; Schubert, PR; Reusch, TBH				Bockelmann, Anna-Christina; Tams, Verena; Ploog, Jana; Schubert, Philipp R.; Reusch, Thorsten B. H.			Quantitative PCR Reveals Strong Spatial and Temporal Variation of the Wasting Disease Pathogen, Labyrinthula zosterae in Northern European Eelgrass (Zostera marina) Beds	PLOS ONE			English	Article							SEAGRASS-PATHOGEN; WADDEN SEA; SYSTEMIC RESISTANCE; PLANT SYMBIOSES; ECOSYSTEMS; TEMPERATURE; SALINITY; PARASITISM; INDUCTION; EVOLUTION	Seagrass beds are the foundation species of functionally important coastal ecosystems worldwide. The world's largest losses of the widespread seagrass Zostera marina (eelgrass) have been reported as a consequence of wasting disease, an infection with the endophytic protist Labyrinthula zosterae. During one of the most extended epidemics in the marine realm, similar to 90% of East and Western Atlantic eelgrass beds died-off between 1932 and 1934. Today, small outbreaks continue to be reported, but the current extent of L. zosterae in European meadows is completely unknown. In this study we quantify the abundance and prevalence of the wasting disease pathogen among 19 Z. marina populations in northern European coastal waters, using quantitative PCR (QPCR) with primers targeting a species specific portion of the internally transcribed spacer (ITS1) of L. zosterae. Spatially, we found marked variation among sites with abundances varying between 0 and 126 cells mg(-1) Z. marina dry weight (mean: 5.7 L. zosterae cells mg(-1) Z. marina dry weight 61.9 SE) and prevalences ranged from 0-88.9%. Temporarily, abundances varied between 0 and 271 cells mg(-1) Z. marina dry weight (mean: 8.5+/-2.6 SE), while prevalences ranged from zero in winter and early spring to 96% in summer. Field concentrations accessed via bulk DNA extraction and subsequent QPCR correlated well with prevalence data estimated via isolation and cultivation from live plant tissue. L. zosterae was not only detectable in black lesions, a sign of Labyrinthula-induced necrosis, but also occurred in green, apparently healthy tissue. We conclude that L. zosterae infection is common (84% infected populations) in (northern) European eelgrass populations with highest abundances during the summer months. In the light of global climate change and increasing rate of marine diseases our data provide a baseline for further studies on the causes of pathogenic outbreaks of L. zosterae.	[Bockelmann, Anna-Christina; Tams, Verena; Ploog, Jana; Schubert, Philipp R.; Reusch, Thorsten B. H.] Helmholtz Ctr Ocean Res GEOMAR, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Bockelmann, AC (corresponding author), Helmholtz Ctr Ocean Res GEOMAR, Kiel, Germany.	abockelmann@geomar.de	Schubert, Philipp/D-6141-2016; Reusch, Thorsten B.H./G-4141-2011; Reusch, Thorsten B. H./B-9311-2019	Schubert, Philipp/0000-0003-1838-7250; Tams, Verena/0000-0002-9539-2603; Reusch, Thorsten B. H./0000-0002-8961-4337	Excellence Cluster 'The Future Ocean' (GEOMAR, Kiel, Germany); Ministry for Agriculture, Nature Conservation and Rural Development of Schleswig-Holstein (LLUR, Germany)	Excellence Cluster 'The Future Ocean' (GEOMAR, Kiel, Germany); Ministry for Agriculture, Nature Conservation and Rural Development of Schleswig-Holstein (LLUR, Germany)	Funding was provided by Excellence Cluster 'The Future Ocean' (GEOMAR, Kiel, Germany), and the Ministry for Agriculture, Nature Conservation and Rural Development of Schleswig-Holstein (LLUR, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy C. E., 1944, JOUR WILDLIFE MANAGEMENT, V8, P269, DOI 10.2307/3796019; AMON JP, 1968, J PROTOZOOL, V15, P543, DOI 10.1111/j.1550-7408.1968.tb02172.x; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; BARTSCH G, 1971, Z ALLG MIKROBIOL, V11, P79; Bergmann N, 2011, MOL ECOL RESOUR, V11, P1076, DOI 10.1111/j.1755-0998.2011.03051.x; Blegvad H, 1935, BERETNING MINETERIET, P1; Blois JC, 1961, CAH BIOL MAR, V2, P223; Bockelmann AC, 2012, MAR ECOL PROG SER, V445, P109, DOI 10.3354/meps09398; Bostrom C., 2003, WORLD ATLAS SEAGRASS, P27; Bowles JW, 2004, MAR ECOL PROG SER, V283, P127, DOI 10.3354/meps283127; BURDICK DM, 1993, MAR ECOL PROG SER, V94, P83, DOI 10.3354/meps094083; Butcher RW, 1934, J CONSEIL, V9; Chapman D. J., 1990, HDB PROTOCTISTA; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; Cook T, 1998, ESTUAR COAST SHELF S, V46, P587, DOI 10.1006/ecss.1997.0283; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; COTTAM C., 1933, Plant Disease Reporter, V17, P46; Cotton AD, 1933, NATURE, V132, P483, DOI 10.1038/132483b0; de Jonge VN, 1996, J COAST CONSERV, V2, P149; DENHARTOG C, 1989, DIS AQUAT ORGAN, V7, P223, DOI 10.3354/dao007223; Dolch T, 2009, SEEGRAS MONITORING S; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; Fischer-Piette E, 1932, CR HEBD ACAD SCI, V195, P1420; Garrett KA, 2006, ANNU REV PHYTOPATHOL, V44, P489, DOI 10.1146/annurev.phyto.44.070505.143420; GIESEN WBJT, 1990, NETH J SEA RES, V25, P395, DOI 10.1016/0077-7579(90)90047-K; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Godet L, 2008, DIS AQUAT ORGAN, V79, P249, DOI 10.3354/dao01897; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hily C, 2002, AQUAT BOT, V72, P37, DOI 10.1016/S0304-3770(01)00195-4; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Karvonen A, 2010, INT J PARASITOL, V40, P1483, DOI 10.1016/j.ijpara.2010.04.015; Kastler T., 1997, BERICHT FORSCHUNGSST, V41, P119; Kniskern JM, 2006, ECOLOGY, V87, P675, DOI 10.1890/05-1327; Martin DL, 2009, MYCOLOGIA, V101, P632, DOI 10.3852/08-171; McKone KL, 2009, MAR ECOL PROG SER, V377, P123, DOI 10.3354/meps07860; Meyer T, 2006, ROSTOCKER MEERESBIOL, V15, P105; MUEHLSTEIN LK, 1988, MAR BIOL, V99, P465, DOI 10.1007/BF00392553; MUEHLSTEIN LK, 1989, DIS AQUAT ORGAN, V7, P211, DOI 10.3354/dao007211; MUEHLSTEIN LK, 1991, MYCOLOGIA, V83, P180, DOI 10.2307/3759933; Oetjen K, 2007, MOL ECOL, V16, P5156, DOI 10.1111/j.1365-294X.2007.03577.x; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Paszkowski U, 2006, CURR OPIN PLANT BIOL, V9, P364, DOI 10.1016/j.pbi.2006.05.008; POKORNY KS, 1967, J PROTOZOOL, V14, P697, DOI 10.1111/j.1550-7408.1967.tb02065.x; Raghukumar S, 2011, BOT MAR, V54, P3, DOI 10.1515/BOT.2011.008; Ralph PJ, 2002, MAR ECOL PROG SER, V226, P265, DOI 10.3354/meps226265; Ramamoorthy V, 2001, CROP PROT, V20, P1, DOI 10.1016/S0261-2194(00)00056-9; RASMUSSEN E, 1977, SEAGRASS ECOSYSTEMS, P00001; REISE K, 1989, HELGOLANDER MEERESUN, V43, P417, DOI 10.1007/BF02365901; Reise K, 2008, HELGOLAND MAR RES, V62, P77, DOI 10.1007/s10152-007-0088-1; Renn CE, 1936, BIOL BULL-US, V70, P148, DOI 10.2307/1537320; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; SCHMOLLER H, 1960, ARCH MIKROBIOL, V36, P365, DOI 10.1007/BF00418643; SHORT FT, 1988, AQUAT BOT, V30, P295, DOI 10.1016/0304-3770(88)90062-9; SHORT FT, 1987, BIOL BULL, V173, P557, DOI 10.2307/1541701; Steele L, 2005, MAR ECOL PROG SER, V303, P123, DOI 10.3354/meps303123; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; VAN DER WERFF A., 1938, Chronica botanica, V4, P498; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; VERGEER LHT, 1995, AQUAT BOT, V52, P35, DOI 10.1016/0304-3770(95)00480-N; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wohlenberg E, 1935, SONDERDRUCK NORDELBI, V11, P1; Wyllie-Echeverria S, 1999, ECON BOT, V53, P419	64	34	34	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62169	10.1371/journal.pone.0062169	http://dx.doi.org/10.1371/journal.pone.0062169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658711	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000321200500018
J	Fujii, M; Nishimori, H; Awazu, A				Fujii, Masashi; Nishimori, Hiraku; Awazu, Akinori			Influences of Excluded Volume of Molecules on Signaling Processes on the Biomembrane	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; EPIDERMAL-GROWTH-FACTOR; MAP KINASE; LATERAL DIFFUSION; HOP DIFFUSION; MEMBRANE; TRANSDUCTION; CELLS; RATES; EQUILIBRIA	We investigate the influences of the excluded volume of molecules on biochemical reaction processes on 2-dimensional surfaces using a model of signal transduction processes on biomembranes. We perform simulations of the 2-dimensional cell-based model, which describes the reactions and diffusion of the receptors, signaling proteins, target proteins, and crowders on the cell membrane. The signaling proteins are activated by receptors, and these activated signaling proteins activate target proteins that bind autonomously from the cytoplasm to the membrane, and unbind from the membrane if activated. If the target proteins bind frequently, the volume fraction of molecules on the membrane becomes so large that the excluded volume of the molecules for the reaction and diffusion dynamics cannot be negligible. We find that such excluded volume effects of the molecules induce non-trivial variations of the signal flow, defined as the activation frequency of target proteins, as follows. With an increase in the binding rate of target proteins, the signal flow varies by i) monotonically increasing; ii) increasing then decreasing in a bell-shaped curve; or iii) increasing, decreasing, then increasing in an S-shaped curve. We further demonstrate that the excluded volume of molecules influences the hierarchical molecular distributions throughout the reaction processes. In particular, when the system exhibits a large signal flow, the signaling proteins tend to surround the receptors to form receptor-signaling protein clusters, and the target proteins tend to become distributed around such clusters. To explain these phenomena, we analyze the stochastic model of the local motions of molecules around the receptor.	[Fujii, Masashi; Nishimori, Hiraku; Awazu, Akinori] Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima, Hiroshima 724, Japan	Hiroshima University	Fujii, M (corresponding author), Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima, Hiroshima 724, Japan.	mfujii0123@hiroshima-u.ac.jp	Awazu, Akinori/G-8980-2019; Fujii, Masashi/S-1516-2019	Fujii, Masashi/0000-0002-1586-6435	Japan Society for the Promotion of Science for Young Scientists; Global Center of Excellence Program G14 (Formation and Development of Mathematical Sciences Based on Modeling and Analysis) of Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; MEXT of Japan [3306, 24115515]; Grants-in-Aid for Scientific Research [24115515] Funding Source: KAKEN	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence Program G14 (Formation and Development of Mathematical Sciences Based on Modeling and Analysis) of Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists to MF (www.jsps.go.jp), by the Global Center of Excellence Program G14 (Formation and Development of Mathematical Sciences Based on Modeling and Analysis) of Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan to HN (www.jsps.go.jp), and by the Grant-in-Aid for Scientific Research on Innovative Areas (Spying minority in biological phenomena (No. 3306) (24115515)) of MEXT of Japan to AA (www.jsps.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal M, 2009, PRAMANA, V71, P359; Aokia K, 2011, P NATL ACAD SCI USA, V108, P12675, DOI 10.1073/pnas.1104030108; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bhide SY, 2000, J PHYS CHEM B, V104, P2607, DOI 10.1021/jp993287z; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Butler AA, 1998, COMP BIOCHEM PHYS B, V121, P19, DOI 10.1016/S0305-0491(98)10106-2; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; Daumas F, 2003, BIOPHYS J, V84, P356, DOI 10.1016/S0006-3495(03)74856-5; Dreux AC, 2006, ATHEROSCLEROSIS, V186, P38, DOI 10.1016/j.atherosclerosis.2005.06.038; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Fernandez C, 2011, J PHYS CHEM B, V115, P1289, DOI 10.1021/jp110285b; Fritsch CC, 2011, CHROMOSOME RES, V19, P63, DOI 10.1007/s10577-010-9168-1; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; JANSSENS PMW, 1987, MICROBIOL REV, V51, P396, DOI 10.1128/MMBR.51.4.396-418.1987; Jiao M, 2010, BIOPHYS J, V99, P914, DOI 10.1016/j.bpj.2010.05.013; Kilburn D, 2010, J AM CHEM SOC, V132, P8690, DOI 10.1021/ja101500g; Kim JS, 2009, BIOPHYS J, V96, P1333, DOI 10.1016/j.bpj.2008.11.030; Kinjo AR, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051902; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lill Y, 2005, CHEMPHYSCHEM, V6, P1633, DOI 10.1002/cphc.200500111; Lin J, 2009, MOL CELL BIOL, V29, P2082, DOI 10.1128/MCB.01634-08; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Mashanov GI, 2006, BIOCHEM SOC T, V34, P983, DOI 10.1042/BST0340983; Matsuoka S, 2006, J CELL SCI, V119, P1071, DOI 10.1242/jcs.02824; Matsuoka S, 2009, BIOPHYS J, V97, P1115, DOI 10.1016/j.bpj.2009.06.007; Mayawala K, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-41; Minton AP, 2010, ANAL BIOCHEM, V397, P247, DOI 10.1016/j.ab.2009.10.023; Minton AP, 1998, METHOD ENZYMOL, V295, P127; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; MINTON AP, 1992, P NATL ACAD SCI USA, V89, P10504, DOI 10.1073/pnas.89.21.10504; Miyanaga Y, 2007, BIOSYSTEMS, V88, P251, DOI 10.1016/j.biosystems.2006.07.011; Nagarajan S, 2011, BIOPHYS J, V100, P2991, DOI 10.1016/j.bpj.2011.03.065; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Takahashi K, 2005, FEBS LETT, V579, P1783, DOI 10.1016/j.febslet.2005.01.072; van der Woning SP, 2009, BIOCHEM BIOPH RES CO, V378, P285, DOI 10.1016/j.bbrc.2008.11.034; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; White DA, 2010, J AM CHEM SOC, V132, P5170, DOI 10.1021/ja909997e; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	54	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62218	10.1371/journal.pone.0062218	http://dx.doi.org/10.1371/journal.pone.0062218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658714	Green Submitted, Green Published, gold			2022-12-25	WOS:000321200500019
J	Lin, WP; Chen, XW; Zhang, LQ; Wu, CY; Huang, ZD; Lin, JH				Lin, Wen-Ping; Chen, Xuan-Wei; Zhang, Li-Qun; Wu, Chao-Yang; Huang, Zi-Da; Lin, Jian-Hua			Effect of Neuroglobin Genetically Modified Bone Marrow Mesenchymal Stem Cells Transplantation on Spinal Cord Injury in Rabbits	PLOS ONE			English	Article							STROMAL CELLS; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; NITRIC-OXIDE; PROMOTE REGENERATION; OXIDATIVE STRESS; GLOBIN FAMILY; GENE-TRANSFER; ADULT-RAT; IN-VIVO	Objective: This study aims to investigate the potentially protective effect of neuroglobin (Ngb) gene-modified bone marrow mesenchymal stem cells (BMSCs) on traumatic spinal cord injury (SCI) in rabbits. Methods: A lentiviral vector containing an Ngb gene was constructed and used to deliver Ngb to BMSCs. Ngb gene-modified BMSCs were then injected at the SCI sites 24 hours after SCI. The motor functions of the rabbits were evaluated by the Basso-Beattie-Bresnahan rating scale. Fluorescence microscopy, quantitative real-time PCRs, Western blots, malondialdehyde (MDA) tests, and terminal deoxynucleotidyltransferase-mediated UTP end labeling assays were also performed. Results: Ngb expression in the Ngb-BMSC group increased significantly. A more significant functional improvement was observed in the Ngb-BMSC group compared with those in the other groups. Traumatic SCI seemingly led to an increase in MDA level and number of apoptotic cells, which can be prevented by Ngb-BMSC treatment. Conclusion: This study demonstrates that Ngb gene-modified BMSCs can strengthen the therapeutic benefits of BMSCs in reducing secondary damage and improving the neurological outcome after traumatic SCI. Therefore, the combined strategy of BMSC transplantation and Ngb gene therapy can be used to treat traumatic SCI.	[Lin, Wen-Ping] Fujian Med Univ, Affiliated Hosp 2, Dept Orthoped Surg, Quanzhou, Fujian Province, Peoples R China; [Chen, Xuan-Wei; Zhang, Li-Qun; Wu, Chao-Yang; Huang, Zi-Da; Lin, Jian-Hua] Fujian Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University; Fujian Medical University	Lin, JH (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Fuzhou, Fujian Province, Peoples R China.	jianhua0918@126.com		Lin, Wenping/0000-0001-5029-5466; Zhang, Liqun/0000-0002-2937-2743; Lin, Jianhua/0000-0003-0698-0292	Specialized Research Fund for the Doctoral Program of Higher Education of China [20060392003]	Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by a grant from the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant number: 20060392003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjos-Afonso F, 2004, J CELL SCI, V117, P5655, DOI 10.1242/jcs.01488; Aslan A, 2009, EUR SPINE J, V18, P1442, DOI 10.1007/s00586-009-1033-6; Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Ates O, 2006, ACTA PHARMACOL SIN, V27, P1317, DOI 10.1111/j.1745-7254.2006.00416.x; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Blesch A, 2002, BRAIN RES BULL, V57, P833, DOI 10.1016/S0361-9230(01)00774-2; Brittain T, 2010, INT J MOL SCI, V11, P2306, DOI 10.3390/ijms11062306; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Brunori M, 2006, FASEB J, V20, P2192, DOI 10.1096/fj.06-6643rev; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Buege J A, 1978, Methods Enzymol, V52, P302; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Cayli SR, 2006, INT J DEV NEUROSCI, V24, P233, DOI 10.1016/j.ijdevneu.2006.04.003; Chang YP, 2006, J CELL BIOCHEM, V97, P501, DOI 10.1002/jcb.20646; Chen WH, 2005, NEUROSCI LETT, V384, P117, DOI 10.1016/j.neulet.2005.04.070; Chen YJ, 2010, EXP MOL PATHOL, V88, P311, DOI 10.1016/j.yexmp.2009.12.002; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; Duong TTH, 2009, J NEUROCHEM, V108, P1143, DOI 10.1111/j.1471-4159.2008.05846.x; Fago A, 2008, IUBMB LIFE, V60, P398, DOI 10.1002/iub.35; Fago A, 2006, J INORG BIOCHEM, V100, P1339, DOI 10.1016/j.jinorgbio.2006.03.009; Fischer-Rasokat U, 2009, CIRC-HEART FAIL, V2, P417, DOI 10.1161/CIRCHEARTFAILURE.109.855023; Fordel E, 2007, FEBS J, V274, P1312, DOI 10.1111/j.1742-4658.2007.05679.x; Garry DJ, 2003, LANCET, V362, P342, DOI 10.1016/S0140-6736(03)14055-X; Gnecchi M, 2009, STEM CELLS, V27, P971, DOI 10.1002/stem.12; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hendriks WTJ, 2004, PROG BRAIN RES, V146, P451; Herold S, 2005, COMP BIOCHEM PHYS A, V142, P124, DOI 10.1016/j.cbpb.2005.06.009; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030; Jakob M, 2010, STEM CELLS DEV, V19, P635, DOI 10.1089/scd.2009.0245; Jin KL, 2008, NEUROSCI LETT, V430, P135, DOI 10.1016/j.neulet.2007.10.031; Kamishina H, 2006, AM J VET RES, V67, P1921, DOI 10.2460/ajvr.67.11.1921; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Kim S, 2006, BRAIN RES, V1123, P27, DOI 10.1016/j.brainres.2006.09.044; Koda M, 2002, J NEUROTRAUM, V19, P777, DOI 10.1089/08977150260139147; Koda M, 2007, EUR SPINE J, V16, P2206, DOI 10.1007/s00586-007-0499-3; Laufs TL, 2004, NEUROSCI LETT, V362, P83, DOI 10.1016/j.neulet.2004.02.072; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Li XM, 2000, RESTOR NEUROL NEUROS, V17, P203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mammen PPA, 2002, J HISTOCHEM CYTOCHEM, V50, P1591, DOI 10.1177/002215540205001203; Martin DR, 2002, EXP HEMATOL, V30, P879, DOI 10.1016/S0301-472X(02)00864-0; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Murray M, 2004, PROG BRAIN RES, V143, P133, DOI 10.1016/S0079-6123(03)43013-6; Nakahara S, 1999, J NEUROPATH EXP NEUR, V58, P442, DOI 10.1097/00005072-199905000-00003; Nakajima H, 2010, SPINE, V35, P497, DOI 10.1097/BRS.0b013e3181b8e89b; Nienhaus K, 2007, IUBMB LIFE, V59, P490, DOI 10.1080/15216540601188538; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ramer MS, 2000, SPINAL CORD, V38, P449, DOI 10.1038/sj.sc.3101055; Ray SK, 1999, ANN NY ACAD SCI, V890, P261, DOI 10.1111/j.1749-6632.1999.tb08001.x; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Szymanski M, 2010, NEUROBIOL AGING, V31, P1835, DOI 10.1016/j.neurobiolaging.2008.10.003; Wakasugi K, 2005, ANN NY ACAD SCI, V1053, P220, DOI 10.1196/annals.1344.020; Wang XY, 2008, STROKE, V39, P1869, DOI 10.1161/STROKEAHA.107.506022; Wang Z, 2006, TISSUE ENG, V12, P1753, DOI 10.1089/ten.2006.12.1753; Weber T, 2003, BIOCHEMISTRY-US, V42, P4277, DOI 10.1021/bi020527j; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wu SF, 2003, J NEUROSCI RES, V72, P343, DOI 10.1002/jnr.10587; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Yune TY, 2008, FREE RADICAL BIO MED, V45, P1190, DOI 10.1016/j.freeradbiomed.2008.07.016; Zhang W, 2010, BRAIN RES, V1359, P256, DOI 10.1016/j.brainres.2010.08.072	71	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63444	10.1371/journal.pone.0063444	http://dx.doi.org/10.1371/journal.pone.0063444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658829	Green Submitted, gold, Green Published			2022-12-25	WOS:000321200500071
J	Campbell, HA; Dwyer, RG; Irwin, TR; Franklin, CE				Campbell, Hamish A.; Dwyer, Ross G.; Irwin, Terri R.; Franklin, Craig E.			Home Range Utilisation and Long-Range Movement of Estuarine Crocodiles during the Breeding and Nesting Season	PLOS ONE			English	Article							CROCODYLUS-POROSUS; NORTHERN-TERRITORY; ABUNDANCE; RIVERS; PERTURBATION; JOHNSTONI; BEHAVIOR; TACTICS	The estuarine crocodile (Crocodylus porosus) is the apex-predator in waterways and coastlines throughout south-east Asia and Australasia. C. porosus pose a potential risk to humans, and management strategies are implemented to control their movement and distribution. Here we used GPS-based telemetry to accurately record geographical location of adult C. porosus during the breeding and nesting season. The purpose of the study was to assess how C. porosus movement and distribution may be influenced by localised social conditions. During breeding, the females (2.92 +/- 0.013 metres total length (TL), mean +/- S.E., n = 4) occupied an area < 1 km length of river, but to nest they travelled up to 54 km away from the breeding area. All tagged male C. porosus sustained high rates of movement (6.49 +/- 0.9 km d(-1); n = 8) during the breeding and nesting period. The orientation of the daily movements differed between individuals revealing two discontinuous behavioural strategies. Five tagged male C. porosus (4.17 +/- 0.14 m TL) exhibited a 'site-fidelic' strategy and moved within well-defined zones around the female home range areas. In contrast, three males (3.81 +/- 0.08 m TL) exhibited 'nomadic' behaviour where they travelled continually throughout hundreds of kilometres of waterway. We argue that the 'site-fidelic' males patrolled territories around the female home ranges to maximise reproductive success, whilst the 'nomadic' males were subordinate animals that were forced to range over a far greater area in search of unguarded females. We conclude that C. porosus are highly mobile animals existing within a complex social system, and mate/con-specific interactions are likely to have a profound effect upon population density and distribution, and an individual's travel potential. We recommend that impacts on socio-spatial behaviour are considered prior to the implementation of management interventions.	[Campbell, Hamish A.; Dwyer, Ross G.; Franklin, Craig E.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Irwin, Terri R.] Australia Zoo, Beerwah, Australia	University of Queensland	Campbell, HA (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	hamish.campbell@uq.edu.au	Franklin, Craig/G-7343-2012	Franklin, Craig/0000-0003-1315-3797; Dwyer, Ross/0000-0003-1136-5489; Campbell, Hamish/0000-0003-1428-1686	Australian Research Council linkage scheme	Australian Research Council linkage scheme(Australian Research Council)	This study was supported by the Australian Research Council linkage scheme with Australia Zoo as industrial partners, and funds donated by the golfer Greg Norman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GR, 1974, COPEIA, P553; Bivand, 2012, RGEOS INTERFACE GEOM; Bivand RS, 2008, USE R, P1; Brien ML, 2008, WILDLIFE RES, V35, P140, DOI 10.1071/WR06116; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Campbell HA, 2010, J ANIM ECOL, V79, P955, DOI 10.1111/j.1365-2656.2010.01709.x; Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; Davidson Z, 2011, BIOL CONSERV, V144, P114, DOI 10.1016/j.biocon.2010.08.005; Di Pierro E, 2008, ECOL RES, V23, P529, DOI 10.1007/s11284-007-0401-0; Donovan TM, 2011, BIOL CONSERV, V144, P2799, DOI 10.1016/j.biocon.2011.06.026; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Franklin CE, 2009, MAR FRESHWATER RES, V60, P284, DOI 10.1071/MF08153; Fukuda Y, 2010, SALTWATER CROCODILE; Fukuda Y, 2007, WILDLIFE RES, V34, P167, DOI 10.1071/WR06110; Fukuda Y, 2011, J WILDLIFE MANAGE, V75, P1253, DOI 10.1002/jwmg.191; GOODWIN TM, 1979, J HERPETOL, V13, P157, DOI 10.2307/1563922; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; JOHNSON CR, 1973, ZOOL J LINN SOC-LOND, V52, P315, DOI 10.1111/j.1096-3642.1973.tb01887.x; Kay W, 2005, POPULATION ECOLOGY C; Kay WR, 2004, WILDLIFE RES, V31, P495, DOI 10.1071/WR04037; Keitt TH, 2012, RGDAL BINDINGS GEOSP; Krebs JR., 1997, BEHAV ECOLOGY EVOLUT; Lang JW, 1987, CROCODILES ALLIGATOR, P279; Letnic M, 2006, WILDLIFE RES, V33, P529, DOI 10.1071/WR05090; Lewis JL, 2012, J HERPETOLO IN PRESS; MACDONALD DW, 1982, COMP IMMUNOL MICROB, V5, P247, DOI 10.1016/0147-9571(82)90045-5; MAGNUSSON WE, 1980, AUST WILDLIFE RES, V7, P149; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; Messel H, 1980, SURVEYS TIDAL WATERW; R Development Core Team, 2010, R LANG ENV STAT COMP; Read MA, 2004, WILDLIFE RES, V31, P527, DOI 10.1071/WR02025; Read MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000949; Reid ML, 1997, AM NAT, V150, P98, DOI 10.1086/286058; Robles CI, 2010, HERPETOL J, V20, P243; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Rooney SM, 1998, MAMMAL REV, V28, P89, DOI 10.1046/j.1365-2907.1998.00028.x; Rosenblatt AE, 2011, J ANIM ECOL, V80, P786, DOI 10.1111/j.1365-2656.2011.01830.x; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Sullivan S, 2010, REPORT DISTRIBUTION; Taborsky M, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P537, DOI 10.1007/978-3-642-02624-9_18; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tucker AD, 1997, J HERPETOL, V31, P114, DOI 10.2307/1565339; van Etten J., 2011, GDISTANCE DISTANCES; Vokoun JC, 2003, N AM J FISH MANAGE, V23, P1020, DOI 10.1577/M02-141; Walsh B., 1987, P249; Webb G., 1989, CROCODILES AUSTR; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P263, DOI 10.1071/WR9780263; WEBB GJW, 1977, COPEIA, P238; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959	51	42	46	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62127	10.1371/journal.pone.0062127	http://dx.doi.org/10.1371/journal.pone.0062127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650510	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000030
J	Chen, YJJ; Vogt, D; Wang, YL; Visel, A; Silberberg, SN; Nicholas, CR; Danjo, T; Pollack, JL; Pennacchio, LA; Anderson, S; Sasai, Y; Baraban, SC; Kriegstein, AR; Alvarez-Buylla, A; Rubenstein, JLR				Chen, Ying-Jiun J.; Vogt, Daniel; Wang, Yanling; Visel, Axel; Silberberg, Shanni N.; Nicholas, Cory R.; Danjo, Teruko; Pollack, Joshua L.; Pennacchio, Len A.; Anderson, Stewart; Sasai, Yoshiki; Baraban, Scott C.; Kriegstein, Arnold R.; Alvarez-Buylla, Arturo; Rubenstein, John L. R.			Use of ''MGE Enhancers'' for Labeling and Selection of Embryonic Stem Cell-Derived Medial Ganglionic Eminence (MGE) Progenitors and Neurons	PLOS ONE			English	Article							HOMEOBOX GENE; INTERNEURON PRECURSORS; GABAERGIC INTERNEURONS; SUBVENTRICULAR ZONE; SPECIFICATION; EXPRESSION; ADULT; FOREBRAIN; DIFFERENTIATION; REQUIREMENT	The medial ganglionic eminence (MGE) is an embryonic forebrain structure that generates the majority of cortical interneurons. MGE transplantation into specific regions of the postnatal central nervous system modifies circuit function and improves deficits in mouse models of epilepsy, Parkinson's disease, pain, and phencyclidine-induced cognitive deficits. Herein, we describe approaches to generate MGE-like progenitor cells from mouse embryonic stem (ES) cells. Using a modified embryoid body method, we provided gene expression evidence that mouse ES-derived Lhx6(+) cells closely resemble immature interneurons generated from authentic MGE-derived Lhx6(+) cells. We hypothesized that enhancers that are active in the mouse MGE would be useful tools in detecting when ES cells differentiate into MGE cells. Here we demonstrate the utility of enhancer elements [422 (DlxI12b), Lhx6, 692, 1056, and 1538] as tools to mark MGE-like cells in ES cell differentiation experiments. We found that enhancers DlxI12b, 692, and 1538 are active in Lhx6-GFP(+) cells, while enhancer 1056 is active in Olig2(+) cells. These data demonstrate unique techniques to follow and purify MGE-like derivatives from ES cells, including GABAergic cortical interneurons and oligodendrocytes, for use in stem cell-based therapeutic assays and treatments.	[Chen, Ying-Jiun J.; Vogt, Daniel; Wang, Yanling; Silberberg, Shanni N.; Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Chen, Ying-Jiun J.; Vogt, Daniel; Wang, Yanling; Silberberg, Shanni N.; Rubenstein, John L. R.] Univ Calif San Francisco, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA; [Visel, Axel; Pennacchio, Len A.] Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA USA; [Visel, Axel; Pennacchio, Len A.] Dept Energy Joint Genome Inst, Walnut Creek, CA USA; [Anderson, Stewart] Univ Penn, Sch Med, Childrens Hosp Philadelphia 3, Philadelphia, PA 19104 USA; [Pollack, Joshua L.; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Neurogenesis & Organogenesis Grp, Kobe, Hyogo, Japan; [Baraban, Scott C.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Nicholas, Cory R.; Kriegstein, Arnold R.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [Pollack, Joshua L.] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; RIKEN; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chen, YJJ (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	nyc600@gmail.com; john.rubenstein@ucsf.edu	Visel, Axel/A-9398-2009	Visel, Axel/0000-0002-4130-7784; /0000-0002-8589-4239; Pennacchio, Len/0000-0002-8748-3732; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Vogt, Daniel/0000-0003-1876-5936	California Institute of Regenerative Medicine; Weston Havens Foundation; Brain & Behavior Research foundation [NIMH R01 MH081880, NIMH R37 MH049428]; Nina Ireland; NIH/NCRR UCSF-CTSI [UL1 RR024131];  [NINDS R01 NS062859A];  [NHGRI R01 HG003988];  [NINDS R01 NS071785]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049428, R01MH081880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071785] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Weston Havens Foundation; Brain & Behavior Research foundation(NARSAD); Nina Ireland; NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the research grants to JLRR from California Institute of Regenerative Medicine, Nina Ireland, Weston Havens Foundation, and NIMH R01 MH081880, and NIMH R37 MH049428; to YJC from Brain & Behavior Research foundation (formerly National Alliance for Research on Schizophrenia and Depression); NINDS R01 NS062859A and NHGRI R01 HG003988 to AV and LAP; NINDS R01 NS071785 to SCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The RNA microarray was done at the Sandler Asthma Basic Research Center Functional Genomics Core Facility (NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131; core director: David Erle, core manager: Andrea Barczak, Core Analyst: Joshua Pollack, Core staff: Rebecca Barbeau). LAP and AV conducted research at the E.O. Lawrence Berkeley National Laboratory, performed under DOE DE-AC02-05CH11231, University of California.	Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Bardet SM, 2008, BRAIN RES BULL, V75, P231, DOI 10.1016/j.brainresbull.2007.10.037; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Braz JM, 2012, NEURON, V74, P663, DOI 10.1016/j.neuron.2012.02.033; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Chen L, 2010, J NEUROSCI, V30, P14824, DOI 10.1523/JNEUROSCI.3742-10.2010; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Daadi MM, 2009, CELL TRANSPLANT, V18, P815, DOI 10.3727/096368909X470829; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; De la Cruz E, 2011, NEUROTHERAPEUTICS, V8, P763, DOI 10.1007/s13311-011-0058-9; Du TG, 2008, DEVELOPMENT, V135, P1559, DOI 10.1242/dev.015123; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Elshatory Y, 2008, J NEUROSCI, V28, P3291, DOI 10.1523/JNEUROSCI.5730-07.2008; Fischer AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010774; Flandin P, 2011, NEURON, V70, P939, DOI 10.1016/j.neuron.2011.04.020; Flandin P, 2010, J NEUROSCI, V30, P2812, DOI 10.1523/JNEUROSCI.4228-09.2010; Fragkouli A, 2009, DEVELOPMENT, V136, P3841, DOI 10.1242/dev.038083; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gelman D, 2011, J NEUROSCI, V31, P16570, DOI 10.1523/JNEUROSCI.4068-11.2011; Ghanem N, 2007, J NEUROSCI, V27, P5012, DOI 10.1523/JNEUROSCI.4725-06.2007; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; Kuwajima T, 2006, J NEUROSCI, V26, P5383, DOI 10.1523/JNEUROSCI.1262-06.2006; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Maroof AM, 2010, J NEUROSCI, V30, P4667, DOI 10.1523/JNEUROSCI.4255-09.2010; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; McKinsey GL, 2013, NEURON, V77, P83, DOI 10.1016/j.neuron.2012.11.035; Medina-Martinez O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004513; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Polley DB, 2006, HEARING RES, V214, P84, DOI 10.1016/j.heares.2006.02.008; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Sebe JY, 2011, DEV NEUROBIOL, V71, P107, DOI 10.1002/dneu.20813; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Stanley EM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.014; Stuhmer T, 2002, CEREB CORTEX, V12, P75, DOI 10.1093/cercor/12.1.75; Sussel L, 1999, DEVELOPMENT, V126, P3359; Tanaka DH, 2011, J NEUROSCI, V31, P14116, DOI 10.1523/JNEUROSCI.2786-11.2011; Turksen K, 2006, METH MOL B, V331, P1; VISEL A, 2013, CELL            0131; Waldau B, 2010, STEM CELLS, V28, P1153, DOI 10.1002/stem.446; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhao Y, 2008, J COMP NEUROL, V510, P79, DOI 10.1002/cne.21772; Zipancic I, 2010, CELL TRANSPLANT, V19, P549, DOI 10.3727/096368910X491383	68	21	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61956	10.1371/journal.pone.0061956	http://dx.doi.org/10.1371/journal.pone.0061956			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658702	Green Submitted, gold, Green Published			2022-12-25	WOS:000319167000024
J	Katargina, O; Russakova, S; Geller, J; Kondrusik, M; Zajkowska, J; Zygutiene, M; Bormane, A; Trofimova, J; Golovljova, I				Katargina, Olga; Russakova, Stanislava; Geller, Julia; Kondrusik, Macije; Zajkowska, Joanna; Zygutiene, Milda; Bormane, Antra; Trofimova, Julia; Golovljova, Irina			Detection and Characterization of Tick-Borne Encephalitis Virus in Baltic Countries and Eastern Poland	PLOS ONE			English	Article							SOUTH-KOREA; MITOCHONDRIAL-DNA; LATVIA; EPIDEMIOLOGY; FLAVIVIRUSES; LITHUANIA; FOCI	Ticks were collected from the vegetation in the Baltic countries Estonia, Latvia, Lithuania and eastern Poland and analyzed for the presence of tick-borne encephalitis virus (TBEV) by amplification of the partial E and NS3 genes. In Estonia we found statistically significant differences in the TBEV prevalence between I. persulcatus and I. ricinus ticks (4.23% and 0.42%, respectively). In Latvia, the difference in TBEV prevalence between the two species was not statistically significant (1.02% for I. persulcatus and 1.51% for I. ricinus, respectively). In Lithuania and Poland TBEV was detected in 0.24% and 0.11% of I. ricinus ticks, respectively. Genetic characterization of the partial E and NS3 sequences demonstrated that the TBEV strains belonged to the European subtype in all countries, as well as to the Siberian subtype in Estonia. We also found that in areas where ranges of two tick species overlap, the TBEV subtypes may be detected not only in their natural vector, but also in sympatric tick species.	[Katargina, Olga; Russakova, Stanislava; Geller, Julia; Golovljova, Irina] Natl Inst Hlth Dev, Dept Virol, Tallinn, Estonia; [Geller, Julia] Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia; [Kondrusik, Macije; Zajkowska, Joanna] Med Univ, Dept Infect Dis & Neuroinfect, Bialystok, Poland; [Zygutiene, Milda] Ctr Communicable Dis & AIDS, Dept Epidemiol Surveillance, Vilnius, Lithuania; [Bormane, Antra] Ctr Dis Prevent & Control Latvia, Infect Dis Surveillance & Immunisat Unit, Riga, Latvia; [Trofimova, Julia] East Univ Hosp, Latvian Ctr Infect Dis, Mol Biol Bacterial Infect Unit, Riga, Latvia	National Institute for Health Development - Estonia; Tallinn University of Technology; Medical University of Bialystok; Centre for Communicable Diseases & AIDS (ULAC) - Lithuania	Golovljova, I (corresponding author), Natl Inst Hlth Dev, Dept Virol, Tallinn, Estonia.	irina.golovljova@tai.ee	Geller, Julia/A-7889-2019	Geller, Julia/0000-0001-6496-9687; Kondrusik, Maciej/0000-0002-6376-5604	European Union [Goce-2003-010284 EDEN]; Estonian Science Foundation [ETF 8691]; Estonian Ministry of Education and Research [SF0940033s09]; European Regional Development Fund (Estonian Research Council, programme TerVE) [3.2.1002.11-0002]	European Union(European Commission); Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Regional Development Fund (Estonian Research Council, programme TerVE)(Estonian Research Council)	This work was supported by the the European Union Grant Goce-2003-010284 EDEN, the Estonian Science Foundation (Grant ETF 8691), Estonian Ministry of Education and Research (project SF0940033s09) and the European Regional Development Fund (Estonian Research Council, programme TerVE, project ZoonRisk 3.2.1002.11-0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEKSEEV AN, 1993, ZH MIKROB EPID IMMUN, P113; Caporale DA, 1995, MOL PHYLOGENET EVOL, V4, P361, DOI 10.1006/mpev.1995.1033; Demina TV, 2010, J MED VIROL, V82, P965, DOI 10.1002/jmv.21765; Dobler G, 2008, INT J MED MICROBIOL, V298, P94, DOI 10.1016/j.ijmm.2008.03.011; Durmisi E, 2011, VECTOR-BORNE ZOONOT, V11, P659, DOI 10.1089/vbz.2010.0054; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; Evstafyev I. L., 2001, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P111; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Geller J, 2012, VECTOR BORN IN PRESS; Golovljova I, 2004, J MED VIROL, V74, P580, DOI 10.1002/jmv.20224; GOLOVLJOVA I, 2008, INT J MED MICROBIOL; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Hall TA, 1999, NUCL ACIDS S; Han HQ, 2001, J MED VIROL, V64, P21, DOI 10.1002/jmv.1012; Han XQ, 2005, J MED VIROL, V77, P249, DOI 10.1002/jmv.20444; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Jaaskelainen AE, 2011, EMERG INFECT DIS, V17, P323, DOI 10.3201/eid1702.101487; Karelis G, 2012, EUR J NEUROL, V19, P62, DOI 10.1111/j.1468-1331.2011.03434.x; Khasnatinov MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007295; Kim SY, 2009, MED VET ENTOMOL, V23, P15, DOI 10.1111/j.1365-2915.2008.00755.x; Kim SY, 2008, VECTOR-BORNE ZOONOT, V8, P7, DOI 10.1089/vbz.2006.0634; KISLENKO GS, 1987, PARAZITOLOGIYA+, V21, P730; Ko S, 2010, J VET SCI, V11, P197, DOI 10.4142/jvs.2010.11.3.197; Korenberg E.I., 1999, Parazitologiya (St. Petersburg), V33, P273; KOZUCH O, 1990, ACTA VIROL, V34, P537; LABUDA M, 1993, MED VET ENTOMOL, V7, P339, DOI 10.1111/j.1365-2915.1993.tb00702.x; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Lundkvist A, 2001, J MED VIROL, V65, P730, DOI 10.1002/jmv.2097; Mavtchoutko V, 2000, J MED VIROL, V60, P216, DOI 10.1002/(SICI)1096-9071(200002)60:2&lt;216::AID-JMV18&gt;3.0.CO;2-Z; Mickiene A, 2001, EUR J CLIN MICROBIOL, V20, P886, DOI 10.1007/s10096-001-0637-5; Pogodina V. V., 2005, Voprosy Virusologii, V50, P7; Randolph S, 1999, TROP MED INT HEALTH, V4, pA34, DOI 10.1046/j.1365-3156.1999.00449.x; Rice MC., 2007, FIELDS VIROLOGY, P1112; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schwaiger M, 2003, J CLIN VIROL, V27, P136, DOI 10.1016/S1386-6532(02)00168-3; Skarpaas T, 2006, EMERG INFECT DIS, V12, P1136, DOI 10.3201/eid1207.051567; Suess J, 2006, INT J MED MICROBIOL, V296, P63, DOI 10.1016/j.ijmm.2005.12.005; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; Suss J, 2003, VACCINE, V21, pS19, DOI 10.1016/S0264-410X(02)00812-5; Suss J, 2002, INT J MED MICROBIOL, V291, P34; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wojcik-Fatla A, 2011, TICKS TICK-BORNE DIS, V2, P16, DOI 10.1016/j.ttbdis.2010.10.001; Yun SM, 2009, VECTOR-BORNE ZOONOT, V9, P287, DOI 10.1089/vbz.2008.0085	43	36	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61374	10.1371/journal.pone.0061374	http://dx.doi.org/10.1371/journal.pone.0061374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650497	gold, Green Published, Green Submitted			2022-12-25	WOS:000319167000012
J	de Jager, CPC; Gemen, EFA; Leuvenink, J; Hilbink, M; Laheij, RJF; van der Poll, T; Wever, PC				de Jager, Cornelis P. C.; Gemen, Eugenie F. A.; Leuvenink, Jacqueline; Hilbink, Mirrian; Laheij, Robert J. F.; van der Poll, Tom; Wever, Peter C.			Dynamics of Peripheral Blood Lymphocyte Subpopulations in the Acute and Subacute Phase of Legionnaires' Disease	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; LEGIONELLA-PNEUMOPHILA; SEPTIC SHOCK; CELL-DEATH; SEPSIS; INFECTION; APOPTOSIS; BACTEREMIA; DIAGNOSIS; PROTEIN	Study Objective: Absolute lymphocytopenia is recognised as an important hallmark of the immune response to severe infection and observed in patients with Legionnaires' disease. To explore the immune response, we studied the dynamics of peripheral blood lymphocyte subpopulations in the acute and subacute phase of LD. Methods and Results: EDTA-anticoagulated blood was obtained from eight patients on the day the diagnosis was made through detection of L. pneumophila serogroup 1 antigen in urine. A second blood sample was obtained in the subacute phase. Multiparametric flow cytometry was used to calculate lymphocyte counts and values for B-cells, T-cells, NK cells, CD4(+) and CD8(+) T-cells. Expression of activation markers was analysed. The values obtained in the subacute phase were compared with an age and gender matched control group. Absolute lymphocyte count (x10(9)/l, median and range) significantly increased from 0.8 (0.4-1.6) in the acute phase to 1.4 (0.8-3.4) in the subacute phase. B-cell count showed no significant change, while T-cell count (x10(6)/l, median and range) significantly increased in the subacute phase (495 (182-1024) versus 979 (507-2708), p = 0.012) as a result of significant increases in both CD4(+) and CD8(+) T-cell counts (374 (146-629) versus 763 (400-1507), p = 0.012 and 119 (29-328) versus 224 (107-862), p = 0.012). In the subacute phase of LD, significant increases were observed in absolute counts of activated CD4(+) T-cells, naive CD4(+) T-cells and memory CD4(+) T-cells. In the CD8(+) T-cell compartment, activated CD8(+) T-cells, naive CD8(+) T-cell and memory CD8(+) T-cells were significantly increased (p<0.05). Conclusion: The acute phase of LD is characterized by absolute lymphocytopenia, which recovers in the subacute phase with an increase in absolute T-cells and re-emergence of activated CD4(+) and CD8(+) T cells. These observations are in line with the suggested role for T-cell activation in the immune response to LD.	[de Jager, Cornelis P. C.; Laheij, Robert J. F.] Jeroen Bosch Hosp, Dept Emergency Med & Intens Care, sHertogenbosch, Netherlands; [Gemen, Eugenie F. A.; Leuvenink, Jacqueline] Jeroen Bosch Hosp, Dept Clin Chem & Hematol, sHertogenbosch, Netherlands; [Hilbink, Mirrian] Jeroen Bosch Hosp, Jeroen Bosch Acad, sHertogenbosch, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1012 WX Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1012 WX Amsterdam, Netherlands; [Wever, Peter C.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, sHertogenbosch, Netherlands	Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Jeroen Bosch Ziekenhuis	de Jager, CPC (corresponding author), Jeroen Bosch Hosp, Dept Emergency Med & Intens Care, sHertogenbosch, Netherlands.	p.de.jager@jbz.nl						Ayala A, 1996, BLOOD, V87, P4261, DOI 10.1182/blood.V87.10.4261.bloodjournal87104261; Bisset LR, 2004, EUR J HAEMATOL, V72, P203, DOI 10.1046/j.0902-4441.2003.00199.x; BLANDER SJ, 1991, J CLIN INVEST, V87, P1054, DOI 10.1172/JCI115065; BRIELAND J, 1994, AM J PATHOL, V145, P1537; Brieland JK, 1996, J IMMUNOL, V157, P5002; Cunha BA, 2008, HEART LUNG, V37, P311, DOI 10.1016/j.hrtlng.2007.12.003; de Jager CPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046561; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; Den Boer JW, 2004, EUR J CLIN MICROBIOL, V23, P871, DOI 10.1007/s10096-004-1248-8; Diederen BMW, 2008, J INFECTION, V56, P1, DOI 10.1016/j.jinf.2007.09.010; Euser SM, 2012, EUR J CLIN MICROBIOL; *EWGLI, 2003, EUR GUID CONTR PREV; Fantin B, 1996, CLIN INFECT DIS, V22, P1096, DOI 10.1093/clinids/22.6.1096; Gacouin A, 2002, INTENS CARE MED, V28, P686, DOI 10.1007/s00134-002-1304-8; Gogos C, 2010, CRIT CARE, V14, DOI 10.1186/cc9031; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hotchkiss RS, 2005, J IMMUNOL, V174, P5110, DOI 10.4049/jimmunol.174.8.5110; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Joshi VD, 2003, FEBS LETT, V555, P180, DOI 10.1016/S0014-5793(03)01271-7; Kraan J, 2003, J BIOL REG HOMEOS AG, V17, P223; LAURENCE J, 1993, ANN INTERN MED, V119, P55, DOI 10.7326/0003-4819-119-1-199307010-00010; Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/00024382-200212000-00001; Lee KY, 2006, PEDIATR PULM, V41, P263, DOI 10.1002/ppul.20374; Lee KY, 2012, YONSEI MED J, V53, P262, DOI 10.3349/ymj.2012.53.2.262; Lee KY, 2011, MED HYPOTHESES, V76, P64, DOI 10.1016/j.mehy.2010.08.032; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; NASH TW, 1988, J IMMUNOL, V140, P3978; Rello J, 2012, MED INTENSIVA; Roy S, 2000, J EXP MED, V192, pF21, DOI 10.1084/jem.192.8.F21; Schouten JA, 2005, NETH J MED, V63, P323; Susa M, 1998, J IMMUNOL, V160, P316; Tanaka H, 1996, EUR RESPIR J, V9, P669, DOI 10.1183/09031936.96.09040669; Tateda K, 1998, CLIN DIAGN LAB IMMUN, V5, P401, DOI 10.1128/CDLI.5.3.401-403.1998; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Trisolini R, 2004, RESP MED, V98, P1222, DOI 10.1016/j.rmed.2004.04.015; Unsinger J, 2009, J LEUKOCYTE BIOL, V85, P382, DOI 10.1189/jlb.0808491; van de Veerdonk FL, 2009, EUR J CLIN MICROBIOL, V28, P371, DOI 10.1007/s10096-008-0638-8; Viasus D, 2013, MEDICINE, V92, P51, DOI 10.1097/MD.0b013e31827f6104; von Baum H, 2011, BUNDESGESUNDHEITSBLA, V54, P688, DOI 10.1007/s00103-011-1287-0; Wever PC, 2000, J CLIN MICROBIOL, V38, P2738, DOI 10.1128/JCM.38.7.2738-2739.2000; WILLIAMS RC, 1983, AM J MED, V75, P807, DOI 10.1016/0002-9343(83)90412-6; WOODHEAD MA, 1986, THORAX, V41, P635, DOI 10.1136/thx.41.8.635; Wyllie DH, 2005, J CLIN PATHOL, V58, P352, DOI 10.1136/jcp.2004.022293; Wyllie DH, 2004, J CLIN PATHOL, V57, P950, DOI 10.1136/jcp.2004.017335; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	47	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62265	10.1371/journal.pone.0062265	http://dx.doi.org/10.1371/journal.pone.0062265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646123	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300035
J	Navarro, J; Votier, SC; Aguzzi, J; Chiesa, JJ; Forero, MG; Phillips, RA				Navarro, Joan; Votier, Stephen C.; Aguzzi, Jacopo; Chiesa, Juan J.; Forero, Manuela G.; Phillips, Richard A.			Ecological Segregation in Space, Time and Trophic Niche of Sympatric Planktivorous Petrels	PLOS ONE			English	Article							COMMON DIVING PETRELS; MAXIMUM DIVE DEPTHS; FEEDING ECOLOGY; SOUTH-GEORGIA; PELECANOIDES-GEORGICUS; HALOBAENA-CAERULEA; SEABIRD COMMUNITY; ANTARCTIC KRILL; ILES-KERGUELEN; BLUE PETRELS	The principle of competitive exclusion postulates that ecologically-similar species are expected to partition their use of resources, leading to niche divergence. The most likely mechanisms allowing such coexistence are considered to be segregation in a horizontal, vertical or temporal dimension, or, where these overlap, a difference in trophic niche. Here, by combining information obtained from tracking devices (geolocator-immersion and time depth recorders), stable isotope analyses of blood, and conventional morphometry, we provide a detailed investigation of the ecological mechanisms that explain the coexistence of four species of abundant, zooplanktivorous seabirds in Southern Ocean ecosystems (blue petrel Halobaena caerulea, Antarctic prion Pachyptila desolata, common diving petrel Pelecanoides urinatrix and South Georgian diving petrel P. georgicus). The results revealed a combination of horizontal, vertical and temporal foraging segregation during the breeding season. The stable isotope and morphological analyses reinforced this conclusion, indicating that each species occupied a distinct trophic space, and that this appears to reflect adaptations in terms of flight performance. In conclusion, the present study indicated that although there was a degree of overlap in some measures of foraging behaviour, overall the four taxa operated in very different ecological space despite breeding in close proximity. We therefore provide important insight into the mechanisms allowing these very large populations of ecologically-similar predators to coexist.	[Navarro, Joan; Aguzzi, Jacopo] CSIC, ICM, Barcelona, Spain; [Votier, Stephen C.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Chiesa, Juan J.] Univ Nacl Quilmes, CONICET, Dept Ciencia & Tecnol, Lab Cronobiol, Buenos Aires, DF, Argentina; [Forero, Manuela G.] CSIC, EBD, Dept Biol Conservac, E-41080 Seville, Spain; [Phillips, Richard A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Plymouth; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Navarro, J (corresponding author), CSIC, ICM, Barcelona, Spain.	joan@icm.csic.es	Navarro, Joan/C-2119-2009; Votier, Stephen C/G-2348-2014; Aguzzi, Jacopo/D-6574-2012	Navarro, Joan/0000-0002-5756-9543; Votier, Stephen C/0000-0002-0976-0167; Aguzzi, Jacopo/0000-0002-1484-8219	Juan de la Cierva program (Spanish Ministry of Economy and Competitiveness); Ramon y Cajal program (Spanish Ministry of Economy and Competitiveness); NERC [bas0100025, NE/I023503/1] Funding Source: UKRI; Natural Environment Research Council [bas0100025, NE/I023503/1] Funding Source: researchfish	Juan de la Cierva program (Spanish Ministry of Economy and Competitiveness); Ramon y Cajal program (Spanish Ministry of Economy and Competitiveness); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Logistical support in Bird Island was provided by the Collaborative Gearing Scheme of the Natural Environment Research Council Antarctic Funding Initiative (AFI-NERC). JN and JA were supported by a postdoctoral contract of the Juan de la Cierva program and Ramon y Cajal program, respectively (Spanish Ministry of Economy and Competitiveness). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi J, 2010, MAR ECOL PROG SER, V418, P47, DOI 10.3354/meps08835; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Batschelet E, 1981, CIRCULAR STAT BIOL; Bocher P, 2000, J ZOOL, V251, P517, DOI 10.1111/j.1469-7998.2000.tb00807.x; Bocher P, 2000, MAR ECOL PROG SER, V208, P249, DOI 10.3354/meps208249; Brooke M, 2004, ALBATROSSES PETRELS; BROOKE MD, 1989, IBIS, V131, P290, DOI 10.1111/j.1474-919X.1989.tb02772.x; BURGER AE, 1988, J FIELD ORNITHOL, V59, P345; CHASTEL O, 1994, POLAR BIOL, V14, P211; Chastel O, 1996, CONDOR, V98, P627, DOI 10.2307/1369575; Cherel Y, 2008, MAR ECOL PROG SER, V366, P281, DOI 10.3354/meps07587; Cherel Y, 2006, BIOL LETTERS, V2, P301, DOI 10.1098/rsbl.2006.0445; Cherel Y, 2002, MAR ECOL PROG SER, V228, P263, DOI 10.3354/meps228263; Cherel Y, 2002, MAR ECOL PROG SER, V228, P283, DOI 10.3354/meps228283; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Collins MA, 2012, DEEP-SEA RES PT II, V59, P189, DOI 10.1016/j.dsr2.2011.07.003; CROXALL JP, 1980, BIOL J LINN SOC, V14, P103, DOI 10.1111/j.1095-8312.1980.tb00101.x; Croxall JP, 1997, J ZOOL, V242, P531, DOI 10.1111/j.1469-7998.1997.tb03854.x; Elliott KH, 2009, WATERBIRDS, V32, P183, DOI 10.1675/063.032.0123; Forero MG, 2004, J ANIM ECOL, V73, P789, DOI 10.1111/j.0021-8790.2004.00852.x; Gause G., 1973, STRUGGLE EXISTENCE; Grant P.R., 1975, J EVOLUTION BIOL, V8, P237; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Guinet C, 1996, ANTARCT SCI, V8, P23, DOI 10.1017/S0954102096000053; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Luque SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015850; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Martin GR, 2001, BRAIN BEHAV EVOLUT, V57, P33, DOI 10.1159/000047224; MASELLO JF, 2012, MAR BIOL, V159, P1809; Masello JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00103.1; Navarro J, 2009, BIOL LETTERS, V5, P545, DOI 10.1098/rsbl.2009.0150; Passos C, 2010, AUK, V127, P100, DOI 10.1525/auk.2009.09036; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Phalan B, 2007, MAR ECOL PROG SER, V340, P271, DOI 10.3354/meps340271; Phillips RA, 2007, AQUAT CONSERV, V17, pS6, DOI 10.1002/aqc.906; Phillips RA, 2005, MAR ECOL PROG SER, V285, P259, DOI 10.3354/meps285259; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips RA, 2011, MAR BIOL, V158, P2199, DOI 10.1007/s00227-011-1725-4; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; Pianka E. R., 2000, EVOLUTIONARY ECOLOGY; PRINCE PA, 1980, J ZOOL, V190, P59, DOI 10.1111/j.1469-7998.1980.tb01423.x; PRINCE PA, 1992, ANTARCT SCI, V4, P433, DOI 10.1017/S0954102092000646; Prince PA., 1982, B BR ANTARCT SURV, V56, P49; Ramos R, 2012, FRONT ECOL ENVIRON, V10, P258, DOI 10.1890/110140; Regular PM, 2010, MAR ECOL PROG SER, V415, P295, DOI 10.3354/meps08752; Reid K, 1997, POLAR BIOL, V17, P17, DOI 10.1007/s003000050100; Schmidt K, 2003, LIMNOL OCEANOGR, V48, P277, DOI 10.4319/lo.2003.48.1.0277; Schmidt K, 2006, LIMNOL OCEANOGR, V51, P2409, DOI 10.4319/lo.2006.51.5.2409; Schreiber EA, 2001, BIOL MARINE BIRDS; Shepard ELC, 2006, MAR ECOL PROG SER, V328, P205, DOI 10.3354/meps328205; VEIT RR, 1993, J ANIM ECOL, V62, P551, DOI 10.2307/5204; WEIMERSKIRCH H, 1986, IBIS, V128, P195, DOI 10.1111/j.1474-919X.1986.tb02669.x; Wilson RP, 2010, FUNCT ECOL, V24, P646, DOI 10.1111/j.1365-2435.2009.01654.x	56	93	99	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62897	10.1371/journal.pone.0062897	http://dx.doi.org/10.1371/journal.pone.0062897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646155	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000319077300109
J	Christensen, NJ; Kepp, KP				Christensen, Niels J.; Kepp, Kasper P.			Stability Mechanisms of a Thermophilic Laccase Probed by Molecular Dynamics	PLOS ONE			English	Article							ENTHALPY-ENTROPY COMPENSATION; TRAMETES-VERSICOLOR; THERMAL-STABILITY; PROTEIN STABILITY; ERYTHRINA-CORALLODENDRON; DIHYDROFOLATE-REDUCTASE; STRUCTURAL FEATURES; POTENTIAL FUNCTIONS; CRYSTAL-STRUCTURE; ION-PAIRS	Laccases are highly stable, industrially important enzymes capable of oxidizing a large range of substrates. Causes for their stability are, as for other proteins, poorly understood. In this work, multiple-seed molecular dynamics (MD) was applied to a Trametes versicolor laccase in response to variable ionic strengths, temperatures, and glycosylation status. Near-physiological conditions provided excellent agreement with the crystal structure (average RMSD similar to 0.92 angstrom) and residual agreement with experimental B-factors. The persistence of backbone hydrogen bonds was identified as a key descriptor of structural response to environment, whereas solvent-accessibility, radius of gyration, and fluctuations were only locally relevant. Backbone hydrogen bonds decreased systematically with temperature in all simulations (similar to 9 per 50 K), probing structural changes associated with enthalpy-entropy compensation. Approaching T-opt (similar to 350 K) from 300 K, this change correlated with a beginning "unzipping" of critical beta-sheets. 0 M ionic strength triggered partial denucleation of the C-terminal (known experimentally to be sensitive) at 400 K, suggesting a general salt stabilization effect. In contrast, F- (but not Cl-) specifically impaired secondary structure by formation of strong hydrogen bonds with backbone NH, providing a mechanism for experimentally observed small anion destabilization, potentially remedied by site-directed mutagenesis at critical intrusion sites. N-glycosylation was found to support structural integrity by increasing persistent backbone hydrogen bonds by similar to 4 across simulations, mainly via prevention of F- intrusion. Hydrogen-bond loss in distinct loop regions and ends of critical beta-sheets suggest potential strategies for laboratory optimization of these industrially important enzymes.	[Christensen, Niels J.; Kepp, Kasper P.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark	Technical University of Denmark	Kepp, KP (corresponding author), Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark.	kpj@kemi.dtu.dk	Kepp, Kasper Planeta/G-1748-2013; Christensen, Niels Johan/J-3820-2014; Kepp, Kasper P./AAA-4626-2021	Kepp, Kasper Planeta/0000-0002-6754-7348; Christensen, Niels Johan/0000-0001-9588-2656; Kepp, Kasper P./0000-0002-6754-7348	Danish Agency for Science, Technology, and Innovation; Technical Science Council (FTP) [10-082488]	Danish Agency for Science, Technology, and Innovation; Technical Science Council (FTP)	The authors acknowledge support from the Danish Agency for Science, Technology, and Innovation, the Technical Science Council (FTP), grant no. 10-082488 (http://en.fi.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MAESTRO DESMOND INTE; [Anonymous], 2011, MAESTRO 9 2; [Anonymous], 2011, DESM MOL DYN SYST 3; Autore F, 2009, ENZYME MICROB TECH, V45, P507, DOI 10.1016/j.enzmictec.2009.08.004; Bae E, 2005, J BIOL CHEM, V280, P30943, DOI 10.1074/jbc.M504216200; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Canas AI, 2010, BIOTECHNOL ADV, V28, P694, DOI 10.1016/j.biotechadv.2010.05.002; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Chen JM, 2001, BIOCHEMISTRY-US, V40, P15280, DOI 10.1021/bi011776v; Colombo G, 1999, J AM CHEM SOC, V121, P6895, DOI 10.1021/ja990420s; Damm W, 1997, J COMPUT CHEM, V18, P1955, DOI 10.1002/(SICI)1096-987X(199712)18:16<1955::AID-JCC1>3.0.CO;2-L; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; Drabik P, 2001, PROTEIN ENG, V14, P747, DOI 10.1093/protein/14.10.747; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Festa G, 2008, PROTEINS, V72, P25, DOI 10.1002/prot.21889; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fu HL, 2009, PROTEINS, V77, P491, DOI 10.1002/prot.22509; Gelo-Pujic M, 1999, APPL ENVIRON MICROB, V65, P5515; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Glykos NM, 2007, ACTA CRYSTALLOGR D, V63, P705, DOI 10.1107/S0907444907014928; Gruia AD, 2003, PROTEINS, V50, P507, DOI 10.1002/prot.10312; GRUNWALD E, 1995, J AM CHEM SOC, V117, P5687, DOI 10.1021/ja00126a009; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hilden K, 2009, BIOTECHNOL LETT, V31, P1117, DOI 10.1007/s10529-009-9998-0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; Ibragimova GT, 1999, BIOPHYS J, V77, P2191, DOI 10.1016/S0006-3495(99)77059-1; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Jensen KP, 2006, J CHEM THEORY COMPUT, V2, P1499, DOI 10.1021/ct600252r; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kallio JP, 2011, FEBS J, V278, P2283, DOI 10.1111/j.1742-4658.2011.08146.x; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kaushik S, 2012, J BIOMOL STRUCT DYN, V29, P905, DOI 10.1080/073911012010525026; Kaushik S, 2011, PROTEIN SCI, V20, P465, DOI 10.1002/pro.578; Koschorreck K, 2008, ARCH BIOCHEM BIOPHYS, V474, P213, DOI 10.1016/j.abb.2008.03.009; KRUG RR, 1976, J PHYS CHEM-US, V80, P2341, DOI 10.1021/j100562a007; KRUG RR, 1976, J PHYS CHEM-US, V80, P2335, DOI 10.1021/j100562a006; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Kunamneni A, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-32; LEE B, 1994, BIOPHYS CHEM, V51, P271, DOI 10.1016/0301-4622(94)00048-4; Li WF, 2005, BIOTECHNOL ADV, V23, P271, DOI 10.1016/j.biotechadv.2005.01.002; Liu J, 2008, J MOL GRAPH MODEL, V27, P529, DOI 10.1016/j.jmgm.2008.09.004; Lumry R, 2003, BIOPHYS CHEM, V105, P545, DOI 10.1016/S0301-4622(03)00065-6; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Matsui I, 2007, FEBS J, V274, P4012, DOI 10.1111/j.1742-4658.2007.05956.x; Missimer JH, 2007, PROTEIN SCI, V16, P1349, DOI 10.1110/ps.062542907; Mitra N, 2003, BIOCHEMISTRY-US, V42, P12208, DOI 10.1021/bi035169e; Naidoo KJ, 1997, PROTEIN ENG, V10, P1249, DOI 10.1093/protein/10.11.1249; Necochea R, 2005, FEMS MICROBIOL LETT, V244, P235, DOI 10.1016/j.femsle.2005.01.054; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; PETSKO GA, 1984, ANNU REV BIOPHYS BIO, V13, P331; Pikkemaat MG, 2002, PROTEIN ENG, V15, P185, DOI 10.1093/protein/15.3.185; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Piscitelli Alessandra, 2010, Bioeng Bugs, V1, P252, DOI 10.4161/bbug.1.4.11438; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001; Rulisek L, 2013, COORDIN CHEM REV, V257, P445, DOI 10.1016/j.ccr.2012.04.019; Ruvinsky AM, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3498743; Sedlak E, 2008, P NATL ACAD SCI USA, V105, P19258, DOI 10.1073/pnas.0806431105; Sola RJ, 2007, CELL MOL LIFE SCI, V64, P2133, DOI 10.1007/s00018-007-6551-y; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Swanwick RS, 2005, CHEMBIOCHEM, V6, P1338, DOI 10.1002/cbic.200500103; Tey LH, 2010, FEBS J, V277, P2171, DOI 10.1111/j.1742-4658.2010.07634.x; Tian JA, 2010, FEBS J, V277, P4901, DOI 10.1111/j.1742-4658.2010.07895.x; TIRADORIVES J, 1990, J AM CHEM SOC, V112, P2773, DOI 10.1021/ja00163a046; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Trevino SR, 2007, J MOL BIOL, V373, P211, DOI 10.1016/j.jmb.2007.07.061; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vogt G, 1997, FOLD DES, V2, pS40, DOI 10.1016/S1359-0278(97)00062-X; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1; YOSHITAKE A, 1993, J GEN MICROBIOL, V139, P179, DOI 10.1099/00221287-139-1-179; Zuegg J, 2000, GLYCOBIOLOGY, V10, P959, DOI 10.1093/glycob/10.10.959	78	39	40	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e61985	10.1371/journal.pone.0061985	http://dx.doi.org/10.1371/journal.pone.0061985			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658618	Green Published, Green Submitted, gold			2022-12-25	WOS:000321662800018
J	Das, SK; Ahmed, S; Ferdous, F; Farzana, FD; Chisti, MJ; Leung, DT; Malek, MA; Talukder, KA; Bardhan, PK; Salam, MA; Faruque, AG; Raqib, R				Das, Sumon Kumar; Ahmed, Shahnawaz; Ferdous, Farzana; Farzana, Fahmida Dil; Chisti, Mohammod Jobayer; Leung, Daniel T.; Malek, Mohammad Abdul; Talukder, Kaisar Ali; Bardhan, Pradip Kumar; Salam, Mohammed Abdus; Faruque, Abu Syed Golam; Raqib, Rubhana			Changing Emergence of Shigella Sero-Groups in Bangladesh: Observation from Four Different Diarrheal Disease Hospitals	PLOS ONE			English	Article							PLESIOMONAS-SHIGELLOIDES; SURVEILLANCE; MULTICENTER; CHILDREN; BURDEN	Background: Shigellosis continues to be a public health challenge for developing countries, including Bangladesh. The aim of the study is to demonstrate recent changes in Shigella sero-groups and their geographical diversity. Methods: Data were extracted from data archive of four diarrheal disease surveillance systems. A 2% sub sample from urban Dhaka Hospital (2008-2011; n = 10,650), and 10% from urban Mirpur Treatment Centre (2009-2011; n = 3,585), were enrolled systematically; whereas, all patients coming from the Health and Demographic Surveillance System area in rural Matlab (2008-2011; n = 6,399) and rural Mirzapur (2010-2011; n = 2,812) were included irrespective of age, sex, and disease severity. A fresh stool specimen was collected for identification of Shigella spp. Of them, 315 (3%) were positive for Shigella in Dhaka, 490 (8%) from Matlab, 109 (3%) from Mirpur and 369 (13%) from Mirzapur and considered as analyzable sample size. Results: Among all Shigella isolates regardless of age, significant decreases in percentage of S. flexneri over time was observed in Mirpur (55 -> 29%; p value of chi(2)-for trend = 0.019) and Mirzapur (59 -> 47%; p = 0.025). A non-significant decrease was also seen in Dhaka (58 -> 48%), while in Matlab there was a non-significant increase (73 -> 81%). Similar patterns were observed among under-5 children at all sites. Emergence of S. sonnei was found in Dhaka (8 -> 25%; p<0.001) and Mirpur (10 -> 33%; p = 0.015), whereas it decreased in Mirzapur (32 -> 23%; p = 0.056). The emergence of S. boydii was seen in all ages in Mirzapur [(3 -> 28%; p<0.001); (3 -> 27%; p<0.001)]. On the other hand, we saw non-significant percent reductions in S. boydii in Dhaka [overall (25 -> 16%); under-5 (16 -> 9%)]. Decreasing rates of Shigella dysenteriae were observed in Matlab, Mirpur and Mirzapur; whereas, in Dhaka it remained unchanged. Conclusion and Significance: Emergence of S. sonnei and S. boydii as important infectious diarrhea etiologies and variations in geographical diversity underscore the need for monitoring, with possible implications for vaccine development.	[Das, Sumon Kumar; Ahmed, Shahnawaz; Ferdous, Farzana; Farzana, Fahmida Dil; Chisti, Mohammod Jobayer; Malek, Mohammad Abdul; Faruque, Abu Syed Golam] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, CNFS, Dhaka, Bangladesh; [Leung, Daniel T.; Raqib, Rubhana] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, CVS, Dhaka, Bangladesh; [Talukder, Kaisar Ali] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, CFWD, Dhaka, Bangladesh; [Chisti, Mohammod Jobayer; Bardhan, Pradip Kumar] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Dhaka Hosp, Dhaka, Bangladesh; [Salam, Mohammed Abdus] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, RAS, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Faruque, AG (corresponding author), Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, CNFS, Dhaka, Bangladesh.	gfaruque@icddrb.org	Das, Sumon Kumar/AAD-1551-2019; Das, Sumon Kumar/T-6384-2019; Chisti, Mohammod J/A-7216-2018	Raqib, Rubhana/0000-0002-8116-4511; FERDOUS, FARZANA/0000-0002-6373-3581; Ahmed, Shahnawaz/0000-0001-8339-4137; Leung, Daniel/0000-0001-8401-0801	Swedish International Development Cooperation Agency (Sida) [MD-0020, GR-00599]; icddr,b; Government of the People's Republic of Bangladesh through IHP-HNPRP; Australian Agency for International Development (AusAID); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Embassy of the Kingdom of the Netherlands (EKN); Swiss Agency for Development and Cooperation (SDC); Department for International Development, UK (DFID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI100923] Funding Source: NIH RePORTER	Swedish International Development Cooperation Agency (Sida); icddr,b; Government of the People's Republic of Bangladesh through IHP-HNPRP; Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Embassy of the Kingdom of the Netherlands (EKN); Swiss Agency for Development and Cooperation (SDC); Department for International Development, UK (DFID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research protocol was funded by Swedish International Development Cooperation Agency (Sida), grant number MD-0020 and GR-00599. icddr,b acknowledges with gratitude the commitment of Sida to its research efforts. Hospital surveillance was funded by icddr,b and the Government of the People's Republic of Bangladesh through IHP-HNPRP. icddr,b acknowledges with gratitude the commitment of the Government of the People's Republic of Bangladesh to the Centre's research efforts. icddr,b also gratefully acknowledges the following donors who provide unrestricted support to the Centre's research efforts: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Embassy of the Kingdom of the Netherlands (EKN), Swedish International Development Cooperation Agency (Sida), Swiss Agency for Development and Cooperation (SDC), and Department for International Development, UK (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chompook P, 2005, B WORLD HEALTH ORGAN, V83, P739; Christopher PRH, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006784.pub4; Clemens J., 1999, GENERIC PROTOCOL EST; Feil EJ, 2012, NAT GENET, V44, P964, DOI 10.1038/ng.2389; Greenhill Claire, 2012, Nat Rev Gastroenterol Hepatol, V9, P487, DOI 10.1038/nrgastro.2012.160; Vinh H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001264; Ha V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-204; Hale TL., 1996, MED MICROBIOLOGY; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Kaminski RW, 2009, EXPERT REV VACCINES, V8, P1693, DOI 10.1586/ERV.09.127; Kelly-Hope LA, 2007, AM J TROP MED HYG, V76, P706, DOI 10.4269/ajtmh.2007.76.706; Khan AM, 2009, J TROP PEDIATRICS, V55, P122, DOI 10.1093/tropej/fmn090; Khan AM, 2004, J TROP PEDIATRICS, V50, P354, DOI 10.1093/tropej/50.6.354; Khatun F, 2011, EPIDEMIOL INFECT, V139, P446, DOI 10.1017/S0950268810001093; SACK DA, 1994, LANCET, V343, P1413, DOI 10.1016/S0140-6736(94)92531-3; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; WHO, 2009, IN VACC RES DIARRH D; World Health Organization, 1987, MAN LAB INV AC ENT I, P9	18	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62029	10.1371/journal.pone.0062029	http://dx.doi.org/10.1371/journal.pone.0062029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658619	Green Submitted, Green Published, gold			2022-12-25	WOS:000321662800020
J	Varadi, E; Vegi, B; Liptoi, K; Barna, J				Varadi, Eva; Vegi, Barbara; Liptoi, Krisztina; Barna, Judit			Methods for Cryopreservation of Guinea Fowl Sperm	PLOS ONE			English	Article							SEMEN CRYOPRESERVATION; GENETIC-RESOURCES; DNA-DAMAGE; SPERMATOZOA; FERTILITY; CHALLENGES; DIVERSITY; CRYOBANK; CREATION; BREEDS	Conservation of indigenous poultry species is an important part of the new Hungarian agricultural strategy. Semen cryopreservation is the most practical method for the long term storage of poultry genetic material. The objective was to compare four protocols for cryopreservation of guinea fowl sperm (slow and fast programmable, freezing in nitrogen vapor, and pellet) and three cryoprotectants (10% ethylene glycol, 6% dimethyl-formamide and 6% dimethyl-acetamide). The efficiency of the methods was examined by in vitro tests (subjective motility scoring, sperm concentration, morphological and live/dead sperm analysis with eosin-aniline staining). Thereafter, the two most promising methods were tested by artificial insemination of frozen-thawed semen (3 times a week for 3 weeks using 300 million spermatozoa/hen), followed by candling of incubated eggs, assessment of fertilization, embryonic death, and hatching rate. The survival rate of live, intact spermatozoa was greatest (p <= 0.05) in pellet method and the slow programmable protocol (with 10% ethylene glycol) (28.6 and 23.5%). The two best protocols (based on in vitro assessment of post-thaw semen quality) were subsequently tested in vivo with artificial insemination. The pellet method yielded a 64% fertility rate compared to slow protocol with only 30% fertility. Regardless, both freezing protocols significantly increased embryonic deaths compared to the control group (16,7; 9,1 and 8,3%, respectively). During the 3-week in vivo trial, fertility increased and early embryonic death decreased over time. According to the results the guinea fowl sperm could tolerate the fast freezing in pellet better than the slower freezing rates and resulted acceptable fertility rate.	[Varadi, Eva] Inst Small Anim Res, Godollo, Hungary; Coordinat Ctr Gene Conservat, Godollo, Hungary		Varadi, E (corresponding author), Inst Small Anim Res, Godollo, Hungary.	varadievi@hotmail.com	Liptoi, Krisztina/S-5484-2018	Liptoi, Krisztina/0000-0002-9083-7570	National Innovation Office [TET_09_FR_ANR_BIO-CryoBird]	National Innovation Office	The research was supported by the National Innovation Office (TET_09_FR_ANR_BIO-CryoBird) (www.nih.gov.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barna J., 2010, WORLDS POULT SCI J, V66, P508; Baumber J, 2003, J ANDROL, V24, P621; Blackburn HD, 2006, POULTRY SCI, V85, P210, DOI 10.1093/ps/85.2.210; Blesbois E, 2007, POULTRY SCI, V86, P555, DOI 10.1093/ps/86.3.555; Blesbois E, 2005, REPRODUCTION, V129, P371, DOI 10.1530/rep.1.00454; BLESBOIS E, 2006, ACTES BRG, V6, P415; Boa-Amponsem K, 2004, WORLD POULTR C JUN 8; Bramwell RK, 2002, AVIAN ADVICE, V4, P1; BURROWS W. H., 1937, POULTRY SCI, V16, P19, DOI 10.3382/ps.0160019; Gee G.F., 1995, P 1 INT S ART INS PO, P262; Hoffmann I, 2005, WORLD POULTRY SCI J, V61, P57, DOI 10.1079/WPS200449; Horvath A, 2003, AQUAT LIVING RESOUR, V16, P457, DOI 10.1016/S0990-7440(03)00084-6; Iaffaldano N, 2011, THERIOGENOLOGY, V76, P794, DOI 10.1016/j.theriogenology.2011.04.012; LAKE PE, 1986, POULTRY SCI, V65, P1, DOI 10.3382/ps.0650001; Linfor JJ, 2002, J ANDROL, V23, P107, DOI 10.1002/j.1939-4640.2002.tb02603.x; Liptoi K, 2004, ACTA VET HUNG, V52, P227, DOI 10.1556/AVet.52.2004.2.11; Lukaszewicz E, 2002, THERIOGENOLOGY, V58, P19, DOI 10.1016/S0093-691X(01)00690-2; Morris ID, 2002, HUM REPROD, V17, P990, DOI 10.1093/humrep/17.4.990; Reedy S.E., 1995, P 1 S ART INS POULTR, P229; Saint Jalme M, 2003, THERIOGENOLOGY, V59, P875, DOI 10.1016/S0093-691X(02)01153-6; Santiago-Moreno J, 2011, POULTRY SCI, V90, P2047, DOI 10.3382/ps.2011-01355; SCHRAMM GP, 1989, ARCH TIERZUCHT, V32, P51; Seigneurin F, 2005, P FRENCH POULTRY RES, P23; Sood S, 2011, ANIM REPROD SCI, V129, P89, DOI 10.1016/j.anireprosci.2011.10.010; Tisdell C, 2003, ECOL ECON, V45, P365, DOI 10.1016/S0921-8009(03)00091-0; TSELUTIN K, 1995, BRIT POULTRY SCI, V36, P805, DOI 10.1080/00071669508417825; Tselutin K, 1999, POULTRY SCI, V78, P586, DOI 10.1093/ps/78.4.586; VANKREY HP, 1966, J REPROD FERTIL, V11, P257, DOI 10.1530/jrf.0.0110257; Vegi B., 2005, P 2 COMB WORKSH FUND, P55; Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3; Woelders H, 2006, POULTRY SCI, V85, P216, DOI 10.1093/ps/85.2.216	31	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62759	10.1371/journal.pone.0062759	http://dx.doi.org/10.1371/journal.pone.0062759			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658648	gold, Green Published, Green Submitted			2022-12-25	WOS:000321662800060
J	Sun, YR; Song, HG; Li, J; Li, Y; Jiang, M; Zhou, JH; Guo, ZH				Sun, Yueru; Song, Haigang; Li, Jie; Li, Yan; Jiang, Ming; Zhou, Jiahai; Guo, Zhihong			Structural Basis of the Induced-Fit Mechanism of 1,4-Dihydroxy-2-Naphthoyl Coenzyme A Synthase from the Crotonase Fold Superfamily	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; CENTER-DOT-PI; MENAQUINONE BIOSYNTHESIS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; PROTEIN STRUCTURES; BICARBONATE ION; COA SYNTHETASE; INHIBITORS	1,4-Dihydroxy-2-naphthoyl coenzyme A (DHNA-CoA) synthase is a typical crotonase fold enzyme with an implicated role of conformational changes in catalysis. We have identified these conformational changes by determining the structures of its Escherichia coli and Synechocystis sp. PCC6803 orthologues in complex with a product analog. The structural changes include the folding of an active-site loop into a beta-hairpin and significant reorientation of a helix at the carboxy terminus. Interestingly, a new interface is formed between the ordered loop and the reoriented helix, both of which also form additional interactions with the coenzyme A moiety of the ligand. Site-directed mutation of the amino acid residues involved in these ligand-induced interactions significantly diminishes the enzyme activity. These results suggest a catalytically essential induced-fit that is likely initiated by the enzyme-ligand interactions at the active site.	[Sun, Yueru; Song, Haigang; Jiang, Ming; Guo, Zhihong] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China; [Sun, Yueru; Song, Haigang; Jiang, Ming; Guo, Zhihong] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Li, Jie; Li, Yan; Zhou, Jiahai] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Zhou, JH (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Lu, Shanghai 200032, Peoples R China.	jiahai@mail.sioc.ac.cn; chguo@ust.hk		Guo, Zhihong/0000-0003-0374-8412	Research Grants Council of the HKSAR government [GRF601209, RPC11SC16]; National Program on Key Basic Research of China [2009CB918600]	Research Grants Council of the HKSAR government(Hong Kong Research Grants Council); National Program on Key Basic Research of China	This work was supported in part by GRF601209 and RPC11SC16 from the Research Grants Council of the HKSAR government (to Z.G.) and 2009CB918600 from the National Program on Key Basic Research of China (to J.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Chen MJ, 2011, BIOCHEMISTRY-US, V50, P5893, DOI 10.1021/bi200376x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Courtois F, 2005, BIOCHEMISTRY-US, V44, P13583, DOI 10.1021/bi051159x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Egli M, 2007, ACCOUNTS CHEM RES, V40, P197, DOI 10.1021/ar068174u; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Fang MH, 2010, BIOCHEMISTRY-US, V49, P2672, DOI 10.1021/bi901432d; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Grisostomi C, 1997, BIOORG CHEM, V25, P297, DOI 10.1006/bioo.1997.1073; Gross J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-117; Guo ZF, 2008, ORG LETT, V10, P649, DOI 10.1021/ol7030153; Guo ZF, 2010, BIOORG MED CHEM LETT, V20, P3855, DOI 10.1016/j.bmcl.2010.05.051; Guo ZF, 2009, BIOCHEMISTRY-US, V48, P1712, DOI 10.1021/bi802165x; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; Hernandez-Guillamon M, 2007, J BIOCHEM, V142, P571, DOI 10.1093/jb/mvm165; Iwig DF, 2005, J AM CHEM SOC, V127, P11612, DOI 10.1021/ja053899z; Jain A, 2007, J PHYS CHEM B, V111, P8680, DOI [10.1021/jp072742l, 10.1021/jp0727421]; Jain A, 2009, PROTEIN SCI, V18, P595, DOI 10.1002/pro.67; Jiang M, 2008, BIOCHEMISTRY-US, V47, P3426, DOI 10.1021/bi7023755; Jiang M, 2007, ORG LETT, V9, P4765, DOI 10.1021/ol702126m; Jiang M, 2007, BIOCHEMISTRY-US, V46, P10979, DOI 10.1021/bi700810x; Jiang M, 2010, J BIOL CHEM, V285, P30159, DOI 10.1074/jbc.M110.147702; Jiang M, 2009, BIOCHEMISTRY-US, V48, P6921, DOI 10.1021/bi900897h; Johnston JM, 2005, ACTA CRYSTALLOGR D, V61, P1199, DOI [10.1107/s0907444905017531, 10.1107/S0904777905017531]; Kanaujia SP, 2007, ACTA CRYSTALLOGR F, V63, P103, DOI 10.1107/S1744309106056521; Kasaragod P, 2010, J BIOL CHEM, V285, P24089, DOI 10.1074/jbc.M110.117606; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Kurosu M, 2007, J MED CHEM, V50, P3973, DOI 10.1021/jm070638m; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li HJ, 2011, BIOCHEMISTRY-US, V50, P9532, DOI 10.1021/bi200877x; Li XK, 2011, ACS MED CHEM LETT, V2, P818, DOI 10.1021/ml200141e; Li XK, 2010, BIOORG MED CHEM LETT, V20, P6306, DOI 10.1016/j.bmcl.2010.08.076; Lu XQ, 2008, BIOORG MED CHEM LETT, V18, P5963, DOI 10.1016/j.bmcl.2008.07.130; Lu XQ, 2012, CHEMBIOCHEM, V13, P129, DOI 10.1002/cbic.201100585; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meganathan R, 2001, VITAM HORM, V61, P173; Minasov G, 2009, CENT STRUCT GENOMICS, DOI [10.2210/pdb3h02/pdb, DOI 10.2210/PDB3H02/PDB]; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Partanen ST, 2004, J MOL BIOL, V342, P1197, DOI 10.1016/j.jmb.2004.07.039; Shevela D, 2007, PHOTOSYNTH RES, V94, P247, DOI 10.1007/s11120-007-9200-2; Song HG, 2012, SCI CHINA CHEM, V55, P98, DOI 10.1007/s11426-011-4448-y; Strater N, 1999, P NATL ACAD SCI USA, V96, P11151, DOI 10.1073/pnas.96.20.11151; Sun LM, 2009, P NATL ACAD SCI USA, V106, P2041, DOI 10.1073/pnas.0812220106; Sun YR, 2012, BIOCHEMISTRY-US, V51, P4580, DOI 10.1021/bi300486j; Truglio JJ, 2003, J BIOL CHEM, V278, P42352, DOI 10.1074/jbc.M307399200; Ulaganathan V, 2007, ACTA CRYSTALLOGR F, V63, P908, DOI 10.1107/S1744309107047720; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510	55	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e63095	10.1371/journal.pone.0063095	http://dx.doi.org/10.1371/journal.pone.0063095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658663	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700091
J	Biggar, KK; Kotani, E; Furusawa, T; Storey, KB				Biggar, Kyle K.; Kotani, Eiji; Furusawa, Toshiharu; Storey, Kenneth B.			Expression of freeze-responsive proteins, Fr10 and Li16, from freeze-tolerant frogs enhances freezing survival of BmN insect cells	FASEB JOURNAL			English	Article						cryobiology; silkworm	RANA-SYLVATICA; WOOD FROG; ANTIFREEZE PROTEIN; UP-REGULATION; GENE; STRESS; INHIBITION; EXPOSURE; SERVER	To date, two novel freeze-responsive proteins, Fr10 and Li16, have been discovered in the wood frog, Rana sylvatica, and likely support freezing survival. Although previous studies have established tissue distribution of each protein, there have been no studies that explore their functional consequences in intolerant cells. To assess the ability of Fr10 and Li16 to confer freeze tolerance, we transfected each protein into a freeze-intolerant silkworm cell line (BmN). Selected controls were the transfection of an unrelated protein (CAT) and a no-transfection sample. Li16 and Fr10 showed 1.8 +/- 0.1- and 1.7 +/- 0.2-fold, respectively, greater survival after freezing at -6 degrees C for 1 h than did transfection controls. To investigate how these novel proteins protect cells from freezing damage, protein structures were predicted from primary amino acid sequences. Analysis of the structures indicated that Fr10 is a secreted protein and may be a new type IV antifreeze protein, whereas Li16 may have intracellular membrane associated functions. This study shows that freezing protection can be provided to intolerant cells by the overexpression of transfected Li16 and Fr10 frog proteins. Results from this study will provide new insights into adapting intolerant cells for medical organ cryoprotection using a natural vertebrate model of tolerance.Biggar, K. K., Kotani, E., Furusawa, T., Storey, K. B. Expression of freeze-responsive proteins, Fr10 and Li16, from freeze-tolerant frogs enhances freezing survival of BmN insect cells.	[Biggar, Kyle K.; Storey, Kenneth B.] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada; [Biggar, Kyle K.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Kotani, Eiji] Kyoto Inst Technol, Grad Sch Sci & Technol, Kyoto 606, Japan; [Furusawa, Toshiharu] Kinugasa Res Fdn Text Sci, Kyoto, Japan	Carleton University; Carleton University; Kyoto Institute of Technology	Storey, KB (corresponding author), Carleton Univ, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada.	kenneth_storey@carleton.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada [6793]; NSERC	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors thank J. M. Storey for editorial review of the manuscript. This work was supported by a Discovery grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada (grant 6793). K. B. S. holds the Canada Research Chair in Molecular Physiology, and K. K. B. held an NSERC postgraduate fellowship.	BRASSEUR R, 1992, PROTEINS, V13, P246, DOI 10.1002/prot.340130307; BROWN M, 1977, J GEN VIROL, V36, P361, DOI 10.1099/0022-1317-36-2-361; Cai Q, 1997, AM J PHYSIOL-REG I, V272, pR1480, DOI 10.1152/ajpregu.1997.272.5.R1480; Cai QY, 1997, GENE, V198, P305, DOI 10.1016/S0378-1119(97)00332-6; Cai QY, 1997, BBA-GENE STRUCT EXPR, V1353, P69, DOI 10.1016/S0167-4781(97)00057-2; De Croos JNA, 2004, J BIOENERG BIOMEMBR, V36, P229, DOI 10.1023/B:JOBB.0000031974.35812.c9; Deng GJ, 1997, FEBS LETT, V402, P17, DOI 10.1016/S0014-5793(96)01466-4; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Heng BC, 2006, J BIOMED SCI, V13, P433, DOI 10.1007/s11373-005-9051-9; Hobbs RS, 2008, TRANSGENIC RES, V17, P33, DOI 10.1007/s11248-007-9128-5; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Kostal V, 2012, P NATL ACAD SCI USA, V109, P3270, DOI 10.1073/pnas.1119986109; Kotani E, 2003, GENE, V320, P67, DOI 10.1016/S0378-1119(03)00811-4; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; McNally JD, 2002, FASEB J, V16, P902, DOI 10.1096/fj.02-0017fje; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Roufayel R, 2011, J EXP ZOOL PART A, V315A, P487, DOI 10.1002/jez.696; STOREY KB, 1992, ANNU REV PHYSIOL, V54, P619, DOI 10.1146/annurev.physiol.54.1.619; Storey KB, 2004, LIFE IN THE FROZEN STATE, P243, DOI 10.1201/9780203647073.ch7; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; Sullivan KJ, 2012, CRYOBIOLOGY, V64, P192, DOI 10.1016/j.cryobiol.2012.01.008; Uemura M, 2006, PHYSIOL PLANTARUM, V126, P81, DOI 10.1111/j.1399-3054.2005.00594.x; Wallis JG, 1997, PLANT MOL BIOL, V35, P323, DOI 10.1023/A:1005886210159; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Yu SO, 2010, CRYOBIOLOGY, V61, P327, DOI 10.1016/j.cryobiol.2010.10.158; Zhang SH, 2007, Z NATURFORSCH C, V62, P583	29	10	12	1	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3376	3383		10.1096/fj.13-230573	http://dx.doi.org/10.1096/fj.13-230573			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23657819				2022-12-25	WOS:000329877600042
J	Bouillon, A; Giganti, D; Benedet, C; Gorgette, O; Petres, S; Crublet, E; Girard-Blanc, C; Witkowski, B; Menard, D; Nilges, M; Mercereau-Puijalon, O; Stoven, V; Barale, JC				Bouillon, Anthony; Giganti, David; Benedet, Christophe; Gorgette, Olivier; Petres, Stephane; Crublet, Elodie; Girard-Blanc, Christine; Witkowski, Benoit; Menard, Didier; Nilges, Michael; Mercereau-Puijalon, Odile; Stoven, Veronique; Barale, Jean-Christophe			In Silico Screening on the Three-dimensional Model of the Plasmodium vivax SUB1 Protease Leads to the Validation of a Novel Anti-parasite Compound	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTILISIN-LIKE PROTEASE-1; ANTIMALARIAL-DRUG DISCOVERY; MALARIA PARASITE; FLEXIBLE DOCKING; ACTIVE-SITE; PROTEINS; INHIBITORS; BINDING; EGRESS; ENERGY	Widespread drug resistance calls for the urgent development of new antimalarials that target novel steps in the life cycle of Plasmodium falciparum and Plasmodium vivax. The essential subtilisin-like serine protease SUB1 of Plasmodium merozoites plays a dual role in egress from and invasion into host erythrocytes. It belongs to a new generation of attractive drug targets against which specific potent inhibitors are actively searched. We characterize here the P. vivax SUB1 enzyme and show that it displays a typical auto-processing pattern and apical localization in P. vivax merozoites. To search for small PvSUB1 inhibitors, we took advantage of the similarity of SUB1 with bacterial subtilisins and generated P. vivax SUB1 three-dimensional models. The structure-based virtual screening of a large commercial chemical compounds library identified 306 virtual best hits, of which 37 were experimentally confirmed inhibitors and 5 had K-i values of <50 mu M for PvSUB1. Interestingly, they belong to different chemical families. The most promising competitive inhibitor of PvSUB1(compound 2) was equally active on PfSUB1 and displayed anti-P. falciparum and Plasmodium berghei activity in vitro and in vivo, respectively. Compound 2 inhibited the endogenous PfSUB1 as illustrated by the inhibited maturation of its natural substrate PfSERA5 and inhibited parasite egress and subsequent erythrocyte invasion. These data indicate that the strategy of in silico screening of three-dimensional models to select for virtual inhibitors combined with stringent biological validation successfully identified several inhibitors of the PvSUB1 enzyme. The most promising hit proved to be a potent cross-inhibitor of PlasmodiumSUB1, laying the groundwork for the development of a globally active small compound antimalarial.	[Bouillon, Anthony; Gorgette, Olivier; Mercereau-Puijalon, Odile; Barale, Jean-Christophe] Inst Pasteur, Unite Immunol Mol Parasites, Dept Parasitol & Mycol, F-75015 Paris, France; [Bouillon, Anthony; Gorgette, Olivier; Mercereau-Puijalon, Odile] CNRS, URA2581, F-75015 Paris, France; [Giganti, David; Nilges, Michael] Inst Pasteur, Unite Bioinformat Struct, Dept Biol Struct & Chim, F-75015 Paris, France; [Giganti, David; Nilges, Michael] CNRS, UMR3258, F-75015 Paris, France; [Benedet, Christophe; Witkowski, Benoit; Menard, Didier] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Petres, Stephane; Crublet, Elodie; Girard-Blanc, Christine] Inst Pasteur, Dept Biol Struct & Chim, F-75015 Paris, France; [Stoven, Veronique; Barale, Jean-Christophe] Mines ParisTech, Ctr Computat Biol, F-77300 Fontainebleau, France; [Stoven, Veronique] Inst Curie, INSERM, U900, F-75248 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Barale, JC (corresponding author), Inst Pasteur, Unite Immunol Mol Parasites, URA CNRS 2581, Dept Parasitol & Mycol, 28 Rue Dr Roux, F-75724 Paris 15, France.	jean-christophe.barale@pasteur.fr	Menard, Didier/O-3294-2013; Mercereau-Puijalon, Odile/AAA-2242-2020; Witkowski, Benoit/T-1118-2019; Nilges, Michael/E-4803-2011	Menard, Didier/0000-0003-1357-4495; Nilges, Michael/0000-0002-1451-8092; petres, stephane/0000-0002-4716-565X	"Fond Dedie: Combattre les Maladies Parasitaires" from Sanofi-Aventis; French Ministry of Research; Institut Carnot-Pasteur Maladies Infectieuses; Carnot grant program of the "Institut Carnot-Pasteur Maladies Infectieuses"	"Fond Dedie: Combattre les Maladies Parasitaires" from Sanofi-Aventis; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut Carnot-Pasteur Maladies Infectieuses; Carnot grant program of the "Institut Carnot-Pasteur Maladies Infectieuses"	This work was supported in part by the "Fond Dedie: Combattre les Maladies Parasitaires" from Sanofi-Aventis and the French Ministry of Research and a grant from the Institut Carnot-Pasteur Maladies Infectieuses.; Ph.D. Fellow of the "Direction Generale pour l'Armement" from the French Ministry of Defense and supported by the Carnot grant program of the "Institut Carnot-Pasteur Maladies Infectieuses."	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ang KKH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001023; [Anonymous], 1999, HDB ANIMAL MODELS IN; Barale JC, 1999, P NATL ACAD SCI USA, V96, P6445, DOI 10.1073/pnas.96.11.6445; Bastianelli G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021812; BERGER A, 1970, PHILOS T R SOC B, V257, P249, DOI 10.1098/rstb.1970.0024; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Blackman MJ, 1998, J BIOL CHEM, V273, P23398, DOI 10.1074/jbc.273.36.23398; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Bouillon A., 2013, METHODS MOL BIOL MAL, P523; Dalton JAR, 2007, BIOINFORMATICS, V23, P1901, DOI 10.1093/bioinformatics/btm262; Dechamps S, 2010, INT J PARASITOL, V40, P1347, DOI 10.1016/j.ijpara.2010.05.008; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Dowse Timothy J., 2008, V47, P121; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gemma S, 2012, BIOORG MED CHEM LETT, V22, P5317, DOI 10.1016/j.bmcl.2012.06.023; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; GRON H, 1992, BIOCHEMISTRY-US, V31, P6011, DOI 10.1021/bi00141a008; GROS P, 1992, PROTEINS, V12, P63, DOI 10.1002/prot.340120108; Grunberg R, 2007, BIOINFORMATICS, V23, P769, DOI 10.1093/bioinformatics/btl655; Grum-Tokars V, 2008, VIRUS RES, V133, P63, DOI 10.1016/j.virusres.2007.02.015; Guiguemde WA, 2012, CHEM BIOL, V19, P116, DOI 10.1016/j.chembiol.2012.01.004; Hindle SA, 2002, J COMPUT AID MOL DES, V16, P129, DOI 10.1023/A:1016399411208; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Jean L, 2005, MOL BIOCHEM PARASIT, V144, P187, DOI 10.1016/j.molbiopara.2005.07.008; Klibanov OM, 2011, PHARMACOTHERAPY, V31, P951, DOI 10.1592/phco.31.10.951; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li QG, 2007, CYTOM PART A, V71A, P297, DOI 10.1002/cyto.a.20380; *MALERA CONS GROUP, 2011, PLOS MED, V0008; McGovern SL, 2003, J MED CHEM, V46, P2895, DOI 10.1021/jm0300330; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Meyers MJ, 2012, CURR TOP MED CHEM, V12, P445; Nicola G, 2008, J COMPUT BIOL, V15, P231, DOI 10.1089/cmb.2007.0178; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Sadowski J, 1997, J COMPUT AID MOL DES, V11, P53, DOI 10.1023/A:1008023427310; Safeukui I, 2004, BIOCHEM PHARMACOL, V68, P1903, DOI 10.1016/j.bcp.2004.05.049; Saify ZS, 2012, BIOORG MED CHEM LETT, V22, P1282, DOI 10.1016/j.bmcl.2011.10.018; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Schapira M, 1999, J MOL RECOGNIT, V12, P177, DOI 10.1002/(SICI)1099-1352(199905/06)12:3<177::AID-JMR451>3.0.CO;2-Z; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Totrov M, 1997, PROTEINS, P215; Withers-Martinez C, 2002, J BIOL CHEM, V277, P29698, DOI 10.1074/jbc.M203088200; Withers-Martinez C, 2012, INT J PARASITOL, V42, P597, DOI 10.1016/j.ijpara.2012.04.005; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	53	16	16	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18561	18573		10.1074/jbc.M113.456764	http://dx.doi.org/10.1074/jbc.M113.456764			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653352	Green Published, hybrid			2022-12-25	WOS:000320721900056
J	Chiluiza, D; Krishna, S; Schumacher, VA; Schlondorff, J				Chiluiza, David; Krishna, Sneha; Schumacher, Valerie A.; Schloendorff, Johannes			Gain-of-function Mutations in Transient Receptor Potential C6 (TRPC6) Activate Extracellular Signal-regulated Kinases 1/2 (ERK1/2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; EXPERIMENTAL MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS; HYPOXIC PULMONARY VASOCONSTRICTION; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; GLOMERULAR MESANGIAL CELLS; HUMAN DIABETIC-NEPHROPATHY; SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE; ANGIOTENSIN-II; CA2+ ENTRY	Gain-of-function mutations in the canonical transient receptor potential 6 (TRPC6) gene are a cause of autosomal dominant focal segmental glomerulosclerosis (FSGS). The mechanisms whereby abnormal TRPC6 activity results in proteinuria remain unknown. The ERK1/2 MAPKs are activated in glomeruli and podocytes in several proteinuric disease models. We therefore examined whether FSGS-associated mutations in TRPC6 result in activation of these kinases. In 293T cells and cultured podocytes, overexpression of gain-of-function TRPC6 mutants resulted in increased ERK1/2 phosphorylation, an effect dependent upon channel function. Pharmacologic inhibitor studies implicated several signaling mediators, including calmodulin and calcineurin, supporting the importance of TRPC6-mediated calcium influx in this process. Through medium transfer experiments, we uncovered two distinct mechanisms for ERK activation by mutant TRPC6, a cell-autonomous, EGF receptor-independent mechanism and a non-cell-autonomous mechanism involving metalloprotease-mediated release of a presumed EGF receptor ligand. The inhibitors KN-92 and H89 were able to block both pathways in mutant TRPC6 expressing cells as well as the prolonged elevation of intracellular calcium levels upon carbachol stimulation seen in these cells. However, these effects appear to be independent of their effects on calcium/calmodulin-dependent protein kinase II and PKA, respectively. Phosphorylation of Thr-70, Ser-282, and Tyr-31/285 were not necessary for ERK activation by mutant TRPC6, although a phosphomimetic TRPC6 S282E mutant was capable of ERK activation. Taken together, these results identify two pathways downstream of mutant TRPC6 leading to ERK activation that may play a role in the development of FSGS.	[Chiluiza, David; Krishna, Sneha; Schloendorff, Johannes] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Chiluiza, David; Schumacher, Valerie A.; Schloendorff, Johannes] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Schumacher, Valerie A.] Boston Childrens Hosp, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Schlondorff, J (corresponding author), Div Nephrol, RN304B,99 Brookline Ave, Boston, MA 02215 USA.	jschlond@bidmc.harvard.edu		Schlondorff, Johannes/0000-0002-9973-9731	National Institutes of Health, NIDDK [K08DK80947]; American Society of Nephrology; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080947] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Society of Nephrology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant K08DK80947. This work was also supported by a Carl W. Gottschalk Research Grant from the American Society of Nephrology.	Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Awazu M, 1999, J AM SOC NEPHROL, V10, P738; Bijian K, 2005, AM J PHYSIOL-RENAL, V289, pF1313, DOI 10.1152/ajprenal.00106.2005; Bijian K, 2004, AM J PHYSIOL-RENAL, V286, pF255, DOI 10.1152/ajprenal.00259.2003; Bokemeyer D, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017576.50319.AC; Bokemeyer D, 2000, J AM SOC NEPHROL, V11, P232, DOI 10.1681/ASN.V112232; Bokemeyer D, 1997, J CLIN INVEST, V100, P582, DOI 10.1172/JCI119568; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Brinkkoetter PT, 2009, J CLIN INVEST, V119, P3089, DOI 10.1172/JCI37978; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Chen CA, 2012, EXP BIOL MED, V237, P777, DOI 10.1258/ebm.2012.011157; Chen J, 2009, AM J PHYSIOL-HEART C, V297, pH417, DOI 10.1152/ajpheart.01130.2008; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF593, DOI 10.1152/ajprenal.00066.2005; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis J, 2012, DEV CELL, V23, P705, DOI 10.1016/j.devcel.2012.08.017; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Doublier S, 2011, KIDNEY INT, V79, P404, DOI 10.1038/ki.2010.398; Eckel J, 2011, J AM SOC NEPHROL, V22, P526, DOI 10.1681/ASN.2010050522; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; Engh RA, 1996, J BIOL CHEM, V271, P26157, DOI 10.1074/jbc.271.42.26157; Espinosa EVP, 2012, BIOCHEM BIOPH RES CO, V417, P853, DOI 10.1016/j.bbrc.2011.12.058; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Flannery PJ, 2006, NEPHRON EXP NEPHROL, V103, pE109, DOI 10.1159/000092196; Fuchs B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-20; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Gorin Y, 2004, BIOCHEM J, V381, P231, DOI 10.1042/BJ20031614; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Hamaguchi A, 2000, J AM SOC NEPHROL, V11, P39, DOI 10.1681/ASN.V11139; Hamaguchi A, 1998, J AM SOC NEPHROL, V9, P372; Harada M, 2012, CIRCULATION, V126, P2051, DOI 10.1161/CIRCULATIONAHA.112.121830; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Horinouchi T, 2012, J PHARMACOL EXP THER, V340, P143, DOI 10.1124/jpet.111.187500; Jiang LN, 2011, EXP BIOL MED, V236, P184, DOI 10.1258/ebm.2010.010237; Kanda S, 2011, MOL BIOL CELL, V22, P1824, DOI 10.1091/mbc.E10-12-0929; Kinoshita H, 2010, CIRC RES, V106, P1849, DOI 10.1161/CIRCRESAHA.109.208314; Koitabashi N, 2010, J MOL CELL CARDIOL, V48, P713, DOI 10.1016/j.yjmcc.2009.11.015; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Krall P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012859; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Kwan HY, 2004, P NATL ACAD SCI USA, V101, P2625, DOI 10.1073/pnas.0304471101; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lemos VS, 2007, BIOCHEM BIOPH RES CO, V352, P130, DOI 10.1016/j.bbrc.2006.10.160; Leuner K, 2010, MOL PHARMACOL, V77, P368, DOI 10.1124/mol.109.057513; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Li XC, 2006, BIOCHEM PHARMACOL, V71, P1711, DOI 10.1016/j.bcp.2006.03.018; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Liu SF, 2010, MOL BIOL REP, V37, P2477, DOI 10.1007/s11033-009-9761-6; Loot AE, 2011, J CARDIOVASC PHARM, V57, P140, DOI 10.1097/FJC.0b013e3181ed088d; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Murshid A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013830; Nijenhuis T, 2011, AM J PATHOL, V179, P1719, DOI 10.1016/j.ajpath.2011.06.033; Nishida M, 2007, J BIOL CHEM, V282, P23117, DOI 10.1074/jbc.M611780200; Nishida M, 2010, J BIOL CHEM, V285, P13244, DOI 10.1074/jbc.M109.074104; Nishioka K, 2011, ARTERIOSCL THROM VAS, V31, P2278, DOI 10.1161/ATVBAHA.110.221010; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Park SJ, 2004, BIOCHEM BIOPH RES CO, V323, P1, DOI 10.1016/j.bbrc.2004.08.047; Pippin JW, 2003, J CLIN INVEST, V111, P877, DOI 10.1172/JCI200315645; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rosker C, 2004, J BIOL CHEM, V279, P13696, DOI 10.1074/jbc.M308108200; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Rubinfeld Hadara, 2004, Methods Mol Biol, V250, P1; Sakai N, 2005, AM J KIDNEY DIS, V45, P54, DOI 10.1053/j.ajkd.2004.08.039; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Samapati R, 2012, AM J RESP CRIT CARE, V185, P160, DOI 10.1164/rccm.201104-0717OC; Schlondorff J, 2009, AM J PHYSIOL-CELL PH, V296, pC558, DOI 10.1152/ajpcell.00077.2008; Schumacher VA, 2011, J AM SOC NEPHROL, V22, P1286, DOI 10.1681/ASN.2010080860; Shen B, 2011, J BIOL CHEM, V286, P19439, DOI 10.1074/jbc.M110.210294; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Sung TS, 2011, AM J PHYSIOL-CELL PH, V301, pC823, DOI 10.1152/ajpcell.00351.2010; Tajeddine N, 2012, J BIOL CHEM, V287, P16146, DOI 10.1074/jbc.M112.340034; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; Tamouza H, 2012, KIDNEY INT, V82, P1284, DOI 10.1038/ki.2012.192; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Tian DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001200; TOMBES RM, 1995, CELL GROWTH DIFFER, V6, P1063; Tomic M, 2011, AM J PHYSIOL-ENDOC M, V301, pE370, DOI 10.1152/ajpendo.00130.2011; Toyoda M, 2004, KIDNEY INT, V66, P1107, DOI 10.1111/j.1523-1755.2004.00798.x; Wada T, 2008, NEPHRON EXP NEPHROL, V109, pE8, DOI 10.1159/000131892; Wang LM, 2012, KIDNEY INT, V81, P1075, DOI 10.1038/ki.2011.472; Wang YQ, 2010, J AM SOC NEPHROL, V21, P1657, DOI 10.1681/ASN.2009121253; Wang YL, 2012, J AM SOC NEPHROL, V23, P1977, DOI 10.1681/ASN.2012040383; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Weissmann N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1660; Werry TD, 2005, TRENDS ENDOCRIN MET, V16, P26, DOI 10.1016/j.tem.2004.11.008; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Yao H, 2009, CELL DEATH DIFFER, V16, P1681, DOI 10.1038/cdd.2009.108; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang H, 2009, EXP BIOL MED, V234, P1029, DOI 10.3181/0901-RM-11; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhu B, 2009, MUTAT RES-FUND MOL M, V664, P84, DOI 10.1016/j.mrfmmm.2008.11.021; Zhu L, 2011, J AM SOC NEPHROL, V22, P1621, DOI 10.1681/ASN.2010111146	108	42	44	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18407	18420		10.1074/jbc.M113.463059	http://dx.doi.org/10.1074/jbc.M113.463059			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645677	Green Published, hybrid			2022-12-25	WOS:000320721900043
J	Land, AM; Law, EK; Carpenter, MA; Lackey, L; Brown, WL; Harris, RS				Land, Allison M.; Law, Emily K.; Carpenter, Michael A.; Lackey, Lela; Brown, William L.; Harris, Reuben S.			Endogenous APOBEC3A DNA Cytosine Deaminase Is Cytoplasmic and Nongenotoxic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBIT LINE-1 RETROTRANSPOSITION; ACTIVATION-INDUCED DEAMINASE; CYTIDINE DEAMINASES; DAMAGE RESPONSE; HUMAN-CELLS; ALU RETROTRANSPOSITION; SOMATIC HYPERMUTATION; ANTIVIRAL ACTIVITY; NUCLEAR IMPORT; H2AX PROTEIN	APOBEC3A (A3A) is a myeloid lineage-specific DNA cytosine deaminase with a role in innate immunity to foreign DNA. Previous studies have shown that heterologously expressed A3A is genotoxic, suggesting that monocytes may have a mechanism to regulate this enzyme. Indeed, we observed no significant cytotoxicity when interferon was used to induce the expression of endogenous A3A in CD14(+)-enriched primary cells or the monocytic cell line THP-1. In contrast, doxycycline-induced A3A in HEK293 cells caused major cytotoxicity at protein levels lower than those observed when CD14(+) cells were stimulated with interferon. Immunofluorescent microscopy of interferon-stimulated CD14(+) and THP-1 cells revealed that endogenous A3A is cytoplasmic, in stark contrast to stably or transiently transfected A3A, which has a cell-wide localization. A3A constructs engineered to be cytoplasmic are also nontoxic in HEK293 cells. These data combine to suggest that monocytic cells use a cytoplasmic retention mechanism to control A3A and avert genotoxicity during innate immune responses.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Inst Mol Virol, Masonic Canc Ctr, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Harris, RS (corresponding author), 321 Church St SE,6-155 Jackson Hall, Minneapolis, MN 55455 USA.	rsh@umn.edu	Brown, William/GXN-2777-2022	Lackey, Lela/0000-0003-2163-4005; Carpenter, Michael/0000-0001-9524-5323	National Institutes of Health [R01 AI064046, P01 GM091743, T32 DE07288, F32 GM095219]; Canadian Institutes for Health Research (CIHR) Postdoctoral Fellowship; National Science Foundation (NSF) Predoctoral Fellowship; National Institutes of Health Molecular Virology Training [T32 AI083196]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064046, T32AI083196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM091743, F32GM095219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research (CIHR) Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); National Science Foundation (NSF) Predoctoral Fellowship(National Science Foundation (NSF)); National Institutes of Health Molecular Virology Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI064046 and P01 GM091743 (to R. S. H.).; Supported by a Canadian Institutes for Health Research (CIHR) Postdoctoral Fellowship.; Supported by National Institutes of Health Grants T32 DE07288 and F32 GM095219.; Supported in part by a National Science Foundation (NSF) Predoctoral Fellowship and National Institutes of Health Molecular Virology Training Grant T32 AI083196.	Aynaud MM, 2012, J BIOL CHEM, V287, P39182, DOI 10.1074/jbc.M112.372722; Bennett RP, 2008, J BIOL CHEM, V283, P7320, DOI 10.1074/jbc.M708567200; Bennett RP, 2006, BIOCHEM BIOPH RES CO, V350, P214, DOI 10.1016/j.bbrc.2006.09.032; Berger A, 2010, J BIOL CHEM, V285, P12248, DOI 10.1074/jbc.M109.090977; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chen WT, 2013, MOL CELL BIOL, V33, P111, DOI 10.1128/MCB.01024-12; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Goila-Gaur R, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-61; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Koning FA, 2011, J VIROL, V85, P13448, DOI 10.1128/JVI.00775-11; Lackey L, 2012, J MOL BIOL, V419, P301, DOI 10.1016/j.jmb.2012.03.011; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Li MMH, 2011, J VIROL, V85, P8197, DOI 10.1128/JVI.00624-11; Lovsin N, 2009, ANN NY ACAD SCI, V1178, P268, DOI 10.1111/j.1749-6632.2009.05006.x; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2008, J VIROL, V82, P987, DOI 10.1128/JVI.01078-07; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Ord D, 2003, EXP CELL RES, V286, P308, DOI 10.1016/S0014-4827(03)00070-3; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Shinohara M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00806; Stenglein MD, 2008, J VIROL, V82, P9591, DOI 10.1128/JVI.02471-07; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Wijesinghe P, 2012, NUCLEIC ACIDS RES, V40, P9206, DOI 10.1093/nar/gks685; Wu CY, 2011, J BIOL CHEM, V286, P30806, DOI 10.1074/jbc.M111.257469; Wu M, 2003, J BIOL CHEM, V278, P27072, DOI 10.1074/jbc.M209814200	55	56	58	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17253	17260		10.1074/jbc.M113.458661	http://dx.doi.org/10.1074/jbc.M113.458661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640892	Green Published, hybrid			2022-12-25	WOS:000320380600021
J	Oguariri, RM; Dai, L; Adelsberger, JW; Rupert, A; Stevens, R; Yang, J; Huang, DW; Lempicki, RA; Zhou, M; Baseler, MW; Lane, HC; Imamichi, T				Oguariri, Raphael M.; Dai, Lue; Adelsberger, Joseph W.; Rupert, Adam; Stevens, Randy; Yang, Jun; Huang, Dawei; Lempicki, Richard A.; Zhou, Ming; Baseler, Michael W.; Lane, H. Clifford; Imamichi, Tomozumi			Interleukin-2 Inhibits HIV-1 Replication in Some Human T Cell Lymphotrophic Virus-1-infected Cell Lines via the Induction and Incorporation of APOBEC3G into the Virion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NECROSIS FACTOR-ALPHA; GAMMA-CHAIN; ANTIVIRAL ACTIVITY; IN-VIVO; FUNCTIONAL COMPONENT; CYTIDINE DEAMINATION; HUMAN MACROPHAGES; CUTTING EDGE; VIF PROTEIN	IL-2 has been used in culture of primary T cells to maintain cell proliferation. We have previously reported that IL-27 inhibits HIV-1 replication in primary T cells in the presence of IL-2. To gain a better understanding of the mechanisms involved in this inhibitory effect, we attempted to investigate in detail the effects of IL-27 and IL-2 using several cell lines. Unexpectedly, IL-27 did not inhibit HIV-1 in T cell lines, whereas IL-2 inhibited HIV-1 replication in the human T cell lymphotrophic virus (HTLV)- 1-transformed T cell lines, MT-2, MT-4, SLB-1, and ATL-2. No effects were seen in HTLV-1-negative cell lines. Utilizing MT-2 cells, we demonstrated that IL-2 treatment inhibited HIV-1 syncytia-inducing ability and dose-dependently decreased supernatant p24 antigen levels by >90%. Using real time PCR and Western blot analysis, we observed that IL-2 treatment induced the host restriction factor, APOBEC3G with accumulation into the lower molecular mass active form as characterized by FPLC. Further analysis revealed that the virus recovered from IL-2-treated MT-2 cells had impaired replication competency. This was found to be due to incorporation of APOBEC3G into the virion despite the presence of Vif. These findings demonstrate a novel role for IL-2 in regulating production of infectious HIV-1 virions in HTLV-1-infected cells through the induction of APOBEC3G.	[Oguariri, Raphael M.; Dai, Lue; Imamichi, Tomozumi] Frederick Natl Lab Canc Res, Lab Human Retrovirol, Frederick, MD 21702 USA; [Adelsberger, Joseph W.; Rupert, Adam; Stevens, Randy; Baseler, Michael W.] Frederick Natl Lab Canc Res, AIDS Monitoring Lab, Frederick, MD 21702 USA; [Yang, Jun; Huang, Dawei; Lempicki, Richard A.] Frederick Natl Lab Canc Res, Lab Immunopathogenesis & Bioinformat, Frederick, MD 21702 USA; [Oguariri, Raphael M.; Dai, Lue; Adelsberger, Joseph W.; Rupert, Adam; Stevens, Randy; Yang, Jun; Huang, Dawei; Lempicki, Richard A.; Baseler, Michael W.; Imamichi, Tomozumi] Frederick Natl Lab Canc Res, Clin Serv Program, Appl & Dev Directorate, Frederick, MD 21702 USA; [Zhou, Ming] Frederick Natl Lab Canc Res, Lab Prote & Analyt Technol, Adv Technol Program Directorate, Sci Applicat Int Corp,Frederick Inc, Frederick, MD 21702 USA; [Lane, H. Clifford] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Imamichi, T (corresponding author), Frederick Natl Lab Canc Res, Lab Human Retrovirol, Appl & Dev Directorate, Sci Applicat Int Corp,Frederick Inc, Bldg 550,Rm 126,1050 Boyles St, Frederick, MD 21702 USA.	timamichi@mail.nih.gov	Lempicki, Richard A/E-1844-2012	Lempicki, Richard A/0000-0002-7059-409X; Imamichi, Tomozumi/0000-0002-1474-1796	National Institutes of Health [HHSN261200800001E]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by a National Institutes of Health Grant under Contract HHSN261200800001E. This work was also supported in part by the National Institute of Allergy and Infectious Diseases.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; BOHNLEIN E, 1989, J VIROL, V63, P1578; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Casoli C, 2007, AIDS REV, V9, P140; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059194; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; Dai L, 2013, J EXP MED, V210, P517, DOI 10.1084/jem.20120572; DiSanto JP, 1995, IMMUNOL REV, V148, P19; Fakruddin JM, 2007, BLOOD, V109, P1841, DOI 10.1182/blood-2006-02-001578; Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0; FOLI BA, 1995, BLOOD, V85, P2114, DOI 10.1182/blood.V85.8.2114.bloodjournal8582114; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Greenwell-Wild T, 2009, BLOOD, V114, P1864, DOI 10.1182/blood-2009-03-211540; HAERTLE T, 1988, J BIOL CHEM, V263, P5870; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hatzakis A, 2000, LANCET, V355, P599, DOI 10.1016/S0140-6736(99)10311-8; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Hou W, 2009, J VIROL, V83, P3834, DOI 10.1128/JVI.01773-08; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Imamichi T, 2003, J VIROL, V77, P1011, DOI 10.1128/JVI.77.2.1011-1020.2003; Imamichi T, 2000, J VIROL, V74, P10958, DOI 10.1128/JVI.74.23.10958-10964.2000; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; KALTER DC, 1991, J IMMUNOL, V146, P298; Kamata M., 2009, PLOS PATHOG, V5; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kobayashi M, 2005, J BIOL CHEM, V280, P18573, DOI 10.1074/jbc.C500082200; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; McNees AL, 2005, J CLIN VIROL, V34, P52, DOI 10.1016/j.jcv.2004.12.018; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Moriuchi H, 1998, J EXP MED, V187, P1689, DOI 10.1084/jem.187.10.1689; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Oguariri RM, 2007, J BIOL CHEM, V282, P3594, DOI 10.1074/jbc.M608150200; PAUWELS R, 1987, J VIROL METHODS, V16, P171, DOI 10.1016/0166-0934(87)90002-4; PERNO CF, 1992, BLOOD, V80, P995; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; Poli G, 1993, Semin Immunol, V5, P165, DOI 10.1006/smim.1993.1020; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; Saifuddin M, 2000, J IMMUNOL, V164, P3941, DOI 10.4049/jimmunol.164.8.3941; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Swaminathan S, 2013, BIOCHEM BIOPH RES CO, V434, P228, DOI 10.1016/j.bbrc.2013.03.046; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xiang JH, 2004, LANCET, V363, P2040, DOI 10.1016/S0140-6736(04)16453-2; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	67	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17812	17822		10.1074/jbc.M113.468975	http://dx.doi.org/10.1074/jbc.M113.468975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640893	Green Published, hybrid			2022-12-25	WOS:000320380600070
J	Kawashima, S; Ueki, Y; Mima, T; Fukuyama, H; Ojika, K; Matsukawa, N				Kawashima, Shoji; Ueki, Yoshino; Mima, Tatsuya; Fukuyama, Hidenao; Ojika, Kosei; Matsukawa, Noriyuki			Differences in Dopaminergic Modulation to Motor Cortical Plasticity between Parkinson's Disease and Multiple System Atrophy	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; OLIVOPONTOCEREBELLAR ATROPHY; DEPENDENT PLASTICITY; EXCITABILITY; RECEPTORS; POTENTIATION; STIMULATION; DIAGNOSIS; CRITERIA	Dopamine modulates the synaptic plasticity in the primary motor cortex (M1). To evaluate whether the functioning of the cortico-striatal circuit is necessary for this modulation, we applied a paired associative stimulation (PAS) protocol that comprised an electric stimulus to the right median nerve at the wrist and subsequent transcranial magnetic stimulation of the left M1, to 10 patients with Parkinson's disease (PD) and 10 with multiple system atrophy of the parkinsonian type (MSA-P) with and without dopamine replacement therapy (-on/off). To investigate the M1 function, motor-evoked potentials (MEPs) were measured before and after the PAS. In both patient groups without medication, the PAS protocol failed to increase the averaged amplitude of MEPs. The dopamine replacement therapy in PD, but not in MSA-P effectively restored the PAS-induced MEP increase. This suggests that not the existence of dopamine itself but the activation of cortico-striatal circuit might play an important role for cortical plasticity in the human M1.	[Kawashima, Shoji; Ueki, Yoshino; Ojika, Kosei; Matsukawa, Noriyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Neurol & Neurosci, Nagoya, Aichi, Japan; [Mima, Tatsuya; Fukuyama, Hidenao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan	Nagoya City University; Kyoto University	Ueki, Y (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Neurol & Neurosci, Nagoya, Aichi, Japan.	yueki@med.nagoya-cu.ac.jp	Fukuyama, Hidenao/AAI-7118-2020	Mima, Tatsuya/0000-0001-7787-4855	Takeda Pharmaceutical Company; Ministry of Education, Culture, Sports, Science and Technology	Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Takeda Pharmaceutical Company and the Ministry of Education, Culture, Sports, Science and Technology to Y.U. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 1997, MOVEMENT DISORD, V12, P315, DOI 10.1002/mds.870120309; Brooks DJ, 2009, MOVEMENT DISORD, V24, P949, DOI 10.1002/mds.22413; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Brown P, 1998, LANCET, V351, P1801, DOI 10.1016/S0140-6736(97)11225-9; Cantello R, 2007, NEUROSCIENCE, V150, P64, DOI 10.1016/j.neuroscience.2007.08.033; Centonze D, 2003, J NEUROSCI, V23, P8506, DOI 10.1523/jneurosci.23-24-08506.2003; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; CHERUBINI E, 1988, J PHYSIOL-LONDON, V400, P677, DOI 10.1113/jphysiol.1988.sp017143; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Eusebio A, 2007, CLIN NEUROPHYSIOL, V118, P815, DOI 10.1016/j.clinph.2007.01.004; FRITH CD, 1986, J NEUROL NEUROSUR PS, V49, P661, DOI 10.1136/jnnp.49.6.661; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Gilman S, 1999, ANN NEUROL, V45, P769, DOI 10.1002/1531-8249(199906)45:6<769::AID-ANA11>3.0.CO;2-G; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; HERRLING PL, 1985, NEUROSCIENCE, V14, P417, DOI 10.1016/0306-4522(85)90301-X; Huang YZ, 2011, BRAIN, V134, P2312, DOI 10.1093/brain/awr158; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Ito S, 2009, AM J NEURORADIOL, V30, P689, DOI 10.3174/ajnr.A1443; Kawashima S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031728; Kita H, 1996, NEUROSCIENCE, V70, P925, DOI 10.1016/0306-4522(95)00410-6; Kolomiets B, 2009, CEREB CORTEX, V19, P2708, DOI 10.1093/cercor/bhp047; Kuhn AA, 2004, CLIN NEUROPHYSIOL, V115, P1786, DOI 10.1016/j.clinph.2004.03.020; Lefaucheur JP, 2005, CLIN NEUROPHYSIOL, V116, P244, DOI 10.1016/j.clinph.2004.11.017; Marchese R, 2000, MOVEMENT DISORD, V15, P1210, DOI 10.1002/1531-8257(200011)15:6<1210::AID-MDS1022>3.0.CO;2-R; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Matsuda Y, 2006, J NEUROSCI, V26, P4803, DOI 10.1523/JNEUROSCI.5312-05.2006; Miyatake S, 2010, J NEUROL, V257, P419, DOI 10.1007/s00415-009-5338-5; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Monte-Silva K, 2010, J PHYSIOL-LONDON, V588, P3415, DOI 10.1113/jphysiol.2010.190181; Morgante F, 2006, BRAIN, V129, P1059, DOI 10.1093/brain/awl031; Nitsche MA, 2010, REV NEUROSCIENCE, V21, P289; Nitsche MA, 2009, J NEUROSCI, V29, P2648, DOI 10.1523/JNEUROSCI.5366-08.2009; OPPENHEIMER DR, 1992, GREENFIELDS NEUROPAT, P988; Osaki Y, 2002, NEUROLOGY, V59, P1486, DOI 10.1212/01.WNL.0000028690.15001.00; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Picconi B, 2004, J NEUROSCI, V24, P5283, DOI 10.1523/JNEUROSCI.1224-04.2004; RINNE JO, 1995, J NEUROL SCI, V132, P156, DOI 10.1016/0022-510X(95)00137-Q; Rolland Y, 2011, J NEUROL NEUROSUR PS, V82, P1025, DOI 10.1136/jnnp.2010.214890; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell J, 2007, PARKINSONISM RELAT D, V13, pS417, DOI 10.1016/S1353-8020(08)70040-3; Sakurai K, 2010, NEURORADIOLOGY, V52, P809, DOI 10.1007/s00234-009-0621-9; SCHNIDER A, 1995, BRAIN, V118, P485, DOI 10.1093/brain/118.2.485; Smiley-Oyen AL, 2003, EXP BRAIN RES, V152, P453, DOI 10.1007/s00221-003-1570-x; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Ueki Y, 2006, ANN NEUROL, V59, P60, DOI 10.1002/ana.20692; Van Laere K, 2010, J NUCL MED, V51, P588, DOI 10.2967/jnumed.109.070144; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Wu AD, 2007, MOVEMENT DISORD, V22, P1587, DOI 10.1002/mds.21565; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	52	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62515	10.1371/journal.pone.0062515	http://dx.doi.org/10.1371/journal.pone.0062515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658735	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100012
J	Paldanius, PM; Ivaska, KK; Hovi, P; Andersson, S; Eriksson, JG; Vaananen, K; Kajantie, E; Makitie, O				Paldanius, Paivi M.; Ivaska, Kaisa K.; Hovi, Petteri; Andersson, Sture; Eriksson, Johan G.; Vaananen, Kalervo; Kajantie, Eero; Makitie, Outi			Total and Carboxylated Osteocalcin Associate with Insulin Levels in Young Adults Born with Normal or Very Low Birth Weight	PLOS ONE			English	Article							BETA-CELL FUNCTION; SERUM OSTEOCALCIN; GLUCOSE-TOLERANCE; PLASMA-GLUCOSE; BONE TURNOVER; RESISTANCE; METABOLISM; MARKERS; ASSAYS; MASS	Objective: Osteocalcin (OC), a bone-derived protein, has been implicated in the regulation of glucose and energy metabolism. Young adults born with very low birth weight (VLBW) have altered glucose regulation and lower bone mineral density (BMD) compared with those born at term. The aim of this study was to explore the association between bone and glucose metabolism in healthy young adults born prematurely or at term. Methods: The cohort of this cross-sectional study comprised 332 non-diabetic young adults (age 18 to 27 years) born either preterm with VLBW (n = 163) or at term (n = 169). OC, carboxylated osteocalcin (cOC) and markers of glucose metabolism were measured at fasting and after a 75-g oral glucose tolerance test (OGTT). Results: VLBW adults were shorter, had lower BMD (p < 0.001) and higher fasting OC (p = 0.027) and cOC (p = 0.005) than term-born subjects. They also had higher 2-hour insulin (p = 0.001) and glucose (p = 0.037) concentrations. OGTT induced a significant reduction in OC (p < 0.001), similar in both groups. OC reduction was not associated with OGTT-induced increases in insulin (p = 0.54). However, fasting total OC and cOC correlated negatively with fasting insulin after adjustment for age, gender, BMD and VLBW status (r = -0.182, p = 0.009 and r = -0.283, p < 0.001, respectively). Conclusion: Adults born with VLBW have higher OC and cOC than their peers born at term. This may in part reflect the mechanisms that underlie their lower BMD and decreased insulin sensitivity. Serum OC appears to be negatively associated with long-term glucose regulation whereas acute changes during OGTT may be mediated via other mechanisms.	[Paldanius, Paivi M.; Hovi, Petteri; Andersson, Sture; Kajantie, Eero; Makitie, Outi] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Paldanius, Paivi M.; Hovi, Petteri; Andersson, Sture; Kajantie, Eero; Makitie, Outi] Univ Helsinki, Inst Clin Med, Helsinki, Finland; [Paldanius, Paivi M.] Novartis Pharma AG, Basel, Switzerland; [Ivaska, Kaisa K.; Vaananen, Kalervo] Univ Turku, Inst Biomed, Dept Cell Biol & Anat, Turku, Finland; [Hovi, Petteri; Eriksson, Johan G.; Kajantie, Eero] Natl Inst Hlth & Welf, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.; Makitie, Outi] Folkhalsan Res Ctr, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Novartis; University of Turku; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center	Paldanius, PM (corresponding author), Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland.	ppaldanius@gmail.com	Ivaska, Kaisa/G-1406-2012; Paldanius, Päivi/AAR-6793-2020	Ivaska, Kaisa/0000-0001-7482-7623; Paldanius, Paivi Maria/0000-0001-5997-4879; Makitie, Outi/0000-0002-4547-001X; Eriksson, Johan/0000-0002-2516-2060	Academy of Finland; Foundation for Pediatric Research; Sigrid Juselius Foundation; Orion-Farmos Research Foundation; Clinical Chemistry Research Foundation; Folkhalsan Research Foundation; Helsinki University Hospital Research Funds; Novo Nordisk Fonden [NNF12OC1016374] Funding Source: researchfish	Academy of Finland(Academy of Finland); Foundation for Pediatric Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Orion-Farmos Research Foundation; Clinical Chemistry Research Foundation; Folkhalsan Research Foundation; Helsinki University Hospital Research Funds; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was financially supported by grants from the Academy of Finland, the Foundation for Pediatric Research, the Sigrid Juselius Foundation, the Orion-Farmos Research Foundation, the Clinical Chemistry Research Foundation, the Folkhalsan Research Foundation and the Helsinki University Hospital Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff S.L, 2004, DIABETES SPECTR, V17, P183, DOI [DOI 10.2337/DIASPECT.17.3.183, 10.2337/diaspect.17.3.183]; Basu R, 2011, J CLIN ENDOCR METAB, V96, P1450, DOI 10.1210/jc.2010-2877; Booth SL, 2013, NAT REV ENDOCRINOL, V9, P43, DOI 10.1038/nrendo.2012.201; Brennan-Speranza TC, 2012, J CLIN INVEST, V122, P4172, DOI 10.1172/JCI63377; Bullo M, 2012, AM J CLIN NUTR, V95, P249, DOI 10.3945/ajcn.111.016642; CARTER DR, 1992, J BONE MINER RES, V7, P137; Clemens TL, 2011, J BONE MINER RES, V26, P677, DOI 10.1002/jbmr.321; Clowes JA, 2002, J CLIN ENDOCR METAB, V87, P3324, DOI 10.1210/jc.87.7.3324; Cryer PE., 1992, WILLIAMS TXB ENDOCRI, P1223; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Gravenstein KS, 2011, J CLIN ENDOCR METAB, V96, pE884, DOI 10.1210/jc.2010-2589; Gundberg CM, 2012, ADV NUTR, V3, P149, DOI 10.3945/an.112.001834; Hack M, 2005, PEDIATR RES, V58, P677, DOI 10.1203/01.PDR.0000180551.93470.56; Hellman J, 1996, J BONE MINER RES, V11, P1165; Henriksen DB, 2003, J BONE MINER RES, V18, P2180, DOI 10.1359/jbmr.2003.18.12.2180; Henriksen DB, 2007, BONE, V40, P723, DOI 10.1016/j.bone.2006.09.025; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045; Iglesias P, 2011, CLIN ENDOCRINOL, V75, P184, DOI 10.1111/j.1365-2265.2011.04035.x; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Kakonen SM, 2000, CLIN CHEM, V46, P332; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Kindblom JM, 2009, J BONE MINER RES, V24, P785, DOI [10.1359/jbmr.081234, 10.1359/JBMR.081234]; Kovacs CS, 2006, PRIMER METABOLIC BON, P63; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leger J, 1997, BRIT MED J, V315, P341; Fernandez-Real JM, 2009, J CLIN ENDOCR METAB, V94, P237, DOI 10.1210/jc.2008-0270; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Motyl KJ, 2010, ARCH BIOCHEM BIOPHYS, V503, P2, DOI 10.1016/j.abb.2010.07.030; Paldanius PM, 2012, CALCIFIED TISSUE INT, V90, P90, DOI 10.1007/s00223-011-9551-8; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Sayer AA, 2005, EARLY HUM DEV, V81, P735, DOI 10.1016/j.earlhumdev.2005.07.003; Schwetz V, 2012, EUR J ENDOCRINOL, V166, P959, DOI 10.1530/EJE-12-0030; Shea MK, 2009, AM J CLIN NUTR, V90, P1230, DOI 10.3945/ajcn.2009.28151; Smith CM, 2011, CLIN ENDOCRINOL, V75, P443, DOI 10.1111/j.1365-2265.2011.04118.x; Szathmari M, 2000, CALCIFIED TISSUE INT, V67, P429, DOI 10.1007/s002230001193; Vaccaro O, 1999, DIABETES CARE, V22, P1490, DOI 10.2337/diacare.22.9.1490; Wallum BJ, 1992, INT TXB DIABETES MEL, P285; Xie D, 2007, BONE, V40, P1352, DOI 10.1016/j.bone.2007.01.007	44	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63036	10.1371/journal.pone.0063036	http://dx.doi.org/10.1371/journal.pone.0063036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658795	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100050
J	Bubl, E; Dorr, M; Philipsen, A; Ebert, D; Bach, M; van Elst, LT				Bubl, Emanuel; Doerr, Michael; Philipsen, Alexandra; Ebert, Dieter; Bach, Michael; van Elst, Ludger Tebartz			Retinal Contrast Transfer Functions in Adults with and without ADHD	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; VISUALLY EVOKED-POTENTIALS; STEADY-STATE RESPONSES; PARKINSONS-DISEASE; SELECTIVE ATTENTION; DEPRESSIVE DISORDER; RATING-SCALE; CHILDREN; DOPAMINE	In previous studies, we found a strong reduction in contrast perception and retinal contrast gain in patients with major depression, which normalized after remission of depression. We also identified a possible role of the dopaminergic system in this effect, because visual contrast perception depends on dopaminergic neurotransmission. Dopamine is also known to play an important role in the pathogenesis of attention deficit hyperactivity disorder (ADHD). Therefore, in order to explore the specificity of retinal contrast gain as a marker of depression in comparison with other psychiatric diseases, we recorded the pattern electroretinogram (PERG) in patients with ADHD. Twenty patients diagnosed with ADHD and 20 matched healthy subjects were studied. Visual pattern electroretinograms were recorded from both eyes. The contrast gain of the patients with attention deficit disorder (ADD) did not differ from the control group, nor did the contrast gain of any ADHD subgroup (predominantly inattentive or combined patients). In the healthy subjects, a significant correlation between depression score and contrast gain was found. As the contrast gain in an earlier study clearly separated the patients with depression from the controls, we assume that retinal contrast gain might be a specific marker in depression.	[Bubl, Emanuel; Doerr, Michael; Philipsen, Alexandra; Ebert, Dieter; van Elst, Ludger Tebartz] Univ Freiburg, Dept Psychiat & Psychotherapy, D-79106 Freiburg, Germany; [Bach, Michael] Univ Freiburg, Univ Eye Hosp, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	van Elst, LT (corresponding author), Univ Freiburg, Dept Psychiat & Psychotherapy, Hugstetter Str 55, D-79106 Freiburg, Germany.	tebartzvanelst@uniklinik-freiburg.de	Bach, Michael/A-6637-2010; Philipsen, Alexandra/E-4505-2017	Bach, Michael/0000-0003-2028-535X; Philipsen, Alexandra/0000-0001-6876-518X; Bubl, Emanuel/0000-0003-4951-8970				Ahrendts J, 2011, WORLD J BIOL PSYCHIA, V12, P260, DOI 10.3109/15622975.2010.518624; Bach M, 1997, SPATIAL VISION, V10, P403, DOI 10.1163/156856897X00311; Bach M, 1999, DOC OPHTHALMOL, V99, P69, DOI 10.1023/A:1002648202420; Bach M., 2006, PRINCIPLES PRACTICE, P185; Bach M., 2000, FREIBURG EVOKED POTE; Bach M., 2007, PREPARATION MONTAGE; Bach M, 2007, GRAEF ARCH CLIN EXP, V245, P965, DOI 10.1007/s00417-006-0474-4; Bach M, 2013, DOC OPHTHALMOL, V126, P1, DOI 10.1007/s10633-012-9353-y; Bartgis J, 2009, DEV NEUROPSYCHOL, V34, P663, DOI 10.1080/87565640902964474; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bellgrove MA, 2009, ARCH GEN PSYCHIAT, V66, P1135, DOI 10.1001/archgenpsychiatry.2009.120; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Biederman J, 2010, AM J PSYCHIAT, V167, P409, DOI 10.1176/appi.ajp.2009.09050736; Bodis-Wollner I, 1998, VISION RES, V38, P1479, DOI 10.1016/S0042-6989(98)00028-5; Bodis-Wollner I, 2006, PRINCIPLES PRACTICE, P867; Brennan AR, 2008, ANN NY ACAD SCI, V1129, P236, DOI 10.1196/annals.1417.007; Bubl E, 2012, BRIT J PSYCHIAT, V201, P151, DOI 10.1192/bjp.bp.111.100560; Bubl E, 2010, BIOL PSYCHIAT, V68, P205, DOI 10.1016/j.biopsych.2010.02.009; Bubl E, 2009, WORLD J BIOL PSYCHIA, V10, P377, DOI 10.1080/15622970701513756; Bundesarztekammer B, 2007, ADHS ERWACHSENENALTE; Djamgoz MBA, 1997, VISION RES, V37, P3509, DOI 10.1016/S0042-6989(97)00129-6; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Faraone SV, 1998, BIOL PSYCHIAT, V44, P951, DOI 10.1016/S0006-3223(98)00240-6; Jonkman LM, 2004, CLIN NEUROPHYSIOL, V115, P1537, DOI 10.1016/j.clinph.2004.01.022; KUPERSMITH MJ, 1982, ARCH NEUROL-CHICAGO, V39, P284, DOI 10.1001/archneur.1982.00510170026007; Langheinrich T, 2000, CLIN NEUROPHYSIOL, V111, P66, DOI 10.1016/S1388-2457(99)00223-0; Lavoie MP, 2009, BIOL PSYCHIAT, V66, P253, DOI 10.1016/j.biopsych.2008.11.020; MAFFEI L, 1981, SCIENCE, V211, P953, DOI 10.1126/science.7466368; Martin L, 2008, ACTA OPHTHALMOL, V86, P259, DOI 10.1111/j.1755-3768.2008.01189.x; MASSON G, 1993, FUND CLIN PHARMACOL, V7, P449, DOI 10.1111/j.1472-8206.1993.tb01041.x; Meigen T, 1999, DOC OPHTHALMOL, V98, P207, DOI 10.1023/A:1002097208337; Normann C, 2007, BIOL PSYCHIAT, V62, P373, DOI 10.1016/j.biopsych.2006.10.006; Retz-Junginger P, 2002, NERVENARZT, V73, P830, DOI 10.1007/s00115-001-1215-x; Roessner V, 2008, J NEURAL TRANSM, V115, P235, DOI 10.1007/s00702-007-0817-2; Rosler M, 2004, NERVENARZT, V75, P888, DOI 10.1007/s00115-003-1622-2; SPECK LB, 1966, ARCH GEN PSYCHIAT, V15, P59; Steer RA, 2003, J PERS ASSESS, V80, P58, DOI 10.1207/S15327752JPA8001_14; van der Stelt O, 2001, COGNITIVE BRAIN RES, V12, P245, DOI 10.1016/S0926-6410(01)00055-6; van Elst LT, 1997, BRAIN, V120, P2219, DOI 10.1093/brain/120.12.2219; VICTOR JD, 1993, VISUAL NEUROSCI, V10, P939, DOI 10.1017/S0952523800006155; WARD MF, 1993, AM J PSYCHIAT, V150, P885	41	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61728	10.1371/journal.pone.0061728	http://dx.doi.org/10.1371/journal.pone.0061728			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658697	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500010
J	Balbas-Martinez, C; Rodriguez-Pinilla, M; Casanova, A; Dominguez, O; Pisano, DG; Gomez, G; Lloreta, J; Lorente, JA; Malats, N; Real, FX				Balbas-Martinez, Cristina; Rodriguez-Pinilla, Maria; Casanova, Ariel; Dominguez, Orlando; Pisano, David G.; Gomez, Gonzalo; Lloreta, Josep; Lorente, Jose A.; Malats, Nuria; Real, Francisco X.			ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors	PLOS ONE			English	Article							TRANSITIONAL-CELL-CARCINOMA; REMODELING GENE ARID1A; PROTEIN EXPRESSION; PIK3CA MUTATIONS; HEPATOCELLULAR-CARCINOMA; FREQUENT MUTATIONS; SOMATIC MUTATIONS; CANCER; LINES; RISK	Urothelial bladder cancer (UBC) is heterogeneous at the clinical, pathological, genetic, and epigenetic levels. Exome sequencing has identified ARID1A as a novel tumor suppressor gene coding for a chromatin remodeling protein that is mutated in UBC. Here, we assess ARID1A alterations in two series of patients with UBC. In the first tumor series, we analyze exons 2-20 in 52 primary UBC and find that all mutant tumors belong to the aggressive UBC phenotype (high grade non-muscle invasive and muscle invasive tumors) (P = 0.05). In a second series (n = 84), we assess ARID1A expression using immunohistochemistry, a surrogate for mutation analysis, and find that loss of expression increases with higher stage/grade, it is inversely associated with FGFR3 overexpression (P = 0.03) but it is not correlated with p53 overexpression (P = 0.30). We also analyzed the expression of cytokeratins in the same set of tumor and find, using unsupervised clustering, that tumors with ARID1A loss of expression are generally KRT5/6-low. In this patient series, loss of ARID1A expression is also associated with worse prognosis, likely reflecting the higher prevalence of losses found in tumors of higher stage and grade. The independent findings in these two sets of patients strongly support the notion that ARID1A inactivation is a key player in bladder carcinogenesis occurring predominantly in FGFR3 wild type tumors.	[Balbas-Martinez, Cristina; Casanova, Ariel; Real, Francisco X.] Spanish Natl Canc Res Ctr, Mol Pathol Programme, Epithelial Carcinogenesis Grp, Madrid, Spain; [Rodriguez-Pinilla, Maria] Spanish Natl Canc Res Ctr, Mol Pathol Programme, Lymphoma Grp, Madrid, Spain; [Dominguez, Orlando] Spanish Natl Canc Res Ctr, Biotechnol Programme, Genom Unit, Madrid, Spain; [Pisano, David G.; Gomez, Gonzalo] Spanish Natl Canc Res Ctr, Struct & Computat Biol Programme, Bioinformat Unit, Madrid, Spain; [Lloreta, Josep] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Lloreta, Josep; Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencias Expt & Salut, Barcelona, Spain; [Lorente, Jose A.] Hosp del Mar, Urol Serv, Barcelona, Spain; [Malats, Nuria] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Genet & Mol Epidemiol Grp, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Centro Nacional de Investigaciones Oncologicas (CNIO)	Real, FX (corresponding author), Spanish Natl Canc Res Ctr, Mol Pathol Programme, Epithelial Carcinogenesis Grp, Madrid, Spain.	freal@cnio.es	Malats, Nuria/H-7041-2015; Lloreta-Trull, Josep/GRR-9682-2022; Dominguez, Orlando/M-7515-2018; Pisano, David/N-5817-2014; Lloreta, J/I-2112-2014; Lloreta-Trull, Josep/AAZ-1229-2020; Arribas, Francisco X Real/H-5275-2015; Gomez-Lopez, Gonzalo/D-9123-2016	Malats, Nuria/0000-0003-2538-3784; Pisano, David/0000-0002-4895-4124; Lloreta, J/0000-0003-1644-9470; Arribas, Francisco X Real/0000-0001-9501-498X; Gomez-Lopez, Gonzalo/0000-0002-4146-0551; Balbas Martinez, Cristina/0000-0002-2565-7733	Consolider ONCOBIO from Ministerio de Economia y Competitividad, Spain [00/0745, PI051436, PI061614, G03/174]; Red Tematica de Investigacion Cooperativa en Cancer from Instituto de Salud Carlos III [D06/0020-RTICC]; Asociacion Espanola Contra el Cancer; EU [201663, 201333]; La Caixa International PhD Fellowship	Consolider ONCOBIO from Ministerio de Economia y Competitividad, Spain; Red Tematica de Investigacion Cooperativa en Cancer from Instituto de Salud Carlos III(Instituto de Salud Carlos III); Asociacion Espanola Contra el Cancer; EU(European Commission); La Caixa International PhD Fellowship(La Caixa Foundation)	This work was supported in part by grant Consolider ONCOBIO from Ministerio de Economia y Competitividad, Spain; grants 00/0745, PI051436, PI061614, G03/174 and Red Tematica de Investigacion Cooperativa en Cancer (grant RD06/0020-RTICC) from Instituto de Salud Carlos III; Asociacion Espanola Contra el Cancer; and EU FP7 grant agreement numbers 201663 (UROMOL) and 201333 (DECANBIO). CBM is recipient of a La Caixa International PhD Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AFS, 2012, JNCI-J NATL CANCER I, V104, P1897, DOI 10.1093/jnci/djs444; Bakkar AA, 2003, CANCER RES, V63, P8108; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Deem AK, 2012, CHROMOSOMA, V121, P131, DOI 10.1007/s00412-011-0358-1; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Guey LT, 2010, EUR UROL, V57, P283, DOI 10.1016/j.eururo.2009.08.001; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hafner C, 2006, J CLIN INVEST, V116, P2201, DOI 10.1172/JCI28163; Hernandez S, 2005, CLIN CANCER RES, V11, P5444, DOI 10.1158/1078-0432.CCR-05-0122; Hernandez S, 2006, J CLIN ONCOL, V24, P3664, DOI 10.1200/JCO.2005.05.1771; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LIN CW, 1985, CANCER RES, V45, P5070; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; Lopez-Knowles E, 2006, CLIN CANCER RES, V12, P6029, DOI 10.1158/1078-0432.CCR-06-0206; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Luis NM, 2007, CLIN TRANSL ONCOL, V9, P5, DOI 10.1007/s12094-007-0003-x; Malats W, 2005, LANCET ONCOL, V6, P678; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; MASTERS JRW, 1986, CANCER RES, V46, P3630; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Real FX, 2007, J CLIN ONCOL, V25, P5341, DOI 10.1200/JCO.2007.13.1904; RIEGER KM, 1995, BRIT J CANCER, V72, P683, DOI 10.1038/bjc.1995.394; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; Sabichi A, 2006, J UROLOGY, V175, P1133, DOI 10.1016/S0022-5347(05)00323-X; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Thomas F, 2012, CANCER, DOI [10.1002/cncr.27587, DOI 10.1002/CNCR.27587.[]; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Vallot C, 2011, JNCI-J NATL CANCER I, V103, P47, DOI 10.1093/jnci/djq470; van Rhijn BWG, 2012, J UROLOGY, V187, P310, DOI 10.1016/j.juro.2011.09.008; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yamamoto S, 2012, MODERN PATHOL, V25, P615, DOI 10.1038/modpathol.2011.189; Yamamoto S, 2012, VIRCHOWS ARCH, V460, P77, DOI 10.1007/s00428-011-1169-8; ZHANG JL, 2011, DATABASE-OXFORD, V20, DOI DOI 10.1088/1674-1056/20/2/026401; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922, 10.1371/journal.pone.0060781]	55	44	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62483	10.1371/journal.pone.0062483	http://dx.doi.org/10.1371/journal.pone.0062483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650517	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000052
J	Cardoso, P; Rigal, F; Fattorini, S; Terzopoulou, S; Borges, PAV				Cardoso, Pedro; Rigal, Francois; Fattorini, Simone; Terzopoulou, Sofia; Borges, Paulo A. V.			Integrating Landscape Disturbance and Indicator Species in Conservation Studies	PLOS ONE			English	Article							ECOLOGICAL THRESHOLDS; ARTHROPOD COMMUNITIES; HABITAT FRAGMENTATION; OCEANIC ISLANDS; TROPICAL FOREST; BIODIVERSITY; AZORES; MANAGEMENT; DIVERSITY; RESPONSES	Successful conservation plans are conditioned by our ability to detect anthropogenic change in space and time and various statistical analyses have been developed to handle this critical issue. The main objective of this paper is to illustrate a new approach for spatial analysis in conservation biology. Here, we propose a two-step protocol. First, we introduce a new disturbance metric which provides a continuous measure of disturbance for any focal communities on the basis of the surrounding landscape matrix. Second, we use this new gradient to estimate species and community disturbance thresholds by implementing a recently developed method called Threshold Indicator Taxa ANalysis (TITAN). TITAN detects changes in species distributions along environmental gradients using indicators species analysis and assesses synchrony among species change points as evidence for community thresholds. We demonstrate our method with soil arthropod assemblages along a disturbance gradient in Terceira Island (Azores, Portugal). We show that our new disturbance metric realistically reflects disturbance patterns, especially in buffer zones (ecotones) between land use categories. By estimating species disturbance thresholds with TITAN along the disturbance gradient in Terceira, we show that species significantly associated with low disturbance differ from those associated with high disturbance in their biogeographical origin (endemics, non-endemic natives and exotics) and taxonomy (order). Finally, we suggest that mapping the disturbance community thresholds may reveal areas of primary interest for conservation, since these may host indigenous species sensitive to high disturbance levels. This new framework may be useful when: (1) both local and regional processes are to be reflected on single disturbance measures; (2) these are better quantified in a continuous gradient; (3) mapping disturbance of large regions using fine scales is necessary; (4) indicator species for disturbance are searched for and; (5) community thresholds are useful to understand the global dynamics of habitats.	[Cardoso, Pedro] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Cardoso, Pedro; Rigal, Francois; Fattorini, Simone; Terzopoulou, Sofia; Borges, Paulo A. V.] Univ Azores, Portuguese Platform Enhancing Ecol Res & Sustaina, Angra Do Heroismo, Azores, Portugal; [Cardoso, Pedro; Rigal, Francois; Fattorini, Simone; Terzopoulou, Sofia; Borges, Paulo A. V.] Univ Azores, Azorean Biodivers Grp GBA, CITA A, Angra Do Heroismo, Azores, Portugal; [Fattorini, Simone] Univ Milan, Dept Biotechnol & Biosci, Water Ecol Team, Milan, Italy; [Terzopoulou, Sofia] Univ Athens, Fac Biol, Dept Ecol & Taxon, Athens 11528, Greece	University of Helsinki; Universidade dos Acores; Universidade dos Acores; University of Milan; University of Milano-Bicocca; National & Kapodistrian University of Athens	Cardoso, P (corresponding author), Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland.	pedro.cardoso@helsinki.fi	Borges, Paulo/H-5153-2019; Fattorini, Simone/AAR-8028-2020; Cardoso, Pedro/AAY-9650-2020; Fattorini, Simone/E-7075-2012; Cardoso, Pedro/A-8820-2008; Borges, Paulo/B-2780-2008	Borges, Paulo/0000-0002-8448-7623; Fattorini, Simone/0000-0002-4517-2135; Cardoso, Pedro/0000-0001-8119-9960; Fattorini, Simone/0000-0002-4517-2135; Cardoso, Pedro/0000-0001-8119-9960; Borges, Paulo/0000-0002-8448-7623; Rigal, Francois/0000-0001-6882-1591	Direccao Regional dos Recursos Florestais [17.01-080203]; Direccao Regional da Ciencia e Tecnologia [M.2.1.2/I/003/2008]; Fundacao Ciencia e Tecnologia [SFRH/BPD/40688/2007, PTDC/BIA-BEC/100182/2008]; Azorean Biodiversity Group (CITA-A)	Direccao Regional dos Recursos Florestais; Direccao Regional da Ciencia e Tecnologia; Fundacao Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Azorean Biodiversity Group (CITA-A)	Data used in this manuscript were obtained in the projects funded by Direccao Regional dos Recursos Florestais (Project: 17.01-080203, 1999-2004) and Direccao Regional da Ciencia e Tecnologia (Project: "Consequences of land-use change on Azorean fauna and flora - the 2010 Target'', M.2.1.2/I/003/2008). Grants and fellowships to the authors were provided by Fundacao Ciencia e Tecnologia (SFRH/BPD/40688/2007 and PTDC/BIA-BEC/100182/2008 for PC and FR, respectively) and Azorean Biodiversity Group (CITA-A) (Summer 2010, 2011 and 2012 grants to SF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Baker ME, 2010, METHODS ECOL EVOL, V1, P25, DOI 10.1111/j.2041-210X.2009.00007.x; Basset Y, 2008, INSECT CONSERV DIVER, V1, P55, DOI 10.1111/j.1752-4598.2007.00011.x; Bonte D, 2008, BASIC APPL ECOL, V9, P726, DOI 10.1016/j.baae.2007.09.008; Borges P. A. V., 2008, INSECT ECOLOGY CONSE, P47; Borges P.A.V., 2010, LIST TERRESTRIAL MAR, P9; Borges PAV, 2006, J BIOGEOGR, V33, P169, DOI 10.1111/j.1365-2699.2005.01324.x; Borges PAV, 2004, B ENTOMOL RES, V94, P111, DOI 10.1079/BER2004289; Borges PAV, 2011, CELEBRATING DARWIN, P93; Brenden TO, 2008, ENVIRON MANAGE, V42, P821, DOI 10.1007/s00267-008-9150-2; Cardoso P, 2007, BIODIVERS CONSERV, V16, P2883, DOI 10.1007/s10531-006-9078-x; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; Cardoso P, 2010, J BIOGEOGR, V37, P1034, DOI 10.1111/j.1365-2699.2009.02264.x; Cardoso P, 2009, ACTA OECOL, V35, P590, DOI 10.1016/j.actao.2009.05.005; Carvalho JC, 2013, OIKOS IN PRESS; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; Comor V, 2008, BIODIVERS CONSERV, V17, P1837, DOI 10.1007/s10531-007-9290-3; Connor SE, 2012, J BIOGEOGR, V39, P1007, DOI 10.1111/j.1365-2699.2011.02671.x; Cuffney TF, 2011, ECOL APPL, V21, P2840, DOI 10.1890/10-2075.1; Cuffney TF, 2010, ECOL APPL, V20, P1384, DOI 10.1890/08-1311.1; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; Donaldson J, 2002, CONSERV BIOL, V16, P1267, DOI 10.1046/j.1523-1739.2002.99515.x; Drake DR, 2009, BIOL INVASIONS, V11, P1483, DOI 10.1007/s10530-008-9392-1; DROTRH. DireccAo Regional do Ordenamento do Territorio e Recursos Hidricos, 2008, CART OC SOL REG AUT; DUELLI P, 1990, BIOL CONSERV, V54, P193, DOI 10.1016/0006-3207(90)90051-P; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ewers RM, 2006, J APPL ECOL, V43, P527, DOI 10.1111/j.1365-2664.2006.01151.x; Fattorini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033995; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Gaspar C, 2011, J INSECT CONSERV, V15, P671, DOI 10.1007/s10841-010-9365-4; Gaston KJ, 2006, J ANIM ECOL, V75, P646, DOI 10.1111/j.1365-2656.2006.01085.x; Groffman P, 2006, ECOSYSTEMS, V9, P1, DOI 10.1007/s10021-003-0142-z; Huggett AJ, 2005, BIOL CONSERV, V124, P301, DOI 10.1016/j.biocon.2005.01.037; Jager H, 2007, BIOL CONSERV, V140, P297, DOI 10.1016/j.biocon.2007.08.014; Jardim R, 2008, FUNCHAL ANGRA HEROIS, P157; Kallimanis AS, 2005, CONSERV BIOL, V19, P534, DOI 10.1111/j.1523-1739.2005.00418.x; King RS, 2011, ECOL APPL, V21, P2833, DOI 10.1890/10-0882.1; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Malanson George P., 1999, Diversity and Distributions, V5, P27, DOI 10.1046/j.1472-4642.1999.00035.x; Martorell C, 2009, CONSERV BIOL, V23, P377, DOI 10.1111/j.1523-1739.2008.01134.x; Meijer SS, 2011, J INSECT CONSERV, V15, P505, DOI 10.1007/s10841-010-9330-2; MORAN VC, 1982, J ANIM ECOL, V51, P289, DOI 10.2307/4325; PAULAY G, 1994, AM ZOOL, V34, P134; Pe'er G, 2011, DIVERS DISTRIB, V17, P1186, DOI 10.1111/j.1472-4642.2011.00795.x; Pryke JS, 2012, LANDSCAPE ECOL, V27, P73, DOI 10.1007/s10980-011-9668-1; R Development Core Team, 2009, R FDN STAT COMP; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Sonderegger DL, 2009, FRONT ECOL ENVIRON, V7, P190, DOI 10.1890/070179; Starzomski BM, 2007, OIKOS, V116, P690, DOI 10.1111/j.2007.0030-1299.15547.x; Steadman DW, 2006, EXTINCTION BIOGEOGRA; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; Triantis KA, 2010, ECOGRAPHY, V33, P285, DOI 10.1111/j.1600-0587.2010.06203.x; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY	59	44	48	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63294	10.1371/journal.pone.0063294	http://dx.doi.org/10.1371/journal.pone.0063294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650560	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000105
J	Ehlen, JC; Hesse, S; Pinckney, L; Paul, KN				Ehlen, J. Christopher; Hesse, September; Pinckney, Lennisha; Paul, Ketema N.			Sex Chromosomes Regulate Nighttime Sleep Propensity during Recovery from Sleep Loss in Mice	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; WHITEHALL-II; FEMALE RATS; DURATION; SIESTA; WAKEFULNESS; OVARIECTOMY; PATTERNS; ESTROGEN; PERIOD	Sex differences in spontaneous sleep amount are largely dependent on reproductive hormones; however, in mice some sex differences in sleep amount during the active phase are preserved after gonadectomy and may be driven by non-hormonal factors. In this study, we sought to determine whether or not these sex differences are driven by sex chromosome complement. Mice from the four core genotype (FCG) mouse model, whose sex chromosome complement (XY, XX) is independent of phenotype (male or female), were implanted with electroencephalographic (EEG) and electromyographic (EMG) electrodes for the recording of sleep-wake states and underwent a 24-hr baseline recording followed by six hours of forced wakefulness. During baseline conditions in mice whose gonads remained intact, males had more total sleep and non-rapid eye movement sleep than females during the active phase. Gonadectomized FCG mice exhibited no sex differences in rest-phase sleep amount; however, during the mid-active-phase (nighttime), XX males had more spontaneous non-rapid eye movement (NREM) sleep than XX females. The XY mice did not exhibit sex differences in sleep amount. Following forced wakefulness there was a change in the factors regulating sleep. XY females slept more during their mid-active phase siestas than XX females and had higher NREM slow wave activity, a measure of sleep propensity. These findings suggest that the process that regulates sleep propensity is sex-linked, and that sleep amount and sleep propensity are regulated differently in males and females following sleep loss.	[Ehlen, J. Christopher; Hesse, September; Pinckney, Lennisha; Paul, Ketema N.] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA	Morehouse School of Medicine	Paul, KN (corresponding author), Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA.	kpaul@msm.edu	Ehlen, Christopher/GXV-9278-2022	Ehlen, J. Christopher/0000-0003-3223-9262	National Institute of Neurological Disorders and Stroke [NS078410, NS060659]; National Institute of General Medical Sciences [GM058268]; Science and Technology Centers Program of the National Science Foundation [IBN-9876754]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS060659, R01NS078410] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Science and Technology Centers Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke awards NS078410, NS060659, National Institute of General Medical Sciences award GM058268, and by the Science and Technology Centers Program of the National Science Foundation under Agreement No. IBN-9876754. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage R, 2007, ACTA PSYCHIAT SCAND, V115, P104, DOI 10.1111/j.1600-0447.2007.00968.x; Arnold AP, 2009, FRONT NEUROENDOCRIN, V30, P1, DOI 10.1016/j.yfrne.2008.11.001; Barker JM, 2010, J NEUROSCI, V30, P9140, DOI 10.1523/JNEUROSCI.0548-10.2010; BRANCHEY M, 1971, PHYSIOL BEHAV, V6, P743, DOI 10.1016/0031-9384(71)90267-8; Cappuccio FP, 2007, HYPERTENSION, V50, P693, DOI 10.1161/HYPERTENSIONAHA.107.095471; Carruth LL, 2002, NAT NEUROSCI, V5, P933, DOI 10.1038/nn922; COLVIN GB, 1969, EXP NEUROL, V25, P616, DOI 10.1016/0014-4886(69)90104-6; De Vries GJ, 2002, J NEUROSCI, V22, P9005; Fang JD, 1996, BRAIN RES, V734, P275, DOI 10.1016/0006-8993(96)00652-X; Gangwisch JE, 2010, SLEEP, V33, P956, DOI 10.1093/sleep/33.7.956; Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021; Li H, 1996, AM J PHYSIOL, V269, pR208; Lyytikainen Peppi, 2011, J Sleep Res, V20, P298, DOI 10.1111/j.1365-2869.2010.00903.x; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; McPhie-Lalmansingh AA, 2008, HORM BEHAV, V54, P565, DOI 10.1016/j.yhbeh.2008.05.016; Miller MA, 2009, SLEEP, V32, P857; Monk TH, 2001, SLEEP, V24, P680, DOI 10.1093/sleep/24.6.680; Naska A, 2007, ARCH INTERN MED, V167, P296, DOI 10.1001/archinte.167.3.296; Paul KN, 2006, SLEEP, V29, P1211, DOI 10.1093/sleep/29.9.1211; Pawlyk AC, 2008, HORM BEHAV, V53, P217, DOI 10.1016/j.yhbeh.2007.09.018; Reimao R, 2000, ARQ NEURO-PSIQUIAT, V58, P39, DOI 10.1590/S0004-282X2000000100006; Schwartz MD, 2011, PHYSIOL BEHAV, V104, P962, DOI 10.1016/j.physbeh.2011.06.016; Wijnen H, 2008, NEURON, V60, P943, DOI 10.1016/j.neuron.2008.12.009; Yamoaka S, 1980, BRAIN RES, V185, P385; Zaregarizi M, 2007, J APPL PHYSIOL, V103, P1332, DOI 10.1152/japplphysiol.00474.2007	25	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62205	10.1371/journal.pone.0062205	http://dx.doi.org/10.1371/journal.pone.0062205			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658713	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000034
J	Murray, DR; Schaller, M; Suedfeld, P				Murray, Damian R.; Schaller, Mark; Suedfeld, Peter			Pathogens and Politics: Further Evidence That Parasite Prevalence Predicts Authoritarianism	PLOS ONE			English	Article							RIGHT-WING AUTHORITARIANISM; INFECTIOUS-DISEASE; ASSORTATIVE SOCIALITY; DISGUST SENSITIVITY; PERCEIVED THREAT; ATTITUDES; CONFORMITY; AVOIDANCE; PREJUDICE; ORIGINS	According to a "parasite stress" hypothesis, authoritarian governments are more likely to emerge in regions characterized by a high prevalence of disease-causing pathogens. Recent cross-national evidence is consistent with this hypothesis, but there are inferential limitations associated with that evidence. We report two studies that address some of these limitations, and provide further tests of the hypothesis. Study 1 revealed that parasite prevalence strongly predicted cross-national differences on measures assessing individuals' authoritarian personalities, and this effect statistically mediated the relationship between parasite prevalence and authoritarian governance. The mediation result is inconsistent with an alternative explanation for previous findings. To address further limitations associated with cross-national comparisons, Study 2 tested the parasite stress hypothesis on a sample of traditional small-scale societies (the Standard Cross-Cultural Sample). Results revealed that parasite prevalence predicted measures of authoritarian governance, and did so even when statistically controlling for other threats to human welfare. (One additional threat-famine-also uniquely predicted authoritarianism.) Together, these results further substantiate the parasite stress hypothesis of authoritarianism, and suggest that societal differences in authoritarian governance result, in part, from cultural differences in individuals' authoritarian personalities.	[Murray, Damian R.; Schaller, Mark; Suedfeld, Peter] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Murray, DR (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	dmurray@psych.ubc.ca			Canada Graduate Scholarship	Canada Graduate Scholarship	This work was supported by a Canada Graduate Scholarship (awarded to DRM; http://www.sshrc-crsh.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2001, AM ECON REV, V91, P1369, DOI 10.1257/aer.91.5.1369; Acemoglu D., 2005, EC ORIGINS DICTATORS; Adorno Theodor W, 1950, AUTHORITARIAN PERSON; Altemeyer, 1996, AUTHORITARIAN SPECTE; Altemeyer B., 1988, ENEMIES FREEDOM UNDE; Cashdan E, HUM NATURE IN PRESS; Cohrs JC, 2009, BASIC APPL SOC PSYCH, V31, P81, DOI 10.1080/01973530802659638; Cohrs J.Christopher., 2005, ANAL SOC ISS PUB POL, V5, P263, DOI DOI 10.1111/J.1530-2415.2005.00071.X; Currie TE, 2012, BEHAV BRAIN SCI, V35, P83, DOI 10.1017/S0140525X11000963; Dirks Robert, 1993, CROSS-CULT RES, V27, P28, DOI DOI 10.1177/106939719302700103; DOTY RM, 1991, J PERS SOC PSYCHOL, V61, P629, DOI 10.1037/0022-3514.61.4.629; Easterly W, 2003, J MONETARY ECON, V50, P3, DOI 10.1016/S0304-3932(02)00200-3; Fabrega H, 1997, MED ANTHROPOL Q, V11, P26, DOI 10.1525/maq.1997.11.1.26; Faulkner J, 2004, GROUP PROCESS INTERG, V7, P333, DOI 10.1177/1368430204046142; Feldman S, 1997, POLIT PSYCHOL, V18, P741, DOI 10.1111/0162-895X.00077; Fincher CL, 2008, P ROY SOC B-BIOL SCI, V275, P2587, DOI 10.1098/rspb.2008.0688; Fincher CL, 2008, P ROY SOC B-BIOL SCI, V275, P1279, DOI 10.1098/rspb.2008.0094; Fincher CL, 2012, BEHAV BRAIN SCI, V35, P61, DOI 10.1017/S0140525X11000021; Gaddis John Lewis, 1997, WE NOW KNOW RETHINKI; Haber S, 2011, AM POLIT SCI REV, V105, P1, DOI 10.1017/S0003055410000584; Hackman J, EVOL HUM BE IN PRESS; Helzer EG, 2011, PSYCHOL SCI, V22, P517, DOI 10.1177/0956797611402514; Henriksen T.H., 2001, J INT AFF, V54, P349; Hetherington M.J., 2009, AUTHORITARIANISM POL; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Jones A, 2008, EMOTION, V8, P613, DOI 10.1037/a0013435; Jugert P, 2009, POLIT PSYCHOL, V30, P693, DOI 10.1111/j.1467-9221.2009.00722.x; Kool VK, 1983, AUTHORITARIANISM CUL; Lavine H, 2005, POLIT PSYCHOL, V26, P219, DOI 10.1111/j.1467-9221.2005.00416.x; Letendre K, 2010, BIOL REV, V85, P669, DOI 10.1111/j.1469-185X.2010.00133.x; Little AC, 2011, P ROY SOC B-BIOL SCI, V278, P2032, DOI 10.1098/rspb.2010.1925; Low B. S., 1988, HUMAN REPRODUCTIVE B, P115; MATHEWS JT, 1989, FOREIGN AFF, V68, P162, DOI 10.2307/20043906; Meloen J., 1996, DEMOCRACY SOCIALIZAT, P20; MURDOCK GP, 1969, ETHNOLOGY, V8, P329, DOI 10.2307/3772907; Murdock GPM, 1949, SOCIAL STRUCTURE; Murray DR, 2012, EUR J SOC PSYCHOL, V42, P180, DOI 10.1002/ejsp.863; Murray DR, 2011, PERS SOC PSYCHOL B, V37, P318, DOI 10.1177/0146167210394451; Murray DR, 2010, J CROSS CULT PSYCHOL, V41, P99, DOI 10.1177/0022022109349510; Navarrete CD, 2007, EVOL HUM BEHAV, V28, P60, DOI 10.1016/j.evolhumbehav.2006.06.002; Navarrete CD, 2006, EVOL HUM BEHAV, V27, P270, DOI 10.1016/j.evolhumbehav.2005.12.001; Nettle D, 2009, TRENDS ECOL EVOL, V24, P618, DOI 10.1016/j.tree.2009.05.013; Neuberg SL, 2011, NEUROSCI BIOBEHAV R, V35, P1042, DOI 10.1016/j.neubiorev.2010.08.011; PERRY RL, 2002, COMP ANAL NATIONS QU; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; ROSS MH, 1983, ETHNOLOGY, V22, P169, DOI 10.2307/3773578; SALES SM, 1973, J PERS SOC PSYCHOL, V28, P44, DOI 10.1037/h0035588; SCHALLER M, 2011, ADV CULTURE PSYCHOL, V1, P99; Schaller M, 2008, J PERS SOC PSYCHOL, V95, P212, DOI 10.1037/0022-3514.95.1.212; Schaller M, 2012, BEHAV BRAIN SCI, V35, P91, DOI 10.1017/S0140525X11001038; Schaller M, 2011, PHILOS T R SOC B, V366, P3418, DOI 10.1098/rstb.2011.0029; Thorisdottir H, 2011, POLIT PSYCHOL, V32, P785, DOI 10.1111/j.1467-9221.2011.00840.x; Thornhill R, 2010, EVOL PSYCHOL-US, V8, P151; Thornhill R, 2009, BIOL REV, V84, P113, DOI 10.1111/j.1469-185X.2008.00062.x; van Leeuwen F, 2012, EVOL HUM BEHAV, V33, P429, DOI 10.1016/j.evolhumbehav.2011.12.005; Vanhanen T., 2003, DEMOCRATIZATION COMP; Vestal T.M., 1999, ETHIOPIA POST COLD W; Whitley BE, 1999, J PERS SOC PSYCHOL, V77, P126, DOI 10.1037/0022-3514.77.1.126; WILSON GM, 1968, COMP STUD SOC HIST, V10, P401, DOI 10.1017/S0010417500005016; Wu BP, 2012, PERS INDIV DIFFER, V53, P50, DOI 10.1016/j.paid.2012.02.023; WYLIE L, 1992, PSYCHOL REP, V71, P1291, DOI 10.2466/PR0.71.8.1291-1298	61	86	88	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62275	10.1371/journal.pone.0062275	http://dx.doi.org/10.1371/journal.pone.0062275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23658718	Green Published, gold			2022-12-25	WOS:000319167000037
J	Filgueiras, MD; Morrot, A; Soares, PMG; Costa, ML; Mermelstein, C				Filgueiras, Marcelo de Carvalho; Morrot, Alexandre; Gomes Soares, Pedro Marcos; Costa, Manoel Luis; Mermelstein, Claudia			Effects of 5-Fluorouracil in Nuclear and Cellular Morphology, Proliferation, Cell Cycle, Apoptosis, Cytoskeletal and Caveolar Distribution in Primary Cultures of Smooth Muscle Cells	PLOS ONE			English	Article							DIFFERENTIATION; CHEMOTHERAPY; FIBROBLASTS; MEMBRANE; SKELETAL; PROTEIN; CANCER; DESMIN	Colon cancer is one of the most prevalent types of cancer in the world and is one of the leading causes of cancer death. The anti-metabolite 5-fluorouracil (5-FU) is widely used in the treatment of patients with colon cancer and other cancer types. 5-FU-based chemotherapy has been shown to be very efficient in the improvement of overall survival of the patients and for the eradication of the disease. Unfortunately, common side effects of 5-FU include severe alterations in the motility of the gastrointestinal tissues. Nevertheless, the molecular and cellular effects of 5-FU in smooth muscle cells are poorly understood. Primary smooth muscle cell cultures are an important tool for studies of the biological consequences of 5-FU at the cellular level. The avian gizzard is one of the most robust organs of smooth muscle cells. Here we studied the molecular and cellular effects of the chemotherapic drug 5-FU in a primary culture of chick gizzard smooth muscle cells. We found that treatment of smooth muscle cells with 5-FU inhibits cell proliferation by the arrest of cells in the G1 phase of cell cycle and induce apoptosis. 5-FU induced a decrease in the percentage of histone H3-positive cells. Treatment of cells with 5-FU induced changes in cellular and nuclear morphology, a decrease in the number of stress fibers and a major decrease in the number of caveolin-3 positive cells. Our results suggest that the disorganization of the actin cytoskeleton and the reduction of caveolin-3 expression could explain the alterations in contractility observed in patients treated with 5-FU. These findings might have an impact in the understanding of the cellular effects of 5-FU in smooth muscle tissues and might help the improvement of new therapeutic protocols for the treatment of colon cancer.	[Filgueiras, Marcelo de Carvalho; Costa, Manoel Luis; Mermelstein, Claudia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Diferenciacao Muscular & Citoesqueleto, Rio De Janeiro, Brazil; [Filgueiras, Marcelo de Carvalho; Gomes Soares, Pedro Marcos] Univ Fed Ceara, Dept Morfol, Fortaleza, Ceara, Brazil; [Filgueiras, Marcelo de Carvalho] Univ Fed Piaui, Teresina, Piaui, Brazil; [Morrot, Alexandre] Univ Fed Rio de Janeiro, Lab Imunol, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Ceara; Universidade Federal do Piaui; Universidade Federal do Rio de Janeiro	Mermelstein, C (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Diferenciacao Muscular & Citoesqueleto, Rio De Janeiro, Brazil.	mermelstein@ufrj.br	Costa, Manoel/B-5009-2010; mermelstein, Claudia S/C-1464-2010; SOARES, PEDRO/V-7562-2019	Costa, Manoel/0000-0002-9037-0085; mermelstein, Claudia S/0000-0002-8897-8526; SOARES, PEDRO/0000-0003-0606-2539	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programas de Apoio aos Nucleos de Excelencia (Pronex)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programas de Apoio aos Nucleos de Excelencia (Pronex)	This work was supported by Brazilian grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and the Programas de Apoio aos Nucleos de Excelencia (Pronex). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMPBELL GR, 1971, J CELL BIOL, V49, P21, DOI 10.1083/jcb.49.1.21; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Costa ML, 2004, BRAZ J MED BIOL RES, V37, P1819, DOI 10.1590/S0100-879X2004001200007; Cragg AH, 1992, VASC INTERV RADIOL, V3, P273; Draeger A, 2003, DEV BIOL, V262, P324, DOI 10.1016/S0012-1606(03)00398-1; DRAEGER A, 1990, J CELL BIOL, V111, P2463, DOI 10.1083/jcb.111.6.2463; GABELLA G, 1989, ANAT EMBRYOL, V180, P213, DOI 10.1007/BF00315880; Gordon SR, 2005, CELL MOTIL CYTOSKEL, V62, P244, DOI 10.1002/cm.20099; Huang L, 2010, BRIT J DERMATOL, V163, P1181, DOI 10.1111/j.1365-2133.2010.09939.x; Keefe DMK, 1997, CLIN SCI, V92, P385, DOI 10.1042/cs0920385; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Matuo R, 2009, J APPL TOXICOL, V29, P308, DOI 10.1002/jat.1411; Mermelstein CS, 2007, CELL TISSUE RES, V327, P343, DOI 10.1007/s00441-006-0296-z; Nelson K, 2002, SUPPORT CARE CANCER, V10, P455, DOI 10.1007/s00520-002-0340-9; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653; Soares PMG, 2008, CANCER CHEMOTH PHARM, V63, P91, DOI 10.1007/s00280-008-0715-9; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Taggart MJ, 2001, NEWS PHYSIOL SCI, V16, P61; Yang B, 1996, CLIN CANCER RES, V2, P1649	20	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63177	10.1371/journal.pone.0063177	http://dx.doi.org/10.1371/journal.pone.0063177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646193	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300148
J	Liu, J; Han, GQ; Liu, H; Qin, CY				Liu, Juan; Han, Guoqing; Liu, Hui; Qin, Chengyong			Suppression of Cholangiocarcinoma Cell Growth by Human Umbilical Cord Mesenchymal Stem Cells: A Possible Role of Wnt and Akt Signaling	PLOS ONE			English	Article							BETA-CATENIN TRANSACTIVATION; BREAST-CANCER; TUMOR STROMA; IN-VITRO; TARGET; PATHWAY; GENE; INHIBITION; EXPRESSION; MODEL	Emerging evidence indicates that human mesenchymal stem cells (hMSCs) can be recruited to tumor sites, and affect the growth of human malignancies. However, little is known about the underlying molecular mechanisms. Here, we observed the effects of hMSCs on the human cholangiocarcinoma cell line, HCCC-9810, using an animal transplantation model, and conditioned media from human umbilical cord-derived mesenchymal stem cells (hUC-MSCs). Animal studies showed that hUC-MSCs can inhibit the growth of cholangiocarcinoma xenograft tumors. In cell culture, conditioned media from hUC-MSCs inhibited proliferation and induced apoptosis of tumor cells in a dose- and time-dependent manner. The proliferation inhibition rate increased from 6.21% to 49.86%, whereas the apoptosis rate increased from 9.3% to 48.1% when HCCC-9810 cells were cultured with 50% hUC-MSC conditioned media for 24 h. Immunoblot analysis showed that the expression of phosphor-PDK1 (Ser241), phosphor-Akt (Ser 437 and Thr308), phosphorylated glycogen synthase kinase 3 beta (phospho-GSK3 beta(Ser9)), beta-catenin, cyclin-D1, and c-myc were down-regulated. We further demonstrated that CHIR99021, a GSK-3 beta inhibitor reversed the suppressive effects of hUC-MSCs on HCCC-9810 cells and increased the expression of beta-catenin. The GSK-3 beta activator, sodium nitroprusside dehydrate (SNP), augmented the anti-tumor effects of hUC-MSCs and decreased the expression of beta-catenin. IGF-1 acted as an Akt activator, and also reversed the suppressive effects of hUC-MSCs on HCCC-9810 cells. All these results suggest that hUC-MSCs could inhibit the malignant phenotype of HCCC-9810 human cholangiocarcinoma cell line. The cross-talk role of Wnt/beta-catenin and PI3K/Akt signaling pathway, with GSK-3 beta as the key enzyme bridging these pathways, may contribute to the inhibition of cholangiocarcinoma cells by hUC-MSCs.	[Liu, Juan; Han, Guoqing; Liu, Hui; Qin, Chengyong] Shandong Univ, Prov Hosp, Dept Gastroenterol, Jinan 250100, Peoples R China	Shandong University	Qin, CY (corresponding author), Shandong Univ, Prov Hosp, Dept Gastroenterol, Jinan 250100, Peoples R China.	qchengyong@yahoo.cn			Shandong Science and Technology Committee of China [2005GG3202192]	Shandong Science and Technology Committee of China	This work was supported by grant number 2005GG3202192 from the Shandong Science and Technology Committee of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2003, CANCER RES, V63, P728; Archuleta TD, 2004, PANMINERVA MED, V46, P61; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; Cho JA, 2009, CANCER-AM CANCER SOC, V115, P311, DOI 10.1002/cncr.24032; Correa S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-303; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Gardner SL, 2004, PEDIATR TRANSPLANT, V8, P28, DOI 10.1111/j.1398-2265.2004.00202.x; Gauthaman K, 2012, J CELL BIOCHEM, V113, P2027, DOI 10.1002/jcb.24073; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Hamada H, 2005, CANCER SCI, V96, P149, DOI 10.1111/j.1349-7006.2005.00032.x; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Higashi M, 2012, PATHOBIOLOGY, V79, P101, DOI 10.1159/000335164; Kaiser MJT, 2003, HISTOCHEM CELL BIOL, V120, P213, DOI 10.1007/s00418-003-0561-0; Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Koh TJ, 2000, J CLIN INVEST, V106, P533, DOI 10.1172/JCI9476; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Li L, 2011, ACTA BIOCH BIOPH SIN, V43, P143, DOI 10.1093/abbs/gmq118; Liu H, 2008, CANCER LETT, V270, P242, DOI 10.1016/j.canlet.2008.05.014; Lu YR, 2008, CANCER BIOL THER, V7, P245, DOI 10.4161/cbt.7.2.5296; Lu ZM, 2004, CELL CYCLE, V3, P571; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; McCleary-Wheeler AL, 2012, MOL CARCINOGEN, V51, P25, DOI 10.1002/mc.20827; Mulholland DJ, 2006, ONCOGENE, V25, P329, DOI 10.1038/sj.onc.1209020; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nathan H, 2007, J GASTROINTEST SURG, V11, P1488, DOI 10.1007/s11605-007-0282-0; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qiao L, 2008, CELL RES, V18, P500, DOI 10.1038/cr.2008.40; Schmitz KJ, 2007, WORLD J GASTROENTERO, V13, P6470, DOI 10.3748/wjg.13.6470; Seshareddy K, 2008, METHOD CELL BIOL, V86, P101, DOI 10.1016/S0091-679X(08)00006-X; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Song SM, 2009, CANCER RES, V69, P1343, DOI 10.1158/0008-5472.CAN-08-4153; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Weston CR, 2001, SCIENCE, V292, P2439, DOI 10.1126/science.1063279; Yoon H, 2011, BIOCHEM BIOPH RES CO, V405, P333, DOI 10.1016/j.bbrc.2010.11.130; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607	48	43	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62844	10.1371/journal.pone.0062844	http://dx.doi.org/10.1371/journal.pone.0062844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646150	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300103
J	Savage, VJ; Chopra, I; O'Neill, AJ				Savage, Victoria J.; Chopra, Ian; O'Neill, Alex J.			Population Diversification in Staphylococcus aureus Biofilms May Promote Dissemination and Persistence	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; LABORATORY STRAINS; COLONY VARIANTS; AGR; HEMOLYSIN; ADAPTATION; MECHANISMS; EXPRESSION; MUTATION; SARA	The biofilm mode of growth can lead to diversification of the bacterial population by promoting the emergence of variants. Here we report the identification and characterization of two major subpopulations of morphological variants arising in biofilms of S. aureus. One of these lacked pigmentation (termed white variants; WVs), whilst the other formed colonies on agar that were larger and paler than the parental strain (termed large pale variants; LPVs). WVs were unable to form biofilms, and exhibited increased proteolysis and haemolysis; all phenotypes attributable to loss-of-function mutations identified in the gene encoding the alternative sigma factor, sigB. For LPVs, no differences in biofilm forming capacity or proteolysis were observed compared with the parental strain. Genetic analysis of LPVs revealed that they had undergone mutation in the accessory gene regulator system (agrA), and deficiency in agr was confirmed by demonstrating loss of both colony spreading and haemolytic activity. The observation that S. aureus biofilms elaborate large subpopulations of sigB and agr mutants, both genotypes that have independently been shown to be of importance in staphylococcal disease, has implications for our understanding of staphylococcal infections involving a biofilm component.	[Savage, Victoria J.; Chopra, Ian; O'Neill, Alex J.] Univ Leeds, Antimicrobial Res Ctr, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England	University of Leeds	O'Neill, AJ (corresponding author), Univ Leeds, Antimicrobial Res Ctr, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England.	a.j.oneill@leeds.ac.uk	Savage, Victoria J/H-3277-2013	Savage, Victoria J/0000-0002-5381-0731; O'Neill, Alex/0000-0003-3222-5493	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC PhD studentship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci M, 2008, J BACTERIOL, V190, P6330, DOI 10.1128/JB.00707-08; Allegrucci M, 2007, J BACTERIOL, V189, P2030, DOI 10.1128/JB.01369-06; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003; Cescutti P, 1998, EUR J BIOCHEM, V251, P971, DOI 10.1046/j.1432-1327.1998.2510971.x; Conlon KM, 2004, J BACTERIOL, V186, P6208, DOI 10.1128/JB.186.18.6208-6219.2004; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Driffield K, 2008, J ANTIMICROB CHEMOTH, V61, P1053, DOI 10.1093/jac/dkn044; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Goerke C, 2004, INT J MED MICROBIOL, V294, P195, DOI 10.1016/j.ijmm.2004.06.013; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Karlsson-Kanth A, 2006, INT J MED MICROBIOL, V296, P229, DOI 10.1016/j.ijmm.2006.01.067; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; Kiedrowski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026714; Kirisits MJ, 2005, APPL ENVIRON MICROB, V71, P4809, DOI 10.1128/AEM.71.8.4809-4821.2005; Koh KS, 2007, J BACTERIOL, V189, P119, DOI 10.1128/JB.00930-06; Lane WJ, 2006, PLOS BIOL, V4, P1491, DOI 10.1371/journal.pbio.0040269; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Marti M, 2010, MICROBES INFECT, V12, P55, DOI 10.1016/j.micinf.2009.10.005; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; O'Neill AJ, 2010, LETT APPL MICROBIOL, V51, P358, DOI 10.1111/j.1472-765X.2010.02885.x; Popat R, 2012, P ROY SOC B-BIOL SCI, V279, P4765, DOI 10.1098/rspb.2012.1976; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Reynolds J, 2011, J MOL BIOL, V412, P862, DOI 10.1016/j.jmb.2011.06.018; Ryder VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047695; RYDER VJ, 2012, PLOS ONE IN PRESS; Schwan WR, 2003, FEMS IMMUNOL MED MIC, V38, P23, DOI 10.1016/S0928-8244(03)00098-1; Sendi P, 2010, J CLIN MICROBIOL, V48, P1720, DOI 10.1128/JCM.01562-09; Singh R, 2010, J MED MICROBIOL, V59, P521, DOI 10.1099/jmm.0.017046-0; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Takeuchi S, 2000, VET MICROBIOL, V71, P169, DOI 10.1016/S0378-1135(99)00158-3; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0; Tsompanidou E, 2011, J BACTERIOL, V193, P1267, DOI 10.1128/JB.01276-10; Tsuji BT, 2008, ANTIMICROB AGENTS CH, V52, P1533, DOI 10.1128/AAC.01254-07; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Yarwood JA, 2007, J BACTERIOL, V189, P7961, DOI 10.1128/JB.00789-07	42	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62513	10.1371/journal.pone.0062513	http://dx.doi.org/10.1371/journal.pone.0062513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646129	Green Published, Green Accepted, gold			2022-12-25	WOS:000319077300072
J	Winston, A; Arenas-Pinto, A; Stohr, W; Fisher, M; Orkin, CM; Aderogba, K; De Burgh-Thomas, A; O'Farrell, N; Lacey, CJN; Leen, C; Dunn, D; Paton, NI				Winston, Alan; Arenas-Pinto, Alejandro; Stoehr, Wolfgang; Fisher, Martin; Orkin, Chloe M.; Aderogba, Kazeem; De Burgh-Thomas, Andrew; O'Farrell, Nigel; Lacey, Charles J. N.; Leen, Clifford; Dunn, David; Paton, Nicholas I.		PIVOT Trial Team	Neurocognitive Function in HIV Infected Patients on Antiretroviral Therapy	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; COGNITIVE IMPAIRMENT; PREVALENCE; VALIDATION; DISORDERS; OUTCOMES; IMPACT; ERA; AGE	Objective: To describe factors associated with neurocognitive (NC) function in HIV-positive patients on stable combination antiretroviral therapy. Design: We undertook a cross-sectional analysis assessing NC data obtained at baseline in patients entering the Protease-Inhibitor-Monotherapy-Versus-Ongoing-Triple therapy (PIVOT) trial. Main outcome measure: NC testing comprised of 5 domains. Raw results were z-transformed using standard and demographically adjusted normative datasets (ND). Global z-scores (NPZ-5) were derived from averaging the 5 domains and percentage of subjects with test scores >1 standard deviation (SD) below population means in at least two domains (abnormal Frascati score) calculated. Patient characteristics associated with NC results were assessed using multivariable linear regression. Results: Of the 587 patients in PIVOT, 557 had full NC results and were included. 77% were male, 68% Caucasian and 28% of Black ethnicity. Mean (SD) baseline and nadir CD4+ lymphocyte counts were 553(217) and 177(117) cells/mu L, respectively, and HIV RNA was <50 copies/mL in all. Median (IQR) NPZ-5 score was -0.5 (-1.2/-0) overall, and -0.3 (-0.7/0.1) and -1.4 (-2/-0.8) in subjects of Caucasian and Black ethnicity, respectively. Abnormal Frascati scores using the standard-ND were observed in 51%, 38%, and 81%, respectively, of subjects overall, Caucasian and Black ethnicity (p < 0.001), but in 62% and 69% of Caucasian and Black subjects using demographically adjusted-ND (p = 0.20). In the multivariate analysis, only Black ethnicity was associated with poorer NPZ-5 scores (P < 0.001). Conclusions: In this large group of HIV-infected subjects with viral load suppression, ethnicity but not HIV-disease factors is closely associated with NC results. The prevalence of abnormal results is highly dependent on control datasets utilised.	[Winston, Alan] Univ London Imperial Coll Sci Technol & Med, Div Med, Infect Dis Sect, London, England; [Winston, Alan] Imperial Coll Healthcare NHS Trust, Dept HIV & GU Med, London, England; [Arenas-Pinto, Alejandro; Stoehr, Wolfgang; Dunn, David; Paton, Nicholas I.] MRC, Clin Trials Unit, London, England; [Arenas-Pinto, Alejandro] UCL, Ctr Sexual Hlth & HIV Res, London, England; [Fisher, Martin] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Orkin, Chloe M.] Royal London Hosp, Ambrose King Ctr, Barts Hlth NHS Trust, London E1 1BB, England; [Aderogba, Kazeem] East Sussex Healthcare Trust, Eastbourne, England; [De Burgh-Thomas, Andrew] Gloucestershire Royal Hosp, Gloucestershire Care Serv, Gloucester GL1 3NN, England; [O'Farrell, Nigel] Ealing Gen Hosp, London, England; [Lacey, Charles J. N.] Univ York, Ctr Immunol & Infect, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Leen, Clifford] Univ Edinburgh, Western Gen Hosp, Reg Infect Dis Unit, Edinburgh Infect Dis, Edinburgh, Midlothian, Scotland; [Leen, Clifford] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Paton, Nicholas I.] Natl Univ Singapore, Singapore 117548, Singapore	Imperial College London; Imperial College London; Medical Research Council Clinical Trials Unit; University of London; University College London; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; Barts Health NHS Trust; Royal London Hospital; Gloucestershire Royal Hospital; Imperial College London; University of Hull; University of York - UK; University of Edinburgh; University of Edinburgh; National University of Singapore	Winston, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Med, Infect Dis Sect, St Marys Hosp Campus,Norfolk Pl, London, England.	a.winston@imperial.ac.uk	Winston, Alan/AGZ-3015-2022	Winston, Alan/0000-0002-5847-8416; Leen, Clifford/0000-0001-8439-7719; Stohr, Wolfgang/0000-0002-6533-2888; Arenas-Pinto, Alejandro/0000-0002-3368-5005; Dunn, David/0000-0003-1836-4446	National Institutes for Health Research Health (NIHR) Technology Assessment programme [06/403/90]; Abbott; Boehringer Ingelheim; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Janssen Cilag; Roche; Pfizer; MRC [MC_U122886352] Funding Source: UKRI; Medical Research Council [MC_U122886352] Funding Source: researchfish; Public Health Agency [SPI/3915/08] Funding Source: researchfish	National Institutes for Health Research Health (NIHR) Technology Assessment programme; Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Roche(Roche Holding); Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Public Health Agency	PIVOT is funded by the National Institutes for Health Research Health (NIHR) Technology Assessment programme (project number 06/403/90). The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Health Technology Assessment programme, NIHR, the National Health Service or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: AW has received honoraria or research grants, or been a consultant or investigator, in clinical trials sponsored by Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Janssen Cilag, Roche, and Pfizer. All other authors have no conflict of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al-Khindi T, 2011, J INT NEUROPSYCH SOC, V17, P956, DOI 10.1017/S1355617711000968; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bansi L, 2010, HIV MED, V11, P432, DOI 10.1111/j.1468-1293.2009.00809.x; Becker JT, 2004, AIDS, V18, pS11, DOI 10.1097/00002030-200401001-00003; Brandt J, 2001, HOPKINS VERBAL LEARN; Carey CL, 2004, CLIN NEUROPSYCHOL, V18, P234, DOI 10.1080/13854040490501448; Ciccarelli N, 2011, NEUROLOGY, V76, P1403, DOI 10.1212/WNL.0b013e31821670fb; Cysique LA, 2009, NEUROLOGY; Cysique LA, 2011, J NEUROVIROL, V17, P176, DOI 10.1007/s13365-011-0021-x; D'Elia LF, 1996, COLOR TRAILS TEST; Dore GJ, 1999, AIDS, V13, P1249, DOI 10.1097/00002030-199907090-00015; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; Garvey L, 2011, HIV CLIN TRIALS, V12, P333, DOI 10.1310/hct1206-333; Garvey L, 2011, EUR J NEUROL, V18, P527, DOI 10.1111/j.1468-1331.2010.03291.x; Gibbs JE, 2006, J PHARMACOL EXP THER, V317, P746, DOI 10.1124/jpet.105.098459; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; JOSKA JA, 2010, AIDS BEHAV; LETENDRE S, 2010, CORRELATES CSF VIRAL; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Levine AJ, 2012, J CLIN EXP NEUROPSYC, V34, P78, DOI 10.1080/13803395.2011.623118; Manly JJ, 2011, J CLIN EXP NEUROPSYC, V33, P853, DOI 10.1080/13803395.2010.547662; Munderi P, 2010, HIV MED, V11, P334, DOI 10.1111/j.1468-1293.2009.00786.x; Norman MA, 2011, J CLIN EXP NEUROPSYC, V33, P793, DOI 10.1080/13803395.2011.559157; Price RW, 1999, AIDS, V13, P1677, DOI 10.1097/00002030-199909100-00011; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Ryan EL, 2004, NEUROLOGY, V62, P957, DOI 10.1212/01.WNL.0000115177.74976.6C; Stavem K, 2005, QUAL LIFE RES, V14, P971, DOI 10.1007/s11136-004-3211-7; Thiyagarajan A, 2010, CLIN MICROBIOL INFEC, V16, P1579, DOI 10.1111/j.1469-0691.2010.03176.x; TRITES R, 1997, NEUROPSYCHOLOGICAL T; Valcour V, 2011, CLIN INFECT DIS, V53, P836, DOI 10.1093/cid/cir524; WINSTON A, 2011, HIV MED; Winston A, 2010, CLIN INFECT DIS, V50, P920, DOI 10.1086/650743; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	33	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61949	10.1371/journal.pone.0061949	http://dx.doi.org/10.1371/journal.pone.0061949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646111	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000319077300021
J	Zemanick, ET; Harris, JK; Wagner, BD; Robertson, CE; Sagel, SD; Stevens, MJ; Accurso, FJ; Laguna, TA				Zemanick, Edith T.; Harris, J. Kirk; Wagner, Brandie D.; Robertson, Charles E.; Sagel, Scott D.; Stevens, Mark J.; Accurso, Frank J.; Laguna, Theresa A.			Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; BARCODED PRIMERS; FEV1 DECLINE; SPUTUM; INFECTIONS; IDENTIFICATION; ANTIBIOTICS; DESMOSINE; CHILDREN; SAMPLES	Background: Pulmonary exacerbations (PEx), frequently associated with airway infection and inflammation, are the leading cause of morbidity in cystic fibrosis (CF). Molecular microbiologic approaches detect complex microbiota from CF airway samples taken during PEx. The relationship between airway microbiota, inflammation, and lung function during CF PEx is not well understood. Objective: To determine the relationships between airway microbiota, inflammation, and lung function in CF subjects treated for PEx. Methods: Expectorated sputum and blood were collected and lung function testing performed in CF subjects during early (0-3d.) and late treatment (>7d.) for PEx. Sputum was analyzed by culture, pyrosequencing of 16S rRNA amplicons, and quantitative PCR for total and specific bacteria. Sputum IL-8 and neutrophil elastase (NE); and circulating C-reactive protein (CRP) were measured. Results: Thirty-seven sputum samples were collected from 21 CF subjects. At early treatment, lower diversity was associated with high relative abundance (RA) of Pseudomonas (r = -0.67, p<0.001), decreased FEV1% predicted (r = 0.49, p = 0.03) and increased CRP (r = -0.58, p = 0.01). In contrast to Pseudomonas, obligate and facultative anaerobic genera were associated with less inflammation and higher FEV1. With treatment, Pseudomonas RA and P. aeruginosa by qPCR decreased while anaerobic genera showed marked variability in response. Change in RA of Prevotella was associated with more variability in FEV1 response to treatment than Pseudomonas or Staphylococcus. Conclusions: Anaerobes identified from sputum by sequencing are associated with less inflammation and higher lung function compared to Pseudomonas at early exacerbation. CF PEx treatment results in variable changes of anaerobic genera suggesting the need for larger studies particularly of patients without traditional CF pathogens.	[Zemanick, Edith T.; Harris, J. Kirk; Sagel, Scott D.; Stevens, Mark J.; Accurso, Frank J.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Wagner, Brandie D.] Univ Colorado, Sch Med, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Laguna, Theresa A.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Laguna, Theresa A.] Univ Minnesota, Amplatz Childrens Hosp, Minneapolis, MN 55455 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zemanick, ET (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA.	edith.zemanick@childrenscolorado.org	Zemanick, Edith T/ABF-9455-2020; Zemanick, Edith/D-5260-2017	Zemanick, Edith T/0000-0002-7507-9337; Zemanick, Edith/0000-0002-7507-9337; ROBERTSON, CHARLES/0000-0002-4136-4121; Harris, Jonathan/0000-0002-2378-4202; Wagner, brandie/0000-0002-2745-0103; Laguna, Theresa/0000-0003-4255-0310	Cystic Fibrosis Foundation [LAGUNA06A, ZEMANI08A0, SAGEL07B0]; National Institutes of Health (NIH/NCRR) [1 UL 1RR025780-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068322] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Cystic Fibrosis Foundation (LAGUNA06A, ZEMANI08A0 and SAGEL07B0) and the National Institutes of Health (NIH/NCRR 1 UL 1RR025780-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amadori A, 2009, RESP MED, V103, P407, DOI 10.1016/j.rmed.2008.09.024; Bittar F, 2010, CLIN MICROBIOL INFEC, V16, P809, DOI 10.1111/j.1469-0691.2010.03236.x; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cohen J., 2003, APPL MULTIPLE REGRES; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collaco JM, 2010, AM J RESP CRIT CARE, V182, P1137, DOI 10.1164/rccm.201001-0057OC; Colombo C, 2005, PEDIATR PULM, V40, P15, DOI 10.1002/ppul.20237; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Daniels TWV, 2013, J CYST FIBROS, V12, P22, DOI 10.1016/j.jcf.2012.05.008; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Eribe ERK, 2008, ANAEROBE, V14, P131, DOI 10.1016/j.anaerobe.2008.04.004; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Harris JK, 2010, APPL ENVIRON MICROB, V76, P3863, DOI 10.1128/AEM.02585-09; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Laguna TA, 2012, PEDIATR PULM, V47, P856, DOI 10.1002/ppul.22525; Laguna TA, 2009, CHEST, V136, P1561, DOI 10.1378/chest.09-0217; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nadkarni MA, 2004, J CLIN MICROBIOL, V42, P5238, DOI 10.1128/JCM.42.11.5238-5244.2004; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Ordonez CL, 2003, AM J RESP CRIT CARE, V168, P1471, DOI 10.1164/rccm.200306-731OC; Parkins MD, 2008, PEDIATR PULM, V43, P490, DOI 10.1002/ppul.20809; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2010, CLIN MICROBIOL INFEC, V16, P1656, DOI 10.1111/j.1469-0691.2010.03189.x; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Sanders DB, 2011, PEDIATR PULM, V46, P393, DOI 10.1002/ppul.21374; Sanders DB, 2010, AM J RESP CRIT CARE, V182, P627, DOI 10.1164/rccm.200909-1421OC; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Tunney MM, 2011, THORAX, V66, P579, DOI 10.1136/thx.2010.137281; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Ulrich M, 2010, THORAX, V65, P978, DOI 10.1136/thx.2010.137745; VanDevanter DR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-137; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Worlitzsch D, 2009, CLIN MICROBIOL INFEC, V15, P454, DOI 10.1111/j.1469-0691.2008.02659.x; Zemanick ET, 2011, PEDIATR PULM, P306; Zemanick ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015101; Zemanick ET, 2010, PEDIATR PULM, V45, P569, DOI 10.1002/ppul.21221; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	55	130	134	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62917	10.1371/journal.pone.0062917	http://dx.doi.org/10.1371/journal.pone.0062917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646159	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300113
J	Zhang, Q; Liu, HZ; McGee, J; Walsh, EJ; Soukup, GA; He, DZZ				Zhang, Qian; Liu, Huizhan; McGee, JoAnn; Walsh, Edward J.; Soukup, Garrett A.; He, David Z. Z.			Identifying MicroRNAs Involved in Degeneration of the Organ of Corti during Age-Related Hearing Loss	PLOS ONE			English	Article							PRODUCT OTOACOUSTIC EMISSIONS; APOPTOSIS-RELATED GENES; HAIR-CELL; TRANSCRIPTIONAL ACTIVATION; INFERIOR COLLICULUS; TUMOR-SUPPRESSOR; UP-REGULATION; SMALL RNAS; TIP-LINK; EXPRESSION	MicroRNAs (miRNAs), a class of short non-coding RNAs that regulate the expression of mRNA targets, are important regulators of cellular senescence and aging. We questioned which miRNAs are involved in age-related degeneration of the organ of Corti (OC), the auditory sensory epithelium that transduces mechanical stimuli to electrical activity in the inner ear. Degeneration of the OC is generally accepted as the main cause of age-related hearing loss (ARHL), a progressive loss of hearing in individuals as they grow older. To determine which miRNAs are involved in the onset and progression of ARHL, miRNA gene expression in the OC of two mouse strains, C57BL/6J and CBA/J, was compared at three different ages using GeneChip miRNA microarray and was validated by real-time PCR. We showed that 111 and 71 miRNAs exhibited differential expression in the C57 and CBA mice, respectively, and that downregulated miRNAs substantially outnumbered upregulated miRNAs during aging. miRNAs that had approximately 2-fold upregulation included members of miR-29 family and miR-34 family, which are known regulators of pro-apoptotic pathways. In contrast, miRNAs that were downregulated by about 2-fold were members of the miR-181 family and miR-183 family, which are known to be important for proliferation and differentiation, respectively. The shift of miRNA expression favoring apoptosis occurred earlier than detectable hearing threshold elevation and hair cell loss. Our study suggests that changes in miRNA expression precede morphological and functional changes, and that upregulation of pro-apoptotic miRNAs and downregulation of miRNAs promoting proliferation and differentiation are both involved in age-related degeneration of the OC.	[Zhang, Qian; Liu, Huizhan; Soukup, Garrett A.; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [McGee, JoAnn; Walsh, Edward J.] Boys Town Natl Res Hosp, Omaha, NE 68131 USA	Creighton University; Boys Town National Research Hospital	Soukup, GA (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.	GarrettSoukup@creighton.edu; hed@creighton.edu	Zhang, Qian/P-7110-2015	McGee, JoAnn/0000-0003-2207-4660; Walsh, Edward/0000-0002-6846-2872; He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	National Institutes of Health (NIH) from the NIDCD [R01 DC004696, R01 DC 009025]; Creighton University School of Medicine; Creighton University School of Medicine from the NCRR, NIH [RR17417-01]; University of Nebraska Microarray Facility from the NCRR, NIH [RR 018788]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417, P20RR018788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009025, R01DC004696] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creighton University School of Medicine; Creighton University School of Medicine from the NCRR, NIH; University of Nebraska Microarray Facility from the NCRR, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work has been supported by the National Institutes of Health (NIH) grant R01 DC004696 to DH from the NIDCD. QZ has been supported by a graduate student fellowship from Creighton University School of Medicine. GS is supported by NIH grant R01 DC 009025 from the NIDCD. We acknowledge the use of the Integrated Biological Imaging Facility (supported by the Creighton University School of Medicine and C06 Grant RR17417-01 from the NCRR, NIH) and the University of Nebraska Microarray Facility (supported by P20 Grant RR 018788 from the NCRR, NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, ONCOL REP, V16, P845; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bates DJ, 2010, AGING CELL, V9, P1, DOI 10.1111/j.1474-9726.2009.00529.x; BELL DW, 1995, CYTOGENET CELL GENET, V70, P263, DOI 10.1159/000134048; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bonifacio LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012519; Cervo PRD, 2009, BLOOD, V113, P6498, DOI 10.1182/blood-2009-02-203174; Chen J, 2011, GYNECOL ONCOL, V121, P200, DOI 10.1016/j.ygyno.2010.12.339; Cichocki F, 2011, J IMMUNOL, V187, P6171, DOI 10.4049/jimmunol.1100835; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Frucht CS, 2011, NEUROSCI LETT, V493, P44, DOI 10.1016/j.neulet.2011.02.017; Frucht CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011502; GILAD O, 1979, J AM AUDITORY SOC, V4, P207; GILAD O, 1979, J AM AUDITORY SOC, V4, P195; GILLEN MF, 1987, J BIOL CHEM, V262, P5308; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Guimaraes P, 2004, HEARING RES, V192, P83, DOI 10.1016/j.heares.2004.01.013; HENRY KR, 1980, AUDIOLOGY, V19, P369; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hu BH, 2009, NEUROSCIENCE, V161, P915, DOI 10.1016/j.neuroscience.2009.03.072; Huang V, 2012, NUCLEIC ACIDS RES, V40, P1695, DOI 10.1093/nar/gkr934; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Inukai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040028; Jimenez AM, 1999, HEARING RES, V138, P91, DOI 10.1016/S0378-5955(99)00154-9; Johnson KR, 1997, HEARING RES, V114, P83, DOI 10.1016/S0378-5955(97)00155-X; Johnson KR, 2000, GENOMICS, V70, P171, DOI 10.1006/geno.2000.6377; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Laine H, 2007, J NEUROSCI, V27, P1434, DOI 10.1523/JNEUROSCI.4956-06.2007; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Li HQ, 2010, CURR OPIN OTOLARYNGO, V18, P459, DOI 10.1097/MOO.0b013e32833e0601; Li HQ, 2010, J NEUROSCI, V30, P3254, DOI 10.1523/JNEUROSCI.4948-09.2010; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797; Long XC, 2011, J BIOL CHEM, V286, P30119, DOI 10.1074/jbc.M111.258814; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Pierce ML, 2008, EVOL DEV, V10, P106, DOI 10.1111/j.1525-142X.2007.00217.x; Provost P, 2010, AGING-US, V2, P166, DOI 10.18632/aging.100131; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Riva C, 2007, EXP GERONTOL, V42, P327, DOI 10.1016/j.exger.2006.10.014; Rubboli F, 1998, GENES FUNCT, V1, P205; Schraders M, 2010, AM J HUM GENET, V86, P604, DOI 10.1016/j.ajhg.2010.02.015; Sha SH, 2008, HEARING RES, V243, P87, DOI 10.1016/j.heares.2008.06.001; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Song L, 2008, J NEUROPHYSIOL, V99, P344, DOI 10.1152/jn.00983.2007; Soukup GA, 2009, BRAIN RES, V1277, P104, DOI 10.1016/j.brainres.2009.02.027; Soukup GA, 2009, DEV BIOL, V328, P328, DOI 10.1016/j.ydbio.2009.01.037; Spongr VP, 1997, J ACOUST SOC AM, V101, P3546, DOI 10.1121/1.418315; Tadros SF, 2008, APOPTOSIS, V13, P1303, DOI 10.1007/s10495-008-0266-x; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tsonis PA, 2007, BIOCHEM BIOPH RES CO, V362, P940, DOI 10.1016/j.bbrc.2007.08.077; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang XN, 2009, CELL CYCLE, V8, P736, DOI 10.4161/cc.8.5.7870; Weeraratne SD, 2012, ACTA NEUROPATHOL, V123, P539, DOI 10.1007/s00401-012-0969-5; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WILLOTT JF, 1991, HEARING RES, V53, P78, DOI 10.1016/0378-5955(91)90215-U; WILLOTT JF, 1986, J NEUROPHYSIOL, V56, P391, DOI 10.1152/jn.1986.56.2.391; Wojakowski W, 2012, THROMB HAEMOSTASIS, V108, P464, DOI 10.1160/TH12-05-0303; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yang WP, 2012, ACTA OTO-LARYNGOL, V132, P123, DOI 10.3109/00016489.2011.631191; Yu L, 2010, CELL BIOL INT, V34, P1219, DOI 10.1042/CBI20100515; Zhang M, 2003, NEUROSCIENCE, V120, P191, DOI 10.1016/S0306-4522(03)00286-0; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034688; Zhao J, 2012, J IMMUNOL, V188, P1266, DOI 10.4049/jimmunol.1101976; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	85	53	61	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62786	10.1371/journal.pone.0062786	http://dx.doi.org/10.1371/journal.pone.0062786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646144	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300097
J	Safaee, M; Clark, AJ; Oh, MC; Ivan, ME; Bloch, O; Kaur, G; Sun, MZ; Kim, JM; Oh, T; Berger, MS; Parsa, AT				Safaee, Michael; Clark, Aaron J.; Oh, Michael C.; Ivan, Michael E.; Bloch, Orin; Kaur, Gurvinder; Sun, Matthew Z.; Kim, Joseph M.; Oh, Taemin; Berger, Mitchel S.; Parsa, Andrew T.			Overexpression of CD97 Confers an Invasive Phenotype in Glioblastoma Cells and Is Associated with Decreased Survival of Glioblastoma Patients	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITOR; TRANSMEMBRANE RECEPTOR CD97; PHASE-II TRIAL; IN-VITRO; ENDOTHELIAL-CELLS; MALIGNANT GLIOMA; CELLULAR LIGAND; EGF-TM7 FAMILY; CANCER CELLS; TUMOR-GROWTH	Mechanisms of invasion in glioblastoma (GBM) relate to differential expression of proteins conferring increased motility and penetration of the extracellular matrix. CD97 is a member of the epidermal growth factor seven-span transmembrane family of adhesion G-protein coupled receptors. These proteins facilitate mobility of leukocytes into tissue. In this study we show that CD97 is expressed in glioma, has functional effects on invasion, and is associated with poor overall survival. Glioma cell lines and low passage primary cultures were analyzed. Functional significance was assessed by transient knockdown using siRNA targeting CD97 or a non-target control sequence. Invasion was assessed 48 hours after siRNA-mediated knockdown using a Matrigel-coated invasion chamber. Migration was quantified using a scratch assay over 12 hours. Proliferation was measured 24 and 48 hours after confirmed protein knockdown. GBM cell lines and primary cultures were found to express CD97. Knockdown of CD97 decreased invasion and migration in GBM cell lines, with no difference in proliferation. Gene-expression based Kaplan-Meier analysis was performed using The Cancer Genome Atlas, demonstrating an inverse relationship between CD97 expression and survival. GBMs expressing high levels of CD97 were associated with decreased survival compared to those with low CD97 (p = 0.007). CD97 promotes invasion and migration in GBM, but has no effect on tumor proliferation. This phenotype may explain the discrepancy in survival between high and low CD97-expressing tumors. This data provides impetus for further studies to determine its viability as a therapeutic target in the treatment of GBM.	[Safaee, Michael; Clark, Aaron J.; Oh, Michael C.; Ivan, Michael E.; Bloch, Orin; Kaur, Gurvinder; Sun, Matthew Z.; Kim, Joseph M.; Oh, Taemin; Berger, Mitchel S.; Parsa, Andrew T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Parsa, AT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	ParsaA@Neurosurg.ucsf.edu		Bloch, Orin/0000-0001-9810-6011; Kim, Joseph/0000-0002-1108-2625; Ivan, Michael/0000-0002-4798-4989	Doris Duke Charitable Foundation; Reza and Georgianna Khatib Endowed Chair in Skull Base Tumor Surgery	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Reza and Georgianna Khatib Endowed Chair in Skull Base Tumor Surgery	Mr. Safaee was supported by a grant from the Doris Duke Charitable Foundation. Dr. Parsa was partially funded by the Reza and Georgianna Khatib Endowed Chair in Skull Base Tumor Surgery. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand M, 2011, J NEURO-ONCOL, V104, P679, DOI 10.1007/s11060-011-0549-x; Aust G, 1997, CANCER RES, V57, P1798; Aust G, 2002, AM J CLIN PATHOL, V118, P699; Becker S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008507; Caminschi I, 2001, J IMMUNOL, V167, P3570, DOI 10.4049/jimmunol.167.7.3570; Chidambaram A, 2012, J NEUROSURG, V116, P843, DOI 10.3171/2011.11.JNS111455; Eichler W, 1997, TISSUE ANTIGENS, V50, P429, DOI 10.1111/j.1399-0039.1997.tb02897.x; Friedlander DR, 1996, CANCER RES, V56, P1939; Galle J, 2006, AM J PATHOL, V169, P1802, DOI 10.2353/ajpath.2006.060006; Gilbert MR, 2012, J NEURO-ONCOL, V106, P147, DOI 10.1007/s11060-011-0650-1; Gray JX, 1996, J IMMUNOL, V157, P5438; Groves MD, 2002, J CLIN ONCOL, V20, P1383, DOI 10.1200/JCO.20.5.1383; HAMANN J, 1995, J IMMUNOL, V155, P1942; Hamann J, 1998, EUR J IMMUNOL, V28, P1701, DOI 10.1002/(SICI)1521-4141(199805)28:05<1701::AID-IMMU1701>3.0.CO;2-2; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Hoang-Vu C, 1999, J CLIN ENDOCR METAB, V84, P1104, DOI 10.1210/jc.84.3.1104; HOLTING T, 1995, EUR J ENDOCRINOL, V132, P229, DOI 10.1530/eje.0.1320229; Kane AJ, 2010, NEUROREPORT, V21, P1018, DOI 10.1097/WNR.0b013e32833f19f2; Kop EN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2049; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; Levin VA, 2006, J NEURO-ONCOL, V78, P295, DOI 10.1007/s11060-005-9098-5; Lin HH, 2000, GENOMICS, V67, P188, DOI 10.1006/geno.2000.6238; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Mahesparan R, 1999, ACTA NEUROPATHOL, V97, P231, DOI 10.1007/s004010050979; Martinkova E, 2010, INT J CANCER, V127, P1240, DOI 10.1002/ijc.25187; MATSUKADO Y, 1961, J NEUROSURG, V18, P636, DOI 10.3171/jns.1961.18.5.0636; Mustafa T, 2005, CANCER EPIDEM BIOMAR, V14, P108; Nechiporuk T, 2001, J BIOL CHEM, V276, P4150, DOI 10.1074/jbc.M004814200; Park JW, 2005, THYROID, V15, P222, DOI 10.1089/thy.2005.15.222; Parsa AT, 2005, J NEUROSURG, V102, P622, DOI 10.3171/jns.2005.102.4.0622; Price A, 1999, CLIN CANCER RES, V5, P845; Qian YM, 1999, IMMUNOLOGY, V98, P303; Rooprai HK, 1999, INT J DEV NEUROSCI, V17, P613, DOI 10.1016/S0736-5748(99)00051-9; Rutkowski MJ, 2011, J NEURO-ONCOL, V105, P165, DOI 10.1007/s11060-011-0576-7; SCHRAPPE M, 1991, CANCER RES, V51, P4986; Stacey M, 2003, BLOOD, V102, P2916, DOI 10.1182/blood-2002-11-3540; Stacey M, 2002, J BIOL CHEM, V277, P29283, DOI 10.1074/jbc.M204306200; Stacey M, 2001, J BIOL CHEM, V276, P18863, DOI 10.1074/jbc.M101147200; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tchaicha JH, 2011, CANCER RES, V71, P6371, DOI 10.1158/0008-5472.CAN-11-0991; Tonn JC, 1998, ANTICANCER RES, V18, P2599; Tonn JC, 2003, ACT NEUR S, V88, P163; Voris HC, 1934, P MAYO CLIN, V9, P396; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005	48	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62765	10.1371/journal.pone.0062765	http://dx.doi.org/10.1371/journal.pone.0062765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658650	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700073
J	Burk, RF; Olson, GE; Hill, KE; Winfrey, VP; Motley, AK; Kurokawa, S				Burk, Raymond F.; Olson, Gary E.; Hill, Kristina E.; Winfrey, Virginia P.; Motley, Amy K.; Kurokawa, Suguru			Maternal-fetal transfer of selenium in the mouse	FASEB JOURNAL			English	Article						selenoprotein P; apolipoprotein E receptor-2; glutathione peroxidase-3; visceral yolk sac; placenta	APOLIPOPROTEIN-E RECEPTOR-2; SELENOPROTEIN P SEPP1; NEUROLOGICAL DYSFUNCTION; BASEMENT-MEMBRANES; DELETION; KIDNEY; MICE; MAINTENANCE; ENDOCYTOSIS; MEGALIN	Selenoprotein P (Sepp1) is taken up by receptor-mediated endocytosis for its selenium. The other extracellular selenoprotein, glutathione peroxidase-3 (Gpx3), has not been shown to transport selenium. Mice with genetic alterations of Sepp1, the Sepp1 receptors apolipoprotein E receptor-2 (apoER2) and megalin, and Gpx3 were used to investigate maternal-fetal selenium transfer. Immunocytochemistry (ICC) showed receptor-independent uptake of Sepp1 and Gpx3 in the same vesicles of d-13 visceral yolk sac cells, suggesting uptake by pinocytosis. ICC also showed apoER2-mediated uptake of maternal Sepp1 in the d-18 placenta. Thus, two selenoprotein-dependent maternal-fetal selenium transfer mechanisms were identified. Selenium was quantified in d-18 fetuses with the mechanisms disrupted. Maternal Sepp1 deletion, which lowers maternal whole-body selenium, decreased fetal selenium under selenium-adequate conditions but deletion of fetal apoER2 did not. Fetal apoER2 deletion did decrease fetal selenium, by 51%, under selenium-deficient conditions, verifying function of the placental Sepp1-apoER2 mechanism. Maternal Gpx3 deletion decreased fetal selenium, by 13%, but only under selenium-deficient conditions. These findings indicate that the selenoprotein uptake mechanisms ensure selenium transfer to the fetus under selenium-deficient conditions. The failure of their disruptions (apoER2 deletion, Gpx3 deletion) to affect fetal selenium under selenium-adequate conditions indicates the existence of an additional maternal-fetal selenium transfer mechanism.Burk, R. F., Olson, G. E., Hill, K. E., Winfrey, V. P., Motley, A. K., and Kurokawa, S. Maternal-fetal transfer of selenium in the mouse.	[Burk, Raymond F.; Hill, Kristina E.; Winfrey, Virginia P.; Motley, Amy K.; Kurokawa, Suguru] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA; [Olson, Gary E.; Winfrey, Virginia P.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Burk, RF (corresponding author), Vanderbilt Univ Sch Med, 1030C Med Res Bldg 4, Nashville, TN 37232 USA.	raymond.burk@vanderbilt.edu			U.S. National Institutes of Health [R37 ES02497, R01 DK82813, P30 ES00267, P30 DK58404]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082813, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002497, P30ES000267] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors are grateful to Lori M. Austin, Teri D. Stevenson, Kristin V. Bradshaw (deceased), and Michelle L. Chatterton for animal husbandry. Dr. Takeshi Naruse (Kaketsuken, The Chemo-Sero-Therapeutic Research Institute, Kumamoto, Japan) kindly provided the hybridoma that produced 9S4, the monoclonal antibody to Sepp1. Dr. Daniel Biemesderfer (Yale University, New Haven, CT, USA) provided the antibody to megalin, and Dr. Joachim Herz (University of Texas Southwestern Medical School, Dallas, TX, USA) provided the antibody to apoER2 and the megalin<SUP>+/-</SUP> mouse strain. These studies were supported by U.S. National Institutes of Health grants R37 ES02497, R01 DK82813, P30 ES00267, and P30 DK58404. The authors declare no conflicts of interest.	Anan Y, 2009, LIFE SCI, V84, P888, DOI 10.1016/j.lfs.2009.03.023; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Burk RF, 2006, BBA-GEN SUBJECTS, V1760, P1789, DOI 10.1016/j.bbagen.2006.08.010; Burk RF, 2011, AM J PHYSIOL-GASTR L, V301, pG32, DOI 10.1152/ajpgi.00064.2011; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Hill KE, 2007, J BIOL CHEM, V282, P10972, DOI 10.1074/jbc.M700436200; Hill KE, 2012, J BIOL CHEM, V287, P40414, DOI 10.1074/jbc.M112.421404; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; KOH TS, 1983, J ASSOC OFF ANA CHEM, V66, P918; Kurokawa S, 2012, J BIOL CHEM, V287, P28717, DOI 10.1074/jbc.M112.383521; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Ma SG, 2002, J BIOL CHEM, V277, P12749, DOI 10.1074/jbc.M111462200; Miyauchi S, 2006, PLACENTA, V27, P550, DOI 10.1016/j.placenta.2005.05.004; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Olson GE, 2010, AM J PHYSIOL-RENAL, V298, pF1244, DOI 10.1152/ajprenal.00662.2009; SAHALI D, 1992, AM J PATHOL, V140, P33; SHEEHAN TMT, 1990, CLIN CHEM, V36, P2124; Trotter JH, 2011, J NEUROSCI, V31, P14413, DOI 10.1523/JNEUROSCI.3135-11.2011; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Zou ZY, 2004, J BIOL CHEM, V279, P34302, DOI 10.1074/jbc.M405608200	24	56	56	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3249	3256		10.1096/fj.13-231852	http://dx.doi.org/10.1096/fj.13-231852			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23651543	Green Published			2022-12-25	WOS:000329877600030
J	Bettaieb, A; Bakke, J; Nagata, N; Matsuo, K; Xi, YN; Liu, SM; AbouBechara, D; Melhem, R; Stanhope, K; Cummings, B; Graham, J; Bremer, A; Zhang, S; Lyssiotis, CA; Zhang, ZY; Cantley, LC; Havel, PJ; Haj, FG				Bettaieb, Ahmed; Bakke, Jesse; Nagata, Naoto; Matsuo, Kosuke; Xi, Yannan; Liu, Siming; AbouBechara, Daniel; Melhem, Ramzi; Stanhope, Kimber; Cummings, Bethany; Graham, James; Bremer, Andrew; Zhang, Sheng; Lyssiotis, Costas A.; Zhang, Zhong-Yin; Cantley, Lewis C.; Havel, Peter J.; Haj, Fawaz G.			Protein Tyrosine Phosphatase 1B Regulates Pyruvate Kinase M2 Tyrosine Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN SENSITIVITY; ENDOPLASMIC-RETICULUM; GLUCOSE-HOMEOSTASIS; METABOLIC SYNDROME; BODY-WEIGHT; PTP1B; ADIPOSITY; BINDING; PKM2; INHIBITORS	Protein-tyrosine phosphatase 1B (PTP1B) is a physiological regulator of glucose homeostasis and adiposity and is a drug target for the treatment of obesity and diabetes. Here we identify pyruvate kinase M2 (PKM2) as a novel PTP1B substrate in adipocytes. PTP1B deficiency leads to increased PKM2 total tyrosine and Tyr(105) phosphorylation in cultured adipocytes and in vivo. Substrate trapping and mutagenesis studies identify PKM2 Tyr-(105) and Tyr-148 as key sites that mediate PTP1B-PKM2 interaction. In addition, in vitro analyses illustrate a direct effect of Tyr-(105) phosphorylation on PKM2 activity in adipocytes. Importantly, PTP1B pharmacological inhibition increased PKM2 Tyr-(105) phosphorylation and decreased PKM2 activity. Moreover, PKM2 Tyr-(105) phosphorylation is regulated nutritionally, decreasing in adipose tissue depots after high-fat feeding. Further, decreased PKM2 Tyr-(105) phosphorylation correlates with the development of glucose intolerance and insulin resistance in rodents, non-human primates, and humans. Together, these findings identify PKM2 as a novel substrate of PTP1B and provide new insights into the regulation of adipose PKM2 activity.	[Bettaieb, Ahmed; Bakke, Jesse; Nagata, Naoto; Matsuo, Kosuke; Xi, Yannan; Liu, Siming; AbouBechara, Daniel; Melhem, Ramzi; Stanhope, Kimber; Cummings, Bethany; Graham, James; Havel, Peter J.; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Stanhope, Kimber; Cummings, Bethany; Graham, James; Havel, Peter J.] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA; [Bremer, Andrew] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; [Zhang, Sheng; Zhang, Zhong-Yin] Indiana Univ, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Lyssiotis, Costas A.; Cantley, Lewis C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Lyssiotis, Costas A.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Haj, Fawaz G.] Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA; [Haj, Fawaz G.] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; Vanderbilt University; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Davis; University of California System; University of California Davis	Haj, FG (corresponding author), Univ Calif Davis, Dept Nutr, 3135 Meyer Hall, Davis, CA 95616 USA.	fghaj@ucdavis.edu	Lyssiotis, Costas A/AAI-1923-2019; Cantley, Lewis C/D-1800-2014; NAGATA, Naoto/D-9261-2012	Lyssiotis, Costas A/0000-0001-9309-6141; Cantley, Lewis C/0000-0002-1298-7653; NAGATA, Naoto/0000-0002-2389-2334; Graham, James/0000-0001-6507-8149; Havel, Peter/0000-0003-3652-8301; Bakke, Jesse/0000-0003-0305-5165	National Institutes of Health [R56DK084317, R01DK090492, AT-003645, HL-075675, HL-091333, DK-087307, CA-69202]; NCI; Juvenile Diabetes Research Foundation Research Foundation Research [1-2009-337]; Training Program in Biomolecular Technology Fellowship [T32-GM008799]; American Diastases Association; University of California, Office of the President; Damon Runyon Cancer Research Foundation Amgen Fellowship [DRG-2056-10]; Agios Pharmaceuticals; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003645] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091333, R01HL075675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090492, R00DK100736, U24DK092993, RC1DK087307, R56DK084317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203, T32GM008799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Juvenile Diabetes Research Foundation Research Foundation Research; Training Program in Biomolecular Technology Fellowship; American Diastases Association; University of California, Office of the President(University of California System); Damon Runyon Cancer Research Foundation Amgen Fellowship; Agios Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R56DK084317 and R01DK090492 (to F. G. H.); AT-003645, HL-075675, HL-091333, and DK-087307 (to P. J. H.); CA-69202 (to Z. Y. Z.); and NCI and National Institutes of Health grants (to L. C. C.). This work was also supported by Juvenile Diabetes Research Foundation Research Grant 1-2009-337) (to F. G. H.), by a Training Program in Biomolecular Technology Fellowship T32-GM008799 (to J. B.), by an American Diastases Association and multicampus award from the University of California, Office of the President (to P. J. H.), and by Damon Runyon Cancer Research Foundation Amgen Fellowship DRG-2056-10 (to C. A. L.). Dr. Cantley owns equity in and receives compensation from Agios Pharmaceuticals and serves on the Board of Directors and Scientific Advisory Board of Agios Pharmaceuticals. Agios Pharmaceuticals is identifying metabolic pathways of cancer cells and developing drugs to inhibit such enzymes to disrupt tumor cell growth and survival.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bettaieb A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034412; Bettaieb A, 2011, J BIOL CHEM, V286, P9225, DOI 10.1074/jbc.M110.186148; Boxer MB, 2010, J MED CHEM, V53, P1048, DOI 10.1021/jm901577g; Breitkopf Susanne B, 2012, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1819s98; Bremer AA, 2011, CTS-CLIN TRANSL SCI, V4, P243, DOI 10.1111/j.1752-8062.2011.00298.x; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Cummings BP, 2011, P NATL ACAD SCI USA, V108, P14670, DOI 10.1073/pnas.1107163108; Cummings BP, 2008, AM J PHYSIOL-REG I, V295, pR1782, DOI 10.1152/ajpregu.90635.2008; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Goldberg MS, 2012, J EXP MED, V209, P217, DOI 10.1084/jem.20111487; Haj FG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036633; Haj FG, 2005, J BIOL CHEM, V280, P15038, DOI 10.1074/jbc.M413240200; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Jiang JK, 2010, BIOORG MED CHEM LETT, V20, P3387, DOI 10.1016/j.bmcl.2010.04.015; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; KAYNE FJ, 1973, ARCH BIOCHEM BIOPHYS, V159, P292, DOI 10.1016/0003-9861(73)90455-4; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Macintyre AN, 2011, MOL CELL, V42, P713, DOI 10.1016/j.molcel.2011.06.003; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Mann JI, 2002, LANCET, V360, P783, DOI 10.1016/S0140-6736(02)09901-4; Matsuo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016446; Miranda S, 2010, CELL SIGNAL, V22, P645, DOI 10.1016/j.cellsig.2009.11.019; Muthusamy VS, 2008, CHEM-BIOL INTERACT, V174, P69, DOI 10.1016/j.cbi.2008.04.016; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Owen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032700; Ramachandran C, 2003, CURR TOP MED CHEM, V3, P749, DOI 10.2174/1568026033452276; Rondinone CM, 2002, DIABETES, V51, P2405, DOI 10.2337/diabetes.51.8.2405; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Spoden GA, 2008, INT J CANCER, V123, P312, DOI 10.1002/ijc.23512; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Stuible M, 2008, J BIOL CHEM, V283, P15740, DOI 10.1074/jbc.M710534200; Swarbrick MM, 2009, ENDOCRINOLOGY, V150, P1670, DOI 10.1210/en.2008-0885; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Urs S, 2006, TRANSGENIC RES, V15, P647, DOI 10.1007/s11248-006-9000-z; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Xie LP, 2003, BIOCHEMISTRY-US, V42, P12792, DOI 10.1021/bi035238p; Yamada E, 1999, BIOCHEM BIOPH RES CO, V256, P257, DOI 10.1006/bbrc.1999.0228; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	62	41	42	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17360	17371		10.1074/jbc.M112.441469	http://dx.doi.org/10.1074/jbc.M112.441469			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640882	Green Published, hybrid			2022-12-25	WOS:000320380600029
J	Nanni, S; Aiello, A; Re, A; Guffanti, A; Benvenuti, V; Colussi, C; Castro-Vega, LJ; Felsani, A; Londono-Vallejo, A; Capogrossi, MC; Bacchetti, S; Gaetano, C; Pontecorvi, A; Farsetti, A				Nanni, Simona; Aiello, Aurora; Re, Agnese; Guffanti, Alessandro; Benvenuti, Valentina; Colussi, Claudia; Castro-Vega, Luis Jaime; Felsani, Armando; Londono-Vallejo, Arturo; Capogrossi, Maurizio C.; Bacchetti, Silvia; Gaetano, Carlo; Pontecorvi, Alfredo; Farsetti, Antonella			Estrogen-Dependent Dynamic Profile of eNOS-DNA Associations in Prostate Cancer	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DIFFERENTIAL EXPRESSION ANALYSIS; RECEPTOR-BETA; BIOCONDUCTOR PACKAGE; TELOMERASE ACTIVITY; ANDROGEN RECEPTOR; CHIP-SEQ; BINDING; GENE; SIRT1	In previous work we have documented the nuclear translocation of endothelial NOS (eNOS) and its participation in combinatorial complexes with Estrogen Receptor Beta (ER beta) and Hypoxia Inducible Factors (HIFs) that determine localized chromatin remodeling in response to estrogen (E2) and hypoxia stimuli, resulting in transcriptional regulation of genes associated with adverse prognosis in prostate cancer (PCa). To explore the role of nuclear eNOS in the acquisition of aggressive phenotype in PCa, we performed ChIP-Sequencing on chromatin-associated eNOS from cells from a primary tumor with poor outcome and from metastatic LNCaP cells. We found that: 1. the eNOS-bound regions (peaks) are widely distributed across the genome encompassing multiple transcription factors binding sites, including Estrogen Response Elements. 2. E2 increased the number of peaks, indicating hormone-dependent eNOS re-localization. 3. Peak distribution was similar with/without E2 with approximate to 55% of them in extragenic DNA regions and an intriguing involvement of the 59 domain of several miRs deregulated in PCa. Numerous potentially novel eNOS-targeted genes have been identified suggesting that eNOS participates in the regulation of large gene sets. The parallel finding of downregulation of a cluster of miRs, including miR-34a, in PCa cells associated with poor outcome led us to unveil a molecular link between eNOS and SIRT1, an epigenetic regulator of aging and tumorigenicity, negatively regulated by miR-34a and in turn activating eNOS. E2 potentiates miR-34a downregulation thus enhancing SIRT1 expression, depicting a novel eNOS/SIRT1 interplay fine-tuned by E2-activated ER signaling, and suggesting that eNOS may play an important role in aggressive PCa.	[Nanni, Simona; Bacchetti, Silvia; Farsetti, Antonella] Natl Canc Inst Regina Elena, Dept Expt Oncol, Rome, Italy; [Nanni, Simona; Aiello, Aurora; Re, Agnese; Colussi, Claudia; Pontecorvi, Alfredo] Univ Cattolica Sacro Cuore, Med Pathol Inst, Rome, Italy; [Aiello, Aurora; Benvenuti, Valentina; Colussi, Claudia; Felsani, Armando; Farsetti, Antonella] Natl Res Council CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Re, Agnese] Univ Messina, Messina, Italy; [Guffanti, Alessandro; Felsani, Armando] Genomnia Srl, Milan, Italy; [Castro-Vega, Luis Jaime; Londono-Vallejo, Arturo] Inst Curie, Paris, France; [Capogrossi, Maurizio C.] Ist Dermopat Immacolata, Rome, Italy; [Gaetano, Carlo] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); University of Messina; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Goethe University Frankfurt	Gaetano, C (corresponding author), Goethe Univ Frankfurt, D-60054 Frankfurt, Germany.	Gaetano@em.uni-frankfurt.de; afarsetti@gmail.com	Re, Agnese/O-4647-2019; Gaetano, Carlo/P-9997-2019; Castro-Vega, Luis Jaime/L-5587-2019; Colussi, Claudia/H-8609-2019; Felsani, Armando/D-1784-2010; Farsetti, Antonella/I-8710-2018; Castro-Vega, Luis Jaime/AAO-9988-2021; Londono-Vallejo, Arturo/ABH-5555-2020; Re, Agnese/E-3673-2016	Gaetano, Carlo/0000-0002-5238-1832; Felsani, Armando/0000-0001-8851-6295; Farsetti, Antonella/0000-0002-8603-7925; Castro-Vega, Luis Jaime/0000-0002-7232-9871; Londono-Vallejo, Arturo/0000-0003-3535-7563; Re, Agnese/0000-0003-0929-6568; Colussi, Claudia/0000-0002-7727-8911; Aiello, Aurora/0000-0002-8303-1528	Associazione Italiana Ricerca sul Cancro; Italian Ministry of Education, University, and Research [PRIN 2008NY72SJ, FIRB RBFR087JMZ, FIRB RBFR10URHP]; FIRC (Federazione Italiana Ricerca sul Cancro) Fellowship; Susan G. Komen for the Cure Foundation; LOEWE Center for Cell and Gene Therapy, Goethe University, Frankfurt (DE)	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education, University, and Research(Ministry of Education, Universities and Research (MIUR)); FIRC (Federazione Italiana Ricerca sul Cancro) Fellowship(Fondazione AIRC per la ricerca sul cancro); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); LOEWE Center for Cell and Gene Therapy, Goethe University, Frankfurt (DE)	This work was supported by the Associazione Italiana Ricerca sul Cancro to AFa; Italian Ministry of Education, University, and Research Grants: PRIN 2008NY72SJ and FIRB RBFR087JMZ to AFa and FIRB RBFR10URHP to S.N. V.B. is recipient of a FIRC (Federazione Italiana Ricerca sul Cancro) Fellowship. A.A. is supported by funding from Susan G. Komen for the Cure Foundation. C.G. research is supported by the LOEWE Center for Cell and Gene Therapy, Goethe University, Frankfurt (DE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chen Y, 2012, NAT METHODS; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Gandellini P, 2009, TRENDS MOL MED, V15, P381, DOI 10.1016/j.molmed.2009.07.004; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Giovannelli P, 2011, FRONT BIOSCI-LANDMRK, V16, P2224, DOI 10.2741/3849; Grasselli A, 2008, CIRC RES, V103, P34, DOI 10.1161/CIRCRESAHA.107.169037; Grober OMV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-36; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Kyo S, 1999, CANCER RES, V59, P5917; Lampson BL, 2012, CANCER; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Misiti S, 2000, MOL CELL BIOL, V20, P3764, DOI 10.1128/MCB.20.11.3764-3771.2000; Nadiminty N, 2012, J BIOL CHEM, V287, P1527, DOI 10.1074/jbc.M111.278705; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Nanni S, 2002, J CLIN INVEST, V110, P219, DOI 10.1172/JCI200215552; Nanni S, 2009, J CLIN INVEST, V119, P1093, DOI 10.1172/JCI35079; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Prehn RT, 1999, CANCER RES, V59, P4161; Re A, 2011, MOL ENDOCRINOL, V25, P2003, DOI 10.1210/me.2011-1024; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; Wu Q, 2011, J BIOL CHEM, V286, P14737, DOI 10.1074/jbc.R110.191791; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00068; Ying L, 2007, CANCER RES, V67, P1407, DOI 10.1158/0008-5472.CAN-06-2149; Zaman MS, 2010, BRIT J CANCER, V103, P256, DOI 10.1038/sj.bjc.6605742; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zeng L, 2008, CIRC RES, V103, P10, DOI 10.1161/CIRCRESAHA.108.179986; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	54	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62522	10.1371/journal.pone.0062522	http://dx.doi.org/10.1371/journal.pone.0062522			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658738	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100013
J	Okahashi, N; Nakata, M; Sumitomo, T; Terao, Y; Kawabata, S				Okahashi, Nobuo; Nakata, Masanobu; Sumitomo, Tomoko; Terao, Yutaka; Kawabata, Shigetada			Hydrogen Peroxide Produced by Oral Streptococci Induces Macrophage Cell Death	PLOS ONE			English	Article							IDENTIFICATION; SANGUINIS; ENDOCARDITIS; VIRULENCE; PILI	Hydrogen peroxide (H2O2) produced by members of the mitis group of oral streptococci plays important roles in microbial communities such as oral biofilms. Although the cytotoxicity of H2O2 has been widely recognized, the effects of H2O2 produced by oral streptococci on host defense systems remain unknown. In the present study, we investigated the effect of H2O2 produced by Streptococcus oralis on human macrophage cell death. Infection by S. oralis was found to stimulate cell death of a THP-1 human macrophage cell line at multiplicities of infection greater than 100. Catalase, an enzyme that catalyzes the decomposition of H2O2, inhibited the cytotoxic effect of S. oralis. S. oralis deletion mutants lacking the spxB gene, which encodes pyruvate oxidase, and are therefore deficient in H2O2 production, showed reduced cytotoxicity toward THP-1 macrophages. Furthermore, H2O2 alone was capable of inducing cell death. The cytotoxic effect seemed to be independent of inflammatory responses, because H2O2 was not a potent stimulator of tumor necrosis factor-a production in macrophages. These results indicate that streptococcal H2O2 plays a role as a cytotoxin, and is implicated in the cell death of infected human macrophages.	[Okahashi, Nobuo] Osaka Univ, Grad Sch Dent, Dept Oral Frontier Biol, Suita, Osaka, Japan; [Nakata, Masanobu; Sumitomo, Tomoko; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka, Japan; [Terao, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Div Microbiol & Infect Dis, Niigata, Japan	Osaka University; Osaka University; Niigata University	Okahashi, N (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral Frontier Biol, Suita, Osaka, Japan.	okahashi@dent.osaka-u.ac.jp	okahashi, nobuo/A-4032-2010	okahashi, nobuo/0000-0002-8045-7021; Terao, Yutaka/0000-0002-4450-5583; Nakata, Masanobu/0000-0003-1686-5415	Japan Society for the Promotion of Science [24390410, 23593027, 24659812]; Grants-in-Aid for Scientific Research [23593027, 23592700, 24659812] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) (#24390410) and (C) (#23593027), and Grants-in Aid for Challenging Exploratory Research (#24659812) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Braun JS, 2002, J CLIN INVEST, V109, P19; BRIDGE PD, 1982, INT J SYST BACTERIOL, V32, P410, DOI 10.1099/00207713-32-4-410; Chen L, 2011, MICROBIOL-SGM, V157, P13, DOI 10.1099/mic.0.039669-0; Chiu B, 1999, AM HEART J, V138, pS534, DOI 10.1016/S0002-8703(99)70294-2; COYKENDALL AL, 1989, CLIN MICROBIOL REV, V2, P315, DOI 10.1128/CMR.2.3.315-328.1989; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; Dyson C, 1999, J INFECTION, V38, P87, DOI 10.1016/S0163-4453(99)90074-9; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Health Protection Agency, 2012, HLTH PROT REP; Hoshino T, 2004, DIAGN MICR INFEC DIS, V48, P195, DOI 10.1016/j.diagmicrobio.2003.10.002; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Nakano K, 2006, J CLIN MICROBIOL, V44, P3313, DOI 10.1128/JCM.00377-06; Nakata M, 2011, J BIOL CHEM, V286, P37566, DOI 10.1074/jbc.M111.239780; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Okahashi N, 2011, FEMS MICROBIOL LETT, V323, P164, DOI 10.1111/j.1574-6968.2011.02375.x; Okahashi N, 2010, BIOCHEM BIOPH RES CO, V391, P1192, DOI 10.1016/j.bbrc.2009.12.029; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Spellerberg B, 1996, MOL MICROBIOL, V19, P803, DOI 10.1046/j.1365-2958.1996.425954.x; Stinson MW, 2003, INFECT IMMUN, V71, P2365, DOI 10.1128/IAI.71.5.2365-2372.2003; Sumitomo T, 2011, J BIOL CHEM, V286, P2750, DOI 10.1074/jbc.M110.171504; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; VANDERMEER JTM, 1991, EUR J CLIN MICROBIOL, V10, P728; Watt Barbara E, 2004, Toxicol Rev, V23, P51, DOI 10.2165/00139709-200423010-00006; Zhu L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/717843	33	30	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62563	10.1371/journal.pone.0062563	http://dx.doi.org/10.1371/journal.pone.0062563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658745	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100018
J	Ghali, B; Anantha, NT; Chan, J; Chau, T				Ghali, Bassma; Anantha, Nayanashri Thalanki; Chan, Jennifer; Chau, Tom			Variability of Grip Kinetics during Adult Signature Writing	PLOS ONE			English	Article							PENCIL GRASP; FORCE; VERIFICATION; LEGIBILITY; KINEMATICS; TASK	Grip kinetics and their variation are emerging as important considerations in the clinical assessment of handwriting pathologies, fine motor rehabilitation, biometrics, forensics and ergonomic pen design. This study evaluated the intra- and inter-participant variability of grip shape kinetics in adults during signature writing. Twenty (20) adult participants wrote on a digitizing tablet using an instrumented pen that measured the forces exerted on its barrel. Signature samples were collected over 10 days, 3 times a day, to capture temporal variations in grip shape kinetics. A kinetic topography (i.e., grip shape image) was derived per signature by time-averaging the measured force at each of 32 locations around the pen barrel. The normalized cross correlations (NCC) of grip shape images were calculated within- and between-participants. Several classification algorithms were implemented to gauge the error rate of participant discrimination based on grip shape kinetics. Four different grip shapes emerged and several participants made grip adjustments (change in grip shape or grip height) or rotated the pen during writing. Nonetheless, intra-participant variation in grip kinetics was generally much smaller than inter-participant force variations. Using the entire grip shape images as a 32-dimensional input feature vector, a K-nearest neighbor classifier achieved an error rate of 1.2 +/- 0.4% in discriminating among participants. These results indicate that writers had unique grip shape kinetics that were repeatable over time but distinct from those of other participants. The topographic analysis of grip kinetics may inform the development of personalized interventions or customizable grips in clinical and industrial applications, respectively.	[Ghali, Bassma; Anantha, Nayanashri Thalanki; Chau, Tom] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Ghali, Bassma; Anantha, Nayanashri Thalanki; Chau, Tom] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Chan, Jennifer] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; University of Toronto; University of Toronto	Chau, T (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada.	tom.chau@utoronto.ca	Chau, Tom TK/C-8426-2009	Chau, Tom TK/0000-0002-7486-0316	Natural Sciences and Engineering Research Council of Canada [CRDPJ 391549]; Syngrafii Inc.; Canada Research Chairs program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Syngrafii Inc.; Canada Research Chairs program(Canada Research Chairs)	This work was financially supported by the Natural Sciences and Engineering Research Council of Canada (Grant number: CRDPJ 391549) (http://www.nserc-crsng.gc.ca/Index_eng.asp), Syngrafii Inc., and the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo R. S. A., 2006, 10 INT WORKSH FRONT; Baur B, 2009, ARCH PHYS MED REHAB, V90, P867, DOI 10.1016/j.apmr.2008.10.015; Baur B, 2009, J HAND THER, V22, P163, DOI 10.1016/j.jht.2008.11.001; BERGMANN KP, 1990, AM J OCCUP THER, V44, P736, DOI 10.5014/ajot.44.8.736; Bulacu M, 2007, THESIS U GRONINGEN N; Burton AW, 2000, AM J OCCUP THER, V54, P9, DOI 10.5014/ajot.54.1.9; Chau T, 2006, ARCH PHYS MED REHAB, V87, P1542, DOI 10.1016/j.apmr.2006.08.328; Dennis JL, 2001, AM J OCCUP THER, V55, P175, DOI 10.5014/ajot.55.2.175; Duda R.O., 2006, PATTERN CLASSIFICATI; Falk TH, 2011, COMPUT METH PROG BIO, V104, pE102, DOI 10.1016/j.cmpb.2010.12.010; Falk TH, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002611; Fernandes DN, 2008, J BIOMECH, V41, P40, DOI 10.1016/j.jbiomech.2007.07.017; Franke K, 2009, LECT NOTES COMPUT SC, V5718, P150, DOI 10.1007/978-3-642-03521-0_14; Furukawa T, 2011, LECT NOTES COMPUT SC, V6540, P114, DOI 10.1007/978-3-642-19376-7_10; Greer T, 1998, CHILD DEV, V69, P888; Hepp-Reymond MC, 2009, BRAIN RES BULL, V79, P365, DOI 10.1016/j.brainresbull.2009.05.013; HERBST NM, 1977, IBM J RES DEV, V21, P245, DOI 10.1147/rd.213.0245; Hermsdorfer J, 2011, HUM MOVEMENT SCI, V30, P807, DOI 10.1016/j.humov.2010.04.004; HERRICK VE, 1961, J EXP EDUC, V30, P215, DOI 10.1080/00220973.1961.11010709; Hooke AW, 2008, J BIOMECH, V41, P2060, DOI 10.1016/j.jbiomech.2008.03.036; Impedovo D, 2008, IEEE T SYST MAN CY C, V38, P609, DOI 10.1109/TSMCC.2008.923866; Johnston JA, 2010, NEUROSCI LETT, V474, P104, DOI 10.1016/j.neulet.2010.03.017; Komi ER, 2007, P I MECH ENG C-J MEC, V221, P1687, DOI 10.1243/09544062JMES700; Komi ER, 2008, P I MECH ENG P-J SPO, V222, P23, DOI 10.1243/17543371JSET9; Kushki A, 2011, RES DEV DISABIL, V32, P1058, DOI 10.1016/j.ridd.2011.01.026; Latash ML, 2003, HUM MOVEMENT SCI, V22, P153, DOI 10.1016/S0167-9457(02)00157-4; Lee SJ, 2009, ERGONOMICS, V52, P601, DOI 10.1080/00140130802422481; Lei HS, 2005, PATTERN RECOGN LETT, V26, P2483, DOI 10.1016/j.patrec.2005.05.005; Poston B, 2010, J NEUROPHYSIOL, V104, P1141, DOI 10.1152/jn.00185.2010; Ramsay JO, 2000, J AM STAT ASSOC, V95, P9; Schmidt E., 2006, ENG SPORT, V6, P57; Schmidt RA, 2011, HUMAN KINETICS, V5th; Schneider AS, 2010, CLIN NEUROPHYSIOL, V121, P1898, DOI 10.1016/j.clinph.2010.04.023; Schwellnus H, 2012, AM J OCCUP THER, V66, P718, DOI 10.5014/ajot.2012.004515; Selin A, 2003, THESIS; Shang X., 2008, MILCOM 2008 IEEE MIL, P1, DOI [10.1109/MILCOM.2008.4753283, DOI 10.1109/MILCOM.2008.4753283]; Shang XX, 2008, LECT NOTES COMPUT SC, V5099, P289, DOI 10.1007/978-3-540-69905-7_33; Shang X, 2008, J ELECTRON IMAGING, V17, DOI 10.1117/1.2892675; Shim JK, 2010, J BIOMECH, V43, P2249, DOI 10.1016/j.jbiomech.2010.04.033; STELMACH GE, 1983, ACTA PSYCHOL, V54, P51, DOI 10.1016/0001-6918(83)90022-7; Stevens A, 2009, THESIS TEXAS WOMANS; Summers J., 2003, AUSTR OCCUPATIONAL T, V50, P148, DOI DOI 10.1046/J.1440-1630.2003.00310.X; Szabo F, 2000, LINEAR ALGEBRA INTRO; TEASDALE N, 1993, ACTA PSYCHOL, V82, P179, DOI 10.1016/0001-6918(93)90011-F; Tseng MH, 1998, OCCUP THER J RES, V18, P207, DOI 10.1177/153944929801800406; Udo H, 2000, IND HEALTH, V38, P47, DOI 10.2486/indhealth.38.47; van Drempt N, 2011, AUST OCCUP THER J, V58, P321, DOI 10.1111/j.1440-1630.2011.00960.x; Wu Z, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P4239, DOI 10.1109/IROS.2006.281951; Yanushkevich S.N., 2018, BIOMETRIC INVERSE PR	49	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63216	10.1371/journal.pone.0063216	http://dx.doi.org/10.1371/journal.pone.0063216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175AF	23658812	Green Submitted, gold, Green Published			2022-12-25	WOS:000321200500062
J	Johnson, LR; Robinson, JD; Lester, KN; Pitcher, JA				Johnson, Laura R.; Robinson, James D.; Lester, Katrina N.; Pitcher, Julie A.			Distinct Structural Features of G Protein-Coupled Receptor Kinase 5 (GRK5) Regulate Its Nuclear Localization and DNA-Binding Ability	PLOS ONE			English	Article							EXPORT SIGNALS; DOMAIN; IDENTIFICATION; EXPRESSION; MEMBRANE; VARIANTS; SEQUENCE; ALPHA	G protein-coupled receptor kinases (GRKs) act to desensitize G protein-coupled receptors (GPCRs). In addition to this role at the plasma membrane, a nuclear function for GRK5, a member of the GRK4 subfamily of GRKs, has been reported. GRK5 phosphorylates and promotes the nuclear export of the histone deacetylase, HDAC5. Here we demonstrate that the possession of a nuclear localization sequence (NLS) is a common feature of GRK4 subfamily members (GRKs 4, 5 and 6). However, the location of the NLS and the ability of these GRKs to bind DNA in vitro are different. The NLSs of GRK5 and 6 bind DNA in vitro, whilst the NLS of GRK4 does not. Using mutants of GRK5 we identify the regions of GRK5 required for DNA-binding in vitro and nuclear localization in cells. The DNA-binding ability of GRK5 requires both the NLS and an N-terminal calmodulin (CaM)-binding site. A functional nuclear export sequence (NES), required for CaM-dependent nuclear export of the kinase, is also identified. Based on our observations we propose a model to explain how nuclear localization of GRK5 may be regulated. Notably, the nuclear localization of GRK5 and 6 is differentially regulated. These results suggest subfamily specific nuclear functions for the GRK4 subfamily members. Identification of GRK specific small molecule inhibitors of nuclear localization and/or function for the GRK4 subfamily may thus be an achievable goal.	[Pitcher, Julie A.] UCL, MRC, Mol Cell Biol Lab, London, England; UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London; University of London; University College London	Pitcher, JA (corresponding author), UCL, MRC, Mol Cell Biol Lab, London, England.	julie.pitcher@ucl.ac.uk	Pitcher, Julie/ABH-2078-2020		Wellcome Trust; MRC	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work was supported by The Wellcome Trust (JAP) and the MRC (LRJ, JDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; Dorn GW, 2009, J MOL MED, V87, P455, DOI 10.1007/s00109-009-0450-7; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Greschik H, 1999, MOL CELL BIOL, V19, P690; Jiang XS, 2007, MOL BIOL CELL, V18, P2960, DOI 10.1091/mbc.E07-01-0013; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; KUNAPULI P, 1994, J BIOL CHEM, V269, P10209; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; LEE JW, 1992, MOL ENDOCRINOL, V6, P1867, DOI 10.1210/me.6.11.1867; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Metaye T, 2005, CELL SIGNAL, V17, P917, DOI 10.1016/j.cellsig.2005.01.002; Moepps B, 1999, GENOMICS, V60, P199, DOI 10.1006/geno.1999.5901; Patial S, 2010, BIOCHEM J, V425, P169, DOI 10.1042/BJ20090908; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Perander M, 2001, J BIOL CHEM, V276, P13015, DOI 10.1074/jbc.M010356200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; Premont RT, 1999, J BIOL CHEM, V274, P29381, DOI 10.1074/jbc.274.41.29381; Premont RT, 1996, J BIOL CHEM, V271, P6403, DOI 10.1074/jbc.271.11.6403; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; Pronin AN, 1997, J BIOL CHEM, V272, P18273, DOI 10.1074/jbc.272.29.18273; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Sorriento D, 2010, HYPERTENSION, V56, P696, DOI 10.1161/HYPERTENSIONAHA.110.155960; Sorriento D, 2008, P NATL ACAD SCI USA, V105, P17818, DOI 10.1073/pnas.0804446105; Stedman DR, 2004, FEBS LETT, V566, P275, DOI 10.1016/j.febslet.2004.04.042	28	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62508	10.1371/journal.pone.0062508	http://dx.doi.org/10.1371/journal.pone.0062508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658733	Green Submitted, gold, Green Published			2022-12-25	WOS:000321200500026
J	Celay, J; Blanco, I; Lazcoz, P; Rotinen, M; Castresana, JS; Encio, I				Celay, Jon; Blanco, Idoia; Lazcoz, Paula; Rotinen, Mirja; Castresana, Javier S.; Enci, Ignacio			Changes in Gene Expression Profiling of Apoptotic Genes in Neuroblastoma Cell Lines upon Retinoic Acid Treatment	PLOS ONE			English	Article							NF-KAPPA-B; CHILDRENS ONCOLOGY GROUP; INDUCED DIFFERENTIATION; MYELOABLATIVE THERAPY; 13-CIS-RETINOIC ACID; NUCLEAR-FACTOR; ACTIVATION; PROTEIN; 9-CIS; INHIBITOR	To determine the effect of retinoic acid (RA) in neuroblastoma we treated RA sensitive neuroblastoma cell lines with 9-cis RA or ATRA for 9 days, or for 5 days followed by absence of RA for another 4 days. Both isomers induced apoptosis and reduced cell density as a result of cell differentiation and/or apoptosis. Flow cytometry revealed that 9-cis RA induced apoptosis more effectively than ATRA. The expression profile of apoptosis and survival pathways was cell line specific and depended on the isomer used.	[Celay, Jon; Blanco, Idoia; Lazcoz, Paula; Rotinen, Mirja; Enci, Ignacio] Univ Publ Navarra, Dept Hlth Sci, Pamplona, Spain; [Castresana, Javier S.] Univ Navarra, Brain Tumor Biol Unit, Sch Sci, E-31080 Pamplona, Spain	Universidad Publica de Navarra; University of Navarra	Encio, I (corresponding author), Univ Publ Navarra, Dept Hlth Sci, Pamplona, Spain.	ignacio.encio@unavarra.es	Celay, Jon/A-7296-2017; Castresana, Javier S/AFT-2167-2022	Celay, Jon/0000-0002-2017-4206; ROTINEN, MIRJA/0000-0002-0755-8360; Castresana, Javier S./0000-0002-2373-482X; Encio, Ignacio/0000-0003-1732-1989	Departmento de Salud, Gobierno de Navarra, Pamplona; Fondo de Investigacion Sanitaria, Madrid, Spain [PI08/1849]	Departmento de Salud, Gobierno de Navarra, Pamplona; Fondo de Investigacion Sanitaria, Madrid, Spain(Instituto de Salud Carlos III)	This work was supported by grants from the Departmento de Salud, Gobierno de Navarra, Pamplona, and from the Fondo de Investigacion Sanitaria (PI08/1849), Madrid, Spain. J.C. and M.R. were fellows from the Departamento de Educacion, and I.B. was a fellow from the Departamento de Industria, Gobierno de Navarra, Pamplona, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrisano T, 2011, NUCLEIC ACIDS RES, V39, P1993, DOI 10.1093/nar/gkq864; Begaud-Grimaud G, 2007, INT J ONCOL, V31, P883; Borriello A, 2002, HAEMATOLOGICA, V87, P196; Borysenko CW, 2006, J CELL PHYSIOL, V209, P1021, DOI 10.1002/jcp.20812; Brown KD, 2002, J BIOL CHEM, V277, P19433, DOI 10.1074/jbc.M111522200; BUNONE G, 1995, EXP CELL RES, V217, P92, DOI 10.1006/excr.1995.1067; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Dufner A, 2006, P NATL ACAD SCI USA, V103, P988, DOI 10.1073/pnas.0510380103; Fang YF, 2011, MOL CARCINOGEN, V50, P24, DOI 10.1002/mc.20687; Furusu A, 2007, J CELL PHYSIOL, V210, P703, DOI 10.1002/jcp.20881; Futami H, 2010, CANCER LETT, V297, P220, DOI 10.1016/j.canlet.2010.05.014; GAETANO C, 1991, PROG CLIN BIOL RES, V366, P165; Irving H, 1998, EUR J CANCER, V34, P111, DOI 10.1016/S0959-8049(97)10027-2; Kim GM, 2001, J NEUROSCI, V21, P6617, DOI 10.1523/JNEUROSCI.21-17-06617.2001; Lamkanfi M, 2004, J BIOL CHEM, V279, P24785, DOI 10.1074/jbc.M400985200; Lazcoz P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-254; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovat PE, 1997, EUR J CANCER, V33, P2075, DOI 10.1016/S0959-8049(97)00242-6; Lovat PE, 1997, J NEURO-ONCOL, V31, P85, DOI 10.1023/A:1005785431343; Lovat PE, 1997, JNCI-J NATL CANCER I, V89, P446, DOI 10.1093/jnci/89.6.446; MATSUMOTO M, 1989, ACTA NEUROPATHOL, V79, P217, DOI 10.1007/BF00294382; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Mercader J, 2007, CELL PHYSIOL BIOCHEM, V20, P1061, DOI 10.1159/000110717; Morriss-Kay GM, 1997, RETINOIDS THEIR PHYS, P79; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Oppenheimer O, 2007, MOL CANCER THER, V6, P1300, DOI 10.1158/1535-7163.MCT-06-0587; Park JR, 2009, PEDIATR BLOOD CANCER, V52, P44, DOI 10.1002/pbc.21784; PONZONI M, 1995, CANCER RES, V55, P853; REDFERN CPF, 1995, EUR J CANCER, V31A, P486, DOI 10.1016/0959-8049(95)00066-R; REDFERN CPF, 1997, RETINOIDS THEIR PHYS, P35; Ronca F, 1999, J BIOL CHEM, V274, P18128, DOI 10.1074/jbc.274.25.18128; Sarkanen JR, 2007, J NEUROCHEM, V102, P1941, DOI 10.1111/j.1471-4159.2007.04676.x; Stehlik C, 2003, J BIOL CHEM, V278, P31941, DOI 10.1074/jbc.M300009200; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; van Noesel MM, 2004, GENE, V325, P1, DOI 10.1016/j.gene.2003.09.042; Voigt A, 2003, MED PEDIATR ONCOL, V40, P205, DOI 10.1002/mpo.10250; Wajant H, 2002, APOPTOSIS, V7, P449, DOI 10.1023/A:1020039225764; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wen L, 2003, J BIOL CHEM, V278, P39251, DOI 10.1074/jbc.M305833200; Westermark UK, 2011, SEMIN CANCER BIOL, V21, P256, DOI 10.1016/j.semcancer.2011.08.001; Yeh PY, 2006, J BIOL CHEM, V281, P167, DOI 10.1074/jbc.M511014200	43	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62771	10.1371/journal.pone.0062771	http://dx.doi.org/10.1371/journal.pone.0062771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650528	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000073
J	Zhou, JH; Manor, B; Liu, DD; Hu, K; Zhang, J; Fang, J				Zhou, Junhong; Manor, Brad; Liu, Dongdong; Hu, Kun; Zhang, Jue; Fang, Jing			The Complexity of Standing Postural Control in Older Adults: A Modified Detrended Fluctuation Analysis Based upon the Empirical Mode Decomposition Algorithm	PLOS ONE			English	Article							NONSTATIONARY TIME-SERIES; PHYSIOLOGICAL COMPLEXITY; CIRCADIAN-RHYTHM; DUAL-TASK; OPEN-LOOP; DYNAMICS; STABILITY; MAGNITUDE; BALANCE; SYSTEM	Human aging into senescence diminishes the capacity of the postural control system to adapt to the stressors of everyday life. Diminished adaptive capacity may be reflected by a loss of the fractal-like, multiscale complexity within the dynamics of standing postural sway (i.e., center-of-pressure, COP). We therefore studied the relationship between COP complexity and adaptive capacity in 22 older and 22 younger healthy adults. COP magnitude dynamics were assessed from raw data during quiet standing with eyes open and closed, and complexity was quantified with a new technique termed empirical mode decomposition embedded detrended fluctuation analysis (EMD-DFA). Adaptive capacity of the postural control system was assessed with the sharpened Romberg test. As compared to traditional DFA, EMD-DFA more accurately identified trends in COP data with intrinsic scales and produced short and long-term scaling exponents (i. e., alpha(Short), alpha(Long)) with greater reliability. The fractal-like properties of COP fluctuations were time-scale dependent and highly complex (i.e., alpha(Short) values were close to one) over relatively short time scales. As compared to younger adults, older adults demonstrated lower short-term COP complexity (i.e., greater alpha(Short) values) in both visual conditions (p>0.001). Closing the eyes decreased short-term COP complexity, yet this decrease was greater in older compared to younger adults (p<0.001). In older adults, those with higher short-term COP complexity exhibited better adaptive capacity as quantified by Romberg test performance (r(2) = 0.38, p<0.001). These results indicate that an age-related loss of COP complexity of magnitude series may reflect a clinically important reduction in postural control system functionality as a new biomarker.	[Zhou, Junhong; Manor, Brad; Zhang, Jue; Fang, Jing] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Manor, Brad] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA USA; [Liu, Dongdong; Zhang, Jue; Fang, Jing] Peking Univ, Coll Engn, Beijing 100871, Peoples R China; [Hu, Kun] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Sleep Med,Med Biodynam Program, Boston, MA 02115 USA; [Hu, Kun] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan	Peking University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Peking University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Central University	Zhang, J (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.	zhangjue@pku.edu.cn	Hu, Kun/AAJ-1897-2020; Hu, Kun/GVS-8580-2022; Zhang, Jue/N-7594-2013	Zhou, Junhong/0000-0002-7931-7646; Hu, Kun/0000-0003-0350-3132	National Institutes of Health [K99HL102241, R00HL102241]; National Science Council in Taiwan (ROC) [NSC 101-2911-I-008-001]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025757] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL102241, K99HL102241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council in Taiwan (ROC)(Ministry of Science and Technology, Taiwan); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Kun Hu (KH), one of the co-authors, is supported by National Institutes of Health Grants K99HL102241 and R00HL102241, and the grant from National Science Council in Taiwan (ROC) NSC 101-2911-I-008-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoud H, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-12; APPLEGATE C, 1988, EXP BRAIN RES, V71, P183; Ashkenazy Y, 2003, PHYSICA A, V323, P19, DOI 10.1016/S0378-4371(03)00008-6; Ashkenazy Y, 2002, PHYSICA A, V316, P662, DOI 10.1016/S0378-4371(02)01453-X; Ashkenazy Y, 2001, PHYS REV LETT, V86, P1900, DOI 10.1103/PhysRevLett.86.1900; Blaszczyk JW, 2001, ACTA NEUROBIOL EXP, V61, P105; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Chen Z, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011104; COLLINS JJ, 1995, EXP BRAIN RES, V104, P480, DOI 10.1007/BF00231982; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; David E, 2002, NEUROBIOL AGING, V23, P1; Delignieres D, 2003, J MOTOR BEHAV, V35, P86, DOI 10.1080/00222890309602124; Duarte M, 2000, NEUROSCI LETT, V283, P173, DOI 10.1016/S0304-3940(00)00960-5; Duarte M, 2001, PHYS LETT A, V283, P124, DOI 10.1016/S0375-9601(01)00188-8; Duarte M, 2008, EXP BRAIN RES, V191, P265, DOI 10.1007/s00221-008-1521-7; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; HAMALAINEN H, 1992, HUM MOVEMENT SCI, V11, P549, DOI 10.1016/0167-9457(92)90015-4; Hausdorff JM, 2001, PHYSICA A, V302, P138, DOI 10.1016/S0378-4371(01)00460-5; HAVLIN S, 1988, PHYS REV LETT, V61, P1438, DOI 10.1103/PhysRevLett.61.1438; Horak F, 1996, HDB PHYSIOL 12, V12, P255; Horvatic D, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18007; Hu K, 2007, NEUROSCIENCE, V149, P508, DOI 10.1016/j.neuroscience.2007.03.058; Hu K, 2004, PHYSICA A, V337, P307, DOI 10.1016/j.physa.2004.01.042; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Hu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048927; Hu K, 2009, P NATL ACAD SCI USA, V106, P2490, DOI 10.1073/pnas.0806087106; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Ivanov PC, 1998, EUROPHYS LETT, V43, P363, DOI 10.1209/epl/i1998-00366-3; Ivanov PC, 2007, P NATL ACAD SCI USA, V104, P20702, DOI 10.1073/pnas.0709957104; Ivanov PC, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041920; Kang HG, 2010, J NEUROPHYSIOL, V104, P3510, DOI 10.1152/jn.00820.2009; Kang HG, 2009, J GERONTOL A-BIOL, V64, P1304, DOI 10.1093/gerona/glp113; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lipsitz LA, 2002, J GERONTOL A-BIOL, V57, pB115, DOI 10.1093/gerona/57.3.B115; Lipsitz LA, 2004, SCI AGING KNOWLEDGE, V16, P16, DOI DOI 10.1126/SAGEKE.2004; Manor B, 2012, PROG NEUROPSYCHOPH; Manor B, 2013, PROG NEURO-PSYCHOPH, V45, P287, DOI 10.1016/j.pnpbp.2012.08.020; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; McChesney JW, 2000, J GERONTOL A-BIOL, V55, pM658, DOI 10.1093/gerona/55.11.M658; Mergner T, 2003, PROG BRAIN RES, V142, P189; Michikawa T, 2009, J ORTHOP SCI, V14, P675, DOI 10.1007/s00776-009-1371-6; Nelson-Wong E, 2012, EUR J APPL PHYSIOL, V112, P1379, DOI 10.1007/s00421-011-2094-x; Norris V, 2005, INT J PHARM MED, V19, P233, DOI 10.2165/00124363-200519040-00005; Peng CK, 2009, ADV DATA SCI ADAPT, V1, P61, DOI 10.1142/S1793536909000035; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Pittman-Polletta B, 2013, BIOL REV IN PRESS; Schmitt DT, 2007, AM J PHYSIOL-REG I, V293, pR1923, DOI 10.1152/ajpregu.00372.2007; Schmitt DT, 2009, IEEE T BIO-MED ENG, V56, P1564, DOI 10.1109/TBME.2009.2014819; SKINNER HB, 1984, CLIN ORTHOP RELAT R, P208; Thurner S, 2002, AUDIOL NEURO-OTOL, V7, P240, DOI 10.1159/000063740; Yeh JR, 2009, MED ENG PHYS, V31, P92, DOI 10.1016/j.medengphy.2008.04.011	54	25	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62585	10.1371/journal.pone.0062585	http://dx.doi.org/10.1371/journal.pone.0062585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650518	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000059
J	Mlisana, K; Sobieszczyk, M; Werner, L; Feinstein, A; van Loggerenberg, F; Naicker, N; Williamson, C; Garrett, N				Mlisana, Koleka; Sobieszczyk, Magdalena; Werner, Lise; Feinstein, Addi; van Loggerenberg, Francois; Naicker, Nivashnee; Williamson, Carolyn; Garrett, Nigel			Challenges of Diagnosing Acute HIV-1 Subtype C Infection in African Women: Performance of a Clinical Algorithm and the Need for Point-of-Care Nucleic-Acid Based Testing	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; COITAL-ACT; HIGH PREVALENCE; SOUTH-AFRICA; VIRAL LOAD; SET-POINT; FOLLOW-UP; HIGH-RISK; TRANSMISSION	Background: Prompt diagnosis of acute HIV infection (AHI) benefits the individual and provides opportunities for public health The aim of this study was to describe most common signs and symptoms of AHI, correlate these with early disease progression and develop a clinical algorithm to identify acute HIV cases in resource limited setting. Methods: 245 South African women at high-risk of HIV-1 were assessed for AHI and received monthly HIV-1 antibody and RNA testing. Signs and symptoms at first HIV-positive visit were compared to HIV-negative visits. Logistic regression identified clinical predictors of AHI. A model-based score was assigned to each predictor to create a risk score for every woman. Results: Twenty-eight women seroconverted after a total of 390 person-years of follow-up with an HIV incidence of 7.2/100 person-years (95%CI 4.5-9.8). Fifty-seven percent reported >= 1 sign or symptom at the AHI visit. Factors predictive of AHI included age <25 years (OR = 3.2; 1.4-7.1), rash (OR = 6.1; 2.4-15.4), sore throat (OR = 2.7; 1.0-7.6), weight loss (OR = 4.4; 1.5-13.4), genital ulcers (OR = 8.0; 1.6-39.5) and vaginal discharge (OR = 5.4; 1.6-18.4). A risk score of 2 correctly predicted AHI in 50.0% of cases. The number of signs and symptoms correlated with higher HIV-1 RNA at diagnosis (r = 0.63; p<0.001). Conclusions: Accurate recognition of signs and symptoms of AHI is critical for early diagnosis of HIV infection. Our algorithm may assist in risk-stratifying individuals for AHI, especially in resource-limited settings where there is no routine testing for AHI. Independent validation of the algorithm on another cohort is needed to assess its utility further. Point-of-care antigen or viral load technology is required, however, to detect asymptomatic, antibody negative cases enabling early interventions and prevention of transmission.	[Mlisana, Koleka; Werner, Lise; van Loggerenberg, Francois; Naicker, Nivashnee; Williamson, Carolyn; Garrett, Nigel] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Mlisana, Koleka] Univ KwaZulu Natal, Dept Med Microbiol, Durban, South Africa; [Mlisana, Koleka] Natl Hlth Lab Serv, Durban, South Africa; [Sobieszczyk, Magdalena; Feinstein, Addi] Columbia Univ, New York, NY USA; [Williamson, Carolyn] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Williamson, Carolyn] Univ Cape Town, Div Med Virol, ZA-7925 Cape Town, South Africa	University of Kwazulu Natal; University of Kwazulu Natal; Columbia University; University of Cape Town; University of Cape Town	Mlisana, K (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.	mlisanak@ukzn.ac.za	; Mlisana, Koleka/N-6204-2013	van Loggerenberg, Francois/0000-0001-5317-7983; , Carolyn/0000-0003-0125-1226; Mlisana, Koleka/0000-0002-8436-3268	National Institute of Allergy and Infectious Disease (NIAID); National Institutes of Health (NIH); US Department of Health and Human Services (DHHS) [AI51794]; National Research Foundation, South Africa [67385]; FOGARTY INTERNATIONAL CENTER [R24TW008863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services (DHHS); National Research Foundation, South Africa(National Research Foundation - South Africa); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CAPRISA is part of the Comprehensive International Program of Research on AIDS (CIPRA), which is funded by the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) and the US Department of Health and Human Services (DHHS) Grant #AI51794 and the National Research Foundation, South Africa, Grant # 67385. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, REP GLOB HIV AIDS EP; Bell SK, 2010, J INFECT DIS, V202, pS278, DOI 10.1086/655655; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; Cohen T, 2011, LANCET, V378, P204, DOI 10.1016/S0140-6736(11)60896-9; FIDLER S., 2011, 6 INT AIDS SOC C HIV; Francois van Loggerenberg AAD, 2012, HIV PREVENTION HIGH; Ghosn J, 2010, J ANTIMICROB CHEMOTH, V65, P741, DOI 10.1093/jac/dkq035; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; HENRARD DR, 1995, J ACQ IMMUN DEF SYND, V9, P305; Hogan CM, 2012, J INFECT DIS, V205, P87, DOI 10.1093/infdis/jir699; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Kaufmann GR, 1998, AIDS PATIENT CARE ST, V12, P759, DOI 10.1089/apc.1998.12.759; Kaufmann GR, 1999, J ACQ IMMUN DEF SYND, V22, P437; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Lavreys L, 2006, CLIN INFECT DIS, V42, P1333, DOI 10.1086/503258; Lavreys L, 2000, CLIN INFECT DIS, V30, P486, DOI 10.1086/313718; Lavreys L, 2002, CLIN INFECT DIS, V35, P77, DOI 10.1086/340862; Lindback S, 2000, AIDS, V14, P2333, DOI 10.1097/00002030-200010200-00014; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Ndung'u T, 2006, VIROLOGY, V347, P247, DOI 10.1016/j.virol.2005.11.047; NIU MT, 1993, J INFECT DIS, V168, P1490, DOI 10.1093/infdis/168.6.1490; Pilcher CD, 2004, AIDS, V18, P517, DOI 10.1097/00002030-200402200-00019; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Serna-Bolea C, 2010, AIDS, V24, P603, DOI 10.1097/QAD.0b013e328335cda3; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; TINDALL B, 1988, ARCH INTERN MED, V148, P945, DOI 10.1001/archinte.148.4.945; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Vanhems P, 2000, J INFECT DIS, V182, P334, DOI 10.1086/315687; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2	43	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62928	10.1371/journal.pone.0062928	http://dx.doi.org/10.1371/journal.pone.0062928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646162	Green Published, gold			2022-12-25	WOS:000319077300116
J	Subhadra, S; Karthik, M; Raman, M				Subhadra, Subhra; Karthik, Mohanraj; Raman, Muthusamy			Development and Validation of Real-Time PCR for Rapid Detection of Mecistocirrus digitatus	PLOS ONE			English	Article							PARASITIC INFECTIONS; MULTIPLEX PCR; CATTLE; DIFFERENTIATION; NEMATODA; TRICHOSTRONGYLIDAE; PREVALENCE; ASSAY	Hematophagous activity of Mecistocirrus digitatus, which causes substantial blood and weight loss in large ruminants, is an emerging challenge due to the economic loss it brings to the livestock industry. Infected animals are treated with anthelmintic drugs, based on the identification of helminth species and the severity of infection; however, traditional methods such as microscopic identification and the counting of eggs for diagnosis and determination of level of infection are laborious, cumbersome and unreliable. To facilitate the detection of this parasite, a SYBR green-based real-time PCR was standardized and validated for the detection of M. digitatus infection in cattle and buffaloes. Oligonucleotides were designed to amplify partial Internal Transcribed Spacer (ITS)-1 sequence of M. digitatus. The specificity of the primers was confirmed by non-amplification of DNA extracted from other commonly occurring gastrointestinal nematodes in ruminants. Plasmids were ligated with partial ITS-1 sequence of M. digitatus, serially diluted (hundred fold) and used as standards in the real-time PCR assay. The quantification cycle (Cq) values were plotted against the standard DNA concentration to produce a standard curve. The assay was sensitive enough to detect one plasmid containing the M. digitatus DNA. Clinical application of this assay was validated by testing the DNA extracted from the faeces of naturally infected cattle (n = 40) and buffaloes (n = 25). The results were compared with our standard curve to calculate the quantity of M. digitatus in each faecal sample. The Cq value of the assay depicted a strong linear relationship with faecal DNA content, with a regression coefficient of 0.984 and efficiency of 99%. This assay has noteworthy advantages over the conventional methods of diagnosis because it is more specific, sensitive and reliable.	[Subhadra, Subhra; Karthik, Mohanraj; Raman, Muthusamy] Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Vet Parasitol, Madras, Tamil Nadu, India	Tamil Nadu Veterinary & Animal Sciences University	Raman, M (corresponding author), Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Vet Parasitol, Madras, Tamil Nadu, India.	raman@tanuvas.org.in	M., Raman/GPP-6589-2022; Muthusamy, Raman/GPS-8338-2022; Raman, Muthusamy/M-1002-2019	Muthusamy, Raman/0000-0002-6747-3799; Subhadra, Subhra/0000-0002-3388-9075; Mohanraj, Karthik/0000-0002-5817-0681	TANUVAS	TANUVAS	The work was supported by TANUVAS funding (http://www.tanuvas.tn.nic.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman M. S., 1991, Veterinary Medical Journal Giza, V39, P119; Bandyopadhyay S, 2010, TROP ANIM HEALTH PRO, V42, P1481, DOI 10.1007/s11250-010-9582-6; Baylis HA, 1923, REC INDIAN MUS, V25, P575; Bhalerao G. D., 1933, Agriculture and Live Stock in India, V3, P354; Bott NJ, 2009, INT J PARASITOL, V39, P1277, DOI 10.1016/j.ijpara.2009.03.002; Caldeira RL, 2003, MEM I OSWALDO CRUZ, V98, P1039, DOI 10.1590/S0074-02762003000800011; FERNANDO ST, 1965, J PARASITOL, V51, P149, DOI 10.2307/3276069; Gasser RB, 2000, INT J PARASITOL, V30, P509, DOI 10.1016/S0020-7519(00)00021-7; Gaur S. N. S., 1973, Philippine Journal of Veterinary Medicine, V12, P64; HOSTE H, 1993, INT J PARASITOL, V23, P1069, DOI 10.1016/0020-7519(93)90128-L; Ivashkin VM., 1947, DOKLADI AKAD NAUKSSR, V56, P1251; Jefferies R, 2009, VET PARASITOL, V166, P112, DOI 10.1016/j.vetpar.2009.07.042; Laha R, 2013, VET WORLD, V6, P109, DOI 10.5455/vetworld.2013.109-112; Learmount J, 2009, VET PARASITOL, V166, P268, DOI 10.1016/j.vetpar.2009.08.017; Marek M, 2005, HELMINTHOLOGIA, V42, P49; Mochizuki R, 2006, J VET MED SCI, V68, P345, DOI 10.1292/jvms.68.345; Raman M, 1996, INDIAN J ANIM SCI, V66, P1010; Roeber F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037327; Sambrook J, 2001, MOL CLONING LAB MANU; Soulsby EJL, 1986, HELMINTHS ARTHROPODS, V7; Sreedhar S, 2009, INDIAN J ANIM RES, V43, P230; STEVENSON LA, 1995, INT J PARASITOL, V25, P483, DOI 10.1016/0020-7519(94)00156-I; Van Aken D, 1998, VET PARASITOL, V74, P29, DOI 10.1016/S0304-4017(97)00142-8; VanAken D, 1997, VET PARASITOL, V69, P255, DOI 10.1016/S0304-4017(96)01132-6; von Samson-Himmestjerna G, 2002, INT J PARASITOL, V32, P1529, DOI 10.1016/S0020-7519(02)00163-7; Wadhwa A, 2011, VET WORLD, V4, P417, DOI 10.5455/vetworld.2011.417-419; WHITLOCK JH, 1960, DIAGNOSIS VET PARASI; Zarlenga DS, 1999, INT J PARASITOL, V29, P1859, DOI 10.1016/S0020-7519(99)00107-1; Zarlenga DS, 2001, VET PARASITOL, V97, P199, DOI 10.1016/S0304-4017(01)00410-1	29	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63019	10.1371/journal.pone.0063019	http://dx.doi.org/10.1371/journal.pone.0063019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646171	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300126
J	Zhang, Y; Wang, Y; Liu, Y; Wang, NP; Qi, YF; Du, J				Zhang, Yi; Wang, Ying; Liu, Yan; Wang, Nanping; Qi, Yongfen; Du, Jie			Kruppel-Like Factor 4 Transcriptionally Regulates TGF-beta 1 and Contributes to Cardiac Myofibroblast Differentiation	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; GENE-EXPRESSION; FACTOR KLF4; ACTIVATION; FIBROSIS; HYPERTROPHY; FIBROBLASTS; KINASE; INFLAMMATION	Angiotensin II (Ang II) plays a major role in the pathogenesis of cardiac fibrosis in hypertension. It is known that Ang II induces TGF-beta 1 expression. How transcription mediates Ang II-induced TGF-beta 1 expression, as well as its contribution to cardiac fibrosis, is unknown. We studied the role of Kruppel-like family transcription factors in Ang II-induced myofibroblast formation. We found that among the Kruppel-like family members, Kruppel-like factor 4 (Klf4) was the highest expressed form in isolated cardiac fibroblasts after Ang II treatment. Klf4 increased expression of alpha-SMA and collagen, as well as increased myofibroblast formation. ChIP assays showed that Klf4 specifically bound to the TGF-b1 promoter. Deletion and mutagenesis analysis showed that the sites at -184 similar to-180 bp and -45 similar to-41 bp in the TGF-beta 1 promoter were responsible for Klf4 transactivation of the TGF-beta 1 promoter. Our studies demonstrate that Klf4 plays a pivotal role in Ang II-induced cardiac myofibroblast differentiation and collagen synthesis through transcriptional upregulation of TGF-beta 1.	[Zhang, Yi; Wang, Ying; Liu, Yan; Wang, Nanping; Qi, Yongfen; Du, Jie] Capital Med Univ, Beijing Anzhen Hosp, Key Lab Remodeling Related Cardiovasc Dis, Minist Educ,Beijing Inst Heart Lung & Blood Vesse, Beijing, Peoples R China	Capital Medical University	Du, J (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Key Lab Remodeling Related Cardiovasc Dis, Minist Educ,Beijing Inst Heart Lung & Blood Vesse, Beijing, Peoples R China.	jdu@bcm.edu	Liu, Yan/S-6650-2017; Wang, Nanping/G-1818-2011; Liu, Yan/J-7597-2019	Liu, Yan/0000-0002-3961-9172; Liu, Yan/0000-0002-3961-9172; Wang, Ying/0000-0002-7852-386X; Wang, Nanping/0000-0002-8528-8132	Chinese Ministry of Science and Technology [2012CB945104, 2012CB517802]; National Natural Science Foundation of China [81230006, 31090363]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Chinese Ministry of Science and Technology (2012CB945104, 2012CB517802) and National Natural Science Foundation of China (81230006, 31090363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai WD, 2004, J BIOL CHEM, V279, P8684, DOI 10.1074/jbc.M308278200; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; CAULFIELD M, 1994, NEW ENGL J MED, V330, P1629, DOI 10.1056/NEJM199406093302301; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Feng WG, 2012, HYPERTENSION, V60, P1226, DOI 10.1161/HYPERTENSIONAHA.112.197871; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Force T, 1998, HYPERTENSION, V31, P152, DOI 10.1161/01.HYP.31.1.152; Haldar SM, 2007, J MOL CELL CARDIOL, V43, P1, DOI 10.1016/j.yjmcc.2007.04.005; Hamaguchi A, 1999, HYPERTENSION, V34, P126, DOI 10.1161/01.HYP.34.1.126; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kawai-Kowase K, 2009, ARTERIOSCL THROM VAS, V29, P99, DOI 10.1161/ATVBAHA.108.172700; Li HX, 2010, J BIOL CHEM, V285, P17846, DOI 10.1074/jbc.M109.076992; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; NAFTILAN AJ, 1990, MOL CELL BIOL, V10, P5536, DOI 10.1128/MCB.10.10.5536; NAFTILAN AJ, 1989, J CLIN INVEST, V83, P1419, DOI 10.1172/JCI114032; Qi GM, 2011, CARDIOVASC TOXICOL, V11, P157, DOI 10.1007/s12012-011-9109-z; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; TAUBMAN MB, 1989, J BIOL CHEM, V264, P526; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; Wang NP, 2002, J BIOL CHEM, V277, P34176, DOI 10.1074/jbc.M203436200; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Wu XQ, 2010, ARTERIOSCL THROM VAS, V30, P471, DOI 10.1161/ATVBAHA.109.184259; Yang M, 2012, ARTERIOSCL THROM VAS, V32, P1675, DOI 10.1161/ATVBAHA.112.248732; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Zhang LP, 2005, ARTERIOSCL THROM VAS, V25, P1148, DOI 10.1161/01.ATV.0000164624.00099.e7; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhou GJ, 2012, J CLIN INVEST, V122, P4727, DOI 10.1172/JCI66056	41	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63424	10.1371/journal.pone.0063424	http://dx.doi.org/10.1371/journal.pone.0063424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646205	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300164
J	Yoon, J; Kikuma, T; Maruyama, J; Kitamoto, K				Yoon, Jaewoo; Kikuma, Takashi; Maruyama, Jun-ichi; Kitamoto, Katsuhiko			Enhanced Production of Bovine Chymosin by Autophagy Deficiency in the Filamentous Fungus Aspergillus oryzae	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; HETEROLOGOUS PROTEINS; CALF CHYMOSIN; DISRUPTION; GENE; SECRETION; LEVEL; YEAST	Aspergillus oryzae has been utilized as a host for heterologous protein production because of its high protein secretory capacity and food-safety properties. However, A. oryzae often produces lower-than-expected yields of target heterologous proteins due to various underlying mechanisms, including degradation processes such as autophagy, which may be a significant bottleneck for protein production. In the present study, we examined the production of heterologous protein in several autophagy (Aoatg) gene disruptants of A. oryzae. We transformed A. oryzae gene disruptants of Aoatg1, Aoatg13, Aoatg4, Aoatg8, or Aoatg15, with a bovine chymosin (CHY) expression construct and found that the production levels of CHY increased up to three fold compared to the control strain. Notably, however, conidia formation by the Aoatg gene disruptants was significantly reduced. As large amounts of conidia are necessary for inoculating large-scale cultures, we also constructed Aoatg gene-conditional expression strains in which the promoter region of the Aoatg gene was replaced with the thiamine-controllable thiA promoter. Conidiation by the resultant transformants was clearly enhanced in the absence of thiamine, while autophagy remained repressed in the presence of thiamine. Moreover, these transformants displayed increased CHY productivity, which was comparable to that of the Aoatg gene disruptants. Consequently, we succeeded in the construction of A. oryzae strains capable of producing high levels of CHY due to defects in autophagy. Our finding suggests that the conditional regulation of autophagy is an effective method for increasing heterologous protein production in A. oryzae.	[Yoon, Jaewoo; Kikuma, Takashi; Maruyama, Jun-ichi; Kitamoto, Katsuhiko] Univ Tokyo, Dept Biotechnol, Tokyo, Japan	University of Tokyo	Kitamoto, K (corresponding author), Univ Tokyo, Dept Biotechnol, Tokyo, Japan.	akitamo@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Challenging Exploratory Research to K. Kitamoto from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; CHRISTENSEN T, 1988, BIO-TECHNOL, V6, P1419, DOI 10.1038/nbt1288-1419; Epple UD, 2001, J BACTERIOL, V183, P5942, DOI 10.1128/JB.183.20.5942-5955.2001; Epple UD, 2003, J BIOL CHEM, V278, P7810, DOI 10.1074/jbc.M209309200; Foltman B., 1970, METHOD ENZYMOL, V19, P421; Funakoshi T, 1997, GENE, V192, P207, DOI 10.1016/S0378-1119(97)00031-0; Higuchi Y, 2009, EUKARYOT CELL, V8, P37, DOI 10.1128/EC.00207-08; Idiris A, 2006, APPL MICROBIOL BIOT, V73, P404, DOI 10.1007/s00253-006-0489-0; Ito K, 2007, BIOCHEM BIOPH RES CO, V360, P407, DOI 10.1016/j.bbrc.2007.06.064; Jin FJ, 2007, APPL MICROBIOL BIOT, V76, P1059, DOI 10.1007/s00253-007-1088-4; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kario E, 2011, J BIOL CHEM, V286, P11479, DOI 10.1074/jbc.M110.177618; Kikuma T, 2006, EUKARYOT CELL, V5, P1328, DOI 10.1128/EC.00024-06; Kikuma T, 2011, FEMS MICROBIOL LETT, V316, P61, DOI 10.1111/j.1574-6968.2010.02192.x; Kimura S, 2011, BIOCHEM BIOPH RES CO, V406, P464, DOI 10.1016/j.bbrc.2011.02.075; Kimura S, 2010, FUNGAL GENET BIOL, V47, P1044, DOI 10.1016/j.fgb.2010.09.003; Kitamoto K, 2002, ADV APPL MICROBIOL, V51, P129, DOI 10.1016/S0065-2164(02)51004-2; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Maruyama JI, 2008, BIOTECHNOL LETT, V30, P1811, DOI 10.1007/s10529-008-9763-9; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Pollack JK, 2009, FUNGAL GENET BIOL, V46, P1, DOI 10.1016/j.fgb.2008.10.010; Punt PJ, 2002, TRENDS BIOTECHNOL, V20, P200, DOI 10.1016/S0167-7799(02)01933-9; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shoji JY, 2005, FEMS MICROBIOL LETT, V244, P41, DOI 10.1016/j.femsle.2005.01.014; Takahashi T, 2006, BIOSCI BIOTECH BIOCH, V70, P135, DOI 10.1271/bbb.70.135; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; TSUCHIYA K, 1994, BIOSCI BIOTECH BIOCH, V58, P895, DOI 10.1271/bbb.58.895; TSUCHIYA K, 1993, APPL MICROBIOL BIOT, V40, P327, DOI 10.1007/BF00170388; Tsuchiya K, 1992, APPL MICROBIOL BIOT, V39, P738; Yanagisawa S, 2013, FEMS MICROBIOL LETT, V338, P168, DOI 10.1111/1574-6968.12047; Yoon J, 2011, APPL MICROBIOL BIOT, V89, P747, DOI 10.1007/s00253-010-2937-0; Yoon J, 2010, APPL ENVIRON MICROB, V76, P5718, DOI 10.1128/AEM.03087-09; Yoon J, 2009, APPL MICROBIOL BIOT, V82, P691, DOI 10.1007/s00253-008-1815-5; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200	37	25	28	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62512	10.1371/journal.pone.0062512	http://dx.doi.org/10.1371/journal.pone.0062512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658635	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800049
J	Ki, MK; Jeoung, MH; Choi, JR; Rho, SS; Kwon, YG; Shim, H; Chung, J; Hong, HJ; Song, BD; Lee, S				Ki, M. K.; Jeoung, M. H.; Choi, J. R.; Rho, S-S; Kwon, Y-G; Shim, H.; Chung, J.; Hong, H. J.; Song, B. D.; Lee, S.			Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro	ONCOGENE			English	Article						Clec14a; C-type lectin-like domain; antibody; angiogenesis; endothelial cell; regulation	METASTATIC COLORECTAL-CANCER; EPIDERMAL-GROWTH-FACTOR; MONOCLONAL-ANTIBODY; INHIBITS ANGIOGENESIS; BEVACIZUMAB; THERAPY; FLUOROURACIL; LEUCOVORIN; CHEMOKINES; VESSELS	It has been suggested that clec14a may be involved in tumor angiogenesis. However, a molecular mechanism has not been clearly identified. In this study, we show for the first time that C-type lectin-like domain (CTLD) of clec14a may be important for regulating cell migration and filopodia formation. Using phage display technology, recombinant human antibodies specific to the CTLDs of human and mouse clec14a (clec14a-CTLD (immunoglobulin G) IgG) were selected. Functional assays using the antibodies showed that clec14a-CTLD IgGs specifically blocked endothelial cell migration and tube formation without affecting cell viability or activation. Further, clec14a-CTLD IgGs inhibited clec14a-mediated cell-cell contact by blocking interaction between CTLDs. Finally, clec14a cross-linking by the clec14a-CTLD IgGs significantly downregulated clec14a expression on the surface of endothelial cells. These results strongly suggest that the clec14a-CTLD may be a key domain in angiogenesis, and that clec14a-CTLD IgGs specifically inhibit angiogenesis by modulating CTLD-mediated cell interactions and clec14a expression on the surface of endothelial cells.	[Ki, M. K.; Jeoung, M. H.; Choi, J. R.; Song, B. D.; Lee, S.] Scripps Korea Antibody Inst, Lab Mol Canc Therapeut, Chunchon 200701, South Korea; [Rho, S-S; Kwon, Y-G] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Shim, H.] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Chung, J.] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Hong, H. J.] Kangwon Natl Univ, Dept Syst Immunol, Coll Biomed Sci, Chunchon, South Korea	Yonsei University; Ewha Womans University; Seoul National University (SNU); Kangwon National University	Lee, S (corresponding author), Scripps Korea Antibody Inst, Lab Mol Canc Therapeut, Hyoja 2 Dong, Chunchon 200701, South Korea.	Lees@skai.or.kr			Scripps Korea Antibody Institute; Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2012R1A2A1A01002916]	Scripps Korea Antibody Institute; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from Scripps Korea Antibody Institute and partly by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012R1A2A1A01002916).	Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Bergsland E, 2004, ONCOLOGIST, V9, P36, DOI 10.1634/theoncologist.9-suppl_1-36; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Dienstmann R, 2012, CURR CLIN PHARMACOL, V7, P137, DOI 10.2174/157488412800228929; Gordon MS, 2001, J CLIN ONCOL, V19, P843, DOI 10.1200/JCO.2001.19.3.843; Huang SM, 2002, MOL CANCER THER, V1, P507; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kim H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Kopetz S, 2010, J CLIN ONCOL, V28, P453, DOI 10.1200/JCO.2009.24.8252; Lee SH, 2011, ARCH PHARM RES, V34, P1223, DOI 10.1007/s12272-011-0821-9; Lee S, 2007, INT IMMUNOL, V19, P1349, DOI 10.1093/intimm/dxm104; Leow CC, 2012, INT J ONCOL, V40, P1321, DOI 10.3892/ijo.2012.1366; Lucio-Eterovic AK, 2009, CLIN CANCER RES, V15, P4589, DOI 10.1158/1078-0432.CCR-09-0575; Mura M, 2012, ONCOGENE, V31, P293, DOI 10.1038/onc.2011.233; Perrotte P, 1999, CLIN CANCER RES, V5, P257; Petit AMV, 1997, AM J PATHOL, V151, P1523; Rho SS, 2011, BIOCHEM BIOPH RES CO, V404, P103, DOI 10.1016/j.bbrc.2010.11.075; Sambrook J, 2001, MOL CLONING LAB MANU; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Spratlin J, 2011, CURR ONCOL REP, V13, P97, DOI 10.1007/s11912-010-0149-5; Teillaud Jean-Luc, 2012, Methods Mol Biol, V911, P3, DOI 10.1007/978-1-61779-968-6_1; Tortora G, 2004, CURR PHARM DESIGN, V10, P11, DOI 10.2174/1381612043453595; Van Meter KE, 2008, ARCH INSECT BIOCHEM, V69, P107, DOI 10.1002/arch.20271; Vestweber D, 2003, EUR J IMMUNOL, V33, P1361, DOI 10.1002/eji.200324011; Vincenzi B, 2008, CRIT REV ONCOL HEMAT, V68, P93, DOI 10.1016/j.critrevonc.2008.07.006; Zilian Olav, 2012, Hum Vaccin Immunother, V8, P1370, DOI 10.4161/hv.21413	29	27	29	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 28	2013	32	48					5449	5457		10.1038/onc.2013.156	http://dx.doi.org/10.1038/onc.2013.156			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	263BE	23644659	Green Published, hybrid			2022-12-25	WOS:000327780800002
J	Wang, YL; Jiang, L; Ji, X; Yang, B; Zhang, Y; Fu, XD				Wang, Yanling; Jiang, Li; Ji, Xiong; Yang, Bo; Zhang, Yi; Fu, Xiang-Dong			Hepatitis B Viral RNA Directly Mediates Down-regulation of the Tumor Suppressor MicroRNA miR-15a/miR-16-1 in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-X PROTEIN; HEPATOCELLULAR-CARCINOMA; LIVER; GENE; REPLICATION; EXPRESSION; TARGET; REPRESSION; ROLES	Hepatitis B virus (HBV) is a key risk factor for the development of hepatocellular carcinoma (HCC). Recent work suggests a functional link between HCC and microRNA expression, but the mechanism underlying the functional interaction between microRNA and HBV infection has remained largely elusive. Here we present evidence that the microRNA machinery serves as a defense system against HBV infection, which, in turn, reprograms the expression of specific microRNAs. We demonstrate a critical role of miR-15a/miR-16-1 in this functional interplay between microRNA and HBV infection, but in contrast to various indirect mechanisms mediated by viral proteins, we unexpectedly found that the HBx transcript directly triggers the down-regulation of miR-15a/miR-16-1 via the microRNA targeting sequences in the viral RNA. Because miR-15a and miR-16-1 are well known tumor suppressor microRNAs in multiple human cancers, our findings raise the intriguing possibility that viral RNA-mediated down-regulation of specific tumor suppressor microRNAs may contribute to HCC development in HBV-infected cells.	[Wang, Yanling; Jiang, Li; Ji, Xiong; Yang, Bo; Zhang, Yi; Fu, Xiang-Dong] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China; [Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Wuhan University; University of California System; University of California San Diego	Fu, XD (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.	xdfu@ucsd.edu		Zhang, Yi/0000-0003-1035-6134	National Institutes of Health [GM049369, GM052872]; China 973 Program [2011CB811300, 2012CB910800]; Chinese 111 Program [B06018]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052872, R01GM049369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China 973 Program(National Basic Research Program of China); Chinese 111 Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM049369 and GM052872. This work was also supported by China 973 Program Grants 2011CB811300 and 2012CB910800) and by Chinese 111 Program Grant B06018.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Arbuthnot P, 2000, J GASTROEN HEPATOL, V15, P357, DOI 10.1046/j.1440-1746.2000.02069.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Gramantieri L, 2008, J CELL MOL MED, V12, P2189, DOI 10.1111/j.1582-4934.2008.00533.x; Hayes CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047490; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Lee SG, 2000, ONCOGENE, V19, P468, DOI 10.1038/sj.onc.1203312; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CF, 2013, J VIROL, V87, P2193, DOI 10.1128/JVI.02831-12; Liu WH, 2011, BBA-GENE REGUL MECH, V1809, P678, DOI 10.1016/j.bbagrm.2011.04.008; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wang Y, 2010, J HEPATOL, V53, P57, DOI 10.1016/j.jhep.2009.12.043; Wong CM, 2002, CLIN CANCER RES, V8, P2266; Wu G, 2011, BRIT J CANCER, V105, P146, DOI 10.1038/bjc.2011.190; Yang LA, 2010, CANCER BIOL THER, V9, P803, DOI 10.4161/cbt.9.10.11440; Yoshikawa T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00637; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195	38	85	92	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18484	18493		10.1074/jbc.M113.458158	http://dx.doi.org/10.1074/jbc.M113.458158			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649629	Green Published, hybrid			2022-12-25	WOS:000320721900050
J	Krokowski, D; Han, J; Saikia, M; Majumder, M; Yuan, CL; Guan, BJ; Bevilacqua, E; Bussolati, O; Broer, S; Arvan, P; Tchorzewski, M; Snider, MD; Puchowicz, M; Croniger, CM; Kimball, SR; Pan, T; Koromilas, AE; Kaufman, RJ; Hatzoglou, M				Krokowski, Dawid; Han, Jaeseok; Saikia, Mridusmita; Majumder, Mithu; Yuan, Celvie L.; Guan, Bo-Jhih; Bevilacqua, Elena; Bussolati, Ovidio; Broeer, Stefan; Arvan, Peter; Tchorzewski, Marek; Snider, Martin D.; Puchowicz, Michelle; Croniger, Colleen M.; Kimball, Scot R.; Pan, Tao; Koromilas, Antonis E.; Kaufman, Randal J.; Hatzoglou, Maria			A Self-defeating Anabolic Program Leads to beta-Cell Apoptosis in Endoplasmic Reticulum Stress-induced Diabetes via Regulation of Amino Acid Flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; OXIDATIVE STRESS; PHOSPHORYLATION; TRANSPORTER; INSULIN; CHOP; DEPHOSPHORYLATION; TRANSLATION; INHIBITION; ACTIVATION	Endoplasmic reticulum (ER) stress-induced responses are associated with the loss of insulin-producing beta-cells in type 2 diabetes mellitus. beta-Cell survival during ER stress is believed to depend on decreased protein synthesis rates that are mediated via phosphorylation of the translation initiation factor eIF2 alpha. It is reported here that chronic ER stress correlated with increased islet protein synthesis and apoptosis in beta-cells in vivo. Paradoxically, chronic ER stress in beta-cells induced an anabolic transcription program to overcome translational repression by eIF2 alpha phosphorylation. This program included expression of amino acid transporter and aminoacyl-tRNA synthetase genes downstream of the stress-induced ATF4-mediated transcription program. The anabolic response was associated with increased amino acid flux and charging of tRNAs for branched chain and aromatic amino acids (e.g. leucine and tryptophan), the levels of which are early serum indicators of diabetes. We conclude that regulation of amino acid transport in beta-cells during ER stress involves responses leading to increased protein synthesis, which can be protective during acute stress but can lead to apoptosis during chronic stress. These studies suggest that the increased expression of amino acid transporters in islets can serve as early diagnostic biomarkers for the development of diabetes.	[Krokowski, Dawid; Saikia, Mridusmita; Majumder, Mithu; Yuan, Celvie L.; Guan, Bo-Jhih; Bevilacqua, Elena; Puchowicz, Michelle; Croniger, Colleen M.; Hatzoglou, Maria] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Snider, Martin D.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Han, Jaeseok; Kaufman, Randal J.] Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Bussolati, Ovidio] Univ Parma, Dept Biomed Biotechnol & Translat Sci, I-43100 Parma, Italy; [Broeer, Stefan] Australian Natl Univ, Res Sch Biol, Canberra, Acton 0200, Australia; [Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Tchorzewski, Marek] Marie Curie Sklodowska Univ, Dept Mol Biol, PL-02031 Lublin, Poland; [Kimball, Scot R.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Koromilas, Antonis E.] McGill Univ, Dept Oncol, Montreal, PQ H3A 0G4, Canada	Case Western Reserve University; Case Western Reserve University; Sanford Burnham Prebys Medical Discovery Institute; University of Parma; Australian National University; University of Michigan System; University of Michigan; Maria Curie-Sklodowska University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Chicago; McGill University	Krokowski, D (corresponding author), Case Western Reserve Univ, Dept Nutr, 10900 Euclid Ave, Cleveland, OH 44106 USA.	krokud@gmail.com; mxh8@case.edu	Broer, Stefan/A-1286-2008; Han, Jaeseok/AAE-6872-2020; Bussolati, Ovidio/B-7589-2013	Broer, Stefan/0000-0002-8040-1634; Bussolati, Ovidio/0000-0002-4301-2939; Tchorzewski, Marek/0000-0002-0718-4223; Saikia, Mridusmita/0000-0002-5848-3303	National Institutes of Health [R37-DK60596, R01-DK53307, DK48280, R37DK042394, R01DK088227, DK15658]; MMPC [U24 DK76174]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042394, R01DK088227, R01DK015658, R01DK060596, P30DK020572, R01DK048280, U24DK076174, R37DK060596, R01DK053307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MMPC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-DK60596 and R01-DK53307 (to M. H.), DK48280 (to P. A.), R37DK042394 and R01DK088227 (to R. J. K.), DK15658 (to S. K.), and MMPC U24 DK76174 (to Case Western Reserve University).	Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Franchi-Gazzola R, 2006, ACTA PHYSIOL, V187, P273, DOI 10.1111/j.1748-1716.2006.01552.x; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120; Huang C., 2013, CURR TOP ME IN PRESS; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Karunakaran S, 2008, BIOCHEM J, V414, P343, DOI 10.1042/BJ20080622; Kaufman RJ, 2010, DIABETES OBES METAB, V12, P99, DOI 10.1111/j.1463-1326.2010.01281.x; Kaufman RJ, 2011, NEW ENGL J MED, V365, P1931, DOI 10.1056/NEJMcibr1109442; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Ku GM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002449; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Majumder M, 2012, MOL CELL BIOL, V32, P992, DOI 10.1128/MCB.06665-11; Malmberg SE, 2008, J BIOL CHEM, V283, P19229, DOI 10.1074/jbc.M801331200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martin L, 2010, J BIOL CHEM, V285, P31944, DOI 10.1074/jbc.M110.153148; McGirr R, 2011, MOL IMAGING BIOL, V13, P962, DOI 10.1007/s11307-010-0435-5; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; Melnik BC, 2012, WORLD J DIABETES, V3, P38, DOI 10.4239/wjd.v3.i3.38; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oslowski CM, 2011, CURR OPIN CELL BIOL, V23, P207, DOI 10.1016/j.ceb.2010.11.005; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; PATHAK VK, 1988, MOL CELL BIOL, V8, P993, DOI 10.1128/MCB.8.2.993; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Shennan DB, 2008, ONCOL REP, V20, P885, DOI 10.3892/or_00000087; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tomi M, 2005, INVEST OPHTH VIS SCI, V46, P2522, DOI 10.1167/iovs.04-1175; Tuckow AP, 2010, AM J PHYSIOL-ENDOC M, V299, pE241, DOI 10.1152/ajpendo.00151.2010; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Yuan CL, 2008, AM J PHYSIOL-ENDOC M, V295, pE216, DOI 10.1152/ajpendo.00545.2007; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877	53	80	82	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17202	17213		10.1074/jbc.M113.466920	http://dx.doi.org/10.1074/jbc.M113.466920			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645676	hybrid, Green Published			2022-12-25	WOS:000320380600017
J	Balderston, NL; Schultz, DH; Helmstetter, FJ				Balderston, Nicholas L.; Schultz, Doug H.; Helmstetter, Fred J.			The Effect of Threat on Novelty Evoked Amygdala Responses	PLOS ONE			English	Article							FEAR-RELEVANT STIMULI; FUNCTIONAL MRI; MASKED STIMULI; ELECTRODERMAL RESPONSES; PHOBIC INDIVIDUALS; NEURAL MECHANISMS; EMOTIONAL STIMULI; HUMAN HIPPOCAMPAL; BRAIN ACTIVATION; RHESUS-MONKEYS	A number of recent papers have suggested that the amygdala plays a role in the brain's novelty detection circuit. In a recent study, we showed that this role may be specific to certain classes of biologically-relevant stimuli, such as human faces. The purpose of the present experiment was to determine whether other biologically-relevant stimuli also evoke novelty specific amygdala responses. To test this idea, we presented novel and repeated images of snakes and flowers while measuring BOLD. Surprisingly, we found that novel images of snakes and flowers evoke more amygdala activity than repeated images of snakes and flowers. Our results further confirm the robustness of the novelty evoked amygdala responses, even when compared with effects more traditionally associated with the amygdala. In addition, our results suggest that threatening stimuli may prime the amygdala to respond to other types of stimuli as well.	[Balderston, Nicholas L.; Schultz, Doug H.; Helmstetter, Fred J.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; [Helmstetter, Fred J.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA	University of Wisconsin System; University of Wisconsin Milwaukee; Medical College of Wisconsin	Helmstetter, FJ (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	fjh@uwm.edu	Schultz, Douglas/AAB-2365-2020; Balderston, Nicholas/U-9126-2019	Schultz, Douglas/0000-0003-0809-9036; Balderston, Nicholas/0000-0002-8565-1544; Helmstetter, Fred/0000-0003-3413-2418	National Institute of Mental Health [MH060668, MH069558]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069558, R01MH060668] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Institute of Mental Health, grants MH060668 and MH069558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balderston NL, 2011, NEUROIMAGE, V55, P1889, DOI 10.1016/j.neuroimage.2011.01.034; Balderston NL, 2010, BEHAV NEUROSCI, V124, P478, DOI 10.1037/a0019927; Blackford JU, 2010, NEUROIMAGE, V50, P1188, DOI 10.1016/j.neuroimage.2009.12.083; Carlsson K, 2004, EMOTION, V4, P340, DOI 10.1037/1528-3542.4.4.340; Cheng DT, 2007, LEARN MEMORY, V14, P485, DOI 10.1101/lm.632007; Cheng DT, 2006, BEHAV NEUROSCI, V120, P1187, DOI 10.1037/0735-7044.120.5.1187; Cheng DT, 2003, BEHAV NEUROSCI, V117, P3, DOI 10.1037/0735-7044.117.1.3; Choi JS, 2010, P NATL ACAD SCI USA, V107, P21773, DOI 10.1073/pnas.1010079108; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; Demos KE, 2008, CEREB CORTEX, V18, P2729, DOI 10.1093/cercor/bhn034; Dilger S, 2003, NEUROSCI LETT, V348, P29, DOI 10.1016/S0304-3940(03)00647-5; Fanselow M.S., 1988, P185; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; Fischer H, 2003, BRAIN RES BULL, V59, P387, DOI 10.1016/S0361-9230(02)00940-1; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FREDRIKSON M, 1976, BIOL PSYCHOL, V4, P305, DOI 10.1016/0301-0511(76)90021-1; Gamer M, 2009, J NEUROSCI, V29, P9123, DOI 10.1523/JNEUROSCI.1883-09.2009; Glascher J, 2007, J NEUROSCI, V27, P4366, DOI 10.1523/JNEUROSCI.3310-06.2007; Grunwald T, 1998, P NATL ACAD SCI USA, V95, P3193, DOI 10.1073/pnas.95.6.3193; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; HUGDAHL K, 1977, J EXP PSYCHOL-HUM L, V3, P608, DOI 10.1037/0278-7393.3.5.608; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; Izquierdo A, 2005, J NEUROSCI, V25, P8534, DOI 10.1523/JNEUROSCI.1232-05.2005; Izquierdo A, 2004, J NEUROPHYSIOL, V91, P2023, DOI 10.1152/jn.00968.2003; Jeneson A, 2010, LEARN MEMORY, V17, P852, DOI 10.1101/lm.1546110; Kalin NH, 2001, J NEUROSCI, V21, P2067, DOI 10.1523/JNEUROSCI.21-06-02067.2001; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; Kirwan CB, 2008, J NEUROSCI, V28, P10541, DOI 10.1523/JNEUROSCI.3456-08.2008; Knight DC, 2004, COGN AFFECT BEHAV NE, V4, P317, DOI 10.3758/CABN.4.3.317; Knight DC, 2004, J NEUROSCI, V24, P218, DOI 10.1523/JNEUROSCI.0433-03.2004; Knight DC, 1999, NEUROREPORT, V10, P3665, DOI 10.1097/00001756-199911260-00037; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Lang P. J., 2005, INT AFFECTIVE PICTUR; Larson CL, 2006, BIOL PSYCHIAT, V60, P410, DOI 10.1016/j.biopsych.2006.03.079; Lever C, 2010, HIPPOCAMPUS, V20, P229, DOI 10.1002/hipo.20671; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Menon V, 2000, HUM BRAIN MAPP, V11, P117, DOI 10.1002/1097-0193(200010)11:2<117::AID-HBM50>3.0.CO;2-M; Michalowski JM, 2009, EMOTION, V9, P306, DOI 10.1037/a0015550; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Nyberg L, 2005, CURR OPIN NEUROL, V18, P424, DOI 10.1097/01.wco.0000168080.99730.1c; Ohman A, 1998, J EXP PSYCHOL GEN, V127, P69, DOI 10.1037/0096-3445.127.1.69; OHMAN A, 1993, J ABNORM PSYCHOL, V102, P121; OHMAN A, 1994, J ABNORM PSYCHOL, V103, P231, DOI 10.1037/0021-843X.103.2.231; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Poppenk J, 2010, J NEUROSCI, V30, P4707, DOI 10.1523/JNEUROSCI.5466-09.2010; Rutishauser U, 2006, NEURON, V49, P805, DOI 10.1016/j.neuron.2006.02.015; Rutishauser U, 2008, P NATL ACAD SCI USA, V105, P329, DOI 10.1073/pnas.0706015105; Sabatinelli D, 2009, J NEUROSCI, V29, P14864, DOI 10.1523/JNEUROSCI.3278-09.2009; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Schultz DH, 2010, J EXP PSYCHOL-ANIM B, V36, P495, DOI 10.1037/a0020263; Schwartz CE, 2003, SCIENCE, V300, P1952, DOI 10.1126/science.1083703; Soares SC, 2009, BEHAV RES THER, V47, P1032, DOI 10.1016/j.brat.2009.07.022; Strange BA, 2001, HIPPOCAMPUS, V11, P690, DOI 10.1002/hipo.1084; Straube T, 2007, NEUROIMAGE, V37, P1427, DOI 10.1016/j.neuroimage.2007.06.023; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Ward R, 2005, CURR BIOL, V15, P571, DOI 10.1016/j.cub.2005.01.056; Weierich MR, 2010, NEUROIMAGE, V49, P2871, DOI 10.1016/j.neuroimage.2009.09.047; Whalen PJ, 1998, J NEUROSCI, V18, P411; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Wright CI, 2006, NEUROBIOL AGING, V27, P361, DOI 10.1016/j.neurobiolaging.2005.01.014; Wright CI, 2003, NEUROIMAGE, V18, P660, DOI 10.1016/S1053-8119(02)00037-X; Yamaguchi S, 2004, J NEUROSCI, V24, P5356, DOI 10.1523/JNEUROSCI.4587-03.2004	68	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63220	10.1371/journal.pone.0063220	http://dx.doi.org/10.1371/journal.pone.0063220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658813	Green Published, gold			2022-12-25	WOS:000321202100057
J	Huen, K; Harley, K; Beckman, K; Eskenazi, B; Holland, N				Huen, Karen; Harley, Kim; Beckman, Kenneth; Eskenazi, Brenda; Holland, Nina			Associations of PON1 and Genetic Ancestry with Obesity in Early Childhood	PLOS ONE			English	Article							SYSTEMIC OXIDATIVE STRESS; BODY-MASS INDEX; POPULATION-STRUCTURE; PARAOXONASE-1 GENE; ENZYME-ACTIVITY; STATUS REQUIRES; BREAST-CANCER; US CHILDREN; RISK-FACTOR; POLYMORPHISMS	Obesity in children has become an epidemic in the U. S. and is particularly prominent in minority populations such as Mexican-Americans. In addition to physical activity and diet, genetics also plays a role in obesity etiology. A few studies in adults and adolescents suggest a link between obesity and paraoxonase 1 (PON1), a multifunctional enzyme that can metabolize organophosphate pesticides and also has antioxidant properties. We determined PON1(192) genotype and arylesterase levels (ARYase, measure of PON1 enzyme quantity), to characterize the relationship between PON1 and obesity in young Mexican-American children (n = 373) living in an agricultural community in California. Since PON1 polymorphisms and obesity both vary between ethnic groups, we estimated proportional genetic ancestry using 106 ancestral informative markers (AIMs). Among children, PON1(192) allele frequencies were 0.5 for both alleles, and the prevalence of obesity was high (15% and 33% at ages two and five, respectively). The average proportion of European, African, and Native American ancestry was 0.40, 0.09, and 0.51, yet there was wide inter-individual variation. We found a significantly higher odds of obesity (9.3 and 2.5-fold) in PON1(192QQ) children compared to PON1(192RR) children at ages two and five, respectively. Similar relationships were seen with BMI Z-scores at age two and waist circumference at age five. After adjusting for genetic ancestry in models of PON1 and BMI Z-score, effect estimates for PON1(192) genotype changed 15% and 9% among two and five year old children, respectively, providing evidence of genetic confounding by population stratification. However even after adjustment for genetic ancestry, the trend of increased BMI Z-scores with increased number of PON1(192) Q alleles remained. Our findings suggest that PON1 may play a role in obesity independent of genetic ancestry and that studies of PON1 and health outcomes, especially in admixed populations, should account for differences due to population stratification.	[Huen, Karen; Harley, Kim; Eskenazi, Brenda; Holland, Nina] Univ Calif Berkeley, Sch Publ Hlth, Ctr Environm Res & Childrens Hlth, Berkeley, CA 94720 USA; [Beckman, Kenneth] Univ Minnesota, Inst Hlth Informat, Biomed Genom Ctr, Minneapolis, MN USA	University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities	Huen, K (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Ctr Environm Res & Childrens Hlth, Berkeley, CA 94720 USA.	khuen@berkeley.edu		Huen, Karen/0000-0003-3604-2096	U.S. Environmental Protection Agency (EPA) [R826886, R82670901]; National Institute of Environmental Health Science (NIEHS) [R01ESO12503-03, PO1 ES009605]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009605] Funding Source: NIH RePORTER	U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency); National Institute of Environmental Health Science (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This publication was made possible by grant numbers R826886 and R82670901 from the U.S. Environmental Protection Agency (EPA) and R01ESO12503-03 and PO1 ES009605 from the National Institute of Environmental Health Science (NIEHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036830; Aviram M, 2005, HANDB EXP PHARM, V170, P263; Bajnok L, 2008, ATHEROSCLEROSIS, V197, P363, DOI 10.1016/j.atherosclerosis.2007.06.001; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Bouchard C, 2009, AM J CLIN NUTR, V89, pS1494, DOI 10.3945/ajcn.2009.27113C; Brophy VH, 2000, PHARMACOGENETICS, V10, P453, DOI 10.1097/00008571-200007000-00008; Bueno AC, 2010, EUR J ENDOCRINOL, V162, P53, DOI 10.1530/EJE-09-0697; Chen J, 2003, ENVIRON HEALTH PERSP, V111, P1403, DOI 10.1289/ehp.6105; Choudhry S, 2008, HUM GENET, V123, P455, DOI 10.1007/s00439-008-0495-7; Connelly PW, 2008, J LIPID RES, V49, P245, DOI 10.1194/jlr.D700022-JLR200; Cossrow N, 2004, J CLIN ENDOCR METAB, V89, P2590, DOI 10.1210/jc.2004-0339; Eskenazi B., 2003, J CHILD HLTH, V1, P3, DOI [DOI 10.3109/713610244, 10.3109/713610244]; Falush D, 2003, GENETICS, V164, P1567; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Fejerman L, 2010, CANCER EPIDEM BIOMAR, V19, P1074, DOI 10.1158/1055-9965.EPI-09-1193; Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124; Ferretti G, 2005, J CLIN ENDOCR METAB, V90, P1728, DOI 10.1210/jc.2004-0486; Ferretti G, 2009, OBESITY SILVER SPRIN; Harley KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023923; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Holland N, 2006, ENVIRON HEALTH PERSP, V114, P985, DOI 10.1289/ehp.8540; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huen K, 2011, ENVIRON MOL MUTAGEN, V52, P105, DOI 10.1002/em.20567; Huen K, 2010, TOXICOL APPL PHARM, V244, P181, DOI 10.1016/j.taap.2009.12.031; Huen K, 2009, ENVIRON HEALTH PERSP, V117, P1632, DOI 10.1289/ehp.0900870; Huen K, 2009, CLIN CHIM ACTA, V402, P67, DOI 10.1016/j.cca.2008.12.019; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Kimm SYS, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e54; Koncsos P, 2010, PEDIATR RES, V67, P309, DOI 10.1203/PDR.0b013e3181c9fb66; Kujiraoka T, 2000, J LIPID RES, V41, P1358; Lai CQ, 2009, HUM GENET, V125, P199, DOI 10.1007/s00439-008-0612-7; Lee YL, 2010, J GENET, V89, P417, DOI 10.1007/s12041-010-0060-8; Li HL, 2003, J MOL MED, V81, P766, DOI 10.1007/s00109-003-0481-4; Lighthall D, 2001, WESTERN J MED, V175, P223, DOI 10.1136/ewjm.175.4.223; Loos RJF, 2009, BRIT J CLIN PHARMACO, V68, P811, DOI 10.1111/j.1365-2125.2009.03523.x; Mackness MI, 2000, CURR OPIN LIPIDOL, V11, P383, DOI 10.1097/00041433-200008000-00007; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martinez-Salazar MF, 2011, GENES NUTR, V6, P361, DOI 10.1007/s12263-011-0215-0; National Center for Health Statistics, 2005, CDC GROWTH CHARTS; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Ogden Cynthia L, 2010, Natl Health Stat Report, P1; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Paragh G, 2009, NEPHRON CLIN PRACT, V113, pC46, DOI 10.1159/000228075; Pritchard JK, 2000, GENETICS, V155, P945; Rankinen T, 2006, MED SCI SPORT EXER, V38, P1863, DOI 10.1249/01.mss.0000233789.01164.4f; Rankinen T, 2010, OBESITY, V18, P322, DOI 10.1038/oby.2009.205; Richter RJ, 2010, ADV EXP MED BIOL, V660, P29, DOI 10.1007/978-1-60761-350-3_4; Richter RJ, 1999, PHARMACOGENETICS, V9, P745, DOI 10.1097/01213011-199912000-00009; Rojas-Garcia AE, 2005, TOXICOL APPL PHARM, V205, P282, DOI 10.1016/j.taap.2004.10.015; Rosas LG, 2011, J IMMIGR MINOR HEALT, V13, P169, DOI 10.1007/s10903-010-9332-x; Rosas LG, 2010, MATERN CHILD HLTH J, V14, P886, DOI 10.1007/s10995-009-0534-6; Rothman K., 1998, MODERN EPIDEMIOLOGY; Seres I, 2010, ADV EXP MED BIOL, V660, P129, DOI 10.1007/978-1-60761-350-3_12; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; Sisson SB, 2009, INT J PEDIATR OBES, V4, P353, DOI 10.3109/17477160902934777; Tang H, 2006, HUM GENET, V119, P624, DOI 10.1007/s00439-006-0175-4; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; Vaught J, 2012, BIOPRESERV BIOBANK, V10, P76, DOI [10.1089/bio.2012.1024, 10.1089/bio.2012.1025]; Veiga L, 2011, EUR J ENDOCRINOL, V164, P213, DOI 10.1530/EJE-10-0825; Warner ML, 2006, OBESITY, V14, P1966, DOI 10.1038/oby.2006.230; Zhao JH, 2011, J OBES, V2011, DOI 10.1155/2011/845148; Ziv E, 2003, PHARMACOGENOMICS, V4, P431, DOI 10.1517/phgs.4.4.431.22758	65	19	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62565	10.1371/journal.pone.0062565	http://dx.doi.org/10.1371/journal.pone.0062565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658746	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100019
J	Maestrale, C; Di Guardo, G; Cancedda, MG; Marruchella, G; Masia, M; Sechi, S; Macciocu, S; Santucciu, C; Petruzzi, M; Ligios, C				Maestrale, Caterina; Di Guardo, Giovanni; Cancedda, Maria Giovanna; Marruchella, Giuseppe; Masia, Mariangela; Sechi, Stefania; Macciocu, Simonetta; Santucciu, Cinzia; Petruzzi, Mara; Ligios, Ciriaco			A Lympho-Follicular Microenvironment Is Required for Pathological Prion Protein Deposition in Chronically Inflamed Tissues from Scrapie-Affected Sheep	PLOS ONE			English	Article							PRPSC ACCUMULATION; CELL RECRUITMENT; EXPRESSION; ARTHRITIS; REPLICATION; FOLLICLES; GLANDS; BETA	In sheep scrapie, pathological prion protein (PrPSc) deposition occurs in the lymphoreticular and central nervous systems. We investigated PrPSc distribution in scrapie-affected sheep showing simultaneous evidence of chronic lymphofollicular, lymphoproliferative/non-lymphofollicular, and/or granulomatous inflammations in their mammary gland, lung, and ileum. To do this, PrPSc detection was carried out via immunohistochemistry and Western Blotting techniques, as well as through inflammatory cell immunophenotyping. Expression studies of gene coding for biological factors modulating the host's inflammatory response were also carried out. We demonstrated that ectopic PrPSc deposition occurs exclusively in the context of lymphofollicular inflammatory sites, inside newly formed and well-organized lymphoid follicles harboring follicular dendritic cells. On the contrary, no PrPSc deposition was detected in granulomas, even when they were closely located to newly formed lymphoid follicles. A significantly more consistent expression of lymphotoxin alpha and beta mRNA was detected in lymphofollicular inflammation compared to the other two types, with lymphotoxin alpha and beta signaling new lymphoid follicles' formation and, likely, the occurrence of ectopic PrPSc deposition inside them. Our findings suggest that, in sheep co-affected by scrapie and chronic inflammatory conditions, only newly formed lymphoid follicles provide a suitable micro-environment that supports the scrapie agent's replication in inflammatory sites, with an increased risk of prion shedding through body secretions/excretions.	[Maestrale, Caterina; Cancedda, Maria Giovanna; Masia, Mariangela; Macciocu, Simonetta; Santucciu, Cinzia; Petruzzi, Mara; Ligios, Ciriaco] Ist Zooprofilatt Sperimentale Sardegna, Dipartimento Sanita Anim, Sassari, Italy; [Di Guardo, Giovanni; Marruchella, Giuseppe] Univ Teramo, Fac Med Vet, Dipartimento Sci Biomediche Comparate, Teramo, Italy; [Sechi, Stefania] AGRIS, DIRPA, Res Unit Genet & Biotechnol, Olmedo, Italy	IZS Della Sardegna; University of Teramo	Ligios, C (corresponding author), Ist Zooprofilatt Sperimentale Sardegna, Dipartimento Sanita Anim, Sassari, Italy.	ciriaco.ligios@izs-sardegna.it	Santucciu, Cinzia/D-1229-2012	Santucciu, Cinzia/0000-0001-9699-3745	Italian Ministry of Health [IZS SA 04/09, IZS SA 05/09]; EMIDA ERA-NET Research Project	Italian Ministry of Health(Ministry of Health, Italy); EMIDA ERA-NET Research Project	This work was supported by IZS SA 04/09 and IZS SA 05/09 RC grants from the Italian Ministry of Health, as well as by an EMIDA ERA-NET 2011 Research Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Andreoletti O, 2002, J GEN VIROL, V83, P2607, DOI 10.1099/0022-1317-83-10-2607; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Armengol MP, 2003, J IMMUNOL, V170, P6320, DOI 10.4049/jimmunol.170.12.6320; Blacklaws BA, 2012, COMP IMMUNOL MICROB, V35, P259, DOI 10.1016/j.cimid.2011.12.003; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; Cheville NF, 2006, INTRO VET PATHOLOGY, P61; Ghosh S, 2005, J IMMUNOL, V174, P2860, DOI 10.4049/jimmunol.174.5.2860; Gonzalez L, 2003, J GEN VIROL, V84, P1339, DOI 10.1099/vir.0.18800-0; Gregori L, 2008, EMERG INFECT DIS, V14, P1406, DOI 10.3201/eid1409.080259; Hamir AN, 2006, VET PATHOL, V43, P367, DOI 10.1354/vp.43-3-367; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Heikenwalder M, 2008, IMMUNITY, V29, P998, DOI 10.1016/j.immuni.2008.10.014; Jackson DG, 2004, APMIS, V112, P526, DOI 10.1111/j.1600-0463.2004.apm11207-0811.x; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P17807, DOI 10.1073/pnas.0407503101; Lacroux C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000238; Ligios C, 2005, NAT MED, V11, P1137, DOI 10.1038/nm1105-1137; Ligios C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000859; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; McCulloch L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002402; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Mounzer RH, 2010, BLOOD, V116, P2173, DOI 10.1182/blood-2009-12-256065; Murakami J, 1999, HEPATOLOGY, V30, P143, DOI 10.1002/hep.510300107; O'Rourke KP, 2008, RHEUMATOL INT, V28, P979, DOI 10.1007/s00296-008-0574-z; Pammer J, 1998, AM J PATHOL, V153, P1353, DOI 10.1016/S0002-9440(10)65720-3; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Sorby R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006885; Thomzig A, 2007, PLOS PATHOG, V3, P659, DOI 10.1371/journal.ppat.0030066; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996; Vascellari M, 2007, J VIROL, V81, P4872, DOI 10.1128/JVI.02148-06; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638	40	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62830	10.1371/journal.pone.0062830	http://dx.doi.org/10.1371/journal.pone.0062830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658779	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100043
J	Hellen, EH; Dana, SK; Zhurov, B; Volkov, E				Hellen, Edward H.; Dana, Syamal K.; Zhurov, Boris; Volkov, Evgeny			Electronic Implementation of a Repressilator with Quorum Sensing Feedback	PLOS ONE			English	Article							MODEL	We investigate the dynamics of a synthetic genetic repressilator with quorum sensing feedback. In a basic genetic ring oscillator network in which three genes inhibit each other in unidirectional manner, an additional quorum sensing feedback loop stimulates the activity of a chosen gene providing competition between inhibitory and stimulatory activities localized in that gene. Numerical simulations show several interesting dynamics, multi-stability of limit cycle with stable steady-state, multi-stability of different stable steady-states, limit cycle with period-doubling and reverse period-doubling, and infinite period bifurcation transitions for both increasing and decreasing strength of quorum sensing feedback. We design an electronic analog of the repressilator with quorum sensing feedback and reproduce, in experiment, the numerically predicted dynamical features of the system. Noise amplification near infinite period bifurcation is also observed. An important feature of the electronic design is the accessibility and control of the important system parameters.	[Hellen, Edward H.] Univ North Carolina Greensboro, Dept Phys & Astron, Greensboro, NC USA; [Dana, Syamal K.] CSIR Indian Inst Chem Biol, Kolkata, India; [Zhurov, Boris; Volkov, Evgeny] Lebedev Phys Inst, Dept Theoret Phys, Moscow, Russia	University of North Carolina; University of North Carolina Greensboro; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute	Hellen, EH (corresponding author), Univ North Carolina Greensboro, Dept Phys & Astron, Greensboro, NC USA.	ehhellen@uncg.edu	Zhurov, Boris/M-6965-2015; Hellen, Edward/AAN-7714-2021; Volkov, Evgeny I/K-9176-2015	Hellen, Edward/0000-0001-5060-7220; 	RFBR [12-02-00529]; CSIR Network project GENESIS	RFBR(Russian Foundation for Basic Research (RFBR)); CSIR Network project GENESIS	E.V. and B.Z. thank RFBR 12-02-00529 for partial support. S.K.D. acknowledges support by the CSIR Network project GENESIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alon U., 2006, INTRO SYSTEMS BIOL D; Bennett MR, 2007, BIOPHYS J, V92, P3501, DOI 10.1529/biophysj.106.095638; Buse O, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066206; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Goryachev AB, 2011, CHEM REV, V111, P238, DOI 10.1021/cr100286z; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hellen EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023286; Hellen EH, 2012, ARXIV12124470; Kobayashi Y, 2010, EUR PHYS J B, V76, P167, DOI 10.1140/epjb/e2010-00200-9; Kobayashi Y, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.060901; Koseska A, 2010, J THEOR BIOL, V263, P189, DOI 10.1016/j.jtbi.2009.11.007; Kuznetsov A, 2005, SIAM J APPL MATH, V65, P392, DOI 10.1137/S0036139903436029; Lerat E, 2004, MOL BIOL EVOL, V21, P903, DOI 10.1093/molbev/msh097; Liu CL, 2011, SCIENCE, V334, P238, DOI 10.1126/science.1209042; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Muller S, 2006, J MATH BIOL, V53, P905, DOI 10.1007/s00285-006-0035-9; Potapov I, 2012, CHAOS, V22, DOI 10.1063/1.4705085; Potapov I, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031901; Prindle A, 2012, NATURE, V481, P39, DOI 10.1038/nature10722; SMITH H, 1987, J MATH BIOL, V25, P169, DOI 10.1007/BF00276388; Strelkowa N, 2010, J R SOC INTERFACE, V7, P1071, DOI 10.1098/rsif.2009.0487; Tuttle LM, 2005, BIOPHYS J, V89, P3873, DOI 10.1529/biophysj.105.064204; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Ullner E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148103; Wagemakers A, 2006, CHAOS, V16, DOI 10.1063/1.2173048; WIESENFELD K, 1986, PHYS REV A, V33, P629, DOI 10.1103/PhysRevA.33.629; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	31	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62997	10.1371/journal.pone.0062997	http://dx.doi.org/10.1371/journal.pone.0062997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658793	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500050
J	Illingworth, CJR; Parts, L; Bergstrom, A; Liti, G; Mustonen, V				Illingworth, Christopher J. R.; Parts, Leopold; Bergstroem, Anders; Liti, Gianni; Mustonen, Ville			Inferring Genome-Wide Recombination Landscapes from Advanced Intercross Lines: Application to Yeast Crosses	PLOS ONE			English	Article							MEIOTIC RECOMBINATION; SACCHAROMYCES-CEREVISIAE; COLLABORATIVE CROSS; GENETIC-ANALYSIS; POPULATION; HOTSPOTS; RATES; DISTRIBUTIONS; FREQUENCY; INFERENCE	Accurate estimates of recombination rates are of great importance for understanding evolution. In an experimental genetic cross, recombination breaks apart and rejoins genetic material, such that the genomes of the resulting isolates are comprised of distinct blocks of differing parental origin. We here describe a method exploiting this fact to infer genome-wide recombination profiles from sequenced isolates from an advanced intercross line (AIL). We verified the accuracy of the method against simulated data. Next, we sequenced 192 isolates from a twelve-generation cross between West African and North American yeast Saccharomyces cerevisiae strains and inferred the underlying recombination landscape at a fine genomic resolution (mean segregating site distance 0.22 kb). Comparison was made with landscapes inferred for a similar cross between four yeast strains, and with a previous single-generation, intra-strain cross (Mancera et al., Nature 2008). Moderate congruence was identified between landscapes (correlation 0.58-0.77 at 5 kb resolution), albeit with variance between mean genome-wide recombination rates. The multiple generations of mating undergone in the AILs gave more precise inference of recombination rates than could be achieved from a single-generation cross, in particular in identifying recombination cold-spots. The recombination landscapes we describe have particular utility; both AILs are part of a resource to study complex yeast traits (see e. g. Parts et al., Genome Res 2011). Our results will enable future applications of this resource to take better account of local linkage structure heterogeneities. Our method has general applicability to other crossing experiments, including a variety of experimental designs.	[Illingworth, Christopher J. R.; Parts, Leopold; Mustonen, Ville] Wellcome Trust Sanger Inst, Cambridge, England; [Parts, Leopold] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Bergstroem, Anders; Liti, Gianni] Univ Nice Sophia Antipolis, Inst Res Canc & Ageing Nice, F-06189 Nice, France	Wellcome Trust Sanger Institute; University of Toronto; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur	Mustonen, V (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	vm5@sanger.ac.uk	Mustonen, Ville/X-1599-2019; Liti, Gianni/I-9929-2014; Illingworth, Christopher/F-1715-2010; Mustonen, Ville/J-1155-2018	Mustonen, Ville/0000-0002-7270-1792; Mustonen, Ville/0000-0002-7270-1792; Bergstrom, Anders/0000-0002-4096-9268; Illingworth, Chris/0000-0002-0030-2784; Parts, Leopold/0000-0002-2618-670X; Liti, Gianni/0000-0002-2318-0775	Wellcome Trust [098051]; Canadian Institute for Advanced Research	Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	The authors would like to acknowledge the Wellcome Trust for support under grant reference 098051. LP was supported by a fellowship from the Canadian Institute for Advanced Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA A, 1989, GENETICS, V123, P683; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Baake E, 2008, B MATH BIOL, V70, P603, DOI 10.1007/s11538-007-9270-5; Broman KW, 2012, G3-GENES GENOM GENET, V2, P199, DOI 10.1534/g3.111.001818; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Clark AG, 2003, AM J HUM GENET, V73, P285, DOI 10.1086/377138; Clark AG, 2010, ANNU REV GENOM HUM G, V11, P45, DOI 10.1146/annurev-genom-082908-150031; Comeron JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002905; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; DARVASI A, 1995, GENETICS, V141, P1199; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; HUBERT R, 1994, NAT GENET, V7, P420, DOI 10.1038/ng0794-420; Hudson RR, 2001, GENETICS, V159, P1805; Illingworth CJR, 2012, MOL BIOL EVOL, V29, P1187, DOI 10.1093/molbev/msr289; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulathinal RJ, 2008, P NATL ACAD SCI USA, V105, P10051, DOI 10.1073/pnas.0801848105; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lichten M, 2011, CELL, V147, P267, DOI 10.1016/j.cell.2011.09.038; Liti G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002912; Liu EY, 2010, BIOINFORMATICS, V26, pi199, DOI 10.1093/bioinformatics/btq187; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; McVean G, 2002, GENETICS, V160, P1231; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Parts L, 2011, GENOME RES, V21, P1131, DOI 10.1101/gr.116731.110; Philip VM, 2011, GENOME RES, V21, P1223, DOI 10.1101/gr.113886.110; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Smukowski CS, 2011, HEREDITY, V107, P496, DOI 10.1038/hdy.2011.44; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; Tsai IJ, 2010, P NATL ACAD SCI USA, V107, P7847, DOI 10.1073/pnas.0908774107; Wakeley J, 2005, COALESCENT THEORY IN; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; WU TC, 1995, GENETICS, V140, P55	38	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62266	10.1371/journal.pone.0062266	http://dx.doi.org/10.1371/journal.pone.0062266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658715	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000321200500020
J	Li, JJ; Zheng, YM; Yan, JX; Li, HJ; Wang, X; He, JZ; Ding, GW				Li, Junjian; Zheng, Yuanming; Yan, Junxia; Li, Hongjian; Wang, Xiang; He, Jizheng; Ding, Guangwei			Effects of Different Regeneration Scenarios and Fertilizer Treatments on Soil Microbial Ecology in Reclaimed Opencast Mining Areas on the Loess Plateau, China	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; ARBUSCULAR MYCORRHIZAL FUNGUS; SURFACE MINE RECLAMATION; ORGANIC-MATTER; SUCCESSION; FOREST; BIOMASS; CARBON; RHIZOSPHERE; POPULATIONS	The soil microbial community in reclaimed mining areas is fundamental to vegetative establishment. However, how this community responds to different regeneration scenarios and fertilizer treatments is poorly understood. This research evaluated plant and soil microbial communities from different regeneration scenarios and different fertilizer treatments. Regeneration scenarios significantly influenced soil bacterial, archaeal, and fungal rDNA abundance. The ratios of fungi to bacteria or archaea were increased with fertilizer application. The diversity of both plants and microbes was lowest in Lotus corniculatus grasslands. Regeneration scenario, fertilizer treatment, and their interaction influenced soil microbial richness, diversity and evenness indices. Labile carbon pool 2 was a significant factor affected plant and microbe communities in July, suggesting that plants and microbes may be competing for nutrients. The higher ratios of positive to negative association were found in soil bacteria and total microbe than in archaea and fungi. Stronger clustering of microbial communities from the same regeneration scenario indicated that the vegetative composition of regeneration site may have a greater influence on soil microbial communities than fertilizer treatment.	[Li, Junjian; Yan, Junxia; Li, Hongjian] Shanxi Univ, Inst Loess Plateau, Taiyuan, Shanxi, Peoples R China; [Li, Junjian; Zheng, Yuanming; He, Jizheng] Chinese Acad Sci, State Key Lab Urban & Reg Ecol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Wang, Xiang] Biol Inst Shanxi, Taiyuan, Shanxi, Peoples R China; [Ding, Guangwei] Northern State Univ, Dept Chem, Aberdeen, SD USA	Shanxi University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Northern State University	He, JZ (corresponding author), Chinese Acad Sci, State Key Lab Urban & Reg Ecol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China.	jzhe@rcees.ac.cn	LI, junjian/HHC-3968-2022; He, Ji-Zheng/A-4488-2009	He, Ji-Zheng/0000-0002-9169-8058	Natural Science Foundation of China [41271530]; National Science and Technology Program [2012BAC10B04, 2008BAD95B04]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Program	This work was financially supported by the Natural Science Foundation of China (41271530) and the National Science and Technology Program (2012BAC10B04 and 2008BAD95B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashagrie Y, 2005, AGR ECOSYST ENVIRON, V106, P89, DOI 10.1016/j.agee.2004.07.015; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Baldrian P, 2008, SOIL BIOL BIOCHEM, V40, P2107, DOI 10.1016/j.soilbio.2008.02.019; Behera N, 2003, FOREST ECOL MANAG, V174, P1, DOI 10.1016/S0378-1127(02)00057-9; Bennett LT, 2008, SOIL BIOL BIOCHEM, V40, P1601, DOI 10.1016/j.soilbio.2008.01.008; [蔡晓布 Cai Xiaobu], 2002, [水土保持学报, Journal of soil and water conservation], V16, P12; Chen BD, 2007, ENVIRON POLLUT, V147, P374, DOI 10.1016/j.envpol.2006.04.027; Chen BD, 2008, J ENVIRON RADIOACTIV, V99, P801, DOI 10.1016/j.jenvrad.2007.10.007; Dimitriu PA, 2010, SOIL BIOL BIOCHEM, V42, P2289, DOI 10.1016/j.soilbio.2010.09.001; Edwards IP, 2006, MICROB ECOL, V52, P679, DOI 10.1007/s00248-006-9097-x; Eskelinen A, 2009, OECOLOGIA, V161, P113, DOI 10.1007/s00442-009-1362-5; Fang M, 2007, APPL SOIL ECOL, V37, P150, DOI 10.1016/j.apsoil.2007.06.001; Frey B, 2006, SOIL BIOL BIOCHEM, V38, P1745, DOI 10.1016/j.soilbio.2005.11.032; Ge Y, 2008, ISME J, V2, P254, DOI 10.1038/ismej.2008.2; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hu SJ, 1999, APPL SOIL ECOL, V13, P21, DOI 10.1016/S0929-1393(99)00015-3; Johnson MJ, 2003, GEODERMA, V114, P279, DOI 10.1016/S0016-7061(03)00045-4; Knelman JE, 2012, SOIL BIOL BIOCHEM, V46, P172, DOI 10.1016/j.soilbio.2011.12.001; Koide RT, 2002, PLANT SOIL, V244, P307, DOI 10.1023/A:1020204004844; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Leybo AI, 2006, MICROBIOLOGY+, V75, P683, DOI 10.1134/S0026261706060105; [李凤民 Li Fengmin], 2003, [生态学报, Acta Ecologica Sinica], V23, P1901; Li Juan, 2008, Agricultural Sciences in China, V7, P336, DOI 10.1016/S1671-2927(08)60074-7; Li Juan, 2008, Zhiwu Shengtai Xuebao, V32, P891, DOI 10.3773/j.issn.1005-264x.2008.04.018; Li JJ, 2011, SOIL SCI, V176, P313, DOI 10.1097/SS.0b013e31821d6e7c; Liang B, 2011, BIOL FERT SOILS, V47, P121, DOI 10.1007/s00374-010-0511-7; Lipson DA, 1998, OECOLOGIA, V113, P406, DOI 10.1007/s004420050393; [龙健 Long Jian], 2003, [生态学报, Acta Ecologica Sinica], V23, P496; Lu R.K, 2000, METHODS SOIL AGROCHE, P127; Lukow T, 2000, FEMS MICROBIOL ECOL, V32, P241, DOI 10.1111/j.1574-6941.2000.tb00717.x; Machulla G, 2005, SOIL SCI SOC AM J, V69, P1069, DOI 10.2136/sssaj2004.0271; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; May LA, 2001, CAN J MICROBIOL, V47, P829, DOI 10.1139/cjm-47-9-829; McCrackin ML, 2008, BIOGEOCHEMISTRY, V87, P143, DOI 10.1007/s10533-007-9173-4; McMahon SK, 2011, SOIL BIOL BIOCHEM, V43, P287, DOI 10.1016/j.soilbio.2010.10.013; Menyailo OV, 2002, PLANT SOIL, V242, P183, DOI 10.1023/A:1016245619357; Mummey DL, 2002, SOIL BIOL BIOCHEM, V34, P1717, DOI 10.1016/S0038-0717(02)00158-X; Mummey DL, 2002, APPL SOIL ECOL, V21, P251, DOI 10.1016/S0929-1393(02)00090-2; Nemergut DR, 2007, MICROB ECOL, V53, P110, DOI 10.1007/s00248-006-9144-7; Rillig MC, 2002, SOIL BIOL BIOCHEM, V34, P1371, DOI 10.1016/S0038-0717(02)00060-3; Rovira P, 2002, GEODERMA, V107, P109, DOI 10.1016/S0016-7061(01)00143-4; Rumpel C, 2004, SOIL BIOL BIOCHEM, V36, P67, DOI 10.1016/j.soilbio.2003.08.020; Schellenberger S, 2010, ENVIRON MICROBIOL, V12, P845, DOI 10.1111/j.1462-2920.2009.02128.x; Shi FC, 2008, ACTA AGR SCAND B-S P, V58, P1, DOI 10.1080/09064710601065970; Singh BK, 2007, APPL SOIL ECOL, V36, P147, DOI 10.1016/j.apsoil.2007.01.004; Sourkova M, 2005, GEODERMA, V129, P73, DOI 10.1016/j.geoderma.2004.12.032; Susyan EA, 2011, EUR J SOIL BIOL, V47, P169, DOI 10.1016/j.ejsobi.2011.04.002; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tscherko D, 2005, BASIC APPL ECOL, V6, P367, DOI 10.1016/j.baae.2005.02.004; Wang B.S., 2000, CHIN J PLANT ECOL, V24, P332; Wang L, 2009, MINING SCI TECHNOLOG, V19, P479, DOI DOI 10.1016/S1674-5264(09)60089-2; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Xiu-ling Zhang, 2008, Journal of Ecology and Rural Environment, V24, P32; Zhang JT, 2010, ECOL ENG, V36, P345, DOI 10.1016/j.ecoleng.2009.04.001; Zhang JT, 2005, J ARID ENVIRON, V63, P458, DOI 10.1016/j.jaridenv.2005.03.027; Zhang QC, 2007, J ENVIRON SCI, V19, P55, DOI 10.1016/S1001-0742(07)60009-6	58	22	27	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63275	10.1371/journal.pone.0063275	http://dx.doi.org/10.1371/journal.pone.0063275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658819	gold, Green Published			2022-12-25	WOS:000321200500066
J	Fognani, E; Giannini, C; Piluso, A; Gragnani, L; Monti, M; Caini, P; Ranieri, J; Urraro, T; Triboli, E; Laffi, G; Zignego, AL				Fognani, Elisa; Giannini, Carlo; Piluso, Alessia; Gragnani, Laura; Monti, Monica; Caini, Patrizio; Ranieri, Jessica; Urraro, Teresa; Triboli, Elisa; Laffi, Giacomo; Zignego, Anna Linda			Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; HCV INFECTION; B-CELLS; EXPRESSION; LYMPHOMA; IDENTIFICATION; PATHOGENESIS; INTERFERON; MANAGEMENT; DIAGNOSIS	Hepatitis C virus infection is closely related to lymphoproliferative disorders (LPDs), including mixed cryoglobulinemia (MC) and some lymphomas. Modification of the expression of specific microRNAs (miRNAs) has been associated with different autoimmune diseases and/or LPDs. No data exist about the modifications in miRNA expression in HCV-associated LPDs. The aim of this study was to analyze the expression levels of a panel of miRNAs previously associated with autoimmune/LPDs in a large population of HCV patients with and without MC or non-Hodgkin's lymphoma (NHL), to identify potential markers of evolution of HCV infection. PBMC expression of miR-Let-7d, miR-16, miR-21, miR-26b, miR-146a and miR-155 was evaluated by real-time PCR in 167 HCV patients (75 with MC [MC-HCV], 11 with HCV-associated NHL [NHL-HCV], 81 without LPD [HCV]) and in 35 healthy subjects (HS). A significant increase in miR-21 (p<0.001), miR-16 (p<0.01) and miR-155 (p<0.01) expression was detected in PBMCs from only NHL patients whereas a significant decrease in miR-26b was detected in both MC and NHL subjects (p<0.01) when compared to HS and HCV groups. A restoration of miR-26b levels was observed in the post-treatment PBMCs of 35 HCV-MC patients experiencing complete virological and clinical response following antiviral therapy. This study, for the first time, shows that specific microRNAs in PBMC from HCV patients who developed MC and/or NHL are modulated differently. The specific, reversible downregulation of miR-26b strongly suggests the key role it plays in the pathogenesis of HCV-related LPDs and its usefulness as a biomarker of the evolution of HCV infection to these disorders.	[Fognani, Elisa; Giannini, Carlo; Piluso, Alessia; Gragnani, Laura; Monti, Monica; Caini, Patrizio; Ranieri, Jessica; Urraro, Teresa; Triboli, Elisa; Laffi, Giacomo; Zignego, Anna Linda] Univ Florence, Dept Expt & Clin Med, Ctr Syst Manifestat Hepatitis Viruses MASVE, Florence, Italy	University of Florence	Zignego, AL (corresponding author), Univ Florence, Dept Expt & Clin Med, Ctr Syst Manifestat Hepatitis Viruses MASVE, Florence, Italy.	a.zignego@dmi.unifi.it	Gragnani, Laura/H-7755-2019; GRAGNANI, LAURA/K-7751-2013; Zignego, Anna Linda/AAL-8205-2021	Gragnani, Laura/0000-0001-6800-9149; GRAGNANI, LAURA/0000-0001-6800-9149; Laffi, Giacomo/0000-0001-6916-1134	Associazione Italiana per la Ricerca sul Cancro (AIRC) Investigator Grant [1461]; Istituto Toscano Tumori (ITT); Fondazione Istituto di Ricerche Virologiche Oretta Bartolomei Corsi; Fondazione Cassa di Risparmio di Pistoia e Pescia; Ente Cassa di Risparmio di Firenze	Associazione Italiana per la Ricerca sul Cancro (AIRC) Investigator Grant(Fondazione AIRC per la ricerca sul cancro); Istituto Toscano Tumori (ITT); Fondazione Istituto di Ricerche Virologiche Oretta Bartolomei Corsi; Fondazione Cassa di Risparmio di Pistoia e Pescia; Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	This work was supported by grants from the "Associazione Italiana per la Ricerca sul Cancro'' (AIRC) Investigator Grant # 1461, "Istituto Toscano Tumori'' (ITT), "Fondazione Istituto di Ricerche Virologiche Oretta Bartolomei Corsi'', "Fondazione Cassa di Risparmio di Pistoia e Pescia'' and "Ente Cassa di Risparmio di Firenze''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizos I, 2011, ARTHRITIS RHEUM-US, V63, P535, DOI 10.1002/art.30131; Andreone P, 1998, ANN INTERN MED, V129, P294, DOI 10.7326/0003-4819-129-4-199808150-00005; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bianchettin G, 2007, J VIROL, V81, P4564, DOI 10.1128/JVI.02104-06; Bouteloup M, 2012, BRIT J HAEMATOL, V156, P279, DOI 10.1111/j.1365-2141.2011.08848.x; Cheng CJ, 2012, CANCER J, V18, P232, DOI 10.1097/PPO.0b013e318258b75b; Craxi A, 2008, MOL ASPECTS MED, V29, P85, DOI 10.1016/j.mam.2007.09.017; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Cubedo E, 2012, BLOOD, V119, P5478, DOI 10.1182/blood-2012-01-403154; de Re V, 2007, ANN NY ACAD SCI, V1107, P308, DOI 10.1196/annals.1381.033; Di Lisio L, 2012, BLOOD, V120, P1782, DOI 10.1182/blood-2012-05-402784; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ferri C, 1995, CLIN EXP RHEUMATOL, V13, pS135; FERRI C, 1994, J INTERN MED, V236, P31, DOI 10.1111/j.1365-2796.1994.tb01116.x; FERRI C, 1993, BLOOD, V82, P3701; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gragnani L, 2011, ARTHRITIS RHEUM-US, V63, P1446, DOI 10.1002/art.30274; Gramantieri L, 2008, J CELL MOL MED, V12, P2189, DOI 10.1111/j.1582-4934.2008.00533.x; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; HARRIS NL, 1994, BLOOD, V84, P1361; Hermine O, 2002, NEW ENGL J MED, V347, P89, DOI 10.1056/NEJMoa013376; Hughes T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3484; Ito M, 2010, CLIN IMMUNOL, V135, P459, DOI 10.1016/j.clim.2010.02.002; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kawamura Y, 2007, AM J MED, V120, P1034, DOI 10.1016/j.amjmed.2007.06.022; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Knight GB, 2010, ARTHRITIS RHEUM-US, V62, P2152, DOI 10.1002/art.27490; Kotani A, 2010, INT J HEMATOL, V92, P255, DOI 10.1007/s12185-010-0633-6; Kumar A, 2011, BBA-GENE REGUL MECH, V1809, P694, DOI 10.1016/j.bbagrm.2011.07.010; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Leng RX, 2011, CYTOKINE GROWTH F R, V22, P141, DOI 10.1016/j.cytogfr.2011.05.002; Li S, 2012, MOL CELL BIOCHEM, V360, P147, DOI 10.1007/s11010-011-1052-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Nassirpour R, 2010, MOL CANCER RES, V8, P717, DOI 10.1158/1541-7786.MCR-09-0291; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Petrarca A, 2010, BLOOD, V116, P335, DOI 10.1182/blood-2009-11-253948; Peveling-Oberhag J, 2012, LEUKEMIA, V26, P1654, DOI 10.1038/leu.2012.29; Pietrogrande M, 2011, AUTOIMMUN REV, V10, P444, DOI 10.1016/j.autrev.2011.01.008; Piluso A, 2013, J VIRAL HEPATITIS, V20, pe107, DOI 10.1111/jvh.12017; Qi RQ, 2012, HEPATOLOGY, V55, P1640, DOI 10.1002/hep.25558; Sansonno D, 1998, J IMMUNOL, V160, P3594; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Takeno A, 2008, BRIT J CANCER, V99, P1307, DOI 10.1038/sj.bjc.6604682; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441; Zignego AL, 2007, DIGEST LIVER DIS, V39, P2, DOI 10.1016/j.dld.2006.06.008; Zignego AL, 1996, ANN INTERN MED, V124, P31, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00006; Zignego AL, 1995, CLIN EXP RHEUMATOL, V13, pS33; ZIGNEGO AL, 1992, J HEPATOL, V15, P382, DOI 10.1016/0168-8278(92)90073-X; Zignego AL, 2000, HEPATOLOGY, V31, P474, DOI 10.1002/hep.510310230; Zignego AL, 2007, WORLD J GASTROENTERO, V13, P2467, DOI 10.3748/wjg.v13.i17.2467; Zignego AL, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980942	59	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62965	10.1371/journal.pone.0062965	http://dx.doi.org/10.1371/journal.pone.0062965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650540	gold, Green Published, Green Submitted			2022-12-25	WOS:000319167000085
J	Rohatgi, N; Aly, H; Marshall, CA; McDonald, WG; Kletzien, RF; Colca, JR; McDaniel, ML				Rohatgi, Nidhi; Aly, Haytham; Marshall, Connie A.; McDonald, William G.; Kletzien, Rolf F.; Colca, Jerry R.; McDaniel, Michael L.			Novel Insulin Sensitizer Modulates Nutrient Sensing Pathways and Maintains beta-Cell Phenotype in Human Islets	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MITOCHONDRIAL PYRUVATE CARRIER; TYPE-2 DIABETIC SUBJECTS; MAMMALIAN TARGET; IN-VITRO; RECEPTOR SUBSTRATE-2; SIGNALING PATHWAY; CYCLE PROGRESSION; DNA-SYNTHESIS; PPAR-GAMMA	Major bottlenecks in the expansion of human beta-cell mass are limited proliferation, loss of beta-cell phenotype, and increased apoptosis. In our previous studies, activation of Wnt and mTOR signaling significantly enhanced human beta-cell proliferation. However, isolated human islets displayed insulin signaling pathway resistance, due in part to chronic activation of mTOR/S6K1 signaling that results in negative feedback of the insulin signaling pathway and a loss of Akt phosphorylation and insulin content. We evaluated the effects of a new generation insulin sensitizer, MSDC-0160, on restoring insulin/IGF-1 sensitivity and insulin content in human beta-cells. This novel TZD has low affinity for binding and activation of PPARc and has insulin-sensitizing effects in mouse models of diabetes and ability to lower glucose in Phase 2 clinical trials. MSDC-0160 treatment of human islets increased AMPK activity and reduced mTOR activity. This was associated with the restoration of IGF-1-induced phosphorylation of Akt, GSK-3, and increased protein expression of Pdx1. Furthermore, MSDC-0160 in combination with IGF-1 and 8 mM glucose increased b-cell specific gene expression of insulin, pdx1, nkx6.1, and nkx2.2, and maintained insulin content without altering glucose-stimulated insulin secretion. Human islets were unable to simultaneously promote DNA synthesis and maintain the beta-cell phenotype. Lithium-induced GSK-3 inhibition that promotes DNA synthesis blocked the ability of MSDC-0160 to maintain the beta-cell phenotype. Conversely, MSDC-0160 prevented an increase in DNA synthesis by blocking beta-catenin nuclear translocation. Due to the counteracting pathways involved in these processes, we employed a sequential ex vivo strategy to first induce human islet DNA synthesis, followed by MSDC-0160 to promote the beta-cell phenotype and insulin content. This new generation PPARc sparing insulin sensitizer may provide an initial tool for relieving inherent human islet insulin signaling pathway resistance that is necessary to preserve the beta-cell phenotype during b-cell expansion for the treatment of diabetes.	[Rohatgi, Nidhi; Aly, Haytham; Marshall, Connie A.; McDaniel, Michael L.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA; [McDonald, William G.; Kletzien, Rolf F.; Colca, Jerry R.] Metab Solut Dev Co, Kalamazoo, MI USA	Washington University (WUSTL)	McDaniel, ML (corresponding author), Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mmcdaniel@wustl.edu	Rohatgi, Nidhi/GWR-1096-2022		National Institutes of Health (NIH) [DK006181, NIH DK00618146S1, DK07296]; NIH Washington University Diabetes Research Center Morphology and Metabolic Analysis Core [DK20579]; American Diabetes Association Grant [7-04-MN-32]; BarnesJewish Hospital Foundation [7401-00]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile Diabetes Research Foundation International (JDRFI) [JDRF-31-2008-382]; MSDC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK006181, P60DK020579, P30DK020579, R56DK006181, T32DK007296] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Washington University Diabetes Research Center Morphology and Metabolic Analysis Core; American Diabetes Association Grant(American Diabetes Association); BarnesJewish Hospital Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation International (JDRFI)(Juvenile Diabetes Research Foundation); MSDC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) Grants DK006181 (MLM), NIH DK00618146S1 (MLM), DK07296 (MLM), NIH Washington University Diabetes Research Center Morphology and Metabolic Analysis Core DK20579 (MLM), American Diabetes Association Grant 7-04-MN-32 (MLM), BarnesJewish Hospital Foundation Grant 7401-00 (MLM). Human islets were obtained from the Integrated Islet Distribution Program (IIDP) sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Juvenile Diabetes Research Foundation International (JDRFI) and the JDRFI Sponsored Islets for Research Program at Washington University (JDRF-31-2008-382). The Washington University Human Studies Committee approved all studies involving the use of isolated cadaver-derived human islets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JRC, WGM and RFK are employees of Metabolic Solutions Development Company (MSDC). MSDC provided limited research funds to the Barnes-Jewish Hospital Foundation for the purchase of human islets. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Bolten CW, 2007, GENE REGUL SYST BIO, V1, P73; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Campbell IW, 2007, DIABETES RES CLIN PR, V76, P163, DOI 10.1016/j.diabres.2006.08.015; Cersosimo E, 2012, AM J PHYSIOL-CELL PH, V302, pC652, DOI 10.1152/ajpcell.00022.2011; Chen ZJ, 2012, J BIOL CHEM, V287, P23537, DOI 10.1074/jbc.M112.363960; Ciaraldi TP, 2002, DIABETES, V51, P30, DOI 10.2337/diabetes.51.1.30; Colca JR, 2013, CLIN PHARMACOL THER, V93, P352, DOI 10.1038/clpt.2013.10; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Colca JR, 2013, PLOS ONE IN PRESS; Desouza CV, 2009, VASC PHARMACOL, V51, P162, DOI 10.1016/j.vph.2009.05.001; Divakaruni AS, 2012, SCIENCE, V337, P41, DOI 10.1126/science.1225601; Efrat Shimon, 2008, Rev Diabet Stud, V5, P116, DOI 10.1900/RDS.2008.5.116; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Gunton JE, 2003, J CLIN ENDOCR METAB, V88, P1323, DOI 10.1210/jc.2002-021394; Gurevitch D, 2010, DIABETES, V59, P2188, DOI 10.2337/db09-0890; Hanley SC, 2008, LAB INVEST, V88, P761, DOI 10.1038/labinvest.2008.41; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; Kim YB, 2002, DIABETES, V51, P443, DOI 10.2337/diabetes.51.2.443; Kwon G, 2006, J BIOL CHEM, V281, P3261, DOI 10.1074/jbc.M508821200; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Leahy JL, 2009, CURR DIABETES REP, V9, P215, DOI 10.1007/s11892-009-0035-4; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Lechner A, 2005, BIOCHEM BIOPH RES CO, V327, P581, DOI 10.1016/j.bbrc.2004.12.043; Leonardini A, 2009, PPAR RES, V2009, DOI 10.1155/2009/818945; Liu H, 2009, DIABETES, V58, P663, DOI 10.2337/db07-1208; Liu YM, 2009, DIABETES OBES METAB, V11, P54, DOI 10.1111/j.1463-1326.2009.01107.x; Marshak S, 1999, DIABETES, V48, P1230, DOI 10.2337/diabetes.48.6.1230; Mcdonald WG, 2012, DIABETES, V61, pA283; Negi S, 2012, CELL TRANSPLANT, V21, P889, DOI 10.3727/096368911X603639; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Patel P, 2010, KIDNEY INT, V77, P319, DOI 10.1038/ki.2009.436; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; ROHATGI N, 2010, OPEN ENDOCRINOL J, V4, P40; Segrelles C, 2006, ONCOGENE, V25, P1174, DOI 10.1038/sj.onc.1209155; Semenkovich CF, 2005, NAT MED, V11, P822, DOI 10.1038/nm0805-822; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Szabat M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.119; Szabat M, 2009, ENDOCRINOLOGY, V150, P1627, DOI 10.1210/en.2008-1224; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Watson ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025975; Wicksteed B, 2003, J BIOL CHEM, V278, P42080, DOI 10.1074/jbc.M303509200; Wu H, 1999, BIOCHEM J, V344, P813, DOI 10.1042/0264-6021:3440813	55	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62012	10.1371/journal.pone.0062012	http://dx.doi.org/10.1371/journal.pone.0062012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650507	Green Published, gold			2022-12-25	WOS:000319167000026
J	Shah, M; Lee, G; Lefebvre, DR; Kronberg, B; Loomis, S; Brauner, SC; Turalba, A; Rhee, DJ; Freitag, SK; Pasquale, LR				Shah, Mamta; Lee, Grace; Lefebvre, Daniel R.; Kronberg, Benjamin; Loomis, Stephanie; Brauner, Stacey C.; Turalba, Angela; Rhee, Douglas J.; Freitag, Suzanne K.; Pasquale, Louis R.			A Cross-Sectional Survey of the Association between Bilateral Topical Prostaglandin Analogue Use and Ocular Adnexal Features	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ORBITAL FAT; MATRIX METALLOPROTEINASES; BIMATOPROST THERAPY; LID SULCUS; LATANOPROST; INVOLVEMENT; TRAVOPROST	We studied the relation between prostaglandin analogue use and ocular adnexal features. We used a prospective, cross-sectional study involving 157 current, 15 past, and 171 never users of prostaglandin analogues. Patients 50 years of age or older and without conditions affecting ocular adnexal anatomy underwent glaucoma medication use history, external digital photography and systematic external adnexal exam. Two masked readers assessed the digital photos for upper lid dermatochalasis and lower lid steatoblepharon using a validated grading scheme. Another masked clinical examiner also assessed upper lid ptosis, levator muscle function, and inferior scleral show. We performed ordinal logistic regression analysis accounting for multiple covariates to assess the relation between prostaglandin analogue use and adnexal features. Multivariable analyses indicated there was a 230-fold increased risk of incremental involution of dermatochalasis (odds ratio (OR) = 2.30; 95% confidence interval (CI) 1.43-3.69; p = 5.44E-04) and a 249-fold increased risk of incremental loss of lower lid steatoblepharon (OR = 2.49; 95% CI, 1.54-4.03; p = 1.98E-04) associated with current prostaglandin analogue use (bimatoprost 0.03%, travoprost 0.005%, or latanoprost 0.004%) versus prostaglandin analogue never or past users. Upper lid ptosis (OR = 4.04; 95% CI, 2.43-6.72; p = 7.37E-08), levator dysfunction (OR = 7.51; 95% CI, 3.39-16.65; p = 6.74E-07) and lower lid retraction (OR = 2.60; 95% CI, 1.58-4.28; p = 1.72E-04) were highly associated with current prostaglandin analogue use versus prostaglandin analogue never or past users. The associations between prostaglandin analogue use and deepening of the upper lid sulci and between prostaglandin analogue use and loss of inferior periorbital fat are confirmed in this multivariable analysis. The associations between prostaglandin analogue use and levator muscle dysfunction and between prostaglandin analogue use and upper lid ptosis represent significant side effects that could impact visual function in glaucoma patients.	[Shah, Mamta] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Lee, Grace; Lefebvre, Daniel R.; Kronberg, Benjamin; Loomis, Stephanie; Brauner, Stacey C.; Turalba, Angela; Rhee, Douglas J.; Freitag, Suzanne K.; Pasquale, Louis R.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA	Boston University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Shah, M (corresponding author), Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.	mshah@bu.edu	Lee, Nahyoung/O-1004-2018	Lee, Nahyoung/0000-0001-7892-2871; Lefebvre, Daniel/0000-0001-8225-4343	Research to Prevent Blindness (RPB) Medical Student Fellowship; Harvard Glaucoma Center of Excellence and a Distinguished Ophthalmology Scholar award	Research to Prevent Blindness (RPB) Medical Student Fellowship; Harvard Glaucoma Center of Excellence and a Distinguished Ophthalmology Scholar award	The study is supported by the Research to Prevent Blindness (RPB) Medical Student Fellowship 2011-2012. The Harvard Glaucoma Center of Excellence and a Distinguished Ophthalmology Scholar award support Dr. LRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 2011, JPN J OPHTHALMOL, V55, P600, DOI 10.1007/s10384-011-0075-6; Alm A, 2008, SURV OPHTHALMOL, V53, pS93, DOI 10.1016/j.survophthal.2008.08.004; [Anonymous], TRAV FULL PROD INF; [Anonymous], LUM FULL PROD INF; [Anonymous], XAL FULL PROD INF; Aydin S, 2010, CUTAN OCUL TOXICOL, V29, P212, DOI 10.3109/15569521003796860; Boboridis K, 2001, BRIT J OPHTHALMOL, V85, P99, DOI 10.1136/bjo.85.1.99; Edwards DT, 2004, OPHTHALMOLOGY, V111, P1029, DOI 10.1016/j.ophtha.2003.08.027; Filippopoulos T, 2008, OPHTHAL PLAST RECONS, V24, P302, DOI 10.1097/IOP.0b013e31817d81df; Garg P, 2012, NEPAL J OPHTHALMOL, V4, P150, DOI 10.3126/nepjoph.v4i1.5867; Inoue K, 2012, J GLAUCOMA; Jayaprakasam A, 2010, ORBIT, V29, P357, DOI 10.3109/01676830.2010.527028; Nakakura S, 2011, OPTOMETRY VISION SCI, V88, P1140, DOI 10.1097/OPX.0b013e3182231202; Ooi YH, 2009, INVEST OPHTH VIS SCI, V50, P5259, DOI 10.1167/iovs.08-3356; Orme M, 2010, CURR MED RES OPIN, V26, P511, DOI 10.1185/03007990903498786; Park J, 2011, JPN J OPHTHALMOL, V55, P22, DOI 10.1007/s10384-010-0904-z; Peplinski LS, 2004, OPTOMETRY VISION SCI, V81, P574, DOI 10.1097/01.opx.0000141791.16683.4a; Pfennigsdorf S, 2012, CLIN OPHTHALMOL, V6, P739, DOI 10.2147/OPTH.S31330; RENFRO L, 1992, DERMATOL CLIN, V10, P505; Romano MR, 2007, INVEST OPHTH VIS SCI, V48, P3677, DOI 10.1167/iovs.06-0896; Schlotzer-Schrehardt U, 2005, OPHTHALMOLOGY, V112, P694, DOI 10.1016/j.ophtha.2004.11.031; Tappeiner C, 2008, KLIN MONATSBL AUGENH, V225, P443, DOI 10.1055/s-2008-1027362; Toris CB, 2008, SURV OPHTHALMOL, V53, pS107, DOI 10.1016/j.survophthal.2008.08.010; Tung JD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001106; Ung T, 2012, OPHTHAL PLAST RECONS, V28, pE42, DOI 10.1097/IOP.0b013e31821d86a5; Weinreb RN, 1997, INVEST OPHTH VIS SCI, V38, P2772	26	46	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61638	10.1371/journal.pone.0061638	http://dx.doi.org/10.1371/journal.pone.0061638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650502	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000019
J	Song, K; Shankar, E; Yang, JY; Bane, KL; Wahdan-Alaswad, R; Danielpour, D				Song, Kyung; Shankar, Eswar; Yang, Jiayi; Bane, Kara L.; Wahdan-Alaswad, Reema; Danielpour, David			Critical Role of a Survivin/TGF-beta/mTORC1 Axis in IGF-I-Mediated Growth of Prostate Epithelial Cells	PLOS ONE			English	Article							BETA-INDUCED APOPTOSIS; RECEPTOR-TYPE-II; CANCER CELLS; MALIGNANT-TRANSFORMATION; TRANSCRIPTION FACTORS; SURVIVIN EXPRESSION; TUMOR SUPPRESSION; IAP PROTEINS; INSULIN; SMAD3	Survivin is a unique member of the inhibitor of apoptosis (IAP) proteins that is overexpressed in numerous cancers through poorly defined mechanisms. One such mechanism may be through constitutive activation of the insulin-like growth factor-I (IGF-I) signaling pathway, implicated in the development and progression of prostate cancer. Using the pre-neoplastic NRP152 rat prostate cell line as a model, we showed that IGF-I induces Survivin expression, and that silencing Survivin by lentiviral-mediated small hairpin RNA (shRNA) represses IGF-I-stimulated cell growth, implicating Survivin as a mediator of this growth response. Moreover, our data support that the induction of Survivin by IGF-I occurs through a transcriptional mechanism that is mediated in part by the PI3K/Akt/mTORC1 pathway. Use of various Survivin promoter-luciferase constructs revealed that the CDE and CHR response elements in the proximal region of the Survivin promoter are involved in this IGF-I response. Transforming growth factor (TGF-beta) signaling antagonists similarly activated the Surivin promoter and rendered cells refractory to further promoter activation by IGF-I. IGF-I suppressed levels of phospho-Smads 2 and 3 with kinetics similar to that of Survivin induction. Suppression of TGF-beta signaling, either by TGF-beta receptor kinase inhibitors or by silencing Smads 2 and 3, induced Survivin expression and promoted cell growth similar to that induced by IGF-I. TGF-beta receptor antagonists also rescued cells from down-regulation of Survivin expression and growth suppression by pharmacological inhibitors of PI3K, Akt, MEK and mTOR. Sh-RNA gene silencing studies suggest that mTORC1 induces while mTORC2 represses the expression of Survivin by IGF-I. Taken together, these results suggest that IGF-I signaling through a PI3K/Akt/mTORC1 mechanism elevates expression of Survivin and promotes growth of prostate epithelial cells by suppressing Smad-dependent autocrine TGF-beta signaling.	[Song, Kyung; Shankar, Eswar; Bane, Kara L.; Danielpour, David] Case Western Reserve Univ, Case Comprehens Canc Ctr Res Labs, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA; [Wahdan-Alaswad, Reema; Danielpour, David] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Yang, Jiayi] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Danielpour, D (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr Res Labs, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA.	dxd49@case.edu	Wahdan-alaswad, Reema/AAA-5604-2021; Shankar, Eswar/E-5139-2015	Shankar, Eswar/0000-0001-8968-838X	National Cancer Institute [R01CA134878]; Case Comprehensive Cancer Center [P30 CA43703]; NATIONAL CANCER INSTITUTE [R01CA134878, P30CA043703] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute grant R01CA134878 (to D. Danielpour) and the Case Comprehensive Cancer Center P30 CA43703 (for use of the Cytometry Core Facility). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Altieri DC, 2012, CANC LETT; Baserga R, 1997, ENDOCRINE, V7, P99, DOI 10.1007/BF02778073; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bonham MJ, 1996, BIOTECHNIQUES, V21, P57; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Chan JM, 2000, GROWTH HORM IGF RES, V10, pS32, DOI 10.1016/S1096-6374(00)90015-7; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; DANIELPOUR D, 1994, CANCER RES, V54, P3413; Danielpour D, 2006, CYTOKINE GROWTH F R, V17, P59, DOI 10.1016/j.cytogfr.2005.09.007; Danielpour D, 1999, J CELL SCI, V112, P169; Davies MA, 1999, CANCER RES, V59, P2551; DiGiovanni J, 2000, P NATL ACAD SCI USA, V97, P3455, DOI 10.1073/pnas.97.7.3455; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Gellibert FO, 2004, J MED CHEM, V47, P4494, DOI 10.1021/jm0400247; Guha M, 2009, CANCER RES, V69, P4954, DOI 10.1158/0008-5472.CAN-09-0584; Hayward SW, 1999, PROSTATE, V39, P205; Hsing AY, 1996, CANCER RES, V56, P5146; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Khan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046737; Kurimchak A, 2012, GENE, V499, P1, DOI 10.1016/j.gene.2012.02.015; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Lucibello FC, 1997, NUCLEIC ACIDS RES, V25, P4921, DOI 10.1093/nar/25.24.4921; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; McMenamin ME, 1999, CANCER RES, V59, P4291; MEGYESI K, 1975, J BIOL CHEM, V250, P8990; Nastiuk KL, 2008, MOL CANCER RES, V6, P231, DOI 10.1158/1541-7786.MCR-07-0386; Nickerson T, 2001, CANCER RES, V61, P6276; Plymate SR, 2007, CLIN CANCER RES, V13, P6429, DOI 10.1158/1078-0432.CCR-07-0648; Pollak M, 2008, CURR OPIN PHARMACOL, V8, P384, DOI 10.1016/j.coph.2008.07.004; Pu H, 2009, CANCER RES, V69, P7366, DOI 10.1158/0008-5472.CAN-09-0758; Riolo MT, 2012, J BIOL CHEM; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Rosa J, 2006, MOL BIOL CELL, V17, P1483, DOI 10.1091/mbc.e05-08-0723; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shariat SF, 2004, CANCER, V100, P751, DOI 10.1002/cncr.20039; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sohn DM, 2006, BIOMED PHARMACOTHER, V60, P289, DOI 10.1016/j.biopha.2006.06.008; Song K, 2006, J BIOL CHEM, V281, P7765, DOI 10.1074/jbc.M511781200; Song K, 2003, J BIOL CHEM, V278, P38342, DOI 10.1074/jbc.M304583200; Song K, 2003, CANCER RES, V63, P4358; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Song K, 2008, CANCER RES, V68, P8173, DOI 10.1158/0008-5472.CAN-08-2290; Song K, 2010, MOL ENDOCRINOL, V24, P2019, DOI 10.1210/me.2010-0165; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Stewart LMV, 2003, EXP CELL RES, V284, P303, DOI 10.1016/S0014(02)00037-X; Tang BW, 1999, CANCER RES, V59, P4834; Tang L, 2012, BIOCHEM BIOPH RES CO, V421, P249, DOI 10.1016/j.bbrc.2012.03.147; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Vaira V, 2007, ONCOGENE, V26, P2678, DOI 10.1038/sj.onc.1210094; Vischioni B, 2004, ANN ONCOL, V15, P1654, DOI 10.1093/annonc/mdh436; Wahdan-Alaswad RS, 2012, MOL CANCER RES, V10, P821, DOI 10.1158/1541-7786.MCR-11-0615; Wahdan-Alaswad RS, 2010, CANCER RES, V70, P9106, DOI 10.1158/0008-5472.CAN-10-1119; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Yang J, 2008, ONCOGENE, V27, P5326, DOI 10.1038/onc.2008.165; Yang JY, 2009, CANCER RES, V69, P2185, DOI 10.1158/0008-5472.CAN-08-3961	64	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61896	10.1371/journal.pone.0061896	http://dx.doi.org/10.1371/journal.pone.0061896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658701	gold, Green Submitted, Green Published			2022-12-25	WOS:000319167000023
J	Ren, WC; Lagerstedt, K; Grimsholm, O; Stern, A; Sun, JB; Fang, Y; Xiang, Z; Martensson, IL				Ren, Weicheng; Lagerstedt, Kristina; Grimsholm, Ola; Stern, Anna; Sun, Jia-Bin; Fang, Yu; Xiang, Zou; Martensson, Inga-Lill			Uncoupling of Natural IgE Production and CD23 Surface Expression Levels	PLOS ONE			English	Article							B-CELL DEVELOPMENT; LYMPHOCYTE RECEPTOR; GENETIC-VARIATION; MICE; C57BL/6; 129/SVJ; MOUSE	CD23, the low affinity receptor for immunoglobulin E (IgE), has been proposed to play a critical role in the regulation of IgE production, based on altered IgE levels in CD23-deficient mice and transgenic mouse models, as well as in mouse strains with mutations in the CD23 gene, e.g. 129 substrains. Here, we have investigated a mouse line termed LxT1 that expresses reduced CD23 surface levels on B cells, and its influence on natural IgE production. Extensive phenotypic analysis showed that CD23 surface expression was reduced in LxT1 compared to the control, without affecting B cell development in general. This CD23 low surface level in LxT1 mice is not as a result of reduced CD23 mRNA expression levels or intracellular accumulation, but linked to a recessive locus, a 129-derived region spanning 28 Mb on chromosome 8, which includes the CD23 gene. Sequence analysis confirmed five mutations within the CD23 coding region in LxT1 mice, the same as those present in New Zealand Black (NZB) and 129 mice. However, this CD23 low phenotype was not observed in all 129 substrains despite carrying these same CD23 mutations in the coding region. Moreover, serum IgE levels in LxT1 mice are as low as those in the C57BL/6 (B6) strain, and much lower than those in 129 substrains. These data indicate that the CD23 surface level and serum IgE level are uncoupled and that neither is directly regulated by the mutations within the CD23 coding region. This study suggests that caution should be taken when interpreting the immunological data derived from mice with different genetic background, especially if the gene of interest is thought to influence CD23 surface expression or serum IgE level.	[Ren, Weicheng; Lagerstedt, Kristina; Grimsholm, Ola; Stern, Anna; Martensson, Inga-Lill] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Sun, Jia-Bin; Fang, Yu; Xiang, Zou] Univ Gothenburg, Dept Microbiol & Immunol, Gothenburg, Sweden; [Fang, Yu; Xiang, Zou; Martensson, Inga-Lill] Univ Gothenburg, Mucosal Immunobiol & Vaccine Ctr, Gothenburg, Sweden; [Fang, Yu] Guiyang Med Coll, Affiliated Hosp, Dept Microbiol & Immunol, Guiyang, Peoples R China	University of Gothenburg; University of Gothenburg; University of Gothenburg; Guizhou Medical University	Martensson, IL (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	lill.martensson@rheuma.gu.se	Grimsholm, Ola/Q-7995-2019; Grimsholm, Ola/U-6779-2019; Grimsholm, Ola/O-9187-2017	Grimsholm, Ola/0000-0003-2064-2556; Grimsholm, Ola/0000-0003-2064-2556; Xiang, Zou/0000-0003-3925-0296; Martensson, Inga-Lill/0000-0003-3415-0560	Swedish Cancer Foundation; Swedish Science Research Council; Torsten and Ragnar Soderbergs Stiftelser; AFA insurances; Reumatikerforbundet; King Gustav V Stiftelse; Lundbergs Stiftelse; Lundgrens Stiftelse; Amlovs Stiftelser; Swedish Medical Society; Adlerbertska stiftelsen; ALF: (Avtalet om lakarutbildning och forskning)	Swedish Cancer Foundation; Swedish Science Research Council; Torsten and Ragnar Soderbergs Stiftelser; AFA insurances; Reumatikerforbundet; King Gustav V Stiftelse; Lundbergs Stiftelse; Lundgrens Stiftelse; Amlovs Stiftelser; Swedish Medical Society; Adlerbertska stiftelsen; ALF: (Avtalet om lakarutbildning och forskning)	This work was supported by grants from the Swedish Cancer Foundation, Swedish Science Research Council (www.vr.se), Torsten and Ragnar Soderbergs Stiftelser, AFA insurances, Reumatikerforbundet, King Gustav V Stiftelse, Lundbergs Stiftelse, Lundgrens Stiftelse, Amlovs Stiftelser, Swedish Medical Society, Adlerbertska stiftelsen, and ALF: (Avtalet om lakarutbildning och forskning) the regional agreement on medical training and clinical research between the Western Gotaland county council and the University of Gothenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Arumugam M, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-14; Bemark M, 2011, J IMMUNOL, V186, P1399, DOI 10.4049/jimmunol.1002881; BETTLER B, 1992, J BIOL CHEM, V267, P185; Bygrave AE, 2004, PLOS BIOL, V2, P1081, DOI 10.1371/journal.pbio.0020243; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; Corcoran LM, 1999, J IMMUNOL, V163, P5836; Ford JW, 2006, CELL IMMUNOL, V243, P107, DOI 10.1016/j.cellimm.2007.01.004; Ford JW, 2009, CELL IMMUNOL, V254, P124, DOI 10.1016/j.cellimm.2008.08.003; FUJIWARA H, 1994, P NATL ACAD SCI USA, V91, P6835, DOI 10.1073/pnas.91.15.6835; Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530; Heidari Y, 2009, GENES IMMUN, V10, P47, DOI 10.1038/gene.2008.78; Hutchins LN, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq008; Kaminski DA, 2007, INT IMMUNOL, V19, P545, DOI 10.1093/intimm/dxm020; Keenan RA, 2008, SCIENCE, V321, P696, DOI 10.1126/science.1157533; KIKUTANI H, 1986, CELL, V47, P657, DOI 10.1016/0092-8674(86)90508-8; Lewis G, 2004, IMMUNOGENETICS, V56, P564, DOI 10.1007/s00251-004-0728-4; Lindsley RC, 2007, BLOOD, V109, P2521, DOI 10.1182/blood-2006-04-018085; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; MAEDA K, 1992, J IMMUNOL, V148, P2340; Morel L, 2004, PLOS BIOL, V2, P1061, DOI 10.1371/journal.pbio.0020241; Payet ME, 1999, J IMMUNOL, V163, P217; RAO M, 1987, J IMMUNOL, V138, P1845; Rauch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005456; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; STIEF A, 1994, J IMMUNOL, V152, P3378; Threadgill DW, 1997, MAMM GENOME, V8, P390, DOI 10.1007/s003359900453; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Yamashita Y, 2007, J IMMUNOL, V179, P740, DOI 10.4049/jimmunol.179.2.740; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Yu LCH, 2003, AM J PHYSIOL-GASTR L, V285, pG223, DOI 10.1152/ajpgi.00445.2002; YU P, 1994, NATURE, V369, P753, DOI 10.1038/369753a0	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62851	10.1371/journal.pone.0062851	http://dx.doi.org/10.1371/journal.pone.0062851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646151	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300104
J	Sepulveda, B; Mesias, R; Li, XT; Yue, ZY; Benson, DL				Sepulveda, Bryan; Mesias, Roxana; Li, Xianting; Yue, Zhenyu; Benson, Deanna L.			Short- and Long-Term Effects of LRRK2 on Axon and Dendrite Growth	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; RICH REPEAT KINASE-2; HIPPOCAMPAL-NEURONS; LOCALIZATION; PROTEINS; BINDING; GENE; PARKINSONISM; CYTOSKELETON; EXPRESSION	Mutations in leucine-rich repeat kinase 2 (LRRK2) underlie an autosomal-dominant form of Parkinson's disease (PD) that is clinically indistinguishable from idiopathic PD. The function of LRRK2 is not well understood, but it has become widely accepted that LRRK2 levels or its kinase activity, which is increased by the most commonly observed mutation (G2019S), regulate neurite growth. However, growth has not been measured; it is not known whether mean differences in length correspond to altered rates of growth or retraction, whether axons or dendrites are impacted differentially or whether effects observed are transient or sustained. To address these questions, we compared several developmental milestones in neurons cultured from mice expressing bacterial artificial chromosome transgenes encoding mouse wildtype-LRRK2 or mutant LRRK2-G2019S, Lrrk2 knockout mice and non-transgenic mice. Over the course of three weeks of development on laminin, the data show a sustained, negative effect of LRRK2-G2019S on dendritic growth and arborization, but counter to expectation, dendrites from Lrrk2 knockout mice do not elaborate more rapidly. In contrast, young neurons cultured on a slower growth substrate, poly-L-lysine, show significantly reduced axonal and dendritic motility in Lrrk2 transgenic neurons and significantly increased motility in Lrrk2 knockout neurons with no significant changes in length. Our findings support that LRRK2 can regulate patterns of axonal and dendritic growth, but they also show that effects vary depending on growth substrate and stage of development. Such predictable changes in motility can be exploited in LRRK2 bioassays and guide exploration of LRRK2 function in vivo.	[Sepulveda, Bryan; Mesias, Roxana; Benson, Deanna L.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Li, Xianting; Yue, Zhenyu] Mt Sinai Sch Med, Friedman Brain Inst, Dept Neurol, New York, NY USA; [Sepulveda, Bryan] Mt Sinai Sch Med, Grad Sch Biol Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Benson, DL (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	Deanna.Benson@mssm.edu		Mesias, Roxana/0000-0002-6198-6809; Benson, Deanna/0000-0001-7037-1147; Li, Xianting/0000-0002-3153-0931	Michael J. Fox Foundation; National Institutes of Health [MH095229, MH099778, MH087004, NS060809, NS055683]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095229, R21MH099778, T32MH087004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060809, R21NS055683] Funding Source: NIH RePORTER	Michael J. Fox Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Michael J. Fox Foundation (D.L.B., Z.Y.) and the National Institutes of Health (MH095229 and MH099778 to D.L.B., MH087004 to B.S., NS060809 and NS055683 to Z.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Andres-Mateos E, 2009, J NEUROSCI, V29, P15846, DOI 10.1523/JNEUROSCI.4357-09.2009; Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; CACERES A, 1986, J NEUROSCI, V6, P714; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Cheng L, 2005, J NEUROSCI, V25, P395, DOI 10.1523/JNEUROSCI.4097-04.2005; Dachsel JC, 2010, PARKINSONISM RELAT D, V16, P650, DOI 10.1016/j.parkreldis.2010.08.018; Di Fonzo A, 2005, LANCET, V365, P412; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Higashi S, 2007, J NEUROCHEM, V100, P368, DOI 10.1111/j.1471-4159.2006.04246.x; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526; Lee S, 2010, J NEUROSCI, V30, P16959, DOI 10.1523/JNEUROSCI.1807-10.2010; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; MANDELL JW, 1995, NEUROBIOL AGING, V16, P229, DOI 10.1016/0197-4580(94)00164-V; Melrose HL, 2007, NEUROSCIENCE, V147, P1047, DOI 10.1016/j.neuroscience.2007.05.027; Mintz CD, 2008, J COMP NEUROL, V510, P351, DOI 10.1002/cne.21799; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Paus M, 2013, BRAIN RES, V1497, P85, DOI 10.1016/j.brainres.2012.12.024; Radner S, 2013, DEV NEUROBIOL, V73, P209, DOI 10.1002/dneu.22057; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; SATO N, 1991, J CELL BIOL, V113, P321, DOI 10.1083/jcb.113.2.321; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Taymans JM, 2006, J NEUROCHEM, V98, P951, DOI 10.1111/j.1471-4159.2006.03919.x; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	40	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61986	10.1371/journal.pone.0061986	http://dx.doi.org/10.1371/journal.pone.0061986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646112	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300022
J	Song, XB; Sun, JL; Mikalsen, T; Roberts, AP; Sundsfjord, A				Song, Xiaobo; Sun, Jinglu; Mikalsen, Theresa; Roberts, Adam P.; Sundsfjord, Arnfinn			Characterisation of the Plasmidome within Enterococcus faecalis Isolated from Marginal Periodontitis Patients in Norway	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ERYTHROMYCIN RESISTANCE; TETRACYCLINE RESISTANCE; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; GENETIC ELEMENTS; ORAL BACTERIA; FAECIUM; SUSCEPTIBILITY; POPULATION	The present study aimed to identify and characterize plasmids in a national collection of oral Enterococcus faecalis (n = 106) isolated from patients with marginal periodontitis. Plasmid replicon typing was performed by multiplex-PCR and sequencing with specific primers for 18 rep-families and 1 unique sequence. Additional plasmid analysis by S1-PFGE was performed for comparison. Totally 120 plasmid replicon amplicons of seven rep-families were identified in 93 E. faecalis strains, e.g. rep9 (prototype pCF10), rep6 (prototype pS86), rep2 (prototype pRE25/pEF1), and rep8 (prototype pAM373). Rep9 was the most predominant rep-family being detected in 81 (76.4%) strains. Forty of these strains were tetracycline resistant and three were erythromycin resistant. Rep6 was the second predominant rep-family being detected in 22 (20.8%) strains. Rep2 was detected in eight (7.5%) strains. All rep2-positive strains were resistant to tetracycline and/or erythromycin and six of them contained Tn916/Tn1545 genes. The rep-positive E. faecalis exhibited divergence in multilocus sequence types (STs). There was a significant correlation between rep9 and ST21, while multiple rep-families appeared in ST40. Totally 145 plasmid bands were identified in 95 E. faecalis strains by S1-PFGE, 59 strains carrying one plasmid, 27 carrying two, five carrying three, three carrying four, and one strain carrying five plasmids. Plasmid sizes varied between 5-150 kbp. There was a significant correlation between the number of plasmids identified by PCR rep-typing and by S1-PFGE. The results indicate that the majority of E. faecalis of marginal periodontitis are likely to be a reservoir for diverse mobile genetic elements and associated antimicrobial resistance determinants.	[Song, Xiaobo; Sun, Jinglu; Mikalsen, Theresa; Sundsfjord, Arnfinn] Univ Tromso, Dept Med Biol, Fac Hlth Sci, Tromso, Norway; [Roberts, Adam P.] UCL, Dept Microbial Dis, UCL Eastman Dent Inst, London, England; [Sundsfjord, Arnfinn] Univ Hosp Northern Norway, Dept Microbiol & Infect Control, Reference Ctr Detect Antimicrobial Resistance Kre, Tromso, Norway	UiT The Arctic University of Tromso; University of London; University College London; UiT The Arctic University of Tromso; University Hospital of North Norway	Song, XB (corresponding author), Univ Tromso, Dept Med Biol, Fac Hlth Sci, Tromso, Norway.	xiaobo.song@uit.no; arnfinn.sundsfjord@uit.no	Roberts, Adam P/C-1787-2008; Sundsfjord, Arnfinn/F-9668-2018; Roberts, Adam/AAU-5493-2021	Roberts, Adam P/0000-0002-0760-3088; Sundsfjord, Arnfinn/0000-0002-3728-2270; Roberts, Adam/0000-0002-0760-3088	European Commission [LSHE-CT-2007-03410 "ACE"]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by research grants from the European Commission (LSHE-CT-2007-03410 "ACE"). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carvalho MDS, 2004, J CLIN MICROBIOL, V42, P1192, DOI 10.1128/JCM.42.3.1192-1198.2004; Clewell DB, 2002, PLASMID, V48, P193, DOI 10.1016/S0147-619X(02)00113-0; Creti R, 2004, J MED MICROBIOL, V53, P13, DOI 10.1099/jmm.0.05353-0; Dahlen G, 2000, ORAL MICROBIOL IMMUN, V15, P309, DOI 10.1034/j.1399-302x.2000.150507.x; Garcia-Migura L, 2011, FOODBORNE PATHOG DIS, V8, P1191, DOI 10.1089/fpd.2011.0897; Gazzola S, 2012, FOOD MICROBIOL, V30, P348, DOI 10.1016/j.fm.2011.12.005; Gevers D, 2003, SYST APPL MICROBIOL, V26, P277, DOI 10.1078/072320203322346137; Handal T, 2003, ANTIMICROB AGENTS CH, V47, P1443, DOI 10.1128/AAC.47.4.1443-1446.2003; Hegstad K, 2010, CLIN MICROBIOL INFEC, V16, P541, DOI 10.1111/j.1469-0691.2010.03226.x; Hollenbeck BL, 2012, VIRULENCE, V3, P421, DOI 10.4161/viru.21282; Jensen LB, 2010, J MICROBIOL METH, V80, P25, DOI 10.1016/j.mimet.2009.10.012; Manson JM, 2010, P NATL ACAD SCI USA, V107, P12269, DOI 10.1073/pnas.1000139107; Murray BE, 1998, EMERG INFECT DIS, V4, P37, DOI 10.3201/eid0401.980106; Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363; Palmer KL, 2010, CURR OPIN MICROBIOL, V13, P632, DOI 10.1016/j.mib.2010.08.004; Pinheiro ET, 2004, INT ENDOD J, V37, P756, DOI 10.1111/j.1365-2591.2004.00865.x; RAMS TE, 1992, ORAL MICROBIOL IMMUN, V7, P249, DOI 10.1111/j.1399-302X.1992.tb00034.x; Ready D, 2006, ANTIMICROB AGENTS CH, V50, P2866, DOI 10.1128/AAC.00217-06; Roberts AP, 2011, FEMS MICROBIOL REV, V35, P856, DOI 10.1111/j.1574-6976.2011.00283.x; Roberts AP, 2010, EXPERT REV ANTI-INFE, V8, P1441, DOI [10.1586/eri.10.106, 10.1586/ERI.10.106]; Rosvoll TCS, 2012, FEMS IMMUNOL MED MIC, V66, P166, DOI 10.1111/j.1574-695X.2012.00997.x; Rosvoll TCS, 2010, FEMS IMMUNOL MED MIC, V58, P254, DOI 10.1111/j.1574-695X.2009.00633.x; Schwarz FV, 2001, PLASMID, V46, P170, DOI 10.1006/plas.2001.1544; Sedgley CM, 2005, ORAL MICROBIOL IMMUN, V20, P10, DOI 10.1111/j.1399-302X.2004.00180.x; SEDGLEY CM, 2004, ENDOD TOPICS, V9, P37; Soares GMS, 2012, J APPL ORAL SCI, V20, P295, DOI 10.1590/S1678-77572012000300002; Smalla K, 2000, HORIZONTAL GENE POOL, P207; Sun JL, 2011, J PERIODONTOL, V82, P626, DOI 10.1902/jop.2010.100378; Sun JL, 2009, J CLIN MICROBIOL, V47, P2218, DOI 10.1128/JCM.00388-09; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Villedieu A, 2004, ANTIMICROB AGENTS CH, V48, P2298, DOI 10.1128/AAC.48.6.2298-2301.2004; Villedieu A, 2003, ANTIMICROB AGENTS CH, V47, P878, DOI 10.1128/AAC.47.3.878-882.2003; Zhu WM, 2010, ANTIMICROB AGENTS CH, V54, P4314, DOI 10.1128/AAC.00185-10	33	20	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62248	10.1371/journal.pone.0062248	http://dx.doi.org/10.1371/journal.pone.0062248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646122	Green Published, gold			2022-12-25	WOS:000319077300034
J	Rapino, F; Jung, M; Fulda, S				Rapino, F.; Jung, M.; Fulda, S.			BAG3 induction is required to mitigate proteotoxicity via selective autophagy following inhibition of constitutive protein degradation pathways	ONCOGENE			English	Article						BAG3; autophagy; proteasome inhibitor; HDAC6; cancer	QUALITY-CONTROL; AGGRESOME FORMATION; CO-CHAPERONES; CANCER CELLS; HEAT-STRESS; APOPTOSIS; MACROAUTOPHAGY; COMPLEX; TARGET; ACTIVATION	Simultaneous inhibition of the two major constitutive protein quality control (PQC) pathways, that is, the ubiquitin-proteasome system (UPS) and the aggresome-autophagy system, has been suggested as a promising strategy to trigger cell death in cancer cells. However, we observed that one third of rhabdomyosarcoma (RMS) cells survives parallel inhibition of the UPS by Bortezomib and the aggresome-autophagy pathway by the cytoplasmic histone deacetylase 6 inhibitor ST80, and is able to regrow upon drug removal, thus pointing to the induction of compensatory pathways. Here, we identify Bcl-2-associated athanogene 3 (BAG3) as a critical mediator of inducible resistance in surviving cells after concomitant blockage of constitutive PQC pathways by mitigating ST80/Bortezomib-triggered proteotoxicity via selective autophagy. ST80/Bortezomib cotreatment upregulates BAG3 mRNA and protein levels in surviving cells in addition to triggering the accumulation of insoluble protein aggregates. Intriguingly, knockdown of BAG3 by RNA interference severely impairs clearance of protein aggregates, significantly increases cell death and reduces long-term survival and clonogenic growth during recovery after ST80/Bortezomib cotreatment. Similarly, inhibition of autophagy by inducible autophagy-related protein 7 knockdown prevents removal of protein aggregates and cell regrowth during recovery after ST80/Bortezomib cotreatment. Also, the inhibition of lysosomal degradation using the V-ATPase pump inhibitor Bafilomycin A1 enhances accumulation of protein aggregates, and completely abolishes regrowth after Bortezomib/ST80-induced proteotoxic stress. By identifying BAG3 as a key mediator of inducible resistance by mitigating proteotoxicity via selective autophagy after inhibition of constitutive PQC systems, our study provides new insights into the regulation of PQC pathways in cancer cells and identifies new targets for therapeutic intervention.	[Rapino, F.; Fulda, S.] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Germany; [Jung, M.] Univ Freiburg, Inst Pharmaceut Sci, D-79106 Freiburg, Germany	Goethe University Frankfurt; University of Freiburg	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Germany.	simone.fulda@kgu.de	Jung, Manfred/Q-8029-2016	Jung, Manfred/0000-0002-6361-7716; Fulda, Simone/0000-0002-0459-6417; Rapino, Francesca/0000-0002-4343-3805	Wilhelm-Sander Stiftung; Deutsche Krebshilfe; Bundesministerium fur Bildung und Forschung [01GM1104C]; Deutsche Forschungsgemeinschaft [JU 295/9-1, SPP1463, JU 295/10-2, CRU 201]	Wilhelm-Sander Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank C Hugenberg for expert secretarial assistance. This work has been partially supported by grants from the Wilhelm-Sander Stiftung, the Deutsche Krebshilfe and the Bundesministerium fur Bildung und Forschung (01GM1104C) (to S F). Work on HDAC inhibitors in the Jung group is supported by the Deutsche Forschungsgemeinschaft (JU 295/9-1 within SPP1463, JU 295/10-2 within CRU 201).	Ammirante M, 2010, P NATL ACAD SCI USA, V107, P7497, DOI 10.1073/pnas.0907696107; Aveic S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026097; Basit F, 2012, J BIOL CHEM, V287, P38767, DOI 10.1074/jbc.M112.398966; Bazzaro M, 2008, CLIN CANCER RES, V14, P7340, DOI 10.1158/1078-0432.CCR-08-0642; Behl C, 2011, AUTOPHAGY, V7, P795, DOI 10.4161/auto.7.7.15844; Behrends Christian, 2012, Int J Cell Biol, V2012, P673290, DOI 10.1155/2012/673290; Bersani F, 2008, EUR J CANCER, V44, P876, DOI 10.1016/j.ejca.2008.02.022; Carew JS, 2010, J CELL MOL MED, V14, P2448, DOI 10.1111/j.1582-4934.2009.00832.x; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Chiappetta G, 2007, J CLIN ENDOCR METAB, V92, P1159, DOI 10.1210/jc.2006-1712; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Du ZX, 2009, J CELL PHYSIOL, V218, P631, DOI 10.1002/jcp.21634; Festa M, 2011, AM J PATHOL, V178, P2504, DOI 10.1016/j.ajpath.2011.02.002; Frankland-Searby S, 2012, BBA-REV CANCER, V1825, P64, DOI 10.1016/j.bbcan.2011.10.003; Fulda S, 1997, CANCER RES, V57, P3823; Gamerdinger M, 2011, J MOL MED, V89, P1175, DOI 10.1007/s00109-011-0795-6; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; Humphreys RC, 2008, ADV EXP MED BIOL, V615, P127, DOI 10.1007/978-1-4020-6554-5_7; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kubota H, 2009, J BIOCHEM, V146, P609, DOI 10.1093/jb/mvp139; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Liao Q, 2001, FEBS LETT, V503, P151, DOI 10.1016/S0014-5793(01)02728-4; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nivon M, 2012, J CELL SCI, V125, P1141, DOI 10.1242/jcs.091041; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Romano MF, 2003, CANCER BIOL THER, V2, P508, DOI 10.4161/cbt.2.5.524; Scott GK, 2008, MOL CANCER RES, V6, P1250, DOI 10.1158/1541-7786.MCR-07-2110; Seidel K, 2012, NEUROPATH APPL NEURO, V38, P39, DOI 10.1111/j.1365-2990.2011.01198.x; Tsukahara F, 2010, BLOOD, V116, P3582, DOI 10.1182/blood-2009-10-249623; Wang HQ, 2008, BIOCHEM BIOPH RES CO, V365, P381, DOI 10.1016/j.bbrc.2007.11.001; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wu WKK, 2010, DRUG RESIST UPDATE, V13, P87, DOI 10.1016/j.drup.2010.04.003; Yao Tso-Pang, 2010, Genes Cancer, V1, P779; Zhang Y, 2012, ONCOL REP, V27, P109, DOI 10.3892/or.2011.1486; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	40	34	34	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 27	2014	33	13					1713	1724		10.1038/onc.2013.110	http://dx.doi.org/10.1038/onc.2013.110			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9QY	23644654	Green Published, Green Submitted			2022-12-25	WOS:000334344700011
J	Dong, YY; Gu, Y; Huan, YJ; Wang, YJ; Liu, Y; Liu, M; Ding, F; Gu, XS; Wang, YJ				Dong, Yingying; Gu, Yun; Huan, Youjuan; Wang, Yingjie; Liu, Yan; Liu, Mei; Ding, Fei; Gu, Xiaosong; Wang, Yongjun			HMGB1 Protein Does Not Mediate the Inflammatory Response in Spontaneous Spinal Cord Regeneration A HINT FOR CNS REGENERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; MOBILITY GROUP BOX-1; TOLL-LIKE RECEPTORS; CENTRAL-NERVOUS-SYSTEM; NEURITE OUTGROWTH; IMMUNE-RESPONSES; PATTERN-RECOGNITION; PRIMARY CULTURES; GEKKO-JAPONICUS; PLASMA-MEMBRANE	Uncontrolled, excessive inflammation contributes to the secondary tissue damage of traumatic spinal cord, and HMGB1 is highlighted for initiation of a vicious self-propagating inflammatory circle by release from necrotic cells or immune cells. Several regenerative-competent vertebrates have evolved to circumvent the second damages during the spontaneous spinal cord regeneration with an unknown HMGB1 regulatory mechanism. By genomic surveys, we have revealed that two paralogs of HMGB1 are broadly retained from fish in the phylogeny. However, their spatial-temporal expression and effects, as shown in lowest amniote gecko, were tightly controlled in order that limited inflammation was produced in spontaneous regeneration. Two paralogs from gecko HMGB1 (gHMGB1) yielded distinct injury and infectious responses, with gHMGB1b significantly up-regulated in the injured cord. The intracellular gHMGB1b induced less release of inflammatory cytokines than gHMGB1a in macrophages, and the effects could be shifted by exchanging one amino acid in the inflammatory domain. Both intracellular proteins were able to mediate neuronal programmed apoptosis, which has been indicated to produce negligible inflammatory responses. In vivo studies demonstrated that the extracellular proteins could not trigger a cascade of the inflammatory cytokines in the injured spinal cord. Signal transduction analysis found that gHMGB1 proteins could not bind with cell surface receptors TLR2 and TLR4 to activate inflammatory signaling pathway. However, they were able to interact with the receptor for advanced glycation end products to potentiate oligodendrocyte migration by activation of both NF kappa B and Rac1/Cdc42 signaling. Our results reveal that HMGB1 does not mediate the inflammatory response in spontaneous spinal cord regeneration, but it promotes CNS regeneration.	[Dong, Yingying; Gu, Yun; Huan, Youjuan; Wang, Yingjie; Liu, Yan; Liu, Mei; Ding, Fei; Gu, Xiaosong; Wang, Yongjun] Nantong Univ, Key Lab Neuroregenerat, Nantong 226007, Peoples R China	Nantong University	Gu, XS (corresponding author), Nantong Univ, Key Lab Neuroregenerat, 19 Qixiu Rd, Nantong 226007, Peoples R China.	neurongu@public.nt.js.cn; wyjbs@ntu.edu.cn		Wang, Yongjun/0000-0001-5040-8926	National Natural Science Foundation of China [31071874, 31171405]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Basic Research Program of Jiangsu Education Department [10KJA180041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Basic Research Program of Jiangsu Education Department	This work was supported by National Natural Science Foundation of China Grants 31071874 and 31171405, the Priority Academic Program Development of Jiangsu Higher Education Institutions, and Basic Research Program of Jiangsu Education Department Grant 10KJA180041.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Andersson U, 2010, BBA-GENE REGUL MECH, V1799, P141, DOI 10.1016/j.bbagrm.2009.11.003; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi ME, 2000, EMBO REP, V1, P109, DOI 10.1093/embo-reports/kvd030; Bianchi ME, 1998, AM J HUM GENET, V63, P1573, DOI 10.1086/302170; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen KB, 2011, SPINE, V36, P2122, DOI 10.1097/BRS.0b013e318203941c; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DASTON MM, 1994, J NEUROCYTOL, V23, P323, DOI 10.1007/BF01188500; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Escobar HM, 2003, CYTOGENET GENOME RES, V101, P33, DOI 10.1159/000073415; Fages C, 2000, J CELL SCI, V113, P611; Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Ferretti P, 2003, DEV DYNAM, V226, P245, DOI 10.1002/dvdy.10226; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Gensel JC, 2012, CELL TISSUE RES, V349, P201, DOI 10.1007/s00441-012-1425-5; Gong HJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S10; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Hasegawa A, 2011, J SURG RES, V169, P85, DOI 10.1016/j.jss.2009.10.015; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P303, DOI 10.1093/molbev/msr207; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Johansson JU, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000278; Kawabata H, 2010, SPINE, V35, P1109, DOI 10.1097/BRS.0b013e3181bd14b6; Kiba T, 2002, DIGESTION, V66, P79, DOI 10.1159/000065594; Kigerl KA, 2009, CURR TOP MICROBIOL, V336, P121, DOI 10.1007/978-3-642-00549-7_7; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Kuniyasu H, 2003, ONCOL REP, V10, P445; Kvarnhammar AM, 2012, IMMUNOLOGY, V136, P11, DOI 10.1111/j.1365-2567.2012.03556.x; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Liu M, 2010, CELL BIOL INT, V34, P153, DOI 10.1042/CBI20090015; Liu Y, 2006, J MOL NEUROSCI, V29, P21, DOI 10.1385/JMN:29:1:21; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Mazet F, 2002, CURR OPIN GENET DEV, V12, P393, DOI 10.1016/S0959-437X(02)00315-5; McLean KE, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-50; Mekhail M, 2012, PROG NEUROBIOL, V96, P322, DOI 10.1016/j.pneurobio.2012.01.008; MERENMIES J, 1991, J BIOL CHEM, V266, P16722; Moleri S, 2011, GENE EXPR PATTERNS, V11, P3, DOI 10.1016/j.gep.2010.08.006; Nesic O, 2001, J NEUROTRAUM, V18, P947, DOI 10.1089/089771501750451857; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pasheva E, 2004, BIOCHEMISTRY-US, V43, P2935, DOI 10.1021/bi035615y; Popovich PG, 2008, NAT REV NEUROSCI, V9, P481, DOI 10.1038/nrn2398; Probert L, 2000, BRAIN, V123, P2005, DOI 10.1093/brain/123.10.2005; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qin JD, 2008, J NEUROSCI RES, V86, P2414, DOI 10.1002/jnr.21692; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; RAUVALA H, 1987, J BIOL CHEM, V262, P16625; Rauvala H, 2007, CURR MOL MED, V7, P725, DOI 10.2174/156652407783220750; READ CM, 1993, NUCLEIC ACIDS RES, V21, P3427, DOI 10.1093/nar/21.15.3427; Rehm BHA, 2001, APPL MICROBIOL BIOT, V57, P579, DOI 10.1007/s00253-001-0844-0; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schwartz M, 2004, TRENDS PHARMACOL SCI, V25, P407, DOI 10.1016/j.tips.2004.06.010; Sessa L, 2007, GENE, V387, P133, DOI 10.1016/j.gene.2006.08.034; Sirbulescu RF, 2011, BRAIN RES REV, V67, P73, DOI 10.1016/j.brainresrev.2010.11.001; Sorci G, 2013, BBA-MOL CELL RES, V1833, P101, DOI 10.1016/j.bbamcr.2012.10.021; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tian L, 2009, TRENDS IMMUNOL, V30, P91, DOI 10.1016/j.it.2008.11.002; Tseng AS, 2007, DEV BIOL, V301, P62, DOI 10.1016/j.ydbio.2006.10.048; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang YJ, 2012, INT J BIOCHEM CELL B, V44, P2288, DOI 10.1016/j.biocel.2012.09.011; Wang YJ, 2012, J CELL BIOCHEM, V113, P1842, DOI 10.1002/jcb.24053; Wang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017878; Wijburg OLC, 1997, IMMUNOLOGY, V92, P252, DOI 10.1046/j.1365-2567.1997.00340.x; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019; Yu B, 2012, NUCLEIC ACIDS RES, V40, P10356, DOI 10.1093/nar/gks750	95	32	33	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18204	18218		10.1074/jbc.M113.463810	http://dx.doi.org/10.1074/jbc.M113.463810			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649623	Green Published, hybrid			2022-12-25	WOS:000320721900025
J	Vaidyanathan, R; Vega, AL; Song, CH; Zhou, Q; Tan, BH; Berger, S; Makielski, JC; Eckhardt, LL				Vaidyanathan, Ravi; Vega, Amanda L.; Song, Chunhua; Zhou, Qing; Tan, Bihua; Berger, Stuart; Makielski, Jonathan C.; Eckhardt, Lee L.			The Interaction of Caveolin 3 Protein with the Potassium Inward Rectifier Channel Kir2.1 PHYSIOLOGY AND PATHOLOGY RELATED TO LONG QT SYNDROME 9 (LQT9)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; HEART-FAILURE; MACROMOLECULAR COMPLEX; KCNJ2 MUTATIONS; MUSCLE-CELLS; TRAFFICKING; EXPRESSION; ARRHYTHMIA; SKELETAL; SODIUM	Mutations in CAV3 cause LQT syndrome 9 (LQT9). A previously reported LQT9 patient had prominent U waves on ECG, a feature that has been correlated with Kir2.1 loss of function. Our objective was to determine whether caveolin 3 (Cav3) associates with Kir2.1 and whether LQT9-associated CAV3 mutations affect the biophysical properties of Kir2.1. Kir2.1 current (I-K1) density was measured using the whole-cell voltage clamp technique. WT-Cav3 did not affect I-K1. However, F97C-Cav3 and T78M-Cav3 decreased I-K1 density significantly by similar to 60%, and P104L-Cav3 decreased I-K1 density significantly by similar to 30% at -60 mV. Immunostained rat heart cryosections and HEK293 cells cotransfected with Kir2.1 and WT-Cav3 both demonstrated colocalization of Kir2.1 and WT-Cav3 by confocal imaging. Cav3 coimmunoprecipitated with Kir2.1 in human ventricular myocytes and in heterologous expression systems. Additionally, FRET efficiency was highly specific, with a molecular distance of 5.6 +/- 0.4 nm, indicating close protein location. Colocalization experiments found that Cav3 and Kir2.1 accumulated in the Golgi compartment. On-cell Western blot analysis showed decreased Kir2.1 cell surface expression by 60% when expressed with F97C-Cav3 and by 20% when expressed with P104L-Cav3 compared with WT-Cav3. This is the first report of an association between Cav3 and Kir2.1. The Cav3 mutations F97C-Cav3, P104L-Cav3, and T78M-Cav3 decreased I-K1 density significantly. This effect was related to a reduced cell surface expression of Kir2.1. Kir2.1 loss of function is additive to the increase described previously in late I-Na, prolonging repolarization and leading to arrhythmia generation in Cav3-mediated LQT9.	[Makielski, Jonathan C.; Eckhardt, Lee L.] Univ Wisconsin, Dept Med, Div Cardiovasc Med, Madison, WI 53792 USA; [Makielski, Jonathan C.; Eckhardt, Lee L.] Univ Wisconsin, Cellular & Mol Arrhythmia Res Program, Madison, WI 53792 USA; [Berger, Stuart] Med Coll Wisconsin, Milwaukee, WI 53226 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin	Eckhardt, LL (corresponding author), 600 Highland Ave,CSC H4-522, Madison, WI 53792 USA.	lle@medicine.wisc.edu	song, chunhua/K-7882-2016; song, chunhua/K-7882-2016	song, chunhua/0000-0001-7563-0339; song, chunhua/0000-0002-4081-2543; Eckhardt, Lee/0000-0001-5792-064X	University of Wisconsin Cellular and Molecular Arrhythmia Research Program; American Heart Association National Scientist Development [11SDG5000003]; University of Wisconsin School of Medicine and Public Health	University of Wisconsin Cellular and Molecular Arrhythmia Research Program; American Heart Association National Scientist Development(American Heart Association); University of Wisconsin School of Medicine and Public Health	This work was supported by the University of Wisconsin Cellular and Molecular Arrhythmia Research Program, by American Heart Association National Scientist Development Grant 11SDG5000003 (to L. E.), and by the University of Wisconsin School of Medicine and Public Health.	Anumonwo JMB, 2010, J MOL CELL CARDIOL, V48, P45, DOI 10.1016/j.yjmcc.2009.08.013; Balijepalli RC, 2008, PROG BIOPHYS MOL BIO, V98, P149, DOI 10.1016/j.pbiomolbio.2009.01.012; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Cheng J., 2013, J MOL CELL IN PRESS; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Couchoux H, 2007, J PHYSIOL-LONDON, V580, P745, DOI 10.1113/jphysiol.2006.124198; Cui S, 2010, J BIOL CHEM, V285, P41732, DOI 10.1074/jbc.M110.153312; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Eckhardt LL, 2007, HEART RHYTHM, V4, P323, DOI 10.1016/j.hrthm.2006.10.025; Galbiati F, 1999, J BIOL CHEM, V274, P25632, DOI 10.1074/jbc.274.36.25632; Gomez R, 2009, CIRC RES, V105, P383, DOI 10.1161/CIRCRESAHA.109.197558; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hare JM, 2000, CIRC RES, V86, P1085, DOI 10.1161/01.RES.86.10.1085; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Leonoudakis D, 2001, J CELL SCI, V114, P987; Miake J, 2003, J CLIN INVEST, V111, P1529, DOI 10.1172/JCI200317959; Milstein ML, 2012, P NATL ACAD SCI USA, V109, pE2134, DOI 10.1073/pnas.1109370109; Petitprez S, 2011, CIRC RES, V108, P294, DOI 10.1161/CIRCRESAHA.110.228312; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Pu JL, 2008, J MOL CELL CARDIOL, V44, P188, DOI 10.1016/j.yjmcc.2007.09.010; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Schwartz PJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P868, DOI 10.1161/CIRCEP.111.962019; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Vaidyanathan R, 2010, J BIOL CHEM, V285, P28000, DOI 10.1074/jbc.M110.110858; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; Wang ZG, 1998, CIRCULATION, V98, P2422, DOI 10.1161/01.CIR.98.22.2422	31	40	42	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17472	17480		10.1074/jbc.M112.435370	http://dx.doi.org/10.1074/jbc.M112.435370			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640888	Green Published, hybrid			2022-12-25	WOS:000320380600039
J	Cottard, F; Asmane, I; Erdmann, E; Bergerat, JP; Kurtz, JE; Ceraline, J				Cottard, Felicie; Asmane, Irene; Erdmann, Eva; Bergerat, Jean-Pierre; Kurtz, Jean-Emmanuel; Ceraline, Jocelyn			Constitutively Active Androgen Receptor Variants Upregulate Expression of Mesenchymal Markers in Prostate Cancer Cells	PLOS ONE			English	Article							N-CADHERIN INCREASES; SPLICE VARIANTS; STEM-CELLS; PROGRESSION; METASTASIS; TRANSITION; RESISTANCE; ADHESION; GROWTH; SNAIL	Androgen receptor (AR) signaling pathway remains the foremost target of novel therapeutics for castration-resistant prostate cancer (CRPC). However, the expression of constitutively active AR variants lacking the carboxy-terminal region in CRPC may lead to therapy inefficacy. These AR variants are supposed to support PCa cell growth in an androgen-depleted environment, but their mode of action still remains unresolved. Moreover, recent studies indicate that constitutively active AR variants are expressed in primary prostate tumors and may contribute to tumor progression. The aim of this study was to investigate the impact of constitutively active AR variants on the expression of tumor progression markers. N-cadherin expression was analyzed in LNCaP cells overexpressing the wild type AR or a constitutively active AR variant by qRT-PCR, Western blot and immunofluorescence. We showed here for the first time that N-cadherin expression was increased in the presence of constitutively active AR variants. These results were confirmed in C4-2B cells overexpressing these AR variants. Although N-cadherin expression is often associated with a downregulation of E-cadherin, this phenomenon was not observed in our model. Nevertheless, in addition to the increased expression of N-cadherin, an upregulation of other mesenchymal markers expression such as VIMENTIN, SNAIL and ZEB1 was observed in the presence of constitutively active variants. In conclusion, our findings highlight novel consequences of constitutively active AR variants on the regulation of mesenchymal markers in prostate cancer.	[Cottard, Felicie; Asmane, Irene; Erdmann, Eva; Bergerat, Jean-Pierre; Kurtz, Jean-Emmanuel; Ceraline, Jocelyn] Univ Strasbourg, INSERM, U1113, Fedrat Med Translat Strasbourg, Strasbourg, France; [Asmane, Irene; Bergerat, Jean-Pierre; Kurtz, Jean-Emmanuel; Ceraline, Jocelyn] CHRU Strasbourg, Hematol & Oncol Unit, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ceraline, J (corresponding author), Univ Strasbourg, INSERM, U1113, Fedrat Med Translat Strasbourg, Strasbourg, France.	ceraline@unistra.fr	Kurtz, Jean-Emmanuel/R-3286-2016	CERALINE, Jocelyn/0000-0001-6476-8797	University of Strasbourg; Ligue Contre le Cancer; Alsace Contre le Cancer; Association pour la Recherche sur les Tumeurs Prostatiques (ARTP)	University of Strasbourg; Ligue Contre le Cancer(Ligue nationale contre le cancer); Alsace Contre le Cancer; Association pour la Recherche sur les Tumeurs Prostatiques (ARTP)	This work was supported by the University of Strasbourg; the Ligue Contre le Cancer, the Alsace Contre le Cancer; and the Association pour la Recherche sur les Tumeurs Prostatiques (ARTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Bergerat JP, 2009, HUM MUTAT, V30, P145, DOI 10.1002/humu.20848; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Ceraline J, 2004, INT J CANCER, V108, P152, DOI 10.1002/ijc.11404; Clarke NW, 2009, ASIAN J ANDROL, V11, P57, DOI 10.1038/aja.2008.29; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Gustavsson H, 2005, PROSTATE, V62, P364, DOI 10.1002/pros.20145; Guyader C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042252; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Jennbacken K, 2006, PROSTATE, V66, P1631, DOI 10.1002/pros.20469; Jennbacken K, 2010, ENDOCR-RELAT CANCER, V17, P469, DOI 10.1677/ERC-10-0015; Jin JK, 2011, INT J CANCER, V128, P2545, DOI 10.1002/ijc.26024; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Lapouge G, 2008, ADV EXP MED BIOL, V617, P529, DOI 10.1007/978-0-387-69080-3_53; Lapouge G, 2007, INT J CANCER, V121, P1238, DOI 10.1002/ijc.22830; Li G, 2001, CANCER RES, V61, P3819; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcias G, 2010, HUM MUTAT, V31, P74, DOI 10.1002/humu.21138; McKeithen D, 2010, PROSTATE, V70, P982, DOI 10.1002/pros.21132; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Nalla AK, 2011, EXP CELL RES, V317, P2512, DOI 10.1016/j.yexcr.2011.07.024; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Takayama K, 2007, ONCOGENE, V26, P4453, DOI 10.1038/sj.onc.1210229; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Tiwari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057329; Tomita K, 2000, CANCER RES, V60, P3650; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107	41	36	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63466	10.1371/journal.pone.0063466	http://dx.doi.org/10.1371/journal.pone.0063466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658830	gold, Green Published, Green Submitted			2022-12-25	WOS:000321200500072
J	Gao, N; Yang, N; Tang, JJ				Gao, Nan; Yang, Ning; Tang, Jijun			Ancestral Genome Inference Using a Genetic Algorithm Approach	PLOS ONE			English	Article							INVERSION	Recent advancement of technologies has now made it routine to obtain and compare gene orders within genomes. Rearrangements of gene orders by operations such as reversal and transposition are rare events that enable researchers to reconstruct deep evolutionary histories. An important application of genome rearrangement analysis is to infer gene orders of ancestral genomes, which is valuable for identifying patterns of evolution and for modeling the evolutionary processes. Among various available methods, parsimony-based methods (including GRAPPA and MGR) are the most widely used. Since the core algorithms of these methods are solvers for the so called median problem, providing efficient and accurate median solver has attracted lots of attention in this field. The "double-cut-and-join" (DCJ) model uses the single DCJ operation to account for all genome rearrangement events. Because mathematically it is much simpler than handling events directly, parsimony methods using DCJ median solvers has better speed and accuracy. However, the DCJ median problem is NP-hard and although several exact algorithms are available, they all have great difficulties when given genomes are distant. In this paper, we present a new algorithm that combines genetic algorithm (GA) with genomic sorting to produce a new method which can solve the DCJ median problem in limited time and space, especially in large and distant datasets. Our experimental results show that this new GA-based method can find optimal or near optimal results for problems ranging from easy to very difficult. Compared to existing parsimony methods which may severely underestimate the true number of evolutionary events, the sorting-based approach can infer ancestral genomes which are much closer to their true ancestors. The code is available at http://phylo.cse.sc.edu.	[Tang, Jijun] Tianjin Univ, Tianjin Key Lab Cognit Comp & Applicat, Tianjin 300072, Peoples R China; [Gao, Nan; Tang, Jijun] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA; [Yang, Ning] Northwestern Polytech Univ, Sch Automat, Xian 710072, Shaanxi, Peoples R China	Tianjin University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Northwestern Polytechnical University	Tang, JJ (corresponding author), Tianjin Univ, Tianjin Key Lab Cognit Comp & Applicat, Tianjin 300072, Peoples R China.	jtang@cse.sc.edu	Tang, Jijun/ABH-6528-2020		National Science Foundation (NSF) [0904179]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by a National Science Foundation (NSF) grant (Number 0904179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron A, 2006, LECT NOTES COMPUT SC, V4175, P163; Bourque G, 2002, GENOME RES, V12, P26; Bulteau L, 2012, SIAM J DISCRETE MATH, V26, P1148, DOI 10.1137/110851390; Caprara A., 2001, Algorithms in Bioinformatics. First International Workshop, WABI 2001. Proceedings (Lecture Notes in Computer Science Vol.2149), P238; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Haghighi M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S5; Hannenhalli S., 1995, Proceedings of the Twenty-Seventh Annual ACM Symposium on the Theory of Computing, P178, DOI 10.1145/225058.225112; Hill T, 2005, BBA-GEN SUBJECTS, V1725, P19, DOI 10.1016/j.bbagen.2005.04.027; Holland, 1975, ADAPTATION NATURAL A; Mitra AP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-159; Moret B M, 2001, Pac Symp Biocomput, P583; Moret BME, 2002, LECT NOTES COMPUT SC, V2452, P521; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; RAUBESON LA, 1992, SCIENCE, V255, P1697, DOI 10.1126/science.255.5052.1697; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Sankoff D, 1998, J COMPUT BIOL, V5, P555, DOI 10.1089/cmb.1998.5.555; Tannier E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-120; Unger R, 1993, 5 INT C GEN ALG; Xu AW, 2008, 8 INT WORKSH ALG BIO, P25; Yancopoulos S, 2005, BIOINFORMATICS, V21, P3340, DOI 10.1093/bioinformatics/bti535	20	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62156	10.1371/journal.pone.0062156	http://dx.doi.org/10.1371/journal.pone.0062156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658708	gold, Green Published, Green Submitted			2022-12-25	WOS:000321200500016
J	Jongeneel-Grimen, B; Busschers, W; Droomers, M; van Oers, HAM; Stronks, K; Kunst, AE				Jongeneel-Grimen, Birthe; Busschers, Wim; Droomers, Mariel; van Oers, Hans A. M.; Stronks, Karien; Kunst, Anton E.			Change in Neighborhood Traffic Safety: Does It Matter in Terms of Physical Activity?	PLOS ONE			English	Article							BUILT-ENVIRONMENT; LOCAL NEIGHBORHOOD; WALKING ACTIVITY; ASSOCIATIONS; PERCEPTIONS; ADULTS; ATTRIBUTES; MULTILEVEL; SAMPLE	Background: There is limited evidence on the causality of previously observed associations between neighborhood traffic safety and physical activity (PA). This study aims to contribute to this evidence by assessing the extent to which changes over time in neighborhood traffic safety were associated with PA. Methods: Data were accessed from the national survey Netherlands Housing Research for 2006 and 2009. The two samples of in total 57,092 Dutch residents aged 18-84 years lived in 320 neighbourhoods. Using multi-level hurdle models, the authors assessed whether the odds of being physically active and the mean hours of PA among active people (in 2009) were related to the levels of neighborhood traffic safety (in 2006) and changes in the levels of neighborhood traffic safety (between 2006 and 2009). Next, we examined if these associations varied according to gender, age, and employment status. Results: Higher levels of neighborhood traffic safety were associated with higher odds of being active (OR 1.080 (1.025-1.139)). An increase in levels of neighborhood traffic safety was associated with increased odds of being active (OR 1.060 (1.006-1.119)). This association was stronger among women, people aged 35 to 59, and those who were gainfully employed. Neither levels of traffic safety nor changes in these levels were associated with the mean hours of PA among people who were physically active (OR 0.997 (0.975-1.020); OR 1.001 (0.978-1.025), respectively). Conclusion: Not only levels of neighborhood traffic safety, but also increases in neighborhood traffic safety were related to increased odds of being active. This relationship supports claims for a causal relationship between neighborhood traffic safety and PA.	[Jongeneel-Grimen, Birthe; Busschers, Wim; Droomers, Mariel; Stronks, Karien; Kunst, Anton E.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [van Oers, Hans A. M.] Natl Inst Publ Hlth & Environm, Ctr Publ Hlth Status & Forecasting, NL-3720 BA Bilthoven, Netherlands; [van Oers, Hans A. M.] Tilburg Univ, Acad Collaborat, Ctr Publ Hlth Brabant, Fac Social Sci, NL-5000 LE Tilburg, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment; Tilburg University	Jongeneel-Grimen, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.jongeneel@amc.uva.nl		Stronks, Karien/0000-0002-0921-2232; Kunst, Anton/0000-0002-3313-5273; van Oers, Hans/0000-0003-4063-2240	Netherlands Organization for Health Research and Development(ZonMW)	Netherlands Organization for Health Research and Development(ZonMW)(Netherlands Organization for Health Research and Development)	The present study is part of the URBAN40 study, which is supported by a grant of The Netherlands Organization for Health Research and Development(ZonMW) (http://www.zonmw.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy CL, 2004, AM J PUBLIC HEALTH, V94, P440, DOI 10.2105/AJPH.94.3.440; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Boone-Heinonen J, 2011, PSYCHOL SPORT EXERC, V12, P54, DOI 10.1016/j.psychsport.2009.09.003; BUHMANN B, 1988, REV INCOME WEALTH, P115; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P143; Cochrane T, 2009, INT J ENV RES PUB HE, V6, P654, DOI 10.3390/ijerph6020654; De Bourdeaudhuij I, 2005, PUBLIC HEALTH NUTR, V8, P886, DOI 10.1079/PHN2005735; De Bourdeaudhuij I, 2003, AM J HEALTH PROMOT, V18, P83, DOI 10.4278/0890-1171-18.1.83; De Greef K, 2011, HEALTH SOC CARE COMM, V19, P178, DOI 10.1111/j.1365-2524.2010.00958.x; de Vries SI, 2007, AM J HEALTH PROMOT, V21, P312, DOI 10.4278/0890-1171-21.4s.312; Duncan M, 2005, INT J BEHAV NUTR PHY, V2, pe11; Foster C, 2004, J EPIDEMIOL COMMUN H, V58, P924, DOI 10.1136/jech.2003.014068; Giles-Corti B, 2002, PREV MED, V35, P601, DOI 10.1006/pmed.2002.1115; Giles-Corti B, 2006, PREV MED, V42, P455, DOI 10.1016/j.ypmed.2006.01.019; Hall KS, 2010, HEALTH EDUC RES, V25, P478, DOI 10.1093/her/cyq019; Hoehner CM, 2005, AM J PREV MED, V28, P105, DOI 10.1016/j.amepre.2004.10.023; Hooker Steven P, 2005, Prev Chronic Dis, V2, pA11; Humpel N, 2004, ANN BEHAV MED, V27, P60, DOI 10.1207/s15324796abm2701_8; Inoue S, 2010, J EPIDEMIOL, V20, P277, DOI 10.2188/jea.JE20090120; Ishii K, 2010, JPN J PHYS FIT SPORT, V59, P215, DOI 10.7600/jspfsm.59.215; Lee C, 2008, BUILD RES INF, V36, P395, DOI 10.1080/09613210802045547; Leslie E, 2005, HEALTH PLACE, V11, P227, DOI 10.1016/j.healthplace.2004.05.005; Li FZ, 2005, J EPIDEMIOL COMMUN H, V59, P558, DOI 10.1136/jech.2004.028399; Matthews C.E., 2002, PHYS ACTIVITY ASSESS, P107; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; McGinn AP, 2007, J URBAN HEALTH, V84, P162, DOI 10.1007/s11524-006-9136-4; Nagel CL, 2008, AM J EPIDEMIOL, V168, P461, DOI 10.1093/aje/kwn158; Oxley J, 1997, ACCIDENT ANAL PREV, V29, P839, DOI 10.1016/S0001-4575(97)00053-5; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; Schwanen T, 2004, URBAN STUD, V41, P579, DOI 10.1080/0042098042000178690; Sjostrom M, 2006, J PUBLIC HEALTH-HEID, V14, P291, DOI 10.1007/s10389-006-0031-y; Sugiyama T, 2009, HEALTH PLACE, V15, P1058, DOI 10.1016/j.healthplace.2009.05.001; Taylor LM, 2008, ANN BEHAV MED, V35, P170, DOI 10.1007/s12160-008-9021-3; Timperio A, 2004, PREV MED, V38, P39, DOI 10.1016/j.ypmed.2003.09.026; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troped PJ, 2003, PREV MED, V37, P304, DOI 10.1016/S0091-7435(03)00137-3; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Vlakveld W.P., 2008, BELEVING VERKEERSONV; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wen XJ, 2009, J ENVIRON HEALTH, V72, P40; Wilcox S, 2003, J GERONTOL B-PSYCHOL, V58, pP329, DOI 10.1093/geronb/58.6.P329	43	23	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62525	10.1371/journal.pone.0062525	http://dx.doi.org/10.1371/journal.pone.0062525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175AF	23658741	gold, Green Published, Green Submitted			2022-12-25	WOS:000321200500028
J	Delnooz, CCS; Pasman, JW; Beckmann, CF; van de Warrenburg, BPC				Delnooz, Catherine C. S. y; Pasman, Jaco W.; Beckmann, Christian F.; van de Warrenburg, Bart P. C.			Task-Free Functional MRI in Cervical Dystonia Reveals Multi-Network Changes That Partially Normalize with Botulinum Toxin	PLOS ONE			English	Article							FOCAL HAND DYSTONIA; IDIOPATHIC TORSION DYSTONIA; VOXEL-BASED MORPHOMETRY; STATE BRAIN NETWORKS; GRAY-MATTER CHANGES; WRITERS CRAMP; BASAL-GANGLIA; SENSORIMOTOR INTEGRATION; SPASMODIC TORTICOLLIS; MOTOR	Cervical dystonia is characterized by involuntary, abnormal movements and postures of the head and neck. Current views on its pathophysiology, such as faulty sensorimotor integration and impaired motor planning, are largely based on studies of focal hand dystonia. Using resting state fMRI, we explored whether cervical dystonia patients have altered functional brain connectivity compared to healthy controls, by investigating 10 resting state networks. Scans were repeated immediately before and some weeks after botulinum toxin injections to see whether connectivity abnormalities were restored. We here show that cervical dystonia patients have reduced connectivity in selected regions of the prefrontal cortex, premotor cortex and superior parietal lobule within a distributed network that comprises the premotor cortex, supplementary motor area, primary sensorimotor cortex, and secondary somatosensory cortex ( sensorimotor network). With regard to a network originating from the occipital cortex ( primary visual network), selected regions in the prefrontal and premotor cortex, superior parietal lobule, and middle temporal gyrus areas have reduced connectivity. In selected regions of the prefrontal, premotor, primary motor and early visual cortex increased connectivity was found within a network that comprises the prefrontal cortex including the anterior cingulate cortex and parietal cortex ( executive control network). Botulinum toxin treatment resulted in a partial restoration of connectivity abnormalities in the sensorimotor and primary visual network. These findings demonstrate the involvement of multiple neural networks in cervical dystonia. The reduced connectivity within the sensorimotor and primary visual networks may provide the neural substrate to expect defective motor planning and disturbed spatial cognition. Increased connectivity within the executive control network suggests excessive attentional control and while this may be a primary trait, perhaps contributing to abnormal motor control, this may alternatively serve a compensatory function in order to reduce the consequences of the motor planning defect inflicted by the other network abnormalities.	[Delnooz, Catherine C. S. y; Pasman, Jaco W.; van de Warrenburg, Bart P. C.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Beckmann, Christian F.] Univ Twente, MIRA Inst, NL-7500 AE Enschede, Netherlands; [Beckmann, Christian F.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; University of Twente; Radboud University Nijmegen	van de Warrenburg, BPC (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands.	B.vandewarrenburg@neuro.umcn.nl	Beckmann, Christian F./E-6374-2012	Beckmann, Christian F./0000-0002-3373-3193	Netherlands Brain Foundation; Prinses Beatrix Fonds; Gossweiler Foundation; Royal Dutch Society for Physical therapy	Netherlands Brain Foundation; Prinses Beatrix Fonds; Gossweiler Foundation; Royal Dutch Society for Physical therapy	BvdW receives research support from the Netherlands Brain Foundation, the Prinses Beatrix Fonds, the Gossweiler Foundation, and the Royal Dutch Society for Physical therapy. The other authors have nothing to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blood AJ, 2004, ANN NEUROL, V55, P744, DOI 10.1002/ana.20108; Bradley D, 2009, BRAIN, V132, P2327, DOI 10.1093/brain/awp156; Byrnes ML, 1998, BRAIN, V121, P977, DOI 10.1093/brain/121.5.977; Cakmur Raif, 2004, Adv Neurol, V94, P37; Castrop F., 2012, MOV DISORD; CeballosBaumann AO, 1997, BRAIN, V120, P571, DOI 10.1093/brain/120.4.571; Consky E, 1990, NEUROLOGY, V40; Curra A, 2004, MOVEMENT DISORD, V19, pS60, DOI 10.1002/mds.20011; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Vries PM, 2008, CLIN NEUROL NEUROSUR, V110, P120, DOI 10.1016/j.clineuro.2007.09.020; de Vries PM, 2012, CLIN NEUROL NEUROSUR, V114, P914, DOI 10.1016/j.clineuro.2012.02.006; de Vries PM, 2009, BRAIN RES, V1285, P58, DOI 10.1016/j.brainres.2009.06.006; Deco G, 2004, EUR J NEUROSCI, V20, P1089, DOI 10.1111/j.1460-9568.2004.03528.x; Defazio G, 2004, LANCET NEUROL, V3, P673, DOI 10.1016/S1474-4422(04)00907-X; Delmaire C, 2005, NEUROLOGY, V64, P1391, DOI 10.1212/01.WNL.0000158424.01299.76; Delnooz CC, 2012, MOV DISORD; Draganski B, 2003, NEUROLOGY, V61, P1228, DOI 10.1212/01.WNL.0000094240.93745.83; Edwards MJ, 2011, MOVEMENT DISORD, V26, P1969, DOI 10.1002/mds.23920; Egger K, 2007, MOVEMENT DISORD, V22, P1538, DOI 10.1002/mds.21619; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fiorio M, 2007, NEUROPSYCHOLOGIA, V45, P2346, DOI 10.1016/j.neuropsychologia.2007.02.005; Forss N, 1998, BRAIN RES, V781, P259, DOI 10.1016/S0006-8993(97)01240-7; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Galati G, 2010, EXP BRAIN RES, V206, P109, DOI 10.1007/s00221-010-2168-8; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hallett M, 2011, NEUROBIOL DIS, V42, P177, DOI 10.1016/j.nbd.2010.08.025; Hanajima R, 1998, ELECTROMYOGR MOTOR C, V109, P391, DOI 10.1016/S0924-980X(98)00036-8; Hanakawa T, 2011, NEUROSCI RES, V70, P144, DOI 10.1016/j.neures.2011.02.010; Hinse P, 1996, J NEUROL, V243, P29; KAJI R, 1995, BRAIN, V118, P511, DOI 10.1093/brain/118.2.511; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Mohammadi B, 2012, HUM BRAIN MAPP, V33, P840, DOI 10.1002/hbm.21250; Moore RD, 2012, NEUROIMAGE, V61, P823, DOI 10.1016/j.neuroimage.2012.03.066; Muller SV, 2005, MOVEMENT DISORD, V20, P58, DOI 10.1002/mds.20293; Munneke J, 2010, BRAIN COGNITION, V72, P368, DOI 10.1016/j.bandc.2009.11.001; Naumann M, 2000, ANN NEUROL, V47, P322, DOI 10.1002/1531-8249(200003)47:3<322::AID-ANA7>3.0.CO;2-E; Nelson RJ, 1996, CURR OPIN NEUROBIOL, V6, P801, DOI 10.1016/S0959-4388(96)80031-6; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Obermann M, 2008, EUR J NEUROL, V15, P831, DOI 10.1111/j.1468-1331.2008.02196.x; Obermann M, 2010, MOVEMENT DISORD, V25, P2627, DOI 10.1002/mds.23321; Opavsky R, 2012, INT J NEUROSCI, V122, P45, DOI 10.3109/00207454.2011.623807; Pantano P, 2011, AM J NEURORADIOL, V32, P81, DOI 10.3174/ajnr.A2242; Peller M, 2006, BRAIN, V129, P2697, DOI 10.1093/brain/awl181; Playford ED, 1998, MOVEMENT DISORD, V13, P309; Ploner CJ, 2005, NEUROLOGY, V64, P1733, DOI 10.1212/01.WNL.0000161869.83783.05; Poser BA, 2006, MAGN RESON MED, V55, P1227, DOI 10.1002/mrm.20900; Possin KL, 2010, NEUROCASE, V16, P466, DOI 10.1080/13554791003730600; Quartarone A, 2008, J NEUROL NEUROSUR PS, V79, P985, DOI 10.1136/jnnp.2007.121632; Quartarone A, 2005, MOVEMENT DISORD, V20, P1488, DOI 10.1002/mds.20626; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Scontrini A, 2011, MOVEMENT DISORD, V26, P742, DOI 10.1002/mds.23447; Shamim EA, 2011, MOVEMENT DISORD, V26, P2107, DOI 10.1002/mds.23827; Siggelkow S, 2002, J CLIN NEUROPHYSIOL, V19, P232, DOI 10.1097/00004691-200206000-00006; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SB, 2009, BEHAV BRAIN RES, V196, P180, DOI 10.1016/j.bbr.2008.09.034; Stamelou M, 2012, BRAIN, V135, P1668, DOI 10.1093/brain/awr224; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Thickbroom GW, 2003, MOVEMENT DISORD, V18, P395, DOI 10.1002/mds.10383; Thomson RHS, 2008, CLIN NEUROPHYSIOL, V119, P52, DOI 10.1016/j.clinph.2007.09.060; Trompetto C, 2006, MOVEMENT DISORD, V21, P777, DOI 10.1002/mds.20801; VANDERKAMP W, 1995, MOVEMENT DISORD, V10, P630, DOI 10.1002/mds.870100516; Walsh RA, 2009, J NEUROL, V256, P1307, DOI 10.1007/s00415-009-5119-1; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558	72	80	81	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62877	10.1371/journal.pone.0062877	http://dx.doi.org/10.1371/journal.pone.0062877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650536	Green Published, gold			2022-12-25	WOS:000319167000081
J	Needham, SR; Hirsch, M; Rolfe, DJ; Clarke, DT; Zanetti-Domingues, LC; Wareham, R; Martin-Fernandez, ML				Needham, Sarah R.; Hirsch, Michael; Rolfe, Daniel J.; Clarke, David T.; Zanetti-Domingues, Laura C.; Wareham, Richard; Martin-Fernandez, Marisa L.			Measuring EGFR Separations on Cells with similar to 10 nm Resolution via Fluorophore Localization Imaging with Photobleaching	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; MOLECULE FLUORESCENCE MICROSCOPY; RECEPTOR TYROSINE KINASES; PLASMA-MEMBRANE; A431 CELLS; DOMAIN ORGANIZATION; CRYSTAL-STRUCTURE; ACTIVATION; DIMERIZATION; BINDING	Detecting receptor dimerisation and other forms of clustering on the cell surface depends on methods capable of determining protein-protein separations with high resolution in the similar to 10-50 nm range. However, this distance range poses a significant challenge because it is too large for fluorescence resonance energy transfer and contains distances too small for all other techniques capable of high-resolution in cells. Here we have adapted the technique of fluorophore localisation imaging with photobleaching to measure inter-receptor separations in the cellular environment. Using the epidermal growth factor receptor, a key cancer target molecule, we demonstrate,10 nm resolution while continuously covering the range of similar to 10-80 nm. By labelling the receptor on cells expressing low receptor numbers with a fluorescent antagonist we have found inter-receptor separations all the way up from 8 nm to 59 nm. Our data are consistent with epidermal growth factor receptors being able to form homo-polymers of at least 10 receptors in the absence of activating ligands.	[Needham, Sarah R.; Hirsch, Michael; Rolfe, Daniel J.; Clarke, David T.; Zanetti-Domingues, Laura C.; Martin-Fernandez, Marisa L.] Harwell Oxford, STFC Rutherford Appleton Lab, Cent Laser Facil, Res Complex Harwell, Didcot, Oxon, England; [Wareham, Richard] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Cambridge	Martin-Fernandez, ML (corresponding author), Harwell Oxford, STFC Rutherford Appleton Lab, Cent Laser Facil, Res Complex Harwell, Didcot, Oxon, England.	marisa.martin-fernandez@stfc.ac.uk	Zanetti-Domingues, Laura Carolina/GWB-9443-2022; Zanetti-Domingues, Laura Carolina/AAJ-1387-2021	Zanetti-Domingues, Laura Carolina/0000-0003-0514-3185; Zanetti-Domingues, Laura Carolina/0000-0003-0514-3185; Needham, Sarah/0000-0002-3311-1036; Hirsch, Michael/0000-0001-6183-6256; Clarke, David/0000-0002-8776-1341; Rolfe, Daniel/0000-0002-8394-8395; martin-fernandez, marisa/0000-0001-5496-6300	Biotechnology and Biological Sciences Research Council [BB/G006911/1]; BBSRC [BB/G007160/1, BB/G006911/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G007160/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council BB/G006911/1. http://www.bbsrc.ac.uk/home/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulrob A, 2010, J BIOL CHEM, V285, P3145, DOI 10.1074/jbc.M109.073338; Ariotti N, 2010, MOL CELL BIOL, V30, P3795, DOI 10.1128/MCB.01615-09; AXELROD D, 1981, J CELL BIOL, V89, P141, DOI 10.1083/jcb.89.1.141; Barrera NP, 2011, ANNU REV BIOCHEM, V80, P247, DOI 10.1146/annurev-biochem-062309-093307; BEERLI RR, 1995, MOL CELL BIOL, V15, P6496; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Churchman LS, 2006, BIOPHYS J, V90, P668, DOI 10.1529/biophysj.105.065599; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Clayton AHA, 2007, BIOCHEMISTRY-US, V46, P4589, DOI 10.1021/bi700002b; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; DURIG U, 1986, J APPL PHYS, V59, P3318, DOI 10.1063/1.336848; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; HENEGOUWEN PMP, 1992, EXP CELL RES, V199, P90; Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415, DOI 10.1016/S0006-3495(02)75585-9; MCCUNE BK, 1989, J BIOL CHEM, V264, P15501; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; NELSON TJ, 1991, J CHROMATOGR, V587, P129, DOI 10.1016/0021-9673(91)85149-A; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Press W. H., 1996, NUMERICAL RECIPES C; Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101; REES AR, 1984, EMBO J, V3, P1843, DOI 10.1002/j.1460-2075.1984.tb02057.x; Rolfe DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P1167, DOI 10.1007/s00249-011-0747-7; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Schierle GSK, 2011, J AM CHEM SOC, V133, P12902, DOI 10.1021/ja201651w; SONG WX, 1993, BIOCHEMISTRY-US, V32, P8602, DOI 10.1021/bi00084a030; Sorkin A, 2001, BIOCHEM SOC T, V29, P480, DOI 10.1042/BST0290480; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; VANBELZEN N, 1988, J CELL PHYSIOL, V134, P413, DOI 10.1002/jcp.1041340312; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yu CX, 2009, BIOCHEM BIOPH RES CO, V378, P376, DOI 10.1016/j.bbrc.2008.11.018; Zanetti-Domingues LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045655; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	49	29	30	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62331	10.1371/journal.pone.0062331	http://dx.doi.org/10.1371/journal.pone.0062331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650512	gold, Green Published, Green Submitted			2022-12-25	WOS:000319167000042
J	Sauer, J; Oldeland, J; Hausdorf, B				Sauer, Jan; Oldeland, Jens; Hausdorf, Bernhard			Continuing Fragmentation of a Widespread Species by Geographical Barriers as Initial Step in a Land Snail Radiation on Crete	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; GENE FLOW; PHYLOGEOGRAPHIC BREAKS; EVOLUTIONARY HISTORY; Y-CHROMOSOME; SHELL SHAPE; PATTERNS; PULMONATA; SELECTION	The phylogeographic structure of the land snail Xerocrassa mesostena on Crete inferred from AFLP markers and mitochondrial cox1 sequences can be explained by three mechanisms: gene flow restriction, population expansion and leptokurtic dispersal. Gene flow restriction by geographic barriers caused subdivision of the gene pool into distinct clusters. Population expansion was probably facilitated by deforestation of Crete in the postglacial. Newly available areas were colonized by leptokurtic dispersal, i.e. slow active expansion resulting in isolation by distance within the clusters and occasional long distance dispersal events that resulted in departures from the isolation by distance model. Less than one percent of the AFLP markers show correlations with environmental variables. Random phylogeographic breaks in the distribution of the mitochondrial haplotype groups indicate that single locus markers, especially mitochondrial DNA, might result in a misleading picture of the phylogeographic structure of a species. Restriction of gene flow between metapopulations caused by geographical barriers can interact with sexual selection resulting in the differentiation of these metapopulations into separate species without noticeable ecological differentiation. Evidence for gene flow between parapatrically distributed evolutionary units representing different stages of the speciation process suggests that the ongoing process of fragmentation of the X. mesostena complex might be an example for parapatric speciation. The lack of ecological differentiation between these units confirms theoretical predictions that divergent selection for local adaptation is not required for rapid speciation.	[Sauer, Jan] Univ Bielefeld, Dept Chem Ecol, D-33615 Bielefeld, Germany; [Sauer, Jan; Hausdorf, Bernhard] Univ Hamburg, Zool Museum, Hamburg, Germany; [Oldeland, Jens] Univ Hamburg, Biozentrum Klein Flottbek, Hamburg, Germany	University of Bielefeld; University of Hamburg; University of Hamburg	Hausdorf, B (corresponding author), Univ Hamburg, Zool Museum, Hamburg, Germany.	hausdorf@zoologie.uni-hamburg.de	Hausdorf, Bernhard/E-9829-2016	Hausdorf, Bernhard/0000-0002-1604-1689; Oldeland, Jens/0000-0002-7833-4903	Deutsche Forschungsgemeinschaft [HA 2763/3-1,2]; Open Access Publication Funds of Bielefeld University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University	This study was partially funded by the priority program "Radiations - Origins of Biological Diversity'' of the Deutsche Forschungsgemeinschaft (HA 2763/3-1,2). In addition we acknowledge the support for the publication fee by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2004, DISTML V 5 FORTRAN C; ARTER HE, 1990, EVOLUTION, V44, P966, DOI 10.1111/j.1558-5646.1990.tb03818.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Balloux F, 2010, HEREDITY, V104, P419, DOI 10.1038/hdy.2009.122; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Bensch S, 2006, MOL ECOL, V15, P161, DOI 10.1111/j.1365-294X.2005.02766.x; Boissinot S, 1997, GENETICS, V146, P1019; BOTTEMA S, 1980, REV PALAEOBOT PALYNO, V31, P193, DOI 10.1016/0034-6667(80)90027-5; Braaker S, 2009, MOL ECOL, V18, P2518, DOI 10.1111/j.1365-294X.2009.04189.x; Buntjer J, 2001, PHYLTOOLS VERSION 1; Cimmery V, 2010, USER GUIDE SAGA VERS; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coyne JA, 2004, SPECIATION; CRONIN MA, 1993, WILDLIFE SOC B, V21, P339; Davison A, 2000, P ROY SOC B-BIOL SCI, V267, P1399, DOI 10.1098/rspb.2000.1156; Davison A, 2002, POPUL ECOL, V44, P129, DOI 10.1007/s101440200016; Dorge N., 1999, Zeitschrift fur Okologie und Naturschutz, V8, P1; Douris V, 1998, EVOLUTION, V52, P116, DOI 10.1111/j.1558-5646.1998.tb05144.x; ESRI, 2008, ARCGIS REL 9 3; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fraley C, 1999, J CLASSIF, V16, P297, DOI 10.1007/s003579900058; Frenzel B, 1992, ATLAS PALEOCLIMATES; Fu YX, 1997, GENETICS, V147, P915; Gavrilets S, 2000, EVOLUTION, V54, P1126; Gittenberger E., 2004, Basteria, V68, P93; Godinho R, 2008, MOL ECOL, V17, P4670, DOI 10.1111/j.1365-294X.2008.03929.x; Gompert Z, 2008, MOL ECOL, V17, P5231, DOI 10.1111/j.1365-294X.2008.03988.x; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; Goodacre SL, 2006, BIOL J LINN SOC, V87, P167, DOI 10.1111/j.1095-8312.2006.00565.x; Goodacre SL, 2001, P ROY SOC B-BIOL SCI, V268, P121, DOI 10.1098/rspb.2000.1339; Greve C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034339; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Hausdorf B, 2011, MOL PHYLOGENET EVOL, V60, P89, DOI 10.1016/j.ympev.2011.03.009; Hausdorf B, 2009, ZOOL J LINN SOC-LOND, V157, P373, DOI 10.1111/j.1096-3642.2008.00504.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hennig C, 2008, PRABCLUS PACKAGE VER; Hoekstra P, 2011, J ZOOL SYST EVOL RES, V49, P266, DOI 10.1111/j.1439-0469.2011.00623.x; Hoelzer G, 2001, SELF ORG POPULATION, P71; Hoelzer GA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000126; Hoso M, 2008, AM NAT, V172, P726, DOI 10.1086/591681; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Irwin DE, 2009, BIOL J LINN SOC, V98, P422, DOI 10.1111/j.1095-8312.2009.01282.x; Irwin DE, 2005, SCIENCE, V307, P414, DOI 10.1126/science.1105201; Irwin DE, 2002, EVOLUTION, V56, P2383; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jobb G, 2007, TREEFINDER VERSION N; Johannesson K, 2001, TRENDS ECOL EVOL, V16, P148, DOI 10.1016/S0169-5347(00)02078-4; Johannesson K, 2010, PHILOS T R SOC B, V365, P1735, DOI 10.1098/rstb.2009.0256; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kuo CH, 2005, GENETICA, V124, P179, DOI 10.1007/s10709-005-2095-y; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Maassen W. J. M., 1995, Basteria, V59, P31; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Nordsieck Hartmut, 2004, Basteria, V68, P51; Parmakelis A, 2005, EVOLUTION, V59, P991; Pidancier N, 2006, MOL PHYLOGENET EVOL, V40, P739, DOI 10.1016/j.ympev.2006.04.002; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; QUADE J, 1994, PALAEOGEOGR PALAEOCL, V108, P41, DOI 10.1016/0031-0182(94)90021-3; R Core Team, 2021, R LANG ENV STAT COMP; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Sauer J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-299; Sauer J, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P437, DOI 10.1007/978-3-642-12425-9_20; Sauer J, 2009, EVOLUTION, V63, P2535, DOI 10.1111/j.1558-5646.2009.00751.x; Scheel BM, 2012, MOL ECOL, V21, P3794, DOI 10.1111/j.1365-294X.2012.05649.x; SCHILTHUIZEN M, 1994, EVOLUTION, V48, P577, DOI 10.1111/j.1558-5646.1994.tb01345.x; Schilthuizen M, 2005, J ZOOL SYST EVOL RES, V43, P133, DOI 10.1111/j.1439-0469.2004.00289.x; Schilthuizen M, 2004, BIOL J LINN SOC, V83, P317, DOI 10.1111/j.1095-8312.2004.00391.x; Schilthuizen M, 2012, BIOL J LINN SOC LOND, V105; Schilthuizen M, 2006, EVOLUTION, V60, P1851, DOI 10.1554/06-114.1; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Smith MA, 2004, MOL ECOL, V13, P3723, DOI 10.1111/j.1365-294X.2004.02301.x; Sokolov EP, 2000, J MOLLUS STUD, V66, P573, DOI 10.1093/mollus/66.4.573; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wakeley J, 2000, EVOLUTION, V54, P1092, DOI 10.1111/j.0014-3820.2000.tb00545.x; Watanabe Y, 2001, MOL ECOL, V10, P2635, DOI 10.1046/j.0962-1083.2001.01388.x; Welter-Schultes FW, 2010, ARCH MOLLUSKENKD, V139, P143, DOI 10.1127/arch.moll/1869-0963/139/143-245; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x; Wright S, 1943, GENETICS, V28, P114; Yang DS, 2009, MOL ECOL, V18, P5115, DOI 10.1111/j.1365-294X.2009.04399.x	93	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62569	10.1371/journal.pone.0062569	http://dx.doi.org/10.1371/journal.pone.0062569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658748	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000057
J	Xu, Y; Xu, QH; Yang, L; Liu, F; Ye, X; Wu, F; Ni, SJ; Tan, C; Cai, GX; Meng, X; Cai, SJ; Du, X				Xu, Ye; Xu, Qinghua; Yang, Li; Liu, Fang; Ye, Xun; Wu, Fei; Ni, Shujuan; Tan, Cong; Cai, Guoxiang; Meng, Xia; Cai, Sanjun; Du, Xiang			Gene Expression Analysis of Peripheral Blood Cells Reveals Toll-Like Receptor Pathway Deregulation in Colorectal Cancer	PLOS ONE			English	Article							PROBE LEVEL; IMMUNITY; BIOCONDUCTOR; INFLAMMATION; FRAMEWORK; GENOMICS; RISK	Colorectal cancer is the leading cause of cancer-related deaths worldwide. The disease is curable when detected at an early stage. However, the compliance rate with current screening recommendations remains poor. An accurate, minimally invasive blood test that has the potential for greater patient compliance would be a welcome addition to the current methods. Recent data have shown that gene expression profile of peripheral blood cells can reflect disease states and thus have diagnostic value. In this study, genome-wide gene expression profiling of peripheral blood cells from 20 healthy controls and 20 colorectal cancer patients were performed using PAXgene (TM) technology and Affymetrix GeneChip (R) microarrays. We identified a list of 1,469 genes that were differentially expressed between the healthy controls and cancer patients. Gene annotation and functional enrichment analysis revealed that those genes are mainly related to immune functions. Particularly, a set of genes belonging to the Toll-Like Receptor pathways were up-regulated in the colorectal cancer patients. These findings provide a new understanding of blood gene expression profile in colorectal cancer. Our result may serve as the basis for further development of blood biomarkers for the diagnosis and treatment of colorectal cancer.	[Xu, Ye; Xu, Qinghua; Yang, Li; Ni, Shujuan; Tan, Cong; Cai, Guoxiang; Cai, Sanjun; Du, Xiang] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Xu, Ye; Yang, Li; Cai, Guoxiang; Cai, Sanjun] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai 200433, Peoples R China; [Ni, Shujuan; Tan, Cong; Du, Xiang] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Xu, Qinghua; Liu, Fang; Ye, Xun; Wu, Fei; Meng, Xia] Fudan Univ, Shanghai Canc Ctr, Inst Merieux Lab, Shanghai, Peoples R China; [Xu, Qinghua; Liu, Fang; Ye, Xun; Wu, Fei; Meng, Xia] BioMerieux Shanghai Co Ltd, Shanghai, Peoples R China; [Ni, Shujuan; Tan, Cong; Du, Xiang] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Ni, Shujuan; Tan, Cong; Du, Xiang] Fudan Univ, Inst Pathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Yang, L (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China.	10211230016@fudan.edu.cn; caisanjun@csco.org.cn; dx2008cn@163.com	XU, Qinghua/AAZ-9641-2021	XU, Qinghua/0000-0002-9380-5566	Chinese National Clinical Key Discipline; Shanghai Science and Technology Commission of Shanghai Municipality [10DJ1400500]; bioMerieux company	Chinese National Clinical Key Discipline; Shanghai Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); bioMerieux company	This work was supported by bioMerieux company. This study was also supported by grants from the Chinese National Clinical Key Discipline (2011-2012) and the Shanghai Science and Technology Commission of Shanghai Municipality (number 10DJ1400500). As QX, FW, FL, XY, BM and XM are the employees of bioMerieux company and have contributed to this work, hence, as one of the funders, bioMerieux company played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aaroe J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2472; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Basith S, 2012, ARCH PHARM RES, V35, P1297, DOI 10.1007/s12272-012-0802-7; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Blake JA, 2008, CURR PROTOC BIOINFOR, P2; Burczynski ME, 2006, PHARMACOGENOMICS, V7, P187, DOI 10.2217/14622416.7.2.187; Cammarota R, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-112; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Han M, 2008, CLIN CANCER RES, V14, P455, DOI 10.1158/1078-0432.CCR-07-1801; Hanash SM, 2011, NAT REV CLIN ONCOL, V8, P142, DOI 10.1038/nrclinonc.2010.220; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Marshall KW, 2010, INT J CANCER, V126, P1177, DOI 10.1002/ijc.24910; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Qin LX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-23; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Rotunno M, 2011, CANCER PREV RES, V4, P1599, DOI 10.1158/1940-6207.CAPR-10-0170; Sato Y, 2009, CANCER MICROENVIRON, V2, pS205, DOI 10.1007/s12307-009-0022-y; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Stamova BS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-49; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tsai CA, 2003, BIOMETRICS, V59, P1071, DOI 10.1111/j.0006-341X.2003.00123.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1288, DOI 10.1001/jama.289.10.1288; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Xu Y, 2011, CANCER BIOL THER, V11, P188, DOI 10.4161/cbt.11.2.13670; Yang BL, 2010, CANCER BIOL THER, V10, P1235, DOI 10.4161/cbt.10.12.13437; Zander T, 2011, CLIN CANCER RES, V17, P3360, DOI 10.1158/1078-0432.CCR-10-0533; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	47	7	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62870	10.1371/journal.pone.0062870	http://dx.doi.org/10.1371/journal.pone.0062870			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650534	Green Submitted, Green Published, gold			2022-12-25	WOS:000319167000079
J	Zhou, S; Raj, SM; Ashok, S; Edwardraja, S; Lee, SG; Park, S				Zhou, Shengfang; Raj, Subramanian Mohan; Ashok, Somasundar; Edwardraja, Selvakumar; Lee, Sun-gu; Park, Sunghoon			Cloning, Expression and Characterization of 3-Hydroxyisobutyrate Dehydrogenase from Pseudomonas denitrificans ATCC 13867	PLOS ONE			English	Article							ESCHERICHIA-COLI; 3-HYDROXYPROPIONIC ACID; PURIFICATION; SEQUENCE; GENE	The gene encoding an NAD+-dependent, 3-hydroxyisobutyrate dehydrogenase (3HIBDH-IV) from Pseudomonas denitrificans ATCC 13867 was cloned and expressed in Escherichia coli BL 21 (DE3) and characterized to understand its physiological relevance in the degradation of 3-hydroxypropionic acid (3-HP). The deduced amino acid sequence showed high similarity to other 3-hydroxyisobutyrate dehydrogenase isozymes (3HIBDHs) of P. denitrificans ATCC 13867. A comparison of 3HIBDH-IV with its relevant enzymes along with molecular docking studies suggested that Lys171, Asn175 and Gly123 are important for its catalytic function on 3-hydroxyacids. The recombinant 3HIBDH-IV was purified to homogeneity utilizing a Ni-NTA-HP resin column in high yield. 3HIBDH-IV was very specific to (S)-3-hydroxyisobutyrate, but also catalyzed the oxidation of 3-HP to malonate semialdehyde. The specific activity and half-saturation constant (K-m) for 3-HP at 30 degrees C and pH 9.0 were determined to be 17 U/mg protein and 1.0 mM, respectively. Heavy metals, such as Ag+ and Hg2+, completely inhibited the 3HIBDH-IV activity, whereas dithiothreitol, 2-mercaptoethanol and ethylenediaminetetraacetic acid increased its activity 1.5-1.8-fold. This paper reports the characteristics of 3HIBDH-IV as well as its probable role in 3-HP degradation.	[Zhou, Shengfang; Raj, Subramanian Mohan; Ashok, Somasundar; Edwardraja, Selvakumar; Lee, Sun-gu; Park, Sunghoon] Pusan Natl Univ, Dept Chem & Biomol Engn, Pusan, South Korea; [Raj, Subramanian Mohan] PRIST Univ, Ctr Res & Dev, Thanjavur, India; [Edwardraja, Selvakumar] Tech Univ Munich, Lehrstuhl Biol Chem, Freising Weihenstephan, Germany	Pusan National University; PRIST (Deemed to be University); Technical University of Munich	Park, S (corresponding author), Pusan Natl Univ, Dept Chem & Biomol Engn, Pusan, South Korea.	parksh@pusan.ac.kr	Edwardraja, Selvakumar/E-3948-2010; Edwardraja, Selvakumar/X-6434-2019	Edwardraja, Selvakumar/0000-0002-4723-5152; Edwardraja, Selvakumar/0000-0002-4723-5152	Pusan National University; Brain Korea 21 program (Pusan National University)	Pusan National University(Pusan National University); Brain Korea 21 program (Pusan National University)	This work was supported by a 2-Year Research Grant of Pusan National University. The authors are grateful to the Brain Korea 21 program (Pusan National University) for their financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber BE, 2008, J BACTERIOL, V190, P1383, DOI 10.1128/JB.01593-07; BLANCHE F, 1992, J BACTERIOL, V174, P1050, DOI 10.1128/jb.174.3.1050-1052.1992; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chowdhury EK, 2003, BIOSCI BIOTECH BIOCH, V67, P438, DOI 10.1271/bbb.67.438; Chowdhury EK, 1996, BIOSCI BIOTECH BIOCH, V60, P2043, DOI 10.1271/bbb.60.2043; Hawes JW, 1996, FEBS LETT, V389, P263, DOI 10.1016/0014-5793(96)00597-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leal NA, 2003, ARCH MICROBIOL, V180, P353, DOI 10.1007/s00203-003-0601-0; Njau RK, 2001, CHEM-BIOL INTERACT, V130, P785, DOI 10.1016/S0009-2797(00)00234-9; Njau RK, 2000, J BIOL CHEM, V275, P38780, DOI 10.1074/jbc.M007432200; NURMIKKO V, 1972, SUOM KEMISTIL, V45, P193; PACKDIBAMRUNG K, 1993, J BIOCHEM, V114, P930, DOI 10.1093/oxfordjournals.jbchem.a124279; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Raj SM, 2008, PROCESS BIOCHEM, V43, P1440, DOI 10.1016/j.procbio.2008.04.027; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rathnasingh C, 2009, BIOTECHNOL BIOENG, V104, P729, DOI 10.1002/bit.22429; ROUGRAFF PM, 1988, J BIOL CHEM, V263, P327; Sambrook J, 2001, MOL CLONING LAB MANU; STRAUSS G, 1993, EUR J BIOCHEM, V215, P633, DOI 10.1111/j.1432-1033.1993.tb18074.x; Tchigvintsev A, 2012, J BIOL CHEM, V287, P1874, DOI 10.1074/jbc.M111.294561; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yao TR, 2010, APPL BIOCHEM BIOTECH, V160, P694, DOI 10.1007/s12010-009-8685-x; Yim SH, 2010, HUM MOL GENET, V19, P1001, DOI 10.1093/hmg/ddp564	24	12	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62666	10.1371/journal.pone.0062666	http://dx.doi.org/10.1371/journal.pone.0062666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658760	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000069
J	Nashine, S; Bhootada, Y; Lewin, AS; Gorbatyuk, M				Nashine, Sonali; Bhootada, Yogesh; Lewin, Alfred S.; Gorbatyuk, Marina			Ablation of C/EBP Homologous Protein Does Not Protect T17M RHO Mice from Retinal Degeneration	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; RHODOPSIN; APOPTOSIS; NRL	Despite the proposed link between ablation of the CHOP protein and delay of the onset of ER stress-mediated disorders including diabetes, Alzheimer Disease, and cardiac hypertrophy, the role of CHOP protein in photoreceptor cell death associated with Autosomal Dominant Retinitis Pigmentosa (ADRP) has not been investigated. T17M RHO transgenic mice carry a mutated human rhodopsin transgene, the expression of which in retina leads to protein misfolding, activation of UPR and progressive retinal degeneration. The purpose of this study is to investigate the role of CHOP protein in T17M RHO retina. Wild-type, CHOP-/-, T17M RHO and T17M RHO CHOP-/-mice were used in the study. Evaluation of the impact of CHOP ablation was performed using electroretinography (ERG), spectral-domain optical coherence tomography (SD-OCT), quantitative Real-Time PCR (qRT-PCR) and western blot analysis. Dark-adapted ERG analysis demonstrated that by 1 month, the T17M RHO CHOP-/- mice had a 70% reduction of the a-wave amplitude compared to the T17M RHO mice. The loss of function in T17M RHO CHOP-/- photoreceptors was associated with a 22-24% decline in the thickness of the outer nuclear layer. These mice had significant reduction in the expression of transcription factors, Crx and Nrl, and also in mouse Rho, and human RHO. The reduction was associated with an 8-fold elevation of the UPR marker, p-eIf-alpha protein and 30% down-regulation of sXbp1 protein. In addition, the histone deacetylase 1 (Hdac1) protein was 2-fold elevated in the T17M RHO CHOP-/- retina. The ablation of CHOP led to a reduction in the expression of photoreceptor-specific transcriptional factors, and both endogenous and exogenous RHO mRNA. Thus, despite its role in promoting apoptosis, CHOP protects rod photoreceptors carrying an ADRP mutation.	[Nashine, Sonali] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX USA; [Bhootada, Yogesh; Gorbatyuk, Marina] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35294 USA; [Lewin, Alfred S.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	University of North Texas System; University of North Texas Health Science Center; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Florida	Gorbatyuk, M (corresponding author), Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35294 USA.	mgortk@uab.edu	NASHINE, SONALI/AAG-1474-2020; Bhootada, Yogesh/AAD-3539-2020	Bhootada, Yogesh/0000-0002-4656-7868; Gorbatyuk, Marina/0000-0001-9060-856X; Lewin, Alfred/0000-0002-4192-9727	National Institutes of Health (NIH) [R01EY020905]; Foundation Fighting Blindness [TA-GT-0409-0508-NTERI]; Hope for Vision and DOD [W81XH-10-2-0003]; Shaler Richardson Professorship endowment; NATIONAL EYE INSTITUTE [R01EY020905, P30EY021721] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Hope for Vision and DOD; Shaler Richardson Professorship endowment; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (NIH) (R01EY020905), the Foundation Fighting Blindness (TA-GT-0409-0508-NTERI), Hope for Vision and DOD W81XH-10-2-0003, and the Shaler Richardson Professorship endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAGNAT F, 2012, CELL DEATH DIFFER; Behrman S, 2011, J CELL BIOL, V192, P919, DOI 10.1083/jcb.201010055; Chen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040801; Chiang WC, 2012, MOL BIOL CELL, V23, P758, DOI 10.1091/mbc.E11-08-0663; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; KUNTE MM, 2012, INVEST OPHTHALMOL VI; Lee ES, 2007, INVEST OPHTH VIS SCI, V48, P2868, DOI 10.1167/iovs.06-0035; Mao HY, 2011, HUM GENE THER, V22, P567, DOI 10.1089/hum.2010.140; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Ohoka N, 2007, J BIOL CHEM, V282, P35687, DOI 10.1074/jbc.M703735200; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Peng GH, 2007, HUM MOL GENET, V16, P2433, DOI 10.1093/hmg/ddm200; Prasanthi RPJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026420; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Schuettengruber B, 2003, MOL CELL BIOL, V23, P6993, DOI 10.1128/MCB.23.19.6993-7004.2003; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Wang FM, 2011, EXP HEMATOL, V39, P999, DOI 10.1016/j.exphem.2011.06.007; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131	28	33	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63205	10.1371/journal.pone.0063205	http://dx.doi.org/10.1371/journal.pone.0063205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646198	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300155
J	Silva, JL; Souza, MC; Ferreira-DaSilva, CT; Silva, LS; Costa, MFS; Padua, TA; Henriques, MD; Morrot, A; Savino, W; Caruso-Neves, C; Pinheiro, AAS				Silva-Filho, Joao Luiz; Souza, Mariana Conceicao; Ferreira-DaSilva, Claudio Teixeira; Silva, Leandro Souza; Souza Costa, Maria Fernanda; Padua, Tatiana Almeida; Henriques, Maria das Gracas; Morrot, Alexandre; Savino, Wilson; Caruso-Neves, Celso; Sa Pinheiro, Ana Acacia			Angiotensin II Is a New Component Involved in Splenic T Lymphocyte Responses during Plasmodium berghei ANKA Infection	PLOS ONE			English	Article							EXPERIMENTAL CEREBRAL MALARIA; TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; CONVERTING-ENZYME; ADHESION MOLECULES; LYMPHOTOXIN-ALPHA; INTERFERON-GAMMA; CELL RESPONSES; UP-REGULATION; RABBIT MODEL	The contribution of T cells in severe malaria pathogenesis has been described. Here, we provide evidence for the potential role of angiotensin II (Ang II) in modulating splenic T cell responses in a rodent model of cerebral malaria. T cell activation induced by infection, determined by 3 to 4-fold enhancement in CD69 expression, was reduced to control levels when mice were treated with 20 mg/kg losartan (IC50 = 0.966 mg/kg/d), an AT(1) receptor antagonist, or captopril (IC50 = 1.940 mg/kg/d), an inhibitor of angiotensin-converting enzyme (ACE). Moreover, the production of interferon-gamma and interleukin-17 by CD4(+) T cells diminished 67% and 70%, respectively, by both treatments. Losartan reduced perforin expression in CD8(+) T cells by 33% while captopril completely blocked it. The upregulation in chemokine receptor expression (CCR2 and CCR5) observed during infection was abolished and CD11a expression was partially reduced when mice were treated with drugs. T cells activated by Plasmodium berghei ANKA antigens showed 6-fold enhance in AT(1) levels in comparison with naive cells. The upregulation of AT(1) expression was reduced by losartan (80%) but not by captopril. Our results suggest that the AT(1)/Ang II axis has a role in the establishment of an efficient T cell response in the spleen and therefore could participate in a misbalanced parasite-induced T cell immune response during P. berghei ANKA infection.	[Silva-Filho, Joao Luiz; Ferreira-DaSilva, Claudio Teixeira; Silva, Leandro Souza; Caruso-Neves, Celso; Sa Pinheiro, Ana Acacia] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, RJ, Brazil; [Souza, Mariana Conceicao; Souza Costa, Maria Fernanda; Padua, Tatiana Almeida; Henriques, Maria das Gracas] Fundacao Oswaldo Cruz, Inst Tecnol Farmacos, Rio De Janeiro, RJ, Brazil; [Morrot, Alexandre] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, RJ, Brazil; [Savino, Wilson] Fundacao Oswaldo Cruz, Dept Imunol, Rio De Janeiro, RJ, Brazil; [Caruso-Neves, Celso] Conselho Nacl Desenvolvimento Cient & Tecnol MCT, Inst Nacl Ciencia & Tecnol Biol & Bioimagem, Rio De Janeiro, RJ, Brazil; [Sa Pinheiro, Ana Acacia] Conselho Nacl Desenvolvimento Cient & Tecnol MCT, Inst Nacl Pesquisa Translac Saude & Ambiente Regi, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Pinheiro, AAS (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, RJ, Brazil.	acacia@biof.ufrj.br	Caruso-Neves, Celso/C-4014-2013; Souza, Mariana/GQQ-6648-2022; Silva-Filho, João Luiz/I-5704-2016; Henriques, Maria das Graças M O/G-2998-2013; Sila, Leandro/B-1381-2018; Costa, Maria Fernanda Furtado de Lima e/ABE-3779-2021; Souza, Mariana/C-1677-2015	Caruso-Neves, Celso/0000-0002-2415-7753; Silva-Filho, João Luiz/0000-0003-4762-2205; Henriques, Maria das Graças M O/0000-0003-3065-0541; Sila, Leandro/0000-0001-8720-0088; Costa, Maria Fernanda Furtado de Lima e/0000-0002-3474-2980; de souza costa, Maria Fernanda/0000-0003-2300-5384; Pinheiro, Ana Acacia/0000-0002-3894-1645; Souza, Mariana/0000-0002-6933-9227	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [INCT-INPeTAm/CNPq/MCT, INCT-INBEB/CNPq/MCT]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [Pronex/FAPERJ E-26/110.562/2010, Pronex/FAPERJ E-26/110.551/2010, APQ1/FAPERJ E-26/110.792/2009, JCNE/FAPERJ E-26/101.450/2010, PRONEM/FAPERJ/CNPq E-26/111.182/2011]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the Brazilian agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INPeTAm/CNPq/MCT, INCT-INBEB/CNPq/MCT) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ (Pronex/FAPERJ E-26/110.562/2010, Pronex/FAPERJ E-26/110.551/2010, APQ1/FAPERJ E-26/110.792/2009, JCNE/FAPERJ E-26/101.450/2010, PRONEM/FAPERJ/CNPq E-26/111.182/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Abu Nabah YN, 2004, CIRCULATION, V110, P3581, DOI 10.1161/01.CIR.0000148824.93600.F3; Andrade WN, 1998, BLOOD, V91, P1653, DOI 10.1182/blood.V91.5.1653.1653_1653_1661; Bannard O, 2009, EUR J IMMUNOL, V39, P2083, DOI 10.1002/eji.200939555; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Belnoue E, 2003, BLOOD, V101, P4253, DOI 10.1182/blood-2002-05-1493; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; Belnoue E, 2003, INFECT IMMUN, V71, P3648, DOI 10.1128/IAI.71.6.3648-3651.2003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bueno LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009623; Cambos M, 2008, INT J PARASITOL, V38, P229, DOI 10.1016/j.ijpara.2007.07.006; Chen XL, 1998, CIRC RES, V83, P952; Claser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018720; COSTEROUSSE O, 1993, BIOCHEM J, V290, P33, DOI 10.1042/bj2900033; Crowley SD, 2008, AM J PHYSIOL-RENAL, V295, pF515, DOI 10.1152/ajprenal.00527.2007; Elias RM, 2005, J IMMUNOL, V174, P790, DOI 10.4049/jimmunol.174.2.790; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; Ferraris FK, 2011, INT IMMUNOPHARMACOL, V11, P1, DOI 10.1016/j.intimp.2010.09.010; GRAU GE, 1986, J IMMUNOL, V137, P2348; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hansen DS, 2003, IMMUNITY, V18, P391, DOI 10.1016/S1074-7613(03)00052-9; Hernandez-Presa MA, 1998, AM J PATHOL, V153, P1825, DOI 10.1016/S0002-9440(10)65697-0; HernandezPresa M, 1997, CIRCULATION, V95, P1532; Hoch NE, 2009, AM J PHYSIOL-REG I, V296, pR208, DOI 10.1152/ajpregu.90521.2008; Ishida H, 2010, BIOCHEM BIOPH RES CO, V402, P790, DOI 10.1016/j.bbrc.2010.10.114; Jurewicz M, 2007, J AM SOC NEPHROL, V18, P1093, DOI 10.1681/ASN.2006070707; Ma NL, 1996, AM J PATHOL, V149, P1745; Martins YC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-85; Nahmod KA, 2003, FASEB J, V17, P491, DOI 10.1096/fj.02-0755fje; Nahmod K, 2010, J PHARMACOL EXP THER, V334, P854, DOI 10.1124/jpet.109.161760; Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ohayon A, 2010, INFECT IMMUN, V78, P4195, DOI 10.1128/IAI.00465-10; Ortego M, 1999, ATHEROSCLEROSIS, V147, P253, DOI 10.1016/S0021-9150(99)00193-8; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Pastore L, 1999, CIRCULATION, V100, P1646, DOI 10.1161/01.CIR.100.15.1646; Piqueras L, 2000, CIRCULATION, V102, P2118, DOI 10.1161/01.CIR.102.17.2118; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; Ruiz-Ortega M, 1998, J IMMUNOL, V161, P430; Ruiz-Ortega M, 2001, CURR OPIN NEPHROL HY, V10, P321, DOI 10.1097/00041552-200105000-00005; Saraiva VB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017174; Sarto BY, 2004, ANN TROP MED PARASIT, V98, P297, DOI 10.1179/000349804225003271; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schofield L, 2007, IMMUNOL CELL BIOL, V85, P130, DOI 10.1038/sj.icb.7100040; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Shao J, 2003, HYPERTENSION, V42, P31, DOI 10.1161/01.HYP.0000075082.06183.4E; Silva JL, 2011, MOL IMMUNOL, V48, P1835, DOI 10.1016/j.molimm.2011.05.008; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6; Suzuki Y, 2000, J NEPHROL, V13, pS101; Tummala PE, 1999, CIRCULATION, V100, P1223, DOI 10.1161/01.CIR.100.11.1223; Vigario AM, 2007, INT J PARASITOL, V37, P963, DOI 10.1016/j.ijpara.2007.01.004; Villegas-Mendez A, 2011, J IMMUNOL, V187, P2885, DOI 10.4049/jimmunol.1100241; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Weiser S, 2007, CYTOKINE, V37, P84, DOI 10.1016/j.cyto.2007.02.021; WILLIAMSON WA, 1978, LANCET, V1, P1328; WRIGHT DH, 1968, BRIT J EXP PATHOL, V49, P379; Yanez DM, 1996, J IMMUNOL, V157, P1620	64	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62999	10.1371/journal.pone.0062999	http://dx.doi.org/10.1371/journal.pone.0062999			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646169	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300124
J	Norbu, N; Wikelski, MC; Wilcove, DS; Partecke, J; Ugyen; Tenzin, U; Sherub; Tempa, T				Norbu, Nawang; Wikelski, Martin C.; Wilcove, David S.; Partecke, Jesko; Ugyen; Tenzin, Ugyen; Sherub; Tempa, Tshering			Partial Altitudinal Migration of a Himalayan Forest Pheasant	PLOS ONE			English	Article							PARTIAL BIRD MIGRATION; GRAND CHALLENGES; POPULATION; HYPOTHESES; MOVEMENTS; EVOLUTION; MIGRANTS; SYSTEMS; MODEL; SEX	Background: Altitudinal migration systems are poorly understood. Recent advances in animal telemetry which enables tracking of migrants across their annual cycles will help illustrate unknown migration patterns and test existing hypotheses. Using telemetry, we show the existence of a complex partial altitudinal migration system in the Himalayas and discuss our findings to help better understand partial and altitudinal migration. Methodology/Principal Findings: We used GPS/accelerometer tags to monitor the migration of Satyr tragopan (Tragopan satyra) in the Bhutan Himalayas. We tagged 38 birds from 2009 - 2011 and found that tragopans are partially migratory. Fall migration lasted from the 3rd week of September till the 3rd week of November with migrants traveling distances ranging from 1.25 km to 13.5 km over 1 to 32 days. Snowfall did not influence the onset of migration. Return migration started by the 1st week of March and lasted until the 1st week of April. Individuals returned within 4 to 10 days and displayed site fidelity. One bird switched from being a migrant to a non-migrant. Tragopans displayed three main migration patterns: 1) crossing multiple mountains; 2) descending/ascending longitudinally; 3) moving higher up in winter and lower down in summer. More females migrated than males; but, within males, body size was not a factor for predicting migrants. Conclusions/Significance: Our observations of migrants traversing over multiple mountain ridges and even of others climbing to higher elevations is novel. We support the need for existing hypotheses to consider how best to explain inter- as well as intra-sexual differences. Most importantly, having shown that the patterns of an altitudinal migration system are complex and not a simple up and down slope movement, we hope our findings will influence the way altitudinal migrations are perceived and thereby contribute to a better understanding of how species may respond to climate change.	[Norbu, Nawang; Ugyen; Tenzin, Ugyen; Sherub; Tempa, Tshering] Ugyen Wangchuck Inst Conservat & Environm, Lamai Gompa, Bumtang, Bhutan; [Norbu, Nawang; Wikelski, Martin C.; Partecke, Jesko] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Norbu, Nawang; Wikelski, Martin C.] Univ Konstanz, Int Max Planck Res Sch Organismal Biol, Constance, Germany; [Wilcove, David S.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; [Tempa, Tshering] Univ Montana, Coll Forestry & Conservat, Missoula, MT 59812 USA	Max Planck Society; Max Planck Society; University of Konstanz; Princeton University; University of Montana System; University of Montana	Norbu, N (corresponding author), Ugyen Wangchuck Inst Conservat & Environm, Lamai Gompa, Bumtang, Bhutan.	norbu.nawang@gmail.com		Wilcove, David S./0000-0002-1354-0503	International Max-Planck Research School for Organismal Biology; Max-Planck Institute for Ornithology	International Max-Planck Research School for Organismal Biology; Max-Planck Institute for Ornithology	The work was supported by the International Max-Planck Research School for Organismal Biology and the Max-Planck Institute for Ornithology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JC, 2009, BEHAV ECOL SOCIOBIOL, V63, P1705, DOI 10.1007/s00265-009-0783-9; [Anonymous], 2020, ECONOMIST 0326; Bell Christopher Paul, 2005, P41; Berthold P, 2001, AUK, V2nd; BirdLife International, 2012, SPEC FACTSH TRAG SAT; Blake JG, 1993, 4 NEOTROPICAL RAIN F, P161; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Boyle WA, 2010, CAN J ZOOL, V88, P204, DOI 10.1139/Z09-133; Boyle WA, 2008, J ANIM ECOL, V77, P1122, DOI 10.1111/j.1365-2656.2008.01451.x; Boyle WA, 2008, OECOLOGIA, V155, P397, DOI 10.1007/s00442-007-0897-6; Boyle WA, 2011, BIOL LETTERS, V7, P661, DOI 10.1098/rsbl.2011.0115; Boyle WA, 2011, EVOL ECOL, V25, P219, DOI 10.1007/s10682-010-9403-4; Boyle WA, 2010, P ROY SOC B-BIOL SCI, V277, P2511, DOI 10.1098/rspb.2010.0344; Brodersen J, 2012, BIOL LETTERS, V8, P21, DOI 10.1098/rsbl.2011.0634; CADE BS, 1993, AUK, V110, P70; Calder W.A. III., 1974, Publications Nuttall Orn Club, VNo. 15, P86; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Chapman BB, 2011, OIKOS, V120, P1761, DOI 10.1111/j.1600-0706.2011.20070.x; Chaves-Campos J, 2003, BIRD CONSERV INT, V13, P45, DOI 10.1017/S0959270903003046; Cristol Daniel A., 1999, Current Ornithology, V15, P33; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; DIXON KEITH L., 1964, CONDOR, V66, P61, DOI 10.2307/1365238; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Gauthreaux S.A. Jr, 1978, Perspectives in Ethology, V3, P17; Grimmett R, 1999, BIRDS INDIA PAKISTAN; Hahn TP, 2004, AUK, V121, P1269, DOI 10.1642/0004-8038(2004)121[1269:FAMBMW]2.0.CO;2; HERZOG PW, 1980, CONDOR, V82, P366, DOI 10.2307/1367557; Hess SC, 2012, WILSON J ORNITHOL, V124, P478, DOI 10.1676/12-005.1; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; *IUCN, 2008, IUCN RED LIST; Jahn AE, 2010, J ANIM ECOL, V79, P983, DOI 10.1111/j.1365-2656.2010.01713.x; Ketterson E.D., 1983, Current Ornithology, V1, P357; KETTERSON ED, 1976, ECOLOGY, V57, P679, DOI 10.2307/1936182; Laymon SA, 2010, SIERRA, V91, P837; LOISELLE BA, 1991, ECOLOGY, V72, P180, DOI 10.2307/1938913; LUNDBERG P, 1987, J THEOR BIOL, V125, P351, DOI 10.1016/S0022-5193(87)80067-X; LUNDBERG P, 1988, TRENDS ECOL EVOL, V3, P172, DOI 10.1016/0169-5347(88)90035-3; LUNDBERG P, 1985, BEHAV ECOL SOCIOBIOL, V17, P185; Mackas RH, 2010, CAN J ZOOL, V88, P369, DOI 10.1139/Z10-013; Morbey YE, 2012, J ORNITHOL, V153, pS207, DOI 10.1007/s10336-012-0854-y; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Powell George V. N., 1994, Bird Conservation International, V4, P161; POWELL GVN, 1995, CONSERV BIOL, V9, P354, DOI 10.1046/j.1523-1739.1995.9020354.x; Pulido F, 2011, OIKOS, V120, P1776, DOI 10.1111/j.1600-0706.2011.19844.x; SCHROEDER MA, 1993, AUK, V110, P21; Schwenk K, 2009, INTEGR COMP BIOL, V49, P7, DOI 10.1093/icb/icp034; Shaw AK, 2011, OIKOS, V120, P1871, DOI 10.1111/j.1600-0706.2011.19443.x; Sibley CG, 1990, DISTRIBUTION TAXONOM; STILES F.G., 1988, TROPICAL RAINFORESTS, P243; Taylor CM, 2007, BIOLOGY LETT, V3, P280, DOI 10.1098/rsbl.2007.0053; Wilcove D.S., 2008, NO WAY HOME DECLINE; Wilcove DS, 2008, ISSUES SCI TECHNOL, V24, P71; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188	54	8	8	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e60979	10.1371/journal.pone.0060979	http://dx.doi.org/10.1371/journal.pone.0060979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658608	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700008
J	Baid, R; Upadhyay, AK; Shinohara, T; Kompella, UB				Baid, Rinku; Upadhyay, Arun K.; Shinohara, Toshimichi; Kompella, Uday B.			Biosynthesis, Characterization, and Efficacy in Retinal Degenerative Diseases of Lens Epithelium-derived Growth Factor Fragment (LEDGF(1-326)), a Novel Therapeutic Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT RETINITIS-PIGMENTOSA; ENDOPLASMIC-RETICULUM STRESS; VITAMIN-A SUPPLEMENTATION; MACULAR DEGENERATION; HIV-1 INTEGRASE; RHODOPSIN GENE; SURVIVAL; LEDGF; RPE; PREVALENCE	For vision-threatening retinitis pigmentosa and dry age-related macular degeneration, there are no United States Food and Drug Administration (FDA)-approved treatments. We identified, biosynthesized, purified, and characterized lens epithelium-derived growth factor fragment (LEDGF(1-326)) as a novel protein therapeutic. LEDGF(1-326) was produced at about 20 mg/liter of culture when expressed in the Escherichia coli system, with about 95% purity and aggregate-free homogeneous population with a mean hydrodynamic diameter of 9 +/- 1 nm. The free energy of unfolding of LEDGF(1-326) was 3.3 +/- 0.5 kcal mol(-1), and melting temperature was 44.8 +/- 0.2 degrees C. LEDGF(1-326) increased human retinal pigment epithelial cell viability from 48.3 +/- 5.6 to 119.3 +/- 21.1% in the presence of P23H mutant rhodopsin-mediated aggregation stress. LEDGF(1-326) also increased retinal pigment epithelial cell FluoSphere uptake to 140 +/- 10%. Eight weeks after single intravitreal injection in Royal College of Surgeons (RCS) rats, LEDGF(1-326) increased the b-wave amplitude significantly from 9.4 +/- 4.6 to 57.6 +/- 8.8 mu V for scotopic electroretinogram and from 10.9 +/- 5.6 to 45.8 +/- 15.2 mu V for photopic electroretinogram. LEDGF(1-326) significantly increased the retinal outer nuclear layer thickness from 6.34 +/- 1.6 to 11.7 +/- 0.7 mu m. LEDGF(1-326) is a potential new therapeutic agent for treating retinal degenerative diseases.	[Baid, Rinku; Upadhyay, Arun K.; Kompella, Uday B.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA; [Kompella, Uday B.] Univ Colorado, Dept Ophthalmol, Aurora, CO 80045 USA; [Shinohara, Toshimichi] Univ Nebraska Med Ctr, Dept Ophthalmol, Omaha, NE 68198 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Nebraska System; University of Nebraska Medical Center	Kompella, UB (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus,12850 E Montview Blvd,C238-V2, Aurora, CO 80045 USA.	uday.kompella@ucdenver.edu	Upadhyay, Arun/D-4510-2014	Shinohara, Toshimichi/0000-0002-7197-9039	National Institutes of Health [EY018940, RC1 EY020361, R21EY17360]; NATIONAL EYE INSTITUTE [RC1EY020361, R01EY018940, R21EY017360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY018940, RC1 EY020361, and R21EY17360 (to U. B. K.).	Albanes D, 1996, J NATL CANCER I, V88, P1560, DOI 10.1093/jnci/88.21.1560; Baid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024616; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P1456, DOI 10.1001/archopht.1993.01090110014001; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Cangemi Francis E, 2007, BMC Ophthalmol, V7, P3, DOI 10.1186/1471-2415-7-3; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Delyfer MN, 2004, BIOL CELL, V96, P261, DOI 10.1016/j.biolcel.2004.01.006; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Fatma N, 2000, INVEST OPHTH VIS SCI, V41, P2648; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gokce I, 2005, J AM CHEM SOC, V127, P9700, DOI 10.1021/ja052632x; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Kuehn BM, 2005, JAMA-J AM MED ASSOC, V293, P1841, DOI 10.1001/jama.293.15.1841; LAVAIL MM, 1975, J HERED, V66, P242, DOI 10.1093/oxfordjournals.jhered.a108621; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; Libby RT, 2010, ADV EXP MED BIOL, V664, P403, DOI 10.1007/978-1-4419-1399-9_46; Machida S, 2001, INVEST OPHTH VIS SCI, V42, P1087; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Matsui H, 2001, INVEST OPHTH VIS SCI, V42, P2935; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Nakamura M, 2000, INVEST OPHTH VIS SCI, V41, P1168; Nishikawa S, 1998, EXP EYE RES, V67, P509, DOI 10.1006/exer.1998.0538; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Nowak Jerzy Z, 2007, Postepy Hig Med Dosw (Online), V61, P83; Ohguro Hiroshi, 2002, Nippon Ganka Gakkai Zasshi, V106, P461; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; Scholtz JM, 2009, METHOD ENZYMOL, V466, P549, DOI 10.1016/S0076-6879(09)66023-7; Sibulesky L, 1999, AM J CLIN NUTR, V69, P656; Singh DP, 1999, INVEST OPHTH VIS SCI, V40, P1444; Singh DP, 2006, J MOL BIOL, V355, P379, DOI 10.1016/j.jmb.2005.10.054; Stuen C, 2003, GENERATIONS, V27, P8; Vets S, 2012, MOL THER, V20, P908, DOI 10.1038/mt.2012.6; WYSZYNSKI RE, 1989, INVEST OPHTH VIS SCI, V30, P2341	43	3	4	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17372	17383		10.1074/jbc.M112.441618	http://dx.doi.org/10.1074/jbc.M112.441618			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640891	Green Published, hybrid			2022-12-25	WOS:000320380600030
J	Kuroiwa, Y; Takakusagi, Y; Kusayanagi, T; Kuramochi, K; Imai, T; Hirayama, T; Ito, I; Yoshida, M; Sakaguchi, K; Sugawara, F				Kuroiwa, Yuki; Takakusagi, Yoichi; Kusayanagi, Tomoe; Kuramochi, Kouji; Imai, Takahiko; Hirayama, Tomoko; Ito, Ichiaki; Yoshida, Michiteru; Sakaguchi, Kengo; Sugawara, Fumio			Identification and Characterization of the Direct Interaction between Methotrexate (MTX) and High-Mobility Group Box 1 (HMGB1) Protein	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; AFFINITY PURIFICATION; BIOTIN DERIVATIVES; CYTOKINE ACTIVITY; BINDING PEPTIDE; RECEPTOR; ACTIVATION; AMPHOTERIN; RECOMMENDATIONS; MIGRATION	Background: Methotrexate (MTX) is an agent used in chemotherapy of tumors and autoimmune disease including rheumatoid arthritis (RA). In addition, MTX has some anti-inflammatory activity. Although dihydrofolate reductase (DHFR) is a well-known target for the anti-tumor effect of MTX, the mode of action for the anti-inflammatory activity of MTX is not fully understood. Methodology/Result: Here, we performed a screening of MTX-binding proteins using T7 phage display with a synthetic biotinylated MTX derivative. We then characterized the interactions using surface plasmon resonance (SPR) analysis and electrophoretic mobility shift assay (EMSA). Using a T7 phage display screen, we identified T7 phages that displayed part of high-mobility group box 1 (HMGB1) protein (K86-V175). Binding affinities as well as likely binding sites were characterized using genetically engineered truncated versions of HMGB1 protein (Al G1-K87, Bj: F88-K181), indicating that MTX binds to HMGB1 via two independent sites with a dissociation constants (K-D) of 0.50 +/- 0.03 mu M for Al and 0.24 +/- 0.01 mu M for Bj. Although MTX did not inhibit the binding of HMGB1 to DNA via these domains, HMGB1/RAGE association was impeded in the presence of MTX. These data suggested that binding of MTX to part of the RAGE-binding region (K149-V175) in HMGB1 might be significant for the anti-inflammatory effect of MTX. Indeed, in murine macrophage-like cells (RAW 264.7), TNF-alpha release and mitogenic activity elicited by specific RAGE stimulation with a truncated monomeric HMGB1 were inhibited in the presence of MTX. Conclusions/Significance: These data demonstrate that HMGB1 is a direct binding protein of MTX. Moreover, binding of MTX to RAGE-binding region in HMGB1 inhibited the HMGB1/RAGE interaction at the molecular and cellular levels. These data might explain the molecular basis underlying the mechanism of action for the anti-inflammatory effect of MTX.	[Kuroiwa, Yuki; Takakusagi, Yoichi; Kusayanagi, Tomoe; Kuramochi, Kouji; Imai, Takahiko; Hirayama, Tomoko; Sakaguchi, Kengo; Sugawara, Fumio] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Ito, Ichiaki; Yoshida, Michiteru] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Noda, Chiba 278, Japan; [Takakusagi, Yoichi] Natl Canc Inst, Natl Inst Hlth, Bethesda, MD USA	Tokyo University of Science; Tokyo University of Science; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sugawara, F (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan.	sugawara@rs.noda.tus.ac.jp	Takakusagi, Yoichi/AAA-1998-2021	Takakusagi, Yoichi/0000-0002-6786-0748; Kuramochi, Kouji/0000-0003-0571-9703	The Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Society for the Promotion of Science; Tokyo University of Science	The Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo University of Science	This work was supported by a Grant-in-Aid for Scientific Research (The Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Society for the Promotion of Science), and research grant from Tokyo University of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Fan JG, 1997, METHOD ENZYMOL, V281, P97; FAN JG, 1991, J BIOL CHEM, V266, P14862; Gargaro AR, 1998, J MOL BIOL, V277, P119, DOI 10.1006/jmbi.1997.1560; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Hardman CH, 1995, BIOCHEMISTRY-US, V34, P16596, DOI 10.1021/bi00051a007; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hreggvidsdottir HS, 2012, MOL MED, V18, P224, DOI 10.2119/molmed.2011.00327; Huttunen HJ, 2004, J INTERN MED, V255, P351, DOI 10.1111/j.1365-2796.2003.01301.x; Huttunen HJ, 2002, CANCER RES, V62, P4805; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Majumdar S, 2001, J IMMUNOL, V167, P2911, DOI 10.4049/jimmunol.167.5.2911; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Novagen, 2009, ORIENTEXPRESSTM CDNA; Novagen, 2009, T7 SEL SYST MAN; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Saito K, 1999, J BIOCHEM, V125, P399, DOI 10.1093/oxfordjournals.jbchem.a022300; Schierbeck H, 2010, MOL MED, V16, P343, DOI 10.2119/molmed.2010.00031; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Stott K, 2006, J MOL BIOL, V360, P90, DOI 10.1016/j.jmb.2006.04.059; Swierkot J, 2006, PHARMACOL REP, V58, P473; Takakusagi Y, 2008, BIOORGAN MED CHEM, V16, P7410, DOI 10.1016/j.bmc.2008.06.007; Takakusagi Y, 2011, MEDCHEMCOMM, V2, P1188, DOI 10.1039/c1md00180a; Takakusagi Y, 2010, EXPERT OPIN DRUG DIS, V5, P361, DOI 10.1517/17460441003653155; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Ueda T, 2010, BBA-GENE REGUL MECH, V1799, P114, DOI 10.1016/j.bbagrm.2009.11.005; Uga H, 2006, MOL PHARMACOL, V70, P1832, DOI 10.1124/mol.106.025866; Visser K, 2009, ANN RHEUM DIS, V68, P1086, DOI 10.1136/ard.2008.094474; WALLACE CA, 1989, ARTHRITIS RHEUM, V32, P677, DOI 10.1002/anr.1780320604; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; Yamamoto A, 1997, J BIOCHEM-TOKYO, V122, P586; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Youn JH, 2011, EUR J IMMUNOL, V41, P2753, DOI 10.1002/eji.201141391; ZIERLER K, 1989, TRENDS BIOCHEM SCI, V14, P314, DOI 10.1016/0968-0004(89)90157-6	40	30	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63073	10.1371/journal.pone.0063073	http://dx.doi.org/10.1371/journal.pone.0063073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658798	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100051
J	Sundstrom, LF; Kaspersson, R; Naslund, J; Johnsson, JI				Sundstrom, L. Fredrik; Kaspersson, Rasmus; Naslund, Joacim; Johnsson, Jorgen I.			Density-Dependent Compensatory Growth in Brown Trout (Salmo trutta) in Nature	PLOS ONE			English	Article							WILD SEA-TROUT; COHO SALMON; BODY-SIZE; RATES; TRAJECTORIES; TEMPERATURE; POPULATION; AGGRESSION; MORTALITY; MIGRATION	Density-dependence is a major ecological mechanism that is known to limit individual growth. To examine if compensatory growth (unusually rapid growth following a period of imposed slow growth) in nature is density-dependent, one-year-old brown trout (Salmo trutta L.) were first starved in the laboratory, and then released back into their natural stream, either at natural or at experimentally increased population density. The experimental trout were captured three times over a one-year period. We found no differences in growth, within the first month after release (May-June), between the starved fish and the control group (i.e. no evidence of compensation). During the summer however (July-September), the starved fish grew more than the control group (i.e. compensation), and the starved fish released into the stream at a higher density, grew less than those released at a natural density, both in terms of weight and length (i.e. density-dependent compensation). Over the winter (October-April), there were no effects of either starvation or density on weight and length growth. After the winter, starved fish released at either density had caught up with control fish in body size, but recapture rates (proxy for survival) did not indicate any costs of compensation. Our results suggest that compensatory growth in nature can be density-dependent. Thus, this is the first study to demonstrate the presence of ecological restrictions on the compensatory growth response in free-ranging animals.	[Sundstrom, L. Fredrik; Kaspersson, Rasmus; Naslund, Joacim; Johnsson, Jorgen I.] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg	Sundstrom, LF (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	fred.sundstrom@gmail.com	Näslund, Joacim/Q-1734-2015; Sundstrom, Fred/E-6736-2011	Näslund, Joacim/0000-0003-1091-2225; Sundstrom, Fred/0000-0002-3157-7289	Swedish Research Council Vetenskapsradet; European Community's Sixth Framework Programme [MOIF-CT-2005-8141]; Swedish Research Council for Agriculture Research and Spatial Planning	Swedish Research Council Vetenskapsradet(Swedish Research Council); European Community's Sixth Framework Programme; Swedish Research Council for Agriculture Research and Spatial Planning	LFS was funded by the Swedish Research Council Vetenskapsradet and as a Marie Curie Outgoing International Fellow under contract MOIF-CT-2005-8141 from the European Community's Sixth Framework Programme. The present work does not necessarily reflect the Community's views and in no way anticipates its future policy in this area. JIJ was funded by the Swedish Research Council for Agriculture Research and Spatial Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; Alvarez D, 2005, P ROY SOC B-BIOL SCI, V272, P601, DOI 10.1098/rspb.2004.2991; Apanius V., 1998, AVIAN GROWTH DEV EVO; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Auer SK, 2010, ECOL LETT, V13, P998, DOI 10.1111/j.1461-0248.2010.01491.x; Ayllon D, 2010, ECOL FRESHW FISH, V19, P420, DOI 10.1111/j.1600-0633.2010.00426.x; Biro PA, 2007, ANIM BEHAV, V73, P891, DOI 10.1016/j.anbehav.2006.10.019; Bohlin T, 2002, J ANIM ECOL, V71, P683, DOI 10.1046/j.1365-2656.2002.00631.x; Bohlin T, 1996, J FISH BIOL, V49, P157; BOHLIN T, 1993, CAN J FISH AQUAT SCI, V50, P224, DOI 10.1139/f93-025; Carlson SM, 2004, EVOL ECOL RES, V6, P955; DELLEFORS C, 1988, J FISH BIOL, V33, P741, DOI 10.1111/j.1095-8649.1988.tb05519.x; Dmitriew CM, 2011, BIOL REV, V86, P97, DOI 10.1111/j.1469-185X.2010.00136.x; HAWKINS CP, 1986, ECOLOGY, V67, P1384, DOI 10.2307/1938694; Hornick JL, 2000, DOMEST ANIM ENDOCRIN, V19, P121, DOI 10.1016/S0739-7240(00)00072-2; Houlihan D, 2001, FOOD INTAKE FISH; Johnsson JI, 2005, OIKOS, V111, P31, DOI 10.1111/j.0030-1299.2005.13972.x; Johnsson JI, 2006, P ROY SOC B-BIOL SCI, V273, P1281, DOI 10.1098/rspb.2005.3437; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Loman J, 2009, ACTA OECOL, V35, P824, DOI 10.1016/j.actao.2009.08.011; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Mobaek R, 2013, OIKOS, V122, P421, DOI 10.1111/j.1600-0706.2012.20888.x; Nephew BC, 2003, HORM BEHAV, V44, P222, DOI 10.1016/j.yhbeh.2003.06.002; Nicieza AG, 1999, FUNCT ECOL, V13, P793, DOI 10.1046/j.1365-2435.1999.00371.x; PETRANKA JW, 1986, ECOLOGY, V67, P729, DOI 10.2307/1937696; Quinn GP, 2003, EXPT DESIGN DATA ANA; SEBER GAF, 1967, J ANIM ECOL, V36, P631, DOI 10.2307/2818; Sundstrom LF, 2004, J FISH BIOL, V65, P1385, DOI 10.1111/j.0022-1112.2004.00537.x; Sundstrom LF, 2005, EVOLUTION, V59, P1560, DOI 10.1111/j.0014-3820.2005.tb01805.x; van Dijk PLM, 2002, OECOLOGIA, V130, P496, DOI 10.1007/s00442-001-0830-3; Vollestad LA, 2003, ANIM BEHAV, V66, P561, DOI 10.1006/anbe.2003.2237; WILSON PN, 1960, BIOL REV, V35, P324, DOI 10.1111/j.1469-185X.1960.tb01327.x; Xu CL, 2010, J FISH BIOL, V76, P2342, DOI 10.1111/j.1095-8649.2010.02619.x	34	14	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63287	10.1371/journal.pone.0063287	http://dx.doi.org/10.1371/journal.pone.0063287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658820	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100060
J	Szczepaniec, A; Raupp, MJ; Parker, RD; Kerns, D; Eubanks, MD				Szczepaniec, Adrianna; Raupp, Michael J.; Parker, Roy D.; Kerns, David; Eubanks, Micky D.			Neonicotinoid Insecticides Alter Induced Defenses and Increase Susceptibility to Spider Mites in Distantly Related Crop Plants	PLOS ONE			English	Article							INDUCED RESISTANCE; SALICYLIC-ACID; JASMONIC ACID; STATISTICAL-ANALYSIS; RESPONSES; TOMATO; TETRANYCHIDAE; SPECIFICITY; HERBIVORES; MUTATION	Background: Chemical suppression of arthropod herbivores is the most common approach to plant protection. Insecticides, however, can cause unintended, adverse consequences for non-target organisms. Previous studies focused on the effects of pesticides on target and non-target pests, predatory arthropods, and concomitant ecological disruptions. Little research, however, has focused on the direct effects of insecticides on plants. Here we demonstrate that applications of neonicotinoid insecticides, one of the most important insecticide classes worldwide, suppress expression of important plant defense genes, alter levels of phytohormones involved in plant defense, and decrease plant resistance to unsusceptible herbivores, spider mites Tetranychus urticae (Acari: Tetranychidae), in multiple, distantly related crop plants. Methodology/Principal Findings: Using cotton (Gossypium hirsutum), corn (Zea mays) and tomato (Solanum lycopersicum) plants, we show that transcription of phenylalanine amonia lyase, coenzyme A ligase, trypsin protease inhibitor and chitinase are suppressed and concentrations of the phytohormone OPDA and salicylic acid were altered by neonicotinoid insecticides. Consequently, the population growth of spider mites increased from 30% to over 100% on neonicotinoid-treated plants in the greenhouse and by nearly 200% in the field experiment. Conclusions/Significance: Our findings are important because applications of neonicotinoid insecticides have been associated with outbreaks of spider mites in several unrelated plant species. More importantly, this is the first study to document insecticide-mediated disruption of plant defenses and link it to increased population growth of a non-target herbivore. This study adds to growing evidence that bioactive agrochemicals can have unanticipated ecological effects and suggests that the direct effects of insecticides on plant defenses should be considered when the ecological costs of insecticides are evaluated.	[Szczepaniec, Adrianna; Eubanks, Micky D.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Raupp, Michael J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Parker, Roy D.] Texas A&M Univ, Texas AgriLife Res & Extens Ctr, Corpus Christi, TX USA; [Kerns, David] Texas A&M Univ, Texas AgriLife Res & Extens Ctr, Lubbock, TX USA	Texas A&M University System; Texas A&M University College Station; University System of Maryland; University of Maryland College Park; Texas A&M University System; Texas A&M University System	Szczepaniec, A (corresponding author), S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA.	adrianna.szczepaniec@sdstate.edu		Szczepaniec, Adrianna/0000-0002-9603-4533	Texas AgriLife Research; USDA National Research Initiative (NRI) [2008-35302-04491]; USDA NRI [2012-67013-19346]; NRI USDA [2005-35303-16269]; Gahan Fellowship; Bamford Fellowship	Texas AgriLife Research; USDA National Research Initiative (NRI)(United States Department of Agriculture (USDA)); USDA NRI(United States Department of Agriculture (USDA)); NRI USDA(United States Department of Agriculture (USDA)); Gahan Fellowship; Bamford Fellowship	This work was supported by grants from Texas AgriLife Research and the USDA National Research Initiative (NRI) to M.D.E. (2008-35302-04491), USDA NRI grant to M.D.E. and A.S. (2012-67013-19346), NRI USDA grant to M.J.R. (2005-35303-16269), and the Gahan and Bamford Fellowships to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ament K, 2004, PLANT PHYSIOL, V135, P2025, DOI 10.1104/pp.104.048694; [Anonymous], USDA NASS AGR CHEM U; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; Cipollini D, 2004, MOL ECOL, V13, P1643, DOI 10.1111/j.1365-294X.2004.02161.x; Croft BA, 1997, ENVIRON ENTOMOL, V26, P391, DOI 10.1093/ee/26.2.391; DAHLSTEN DL, 1969, CALIF AGR, V23, P4; DEBACH P, 1977, CALIF AGR, V31, P8; Dermauw W, 2012, INSECT BIOCHEM MOLEC, V42, P455, DOI 10.1016/j.ibmb.2012.03.002; Dutcher J.D., 2007, GEN CONCEPTS INTEGRA, P27, DOI [10.1007/978-1-4020-6061-8_2, DOI 10.1007/978-1-4020-6061-8_2]; Ford KA, 2010, P NATL ACAD SCI USA, V107, P17527, DOI 10.1073/pnas.1013020107; Gupta G, 2007, J ECON ENTOMOL, V100, P830, DOI 10.1603/0022-0493(2007)100[830:PACIFM]2.0.CO;2; Halim VA, 2009, PLANT J, V57, P230, DOI 10.1111/j.1365-313X.2008.03688.x; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Kant MR, 2004, PLANT PHYSIOL, V135, P483, DOI 10.1104/pp.103.038315; Karthikeyan Gandhi, 2009, Archives of Phytopathology and Plant Protection, V42, P1, DOI 10.1080/03235400600914314; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Li CY, 2002, PLANT PHYSIOL, V130, P494, DOI 10.1104/pp.005314; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matheny A. L., 2009, Outlooks on Pest Management, V20, P51, DOI 10.1564/20apr02; MULLINS JW, 1993, ACS SYM SER, V524, P183; Pratt P. D., 2000, Journal of Environmental Horticulture, V18, P218; PYKE DA, 1986, ECOLOGY, V67, P240, DOI 10.2307/1938523; R Core Team, 2022, R LANG ENV STAT COMP; Raupp Michael J., 2004, Journal of Arboriculture, V30, P108; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; Relyea R, 2006, ECOL LETT, V9, P1157, DOI 10.1111/j.1461-0248.2006.00966.x; Relyea RA, 2009, OECOLOGIA, V159, P363, DOI [10.1007/s00442-008-1141-8, 10.1007/s00442-008-1213-9]; Roy M, 1999, ENVIRON ENTOMOL, V28, P735, DOI 10.1093/ee/28.4.735; *SAS I, 2008, SAS SYST WIND VERS 9; Sclar DC, 1998, J ECON ENTOMOL, V91, P250, DOI 10.1093/jee/91.1.250; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Smith JF, 2010, EARLY SEASON MANAGEM; Smith JL, 2009, PEST MANAG SCI, V65, P497, DOI 10.1002/ps.1714; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Stout MJ, 1998, OECOLOGIA, V113, P74, DOI 10.1007/s004420050355; Szczepaniec A, 2009, MECH UNDERLYING OUTB; Szczepaniec A, 2013, EXP APPL ACAROL, V59, P307, DOI 10.1007/s10493-012-9614-1; Szczepaniec A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020018; Thaler JS, 2002, J CHEM ECOL, V28, P1131, DOI 10.1023/A:1016225515936; Thielert W., 2006, Pflanzenschutz-Nachrichten Bayer, V59, P73; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Wu Y, 2004, ACTA GOSSYPII SINICA, V2, P1; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhu-Salzman K, 2004, PLANT PHYSIOL, V134, P420, DOI 10.1104/pp.103.028324	48	59	64	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62620	10.1371/journal.pone.0062620	http://dx.doi.org/10.1371/journal.pone.0062620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658754	Green Submitted, Green Published, gold			2022-12-25	WOS:000321202100022
J	Zehendner, CM; Luhmann, HJ; Yang, JW				Zehendner, Christoph M.; Luhmann, Heiko J.; Yang, Jenq-Wei			A Simple and Novel Method to Monitor Breathing and Heart Rate in Awake and Urethane-Anesthetized Newborn Rodents	PLOS ONE			English	Article							BRAIN BLOOD-FLOW; VENTILATORY RESPONSE; NEONATAL-RAT; IN-VIVO; MICE; ANESTHESIA; HYPOXIA; CORTEX; STIMULATION; HYPERCAPNIA	Rodents are most useful models to study physiological and pathophysiological processes in early development, because they are born in a relatively immature state. However, only few techniques are available to monitor non-invasively heart frequency and respiratory rate in neonatal rodents without restraining or hindering access to the animal. Here we describe experimental procedures that allow monitoring of heart frequency by electrocardiography (ECG) and breathing rate with a piezoelectric transducer (PZT) element without hindering access to the animal. These techniques can be easily installed and are used in the present study in unrestrained awake and anesthetized neonatal C57/Bl6 mice and Wistar rats between postnatal day 0 and 7. In line with previous reports from awake rodents we demonstrate that heart rate in rats and mice increases during the first postnatal week. Respiratory frequency did not differ between both species, but heart rate was significantly higher in mice than in rats. Further our data indicate that urethane, an agent that is widely used for anesthesia, induces a hypoventilation in neonates whilst heart rate remains unaffected at a dose of 1 g per kg body weight. Of note, hypoventilation induced by urethane was not detected in rats at postnatal 0/1. To verify the detected hypoventilation we performed blood gas analyses. We detected a respiratory acidosis reflected by a lower pH and elevated level in CO2 tension (pCO(2)) in both species upon urethane treatment. Furthermore we found that metabolism of urethane is different in P0/1 mice and rats and between P0/1 and P6/7 in both species. Our findings underline the usefulness of monitoring basic cardio-respiratory parameters in neonates during anesthesia. In addition our study gives information on developmental changes in heart and breathing frequency in newborn mice and rats and the effects of urethane in both species during the first postnatal week.	[Zehendner, Christoph M.; Luhmann, Heiko J.; Yang, Jenq-Wei] Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, Mainz, Germany	Johannes Gutenberg University of Mainz	Zehendner, CM (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, Mainz, Germany.	Zehendner@uni-mainz.de; YangJ@uni-mainz.de	Luhmann, Heiko J./N-8797-2019	Luhmann, Heiko J./0000-0002-7934-8661	DFG; University Medical Center of the Johannes Gutenberg-University Mainz	DFG(German Research Foundation (DFG)); University Medical Center of the Johannes Gutenberg-University Mainz	This work was supported by DFG grants to HJL and a Stage 1 grant to CMZ by the University Medical Center of the Johannes Gutenberg-University Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SM, 2012, J NEUROSCI, V32, P9511, DOI 10.1523/JNEUROSCI.1212-12.2012; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Ayers P, 2008, NUTR CLIN PRACT, V23, P122, DOI 10.1177/0884533608314534; BARTELS H, 1979, RESP PHYSIOL, V36, P375, DOI 10.1016/0034-5687(79)90049-5; Bleich HL, 1980, NEW ENGL J MED, V303, P436, DOI [10.1056/ NEJM198008213030806, DOI 10.1056/NEJM198008213030806]; Brockmann MD, 2011, NEURON, V71, P332, DOI 10.1016/j.neuron.2011.05.041; Cabot RC, 2012, NEW ENGL J MED, V366, P2409, DOI [10.1056/ NEJMcpc1109276, DOI 10.1056/NEJMCPC1109276]; DEWILDT DJ, 1983, BRIT J PHARMACOL, V79, P461; DOWNING SE, 1977, AM J PHYSIOL, V233, pH451, DOI 10.1152/ajpheart.1977.233.4.H451; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; FIELD KJ, 1993, LAB ANIM, V27, P258, DOI 10.1258/002367793780745471; Franceschini MA, 2010, NEUROIMAGE, V51, P1367, DOI 10.1016/j.neuroimage.2010.03.060; Fritz KI, 2005, PEDIATR RES, V57, P299, DOI 10.1203/01.PDR.0000148718.47137.9B; GOOTMAN PM, 1986, AM J PHYSIOL, V251, pH748, DOI 10.1152/ajpheart.1986.251.4.H748; Hilaire G, 1997, NEUROSCI LETT, V224, P13, DOI 10.1016/S0304-3940(97)13458-9; Hoffler U, 2003, J PHARMACOL EXP THER, V305, P557, DOI 10.1124/jpet.102.049072; HOU PCL, 1989, RESP PHYSIOL, V78, P265, DOI 10.1016/0034-5687(89)90103-5; Lu H, 1998, ANESTH ANALG, V87, P854, DOI 10.1097/00000539-199810000-00020; MAGGI CA, 1986, EXPERIENTIA, V42, P292, DOI 10.1007/BF01942510; Masamoto K, 2012, J CEREBRAL BLOOD FLO; Matrot B, 2005, J APPL PHYSIOL, V98, P365, DOI 10.1152/japplphysiol.00803.2004; MORTOLA JP, 1989, RESP PHYSIOL, V78, P31, DOI 10.1016/0034-5687(89)90140-0; Pagliardini S, 2012, J NEUROSCI, V32, P11259, DOI 10.1523/JNEUROSCI.0948-12.2012; PATON JFR, 1995, PFLUG ARCH EUR J PHY, V430, P115, DOI 10.1007/BF00373846; Ramanantsoa N, 2007, AM J PHYSIOL-REG I, V293, pR2027, DOI 10.1152/ajpregu.00349.2007; Robinson DM, 2000, J APPL PHYSIOL, V88, P1907, DOI 10.1152/jappl.2000.88.5.1907; Salmon AG, 1991, RISKS CARCINOGENESIS; Sato S, 2008, AM J PHYSIOL-HEART C, V294, pH1708, DOI 10.1152/ajpheart.01122.2007; Sato S, 2006, MED BIOL ENG COMPUT, V44, P353, DOI 10.1007/s11517-006-0047-z; Schmidt RF, 2011, PHYSL MENSCHEN PATHO, DOI DOI 10.1007/978-3-642-01651-6.ACCESSED; Tankersley CG, 1997, J APPL PHYSIOL, V82, P874, DOI 10.1152/jappl.1997.82.3.874; Teppema LJ, 2010, PHYSIOL REV, V90, P675, DOI 10.1152/physrev.00012.2009; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Thal SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050752; Willie CK, 2012, J PHYSIOL-LONDON, V590, P3261, DOI 10.1113/jphysiol.2012.228551; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009	36	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62628	10.1371/journal.pone.0062628	http://dx.doi.org/10.1371/journal.pone.0062628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658756	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100024
J	Fallis, BA; Dhalla, IA; Klemensberg, J; Bell, CM				Fallis, Brooks A.; Dhalla, Irfan A.; Klemensberg, Jason; Bell, Chaim M.			Primary Medication Non-Adherence after Discharge from a General Internal Medicine Service	PLOS ONE			English	Article							ADHERENCE; THERAPY; HOSPITALIZATION; DISCONTINUATION; MORTALITY; IMPACT; CARE	Background: Medication non-adherence frequently leads to suboptimal patient outcomes. Primary non-adherence, which occurs when a patient does not fill an initial prescription, is particularly important at the time of hospital discharge because new medications are often being prescribed to treat an illness rather than for prevention. Methods: We studied older adults consecutively discharged from a general internal medicine service at a large urban teaching hospital to determine the prevalence of primary non-adherence and identify characteristics associated with primary non-adherence. We reviewed electronic prescriptions, electronic discharge summaries and pharmacy dispensing data from April to August 2010 for drugs listed on the public formulary. Primary non-adherence was defined as failure to fill one or more new prescriptions after hospital discharge. In addition to descriptive analyses, we developed a logistical regression model to identify patient characteristics associated with primary non-adherence. Results: There were 493 patients eligible for inclusion in our study, 232 of whom were prescribed new medications. In total, 66 (28%) exhibited primary non-adherence at 7 days after discharge and 55 (24%) at 30 days after discharge. Examples of medications to which patients were non-adherent included antibiotics, drugs for the management of coronary artery disease (e. g. beta-blockers, statins), heart failure (e. g. beta-blockers, angiotensin converting enzyme inhibitors, furosemide), stroke (e. g. statins, clopidogrel), diabetes (e. g. insulin), and chronic obstructive pulmonary disease (e. g. long-acting bronchodilators, prednisone). Discharge to a nursing home was associated with an increased risk of primary non-adherence (OR 2.25, 95% CI 1.01-4.95). Conclusions: Primary non-adherence after medications are newly prescribed during a hospitalization is common, and was more likely to occur in patients discharged to a nursing home.	[Fallis, Brooks A.; Dhalla, Irfan A.; Bell, Chaim M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Dhalla, Irfan A.; Bell, Chaim M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Dhalla, Irfan A.] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.; Klemensberg, Jason] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.; Bell, Chaim M.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Bell, Chaim M.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bell, CM (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	cbell@mtsinai.on.ca	Bell, Chaim/C-4611-2015	Bell, Chaim/0000-0002-3778-9469	Canadian Institutes of Health Research; Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care	Dr. Bell is supported by a Canadian Institutes of Health Research and Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care. The funding agencies had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript. The corresponding author had full access to all of the data and takes responsibility for the integrity of the data and the accuracy of the data analysis. The authors report no conflicts of interest.	Baudendistel TE, 2011, J HOSP MED, V6, P487, DOI 10.1002/jhm.998; BEARDON PHG, 1993, BRIT MED J, V307, P846, DOI 10.1136/bmj.307.6908.846; Bell CM, 2011, JAMA-J AM MED ASSOC, V306, P840, DOI 10.1001/jama.2011.1206; Boockvar KS, 2007, J AM GERIATR SOC, V55, P1078, DOI 10.1111/j.1532-5415.2007.01235.x; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Fischer MA, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2011.05.028; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Ho PM, 2006, ARCH INTERN MED, V166, P1842, DOI 10.1001/archinte.166.17.1842; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jackevicius CA, 2008, CIRCULATION, V117, P1028, DOI 10.1161/CIRCULATIONAHA.107.706820; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Maslove DM, 2009, J GEN INTERN MED, V24, P995, DOI 10.1007/s11606-009-1053-2; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Raebel MA, 2011, ANN PHARMACOTHER, V45, P1053, DOI 10.1345/aph.1Q146; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af	17	66	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61735	10.1371/journal.pone.0061735	http://dx.doi.org/10.1371/journal.pone.0061735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658698	Green Published, Green Submitted, gold			2022-12-25	WOS:000321200500011
J	Huveneers, C; Rogers, PJ; Semmens, JM; Beckmann, C; Kock, AA; Page, B; Goldsworthy, SD				Huveneers, Charlie; Rogers, Paul J.; Semmens, Jayson M.; Beckmann, Crystal; Kock, Alison A.; Page, Brad; Goldsworthy, Simon D.			Effects of an Electric Field on White Sharks: In Situ Testing of an Electric Deterrent	PLOS ONE			English	Article							LATERAL-LINE ORGANS; CARCHARODON-CARCHARIAS; BEHAVIORAL-RESPONSES; ELECTRORECEPTION; INNERVATION; SYSTEM; ISLAND; SENSE	Elasmobranchs can detect minute electromagnetic fields, <1 nVcm(-1), using their ampullae of Lorenzini. Behavioural responses to electric fields have been investigated in various species, sometimes with the aim to develop shark deterrents to improve human safety. The present study tested the effects of the Shark Shield Freedom7 (TM) electric deterrent on (1) the behaviour of 18 white sharks (Carcharodon carcharias) near a static bait, and (2) the rates of attacks on a towed seal decoy. In the first experiment, 116 trials using a static bait were performed at the Neptune Islands, South Australia. The proportion of baits taken during static bait trials was not affected by the electric field. The electric field, however, increased the time it took them to consume the bait, the number of interactions per approach, and decreased the proportion of interactions within two metres of the field source. The effect of the electric field was not uniform across all sharks. In the second experiment, 189 tows using a seal decoy were conducted near Seal Island, South Africa. No breaches and only two surface interactions were observed during the tows when the electric field was activated, compared with 16 breaches and 27 surface interactions without the electric field. The present study suggests that the behavioural response of white sharks and the level of risk reduction resulting from the electric field is contextually specific, and depends on the motivational state of sharks.	[Huveneers, Charlie; Rogers, Paul J.; Page, Brad; Goldsworthy, Simon D.] South Australian Res & Dev Inst Aquat Sci, Threatened Endangered & Protected Species Sub Pro, Adelaide, SA, Australia; [Huveneers, Charlie; Beckmann, Crystal] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Semmens, Jayson M.] Univ Tasmania, Fisheries Aquaculture & Coasts Ctr, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Kock, Alison A.] Univ Cape Town, Dept Zool, ZA-7925 Cape Town, Western Cape, South Africa; [Kock, Alison A.] Shark Spotters, Cape Town, Western Cape, South Africa	Flinders University South Australia; University of Tasmania; University of Cape Town	Huveneers, C (corresponding author), South Australian Res & Dev Inst Aquat Sci, Threatened Endangered & Protected Species Sub Pro, Adelaide, SA, Australia.	charlie.huveneers@sa.gov.au		Goldsworthy, Simon/0000-0003-4988-9085; Beckmann, Crystal/0000-0002-1704-9578; Huveneers, Charlie/0000-0001-8937-1358; Semmens, Jayson/0000-0003-1742-6692; Kock, Alison/0000-0001-9981-1652	SafeWork SA; Winifred Violet Scott Charitable Trust; Neiser Foundation; University of Adelaide; Flinders University; Wildlife Conservation Fund; Nature Foundation of South Australia; Solar Online; Australian Research Council's Discovery Projects funding scheme [DP0988554]; umbrella of a Save Our Seas Foundation	SafeWork SA; Winifred Violet Scott Charitable Trust; Neiser Foundation; University of Adelaide; Flinders University; Wildlife Conservation Fund; Nature Foundation of South Australia; Solar Online; Australian Research Council's Discovery Projects funding scheme(Australian Research Council); umbrella of a Save Our Seas Foundation	This project was funded by SafeWork SA, Winifred Violet Scott Charitable Trust, Neiser Foundation, University of Adelaide, Flinders University, Wildlife Conservation Fund, Nature Foundation of South Australia, and Solar Online. This research was also partly supported under Australian Research Council's Discovery Projects funding scheme (project number DP0988554; www.arc.gov.au). Fieldwork in South Africa was funded under the umbrella of a Save Our Seas Foundation grant provided to AAK as part of a white shark monitoring project. The authors thank Andrew Fox, Jennifer Taylor, and Rachel Robbins from the Rodney Fox Shark Expeditions for the logistic support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SD, 2011, MAR BIOL, V158, P1233, DOI 10.1007/s00227-011-1643-5; BLONDER BI, 1988, COPEIA, P33, DOI 10.2307/1445919; BRATTON BO, 1987, ENVIRON BIOL FISH, V20, P241; Brill R, 2009, FISH B-NOAA, V107, P298; Broad A, 2010, MAR ECOL PROG SER, V408, P295, DOI 10.3354/meps08591; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Bruce BD., 2011, EFFECTS BERLEYING DI; Burgess GH, 2010, CRC MAR BIOL SER, P541; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chapple TK, 2011, BIOL LETTERS, V7, P581, DOI 10.1098/rsbl.2011.0124; Curtis T.H., 2012, GLOBAL PERSPECTIVES; Czech-Damal NU, 2012, P ROY SOC B-BIOL SCI, V279, P663, DOI 10.1098/rspb.2011.1127; De Vos A, 2010, BIOL LETTERS, V6, P48, DOI 10.1098/rsbl.2009.0628; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Fay MP, 2010, R J, V2, P53; Gilbert P.W., 1973, Underwater J Inf Bull, V5, P69; Gubili C, 2012, GLOBAL PERSPECTIVES; Haine OS, 2001, MAR FRESHWATER RES, V52, P291, DOI 10.1071/MF00036; Huveneers C., 2012, SARDI RES REPORT SER; Jordan LK, 2011, J EXP MAR BIOL ECOL, V409, P345, DOI 10.1016/j.jembe.2011.09.016; JORGENSEN JM, 1972, Z ZELLFORSCH MIK ANA, V130, P362; Kajiura SM, 2002, J EXP BIOL, V205, P3609; Kalmijn A.J., 1978, P507; Kalmijn A.J., 1974, P147; KALMIJN AJ, 1971, J EXP BIOL, V55, P371; KALMIJN AJ, 1966, NATURE, V212, P1232, DOI 10.1038/2121232b0; Laroche RK, 2008, ANIM BEHAV, V76, P1901, DOI 10.1016/j.anbehav.2008.06.025; LOWE CG, 1994, MAR BIOL, V120, P161; Malcolm H., 2001, REV BIOL STATUS WHIT; Marcotte MM, 2008, MAR TECHNOL SOC J, V42, P53, DOI 10.4031/002533208786829133; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; New JG, 1997, BRAIN BEHAV EVOLUT, V50, P244, DOI 10.1159/000113338; Northcutt R.G., 1986, P257; NORTHCUTT RG, 1992, J COMP NEUROL, V325, P95, DOI 10.1002/cne.903250109; Northcutt RG, 2000, J COMP NEUROL, V421, P570; PAULIN MG, 1995, J THEOR BIOL, V174, P325, DOI 10.1006/jtbi.1995.0102; PETERS RC, 1985, J EXP BIOL, V118, P99; Rigg DP, 2009, MAR FRESHWATER RES, V60, P942, DOI 10.1071/MF08180; Robbins WD, 2011, FISH RES, V109, P100, DOI 10.1016/j.fishres.2011.01.023; SCHEICH H, 1986, NATURE, V319, P401, DOI 10.1038/319401a0; Sepulveda CA, 2007, MAR BIOL, V152, P1087, DOI 10.1007/s00227-007-0757-2; Sisneros JA, 1998, J COMP PHYSIOL A, V183, P87, DOI 10.1007/s003590050237; Smit C.F., 2003, S AFRICAN J STAT, V37, P59; Smith E. D., 1974, Transactions of the South African Institute of Electrical Engineers, V65, P166; Smith E.D., 1990, S AFRICAN SHIPPING N, P40; Smith E.D., 1973, CIVIL ENG PUBLIC WOR, V68, P174; Smith ED, 1966, GEO MAR TECH, V2, P10; Tricas TC, 1995, NEUROSCI LETT, V202, P129, DOI 10.1016/0304-3940(95)12230-3; West JG, 2011, MAR FRESHWATER RES, V62, P744, DOI 10.1071/MF10181; Wueringer BE, 2012, BRAIN BEHAV EVOLUT, V80, P97, DOI 10.1159/000339873	51	27	27	5	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62730	10.1371/journal.pone.0062730	http://dx.doi.org/10.1371/journal.pone.0062730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658766	Green Published, gold			2022-12-25	WOS:000321200500034
J	Magalhaes, V; Andrade, EB; Alves, J; Ribeiro, A; Kim, KS; Lima, M; Trieu-Cuot, P; Ferreira, P				Magalhaes, Vanessa; Andrade, Elva Bonifacio; Alves, Joana; Ribeiro, Adilia; Kim, Kwang Sik; Lima, Margarida; Trieu-Cuot, Patrick; Ferreira, Paula			Group B Streptococcus Hijacks the Host Plasminogen System to Promote Brain Endothelial Cell Invasion	PLOS ONE			English	Article							BORRELIA-BURGDORFERI; EXTRACELLULAR-MATRIX; NEONATAL MENINGITIS; BACTERIAL INVASION; BARRIER; SURFACE; PENETRATION; INFECTION; BINDING; ACTIVATION	Group B Streptococcus (GBS) is the leading cause of meningitis in neonates. We have previously shown that plasminogen, once recruited to the GBS cell surface and converted into plasmin by host-derived activators, leads to an enhancement of bacterial virulence. Here, we investigated whether plasmin(ogen) bound at the GBS surface contributes to blood-brain barrier penetration and invasion of the central nervous system. For that purpose, GBS strain NEM316 preincubated with or without plasminogen plus tissue type plasminogen activator was analyzed for the capacity to adhere to, invade and transmigrate the human brain microvascular endothelial cell (hBMEC) monolayer, and to penetrate the central nervous system using a neonatal mouse model. At earlier times of infection, plasmin(ogen)-treated GBS exhibited a significant increase in adherence to and invasion of hBMECs. Later, injury of hBMECs were observed with plasmin(ogen)-treated GBS that displayed a plasmin-like activity. The same results were obtained when hBMECs were incubated with whole human plasma and infected with untreated GBS. To confirm that the observed effects were due to the recruitment and activation of plasminogen on GBS surface, the bacteria were first incubated with epsilon-aminocaproic acid (epsilon ACA), an inhibitor of plasminogen binding, and thereafter with plasmin(ogen). A significant decrease in the hBMECs injury that was correlated with a decrease of the GBS surface proteolytic activity was observed. Furthermore, plasmin(ogen)-treated GBS infected more efficiently the brain of neonatal mice than the untreated bacteria, indicating that plasmin(ogen) bound to GBS surface may facilitate the traversal of the blood-brain barrier. A higher survival rate was observed in offspring born from epsilon ACA-treated mothers, compared to untreated mice, and no brain infection was detected in these neonates. Our findings suggest that capture of the host plasmin(ogen) by the GBS surface promotes the crossing of the blood-brain barrier and contributes to the establishment of meningitis.	[Magalhaes, Vanessa; Andrade, Elva Bonifacio; Alves, Joana; Ribeiro, Adilia; Ferreira, Paula] Univ Porto, ICBAS, P-4100 Oporto, Portugal; [Magalhaes, Vanessa; Andrade, Elva Bonifacio; Alves, Joana; Ribeiro, Adilia; Ferreira, Paula] IBMC, Oporto, Portugal; [Magalhaes, Vanessa] UFP, Fac Ciencias Saude, Oporto, Portugal; [Kim, Kwang Sik] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Lima, Margarida] CHP, HSA, Dept Hematol, Oporto, Portugal; [Trieu-Cuot, Patrick] CNRS, Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, ERL3526, Paris, France	Universidade do Porto; Universidade do Porto; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ferreira, P (corresponding author), Univ Porto, ICBAS, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	pauferr@icbas.up.pt	Alves, Joana EV/J-6866-2013; Magalhães, Vanessa/GPS-9333-2022; Lima, Margarida/S-7466-2016; Andrade, Elva Bonifácio/K-3096-2013; Magalhães, Vanessa/M-3095-2013; Ferreira, Paula/J-6149-2013	Alves, Joana EV/0000-0003-3131-9834; Lima, Margarida/0000-0001-9702-5260; Andrade, Elva Bonifácio/0000-0002-1941-580X; Magalhães, Vanessa/0000-0001-6081-117X; Ferreira, Paula/0000-0001-8639-9224; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Ribeiro, Adilia/0000-0002-0142-3182	Fundacao para a Ciencia e Tecnologia (FCT); Fundo Europeu de Desenvolvimento Regional (FEDER); Programa Operacional Fatores de Competitividade (COMPETE) [PTDC/SAU-MIC/111387/2009]; PhD FCT fellowship [SFRH/BD/38380/2007, SRFH/BD/77232/2011]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission); Programa Operacional Fatores de Competitividade (COMPETE); PhD FCT fellowship	This work was supported by research funding from Fundacao para a Ciencia e Tecnologia (FCT), Fundo Europeu de Desenvolvimento Regional (FEDER) and Programa Operacional Fatores de Competitividade (COMPETE) through the grant no PTDC/SAU-MIC/111387/2009. Elva Bonifacio Andrade and Joana Alves were supported by a PhD FCT fellowship SFRH/BD/38380/2007 and SRFH/BD/77232/2011, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1474; Berardi A, 2010, Minerva Pediatr, V62, P51; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; Chang YC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002082; Coleman JL, 2000, METHODS, V21, P133, DOI 10.1006/meth.2000.0984; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Coleman JL, 1999, INFECT IMMUN, V67, P3929, DOI 10.1128/IAI.67.8.3929-3936.1999; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Collen D, 2001, Hematology Am Soc Hematol Educ Program, P1; COLLEN D, 1975, THROMB DIATH HAEMOST, V34, P403, DOI 10.1055/s-0038-1651399; Degen JL, 2007, J THROMB HAEMOST, V5, P24, DOI 10.1111/j.1538-7836.2007.02519.x; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; EDWARDS MS, 1985, J PEDIATR-US, V106, P717, DOI 10.1016/S0022-3476(85)80342-5; Gebbia JA, 1999, J CLIN INVEST, V103, P81, DOI 10.1172/JCI5171; Grab DJ, 2005, INFECT IMMUN, V73, P1014, DOI 10.1128/IAI.73.2.1014-1022.2005; Huang SH, 2000, MICROBES INFECT, V2, P1237, DOI 10.1016/S1286-4579(00)01277-6; Join-Lambert O, 2010, PROG NEUROBIOL, V91, P130, DOI 10.1016/j.pneurobio.2009.12.004; Kim KJ, 2003, CELL MICROBIOL, V5, P245, DOI 10.1046/j.1462-5822.2003.t01-1-00271.x; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Kim KS, 2006, INT J PARASITOL, V36, P607, DOI 10.1016/j.ijpara.2006.01.013; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Kinnby B, 2008, MICROBIOL-SGM, V154, P924, DOI 10.1099/mic.0.2007/013235-0; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Li ZQ, 1999, J INFECT DIS, V179, P907, DOI 10.1086/314654; Magalhaes V, 2007, MICROBES INFECT, V9, P1276, DOI 10.1016/j.micinf.2007.06.001; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Maisey Heather C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000811; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; Nilsson I M, 1980, J Clin Pathol Suppl (R Coll Pathol), V14, P41; Nitsche-Schmitz DP, 2007, THROMB HAEMOSTASIS, V98, P488, DOI 10.1160/TH07-03-0179; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Nordstrand A, 2001, INFECT IMMUN, V69, P5832, DOI 10.1128/IAI.69.9.5832-5839.2001; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Sanderson-Smith ML, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/272148; Stevens JP, 2003, ARCH DIS CHILD-FETAL, V88, P179; Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780; Stins MF, 1997, J NEUROIMMUNOL, V76, P81, DOI 10.1016/S0165-5728(97)00036-2; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; Tazi A, 2011, CURR OPIN MICROBIOL; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Tenenbaum T, 2007, MICROBES INFECT, V9, P714, DOI 10.1016/j.micinf.2007.02.015; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; WONG AP, 1992, AM J PHYSIOL, V263, pF1112, DOI 10.1152/ajprenal.1992.263.6.F1112	49	21	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63244	10.1371/journal.pone.0063244	http://dx.doi.org/10.1371/journal.pone.0063244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658816	Green Submitted, Green Published, gold			2022-12-25	WOS:000321200500064
J	Bohmer, SA; Weibrecht, I; Soderberg, O; Bohmer, FD				Bohmer, Sylvia-Annette; Weibrecht, Irene; Soderberg, Ola; Bohmer, Frank-D.			Association of the Protein-Tyrosine Phosphatase DEP-1 with Its Substrate FLT3 Visualized by In Situ Proximity Ligation Assay	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FLUORESCENCE MICROSCOPY; ENDOPLASMIC-RETICULUM; CELL; 1B; DEPHOSPHORYLATION; INACTIVATION; MECHANISM; REVEALS; PTP1B	Protein-tyrosine phosphatases (PTPs) are important regulators of signal transduction processes. Essential for the functional characterization of PTPs is the identification of their physiological substrates, and an important step towards this goal is the demonstration of a physical interaction. The association of PTPs with their cellular substrates is, however, often transient and difficult to detect with unmodified proteins at endogenous levels. Density-enhanced phosphatase-1 (DEP-1/PTPRJ) is a regulator of hematopoietic cell functions, and a candidate tumor suppressor. However, association of DEP-1 with any of its proposed substrates at endogenous levels has not yet been shown. We have previously obtained functional and biochemical evidence for a direct interaction of DEP-1 with the hematopoietic receptor-tyrosine kinase Fms-like tyrosine kinase-3 (FLT3). In the current study we have used the method of in situ proximity ligation assay (in situ PLA) to validate this interaction at endogenous levels, and to further characterize it. In situ PLA readily detected association of endogenous DEP1 and FLT3 in the human acute monocytic leukemia cell line THP-1, which was enhanced by FLT3 ligand (FL) stimulation in a time-dependent manner. Association peaked between 10 and 20 min of stimulation and returned to basal levels at 30 min. This time course was similar to the time course of FLT3 autophosphorylation. FLT3 kinase inhibition and DEP-1 oxidation abrogated association. Consistent with a functional role of DEP-1-FLT3 interaction, stable knockdown of DEP-1 in THP-1 cells enhanced FL-induced ERK1/2 activation. These findings support that FLT3 is a bona fide substrate of DEP-1 and that interaction occurs mainly via an enzyme-substrate complex formation triggered by FLT3 ligand stimulation.	[Bohmer, Sylvia-Annette; Bohmer, Frank-D.] Jena Univ Hosp, Inst Mol Cell Biol, Ctr Mol Biomed, Jena, Germany; [Weibrecht, Irene; Soderberg, Ola] Uppsala Univ, Rudbeck Lab, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden	Friedrich Schiller University of Jena; Uppsala University	Bohmer, FD (corresponding author), Jena Univ Hosp, Inst Mol Cell Biol, Ctr Mol Biomed, Jena, Germany.	boehmer@med.uni-jena.de	Söderberg, Ola/O-5130-2017	Söderberg, Ola/0000-0003-2883-1925	Deutsche Krebshilfe [108401, TP2]; Swedish Foundation for Strategic Research	Deutsche Krebshilfe(Deutsche Krebshilfe); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	Deutsche Krebshilfe (Collaborative grant 108401, TP2 to F.D.B.), and to the Swedish Foundation for Strategic Research (to I.W. and O.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Anderie I, 2007, CELL SIGNAL, V19, P582, DOI 10.1016/j.cellsig.2006.08.007; Arora D, 2011, J BIOL CHEM, V286, P10918, DOI 10.1074/jbc.M110.205021; Biskup C, 2004, J CELL SCI, V117, P5165, DOI 10.1242/jcs.01397; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Gavrilovic M, 2011, CYTOM PART A, V79A, P518, DOI 10.1002/cyto.a.21087; Godfrey R, 2012, BLOOD, V119, P4499, DOI 10.1182/blood-2011-02-336446; Gross S, 1999, J BIOL CHEM, V274, P26378, DOI 10.1074/jbc.274.37.26378; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Iervolino A, 2006, CANCER RES, V66, P6280, DOI 10.1158/0008-5472.CAN-06-0228; Jandt E, 2003, ONCOGENE, V22, P4175, DOI 10.1038/sj.onc.1206652; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Kappert K, 2007, FASEB J, V21, P523, DOI 10.1096/fj.06-6219com; Karagyozov L, 2008, NUCLEIC ACIDS RES, V36, P4443, DOI 10.1093/nar/gkn391; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Machide M, 2006, J BIOL CHEM, V281, P8765, DOI 10.1074/jbc.M512298200; Mahboobi S, 2006, J MED CHEM, V49, P3101, DOI 10.1021/jm058033i; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Petermann A, 2011, BRAIN PATHOL, V21, P405, DOI 10.1111/j.1750-3639.2010.00464.x; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Schmidt-Arras D, 2009, BLOOD, V113, P3568, DOI 10.1182/blood-2007-10-121426; Senis YA, 2009, BLOOD, V113, P4942, DOI 10.1182/blood-2008-08-174318; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Yang T, 2006, J NEUROBIOL, V66, P1420, DOI 10.1002/neu.20291; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	31	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62871	10.1371/journal.pone.0062871	http://dx.doi.org/10.1371/journal.pone.0062871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650535	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000080
J	Yang, J; Swenson, NG; Cao, M; Chuyong, GB; Ewango, CEN; Howe, R; Kenfack, D; Thomas, D; Wolf, A; Lin, LX				Yang, Jie; Swenson, Nathan G.; Cao, Min; Chuyong, George B.; Ewango, Corneille E. N.; Howe, Robert; Kenfack, David; Thomas, Duncan; Wolf, Amy; Lin, Luxiang			A Phylogenetic Perspective on the Individual Species-Area Relationship in Temperate and Tropical Tree Communities	PLOS ONE			English	Article							NEUTRAL THEORY; NULL MODELS; RAIN-FOREST; DIVERSITY; ECOLOGY; SCALE; TRAIT	Ecologists have historically used species-area relationships (SARs) as a tool to understand the spatial distribution of species. Recent work has extended SARs to focus on individual-level distributions to generate individual species area relationships (ISARs). The ISAR approach quantifies whether individuals of a species tend have more or less species richness surrounding them than expected by chance. By identifying richness 'accumulators' and 'repellers', respectively, the ISAR approach has been used to infer the relative importance of abiotic and biotic interactions and neutrality. A clear limitation of the SAR and ISAR approaches is that all species are treated as evolutionarily independent and that a large amount of work has now shown that local tree neighborhoods exhibit non-random phylogenetic structure given the species richness. Here, we use nine tropical and temperate forest dynamics plots to ask: (i) do ISARs change predictably across latitude?; (ii) is the phylogenetic diversity in the neighborhood of species accumulators and repellers higher or lower than that expected given the observed species richness?; and (iii) do species accumulators, repellers distributed non-randomly on the community phylogenetic tree? The results indicate no clear trend in ISARs from the temperate zone to the tropics and that the phylogenetic diversity surrounding the individuals of species is generally only non-random on very local scales. Interestingly the distribution of species accumulators and repellers was non-random on the community phylogenies suggesting the presence of phylogenetic signal in the ISAR across latitude.	[Yang, Jie; Cao, Min; Lin, Luxiang] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China; [Yang, Jie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Swenson, Nathan G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Chuyong, George B.] Univ Buea, Dept Bot & Plant Physiol, Buea, Cameroon; [Ewango, Corneille E. N.] Ctr Format & Rech Conservat Forestiere CEFRECOF E, Reserve De Faune A Okapi, DEM REP CONGO; [Howe, Robert; Wolf, Amy] Univ Wisconsin, Dept Nat & Appl Sci, Green Bay, WI 54302 USA; [Kenfack, David] Smithsonian Inst, Smithsonian Global Earth Observ Network, Washington, DC USA; [Thomas, Duncan] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Michigan State University; University of Wisconsin System; Smithsonian Institution; Smithsonian Tropical Research Institute; Oregon State University	Lin, LX (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China.	linluxa@xtbg.ac.cn		Kenfack, David/0000-0001-8208-3388	United States National Science Foundation [DEB - 1046113]; National Science Foundation of China [31061160188, 31000201]; Queensland-Chinese Academy of Science Joint Biotechnology Projects [GJHZ1130]; Direct For Biological Sciences [1046113] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Queensland-Chinese Academy of Science Joint Biotechnology Projects; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was conducted as a part of a Dimensions of Biodiversity IRCN workshop in Changbaishan, China, funded by the United States National Science Foundation (DEB - 1046113). This study was supported by the National Science Foundation of China (31061160188 and 31000201) and the Queensland-Chinese Academy of Science Joint Biotechnology Projects (GJHZ1130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Chesson P, 2000, THEOR POPUL BIOL, V58, P211, DOI 10.1006/tpbi.2000.1486; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lan GY, 2011, FOREST ECOL MANAG, V262, P1507, DOI 10.1016/j.foreco.2011.06.052; Losos EC, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P3; MADDISON WP, 1991, EVOLUTION, V45, P1184, DOI [10.1111/j.1558-5646.1991.tb04385.x, 10.2307/2409726]; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mi XC, 2012, AM NAT, V180, pE17, DOI 10.1086/665999; Orme D, 2012, CAPER COMPARATIVE AN; R Development Core Team, 2012, R LANG ENV STAT COMP; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Swenson NG, 2011, AM J BOT, V98, P472, DOI 10.3732/ajb.1000289; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Tilman D., 1982, Monographs in Population Biology, pi; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wiegand T, 2007, P NATL ACAD SCI USA, V104, P19029, DOI 10.1073/pnas.0705621104; Wiegand T, 2012, P ROY SOC B-BIOL SCI, V279, P3312, DOI 10.1098/rspb.2012.0376; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	40	12	18	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63192	10.1371/journal.pone.0063192	http://dx.doi.org/10.1371/journal.pone.0063192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650553	gold, Green Published, Green Submitted			2022-12-25	WOS:000319167000098
J	Mabalirajan, U; Ahmad, T; Rehman, R; Leishangthem, GD; Dinda, AK; Agrawal, A; Ghosh, B; Sharma, SK				Mabalirajan, Ulaganathan; Ahmad, Tanveer; Rehman, Rakhshinda; Leishangthem, Geeta Devi; Dinda, Amit Kumar; Agrawal, Anurag; Ghosh, Balaram; Sharma, Surendra Kumar			Baicalein Reduces Airway Injury in Allergen and IL-13 Induced Airway Inflammation	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; INDUCED APOPTOSIS; PROTECTS; CELLS; 12/15-LIPOXYGENASE; EXPRESSION; ASTHMA; LIPOXYGENASE; PATHWAY; STRESS	Background: Baicalein, a bioflavone present in the dry roots of Scutellaria baicalensis Georgi, is known to reduce eotaxin production in human fibroblasts. However, there are no reports of its anti-asthma activity or its effect on airway injury. Methodology/Principal Findings: In a standard experimental asthma model, male Balb/c mice that were sensitized with ovalbumin (OVA), treated with baicalein (10 mg/kg, ip) or a vehicle control, either during (preventive use) or after OVA challenge (therapeutic use). In an alternate model, baicalein was administered to male Balb/c mice which were given either IL-4 or IL-13 intranasally. Features of asthma were determined by estimating airway hyperresponsiveness (AHR), histopathological changes and biochemical assays of key inflammatory molecules. Airway injury was determined with apoptotic assays, transmission electron microscopy and assessing key mitochondrial functions. Baicalein treatment reduced AHR and inflammation in both experimental models. TGF-beta(1), sub-epithelial fibrosis and goblet cell metaplasia, were also reduced. Furthermore, baicalein treatment significantly reduced 12/15-LOX activity, features of mitochondrial dysfunctions, and apoptosis of bronchial epithelia. Conclusion/Significance: Our findings demonstrate that baicalein can attenuate important features of asthma, possibly through the reduction of airway injury and restoration of mitochondrial function.	[Mabalirajan, Ulaganathan; Ahmad, Tanveer; Rehman, Rakhshinda; Agrawal, Anurag; Ghosh, Balaram] CSIR Inst Genom & Integrat Biol, Immunogenet Mol Lab, Delhi, India; [Mabalirajan, Ulaganathan; Ahmad, Tanveer; Rehman, Rakhshinda; Agrawal, Anurag; Ghosh, Balaram] CSIR Inst Genom & Integrat Biol, Ctr Excellence Translat Res Asthma & Lung Dis, Delhi, India; [Leishangthem, Geeta Devi; Dinda, Amit Kumar] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Sharma, Surendra Kumar] All India Inst Med Sci, Dept Med, Div Pulm Crit Care & Sleep Med, New Delhi 110029, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Mabalirajan, U (corresponding author), CSIR Inst Genom & Integrat Biol, Immunogenet Mol Lab, Mall Rd, Delhi, India.	um.rajan@igib.res.in	Agrawal, Anurag/GZL-5821-2022; Leishangthem, Geeta Devi/AAE-6153-2022; Rehman, Rakhshinda/AAC-4141-2022	Rehman, Rakhshinda/0000-0002-1755-3416; Agrawal, Anurag/0000-0002-0340-5252; Ahmad, Tanveer/0000-0002-8384-5273	Council of Scientific and Industrial Research, Government of India [BSC 0116, MLP 5502]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants BSC 0116 and MLP 5502 from the Council of Scientific and Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Aguirre L, 2009, J IMMUNOL, V183, P5379, DOI 10.4049/jimmunol.0900228; Borish L, 2011, CURR ALLERGY ASTHM R, V11, P7, DOI 10.1007/s11882-010-0153-8; Chang WT, 2011, J CELL BIOCHEM, V112, P2873, DOI 10.1002/jcb.23201; Chilvers MA, 2001, EUR RESPIR J, V18, P965, DOI 10.1183/09031936.01.00093001; Choi JH, 2010, EXP MOL MED, V42, P811, DOI 10.3858/emm.2010.42.12.084; Donald G, 2012, CURR DRUG TARGETS, V13, P1772, DOI 10.2174/138945012804545470; Gao JB, 2011, MOL CANCER THER, V10, P1774, DOI 10.1158/1535-7163.MCT-11-0304; He R, 2010, ANN NY ACAD SCI, V1183, P13, DOI 10.1111/j.1749-6632.2009.05128.x; He XL, 2009, BRAIN RES, V1249, P212, DOI 10.1016/j.brainres.2008.10.005; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Hu Q, 2009, NEPHROL DIAL TRANSPL, V24, P3033, DOI 10.1093/ndt/gfp245; Huang Yu, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P177, DOI 10.2174/1568006043586206; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Kim SJ, 2012, MOL MED REP, V6, P1443, DOI 10.3892/mmr.2012.1085; Kimura Y, 1997, J ETHNOPHARMACOL, V57, P63, DOI 10.1016/S0378-8741(97)00045-7; KUHN H, 1990, J BIOL CHEM, V265, P1454; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lapchak PA, 2007, NEUROSCIENCE, V150, P585, DOI 10.1016/j.neuroscience.2007.09.033; Li HY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/267890; Li QX, 2004, J BIOL CHEM, V279, P11570, DOI 10.1074/jbc.M311773200; Li ZF, 2009, HEPATOB PANCREAT DIS, V8, P201; Mabalirajan U, 2008, J IMMUNOL, V181, P3540, DOI 10.4049/jimmunol.181.5.3540; Mabalirajan U, 2013, SCI REP-UK, V3, DOI 10.1038/srep01540; Mabalirajan U, 2013, SCI REP-UK, V3, DOI 10.1038/srep01349; Mabalirajan U, 2010, INT IMMUNOPHARMACOL, V10, P1514, DOI 10.1016/j.intimp.2010.08.025; Mabalirajan U, 2010, J ALLERGY CLIN IMMUN, V125, P626, DOI 10.1016/j.jaci.2009.10.065; Mabalirajan U, 2009, J IMMUNOL, V183, P2059, DOI 10.4049/jimmunol.0900342; Mabalirajan U, 2009, AM J PHYSIOL-LUNG C, V297, pL411, DOI 10.1152/ajplung.00138.2009; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; Mu X, 2009, PHARMACOL BIOCHEM BE, V92, P642, DOI 10.1016/j.pbb.2009.03.008; Nakajima T, 2001, PLANTA MED, V67, P132, DOI 10.1055/s-2001-11532; Netea MG, 2005, ANTIMICROB AGENTS CH, V49, P3991, DOI 10.1128/AAC.49.10.3991-3996.2005; Schewe T, 2002, BIOL CHEM, V383, P365, DOI 10.1515/BC.2002.041; Song JX, 2012, CHIN MED-UK, V7, DOI 10.1186/1749-8546-7-1; Suzukawa M, 2012, J IMMUNOL, V189, P3641, DOI 10.4049/jimmunol.1200461; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; TANNO Y, 1989, AM J CHINESE MED, V17, P45, DOI 10.1142/S0192415X89000085; Thomas B, 2010, J ALLERGY CLIN IMMUN, V126, P722, DOI 10.1016/j.jaci.2010.05.046; van Leyen K, 2006, STROKE, V37, P3014, DOI 10.1161/01.STR.0000249004.25444.a5; Wood LG, 2003, EUR RESPIR J, V21, P177, DOI 10.1183/09031936.03.00017003a; Yang LP, 2009, INVEST OPHTH VIS SCI, V50, P2319, DOI 10.1167/iovs.08-2642; You KR, 2002, J BIOL CHEM, V277, P3870, DOI 10.1074/jbc.M109284200; Zhang Y, 2013, FOOD CHEM TOXICOL, V53, P325, DOI 10.1016/j.fct.2012.12.019; Zhao JM, 2011, P NATL ACAD SCI USA, V108, P14246, DOI 10.1073/pnas.1018075108; Zhao JM, 2009, AM J RESP CRIT CARE, V179, P782, DOI 10.1164/rccm.200811-1744OC	47	38	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62916	10.1371/journal.pone.0062916	http://dx.doi.org/10.1371/journal.pone.0062916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646158	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300112
J	Matsuoka, RL; Sun, LO; Katayama, K; Yoshida, Y; Kolodkin, AL				Matsuoka, Ryota L.; Sun, Lu O.; Katayama, Kei-ichi; Yoshida, Yutaka; Kolodkin, Alex L.			Sema6B, Sema6C, and Sema6D Expression and Function during Mammalian Retinal Development	PLOS ONE			English	Article							LAMINA-RESTRICTED PROJECTION; HIPPOCAMPAL MOSSY FIBERS; MOUSE RETINA; TRANSMEMBRANE SEMAPHORINS; SYNAPSE FORMATION; SPINAL-CORD; CELL-TYPES; ROLES; DSCAM; CONE	In the vertebrate retina, the formation of neural circuits within discrete laminae is critical for the establishment of retinal visual function. Precise formation of retinal circuits requires the coordinated actions of adhesive and repulsive molecules, including repulsive transmembrane semaphorins (Sema6A, Sema5A, and Sema5B). These semaphorins signal through different Plexin A (PlexA) receptors, thereby regulating distinct aspects of retinal circuit assembly. Here, we investigate the physiological roles of three Class 6 transmembrane semaphorins (Sema6B, Sema6C, and Sema6D), previously identified as PlexA receptor ligands in non-retinal tissues, in mammalian retinal development. We performed expression analysis and also phenotypic analyses of mice that carry null mutations in each of genes encoding these proteins using abroad range of inner and outer retinal markers. We find that these Class 6 semaphorins are uniquely expressed throughout postnatal retinal development in specific domains and cell types of the developing retina. However, we do not observe defectsin stereotypical lamina-specific neurite stratification of retinal neuron subtypes in Sema6B(-/-) or Sema6C(-/-); Sema6D(-/-) retinas. These findings indicate these Class 6 transmembrane semaphorins are unlikely to serve as major PlexA receptor ligands for the assembly of murine retinal circuit laminar organization.	[Matsuoka, Ryota L.; Sun, Lu O.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Katayama, Kei-ichi; Yoshida, Yutaka] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA	Howard Hughes Medical Institute; Johns Hopkins University; Cincinnati Children's Hospital Medical Center	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu	Matsuoka, Ryota L./K-5439-2019; Sun, Lu O/P-9339-2015; Katayama, Kei-ichi/J-4699-2013	Matsuoka, Ryota L./0000-0001-6214-2889; Sun, Lu O/0000-0002-9293-7241; Katayama, Kei-ichi/0000-0003-0527-4644	National Institutes of Health (NIH) [R01 NS35165, R01 NS065048]; Howard Hughes Medical Institute; Nakajima Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065048, R01NS035165] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Nakajima Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) R01 NS35165 and NIH R01 NS065048 (http://www.nih.gov/), the Howard Hughes Medical Institute (http://www.hhmi.org/), and The Nakajima Foundation (http://www.nakajimafound.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Fuerst PG, 2010, GENESIS, V48, P578, DOI 10.1002/dvg.20662; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Leslie JR, 2011, DEVELOPMENT, V138, P4085, DOI 10.1242/dev.066076; Matsuoka RL, 2012, J NEUROSCI, V32, P6859, DOI 10.1523/JNEUROSCI.0267-12.2012; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Takamatsu H, 2010, NAT IMMUNOL, V11, P594, DOI 10.1038/ni.1885; Tawarayama H, 2010, J NEUROSCI, V30, P7049, DOI 10.1523/JNEUROSCI.0073-10.2010; Timofeev K, 2012, NEURON, V75, P80, DOI 10.1016/j.neuron.2012.04.037; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Xiao T, 2011, CELL, V146, P164, DOI 10.1016/j.cell.2011.06.016; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032; Zhu XM, 2002, MOL VIS, V8, P462	25	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63207	10.1371/journal.pone.0063207	http://dx.doi.org/10.1371/journal.pone.0063207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646199	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300156
J	McKenzie, F; Ellison-Loschmann, L; Jeffreys, M; Firestone, R; Pearce, N; Romieu, I				McKenzie, Fiona; Ellison-Loschmann, Lis; Jeffreys, Mona; Firestone, Ridvan; Pearce, Neil; Romieu, Isabelle			Cigarette Smoking and Risk of Breast Cancer in a New Zealand Multi-Ethnic Case-Control Study	PLOS ONE			English	Article							PASSIVE SMOKING; ACTIVE SMOKING; WOMEN; TOBACCO	Background: The association between breast cancer and tobacco smoke is currently unclear. The aim of this study was to assess the effect of smoking behaviours on the risk of breast cancer among three ethnic groups of New Zealand women. Methods: A population-based case-control study was conducted including breast cancer cases registered on the New Zealand Cancer Registry between 2005 and 2007. Controls were matched by ethnicity and 5-year age-group. Logistic regression was used to estimate the association between breast cancer and smoking at different time points across the lifecourse, for each ethnic group. Estimated odds ratios (OR) were adjusted for established risk factors. Results: The study comprised 1,799 cases (302 Maori, 70 Pacific, 1,427 non-Maori/non-Pacific) and 2,540 controls (746 Maori, 191 Pacific, 1,603 non-Maori/non-Pacific). There was no clear association between smoking and breast cancer for non-Maori/non-Pacific women, although non-Maori/non-Pacific ex-smokers had statistically significant increased risk of breast cancer when smoking duration was 20 years or more, and this remained significant in the fully adjusted model (OR 1.31, 95% CI 1.03 to 1.66). Maori showed more consistent increased risk of breast cancer with increasing duration among current smokers (<20 years OR 1.61, 95% CI 0.55 to 4.74; 20+ years OR 2.03, 95% CI 1.29 to 3.22). There was a clear pattern of shorter duration since smoking cessation being associated with increased likelihood of breast cancer, and this was apparent for all ethnic groups. Conclusion: There was no clear pattern for cigarette smoking and breast cancer incidence in non-Maori/non-Pacific women, but increased risks were observed for Maori and Pacific women. These findings suggest that lowering the prevalence of smoking, especially among Maori and Pacific women, could be important for reducing breast cancer incidence.	[McKenzie, Fiona; Romieu, Isabelle] Int Agcy Res Canc, F-69372 Lyon, France; [McKenzie, Fiona; Ellison-Loschmann, Lis; Firestone, Ridvan; Pearce, Neil] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Jeffreys, Mona] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Pearce, Neil] London Sch Hyg & Trop Med, London WC1, England	World Health Organization; International Agency for Research on Cancer (IARC); Massey University; University of Bristol; University of London; London School of Hygiene & Tropical Medicine	McKenzie, F (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	mckenzief@fellows.iarc.fr	Jeffreys, Mona/W-3425-2019; Firestone, Riz/AAU-2414-2021	Firestone, Riz/0000-0003-2834-8044; Pearce, Neil/0000-0002-9938-7852; Jeffreys, Mona/0000-0002-2617-0361	Cancer Society of New Zealand; Massey University Research Fund; Genesis Oncology Trust Postdoctoral Fellowship; Programme Grant from the Health Research Council of New Zealand	Cancer Society of New Zealand; Massey University Research Fund; Genesis Oncology Trust Postdoctoral Fellowship; Programme Grant from the Health Research Council of New Zealand	The New Zealand Breast Cancer Study was supported by the Cancer Society of New Zealand and the Massey University Research Fund. FM is currently funded through a Genesis Oncology Trust Postdoctoral Fellowship. The Centre for Public Health Research, Massey University Wellington is supported by a Programme Grant from the Health Research Council of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TP, 2009, CANCER CAUSE CONTROL, V20, P1837, DOI 10.1007/s10552-009-9376-1; Al-Delaimy WK, 2004, CANCER EPIDEM BIOMAR, V13, P398; Ambrosone CB, 2008, CANCER EPIDEM BIOMAR, V17, P15, DOI 10.1158/1055-9965.EPI-07-0598; Band PR, 2002, LANCET, V360, P1044, DOI 10.1016/S0140-6736(02)11140-8; BARON JA, 1990, AM J OBSTET GYNECOL, V162, P502, DOI 10.1016/0002-9378(90)90420-C; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Chen CZ, 2005, ENVIRON HEALTH PERSP, V113, P412, DOI 10.1289/ehp.7436; Conway K, 2002, CANCER RES, V62, P1987; Cui Y, 2006, BREAST CANCER RES TR, V100, P293, DOI 10.1007/s10549-006-9255-3; Deroo LA, 2011, AM J EPIDEMIOL, V174, P390, DOI 10.1093/aje/kwr090; Egan KM, 2002, EPIDEMIOLOGY, V13, P138, DOI 10.1097/00001648-200203000-00007; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Godin G, 1997, MED SCI SPORTS EXERC, pS36, DOI [10.2466/03.27.PMS.120v19x7, DOI 10.2466/03.27.PMS.120V19X7]; Gram IT, 2005, CANCER EPIDEM BIOMAR, V14, P61; Ha M, 2007, AM J EPIDEMIOL, V166, P55, DOI 10.1093/aje/kwm045; Hanaoka T, 2005, INT J CANCER, V114, P317, DOI 10.1002/ijc.20709; Hecht SS, 2002, ENVIRON MOL MUTAGEN, V39, P119, DOI 10.1002/em.10071; International Agency for Research on Cancer, 2012, REV HUM CARC PERS HA, V100; International Agency for Research on Cancer, 2004, TOB SMOK INV SMOK, V83; JEFFREYS M, 2012, CANCER CAUSE CONTROL, P21; Johnson KC, 2000, CANCER CAUSE CONTROL, V11, P211, DOI 10.1023/A:1008906105790; Johnson KC, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.035931; Lawlor DA, 2004, BRIT J CANCER, V91, P512, DOI 10.1038/sj.bjc.6601916; Lawton BA, 2008, CLIMACTERIC, V11, P467, DOI 10.1080/13697130802351094; Li CI, 2005, CANCER CAUSE CONTROL, V16, P975, DOI 10.1007/s10552-005-2906-6; Luo JH, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1016; MACMAHON B, 1982, NEW ENGL J MED, V307, P1062, DOI 10.1056/NEJM198210213071707; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; *MIN SOC DEV, 2007, SOC REP; Ministry of Health, 2011, MAOR SMOK TOB US 201; Ministry of Health, 2012, CANC NEW REG DEATHS; Olson JE, 2005, MAYO CLIN PROC, V80, P1423, DOI 10.4065/80.11.1423; PALMER JR, 1993, EPIDEMIOL REV, V15, P145, DOI 10.1093/oxfordjournals.epirev.a036098; Pokoradi AJ, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.059; Reynolds P, 2004, JNCI-J NATL CANCER I, V96, P29, DOI 10.1093/jnci/djh002; Russo J, 1982, Breast Cancer Res Treat, V2, P5, DOI 10.1007/BF01805718; Russo J, 1993, Eur J Cancer Prev, V2 Suppl 3, P85; Salmond C., 2007, NZDEP2006 INDEX DEPR; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Terry PD, 2002, INT J CANCER, V100, P723, DOI 10.1002/ijc.10536; Terry PD, 2002, CANCER EPIDEM BIOMAR, V11, P953; Xue F, 2011, ARCH INTERN MED, V171, P125, DOI 10.1001/archinternmed.2010.503	42	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63132	10.1371/journal.pone.0063132	http://dx.doi.org/10.1371/journal.pone.0063132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646186	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000319077300141
J	Chapman, SK; Newman, GS; Hart, SC; Schweitzer, JA; Koch, GW				Chapman, Samantha K.; Newman, Gregory S.; Hart, Stephen C.; Schweitzer, Jennifer A.; Koch, George W.			Leaf Litter Mixtures Alter Microbial Community Development: Mechanisms for Non-Additive Effects in Litter Decomposition	PLOS ONE			English	Article							FATTY-ACID ANALYSIS; ECOSYSTEM FUNCTION; SPECIES-DIVERSITY; FOREST SOILS; DYNAMICS; BIOMASS; CHEMISTRY; RATES; SUCCESSION; CARBON	To what extent microbial community composition can explain variability in ecosystem processes remains an open question in ecology. Microbial decomposer communities can change during litter decomposition due to biotic interactions and shifting substrate availability. Though relative abundance of decomposers may change due to mixing leaf litter, linking these shifts to the non-additive patterns often recorded in mixed species litter decomposition rates has been elusive, and links community composition to ecosystem function. We extracted phospholipid fatty acids (PLFAs) from single species and mixed species leaf litterbags after 10 and 27 months of decomposition in a mixed conifer forest. Total PLFA concentrations were 70% higher on litter mixtures than single litter types after 10 months, but were only 20% higher after 27 months. Similarly, fungal-to-bacterial ratios differed between mixed and single litter types after 10 months of decomposition, but equalized over time. Microbial community composition, as indicated by principal components analyses, differed due to both litter mixing and stage of litter decomposition. PLFA biomarkers a15:0 and cy17:0, which indicate gram-positive and gram-negative bacteria respectively, in particular drove these shifts. Total PLFA correlated significantly with single litter mass loss early in decomposition but not at later stages. We conclude that litter mixing alters microbial community development, which can contribute to synergisms in litter decomposition. These findings advance our understanding of how changing forest biodiversity can alter microbial communities and the ecosystem processes they mediate.	[Chapman, Samantha K.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Newman, Gregory S.; Schweitzer, Jennifer A.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Hart, Stephen C.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Koch, George W.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	Villanova University; University of Tennessee System; University of Tennessee Knoxville; University of California System; University of California Merced; Northern Arizona University	Chapman, SK (corresponding author), Villanova Univ, Dept Biol, Villanova, PA 19085 USA.	samantha.chapman@villanova.edu	Newman, Greg/B-9456-2015; Newman, Greg/AAW-9419-2020	Newman, Greg/0000-0001-8932-0809; Newman, Greg/0000-0001-8932-0809				Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Aneja MK, 2006, MICROB ECOL, V52, P127, DOI 10.1007/s00248-006-9006-3; Aneja MK, 2004, J MICROBIOL METH, V59, P223, DOI 10.1016/j.mimet.2004.07.005; [Anonymous], 1996, SOIL MICROBIOLOGY BI; Ball BA, 2009, SOIL BIOL BIOCHEM, V41, P1155, DOI 10.1016/j.soilbio.2009.02.025; Bardgett RD, 2004, SOIL BIOL BIOCHEM, V36, P555, DOI 10.1016/j.soilbio.2003.11.002; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P317, DOI 10.1016/S0038-0717(98)00121-7; Baumann K, 2009, SOIL BIOL BIOCHEM, V41, P1966, DOI 10.1016/j.soilbio.2009.06.022; BLACK RLB, 1977, T BRIT MYCOL SOC, V68, P284, DOI 10.1016/S0007-1536(77)80020-X; BLAIR JM, 1990, ECOLOGY, V71, P1976, DOI 10.2307/1937606; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bray SR, 2012, SOIL BIOL BIOCHEM, V49, P30, DOI 10.1016/j.soilbio.2012.02.009; Chapman SK, 2007, PLANT SOIL, V299, P153, DOI 10.1007/s11104-007-9372-8; Chapman SK, 2010, OECOLOGIA, V162, P763, DOI 10.1007/s00442-009-1498-3; Cotrufo MF, 2010, PLANT SOIL, V334, P365, DOI 10.1007/s11104-010-0388-0; De Marco A, 2011, PLANT SOIL, V344, P305, DOI 10.1007/s11104-011-0748-4; Frankland JC, 1998, MYCOL RES, V102, P1, DOI 10.1017/S0953756297005364; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Hansen RA, 1998, APPL SOIL ECOL, V9, P17, DOI 10.1016/S0929-1393(98)00048-1; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hattenschwiler S, 2005, P NATL ACAD SCI USA, V102, P1519, DOI 10.1073/pnas.0404977102; Hernandez DL, 2010, PLANT SOIL, V335, P397, DOI 10.1007/s11104-010-0428-9; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; HU S, 1995, SOIL BIOL BIOCHEM, V27, P1127, DOI 10.1016/0038-0717(95)00041-C; Kaneko N, 1999, ECOL RES, V14, P131, DOI 10.1046/j.1440-1703.1999.00292.x; Koide Kanade, 2005, Mycoscience, V46, P280, DOI 10.1007/s10267-005-0247-7; Kominoski JS, 2007, ECOLOGY, V88, P1167, DOI 10.1890/06-0674; Leary WMO, 1988, MICROBIAL LIPIDS, P117; Lecerf A, 2011, ECOLOGY, V92, P160, DOI 10.1890/10-0315.1; Leckie SE, 2005, FOREST ECOL MANAG, V220, P88, DOI 10.1016/j.foreco.2005.08.007; Lundquist EJ, 1999, SOIL BIOL BIOCHEM, V31, P221, DOI 10.1016/S0038-0717(98)00093-5; McMahon SK, 2005, SOIL SCI SOC AM J, V69, P1238, DOI 10.2136/sssaj2004.0289; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; Meier CL, 2010, SOIL BIOL BIOCHEM, V42, P1447, DOI 10.1016/j.soilbio.2010.05.005; Meier CL, 2008, P NATL ACAD SCI USA, V105, P19780, DOI 10.1073/pnas.0805600105; Mitchell RJ, 2012, PLANT SOIL, V351, P355, DOI 10.1007/s11104-011-0968-7; Nakamura A, 2003, BIOL FERT SOILS, V38, P288, DOI 10.1007/s00374-003-0658-6; Osono T, 2006, SOIL BIOL BIOCHEM, V38, P2743, DOI 10.1016/j.soilbio.2006.04.028; Poll C, 2008, SOIL BIOL BIOCHEM, V40, P1306, DOI 10.1016/j.soilbio.2007.04.002; Poll C, 2010, MICROB ECOL, V59, P130, DOI 10.1007/s00248-009-9541-9; Purahong W, 2011, FUNGAL DIVERS, V47, P1, DOI 10.1007/s13225-010-0083-8; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ramsey PW, 2006, PEDOBIOLOGIA, V50, P275, DOI 10.1016/j.pedobi.2006.03.003; Schimel JP, 2007, SOIL BIOL BIOCHEM, V39, P1428, DOI 10.1016/j.soilbio.2006.12.037; Schweitzer JA, 2005, ECOLOGY, V86, P2834, DOI 10.1890/04-1955; Schweitzer JA, 2008, ECOLOGY, V89, P773, DOI 10.1890/07-0337.1; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; SUBERKROPP K, 1976, ECOLOGY, V57, P707, DOI 10.2307/1936184; Swan CM, 2006, OECOLOGIA, V149, P107, DOI 10.1007/s00442-006-0436-x; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Torres PA, 2005, SOIL BIOL BIOCHEM, V37, P49, DOI 10.1016/j.soilbio.2004.04.042; Vos VCA, 2011, OIKOS, V120, P1092, DOI 10.1111/j.1600-0706.2010.18650.x; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810; Wilkinson SC, 2002, SOIL BIOL BIOCHEM, V34, P189, DOI 10.1016/S0038-0717(01)00168-7; Wilkinson SJ, 1989, MICROBIAL LIPIDS; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533	60	101	106	7	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62671	10.1371/journal.pone.0062671	http://dx.doi.org/10.1371/journal.pone.0062671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658639	Green Published, gold			2022-12-25	WOS:000321662800053
J	Kim, H; Claps, G; Moller, A; Bowtell, D; Lu, X; Ronai, ZA				Kim, H.; Claps, G.; Moeller, A.; Bowtell, D.; Lu, X.; Ronai, Z. A.			Siah2 regulates tight junction integrity and cell polarity through control of ASPP2 stability	ONCOGENE			English	Article						ASPP2; Siah2; epithelial polarity; tight junction; hypoxia	APOPTOSIS-STIMULATING PROTEIN; UBIQUITIN LIGASE; P53; ASPP2/(53BP2L); TUMORIGENESIS; INHIBITION; HOMOLOG; HYPOXIA; GROWTH; HIF	Changes in cell adhesion and polarity are closely associated with epithelial cell transformation and metastatic capacity. The tumor suppressor protein ASPP (Apoptosis-Stimulating Proteins of p53) 2 has been implicated in control of cell adhesion and polarity through its effect on the PAR complex. Here we demonstrate that under hypoxic conditions, the ubiquitin ligase Siah (seven in absentia homolog) 2 controls ASPP2 availability, with concomitant effect on epithelial cell polarity. LC-MS/MS analysis identified ASPP2 and ASPP1 as Siah2-interacting proteins. Biochemical analysis confirmed this interaction and mapped degron motifs within ASPP2, which are required for Siah2-mediated ubiquitination and proteasomal-dependent degradation. Inhibition of Siah2 expression increases ASPP2 levels and enhances ASPP2-dependent maintenance of tight junction (TJ) integrity, and polarized architecture in three dimensional (3D) organotypic culture. Conversely, increase of Siah2 expression under hypoxia decreases ASPP2 levels and the formation of apical polarity in 3D culture. In all, our studies demonstrate the role of Siah2 in regulation of TJ integrity and cell polarity under hypoxia, through its regulation of ASPP2 stability.	[Kim, H.; Claps, G.; Ronai, Z. A.] Sanford Burnham Med Res Inst, Ctr Canc, Signal Transduct Program, La Jolla, CA 92037 USA; [Moeller, A.; Bowtell, D.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic, Australia; [Bowtell, D.] Univ Melbourne, Dept Biochem, Parkville, Vic 3052, Australia; [Lu, X.] Ludwig Inst Canc Res, Nuffield Dept Med, Oxford, England	Sanford Burnham Prebys Medical Discovery Institute; Peter Maccallum Cancer Center; University of Melbourne; Ludwig Institute for Cancer Research; University of Oxford	Ronai, ZA (corresponding author), Sanford Burnham Med Res Inst, Ctr Canc, Signal Transduct Program, La Jolla, CA 92037 USA.	ronai@sbmri.org	Möller, Andreas/O-1063-2015; Bowtell, David/H-1007-2016; Claps, Giuseppina/G-6180-2018	Möller, Andreas/0000-0002-8618-6998; Bowtell, David/0000-0001-9089-7525; Lu, Xin/0000-0002-6587-1152; Kim, Hyungsoo/0000-0002-8189-5939; Claps, Giuseppina/0000-0002-3064-0063; RONAI, ZEEV/0000-0002-3859-0400	NCI [CA111515, CA128814]; NATIONAL CANCER INSTITUTE [P01CA128814, R01CA111515, P30CA030199] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Laurence M Brill of the SBMRI Proteomics Facility for mass spectrometric analysis of the Siah2-binding proteins. Support by NCI grants CA111515 and CA128814 (to ZR) is gratefully acknowledged.	Ahmed AU, 2008, JNCI-J NATL CANCER I, V100, P1606, DOI 10.1093/jnci/djn365; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Calzado MA, 2009, BIOL CHEM, V390, P1079, DOI 10.1515/BC.2009.112; Chen D, 2005, CELL DEATH DIFFER, V12, P358, DOI 10.1038/sj.cdd.4401536; Chen MF, 2011, P NATL ACAD SCI USA, V108, P9119, DOI 10.1073/pnas.1100028108; Cong WL, 2010, CURR BIOL, V20, P1408, DOI 10.1016/j.cub.2010.06.024; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Feigin ME, 2009, CURR OPIN CELL BIOL, V21, P694, DOI 10.1016/j.ceb.2009.07.003; Fogal V, 2005, CELL DEATH DIFFER, V12, P369, DOI 10.1038/sj.cdd.4401562; Habelhah H, 2004, J BIOL CHEM, V279, P53782, DOI 10.1074/jbc.M410315200; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; House CM, 2009, CANCER RES, V69, P8835, DOI 10.1158/0008-5472.CAN-09-1676; Kampa KM, 2009, P NATL ACAD SCI USA, V106, P4390, DOI 10.1073/pnas.0809080106; Kim H, 2011, MOL CELL, V44, P532, DOI 10.1016/j.molcel.2011.08.045; Langton PF, 2009, CURR BIOL, V19, P1969, DOI 10.1016/j.cub.2009.10.027; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Liu ZJ, 2005, FEBS LETT, V579, P1587, DOI 10.1016/j.febslet.2005.01.069; Moller A, 2009, ONCOGENE, V28, P289, DOI 10.1038/onc.2008.382; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Qi JF, 2008, P NATL ACAD SCI USA, V105, P16713, DOI 10.1073/pnas.0804063105; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Schmidt RL, 2007, CANCER RES, V67, P11798, DOI 10.1158/0008-5472.CAN-06-4471; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Szczepanowski M, 2007, BIOCHEM BIOPH RES CO, V362, P485, DOI 10.1016/j.bbrc.2007.08.042; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Zhu ZY, 2005, J BIOL CHEM, V280, P34473, DOI 10.1074/jbc.M503736200	31	17	17	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2014	33	15					2004	2010		10.1038/onc.2013.149	http://dx.doi.org/10.1038/onc.2013.149			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RK	23644657	Green Accepted			2022-12-25	WOS:000334346300013
J	Mizuno, K; Boudko, S; Engel, J; Bachinger, HP				Mizuno, Kazunori; Boudko, Sergei; Engel, Juergen; Baechinger, Hans Peter			Vascular Ehlers-Danlos Syndrome Mutations in Type III Collagen Differently Stall the Triple Helical Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; OSTEOGENESIS IMPERFECTA; TRIMERIZATION DOMAIN; CONNECTIVE-TISSUE; NC2 DOMAIN; CHAIN; DISORDER; FIBRILS; PEPTIDE; HAPLOINSUFFICIENCY	Vascular Ehlers-Danlos syndrome (EDS) type IV is the most severe form of EDS. In many cases the disease is caused by a point mutation of Gly in type III collagen. Aslower folding of the collagen helix is a potential cause for over-modifications. However, little is known about the rate of folding of type III collagen in patients with EDS. To understand the molecular mechanism of the effect of mutations, a system was developed for bacterial production of homotrimeric model polypeptides. The C-terminal quarter, 252 residues, of the natural human type III collagen was attached to (GPP)(7) with the type XIX collagen trimerization domain (NC2). The natural collagen domain forms a triple helical structure without 4-hydroxylation of proline at a low temperature. At 33 degrees C, the natural collagenous part is denatured, but the C-terminal (GPP)(7)-NC2 remains intact. Switching to a low temperature triggers the folding of the type III collagen domain in a zipper-like fashion that resembles the natural process. We used this system for the two known EDS mutations (Gly-to-Val) in the middle at Gly-910 and at the C terminus at Gly-1018. In addition, wild-type and Gly-to-Ala mutants were made. The mutations significantly slow down the overall rate of triple helix formation. The effect of the Gly-to-Val mutation is much more severe compared with Gly-to-Ala. This is the first report on the folding of collagen with EDS mutations, which demonstrates local delays in the triple helix propagation around the mutated residue.	[Mizuno, Kazunori; Boudko, Sergei; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland Res Ctr, Portland, OR 97239 USA; [Boudko, Sergei; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Oregon Health & Science University; Oregon Health & Science University; University of Basel	Bachinger, HP (corresponding author), Shriners Hosp Children, Portland Res Ctr, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org	Mizuno, Kazunori/AAY-7613-2021	Mizuno, Kazunori/0000-0003-3354-6264; Boudko, Sergei/0000-0003-3856-4859	Shriners Hospitals for Children	Shriners Hospitals for Children	This work was supported by a grant from Shriners Hospitals for Children (to H. P. B.).	Aebi U., 2006, CELL BIOL LAB HDB, P241; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; Bachinger HP, 2005, PROTEIN FOLDING HANDBOOK, P1059; Baumann M, 2012, AM J HUM GENET, V90, P201, DOI 10.1016/j.ajhg.2011.12.004; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439; Boudko S. P., 2012, INT J BIOCH CELL BIO, V44; Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200; Boudko SP, 2012, J BIOL CHEM, V287, P44536, DOI 10.1074/jbc.M112.417543; Boudko SP, 2010, J BIOL CHEM, V285, P23721, DOI 10.1074/jbc.M110.128405; Boudko SP, 2009, J MOL BIOL, V392, P787, DOI 10.1016/j.jmb.2009.07.057; Boudko SP, 2008, J BIOL CHEM, V283, P34345, DOI 10.1074/jbc.M806352200; Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; Colige A, 2004, J INVEST DERMATOL, V123, P656, DOI 10.1111/j.0022-202X.2004.23406.x; Colige A, 2005, J BIOL CHEM, V280, P34397, DOI 10.1074/jbc.M506458200; Cooper TK, 2010, VET PATHOL, V47, P1028, DOI 10.1177/0300985810374842; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; De Paepe A, 2012, CLIN GENET, V82, P1, DOI 10.1111/j.1399-0004.2012.01858.x; DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x; FLEISCHMAJER R, 1990, J STRUCT BIOL, V105, P162, DOI 10.1016/1047-8477(90)90110-X; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P59, DOI 10.1177/39.1.1983874; KEENE DR, 1987, J CELL BIOL, V105, P2393, DOI 10.1083/jcb.105.5.2393; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Malfait F, 2005, AM J MED GENET C, V139C, P17, DOI 10.1002/ajmg.c.30070; Mizuno K, 2010, BIOPHYS J, V98, P3004, DOI 10.1016/j.bpj.2010.03.019; MORRIS NP, 1986, J BIOL CHEM, V261, P5638; Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381; Okuyama K, 2009, ACTA CRYSTALLOGR D, V65, P1007, DOI 10.1107/S0907444909023051; PINNELL SR, 1972, NEW ENGL J MED, V286, P1013, DOI 10.1056/NEJM197205112861901; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; RICHARDS AJ, 1991, J MED GENET, V28, P458, DOI 10.1136/jmg.28.7.458; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Schmid FX, 2002, ADV PROTEIN CHEM, V59, P243; Schwarze U, 2001, AM J HUM GENET, V69, P989, DOI 10.1086/324123; Smith LB, 2011, CARDIOVASC RES, V90, P182, DOI 10.1093/cvr/cvq356; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; Wang WM, 2003, J BIOL CHEM, V278, P19549, DOI 10.1074/jbc.M300767200; Wirz JA, 2011, MATRIX BIOL, V30, P9, DOI 10.1016/j.matbio.2010.09.005; Wu JJ, 2010, J BIOL CHEM, V285, P18537, DOI 10.1074/jbc.M110.112904; Yoshizumi A, 2011, J BIOL CHEM, V286, P17512, DOI 10.1074/jbc.M110.217364; Yu ZX, 2010, PROTEIN SCI, V19, P775, DOI 10.1002/pro.356	50	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19166	19176		10.1074/jbc.M113.462002	http://dx.doi.org/10.1074/jbc.M113.462002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23645670	Green Published, hybrid			2022-12-25	WOS:000321335800050
J	Guerriero, CJ; Weiberth, KF; Brodsky, JL				Guerriero, Christopher J.; Weiberth, Kurt F.; Brodsky, Jeffrey L.			Hsp70 Targets a Cytoplasmic Quality Control Substrate to the San1p Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ER-ASSOCIATED DEGRADATION; A-FACTOR TRANSPORTER; TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; PROTEIN-DEGRADATION; MISFOLDED PROTEINS; MOLECULAR CHAPERONES; AAA-ATPASE	Accumulation of misfolded proteins in cellular compartments can result in stress-induced cell death. In the endoplasmic reticulum (ER), ER-associated degradation clears aberrant proteins from the secretory pathway. In the cytoplasm and nucleus, this job is left to the cytoplasmic quality control (CytoQC) machinery. Both processes utilize chaperones and the ubiquitin-proteasome system to aid in protein elimination. Previous studies in yeast have drawn comparisons between these processes using data from structurally and topologically different substrates. We sought to draw a direct comparison between ERAD and CytoQC by studying the elimination of a single misfolded domain that, depending on its residence, is disposed by either of these pathways. The truncated, second nucleotide binding domain (NBD2*) from a yeast ERAD substrate, Ste6p*, resides at the cytoplasmic face of the ER. We show that a soluble form of NBD2* is cytoplasmic and unlike wild-type NBD2 is targeted for proteasome-mediated degradation. In contrast to Ste6p*, which employs the ER-localized Doa10p ubiquitin ligase, NBD2* is ubiquitinated by a nuclear E3 ligase San1p, a factor that is also required for its degradation. Although the yeast cytoplasmic Hsp70 chaperone, Ssa1p, has been thought to facilitate the nuclear import or to maintain the solubility of most CytoQC substrates, we discovered that Ssa1p facilitates the interaction between San1p and NBD2*, demonstrating that chaperones can aid in substrate recognition and San1p-dependent protein degradation. These results emphasize the diverse action of molecular chaperones during CytoQC.	[Guerriero, Christopher J.; Weiberth, Kurt F.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, A320 Langley Hall, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu		Guerriero, Christopher/0000-0002-1046-2300	National Institutes of Health National Research Service [1F32GM090364, GM75061, DK79307]; American Heart Association [09POST2140058]; Beckman Scholars award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061, F32GM090364] Funding Source: NIH RePORTER	National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Beckman Scholars award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health National Research Service Award 1F32GM090364 (to C. J. G.) and Grants GM75061 and DK79307 (University of Pittsburgh George O'Brien Kidney Research Center) (to J. L. B.). This work was also supported by American Heart Association Grant 09POST2140058 (to C. J. G.) and a Beckman Scholars award (to K. F. W.).	ADAMS A, 1997, METHODS YEAST GENETI, P145; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Amberg D. C., 2005, METHODS YEAST GENETI, P149; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; BERKOWER C, 1991, EMBO J, V10, P3777, DOI 10.1002/j.1460-2075.1991.tb04947.x; BERKOWER C, 1994, MOL BIOL CELL, V5, P1185, DOI 10.1091/mbc.5.11.1185; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; Carmichael J, 2000, P NATL ACAD SCI USA, V97, P9701, DOI 10.1073/pnas.170280697; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Dasgupta A, 2004, J BIOL CHEM, V279, P26830, DOI 10.1074/jbc.M400894200; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fredrickson EK, 2013, J BIOL CHEM, V288, P6130, DOI 10.1074/jbc.M112.406710; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Gaczynska Maria, 2005, V301, P3; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hagiwara M, 2012, ANTIOXID REDOX SIGN, V16, P1119, DOI 10.1089/ars.2011.4495; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; JONES EW, 1984, ANNU REV GENET, V18, P233, DOI 10.1146/annurev.ge.18.120184.001313; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Kriegenburg F, 2012, FEBS J, V279, P532, DOI 10.1111/j.1742-4658.2011.08456.x; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lee DH, 2010, BIOCHEM BIOPH RES CO, V391, P1056, DOI 10.1016/j.bbrc.2009.12.018; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; Loayza D, 1998, MOL CELL BIOL, V18, P779, DOI 10.1128/MCB.18.2.779; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Mandal AK, 2010, MOL BIOL CELL, V21, P1439, DOI 10.1091/mbc.E09-09-0779; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; MIZUNAGA T, 1990, J BIOCHEM, V108, P846, DOI 10.1093/oxfordjournals.jbchem.a123291; MOIR D, 1982, GENETICS, V100, P547; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Park SY, 2010, BIOCHEM BIOPH RES CO, V391, P1449, DOI 10.1016/j.bbrc.2009.12.090; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Prasad R, 2012, BIOCHEM BIOPH RES CO, V425, P689, DOI 10.1016/j.bbrc.2012.07.080; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; SANDERS SL, 1992, CELL, V69, P353, DOI 10.1016/0092-8674(92)90415-9; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Sullivan ML, 2003, J HISTOCHEM CYTOCHEM, V51, P545, DOI 10.1177/002215540305100417; Summers DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052099; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Theodoraki MA, 2012, J BIOL CHEM, V287, P23911, DOI 10.1074/jbc.M112.341164; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Varshavsky AV, 2006, PROTEIN SCI, V15, P647, DOI 10.1110/ps.052012306; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Wang SY, 2011, J BIOL CHEM, V286, P29376, DOI 10.1074/jbc.M111.233346; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zhang Yimao, 2002, Methods Mol Med, V70, P257	99	61	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18506	18520		10.1074/jbc.M113.475905	http://dx.doi.org/10.1074/jbc.M113.475905			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653356	hybrid, Green Published			2022-12-25	WOS:000320721900052
J	Knyazev, DG; Lents, A; Krause, E; Ollinger, N; Siligan, C; Papinski, D; Winter, L; Horner, A; Pohl, P				Knyazev, Denis G.; Lents, Alexander; Krause, Eberhard; Ollinger, Nicole; Siligan, Christine; Papinski, Daniel; Winter, Lukas; Horner, Andreas; Pohl, Peter			The Bacterial Translocon SecYEG Opens upon Ribosome Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-CONDUCTING CHANNEL; PLANAR LIPID BILAYERS; ENDOPLASMIC-RETICULUM MEMBRANE; ESCHERICHIA-COLI; WATER PERMEABILITY; POLYPEPTIDE-CHAIN; SMALL MOLECULES; PLUG DOMAIN; COMPLEX; PURIFICATION	In co-translational translocation, the ribosome funnel and the channel of the protein translocation complex SecYEG are aligned. For the nascent chain to enter the channel immediately after synthesis, a yet unidentified signal triggers displacement of the SecYEG sealing plug from the pore. Here, we show that ribosome binding to the resting SecYEG channel triggers this conformational transition. The purified and reconstituted SecYEG channel opens to form a large ion-conducting channel, which has the conductivity of the plug deletion mutant. The number of ion-conducting channels inserted into the planar bilayer per fusion event roughly equals the number of SecYEG channels counted by fluorescence correlation spectroscopy in a single proteoliposome. Thus, the open probability of the channel must be close to unity. To prevent the otherwise lethal proton leak, a closed post-translational conformation of the SecYEG complex bound to a ribosome must exist.	[Knyazev, Denis G.; Lents, Alexander; Ollinger, Nicole; Siligan, Christine; Papinski, Daniel; Winter, Lukas; Horner, Andreas; Pohl, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4020 Linz, Austria; [Krause, Eberhard] Leibniz Inst Mol Pharmacol FMP, D-13125 Berlin, Germany	Johannes Kepler University Linz; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Pohl, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria.	peter.pohl@jku.at	Horner, Andreas/F-6427-2013; Knyazev, Denis G/E-5045-2019; Pohl, Peter/A-5361-2008	Horner, Andreas/0000-0002-5328-1745; Knyazev, Denis G/0000-0003-3197-1849; Pohl, Peter/0000-0002-1792-2314; Ollinger, Nicole/0000-0003-2659-6968	Austrian Science Fund (FWF) [P20872]; Austrian Science Fund (FWF) [P 20872] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Grant P20872 (to P. P.).	Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; BORGESE N, 1974, J MOL BIOL, V88, P559, DOI 10.1016/0022-2836(74)90408-2; Bostina M, 2005, J MOL BIOL, V352, P1035, DOI 10.1016/j.jmb.2005.08.005; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Clemons WM, 2001, J MOL BIOL, V310, P827, DOI 10.1006/jmbi.2001.4778; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Erdmann F, 2010, BIOCHEM BIOPH RES CO, V396, P714, DOI 10.1016/j.bbrc.2010.04.168; Erokhova L, 2011, J BIOL CHEM, V286, P39926, DOI 10.1074/jbc.M111.291864; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; FRESNO M, 1976, EUR J BIOCHEM, V68, P355, DOI 10.1111/j.1432-1033.1976.tb10822.x; Gumbart J, 2009, STRUCTURE, V17, P1453, DOI 10.1016/j.str.2009.09.010; Gumbart JC, 2013, J AM CHEM SOC, V135, P2291, DOI 10.1021/ja310777k; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Krylov AV, 2001, J GEN PHYSIOL, V118, P333, DOI 10.1085/jgp.118.4.333; Kusters I, 2011, STRUCTURE, V19, P430, DOI 10.1016/j.str.2010.12.016; Lange S, 2010, J PROTEOME RES, V9, P4113, DOI 10.1021/pr1003054; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; MILLER C, 1982, BIOPHYS J, V38, P227, DOI 10.1016/S0006-3495(82)84552-9; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Nijeholt JALA, 2011, J BIOL CHEM, V286, P43881, DOI 10.1074/jbc.M111.297507; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Pohl P, 2001, P NATL ACAD SCI USA, V98, P9624, DOI 10.1073/pnas.161299398; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; Saparov SM, 2001, J BIOL CHEM, V276, P31515, DOI 10.1074/jbc.M104267200; Schaletzky J, 2006, MOL BIOL CELL, V17, P3860, DOI 10.1091/mbc.e06-05-0439; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; SIMON SM, 1989, P NATL ACAD SCI USA, V86, P6176, DOI 10.1073/pnas.86.16.6176; SIMON SM, 1992, CELL, V69, P677, DOI 10.1016/0092-8674(92)90231-Z; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wonderlin WF, 2009, PFLUG ARCH EUR J PHY, V457, P917, DOI 10.1007/s00424-008-0545-y	38	37	37	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					17941	17946		10.1074/jbc.M113.477893	http://dx.doi.org/10.1074/jbc.M113.477893			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645666	hybrid, Green Published			2022-12-25	WOS:000320721900001
J	Mackie, AR; Krishnamurthy, P; Verma, SK; Thorne, T; Ramirez, V; Qin, G; Abramova, T; Hamada, H; Losordo, DW; Kishore, R				Mackie, Alexander R.; Krishnamurthy, Prasanna; Verma, Suresh K.; Thorne, Tina; Ramirez, Veronica; Qin, Gangjian; Abramova, Tatiana; Hamada, Hiromichi; Losordo, Douglas W.; Kishore, Raj			Alcohol Consumption Negates Estrogen-mediated Myocardial Repair in Ovariectomized Mice by Inhibiting Endothelial Progenitor Cell Mobilization and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE REPLACEMENT THERAPY; DOSE-DEPENDENT ACTIVATION; N-TERMINAL KINASE; CARDIOVASCULAR-DISEASE; ARTERIAL INJURY; CHRONIC ETHANOL; RECEPTOR-BETA; INFARCTION; ESTRADIOL; RECOVERY	We have shown previously that estrogen (estradiol, E2) supplementation enhances voluntary alcohol consumption in ovariectomized female rodents and that increased alcohol consumption impairs ischemic hind limb vascular repair. However, the effect of E2-induced alcohol consumption on post-infarct myocardial repair and on the phenotypic/functional properties of endothelial progenitor cells (EPCs) is not known. Additionally, the molecular signaling of alcohol-estrogen interactions remains to be elucidated. This study examined the effect of E2-induced increases in ethanol consumption on post-infarct myocardial function/repair. Ovariectomized female mice, implanted with 17 beta-E2 or placebo pellets were given access to alcohol for 6 weeks and subjected to acute myocardial infarction. Left ventricular functions were consistently depressed in mice consuming ethanol compared with those receiving only E2. Alcohol-consuming mice also displayed significantly increased infarct size and reduced capillary density. Ethanol consumption also reduced E2-induced mobilization and homing of EPCs to injured myocardium compared with the E2-alone group. In vitro, exposure of EPCs to ethanol suppressed E2-induced proliferation, survival, and migration and markedly altered E2-induced estrogen receptor-dependent cell survival signaling and gene expression. Furthermore, ethanol-mediated suppression of EPC biology was endothelial nitric oxide synthase-dependent because endothelial nitric oxide synthase-null mice displayed an exaggerated response to post-acute myocardial infarction left ventricular functions. These data suggest that E2 modulation of alcohol consumption, and the ensuing EPC dysfunction, may negatively compete with the beneficial effects of estrogen on post-infarct myocardial repair.	[Mackie, Alexander R.; Krishnamurthy, Prasanna; Verma, Suresh K.; Thorne, Tina; Ramirez, Veronica; Qin, Gangjian; Abramova, Tatiana; Hamada, Hiromichi; Losordo, Douglas W.; Kishore, Raj] Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Kishore, R (corresponding author), Northwestern Univ, Feinberg Cardiovasc Res Inst, 303 E Super St, Chicago, IL 60611 USA.	r-kishore@northwestern.edu	Verma, Suresh/AAU-9979-2020	Losordo, Douglas/0000-0002-6857-7506; KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364; Verma, Suresh Kumar/0000-0002-0739-1302	National Institute of Health [HL091983, HL105597, HL095874, HL053354, HL108795, HL093439, HL113541]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108795, R01HL095874, R01HL113541, R01HL091983, R01HL093439, R01HL053354, R37HL053354, R01HL105597] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institute of Health Grants HL091983, HL105597, HL095874, HL053354, and HL108795 (to R. K.) and HL093439 and HL113541 (to G. Q.).	Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Chilvers CED, 2003, EUR HEART J, V24, P2197, DOI 10.1016/j.ehj.2003.09.019; Ford MM, 2004, ALCOHOL CLIN EXP RES, V28, P20, DOI 10.1097/01.ALC.0000108647.62718.5A; Ford MM, 2002, ALCOHOL, V26, P103, DOI 10.1016/S0741-8329(01)00203-8; GAVALER JS, 1991, ALCOHOL ALCOHOLISM, P327; GAZIANO JM, 1993, NEW ENGL J MED, V329, P1829, DOI 10.1056/NEJM199312163292501; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Hamada H, 2006, CIRCULATION, V114, P2261, DOI 10.1161/CIRCULATIONAHA.106.631465; HilakiviClarke L, 1996, J STUD ALCOHOL, V57, P162, DOI 10.15288/jsa.1996.57.162; Hill S. Y, 1984, ALCOHOL PROBLEMS WOM, P121; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Jonsson ASM, 2001, J INFECT DIS, V184, P761, DOI 10.1086/322985; Jujo K, 2010, P NATL ACAD SCI USA, V107, P11008, DOI 10.1073/pnas.0914248107; Jung Y, 2008, GASTROENTEROLOGY, V134, P1532, DOI 10.1053/j.gastro.2008.02.022; Kishore R, 2005, J CLIN INVEST, V115, P1785, DOI 10.1172/JCI22849; Kishore R, 2003, CIRC RES, V93, P932, DOI 10.1161/01.RES.0000102400.22370.20; Kishore R, 2001, J BIOL CHEM, V276, P41930, DOI 10.1074/jbc.M107181200; KLATSKY AL, 1994, ALCOHOL CLIN EXP RES, V18, P88, DOI 10.1111/j.1530-0277.1994.tb00886.x; Krasinski K, 1997, CIRCULATION, V95, P1768; Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369; Kuhlmann CRW, 2004, ALCOHOL CLIN EXP RES, V28, P1005, DOI 10.1097/01.ALC.0000130811.92457.0D; Lindenfield J, 2003, J AM COLL CARDIOL, V42, P1238, DOI 10.1016/S0735-1097(03)00938-0; Liu J, 2002, J BIOL CHEM, V277, P20927, DOI 10.1074/jbc.M110712200; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Luedemann C, 2005, ALCOHOL CLIN EXP RES, V29, P930, DOI 10.1097/01.ALC.0000171037.90100.6B; Mackie AR, 2012, CIRC RES, V111, P312, DOI 10.1161/CIRCRESAHA.112.266015; Masuda H, 2007, CIRC RES, V101, P598, DOI 10.1161/CIRCRESAHA.106.144006; MEDINA KL, 1994, P NATL ACAD SCI USA, V91, P5382, DOI 10.1073/pnas.91.12.5382; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Merritt R, 1997, J CARDIOVASC PHARM, V30, P19, DOI 10.1097/00005344-199707000-00004; Mukamal KJ, 2003, ARTERIOSCL THROM VAS, V23, P2252, DOI 10.1161/01.ATV.0000101183.58453.39; Okubo Y, 1998, J BIOL CHEM, V273, P25961, DOI 10.1074/jbc.273.40.25961; PREEDY VR, 1993, BRIT HEART J, V69, P197; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Puddey IB, 2001, CLIN EXP PHARMACOL P, V28, P1020, DOI 10.1046/j.1440-1681.2001.03572.x; Rajasingh J, 2007, ENDOCRINOLOGY, V148, P3618, DOI 10.1210/en.2006-1357; REGAN TJ, 1990, JAMA-J AM MED ASSOC, V264, P377, DOI 10.1001/jama.264.3.377; Reid ML, 2003, PHARMACOL BIOCHEM BE, V74, P381, DOI 10.1016/S0091-3057(02)01008-0; Roncalli J, 2011, J AM COLL CARDIOL, V57, P2444, DOI 10.1016/j.jacc.2010.11.069; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; RUBIN E, 1994, ALCOHOL CLIN EXP RES, V18, P111, DOI 10.1111/j.1530-0277.1994.tb00889.x; Rubin E, 1996, ALCOHOL CARDIOVASCUL, P127; Schoppet M, 2001, HERZ, V26, P345, DOI 10.1007/PL00002037; Singh AK, 2009, ALCOHOL ALCOHOLISM, V44, P185, DOI 10.1093/alcalc/agn109; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30; Thal MA, 2012, CIRC RES, V111, P180, DOI 10.1161/CIRCRESAHA.112.270462; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Williams GD., 1989, ALCOHOL RES HEALTH, V1989, P366; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Zhu Y, 2002, SCIENCE, V295, P505, DOI 10.1126/science.1065250	56	4	4	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18022	18034		10.1074/jbc.M113.468009	http://dx.doi.org/10.1074/jbc.M113.468009			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645678	Green Published, hybrid			2022-12-25	WOS:000320721900009
J	Zhang, MX; Patriarchi, T; Stein, IS; Qian, H; Matt, L; Nguyen, M; Xiang, YK; Hell, JW				Zhang, Mingxu; Patriarchi, Tommaso; Stein, Ivar S.; Qian, Hai; Matt, Lucas; Minh Nguyen; Xiang, Yang K.; Hell, Johannes W.			Adenylyl Cyclase Anchoring by a Kinase Anchor Protein AKAP5 (AKAP79/150) Is Important for Postsynaptic beta-Adrenergic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; RECEPTOR GLUR1 SUBUNIT; GLUR2-LACKING AMPA RECEPTORS; HIPPOCAMPAL CA1 REGION; D-ASPARTATE RECEPTOR; CALCIUM-CHANNEL CA(V)1.2; SYNAPTIC PLASTICITY; BETA(2)-ADRENERGIC RECEPTOR; GLUTAMATE RECEPTORS; PHOSPHORYLATION SITES	Recent evidence indicates that the A kinase anchor protein AKAP5 (AKAP79/150) interacts not only with PKA but also with various adenylyl cyclase (AC) isoforms. However, the physiological relevance of AC-AKAP5 binding is largely unexplored. We now show that postsynaptic targeting of AC by AKAP5 is important for phosphorylation of the AMPA-type glutamate receptor subunit GluA1 on Ser-845 by PKA and for synaptic plasticity. Phosphorylation of GluA1 on Ser-845 is strongly reduced (by 70%) under basal conditions in AKAP5 KO mice but not at all in D36 mice, in which the PKA binding site of AKAP5 (i.e. the C-terminal 36 residues) has been deleted without affecting AC association with GluA1. The increase in Ser-845 phosphorylation upon beta-adrenergic stimulation is much more severely impaired in AKAP5 KO than in D36 mice. In parallel, long term potentiation induced by a 5-Hz/180-s tetanus, which mimics the endogenous theta-rhythm and depends on beta-adrenergic stimulation, is only modestly affected in acute forebrain slices from D36 mice but completely abrogated in AKAP5 KO mice. Accordingly, anchoring of not only PKA but also AC by AKAP5 is important for regulation of postsynaptic functions and specifically AMPA receptor activity.	[Zhang, Mingxu; Stein, Ivar S.; Qian, Hai; Hell, Johannes W.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Zhang, Mingxu; Patriarchi, Tommaso; Stein, Ivar S.; Matt, Lucas; Minh Nguyen; Xiang, Yang K.; Hell, Johannes W.] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95615 USA	University of Iowa; University of California System; University of California Davis	Hell, JW (corresponding author), 451 E Hlth Sci Dr, Davis, CA 95616 USA.	jwhell@ucdavis.edu	Hell, Johannes W./P-5085-2019; Patriarchi, Tommaso/AAK-8653-2020	Patriarchi, Tommaso/0000-0001-9351-3734; Matt, Lucas/0000-0003-3235-5140	National Institutes of Health [NS078792, AG017502]; University of Iowa; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017502, R56AG017502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS078792 and AG017502 (to J. W. H.). This work was also supported by a presidential predoctoral fellowship from the University of Iowa (to M. Z.).	Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; CARR DW, 1992, J BIOL CHEM, V267, P16816; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; El-Hussein AE, 2000, SCIENCE, V290, P1364; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Gelinas JN, 2005, J NEUROSCI, V25, P3294, DOI 10.1523/JNEUROSCI.4175-04.2005; Gomez LL, 2002, J NEUROSCI, V22, P7027; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Gray EE, 2007, J NEUROPHYSIOL, V98, P2488, DOI 10.1152/jn.00473.2007; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Hall DD, 2006, BIOCHEMISTRY-US, V45, P3448, DOI 10.1021/bi051593z; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Hammond RS, 2008, J NEUROSCI, V28, P7513, DOI 10.1523/JNEUROSCI.1951-08.2008; Havekes R, 2012, J NEUROSCI, V32, P18137, DOI 10.1523/JNEUROSCI.3612-12.2012; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hoogland TM, 2004, J NEUROSCI, V24, P8416, DOI 10.1523/JNEUROSCI.1677-04.2004; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Katsuki H, 1997, J NEUROPHYSIOL, V77, P3013, DOI 10.1152/jn.1997.77.6.3013; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; Lin FB, 2000, J BIOL CHEM, V275, P19025, DOI 10.1074/jbc.275.25.19025; Lin L, 2011, J NEUROSCI, V31, P1323, DOI 10.1523/JNEUROSCI.5383-10.2011; Lin YW, 2003, J NEUROSCI, V23, P4173; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lu Y, 2008, J PHYSIOL-LONDON, V586, P4155, DOI 10.1113/jphysiol.2008.151662; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Lu Y, 2011, J BIOL CHEM, V286, P26496, DOI 10.1074/jbc.M111.254912; Magazanik LG, 1997, J PHYSIOL-LONDON, V505, P655, DOI 10.1111/j.1469-7793.1997.655ba.x; Makino Y, 2011, P NATL ACAD SCI USA, V108, P8450, DOI 10.1073/pnas.1105261108; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Mehta S, 2001, J BIOL CHEM, V276, P16092, DOI 10.1074/jbc.M100643200; Minzenberg MJ, 2008, SCIENCE, V322, P1700, DOI 10.1126/science.1164908; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; NIELSON KA, 1994, BEHAV NEURAL BIOL, V62, P190, DOI 10.1016/S0163-1047(05)80017-2; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Qian H, 2012, J NEUROPHYSIOL, V107, P2703, DOI 10.1152/jn.00374.2011; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shankar S, 1998, J NEUROPHYSIOL, V79, P334, DOI 10.1152/jn.1998.79.1.334; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Strange BA, 2004, P NATL ACAD SCI USA, V101, P11454, DOI 10.1073/pnas.0404282101; Strange BA, 2003, P NATL ACAD SCI USA, V100, P13626, DOI 10.1073/pnas.1635116100; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Swayze RD, 2004, NEUROPHARMACOLOGY, V47, P764, DOI 10.1016/j.neuropharm.2004.07.014; Tao JC, 2003, EMBO J, V22, P6419, DOI 10.1093/emboj/cdg628; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Valtschanoff JG, 2000, EUR J NEUROSCI, V12, P3605, DOI 10.1046/j.1460-9568.2000.00256.x; Vanhoose AM, 2003, J NEUROSCI, V23, P5827; Walling SG, 2004, J NEUROSCI, V24, P598, DOI 10.1523/JNEUROSCI.4426-03.2004; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Weisenhaus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010325; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Willoughby D, 2010, J BIOL CHEM, V285, P20328, DOI 10.1074/jbc.M110.120725; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	108	49	50	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17918	17931		10.1074/jbc.M112.449462	http://dx.doi.org/10.1074/jbc.M112.449462			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23649627	hybrid, Green Published			2022-12-25	WOS:000320380600079
J	Fang, Y; Wei, JH; Cao, JZ; Zhao, HW; Liao, B; Qiu, SP; Wang, DH; Luo, JH; Chen, W				Fang, Yong; Wei, Jinhuan; Cao, Jiazheng; Zhao, Hongwei; Liao, Bing; Qiu, Shaopeng; Wang, Daohu; Luo, Junhang; Chen, Wei			Protein Expression of ZEB2 in Renal Cell Carcinoma and Its Prognostic Significance in Patient Survival	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SMAD-INTERACTING PROTEIN-1; E-CADHERIN REPRESSORS; REGULATES E-CADHERIN; TRANSCRIPTION FACTORS; TUMOR PROGRESSION; OVARIAN-CARCINOMA; MIR-200 FAMILY; SIP1; CANCER	Background: ZEB2 has been reportedly shown to mediate the epithelial-to-mesenchymal transition (EMT) and disease aggressiveness in human tumors. However, the expression status of ZEB2 in renal cell carcinoma (RCC) and ZEB2's clinicopathologic/prognostic significance are poorly understood. Methodology/Principal Findings: In this study, tissue microarray, immunohistochemistry (IHC) and western blot analyses were utilized to investigate the ZEB2 expression status in RCC and adjacent renal tissue samples. In our study, samples from 116 RCC patients treated with radical nephrectomy were used as a training set to generate a ZEB2 optimal cut-point for patient outcome by receiver operating characteristic (ROC) analysis. For validation, the correlation of ZEB2 expression with the clinical characteristics and patient outcomes in another set (including 113 patients) was analyzed to validate the obtained cut-point. In the training and validation sets, high expression of ZEB2, defined by ROC analysis, predicted a poorer overall survival and progression-free survival, as evidenced by the univariate and multivariate analyses. In different subsets of overall patients, ZEB2 expression was also a prognostic indicator in patients with stage I/II, stage III/IV, grade 1/2 and grade 3/4 disease (P<0.05). Downregulation of ZEB2 by shRNA decreased the migration and invasion ability of 769-P cells in vitro. Furthermore, high ZEB2 expression was positively correlated with vimentin expression and inversely linked to E-cadherin expression in RCC. Conclusions/Significance: Our findings provide a basis for the concept that high ZEB2 expression in RCC may be important in the acquisition of an aggressive phenotype. This evidence suggests that ZEB2 overexpression (examined by IHC) is an independent biomarker for the poor prognosis of patients with RCC.	[Fang, Yong; Wei, Jinhuan; Qiu, Shaopeng; Wang, Daohu; Luo, Junhang; Chen, Wei] Sun Yat Sen Univ, Dept Urol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Cao, Jiazheng] Sun Yat Sen Univ, Affiliated Jiangmen Hosp, Dept Urol, Jiangmen, Peoples R China; [Zhao, Hongwei] Qingdao Univ, Coll Med, Affiliated Yantai Yuhuangding Hosp, Dept Urol, Yantai, Peoples R China; [Liao, Bing] Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Qingdao University; Sun Yat Sen University	Luo, JH (corresponding author), Sun Yat Sen Univ, Dept Urol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	unhangluo@126.com; chenw3@mail.sysu.edu.cn						[Anonymous], 2008, CANC INCIDENCE 5 CON, VIX, P1; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Bettendorf U, 2009, PATHOLOGE, V30, P20, DOI [10.1007/s00292-008-1121-0, 10.1007/s00292-009-1179-3]; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Cai MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032838; Cai MY, 2011, GUT, V60, P967, DOI 10.1136/gut.2010.231993; Cai MY, 2011, MOL MED, V17, P12, DOI 10.2119/molmed.2010.00103; Cai MY, 2010, CANCER SCI, V101, P1543, DOI 10.1111/j.1349-7006.2010.01560.x; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Harada K, 2012, BJU INT, V110, pE1131, DOI 10.1111/j.1464-410X.2012.11297.x; Imamichi Y, 2007, ONCOGENE, V26, P2381, DOI 10.1038/sj.onc.1210012; Kim SP, 2011, J UROLOGY, V185, P2035, DOI 10.1016/j.juro.2011.02.059; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Lam JS, 2006, J CLIN ONCOL, V24, P5565, DOI 10.1200/JCO.2006.08.1794; Maeda G, 2005, INT J ONCOL, V27, P1535; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685; Oztas E, 2010, EXP MOL PATHOL, V89, P182, DOI 10.1016/j.yexmp.2010.05.010; Ozturk N, 2006, P NATL ACAD SCI USA, V103, P2178, DOI 10.1073/pnas.0510877103; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Sakamoto K, 2012, ANN SURG ONCOL, V19, P612, DOI 10.1245/s10434-011-2052-1; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Grunsven LA, 2003, J BIOL CHEM, V278, P26135, DOI 10.1074/jbc.M300597200; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yoshida J, 2009, MED MOL MORPHOL, V42, P82, DOI 10.1007/s00795-008-0436-5	36	58	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62558	10.1371/journal.pone.0062558	http://dx.doi.org/10.1371/journal.pone.0062558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658743	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500029
J	Shah, SN; Cope, L; Poh, W; Belton, A; Roy, S; Talbot, CC; Sukumar, S; Huso, DL; Resar, LMS				Shah, Sandeep N.; Cope, Leslie; Poh, Weijie; Belton, Amy; Roy, Sujayita; Talbot, C. Conover, Jr.; Sukumar, Saraswati; Huso, David L.; Resar, Linda M. S.			HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELL; MESENCHYMAL TRANSITION; UTERINE TUMORIGENESIS; EPITHELIAL-CELLS; TRANSGENIC MICE; TARGET GENE; C-MYC; TRANSFORMATION; TRANSCRIPTION	Emerging evidence suggests that tumor cells metastasize by co-opting stem cell transcriptional networks, although the molecular underpinnings of this process are poorly understood. Here, we show for the first time that the high mobility group A1 (HMGA1) gene drives metastatic progression in triple negative breast cancer cells (MDA-MB-231, Hs578T) by reprogramming cancer cells to a stem-like state. Silencing HMGA1 expression in invasive, aggressive breast cancer cells dramatically halts cell growth and results in striking morphologic changes from mesenchymal-like, spindle-shaped cells to cuboidal, epithelial-like cells. Mesenchymal genes (Vimentin, Snail) are repressed, while E-cadherin is induced in the knock-down cells. Silencing HMGA1 also blocks oncogenic properties, including proliferation, migration, invasion, and orthotopic tumorigenesis. Metastatic progression following mammary implantation is almost completely abrogated in the HMGA1 knock-down cells. Moreover, silencing HMGA1 inhibits the stem cell property of three-dimensional mammosphere formation, including primary, secondary, and tertiary spheres. In addition, knock-down of HMGA1 depletes cancer initiator/cancer stem cells and prevents tumorigenesis at limiting dilutions. We also discovered an HMGA1 signature in triple negative breast cancer cells that is highly enriched in embryonic stem cells. Together, these findings indicate that HMGA1 is a master regulator of tumor progression in breast cancer by reprogramming cancer cells through stem cell transcriptional networks. Future studies are needed to determine how to target HMGA1 in therapy.	[Shah, Sandeep N.; Belton, Amy; Roy, Sujayita; Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Cope, Leslie; Sukumar, Saraswati; Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Cope, Leslie] Johns Hopkins Univ, Sch Med, Dept Biostat, Baltimore, MD USA; [Poh, Weijie; Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Pathobiol Grad Program, Baltimore, MD USA; [Talbot, C. Conover, Jr.] Johns Hopkins Univ, Sch Med, Inst Basic Biomed Sci, Baltimore, MD USA; [Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Comparat Mol & Pathobiol, Baltimore, MD USA; [Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Inst Cellular Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Resar, LMS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA.	lresar@jhmi.edu			NIH [R21 CA2149550-0131, RO1 CA092339]; Safeway Breast Cancer Fund; Maryland Technology Development Corporation (TEDCO) State of Maryland Stem Cell Initiative Exploratory Award [2009-MSCRFE-0105-00]; Maryland Technology Development Corporation (TEDCO) State of Maryland Stem Cell Research Fund [2011-MSCRFE-0135-00]; TEDCO State of Maryland Stem Cell Initiative Exploratory Award [2011-MSCRFE-0102-00]; NATIONAL CANCER INSTITUTE [R01CA092339] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Safeway Breast Cancer Fund; Maryland Technology Development Corporation (TEDCO) State of Maryland Stem Cell Initiative Exploratory Award; Maryland Technology Development Corporation (TEDCO) State of Maryland Stem Cell Research Fund; TEDCO State of Maryland Stem Cell Initiative Exploratory Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by the following: LMSR: NIH R21 CA2149550-0131, NIH RO1 CA092339, Safeway Breast Cancer Fund, Maryland Technology Development Corporation (TEDCO) State of Maryland Stem Cell Initiative Exploratory Award 2009-MSCRFE-0105-00. SNS: Maryland Technology Development Corporation (TEDCO) State of Maryland Stem Cell Research Fund 2011-MSCRFE-0135-00. AB: TEDCO State of Maryland Stem Cell Initiative Exploratory Award 2011-MSCRFE-0102-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Belton A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030034; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Dang CV, 2012, CANCER DISCOV, V2, P304, DOI 10.1158/2159-8290.CD-12-0069; Dhar A, 2004, ONCOGENE, V23, P4466, DOI 10.1038/sj.onc.1207581; Di Cello F, 2013, LEUK LYMPHOMA; Di Cello F, 2008, MOL CANCER THER, V7, P2090, DOI 10.1158/1535-7163.MCT-07-2282; Dolde CE, 2002, BREAST CANCER RES TR, V71, P181, DOI 10.1023/A:1014444114804; Flohr AM, 2003, HISTOL HISTOPATHOL, V18, P999, DOI 10.14670/HH-18.999; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hillion J, 2009, MOL CANCER RES, V7, P1803, DOI 10.1158/1541-7786.MCR-08-0336; Hillion J, 2008, CANCER RES, V68, P10121, DOI 10.1158/0008-5472.CAN-08-2121; Hommura F, 2004, MOL CANCER RES, V2, P305; Hristov AC, 2010, MODERN PATHOL, V23, P98, DOI 10.1038/modpathol.2009.139; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Karp JE, 2011, BLOOD, V117, P3302, DOI 10.1182/blood-2010-09-310862; Lee JS, 2010, CANCER BIOL THER, V9, P1017, DOI 10.4161/cbt.9.12.11804; Liau SS, 2006, CANCER RES, V66, P11613, DOI 10.1158/0008-5472.CAN-06-1460; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Muromoto R, 2008, INT IMMUNOL, V20, P395, DOI 10.1093/intimm/dxm154; Nelson DM, 2011, LEUKEMIA LYMPHOMA, V52, P1999, DOI 10.3109/10428194.2011.591012; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pedulla ML, 2001, GENE, V271, P51, DOI 10.1016/S0378-1119(01)00500-5; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Resar LMS, 2010, CANCER RES, V70, P436, DOI 10.1158/0008-5472.CAN-09-1212; Schuldenfrei A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-549; Semenza GL, 2012, ONCOGENE IN PRESS; Shah SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048533; Shah SN, 2012, HISTOL HISTOPATHOL, V27, P567, DOI 10.14670/HH-27.567; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Takaha N, 2004, PROSTATE, V60, P160, DOI 10.1002/pros.20049; Tesfaye A, 2007, CANCER RES, V67, P3998, DOI 10.1158/0008-5472.CAN-05-1684; Thibodeaux CA, 2009, BREAST CANCER RES TR, V116, P281, DOI 10.1007/s10549-008-0127-x; Tront JS, 2010, CANCER RES, V70, P9671, DOI 10.1158/0008-5472.CAN-10-2177; WILLIAMS MD, 2013, ANAL BIOANAL CHEM; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Xu Y, 2004, CANCER RES, V64, P3371, DOI 10.1158/0008-5472.CAN-04-0044; Zhou GL, 2001, P NATL ACAD SCI USA, V98, P13966, DOI 10.1073/pnas.241526198	48	101	105	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63419	10.1371/journal.pone.0063419	http://dx.doi.org/10.1371/journal.pone.0063419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658826	gold, Green Published, Green Submitted			2022-12-25	WOS:000321200500068
J	Chakraborty, D; Conley, SM; Naash, MI				Chakraborty, Dibyendu; Conley, Shannon M.; Naash, Muna I.			Overexpression of Retinal Degeneration Slow (RDS) Protein Adversely Affects Rods in the rd7 Model of Enhanced S-Cone Syndrome	PLOS ONE			English	Article							NUCLEAR RECEPTOR NR2E3; OF-FUNCTION PHENOTYPE; PERIPHERIN/RDS CAUSES; MUTATION; GENE; EXPRESSION; OLIGOMERIZATION; MORPHOGENESIS; NRL; TRANSCRIPTION	The nuclear receptor NR2E3 promotes expression of rod photoreceptor genes while repressing cone genes. Mice lacking NR2E3 (Nr2e3(rd7/rd7) referred to here as rd7) are a model for enhanced S-cone syndrome, a disease associated with increased sensitivity to blue light and night blindness. Rd7 retinas have reduced levels of the outer segment (OS) structural protein retinal degeneration slow (RDS). We test the hypothesis that increasing RDS levels would improve the Rd7 phenotype. Transgenic mice over-expressing normal mouse peripherin/RDS (NMP) in rods and cones were crossed onto the rd7 background. Disease phenotypes were assessed in NMP/rd7 eyes and compared to wild-type (WT) and rd7 eyes at postnatal day 30. NMP/rd7 retinas expressed total RDS (transgenic and endogenous) message at WT levels, and NMP protein was correctly localized to the OS. NMP/rd7 retinas have shorter OSs compared to rd7 and WT and significantly reduced number of rosettes. NMP/rd7 mice also exhibited significant deficits in scotopic ERG amplitudes compared to rd7 while photopic amplitudes remained unaffected. Protein levels of rhodopsin, RDS, and the RDS homologue ROM-1 were significantly reduced in the NMP/rd7 retinas compared to rd7. We show that correcting the levels of RDS gene expression does not improve the phenotype of the rd7 suggesting that RDS deficiency is not responsible for the defect in this model. We suggest that the specific rod defect in the NMP/rd7 is likely associated with ongoing problems in the rd7 that are related to the expression of cone genes in rod cells, a characteristic of the model.	[Chakraborty, Dibyendu; Conley, Shannon M.; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Naash, MI (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA.	muna-naash@ouhsc.edu			NIH [EY10609-MIN, EY018512-SMC]; Foundation Fighting Blindness; Oklahoma Center for the Advancement of Science and Technology; NATIONAL EYE INSTITUTE [R56EY010609, F32EY018512, R01EY010609, R55EY010609] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Oklahoma Center for the Advancement of Science and Technology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by funding from the NIH (EY10609-MIN, EY018512-SMC), The Foundation Fighting Blindness (MIN), and the Oklahoma Center for the Advancement of Science and Technology (MIN, SMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2010, HUM MOL GENET, V19, P4799, DOI 10.1093/hmg/ddq410; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; Chavala SH, 2005, BRIT J OPHTHALMOL, V89, P1065, DOI 10.1136/bjo.2005.068130; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Cheng H, 2011, HUM MOL GENET, V20, P4102, DOI 10.1093/hmg/ddr334; Cheng T, 1997, J NEUROSCI, V17, P8118, DOI 10.1523/jneurosci.17-21-08118.1997; Conley SM, 2012, ADV EXP MED BIOL, V723, P657, DOI 10.1007/978-1-4614-0631-0_83; Conley SM, 2010, BIOCHEMISTRY-US, V49, P905, DOI 10.1021/bi901622w; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Ding XQ, 2005, BIOCHEMISTRY-US, V44, P4897, DOI 10.1021/bi048414i; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Farjo R, 2007, J COMP NEUROL, V504, P619, DOI 10.1002/cne.21476; FISHMAN GA, 1976, BRIT J OPHTHALMOL, V60, P345, DOI 10.1136/bjo.60.5.345; Gire AI, 2007, MOL VIS, V13, P1970; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Han ZC, 2012, J CLIN INVEST, V122, P3221, DOI 10.1172/JCI64833; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; Hayashi T, 2005, OPHTHALMOLOGY, V112, P2115, DOI 10.1016/j.ophtha.2005.07.002; JACOBSON SG, 1990, INVEST OPHTH VIS SCI, V31, P827; JACOBSON SG, 1991, AM J OPHTHALMOL, V111, P446, DOI 10.1016/S0002-9394(14)72379-7; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; Lam BL, 2007, AM J OPHTHALMOL, V144, P157, DOI 10.1016/j.ajo.2007.03.012; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Nour M, 2004, INVEST OPHTH VIS SCI, V45, P2514, DOI 10.1167/iovs.04-0065; Nour M, 2008, ADV EXP MED BIOL, V613, P129, DOI 10.1007/978-0-387-74904-4_14; Nystuen AM, 2008, MAMM GENOME, V19, P623, DOI 10.1007/s00335-008-9138-5; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016	42	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63321	10.1371/journal.pone.0063321	http://dx.doi.org/10.1371/journal.pone.0063321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650562	Green Published, Green Submitted, gold			2022-12-25	WOS:000319167000107
J	Yang, YX; Liao, QJ; Wei, F; Li, XL; Zhang, WL; Fan, SQ; Shi, L; Li, XY; Gong, ZJ; Ma, J; Zhou, M; Xiang, JJ; Peng, SP; Xiang, B; Deng, H; Yang, YB; Li, Y; Xiong, W; Zeng, ZY; Li, GY				Yang, Yixin; Liao, Qianjin; Wei, Fang; Li, Xiaoling; Zhang, Wenling; Fan, Songqing; Shi, Lei; Li, Xiayu; Gong, Zhaojian; Ma, Jian; Zhou, Ming; Xiang, Juanjuan; Peng, Shuping; Xiang, Bo; Deng, Hao; Yang, Yunbo; Li, Yong; Xiong, Wei; Zeng, Zhaoyang; Li, Guiyuan			LPLUNC1 Inhibits Nasopharyngeal Carcinoma Cell Growth via Down-Regulation of the MAP Kinase and Cyclin D1/E2F Pathways	PLOS ONE			English	Article							SUPPRESSION SUBTRACTIVE HYBRIDIZATION; CANDIDATE MOLECULAR MARKERS; EPSTEIN-BARR-VIRUS; CDNA MICROARRAY; SUSCEPTIBILITY LOCUS; INCREASING PROTEIN; SIGNALING PATHWAY; SPLUNC1 PROTEIN; CHROMOSOME 3P21; EXPRESSION	Long-palate, lung and nasal epithelium clone 1 (LPLUNC1) gene expression is relatively tissue specific. It is highly expressed in nontumor nasopharyngeal epithelial tissues, but its expression is reduced in nasopharyngeal carcinoma (NPC), indicating that LPLUNC1 may be associated with the tumorigenesis of NPC. To study the effects of LPLUNC1 on NPC tumorigenesis, a full-length LPLUNC1 expression plasmid was stably transfected into the NPC cell line, 5-8F. Our data indicated that LPLUNC1 inhibited NPC cell proliferation in vitro and tumor formation in vivo. LPLUNC1 also delayed cell cycle progression from G1 to S phase and inhibited the expression of cyclin D1, cyclin-dependent kinase 4 (CDK4) and phosphorylated Rb. To further investigate the molecular mechanisms underlying the suppressive effects of LPLUNC1 on NPC tumorigenesis, cDNA microarray was performed. These studies revealed that LPLUNC1 inhibited the expression of certain mitogen-activated protein (MAP) kinases (MAPK) kinases and cell cycle-related molecules. Western blotting confirmed that the expression of MEK1, phosphorylated ERK1/2, phosphorylated JNK1/2, c-Myc and c-Jun were inhibited by LPLUNC1. Furthermore, the transcriptional activity of AP-1 was down-regulated by LPLUNC1, suggesting that the MAPK signaling pathway is regulated by LPLUNC1. Taken together, the present study indicates that LPLUNC1 delays NPC cell growth by inhibiting the MAPK and cyclin D1/E2F pathways and suggests that LPLUNC1 may represent a promising candidate tumor suppressor gene associated with NPC.	[Yang, Yixin; Li, Xiaoling; Li, Xiayu; Deng, Hao; Xiong, Wei; Zeng, Zhaoyang; Li, Guiyuan] Cent S Univ, Xiangya Hosp 3, Hunan Key Lab Nonresolving Inflammat & Canc, Dis Genome Res Ctr, Changsha 410083, Hunan, Peoples R China; [Yang, Yixin; Liao, Qianjin; Wei, Fang; Li, Xiaoling; Zhang, Wenling; Gong, Zhaojian; Ma, Jian; Zhou, Ming; Xiang, Juanjuan; Peng, Shuping; Xiang, Bo; Xiong, Wei; Zeng, Zhaoyang; Li, Guiyuan] Cent S Univ, Minist Hlth, Key Lab Carcinogenesis, Canc Res Inst, Changsha 410083, Hunan, Peoples R China; [Yang, Yixin; Liao, Qianjin; Wei, Fang; Li, Xiaoling; Zhang, Wenling; Gong, Zhaojian; Ma, Jian; Zhou, Ming; Xiang, Juanjuan; Peng, Shuping; Xiang, Bo; Xiong, Wei; Zeng, Zhaoyang; Li, Guiyuan] Cent S Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Canc Res Inst, Changsha 410083, Hunan, Peoples R China; [Li, Xiaoling; Xiong, Wei; Zeng, Zhaoyang; Li, Guiyuan] Cent S Univ, Hunan Prov Tumor Hosp, Xiangya Sch Med, Changsha 410083, Hunan, Peoples R China; [Li, Xiaoling; Xiong, Wei; Zeng, Zhaoyang; Li, Guiyuan] Cent S Univ, Affiliated Tumor Hosp, Xiangya Sch Med, Changsha 410083, Hunan, Peoples R China; [Fan, Songqing; Shi, Lei; Gong, Zhaojian; Yang, Yunbo] Cent S Univ, Xiangya Hosp 2, Changsha 410083, Hunan, Peoples R China; [Li, Yong] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; University of Louisville	Zeng, ZY (corresponding author), Cent S Univ, Xiangya Hosp 3, Hunan Key Lab Nonresolving Inflammat & Canc, Dis Genome Res Ctr, Changsha 410083, Hunan, Peoples R China.	zengzhaoyang@xysm.net; ligy@xysm.net	li, xia/HHZ-7468-2022; Deng, Hao/O-6340-2017	Deng, Hao/0000-0003-3240-4352	National High Technology Research and Development Program of China [2012AA02A206]; National Natural Science Foundation of China [91229122, 81071644, 81172189, 81101509, 81171930, 81272254, 81272298]; 111 Project [111-2-12]; Hunan Province Natural Sciences Foundation of China [10JJ7003]; Fundamental Research Funds for the Central Universities [2011JQ020]; National Science Foundation for Post-doctoral Scientists of China [20110491758]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); Hunan Province Natural Sciences Foundation of China(Natural Science Foundation of Hunan Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC))	This study was supported by grants from the National High Technology Research and Development Program of China (2012AA02A206), the National Natural Science Foundation of China (91229122, 81071644, 81172189, 81101509, 81171930, 81272254 and 81272298), the 111 Project (111-2-12), the Hunan Province Natural Sciences Foundation of China (10JJ7003), the Fundamental Research Funds for the Central Universities (2011JQ020) and the National Science Foundation for Post-doctoral Scientists of China (20110491758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JA, 2008, J LEUKOCYTE BIOL, V83, P1201, DOI 10.1189/jlb.0507302; Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Deng LW, 1998, GENE CHROMOSOME CANC, V23, P21, DOI 10.1002/(SICI)1098-2264(199809)23:1<21::AID-GCC4>3.0.CO;2-8; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Feng BJ, 2002, NAT GENET, V31, P395, DOI 10.1038/ng932; Finzi L, 2009, J IMMUNOL, V182, P2269, DOI 10.4049/jimmunol.0801768; Freeman SM, 2004, DRUG NEWS PERSPECT, V17, P237, DOI 10.1358/dnp.2004.17.4.829050; GAZZANOSANTORO H, 1994, INFECT IMMUN, V62, P1185, DOI 10.1128/IAI.62.4.1185-1191.1994; He Y, 2005, J MED GENET, V42, P172, DOI 10.1136/jmg.2004.022616; HILDESHEIM A, 1993, EPIDEMIOL REV, V15, P466, DOI 10.1093/oxfordjournals.epirev.a036130; Peng C, 2007, MOL CELL BIOCHEM, V303, P141, DOI 10.1007/s11010-007-9466-x; Peng SP, 2006, ONCOLOGY-BASEL, V71, P273, DOI 10.1159/000106073; Xiong W, 2004, CANCER RES, V64, P1972, DOI 10.1158/0008-5472.CAN-03-3253; Yang YX, 2007, MOL IMMUNOL, V44, P984, DOI 10.1016/j.molimm.2006.03.013; Zeng ZY, 2007, HUM PATHOL, V38, P120, DOI 10.1016/j.humpath.2006.06.023; Zeng ZY, 2007, J CANCER RES CLIN, V133, P71, DOI 10.1007/s00432-006-0136-2; Zeng ZY, 2011, SCI CHINA LIFE SCI, V54, P966, DOI 10.1007/s11427-011-4223-5; Zeng ZY, 2006, GENET MED, V8, P156, DOI 10.1097/01.gim.0000196821.87655.d0; Zhang BC, 2003, GENE CHROMOSOME CANC, V38, P80, DOI 10.1002/gcc.10247; Zhang WL, 2012, J MOL HISTOL, V43, P297, DOI 10.1007/s10735-012-9392-4; Zhang WL, 2009, ACTA BIOCH BIOPH SIN, V41, P414, DOI 10.1093/abbs/gmp025; Zhou HD, 2006, MOL IMMUNOL, V43, P1864, DOI 10.1016/j.molimm.2005.10.021; Zhou HD, 2008, MOL CELL BIOCHEM, V309, P191, DOI 10.1007/s11010-007-9659-3; Zhou YH, 2008, EUR J CANCER PREV, V17, P561, DOI 10.1097/CEJ.0b013e328305a0e8; Zhou YH, 2008, INT J CANCER, V123, P2065, DOI 10.1002/ijc.23727	26	36	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62869	10.1371/journal.pone.0062869	http://dx.doi.org/10.1371/journal.pone.0062869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650533	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000078
J	Pilakka-Kanthikeel, S; Atluri, VSR; Sagar, V; Saxena, SK; Nair, M				Pilakka-Kanthikeel, Sudheesh; Atluri, Venkata Subba Rao; Sagar, Vidya; Saxena, Shailendra K.; Nair, Madhavan			Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood-Brain Barrier for Neuro-Protection Using Magnetic Nano Carriers: An In-Vitro Study	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; HIV-ASSOCIATED DEMENTIA; CENTRAL-NERVOUS-SYSTEM; LONG-TERM-MEMORY; FACTOR PREVENTS; SUBSTANTIA-NIGRA; EXPOSURE ALTERS; RAT HIPPOCAMPUS; SPINE DENSITY; CELL-DEATH	Parenteral use of drugs; such as opiates exert immunomodulatory effects and serve as a cofactor in the progression of HIV-1 infection, thereby potentiating HIV related neurotoxicity ultimately leading to progression of NeuroAIDS. Morphine exposure is known to induce apoptosis, down regulate cAMP response element-binding (CREB) expression and decrease in dendritic branching and spine density in cultured cells. Use of neuroprotective agent; brain derived neurotropic factor (BDNF), which protects neurons against these effects, could be of therapeutic benefit in the treatment of opiate addiction. Previous studies have shown that BDNF was not transported through the blood brain barrier (BBB) in-vivo.; and hence it is not effective in-vivo. Therefore development of a drug delivery system that can cross BBB may have significant therapeutic advantage. In the present study, we hypothesized that magnetically guided nanocarrier may provide a viable approach for targeting BDNF across the BBB. We developed a magnetic nanoparticle (MNP) based carrier bound to BDNF and evaluated its efficacy and ability to transmigrate across the BBB using an in-vitro BBB model. The end point determinations of BDNF that crossed BBB were apoptosis, CREB expression and dendritic spine density measurement. We found that transmigrated BDNF was effective in suppressing the morphine induced apoptosis, inducing CREB expression and restoring the spine density. Our results suggest that the developed nanocarrier will provide a potential therapeutic approach to treat opiate addiction, protect neurotoxicity and synaptic density degeneration.	[Pilakka-Kanthikeel, Sudheesh; Atluri, Venkata Subba Rao; Sagar, Vidya; Nair, Madhavan] Florida Int Univ, Herbert Wertheim Coll Med, Inst NeuroImmune Pharmacol, Dept Immunol, Miami, FL 33199 USA; [Saxena, Shailendra K.] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	State University System of Florida; Florida International University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Nair, M (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Inst NeuroImmune Pharmacol, Dept Immunol, Miami, FL 33199 USA.	nairm@fiu.edu	Saxena, Shailendra K/ABK-6489-2022; Saxena, Shailendra K/X-4252-2019; Atluri, Venkata/G-3277-2014	Saxena, Shailendra K/0000-0003-2856-4185; Saxena, Shailendra K/0000-0003-2856-4185; Atluri, Venkata/0000-0002-8070-6745	National Institute of Drug abuse [1R01-DA027049]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027049] Funding Source: NIH RePORTER	National Institute of Drug abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grant from National Institute of Drug abuse (1R01-DA027049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala-Barraza SR, 2010, J DRUG TARGET, V18, P179, DOI 10.3109/10611860903318134; Alexiou C, 2006, EUR BIOPHYS J BIOPHY, V35, P446, DOI 10.1007/s00249-006-0042-1; Alonso M, 2005, LEARN MEMORY, V12, P504, DOI 10.1101/lm.27305; ALTAR CA, 1992, P NATL ACAD SCI USA, V89, P11347, DOI 10.1073/pnas.89.23.11347; AYRE SG, 1989, MED HYPOTHESES, V29, P283, DOI 10.1016/0306-9877(89)90113-8; Bachis A, 2003, J NEUROSCI, V23, P5715; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; BETZ AL, 1980, BRAIN RES, V192, P17, DOI 10.1016/0006-8993(80)91004-5; BETZ AL, 1986, ANNU REV PHYSIOL, V48, P241; BETZ AL, 1978, SCIENCE, V202, P225, DOI 10.1126/science.211586; Blitts B, 2003, NEUROSCIENCE, V118, P271, DOI 10.1016/S0306-4522(02)00970-3; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Boyum A, 1968, SCAND J CLIN LAB INV, P77; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Cammarota M, 2000, MOL BRAIN RES, V76, P36, DOI 10.1016/S0169-328X(99)00329-0; Chapleau CA, 2008, J NEUROSCI METH, V169, P182, DOI 10.1016/j.jneumeth.2007.12.006; Chertok B, 2008, BIOMATERIALS, V29, P487, DOI 10.1016/j.biomaterials.2007.08.050; Frankfurt M, 2011, SYNAPSE, V65, P955, DOI 10.1002/syn.20918; FREIER DO, 1993, J PHARMACOL EXP THER, V265, P81; FUCHS BA, 1993, J PHARMACOL EXP THER, V266, P417; Gandhi N, 2010, J NEUROVIROL, V16, P294, DOI 10.3109/13550284.2010.499891; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; Goswami R, 1998, J NEUROCHEM, V70, P1376; Guo CJ, 2002, J INVEST MED, V50, P435, DOI 10.1136/jim-50-06-03; Han B, 2009, ADDICTION, V104, P88, DOI 10.1111/j.1360-0443.2008.02411.x; Han BH, 2000, NEUROBIOL DIS, V7, P38; HURWITZ AA, 1994, ADV NEUROIMMUNOL, V4, P249, DOI 10.1016/S0960-5428(06)80263-9; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Ito A, 2005, J BIOSCI BIOENG, V100, P1, DOI 10.1263/jbb.100.1; Itoh K, 2000, ACTA NEUROPATHOL, V99, P376, DOI 10.1007/s004010051139; James HJ, 1999, NEUROPATH APPL NEURO, V25, P380, DOI 10.1046/j.1365-2990.1999.00195.x; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kwon M, 2011, J NEUROSCI, V31, P9735, DOI 10.1523/JNEUROSCI.6785-10.2011; Kwon SG, 2007, J AM CHEM SOC, V129, P12571, DOI 10.1021/ja074633q; Li YF, 2007, NEUROSCI LETT, V418, P227, DOI 10.1016/j.neulet.2007.03.023; Lubbe AS, 1996, CANCER RES, V56, P4694; Mahajan SD, 2005, CLIN IMMUNOL, V115, P323, DOI 10.1016/j.clim.2005.02.004; Mamounas LA, 1995, J NEUROSCI, V15, P7929; Mandel RJ, 1999, EXP NEUROL, V155, P59, DOI 10.1006/exnr.1998.6961; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Mocchetti I, 2007, ANN NY ACAD SCI, V1122, P144, DOI 10.1196/annals.1403.010; Nair MPN, 1997, CLIN DIAGN LAB IMMUN, V4, P127, DOI 10.1128/CDLI.4.2.127-132.1997; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nosheny RL, 2007, EUR J NEUROSCI, V25, P2275, DOI 10.1111/j.1460-9568.2007.05506.x; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pardridge WM, 1998, PHARMACEUT RES, V15, P576, DOI 10.1023/A:1011981927620; Persidsky Y, 1997, J IMMUNOL, V158, P3499; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Purohit V, 2011, MOL NEUROBIOL, V44, P102, DOI 10.1007/s12035-011-8195-z; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Roy S, 1996, NEUROCHEM RES, V21, P1375, DOI 10.1007/BF02532379; Saiyed ZM, 2007, J BIOTECHNOL, V131, P240, DOI 10.1016/j.jbiotec.2007.06.017; Saiyed ZM, 2007, ANAL BIOCHEM, V363, P288, DOI 10.1016/j.ab.2007.01.008; Saiyed ZM, 2010, INT J NANOMED, V5, P157; Saiyed ZM, 2009, J NEUROVIROL, V15, P343, DOI 10.1080/13550280903062813; Sarti F, 2007, EUR J NEUROSCI, V26, P749, DOI 10.1111/j.1460-9568.2007.05689.x; Silva GA, 2007, SURG NEUROL, V67, P113, DOI 10.1016/j.surneu.2006.08.033; Singhal PC, 1998, J IMMUNOL, V160, P1886; Singhal PG, 1999, J LEUKOCYTE BIOL, V66, P650, DOI 10.1002/jlb.66.4.650; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Stefano GB, 1996, CRIT REV IMMUNOL, V16, P109, DOI 10.1615/CritRevImmunol.v16.i2.10; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; Suri Sarabjeet Singh, 2007, J Occup Med Toxicol, V2, P16, DOI 10.1186/1745-6673-2-16; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Viola HE, 2000, J NEUROSCI, V20; Wallace DR, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/65741; Wang GJ, 2004, BRAIN, V127, P2452, DOI 10.1093/brain/awh269; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; Xia Y, 2010, NEUROPHARMACOLOGY, V58, P330, DOI 10.1016/j.neuropharm.2009.10.009; Yin DL, 1999, NATURE, V397, P218, DOI 10.1038/16612	72	68	71	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62241	10.1371/journal.pone.0062241	http://dx.doi.org/10.1371/journal.pone.0062241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23653680	gold, Green Published			2022-12-25	WOS:000319077300033
J	Sanvitale, CE; Kerr, G; Chaikuad, A; Ramel, MC; Mohedas, AH; Reichert, S; Wang, Y; Triffitt, JT; Cuny, GD; Yu, PB; Hill, CS; Bullock, AN				Sanvitale, Caroline E.; Kerr, Georgina; Chaikuad, Apirat; Ramel, Marie-Christine; Mohedas, Agustin H.; Reichert, Sabine; Wang, You; Triffitt, James T.; Cuny, Gregory D.; Yu, Paul B.; Hill, Caroline S.; Bullock, Alex N.			A New Class of Small Molecule Inhibitor of BMP Signaling	PLOS ONE			English	Article							TGF-BETA; CELL-MEMBRANE; BONE; CRYSTALLIZATION; IDENTIFICATION; RECEPTORS; PROTEINS; TARGET; GROWTH; VEGF	Growth factor signaling pathways are tightly regulated by phosphorylation and include many important kinase targets of interest for drug discovery. Small molecule inhibitors of the bone morphogenetic protein (BMP) receptor kinase ALK2 (ACVR1) are needed urgently to treat the progressively debilitating musculoskeletal disease fibrodysplasia ossificans progressiva (FOP). Dorsomorphin analogues, first identified in zebrafish, remain the only BMP inhibitor chemotype reported to date. By screening an assay panel of 250 recombinant human kinases we identified a highly selective 2-aminopyridine-based inhibitor K02288 with in vitro activity against ALK2 at low nanomolar concentrations similar to the current lead compound LDN-193189. K02288 specifically inhibited the BMP-induced Smad pathway without affecting TGF-beta signaling and induced dorsalization of zebrafish embryos. Comparison of the crystal structures of ALK2 with K02288 and LDN-193189 revealed additional contacts in the K02288 complex affording improved shape complementarity and identified the exposed phenol group for further optimization of pharmacokinetics. The discovery of a new chemical series provides an independent pharmacological tool to investigate BMP signaling and offers multiple opportunities for pre-clinical development.	[Sanvitale, Caroline E.; Kerr, Georgina; Chaikuad, Apirat; Bullock, Alex N.] Univ Oxford, Struct Genom Consortium, Oxford, England; [Ramel, Marie-Christine; Reichert, Sabine; Hill, Caroline S.] Canc Res UK London Res Inst, Lab Dev Signalling, London, England; [Mohedas, Agustin H.; Yu, Paul B.] Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA 02115 USA; [Mohedas, Agustin H.; Yu, Paul B.] Harvard Univ, Sch Med, Boston, MA USA; [Wang, You; Cuny, Gregory D.] Brigham & Womens Hosp, Lab Drug Discovery Neurodegenerat, Cambridge, MA USA; [Wang, You; Cuny, Gregory D.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Triffitt, James T.] Univ Oxford, Botnar Res Ctr, Oxford, England	University of Oxford; Cancer Research UK; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; University of Oxford	Bullock, AN (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford, England.	alex.bullock@sgc.ox.ac.uk	Yu, Paul B./J-7540-2019	Yu, Paul B./0000-0003-2145-4944; Cuny, Gregory/0000-0002-3188-4748; Hill, Caroline/0000-0002-8632-0480; Chaikuad, Apirat/0000-0003-1120-2209	University of Oxford FOP Research Fund; Roemex Postdoctoral Fellowship; Cancer Research UK; NIAMS/NIH grant [AR057374]; Leducq Foundation Translatlantic Network Award; Harvard NeuroDiscovery Center; AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057374] Funding Source: NIH RePORTER; Cancer Research UK [15681] Funding Source: researchfish	University of Oxford FOP Research Fund; Roemex Postdoctoral Fellowship; Cancer Research UK(Cancer Research UK); NIAMS/NIH grant; Leducq Foundation Translatlantic Network Award(Leducq Foundation); Harvard NeuroDiscovery Center; AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Cancer Research UK(Cancer Research UK)	This work was in part supported by the University of Oxford FOP Research Fund (to C.E.S.), a Roemex Postdoctoral Fellowship (to G.K.), Cancer Research UK (to M.-C.R., S.R. and C.S.H.), a NIAMS/NIH grant AR057374 and Leducq Foundation Translatlantic Network Award (to P.B.Y.), and the Harvard NeuroDiscovery Center (to G.D.C. and Y.W.). The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust [092809/Z/10/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have declared that no competing interests exist. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust [092809/Z/10/Z]. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The SGC is an open access not-for-profit organization. The authors are members of the University of Oxford and have no links to commercial employment, consultancy, patents, or products.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; Cannon JE, 2010, BRIT J PHARMACOL, V161, P140, DOI 10.1111/j.1476-5381.2010.00871.x; Chaikuad A, 2012, J BIOL CHEM, V287, P36990, DOI 10.1074/jbc.M112.365932; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594; Dorey K, 2006, DEV BIOL, V292, P303, DOI 10.1016/j.ydbio.2006.01.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Gandhi L, 2012, CLIN CANCER RES, V18, P3737, DOI 10.1158/1078-0432.CCR-11-2393; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hilton S, 2010, BIOORGAN MED CHEM, V18, P707, DOI 10.1016/j.bmc.2009.11.058; Hong CC, 2009, CYTOKINE GROWTH F R, V20, P409, DOI 10.1016/j.cytogfr.2009.10.021; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kaplan FS, 2007, EXPERT OPIN BIOL TH, V7, P705, DOI 10.1517/14712598.7.5.705; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee YC, 2011, CANCER RES, V71, P5194, DOI 10.1158/0008-5472.CAN-10-4374; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Saeed O, 2012, ARTERIOSCL THROM VAS, V32, P299, DOI 10.1161/ATVBAHA.111.240101; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shi S, 2011, NEUROBIOL DIS, V41, P353, DOI 10.1016/j.nbd.2010.10.003; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shore EM, 2010, NAT REV RHEUMATOL, V6, P518, DOI 10.1038/nrrheum.2010.122; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Steinbicker AU, 2011, BLOOD, V117, P4915, DOI 10.1182/blood-2010-10-313064; Theurl I, 2011, BLOOD, V118, P4977, DOI 10.1182/blood-2011-03-345066; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Wang LJ, 2012, INFLAMM BOWEL DIS, V18, P112, DOI 10.1002/ibd.21675; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu MY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000593; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Younis Y, 2012, J MED CHEM, V55, P3479, DOI 10.1021/jm3001373; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	49	154	166	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62721	10.1371/journal.pone.0062721	http://dx.doi.org/10.1371/journal.pone.0062721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646137	Green Published, gold			2022-12-25	WOS:000319077300090
J	Camus, SMJ; Blois-Heulin, C; Li, Q; Hausberger, M; Bezard, E				Camus, Sandrine M. J.; Blois-Heulin, Catherine; Li, Qin; Hausberger, Martine; Bezard, Erwan			Behavioural Profiles in Captive-Bred Cynomolgus Macaques: Towards Monkey Models of Mental Disorders?	PLOS ONE			English	Article							CEREBROSPINAL-FLUID CONCENTRATIONS; CORTICOTROPIN-RELEASING-FACTOR; NONHUMAN-PRIMATES; SOCIAL-BEHAVIOR; ANIMAL-MODELS; INDIVIDUAL-DIFFERENCES; RHESUS-MONKEYS; MACACA-FASCICULARIS; PERSONALITY-TRAITS; COPING HYPOTHESIS	Background: To date, experimental and preclinical studies on neuropsychiatric conditions have almost exclusively been performed in experimentally-induced animal models and have only rarely relied upon an ethological approach where animals have been observed in more naturalistic settings. The laboratory species of choice has been the rodent while the potential of more closely-related non-human primates have remained largely underexplored. Methods: The present study, therefore, aimed at investigating the possible existence of spontaneous atypical/abnormal behaviours displayed by 40 cynomolgus macaques in captive conditions using an unbiased ethological scan-sampling analysis followed by multifactorial correspondence analysis and a hierarchical clustering. Results: The study identified five distinct profiles (groups A to E) that significantly differed on several behaviours, body postures, body orientations, gaze directions and locations in the cage environment. We suggest that animals from the low n groups (D and E) present depressive-like and anxious-like symptoms, reminiscent of depressive and generalized anxiety disorders. Inter-individual differences were highlighted through unbiased ethological observations of spontaneous behaviours and associated parameters, although these were not associated with differences in plasma or cerebrospinal fluid levels of either stress-related hormones or monoamines, i.e. in accordance with the human situation. Conclusions: No interventional behavioural testing was required to discriminate between 3 typical and 2 atypical ethologically-defined behavioural profiles, reminiscent of certain depressive-like and anxiety-like symptoms. The use of unbiased behavioural observations might, thus, allow the identification of animal models of human mental/behavioural disorders and their most appropriate control groups.	[Camus, Sandrine M. J.; Bezard, Erwan] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Blois-Heulin, Catherine] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Paimpont, France; [Li, Qin] China Acad Med Sci, Inst Lab Anim Sci, Beijing, Peoples R China; [Li, Qin; Bezard, Erwan] Motac Neurosci Ltd, Manchester, Lancs, England; [Hausberger, Martine] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France; [Bezard, Erwan] CNRS, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Bezard, E (corresponding author), Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France.	erwan.bezard@u-bordeaux2.fr	Bezard, Erwan/ABD-5153-2021	Bezard, Erwan/0000-0002-0410-4638	Agence Nationale de la Recherche grants [ANR-08-MNP-018 MCHPRIMAPARK]; Biotheque Primate - Centre National de la Recherche Scientifique Life Sciences Department; Motac Neuroscience Ltd. (UK)	Agence Nationale de la Recherche grants(French National Research Agency (ANR)); Biotheque Primate - Centre National de la Recherche Scientifique Life Sciences Department; Motac Neuroscience Ltd. (UK)	This work was supported by ANR-08-MNP-018 MCHPRIMAPARK Agence Nationale de la Recherche grants (EB), Biotheque Primate - Centre National de la Recherche Scientifique Life Sciences Department (EB), and an unrestricted grant from Motac Neuroscience Ltd. (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; Albelda N, 2012, NEUROSCI BIOBEHAV R, V36, P47, DOI 10.1016/j.neubiorev.2011.04.006; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; Berton O, 2012, SCIENCE, V338, P75, DOI 10.1126/science.1222940; Bertrand M., 1969, BEHAV REPERTOIRE STU; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Bezard E, 2011, MOVEMENT DISORD, V26, P993, DOI 10.1002/mds.23696; BOLIG R, 1992, INT J PRIMATOL, V13, P287, DOI 10.1007/BF02547817; Brent L, 2002, INT J PRIMATOL, V23, P147, DOI 10.1023/A:1013206125884; Brune M, 2006, NEUROSCI BIOBEHAV R, V30, P1246, DOI 10.1016/j.neubiorev.2006.09.002; BUIRSKI P, 1973, Primates, V14, P67, DOI 10.1007/BF01730516; Camus SM, 2013, PLOS ONE IN PRESS; CHENEY DL, 1990, COGNITION, V37, P167, DOI 10.1016/0010-0277(90)90022-C; Claessens SEF, 2011, PSYCHOPHARMACOLOGY, V214, P141, DOI 10.1007/s00213-010-2118-y; CLARKE AS, 1988, INT J PRIMATOL, V9, P347, DOI 10.1007/BF02737382; Clarke AS, 1996, BIOL PSYCHIAT, V40, P338, DOI 10.1016/0006-3223(95)00663-X; Clubb R, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P58, DOI 10.1079/9780851990040.0058; COOPER JJ, 1993, ANIM BEHAV, V45, P616, DOI 10.1006/anbe.1993.1072; Coplan JD, 1998, ARCH GEN PSYCHIAT, V55, P473, DOI 10.1001/archpsyc.55.5.473; Coplan JD, 1996, P NATL ACAD SCI USA, V93, P1619, DOI 10.1073/pnas.93.4.1619; CROCKETT CM, 1995, J COMP PSYCHOL, V109, P368, DOI 10.1037/0735-7036.109.4.368; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Waal F.B.M., 1990, PEACEMAKING PRIMATES; De Waal Frans, 2009, QUESTION ANIMAL CULT, P19; Desbiolles C, 2007, BEHAV TRAITS VERVET; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Ellenbroek BA, 2002, BEHAV GENET, V32, P349, DOI 10.1023/A:1020214322065; Fairbanks LA, 2001, J COMP PSYCHOL, V115, P22, DOI 10.1037/0735-7036.115.1.22; FORDHAM DP, 1991, ANIM PROD, V52, P287, DOI 10.1017/S0003356100012794; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Fureix C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039280; Geracioti T D Jr, 1997, Depress Anxiety, V6, P89, DOI 10.1002/(SICI)1520-6394(1997)6:3<89::AID-DA1>3.0.CO;2-0; Gilmer WS, 2003, J AFFECT DISORDERS, V75, P97, DOI 10.1016/S0165-0327(03)00046-6; HARLOW HF, 1965, P NATL ACAD SCI USA, V54, P90, DOI 10.1073/pnas.54.1.90; HARLOW HF, 1974, BEHAV BIOL, V12, P273, DOI 10.1016/S0091-6773(74)91475-8; Henry DB, 2005, J FAM PSYCHOL, V19, P121, DOI 10.1037/0893-3200.19.1.121; HESSING MJC, 1993, APPL ANIM BEHAV SCI, V37, P285, DOI 10.1016/0168-1591(93)90118-9; Jensen KH, 1996, PHYSIOL BEHAV, V59, P741, DOI 10.1016/0031-9384(95)02159-0; Kalin NH, 2003, ANN NY ACAD SCI, V1008, P189, DOI 10.1196/annals.1301.021; KALIN NH, 1989, SCIENCE, V243, P1718, DOI 10.1126/science.2564702; LAWRENCE AB, 1991, APPL ANIM BEHAV SCI, V30, P73, DOI 10.1016/0168-1591(91)90086-D; Lipska BK, 2000, NEUROPSYCHOPHARMACOL, V23, P223, DOI 10.1016/S0893-133X(00)00137-8; Lutz C, 2003, AM J PRIMATOL, V60, P1, DOI 10.1002/ajp.10075; Maalouf FT, 2011, DEPRESS ANXIETY, V28, P946, DOI 10.1002/da.20884; MAESTRIPIERI D, 1991, DEV PSYCHOBIOL, V24, P571, DOI 10.1002/dev.420240805; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; Mason GJ, 2006, STEROTYPIC ANIMAL BE; Mathew SJ, 2002, STRESS, V5, P185, DOI 10.1080/1025389021000010521; Meissner W, 2006, NEUROBIOL DIS, V22, P586, DOI 10.1016/j.nbd.2006.01.009; Miller G, 2010, SCIENCE, V327, P770, DOI 10.1126/science.327.5967.770-a; Montaudouin S, 2004, BEHAV PROCESS, V67, P235, DOI 10.1016/j.beproc.2004.02.008; NAKAMICHI M, 1990, PRIMATES, V31, P213, DOI 10.1007/BF02380943; Nelson EE, 2009, NEUROPSYCHOPHARMACOL, V34, P90, DOI 10.1038/npp.2008.150; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Prins J, 2011, EXPERT OPIN INV DRUG, V20, P1107, DOI 10.1517/13543784.2011.594039; Rao Uma, 2009, Dialogues Clin Neurosci, V11, P45; Rascol O, 2012, ANTIDYSKINETIC EFFEC; Roonwal M. L., 1977, PRIMATES S ASIA ECOL; ROSE RM, 1978, PSYCHOSOM MED, V40, P60, DOI 10.1097/00006842-197802000-00007; ROSENBLUM LA, 1984, CHILD DEV, V55, P305, DOI 10.1111/j.1467-8624.1984.tb00293.x; Rouff JH, 2005, AM J PRIMATOL, V67, P177, DOI 10.1002/ajp.20176; RUSHEN J, 1993, ANIM BEHAV, V45, P613, DOI 10.1006/anbe.1993.1071; Rygula R, 2008, BEHAV PHARMACOL, V19, P183, DOI 10.1097/FBP.0b013e3282fe8871; Rylander D, 2010, NEUROBIOL DIS, V39, P352, DOI 10.1016/j.nbd.2010.05.001; Schino G, 1996, ANXIETY, V2, P186; Shannon C, 2005, AM J PSYCHIAT, V162, P1658, DOI 10.1176/appi.ajp.162.9.1658; Shivel CA, 2012, EXP NEUROL, V233, P87, DOI 10.1016/j.expneurol.2011.09.026; Shively CA, 1997, BIOL PSYCHIAT, V41, P871, DOI 10.1016/S0006-3223(96)00185-0; Shively CA, 2005, BIOL PSYCHOL, V69, P67, DOI 10.1016/j.biopsycho.2004.11.006; SOUTHWICK CH, 1967, BEHAVIOUR, V28, P182, DOI 10.1163/156853967X00235; STEVENSON-HINDE J, 1980, Primates, V21, P498, DOI 10.1007/BF02373838; SUOMI SJ, 1975, J ABNORM PSYCHOL, V84, P576, DOI 10.1037/h0077066; Suomi SJ, 1997, BRIT MED BULL, V53, P170; SUOMI SJ, 1983, DEV PSYCHOL, V19, P770; Suomi SJ, 1991, NEUROBIOLOGY LEARNIN, P195; Taylor WJ, 1998, CONTEMP TOP LAB ANIM, V37, P47; Thierry B., 2000, Primate Research, V16, P203; Thierry B, 2000, ETHOLOGY, V106, P713, DOI 10.1046/j.1439-0310.2000.00583.x; TINBERGEN N., 1952, QUART REV BIOL, V27, P1; Troisi A, 2002, STRESS, V5, P46, DOI 10.1080/10253890290012378; van der Staay FJ, 2006, BRAIN RES REV, V52, P131, DOI 10.1016/j.brainresrev.2006.01.006; Vandeleest JJ, 2011, APPL ANIM BEHAV SCI, V132, P81, DOI 10.1016/j.applanim.2011.02.010; Veen G, 2011, PSYCHIAT RES, V185, P121, DOI 10.1016/j.psychres.2009.07.013; Weatherall D., 2006, USE NONHUMAN PRIMATE; Williamson DE, 2003, BIOL PSYCHIAT, V53, P284, DOI 10.1016/S0006-3223(02)01601-3; Wurbel H, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P86, DOI 10.1079/9780851990040.0086	89	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62141	10.1371/journal.pone.0062141	http://dx.doi.org/10.1371/journal.pone.0062141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658620	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800029
J	Tesniere, C; Delobel, P; Pradal, M; Blondin, B				Tesniere, Catherine; Delobel, Pierre; Pradal, Martine; Blondin, Bruno			Impact of Nutrient Imbalance on Wine Alcoholic Fermentations: Nitrogen Excess Enhances Yeast Cell Death in Lipid-Limited Must	PLOS ONE			English	Article							CHRONOLOGICAL LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; PLASMA-MEMBRANE; SCH9; DESICCATION; TOLERANCE; TREHALOSE; VIABILITY; REVEALS	We evaluated the consequences of nutritional imbalances, particularly lipid/nitrogen imbalances, on wine yeast survival during alcoholic fermentation. We report that lipid limitation (ergosterol limitation in our model) led to a rapid loss of viability during the stationary phase of fermentation and that the cell death rate is strongly modulated by nitrogen availability and nature. Yeast survival was reduced in the presence of excess nitrogen in lipid-limited fermentations. The rapidly dying yeast cells in fermentations in high nitrogen and lipid-limited conditions displayed a lower storage of the carbohydrates trehalose and glycogen than observed in nitrogen-limited cells. We studied the cell stress response using HSP12 promoter-driven GFP expression as a marker, and found that lipid limitation triggered a weaker stress response than nitrogen limitation. We used a SCH9-deleted strain to assess the involvement of nitrogen signalling pathways in the triggering of cell death. Deletion of SCH9 increased yeast viability in the presence of excess nitrogen, indicating that a signalling pathway acting through Sch9p is involved in this nitrogen-triggered cell death. We also show that various nitrogen sources, but not histidine or proline, provoked cell death. Our various findings indicate that lipid limitation does not elicit a transcriptional programme that leads to a stress response protecting yeast cells and that nitrogen excess triggers cell death by modulating this stress response, but not through HSP12. These results reveal a possibly negative role of nitrogen in fermentation, with reported effects referring to ergosterol limitation conditions. These effects should be taken into account in the management of alcoholic fermentations.	[Tesniere, Catherine; Delobel, Pierre; Pradal, Martine; Blondin, Bruno] INRA, UMR1083, F-34060 Montpellier, France; [Tesniere, Catherine; Delobel, Pierre; Pradal, Martine; Blondin, Bruno] SupAgro, UMR1083, Montpellier, France; [Tesniere, Catherine; Delobel, Pierre; Pradal, Martine; Blondin, Bruno] Univ Montpellier I, UMR1083, Montpellier, France	INRAE; Universite de Montpellier; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Universite de Montpellier	Tesniere, C (corresponding author), INRA, UMR1083, F-34060 Montpellier, France.	tesniere@supagro.inra.fr	Tesnière, Catherine/L-8771-2018	Tesnière, Catherine/0000-0003-4865-9229; Delobel, pierre/0000-0002-8770-3192	INRA	INRA	Grants have been obtained from INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2009, BBA-BIOMEMBRANES, V1788, P743, DOI 10.1016/j.bbamem.2008.12.002; Agenbach W. A., 1977, P S AFR SOC EN VIT 2, P66; Alexandre H., 1994, BLOOD CELLS, V146, P11; Ambroset C, 2012, G3, V1, P263; BELY M, 1990, J FERMENT BIOENG, V70, P246, DOI 10.1016/0922-338X(90)90057-4; BELY M, 1990, AM J ENOL VITICULT, V41, P319; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cramer AC, 2002, BIOTECHNOL BIOENG, V77, P49, DOI 10.1002/bit.10133; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Delobel P, 2012, LETT APPL MICROBIOL, V55, P338, DOI 10.1111/j.1472-765X.2012.03301.x; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fornairon-Bonnefond C, 2002, J BIOSCI BIOENG, V93, P176, DOI 10.1263/jbb.93.176; Ge HY, 2010, NUCLEIC ACIDS RES, V38, P143, DOI 10.1093/nar/gkp849; GROAT M, 1978, AM J ENOL VITICULT, V29, P112; Houtman AC, 1986, S AFR J ENOL VITIC, V1, P39; Huang XH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002493; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Lavoie H, 2008, EUKARYOT CELL, V7, P1127, DOI 10.1128/EC.00330-07; Loewith R, 2010, ENZYMES, V27, P147, DOI 10.1016/S1874-6047(10)27009-9; Luparia V, 2004, APPL MICROBIOL BIOT, V65, P25, DOI 10.1007/s00253-003-1549-3; Matecic M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000921; Orozco H, 2012, MECH AGEING DEV, V133, P348, DOI 10.1016/j.mad.2012.03.013; Pacheco A, 2009, MICROBIOL-SGM, V155, P2021, DOI 10.1099/mic.0.025981-0; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rohde JR, 2008, CURR OPIN MICROBIOL, V11, P153, DOI 10.1016/j.mib.2008.02.013; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Rossignol T, 2004, ANAL EXPRESSION GENO; Roustan JL, 2002, BIOTECHNOL LETT, V24, P1059, DOI 10.1023/A:1016078429200; Sablayrolles JM, 2009, FOOD RES INT, V42, P418, DOI 10.1016/j.foodres.2008.12.016; SABLAYROLLES J M, 1987, Biotechnology Techniques, V1, P181; Sales K, 2000, BBA-BIOMEMBRANES, V1463, P267, DOI 10.1016/S0005-2736(99)00215-1; Santos J, 2008, MICROBIOL-SGM, V154, P422, DOI 10.1099/mic.0.2007/011445-0; Santos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037090; Shamrock VJ, 2008, CAN J MICROBIOL, V54, P559, DOI [10.1139/W08-044, 10.1139/w08-044]; Shin CS, 2009, J CELL SCI, V122, P2089, DOI 10.1242/jcs.047191; Smets B, 2008, FEMS YEAST RES, V8, P1276, DOI 10.1111/j.1567-1364.2008.00432.x; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; VANDERREST ME, 1995, MICROBIOL REV, V59, P304, DOI 10.1128/MMBR.59.2.304-322.1995; Wei M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000467; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zara G, 2009, FEMS YEAST RES, V9, P217, DOI 10.1111/j.1567-1364.2008.00472.x	50	36	37	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61645	10.1371/journal.pone.0061645	http://dx.doi.org/10.1371/journal.pone.0061645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658613	Green Published, gold			2022-12-25	WOS:000318343700018
J	Chen, SF; Lin, YS; Jao, SW; Chang, YC; Liu, CL; Lin, YJ; Nieh, S				Chen, Su-Feng; Lin, Yaoh-Shiang; Jao, Shu-Wen; Chang, Yun-Ching; Liu, Chia-Lin; Lin, Yu-Ju; Nieh, Shin			Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROGNOSTIC IMPACT; DRUG-RESISTANCE; BREAST-CANCER; TUMOR-GROWTH; E-CADHERIN; EXPRESSION; CD133; SURVIVAL; OPINION	Background: Metastasis occurs in a series of discrete steps involving invasion, angiogenesis, lymphovascular space permeation, and establishment of secondary tumors. Malignant pleural effusion (MPE), a type of tumor metastasis, is usually a poor prognostic sign for patients with pulmonary adenocarcinoma, although its underlying mechanism has received less attention than other types of metastases have. The objective of the current study was to confirm whether cancer stem cells (CSCs) in MPE contribute to the "metastatic cascade'' through the epithelial - mesenchymal transition (EMT), anoikis, and adaptation in the microenvironment. Methods: Pulmonary tissue and corresponding cell blocks of MPE samples from 20 patients with primary adenocarcinoma were analyzed by immunohistochemical staining with CSC-representative markers (CD133, Nanog, and OCT-4) and EMT-associated markers (E-cadherin and vimentin). Correlations between these variables and clinico-pathological parameters were analyzed. Primary cultures from eight cases of MPE were investigated to characterize the CSC properties, including marker expression, sphere formation, and differentiation. Results: Expressions of CSC-representative markers for 20 cases of MPE cell blocks were quite diverse and variable ranging from 15% to 90%. Stronger expression of CSC-representative markers and alteration of EMT-associated markers were found at the invasive fronts and in MPEs compared with the expression in primary pulmonary tumor tissues. The expression of OCT-4 in MPEs significantly related to distant metastasis and stage, as well as inversely correlated with patient survival. Primary cultures confirmed the CSC properties in MPE. Five of eight cases of MPE yielded adequate cell clusters, which also showed variable expressions of CSC markers in addition to sphere formation and the ability for differentiation and metastasis. Conclusion: This pilot study offers a better understanding of the metastatic cascade. Establishing a model of MPE will provide further insight into the role of CSCs in metastasis and may explain the high therapeutic failure rates for patients with MPE.	[Chen, Su-Feng] China Med Univ, Dept Dent Hyg, Taichung, Taiwan; [Lin, Yaoh-Shiang] Kaohsiung Vet Gen Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Jao, Shu-Wen] Natl Def Med Ctr, Div Colon & Rectal Surg, Taipei, Taiwan; [Jao, Shu-Wen; Chang, Yun-Ching; Liu, Chia-Lin; Lin, Yu-Ju; Nieh, Shin] Triserv Gen Hosp, Taipei, Taiwan; [Chang, Yun-Ching; Liu, Chia-Lin] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lin, Yu-Ju; Nieh, Shin] Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan	China Medical University Taiwan; Kaohsiung Veterans General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Nieh, S (corresponding author), Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan.	niehshin1014@yahoo.com.tw	Yang, Xiaohan/AAM-2449-2020; Yang, Xiaohan/A-6975-2011	Yang, Xiaohan/0000-0001-5207-4210; Yang, Xiaohan/0000-0001-5207-4210	National Science Council, Republic of China [NSC100-2320-B-016-009]; Tri-Service General Hospital [TSGH-C101-076]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	This study was partly supported by the National Science Council, Republic of China, Grant Nos. NSC100-2320-B-016-009 and by the Tri-Service General Hospital, Grant No. TSGH-C101-076. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antic T, 2012, DIAGN CYTOPATHOL, V40, P311, DOI 10.1002/dc.21563; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Basak SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005884; Bertrand K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/534139; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen KL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-72; Chen SF, 2007, HISTOPATHOLOGY, V51, P173, DOI 10.1111/j.1365-2559.2007.02755.x; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031864; Cheng DS, 2000, CHEST, V118, P1747, DOI 10.1378/chest.118.6.1747; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Elloul S, 2010, CLIN EXP METASTAS, V27, P161, DOI 10.1007/s10585-010-9315-2; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Guo HS, 2012, ONCOL REP, V27, P880, DOI 10.3892/or.2011.1559; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hackbarth JS, 2010, CLIN BIOCHEM, V43, P1051, DOI 10.1016/j.clinbiochem.2010.05.016; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Hsu IL, 2009, LUNG CANCER, V65, P371, DOI 10.1016/j.lungcan.2008.12.007; Ishigami S, 2010, ANTICANCER RES, V30, P2453; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Keam B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2834; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Mancini R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021320; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moncharmont C, 2012, CANCER LETT, V322, P139, DOI 10.1016/j.canlet.2012.03.024; NAGASAWA T, 1983, ACTA CYTOL, V27, P119; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Park SY, 2007, ARCH PATHOL LAB MED, V131, P1561; Perona R, 2011, CLIN TRANSL ONCOL, V13, P289, DOI 10.1007/s12094-011-0656-3; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Rapp UR, 2008, CELL CYCLE, V7, P45, DOI 10.4161/cc.7.1.5203; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sikora JJ, 2004, CANCER DETECT PREV, V28, P325, DOI 10.1016/j.cdp.2004.04.003; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Thelmo MC, 2010, FETAL PEDIATR PATHOL, V29, P45, DOI 10.3109/15513810903266625; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Viale G, 2008, JNCI-J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Wei L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3042; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476	53	79	85	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e54659	10.1371/journal.pone.0054659	http://dx.doi.org/10.1371/journal.pone.0054659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23861841	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000001
J	Chen, S; Xiang, Y; Deng, J; Liu, YL; Li, SH				Chen, Sha; Xiang, Yue; Deng, Jiao; Liu, Yanling; Li, Shaohua			Simultaneous Analysis of Anthocyanin and Non-Anthocyanin Flavonoid in Various Tissues of Different Lotus (Nelumbo) Cultivars by HPLC-DAD-ESI-MSn	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; NUCIFERA GAERTN.; BIOSYNTHESIS; CHROMATOGRAPHY; LEAVES; POLYPHENOLS; FRUITS; PETALS; PARTS; ACID	A validated HPLC-DAD-ESI-MSn method for the analysis of non-anthocyanin flavonoids was applied to nine different tissues of twelve lotus genotypes of Nelumbo nucifera and N. lutea, together with an optimized anthocyanin extraction and separation protocol for lotus petals. A total of five anthocyanins and twenty non-anthocyanin flavonoids was identified and quantified. Flavonoid contents and compositions varied with cultivar and tissue and were used as a basis to divide tissues into three groups characterized by kaempferol and quercetin derivatives. Influences on flower petal coloration were investigated by principal components analyses. High contents of kaempferol glycosides were detected in the petals of N. nucifera while high quercetin glycoside concentrations occurred in N. lutea. Based on these results, biosynthetic pathways leading to specific compounds in lotus tissues are deduced through metabolomic analysis of different genotypes and tissues and correlations among flavonoid compounds.	[Chen, Sha; Xiang, Yue; Deng, Jiao; Liu, Yanling; Li, Shaohua] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China; [Chen, Sha; Li, Shaohua] Chinese Acad Sci, Inst Bot, Beijing Key Lab Grape Sci & Enol, Beijing, Peoples R China; [Chen, Sha; Li, Shaohua] Chinese Acad Sci, Inst Bot, Lab Plant Resource, Beijing, Peoples R China; [Chen, Sha; Xiang, Yue; Deng, Jiao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, SH (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China.	shhli@wbgcas.cn	liu, yan/HCI-5542-2022	Chao, Yin Kai/0000-0001-8649-8783; Chen, Sha/0000-0003-1387-9133	Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-EW-J-20]	Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This research was financially supported by The Knowledge Innovation Project of the Chinese Academy of Sciences, No. KSCX2-EW-J-20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Garcia B, 2012, J AGR FOOD CHEM, V60, P3635, DOI 10.1021/jf300022u; Bogs J, 2006, PLANT PHYSIOL, V140, P279, DOI 10.1104/pp.105.073262; Chen S, 2012, ANAL CHIM ACTA, V724, P127, DOI 10.1016/j.aca.2012.02.051; Chen S, 2012, J CHROMATOGR A, V1227, P145, DOI 10.1016/j.chroma.2011.12.098; Gouveia S, 2011, FOOD CHEM, V129, P333, DOI 10.1016/j.foodchem.2011.04.078; Guo HB, 2009, GENET RESOUR CROP EV, V56, P323, DOI 10.1007/s10722-008-9366-2; Guo XF, 2010, PHYTOCHEM ANALYSIS, V21, P268, DOI 10.1002/pca.1196; Imsabai W, 2010, POSTHARVEST BIOL TEC, V58, P57, DOI 10.1016/j.postharvbio.2010.04.007; Jung HA, 2003, ARCH PHARM RES, V26, P279, DOI 10.1007/BF02976956; Kashiwada Y, 2005, BIOORGAN MED CHEM, V13, P443, DOI 10.1016/j.bmc.2004.10.020; Kredy HM, 2010, EUR FOOD RES TECHNOL, V231, P387, DOI 10.1007/s00217-010-1287-6; Lee HK, 2005, INT J FOOD SCI TECH, V40, P709, DOI 10.1111/j.1365-2621.2005.00990.x; Liang ZC, 2012, FOOD CHEM, V132, P730, DOI 10.1016/j.foodchem.2011.11.009; Martin Bueno J, 2012, CRIT REV ANAL CHEM, V42, P126; Masuda J, 2012, J JPN SOC HORTIC SCI, V81, P67, DOI 10.2503/jjshs1.81.67; MATEK Vladimir, 1987, DANAS; Mattivi F, 2006, J AGR FOOD CHEM, V54, P7692, DOI 10.1021/jf061538c; MERVOYER C, 2012, PLANTA MED, V78, P1257; Mukherjee D, 2010, J ETHNOPHARMACOL, V128, P490, DOI 10.1016/j.jep.2010.01.015; Pfeiffer P, 2011, ACTA ALIMENT HUNG, V40, P150, DOI 10.1556/AAlim.40.2011.Suppl.15; Rai S, 2006, J ETHNOPHARMACOL, V104, P322, DOI 10.1016/j.jep.2005.09.025; Ryan KG, 2002, PHYTOCHEMISTRY, V59, P23, DOI 10.1016/S0031-9422(01)00404-6; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; Steffensen SK, 2011, J AGR FOOD CHEM, V59, P12073, DOI 10.1021/jf202969e; Sun JH, 2012, RAPID COMMUN MASS SP, V26, P1123, DOI 10.1002/rcm.6209; Treutter D, 2006, ENVIRON CHEM LETT, V4, P147, DOI 10.1007/s10311-006-0068-8; Valls J, 2009, J CHROMATOGR A, V1216, P7143, DOI 10.1016/j.chroma.2009.07.030; Wang Q., 2005, COLORED ILLUSTRATION; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Wu JZ, 2007, FOOD CHEM, V105, P540, DOI 10.1016/j.foodchem.2007.04.011; Yang RZ, 2009, J CHROMATOGR A, V1216, P106, DOI 10.1016/j.chroma.2008.11.046	31	37	37	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62291	10.1371/journal.pone.0062291	http://dx.doi.org/10.1371/journal.pone.0062291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646125	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300038
J	Lu, J; Xin, SC; Meng, H; Veldman, M; Schoenfeld, D; Che, C; Yan, RB; Zhong, HB; Li, S; Lin, S				Lu, Jing; Xin, Shengchang; Meng, Huan; Veldman, Matt; Schoenfeld, David; Che, Chao; Yan, Ruibin; Zhong, Hanbing; Li, Song; Lin, Shuo			A Novel Anti-Tumor Inhibitor Identified by Virtual Screen with PLK1 Structure and Zebrafish Assay	PLOS ONE			English	Article							POLO-LIKE-KINASE; CANCER-CELLS; PROGNOSTIC-SIGNIFICANCE; CENTRIOLE DUPLICATION; EMBRYONIC-DEVELOPMENT; DOWN-REGULATION; DNA-DAMAGE; PROTEIN; EXPRESSION; DROSOPHILA	Polo-like kinase 1 (PLK1), one of the key regulators of mitosis, is a target for cancer therapy due to its abnormally high activity in several tumors. Plk1 is highly conserved and shares a nearly identical 3-D structure between zebrafish and humans. The initial 10 mitoses of zebrafish embryonic cleavages occur every similar to 30 minutes, and therefore provide a rapid assay to evaluate mitosis inhibitors including those targeting Plk1. To increase efficiency and specificity, we first performed a computational virtual screen of similar to 60000 compounds against the human Plk1 3-D structure docked to both its kinase and Polo box domain. 370 candidates with the top free-energy scores were subjected to zebrafish assay and 3 were shown to inhibit cell division. Compared to general screen for compounds inhibiting zebrafish embryonic cleavage, computation increased the efficiency by 11 folds. One of the 3 compounds, named I2, was further demonstrated to effectively inhibit multiple tumor cell proliferation in vitro and PC3 prostate cancer growth in Xenograft mouse model in vivo. Furthermore, I2 inhibited Plk1 enzyme activity in a dose dependent manner. The IC50 values of I2 in these assays are compatible to those of ON-01910, a Plk1 inhibitor currently in Phase III clinic trials. Our studies demonstrate that zebrafish assays coupled with computational screening significantly improves the efficiency of identifying specific regulators of biological targets. The PLK1 inhibitor I2, and its analogs, may have potential in cancer therapeutics.	[Lu, Jing; Xin, Shengchang; Che, Chao; Yan, Ruibin; Zhong, Hanbing; Li, Song; Lin, Shuo] Peking Univ, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Lu, Jing; Meng, Huan; Veldman, Matt; Schoenfeld, David; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Peking University; University Town of Shenzhen; University of California System; University of California Los Angeles	Lin, S (corresponding author), Peking Univ, Shenzhen Grad Sch, Shenzhen, Peoples R China.	shuolin@ucla.edu	WANG, Jiangxin/AFE-8446-2022; Meng, Huan/AAM-1072-2020; Meng, Huan/T-7954-2017; lu, shuhuan/AAV-6927-2020	WANG, Jiangxin/0000-0002-9917-067X; Meng, Huan/0000-0001-8844-3938; Meng, Huan/0000-0001-8844-3938; Che, Chao/0000-0001-7773-0907	National Institutes of Health [DK54508, HL097561, 973-2009CB941203, 973-ZYC201006170364A, JC201005270280A]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was in part supported by research grants from the National Institutes of Health to SL (DK54508 and HL097561) and to ZH/SL (973-2009CB941203, 973-ZYC201006170364A, and JC201005270280A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Andrysik Z, 2010, NUCLEIC ACIDS RES, V38, P2931, DOI 10.1093/nar/gkq011; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Cogswell JP, 2000, CELL GROWTH DIFFER, V11, P615; Eckerdt F, 2006, CANCER RES, V66, P6895, DOI 10.1158/0008-5472.CAN-06-0358; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; HOLTRICH U, 1994, P NATL ACAD SCI USA, V91, P1736, DOI 10.1073/pnas.91.5.1736; Hudson JW, 2001, CURR BIOL, V11, P441, DOI 10.1016/S0960-9822(01)00117-8; Jeong K, 2010, DEV BIOL, V345, P34, DOI 10.1016/j.ydbio.2010.06.004; Knecht R, 1999, CANCER RES, V59, P2794; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Lu LY, 2008, MOL CELL BIOL, V28, P6870, DOI 10.1128/MCB.00392-08; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; McInnes C, 2005, CURR TOP MED CHEM, V5, P181, DOI 10.2174/1568026053507660; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Spankuch-Schmitt B, 2002, ONCOGENE, V21, P3162, DOI 10.1038/sj.onc.1205412; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; SUNKEL CE, 1988, J CELL SCI, V89, P25; Tan JL, 2011, METHOD CELL BIOL, V105, P493, DOI 10.1016/B978-0-12-381320-6.00021-7; van de Weerdt BCM, 2008, BBA-MOL CELL RES, V1783, P1015, DOI 10.1016/j.bbamcr.2008.02.019; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Wolf G, 1997, ONCOGENE, V14, P543, DOI 10.1038/sj.onc.1200862; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182; Zhong H, MOL BIOSYST, V6, P1463; Zhong HB, 2010, MOL BIOSYST, V6, P1463, DOI 10.1039/b919743e; Zimmerman WC, 2007, P NATL ACAD SCI USA, V104, P1847, DOI 10.1073/pnas.0610856104	39	31	32	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e53317	10.1371/journal.pone.0053317	http://dx.doi.org/10.1371/journal.pone.0053317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658603	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700001
J	Chen, SY; Huang, X; Yan, XQ; Liang, Y; Wang, YZ; Li, XF; Peng, XJ; Ma, XY; Zhang, LX; Cai, YY; Ma, T; Cheng, LQ; Qi, DM; Zheng, HJ; Yang, XH; Li, XX; Liu, GS				Chen, Shuangyan; Huang, Xin; Yan, Xueqing; Liang, Ye; Wang, Yuezhu; Li, Xiaofeng; Peng, Xianjun; Ma, Xingyong; Zhang, Lexin; Cai, Yueyue; Ma, Tian; Cheng, Liqin; Qi, Dongmei; Zheng, Huajun; Yang, Xiaohan; Li, Xiaoxia; Liu, Gongshe			Transcriptome Analysis in Sheepgrass (Leymus chinensis): A Dominant Perennial Grass of the Eurasian Steppe	PLOS ONE			English	Article							FREEZING TOLERANCE; SSR-MARKERS; ARABIDOPSIS-THALIANA; COLD-ACCLIMATION; MICROSATELLITE MARKERS; PHYLOGENETIC ANALYSIS; GENOME ANNOTATION; GENE DISCOVERY; SALT TOLERANCE; TRITICEAE	Background: Sheepgrass [Leymus chinensis (Trin.) Tzvel.] is an important perennial forage grass across the Eurasian Steppe and is known for its adaptability to various environmental conditions. However, insufficient data resources in public databases for sheepgrass limited our understanding of the mechanism of environmental adaptations, gene discovery and molecular marker development. Results: The transcriptome of sheepgrass was sequenced using Roche 454 pyrosequencing technology. We assembled 952,328 high-quality reads into 87,214 unigenes, including 32,416 contigs and 54,798 singletons. There were 15,450 contigs over 500 bp in length. BLAST searches of our database against Swiss-Prot and NCBI non-redundant protein sequences (nr) databases resulted in the annotation of 54,584 (62.6%) of the unigenes. Gene Ontology (GO) analysis assigned 89,129 GO term annotations for 17,463 unigenes. We identified 11,675 core Poaceae-specific and 12,811 putative sheepgrass-specific unigenes by BLAST searches against all plant genome and transcriptome databases. A total of 2,979 specific freezing-responsive unigenes were found from this RNAseq dataset. We identified 3,818 EST-SSRs in 3,597 unigenes, and some SSRs contained unigenes that were also candidates for freezing-response genes. Characterizations of nucleotide repeats and dominant motifs of SSRs in sheepgrass were also performed. Similarity and phylogenetic analysis indicated that sheepgrass is closely related to barley and wheat. Conclusions: This research has greatly enriched sheepgrass transcriptome resources. The identified stress-related genes will help us to decipher the genetic basis of the environmental and ecological adaptations of this species and will be used to improve wheat and barley crops through hybridization or genetic transformation. The EST-SSRs reported here will be a valuable resource for future gene-phenotype studies and for the molecular breeding of sheepgrass and other Poaceae species.	[Chen, Shuangyan; Huang, Xin; Yan, Xueqing; Liang, Ye; Li, Xiaofeng; Peng, Xianjun; Ma, Xingyong; Zhang, Lexin; Cai, Yueyue; Ma, Tian; Cheng, Liqin; Qi, Dongmei; Li, Xiaoxia; Liu, Gongshe] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Huang, Xin; Yan, Xueqing; Liang, Ye; Ma, Xingyong; Zhang, Lexin; Cai, Yueyue; Li, Xiaoxia] Chinese Acad Sci, Grad Schoo1, Beijing, Peoples R China; [Wang, Yuezhu; Zheng, Huajun] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Yang, Xiaohan] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; United States Department of Energy (DOE); Oak Ridge National Laboratory	Chen, SY (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China.	sychen@ibcas.ac.cn; lixx258258@163.com; liugs@ibcas.ac.cn	Yang, Xiaohan/AAM-2449-2020; Yang, Xiaohan/A-6975-2011	Yang, Xiaohan/0000-0001-5207-4210; Yang, Xiaohan/0000-0001-5207-4210	National High Technology Research and Development Program of China ("863") [2011AA100209]; National Natural Science Foundation of China [30970291, 31170316]; Key Project of the Chinese Academy of Sciences [KSCX2-EW-J-1]; Project of Ningxia Agricultural Comprehensive Development Office [NNTK-11-04, NTKJ-2012-03]	National High Technology Research and Development Program of China ("863")(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Chinese Academy of Sciences(Chinese Academy of Sciences); Project of Ningxia Agricultural Comprehensive Development Office	This work was supported by the National High Technology Research and Development Program of China ("863", 2011AA100209), the National Natural Science Foundation of China (30970291; 31170316), the Key Project of the Chinese Academy of Sciences (KSCX2-EW-J-1), and the Project of Ningxia Agricultural Comprehensive Development Office (NNTK-11-04; NTKJ-2012-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Bai WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012125; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Bushman BS, 2008, GENOME, V51, P779, DOI 10.1139/G08-062; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Chen PD, 2005, THEOR APPL GENET, V111, P941, DOI 10.1007/s00122-005-0026-z; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X; da Maia LC, 2009, GENET MOL BIOL, V32, P822, DOI 10.1590/S1415-47572009005000091; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Deschamps S, 2010, PLANT GENOME-US, V3, P53, DOI 10.3835/plantgenome2009.09.0026; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Fan X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-247; Fursova OV, 2009, GENE, V429, P98, DOI 10.1016/j.gene.2008.10.016; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; He RF, 2012, AM J BOT, V99, P232, DOI 10.3732/ajb.1100429; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; [马红媛 Hongyuan Ma], 2007, [植物学通报, Chinese Bulletin of Botany], V24, P181; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Jin H, 2006, PLANT SCI, V170, P1081, DOI 10.1016/j.plantsci.2006.01.002; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liu X, 2001, ACTA BOT SIN, V43, P948; Liu ZP, 2008, MOL PHYLOGENET EVOL, V46, P278, DOI 10.1016/j.ympev.2007.10.009; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Ma PD, 2012, APPL BIOCHEM BIOTECH, V166, P479, DOI 10.1007/s12010-011-9443-4; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Niu SL, 2008, J EXP BOT, V59, P1431, DOI 10.1093/jxb/ern051; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Palmer NA, 2012, BIOENERG RES, V5, P649, DOI 10.1007/s12155-011-9171-1; Peng XJ, 2011, PLANT CELL REP, V30, P1493, DOI 10.1007/s00299-011-1058-2; Qi LL, 2008, THEOR APPL GENET, V117, P1155, DOI 10.1007/s00122-008-0853-9; Reyes JC, 2006, CURR OPIN PLANT BIOL, V9, P21, DOI 10.1016/j.pbi.2005.11.010; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sha LN, 2008, BIOCHEM GENET, V46, P605, DOI 10.1007/s10528-008-9175-5; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Subbarao GV, 2007, PLANT SOIL, V299, P55, DOI 10.1007/s11104-007-9360-z; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Sun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053632; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Troncoso-Ponce MA, 2011, PLANT J, V68, P1014, DOI 10.1111/j.1365-313X.2011.04751.x; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Victoria FC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-15; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang LJ, 2009, BIOTECHNOL LETT, V31, P313, DOI 10.1007/s10529-008-9864-5; Wang RZ, 2008, J PLANT GROWTH REGUL, V27, P39, DOI 10.1007/s00344-007-9029-0; WANG RRC, 1994, GENOME, V37, P231, DOI 10.1139/g94-032; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Wang YH, 2007, CLIMATIC CHANGE, V82, P437, DOI 10.1007/s10584-006-9145-z; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Xiong LM, 2002, P NATL ACAD SCI USA, V99, P10899, DOI 10.1073/pnas.162111599; Xu ZZ, 2006, PLANTA, V224, P1080, DOI 10.1007/s00425-006-0281-5; Xu ZZ, 2009, J EXP BOT, V60, P3737, DOI 10.1093/jxb/erp216; Young ET, 2000, GENETICS, V154, P1053; ZHANG HB, 1991, AM J BOT, V78, P871, DOI 10.2307/2445166; Zhang L, 2010, J ENVIRON QUAL, V39, P251, DOI 10.2134/jeq2009.0109; Zhang WD, 2004, GRASS FORAGE SCI, V59, P180, DOI 10.1111/j.1365-2494.2004.00419.x; Zhou Q, 2008, J GENET GENOMICS, V35, P639, DOI 10.1016/S1673-8527(08)60085-5; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102; Zhu J, 2008, P NATL ACAD SCI USA, V105, P4945, DOI 10.1073/pnas.0801029105	88	79	85	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67974	10.1371/journal.pone.0067974	http://dx.doi.org/10.1371/journal.pone.0067974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861841	gold, Green Published, Green Submitted			2022-12-25	WOS:000323350700067
J	Liu, KC; Ge, W				Liu, Ka-Cheuk; Ge, Wei			Evidence for Gating Roles of Protein Kinase A and Protein Kinase C in Estradiol-Induced Luteinizing Hormone Receptor (lhcgr) Expression in Zebrafish Ovarian Follicle Cells	PLOS ONE			English	Article							MEMBRANE ESTROGEN-RECEPTOR; BRAIN TYROSINE-HYDROXYLASE; NITRIC-OXIDE SYNTHASE; GONADOTROPIN RECEPTORS; GENE-EXPRESSION; MESSENGER-RNA; FUNCTIONAL-CHARACTERIZATION; DIFFERENTIAL REGULATION; DOWN-REGULATION; UP-REGULATION	Estradiol (E2) stimulates luteinizing hormone receptor (lhcgr) expression in zebrafish follicle cells via nuclear estrogen receptors (nERs) that are likely expressed on the membrane, and lhcgr responds to E2 in a biphasic manner during 24-h treatment. These observations raise an interesting question on the signaling mechanism underlying E2 regulation, in particular the biphasic response of lhcgr expression. In the present study, we demonstrated that E2 regulation of lhcgr was significantly influenced by the activity of cAMP-PKA pathway. Activation of cAMP-PKA pathway by forskolin or db-cAMP suppressed E2-stimulated lhcgr expression in short-term (3 h) but enhanced its effect in long-term (24 h), suggesting differential roles of PKA at these two phases of lhcgr response. PKA inhibitor H89 showed reversed effects. In contrast, PKC pathway had consistent permissive effect on E2-induced lhcgr expression as evidenced by strong inhibition of E2 effect by PKC inhibitors GF109203X and Ro-31-8220 at both 3 and 24 h. One of the mechanisms by which PKA and PKC gated E2 effect might be through regulating nERs, particularly esr2a. Despite the strong influence of PKA and PKC, our data did not suggest direct mediating roles for these two pathways in E2 stimulation of lhcgr expression; yet they likely play critical gating roles in E2 signal transduction. As a follow-up study to our previous report on E2 regulation of gonadotropin receptors in the zebrafish ovary, the present study provides further evidence for the involvement of classical intracellular signal transduction pathways in E2 stimulation of lhcgr expression in the follicle cells.	[Ge, Wei] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Ctr Cell & Dev Biol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Ge, W (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	weige@cuhk.edu.hk	Ma, Miaojun/E-1320-2012	Ma, Miaojun/0000-0001-7046-9574; Liu, Kun/0000-0001-9127-053X; Liu, Ka Cheuk/0000-0001-6082-8801	Research Grants Council [CUHK464707, 464308, 464409]; Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region	Research Grants Council(Hong Kong Research Grants Council); Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region	The work was substantially supported by grants from the Research Grants Council (CUHK464707, 464308 and 464409) and the Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region to W.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder's website: http://www.ugc.edu.hk/eng/rgc/grf/grf.htm	Amsterdam A, 2002, MOL CELL ENDOCRINOL, V187, P69, DOI 10.1016/S0303-7207(01)00701-8; Burns KH, 2002, ENDOCRINOLOGY, V143, P2823, DOI 10.1210/en.143.8.2823; Byers M, 1997, MOL ENDOCRINOL, V11, P172, DOI 10.1210/me.11.2.172; Caiazza F, 2007, BIOCHEM BIOPH RES CO, V359, P102, DOI 10.1016/j.bbrc.2007.05.059; CATT KJ, 1991, J BIOENERG BIOMEMBR, V23, P7; Chaube R, 2005, J NEUROENDOCRINOL, V17, P91, DOI 10.1111/j.1365-2826.2005.01282.x; Chaube R, 2005, GEN COMP ENDOCR, V141, P116, DOI 10.1016/j.ygcen.2004.12.010; Chen DB, 2004, ENDOCRINOLOGY, V145, P113, DOI 10.1210/en.2003-0547; CHEN JH, 1994, SCIENCE, V263, P1278, DOI 10.1126/science.8122111; Chen LH, 2011, CELL SIGNAL, V23, P497, DOI 10.1016/j.cellsig.2010.11.005; Chiang CH, 2000, J CLIN ENDOCR METAB, V85, P3828, DOI 10.1210/jc.85.10.3828; De Marinis YZ, 2010, DIABETOLOGIA, V53, P717, DOI 10.1007/s00125-009-1635-x; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; De Servi B, 2005, ONCOGENE, V24, P4946, DOI 10.1038/sj.onc.1208676; Dewing P, 2008, ENDOCRINOLOGY, V149, P5934, DOI 10.1210/en.2008-0847; Hatae J, 2009, J PHYSIOL SCI, V59, P181, DOI 10.1007/s12576-009-0023-0; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Jaubert AM, 2007, ENDOCRINOLOGY, V148, P2444, DOI 10.1210/en.2006-1329; Jeng SR, 2007, GEN COMP ENDOCR, V154, P161, DOI 10.1016/j.ygcen.2007.05.026; Kazi AA, 2009, BIOL REPROD, V81, P378, DOI 10.1095/biolreprod.109.076117; Kobayashi T, 2008, GEN COMP ENDOCR, V156, P595, DOI 10.1016/j.ygcen.2008.02.010; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; Le HH, 2010, ENDOCRINOLOGY, V151, P5689, DOI 10.1210/en.2010-0710; Lee MY, 2008, CELL RES, V18, P491, DOI 10.1038/cr.2008.42; LEUNG PCK, 1992, ENDOCR REV, V13, P476, DOI 10.1210/er.13.3.476; Levin ER, 2011, MOL ENDOCRINOL, V25, P377, DOI 10.1210/me.2010-0284; Li CW, 2012, GEN COMP ENDOCR, V176, P420, DOI 10.1016/j.ygcen.2011.12.032; Liu KC, 2013, GEN COMP ENDOCR, V181, P288, DOI 10.1016/j.ygcen.2012.07.032; Liu KC, 2011, ENDOCRINOLOGY, V152, P4418, DOI 10.1210/en.2011-1065; Liu XC, 2009, BIOL REPROD, V80, P1253, DOI 10.1095/biolreprod.108.070250; Longo M, 2006, J MOL ENDOCRINOL, V37, P489, DOI 10.1677/jme.1.02055; Lucas TF, 2008, BIOL REPROD, V78, P101; Luckenbach JA, 2011, GEN COMP ENDOCR, V171, P52, DOI 10.1016/j.ygcen.2010.12.016; Maharjan S, 2010, J NEUROCHEM, V112, P42, DOI 10.1111/j.1471-4159.2009.06430.x; Marlatt VL, 2008, MOL CELL ENDOCRINOL, V283, P38, DOI 10.1016/j.mce.2007.10.013; Menon B, 2011, MOL ENDOCRINOL, V25, P282, DOI 10.1210/me.2010-0366; Menuet A, 2004, J MOL ENDOCRINOL, V32, P975, DOI 10.1677/jme.0.0320975; Mhyre AJ, 2006, ENDOCRINOLOGY, V147, P1796, DOI 10.1210/en.2005-1316; MIGLIACCIO S, 1993, MOL ENDOCRINOL, V7, P1133, DOI 10.1210/me.7.9.1133; Migliaccio S, 1998, STEROIDS, V63, P352, DOI 10.1016/S0039-128X(98)00040-3; Migliaccio S, 1998, ENDOCRINOLOGY, V139, P4598, DOI 10.1210/en.139.11.4598; Mize AL, 2002, NEUROENDOCRINOLOGY, V76, P339, DOI 10.1159/000067583; Nelson ER, 2007, MOL REPROD DEV, V74, P1105, DOI 10.1002/mrd.20634; Nelson ER, 2010, ENDOCRINOLOGY, V151, P1668, DOI 10.1210/en.2009-1447; Oba Y, 1999, BIOCHEM BIOPH RES CO, V263, P584, DOI 10.1006/bbrc.1999.1346; Oba Y, 1999, BIOCHEM BIOPH RES CO, V265, P366, DOI 10.1006/bbrc.1999.1700; Pang Y, 2008, ENDOCRINOLOGY, V149, P3410, DOI 10.1210/en.2007-1663; Pang YF, 2010, DEV BIOL, V342, P194, DOI 10.1016/j.ydbio.2010.03.027; Pang YF, 2009, GEN COMP ENDOCR, V161, P58, DOI 10.1016/j.ygcen.2008.10.003; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Pinzone JJ, 2004, MOL CELL BIOL, V24, P4605, DOI 10.1128/MCB.24.11.4605-4612.2004; Qiu J, 2003, J NEUROSCI, V23, P9529; Radice S, 2004, CHEM-BIOL INTERACT, V147, P185, DOI 10.1016/j.cbi.2003.12.006; REE AH, 1992, ENDOCRINOLOGY, V131, P1810, DOI 10.1210/en.131.4.1810; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; SACEDA M, 1991, J BIOL CHEM, V266, P17809; Sheldahl LC, 2008, NEUROSCIENCE, V153, P751, DOI 10.1016/j.neuroscience.2008.02.035; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Soverchia L, 2005, TOXICOL APPL PHARM, V209, P236, DOI 10.1016/j.taap.2005.04.013; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Tischkau SA, 2000, J NEUROSCI, V20, P7830; Tonetti DA, 2000, BRIT J CANCER, V83, P782, DOI 10.1054/bjoc.2000.1326; Vasudevan N, 2007, ENDOCR REV, V28, P1, DOI 10.1210/er.2005-0021; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Zhang CG, 2010, ENDOCRINOLOGY, V151, P4477, DOI 10.1210/en.2010-0177; Zhang HH, 2010, ENDOCRINOLOGY, V151, P3874, DOI 10.1210/en.2009-1356; Zhang MJ, 2009, MOL HUM REPROD, V15, P399, DOI 10.1093/molehr/gap031; Zhang ZG, 2002, BIOCHEM BIOPH RES CO, V294, P926, DOI 10.1016/S0006-291X(02)00348-0; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092; Zhou R, 2011, BIOL REPROD, V85, P615, DOI 10.1095/biolreprod.111.091884	75	26	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62524	10.1371/journal.pone.0062524	http://dx.doi.org/10.1371/journal.pone.0062524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658740	gold, Green Submitted, Green Published			2022-12-25	WOS:000321202100014
J	He, ZY; Xiong, LP; Han, S; Chen, AX; Qiu, JW; Fu, XS				He Zhongyi; Xiong Liping; Han Sheng; Chen Aixi; Qiu Jianwei; Fu Xisheng			Tribological and Antioxidation Synergistic Effect Study of Sulfonate-Modified Nano Calcium Carbonate	PLOS ONE			English	Article							CACO3 NANOPARTICLES	A middle base number sulphonate-modified nano calcium carbonate (SMC) with an average size of 35 nm was synthesized, and its tribological and antioxidation synergistic behaviors with ashless antioxidant N-phenyl-alpha-naphthylamine (T531) in hydrogenated oil (5Cst) were evaluated. The results demonstrate that adding this synethesized additive even at a low amount (<2.0 wt.%) can evidently improve its load-carrying capacity by 1.5 times and enhance its antiwear performance; in addition, the friction-reducing effect of additive in the high load was better than that in low load. The SMC have a good synergistic antioxidation effect with T531, which verifies the nano calcium carbonate compound was a kind of multifunctional and high-performance additive. The chemical composition of the rubbing surface which formed on the boundary film was analyzed by using scanning electron microscopy (SEM) and X-ray photoelectron spectroscopy (XPS). The results indicating that the excellent antiwear and load-carrying performance could be attributed to the forming of boundary lubrication film which composed of calcium carbonate, oxides, ferrites, sulphide and FeSO4, and so on. Its ability to increase oxidation free energy of base oil is the main reason for increasing its antioxidant collaboration property with ashless antioxidant T531.	[He Zhongyi; Xiong Liping; Chen Aixi] East China Jiaotong Univ, Sch Basic Sci, Nanchang, Peoples R China; [He Zhongyi; Han Sheng] Shanghai Inst Technol, Shanghai, Peoples R China; [Qiu Jianwei; Fu Xisheng] PetroChina Lanzhou Lubricating Oil R&D Inst, Lanzhou, Peoples R China	East China Jiaotong University; Shanghai Institute of Technology; China National Petroleum Corporation	He, ZY (corresponding author), East China Jiaotong Univ, Sch Basic Sci, Nanchang, Peoples R China.	zhongyihe@yahoo.com.cn		Thomas, Stacey/0000-0002-5666-4311	Chinese Natural Science Foundation [21163006]; Jiangxi Provincial Natural Science Foundation [20122BAB203011]	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Natural Science Foundation	The work reported here was sponsored by Chinese Natural Science Foundation (No: 21163006); Jiangxi Provincial Natural Science Foundation (No: 20122BAB203011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakunin VN, 2004, J NANOPART RES, V6, P273, DOI 10.1023/B:NANO.0000034720.79452.e3; Battez AH, 2008, WEAR, V265, P422, DOI 10.1016/j.wear.2007.11.013; Chen H, 2008, WEAR, V265, P1504, DOI 10.1016/j.wear.2008.02.034; FIERRO G, 1989, CORROSION, V45, P814, DOI 10.5006/1.3584988; Fu X, 1996, LUBR SCI, V8, P269; GIASSON S, 1994, THIN SOLID FILMS, V252, P111, DOI 10.1016/0040-6090(94)90782-X; He ZY, 2011, MATER SCI FORUM, V694, P98, DOI 10.4028/www.scientific.net/MSF.694.98; Hu HQ, 2008, TRIBOL INT, V41, P549, DOI 10.1016/j.triboint.2007.11.020; Ji XB, 2011, TRIBOL LETT, V41, P113, DOI 10.1007/s11249-010-9688-z; Jin DL, 2008, MATER LETT, V62, P1565, DOI 10.1016/j.matlet.2007.09.023; [李久盛 LI Jiusheng], 2008, [分析科学学报, Journal of Analytical Science], V24, P189; Li T, 2010, LUBES FUELS, V20, P30; Michael TC, 2006, TRIBOL T, V592, P49; Wager C. D., 1979, HDB XRAY PHOTOELECTR; Wang LB, 2007, TRIBOL INT, V40, P1179, DOI 10.1016/j.triboint.2006.12.003; Xiangdong S, 2004, LUBR ENG, V164, P92; Xiong LP, 2011, LUBR SCI, V23, P33, DOI 10.1002/ls.139; Yao JB, 1996, TRIBOL T, V39, P498, DOI 10.1080/10402009608983559; Yao W, 2007, LUBRICATING OIL, V22, P1; Yu HL, 2008, SURF COAT TECH, V203, P28, DOI 10.1016/j.surfcoat.2008.07.032; Zhang M, 2009, TRIBOL INT, V42, P1029, DOI 10.1016/j.triboint.2009.02.012	21	16	18	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62050	10.1371/journal.pone.0062050	http://dx.doi.org/10.1371/journal.pone.0062050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658705	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100005
J	Lu, SH; Wang, JX; Ma, Q; Yang, J; Li, X; Yuan, YJ				Lu, Shuhuan; Wang, Jiangxin; Ma, Qian; Yang, Jie; Li, Xia; Yuan, Ying-Jin			Phospholipid Metabolism in an Industry Microalga Chlorella sorokiniana: The Impact of Inoculum Sizes	PLOS ONE			English	Article							LIPID CLASS COMPOSITION; BIODIESEL PRODUCTION; FATTY-ACID; CHAIN UNSATURATION; ENDOTHELIAL-CELLS; PHOTOSYSTEM-II; PHOSPHATIDYLGLYCEROL; CHLAMYDOMONAS; ACCUMULATION; PATHWAYS	Chlorella sorokiniana is an important industry microalga potential for biofuel production. Inoculum size is one of the important factors in algal large-scale culture, and has great effects on the growth, lipid accumulation and metabolism of microalgae. As the first barrier of cell contents, membrane plays a vital role in algal inoculum-related metabolism. The knowledge of phospholipids, the main membrane component and high accumulation of phospholipids as the major content of total lipids mass in some microalgae, is necessary to understand the role of membrane in cell growth and metabolism under different inoculum density. Profiling of C. sorokiniana phospholipids with LC-MS led to the identification of 119 phospholipid species. To discover the phospholipid molecules most related to change of inoculum sizes, Partial Least Squares Discriminant Analysis (PLS-DA) was employed and the results revealed that inoculum sizes significantly affected phospholipid profiling. Phosphatidylglycerol (PG), phosphatidyl-ethanolamine (PE) and several phosphatidylcholine (PC) species might play an important role under our experimental conditions. Further analysis of these biomarkers indicated that cell membrane status of C. sorokiniana might play an important role in the adaption to the inoculum sizes. And the culture with inoculum size of 1x10(6) cells mL(-1) presented the best membrane status with the highest content of PC and PG, and the lowest content of PE. We discovered that the inoculum size of 1x10(6) cells mL(-1) might provide the best growth condition for C. sorokiniana. Also we proposed that PG, PE and several PC may play an important role in inoculum-related metabolism in C. sorokiniana, which may work through thylakoid membrane and photosynthetic pathway. Thus this study would provide more potential targets for metabolic engineering to improve biofuel production and productivity in microalgae.	[Lu, Shuhuan; Wang, Jiangxin; Ma, Qian; Yang, Jie; Li, Xia; Yuan, Ying-Jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China; [Lu, Shuhuan; Wang, Jiangxin; Ma, Qian; Yang, Jie; Li, Xia; Yuan, Ying-Jin] Tianjin Univ, Sch Chem Engn & Technol, Dept Pharmaceut Engn, Tianjin 300072, Peoples R China; [Lu, Shuhuan] CABIO Bioengn Wuhan Co Ltd, Wuhan, Hubei, Peoples R China	Tianjin University; Tianjin University	Yuan, YJ (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn	WANG, Jiangxin/AFE-8446-2022; Meng, Huan/AAM-1072-2020; Meng, Huan/T-7954-2017; lu, shuhuan/AAV-6927-2020	WANG, Jiangxin/0000-0002-9917-067X; Meng, Huan/0000-0001-8844-3938; Meng, Huan/0000-0001-8844-3938; Che, Chao/0000-0001-7773-0907	National Basic Research Program of China ("973" Program) [2013CB733601]; National High Technology Research and Development Program of China ("863" Program) [2012AA02A701]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097561] Funding Source: NIH RePORTER	National Basic Research Program of China ("973" Program)(National Basic Research Program of China); National High Technology Research and Development Program of China ("863" Program)(National High Technology Research and Development Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful for the financial support from the National Basic Research Program of China ("973" Program: 2013CB733601), and the National High Technology Research and Development Program of China ("863" Program: 2012AA02A701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisz SA, 2011, J LIPID RES, V52, P2012, DOI 10.1194/jlr.M016873; Ballottari M, 2011, BIOCHIM BIOPHYS ACTA, V1817, P143; Beal CM, 2013, RENEW ENERG, V50, P86, DOI 10.1016/j.renene.2012.06.027; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brennan L, 2010, RENEW SUST ENERG REV, V14, P557, DOI 10.1016/j.rser.2009.10.009; Bumbak F, 2011, APPL MICROBIOL BIOT, V91, P31, DOI 10.1007/s00253-011-3311-6; Carswell H, 2012, BRIT J PHARMACOL, V90, P175; Cengiz EI, 2012, TURK J FISH AQUAT SC, V12, P31, DOI 10.4194/1303-2712-v12_1_05; Chen GQ, 2008, FOOD CHEM, V109, P88, DOI 10.1016/j.foodchem.2007.12.022; Chen GQ, 2007, FOOD CHEM, V104, P1580, DOI 10.1016/j.foodchem.2007.03.008; Chen L, 2012, BIORESOURCE TECHNOL, V111, P208, DOI 10.1016/j.biortech.2012.02.033; Chiou SY, 2001, J BIOTECHNOL, V85, P247, DOI 10.1016/S0168-1656(00)00346-1; Cuaresma M, 2009, BIOTECHNOL BIOENG, V104, P352, DOI 10.1002/bit.22394; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; Deng XD, 2009, AFR J MICROBIOL RES, V3, P1008; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; Goncharova SN, 2004, RUSS J PLANT PHYSL+, V51, P169, DOI 10.1023/B:RUPP.0000019209.10747.9d; Guschina IA, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2_1; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; He H, 2011, ENERG FUEL, V25, P4770, DOI 10.1021/ef201061J; Ivanov AG, 2012, BBA-BIOENERGETICS, V1817, P1374, DOI 10.1016/j.bbabio.2012.03.010; Johnson MB, 2010, APPL MICROBIOL BIOT, V85, P525, DOI 10.1007/s00253-009-2133-2; Johnson MB, 2009, ENERG FUEL, V23, P5179, DOI 10.1021/ef900704h; Joyard J, 2010, PROG LIPID RES, V49, P128, DOI 10.1016/j.plipres.2009.10.003; Kacka A, 2008, BIORESOURCE TECHNOL, V99, P8348, DOI 10.1016/j.biortech.2008.02.042; Khandelia H, 2009, BIOPHYS J, V96, P2734, DOI 10.1016/j.bpj.2009.01.007; Kubota H, 2010, BBA-BIOENERGETICS, V1797, P98, DOI 10.1016/j.bbabio.2009.09.001; Lei AP, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-18; Li XF, 2007, BIOTECHNOL BIOENG, V98, P764, DOI 10.1002/bit.21489; Li Y, 2011, ALGAE BIOFUELS; Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1; Li YC, 2012, BIOTECHNOL BIOENG, V109, P2222, DOI 10.1002/bit.24491; Lin S, 2011, GENE, V473, P139, DOI 10.1016/j.gene.2010.11.011; Lin WC, 2007, BIOPHYS J, V92, P2831, DOI 10.1529/biophysj.106.095422; Liu J, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-68; Lu N, 2012, EUR J LIPID SCI TECH, V114, P253, DOI 10.1002/ejlt.201100248; Lu SH, 2012, BIOTECHNOL BIOENG, V109, P1651, DOI 10.1002/bit.24447; Ma Q, 2013, BIOTECHNOL BIOENG, V110, P773, DOI 10.1002/bit.24762; Mock T, 2002, PHYTOCHEMISTRY, V61, P53, DOI 10.1016/S0031-9422(02)00215-7; Morita M, 2002, BIOTECHNOL BIOENG, V77, P155, DOI 10.1002/bit.10119; Muradyan EA, 2004, RUSS J PLANT PHYSL+, V51, P53, DOI 10.1023/B:RUPP.0000011303.11957.48; Niemela PS, 2006, BIOPHYS J, V90, P851, DOI 10.1529/biophysj.105.067371; Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X; Pienkos PT, 2009, BIOFUEL BIOPROD BIOR, V3, P431, DOI 10.1002/bbb.159; Pineau B, 2004, EUR J BIOCHEM, V271, P329, DOI 10.1046/j.1432-1033.2003.03931.x; Prinetti A, 2009, BBA-BIOMEMBRANES, V1788, P184, DOI 10.1016/j.bbamem.2008.09.001; Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Sakamoto A, 2004, PLANT CELL ENVIRON, V27, P99, DOI 10.1046/j.0016-8025.2003.01131.x; Salvador GA, 2002, J NEUROSCI RES, V70, P283, DOI 10.1002/jnr.10385; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Singh NK, 2011, AGRON SUSTAIN DEV, V31, P605, DOI 10.1007/s13593-011-0018-0; Soh L, 2011, GREEN CHEM, V13, P1422, DOI 10.1039/c1gc15068e; Stephenson AL, 2010, BIOFUELS-UK, V1, P47, DOI 10.4155/BFS.09.1; Sun XL, 2011, PLANT CELL REP, V30, P1939, DOI 10.1007/s00299-011-1102-2; Tian HC, 2010, APPL MICROBIOL BIOT, V87, P1507, DOI 10.1007/s00253-010-2615-2; Van Gerpen J, 2005, FUEL PROCESS TECHNOL, V86, P1097, DOI 10.1016/j.fuproc.2004.11.005; Wada H, 2010, LIPIDS PHOTOSYNTHESI, P243; Wang JX, 2009, PLANTA, V230, P191, DOI 10.1007/s00425-009-0932-4; Wang L, 2010, BIORESOURCE TECHNOL, V101, P2623, DOI 10.1016/j.biortech.2009.10.062; Wu ZC, 2012, BIORESOURCE TECHNOL, V110, P496, DOI 10.1016/j.biortech.2012.01.101; Wyatt NB, 2012, BIOTECHNOL BIOENG, V109, P493, DOI 10.1002/bit.23319; Yang FX, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-13; Yang J, 2012, OMICS, V16, P374, DOI 10.1089/omi.2011.0127; Yang J, 2012, MOL BIOSYST, V8, P1789, DOI 10.1039/c2mb05510d; Yang J, 2011, MOL BIOSYST, V7, P2428, DOI 10.1039/c1mb00002k; Yang S, 2008, BBA-MOL CELL BIOL L, V1781, P123, DOI 10.1016/j.bbalip.2007.11.005; Yang S, 2007, BBA-MOL CELL BIOL L, V1771, P600, DOI 10.1016/j.bbalip.2007.02.011; Yang S, 2009, CHEM PHYS LIPIDS, V159, P13, DOI 10.1016/j.chemphyslip.2009.02.004; Yoshioka M, 2012, AQUACULTURE, V338, P111, DOI 10.1016/j.aquaculture.2012.01.005; Yu B, 2003, PLANT J, V36, P762, DOI 10.1046/j.1365-313X.2003.01918.x; Zhang CF, 2010, FOOD CHEM, V120, P864, DOI 10.1016/j.foodchem.2009.11.029; Zhao LY, 2004, J COLLOID INTERF SCI, V274, P55, DOI 10.1016/j.jcis.2003.12.009; Zhu L, 2012, BIOCHEM CELL BIOL, V90, P188, DOI [10.1139/O11-081, 10.1139/o11-081]	75	31	32	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70827	10.1371/journal.pone.0070827	http://dx.doi.org/10.1371/journal.pone.0070827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23658603	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000140
J	Chen, JY; Tang, YA; Li, WS; Chiou, YC; Shieh, JM; Wang, YC				Chen, Jia-Yang; Tang, Yen-An; Li, Wen-Shan; Chiou, Yu-Ching; Shieh, Jiunn-Min; Wang, Yi-Ching			A Synthetic Podophyllotoxin Derivative Exerts Anti-Cancer Effects by Inducing Mitotic Arrest and Pro-Apoptotic ER Stress in Lung Cancer Preclinical Models	PLOS ONE			English	Article							ANTIMITOTIC ACTIVITY; NATURAL-PRODUCTS; BINDING AGENTS; DRUG DISCOVERY; RESISTANCE; TUBULIN; MITOSIS; MICROTUBULES; EXPRESSION; KINASES	Some potent chemotherapy drugs including tubulin-binding agents had been developed from nature plants, such as podophyllotoxin and paclitaxel. However, poor cytotoxic selectivity, serious side-effects, and limited effectiveness are still the major concerns in their therapeutic application. We developed a fully synthetic podophyllotoxin derivative named Ching001 and investigated its anti-tumor growth effects and mechanisms in lung cancer preclinical models. Ching001 showed a selective cytotoxicity to different lung cancer cell lines but not to normal lung cells. Ching001 inhibited the polymerization of microtubule resulting in mitotic arrest as evident by the accumulation of mitosis-related proteins, survivin and aurora B, thereby leading to DNA damage and apoptosis. Ching001 also activated pro-apoptotic ER stress signaling pathway. Intraperitoneal injection of 2 mg/kg Ching001 significantly inhibited the tumor growth of A549 xenograft, while injection of 0.2 mg/kg Ching001 decreased the lung colonization ability of A549 cells in experimental metastasis assay. These anti-tumor growth and lung colonization inhibition effects were stronger than those of paclitaxel treatment at the same dosage. The xenograft tumor tissue stains further confirmed that Ching001 induced mitosis arrest and tumor apoptosis. In addition, the hematology and biochemistry tests of blood samples as well as tissue examinations indicated that Ching001 treatment did not show apparent organ toxicities in tested animals. We provided preclinical evidence that novel synthetic microtubule inhibitor Ching001, which can trigger DNA damage and apoptosis by inducing mitotic arrest and ER stress, is a potential anti-cancer compound for further drug development.	[Chen, Jia-Yang; Tang, Yen-An; Wang, Yi-Ching] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Li, Wen-Shan; Chiou, Yu-Ching] Acad Sinica, Inst Chem, Taipei 115, Taiwan; [Chiou, Yu-Ching] Natl Taiwan Normal Univ, Dept Chem, Taipei, Taiwan; [Shieh, Jiunn-Min] Chi Mei Med Ctr, Dept Internal Med, Div Chest Med, Tainan, Taiwan; [Shieh, Jiunn-Min] Chia Nan Univ Pharm & Sci, Ctr Gen Educ, Tainan, Taiwan; [Wang, Yi-Ching] Natl Cheng Kung Univ, Dept Pharmacol, Tainan, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; National Taiwan Normal University; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; National Cheng Kung University	Shieh, JM (corresponding author), Chi Mei Med Ctr, Dept Internal Med, Div Chest Med, Tainan, Taiwan.	shieh225@ms29.hinet.net; ycw5798@mail.ncku.edu.tw	Li, Wen-Shan/F-1972-2015; CHEN, JIA-YANG/M-8413-2014; Wang, Yi-Ching/J-8702-2019; Peng, Hongquan/AAI-6239-2021; Chen, Jianping/C-4225-2009	Li, Wen-Shan/0000-0002-8359-4582; CHEN, JIA-YANG/0000-0001-9159-7591; Wang, Yi-Ching/0000-0002-7694-2067; Peng, Hongquan/0000-0003-4893-7903; Li, Wei/0000-0002-9991-7892; Chen, Jianping/0000-0001-6494-5271; Chen, Hui/0000-0002-0048-0193	Chi Mei Medical Center, Taiwan [CMNCKU10107]; National Science Council, Taiwan [NSC 101-2325-B-006-008]	Chi Mei Medical Center, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants CMNCKU10107 from the Chi Mei Medical Center, Taiwan (JMS) and NSC 101-2325-B-006-008 from the National Science Council, Taiwan (YCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; Bohlin L, 1996, DRUG DISCOV TODAY, V1, P343, DOI 10.1016/1359-6446(96)10028-3; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chang JY, 2004, MOL PHARMACOL, V65, P77, DOI 10.1124/mol.65.1.77; Chen JJW, 2001, CANCER RES, V61, P5223; Cragg GM, 1998, MED RES REV, V18, P315, DOI 10.1002/(SICI)1098-1128(199809)18:5<315::AID-MED3>3.0.CO;2-W; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Desbene Stephanie, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P71, DOI 10.2174/1568011023354353; Domingo-Sananes MR, 2011, PHILOS T R SOC B, V366, P3584, DOI 10.1098/rstb.2011.0087; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Felix CA, 1998, BBA-GENE STRUCT EXPR, V1400, P233, DOI 10.1016/S0167-4781(98)00139-0; Fojo T, 2007, ANN ONCOL, V18, pV3, DOI 10.1093/annonc/mdm172; Imbert TF, 1998, BIOCHIMIE, V80, P207, DOI 10.1016/S0300-9084(98)80004-7; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kawanobe T, 2012, BIOCHEM BIOPH RES CO, V418, P736, DOI 10.1016/j.bbrc.2012.01.090; Komericki P, 2011, SEX TRANSM DIS, V38, P216, DOI 10.1097/OLQ.0b013e3181f68ebb; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Lara PN, 2009, J CLIN ONCOL, V27, P2530, DOI 10.1200/JCO.2008.20.1061; Liu EH, 2009, MINI-REV MED CHEM, V9, P1547, DOI 10.2174/138955709790361520; Lv M, 2011, MINI-REV MED CHEM, V11, P901, DOI 10.2174/138955711796575461; Mano M, 2006, CANCER TREAT REV, V32, P106, DOI 10.1016/j.ctrv.2005.12.008; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; PEDERSENBJERGAARD J, 1992, LEUKEMIA RES, V16, P61, DOI 10.1016/0145-2126(92)90102-D; SACKETT DL, 1993, PHARMACOL THERAPEUT, V59, P163, DOI 10.1016/0163-7258(93)90044-E; Schonbrunn E, 1999, J STRUCT BIOL, V128, P211, DOI 10.1006/jsbi.1999.4183; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Tapia C, 2006, AM J SURG PATHOL, V30, P83, DOI 10.1097/01.pas.0000183572.94140.43; Wall ME, 1998, MED RES REV, V18, P299	29	265	274	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62082	10.1371/journal.pone.0062082	http://dx.doi.org/10.1371/journal.pone.0062082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646116	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300026
J	Wang, H; Chen, K; Pan, YF; Jing, FY; Liu, H				Wang, Hui; Chen, Kun; Pan, Yifeng; Jing, Fangyuan; Liu, He			Associations and Impact Factors between Living Arrangements and Functional Disability among Older Chinese Adults	PLOS ONE			English	Article							SOCIAL SUPPORT; MARITAL-STATUS; DEPRESSIVE SYMPTOMS; HEALTH-STATUS; MORTALITY; GENDER; INTEGRATION; PREDICTORS; CANCER; STAGE	Objectives: To examine the association of living arrangements with functional disability among older persons and explore the mediation of impact factors on the relationship. Design: Cross-sectional analysis using data from Healthy Aging study in Zhejiang Province. Participants: Analyzed sample was drawn from a representative rural population of older persons in Wuyi County, Zhejiang Province, including 1542 participants aged 60 and over in the second wave of the study. Measurements: Living arrangements, background, functional disability, self-rated health, number of diseases, along with contemporaneous circumstances including income, social support (physical assistance and emotional support). Instrument was Activities of Daily Living (ADL) scale, including Basic Activities Daily Living (BADL) and Instrumental Activities of Daily Living (IADL). Results: Living arrangements were significantly associated with BADL, IADL and ADL disability. Married persons living with or without children were more advantaged on all three dimensions of functional disability. Unmarried older adults living with children only had the worst functional status, even after controlling for background, social support, income and health status variables (compared with the unmarried living alone, beta for BADL: -1.262, beta for IADL: -2.112, beta for ADL: -3.388; compared with the married living with children only, beta for BADL: -1.166, beta for IADL: -2.723, beta for ADL: -3.902). In addition, older adults without difficulty in receiving emotional support, in excellent health and with advanced age had significantly better BADL, IADL and ADL function. However, a statistically significant association between physical assistance and functional disability was not found. Conclusion: Functional disabilities vary by living arrangements with different patterns and other factors. Our results highlight the association of unmarried elders living with children only and functioning decline comparing with other types. Our study implies policy makers should pay closer attention to unmarried elders living with children in community. Community service especially emotional support such as psychological counseling is important social support and should be improved.	[Wang, Hui; Chen, Kun; Pan, Yifeng; Jing, Fangyuan; Liu, He] Zhejiang Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hui] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Provincial Center for Disease Control & Prevention	Chen, K (corresponding author), Zhejiang Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	ck@zju.edu.cn	wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022	YANG, CHIEN-MING/0000-0001-8144-8496; wang, huaizhou/0000-0002-4126-100X	Zhejiang Research Center on Aging	Zhejiang Research Center on Aging	The source of funding that has supported our research is from Zhejiang Research Center on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWIN DF, 1985, J MARRIAGE FAM, V47, P319, DOI 10.2307/352132; AUSLANDER GK, 1991, J AGING HEALTH, V3, P493, DOI [DOI 10.1177/089826439100300404, DOI 10.1177/089826439100.300404]; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Beydoun MA, 2005, SOC SCI MED, V60, P2045, DOI 10.1016/j.socscimed.2004.08.063; BLAZER DG, 1982, AM J EPIDEMIOL, V115, P684, DOI 10.1093/oxfordjournals.aje.a113351; BROADHEAD WE, 1983, AM J EPIDEMIOL, V117, P521, DOI 10.1093/oxfordjournals.aje.a113575; Chen FN, 2008, J FAM ISSUES, V29, P1379, DOI 10.1177/0192513X07313602; Cheng Ching-Yu, 2006, J Gerontol Nurs, V32, P16, DOI 10.3928/00989134-20060901-05; Cheng CY, 2006, J GERONTOLOGICAL NUR, V9, P24; Chou KL, 2006, AGING MENT HEALTH, V10, P583, DOI 10.1080/13607860600641150; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Davis MA, 1997, AM J PUBLIC HEALTH, V87, P371, DOI 10.2105/AJPH.87.3.371; Denton M, 1999, SOC SCI MED, V48, P1221, DOI 10.1016/S0277-9536(98)00421-3; GOODWIN JS, 1987, JAMA-J AM MED ASSOC, V258, P3125, DOI 10.1001/jama.258.21.3125; GRIMBY G, 1988, SCAND J REHABIL MED, V20, P93; House J.S., 1981, WORK STRESS SOCIAL S; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; HUGHES M, 1981, AM J SOCIOL, V87, P48, DOI 10.1086/227419; Hughes ME, 2002, J SOCIOL, V87, P48; Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47; Hupcey JE, 1998, J ADV NURS, V27, P1231, DOI 10.1046/j.1365-2648.1998.01231.x; Jefferson AL, 2008, AM J GERIAT PSYCHIAT, V16, P375, DOI 10.1097/JGP.0b013e318162f197; JOUNG IMA, 1994, INT J EPIDEMIOL, V23, P91, DOI 10.1093/ije/23.1.91; Kharicha K, 2007, BRIT J GEN PRACT, V57, P271; Knodel J, 2002, PATTERNS DETERMINANT, P143; Koskinen S, 2007, INT J EPIDEMIOL, V36, P1255, DOI 10.1093/ije/dym212; LAWTON MP, 1984, RES AGING, V6, P323, DOI 10.1177/0164027584006003002; Lawton MP, 1976, HDB PSYCHOL AGING; Lennartsson C, 1999, RES AGING, V21, P657, DOI 10.1177/0164027599215002; Li LW, 2009, SOC SCI MED, V68, P220, DOI 10.1016/j.socscimed.2008.10.013; Litwin H, 2012, J AGING HEALTH, V24, P846, DOI 10.1177/0898264312436714; Lund R, 2002, SOC SCI MED, V55, P673, DOI 10.1016/S0277-9536(01)00219-2; Macran S, 1996, SOC SCI MED, V42, P1203, DOI 10.1016/0277-9536(95)00432-7; MOEN P, 1989, AM SOCIOL REV, V54, P635, DOI 10.2307/2095884; Mor-Barak M E, 1991, J Appl Gerontol, V10, P293, DOI 10.1177/073346489101000305; MORITZ DJ, 1993, J CLIN EPIDEMIOL, V46, P443, DOI 10.1016/0895-4356(93)90021-R; Russell D, 2009, J GERONTOL B-PSYCHOL, V64, P95, DOI 10.1093/geronb/gbn002; Sarwari AR, 1998, AM J EPIDEMIOL, V147, P370; Sereny M, 2011, RES AGING, V33, P172, DOI 10.1177/0164027510392387; Shin JK, 2008, PSYCHIAT INVEST, V5, P155, DOI 10.4306/pi.2008.5.3.155; Taylor MG, 2004, J GERONTOL B-PSYCHOL, V59, pS238, DOI 10.1093/geronb/59.4.S238; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Vanderhorst RK, 2005, AGING MENT HEALTH, V9, P517, DOI 10.1080/13607860500193062; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Waite LJ, 1999, J GERONTOL B-PSYCHOL, V54, pS136, DOI 10.1093/geronb/54B.3.S136; Wang JJ, 2001, INT J NURS STUD, V38, P339, DOI 10.1016/S0020-7489(00)00072-9; Wong YS, 2009, J CROSS-CULT GERONTO, V24, P209, DOI 10.1007/s10823-008-9081-7; Wu Z, 2008, SPRINGER SERIES DEMO, V20, P197; Yeh SCJ, 2004, SOC BEHAV PERSONAL, V32, P129, DOI 10.2224/sbp.2004.32.2.129; You KS, 2009, ARCH PSYCHIAT NURS, V23, P309, DOI 10.1016/j.apnu.2008.07.003; Zhang H, 2004, FILIAL PIETY PRACTIC, P63; Zunzunegui MV, 2001, INT J EPIDEMIOL, V30, P1090, DOI 10.1093/ije/30.5.1090; Zyzanski S J, 1989, Fam Med, V21, P199	54	90	99	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53879	10.1371/journal.pone.0053879	http://dx.doi.org/10.1371/journal.pone.0053879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23843989	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400094
